PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kahle, KT; Kulkarni, AV; Limbrick, DD; Warf, BC				Kahle, Kristopher T.; Kulkarni, Abhaya V.; Limbrick, David D., Jr.; Warf, Benjamin C.			Hydrocephalus in children	LANCET			English	Review							ENDOSCOPIC 3RD VENTRICULOSTOMY; CHOROID-PLEXUS CAUTERIZATION; CEREBROSPINAL-FLUID SHUNT; TERM-FOLLOW-UP; CHILDHOOD HYDROCEPHALUS; CONGENITAL HYDROCEPHALUS; INFANT HYDROCEPHALUS; PEDIATRIC-PATIENTS; POSTHEMORRHAGIC HYDROCEPHALUS; COMMUNICATING HYDROCEPHALUS	Hydrocephalus is a common disorder of cerebral spinal fluid (CSF) physiology resulting in abnormal expansion of the cerebral ventricles. Infants commonly present with progressive macrocephaly whereas children older than 2 years generally present with signs and symptoms of intracranial hypertension. The classic understanding of hydrocephalus as the result of obstruction to bulk flow of CSF is evolving to models that incorporate dysfunctional cerebral pulsations, brain compliance, and newly characterised water-transport mechanisms. Hydrocephalus has many causes. Congenital hydrocephalus, most commonly involving aqueduct stenosis, has been linked to genes that regulate brain growth and development. Hydrocephalus can also be acquired, mostly from pathological processes that affect ventricular outflow, subarachnoid space function, or cerebral venous compliance. Treatment options include shunt and endoscopic approaches, which should be individualised to the child. The long-term outcome for children that have received treatment for hydrocephalus varies. Advances in brain imaging, technology, and understanding of the pathophysiology should ultimately lead to improved treatment of the disorder.	[Kahle, Kristopher T.; Warf, Benjamin C.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Kulkarni, Abhaya V.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Limbrick, David D., Jr.] Washington Univ, St Louis Childrens Hosp, Sch Med, Div Neurosurg, St Louis, MO 63110 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); St. Louis Children's Hospital; Washington University (WUSTL)	Warf, BC (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA.	benjamin.warf@childrens.harvard.edu						Adle-Biassette H, 2013, ACTA NEUROPATHOL, V126, P427, DOI 10.1007/s00401-013-1146-1; Anik I, 2010, PEDIATR NEUROSURG, V46, P344, DOI 10.1159/000323413; Assemat E, 2013, EXP CELL RES, V319, P2514, DOI 10.1016/j.yexcr.2013.07.011; Aziz AA, 2005, PEDIATR RADIOL, V35, P815, DOI 10.1007/s00247-005-1456-0; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bateman G, 2010, J NEUROSURG-PEDIATR, V5, P20, DOI 10.3171/2009.8.PEDS09204; Bateman GA, 2007, J NEUROSURG, V107, P439, DOI 10.3171/PED-07/12/439; Bateman GA, 2014, J NEUROSURG-PEDIATR, V13, P125, DOI 10.3171/2013.10.PEDS13343; Battal B, 2011, BRIT J RADIOL, V84, P758, DOI 10.1259/bjr/66206791; Bouras T, 2011, J NEUROSURG-PEDIATR, V7, P643, DOI 10.3171/2011.4.PEDS10503; Bradley Jr WG, 2014, AJNR AM J NEURORADIO; Buckley RT, 2012, J NEUROSURG-PEDIATR, V9, P630, DOI 10.3171/2012.2.PEDS11331; Castaneyra-Ruiz L, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-18; Cengiz P, 2008, PEDIATR CRIT CARE ME, V9, P524, DOI 10.1097/PCC.0b013e3181849dc9; Cherian S, 2004, NEUROPATH APPL NEURO, V30, P585, DOI 10.1111/j.1365-2990.2004.00588.x; Christensen IB, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00344; Collmann H, 2005, CHILD NERV SYST, V21, P902, DOI 10.1007/s00381-004-1116-y; Dalen K, 2008, NEUROPEDIATRICS, V39, P146, DOI 10.1055/s-0028-1085463; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; de Vries LS, 2013, ARCH DIS CHILD-FETAL, V98, pF284, DOI 10.1136/archdischild-2012-303158; Dominguez-Pinos MD, 2005, J NEUROPATH EXP NEUR, V64, P595, DOI 10.1097/01.jnen.0000171648.86718.bb; Drake J, 2006, J NEUROSURG, V105, P118, DOI 10.3171/ped.2006.105.2.118; Drake JM, 2007, NEUROSURGERY, V60, P881, DOI 10.1227/01.NEU.0000255420.78431.E7; Drake JM, 1998, NEUROSURGERY, V43, P294, DOI 10.1097/00006123-199808000-00068; Drielsma A, 2012, J MED GENET, V49, P708, DOI 10.1136/jmedgenet-2012-101190; Durnford AJ, 2011, J NEUROSURG-PEDIATR, V8, P489, DOI 10.3171/2011.8.PEDS1166; Ekici AB, 2010, MOL SYNDROMOL, V1, P99, DOI 10.1159/000319859; Engelhardt E, 2015, ANN NEUROL, V77, P154, DOI 10.1002/ana.24313; Faggin R, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10303; Felderhoff-Mueser U, 2001, ARCH DIS CHILD, V84, P369, DOI 10.1136/adc.84.4.369; Feng HL, 2008, J NEUROSURG, V109, P923, DOI 10.3171/JNS/2008/109/11/0923; Feng XC, 2009, J NEUROSCI RES, V87, P1150, DOI 10.1002/jnr.21927; Filippidis AS, 2011, CHILD NERV SYST, V27, P27, DOI 10.1007/s00381-010-1227-6; Flannery AM, 2014, J NEUROSURG-PEDIATR, V14, P3, DOI 10.3171/2014.7.PEDS14321; Garne E, 2010, EUR J PAEDIATR NEURO, V14, P150, DOI 10.1016/j.ejpn.2009.03.005; Greitz D, 2007, CHILD NERV SYST, V23, P487, DOI 10.1007/s00381-007-0303-z; Gupta N, 2007, J NEUROSURG, V106, P334, DOI 10.3171/ped.2007.106.5.334; Halevy A, 2014, J CHILD NEUROL; Hampton LE, 2013, J INT NEUROPSYCH SOC, V19, P127, DOI 10.1017/S1355617712001117; Harris CA, 2012, NEUROSURGERY, V70, P1589, DOI 10.1227/NEU.0b013e318244695f; Hirsch S, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/5287; Hunt RW, 2003, J NEUROL NEUROSUR PS, V74, P658, DOI 10.1136/jnnp.74.5.658; Ibrahim I, 2008, PEDIATR NEUROSURG, V44, P68, DOI 10.1159/000110667; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Ishida-Takagishi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1861; Jenkinson MD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-4; Jimenez AJ, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28426; JONES RFC, 1990, NEUROSURGERY, V26, P86, DOI 10.1227/00006123-199001000-00012; Kandasamy J, 2011, CHILD NERV SYST, V27, P575, DOI 10.1007/s00381-010-1290-z; Karimy JK, 2015, J NEUROSCI METH, V241, P78, DOI 10.1016/j.jneumeth.2014.12.015; Kariyattil R, 2007, J NEUROSURG, V106, P350, DOI 10.3171/ped.2007.106.5.350; Kestle J, 2000, PEDIATR NEUROSURG, V33, P230, DOI 10.1159/000055960; Kestle JRW, 2011, J NEUROSURG-PEDIATR, V8, P22, DOI 10.3171/2011.4.PEDS10551; Kestle JRW, 2005, J NEUROSURG, V102, P141, DOI 10.3171/jns.2005.102.2.0141; Klebermass-Schrehof K, 2013, ARCH DIS CHILD-FETAL, V98, pF291, DOI 10.1136/archdischild-2012-302323; Klimo P, 2011, J NEUROSURG-PEDIATR, V8, P600, DOI 10.3171/2011.8.PEDS11346; Kulkarni AV, 2014, J NEUROSURG-PEDIATR, V14, P224, DOI 10.3171/2014.6.PEDS13492; Kulkarni AV, 2013, J NEUROSURG-PEDIATR, V12, P334, DOI 10.3171/2013.7.PEDS12637; Kulkarni AV, 2010, J NEUROSURG-PEDIATR, V6, P310, DOI 10.3171/2010.8.PEDS103; Kulkarni AV, 2010, NEUROSURGERY, V67, P588, DOI 10.1227/01.NEU.0000373199.79462.21; Kulkarni AV, 2010, CHILD NERV SYST, V26, P737, DOI 10.1007/s00381-010-1131-0; Kulkarni AV, 2010, CHILD NERV SYST, V26, P75, DOI 10.1007/s00381-009-0983-7; Kulkarni AV, 2009, J PEDIATR-US, V155, P254, DOI 10.1016/j.jpeds.2009.02.048; Kulkarni AV, 2001, J NEUROSURG, V94, P195, DOI 10.3171/jns.2001.94.2.0195; Lacy M, 2008, PEDIATR NEUROSURG, V44, P376, DOI 10.1159/000149904; Lacy M, 2012, PEDIATR NEUROSURG, V48, P73, DOI 10.1159/000339313; Lane JD, 2014, J NEUROSURG-PEDIATR, V13, P140, DOI 10.3171/2013.11.PEDS13394; Lattke M, 2012, J NEUROSCI, V32, P11511, DOI 10.1523/JNEUROSCI.0182-12.2012; Lee L, 2013, J NEUROSCI RES, V91, P1117, DOI 10.1002/jnr.23238; Lehtinen MK, 2013, J NEUROSCI, V33, P17553, DOI 10.1523/JNEUROSCI.3258-13.2013; Leliefeld PH, 2008, J NEUROSURG-PEDIATR, V2, P163, DOI 10.3171/PED/2008/2/9/163; Leliefeld PH, 2010, J NEUROSURG-PEDIATR, V5, P562, DOI 10.3171/2010.2.PEDS09309; Lindquist B, 2008, ACTA PAEDIATR, V97, P596, DOI 10.1111/j.1651-2227.2008.00747.x; Lindquist B, 2011, CHILD NERV SYST, V27, P597, DOI 10.1007/s00381-010-1311-y; Lutz Barry R, 2013, Surg Neurol Int, V4, pS38, DOI 10.4103/2152-7806.109197; LYONNET S, 1992, GENOMICS, V14, P508, DOI 10.1016/S0888-7543(05)80254-X; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; Mandell JG, 2015, J NEUROSURG-PEDIATR, V15, P125, DOI 10.3171/2014.9.PEDS12427; Mao XY, 2006, EUR J NEUROSCI, V23, P2929, DOI 10.1111/j.1460-9568.2006.04829.x; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Merhar S, 2012, NEONATOLOGY, V101, P1, DOI 10.1159/000323498; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Morales DM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011973; Muehlmann M, 2013, INVEST RADIOL, V48, P543, DOI 10.1097/RLI.0b013e31828ad504; Munch TN, 2014, J NEUROL NEUROSUR PS, V85, P1253, DOI 10.1136/jnnp-2013-306941; Munch TN, 2012, BRAIN, V135, P2409, DOI 10.1093/brain/aws158; Nonaka Y, 2008, J NEUROS-PEDIATR, V1, P68, DOI 10.3171/PED-08/01/068; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Papadopoulos MC, 2008, PROG BRAIN RES, V170, P589, DOI 10.1016/S0079-6123(08)00446-9; Pattison AJ, 2014, IEEE T MED IMAGING, V33, P1373, DOI 10.1109/TMI.2014.2311456; Persson EK, 2006, NEUROPEDIATRICS, V37, P330, DOI 10.1055/s-2007-964868; Poca MA, 2005, EXPERT OPIN PHARMACO, V6, P1525, DOI 10.1517/14656566.6.9.1525; Pollack IF, 1999, NEUROSURGERY, V45, P1399, DOI 10.1097/00006123-199912000-00026; POPLE IK, 1995, NEUROSURGERY, V36, P698, DOI 10.1227/00006123-199504000-00009; QUENCER RM, 1992, AM J NEURORADIOL, V13, P601; Rangel-Castilla L, 2012, WORLD NEUROSURG, V77, P555, DOI [10.1016/J.WNEU.2011.06.038, 10.1016/j.wneu.2011.06.038]; Ratilal B, 2008, J NEUROS-PEDIATR, V1, P48, DOI 10.3171/PED-08/01/048; Rekate HL, 2008, CHILD NERV SYST, V24, P423, DOI 10.1007/s00381-008-0579-7; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P27, DOI 10.1016/j.spen.2009.01.001; Richards HK, 2009, J NEUROSURG-PEDIATR, V4, P389, DOI 10.3171/2009.4.PEDS09210; Riva-Cambrin J, 2012, J NEUROSURG-PEDIATR, V9, P473, DOI 10.3171/2012.1.PEDS11292; Sacko O, 2010, J NEUROSURG-PEDIATR, V5, P68, DOI 10.3171/2009.8.PEDS08108; SCARFF JE, 1970, J NEUROSURG, V33, P1, DOI 10.3171/jns.1970.33.1.0001; Schiff SJ, 2012, J NEUROSURG-PEDIATR, V10, P161, DOI 10.3171/2012.5.PEDS11557; Schmitz T, 2007, PEDIATR RES, V61, P722, DOI 10.1203/pdr.0b013e31805341f1; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Simon TD, 2014, J PEDIATR-US, V164, P1462, DOI 10.1016/j.jpeds.2014.02.013; Singh I, 2008, NEUROSURG REV, V31, P319, DOI 10.1007/s10143-008-0137-5; Sival Deborah A, 2008, Cerebrospinal Fluid Res, V5, P21, DOI 10.1186/1743-8454-5-21; Smith AD, 2012, COGN PROCESS, V13, pS329, DOI 10.1007/s10339-012-0505-5; Smith ER, 2004, J NEUROSURG, V100, P90, DOI 10.3171/ped.2004.100.2.0090; STOLL C, 1992, EUR J EPIDEMIOL, V8, P797, DOI 10.1007/BF00145322; Stone SSD, 2014, J NEUROSURG-PEDIATR, V14, P439, DOI 10.3171/2014.7.PEDS14152; Strahle J, 2012, TRANSL STROKE RES, V3, pS25, DOI 10.1007/s12975-012-0182-9; Tuan TJ, 2011, PEDIATR INFECT DIS J, V30, P731, DOI 10.1097/INF.0b013e318218ac0e; Tully HM, 2014, EUR J MED GENET, V57, P359, DOI 10.1016/j.ejmg.2014.06.002; Vinchon M, 2012, CHILD NERV SYST, V28, P847, DOI 10.1007/s00381-012-1723-y; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Warf BC, 2005, J NEUROSURG, V102, P1, DOI 10.3171/ped.2005.102.1.0001; Warf BC, 2005, J NEUROSURG, V103, P475, DOI 10.3171/ped.2005.103.6.0475; Warf B, 2009, J NEUROS-PEDIATR, V4, P564, DOI 10.3171/2009.7.PEDS09136; Warf Benjamin C, 2014, Neurosurgery, V61 Suppl 1, P105, DOI 10.1227/NEU.0000000000000376; Warf BC, 2013, CHILD NERV SYST, V29, P935, DOI 10.1007/s00381-013-2072-1; Warf BC, 2012, J NEUROSURG-PEDIATR, V10, P108, DOI 10.3171/2012.4.PEDS1253; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P377, DOI 10.3171/2011.7.PEDS1198; Warf BC, 2011, CHILD NERV SYST, V27, P1589, DOI 10.1007/s00381-011-1484-z; Warf BC, 2010, J NEUROSURG-PEDIATR, V5, P143, DOI 10.3171/2009.9.PEDS09196; Waybright T, 2010, J PROTEOMICS, V73, P1156, DOI 10.1016/j.jprot.2010.02.004; Whitelaw A, 2001, COCHRANE DB SYST REV, V2, pCD002270; Whitelaw A, 2012, ARCH DIS CHILD-FETAL, V97, pF229, DOI 10.1136/adc.2010.190173; Wu Q, 1998, AM J PHYSIOL-CELL PH, V275, pC1565, DOI 10.1152/ajpcell.1998.275.6.C1565; Yamada S, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.01.039; Yamasaki M, 2011, J NEUROSURG-PEDIATR, V8, P411, DOI 10.3171/2011.7.PEDS10531; Young CC, 2013, CEREB CORTEX, V23, P647, DOI 10.1093/cercor/bhs049; Yuan W, 2013, AM J NEURORADIOL, V34, P439, DOI 10.3174/ajnr.A3218; Yuan W, 2009, AM J NEURORADIOL, V30, P1792, DOI 10.3174/ajnr.A1663; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5	142	258	266	5	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					788	799		10.1016/S0140-6736(15)60694-8	http://dx.doi.org/10.1016/S0140-6736(15)60694-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26256071				2022-12-28	WOS:000370418000039
J	Greene, JA; Watkins, ES				Greene, Jeremy A.; Watkins, Elizabeth S.			The Vernacular of Risk - Rethinking Direct-to-Consumer Advertising of Pharmaceuticals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFORMATION		[Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21218 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA; [Watkins, Elizabeth S.] Univ Calif San Francisco, Sch Med, Dept Anthropol Hist & Social Med, San Francisco, CA USA	Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco	Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21218 USA.							Food and Drug Administration, 2015, BRIEF SUMM AD DIR US; Greene Jeremy, 2012, PRESCRIBED WRITING F; Mintzes B, 2012, ANNU REV PUBL HEALTH, V33, P259, DOI 10.1146/annurev-publhealth-031811-124540; NIGHTINGALE SL, 1995, INT J TECHNOL ASSESS, V11, P399, DOI 10.1017/S026646230000862X; Shrank WH, 2007, HEALTH AFFAIR, V26, P731, DOI 10.1377/hlthaff.26.3.731	5	5	5	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1087	1089		10.1056/NEJMp1507924	http://dx.doi.org/10.1056/NEJMp1507924			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR7UG	26287749				2022-12-28	WOS:000361556400002
J	Drozdov, AP; Eremets, MI; Troyan, IA; Ksenofontov, V; Shylin, SI				Drozdov, A. P.; Eremets, M. I.; Troyan, I. A.; Ksenofontov, V.; Shylin, S. I.			Conventional superconductivity at 203 kelvin at high pressures in the sulfur hydride system	NATURE			English	Article							HYDROGEN; METALLIZATION; SULFIDE	A superconductor is a material that can conduct electricity without resistance below a superconducting transition temperature, T-c. The highest T-c that has been achieved to date is in the copper oxide system(1): 133 kelvin at ambient pressure(2) and 164 kelvin at high pressures(3). As the nature of superconductivity in these materials is still not fully understood (they are not conventional superconductors), the prospects for achieving still higher transition temperatures by this route are not clear. In contrast, the Bardeen-Cooper-Schrieffer theory of conventional superconductivity gives a guide for achieving high T-c with no theoretical upper bound-all that is needed is a favourable combination of high-frequency phonons, strong electron-phonon coupling, and a high density of states(4). These conditions can in principle be fulfilled for metallic hydrogen and covalent compounds dominated by hydrogen(5,6), as hydrogen atoms provide the necessary high-frequency phonon modes as well as the strong electron-phonon coupling. Numerous calculations support this idea and have predicted transition temperatures in the range 50-235 kelvin for many hydrides(7), but only a moderate T-c of 17 kelvin has been observed experimentally(8). Here we investigate sulfur hydride(9), where a T-c of 80 kelvin has been predicted(10). We find that this system transforms to a metal at a pressure of approximately 90 gigapascals. On cooling, we see signatures of superconductivity: a sharp drop of the resistivity to zero and a decrease of the transition temperature with magnetic field, with magnetic susceptibility measurements confirming a T-c of 203 kelvin. Moreover, a pronounced isotope shift of T-c in sulfur deuteride is suggestive of an electron-phonon mechanism of superconductivity that is consistent with the Bardeen-Cooper-Schrieffer scenario. We argue that the phase responsible for high-T-c superconductivity in this system is likely to be H3S, formed from H2S by decomposition under pressure. These findings raise hope for the prospects for achieving room-temperature superconductivity in other hydrogen-based materials.	[Drozdov, A. P.; Eremets, M. I.; Troyan, I. A.] Max Planck Inst Chem, D-55128 Mainz, Germany; [Ksenofontov, V.; Shylin, S. I.] Johannes Gutenberg Univ Mainz, Inst Anorgan Chem & Analyt Chem, D-55099 Mainz, Germany	Max Planck Society; Johannes Gutenberg University of Mainz	Eremets, MI (corresponding author), Max Planck Inst Chem, Hahn Meitner Weg 1, D-55128 Mainz, Germany.	m.eremets@mpic.de	Troyan, Ivan/AAQ-9617-2021; Shylin, Sergii/F-7898-2015; Drozdov, Alexander/Q-8609-2018	Troyan, Ivan/0000-0001-8065-1687; Shylin, Sergii/0000-0003-2104-1912; Drozdov, Alexander/0000-0001-6444-9016	European Research Council [267777]; DFG [1458]; Grants-in-Aid for Scientific Research [26000006] Funding Source: KAKEN	European Research Council(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support provided by the European Research Council under the 2010 Advanced Grant 267777 is acknowledged. We appreciate help provided in MPI Chemie by U. Poschl. We thank P. Alireza and G. Lonzarich for help with samples of CuTi; J. Kamarad, S. Toser and C. Q. Jin for sharing their experience on SQUID measurements; K. Shimizu and his group for cooperation; P. Chu and his group for many discussions and collaboration, and L. Pietronero, M. Calandra and T. Timusk for discussions. V.K. and S. I. S. acknowledge the DFG (Priority Program No. 1458) for support. M.I.E. thanks H. Musshof and R. Wittkowski for precision machining of the DACs.	Akashi R., 2015, PREPRINT; An JM, 2001, PHYS REV LETT, V86, P4366, DOI 10.1103/PhysRevLett.86.4366; ASHCROFT NW, 1968, PHYS REV LETT, V21, P1748, DOI 10.1103/PhysRevLett.21.1748; Ashcroft NW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187002; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Bernstein N, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.060511; Cohen Marvin L., 2011, BCS: 50 Years, P375, DOI 10.1142/9789814304665_0015; Drozdov A. P., 2014, PREPRINT; Duan DF, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.180502; Duan DF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06968; Eremets MI, 2008, SCIENCE, V319, P1506, DOI 10.1126/science.1153282; Eremets MI, 2011, NAT MATER, V10, P927, DOI [10.1038/NMAT3175, 10.1038/nmat3175]; Eremets MI, 2003, J RAMAN SPECTROSC, V34, P515, DOI 10.1002/jrs.1044; Errea I, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.157004; Flores-Livas J. A., 2015, PREPRINT; Fujihisa H, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214102; GAO L, 1994, PHYS REV B, V50, P4260, DOI 10.1103/PhysRevB.50.4260; GINZBURG VL, 1992, CONTEMP PHYS, V33, P15, DOI 10.1080/00107519208219137; Gregoryanz E, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064504; Kometani S, 1997, J PHYS SOC JPN, V66, P2564, DOI 10.1143/JPSJ.66.2564; Landau L. D., 1960, ELECTRODYNAMICS CONT, V8, P173; Li YW, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4874158; MATULA RA, 1979, J PHYS CHEM REF DATA, V8, P1147, DOI 10.1063/1.555614; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Papaconstantopoulos DA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.184511; Sakashita M, 1997, PHYS REV LETT, V79, P1082, DOI 10.1103/PhysRevLett.79.1082; SCHILLING A, 1993, NATURE, V363, P56, DOI 10.1038/363056a0; SENOUSSI S, 1988, J PHYS-PARIS, V49, P2163, DOI 10.1051/jphyscol:19888969; SHIMIZU H, 1995, PHYS REV B, V51, P9391, DOI 10.1103/PhysRevB.51.9391; SHIMIZU H, 1992, J CHEM PHYS, V97, P7137, DOI 10.1063/1.463538; Strobel TA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.255503; Wang YC, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4861966	33	1257	1280	52	1157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					73	+		10.1038/nature14964	http://dx.doi.org/10.1038/nature14964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26280333	Green Submitted			2022-12-28	WOS:000360594100027
J	Rouzaud, M; Boralevi, F				Rouzaud, Marie; Boralevi, Franck			Multiple Mucosal Neuroma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rouzaud, Marie; Boralevi, Franck] Bordeaux Univ Hosp, Bordeaux, France	CHU Bordeaux	Rouzaud, M (corresponding author), Bordeaux Univ Hosp, Bordeaux, France.	franck.boralevi@chu-bordeaux.fr		boralevi, franck/0000-0002-0477-5909					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					756	756		10.1056/NEJMicm1412999	http://dx.doi.org/10.1056/NEJMicm1412999			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287851				2022-12-28	WOS:000359709400012
J	Richards, JS; Dowell, SM; Quinones, ME; Kerr, GS				Richards, John S.; Dowell, Sharon M.; Quinones, Mercedes E.; Kerr, Gail S.			How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TUMOR-NECROSIS-FACTOR; MODIFYING ANTIRHEUMATIC DRUGS; B-VIRUS REACTIVATION; INTERSTITIAL LUNG-DISEASE; HEPATITIS-C INFECTION; ANTI-TNF-ALPHA; COSTIMULATION MODULATOR ABATACEPT; UPDATED CONSENSUS STATEMENT; SQUAMOUS-CELL CARCINOMA; BRITISH-SOCIETY	Although biologic disease modifying anti-rheumatic drugs (bDMARDs) have improved the quality of life of patients with rheumatoid arthritis, side effects remain a problem, especially for patients with pre-existing comorbidities. Randomized controlled trials of such drugs in rheumatoid arthritis typically exclude patients with comorbidities and are of short duration, so they do not provide data on adverse events in these people. Other data sources such as national bDMARD registries are limited by the preselection of patients for both conventional synthetic chemical compound disease modifying anti-rheumatic drugs (csDMARDs) and bDMARDs, and although these databases document comorbidity, they rarely report its severity. This too limits definitive statements on the progression or resolution of pre-existing disease. Although bDMARDs may not be contraindicated in patients with rheumatoid arthritis and certain comorbid diseases, additional assessments or precautions are recommended. This review summarizes current data on the use of bDMARDs in people with rheumatoid arthritis and common comorbid diseases. It provides an evidence base for doctors and their patients when discussing and selecting the appropriate bDMARDs.	[Richards, John S.; Kerr, Gail S.] Vet Affairs Med Ctr, Washington, DC 20422 USA; [Richards, John S.; Kerr, Gail S.] Georgetown Univ, Washington, DC USA; [Dowell, Sharon M.; Quinones, Mercedes E.; Kerr, Gail S.] Howard Univ, Washington, DC 20059 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; Howard University	Richards, JS (corresponding author), Vet Affairs Med Ctr, Washington, DC 20422 USA.	john.richards1@va.gov						Abedin Moeen, 2006, Cardiol Rev, V14, P50, DOI 10.1097/01.crd.0000178320.51474.ac; Aboulafia DM, 2000, MAYO CLIN PROC, V75, P1093, DOI 10.4065/75.10.1093; Arunprasath P, 2011, J CANCER RES THER, V7, P346, DOI 10.4103/0973-1482.87003; Ascherman Dana P, 2010, Curr Rheumatol Rep, V12, P363, DOI 10.1007/s11926-010-0116-z; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Aslanidis S, 2007, CLIN RHEUMATOL, V26, P261, DOI 10.1007/s10067-006-0394-z; Atzeni F, 2010, AUTOIMMUN REV, V9, P835, DOI 10.1016/j.autrev.2010.07.018; Baecklund E, 1998, BRIT MED J, V317, P180, DOI 10.1136/bmj.317.7152.180; Baldini EH, 1997, CHEST, V112, pS229, DOI 10.1378/chest.112.4_Supplement.229S; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barone M, 2015, HEPATOLOGY, V62, P40, DOI 10.1002/hep.27716; Barrett JH, 1999, ARTHRITIS RHEUM, V42, P1219, DOI 10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G; Bauer H, 2013, JOINT BONE SPINE, V80, P91, DOI 10.1016/j.jbspin.2012.08.001; Berthelsen BG, 2010, RHEUMATOLOGY, V49, P2225, DOI 10.1093/rheumatology/keq185; Bili A, 2014, ARTHRIT CARE RES, V66, P355, DOI 10.1002/acr.22166; Bingham Clifton O 3rd, 2015, Ann Rheum Dis, V74, P818, DOI 10.1136/annrheumdis-2013-204427; Bingham CO, 2010, ARTHRITIS RHEUM-US, V62, P64, DOI 10.1002/art.25034; Bombardier C, 2012, J RHEUMATOL, V39, P1583, DOI 10.3899/jrheum.120165; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bongartz T, 2010, ARTHRITIS RHEUM-US, V62, P1583, DOI 10.1002/art.27405; Boue F, 2006, J CLIN ONCOL, V24, P4123, DOI 10.1200/JCO.2005.05.4684; Boulton JG, 2007, RHEUMATOLOGY, V46, P178, DOI 10.1093/rheumatology/kel322; Brunasso AMG, 2011, RHEUMATOLOGY, V50, P1700, DOI 10.1093/rheumatology/ker190; Buch MH, 2011, ANN RHEUM DIS, V70, P909, DOI 10.1136/ard.2010.144998; Cacciapaglia F, 2011, AUTOIMMUN REV, V10, P631, DOI 10.1016/j.autrev.2011.04.014; Caporali R, 2010, ARTHRIT CARE RES, V62, P749, DOI 10.1002/acr.20130; Carroll MB, 2008, SEMIN ARTHRITIS RHEU, V38, P208, DOI 10.1016/j.semarthrit.2007.10.011; Carter JD, 2009, J RHEUMATOL, V36, P635, DOI 10.3899/jrheum.080545; Cavazzana I, 2008, AUTOIMMUN REV, V8, P104, DOI 10.1016/j.autrev.2008.05.002; Cepeda EJ, 2008, ANN RHEUM DIS, V67, P710, DOI 10.1136/ard.2007.081513; Chakravarty EF, 2003, J RHEUMATOL, V30, P241; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coletta AP, 2002, EUR J HEART FAIL, V4, P559, DOI 10.1016/S1388-9842(02)00121-6; Coppola N, 2012, DIGEST LIVER DIS, V44, P49, DOI 10.1016/j.dld.2011.07.016; Corcorran MA, 2013, J AM ACAD DERMATOL, V69, pE178, DOI 10.1016/j.jaad.2013.04.018; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; Dadoun S, 2013, JOINT BONE SPINE, V80, P29, DOI 10.1016/j.jbspin.2012.02.005; Demir R, 1999, RHEUMATOL INT, V19, P19, DOI 10.1007/s002960050093; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Dixon WG, 2010, ARTHRIT CARE RES, V62, P755, DOI 10.1002/acr.20129; Dixon WG, 2010, ANN RHEUM DIS, V69, P1086, DOI 10.1136/ard.2009.120626; Dragonas C, 2012, RHEUMATOLOGY, V51, P1520, DOI 10.1093/rheumatology/kes051; Eisenberg RA, 2013, J CLIN IMMUNOL, V33, P388, DOI 10.1007/s10875-012-9813-x; Ennishi D, 2010, BLOOD, V116, P5119, DOI 10.1182/blood-2010-06-289231; Ferri C, 2011, AUTOIMMUN REV, V11, P48, DOI 10.1016/j.autrev.2011.07.005; Foran JM, 2000, J CLIN ONCOL, V18, P317, DOI 10.1200/JCO.2000.18.2.317; Furst DE, 2013, ANN RHEUM DIS, V72, P2, DOI 10.1136/annrheumdis-2013-203348; Gabbay E, 1997, AM J RESP CRIT CARE, V156, P528, DOI 10.1164/ajrccm.156.2.9609016; Gabriel SE, 2008, ARTHRITIS RHEUM, V58, P637, DOI 10.1002/art.23280; Gaujoux-Viala C, 2014, JOINT BONE SPINE, V81, P287, DOI 10.1016/j.jbspin.2014.05.002; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Genovese MC, 2008, ARTHRITIS RHEUM, V58, pS1672; Gerhold K, 2015, RHEUMATOLOGY OXFORD; Germanidis G, 2012, J HEPATOL, V56, P1420, DOI 10.1016/j.jhep.2011.10.011; Ghrenassia E, 2012, JOINT BONE SPINE, V79, P100, DOI 10.1016/j.jbspin.2011.07.003; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Hadjinicolaou AV, 2012, RHEUMATOLOGY, V51, P653, DOI 10.1093/rheumatology/ker290; Hatemi G, 2013, J RHEUMATOL, V40, P1938, DOI 10.3899/jrheum.131218; Herrinton LJ, 2013, PHARMACOEPIDEM DR S, V22, P394, DOI 10.1002/pds.3409; Hua C, 2014, ARTHRIT CARE RES, V66, P1016, DOI 10.1002/acr.22246; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Hyrich KL, 2014, RHEUMATOLOGY, V53, P1377, DOI 10.1093/rheumatology/ket409; Jani M, 2014, NAT REV RHEUMATOL, V10, P284, DOI 10.1038/nrrheum.2013.197; Kapetanovic MC, 2011, SCAND J RHEUMATOL, V40, P433, DOI 10.3109/03009742.2011.573503; Kawashiri SY, 2012, RHEUMATOL INT, V32, P4023, DOI 10.1007/s00296-010-1525-z; Khanna D, 2004, ARTHRITIS RHEUM-US, V50, P1040, DOI 10.1002/art.20164; Kim PS, 2012, ARTHRIT CARE RES, V64, P1265, DOI 10.1002/acr.21654; Kim SJ, 2013, EUR J CANCER, V49, P3486, DOI 10.1016/j.ejca.2013.07.006; Kishida D, 2011, MOD RHEUMATOL, V21, P215, DOI 10.1007/s10165-010-0365-8; Koo YX, 2011, ANN HEMATOL, V90, P1219, DOI 10.1007/s00277-011-1241-0; Krause ML, 2014, THER ADV MUSCULOSKEL, V6, P169, DOI 10.1177/1759720X14551568; Kremer JM, 1997, ARTHRITIS RHEUM, V40, P1829, DOI 10.1002/art.1780401016; Lau GKK, 2008, HEPATOL INT, V2, P152, DOI 10.1007/s12072-008-9056-3; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lin KM, 2013, J MICROBIOL IMMUNOL, V46, P65, DOI 10.1016/j.jmii.2011.12.020; Listing J, 2008, ARTHRITIS RHEUM-US, V58, P667, DOI 10.1002/art.23281; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Mahadevan U, 2013, CLIN GASTROENTEROL H, V11, P286, DOI 10.1016/j.cgh.2012.11.011; Mahajan TD, 2010, JCR-J CLIN RHEUMATOL, V16, P332, DOI 10.1097/RHU.0b013e3181f4cd92; Mariette X, 2010, ANN RHEUM DIS, V69, P400, DOI 10.1136/ard.2009.117762; Montiel PM, 2008, LIVER INT, V28, P718, DOI 10.1111/j.1478-3231.2007.01665.x; Matera MG, 2010, PULM PHARMACOL THER, V23, P121, DOI 10.1016/j.pupt.2009.10.007; Mathias SD, 2000, CLIN THER, V22, P128, DOI 10.1016/S0149-2918(00)87984-9; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mercer LK, 2015, ANN RHEUM DIS, V74, P1087, DOI 10.1136/annrheumdis-2013-204851; Michaud TL, 2014, AM J MED, V127, P1208, DOI 10.1016/j.amjmed.2014.06.012; Mohr M, 2011, SCAND J RHEUMATOL, V40, P400, DOI 10.3109/03009742.2011.599072; Mori S, 2012, RHEUMATOLOGY, P2; Mori S, 2013, ANN RHEUM DIS, V72, P1362, DOI 10.1136/annrheumdis-2012-202658; Mori S, 2012, ANN RHEUM DIS, V71, P2006, DOI 10.1136/annrheumdis-2012-201950; Nagai K, 2012, EUR J PHARMACOL, V687, P39, DOI 10.1016/j.ejphar.2012.04.038; Nagao A, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-10; Nagashima T, 2012, RHEUMATOL INT, V32, P2231, DOI 10.1007/s00296-011-2060-2; Nota I, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-333; Ogata A, 2011, ANN RHEUM DIS, V70, P1164, DOI 10.1136/ard.2010.132845; Ono A, 2012, J HEPATOL, V57, P508, DOI 10.1016/j.jhep.2012.04.037; Orban T, 2014, DIABETES, V63, P3449, DOI 10.2337/db14-0047; Ottaviani S, 2013, JOINT BONE SPINE, V80, P435, DOI 10.1016/j.jbspin.2012.10.018; PAOLISSO G, 1991, METABOLISM, V40, P902, DOI 10.1016/0026-0495(91)90064-4; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pehlivan Yavuz, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2012-006585; Perez-Alvarez R, 2011, SEMIN ARTHRITIS RHEU, V41, P256, DOI 10.1016/j.semarthrit.2010.11.002; Perrillo RP, 2015, GASTROENTEROLOGY, V148, P221, DOI 10.1053/j.gastro.2014.10.038; Pescovitz MD, 2014, DIABETES CARE, V37, P453, DOI 10.2337/dc13-0626; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Pham Thao, 2008, Joint Bone Spine, V75 Suppl 1, pS1, DOI 10.1016/S1297-319X(08)73620-0; Pyrpasopoulou A, 2011, RHEUMATOL INT, V31, P403, DOI 10.1007/s00296-009-1202-2; Raaschou P, 2014, ANN RHEUM DIS; Rafnsson V, 2001, CANCER CAUSE CONTROL, V12, P95, DOI 10.1023/A:1008983416836; Raghavendran RR, 2008, RHEUMATOLOGY, V47, P1838, DOI 10.1093/rheumatology/ken384; Rahier J F, 2009, J Crohns Colitis, V3, P47, DOI 10.1016/j.crohns.2009.02.010; Rahier JF, 2010, RHEUMATOLOGY, V49, P1815, DOI 10.1093/rheumatology/keq183; Reddy KR, 2015, GASTROENTEROLOGY, V148, P215, DOI 10.1053/j.gastro.2014.10.039; Roubille C, 2014, SEMIN ARTHRITIS RHEU, V43, P613, DOI 10.1016/j.semarthrit.2013.09.005; Roux CH, 2013, J RHEUMATOL, V40, P99, DOI 10.3899/jrheum.120599; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Sarrecchia Cesare, 2005, Journal of Infection and Chemotherapy, V11, P189, DOI 10.1007/s10156-005-0385-z; Schiff MH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3455; Senel S, 2011, CLIN RHEUMATOL, V30, P1369, DOI 10.1007/s10067-011-1782-6; Sichletidis L, 2006, INT J TUBERC LUNG D, V10, P1127; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Skomsvoll JF, 1998, SCAND J RHEUMATOL, P109, DOI 10.1080/03009742.1998.11720781; Smith KJ, 2001, J AM ACAD DERMATOL, V45, P953, DOI 10.1067/mjd.2001.117725; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Souto A, 2015, ARTHRITIS RHEUMATOL, V67, P117, DOI 10.1002/art.38894; Souto A, 2014, RHEUMATOLOGY, V53, P1872, DOI 10.1093/rheumatology/keu172; Strangfeld A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2904; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Suissa S, 2008, PULM PHARMACOL THER, V21, P234, DOI 10.1016/j.pupt.2007.03.003; Tay L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2174; Pham T, 2012, JOINT BONE SPINE, V79, P1, DOI 10.1016/S1297-319X(12)70011-8; Tiippana-Kinnunen T, 2013, SCAND J RHEUMATOL, V42, P451, DOI 10.3109/03009742.2013.790073; Tsuboi H, 2011, MOD RHEUMATOL, V21, P701, DOI 10.1007/s10165-011-0470-3; van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216; van Assen S, 2010, ARTHRITIS RHEUM-US, V62, P75, DOI 10.1002/art.25033; van Vollenhoven RF, 2013, ANN RHEUM DIS, V72, P1496, DOI 10.1136/annrheumdis-2012-201956; Vassallo Robert, 2002, Chest, V122, P1093, DOI 10.1378/chest.122.3.1093; Verhelst X, 2010, EUR J GASTROEN HEPAT, V22, P494, DOI 10.1097/MEG.0b013e3283329d13; Verstappen SMM, 2011, ANN RHEUM DIS, V70, P823, DOI 10.1136/ard.2010.140822; Wang YJ, 2014, CURR OPIN INFECT DIS, V27, P303, DOI 10.1097/QCO.0000000000000074; Weinblatt M, 2006, ARTHRITIS RHEUM, V54, P2807, DOI 10.1002/art.22070; Weisman MH, 2007, RHEUMATOLOGY, V46, P1122, DOI 10.1093/rheumatology/kem033; Winthrop KL, 2009, EMERG INFECT DIS, V15, P1556, DOI 10.3201/eid1510.090310; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864; Wu CY, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0449-5; Yamamoto K, 2015, J RHEUMATOL; Yazici O, 2014, WORLD J GASTROENTERO, V20, P6716, DOI 10.3748/wjg.v20.i22.6716; Zein NN, 2005, J HEPATOL, V42, P315, DOI 10.1016/j.jhep.2004.11.025	153	10	13	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2015	351								h3658	10.1136/bmj.h3658	http://dx.doi.org/10.1136/bmj.h3658			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7OR	26282936				2022-12-28	WOS:000360078100001
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: What should senior doctors be paid?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		BMA, PAY SCAL CONS ENGL 2; Campbell D, 2013, GUARDIAN; Dayan M, 2014, IS GEN PRACTICE CRIS; Dudman J, 2015, GUARDIAN; Flynn P, BMA CONS C 2014; House of Commons Library, 2013, CIV SERV MPS SAL; Hunt J., 2015, MAKING HEALTHCARE MO; Ministry of Defence, 2015, ARM OFF RAT PAY; Police Superintendents' Association of England and Wales, 2014, SUP PAY SCAL	9	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2015	351								h4373	10.1136/bmj.h4373	http://dx.doi.org/10.1136/bmj.h4373			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2YN	26275618	Green Published, Bronze			2022-12-28	WOS:000359744000001
J	Basaria, S; Harman, M; Travison, TG; Hodis, H; Tsitouras, P; Budoff, M; Pencina, KM; Vita, J; Dzekov, C; Mazer, NA; Coviello, AD; Knapp, PE; Hally, K; Pinjic, E; Yan, MZ; Storer, T; Bhasin, S				Basaria, Shehzad; Harman, Mitchell; Travison, Thomas G.; Hodis, Howard; Tsitouras, Panayiotis; Budoff, Matthew; Pencina, Karol M.; Vita, Joseph; Dzekov, Connie; Mazer, Norman A.; Coviello, Andrea D.; Knapp, Philip E.; Hally, Kathleen; Pinjic, Emma; Yan, Mingzhu; Storer, ThomasW.; Bhasin, Shalender			Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOGENOUS SEX-HORMONES; INTIMA-MEDIA THICKNESS; ELDERLY-MEN; ERECTILE DYSFUNCTION; BODY-COMPOSITION; CARDIOVASCULAR-DISEASE; CORONARY CALCIUM; MUSCLE STRENGTH; DOUBLE-BLIND; THERAPY	IMPORTANCE Testosterone use in older men is increasing, but its long-term effects on progression of atherosclerosis are unknown. OBJECTIVE To determine the effect of testosterone administration on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels. DESIGN, SETTING, AND PARTICIPANTS Testosterone's Effects on Atherosclerosis Progression in Aging Men(TEAAM) was a placebo-controlled, double-blind, parallel-group randomized trial involving 308 men 60 years or older with low or low-normal testosterone levels (100-400 ng/dL; free testosterone <50 pg/mL), recruited at 3 US centers. Recruitment took place between September 2004 and February 2009; the last participant completed the study in May 2012. INTERVENTIONS One hundred fifty-six participants were randomized to receive 7.5 g of 1% testosterone and 152 were randomized to receive placebo gel packets daily for 3 years. The dose was adjusted to achieve testosterone levels between 500 and 900 ng/dL. MAIN OUTCOMES AND MEASURES Coprimary outcomes included common carotid artery intima-media thickness and coronary artery calcium; secondary outcomes included sexual function and health-related quality of life. RESULTS Baseline characteristics were similar between groups: patients were a mean age of 67.6 years; 42% had hypertension; 15%, diabetes; 15%, cardiovascular disease; and 27%, obesity. The rate of change in intima-media thickness was 0.010 mm/year in the placebo group and 0.012 mm/year in the testosterone group (mean difference adjusted for age and trial site, 0.0002 mm/year; 95% CI, -0.003 to 0.003, P = .89). The rate of change in the coronary artery calcium score was 41.4 Agatston units/year in the placebo group and 31.4 Agatston units/year in the testosterone group (adjusted mean difference, -10.8 Agatston units/year; 95% CI, -45.7 to 24.2; P = .54). Changes in intima-media thickness or calcium scores were not associated with change in testosterone levels among individuals assigned to receive testosterone. Sexual desire, erectile function, overall sexual function scores, partner intimacy, and health-related quality of life did not differ significantly between groups. Hematocrit and prostate-specific antigen levels increased more in testosterone group. CONCLUSIONS AND RELEVANCE Among older men with low or low-normal testosterone levels, testosterone administration for 3 years vs placebo did not result in a significant difference in the rates of change in either common carotid artery intima-media thickness or coronary artery calcium nor did it improve overall sexual function or health-related quality of life. Because this trial was only powered to evaluate atherosclerosis progression, these findings should not be interpreted as establishing cardiovascular safety of testosterone use in older men.	[Basaria, Shehzad; Travison, Thomas G.; Pencina, Karol M.; Hally, Kathleen; Pinjic, Emma; Storer, ThomasW.; Bhasin, Shalender] Harvard Univ, Brigham & Womens Hosp, Sch Med, Res Program Mens Hlth Aging & Metab,Boston Claude, Boston, MA 02115 USA; [Harman, Mitchell; Tsitouras, Panayiotis] Kronos Longev Res Inst, Phoenix, AZ USA; [Harman, Mitchell] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Hodis, Howard; Yan, Mingzhu] Univ So Calif, Keck Sch Med, Atherosclerosis Res Unit, Los Angeles, CA 90033 USA; [Tsitouras, Panayiotis] Univ Oklahoma, DWR Dept Geriatr Med, Oklahoma City, OK USA; [Budoff, Matthew] Harbor UCLA Med Ctr, Div Cardiol, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Vita, Joseph] Boston Univ, Sch Med, Div Cardiol, Boston, MA 02118 USA; [Dzekov, Connie] Charles R Drew Univ Med & Sci, Div Endocrinol Metab & Mol Med, Los Angeles, CA 90059 USA; [Mazer, Norman A.; Coviello, Andrea D.; Knapp, Philip E.] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Basel, Switzerland; [Mazer, Norman A.] Boston Univ, Sch Med, Div Endocrinol, Boston, MA 02118 USA; [Travison, Thomas G.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southern California; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Boston University; Charles R. Drew University of Medicine & Science; Roche Holding; Boston University; Harvard University; Hebrew SeniorLife	Bhasin, S (corresponding author), Harvard Univ, Dept Med, Med Sch,Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab,Boston Claude, 221 Longwood Ave, Boston, MA 02115 USA.	sbhasin@partners.org	Mazer, Norman A/HGU-8266-2022; Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946; Basaria, Shehzad/0000-0003-1749-8549	Solvay Pharmaceuticals Inc; Abbvie Pharmaceuticals Inc; Aurora Foundation; Boston Claude D. Pepper Older Americans Independence Center [5P30AG031679]; Boston University's Clinical and Translational Science Institute [1UL1RR025771]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG031679] Funding Source: NIH RePORTER	Solvay Pharmaceuticals Inc(Solvay SA); Abbvie Pharmaceuticals Inc(AbbVie); Aurora Foundation; Boston Claude D. Pepper Older Americans Independence Center; Boston University's Clinical and Translational Science Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This investigator-initiated study was supported by a grant from Solvay Pharmaceuticals Inc and later by Abbvie Pharmaceuticals Inc, when Abbvie acquired the Androgel brand from Solvay Pharmaceuticals, and by a grant from the Aurora Foundation to the Kronos Longevity Research Institute. Additional support was provided by grants 5P30AG031679 from the Boston Claude D. Pepper Older Americans Independence Center and 1UL1RR025771 from the Boston University's Clinical and Translational Science Institute. Testosterone and placebo gel for the study were provided by Solvay Pharmaceuticals Inc and later by Abbvie Pharmaceuticals.	Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; Baillargeon J, 2013, JAMA INTERN MED, V173, P1465, DOI 10.1001/jamainternmed.2013.6895; BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 2012, JAMA-J AM MED ASSOC, V307, P931, DOI 10.1001/jama.2012.227; Bhasin S, 2011, DIABETES CARE, V34, P2464, DOI 10.2337/dc11-0888; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; BLANKENHORN DH, 1993, CIRCULATION, V88, P20, DOI 10.1161/01.CIR.88.1.20; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Budoff MJ, 2000, AM J CARDIOL, V86, P8, DOI 10.1016/S0002-9149(00)00820-1; BUENA F, 1993, FERTIL STERIL, V59, P1118; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Grey PB, 2005, J CLIN ENDOCR METAB, V90, P3838; Harman SM, 2014, ANN INTERN MED, V161, P249, DOI 10.7326/M14-0353; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 1996, ANN INTERN MED, V124, P548, DOI 10.7326/0003-4819-124-6-199603150-00002; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Jain P, 2000, J UROLOGY, V164, P371, DOI 10.1016/S0022-5347(05)67363-6; Jasuja GK, 2013, AM J PHARM BENEFITS, V5, pe122; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Marks LS, 2006, JAMA-J AM MED ASSOC, V296, P2351, DOI 10.1001/jama.296.19.2351; Mazer NA, 2009, STEROIDS, V74, P512, DOI 10.1016/j.steroids.2009.01.008; Muller M, 2004, CIRCULATION, V109, P2074, DOI 10.1161/01.CIR.0000125854.51637.06; Muller M, 2003, J CLIN ENDOCR METAB, V88, P5076, DOI 10.1210/jc.2003-030611; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; Nathan L, 2001, P NATL ACAD SCI USA, V98, P3589, DOI 10.1073/pnas.051003698; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Paige NM, 2001, J UROLOGY, V166, P1774, DOI 10.1016/S0022-5347(05)65673-X; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salameh WA, 2010, STEROIDS, V75, P169, DOI 10.1016/j.steroids.2009.11.004; Schoenfeld MJ, 2013, J SEX MED, V10, P1401, DOI 10.1111/jsm.12114; Shores MM, 2012, J CLIN ENDOCR METAB, V97, P2050, DOI 10.1210/jc.2011-2591; Snyder PJ, 2014, CLIN TRIALS, V11, P362, DOI 10.1177/1740774514524032; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Srinivas-Shankar U, 2010, J CLIN ENDOCR METAB, V95, P639, DOI 10.1210/jc.2009-1251; van Buuren S, 2000, MULTIVARIATE IMPUTAT; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	43	143	145	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					570	581		10.1001/jama.2015.8881	http://dx.doi.org/10.1001/jama.2015.8881			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262795				2022-12-28	WOS:000359388600016
J	Wu, K; Chen, J; McBride, JR; Lian, T				Wu, K.; Chen, J.; McBride, J. R.; Lian, T.			Efficient hot-electron transfer by a plasmon-induced interfacial charge-transfer transition	SCIENCE			English	Article							SEMICONDUCTOR QUANTUM RODS; SMALL METAL PARTICLES; GOLD NANOPARTICLES; SURFACE-PLASMONS; ABSORPTION; NANOSTRUCTURES; GENERATION; SOLAR; PHOTODETECTION; SPECTROSCOPY	Plasmon-induced hot-electron transfer from metal nanostructures is a potential new paradigm for solar energy conversion; however, the reported efficiencies of devices based on this concept are often low because of the loss of hot electrons via ultrafast electron-electron scattering. We propose a pathway, called the plasmon-induced interfacial charge-transfer transition (PICTT), that enables the decay of a plasmon by directly exciting an electron from the metal to a strongly coupled acceptor. We demonstrated this concept in cadmium selenide nanorods with gold tips, in which the gold plasmon was strongly damped by cadmium selenide through interfacial electron transfer. The quantum efficiency of the PICTT process was high (>24%), independent of excitation photon energy over a similar to 1-electron volt range, and dependent on the excitation polarization.	[Wu, K.; Chen, J.; Lian, T.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [McBride, J. R.] Vanderbilt Univ, Vanderbilt Inst Nanoscale Sci & Engn, Dept Chem, Nashville, TN 37235 USA	Emory University; Vanderbilt University	Lian, T (corresponding author), Emory Univ, Dept Chem, 1515 Dickey Dr, Atlanta, GA 30322 USA.	tlian@emory.edu	McBride, James/D-2934-2012	McBride, James/0000-0003-0161-7283; Chen, Jinquan/0000-0003-0652-1379	U.S. Department of Energy, Office of Basic Energy Sciences, Solar Photochemistry Program [DE-FG02-12ER16347]; NSF [CHE-1213758, EPS-1004083]	U.S. Department of Energy, Office of Basic Energy Sciences, Solar Photochemistry Program(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This work was funded by the U.S. Department of Energy, Office of Basic Energy Sciences, Solar Photochemistry Program (grant DE-FG02-12ER16347). J.R.M. acknowledges financial support from NSF (grant CHE-1213758). Scanning transmission electron microscope and energy-dispersive x-ray spectroscope images were acquired using an FEI Tecnai Osiris electron microscope purchased with support from NSF (grant EPS-1004083).	Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Brongersma ML, 2015, NAT NANOTECHNOL, V10, P25, DOI [10.1038/NNANO.2014.311, 10.1038/nnano.2014.311]; Chen HM, 2012, ACS NANO, V6, P7362, DOI 10.1021/nn3024877; CHEN QY, 1986, PHYS REV LETT, V57, P2737, DOI 10.1103/PhysRevLett.57.2737; Chou KC, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.153413; Christopher P, 2011, NAT CHEM, V3, P467, DOI [10.1038/NCHEM.1032, 10.1038/nchem.1032]; Clavero C, 2014, NAT PHOTONICS, V8, P95, DOI [10.1038/nphoton.2013.238, 10.1038/NPHOTON.2013.238]; FANN WS, 1992, PHYS REV B, V46, P13592, DOI 10.1103/PhysRevB.46.13592; Fowler RH, 1931, PHYS REV, V38, P45, DOI 10.1103/PhysRev.38.45; Furube A, 2007, J AM CHEM SOC, V129, P14852, DOI 10.1021/ja076134v; Giugni A, 2013, NAT NANOTECHNOL, V8, P845, DOI [10.1038/NNANO.2013.207, 10.1038/nnano.2013.207]; Govorov AO, 2013, J PHYS CHEM C, V117, P16616, DOI 10.1021/jp405430m; Hartland GV, 2011, CHEM REV, V111, P3858, DOI 10.1021/cr1002547; HOVEL H, 1993, PHYS REV B, V48, P18178, DOI 10.1103/PhysRevB.48.18178; Hu JT, 2001, SCIENCE, V292, P2060, DOI 10.1126/science.1060810; Iline A, 1999, SURF SCI, V436, P51, DOI 10.1016/S0039-6028(99)00607-X; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Kale MJ, 2014, NANO LETT, V14, P5405, DOI 10.1021/nl502571b; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; KIWI J, 1979, NATURE, V281, P657, DOI 10.1038/281657a0; Knight MW, 2011, SCIENCE, V332, P702, DOI 10.1126/science.1203056; KOLB DM, 1974, Z PHYS CHEM NEUE FOL, V93, P1, DOI 10.1524/zpch.1974.93.1-6.001; Lee YK, 2011, NANO LETT, V11, P4251, DOI 10.1021/nl2022459; Li JT, 2014, J AM CHEM SOC, V136, P8438, DOI 10.1021/ja503508g; Li W, 2014, NANO LETT, V14, P3510, DOI 10.1021/nl501090w; Linic S, 2011, NAT MATER, V10, P911, DOI [10.1038/NMAT3151, 10.1038/nmat3151]; Long R, 2014, J AM CHEM SOC, V136, P4343, DOI 10.1021/ja5001592; Marimuthu A, 2013, SCIENCE, V339, P1590, DOI 10.1126/science.1231631; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Mubeen S, 2013, NAT NANOTECHNOL, V8, P247, DOI 10.1038/nnano.2013.18; MULLER U, 1988, PHYS REV B, V38, P7814, DOI 10.1103/PhysRevB.38.7814; PERSSON BNJ, 1993, SURF SCI, V281, P153, DOI 10.1016/0039-6028(93)90865-H; Petek H, 2000, SCIENCE, V288, P1402, DOI 10.1126/science.288.5470.1402; Petek H, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4746801; SCHMIDTOTT A, 1980, PHYS REV LETT, V45, P1284, DOI 10.1103/PhysRevLett.45.1284; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Shabaev A, 2004, NANO LETT, V4, P1821, DOI 10.1021/nl049216f; Shaviv E, 2011, ACS NANO, V5, P4712, DOI 10.1021/nn200645h; Sonnichsen C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077402; Steiner D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.056805; Thomann I, 2011, NANO LETT, V11, P3440, DOI 10.1021/nl201908s; Tian Y, 2005, J AM CHEM SOC, V127, P7632, DOI 10.1021/ja042192u; Tice DB, 2013, J PHYS CHEM C, V117, P13289, DOI 10.1021/jp402936u; Voisin C, 2001, J PHYS CHEM B, V105, P2264, DOI 10.1021/jp0038153; Wu KF, 2013, NANO LETT, V13, P5255, DOI 10.1021/nl402730m; Yu P, 2013, J PHYS CHEM LETT, V4, P3596, DOI 10.1021/jz401985k	46	749	759	56	925	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					632	635		10.1126/science.aac5443	http://dx.doi.org/10.1126/science.aac5443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250682				2022-12-28	WOS:000359092900039
J	Wahl, MC; Luhrmann, R				Wahl, Markus C.; Luehrmann, Reinhard			SnapShot: Spliceosome Dynamics III	CELL			English	Editorial Material							SPINAL MUSCULAR-ATROPHY; RNA; MICE	The complex compositional and conformational dynamics of spliceosomes required for regulated splicing are prone to malfunction when mutations affect splicing factors or cis-acting regulatory sequences. Indeed, many such mutations have been linked to heritable diseases or malignancies in humans. Small molecule modulators and antisense oligonucleotides or analogs harbor great potential for therapies and several substances that can modulate splicing events have entered clinical trials.	[Wahl, Markus C.] Free Univ Berlin, Lab Struct Biochem, D-14195 Berlin, Germany; [Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cell Biochem, D-37077 Gottingen, Germany	Free University of Berlin; Max Planck Society	Wahl, MC (corresponding author), Free Univ Berlin, Lab Struct Biochem, D-14195 Berlin, Germany.		Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307				Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Palacino J, 2015, NAT CHEM BIOL, V11, P511, DOI [10.1038/NCHEMBIO.1837, 10.1038/nchembio.1837]; Sleeman J, 2013, BIOCHEM SOC T, V41, P871, DOI 10.1042/BST20120016; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164	10	3	4	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3							690.e1	10.1016/j.cell.2015.07.033	http://dx.doi.org/10.1016/j.cell.2015.07.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232231	Bronze			2022-12-28	WOS:000358801800027
J	Stepanenko, A; Kaufmann, F				Stepanenko, Alexander; Kaufmann, Friedrich			A novel total artificial heart: search for haemocompatibility	LANCET			English	Editorial Material							VENTRICULAR ASSIST DEVICE; CIRCULATORY SUPPORT; TRANSPLANTATION; REGISTRY; FLOW; PUMP		[Stepanenko, Alexander; Kaufmann, Friedrich] Deutsch Herzzentrum Berlin, Dept Cardiothorac & Vasc Surg, D-13353 Berlin, Germany	German Heart Center Berlin	Stepanenko, A (corresponding author), Deutsch Herzzentrum Berlin, Dept Cardiothorac & Vasc Surg, D-13353 Berlin, Germany.	stepanenko@dhzb.de		stepanenko, alexander/0000-0001-9715-2112				Carpentier A, 2015, LANCET; Cheung A, 2011, ANN THORAC SURG, V91, P1294, DOI 10.1016/j.athoracsur.2010.08.031; Copeland JG, 2004, NEW ENGL J MED, V351, P859, DOI 10.1056/NEJMoa040186; Hetzer R, 2010, J HEART LUNG TRANSPL, V29, P822, DOI 10.1016/j.healun.2010.02.012; Holman WL, 2013, J THORAC CARDIOV SUR, V146, P437, DOI 10.1016/j.jtcvs.2013.02.018; Joyce L D, 1988, ASAIO Trans, V34, P703; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Krabatsch T, 2011, CIRCULATION, V124, pS179, DOI 10.1161/CIRCULATIONAHA.110.011502; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; Potapov EV, 2000, CIRCULATION, V102, P183; Stepanenko A, 2014, ANN CARDIOTHORAC SUR, V3, P538, DOI 10.3978/j.issn.2225-319X.2014.08.07; SZEFNER J, 1995, INT J ARTIF ORGANS, V18, P633, DOI 10.1177/039139889501801016; Torregrossa G, 2014, ASAIO J, V60, P626, DOI 10.1097/MAT.0000000000000132	13	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1517	1519		10.1016/S0140-6736(15)60999-0	http://dx.doi.org/10.1016/S0140-6736(15)60999-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26231460				2022-12-28	WOS:000362878200009
J	Koh, HK; Rudd, RE				Koh, Howard K.; Rudd, Rima E.			The Arc of Health Literacy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Koh, Howard K.; Rudd, Rima E.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Koh, Howard K.] Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Koh, HK (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, 677 Huntington Ave,Kresge 401, Boston, MA 02115 USA.	hkoh@hsph.harvard.edu						Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Brach Cindy, 2012, 10 ATTRIBUTES HLTH L; DeWalt D.A.C.L, HLTH LITERACY UNIVER; Hernandez Lyla M, 2013, HLTH LITERACY IMPROV; Koh HK, 2013, HEALTH AFFAIR, V32, P357, DOI 10.1377/hlthaff.2012.1205; Levitt L, 2015, JAMA-J AM MED ASSOC, V313, P555, DOI 10.1001/jama.2014.17419; OECD, 2013, OECD SKILLS OUTL 201, P45, DOI 10.1787/9789264204256-5-en; The Joint Commission, 2007, WHAT DID DOCT SAY IM; US Department of Education National Center for Education Statistics (NCES), 2006, HLTH LIT AM AD RES 2	9	53	54	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1225	1226		10.1001/jama.2015.9978	http://dx.doi.org/10.1001/jama.2015.9978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26247161				2022-12-28	WOS:000362110700005
J	Woo, CY; Strandberg, EJ; Schmiegelow, MD; Pitt, AL; Hlatky, MA; Owens, DK; Goldhaber-Fiebert, JD				Woo, Christopher Y.; Strandberg, Erika J.; Schmiegelow, Michelle D.; Pitt, Allison L.; Hlatky, Mark A.; Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.			Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; PERMANENT PACEMAKER; EJECTION FRACTION; SUPER-RESPONSE; TRIAL; HEALTH; POPULATION; SURVIVAL; METAANALYSIS; INFECTIONS	Background: Cardiac resynchronization therapy (CRT) reduces mortality and heart failure hospitalizations in patients with mild heart failure. Objective: To estimate the cost-effectiveness of adding CRT to an implantable cardioverter-defibrillator (CRT-D) compared with implantable cardioverter-defibrillator (ICD) alone among patients with left ventricular systolic dysfunction, prolonged intraventricular conduction, and mild heart failure. Design: Markov decision model. Data Sources: Clinical trials, clinical registries, claims data from Centers for Medicare & Medicaid Services, and Centers for Disease Control and Prevention life tables. Target Population: Patients aged 65 years or older with a left ventricular ejection fraction (LVEF) of 30% or less, QRS duration of 120 milliseconds or more, and New York Heart Association (NYHA) class I or II symptoms. Time Horizon: Lifetime. Perspective: Societal. Intervention: CRT-D or ICD alone. Outcome Measures: Life-years, quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: Use of CRT-D increased life expectancy (9.8 years versus 8.8 years), QALYs (8.6 years versus 7.6 years), and costs ($286 500 versus $228 600), yielding a cost per QALY gained of $61 700. Results of Sensitivity Analyses: The cost-effectiveness of CRT-D was most dependent on the degree of mortality reduction: When the risk ratio for death was 0.95, the ICER increased to $119 600 per QALY. More expensive CRT-D devices, shorter CRT-D battery life, and older age also made the cost-effectiveness of CRT-D less favorable. Limitations: The estimated mortality reduction for CRT-D was largely based on a single trial. Data on patients with NYHA class I symptoms were limited. The cost-effectiveness of CRT-D in patients with NYHA class I symptoms remains uncertain. Conclusion: In patients with an LVEF of 30% or less, QRS duration of 120 milliseconds or more, and NYHA class II symptoms, CRT-D appears to be economically attractive relative to ICD alone when a reduction in mortality is expected.	[Woo, Christopher Y.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Schmiegelow, Michelle D.; Hlatky, Mark A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA; [Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Gentofte Univ Hosp, Copenhagen, Denmark	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Copenhagen; Herlev & Gentofte Hospital	Woo, CY (corresponding author), Stanford Univ, Sch Med, Div Cardiovasc Med, Falk Cardiovasc Res Bldg,870 Quarry Rd, Stanford, CA 94305 USA.	cywoo@stanford.edu		Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192; Hlatky, Mark/0000-0003-4686-9441	National Institutes of Health; University of Copenhagen; U.S. Department of Veterans Affairs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Copenhagen; U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	National Institutes of Health, University of Copenhagen, U.S. Department of Veterans Affairs.	Al-Majed NS, 2011, ANN INTERN MED, V154, P401, DOI 10.7326/0003-4819-154-6-201103150-00313; Arias Elizabeth, 2012, Natl Vital Stat Rep, V61, P1; Banka G, 2013, J AM COLL CARDIOL, V61, P1440, DOI 10.1016/j.jacc.2012.12.022; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Calvert MJ, 2005, EUR HEART J, V26, P2681, DOI 10.1093/eurheartj/ehi662; Cheng A, 2010, J AM COLL CARDIOL, V56, P1651, DOI 10.1016/j.jacc.2010.06.037; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007; Feldman AM, 2005, J AM COLL CARDIOL, V46, P2311, DOI 10.1016/j.jacc.2005.08.033; Finegold JA, 2013, J AM COLL CARDIOL, V62, P2406, DOI 10.1016/j.jacc.2013.07.080; Gohler A, 2009, VALUE HEALTH, V12, P185, DOI 10.1111/j.1524-4733.2008.00425.x; Goldenberg I, 2010, CIRCULATION, V122, P1265, DOI 10.1161/CIRCULATIONAHA.110.940148; Hartman M, 2008, HEALTH AFFAIR, V27, pW1, DOI 10.1377/hlthaff.27.1.w1; Heidenreich PA, 2010, J AM COLL CARDIOL, V56, P362, DOI 10.1016/j.jacc.2010.02.053; Hsu JC, 2012, J AM COLL CARDIOL, V59, P2366, DOI 10.1016/j.jacc.2012.01.065; Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497; Kramer DB, 2013, CIRC-CARDIOVASC QUAL, V6, P488, DOI 10.1161/CIRCOUTCOMES.111.000054; Kremers MS, 2013, HEART RHYTHM, V10, pE59, DOI 10.1016/j.hrthm.2013.01.035; Kutyifa V, 2013, J AM COLL CARDIOL, V61, P936, DOI 10.1016/j.jacc.2012.11.051; Linde C, 2011, EUR HEART J, V32, P1631, DOI 10.1093/eurheartj/ehq408; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Margey R, 2010, EUROPACE, V12, P64, DOI 10.1093/europace/eup362; Masoudi FA, 2014, ANN INTERN MED, V160, P603, DOI 10.7326/M13-1879; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Nichol G, 2004, ANN INTERN MED, V141, P343, DOI 10.7326/0003-4819-141-5-200409070-00102; Noyes K, 2013, J CARDIOVASC ELECTR, V24, P66, DOI 10.1111/j.1540-8167.2012.02413.x; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Oetgen WJ, 2013, J AM COLL CARDIOL, V61, P1318, DOI 10.1016/j.jacc.2012.12.017; Pagourelias ED, 2014, NEW ENGL J MED, V371, P477, DOI 10.1056/NEJMc1407182; Rickard J, 2010, HEART RHYTHM, V7, P885, DOI 10.1016/j.hrthm.2010.04.005; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Santangeli P, 2011, J INTERV CARD ELECTR, V32, P125, DOI 10.1007/s10840-011-9584-y; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Uslan DZ, 2007, ARCH INTERN MED, V167, P669, DOI 10.1001/archinte.167.7.669; van Rees JB, 2011, J AM COLL CARDIOL, V58, P995, DOI 10.1016/j.jacc.2011.06.007; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yao GQ, 2007, EUR HEART J, V28, P42, DOI 10.1093/eurheartj/ehl382; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	44	18	18	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					417	+		10.7326/M14-1804	http://dx.doi.org/10.7326/M14-1804			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26301323	Green Accepted			2022-12-28	WOS:000361365900016
J	Korem, T; Zeevi, D; Suez, J; Weinberger, A; Avnit-Sagi, T; Pompan-Lotan, M; Matot, E; Jona, G; Harmelin, A; Cohen, N; Sirota-Madi, A; Thaiss, CA; Pevsner-Fischer, M; Sorek, R; Xavier, RJ; Elinav, E; Segal, E				Korem, Tal; Zeevi, David; Suez, Jotham; Weinberger, Adina; Avnit-Sagi, Tali; Pompan-Lotan, Maya; Matot, Elad; Jona, Ghil; Harmelin, Alon; Cohen, Nadav; Sirota-Madi, Alexandra; Thaiss, Christoph A.; Pevsner-Fischer, Meirav; Sorek, Rotem; Xavier, Ramnik J.; Elinav, Eran; Segal, Eran			MICROBIOME Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples	SCIENCE			English	Article							REPLICATION; IDENTIFICATION; CHROMOSOMES; DIVERSITY; BACTERIAL; GENOMES; CANCER; CYCLE	Metagenomic sequencing increased our understanding of the role of the microbiome in health and disease, yet it only provides a snapshot of a highly dynamic ecosystem. Here, we show that the pattern of metagenomic sequencing read coverage for different microbial genomes contains a single trough and a single peak, the latter coinciding with the bacterial origin of replication. Furthermore, the ratio of sequencing coverage between the peak and trough provides a quantitative measure of a species' growth rate. We demonstrate this in vitro and in vivo, under different growth conditions, and in complex bacterial communities. For several bacterial species, peak-to-trough coverage ratios, but not relative abundances, correlated with the manifestation of inflammatory bowel disease and type II diabetes.	[Korem, Tal; Zeevi, David; Weinberger, Adina; Avnit-Sagi, Tali; Pompan-Lotan, Maya; Matot, Elad; Cohen, Nadav; Segal, Eran] Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; [Korem, Tal; Zeevi, David; Weinberger, Adina; Avnit-Sagi, Tali; Pompan-Lotan, Maya; Matot, Elad; Cohen, Nadav; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Suez, Jotham; Thaiss, Christoph A.; Pevsner-Fischer, Meirav; Elinav, Eran] Weizmann Inst Sci, Immunol Dept, IL-76100 Rehovot, Israel; [Jona, Ghil] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Sirota-Madi, Alexandra; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Cambridge, MA 02138 USA; [Sirota-Madi, Alexandra; Xavier, Ramnik J.] Broad Inst, Cambridge, MA USA; [Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Weizmann Institute of Science	Elinav, E (corresponding author), Weizmann Inst Sci, Immunol Dept, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il; eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019; Korem, Tal/D-4155-2018; Elinav, Eran/ABE-8881-2020; Suez, Jotham/AAZ-5433-2020	Korem, Tal/0000-0002-0609-0858; Elinav, Eran/0000-0002-5775-2110; Suez, Jotham/0000-0003-3836-972X; Segal, Eran/0000-0002-6859-1164; Zeevi, David/0000-0002-6492-6078; Jona, Ghil/0000-0002-4526-6182	Ministry of Science, Technology, and Space, Israel; Strauss Institute fellowship for nutritional research; Boehringer Ingelheim Fonds Ph.D. Fellowship; Leona M. and Harry B. Helmsley Charitable Trust; Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique); European Research Council; German-Israel Binational foundation; Israel Science Foundation (ISF); Minerva Foundation; Rising Tide foundation; European Research Council (ERC); ISF; estate of Jack Gitlitz; estate of Lydia Hershkovich; estate of Samuel and Alwyn J. Weber; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Ministry of Science, Technology, and Space, Israel(Ministry of Science, Technology and Space (MOST), Israel); Strauss Institute fellowship for nutritional research; Boehringer Ingelheim Fonds Ph.D. Fellowship(Boehringer Ingelheim); Leona M. and Harry B. Helmsley Charitable Trust; Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); German-Israel Binational foundation; Israel Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation; Rising Tide foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); ISF(Israel Science Foundation); estate of Jack Gitlitz; estate of Lydia Hershkovich; estate of Samuel and Alwyn J. Weber; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the Segal and Elinav laboratories for fruitful discussions. T.K. and D.Z. are supported by the Ministry of Science, Technology, and Space, Israel. T.K. is the recipient of the Strauss Institute fellowship for nutritional research. C.A.T. is the recipient of a Boehringer Ingelheim Fonds Ph.D. Fellowship. E.E. is supported by Yael and Rami Ungar, Israel; Leona M. and Harry B. Helmsley Charitable Trust; the Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; John L. and Vera Schwartz, Pacific Palisades; Alan Markovitz, Canada; Cynthia Adelson, Canada; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; Mr. and Mrs. Donald L. Schwarz, Sherman Oaks; grants funded by the European Research Council; the German-Israel Binational foundation; the Israel Science Foundation (ISF); the Minerva Foundation; and the Rising Tide foundation. E.E. is the incumbent of the Rina Gudinski Career Development Chair. This work was supported by grants from the European Research Council (ERC) and the ISF to E.S. The European Nucleotide Archive (ENA) accession number for the microbial shotgun sequences is PRJEB9718. The pipeline tool will be made publicly available at http://genie.weizmann.ac.il/software/bac_growth.html. All human studies were approved by the Tel Aviv Sourasky Medical Center Institutional Review Board, approval numbers TLV-0658-12, TLV-0050-13, and TLV-0522-10, and the Weizmann Institute of Science Bioethics and Embryonic Stem Cell Research oversight (ESCRO) committee. The trial was reported to https://clinicaltrials.gov, identifier NCT01892956. The study did not necessitate or involve randomization. Author contributions: T.K. and D.Z. conceived the project, designed and conducted the analyses, interpreted the results, and wrote the manuscript. J.S. devised and performed all experiments in mice, anaerobic, and pathogenic bacteria. A.W. directed some of the experiments and the production of libraries and sequencing from samples collected in this study and provided critical insights to the manuscript. T.K., D.Z., J.S., and A.W. equally contributed to this work. T.A.-S., M. P.-L., and E.M. performed experiments and extraction and sequencing of samples. M.P.-F. performed experiments. G.J. performed chemostat experiments. A.H. supervised germ-free mouse experiments. N.C. aided in the design of the computational pipeline and in conducting the analyses. A. S.-M. and R.J.X. directed the PRISM cohort. C.A.T. and E.E. directed the circadian experiments. R.S. and E.S. directed the dietary intervention study. E.E. and E.S. conceived and directed the project and analyses, designed experiments, interpreted the results, and wrote the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; BREMER H, 1977, J THEOR BIOL, V69, P645, DOI 10.1016/0022-5193(77)90373-3; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; HINNEBUSCH J, 1993, MOL MICROBIOL, V10, P917, DOI 10.1111/j.1365-2958.1993.tb00963.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Markowitz VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040151; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Xu J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r27; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	26	236	257	6	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1101	1106		10.1126/science.aac4812	http://dx.doi.org/10.1126/science.aac4812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26229116	Green Accepted			2022-12-28	WOS:000360628900042
J	Cattin, AL; Burden, JJ; Van Emmenis, L; Mackenzie, FE; Hoving, JJA; Calavia, NG; Guo, YP; McLaughlin, M; Rosenberg, LH; Quereda, V; Jamecna, D; Napoli, I; Parrinello, S; Enver, T; Ruhrberg, C; Lloyd, AC				Cattin, Anne-Laure; Burden, Jemima J.; Van Emmenis, Lucie; Mackenzie, Francesca E.; Hoving, Julian J. A.; Calavia, Noelia Garcia; Guo, Yanping; McLaughlin, Maeve; Rosenberg, Laura H.; Quereda, Victor; Jamecna, Denisa; Napoli, Ilaria; Parrinello, Simona; Enver, Tariq; Ruhrberg, Christiana; Lloyd, Alison C.			Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves	CELL			English	Article							ENDOTHELIAL-CELLS; IN-VIVO; MIGRATION; METASTASIS; TISSUE; VEGF; MICE; ANGIOGENESIS; FIBROBLASTS; HOMEOSTASIS	The peripheral nervous system has remarkable regenerative capacities in that it can repair a fully cut nerve. This requires Schwann cells to migrate collectively to guide regrowing axons across a 'bridge' of new tissue, which forms to reconnect a severed nerve. Here we show that blood vessels direct the migrating cords of Schwann cells. This multicellular process is initiated by hypoxia, selectively sensed by macrophages within the bridge, which via VEGF-A secretion induce a polarized vasculature that relieves the hypoxia. Schwann cells then use the blood vessels as "tracks'' to cross the bridge taking regrowing axons with them. Importantly, disrupting the organization of the newly formed blood vessels in vivo, either by inhibiting the angiogenic signal or by re-orienting them, compromises Schwann cell directionality resulting in defective nerve repair. This study provides important insights into how the choreography of multiple cell-types is required for the regeneration of an adult tissue.	[Cattin, Anne-Laure; Burden, Jemima J.; Van Emmenis, Lucie; Hoving, Julian J. A.; Calavia, Noelia Garcia; McLaughlin, Maeve; Rosenberg, Laura H.; Quereda, Victor; Jamecna, Denisa; Napoli, Ilaria; Parrinello, Simona; Lloyd, Alison C.] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; [Guo, Yanping; Enver, Tariq; Lloyd, Alison C.] UCL, UCL Canc Inst, London WC1E 6DD, England; [Mackenzie, Francesca E.; Ruhrberg, Christiana] UCL Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England	University of London; University College London; University of London; University College London; University of London; University College London	Lloyd, AC (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	alison.lloyd@ucl.ac.uk	Quereda, Victor/J-8120-2019; Ruhrberg, Christiana/C-6404-2009; Burden, Jemima/Q-1228-2017	Quereda, Victor/0000-0002-9966-9104; Ruhrberg, Christiana/0000-0002-3212-9381; Burden, Jemima/0000-0001-5894-7043; Napoli, Ilaria/0000-0002-0649-1950; Guo, Yanping/0000-0001-6217-7133	CRUK [C378/A17135]; Worldwide Cancer Research; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J00930X/1]; Rosetrees Trust [A533]; Biotechnology and Biological Sciences Research Council [BB/I008373/1] Funding Source: researchfish; Cancer Research UK [17135, 13100, 11244, 12796] Funding Source: researchfish; Worldwide Cancer Research [12-0041] Funding Source: researchfish; BBSRC [BB/I008373/1] Funding Source: UKRI	CRUK(Cancer Research UK); Worldwide Cancer Research; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rosetrees Trust(Rosetrees Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a programme grant from CRUK (C378/A17135). I.N. was supported by Worldwide Cancer Research. F.M. and C.R. were supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/J00930X/1) and the Rosetrees Trust (A533). We thank UCL Biological Services for the maintenance of the animals and useful advice, W. Macklin and M. Kerschensteiner for the PLP-EGFP mice, N. Ferrara and Genentech for the Vegfa floxed mice, K. Davidson for help with genotyping, A. Fantin for helpful suggestions, S. Mole for HDFs, T. Nightingale for HUVECs, P. Munro for assistance with SBF/SEM, and E. Paluch, Y. Mao, and M. Tozluoglu for advice on cell migration. A.C.L. would like to dedicate this work to the memory of Alan Hall and Chris Marshall, who both mentored her throughout her career.	AVELLINO AM, 1995, EXP NEUROL, V136, P183, DOI 10.1006/exnr.1995.1095; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Heermann S, 2013, CELL ADHES MIGR, V7, P18, DOI 10.4161/cam.22123; JURECKA W, 1975, ACTA NEUROPATHOL, V32, P299, DOI 10.1007/BF00696792; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Lugassy C, 2007, ADV ANAT PATHOL, V14, P195, DOI 10.1097/PAP.0b013e31805048d9; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Young RJ, 2010, METHODS MOL BIOL, V611, P151, DOI 10.1007/978-1-60327-345-9_12; Zochodne DW, 2008, NEUROBIOLOGY OF PERIPHERAL NERVE REGENERATION, P1, DOI 10.1017/CBO9780511541759	42	427	449	19	126	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1127	1139		10.1016/j.cell.2015.07.021	http://dx.doi.org/10.1016/j.cell.2015.07.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26279190	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000360589900021
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Sacubitril/Valsartan (Entresto) for Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							NEPRILYSIN INHIBITION; ENALAPRIL						Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2015, MED LETT DRUGS THER, V57, P9; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Packer M, 2015, CIRCULATION, V131, P54, DOI 10.1161/CIRCULATIONAHA.114.013748; Vardeny O, 2014, JACC-HEART FAIL, V2, P663, DOI 10.1016/j.jchf.2014.09.001	4	8	8	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					722	723		10.1001/jama.2015.9398	http://dx.doi.org/10.1001/jama.2015.9398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284725				2022-12-28	WOS:000360019100022
J	Hankey, GJ				Hankey, Graeme J.			Adding neurovascular thrombectomy to IV t-PA reduced disability in acute ischemic stroke Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Western Australia, Perth, WA 6009, Australia	University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Perth, WA 6009, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					JC5	JC5		10.7326/ACPJC-2015-163-4-005	http://dx.doi.org/10.7326/ACPJC-2015-163-4-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26280440				2022-12-28	WOS:000364673500006
J	Kampinga, HH				Kampinga, Harm H.			MOLECULAR BIOLOGY It takes two to untangle	NATURE			English	Editorial Material							PROTEINS; AGGREGATION; PROTEOSTASIS; MACHINES		Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands	University of Groningen	Kampinga, HH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands.	h.h.kampinga@umcg.nl		Kampinga, Harm/0000-0002-8966-8466				Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Kakkar V, 2012, CURR TOP MED CHEM, V12, P2479; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAMPINGA HH, 1993, J CELL SCI, V104, P11; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56	11	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					169	170		10.1038/nature14640	http://dx.doi.org/10.1038/nature14640			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26245378				2022-12-28	WOS:000359386900020
J	de Souza, RJ; Mente, A; Maroleanu, A; Cozma, AI; Ha, V; Kishibe, T; Uleryk, E; Budylowski, P; Schunemann, H; Beyene, J; Anand, SS				de Souza, Russell J.; Mente, Andrew; Maroleanu, Adriana; Cozma, Adrian I.; Ha, Vanessa; Kishibe, Teruko; Uleryk, Elizabeth; Budylowski, Patrick; Schuenemann, Holger; Beyene, Joseph; Anand, Sonia S.			Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; HYDROGENATED VEGETABLE-OILS; DIETARY LINOLEIC-ACID; RED MEAT CONSUMPTION; SUDDEN CARDIAC DEATH; DAIRY PRODUCT INTAKE; ADIPOSE-TISSUE; MYOCARDIAL-INFARCTION; FOOD SOURCES; FOLLOW-UP	OBJECTIVE To systematically review associations between intake of saturated fat and trans unsaturated fat and all cause mortality, cardiovascular disease (CVD) and associated mortality, coronary heart disease (CHD) and associated mortality, ischemic stroke, and type 2 diabetes. DESIGN Systematic review and meta-analysis. DATA SOURCES Medline, Embase, Cochrane Central Registry of Controlled Trials, Evidence-Based Medicine Reviews, and CINAHL from inception to 1 May 2015, supplemented by bibliographies of retrieved articles and previous reviews. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Observational studies reporting associations of saturated fat and/or trans unsaturated fat (total, industrially manufactured, or from ruminant animals) with all cause mortality, CHD/CVD mortality, total CHD, ischemic stroke, or type 2 diabetes. DATA EXTRACTION AND SYNTHESIS Two reviewers independently extracted data and assessed study risks of bias. Multivariable relative risks were pooled. Heterogeneity was assessed and quantified. Potential publication bias was assessed and subgroup analyses were undertaken. The GRADE approach was used to evaluate quality of evidence and certainty of conclusions. RESULTS For saturated fat, three to 12 prospective cohort studies for each association were pooled (five to 17 comparisons with 90 501-339 090 participants). Saturated fat intake was not associated with all cause mortality (relative risk 0.99, 95% confidence interval 0.91 to 1.09), CVD mortality (0.97, 0.84 to 1.12), total CHD (1.06, 0.95 to 1.17), ischemic stroke (1.02, 0.90 to 1.15), or type 2 diabetes (0.95, 0.88 to 1.03). There was no convincing lack of association between saturated fat and CHD mortality (1.15, 0.97 to 1.36; P= 0.10). For trans fats, one to six prospective cohort studies for each association were pooled (two to seven comparisons with 12 942-230 135 participants). Total trans fat intake was associated with all cause mortality (1.34, 1.16 to 1.56), CHD mortality (1.28, 1.09 to 1.50), and total CHD (1.21, 1.10 to 1.33) but not ischemic stroke (1.07, 0.88 to 1.28) or type 2 diabetes (1.10, 0.95 to 1.27). Industrial, but not ruminant, trans fats were associated with CHD mortality (1.18 (1.04 to 1.33) v 1.01 (0.71 to 1.43)) and CHD (1.42 (1.05 to 1.92) v 0.93 (0.73 to 1.18)). Ruminant trans-palmitoleic acid was inversely associated with type 2 diabetes (0.58, 0.46 to 0.74). The certainty of associations between saturated fat and all outcomes was "very low." The certainty of associations of trans fat with CHD outcomes was "moderate" and "very low" to "low" for other associations. CONCLUSIONS Saturated fats are not associated with all cause mortality, CVD, CHD, ischemic stroke, or type 2 diabetes, but the evidence is heterogeneous with methodological limitations. Trans fats are associated with all cause mortality, total CHD, and CHD mortality, probably because of higher levels of intake of industrial trans fats than ruminant trans fats. Dietary guidelines must carefully consider the health effects of recommendations for alternative macronutrients to replace trans fats and saturated fats.	[de Souza, Russell J.; Mente, Andrew; Ha, Vanessa; Beyene, Joseph; Anand, Sonia S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [de Souza, Russell J.; Mente, Andrew; Maroleanu, Adriana; Beyene, Joseph; Anand, Sonia S.] McMaster Univ, Chanchlani Res Ctr, Hamilton, ON L8N 3Z5, Canada; [de Souza, Russell J.; Cozma, Adrian I.; Ha, Vanessa] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [de Souza, Russell J.; Cozma, Adrian I.; Ha, Vanessa; Budylowski, Patrick] St Michaels Hosp, Clin Nutr & Risk Factor Modificat Ctr, Toronto, ON M5B 1W8, Canada; [Mente, Andrew; Anand, Sonia S.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Kishibe, Teruko] St Michaels Hosp, Scotiabank Hlth Sci Lib, Toronto, ON M5B 1W8, Canada; [Uleryk, Elizabeth] Hosp Sick Children, Hosp Lib & Arch, Toronto, ON M5G 1X8, Canada; [Schuenemann, Holger; Anand, Sonia S.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; Population Health Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University	Anand, SS (corresponding author), McMaster Univ, 1280 Main St W,MDCL 3204, Hamilton, ON L8N 3Z5, Canada.	anands@mcmaster.ca	de Souza, Russell J/ABB-7735-2021; Kishibe, Teruko/AAE-5393-2019	de Souza, Russell J/0000-0001-8945-513X; Kishibe, Teruko/0000-0001-8797-7137; Uleryk, Elizabeth/0000-0002-8989-5597; Schunemann, Holger/0000-0003-3211-8479	WHO	WHO(World Health Organization)	This study was funded by WHO, which defrayed costs associated with preparing the draft manuscript, including information specialist and technical support and article retrieval costs. This systematic review was presented by RJdeS at the 5th Nutrition Guidelines Advisory Group (NUGAG) meeting in Hangzhou, China (4-7 March, 2013), the 6th NUGAG meeting in Copenhagen, Denmark (21-24 Oct, 2013), and the 7th NUGAG meeting in Geneva, Switzerland (9-12 Sept, 2014); and via skype during the 8th NUGAG meeting in Fukuoka, Japan (9-12 June, 2015). WHO covered travel and accommodation costs for RJdeS to attend these meetings. The research questions for the review were discussed and developed by the WHO Nutrition Guidance Expert Advisory Group (NUGAG) Subgroup on Diet and Health and the protocol was agreed by the WHO NUGAG Subgroup on Diet and Health; however, neither WHO nor the WHO NUGAG Subgroup on Diet and Health had any role in data collection or analysis.	ABBEY M, 1994, ATHEROSCLEROSIS, V106, P99, DOI 10.1016/0021-9150(94)90086-8; Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1461; Alhazmi A, 2014, PUBLIC HEALTH NUTR, V17, P1587, DOI 10.1017/S1368980013001870; Alhazmi A, 2012, J AM COLL NUTR, V31, P243, DOI 10.1080/07315724.2012.10720425; Allison DB, 1999, J AM DIET ASSOC, V99, P166, DOI 10.1016/S0002-8223(99)00041-3; ARO A, 1995, LANCET, V345, P273, DOI 10.1016/S0140-6736(95)90273-2; Aronis KN, 2012, AM J CLIN NUTR, V96, P1093, DOI 10.3945/ajcn.112.040576; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; Atkinson C, 2011, PUBLIC HEALTH, V125, P345, DOI 10.1016/j.puhe.2011.03.002; Aune D, 2013, CANCER CAUSE CONTROL, V24, P611, DOI 10.1007/s10552-012-0139-z; Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Baylin A, 2003, J NUTR, V133, P1186, DOI 10.1093/jn/133.4.1186; Bendsen NT, 2011, EUR J CLIN NUTR, V65, P773, DOI 10.1038/ejcn.2011.34; Block RC, 2008, AM HEART J, V156, P1117, DOI 10.1016/j.ahj.2008.07.014; Boniface DR, 2002, EUR J CLIN NUTR, V56, P786, DOI 10.1038/sj.ejcn.1601509; Borenstein M, 2008, INTRO METAANALYSIS; Brouwer IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009434; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chajes V, 2008, AM J EPIDEMIOL, V167, P1312, DOI 10.1093/aje/kwn069; Chien KL, 2013, ATHEROSCLEROSIS, V230, P140, DOI 10.1016/j.atherosclerosis.2013.06.015; Chiuve SE, 2009, AM HEART J, V158, P761, DOI 10.1016/j.ahj.2009.08.015; Choi Y, 2013, WORLD J GASTROENTERO, V19, P1020, DOI 10.3748/wjg.v19.i7.1020; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Clifton PM, 2004, J NUTR, V134, P1848; Colon-Ramos U, 2006, J NUTR, V136, P2887, DOI 10.1093/jn/136.11.2887; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; De Goede J, 2015, CIRCULATION, P131; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doell D, 2012, FOOD ADDIT CONTAM A, V29, P861, DOI 10.1080/19440049.2012.664570; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Esrey KL, 1996, J CLIN EPIDEMIOL, V49, P211, DOI 10.1016/0895-4356(95)00066-6; FAO, 2010, FATS FATT AC HUM NUT; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; FEHILY AM, 1993, BRIT J NUTR, V69, P303, DOI 10.1079/BJN19930035; Food Standards Australia New Zealand, TRANS FATT AC; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Franz M.J., 2003, DIABETES CARE, V26, P51; Gayet-Boyer C, 2014, BRIT J NUTR, V112, P1914, DOI 10.1017/S0007114514002578; Gebauer SK, 2011, ADV NUTR, V2, P332, DOI 10.3945/an.111.000521; Ghahremanpour F, 2008, ANN NUTR METAB, V52, P24, DOI 10.1159/000114291; Gillman MW, 1997, JAMA-J AM MED ASSOC, V278, P2145, DOI 10.1001/jama.278.24.2145; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GOLDBOURT U, 1993, CARDIOLOGY, V82, P100, DOI 10.1159/000175862; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; Greenhouse JB, 2009, HDB RES SYNTHESIS ME, P423; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Harcombe Z, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000196; He K, 2003, BRIT MED J, V327, P777, DOI 10.1136/bmj.327.7418.777; Health Canada Statistics Canada Canadian Community Health Survey, 2009, NUTR INT FOOD PROV R, V1-3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hooper Lee, 2015, Cochrane Database Syst Rev, pCD011737, DOI 10.1002/14651858.CD011737; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2010, AM J CLIN NUTR, V91, P1541, DOI 10.3945/ajcn.2010.29622; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jakobsen MU, 2008, INT J EPIDEMIOL, V37, P173, DOI 10.1093/ije/dym243; Jakobsen MU, 2010, AM J CLIN NUTR, V91, P1764, DOI 10.3945/ajcn.2009.29099; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jakobsen MU, 2004, AM J EPIDEMIOL, V160, P141, DOI 10.1093/aje/kwh193; KANNEL WB, 1986, AM HEART J, V112, P825, DOI 10.1016/0002-8703(86)90481-3; KATAN MB, 1995, ANNU REV NUTR, V15, P473, DOI [10.1146/annurev.nu.15.070195.002353, 10.1146/annurev.nutr.15.1.473]; Kemeny Z, 2001, J AM OIL CHEM SOC, V78, P973, DOI 10.1007/s11746-001-0374-0; Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255; Kiage JN, 2014, AM J CLIN NUTR, V99, P1071, DOI 10.3945/ajcn.113.075713; Kiage JN, 2013, AM J CLIN NUTR, V97, P1121, DOI 10.3945/ajcn.112.049064; Kris-Etherton PM, 2012, LIPIDS, V47, P931, DOI 10.1007/s11745-012-3704-z; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kromhout D, 2000, INT J EPIDEMIOL, V29, P260, DOI 10.1093/ije/29.2.260; KUSHI LH, 1985, NEW ENGL J MED, V312, P811, DOI 10.1056/NEJM198503283121302; Laake I, 2012, BRIT J NUTR, V108, P743, DOI 10.1017/S0007114511005897; Larsson SC, 2013, AM J EPIDEMIOL; Lee JE, 2013, AM J CLIN NUTR, V98, P1032, DOI 10.3945/ajcn.113.062638; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; Leosdottir M, 2005, J INTERN MED, V258, P153, DOI 10.1111/j.1365-2796.2005.01520.x; Leosdottir M, 2007, EUR J CARDIOV PREV R, V14, P701, DOI 10.1097/HJR.0b013e3282a56c45; LEREN P, 1970, CIRCULATION, V42, P935, DOI 10.1161/01.CIR.42.5.935; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; Lindstrom J, 2006, DIABETOLOGIA, V49, P912, DOI 10.1007/s00125-006-0198-3; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mahendran Y, 2014, AM J CLIN NUTR, V99, P79, DOI 10.3945/ajcn.113.069740; Mann JI, 1997, HEART, V78, P450, DOI 10.1136/hrt.78.5.450; Mauger JF, 2003, AM J CLIN NUTR, V78, P370, DOI 10.1093/ajcn/78.3.370; MCGEE D, 1985, INT J EPIDEMIOL, V14, P97, DOI 10.1093/ije/14.1.97; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Micha R, 2012, CURR ATHEROSCLER REP, V14, P515, DOI 10.1007/s11883-012-0282-8; Micha R, 2010, LIPIDS, V45, P893, DOI 10.1007/s11745-010-3393-4; Micha R, 2010, AM J CLIN NUTR, V91, P883, DOI 10.3945/ajcn.2009.28877; Misirli G, 2012, AM J EPIDEMIOL, V176, P1185, DOI 10.1093/aje/kws205; Mozaffarian D, 2007, EUR J CLIN NUTR, V61, P1004, DOI 10.1038/sj.ejcn.1602608; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2004, AM J CLIN NUTR, V80, P1521, DOI 10.1093/ajcn/80.6.1521; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Mozaffarian D, 2013, AM J CLIN NUTR, V97, P854, DOI 10.3945/ajcn.112.045468; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1; O'Sullivan TA, 2013, AM J PUBLIC HEALTH, V103, pE31, DOI 10.2105/AJPH.2013.301492; Oh K, 2005, AM J EPIDEMIOL, V161, P672, DOI 10.1093/aje/kwi085; Oomen CM, 2001, LANCET, V357, P746, DOI 10.1016/S0140-6736(00)04166-0; Otto MCD, 2012, AM J CLIN NUTR, V96, P397, DOI 10.3945/ajcn.112.037770; Oxford Centre for Evidence-based Medicine, 2009, LEV EV; Pan A, 2013, JAMA INTERN MED, V173, P1328, DOI 10.1001/jamainternmed.2013.6633; Park Y, 2009, BRIT J NUTR, V102, P1355, DOI 10.1017/S0007114509990298; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Perez-Jimenez F, 2001, DIABETOLOGIA, V44, P2038, DOI 10.1007/s001250100009; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; POSNER BM, 1991, ARCH INTERN MED, V151, P1181, DOI 10.1001/archinte.151.6.1181; Ramsden CE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8707; Rasmussen BM, 2006, AM J CLIN NUTR, V83, P221; Ratnayake WMN, 2009, J AOAC INT, V92, P1258; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; Rohrmann S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-63; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Santaren ID, 2014, AM J CLIN NUTR, V100, P1532, DOI 10.3945/ajcn.114.092544; Sauvaget C, 2004, STROKE, V35, P1531, DOI 10.1161/01.STR.0000130426.52064.09; Scarborough P, 2010, AM J CLIN NUTR, V92, P458, DOI 10.3945/ajcn.2010.29504; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Seino F, 1997, J NUTR SCI VITAMINOL, V43, P83, DOI 10.3177/jnsv.43.83; Seymour D, 1969, CIRCULATION       S2, V40, P1, DOI DOI 10.1161/01.CIR.40.1S2.II-1; Sharma RB, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0492-2; SHEKELLE RB, 1981, NEW ENGL J MED, V304, P65, DOI 10.1056/NEJM198101083040201; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; Simila ME, 2012, EUR J CLIN NUTR, V66, P716, DOI 10.1038/ejcn.2012.24; Siri-Tarino PW, 2010, CURR ATHEROSCLER REP, V12, P384, DOI 10.1007/s11883-010-0131-6; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907; Smith-Warner SA, 2001, INT J CANCER, V92, P767, DOI 10.1002/1097-0215(20010601)92:5&lt;767::AID-IJC1247&gt;3.0.CO;2-0; Song Y, 2004, DIABETES CARE, V27, P2108, DOI 10.2337/diacare.27.9.2108; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stamler J, 2010, AM J CLIN NUTR, V91, P497, DOI 10.3945/ajcn.2010.29216; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun Q, 2007, AM J CLIN NUTR, V86, P929, DOI 10.1093/ajcn/86.4.929; SVENSSON L, 1982, LIPIDS, V17, P50, DOI 10.1007/BF02535122; Tanasescu M, 2004, AM J CLIN NUTR, V79, P999; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; Trichopoulou A, 2006, J INTERN MED, V259, P583, DOI 10.1111/j.1365-2796.2006.01638.x; Tucker KL, 2005, J NUTR, V135, P556, DOI 10.1093/jn/135.3.556; Turcot V, 2014, J HUM NUTR DIET; TURPEINEN O, 1979, INT J EPIDEMIOL, V8, P99, DOI 10.1093/ije/8.2.99; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; vandeVijver LPL, 1996, ATHEROSCLEROSIS, V126, P155, DOI 10.1016/0021-9150(96)05906-0; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Vinikoor LC, 2010, CANCER CAUSE CONTROL, V21, P171, DOI 10.1007/s10552-009-9447-3; Virtanen JK, 2014, ARTERIOSCL THROM VAS, V34, P2679, DOI 10.1161/ATVBAHA.114.304082; Wakai K, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-12; Wang Q, 2014, CIRCULATION, V129, P1099; Wang QY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000914; [王涛 Wang Tao], 2011, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V31, P1164; Wells G., NEWCASTLE OTTAWA SCA; Wennberg M, 2009, PUBLIC HEALTH NUTR, V12, P1477, DOI 10.1017/S1368980008004503; Wiberg B, 2006, STROKE, V37, P2898, DOI 10.1161/01.STR.0000249056.24657.8b; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; WILLETT WC, 1994, AM J PUBLIC HEALTH, V84, P722, DOI 10.2105/AJPH.84.5.722; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, WHO HDB GUID DEV; Wright JD, 2003, DIETARY INTAKES 10 K; Xu JQ, 2006, AM J CLIN NUTR, V84, P894, DOI 10.1093/ajcn/84.4.894; Yaemsiri S, 2012, ANN NEUROL, V72, P704, DOI 10.1002/ana.23555; Yakoob MY, 2013, CIRCULATION, V127; Yamagishi K, 2013, CEREBROVASC DIS, V36, P38, DOI [10.1159/000351205, 10.1159/000351151]; Yamagishi K, 2013, EUR HEART J, V34, P1225, DOI 10.1093/eurheartj/eht043; Zhu HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070955	178	712	724	16	270	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2015	351								h3978	10.1136/bmj.h3978	http://dx.doi.org/10.1136/bmj.h3978			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XN	26268692	Green Published, hybrid			2022-12-28	WOS:000359741200003
J	McCartney, M				McCartney, Margaret			Margaret McCartney: The power of patients' stories	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2015	351								h4259	10.1136/bmj.h4259	http://dx.doi.org/10.1136/bmj.h4259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XA	26261244	Green Published, Bronze			2022-12-28	WOS:000359739800001
J	Tessler, ZD; Vorosmarty, CJ; Grossberg, M; Gladkova, I; Aizenman, H; Syvitski, JPM; Foufoula-Georgiou, E				Tessler, Z. D.; Voeroesmarty, C. J.; Grossberg, M.; Gladkova, I.; Aizenman, H.; Syvitski, J. P. M.; Foufoula-Georgiou, E.			Profiling risk and sustainability in coastal deltas of the world	SCIENCE			English	Article							SEA-LEVEL RISE; IMPACT; VULNERABILITY; TRENDS	Deltas are highly sensitive to increasing risks arising from local human activities, land subsidence, regional water management, global sea-level rise, and climate extremes. We quantified changing flood risk due to extreme events using an integrated set of global environmental, geophysical, and social indicators. Although risks are distributed across all levels of economic development, wealthy countries effectively limit their present-day threat by gross domestic product-enabled infrastructure and coastal defense investments. In an energy-constrained future, such protections will probably prove to be unsustainable, raising relative risks by four to eight times in the Mississippi and Rhine deltas and by one-and-a-half to four times in the Chao Phraya and Yangtze deltas. The current emphasis on short-term solutions for the world's deltas will greatly constrain options for designing sustainable solutions in the long term.	[Tessler, Z. D.; Voeroesmarty, C. J.] CUNY, Environm CrossRd Initiat, New York, NY 10031 USA; [Voeroesmarty, C. J.] CUNY City Coll, Dept Civil Engn, New York, NY 10031 USA; [Grossberg, M.; Gladkova, I.; Aizenman, H.] CUNY City Coll, Dept Comp Sci, New York, NY 10031 USA; [Syvitski, J. P. M.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Foufoula-Georgiou, E.] Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities	Tessler, ZD (corresponding author), CUNY, Environm CrossRd Initiat, New York, NY 10031 USA.	ztessler@ccny.cuny.edu		Syvitski, Jaia/0000-0003-3116-6997; Foufoula-Georgiou, Efi/0000-0003-1078-231X	NASA [NNX12AD28G]; NSF [1343458, 1342944, 1115025]; Division Of Earth Sciences [1242458] Funding Source: National Science Foundation; ICER [1342944, 1343458] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Data are available as supplementary materials on Science Online. This work was supported by NASA (Land Cover/Land Use Change Program grant NNX12AD28G) and NSF (Belmont Forum Coastal Vulnerability awards 1343458 and 1342944, and Dynamics of Coupled Natural and Human Systems award 1115025). The authors report no conflicts of interest. The authors thank B. Fekete and P. Green for helpful comments on the manuscript.	Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Bucx T, 2010, 1 DELT ALL INT; Budiyono Y, 2015, NAT HAZARDS, V75, P389, DOI 10.1007/s11069-014-1327-9; Cutter SL, 1996, PROG HUM GEOG, V20, P529, DOI 10.1177/030913259602000407; Dankers R, 2014, P NATL ACAD SCI USA, V111, P3257, DOI 10.1073/pnas.1302078110; Day JW, 2014, ECOL ENG, V65, P33, DOI 10.1016/j.ecoleng.2013.08.003; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Ericson JP, 2006, GLOBAL PLANET CHANGE, V50, P63, DOI 10.1016/j.gloplacha.2005.07.004; GORNITZ V, 1991, GLOBAL PLANET CHANGE, V89, P379, DOI 10.1016/0921-8181(91)90118-G; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Higgins S, 2013, GEOPHYS RES LETT, V40, P3898, DOI 10.1002/grl.50758; Horton BP, 2014, QUATERNARY SCI REV, V84, P1, DOI 10.1016/j.quascirev.2013.11.002; Jevrejeva S, 2014, GLOBAL PLANET CHANGE, V113, P11, DOI 10.1016/j.gloplacha.2013.12.004; Kabat P, 2009, NAT GEOSCI, V2, P450, DOI 10.1038/ngeo572; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kuenzer C, 2013, SUSTAIN SCI, V8, P565, DOI 10.1007/s11625-012-0195-z; Mazzotti S, 2009, GEOLOGY, V37, P771, DOI 10.1130/G25640A.1; National Research Council, 2010, LANDSC EDG NEW HOR R; Renaud FG, 2013, CURR OPIN ENV SUST, V5, P644, DOI 10.1016/j.cosust.2013.11.007; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Syvitski JPM, 2007, GLOBAL PLANET CHANGE, V57, P261, DOI 10.1016/j.gloplacha.2006.12.001; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; U.S. Energy Information Administration, 2015, DOEEIA0383; Van Koningsveld M, 2008, J COASTAL RES, V24, P367, DOI 10.2112/07A-0010.1; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty C. J., 2013, PHILOS T R SOC LON A, V371; Vorosmarty CJ, 2003, GLOBAL PLANET CHANGE, V39, P169, DOI 10.1016/S0921-8181(03)00023-7; Wang HJ, 2007, GLOBAL PLANET CHANGE, V57, P331, DOI 10.1016/j.gloplacha.2007.01.003; Woodroffe CD, 2006, COAST SYST CONT MARG, V10, P277; Yang YCE, 2015, NAT HAZARDS, V75, P2773, DOI 10.1007/s11069-014-1459-y; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0	33	324	335	27	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					638	643		10.1126/science.aab3574	http://dx.doi.org/10.1126/science.aab3574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250684	Green Published			2022-12-28	WOS:000359092900041
J	Glasziou, P				Glasziou, Paul			Music in hospital	LANCET			English	Editorial Material									Bond Univ, Ctr Res Evidence Based Practice, Robina, Qld 4229, Australia	Bond University	Glasziou, P (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Robina, Qld 4229, Australia.	paul_glasziou@bond.edu.au	Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				Bradt J, 2013, COCHRANE DB SYST REV, V12; Bradt J, 2014, COCHRANE DB SYST REV, V12; Glasziou PP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001690; GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126; Hole J, 2015, LANCET; Levitin D.J., 2007, THIS IS YOUR BRAIN M	6	2	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1609	1610		10.1016/S0140-6736(15)60640-7	http://dx.doi.org/10.1016/S0140-6736(15)60640-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU0HS	26277245				2022-12-28	WOS:000363197500009
J	Grun, D; Lyubimova, A; Kester, L; Wiebrands, K; Basak, O; Sasaki, N; Clevers, H; van Oudenaarden, A				Grun, Dominic; Lyubimova, Anna; Kester, Lennart; Wiebrands, Kay; Basak, Onur; Sasaki, Nobuo; Clevers, Hans; van Oudenaarden, Alexander			Single-cell messenger RNA sequencing reveals rare intestinal cell types	NATURE			English	Article							STEM-CELLS; SEQ; DIFFERENTIATION; HETEROGENEITY; LINEAGE; COLON; CRYPT	Understanding the development and function of an organ requires the characterization of all of its cell types. Traditional methods for visualizing and isolating subpopulations of cells are based on messenger RNA or protein expression of only a few known marker genes. The unequivocal identification of a specific marker gene, however, poses a major challenge, particularly if this cell type is rare. Identifying rare cell types, such as stem cells, short-lived progenitors, cancer stem cells, or circulating tumour cells, is crucial to acquire a better understanding of normal or diseased tissue biology. To address this challenge we first sequenced the transcriptome of hundreds of randomly selected cells from mouse intestinal organoids(1), cultured self-organizing epithelial structures that contain all cell lineages of the mammalian intestine. Organoid buds, like intestinal crypts, harbour stem cells that continuously differentiate into a variety of cell types, occurring at widely different abundances(2). Since available computational methods can only resolve more abundant cell types, we developed RaceID, an algorithm for rare cell type identification in complex populations of single cells. We demonstrate that this algorithm can resolve cell types represented by only a single cell in a population of randomly sampled organoid cells. We use this algorithm to identify Reg4 as a novel marker for enteroendocrine cells, a rare population of hormone-producing intestinal cells(3). Next, we use Reg4 expression to enrich for these rare cells and investigate the heterogeneity within this population. RaceID confirmed the existence of known enteroendocrine lineages, and moreover discovered novel subtypes, which we subsequently validated in vivo. Having validated RaceID we then applied the algorithm to ex vivo-isolated Lgr5-positive stem cells and their direct progeny. We find that Lgr5-positive cells represent a homogenous abundant population of stem cells mixed with a rare population of Lgr5-positive secretory cells. We envision broad applicability of our method for discovering rare cell types and the corresponding marker genes in healthy and diseased organs.	[Grun, Dominic; Lyubimova, Anna; Kester, Lennart; Wiebrands, Kay; Basak, Onur; Sasaki, Nobuo; Clevers, Hans; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Grun, Dominic; Lyubimova, Anna; Kester, Lennart; Wiebrands, Kay; Basak, Onur; Sasaki, Nobuo; Clevers, Hans; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Oudenaarden, A (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands.	a.vanoudenaarden@hubrecht.eu	Sasaki, Nobuo/HDO-8251-2022; Basak, Onur/GLV-6113-2022; van Oudenaarden, Alexander/AAA-1705-2019	Sasaki, Nobuo/0000-0002-8798-7244; Basak, Onur/0000-0002-6864-3403; Kester, Lennart/0000-0002-8259-9971	European Research Council [ERC-AdG 294325-GeneNoiseControl]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award	European Research Council(European Research Council (ERC)European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award(Netherlands Organization for Scientific Research (NWO))	This work was supported by an European Research Council Advanced grant (ERC-AdG 294325-GeneNoiseControl) and a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award.	Baker ME, 2002, J ENDOCRINOL, V175, P121, DOI 10.1677/joe.0.1750121; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Egerod KL, 2012, ENDOCRINOLOGY, V153, P5782, DOI 10.1210/en.2012-1595; Engelstoft MS, 2013, CURR OPIN PHARMACOL, V13, P912, DOI 10.1016/j.coph.2013.09.018; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li N, 2014, STEM CELL REP, V3, P876, DOI 10.1016/j.stemcr.2014.09.011; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Saruta M, 2005, PEPTIDES, V26, P1196, DOI 10.1016/j.peptides.2005.01.014; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737	31	677	692	14	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					251	+		10.1038/nature14966	http://dx.doi.org/10.1038/nature14966			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26287467				2022-12-28	WOS:000360927400039
J	Koren, S; Reavie, L; Couto, JP; De Silva, D; Stadler, MB; Roloff, T; Britschgi, A; Eichlisberger, T; Kohler, H; Aina, O; Cardiff, RD; Bentires-Alj, M				Koren, Shany; Reavie, Linsey; Couto, Joana Pinto; De Silva, Duvini; Stadler, Michael B.; Roloff, Tim; Britschgi, Adrian; Eichlisberger, Tobias; Kohler, Hubertus; Aina, Olulanu; Cardiff, Robert D.; Bentires-Alj, Mohamed			PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours	NATURE			English	Article							STEM-CELLS; GLAND; MOUSE; BASAL; EXPRESSION; PROGENITORS; POPULATION; MUTATIONS	The adult mouse mammary epithelium contains self-sustained cell lineages that form the inner luminal and outer basal cell layers, with stem and progenitor cells contributing to its proliferative and regenerative potential(1-4). A key issue in breast cancer biology is the effect of genomic lesions in specific mammary cell lineages on tumour heterogeneity and progression. The impact of transforming events on fate conversion in cancer cells of origin and thus their contribution to tumour heterogeneity remains largely elusive. Using in situ genetic lineage tracing and limiting dilution transplantation, we have unravelled the potential of PIK3CA(H1047R), one of the most frequent mutations occurring in human breast cancer(5), to induce multipotency during tumorigenesis in the mammary gland. Here we show that expression of PIK3CA(H1047R) in lineage-committed basal Lgr5-positive and luminal keratin-8-positive cells of the adult mouse mammary gland evokes cell dedifferentiation into a multipotent stem-like state, suggesting this to be a mechanism involved in the formation of heterogeneous, multi-lineage mammary tumours. Moreover, we show that the tumour cell of origin influences the frequency of malignant mammary tumours. Our results define a key effect of PIK3CA(H1047R) on mammary cell fate in the pre-neoplastic mammary gland and show that the cell of origin of PIK3CA(H1047R) tumours dictates their malignancy, thus revealing a mechanism underlying tumour heterogeneity and aggressiveness.	[Koren, Shany; Reavie, Linsey; Couto, Joana Pinto; De Silva, Duvini; Stadler, Michael B.; Roloff, Tim; Britschgi, Adrian; Eichlisberger, Tobias; Kohler, Hubertus; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland; [Stadler, Michael B.] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Aina, Olulanu; Cardiff, Robert D.] Univ Calif Davis, Dept Pathol, Ctr Comparat Med, Davis, CA 95616 USA	Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; University of California System; University of California Davis	Bentires-Alj, M (corresponding author), Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland.	Bentires@fmi.ch	; Bentires-Alj, Mohamed/F-4484-2015	Eichlisberger, Tobias/0000-0003-3293-5962; Bentires-Alj, Mohamed/0000-0001-6344-1127; Koren, Shany/0000-0002-3695-4194	National Cancer Institute [U01 CA141582]; Novartis Research Foundation; European Research Council (ERC) [243211-PTPsBDC]; Swiss Cancer League; Swiss National Foundation; Krebsliga Beider Basel; NATIONAL CANCER INSTITUTE [U01CA141582] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis Research Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Swiss Cancer League; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Krebsliga Beider Basel; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank R. Thierry for help with image processing and quantification, S. Bichet and A. Bogucki for assistance with immunohistochemical staining, S. Thiry for assistance with the microarray analysis, L. Gelman, S. Bourke and M. Kirschmann for help with microscopy, C. Blanpain, B. Roska, B. Kinzel, J. Tchorz and A. Isken for providing mouse lines, and members of the Bentires-Alj group for their feedback. O.A. and R.D.C. were supported by National Cancer Institute grant U01 CA141582. Research in the laboratory of M. B.-A. is supported by the Novartis Research Foundation, the European Research Council (ERC starting grant 243211-PTPsBDC), the Swiss Cancer League, the Swiss National Foundation, and the Krebsliga Beider Basel.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; DEOME KB, 1959, CANCER RES, V19, P515; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koren S, 2013, FEBS J, V280, P2758, DOI 10.1111/febs.12175; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Meier-Abt F, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3419; Meyer DS, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.38; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tao LW, 2014, STEM CELL REP, V2, P770, DOI 10.1016/j.stemcr.2014.04.004; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851	32	195	200	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					114	+		10.1038/nature14669	http://dx.doi.org/10.1038/nature14669			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26266975				2022-12-28	WOS:000360594100036
J	Ackerman, LKG; Lovell, MM; Weix, DJ				Ackerman, Laura K. G.; Lovell, Matthew M.; Weix, Daniel J.			Multimetallic catalysed cross-coupling of aryl bromides with aryl triflates	NATURE			English	Article							UNACTIVATED ARENES; HALIDES; TRANSITION; IODOARENES; ARYLATION; BIARYLS; COBALT	The advent of transition-metal catalysed strategies for forming new carbon-carbon bonds has revolutionized the field of organic chemistry, enabling the efficient synthesis of ligands, materials, and biologically active molecules(1-3). In cases where a single metal fails to promote a selective or efficient transformation, the synergistic cooperation(4) of two distinct catalysts-multimetallic catalysis-can be used instead. Many important reactions rely on multimetallic catalysis(5-10), such as the Wacker oxidation of olefins(6-8) and the Sonogashira coupling of alkynes with aryl halides(9,10), but this approach has largely been limited to the use of metals with distinct reactivities, with only one metal catalyst undergoing oxidative addition(11,12). Here, we demonstrate that cooperativity between two group 10 metal catalysts-(bipyridine)nickel and (1,3-bis(diphenylphosphino) propane) palladiumenables a general cross-Ullmann reaction (the cross-coupling of two different aryl electrophiles)(13-15). Our method couples aryl bromides with aryl triflates directly, eliminating the use of arylmetal reagents and avoiding the challenge of differentiating between multiple carbon-hydrogen bonds that is required for direct arylation methods(16,17). Selectivity can be achieved without an excess of either substrate and originates from the orthogonal reactivity of the two catalysts and the relative stability of the two arylmetal intermediates. While (1,3-bis(diphenylphosphino) propane) palladium reacts preferentially with aryl triflates to afford a persistent intermediate, (bipyridine) nickel reacts preferentially with aryl bromides to form a transient, reactive intermediate. Although each catalyst forms less than 5 per cent cross-coupled product in isolation, together they are able to achieve a yield of up to 94 per cent. Our results reveal a new method for the synthesis of biaryls, heteroaryls, and dienes, as well as a general mechanism for the selective transfer of ligands between two metal catalysts. We anticipate that this reaction will simplify the synthesis of pharmaceuticals, many of which are currently made with pre-formed organometallic reagents(1-3), and lead to the discovery of new multimetallic reactions.	[Ackerman, Laura K. G.; Lovell, Matthew M.; Weix, Daniel J.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of Rochester	Weix, DJ (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	daniel.weix@rochester.edu		Weix, Daniel/0000-0002-9552-3378	NIH [R01 GM097243]; NSF [NSF DGE-1419118]; Elon Huntington Hooker Fellowship (Univ. Rochester); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Elon Huntington Hooker Fellowship (Univ. Rochester); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (R01 GM097243). L.K.G.A acknowledges both an NSF Graduate Fellowship (NSF DGE-1419118) and an Elon Huntington Hooker Fellowship (Univ. Rochester). D.J.W is an Alfred P. Sloan Research Fellow and a Camille Dreyfus Teacher Scholar. We thank Z. Melchor (Univ. Rochester) for preliminary exploration of coupling electron-poor aryl halides, and S. Wu for assistance with graphics.	Ackermann L., 2009, MODERN ARYLATION MET; Allen AE, 2012, CHEM SCI, V3, P633, DOI 10.1039/c2sc00907b; Busacca CA, 2011, ADV SYNTH CATAL, V353, P1825, DOI 10.1002/adsc.201100488; Chinchilla R, 2007, CHEM REV, V107, P874, DOI 10.1021/cr050992x; Durak LJ, 2014, ORGANOMETALLICS, V33, P620, DOI 10.1021/om401221v; Everson DA, 2012, J AM CHEM SOC, V134, P6146, DOI 10.1021/ja301769r; FANTA PE, 1974, SYNTHESIS-STUTTGART, P9, DOI 10.1055/s-1974-23219; Fischer H, 2001, CHEM REV, V101, P3581, DOI 10.1021/cr990124y; Gomes P, 2002, TETRAHEDRON, V58, P8417, DOI 10.1016/S0040-4020(02)01030-X; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Hatakeyama T, 2009, J AM CHEM SOC, V131, P11949, DOI 10.1021/ja9039289; Kamikawa T, 1997, TETRAHEDRON LETT, V38, P7087, DOI 10.1016/S0040-4039(97)01655-9; Ko S, 2005, ANGEW CHEM INT EDIT, V44, P455, DOI 10.1002/anie.200462006; Lipshutz B. H., 2013, ORGANOMETALLICS SYNT, P319; Littke AF, 2000, J AM CHEM SOC, V122, P4020, DOI 10.1021/ja0002058; Magano J, 2011, CHEM REV, V111, P2177, DOI 10.1021/cr100346g; Michel B.W., 2014, ORG REACTIONS, P75, DOI [10.1002/0471264180.or084.02, DOI 10.1002/0471264180.OR084.02]; Panteleev J, 2011, ANGEW CHEM INT EDIT, V50, P9089, DOI 10.1002/anie.201103692; Perez-Temprano MH, 2012, CHEM-EUR J, V18, P1864, DOI 10.1002/chem.201102888; Proutiere F, 2011, ANGEW CHEM INT EDIT, V50, P8192, DOI 10.1002/anie.201101746; Rosen BM, 2011, CHEM REV, V111, P1346, DOI 10.1021/cr100259t; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Shibasaki M., 2004, MULTIMETALLIC CATALY; SMIDT J, 1962, ANGEW CHEM INT EDIT, V74, P93, DOI 10.1002/ange.19620740302; SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467, DOI 10.1016/s0040-4039(00)91094-3; Stuart DR, 2007, SCIENCE, V316, P1172, DOI 10.1126/science.1141956; Studer A, 2001, CHEM-EUR J, V7, P1159, DOI 10.1002/1521-3765(20010316)7:6<1159::AID-CHEM1159>3.0.CO;2-I; Takacs JM, 2003, CURR ORG CHEM, V7, P369, DOI 10.2174/1385272033372851; Ullmann F, 1901, BER DTSCH CHEM GES, V34, P2174, DOI 10.1002/cber.190103402141; Weber D, 2011, CHEM COMMUN, V47, P5172, DOI 10.1039/c1cc11055a	30	186	186	10	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					454	+		10.1038/nature14676	http://dx.doi.org/10.1038/nature14676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26280337	Green Accepted			2022-12-28	WOS:000360069300035
J	Grubert, F; Zaugg, JB; Kasowski, M; Ursu, O; Spacek, DV; Martin, AR; Greenside, P; Srivas, R; Phanstiel, DH; Pekowska, A; Heidari, N; Euskirchen, G; Huber, W; Pritchard, JK; Bustamante, CD; Steinmetz, LM; Kundaje, A; Snyder, M				Grubert, Fabian; Zaugg, Judith B.; Kasowski, Maya; Ursu, Oana; Spacek, Damek V.; Martin, Alicia R.; Greenside, Peyton; Srivas, Rohith; Phanstiel, Doug H.; Pekowska, Aleksandra; Heidari, Nastaran; Euskirchen, Ghia; Huber, Wolfgang; Pritchard, Jonathan K.; Bustamante, Carlos D.; Steinmetz, Lars M.; Kundaje, Anshul; Snyder, Michael			Genetic Control of Chromatin States in Humans Involves Local and Distal Chromosomal Interactions	CELL			English	Article							LONG-RANGE INTERACTION; HUMAN GENOME; SUSCEPTIBILITY LOCI; ALZHEIMERS-DISEASE; CROHNS-DISEASE; HUMAN-CELLS; VARIANTS; DNA; TRANSCRIPTION; METAANALYSIS	Deciphering the impact of genetic variants on gene regulation is fundamental to understanding human disease. Although gene regulation often involves long-range interactions, it is unknown to what extent non-coding genetic variants influence distal molecular phenotypes. Here, we integrate chromatin profiling for three histone marks in lymphoblastoid cell lines (LCLs) from 75 sequenced individuals with LCL-specific Hi-C and ChIA-PET-based chromatin contact maps to uncover one of the largest collections of local and distal histone quantitative trait loci (hQTLs). Distal QTLs are enriched within topologically associated domains and exhibit largely concordant variation of chromatin state coordinated by proximal and distal non-coding genetic variants. Histone QTLs are enriched for common variants associated with autoimmune diseases and enable identification of putative target genes of disease-associated variants from genome-wide association studies. These analyses provide insights into how genetic variation can affect human disease phenotypes by coordinated changes in chromatin at interacting regulatory elements.	[Grubert, Fabian; Zaugg, Judith B.; Kasowski, Maya; Ursu, Oana; Spacek, Damek V.; Martin, Alicia R.; Srivas, Rohith; Phanstiel, Doug H.; Heidari, Nastaran; Euskirchen, Ghia; Pritchard, Jonathan K.; Bustamante, Carlos D.; Steinmetz, Lars M.; Kundaje, Anshul; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Zaugg, Judith B.; Pekowska, Aleksandra; Huber, Wolfgang; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Greenside, Peyton] Stanford Univ, Sch Med, Biomed Informat Grad Training Program, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; European Molecular Biology Laboratory (EMBL); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Kundaje, Anshul/Y-2598-2019; Kundaje, Anshul/Y-2739-2019; Pekowska, Aleksandra/AAC-5143-2020	Kundaje, Anshul/0000-0003-3084-2287; Kundaje, Anshul/0000-0003-3084-2287; Pekowska, Aleksandra/0000-0002-0425-4388; Huber, Wolfgang/0000-0002-0474-2218; Ursu, Oana/0000-0001-8743-4730; Srivas, Rohith/0000-0001-9495-9949; Snyder, Michael/0000-0003-0784-7987; Steinmetz, Lars/0000-0002-3962-2865; Bustamante, Carlos D./0000-0002-4187-7920; Zaugg, Judith B./0000-0001-8324-4040; Martin, Alicia/0000-0003-0241-3522	Vera Moulton Wall Center for Pulmonary Vascular Disease; Swiss National Foundation; NIH Medical Scientist Training Program Training Grant [T32GM007205]; Gabilan Stanford Graduate Fellowship; NIH/NHGRI [T32 HG000044]; Genentech Graduate Fellowship; NIH Genetics and Developmental Biology Training Program [T32 GM007790]; Stanford Biomedical Informatics Training Grant from the National Library of Medicine [LM-07033]; Damon Runyon Cancer Research Foundation [DRG-2187-14, DRG-2122-12]; EC; NIH [R01ES025009, U41-HG007000-02S1, 5U54HG006996-03, 5U01HL107393-04]; European Research Council; Alfred Sloan Foundation; Genetics Department, Stanford University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393, R01HL122887] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007000, P50HG007735, T32HG000044, U01HG007919, K99HG008662, U54HG006996, P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, T32GM007790] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Vera Moulton Wall Center for Pulmonary Vascular Disease; Swiss National Foundation(Swiss National Science Foundation (SNSF)); NIH Medical Scientist Training Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabilan Stanford Graduate Fellowship; NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Genentech Graduate Fellowship; NIH Genetics and Developmental Biology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Biomedical Informatics Training Grant from the National Library of Medicine; Damon Runyon Cancer Research Foundation; EC(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Alfred Sloan Foundation(Alfred P. Sloan Foundation); Genetics Department, Stanford University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Our work was supported by grants from the Vera Moulton Wall Center for Pulmonary Vascular Disease (F.G., M.K.), Swiss National Foundation (J.B.Z.), NIH Medical Scientist Training Program Training Grant T32GM007205 (M.K.), Gabilan Stanford Graduate Fellowship (O.U.), NIH/NHGRI T32 HG000044 and the Genentech Graduate Fellowship (D.V.S), NIH Genetics and Developmental Biology Training Program T32 GM007790 (A.R.M), the Stanford Biomedical Informatics Training Grant from the National Library of Medicine (LM-07033) (P.G.), R.S. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2187-14), D.H.P. is a Damon Runyon fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2122-12), EC FP7 project "RADIANT'' (A.P., W.H.), NIH and from the European Research Council (L.M.S), Alfred Sloan Foundation and NIH R01ES025009 and NIH U41-HG007000-02S1 (subcontract) (A.K.), NIH 5U54HG006996-03 and 5U01HL107393-04, and Genetics Department, Stanford University (M.S.). C.D.B. is a founder of Identify Genomics and a science advisory board member for AncestryDNA, InVitae, Personalis and Identify Genomics; L.M.S. is a founder and member of the science advisory board for Sophia Genetics; M.S. is a founder and member of the science advisory board of Personalis and a science advisory board member of Genapsys and AxioMX. We would like to thank Prof. Stephen Montgomery and members of the M.S. lab for critical comments on the manuscript. We would also like to thank Gerald Quon and Abhishek Sarkar for sharing GWAS summary statistics and SCGPM and SCG3 administrators for compute support and supplementary website hosting.	Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Phanstiel DH, 2015, BIOINFORMATICS; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	39	200	206	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1051	1065		10.1016/j.cell.2015.07.048	http://dx.doi.org/10.1016/j.cell.2015.07.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26300125	Bronze, Green Accepted			2022-12-28	WOS:000360589900015
J	Tylee, T; Hirsch, IB				Tylee, Tracy; Hirsch, Irl B.			Costs Associated With Using Different Insulin Preparations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tylee, Tracy; Hirsch, Irl B.] Univ Washington, Sch Med, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Hirsch, IB (corresponding author), Univ Washington, Sch Med, 4245 Roosevelt Way NE,Third Floor, Seattle, WA 98105 USA.	ihirsch@uw.edu						Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Gal A, 2013, NOVO NORDISK INSULIN; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Jehle PM, 1999, LANCET, V354, P1604, DOI 10.1016/S0140-6736(98)12459-5; Lipska KJ, 2014, JAMA-J AM MED ASSOC, V311, P2331, DOI 10.1001/jama.2014.6316; Mannucci E, 2009, DIABETES OBES METAB, V11, P53, DOI 10.1111/j.1463-1326.2008.00934.x; Mendosa D, 2001, IS COST INSULIN SKYR; Muller N, 2013, DIABETES CARE, V36, P1865, DOI 10.2337/dc12-1694	8	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					665	666		10.1001/jama.2015.7032	http://dx.doi.org/10.1001/jama.2015.7032			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284715				2022-12-28	WOS:000360019100010
J	Long, MD				Long, Maureen D.			How mountains get made	SCIENCE			English	Editorial Material							CRUSTAL DEFORMATION; TAIWAN; ANISOTROPY; DEEP		Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Yale University	Long, MD (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	maureen.long@yale.edu	Long, Maureen D/A-1383-2009	Long, Maureen D/0000-0003-1936-3840				COWARD MP, 1983, J STRUCT GEOL, V5, P113, DOI 10.1016/0191-8141(83)90037-8; DAVIS D, 1983, J GEOPHYS RES, V88, P1153, DOI 10.1029/JB088iB02p01153; Huang TY, 2015, SCIENCE, V349, P720, DOI 10.1126/science.aab1879; Ko B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7586; Long MD, 2010, EARTH PLANET SC LETT, V297, P341, DOI 10.1016/j.epsl.2010.06.036; Moschetti MP, 2010, NATURE, V464, P885, DOI 10.1038/nature08951; Pfiffner OA, 2006, GEOL SOC AM SPEC PAP, V414, P153, DOI 10.1130/2006.2414(09); Schulte-Pelkum V, 2014, EARTH PLANET SC LETT, V402, P221, DOI 10.1016/j.epsl.2014.01.050; Ward D, 2012, GEOPHYS J INT, V190, P1123, DOI 10.1111/j.1365-246X.2012.05528.x; Wu FT, 2014, J ASIAN EARTH SCI, V90, P173, DOI 10.1016/j.jseaes.2014.03.024; Wu FT, 1997, TECTONOPHYSICS, V274, P191, DOI 10.1016/S0040-1951(96)00304-6	11	1	1	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					687	688		10.1126/science.aac8671	http://dx.doi.org/10.1126/science.aac8671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273039				2022-12-28	WOS:000359415100015
J	Volkow, ND; Morales, M				Volkow, Nora D.; Morales, Marisela			The Brain on Drugs: From Reward to Addiction	CELL			English	Review							VENTRAL TEGMENTAL AREA; DOPAMINE D2 RECEPTORS; POSITRON-EMISSION-TOMOGRAPHY; COCAINE-INDUCED PLASTICITY; MEDIAL PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS SHELL; DORSAL STRIATUM; SYNAPTIC PLASTICITY; LATERAL HABENULA; ORBITOFRONTAL CORTEX	Advances in neuroscience identified addiction as a chronic brain disease with strong genetic, neurodevelopmental, and sociocultural components. We here discuss the circuit-and cell-level mechanisms of this condition and its co-option of pathways regulating reward, self-control, and affect. Drugs of abuse exert their initial reinforcing effects by triggering supraphysiologic surges of dopamine in the nucleus accumbens that activate the direct striatal pathway via D1 receptors and inhibit the indirect striato-cortical pathway via D2 receptors. Repeated drug administration triggers neuroplastic changes in glutamatergic inputs to the striatum and midbrain dopamine neurons, enhancing the brain's reactivity to drug cues, reducing the sensitivity to non-drug rewards, weakening self-regulation, and increasing the sensitivity to stressful stimuli and dysphoria. Drug-induced impairments are long lasting; thus, interventions designed to mitigate or even reverse them would be beneficial for the treatment of addiction.	[Volkow, Nora D.; Morales, Marisela] NIDA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000543] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Al-Hasani R, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00096; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; BANNON MJ, 1983, PHARMACOL REV, V35, P53; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Berrendero F, 2010, NEUROSCI BIOBEHAV R, V35, P220, DOI 10.1016/j.neubiorev.2010.02.006; Black KJ, 2010, J NEUROSCI, V30, P16284, DOI 10.1523/JNEUROSCI.2590-10.2010; Bloomfield MAP, 2014, PSYCHOPHARMACOLOGY, V231, P2251, DOI 10.1007/s00213-014-3523-4; Bock R, 2013, NAT NEUROSCI, V16, P632, DOI 10.1038/nn.3369; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Bowers MS, 2010, NEURON, V67, P11, DOI 10.1016/j.neuron.2010.06.004; Butelman ER, 2012, TRENDS NEUROSCI, V35, P587, DOI 10.1016/j.tins.2012.05.005; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; Caine SB, 2012, EXP CLIN PSYCHOPHARM, V20, P352, DOI 10.1037/a0029135; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Cheer J. F., 2014, BRAIN RES; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Chiuccariello L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060382; Cohen JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06346; Commons KG, 2009, J CHEM NEUROANAT, V38, P273, DOI 10.1016/j.jchemneu.2009.05.005; Conrad KL, 2010, NEUROSCIENCE, V169, P182, DOI 10.1016/j.neuroscience.2010.04.056; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cruz FC, 2014, J NEUROSCI, V34, P7437, DOI 10.1523/JNEUROSCI.0238-14.2014; Danjo T, 2014, P NATL ACAD SCI USA, V111, P6455, DOI 10.1073/pnas.1404323111; De Roo M, 2008, PROG BRAIN RES, V169, P199, DOI 10.1016/S0079-6123(07)00011-8; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Forti M, 2014, SCHIZOPHRENIA BULL, V40, P1509, DOI 10.1093/schbul/sbt181; Dobi A, 2011, J NEUROSCI, V31, P1895, DOI 10.1523/JNEUROSCI.5375-10.2011; Domino EF, 2015, PROG NEURO-PSYCHOPH, V59, P100, DOI 10.1016/j.pnpbp.2015.01.007; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Ehrich JM, 2014, NEUROPSYCHOPHARMACOL, V39, P3036, DOI 10.1038/npp.2014.157; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Fiorentini C, 2010, CURR OPIN PHARMACOL, V10, P87, DOI 10.1016/j.coph.2009.09.008; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Fonseca MS, 2015, CURR BIOL, V25, P306, DOI 10.1016/j.cub.2014.12.002; Georges F, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0003.2001; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gianoulakis C, 2009, CURR TOP MED CHEM, V9, P999, DOI 10.2174/156802609789630956; Giuliano C, 2013, PSYCHOPHARMACOLOGY, V227, P137, DOI 10.1007/s00213-012-2949-9; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gore BB, 2013, J NEUROSCI, V33, P8640, DOI 10.1523/JNEUROSCI.5532-12.2013; Goudriaan AE, 2013, ADDICT BEHAV, V38, P1509, DOI 10.1016/j.addbeh.2012.04.006; Groman SM, 2012, J NEUROSCI, V32, P5843, DOI 10.1523/JNEUROSCI.0029-12.2012; Grosshans M, 2015, INT CLIN PSYCHOPHARM, V30, P237, DOI 10.1097/YIC.0000000000000069; Grueter BA, 2012, CURR OPIN NEUROBIOL, V22, P545, DOI 10.1016/j.conb.2011.09.009; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Guterstam J, 2013, INT J NEUROPSYCHOPH, V16, P763, DOI 10.1017/S1461145712000818; Hearing MC, 2011, INT J NEUROPSYCHOPH, V14, P784, DOI 10.1017/S1461145710001173; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Heller EA, 2014, NAT NEUROSCI, V17, P1720, DOI 10.1038/nn.3871; Hennigan K, 2015, J NEUROSCI, V35, P198, DOI 10.1523/JNEUROSCI.0927-14.2015; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Jasinska AJ, 2014, NEUROSCI BIOBEHAV R, V38, P1, DOI 10.1016/j.neubiorev.2013.10.013; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kenny PJ, 2014, DIALOGUES CLIN NEURO, V16, P335; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kim J, 2011, BIOL PSYCHIAT, V69, P1026, DOI 10.1016/j.biopsych.2011.01.013; Koob GF, 2014, NEUROPHARMACOLOGY, V76, P370, DOI 10.1016/j.neuropharm.2013.05.024; Koob GF, 2013, CURR OPIN NEUROBIOL, V23, P559, DOI 10.1016/j.conb.2013.03.011; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Koya E, 2009, NEUROPHARMACOLOGY, V56, P177, DOI 10.1016/j.neuropharm.2008.04.022; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lavaur J, 2009, J NEUROCHEM, V111, P1129, DOI 10.1111/j.1471-4159.2009.06405.x; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luo ZC, 2011, J NEUROSCI, V31, P13180, DOI 10.1523/JNEUROSCI.2369-11.2011; MacAskill AF, 2014, NAT NEUROSCI, V17, P1198, DOI 10.1038/nn.3783; Mahler SV, 2014, NAT NEUROSCI, V17, P577, DOI 10.1038/nn.3664; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Marcellino D, 2008, J BIOL CHEM, V283, P26016, DOI 10.1074/jbc.M710349200; Margolis EB, 2014, J NEUROSCI, V34, P14707, DOI 10.1523/JNEUROSCI.2144-14.2014; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Martinez D, 2011, AM J PSYCHIAT, V168, P634, DOI 10.1176/appi.ajp.2010.10050748; Martinez D, 2009, NEUROPSYCHOPHARMACOL, V34, P1774, DOI 10.1038/npp.2008.235; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McDevitt RA, 2014, CELL REP, V8, P1857, DOI 10.1016/j.celrep.2014.08.037; Meye FJ, 2015, NAT NEUROSCI, V18, P376, DOI 10.1038/nn.3923; Mitchell JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002902; Miyazaki KW, 2014, CURR BIOL, V24, P2033, DOI 10.1016/j.cub.2014.07.041; Moore RJ, 1998, SYNAPSE, V28, P1; Murphy NP, 2015, ACS CHEM NEUROSCI, V6, P94, DOI 10.1021/cn500295q; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Nestler Eric J, 2012, Clin Psychopharmacol Neurosci, V10, P136, DOI 10.9758/cpn.2012.10.3.136; Norman AB, 2011, J PHARMACOL EXP THER, V338, P724, DOI 10.1124/jpet.111.183244; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Ogawa SK, 2014, CELL REP, V8, P1105, DOI 10.1016/j.celrep.2014.06.042; Owesson-White CA, 2009, EUR J NEUROSCI, V30, P1117, DOI 10.1111/j.1460-9568.2009.06916.x; Paladini CA, 2014, NEUROSCIENCE, V282, P109, DOI 10.1016/j.neuroscience.2014.07.032; Panagis G, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00092; Parikh V, 2014, NEUROCHEM INT, V75, P54, DOI 10.1016/j.neuint.2014.05.016; Park K, 2013, J NEUROSCI, V33, P15827, DOI 10.1523/JNEUROSCI.1935-13.2013; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Payer DE, 2014, NEUROPSYCHOPHARMACOL, V39, P311, DOI 10.1038/npp.2013.192; Pelloux Y, 2013, EUR J NEUROSCI, V38, P3018, DOI 10.1111/ejn.12289; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Piazza PV, 2013, PSYCHOPHARMACOLOGY, V229, P387, DOI 10.1007/s00213-013-3224-4; Qi J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6390; Robins L N, 1985, NIDA Res Monogr, V56, P178; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Romero J, 1997, MOL BRAIN RES, V46, P100, DOI 10.1016/S0169-328X(96)00277-X; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Root DH, 2014, J NEUROSCI, V34, P13906, DOI 10.1523/JNEUROSCI.2029-14.2014; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Satterlee JS, 2014, J NEUROSCI, V34, P15170, DOI 10.1523/JNEUROSCI.3236-14.2014; Schlosburg JE, 2013, J NEUROSCI, V33, P19384, DOI 10.1523/JNEUROSCI.1979-13.2013; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seedall RB, 2013, DRUG ALCOHOL DEPEN, V133, P751, DOI 10.1016/j.drugalcdep.2013.06.035; Seeman P, 2015, SYNAPSE, V69, P183, DOI 10.1002/syn.21805; Serrano A, 2011, PHARMACOL THERAPEUT, V132, P215, DOI 10.1016/j.pharmthera.2011.06.005; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Smith MA, 2013, PHARMACOL BIOCHEM BE, V104, P40, DOI 10.1016/j.pbb.2012.12.026; Smith RJ, 2013, CURR OPIN NEUROBIOL, V23, P546, DOI 10.1016/j.conb.2013.01.026; Song R, 2012, P NATL ACAD SCI USA, V109, P17675, DOI 10.1073/pnas.1205297109; Staley JK, 1996, J NEUROSCI, V16, P6100; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Steinberg EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094771; Tejeda HA, 2012, PSYCHOPHARMACOLOGY, V224, P289, DOI 10.1007/s00213-012-2752-7; Thanos PK, 2001, J NEUROCHEM, V78, P1094, DOI 10.1046/j.1471-4159.2001.00492.x; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Trifilieff P, 2013, MOL PSYCHIATR, V18, P1025, DOI 10.1038/mp.2013.57; Tseng A, 2013, NEUROPHARMACOLOGY, V73, P290, DOI 10.1016/j.neuropharm.2013.06.001; Urban NBL, 2012, BIOL PSYCHIAT, V71, P677, DOI 10.1016/j.biopsych.2011.12.018; van Huijstee AN, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00466; Velasquez KM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00174; Visanji NP, 2006, NEUROPHARMACOLOGY, V50, P36, DOI 10.1016/j.neuropharm.2005.07.013; Volkow ND, 2014, MOL PSYCHIATR, V19, P1037, DOI 10.1038/mp.2014.58; Volkow ND, 2014, NEUROPHARMACOLOGY, V76, P235, DOI 10.1016/j.neuropharm.2013.05.007; Volkow N D, 2001, J Neurosci, V21, pRC121; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 2005, J NEUROSCI, V25, P3932, DOI 10.1523/JNEUROSCI.0433-05.2005; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 1996, PSYCHIAT RES-NEUROIM, V67, P29, DOI 10.1016/0925-4927(96)02817-X; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Volkow ND, 1999, J PHARMACOL EXP THER, V291, P409; VOLKOW ND, 1995, ARCH GEN PSYCHIAT, V52, P456; Volkow ND, 2008, NEUROIMAGE, V39, P1266, DOI 10.1016/j.neuroimage.2007.09.059; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2015, TRENDS NEUROSCI, V38, P345, DOI 10.1016/j.tins.2015.04.002; Volkow ND, 2014, P NATL ACAD SCI USA, V111, pE3149, DOI 10.1073/pnas.1411228111; Volkow ND, 2013, J NEUROSCI, V33, P4527, DOI 10.1523/JNEUROSCI.5261-12.2013; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Volkow ND, 2010, BIOL PSYCHIAT, V68, P685, DOI 10.1016/j.biopsych.2010.08.002; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Wang GJ, 2012, MOL PSYCHIATR, V17, P918, DOI 10.1038/mp.2011.86; Weerts EM, 2011, ALCOHOL CLIN EXP RES, V35, P2162, DOI 10.1111/j.1530-0277.2011.01565.x; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194; Yoder KK, 2009, ALCOHOL CLIN EXP RES, V33, P139, DOI 10.1111/j.1530-0277.2008.00821.x; Zhang SL, 2015, NAT NEUROSCI, V18, P386, DOI 10.1038/nn.3945; Zubieta JK, 1996, NAT MED, V2, P1225, DOI 10.1038/nm1196-1225; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	170	671	685	20	290	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					712	725		10.1016/j.cell.2015.07.046	http://dx.doi.org/10.1016/j.cell.2015.07.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276628	Bronze			2022-12-28	WOS:000359741400007
J	Berndt, A; Deisseroth, K				Berndt, Andre; Deisseroth, Karl			Expanding the optogenetics toolkit	SCIENCE			English	Editorial Material							CHLORIDE CHANNEL; CHANNELRHODOPSIN		[Berndt, Andre; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Berndt, A (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	mohamady, mahin/G-2175-2016	Berndt, Andre/0000-0003-4758-5598	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	14	24	26	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					590	591		10.1126/science.aac7889	http://dx.doi.org/10.1126/science.aac7889			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250674	Green Accepted			2022-12-28	WOS:000359092900024
J	Erwin, DH				Erwin, Douglas H.			David M. Raup (1933-2015) OBITUARY	NATURE			English	Biographical-Item									[Erwin, Douglas H.] Natl Museum Nat Hist, Dept Palaeobiol, Smithsonian Inst, Washington, DC 20560 USA; [Erwin, Douglas H.] Santa Fe Inst, Santa Fe, NM USA	Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute	Erwin, DH (corresponding author), Natl Museum Nat Hist, Dept Palaeobiol, Smithsonian Inst, Washington, DC 20560 USA.	erwind@si.edu		Erwin, Douglas/0000-0003-2518-5614				RAUP DM, PUBLICATION LIST	1	0	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					36	36		10.1038/524036a	http://dx.doi.org/10.1038/524036a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26245575	Bronze			2022-12-28	WOS:000359002300021
J	Lv, J; Qi, L; Yu, CQ; Yang, L; Guo, Y; Chen, YP; Bian, Z; Sun, D; Du, JW; Ge, PF; Tang, ZZ; Hou, W; Li, YJ; Chen, JS; Chen, ZM; Li, LM				Lv, Jun; Qi, Lu; Yu, Canqing; Yang, Ling; Guo, Yu; Chen, Yiping; Bian, Zheng; Sun, Dianjianyi; Du, Jianwei; Ge, Pengfei; Tang, Zhenzhu; Hou, Wei; Li, Yanjie; Chen, Junshi; Chen, Zhengming; Li, Liming		China Kadoorie Biobank Collaborati	Consumption of spicy foods and total and cause specific mortality: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUT MICROBIOME; CHRONIC DISEASE; DIETARY SPICES; POTENTIAL ROLE; RED-PEPPER; CAPSAICINOIDS; ASSOCIATION; METABOLISM; METAGENOME; KADOORIE	OBJECTIVE To examine the associations between the regular consumption of spicy foods and total and cause specific mortality. DESIGN Population based prospective cohort study. SETTING China Kadoorie Biobank in which participants from 10 geographically diverse areas across China were enrolled between 2004 and 2008. PARTICIPANTS 199 293 men and 288 082 women aged 30 to 79 years at baseline after excluding participants with cancer, heart disease, and stroke at baseline. MAIN EXPOSURE MEASURES Consumption frequency of spicy foods, self reported once at baseline. Main outcome measures Total and cause specific mortality. RESULTS During 3 500 004 person years of follow-up between 2004 and 2013 (median 7.2 years), a total of 11 820 men and 8404 women died. Absolute mortality rates according to spicy food consumption categories were 6.1, 4.4, 4.3, and 5.8 deaths per 1000 person years for participants who ate spicy foods less than once a week, 1 or 2, 3 to 5, and 6 or 7 days a week, respectively. Spicy food consumption showed highly consistent inverse associations with total mortality among both men and women after adjustment for other known or potential risk factors. In the whole cohort, compared with those who ate spicy foods less than once a week, the adjusted hazard ratios for death were 0.90 (95% confidence interval 0.84 to 0.96), 0.86 (0.80 to 0.92), and 0.86 (0.82 to 0.90) for those who ate spicy food 1 or 2, 3 to 5, and 6 or 7 days a week, respectively. Compared with those who ate spicy foods less than once a week, those who consumed spicy foods 6 or 7 days a week showed a 14% relative risk reduction in total mortality. The inverse association between spicy food consumption and total mortality was stronger in those who did not consume alcohol than those who did (P=0.033 for interaction). Inverse associations were also observed for deaths due to cancer, ischemic heart diseases, and respiratory diseases. CONCLUSION In this large prospective study, the habitual consumption of spicy foods was inversely associated with total and certain cause specific mortality, independent of other risk factors of death.	[Lv, Jun; Yu, Canqing; Sun, Dianjianyi; Li, Liming] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China; [Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Qi, Lu] Harvard Univ, Sch Med, Boston, MA USA; [Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford OX1 2JD, England; [Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford OX1 2JD, England; [Guo, Yu; Bian, Zheng; Li, Liming] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Du, Jianwei] Hainan Ctr Dis Control & Prevent, Haikou, Hainan, Peoples R China; [Ge, Pengfei] Gansu Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Tang, Zhenzhu] Guangxi Ctr Dis Control & Prevent, Liuzhou, Guangxi, Peoples R China; [Hou, Wei] Licang Ctr Dis Control & Prevent, Qingdao, Shandong, Peoples R China; [Li, Yanjie] Nangang Ctr Dis Control & Prevent, Harbin, Heilongjiang, Peoples R China; [Chen, Junshi] China Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China	Peking University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Oxford; University of Oxford; Chinese Academy of Medical Sciences - Peking Union Medical College	Li, LM (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China.	lmlee@vip.163.com	Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870; Sun, Dianjianyi/0000-0003-3651-6693; Chen, Zhengming/0000-0001-6423-105X	National Natural Science Foundation of China [81390541, 81390544]; National Key Technologies research and development programme in the 12th five-year plan; Chinese Ministry of Science and Technology [2011BAI09B01]; Wellcome Trust in the UK [088158/Z/09/Z]; Kadoorie Charitable Foundation in Hong Kong; National Institutes of Health from the National Heart, Lung, and Blood Institute [HL071981, HL034594, HL126024]; National Institute of Diabetes and Digestive and Kidney Diseases [DK091718, DK100383, DK078616]; Boston Obesity Nutrition Research Center [DK46200]; United States-Israel Binational Science Foundation [2011036]; American Heart Association [0730094N]; Medical Research Council [MC_U137686851] Funding Source: researchfish; MRC [MC_U137686851] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL126024, R01HL071981, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100383, R01DK078616, U01DK078616, P30DK046200, R01DK091718] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies research and development programme in the 12th five-year plan; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Wellcome Trust in the UK(Instituto de Salud Carlos IIIWellcome Trust); Kadoorie Charitable Foundation in Hong Kong; National Institutes of Health from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston Obesity Nutrition Research Center; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); American Heart Association(American Heart Association); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Natural Science Foundation of China (81390541, 81390544), National Key Technologies research and development programme in the 12th five-year plan, Chinese Ministry of Science and Technology (2011BAI09B01, 2012-14), Wellcome Trust in the UK (088158/Z/09/Z), and Kadoorie Charitable Foundation in Hong Kong. LQ is supported by National Institutes of Health grants from the National Heart, Lung, and Blood Institute (HL071981, HL034594, HL126024), National Institute of Diabetes and Digestive and Kidney Diseases (DK091718, DK100383, DK078616), Boston Obesity Nutrition Research Center (DK46200), and United States-Israel Binational Science Foundation (grant 2011036). LQ was a recipient of the American Heart Association scientist development award (0730094N). The funders had no role in the study design, data collection, data analysis and interpretation, writing of the report, or the decision to submit the article for publication.	Adams MJ, 2009, THROMB RES, V124, P721, DOI 10.1016/j.thromres.2009.05.001; Aggarwal BB, 2009, EXP BIOL MED, V234, P825, DOI 10.3181/0902-MR-78; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Billing J, 1998, Q REV BIOL, V73, P3, DOI 10.1086/420058; Bley K, 2012, TOXICOL PATHOL, V40, P847, DOI 10.1177/0192623312444471; Canesso MCC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0240-4; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Leclercq S, 2014, BIOL PSYCHIAT, V76, P725, DOI 10.1016/j.biopsych.2014.02.003; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Luo XJ, 2011, EUR J PHARMACOL, V650, P1, DOI 10.1016/j.ejphar.2010.09.074; Nilius B, 2013, REV PHYSIOL BIOCH P, V164, P1, DOI 10.1007/112_2013_11; Peng J, 2010, EUR J PHARMACOL, V627, P1, DOI 10.1016/j.ejphar.2009.10.053; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Saito M, 2013, CURR OPIN LIPIDOL, V24, P71, DOI 10.1097/MOL.0b013e32835a4f40; Sayon-Orea C, 2011, NUTR REV, V69, P419, DOI 10.1111/j.1753-4887.2011.00403.x; Sharma SK, 2013, EUR J PHARMACOL, V720, P55, DOI 10.1016/j.ejphar.2013.10.053; Sherman PW, 1999, BIOSCIENCE, V49, P453, DOI 10.2307/1313553; Srinivasan K, 2013, FOOD FUNCT, V4, P503, DOI 10.1039/c2fo30249g; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tapsell Linda C, 2006, Med J Aust, V185, pS1; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Whiting S, 2012, APPETITE, V59, P341, DOI 10.1016/j.appet.2012.05.015; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Yang L, 2012, INT J EPIDEMIOL, V41, P1101, DOI 10.1093/ije/dys075; Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269; Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224; Zhao WH, 2010, BIOMED ENV SCI S, V23, P1; Zsombok A, 2013, J DIABETES COMPLICAT, V27, P287, DOI 10.1016/j.jdiacomp.2012.11.006	40	125	143	10	86	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2015	351								h3942	10.1136/bmj.h3942	http://dx.doi.org/10.1136/bmj.h3942			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AQ	26242395	Green Published, hybrid			2022-12-28	WOS:000359387300002
J	Steenkamp, MM; Litz, BT; Hoge, CW; Marmar, CR				Steenkamp, Maria M.; Litz, Brett T.; Hoge, Charles W.; Marmar, Charles R.			Psychotherapy for Military-Related PTSD A Review of Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSTTRAUMATIC-STRESS-DISORDER; EYE-MOVEMENT DESENSITIZATION; COGNITIVE PROCESSING THERAPY; REALITY EXPOSURE THERAPY; VIETNAM VETERANS; COMBAT VETERANS; HEALTH-CARE; BEHAVIORAL THERAPY; SELF-MANAGEMENT; WAR VETERANS	IMPORTANCE Posttraumatic stress disorder (PTSD) is a disabling psychiatric disorder common among military personnel and veterans. First-line psychotherapies most often recommended for PTSD consist mainly of "trauma-focused" psychotherapies that involve focusing on details of the trauma or associated cognitive and emotional effects. OBJECTIVE To examine the effectiveness of psychotherapies for PTSD in military and veteran populations. EVIDENCE REVIEW PubMed, PsycINFO, and PILOTS were searched for randomized clinical trials (RCTs) of individual and group psychotherapies for PTSD in military personnel and veterans, published from January 1980 to March 1, 2015. We also searched reference lists of articles, selected reviews, and meta-analyses. Of 891 publications initially identified, 36 were included. FINDINGS Two trauma-focused therapies, cognitive processing therapy (CPT) and prolonged exposure, have been the most frequently studied psychotherapies for military-related PTSD. Five RCTs of CPT (that included 481 patients) and 4 RCTs of prolonged exposure (that included 402 patients) met inclusion criteria. Focusing on intent-to-treat outcomes, within-group posttreatment effect sizes for CPT and prolonged exposure were large (Cohen d range, 0.78-1.10). CPT and prolonged exposure also outperformed waitlist and treatment-as-usual control conditions. Forty-nine percent to 70% of participants receiving CPT and prolonged exposure attained clinically meaningful symptom improvement (defined as a 10- to 12-point decrease in interviewer-assessed or self-reported symptoms). However, mean posttreatment scores for CPT and prolonged exposure remained at or above clinical criteria for PTSD, and approximately two-thirds of patients receiving CPT or prolonged exposure retained their PTSD diagnosis after treatment (range, 60%-72%). CPT and prolonged exposure were marginally superior compared with non-trauma-focused psychotherapy comparison conditions. CONCLUSIONS AND RELEVANCE In military and veteran populations, trials of the first-line trauma-focused interventions CPT and prolonged exposure have shown clinically meaningful improvements for many patients with PTSD. However, nonresponse rates have been high, many patients continue to have symptoms, and trauma-focused interventions show marginally superior results compared with active control conditions. There is a need for improvement in existing PTSD treatments and for development and testing of novel evidence-based treatments, both trauma-focused and non-trauma-focused.	[Steenkamp, Maria M.; Marmar, Charles R.] NYU, Langone Sch Med, Steven & Alexandra Cohen Vet Ctr Posttraumat Stre, New York, NY 10016 USA; [Litz, Brett T.] Boston Univ, Sch Med, VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA 02118 USA; [Hoge, Charles W.] Walter Reed Army Inst Res, Silver Spring, MD USA	New York University; NYU Langone Medical Center; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Steenkamp, MM (corresponding author), NYU, Langone Sch Med, Steven & Alexandra Cohen Vet Ctr Posttraumat Stre, One Pk Ave,Room 8-107, New York, NY 10016 USA.	maria.steenkamp@nyumc.org	Marmar, Charles R./O-1902-2017	Marmar, Charles R./0000-0001-8427-5607; Litz, Brett/0000-0002-0479-8887				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Beidel DC, 2011, J ANXIETY DISORD, V25, P224, DOI 10.1016/j.janxdis.2010.09.006; Benish SG, 2008, CLIN PSYCHOL REV, V28, P746, DOI 10.1016/j.cpr.2007.10.005; Bormann JE, 2013, PSYCHOL TRAUMA-US, V5, P259, DOI 10.1037/a0027522; Bormann JE, 2008, J HOLIST NURS, V26, P109, DOI 10.1177/0898010107311276; BOUDEWYNS PA, 1990, BEHAV THER, V21, P63, DOI 10.1016/S0005-7894(05)80189-3; Boudewyns PA, 1996, CLIN PSYCHOL PSYCHOT, V3, P185, DOI 10.1002/(SICI)1099-0879(199609)3:3<185::AID-CPP101>3.0.CO;2-0; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Buckley TC, 2004, MIL MED, V169, P536, DOI 10.7205/MILMED.169.7.536; Carlson JG, 1998, J TRAUMA STRESS, V11, P3, DOI 10.1023/A:1024448814268; Church D, 2013, J NERV MENT DIS, V201, P153, DOI 10.1097/NMD.0b013e31827f6351; COOPER NA, 1989, BEHAV THER, V20, P381, DOI 10.1016/S0005-7894(89)80057-7; Department of Defense, 2010, VA DOD CLIN PRACT GU; Devilly GJ, 1998, BEHAV THER, V29, P435, DOI 10.1016/S0005-7894(98)80042-7; Dunn NJ, 2007, J TRAUMA STRESS, V20, P221, DOI 10.1002/jts.20214; Engel CC, 2014, MED CARE, V52, pS57, DOI 10.1097/MLR.0000000000000237; Forbes D, 2012, J ANXIETY DISORD, V26, P442, DOI 10.1016/j.janxdis.2012.01.006; Forbes D, 2010, J TRAUMA STRESS, V23, P537, DOI 10.1002/jts.20565; Frueh BC, 2007, J TELEMED TELECARE, V13, P142, DOI 10.1258/135763307780677604; Gerger H, 2014, J CLIN PSYCHOL, V70, P601, DOI 10.1002/jclp.22059; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hundt NE, 2014, MIL MED, V179, P942, DOI 10.7205/MILMED-D-14-00128; IOM (Institute of Medicine), 2014, TREATM POSTTR STRESS; Jain S, 2012, MIL MED, V177, P1015, DOI 10.7205/MILMED-D-11-00290; JENSEN JA, 1994, BEHAV THER, V25, P311, DOI 10.1016/S0005-7894(05)80290-4; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Karlin BE, 2014, AM PSYCHOL, V69, P19, DOI 10.1037/a0033888; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; KEANE TM, 1989, BEHAV THER, V20, P245, DOI 10.1016/S0005-7894(89)80072-3; Kearney DJ, 2013, J CLIN PSYCHOL, V69, P14, DOI 10.1002/jclp.21911; Kent M, 2011, J TRAUMA STRESS, V24, P591, DOI 10.1002/jts.20685; Kip KE, 2013, MIL MED, V178, P1298, DOI 10.7205/MILMED-D-13-00298; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Kuckertz JM, 2014, BEHAV RES THER, V63, P25, DOI 10.1016/j.brat.2014.09.002; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Lande RG, 2010, COMPLEMENT THER MED, V18, P256, DOI 10.1016/j.ctim.2010.08.004; Litz BT, 2007, AM J PSYCHIAT, V164, P1676, DOI 10.1176/appi.ajp.2007.06122057; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Markowitz JC, 2015, AM J PSYCHIAT, V172, P430, DOI 10.1176/appi.ajp.2014.14070908; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; McFall M, 1999, J TRAUMA STRESS, V12, P501, DOI 10.1023/A:1024771121189; McLay RN, 2011, CYBERPSYCH BEH SOC N, V14, P223, DOI 10.1089/cyber.2011.0003; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Moradi AR, 2014, BEHAV RES THER, V56, P68, DOI 10.1016/j.brat.2014.03.002; Morland LA, 2014, J CLIN PSYCHIAT, V75, P470, DOI 10.4088/JCP.13m08842; Nacasch N, 2011, J CLIN PSYCHIAT, V72, P1174, DOI 10.4088/JCP.09m05682blu; Niles BL, 2012, PSYCHOL TRAUMA-US, V4, P538, DOI 10.1037/a0026161; Pitman RK, 1996, COMPR PSYCHIAT, V37, P419, DOI 10.1016/S0010-440X(96)90025-5; Possemato K, 2011, J TELEMED TELECARE, V17, P245, DOI 10.1258/jtt.2011.100909; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Price M, 2013, CLIN PSYCHOL PSYCHOT, V20, P277, DOI 10.1002/cpp.1768; Rauch SAM, 2015, DEPRESS ANXIETY, V32, P204, DOI 10.1002/da.22331; Ready DJ, 2010, CYBERPSYCH BEH SOC N, V13, P49, DOI 10.1089/cyber.2009.0239; Resick PA, 2015, J CONSULT CLIN PSYCH, V83, P1058, DOI 10.1037/ccp0000016; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; Rogers S, 1999, J ANXIETY DISORD, V13, P119, DOI 10.1016/S0887-6185(98)00043-7; Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625; Ruzek J.I., 2012, DISSEMINATION IMPLEM, P78; Savoca Elizabeth, 2000, J Ment Health Policy Econ, V3, P199, DOI 10.1002/mhp.102; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schnurr PP, 2015, CONTEMP CLIN TRIALS, V41, P75, DOI 10.1016/j.cct.2014.11.017; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Shiner B, 2013, ADM POLICY MENT HLTH, V40, P311, DOI 10.1007/s10488-012-0421-0; Sloan DM, 2013, PSYCHOL TRAUMA-US, V5, P176, DOI 10.1037/a0026291; Steenkamp MM, 2011, COGN BEHAV PRACT, V18, P98, DOI 10.1016/j.cbpra.2009.08.006; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Stein NR, 2012, BEHAV MODIF, V36, P787, DOI 10.1177/0145445512446945; Strachan M, 2012, BEHAV THER, V43, P560, DOI 10.1016/j.beth.2011.03.003; Suris A, 2013, J TRAUMA STRESS, V26, P28, DOI 10.1002/jts.21765; TENNANT C, 1986, PSYCHOL MED, V16, P833, DOI 10.1017/S0033291700011843; Watson CG, 1997, J CLIN PSYCHOL, V53, P917, DOI 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yehuda R, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0048; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690	80	539	547	7	147	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					489	500		10.1001/jama.2015.8370	http://dx.doi.org/10.1001/jama.2015.8370			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO1OI	26241600				2022-12-28	WOS:000358924500013
J	Bibring, JP; Taylor, MGGT; Alexander, C; Auster, U; Biele, J; Finzi, AE; Goesmann, F; Klingelhoefer, G; Kofman, W; Mottola, S; Seidensticker, KJ; Spohn, T; Wright, I				Bibring, J-P; Taylor, M. G. G. T.; Alexander, C.; Auster, U.; Biele, J.; Finzi, A. Ercoli; Goesmann, F.; Klingelhoefer, G.; Kofman, W.; Mottola, S.; Seidensticker, K. J.; Spohn, T.; Wright, I.			PHILAE'S FIRST DAYS ON THE COMET	SCIENCE			English	Editorial Material													Kofman, Wlodek/C-4556-2008; Biele, Jens/ABI-1218-2020	Kofman, Wlodek/0000-0002-6744-8796; Biele, Jens/0000-0002-7414-829X; Seidensticker, Klaus J./0000-0003-3671-3769	STFC [ST/I001964/1, ST/L000776/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001964/1, ST/L000776/1] Funding Source: researchfish; UK Space Agency [ST/K001973/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency			0	23	23	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					493	493		10.1126/science.aac5116	http://dx.doi.org/10.1126/science.aac5116			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228139				2022-12-28	WOS:000358713300044
J	Shrank, WH; Barlow, JF; Brennan, TA				Shrank, William H.; Barlow, Jane F.; Brennan, Troyen A.			New Therapies in the Treatment of High Cholesterol An Argument to Return to Goal-Based Lipid Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STATIN THERAPY; HYPERCHOLESTEROLEMIA		[Shrank, William H.; Barlow, Jane F.; Brennan, Troyen A.] CVS Hlth, Woonsocket, RI USA		Shrank, WH (corresponding author), 1 CVS Dr, Woonsocket, RI 02895 USA.	william.shrank@cvshealth.com						Brennan T, 2014, JAMA-J AM MED ASSOC, V312, P593, DOI 10.1001/jama.2014.8897; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Hayward RA, 2012, CIRC-CARDIOVASC QUAL, V5, P2, DOI 10.1161/CIRCOUTCOMES.111.964676; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Pandya A, 2015, JAMA-J AM MED ASSOC, V314, P142, DOI 10.1001/jama.2015.6822; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	9	34	34	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1443	1444		10.1001/jama.2015.10017	http://dx.doi.org/10.1001/jama.2015.10017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26258765				2022-12-28	WOS:000362647800005
J	Wen, L; Tang, FC				Wen, Lu; Tang, Fuchou			COMPUTATIONAL BIOLOGY How to catch rare cell types	NATURE			English	Editorial Material							RNA-SEQ; TRANSCRIPTOMICS		[Wen, Lu; Tang, Fuchou] Peking Univ, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China	Peking University	Wen, L (corresponding author), Peking Univ, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China.	wenlu.wl@gmail.com; tangfuchou@pku.edu.cn						Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Eberwine J, 2014, NAT METHODS, V11, P25, DOI 10.1038/nmeth.2769; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; May CL, 2010, MOL CELL ENDOCRINOL, V323, P70, DOI 10.1016/j.mce.2009.12.009; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173	10	5	5	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					197	198		10.1038/nature15204	http://dx.doi.org/10.1038/nature15204			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26287456				2022-12-28	WOS:000360927400025
J	Rossor, M; Knapp, M				Rossor, Martin; Knapp, Martin			Can we model a cognitive footprint of interventions and policies to help to meet the global challenge of dementia?	LANCET			English	Editorial Material							RISK COMPENSATION; BRAIN		[Rossor, Martin] UCL Inst Neurol, London WC1N 3BG, England; [Knapp, Martin] Univ London London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London WC2A 2AE, England	University of London; University College London; University of London; London School Economics & Political Science	Rossor, M (corresponding author), UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.	m.rossor@ucl.ac.uk	Rossor, Martin/C-1598-2008	Rossor, Martin/0000-0001-8215-3120; Knapp, Martin/0000-0003-1427-0215	Medical Research Council [MR/K006584/1] Funding Source: Medline; National Institute for Health Research [NF-SI-0512-10033, NF-SI-0512-10158] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Ailshire JA, 2015, J GERONTOL B-PSYCHOL, V70, P322, DOI 10.1093/geronb/gbu064; [Anonymous], 2014, LANCET NEUROL, V13, P747; Banks J, 2012, ECON J, V122, P418, DOI 10.1111/j.1468-0297.2012.02499.x; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Clouston SAP, 2012, INT J EPIDEMIOL, V41, P1729, DOI 10.1093/ije/dys148; Ford M.A., 2014, SPORTS RELATED CONCU; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Huang PC, 2012, ENVIRON INT, V40, P88, DOI 10.1016/j.envint.2011.10.011; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Lees C, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130010; Lincoln P, 2014, LANCET, V383, P1805, DOI 10.1016/S0140-6736(14)60758-3; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Murray L, 2010, J CHILD PSYCHOL PSYC, V51, P1150, DOI 10.1111/j.1469-7610.2010.02259.x; Phillips RO, 2011, RISK ANAL, V31, P1187, DOI 10.1111/j.1539-6924.2011.01589.x; Rodrigues CL, 2012, NEUROLOGY, V78, P861, DOI 10.1212/WNL.0b013e31824c46d1; Swiger KJ, 2013, MAYO CLIN PROC, V88, P1213, DOI 10.1016/j.mayocp.2013.07.013; Thompson DC, 2009, COCHRANE LIB, V1, P1	20	12	12	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					1008	1010		10.1016/S0140-6736(15)60248-3	http://dx.doi.org/10.1016/S0140-6736(15)60248-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR2TE	26233601	Green Accepted, Green Submitted			2022-12-28	WOS:000361182700033
J	Hurley, R				Hurley, Richard			ASSISTED DYING A doctor who chose an assisted death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Chambaere K, 2015, NEW ENGL J MED, V372, P1179, DOI 10.1056/NEJMc1414527; Commission Federale de Controle et d'Evaluation de l'Euthanasie, 2014, 6 COMM FED CONTR EV; Dierickx S, 2015, JAMA INTERN MED, V175, P1703, DOI 10.1001/jamainternmed.2015.3982; Portail des Services Publics Belges, EUTH DROIT STRICT RE	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4385	10.1136/bmj.h4385	http://dx.doi.org/10.1136/bmj.h4385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7PU	26289051				2022-12-28	WOS:000360081100004
J	Worster, A				Worster, Andrew			Baseline plus 1-hour high-sensitivity cardiac troponin T improved early rule-out and rule-in of acute MI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Worster, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Kavsak PA, 2013, JAMA INTERN MED, V173, P477, DOI 10.1001/jamainternmed.2013.2270; Kohn MA, 2013, ACAD EMERG MED, V20, P1194, DOI 10.1111/acem.12255	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					JC12	JC12		10.7326/ACPJC-2015-163-4-012	http://dx.doi.org/10.7326/ACPJC-2015-163-4-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26280434				2022-12-28	WOS:000364673500020
J	Mayle, R; Campbell, IM; Beck, CR; Yu, Y; Wilson, M; Shaw, CA; Bjergbaek, L; Lupski, JR; Ira, G				Mayle, Ryan; Campbell, Ian M.; Beck, Christine R.; Yu, Yang; Wilson, Marenda; Shaw, Chad A.; Bjergbaek, Lotte; Lupski, James R.; Ira, Grzegorz			Mus81 and converging forks limit the mutagenicity of replication fork breakage	SCIENCE			English	Article							CONSERVATIVE DNA-SYNTHESIS; IN-VIVO; REPAIR; YEN1; RECOMBINATION; CEREVISIAE; MECHANISMS; NUCLEASES; EXCHANGE; DIVERSE	Most spontaneous DNA double-strand breaks (DSBs) result from replication-fork breakage. Break-induced replication (BIR), a genome rearrangement-prone repair mechanism that requires the Pol32/POLD3 subunit of eukaryotic DNA Pol delta, was proposed to repair broken forks, but how genome destabilization is avoided was unknown. We show that broken fork repair initially uses error-prone Pol32-dependent synthesis, but that mutagenic synthesis is limited to within a few kilobases from the break by Mus81 endonuclease and a converging fork. Mus81 suppresses template switches between both homologous sequences and diverged human Alu repetitive elements, highlighting its importance for stability of highly repetitive genomes. We propose that lack of a timely converging fork or Mus81 may propel genome instability observed in cancer.	[Mayle, Ryan; Campbell, Ian M.; Beck, Christine R.; Yu, Yang; Wilson, Marenda; Shaw, Chad A.; Lupski, James R.; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bjergbaek, Lotte] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Aarhus University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Ira, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.	gira@bcm.edu	Pinheiro, Maísa/E-7424-2012; Bjergbæk, Lotte/AAW-6302-2021	Campbell, Ian/0000-0002-3749-2884; Bjergbaek, Lotte/0000-0002-8233-3356; Wilson, Marenda/0000-0003-1610-1044	National Institutes of Health (NIH) [GM080600, NS058529, HG006542, NS083159]; Regeneron Pharmaceuticals; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, F31NS083159] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regeneron Pharmaceuticals(Regeneron); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Hastings, A. Malkova, S. Rosenberg, and D. Bates for critical comments on the manuscript. This work was supported by National Institutes of Health (NIH) grants GM080600 to G.I., NS058529 and HG006542 to J.R.L., and NS083159 to I.M.C. C.R.B is a Howard Hughes Medical Institute fellow of the Damon Runyon Cancer Research Foundation (DRG 2155-13). J.R.L. is a paid consultant for Regeneron Pharmaceuticals and has stock options in Lasergen.	Blanco MG, 2014, MOL CELL, V54, P94, DOI 10.1016/j.molcel.2014.02.011; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Carvalho CMB, 2013, NAT GENET, V45, P1319, DOI 10.1038/ng.2768; Clausen AR, 2015, NAT STRUCT MOL BIOL, V22, P185, DOI 10.1038/nsmb.2957; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; Donnianni RA, 2013, P NATL ACAD SCI USA, V110, P13475, DOI 10.1073/pnas.1309800110; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Eissler CL, 2014, MOL CELL, V54, P80, DOI 10.1016/j.molcel.2014.02.012; Gu S, 2015, HUM MOL GENET, V24, P4061, DOI 10.1093/hmg/ddv146; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Jain S, 2009, GENE DEV, V23, P291, DOI 10.1101/gad.1751209; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; McGuffee SR, 2013, MOL CELL, V50, P123, DOI 10.1016/j.molcel.2013.03.004; Muller CA, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt878; Munoz-Galvan S, 2012, MOL CELL BIOL, V32, P1592, DOI 10.1128/MCB.00111-12; Nielsen I, 2009, NAT METHODS, V6, P753, DOI [10.1038/NMETH.1372, 10.1038/nmeth.1372]; Pepe A, 2014, CELL REP, V7, P1048, DOI 10.1016/j.celrep.2014.04.007; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585	28	133	134	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					742	747		10.1126/science.aaa8391	http://dx.doi.org/10.1126/science.aaa8391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273056	Green Accepted			2022-12-28	WOS:000359415100038
J	Trenberth, KE				Trenberth, Kevin E.			Has there been a hiatus?	SCIENCE			English	Editorial Material							PACIFIC; CIRCULATION; ATLANTIC		Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Trenberth, KE (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	trenbert@ucar.edu	Trenberth, Kevin Edward/A-5683-2012	Trenberth, Kevin Edward/0000-0002-1445-1000				Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Chen XY, 2014, SCIENCE, V345, P897, DOI 10.1126/science.1254937; Clement A, 2014, SCIENCE, V343, P976, DOI 10.1126/science.1248115; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Hartmann DL, 2015, GEOPHYS RES LETT, V42, P1894, DOI 10.1002/2015GL063083; IPCC, 2013, CLIMATE CHANGE 2022; Karl TR, 2015, SCIENCE, V348, P1469, DOI 10.1126/science.aaa5632; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; McGregor S, 2014, NAT CLIM CHANGE, V4, P888, DOI [10.1038/nclimate2330, 10.1038/NCLIMATE2330]; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Nieves V, 2015, SCIENCE, V349, P532, DOI 10.1126/science.aaa4521; Santer BD, 2014, NAT GEOSCI, V7, P185, DOI [10.1038/ngeo2098, 10.1038/NGEO2098]; Srokosz MA, 2015, SCIENCE, V348, DOI 10.1126/science.1255575; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P911, DOI [10.1038/NCLIMATE2341, 10.1038/nclimate2341]; Trenberth KE, 2014, J CLIMATE, V27, P3129, DOI 10.1175/JCLI-D-13-00294.1; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165	18	136	143	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					691	692		10.1126/science.aac9225	http://dx.doi.org/10.1126/science.aac9225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273042	Green Published			2022-12-28	WOS:000359415100018
J	Font-Burgada, J; Shalapour, S; Ramaswamy, S; Hsueh, B; Rossell, D; Umemura, A; Taniguchi, K; Nakagawa, H; Valasek, MA; Ye, L; Kopp, JL; Sander, M; Carter, H; Deisseroth, K; Verma, IM; Karin, M				Font-Burgada, Joan; Shalapour, Shabnam; Ramaswamy, Suvasini; Hsueh, Brian; Rossell, David; Umemura, Atsushi; Taniguchi, Koji; Nakagawa, Hayato; Valasek, Mark A.; Ye, Li; Kopp, Janel L.; Sander, Maike; Carter, Hannah; Deisseroth, Karl; Verma, Inder M.; Karin, Michael			Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer	CELL			English	Article							STEM-CELL NICHE; MOUSE-LIVER; COMPENSATORY PROLIFERATION; PROGENITOR CELLS; MURINE MODEL; ADULT; IDENTIFICATION; TRANSPLANTATION; STEATOHEPATITIS; REPOPULATION	Compensatory proliferation triggered by hepatocyte loss is required for liver regeneration and maintenance but also promotes development of hepatocellular carcinoma (HCC). Despite extensive investigation, the cells responsible for hepatocyte restoration or HCC development remain poorly characterized. We used genetic lineage tracing to identify cells responsible for hepatocyte replenishment following chronic liver injury and queried their roles in three distinct HCC models. We found that a pre-existing population of periportal hepatocytes, located in the portal triads of healthy livers and expressing low amounts of Sox9 and other bile-duct-enriched genes, undergo extensive proliferation and replenish liver mass after chronic hepatocyte-depleting injuries. Despite their high regenerative potential, these so-called hybrid hepatocytes do not give rise to HCC in chronically injured livers and thus represent a unique way to restore tissue function and avoid tumorigenesis. This specialized set of pre-existing differentiated cells may be highly suitable for cell-based therapy of chronic hepatocyte-depleting disorders.	[Font-Burgada, Joan; Shalapour, Shabnam; Umemura, Atsushi; Taniguchi, Koji; Nakagawa, Hayato; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Valasek, Mark A.; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Kopp, Janel L.; Sander, Maike] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Kopp, Janel L.; Sander, Maike] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Carter, Hannah] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Ramaswamy, Suvasini; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Hsueh, Brian; Ye, Li; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Neurosci Program, Dept Bioengn, Stanford, CA 94305 USA; [Hsueh, Brian; Ye, Li; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Neurosci Program, Dept Psychiat, Stanford, CA 94305 USA; [Hsueh, Brian; Ye, Li; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Neurosci Program, Dept Behav Sci, Stanford, CA 94305 USA; [Rossell, David] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Nakagawa, Hayato] Univ Tokyo, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan; [Kopp, Janel L.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Warwick; University of Tokyo; University of British Columbia	Font-Burgada, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jfontburgada@ucsd.edu; karinoffice@ucsd.edu	Rossell, David/AAM-4292-2021; Sander, Maike/N-6615-2016; Nakagawa, Hayato/I-2837-2012; Carter, Hannah/R-8425-2017	Rossell, David/0000-0002-7104-5789; Sander, Maike/0000-0001-5308-7785; Nakagawa, Hayato/0000-0002-6973-5094; Valasek, Mark/0000-0003-1721-3451; Carter, Hannah/0000-0002-1729-2463; Umemura, Atsushi/0000-0002-7433-8501	CIRM Training Grant II [TG2-01154]; Rotary Foundation; JSPS; Uehara Memorial Foundation Fellowship; DFG; CRI-Irvington fellowship; Japanese Society of Gastroenterology; Tokyo Society of Medical Sciences; Kanae Foundation; NIH [CA118165, CA155120, HL053670, AI048034, DK078803, DK068471, F32CA136124]; Superfund basic research program [ES010337]; Cancer Ctr Core Grant [P30 CA014195-38]; Frances C. Berger Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; JDRF; Grants-in-Aid for Scientific Research [15K19313] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [F32CA136124, P30CA014195, R01CA118165, R01CA155120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048034, R37AI048034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078803, R01DK068471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	CIRM Training Grant II; Rotary Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation Fellowship; DFG(German Research Foundation (DFG)); CRI-Irvington fellowship; Japanese Society of Gastroenterology(Japanese Society of Gastroenterology); Tokyo Society of Medical Sciences; Kanae Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Superfund basic research program; Cancer Ctr Core Grant; Frances C. Berger Foundation; Leona M. and Harry B. Helmsley Charitable Trust; JDRF(Juvenile Diabetes Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. D. Brenner, T. Kissileva, M. Grompe, and G. Napolitano for comments, M. Vasseur-Cognet for TTR-Cre<SUP>ERT</SUP> mice, P. Chambon for Alb-Cre<SUP>ERT</SUP>, and W. Sandgren for MUP-uPA mice. Technical support was provided by the UCSD Neuroscience Microscopy Shared Facility (P30 NS047101), the IGM Genomics Center, human stem cell core facility, and the Vector Core Developmental Lab. J.F.-B. was supported by CIRM Training Grant II (TG2-01154); A.U. by a Global Grant Scholarship from The Rotary Foundation; K.T. by a postdoctoral fellowship for Research Abroad, Research Fellowship for Young Scientists from the JSPS, and the Uehara Memorial Foundation Fellowship; S.S. by the DFG and a CRI-Irvington fellowship; and H.N. by the Japanese Society of Gastroenterology, The Tokyo Society of Medical Sciences, and Kanae Foundation. Research was supported by NIH grants CA118165 and CA155120 and the Superfund basic research program (ES010337) to M.K., who holds the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases and is an ACS Research Professor, and NIH grants HL053670 and AI048034, Cancer Ctr Core Grant (P30 CA014195-38), the Frances C. Berger Foundation, and Leona M. and Harry B. Helmsley Charitable Trust grant 2012-PG-MED002 to I.M.V. M.S. was supported by NIH grants DK078803 and DK068471, and J.L.K. by NIH grant F32CA136124 and an Advanced Postdoctoral Fellowship from the JDRF.	Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453; Bissig KD, 2007, P NATL ACAD SCI USA, V104, P20507, DOI 10.1073/pnas.0710528105; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791; Fleming KE, 2013, LIVER INT, V33, P525, DOI 10.1111/liv.12099; Forbes SJ, 2015, J HEPATOL, V62, pS157, DOI 10.1016/j.jhep.2015.02.040; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Kaneko K, 2015, HEPATOLOGY, V61, P2056, DOI 10.1002/hep.27685; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kisseleva T, 2010, CURR OPIN GASTROEN, V26, P395, DOI 10.1097/MOG.0b013e32833a6bec; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nakagawa H, 2014, P NATL ACAD SCI USA, V111, P1090, DOI 10.1073/pnas.1322731111; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3; Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112	52	307	319	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					766	779		10.1016/j.cell.2015.07.026	http://dx.doi.org/10.1016/j.cell.2015.07.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276631	Green Accepted, Bronze			2022-12-28	WOS:000359741400011
J	Warkentin, TE				Warkentin, Theodore E.			Ischemic Limb Gangrene with Pulses	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEPARIN-INDUCED THROMBOCYTOPENIA; DISSEMINATED INTRAVASCULAR COAGULATION; SYMMETRICAL PERIPHERAL GANGRENE; PHLEGMASIA CERULEA DOLENS; INFECTIOUS PURPURA FULMINANS; MENINGOCOCCAL SEPTIC SHOCK; DEEP-VEIN THROMBOSIS; V-LEIDEN MUTATION; PROTEIN-C; SEVERE SEPSIS		[Warkentin, Theodore E.] McMaster Univ, Dept Pathol & Mol Med, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Warkentin, Theodore E.] McMaster Univ, Dept Med, Michael G DeGroote Sch Med, Hamilton, ON, Canada	McMaster University; McMaster University	Warkentin, TE (corresponding author), Hamilton Gen Hosp, Hamilton Reg Lab, Program Med, Rm 1-270B,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	twarken@mcmaster.ca		Lipsker, Dan/0000-0003-4675-0336; Warkentin, Theodore Earl/0000-0002-8046-7588	Instrumentation Laboratory; Pfizer Canada	Instrumentation Laboratory; Pfizer Canada(Pfizer)	Dr. Warkentin reports receiving fees for serving on an advisory board from Instrumentation Laboratory, consulting fees from W.L. Gore, lecture fees from Instrumentation Laboratory and Pfizer Canada, and fees for providing expert testimony in cases regarding thrombocytopenia, coagulopathy, or ischemic limb losses. He also reports that his institution has received fees from W.L. Gore to provide laboratory testing for a randomized, controlled trial of heparin-coated versus non-heparin-coated hemodialysis grafts. No other potential conflict of interest relevant to this article was reported.	Ames PRJ, 2009, CLIN RHEUMATOL, V28, pS3, DOI 10.1007/s10067-008-1010-1; Barraud S, 1904, DTSCH Z CHIR, V74, P237; BELL WR, 1985, AM J MED, V79, P423, DOI 10.1016/0002-9343(85)90028-2; Betrosian AP, 2006, AM J MED SCI, V332, P339, DOI 10.1097/00000441-200612000-00006; Bhoola PH, 2014, J FOOT ANKLE SURG; BRANDTZAEG P, 1989, THROMB RES, V55, P459, DOI 10.1016/0049-3848(89)90054-6; Chang JC, 2004, THER APHER DIAL, V8, P413, DOI 10.1111/j.1526-0968.2004.00184.x; Chen CF, 2012, QJM-INT J MED, V105, P279, DOI 10.1093/qjmed/hcr002; Childers BJ, 2003, AM SURGEON, V69, P86; Christiansen CB, 2012, SCAND J INFECT DIS, V44, P635, DOI 10.3109/00365548.2012.672765; Colak Taner, 2003, Ulus Travma Acil Cerrahi Derg, V9, P222; COLE MS, 1988, SURGERY, V103, P271; Erdoes LS, 2011, AM SURGEON, V77, P1606; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; FIJNVANDRAAT K, 1995, THROMB HAEMOSTASIS, V73, P15; FOX B, 1971, ARCH DIS CHILD, V46, P680, DOI 10.1136/adc.46.249.680; Gando S, 2010, CRIT CARE MED, V38, pS35, DOI 10.1097/CCM.0b013e3181c9e31d; Geddings JE, 2013, BLOOD, V122, P1873, DOI 10.1182/blood-2013-04-460139; Ghosh SK, 2010, J EUR ACAD DERMATOL, V24, P214, DOI 10.1111/j.1468-3083.2009.03329.x; Greinacher A, 2015, NEW ENGL J MED, V373, P252, DOI 10.1056/NEJMcp1411910; Grim Hostetler Sarah, 2012, J Clin Aesthet Dermatol, V5, P38; GROB JJ, 1989, J AM ACAD DERMATOL, V20, P1063, DOI 10.1016/S0190-9622(89)70133-X; Haimovici H, 1965, J CARDIOVASC SURG, V5, P164; HAMDY RC, 1993, J PEDIATR ORTHOPED, V13, P447, DOI 10.1097/01241398-199307000-00006; Hammadah Muhammad, 2013, Avicenna J Med, V3, P109, DOI 10.4103/2231-0770.120504; HAYES MA, 1992, INTENS CARE MED, V18, P433, DOI 10.1007/BF01694349; Hellum M, 2014, THROMB RES, V133, P507, DOI 10.1016/j.thromres.2013.12.031; Hotchkiss R, 2014, CURR REV MUSCULOSKEL, P747; Josephson C, 2001, PEDIATR RES, V50, P345, DOI 10.1203/00006450-200109000-00009; Kalajian AH, 2007, ARCH DERMATOL, V143, P1314, DOI 10.1001/archderm.143.10.1314; Kato Y, 2007, T ROY SOC TROP MED H, V101, P1045, DOI 10.1016/j.trstmh.2007.04.015; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; KIRKLAND KB, 1993, CLIN INFECT DIS, V16, P629, DOI 10.1093/clind/16.5.629; Knight TT, 2000, AM SURGEON, V66, P196; Kondaveeti S, 1999, PEDIATR INFECT DIS J, V18, P893, DOI 10.1097/00006454-199910000-00011; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Levi M, 2013, MINERVA ANESTESIOL, V79, P294; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Linkins LA, 2012, CHEST S, V141, pe495S; Meissner MH, 2012, PHLEBOLOGY, V27, P78, DOI [10.1258/phleb.2012.012S11, 10.1258/phleb.2012.012s11]; MOLOS MA, 1985, ARCH DERMATOL, V121, P1057, DOI 10.1001/archderm.121.8.1057; Padjas A, 2005, BLOOD COAGUL FIBRIN, V16, P567, DOI 10.1097/01.mbc.0000191910.24780.81; Perkins JMT, 1996, BRIT J SURG, V83, P19, DOI 10.1002/bjs.1800830106; Piccin A, 2014, THROMB RES, V134, P63, DOI 10.1016/j.thromres.2014.04.019; Price VE, 2011, SEMIN FETAL NEONAT M, V16, P318, DOI 10.1016/j.siny.2011.07.009; QVARFORDT P, 1983, ANN SURG, V197, P450, DOI 10.1097/00000658-198304000-00013; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; REINSTEIN L, 1980, ARCH PHYS MED REHAB, V61, P97; Rice L, 2013, HEPARIN INDUCED THRO, P608; ROBBOY SJ, 1973, BRIT J DERMATOL, V88, P221, DOI 10.1111/j.1365-2133.1973.tb07538.x; Sharif M, 2015, INT J STD AIDS; Sharma BD, 2004, TROP DOCT, V34, P2, DOI 10.1177/004947550403400102; SHIMAMURA K, 1983, ARCH PATHOL LAB MED, V107, P543; Siegal DM, 2012, NEW ENGL J MED, V367, P879, DOI 10.1056/NEJMc1207074; Smith OP, 1999, BRIT J HAEMATOL, V104, P202, DOI 10.1046/j.1365-2141.1999.01186.x; Smythe MA, 2002, AM J HEMATOL, V71, P50, DOI 10.1002/ajh.10181; Srinivasan AF, 2004, ARCH INTERN MED, V164, P66, DOI 10.1001/archinte.164.1.66; Vadivel K, 2013, HEMOSTASIS THROMBOSI, P208; Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03; Wada H, 2013, J THROMB HAEMOST, V11, P2078, DOI 10.1111/jth.12366; Warkentin TE, 2001, NEW ENGL J MED, V344, P1286, DOI 10.1056/NEJM200104263441704; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; Warkentin TE, 1997, ANN INTERN MED, V127, P804, DOI 10.7326/0003-4819-127-9-199711010-00005; Warkentin TE, 2001, ANN INTERN MED, V135, P589, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00009; Warkentin TE, 2013, HEMOSTASIS THROMBOSI, P1308; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Warkentin TE, 2015, BLOOD, V126, P486, DOI 10.1182/blood-2015-01-622787; Warkentin TE, 2015, SEMIN THROMB HEMOST, V41, P49, DOI 10.1055/s-0034-1398381; Warkentin TE, 2014, EXPERT OPIN DRUG SAF, V13, P25, DOI 10.1517/14740338.2013.823946; Warkentin TE, 2010, HEMATOL ONCOL CLIN N, V24, P755, DOI 10.1016/j.hoc.2010.05.009; Warner PM, 2003, J BURN CARE REHABIL, V24, P119, DOI 10.1097/01.BCR.0000066789.79129.C2; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; WATANABE T, 1979, PATHOL RES PRACT, V165, P311, DOI 10.1016/S0344-0338(79)80078-3; WEAVER FA, 1988, SOUTH MED J, V81, P306, DOI 10.1097/00007611-198803000-00005; Wollina Uwe, 2007, Int J Low Extrem Wounds, V6, P148, DOI 10.1177/1534734607305308; WYNNE JM, 1977, S AFR MED J, V52, P117; Zarychanski R, 2015, CRIT CARE MED, V43, P511, DOI 10.1097/CCM.0000000000000763	77	55	63	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					642	655		10.1056/NEJMra1316259	http://dx.doi.org/10.1056/NEJMra1316259			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LE	26267624				2022-12-28	WOS:000359707700009
J	Young, DJ; Guydosh, NR; Zhang, F; Hinnebusch, AG; Green, R				Young, David J.; Guydosh, Nicholas R.; Zhang, Fan; Hinnebusch, Alan G.; Green, Rachel			Rli1/ABCE1 Recycles Terminating Ribosomes and Controls Translation Reinitiation in 3 ' UTRs In Vivo	CELL			English	Article							EUKARYOTIC TRANSLATION; MESSENGER-RNA; DISSOCIATION; INITIATION; COMPLEXES; SUBUNITS; BINDING; BIOSYNTHESIS; RECOGNITION; RESOLUTION	To study the function of Rli1/ABCE1 in vivo, we used ribosome profiling and biochemistry to characterize its contribution to ribosome recycling. When Rli1 levels were diminished, 80S ribosomes accumulated both at stop codons and in the adjoining 3'UTRs of most mRNAs. Frequently, these ribosomes reinitiated translation without the need for a canonical start codon, as small peptide products predicted by 3'UTR ribosome occupancy in all three reading frames were confirmed by western analysis and mass spectrometry. Eliminating the ribosome-rescue factor Dom34 dramatically increased 3'UTR ribosome occupancy in Rli1 depleted cells, indicating that Dom34 clears the bulk of unrecycled ribosomes. Thus, Rli1 is crucial for ribosome recycling in vivo and controls ribosome homeostasis. 3'UTR translation occurs in wild-type cells as well, and observations of elevated 3'UTR ribosomes during stress suggest that modulating recycling and reinitiation is involved in responding to environmental changes.	[Young, David J.; Zhang, Fan; Hinnebusch, Alan G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Guydosh, Nicholas R.; Green, Rachel] Johns Hopkins Univ, Howard Hughes Med Inst, Sch Med, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; Johns Hopkins University	Hinnebusch, AG (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	ahinnebusch@nih.gov; ragreen@jhmi.edu	Guydosh, Nicholas/AFQ-5807-2022	Guydosh, Nicholas/0000-0001-7116-326X	Intramural Research Program of the NIH; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Proteomics data and analysis were performed by Susan Fishbain, Paige Gottlieb, Ioanna Ntai, and Paul Thomas of the Proteomics Center of Excellence at Northwestern University. We thank Tom Dever, Jon Lorsch, and members of our laboratories for many helpful suggestions during the course of this work. This study was funded in part by the Intramural Research Program of the NIH (A.G.H.) and by HHMI (R.G.).	Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Atkins JF, 2007, RNA, V13, P803, DOI 10.1261/rna.487907; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bhattacharya A, 2010, MOL CELL BIOL, V30, P5562, DOI 10.1128/MCB.00618-10; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; FREEDMAN ML, 1968, J MOL BIOL, V33, P315, DOI 10.1016/0022-2836(68)90297-0; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Herr AJ, 2004, J BIOL CHEM, V279, P11081, DOI 10.1074/jbc.M311491200; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12-386497-0.00002-5, 10.1016/B978-0-12.386497.000002-5]; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; MaalOe O, 1966, CONTROL MACROMOLECUL; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; PARK EC, 1992, P NATL ACAD SCI USA, V89, P1249, DOI 10.1073/pnas.89.4.1249; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Preis A, 2014, CELL REP, V8, P59, DOI 10.1016/j.celrep.2014.04.058; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Skabkin MA, 2013, MOL CELL, V51, P249, DOI 10.1016/j.molcel.2013.05.026; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Thompson SR, 2012, TRENDS MICROBIOL, V20, P558, DOI 10.1016/j.tim.2012.08.002; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	40	128	129	6	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					872	884		10.1016/j.cell.2015.07.041	http://dx.doi.org/10.1016/j.cell.2015.07.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276635	Bronze, Green Accepted			2022-12-28	WOS:000359741400019
J	Poets, CF; Roberts, RS; Schmidt, B; Whyte, RK; Asztalos, EV; Bader, D; Bairam, A; Moddemann, D; Peliowski, A; Rabi, Y; Solimano, A; Nelson, H				Poets, Christian F.; Roberts, Robin S.; Schmidt, Barbara; Whyte, Robin K.; Asztalos, Elizabeth V.; Bader, David; Bairam, Aida; Moddemann, Diane; Peliowski, Abraham; Rabi, Yacov; Solimano, Alfonso; Nelson, Harvey		Canadian Oxygen Trial Invest	Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; NEONATAL CAFFEINE THERAPY; BIRTH-WEIGHT INFANTS; MECHANICAL VENTILATION; PREMATURE-INFANTS; CLINICAL-TRIAL; APNEA; EPISODES; NEURODEVELOPMENT; RETINOPATHY	IMPORTANCE Extremely preterm infants may experience intermittent hypoxemia or bradycardia for many weeks after birth. The prognosis of these events is uncertain. OBJECTIVE To determine the association between intermittent hypoxemia or bradycardia and late death or disability. DESIGN, SETTING, AND PARTICIPANTS Post hoc analysis of data from the inception cohort assembled for the Canadian Oxygen Trial in 25 hospitals in Canada, the United States, Argentina, Finland, Germany, and Israel, including 1019 infants with gestational ages of 23 weeks 0 days through 27 weeks 6 days who were born between December 2006 and August 2010 and survived to a postmenstrual age of 36 weeks. Follow-up assessments occurred between October 2008 and August 2012. EXPOSURES Episodes of hypoxemia (pulse oximeter oxygen saturation <80%) or bradycardia (pulse rate <80/min) for 10 seconds or longer. Values were sampled every 10 seconds within 24 hours after birth until at least 36 weeks' postmenstrual age. MAIN OUTCOMES AND MEASURES The primary outcome was a composite of death after 36 weeks' postmenstrual age, motor impairment, cognitive or language delay, severe hearing loss, or bilateral blindness at 18 months' corrected age. Secondary outcomes were motor impairment, cognitive or language delay, and severe retinopathy of prematurity. RESULTS Downloaded saturation and pulse rate data were available for a median of 68.3 days (interquartile range, 56.8-86.0 days). Mean percentages of recorded time with hypoxemia for the least and most affected 10% of infants were 0.4% and 13.5%, respectively. Corresponding values for bradycardia were 0.1% and 0.3%. The primary outcome was ascertained for 972 infants and present in 414 (42.6%). Hypoxemic episodes were associated with an estimated increased risk of late death or disability at 18 months of 56.5% in the highest decile of hypoxemic exposure vs 36.9% in the lowest decile (modeled relative risk, 1.53; 95% CI, 1.21-1.94). This association was significant only for prolonged hypoxemic episodes lasting at least 1 minute (relative risk, 1.66; 95% CI, 1.35-2.05 vs for shorter episodes, relative risk, 1.01; 95% CI, 0.77-1.32). Relative risks for all secondary outcomes were similarly increased after prolonged hypoxemia. Bradycardia did not alter the prognostic value of hypoxemia. CONCLUSIONS AND RELEVANCE Among extremely preterm infants who survived to 36 weeks' postmenstrual age, prolonged hypoxemic episodes during the first 2 to 3 months after birth were associated with adverse 18-month outcomes. If confirmed in future studies, further research on the prevention of such episodes is needed.	[Poets, Christian F.] Tuebingen Univ Hosp, Dept Neonatol, D-72076 Tubingen, Germany; [Roberts, Robin S.; Schmidt, Barbara; Nelson, Harvey] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Schmidt, Barbara] Univ Penn, Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Whyte, Robin K.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Asztalos, Elizabeth V.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Bader, David] Bnai Zion Med Ctr, Dept Neonatol, Haifa, Israel; [Bairam, Aida] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Moddemann, Diane] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Peliowski, Abraham] Royal Alexandra Hosp, Edmonton, AB, Canada; [Rabi, Yacov] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Solimano, Alfonso] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; McMaster University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Dalhousie University; University of Toronto; Bnai Zion Medical Center; Laval University; University of Manitoba; Royal Alexandra Hospital; University of Calgary; University of British Columbia	Poets, CF (corresponding author), Tuebingen Univ Hosp, Dept Neonatol, Calwerstr 7, D-72076 Tubingen, Germany.	christian-f.poets@med.uni-tuebingen.de	Asztalos, Elizabeth/L-8834-2019; Shah, Prakesh S/I-8098-2013	Asztalos, Elizabeth/0000-0002-9468-2860; Bairam, Aida/0000-0003-3475-6546; Kallankari, Hanna/0000-0003-0738-7351; Hallman, Mikko/0000-0002-8172-729X; Bassler, Dirk/0000-0003-2358-4419; Arnon, Shmuel/0000-0002-6765-1583	Canadian Institutes of Health Research [MCT-79217]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded exclusively by Canadian Institutes of Health Research grant MCT-79217.	Bayley N, 2006, MANUAL BAYLEY SCALES; BOLIVAR JM, 1995, J PEDIATR-US, V127, P767, DOI 10.1016/S0022-3476(95)70171-0; BUCHER HU, 1988, EUR J PEDIATR, V147, P288, DOI 10.1007/BF00442697; Cheung PY, 1999, PEDIATR PULM, V27, P14, DOI 10.1002/(SICI)1099-0496(199901)27:1<14::AID-PPUL4>3.3.CO;2-S; Di Fiore JM, 2012, PEDIATR RES, V72, P606, DOI 10.1038/pr.2012.132; Doyle LW, 2014, J PEDIATR-US, V165, P356, DOI 10.1016/j.jpeds.2014.04.016; Esquer C, 2008, NEONATOLOGY, V94, P100, DOI 10.1159/000116634; HENDERSONSMART DJ, 2010, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD000140.PUB2; Janvier Annie, 2004, J Perinatol, V24, P763, DOI 10.1038/sj.jp.7211182; KOONS AH, 1993, AM J PERINAT, V10, P208, DOI 10.1055/s-2007-994719; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; LEVITT GA, 1988, EARLY HUM DEV, V16, P235, DOI 10.1016/0378-3782(88)90104-1; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; Martin RJ, 2011, NEONATOLOGY, V100, P303, DOI 10.1159/000329922; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pantalitschka T, 2009, ARCH DIS CHILD-FETAL, V94, pF245, DOI 10.1136/adc.2008.148981; Pillekamp F, 2007, NEONATOLOGY, V91, P155, DOI 10.1159/000097446; Poets CF, 2010, ACTA PAEDIATR, V99, P172, DOI 10.1111/j.1651-2227.2009.01604.x; Poets CF, 1999, BIOL NEONATE, V76, P207, DOI 10.1159/000014160; POETS CF, 1992, J PEDIATR-US, V120, P447, DOI 10.1016/S0022-3476(05)80919-9; Rhein LM, 2014, JAMA PEDIATR, V168, P250, DOI 10.1001/jamapediatrics.2013.4371; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Schmidt B, 2013, JAMA-J AM MED ASSOC, V309, P2111, DOI 10.1001/jama.2013.5555; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024; Steer P, 2004, ARCH DIS CHILD-FETAL, V89, pF499, DOI 10.1136/adc.2002.023432	26	220	223	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					595	603		10.1001/jama.2015.8841	http://dx.doi.org/10.1001/jama.2015.8841			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262797	Bronze			2022-12-28	WOS:000359388600018
J	Wilker, JJ				Wilker, Jonathan J.			Positive charges and underwater adhesion	SCIENCE			English	Editorial Material							MARINE-MUSSEL ADHESIVE		[Wilker, Jonathan J.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Wilker, Jonathan J.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wilker, JJ (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	wilker@purdue.edu			Direct For Mathematical & Physical Scien [1309787] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; Kem MP, 2015, BIOMETALS, V28, P445, DOI 10.1007/s10534-015-9827-y; Lee BP, 2006, MACROMOLECULES, V39, P1740, DOI 10.1021/ma0518959; Maier GP, 2015, SCIENCE, V349, P628, DOI 10.1126/science.aab0556; Meredith HJ, 2014, ADV FUNCT MATER, V24, P3259, DOI 10.1002/adfm.201303536; Mian SA, 2010, J PHYS CHEM C, V114, P20793, DOI 10.1021/jp1070538; Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759; Shao H, 2010, ADV MATER, V22, P729, DOI 10.1002/adma.200902380; White JD, 2011, MACROMOLECULES, V44, P5085, DOI 10.1021/ma201044x; Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]	10	44	49	15	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					582	583		10.1126/science.aac8174	http://dx.doi.org/10.1126/science.aac8174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250668				2022-12-28	WOS:000359092900019
J	Unwin, D; Tobin, S				Unwin, David; Tobin, Simon			CASE REVIEW A patient request for some "deprescribing"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GAMMA-GLUTAMYL-TRANSFERASE; TREATMENT DECISION-MAKING; FATTY LIVER-DISEASE; METABOLIC SYNDROME; OUTCOMES; IMPACT		[Unwin, David; Tobin, Simon] Norwood Surg, Southport, Qld PR9 7EG, Australia		Unwin, D (corresponding author), Norwood Surg, Southport, Qld PR9 7EG, Australia.	unwin5@btinternet.com						Blonde L, 2004, CURR MED RES OPIN, V20, P565, DOI 10.1185/030079904125003278; Boussageon R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001204; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Deber RB, 2007, HEALTH EXPECT, V10, P248, DOI 10.1111/j.1369-7625.2007.00441.x; Dixon JB, 2006, OBES SURG, V16, P1278, DOI 10.1381/096089206778663805; Frank J.D, 1961, PERSUASION HEALING; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Mandelblatt J, 2006, J CLIN ONCOL, V24, P4908, DOI 10.1200/JCO.2006.07.1159; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reeve E, 2014, BRIT J CLIN PHARMACO, V78, P738, DOI 10.1111/bcp.12386; Sattar N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4596; Taylor R, 2013, DIABETIC MED, V30, P267, DOI 10.1111/dme.12039; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Volek Jeff S, 2005, Nutr Metab (Lond), V2, P31, DOI 10.1186/1743-7075-2-31; Volek JS, 2009, LIPIDS, V44, P297, DOI 10.1007/s11745-008-3274-2; Wilson SR, 2010, AM J RESP CRIT CARE, V181, P566, DOI 10.1164/rccm.200906-0907OC	17	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2015	351								h4023	10.1136/bmj.h4023	http://dx.doi.org/10.1136/bmj.h4023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AO	26239952				2022-12-28	WOS:000359387100004
J	Koh, JS; Yang, E; Jung, GP; Jung, SP; Son, JH; Lee, SI; Jablonski, PG; Wood, RJ; Kim, HY; Cho, KJ				Koh, Je-Sung; Yang, Eunjin; Jung, Gwang-Pil; Jung, Sun-Pill; Son, Jae Hak; Lee, Sang-Im; Jablonski, Piotr G.; Wood, Robert J.; Kim, Ho-Young; Cho, Kyu-Jin			Jumping on water: Surface tension-dominated jumping of water striders and robotic insects	SCIENCE			English	Article							CATAPULT MECHANISM; FLOATING OBJECTS; WALKING; LOCOMOTION; SUPERHYDROPHOBICITY; HYDRODYNAMICS; LEGS	Jumping on water is a unique locomotion mode found in semi-aquatic arthropods, such as water striders. To reproduce this feat in a surface tension-dominant jumping robot, we elucidated the hydrodynamics involved and applied them to develop a bio-inspired impulsive mechanism that maximizes momentum transfer to water. We found that water striders rotate the curved tips of their legs inward at a relatively low descending velocity with a force just below that required to break the water surface (144 millinewtons/meter). We built a 68-milligram at-scale jumping robotic insect and verified that it jumps on water with maximum momentum transfer. The results suggest an understanding of the hydrodynamic phenomena used by semi-aquatic arthropods during water jumping and prescribe a method for reproducing these capabilities in artificial systems.	[Koh, Je-Sung; Jung, Gwang-Pil; Jung, Sun-Pill; Cho, Kyu-Jin] Seoul Natl Univ, Dept Mech & Aerosp Engn, Biorobot Lab, Seoul 151744, South Korea; [Koh, Je-Sung; Wood, Robert J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Koh, Je-Sung; Wood, Robert J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Yang, Eunjin; Kim, Ho-Young] Seoul Natl Univ, Dept Mech & Aerosp Engn, Micro Fluid Mech Lab, Seoul 151744, South Korea; [Son, Jae Hak; Lee, Sang-Im; Jablonski, Piotr G.] Seoul Natl Univ, Sch Biol Sci, Lab Behav Ecol & Evolut, Seoul 151742, South Korea; [Lee, Sang-Im; Kim, Ho-Young; Cho, Kyu-Jin] Seoul Natl Univ, Inst Adv Machines & Design, Seoul 151744, South Korea; [Jablonski, Piotr G.] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland	Seoul National University (SNU); Harvard University; Harvard University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences	Kim, HY (corresponding author), Seoul Natl Univ, Dept Mech & Aerosp Engn, Micro Fluid Mech Lab, Seoul 151744, South Korea.	hyk@snu.ac.kr; kjcho@snu.ac.kr	Kim, Ho-Young/H-8158-2014; Jablonski, Piotr G/A-2753-2015	Koh, Je-sung/0000-0002-7739-0882; /0000-0002-8333-0106	National Research Foundation of Korea [2013K000371, 2014048162, 2014023206, 2013R1A2A2A01006394]; Defense Acquisition Program Administration [UD130070ID]; Wyss Institute for Biologically Inspired Engineering	National Research Foundation of Korea(National Research Foundation of Korea); Defense Acquisition Program Administration; Wyss Institute for Biologically Inspired Engineering	This work was supported by National Research Foundation of Korea (grant nos. 2013K000371, 2014048162, 2014023206, and 2013R1A2A2A01006394), a grant to Bio-Mimetic Robot Research Center funded by Defense Acquisition Program Administration (grant no. UD130070ID), and the Wyss Institute for Biologically Inspired Engineering. We thank H. Choi and B. Shin for their helpful discussions.	Birkmeyer P, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2683, DOI 10.1109/IROS.2009.5354561; Burrows M, 2013, J EXP BIOL, V216, P1973, DOI 10.1242/jeb.083683; Burrows M, 2012, CURR BIOL, V22, pR990, DOI 10.1016/j.cub.2012.10.045; Bush JWM, 2006, ANNU REV FLUID MECH, V38, P339, DOI 10.1146/annurev.fluid.38.050304.092157; Denny M. W., 1993, AIR WATER BIOL PHYS; Denny MW, 2004, J EXP BIOL, V207, P1601, DOI 10.1242/jeb.00908; Feng XQ, 2007, LANGMUIR, V23, P4892, DOI 10.1021/la063039b; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Glasheen JW, 1996, NATURE, V380, P340, DOI 10.1038/380340a0; Hu DL, 2010, J FLUID MECH, V644, P5, DOI 10.1017/S0022112009992205; Hu DL, 2003, NATURE, V424, P663, DOI 10.1038/nature01793; Ji XY, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021607; Keller JB, 1998, PHYS FLUIDS, V10, P3009, DOI 10.1063/1.869820; Koh JS, 2013, IEEE INT C INT ROBOT, P3796, DOI 10.1109/IROS.2013.6696899; Lee DG, 2008, LANGMUIR, V24, P142, DOI 10.1021/la702437c; Lee DG, 2009, J FLUID MECH, V624, P23, DOI 10.1017/S002211200900593X; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Noh M, 2012, IEEE T ROBOT, V28, P1007, DOI 10.1109/TRO.2012.2198510; Shin B, 2008, P IEEE RAS-EMBS INT, P127, DOI 10.1109/BIOROB.2008.4762896; Song YS, 2007, IEEE T ROBOT, V23, P578, DOI 10.1109/TRO.2007.895075; Suter RB, 1997, J EXP BIOL, V200, P2523; Vella D, 2008, LANGMUIR, V24, P8701, DOI 10.1021/la800245k; Vella D, 2006, LANGMUIR, V22, P5979, DOI 10.1021/la060606m; Vella D, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3427241; Whitney JP, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/11/115021; Wood RJ, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885509; Wood RJ, 2008, IEEE T ROBOT, V24, P341, DOI 10.1109/TRO.2008.916997; Zhang XB, 2011, ACS APPL MATER INTER, V3, P2630, DOI 10.1021/am200382g; Zhao J, 2012, ACS APPL MATER INTER, V4, P3706, DOI 10.1021/am300794z; Zheng QS, 2009, J ADHES SCI TECHNOL, V23, P493, DOI 10.1163/156856108X379155	30	194	204	38	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					517	521		10.1126/science.aab1637	http://dx.doi.org/10.1126/science.aab1637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228144				2022-12-28	WOS:000358713300051
J	Tarduno, JA; Cottrell, RD; Davis, WJ; Nimmo, F; Bono, RK				Tarduno, John A.; Cottrell, Rory D.; Davis, William J.; Nimmo, Francis; Bono, Richard K.			A Hadean to Paleoarchean geodynamo recorded by single zircon crystals	SCIENCE			English	Article							BILLION YEARS AGO; JACK HILLS; METAMORPHIC REPLACEMENT; AUSTRALIA IMPLICATIONS; PALEOMAGNETIC FIELD; MINERAL INCLUSIONS; DETRITAL ZIRCON; MAGMA-OCEAN; SOLAR-WIND; EARTH	Knowing when the geodynamo started is important for understanding the evolution of the core, the atmosphere, and life on Earth. We report full-vector paleointensity measurements of Archean to Hadean zircons bearing magnetic inclusions from the Jack Hills conglomerate (Western Australia) to reconstruct the early geodynamo history. Data from zircons between 3.3 billion and 4.2 billion years old record magnetic fields varying between 1.0 and 0.12 times recent equatorial field strengths. A Hadean geomagnetic field requires a core-mantle heat flow exceeding the adiabatic value and is suggestive of plate tectonics and/or advective magmatic heat transport. The existence of a terrestrial magnetic field before the Late Heavy Bombardment is supported by terrestrial nitrogen isotopic evidence and implies that early atmospheric evolution on both Earth and Mars was regulated by dynamo behavior.	[Tarduno, John A.; Cottrell, Rory D.; Bono, Richard K.] Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; [Tarduno, John A.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Davis, William J.] Geol Survey Canada, Ottawa, ON K1A 0E8, Canada; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of Rochester; University of Rochester; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of California System; University of California Santa Cruz	Tarduno, JA (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	john.tarduno@rochester.edu	Bono, Richard/S-5265-2019	Bono, Richard/0000-0002-8222-2218; Cottrell, Rory/0000-0003-4174-6389; Davis, William/0000-0002-3628-5613; Tarduno, John/0000-0002-0490-0124	U.S. NSF [EAR-0619467, EAR-1015269]; Division Of Earth Sciences [1039846] Funding Source: National Science Foundation	U.S. NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge the late William Goree for his efforts in developing the ultrahigh-sensitivity SQUID magnetometer used in this study. We also thank G. Kloc for assistance in sample preparation; T. Pestaj for assistance in the SHRIMP laboratory; and S. Wilde, J. Valley, D. Trail, and C. Manning for helpful discussions. The data presented in this manuscript are tabulated in the supplementary materials. This work was supported by the U.S. NSF (grants EAR-0619467 and EAR-1015269).	Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; COMPSTON W, 1986, NATURE, V321, P766, DOI 10.1038/321766a0; de Niem D, 2012, ICARUS, V221, P495, DOI 10.1016/j.icarus.2012.07.032; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Gomi H, 2013, PHYS EARTH PLANET IN, V224, P88, DOI 10.1016/j.pepi.2013.07.010; Hopkins M, 2012, GEOLOGY, V40, pE281, DOI 10.1130/G33285C.1; Hutchins KS, 1997, J GEOPHYS RES-PLANET, V102, P9183, DOI 10.1029/96JE03838; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Lammer H, 2014, MON NOT R ASTRON SOC, V439, P3225, DOI 10.1093/mnras/stu085; Marty B, 2013, SCIENCE, V342, P101, DOI 10.1126/science.1240971; Moore WB, 2013, NATURE, V501, P501, DOI 10.1038/nature12473; O'Neill C, 2014, EARTH PLANET SC LETT, V406, P49, DOI 10.1016/j.epsl.2014.08.034; Olson P, 2013, SCIENCE, V342, P431, DOI 10.1126/science.1243477; Ozima M, 2005, NATURE, V436, P655, DOI 10.1038/nature03929; Rasmussen B, 2012, GEOLOGY, V40, pE282, DOI 10.1130/G33959Y.1; Rasmussen B, 2010, PRECAMBRIAN RES, V180, P26, DOI 10.1016/j.precamres.2010.03.004; Tarduno JA, 2007, NATURE, V446, P657, DOI 10.1038/nature05667; Tarduno JA, 2014, PHYS EARTH PLANET IN, V233, P68, DOI 10.1016/j.pepi.2014.05.007; Tarduno JA, 2013, EARTH PLANET SC LETT, V367, P123, DOI 10.1016/j.epsl.2013.02.008; Tarduno JA, 2012, SCIENCE, V338, P939, DOI 10.1126/science.1223932; Tarduno JA, 2010, SCIENCE, V327, P1238, DOI 10.1126/science.1183445; Valley JW, 2014, NAT GEOSCI, V7, P219, DOI [10.1038/ngeo2075, 10.1038/NGEO2075]; Zhang P, 2015, NATURE, V517, P605, DOI 10.1038/nature14090	24	152	158	2	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					521	524		10.1126/science.aaa9114	http://dx.doi.org/10.1126/science.aaa9114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228145				2022-12-28	WOS:000358713300052
J	Cesar-Razquin, A; Snijder, B; Frappier-Brinton, T; Isserlin, R; Gyimesi, G; Bai, XY; Reithmeier, RA; Hepworth, D; Hediger, MA; Edwards, AM; Superti-Furga, G				Cesar-Razquin, Adrian; Snijder, Berend; Frappier-Brinton, Tristan; Isserlin, Ruth; Gyimesi, Gergely; Bai, Xiaoyun; Reithmeier, Reinhart A.; Hepworth, David; Hediger, Matthias A.; Edwards, Aled M.; Superti-Furga, Giulio			A Call for Systematic Research on Solute Carriers	CELL			English	Review							GENE-COEXPRESSION NETWORK; CRYO-EM STRUCTURE; DRUG DISCOVERY; HUMAN-CELLS; MEMBRANE-PROTEINS; BLOOD METABOLITES; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; HUMAN PROTEOME; TRANSPORTER	Solute carrier (SLC) membrane transport proteins control essential physiological functions, including nutrient uptake, ion transport, and waste removal. SLCs interact with several important drugs, and a quarter of the more than 400 SLC genes are associated with human diseases. Yet, compared to other gene families of similar stature, SLCs are relatively understudied. The time is right for a systematic attack on SLC structure, specificity, and function, taking into account kinship and expression, as well as the dependencies that arise from the common metabolic space.	[Cesar-Razquin, Adrian; Snijder, Berend; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Frappier-Brinton, Tristan; Edwards, Aled M.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Isserlin, Ruth] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Gyimesi, Gergely; Hediger, Matthias A.] Univ Bern, NCCR TransCure, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Gyimesi, Gergely; Hediger, Matthias A.] Univ Bern, NCCR TransCure, Swiss Natl Ctr Competence Res, CH-3012 Bern, Switzerland; [Bai, Xiaoyun; Reithmeier, Reinhart A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Hepworth, David] Pfizer Worldwide Res & Dev, Worldwide Med Chem, Cambridge, MA 02139 USA; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Bern; University of Bern; University of Toronto; Pfizer; Medical University of Vienna	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.	matthias.hediger@ibmm.unibe.ch; aled.edwards@utoronto.ca; gsuperti@cemm.oeaw.ac.at	Snijder, Berend/M-2998-2017; Snijder, Berend/O-9206-2019; Gyimesi, Gergely/AAL-7340-2021; Superti-Furga, Giulio/AAE-5681-2019	Snijder, Berend/0000-0003-3386-6583; Gyimesi, Gergely/0000-0002-2054-4633; Hediger, Matthias/0000-0003-1946-027X; Cesar-Razquin, Adrian/0000-0002-1620-7079; Edwards, Aled/0000-0002-4782-6016	Austrian Academy of Sciences; ERC [250179]; Swiss National Science Foundation [P300P3_147897]; Marie Curie Actions International Fellowship Program (IFP) TransCure; Swiss National Center of Competence in Research (NCCR TransCure); AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Eshelman Institute for Innovation; Genome Canada; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust	Austrian Academy of Sciences; ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Actions International Fellowship Program (IFP) TransCure; Swiss National Center of Competence in Research (NCCR TransCure); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank all of the participants of the SLC workshop in Vienna, November 6 and 7, 2014 at CeMM and various members of the Superti-Furga laboratory for discussions and H.E. Susan le Jeune d'Allegeershecque and the British Embassy for graceful hosting. The work was funded by the Austrian Academy of Sciences (G.S.-F., A.C.R., B.S.), ERC grant agreement number 250179 (G.S.-F), the Swiss National Science Foundation (project number P300P3_147897 to B.S.), the Marie Curie Actions International Fellowship Program (IFP) TransCure (G.G.), and the Swiss National Center of Competence in Research (NCCR TransCure). D.H. is an employee and shareholder of Pfizer, Inc. G.S.-F. is a founder and shareholder of Haplogen, GmbH. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Eshelman Institute for Innovation, Genome Canada, Janssen, Merck & Co., Novartis Pharma AG, the Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust.	Abdul-Ghani MA, 2014, J INTERN MED, V276, P352, DOI 10.1111/joim.12244; Abplanalp J, 2013, HUM MOL GENET, V22, P3218, DOI 10.1093/hmg/ddt175; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Bailey DG, 2010, BRIT J CLIN PHARMACO, V70, P645, DOI 10.1111/j.1365-2125.2010.03722.x; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Brinkman RR, 2006, NAT REV GENET, V7, P249, DOI 10.1038/nrg1828; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Clemencon B, 2015, METHOD ENZYMOL, V556, P241, DOI 10.1016/bs.mie.2014.12.011; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Deng D., 2015, NATURE; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fauman EB, 2011, CURR OPIN CHEM BIOL, V15, P463, DOI 10.1016/j.cbpa.2011.05.020; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Giacomini KM, 2013, CLIN PHARMACOL THER, V94, P23, DOI 10.1038/clpt.2013.12; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Kell DB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00231; Kell DB, 2011, DRUG DISCOV TODAY, V16, P704, DOI 10.1016/j.drudis.2011.05.010; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; Krumpochova P, 2012, FASEB J, V26, P738, DOI 10.1096/fj.11-195743; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lambert JP, 2015, J PROTEOMICS, V118, P81, DOI 10.1016/j.jprot.2014.09.011; Lin L., 2015, NAT REV DRUG DISCOV; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Moraes I, 2014, BBA-BIOMEMBRANES, V1838, P78, DOI 10.1016/j.bbamem.2013.07.010; Mulkidjanian AY, 2009, TRENDS BIOCHEM SCI, V34, P206, DOI 10.1016/j.tibs.2009.01.005; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Petschnigg J, 2014, NAT METHODS, V11, P585, DOI [10.1038/NMETH.2895, 10.1038/nmeth.2895]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rask-Andersen M, 2013, MOL ASPECTS MED, V34, P702, DOI 10.1016/j.mam.2012.07.015; Ratnam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115460; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Saliba AE, 2014, NAT METHODS, V11, P47, DOI 10.1038/nmeth.2734; Scalise Mariafrancesca, 2013, Pharmaceutics, V5, P472, DOI 10.3390/pharmaceutics5030472; Schlessinger A, 2013, CLIN PHARMACOL THER, V94, P19, DOI 10.1038/clpt.2013.73; Schlessinger A, 2013, CURR TOP MED CHEM, V13, P843, DOI 10.2174/1568026611313070007; Schlessinger A, 2010, PROTEIN SCI, V19, P412, DOI 10.1002/pro.320; Schrum JP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002212; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Snijder B, 2014, NAT BIOTECHNOL, V32, P755, DOI 10.1038/nbt.2974; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Williams AJ, 2012, DRUG DISCOV TODAY, V17, P1188, DOI 10.1016/j.drudis.2012.05.016; Winter GE, 2014, NAT CHEM BIOL, V10, P768, DOI [10.1038/NCHEMBIO.1590, 10.1038/nchembio.1590]; Zeev-Ben-Mordehai T, 2014, STRUCTURE, V22, P1687, DOI 10.1016/j.str.2014.09.005; Zhang Q, 2014, DRUG METAB DISPOS, V42, P1656, DOI 10.1124/dmd.114.058883; Zhou Q, 2015, CELL RES, V25, P551, DOI 10.1038/cr.2015.47	84	311	314	12	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					478	487		10.1016/j.cell.2015.07.022	http://dx.doi.org/10.1016/j.cell.2015.07.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232220	Bronze			2022-12-28	WOS:000358801800008
J	Haberer, G; Mayer, KFX				Haberer, Georg; Mayer, Klaus F. X.			Barley: From Brittle to Stable Harvest	CELL			English	Editorial Material							DOMESTICATION; GENES	Selection and domestication of plants with genes that prevent grains from shattering in cereals was essential for human civilization's transition to agriculture-based societies. In this issue, Pourkheirandish et al. show that domestication of barley required evolution of a molecular system distinct from other grains, such as rice and maize, and reveal that present-day cultivars derive from two ancient domestication centers.	[Haberer, Georg; Mayer, Klaus F. X.] Helmholtz Ctr Munich, Plant Genome & Syst Biol, D-85764 Neuherberg, Germany; [Mayer, Klaus F. X.] Tech Univ Munich, Sch Life Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Mayer, Klaus F. X.] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; King Saud University	Mayer, KFX (corresponding author), Helmholtz Ctr Munich, Plant Genome & Syst Biol, D-85764 Neuherberg, Germany.	k.mayer@helmholtz-muenchen.de	Mayer, Klaus FX/M-7941-2015	Mayer, Klaus FX/0000-0001-6484-1077; Haberer, Georg/0000-0002-6612-6939				Doust AN, 2014, AM J BOT, V101, P1759, DOI 10.3732/ajb.1400186; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044	7	8	10	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					469	471		10.1016/j.cell.2015.07.023	http://dx.doi.org/10.1016/j.cell.2015.07.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232216	Bronze			2022-12-28	WOS:000358801800004
J	Kasthuri, N; Hayworth, KJ; Berger, DR; Schalek, RL; Conchello, JA; Knowles-Barley, S; Lee, D; Vazquez-Reina, A; Kaynig, V; Jones, TR; Roberts, M; Morgan, JL; Tapia, JC; Seung, HS; Roncal, WG; Vogelstein, JT; Burns, R; Sussman, DL; Priebe, CE; Pfister, H; Lichtman, JW				Kasthuri, Narayanan; Hayworth, Kenneth Jeffrey; Berger, Daniel Raimund; Schalek, Richard Lee; Conchello, Jose Angel; Knowles-Barley, Seymour; Lee, Dongil; Vazquez-Reina, Amelio; Kaynig, Verena; Jones, Thouis Raymond; Roberts, Mike; Morgan, Josh Lyskowski; Tapia, Juan Carlos; Seung, H. Sebastian; Roncal, William Gray; Vogelstein, Joshua Tzvi; Burns, Randal; Sussman, Daniel Lewis; Priebe, Carey Eldin; Pfister, Hanspeter; Lichtman, Jeff William			Saturated Reconstruction of a Volume of Neocortex	CELL			English	Article							PYRAMIDAL NEURONS; DIRECTION-SELECTIVITY; SYNAPTIC CONNECTIONS; WIRING SPECIFICITY; DENDRITIC SPINES; RAT HIPPOCAMPUS; TOTAL NUMBER; SYNAPSES; CIRCUIT; CORTEX	We describe automated technologies to probe the structure of neural tissue at nanometer resolution and use them to generate a saturated reconstruction of a sub-volume of mouse neocortex in which all cellular objects (axons, dendrites, and glia) and many sub-cellular components (synapses, synaptic vesicles, spines, spine apparati, postsynaptic densities, and mitochondria) are rendered and itemized in a database. We explore these data to study physical properties of brain tissue. For example, by tracing the trajectories of all excitatory axons and noting their juxtapositions, both synaptic and nonsynaptic, with every dendritic spine we refute the idea that physical proximity is sufficient to predict synaptic connectivity (the so-called Peters' rule). This online minable database provides general access to the intrinsic complexity of the neocortex and enables further data-driven inquiries.	[Kasthuri, Narayanan; Hayworth, Kenneth Jeffrey; Berger, Daniel Raimund; Schalek, Richard Lee; Conchello, Jose Angel; Knowles-Barley, Seymour; Lee, Dongil; Jones, Thouis Raymond; Morgan, Josh Lyskowski; Tapia, Juan Carlos; Lichtman, Jeff William] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Kasthuri, Narayanan; Hayworth, Kenneth Jeffrey; Berger, Daniel Raimund; Schalek, Richard Lee; Conchello, Jose Angel; Knowles-Barley, Seymour; Lee, Dongil; Jones, Thouis Raymond; Morgan, Josh Lyskowski; Tapia, Juan Carlos; Lichtman, Jeff William] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Vazquez-Reina, Amelio; Kaynig, Verena; Jones, Thouis Raymond; Roberts, Mike; Pfister, Hanspeter] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Roncal, William Gray; Burns, Randal] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Sussman, Daniel Lewis] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Priebe, Carey Eldin] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD 21218 USA; [Seung, H. Sebastian] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Vogelstein, Joshua Tzvi] Duke Univ, Dept Stat Sci & Neurobiol, Durham, NC 27708 USA	Harvard University; Harvard University; Harvard University; Johns Hopkins University; Harvard University; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Duke University	Kasthuri, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	bobby.kasthuri@gmail.com; jeff@mcb.harvard.edu	Vogelstein, Joshua/AAG-5489-2019	Vogelstein, Joshua/0000-0003-2487-6237; Jones, Thouis/0000-0001-6584-9660; Pfister, Hanspeter/0000-0002-3620-2582; Burns, Randal/0000-0002-2924-1997; Sussman, Daniel/0000-0002-8307-2610	NIH/NINDS [1DP2OD006514-01, TR01 1R01NS076467-01, 1U01NS090449-01]; Conte [1P50MH09427101]; MURI Army Research Office [W911NF1210594, IIS-1447786]; NSF [OIA-1125087, IIS-1110955]; DARPA [HR0011-14-2-0004]; Human Frontier Science Program [RGP0051/2014]; JHU Applied Physics Laboratory; Research Program for Applied Neuroscience; Howard Hughes Medical Institute; Nvidia; Intel; Google; CRCNS [1R01EB016411]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090449, R01NS076467] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Conte; MURI Army Research Office; NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Human Frontier Science Program(Human Frontier Science Program); JHU Applied Physics Laboratory; Research Program for Applied Neuroscience; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Nvidia; Intel(Intel Corporation); Google(Google Incorporated); CRCNS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledged support from the NIH/NINDS (1DP2OD006514-01, TR01 1R01NS076467-01, and 1U01NS090449-01), Conte (1P50MH09427101), MURI Army Research Office (contract no. W911NF1210594 and IIS-1447786), CRCNS 1R01EB016411), NSF (OIA-1125087 and IIS-1110955), DARPA (HR0011-14-2-0004), the Human Frontier Science Program (RGP0051/2014), the JHU Applied Physics Laboratory, the Research Program for Applied Neuroscience, the Howard Hughes Medical Institute, Nvidia, Intel, and Google. We are also grateful to the Center for the Developing Child at Harvard University for providing tracers, Masconomet Regional High School, and Priya Manavalan and Kunal Lillaney at the Open Connectome Project for help with data management.	Anderson JR, 2011, MOL VIS, V17; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Benavides-Piccione R, 2002, J NEUROCYTOL, V31, P337, DOI 10.1023/A:1024134312173; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Burns R., 2013, P 25 INT C SCI STAT; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; da Costa NM, 2013, NEUROIMAGE, V80, P27, DOI 10.1016/j.neuroimage.2013.04.054; Deans JK, 2007, J PHYSIOL-LONDON, V583, P555, DOI 10.1113/jphysiol.2007.137711; Druckmann S, 2014, NEURON, V81, P629, DOI 10.1016/j.neuron.2013.11.026; Eberle A.L., 2015, J MICROSC; FRIEDMAN PL, 1981, J NEUROCYTOL, V10, P111, DOI 10.1007/BF01181748; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Haehn D., 2014, P IEEE T VISUALIZATI; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hayworth KJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00068; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Hill SL, 2012, P NATL ACAD SCI USA, V109, pE2885, DOI 10.1073/pnas.1202128109; Kaynig V., 2013, ARXIV13037186; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Krieger P, 2007, J NEUROSCI, V27, P11473, DOI 10.1523/JNEUROSCI.1182-07.2007; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lichtman JW, 2014, NAT NEUROSCI, V17, P1448, DOI 10.1038/nn.3837; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H., 2012, HUMAN BRAIN PROJECT; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nunez-Iglesias J, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00034; PETERS A, 1991, ANAT REC, V229, P384, DOI 10.1002/ar.1092290311; Plaza SM, 2014, CURR OPIN NEUROBIOL, V25, P201, DOI 10.1016/j.conb.2014.01.019; Popov VI, 2009, SYNAPSE, V63, P369, DOI 10.1002/syn.20613; PURPURA DP, 1975, ADV NEUROL, V12, P91; Ramon y Cajal S, 1899, TEXTURA SISTEMA NERV; Sherrington C, 1906, INTEGRATIVE ACTION N; Sinha A., 2013, 3 ANN HOPK IM C; SMILEY JF, 1993, CEREB CORTEX, V3, P223, DOI 10.1093/cercor/3.3.223; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sorra KE, 1998, J COMP NEUROL, V398, P225; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tapia JC, 2012, NAT PROTOC, V7, P193, DOI 10.1038/nprot.2011.439; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Turney SG, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001352; VANHARREVELD A, 1965, J CELL BIOL, V25, P117, DOI 10.1083/jcb.25.1.117; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vazquez-Reina A, 2011, IEEE I CONF COMP VIS, P177, DOI 10.1109/ICCV.2011.6126240; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007	58	522	527	3	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					648	661		10.1016/j.cell.2015.06.054	http://dx.doi.org/10.1016/j.cell.2015.06.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232230	Bronze			2022-12-28	WOS:000358801800022
J	Van Vranken, JG; Rutter, J				Van Vranken, Jonathan G.; Rutter, Jared			You Down With ETC? Yeah, You Know D!	CELL			English	Editorial Material							PYRUVATE	Although the mitochondrial electron transport chain (ETC) is best known for its role in ATP synthesis, two studies, Sullivan et al. and Birsoy et al., conclude that its only essential function in proliferating cells is making aspartate (D).	[Van Vranken, Jonathan G.; Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	rutter@biochem.utah.edu						Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Fujii T, 2014, MOL GENET METAB, V112, P133, DOI 10.1016/j.ymgme.2014.04.008; KELSAY JL, 1972, J NUTR, V102, P661, DOI 10.1093/jn/102.5.661; Nikiforov A., 2015, CRIT REV BIOCHEM MOL, P1, DOI DOI 10.3109/10409238.2015.1028612; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; WUU JA, 1988, CLIN CHEM, V34, P1610	7	10	10	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					471	473		10.1016/j.cell.2015.07.027	http://dx.doi.org/10.1016/j.cell.2015.07.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232217	Bronze			2022-12-28	WOS:000358801800005
J	Janlert, U				Janlert, Urban			Long working hours: an avoidable cause of stroke?	LANCET			English	Editorial Material							CARDIOVASCULAR-DISEASE		Umea Univ, Div Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, SE-90187 Umea, Sweden	Umea University	Janlert, U (corresponding author), Umea Univ, Div Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, SE-90187 Umea, Sweden.	urban.janlert@umu.se						Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Elkind MS, 2015, ANN NY ACAD SCI, V1338, P115; Ji C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005683; Kang MY, 2012, J OCCUP ENVIRON MED, V54, P532, DOI 10.1097/JOM.0b013e31824fe192; Karasek R., 1990, HLTH WORK STRESS PRO; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; OECD, 2015, WORK LIF BAL BETT LI; Pimenta AM, 2015, EUR J PUBLIC HEALTH, V25, P683, DOI 10.1093/eurpub/cku245; Resnik WH, 1963, ARCH INTERN MED, V112, P792; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; White J, 2003, WORKING LONG HOURS	12	2	2	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1710	1711		10.1016/S0140-6736(15)61000-5	http://dx.doi.org/10.1016/S0140-6736(15)61000-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV0WK	26298821	Green Submitted, hybrid			2022-12-28	WOS:000363974200008
J	Wexner, SD				Wexner, Steven D.			Percutaneous tibial nerve stimulation in faecal incontinence	LANCET			English	Editorial Material							TRIAL		Ctr Digest Dis, Dept Colorectal Surg, Cleveland Clin, Weston, FL 33331 USA	Cleveland Clinic Foundation	Wexner, SD (corresponding author), Ctr Digest Dis, Dept Colorectal Surg, Cleveland Clin, Weston, FL 33331 USA.	wexners@ccf.org						Brown HW, 2012, INT J CLIN PRACT, V66, P1101, DOI 10.1111/ijcp.12018; Eleouet M, 2010, INT J COLORECTAL DIS, V25, P1127, DOI 10.1007/s00384-010-0960-3; George AT, 2013, BRIT J SURG, V100, P330, DOI 10.1002/bjs.9000; Horrocks EJ, 2014, BRIT J SURG, V101, P457, DOI 10.1002/bjs.9391; Hotouras A, 2012, COLORECTAL DIS, V14, P1101, DOI 10.1111/j.1463-1318.2011.02906.x; Kaiser AM, 2014, SURG ENDOSC, V28, P2277, DOI 10.1007/s00464-014-3464-3; Knowles CH, 2015, LANCET; Leroi AM, 2012, AM J GASTROENTEROL, V107, P1888, DOI 10.1038/ajg.2012.330; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823; Thin NN, 2015, BRIT J SURG, V102, P349, DOI 10.1002/bjs.9695; Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77; Wexner SD, 2010, ANN SURG, V251, P441, DOI 10.1097/SLA.0b013e3181cf8ed0	13	4	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1605	1606		10.1016/S0140-6736(15)60508-6	http://dx.doi.org/10.1016/S0140-6736(15)60508-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26293316				2022-12-28	WOS:000363197500007
J	Siemieniuk, RAC; Meade, MO; Alonso-Coello, P; Briel, M; Evaniew, N; Prasad, M; Alexander, PE; Fei, YT; Vandvik, PO; Loeb, M; Guyatt, GH				Siemieniuk, Reed A. C.; Meade, Maureen O.; Alonso-Coello, Pablo; Briel, Matthias; Evaniew, Nathan; Prasad, Manya; Alexander, Paul E.; Fei, Yutong; Vandvik, Per O.; Loeb, Mark; Guyatt, Gordon H.			Corticosteroid Therapy for Patients Hospitalized With Community Acquired Pneumonia A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATORY RESPONSE; ECONOMIC BURDEN; GUIDELINES; MANAGEMENT; ADULTS; HYDROCORTISONE; CONSENSUS; SEVERITY; DEXAMETHASONE	Background: Community-acquired pneumonia (CAP) is common and often severe. Purpose: To examine the effect of adjunctive corticosteroid therapy on mortality, morbidity, and duration of hospitalization in patients with CAP. Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials through 24 May 2015. Study Selection: Randomized trials of systemic corticosteroids in hospitalized adults with CAP. Data Extraction: Two reviewers independently extracted study data and assessed risk of bias. Quality of evidence was assessed with the Grading of Recommendations Assessment, Development, and Evaluation system by consensus among the authors. Data Synthesis: The median age was typically in the 60s, and approximately 60% of patients were male. Adjunctive corticosteroids were associated with possible reductions in all-cause mortality (12 trials; 1974 patients; risk ratio [RR], 0.67 [95% CI, 0.45 to 1.01]; risk difference [RD], 2.8%; moderate certainty), need for mechanical ventilation (5 trials; 1060 patients; RR, 0.45 [CI, 0.26 to 0.79]; RD, 5.0%; moderate certainty), and the acute respiratory distress syndrome (4 trials; 945 patients; RR, 0.24 [CI, 0.10 to 0.56]; RD, 6.2%; moderate certainty). They also decreased time to clinical stability (5 trials; 1180 patients; mean difference, -1.22 days [CI, -2.08 to -0.35 days]; high certainty) and duration of hospitalization (6 trials; 1499 patients; mean difference, -1.00 day [CI, -1.79 to -0.21 days]; high certainty). Adjunctive corticosteroids increased frequency of hyperglycemia requiring treatment (6 trials; 1534 patients; RR, 1.49 [CI, 1.01 to 2.19]; RD, 3.5%; high certainty) but did not increase frequency of gastrointestinal hemorrhage. Limitations: There were few events and trials for many outcomes. Trials often excluded patients at high risk for adverse events. Conclusion: For hospitalized adults with CAP, systemic corticosteroid therapy may reduce mortality by approximately 3%, need for mechanical ventilation by approximately 5%, and hospital stay by approximately 1 day.	McMaster Univ, Hamilton, ON L8S 4K1, Canada; Inst Invest Biomed St Pau, Barcelona, Spain; Univ Basel Hosp, CH-4031 Basel, Switzerland; Univ Oslo, Oslo, Norway	McMaster University; University of Basel; University of Oslo	Siemieniuk, RAC (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	reed.siemieniuk@medportal.ca	Briel, Matthias/AAT-9284-2021; Prasad, Manya/AAQ-6436-2021	Alonso-Coello, Pablo/0000-0002-8001-8504; Briel, Matthias/0000-0002-2070-5230				Akl EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057132; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; British Thoracic Society Standards of Care Committee, 2001, THORAX S4, V56, pIV1; Busse JWGG, 2013, MODIFICATION COCHRAN; Capelastegui A, 2009, CHEST, V136, P1079, DOI 10.1378/chest.08-2950; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Chen YJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007720.pub2; Cheng M, 2014, RESP CARE, V59, P557, DOI 10.4187/respcare.02758; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Ebrahim S, 2014, J CLIN EPIDEMIOL, V67, P560, DOI 10.1016/j.jclinepi.2013.11.014; El-Ghamrawy AH., 2006, EGYPT J CHEST DIS TU, V55, P91; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Estenssoro E, 2002, CRIT CARE MED, V30, P2450, DOI 10.1097/00003246-200211000-00008; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2012, J CLIN EPIDEMIOL, V65, P1243, DOI 10.1016/j.jclinepi.2012.07.013; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Higgins J., 2009, COCHRANE HDB SYSTEMA; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Knapp G, 2000, ST HEAL T, V77, P34; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARIK P, 1993, CHEST, V104, P389, DOI 10.1378/chest.104.2.389; MCHARDY VU, 1972, BRIT MED J, V4, P569, DOI 10.1136/bmj.4.5840.569; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Mikami K, 2007, LUNG, V185, P249, DOI 10.1007/s00408-007-9020-3; Monton C, 1999, EUR RESPIR J, V14, P218, DOI 10.1034/j.1399-3003.1999.14a37.x; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nafae RM, 2013, EGYPT J CHEST DIS TU, V62, P439, DOI 10.1016/j.ejcdt.2013.03.009; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Peter JV, 2008, BMJ-BRIT MED J, V336, P1006, DOI 10.1136/bmj.39537.939039.BE; Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012; Remmelts HHF, 2012, CLIN VACCINE IMMUNOL, V19, P1532, DOI 10.1128/CVI.00423-12; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sabry NA, 2011, PHARM PHARM, V2, P73, DOI DOI 10.4236/PP.2011.22009; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Thomas CP, 2012, CHEST, V142, P973, DOI 10.1378/chest.11-1160; Tikkinen KAO, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-150; Toba A, 2010, RESPIROLOGY, V15, P319, DOI 10.1111/j.1440-1843.2009.01685.x; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; WAGNER HN, 1956, B JOHNS HOPKINS HOSP, V98, P197; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wood-Baker RR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub2; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; Yu H, 2012, J AM GERIATR SOC, V60, P2137, DOI 10.1111/j.1532-5415.2012.04208.x	57	213	226	0	60	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7					519	+		10.7326/M15-0715	http://dx.doi.org/10.7326/M15-0715			26	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26258555				2022-12-28	WOS:000362496400005
J	Robertson, CT				Robertson, Christopher T.			New DTCA Guidance - Enough to Empower Consumers?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Arizona, James E Rogers Coll Law, Tucson, AZ 85721 USA	University of Arizona	Robertson, CT (corresponding author), Univ Arizona, James E Rogers Coll Law, Tucson, AZ 85721 USA.			Robertson, Christopher/0000-0001-6188-8005				[Anonymous], 2015, GUID IND BRIEF SUMM; BEN-SHAHAR OMRI, 2014, MORE YOU WANTED KNOW; Biegler P, 2013, AM J BIOETHICS, V13, P3, DOI 10.1080/15265161.2013.776127; FUNG ARCHON, 2008, FULL DISCLOSURE PERI	4	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1085	1087		10.1056/NEJMp1508548	http://dx.doi.org/10.1056/NEJMp1508548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR7UG	26287748	Green Published			2022-12-28	WOS:000361556400001
J	Margalit, Y; Zhou, ZF; Machluf, S; Rohrlich, D; Japha, Y; Folman, R				Margalit, Yair; Zhou, Zhifan; Machluf, Shimon; Rohrlich, Daniel; Japha, Yonathan; Folman, Ron			A self-interfering clock as a "which path" witness	SCIENCE			English	Article							QUANTUM; TIME	In Einstein's general theory of relativity, time depends locally on gravity; in standard quantum theory, time is global-all clocks "tick" uniformly. We demonstrate a new tool for investigating time in the overlap of these two theories: a self-interfering clock, comprising two atomic spin states. We prepare the clock in a spatial superposition of quantum wave packets, which evolve coherently along two paths into a stable interference pattern. If we make the clock wave packets "tick" at different rates, to simulate a gravitational time lag, the clock time along each path yields "which path" information, degrading the pattern's visibility. In contrast, in standard interferometry, time cannot yield "which path" information. This proof-of-principle experiment may have implications for the study of time and general relativity and their impact on fundamental effects such as decoherence and the emergence of a classical world.	[Margalit, Yair; Zhou, Zhifan; Machluf, Shimon; Rohrlich, Daniel; Japha, Yonathan; Folman, Ron] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel	Ben Gurion University	Folman, R (corresponding author), Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel.	folman@bgu.ac.il	Rohrlich, Daniel/F-2316-2012; Zhou, Zhifan/AEU-8153-2022; zhou, zhifan/CAF-6829-2022	Zhou, Zhifan/0000-0001-6323-6756; Margalit, Yair/0000-0002-9180-3700; ROHRLICH, Daniel/0000-0002-6252-3048; Folman, Ron/0000-0002-3449-2563	Israeli Science Foundation; European Commission "MatterWave"' consortium [FP7-ICT-601180]; German-Israeli DIP project - Deutsche Forschungsgemeinschaft; Israeli Council for Higher Education; Ministry of Immigrant Absorption (Israel); John Templeton Foundation [43297]; Israel Science Foundation [1190/13]	Israeli Science Foundation(Israel Science Foundation); European Commission "MatterWave"' consortium; German-Israeli DIP project - Deutsche Forschungsgemeinschaft; Israeli Council for Higher Education; Ministry of Immigrant Absorption (Israel); John Templeton Foundation; Israel Science Foundation(Israel Science Foundation)	We thank Z. Binshtok, S. Zhou, M. Keil, D. Groswasser, Y. Bar-Haim, and M. Givon for their assistance and the Ben-Gurion University of the Negev nanofabrication facility for providing the high-quality chip. This work is funded in part by the Israeli Science Foundation, the European Commission "MatterWave"' consortium (FP7-ICT-601180), and the German-Israeli DIP project (Quantum phenomena in hybrid systems) supported by the Deutsche Forschungsgemeinschaft. We also acknowledge support from the program for outstanding postdoctoral researchers of the Israeli Council for Higher Education and from the Ministry of Immigrant Absorption (Israel). D.R. thanks the John Templeton Foundation (Project ID 43297) and the Israel Science Foundation (grant 1190/13) for support. The opinions expressed in this publication do not necessarily reflect the views of the John Templeton Foundation.	Aharonov Y, 2005, QUANTUM PARADOXES: QUANTUM THEORY FOR THE PERPLEXED, P1, DOI 10.1002/9783527619115; Bassi A, 2013, REV MOD PHYS, V85, P471, DOI 10.1103/RevModPhys.85.471; Bohr N, 1951, A EINSTEIN PHILOS SC, P201; COLELLA R, 1975, PHYS REV LETT, V34, P1472, DOI 10.1103/PhysRevLett.34.1472; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; Dimopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.111102; Diosi L, 2013, J PHYS CONF SER, V442, DOI 10.1088/1742-6596/442/1/012001; Durr S, 1998, NATURE, V395, P33, DOI 10.1038/25653; Georgescu I, 2014, NAT PHYS, V10, P253, DOI 10.1038/nphys2934; Kuhn CCN, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/073035; Lan SY, 2013, SCIENCE, V339, P554, DOI 10.1126/science.1230767; Machluf S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3424; Moerchen M, 2015, SCIENCE, V347, P1083; Muntinga H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.093602; Peil S, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.014101; Penrose R., 1989, EMPERORS NEW MIND CO; Pikovski I., 2015, NAT PHYS; RAUCH H, 1975, PHYS LETT A, V54, P425, DOI 10.1016/0375-9601(75)90798-7; Rauch H., 2000, NEUTRON INTERFEROMET; Schleich WP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.010401; Smolin Lee, 2014, TIME REBORN; Zych M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1498	22	55	55	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1205	1208		10.1126/science.aac6498	http://dx.doi.org/10.1126/science.aac6498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26249229	Green Submitted			2022-12-28	WOS:000360968400038
J	Lazazzera, BA; Hughes, D				Lazazzera, Beth A.; Hughes, Diarmaid			GENETICS Location affects sporulation	NATURE			English	Editorial Material							BACILLUS-SUBTILIS; REPLICATION; EXPRESSION; BACTERIA; GENES	Monitored changes in the number of copies of a gene during DNA replication control the timing of sporulation in bacteria. This discovery links replication to the concept that a gene's location on a chromosome can influence cell traits.	[Lazazzera, Beth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Hughes, Diarmaid] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden	University of California System; University of California Los Angeles; Uppsala University	Lazazzera, BA (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	bethl@microbio.ucla.edu; diarmaid.hughes@imbim.uu.se	Hughes, Diarmaid/A-9487-2014	Hughes, Diarmaid/0000-0002-7456-9182				Block DHS, 2012, NUCLEIC ACIDS RES, V40, P8979, DOI 10.1093/nar/gks694; Bremer H., 1996, E COLI SALMONELLA CE, V2, P1553; Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Levine JH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001252; Narula J, 2015, CELL, V162, P328, DOI 10.1016/j.cell.2015.06.012; SCHMID MB, 1987, J BACTERIOL, V169, P2872, DOI 10.1128/jb.169.6.2872-2875.1987; Sousa C, 1997, MICROBIOL-SGM, V143, P2071, DOI 10.1099/00221287-143-6-2071; Veening JW, 2009, GENE DEV, V23, P1959, DOI 10.1101/gad.528209	9	2	2	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					42	43		10.1038/nature15207	http://dx.doi.org/10.1038/nature15207			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26287460				2022-12-28	WOS:000360594100020
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: What you don't learn at medical school	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2015	351								h4510	10.1136/bmj.h4510	http://dx.doi.org/10.1136/bmj.h4510			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7QF	26296586	Bronze			2022-12-28	WOS:000360082200002
J	Liu, YZ; Wu, F; Lu, L; Lin, D; Zhang, K				Liu, Yizhi; Wu, Frances; Lu, Lin; Lin, Danni; Zhang, Kang			Examination of the Retina	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liu, Yizhi; Lu, Lin; Zhang, Kang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Frances; Lin, Danni; Zhang, Kang] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Wu, Frances; Lin, Danni; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California San Diego	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	yzliu62@yahoo.com	liu, yi/GXE-9662-2022; Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697	State Key Laboratory of Ophthalmology, Sun Yat-sen University; Zhongshan Ophthalmic Center, Sun Yat-sen University; 973 Program [2015CB94600, 2012CB917304]	State Key Laboratory of Ophthalmology, Sun Yat-sen University; Zhongshan Ophthalmic Center, Sun Yat-sen University; 973 Program(National Basic Research Program of China)	Supported by the State Key Laboratory of Ophthalmology and Zhongshan Ophthalmic Center, Sun Yat-sen University, and grants from the 973 Program (2015CB94600 and 2012CB917304).	Albert D.M., 2008, ALBERT JAKOBIECS PRI; Harris, 2001, RETINA, P2068; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745	3	5	5	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8							e9	10.1056/NEJMvcm1308125	http://dx.doi.org/10.1056/NEJMvcm1308125			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287871				2022-12-28	WOS:000359709400001
J	Zhao, L; Oliver, E; Maratou, K; Atanur, SS; Dubois, OD; Cotroneo, E; Chen, CN; Wang, L; Arce, C; Chabosseau, PL; Ponsa-Cobas, J; Frid, MG; Moyon, B; Webster, Z; Aldashev, A; Ferrer, J; Rutter, GA; Stenmark, KR; Aitman, TJ; Wilkins, MR				Zhao, Lan; Oliver, Eduardo; Maratou, Klio; Atanur, Santosh S.; Dubois, Olivier D.; Cotroneo, Emanuele; Chen, Chien-Nien; Wang, Lei; Arce, Cristina; Chabosseau, Pauline L.; Ponsa-Cobas, Joan; Frid, Maria G.; Moyon, Benjamin; Webster, Zoe; Aldashev, Almaz; Ferrer, Jorge; Rutter, Guy A.; Stenmark, Kurt R.; Aitman, Timothy J.; Wilkins, Martin R.			The zinc transporter ZIP12 regulates the pulmonary vascular response to chronic hypoxia	NATURE			English	Article							HYPERTENSION; EXPRESSION; INHIBITION	The typical response of the adult mammalian pulmonary circulation to a low oxygen environment is vasoconstriction and structural remodelling of pulmonary arterioles, leading to chronic elevation of pulmonary artery pressure (pulmonary hypertension) and right ventricular hypertrophy. Some mammals, however, exhibit genetic resistance to hypoxia-induced pulmonary hypertension(1-3). We used a congenic breeding program and comparative genomics to exploit this variation in the rat and identified the gene Slc39a12 as a major regulator of hypoxia-induced pulmonary vascular remodelling. Slc39a12 encodes the zinc transporter ZIP12. Here we report that ZIP12 expression is increased in many cell types, including endothelial, smooth muscle and interstitial cells, in the remodelled pulmonary arterioles of rats, cows and humans susceptible to hypoxia-induced pulmonary hypertension. We show that ZIP12 expression in pulmonary vascular smooth muscle cells is hypoxia dependent and that targeted inhibition of ZIP12 inhibits the rise in intracellular labile zinc in hypoxia-exposed pulmonary vascular smooth muscle cells and their proliferation in culture. We demonstrate that genetic disruption of ZIP12 expression attenuates the development of pulmonary hypertension in rats housed in a hypoxic atmosphere. This new and unexpected insight into the fundamental role of a zinc transporter in mammalian pulmonary vascular homeostasis suggests a new drug target for the pharmacological management of pulmonary hypertension.	[Zhao, Lan; Oliver, Eduardo; Dubois, Olivier D.; Cotroneo, Emanuele; Chen, Chien-Nien; Wang, Lei; Arce, Cristina; Wilkins, Martin R.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Pharmacol & Therapeut, Div Expt Med, London W12 0NN, England; [Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Cell Biol & Funct Genom, Div Diabet Endocrinol & Metab, London W12 0NN, England; [Ponsa-Cobas, Joan; Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Sect Epigen & Dis,Dept Med, London W12 0NN, England; [Maratou, Klio; Atanur, Santosh S.; Chabosseau, Pauline L.; Aitman, Timothy J.] Hammersmith Hosp, Med Res Council Clin Sci Ctr, Physiol Genom & Med Grp, London W12 0NN, England; [Moyon, Benjamin; Webster, Zoe] Hammersmith Hosp, Med Res Council Clin Sci Ctr, Transgen & Embryon Stem Cell Lab, London W12 0NN, England; [Aldashev, Almaz] Inst Mol Biol & Med, Bishkek 720040, Kyrgyzstan; [Frid, Maria G.; Stenmark, Kurt R.] Univ Colorado, Dept Pediat & Med, Div Crit Care Med, Denver, CO 80045 USA; [Frid, Maria G.; Stenmark, Kurt R.] Univ Colorado, Cardiovasc Pulm Res Labs, Denver, CO 80045 USA	Imperial College London; Imperial College London; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Ministry of Health - Kyrgyzstan; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Zhao, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Pharmacol & Therapeut, Div Expt Med, London W12 0NN, England.	l.zhao@imperial.ac.uk	stenmark, kurt/AAH-3124-2022; Wilkins, Martin/ABH-1140-2021; Oliver, Eduardo/D-4971-2012; Oliver, Eduardo/AHB-8417-2022; Ferrer, Jorge/A-3176-2012; stenmark, kurt/AFI-6776-2022	Wilkins, Martin/0000-0003-3926-1171; Oliver, Eduardo/0000-0001-9340-882X; Ferrer, Jorge/0000-0002-5959-5729; Maratou, Klio/0000-0001-6061-2322; Aitman, Timothy/0000-0002-7875-4502; ALDASHEV, Almaz/0000-0002-4793-2206; Rutter, Guy/0000-0001-6360-0343	British Heart Foundation [PG/95170, PG/98018, PG/2000137, PG/04/035/16912, PG/12/61/29818, PG/10/59/28478, RG/10/16/28575]; Wellcome Trust [WT098424AIA]; MRC [MR/J0003042/1]; Royal Society; European Research Council [268880]; MRC [MR/K001981/1, MC_U120061454, MR/L02036X/1] Funding Source: UKRI; British Heart Foundation [PG/10/34/28338] Funding Source: researchfish; Medical Research Council [MR/K001981/1, MC_U120061454] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by successive grants from British Heart Foundation to M.R.W. and L.Z. (PG/95170, PG/98018, PG/2000137, PG/04/035/16912, PG/12/61/29818, PG/10/59/28478 and RG/10/16/28575). G.A.R. was supported by a Wellcome Trust Senior Investigator Award (WT098424AIA), MRC Programme Grant (MR/J0003042/1) and a Royal Society Research Merit Award. T.A. acknowledges support from European Research Council Advanced Grant ERC-2010-AdG, number 268880. We thank A. I. Garcia-Diaz for advice on genotyping techniques and R. Edwards for advice on antibody production. We thank C. Haley for discussions on the rat genetic map.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aplin AC, 2015, METHODS MOL BIOL, V1214, P255, DOI 10.1007/978-1-4939-1462-3_16; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Beasley NJP, 2001, CANCER RES, V61, P5262; Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Bernal PJ, 2011, AM J PHYSIOL-LUNG C, V300, pL874, DOI 10.1152/ajplung.00328.2010; Chen QG, 2012, UROL ONCOL-SEMIN ORI, V30, P906, DOI 10.1016/j.urolonc.2010.11.010; Chowanadisai W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111535; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Cotroneo E, 2015, CIRC RES, V116, P1680, DOI 10.1161/CIRCRESAHA.116.305265; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Edwards Robert J, 2006, Methods Mol Biol, V320, P173; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; Grattan BJ, 2012, NUTRIENTS, V4, P648, DOI 10.3390/nu4070648; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; PAN LC, 1993, TOXICOLOGY, V79, P21, DOI 10.1016/0300-483X(93)90203-5; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Rhodes J, 2005, J APPL PHYSIOL, V98, P1092, DOI 10.1152/japplphysiol.01017.2004; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; Wilkins MR, 2015, CIRCULATION, V131, P582, DOI 10.1161/CIRCULATIONAHA.114.006977; Zhang YQ, 2010, CLIN CANCER RES, V16, P1423, DOI 10.1158/1078-0432.CCR-09-2405; Zhao L, 2001, CIRCULATION, V103, P442; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117; Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176	34	88	95	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					356	U229		10.1038/nature14620	http://dx.doi.org/10.1038/nature14620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26258299	Green Accepted, Green Submitted			2022-12-28	WOS:000359714000037
J	Zhang, MWB; Ho, RCM				Zhang, Melvyn W. B.; Ho, Roger C. M.			MEDICINE AND THE MEDIA Ketamine's potential as a rapid antidepressant was overplayed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TREATMENT-RESISTANT DEPRESSION; ELECTROCONVULSIVE-THERAPY; ABUSE; MOOD		[Zhang, Melvyn W. B.] Inst Mental Hlth, Natl Addict Management Serv, Singapore, Singapore; [Ho, Roger C. M.] Natl Univ Singapore, Dept Psychol Med, Singapore 117548, Singapore	National University of Singapore	Zhang, MWB (corresponding author), Inst Mental Hlth, Natl Addict Management Serv, Singapore, Singapore.		Ho, Roger/ABD-8859-2021; Ho, Roger C./ABD-9061-2021	Ho, Roger C./0000-0001-9629-4493				Al-Harbi KS, 2012, PATIENT PREFER ADHER, V6, P369, DOI 10.2147/PPA.S29716; Barr AM, 2002, TRENDS PHARMACOL SCI, V23, P475, DOI 10.1016/S0165-6147(02)02086-2; Canadian Agency for Drugs and Technologies in Health, 2014, INTR KET TREATM MENT; Charney DS, 2002, ARCH GEN PSYCHIAT, V59, P262, DOI 10.1001/archpsyc.59.3.262; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; De Luca MT, 2011, PSYCHOPHARMACOLOGY, V214, P549, DOI 10.1007/s00213-010-2062-x; DEVANAND DP, 1991, PSYCHIAT CLIN N AM, V14, P905; Diamond PR, 2014, J PSYCHOPHARMACOL, V28, P536, DOI 10.1177/0269881114527361; Kellner CH, 2014, AM J PSYCHIAT, V171, P796, DOI 10.1176/appi.ajp.2014.14030354; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Morgan CJA, 2010, ADDICTION, V105, P121, DOI 10.1111/j.1360-0443.2009.02761.x; Noppers IM, 2011, PAIN, V152, P2173, DOI 10.1016/j.pain.2011.03.026; Sackeim Harold A., 2001, Journal of Clinical Psychiatry, V62, P10; Siddique H., 2014, GUARDIAN; Trujillo KA, 2011, ILAR J, V52, P366, DOI 10.1093/ilar.52.3.366; Xu K, 2015, EXP BIOL MED, V240, P145, DOI 10.1177/1535370214549531	16	15	15	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4467	10.1136/bmj.h4467	http://dx.doi.org/10.1136/bmj.h4467			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP7PU	26290499				2022-12-28	WOS:000360081100009
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The government's plan to blame and shame people for having disease	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Conservative Party The, 2015, MAN 2015; Department for Work and Pensions, 2015, IND REV IMP EMPL OUT; DrugScope, 2011, BIT BRIEF WELF REF W; Friedli L, 2015, MED HUMANIT, V41, P40, DOI 10.1136/medhum-2014-010622	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2015	351								h4368	10.1136/bmj.h4368	http://dx.doi.org/10.1136/bmj.h4368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7OR	26283627	Green Published, Bronze			2022-12-28	WOS:000360078100004
J	Klenk, HD; Becker, S				Klenk, Hans-Dieter; Becker, Stephan			Ebola virus vaccines-preparing for the unexpected	SCIENCE			English	Editorial Material							INFECTION; PRIMATES		[Klenk, Hans-Dieter; Becker, Stephan] Univ Marburg, Inst Virol, D-35032 Marburg, Germany	Philipps University Marburg	Klenk, HD (corresponding author), Univ Marburg, Inst Virol, D-35032 Marburg, Germany.	klenk@staf.uni-marburg.de						Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Klenk HD, 2000, NAT MED, V6, P1322, DOI 10.1038/82126; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920; Marzi A, 2015, SCIENCE, V348, P439, DOI 10.1126/science.aaa4919; Mire C. E., 2015, BIOL PATHOGENESIS RH, P587; Mire CE, 2015, NATURE, V520, P688, DOI 10.1038/nature14428; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Rampling T, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1411627, DOI 10.1056/NEJMOA1411627, 10.1056/NEJMoa1411627.]; Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321	14	6	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					693	694		10.1126/science.aad0681	http://dx.doi.org/10.1126/science.aad0681			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO8JO	26273043				2022-12-28	WOS:000359415100019
J	Du, P; Wang, LF; Sliz, P; Gregory, RI				Du, Peng; Wang, Longfei; Sliz, Piotr; Gregory, Richard I.			A Biogenesis Step Upstream of Microprocessor Controls miR-17 similar to 92 Expression	CELL			English	Article							POLYADENYLATION FACTOR CPSF-73; MICRORNA BIOGENESIS; TERTIARY STRUCTURE; MIR-17-92 CLUSTER; PROGENITORS; COMPLEX; ASSOCIATION; COMPONENT; DELETION; PROTEIN	The precise control of miR-17 similar to 92 microRNA (miRNA) is essential for normal development, and overexpression of certain miRNAs from this cluster is oncogenic. Here, we find that the relative expression of the six miRNAs processed from the primary (pri-miR-17 similar to 92) transcript is dynamically regulated during embryonic stem cell (ESC) differentiation. Pri-miR-17 similar to 92 is processed to a biogenesis intermediate, termed "progenitor-miRNA'' (pro-miRNA). Pro-miRNA is an efficient substrate for Microprocessor and is required to selectively license production of pre-miR-17, pre-miR-18a, pre-miR-19a, pre-miR- 20a, and pre-miR-19b from this cluster. Two complementary cis-regulatory repression domains within pri-miR-17 similar to 92 are required for the blockade of miRNA processing through the formation of an autoinhibitory RNA conformation. The endonuclease CPSF3 (CPSF73) and the spliceosome-associated ISY1 are responsible for pro-miRNA biogenesis and expression of all miRNAs within the cluster except miR-92. Thus, developmentally regulated pro-miRNA processing is a key step controlling miRNA expression and explains the posttranscriptional control of miR-17 similar to 92 expression in development.	[Du, Peng; Gregory, Richard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Du, Peng; Wang, Longfei; Sliz, Piotr; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sliz, Piotr; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gregory, Richard I.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Gregory, RI (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	rgregory@enders.tch.harvard.edu		Sliz, Piotr/0000-0002-6522-0835	US National Institute of General Medical Sciences (NIGMS) [R01GM086386]; National Cancer Institute [R01CA163647]; NATIONAL CANCER INSTITUTE [R01CA163647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Andrea Ventura (MSKCC) for providing the miR-17 similar to 92<SUP>-/-</SUP> ESCs, Dr. Hanno Stein of the Proteomics Center at Boston Children's Hospital for expertise in the microcapillary HPLC and MS, and Dr. Fred Alt's laboratory for advice with CRISPR/Cas9. This work was supported by a grant to R.I.G. from the US National Institute of General Medical Sciences (NIGMS) (R01GM086386) and to P.S. from the National Cancer Institute (R01CA163647).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bian S, 2013, CELL REP, V3, P1398, DOI 10.1016/j.celrep.2013.03.037; Chakraborty S, 2012, RNA, V18, P1014, DOI 10.1261/rna.031039.111; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chaulk SG, 2014, NUCLEIC ACIDS RES, V42, P5234, DOI 10.1093/nar/gku133; Chaulk SG, 2011, RNA BIOL, V8, P1105, DOI 10.4161/rna.8.6.17410; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Dix I, 1999, RNA, V5, P360, DOI 10.1017/S1355838299981396; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Kataoka N, 2009, MOL CELL BIOL, V29, P3243, DOI 10.1128/MCB.00360-09; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Li YM, 2012, BLOOD, V119, P4486, DOI 10.1182/blood-2011-09-378687; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Marrone AK, 2014, J AM SOC NEPHROL, V25, P1440, DOI 10.1681/ASN.2013040390; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nittner D, 2012, NAT CELL BIOL, V14, P958, DOI 10.1038/ncb2556; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2013, ELIFE, V2, DOI 10.7554/eLife.00822; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Patel V, 2013, P NATL ACAD SCI USA, V110, P10765, DOI 10.1073/pnas.1301693110; Sandhu SK, 2013, P NATL ACAD SCI USA, V110, P18208, DOI 10.1073/pnas.1315365110; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thornton JE, 2014, NUCLEIC ACIDS RES, V42, P11777, DOI 10.1093/nar/gku805; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647	43	64	65	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					885	899		10.1016/j.cell.2015.07.008	http://dx.doi.org/10.1016/j.cell.2015.07.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26255770	Bronze, Green Accepted			2022-12-28	WOS:000359741400020
J	Kushnir, VA; Barad, DH; Albertini, DF; Darmon, SK; Gleicher, N				Kushnir, Vitaly A.; Barad, David H.; Albertini, David F.; Darmon, Sarah K.; Gleicher, Norbert			Outcomes of Fresh and Cryopreserved Oocyte Donation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kushnir, Vitaly A.; Barad, David H.; Albertini, David F.; Darmon, Sarah K.; Gleicher, Norbert] Ctr Human Reprod, New York, NY 10021 USA		Kushnir, VA (corresponding author), Ctr Human Reprod, 21 E 69th St, New York, NY 10021 USA.	vkushnir@thechr.com	Barad, David/AAF-4332-2021; Albertini, David/AAD-3856-2021	Albertini, David/0000-0001-6536-2828				Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028; Centers for Disease Control and Prevention; American Society for Reproductive Medicine, 2014, SOC ASS REPR TECHN 2; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; Kawwass JF, 2013, JAMA-J AM MED ASSOC, V310, P2426, DOI 10.1001/jama.2013.280924; Society for Assisted Reproductive Technology, 2015, NAT DAT SUMM	5	23	24	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					623	624		10.1001/jama.2015.7556	http://dx.doi.org/10.1001/jama.2015.7556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262802	Bronze			2022-12-28	WOS:000359388600023
J	Lowe, J; Whatley, B; Kashani, S; Howlett, D				Lowe, James; Whatley, Ben; Kashani, Shahram; Howlett, David			CASE REVIEW A 22 year old woman with bilateral panuveitis and parotid swelling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BRITISH-THORACIC-SOCIETY; SARCOIDOSIS; MANIFESTATIONS; DIAGNOSIS; THERAPY; DISEASE		[Lowe, James; Whatley, Ben; Kashani, Shahram] Eastbourne Dist Gen Hosp, Dept Ophthalmol, Eastbourne BN21 2UD, E Sussex, England; [Howlett, David] Eastbourne Dist Gen Hosp, Dept Radiol, Eastbourne BN21 2UD, E Sussex, England		Lowe, J (corresponding author), Eastbourne Dist Gen Hosp, Dept Ophthalmol, Eastbourne BN21 2UD, E Sussex, England.	james.lowe1@nhs.net						Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Bradley D, 2002, SEM RESP CRIT CARE M, V23, P543, DOI 10.1055/s-2002-36518; BRINCKER H, 1986, CANCER TREAT REV, V13, P147, DOI 10.1016/0305-7372(86)90002-2; Du Bois R, 2005, EUR RESP MON, V32, P64, DOI DOI 10.1183/1025448X.00032005; Edelsten C, 1999, EYE, V13, P748, DOI 10.1038/eye.1999.221; Erkan AN, 2006, EUR ARCH OTO-RHINO-L, V263, P487, DOI 10.1007/s00405-005-1021-3; Gadodia A, 2011, DENTOMAXILLOFAC RAD, V40, P403, DOI 10.1259/dmfr/17889378; Gibson GJ, 1996, THORAX, V51, P238, DOI 10.1136/thx.51.3.238; Gottlieb JE, 1997, CHEST, V111, P623, DOI 10.1378/chest.111.3.623; Grutters JC, 2003, CHEST, V124, P186, DOI 10.1378/chest.124.1.186; Howlett DC, 2007, AM J ROENTGENOL, V188, P223, DOI 10.2214/AJR.05.1549; Judson MA, 2014, SARCOIDOSIS VASC DIF, V31, P19; Judson MA, 1999, SARCOIDOSIS VASC DIF, V16, P75; Keir G, 2010, SEMIN RESP CRIT CARE, V31, P409, DOI 10.1055/s-0030-1262209; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Omoti AE, 2007, ANN AFR MED, V6, P89, DOI 10.4103/1596-3519.55728; Schutt AC, 2010, RESP MED, V104, P717, DOI 10.1016/j.rmed.2009.12.009; von Bartheld MB, 2013, JAMA-J AM MED ASSOC, V309, P2457, DOI 10.1001/jama.2013.5823; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691	20	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2015	351								h4178	10.1136/bmj.h4178	http://dx.doi.org/10.1136/bmj.h4178			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XG	26265714				2022-12-28	WOS:000359740400002
J	Ling, JP; Pletnikova, O; Troncoso, JC; Wong, PC				Ling, Jonathan P.; Pletnikova, Olga; Troncoso, Juan C.; Wong, Philip C.			TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEIC-ACID BINDING; RNA; DEGENERATION; MECHANISMS; DROSOPHILA; MUTATIONS; DEPLETION; DOMAIN	Cytoplasmic aggregation of TDP-43, accompanied by its nuclear clearance, is a key common pathological hallmark of amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD). However, a limited understanding of this RNA-binding protein (RBP) impedes the clarification of pathogenic mechanisms underlying TDP-43 proteinopathy. In contrast to RBPs that regulate splicing of conserved exons, we found that TDP-43 repressed the splicing of nonconserved cryptic exons, maintaining intron integrity. When TDP-43 was depleted from mouse embryonic stem cells, these cryptic exons were spliced into messenger RNAs, often disrupting their translation and promoting nonsense-mediated decay. Moreover, enforced repression of cryptic exons prevented cell death in TDP-43-deficient cells. Furthermore, repression of cryptic exons was impaired in ALS-FTD cases, suggesting that this splicing defect could potentially underlie TDP-43 proteinopathy.	[Ling, Jonathan P.; Pletnikova, Olga; Troncoso, Juan C.; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	wong@jhmi.edu		Ling, Jonathan/0000-0003-1927-9729	Robert Packard Center for ALS Research, Muscular Dystrophy Association; Amyotrophic Lateral Sclerosis Association; Target ALS; Johns Hopkins University Neuropathology Pelda fund; Johns Hopkins Alzheimer's Disease Research Center [NIH P50AG05146]; Samuel I. Newhouse Foundation; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	Robert Packard Center for ALS Research, Muscular Dystrophy Association; Amyotrophic Lateral Sclerosis Association; Target ALS; Johns Hopkins University Neuropathology Pelda fund; Johns Hopkins Alzheimer's Disease Research Center; Samuel I. Newhouse Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Schaughency, S. Wheelan, and the rest of the Next Generation Sequencing Center [Johns Hopkins Medical Institution (JHMI)] staff for their RNA sequencing service. We also thank X. Zhang for flow cytometry assistance (Ross Flow Cytometry Core, JHMI), R. Roth for confocal imaging, and J. Bedont for editorial support. Last, we thank P. Rabin for encouragement and support of FTD studies and C. Onyike for clinical evaluations of cases of frontotemporal lobar degeneration (FTLD). This work was supported in part by The Robert Packard Center for ALS Research, Muscular Dystrophy Association, the Amyotrophic Lateral Sclerosis Association, Target ALS, the Johns Hopkins University Neuropathology Pelda fund, the Johns Hopkins Alzheimer's Disease Research Center (NIH P50AG05146), and the Samuel I. Newhouse Foundation. J.P.L. and P.C.W. have filed a patent application (number 62/180,988) in the United States that pertains to using incorporation of cryptic exons in RNA transcripts identified in human diseases exhibiting TDP-43 proteinopathy as the basis for biomarkers and therapeutic targets/strategies. Raw sequencing files (100 bp, paired-end) have been deposited at the National Center for Biotechnology Information Sequence Read Archive under SRP057819 and SRP057948. The authors declare no conflicts of interest. J.P.L. and P.C.W. designed, analyzed, and interpreted experiments. J.P.L. performed all studies. O.P. and J.C.T. evaluated brain tissues of ALS and FTLD cases and controls. J.P.L. and P.C.W. wrote the manuscript, and all authors discussed results and approved the manuscript.	Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Janssens J, 2013, HUM MOL GENET, V22, pR77, DOI 10.1093/hmg/ddt349; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Yang CX, 2014, P NATL ACAD SCI USA, V111, pE1121, DOI 10.1073/pnas.1322641111; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166	27	246	247	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					650	655		10.1126/science.aab0983	http://dx.doi.org/10.1126/science.aab0983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250685	Green Accepted			2022-12-28	WOS:000359092900044
J	Perkel, JM				Perkel, Jeffrey M.			TIME TO TAKE STOCK	NATURE			English	Editorial Material														Waldrop, M Mitchell/0000-0002-8063-1472; Perkel, Jeffrey/0000-0001-5699-1008				Yousef AF, 2011, JALA-J LAB AUTOM, V16, P82, DOI 10.1016/j.jala.2009.07.004	1	4	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					125	126		10.1038/524125a	http://dx.doi.org/10.1038/524125a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26245582	Bronze			2022-12-28	WOS:000359002300045
J	Veiseh, O; Langer, R				Veiseh, Omid; Langer, Robert			DIABETES A smart insulin patch	NATURE			English	Editorial Material								A microneedle-containing patch that is designed to sense elevated blood glucose levels and to respond by releasing insulin could offer people with diabetes a less-painful and more-reliable way to manage their condition.	[Veiseh, Omid; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Veiseh, Omid; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Veiseh, Omid; Langer, Robert] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital	Veiseh, O (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	veiseho@mit.edu; rlanger@mit.edu	Veiseh, Omid/N-1137-2019; Veiseh, Omid/GLS-9547-2022	Veiseh, Omid/0000-0003-1153-8079				Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Dolgin E, 2014, NAT MED, V20, P9, DOI 10.1038/nm0114-9; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Schoellhammer CM, 2014, EXPERT OPIN DRUG DEL, V11, P393, DOI 10.1517/17425247.2014.875528; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Skyler JS, 2015, NAT REV ENDOCRINOL, V11, P75, DOI 10.1038/nrendo.2014.228; Veiseh O, 2015, NAT REV DRUG DISCOV, V14, P45, DOI 10.1038/nrd4477; Yu JC, 2015, P NATL ACAD SCI USA, V112, P8260, DOI 10.1073/pnas.1505405112	8	38	42	11	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					39	40		10.1038/524039a	http://dx.doi.org/10.1038/524039a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26245577				2022-12-28	WOS:000359002300023
J	Dedert, EA; McDuffie, JR; Stein, R; McNiel, JM; Kosinski, AS; Freiermuth, CE; Hemminger, A; Williams, JW				Dedert, Eric A.; McDuffie, Jennifer R.; Stein, Roy; McNiel, J. Murray; Kosinski, Andrzej S.; Freiermuth, Caroline E.; Hemminger, Adam; Williams, John W., Jr.			Electronic Interventions for Alcohol Misuse and Alcohol Use Disorders A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; PERSONALIZED NORMATIVE FEEDBACK; BEHAVIORAL-COUNSELING INTERVENTIONS; COMPUTER-DELIVERED INTERVENTIONS; REDUCING HEAVY DRINKING; SERVICES TASK-FORCE; PRIMARY-CARE; COLLEGE-STUDENTS; SELF-HELP; RECOMMENDATION STATEMENT	Background: The use of electronic interventions (e-interventions) may improve treatment of alcohol misuse. Purpose: To characterize treatment intensity and systematically review the evidence for efficacy of e-interventions, relative to controls, for reducing alcohol consumption and alcohol-related impairment in adults and college students. Data Sources: MEDLINE (via PubMed) from January 2000 to March 2015 and the Cochrane Library, EMBASE, and PsycINFO from January 2000 to August 2014. Study Selection: English-language, randomized, controlled trials that involved at least 50 adults who misused alcohol; compared an e-intervention group with a control group; and reported outcomes at 6 months or longer. Data Extraction: Two reviewers abstracted data and independently rated trial quality and strength of evidence. Data Synthesis: In 28 unique trials, the modal e-intervention was brief feedback on alcohol consumption. Available data suggested a small reduction in consumption (approximately 1 drink per week) in adults and college students at 6 months but not at 12 months. There was no statistically significant effect on meeting drinking limit guidelines in adults or on binge-drinking episodes or social consequences of alcohol in college students. Limitations: E-interventions that ranged in intensity were combined in analyses. Quantitative results do not apply to short-term outcomes or alcohol use disorders. Conclusion: Evidence suggests that low-intensity e-inter ventions produce small reductions in alcohol consumption at 6 months, but there is little evidence for longer-term, clinically significant effects, such as meeting drinking limits. Future e-interventions could provide more intensive treatment and possibly human support to assist persons in meeting recommended drinking limits.	Duke Univ, Med Ctr, Sch Med, Durham Vet Affairs Med Ctr, Durham, NC 27710 USA; Duke Clin Res Inst, Durham, NC USA; Univ S Florida, Tampa, FL USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; State University System of Florida; University of South Florida	Dedert, EA (corresponding author), Durham Vet Affairs Med Ctr, 508 Fulton St,Bldg 16,2nd Floor, Durham, NC 27705 USA.	eric.dedert@duke.edu	Williams, John/AAM-4572-2020	Williams, John/0000-0002-5267-5558; Freiermuth, Caroline/0000-0001-9901-8419	U.S. Department of Veterans Affairs; Veterans Affairs [IK2CX000718] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Primary Funding Source: U.S. Department of Veterans Affairs.	Agency for Healthcare Research and Quality, 2008, METHODS GUIDE EFFECT; Barnett NP, 2014, EXP CLIN PSYCHOPHARM, V22, P86, DOI 10.1037/a0034821; Barry Kristen L, 2004, Subst Abus, V25, P27, DOI 10.1300/J465v25n01_05; Berg AO, 2004, ANN INTERN MED, V140, P554, DOI 10.7326/0003-4819-140-7-200404060-00016; Bewick BM, 2008, PREV MED, V47, P17, DOI 10.1016/j.ypmed.2008.01.005; Bischof G, 2008, DRUG ALCOHOL DEPEN, V93, P244, DOI 10.1016/j.drugalcdep.2007.10.003; Boon B, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1695; Brendryen H, 2014, ADDICTION, V109, P218, DOI 10.1111/add.12383; Carey KB, 2012, CLIN PSYCHOL REV, V32, P690, DOI 10.1016/j.cpr.2012.08.001; Carey KB, 2009, ADDICTION, V104, P1807, DOI 10.1111/j.1360-0443.2009.02691.x; Collins SE, 2014, J STUD ALCOHOL DRUGS, V75, P982, DOI 10.15288/jsad.2014.75.982; Cucciare MA, 2013, J STUD ALCOHOL DRUGS, V74, P428, DOI 10.15288/jsad.2013.74.428; Cunningham JA, 2006, MED INFORM INTERNET, V31, P53, DOI 10.1080/14639230600562816; Cunningham JA, 2009, ADDICTION, V104, P2023, DOI 10.1111/j.1360-0443.2009.02726.x; Dawson DA, 2012, DRUG ALCOHOL REV, V31, P141, DOI 10.1111/j.1465-3362.2011.00335.x; Dedert E., 2014, E INTERVENTIONS ALCO; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donoghue K, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3193; Elliott JC, 2008, ADDICT BEHAV, V33, P994, DOI 10.1016/j.addbeh.2008.03.006; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Gustafson DH, 2014, JAMA PSYCHIAT, V71, P566, DOI 10.1001/jamapsychiatry.2013.4642; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Ham LS, 2003, CLIN PSYCHOL REV, V23, P719, DOI 10.1016/S0272-7358(03)00071-0; Hansen ABG, 2012, J MED INTERNET RES, V14, P3, DOI 10.2196/jmir.1883; Hasin DS, 2013, ADDICTION, V108, P1230, DOI 10.1111/add.12127; Hester RK, 2012, PSYCHOL ADDICT BEHAV, V26, P1, DOI 10.1037/a0024753; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Khadjesari Z, 2011, ADDICTION, V106, P267, DOI 10.1111/j.1360-0443.2010.03214.x; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kypri K, 2004, ADDICTION, V99, P1410, DOI 10.1111/j.1360-0443.2004.00847.x; Kypri K, 2008, ARCH INTERN MED, V168, P530, DOI 10.1001/archinternmed.2007.109; Kypri K, 2009, ARCH INTERN MED, V169, P1508, DOI 10.1001/archinternmed.2009.249; LaBrie JW, 2013, J CONSULT CLIN PSYCH, V81, P1074, DOI 10.1037/a0034087; Lewis MA, 2014, J CONSULT CLIN PSYCH, V82, P429, DOI 10.1037/a0035550; McBride O, 2009, DRUG ALCOHOL DEPEN, V99, P272, DOI 10.1016/j.drugalcdep.2008.08.008; Monahan CJ, 2013, ADDICT BEHAV, V38, P1719, DOI 10.1016/j.addbeh.2012.09.004; Moreira MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044120; Moyer VA, 2013, ANN INTERN MED, V159, P210, DOI 10.7326/0003-4819-159-3-201308060-00652; Mundt JC, 2006, J SUBST ABUSE TREAT, V30, P21, DOI 10.1016/j.jsat.2005.08.010; National Institute on Alcohol Abuse and Alcoholism, DRINKING LEVELS DEFI; Neighbors C, 2004, J CONSULT CLIN PSYCH, V72, P434, DOI 10.1037/0022-006X.72.3.434; Neighbors C, 2010, J CONSULT CLIN PSYCH, V78, P898, DOI 10.1037/a0020766; Neumann T, 2006, J TRAUMA, V61, P805, DOI 10.1097/01.ta.0000196399.29893.52; Nilsen P, 2010, ADDICTION, V105, P954, DOI 10.1111/j.1360-0443.2009.02779.x; Pew Research Center, HLTH FACT SHEET; Riper H, 2008, ADDICTION, V103, P218, DOI 10.1111/j.1360-0443.2007.02063.x; Riper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099912; Riper H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1691; Rooke S, 2010, ADDICTION, V105, P1381, DOI 10.1111/j.1360-0443.2010.02975.x; Schulz DN, 2013, J MED INTERNET RES, V15, P53, DOI 10.2196/jmir.2568; Sinadinovic K, 2012, DRUG ALCOHOL DEPEN, V126, P42, DOI 10.1016/j.drugalcdep.2012.04.016; Slutske WS, 2005, ARCH GEN PSYCHIAT, V62, P321, DOI 10.1001/archpsyc.62.3.321; Vernon ML, 2010, J SUBST ABUSE TREAT, V38, P203, DOI 10.1016/j.jsat.2009.11.001; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Voogt C, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2817; Voogt CV, 2013, ALCOHOL ALCOHOLISM, V48, P312, DOI 10.1093/alcalc/ags133; Wallace P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014740; Walters ST, 2009, J CONSULT CLIN PSYCH, V77, P64, DOI 10.1037/a0014472; Watson JM, 2013, DRUG ALCOHOL REV, V32, P356, DOI 10.1111/dar.12037; White A, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1479; Williams EC, 2011, PSYCHOL ADDICT BEHAV, V25, P206, DOI 10.1037/a0022102	61	65	65	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					205	+		10.7326/M15-0285	http://dx.doi.org/10.7326/M15-0285			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO6EX	26237752	Green Accepted			2022-12-28	WOS:000359251100009
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Perfect people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2015, BBC RADIO 4     0609; Martinson J, 2015, GUARDIAN; McCrum K, 2015, MIRROR          0513; Nelson Z, 2005, INDEPENDENT	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2015	351								h4120	10.1136/bmj.h4120	http://dx.doi.org/10.1136/bmj.h4120			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AO	26239733	Bronze			2022-12-28	WOS:000359387100005
J	Sedgwick, P				Sedgwick, Philip			Multistage sampling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									St Georges Univ London, Inst Med & Biomed Educ, London, England	St Georges University London	Sedgwick, P (corresponding author), St Georges Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Barrett G, 2006, BMJ-BRIT MED J, V332, P1068, DOI 10.1136/bmj.38805.473738.7C; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2276; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1215; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7016	4	20	20	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2015	351								h4155	10.1136/bmj.h4155	http://dx.doi.org/10.1136/bmj.h4155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UE	26231184				2022-12-28	WOS:000359011300010
J	Birsoy, K; Wang, T; Chen, WW; Freinkman, E; Abu-Remaileh, M; Sabatini, DM				Birsoy, Kivanc; Wang, Tim; Chen, Walter W.; Freinkman, Elizaveta; Abu-Remaileh, Monther; Sabatini, David M.			An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis	CELL			English	Article							PYRUVATE THERAPY; ANTIMYCIN-A; COMPLEX-III; METABOLISM; SENSITIVITY; GROWTH; BIOSYNTHESIS; EXPRESSION; MUTATIONS; INCREASE	The mitochondrial electron transport chain (ETC) enables many metabolic processes, but why its inhibition suppresses cell proliferation is unclear. It is also not well understood why pyruvate supplementation allows cells lacking ETC function to proliferate. We used a CRISPR-based genetic screen to identify genes whose loss sensitizes human cells to phenformin, a complex I inhibitor. The screen yielded GOT1, the cytosolic aspartate aminotransferase, loss of which kills cells upon ETC inhibition. GOT1 normally consumes aspartate to transfer electrons into mitochondria, but, upon ETC inhibition, it reverses to generate aspartate in the cytosol, which partially compensates for the loss of mitochondrial aspartate synthesis. Pyruvate stimulates aspartate synthesis in a GOT1-dependent fashion, which is required for pyruvate to rescue proliferation of cells with ETC dysfunction. Aspartate supplementation or overexpression of an aspartate transporter allows cells without ETC activity to proliferate. Thus, enabling aspartate synthesis is an essential role of the ETC in cell proliferation.	[Birsoy, Kivanc; Wang, Tim; Chen, Walter W.; Freinkman, Elizaveta; Abu-Remaileh, Monther; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Birsoy, Kivanc; Wang, Tim; Chen, Walter W.; Abu-Remaileh, Monther; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Birsoy, Kivanc; Wang, Tim; Chen, Walter W.; Abu-Remaileh, Monther; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Birsoy, Kivanc; Wang, Tim; Chen, Walter W.; Abu-Remaileh, Monther; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Abu-Remaileh, Monther/M-3747-2016	Wang, Timothy/0000-0001-5730-3019; Chen, Walter/0000-0002-7752-9581; Abu-Remaileh, Monther/0000-0003-3772-0477; /0000-0002-1446-7256	NIH [CA103866, AI047389]; Jane Coffin Childs Memorial Fund Fellowship; Leukemia and Lymphoma Society Special Fellow Award; NATIONAL CANCER INSTITUTE [F31CA189437, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM007287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund Fellowship; Leukemia and Lymphoma Society Special Fellow Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of Sabatini Lab, particularly Andrew Mullen, for helpful suggestions; C. Moraes, I.F.M. de Coo, Doug Wallace, Navdeep Chandel, and Giovanni Manfredi for providing WT 143B, CYTB 143B, 143B Rho, and MERRF 143B cell lines; and Dan Gui and Lucas Sullivan for NAD measurements. This work was supported by NIH (CA103866 and AI047389) grants to D.M.S., and the Jane Coffin Childs Memorial Fund Fellowship and Leukemia and Lymphoma Society Special Fellow Award to K.B. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34; De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.3.CO;2-Q; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; DiMauro S, 2010, Acta Myol, V29, P333; Fendt SM, 2013, CANCER RES, V73, P4429, DOI 10.1158/0008-5472.CAN-13-0080; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Fujii T, 2014, MOL GENET METAB, V112, P133, DOI 10.1016/j.ymgme.2014.04.008; Geissler A, 2000, MOL BIOL CELL, V11, P3977, DOI 10.1091/mbc.11.11.3977; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Han YH, 2008, ONCOL REP, V20, P689, DOI 10.3892/or_00000061; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; HARRIS M, 1980, SOMAT CELL GENET, V6, P699, DOI 10.1007/BF01538969; HOWELL N, 1979, SOMAT CELL GENET, V5, P833, DOI 10.1007/BF01542645; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; KULMACZ RJ, 1989, PROSTAGLANDINS, V38, P277, DOI 10.1016/0090-6980(89)90133-0; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9; SAFER B, 1975, CIRC RES, V37, P527, DOI 10.1161/01.RES.37.5.527; Saito K, 2012, BBA-GEN SUBJECTS, V1820, P632, DOI 10.1016/j.bbagen.2011.08.006; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Toney MD, 2014, ARCH BIOCHEM BIOPHYS, V544, P119, DOI 10.1016/j.abb.2013.10.002; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006; WUU JA, 1988, CLIN CHEM, V34, P1610	55	709	724	13	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					540	551		10.1016/j.cell.2015.07.016	http://dx.doi.org/10.1016/j.cell.2015.07.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232224	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000358801800014
J	Parsons, MJ; Brancaccio, M; Sethi, S; Maywood, ES; Satija, R; Edwards, JK; Jagannath, A; Couch, Y; Finelli, MJ; Smyllie, NJ; Esapa, C; Butler, R; Barnard, AR; Chesham, JE; Saito, S; Joynson, G; Wells, S; Foster, RG; Oliver, PL; Simon, MM; Mallon, AM; Hastings, MH; Nolan, PM				Parsons, Michael J.; Brancaccio, Marco; Sethi, Siddharth; Maywood, Elizabeth S.; Satija, Rahul; Edwards, Jessica K.; Jagannath, Aarti; Couch, Yvonne; Finelli, Mattea J.; Smyllie, Nicola J.; Esapa, Christopher; Butler, Rachel; Barnard, Alun R.; Chesham, Johanna E.; Saito, Shoko; Joynson, Greg; Wells, Sara; Foster, Russell G.; Oliver, Peter L.; Simon, Michelle M.; Mallon, Ann-Marie; Hastings, Michael H.; Nolan, Patrick M.			The Regulatory Factor ZFHX3 Modifies Circadian Function in SCN via an AT Motif-Driven Axis	CELL			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; GASTRIN-RELEASING-PEPTIDE; SUPRACHIASMATIC NUCLEUS; CLOCK NEURONS; TRANSCRIPTION; ATBF1; GENE; RHYTHMS; MOUSE; MICE	We identified a dominant missense mutation in the SCN transcription factor Zfhx3, termed short circuit (Zfhx3(Sci)), which accelerates circadian locomotor rhythms in mice. ZFHX3 regulates transcription via direct interaction with predicted AT motifs in target genes. The mutant protein has a decreased ability to activate consensus AT motifs in vitro. Using RNA sequencing, we found minimal effects on core clock genes in Zfhx3(Sci/+) SCN, whereas the expression of neuropeptides critical for SCN intercellular signaling was significantly disturbed. Moreover, mutant ZFHX3 had a decreased ability to activate AT motifs in the promoters of these neuropeptide genes. Lentiviral transduction of SCN slices showed that the ZFHX3-mediated activation of AT motifs is circadian, with decreased amplitude and robustness of these oscillations in Zfhx3(Sci/+) SCN slices. In conclusion, by cloning Zfhx3(Sci), we have uncovered a circadian transcriptional axis that determines the period and robustness of behavioral and SCN molecular rhythms.	[Parsons, Michael J.; Sethi, Siddharth; Edwards, Jessica K.; Esapa, Christopher; Joynson, Greg; Wells, Sara; Simon, Michelle M.; Mallon, Ann-Marie; Nolan, Patrick M.] MRC Harwell, Didcot OX11 0RD, Oxon, England; [Brancaccio, Marco; Maywood, Elizabeth S.; Smyllie, Nicola J.; Chesham, Johanna E.; Hastings, Michael H.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Satija, Rahul] New York Genome Ctr, New York, NY 10013 USA; [Satija, Rahul] NYU, Dept Biol, New York, NY 10012 USA; [Jagannath, Aarti; Butler, Rachel; Barnard, Alun R.; Foster, Russell G.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Couch, Yvonne] Univ Oxford, Radcliffe Dept Clin Med, Acute Stroke Program, Oxford OX3 9DU, England; [Finelli, Mattea J.; Oliver, Peter L.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3PT, England; [Saito, Shoko] Erasmus MC, Dept Genet, NL-3000 CA Rotterdam, Netherlands; [Saito, Shoko] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan	MRC Harwell; MRC Laboratory Molecular Biology; New York University; University of Oxford; University of Oxford; University of Oxford; Erasmus University Rotterdam; Erasmus MC; University of Tsukuba	Nolan, PM (corresponding author), MRC Harwell, Harwell Sci & Innovat Campus, Didcot OX11 0RD, Oxon, England.	p.nolan@har.mrc.ac.uk	Satija, Rahul/AAF-9564-2019; Jagannath, Aarti/GQA-7297-2022; Brancaccio, Marco/ABD-8086-2021; Oliver, Peter/AAS-4022-2020; Finelli, Mattea/AAD-5783-2022; Nolan, Patrick/W-3918-2019	Brancaccio, Marco/0000-0001-8053-5221; Nolan, Patrick/0000-0001-5550-0334; Jagannath, Aarti/0000-0003-2132-8200; Smyllie, Nicola/0000-0002-6324-1421; Oliver, Peter/0000-0003-3347-2461; FOSTER, RUSSELL/0000-0001-6055-2067; Hastings, Michael Harvey/0000-0001-8576-6651; Finelli, Mattea/0000-0002-0152-3642; Sethi, Siddharth/0000-0002-4398-4295	MRC; 6th Framework Project EUCLOCK [018741]; MRC Biomedical Informatics Fellowship; European Research Council Starting Grant "PAROSIN''; WT grant [090684/Z/09/Z]; Medical Research Council [MC_U142684173, MC_U105170643, MC_UP_1502/1] Funding Source: researchfish; MRC [MC_U142684173, MC_U105170643, MC_U142684171, MC_UP_1502/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 6th Framework Project EUCLOCK(European Commission); MRC Biomedical Informatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council Starting Grant "PAROSIN''; WT grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	P.M.N. and M.H.H. were supported by the MRC and by the 6th Framework Project EUCLOCK (No. 018741). R.S. was supported by an MRC Biomedical Informatics Fellowship. P.L.O. and M.J.F. were supported by a European Research Council Starting Grant "PAROSIN'' awarded to P.L.O. A.J. was supported by a WT grant (090684/Z/09/Z). We thank Dr. Takahashi for generously providing the PER2::LUC knockin mice. We thank Dr. Filippo Tamanini for the CLOCK and BMAL expression vectors. We thank Dr. Jurgen Ripperger for generously providing the DBP expression vector. We thank the biomedical staff at the Mary Lyon Center, MRC Harwell, and the Ares Facility, Cambridge. Thanks to Steve Thomas for reformatting the figure images, and thanks to Helen Hilton for work validating the anti-ZFHX3 antibody.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; ALBERS HE, 1995, NEUROSCI LETT, V191, P63, DOI 10.1016/0304-3940(95)11559-1; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; An S, 2013, P NATL ACAD SCI USA, V110, pE4355, DOI 10.1073/pnas.1307088110; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bacon Y, 2004, GENES BRAIN BEHAV, V3, P196, DOI 10.1111/j.1601-183X.2004.00070.x; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bedont JL, 2014, CELL REP, V7, P609, DOI 10.1016/j.celrep.2014.03.060; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Bozek K, 2010, BIOSYSTEMS, V102, P61, DOI 10.1016/j.biosystems.2010.07.010; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Brown TM, 2005, J NEUROSCI, V25, P11155, DOI 10.1523/JNEUROSCI.3821-05.2005; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Gold DA, 2007, BRAIN RES, V1140, P19, DOI 10.1016/j.brainres.2005.11.080; Hatori M, 2014, ELIFE, V3, DOI 10.7554/eLife.03357; Ishii Y, 2003, J COMP NEUROL, V465, P57, DOI 10.1002/cne.10807; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee IT, 2015, NEURON, V85, P1086, DOI 10.1016/j.neuron.2015.02.006; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Maywood ES, 2013, P NATL ACAD SCI USA, V110, P9547, DOI 10.1073/pnas.1220894110; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Mori Y, 2007, INT J CANCER, V121, P241, DOI 10.1002/ijc.22654; Prosser HM, 2007, P NATL ACAD SCI USA, V104, P648, DOI 10.1073/pnas.0606884104; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; SHINOHARA K, 1993, J NEUROSCI, V13, P793; Sun XD, 2012, GENESIS, V50, P819, DOI 10.1002/dvg.22041; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; VanDunk C, 2011, J NEUROSCI, V31, P6457, DOI 10.1523/JNEUROSCI.5385-10.2011; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	47	42	44	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					607	621		10.1016/j.cell.2015.06.060	http://dx.doi.org/10.1016/j.cell.2015.06.060			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232227	Green Published, hybrid			2022-12-28	WOS:000358801800019
J	Akbari, OS; Bellen, HJ; Bier, E; Bullock, SL; Burt, A; Church, GM; Cook, KR; Duchek, P; Edwards, OR; Esvelt, KM; Gantz, VM; Golic, KG; Gratz, SJ; Harrison, MM; Hayes, KR; James, AA; Kaufman, TC; Knoblich, J; Malik, HS; Matthews, KA; O'Connor-Giles, KM; Parks, AL; Perrimon, N; Port, F; Russell, S; Ueda, R; Wildonger, J				Akbari, Omar S.; Bellen, Hugo J.; Bier, Ethan; Bullock, Simon L.; Burt, Austin; Church, George M.; Cook, Kevin R.; Duchek, Peter; Edwards, Owain R.; Esvelt, Kevin M.; Gantz, Valentino M.; Golic, Kent G.; Gratz, Scott J.; Harrison, Melissa M.; Hayes, Keith R.; James, Anthony A.; Kaufman, Thomas C.; Knoblich, Juergen; Malik, Harmit S.; Matthews, Kathy A.; O'Connor-Giles, Kate M.; Parks, Annette L.; Perrimon, Norbert; Port, Fillip; Russell, Steven; Ueda, Ryu; Wildonger, Jill			Safeguarding gene drive experiments in the laboratory	SCIENCE			English	Editorial Material							TOOLS; GERMLINE		[Akbari, Omar S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92507 USA; [Akbari, Omar S.] Univ Calif Riverside, Ctr Dis Vector Res, Inst Integrat Genome Biol, Riverside, CA 92507 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Bier, Ethan; Gantz, Valentino M.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92095 USA; [Bullock, Simon L.; Port, Fillip] MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 0QH, England; [Burt, Austin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Church, George M.] Harvard Univ, Sch Med, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Church, George M.; Esvelt, Kevin M.; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Cook, Kevin R.; Kaufman, Thomas C.; Matthews, Kathy A.; Parks, Annette L.] Indiana Univ, Dept Biol, Bloomington Drosophila Stock Ctr, Bloomington, IN 47405 USA; [Duchek, Peter; Knoblich, Juergen] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Edwards, Owain R.] CSIRO Ctr Environm & Life Sci, Floreat, WA 6014, Australia; [Golic, Kent G.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Gratz, Scott J.; O'Connor-Giles, Kate M.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Harrison, Melissa M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Hayes, Keith R.] CSIRO Biosecur Flagship, Hobart, Tas 7001, Australia; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; [O'Connor-Giles, Kate M.] Univ Wisconsin, Lab Cell & Mol Biol, Madison, WI 53706 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Ueda, Ryu] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Ueda, Ryu] Natl Inst Genet, NIG Fly Stock Ctr, Mishima, Shizuoka 4118540, Japan; [Wildonger, Jill] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of California System; University of California San Diego; MRC Laboratory Molecular Biology; Imperial College London; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Irvine; University of California System; University of California Irvine; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Cambridge; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Wisconsin System; University of Wisconsin Madison	Bier, E (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92095 USA.	ebier@ucsd.edu; kevin.esvelt@wyss.harvard.edu	Knoblich, Juergen A/C-2974-2015; Hayes, Keith R/A-4550-2009; Edwards, Owain Rhys/B-9707-2008	Knoblich, Juergen A/0000-0002-6751-3404; Hayes, Keith R/0000-0003-4094-3575; Edwards, Owain Rhys/0000-0003-3861-7906; Burt, Austin/0000-0001-5146-9640; Akbari, Omar/0000-0002-6853-9884; Parks, Annette/0000-0002-4619-2277; Cook, Kevin/0000-0001-9260-364X; James, Anthony/0000-0001-5577-3308; Gantz, Valentino/0000-0003-2453-0711; church, george/0000-0001-6232-9969; O'Connor-Giles, Kate/0000-0002-2259-8408; Port, Fillip/0000-0002-5157-4835; Bullock, Simon/0000-0001-9491-4548; Perrimon, Norbert/0000-0001-7542-472X; Bellen, Hugo/0000-0001-5992-5989	MRC [MC_U105178790] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110713, R01AI070654, R37AI029746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK102669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133, R01GM065604] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER; Medical Research Council [MC_U105178790] Funding Source: Medline; NIAID NIH HHS [R37 AI029746, R01 AI110713, R01 AI070654] Funding Source: Medline; NIDDK NIH HHS [K99 DK102669] Funding Source: Medline; NIGMS NIH HHS [R01 GM065604, T32 GM007133] Funding Source: Medline; NIH HHS [P40 OD018537] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; DiCarlo J. E., 2015, BIORXIV013896; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Henkel R. D., 2012, APPL BIOSAF, V17, P171, DOI [DOI 10.1177/153567601201700402, 10.1177/153567601201700402]; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; National Research Council, 2015, DELSBLS1506 NAT AC S; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Port F, 2015, G3-GENES GENOM GENET, V5, P1493, DOI 10.1534/g3.115.019083; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110	15	166	174	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					927	929		10.1126/science.aac7932	http://dx.doi.org/10.1126/science.aac7932			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26229113	Green Submitted, Green Accepted			2022-12-28	WOS:000360646800021
J	Lewis, SL; Edwards, DP; Galbraith, D				Lewis, Simon L.; Edwards, David P.; Galbraith, David			Increasing human dominance of tropical forests	SCIENCE			English	Review							DROUGHT SENSITIVITY; TREE RECRUITMENT; RAIN-FORESTS; CLIMATE; CARBON; BIODIVERSITY; LAND; DEFORESTATION; FRAGMENTATION; CONSEQUENCES	Tropical forests house over half of Earth's biodiversity and are an important influence on the climate system. These forests are experiencing escalating human influence, altering their health and the provision of important ecosystem functions and services. Impacts started with hunting and millennia-old megafaunal extinctions (phase I), continuing via low-intensity shifting cultivation (phase II), to today's global integration, dominated by intensive permanent agriculture, industrial logging, and attendant fires and fragmentation (phase III). Such ongoing pressures, together with an intensification of global environmental change, may severely degrade forests in the future (phase IV, global simplification) unless new "development without destruction" pathways are established alongside climate change-resilient landscape designs.	[Lewis, Simon L.] UCL, Dept Geog, London, England; [Lewis, Simon L.; Galbraith, David] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Edwards, David P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; University of Leeds; University of Sheffield	Lewis, SL (corresponding author), UCL, Dept Geog, London, England.	s.l.lewis@leeds.ac.uk	Edwards, David/AAC-5091-2019; Galbraith, David/AAE-8162-2019	Edwards, David/0000-0001-8562-3853; Galbraith, David/0000-0002-5555-4823; Lewis, Simon/0000-0002-8066-6851	European Research Council (T-FORCES)	European Research Council (T-FORCES)(European Research Council (ERC))	We thank the World Climate Research Programme's Working Group on Coupled Modelling, the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison, the Global Organization for Earth System Science Portals and climate modeling groups (see Fig. 3 legend for list) for CMIP and other model output; our three reviewers; and M. Irving and P. Zalazowski for assistance with the figures. S.L.L. is supported by the European Research Council (T-FORCES) and a Phillip Leverhulme Prize.	Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; Anderson RG, 2011, FRONT ECOL ENVIRON, V9, P174, DOI 10.1890/090179; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Banin L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1179, DOI 10.1111/j.1466-8238.2012.00778.x; Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Barlow J, 2012, BIOL CONSERV, V151, P45, DOI 10.1016/j.biocon.2011.10.013; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Betts RA, 2015, BIOGEOSCIENCES, V12, P1317, DOI 10.5194/bg-12-1317-2015; Bicknell JE, 2014, CURR BIOL, V24, pR1119, DOI 10.1016/j.cub.2014.10.067; Blaser J, 2011, ITTO TECHNICAL SERIE, V38; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Brodie JF, 2009, SCIENCE, V326, P364, DOI 10.1126/science.326_364b; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Caves EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065618; Chazdon R.L, 2014, 2 GROWTH; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Cox PA, 2000, CONSERV BIOL, V14, P1237, DOI 10.1046/j.1523-1739.2000.00017.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Devaraju N, 2015, P NATL ACAD SCI USA, V112, P3257, DOI 10.1073/pnas.1423439112; Dick CW, 2013, ECOL EVOL, V3, P162, DOI 10.1002/ece3.441; Doughty CE, 2013, ANNU REV ENV RESOUR, V38, P503, DOI 10.1146/annurev-environ-032012-095147; Edwards DP, 2014, TRENDS ECOL EVOL, V29, P511, DOI 10.1016/j.tree.2014.07.003; Edwards DP, 2014, CONSERV LETT, V7, P302, DOI 10.1111/conl.12076; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Ewers RM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7836; FAO, 2010, 163 FAO; Fauset S, 2012, ECOL LETT, V15, P1120, DOI 10.1111/j.1461-0248.2012.01834.x; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Frausin V, 2014, HUM ECOL, V42, P695, DOI 10.1007/s10745-014-9686-0; Galbraith D, 2010, NEW PHYTOL, V187, P647, DOI 10.1111/j.1469-8137.2010.03350.x; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gilroy JJ, 2014, NAT CLIM CHANGE, V4, P503, DOI [10.1038/nclimate2200, 10.1038/NCLIMATE2200]; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; Grace J, 2014, GLOBAL CHANGE BIOL, V20, P3238, DOI 10.1111/gcb.12600; Groombridge B., 2003, WORLD ATLAS BIODIVER; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harrison RD, 2013, ECOL LETT, V16, P687, DOI 10.1111/ele.12102; Huntingford C, 2013, NAT GEOSCI, V6, P268, DOI [10.1038/ngeo1741, 10.1038/NGEO1741]; Intergovernmental Panel on Climate Change, 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Lawrence D, 2015, NAT CLIM CHANGE, V5, P27, DOI [10.1038/nclimate2430, 10.1038/NCLIMATE2430]; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Magnago LFS, 2014, J ECOL, V102, P475, DOI 10.1111/1365-2745.12206; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Malhi Y, 2014, ANNU REV ENV RESOUR, V39, P125, DOI 10.1146/annurev-environ-030713-155141; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Mercer B., 2015, TROPICAL FORESTS REV; Meyfroidt P, 2010, P NATL ACAD SCI USA, V107, P20917, DOI 10.1073/pnas.1014773107; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Omeja PA, 2011, FOREST ECOL MANAG, V261, P703, DOI 10.1016/j.foreco.2010.11.029; Oslisly R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0304; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parmentier I, 2007, J ECOL, V95, P1058, DOI 10.1111/j.1365-2745.2007.01273.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Poulsen JR, 2013, BIOL CONSERV, V163, P122, DOI 10.1016/j.biocon.2013.03.021; PriceWaterhouseCoopers, 2015, WORLD 2050 WILL SHIF; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rammig A, 2010, NEW PHYTOL, V187, P694, DOI 10.1111/j.1469-8137.2010.03318.x; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Robinson J., 2000, HUNTING SUSTAINABILI; Rosa IMD, 2014, GLOBAL CHANGE BIOL, V20, P1707, DOI 10.1111/gcb.12523; Rudel TK, 2010, LAND USE POLICY, V27, P95, DOI 10.1016/j.landusepol.2009.09.021; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schmitz C, 2014, AGR ECON-BLACKWELL, V45, P69, DOI 10.1111/agec.12090; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; United Nations, 2014, PROB POP PROJ BAS WO; United Nations, 2015, NEW YORL DECL FOR; Vira B., 2015, FORESTS TREES LANDSC; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005	88	392	407	22	483	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					827	832		10.1126/science.aaa9932	http://dx.doi.org/10.1126/science.aaa9932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293955	Green Accepted			2022-12-28	WOS:000359832700038
J	Cao, Y; Willett, WC; Rimm, EB; Stampfer, MJ; Giovannucci, EL				Cao, Yin; Willett, Walter C.; Rimm, Eric B.; Stampfer, Meir J.; Giovannucci, Edward L.			Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CIGARETTE-SMOKING; POOLED ANALYSIS; BREAST-CANCER; HEART-FAILURE; CONSUMPTION; METAANALYSIS; ACETALDEHYDE; GUIDELINES; TOBACCO; WOMEN	OBJECTIVES To quantify risk of overall cancer across all levels of alcohol consumption among women and men separately, with a focus on light to moderate drinking and never smokers; and assess the influence of drinking patterns on overall cancer risk. DESIGN Two prospective cohort studies. SETTING Health professionals in the United States. PARTICIPANTS 88 084 women and 47 881 men participating in the Nurses' Health Study (from 1980) and Health Professionals Follow-up Study (from 1986), followed until 2010. MAIN OUTCOMES AND MEASURES Relative risks of cancer. RESULTS 19 269 and 7571 (excluding non-advanced prostate cancers) incident cancers were documented among women and men, respectively, over 3 144 853 person years. Compared with non-drinkers, light to moderate drinkers had relative risks of total cancer of 1.02 (95% confidence interval 0.98 to 1.06) and 1.04 (1.00 to 1.09; P-trend=0.12) for alcohol intake of 0.1-4.9 and 5-14.9 g/day among women, respectively. Corresponding values for men were 1.03 (0.96 to 1.11), 1.05 (0.97 to 1.12), and 1.06 (0.98 to 1.15; P-trend=0.31) for alcohol intake of 0.1-4.9, 5-14.9, and 15-29.9 g/day, respectively. Associations for light to moderate drinking and total cancer were similar among ever or never smokers, although alcohol consumption above moderate levels (in particular >= 30 g/day) was more strongly associated with risk of total cancer among ever smokers than never smokers. For a priori defined alcohol related cancers in men, risk was not appreciably increased for light and moderate drinkers who never smoked (P-trend=0.18). However, for women, even an alcohol consumption of 5-14.9 g/day was associated with increased risk of alcohol related cancer (relative risk 1.13 (95% confidence interval 1.06 to 1.20)), driven by breast cancer. More frequent and heavy episodic drinking was not further associated with risk of total cancer after adjusting for total alcohol intake. CONCLUSION Light to moderate drinking is associated with minimally increased risk of overall cancer. For men who have never smoked, risk of alcohol related cancers is not appreciably increased for light and moderate drinking (up to two drinks per day). However, for women who have never smoked, risk of alcohol related cancers (mainly breast cancer) increases even within the range of up to one alcoholic drink a day.	[Cao, Yin; Willett, Walter C.; Rimm, Eric B.; Stampfer, Meir J.; Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Willett, Walter C.; Rimm, Eric B.; Stampfer, Meir J.; Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Willett, Walter C.; Rimm, Eric B.; Stampfer, Meir J.; Giovannucci, Edward L.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Willett, Walter C.; Rimm, Eric B.; Stampfer, Meir J.; Giovannucci, Edward L.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Giovannucci, EL (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	egiovann@hsph.harvard.edu	Cao, Yin/ABE-2332-2021	Cao, Yin/0000-0001-9835-7662	US National Institutes of Health [UM1 CA186107, P01 CA87969, P01 CA55075, UM1 CA167552]; NATIONAL CANCER INSTITUTE [UM1CA186107, P01CA055075, UM1CA167552, P01CA087969] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the US National Institutes of Health (UM1 CA186107, P01 CA87969, P01 CA55075, and UM1 CA167552). The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Bagnardi V, 2013, ANN ONCOL, V24, P301, DOI 10.1093/annonc/mds337; BLOT WJ, 1988, CANCER RES, V48, P3282; Boffetta P, 2006, INT J CANCER, V119, P884, DOI 10.1002/ijc.21903; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cho E, 2012, AM J CLIN NUTR, V95, P413, DOI 10.3945/ajcn.111.022145; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Djousse L, 2008, CURR ATHEROSCLER REP, V10, P117, DOI 10.1007/s11883-008-0017-z; Freudenheim JL, 2005, AM J CLIN NUTR, V82, P657, DOI 10.1093/ajcn/82.3.657; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Latino-Martel P, 2011, CAN MED ASSOC J, V183, P1861, DOI 10.1503/cmaj.110363; Marshall TA, 2011, J AM DENT ASSOC, V142, P654, DOI 10.14219/jada.archive.2011.0248; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Nelson DE, 2013, AM J PUBLIC HEALTH, V103, P641, DOI 10.2105/AJPH.2012.301199; Padilla H, 2010, PHYSICIAN SPORTSMED, V38, P84, DOI 10.3810/psm.2010.10.1812; Petti S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078999, 10.1371/journal.pone.0073827]; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rosner BA, 1996, STAT MED, V15, P293, DOI 10.1002/(SICI)1097-0258(19960215)15:3<293::AID-SIM166>3.0.CO;2-E; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; SEITZ HK, 1990, GASTROENTEROLOGY, V98, P406, DOI 10.1016/0016-5085(90)90832-L; Singletary KW, 2001, JAMA-J AM MED ASSOC, V286, P2143, DOI 10.1001/jama.286.17.2143; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Tramacere I, 2010, INT J CANCER, V126, P1474, DOI 10.1002/ijc.24936; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	37	151	155	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2015	351								h4238	10.1136/bmj.h4238	http://dx.doi.org/10.1136/bmj.h4238			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7OS	26286216	hybrid, Green Published			2022-12-28	WOS:000360078200002
J	Cruz-Flores, S				Cruz-Flores, Salvador			Review: In lacunar stroke, single antiplatelet therapy reduces recurrent stroke more than placebo Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ASPIRIN		Texas Tech Univ, Hlth Sci Ctr El Paso, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Cruz-Flores, S (corresponding author), Texas Tech Univ, Hlth Sci Ctr El Paso, El Paso, TX 79905 USA.		Cruz-Flores, Salvador/AAR-1233-2020	Cruz-Flores, Salvador/0000-0003-4998-1471				Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					JC6	JC6		10.7326/ACPJC-2015-163-4-006	http://dx.doi.org/10.7326/ACPJC-2015-163-4-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26280441				2022-12-28	WOS:000364673500008
J	Kahan, S; Theim, K				Kahan, Scott; Theim, Kelly			Review: Some commercial or proprietary weight-loss programs increase weight loss	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kahan, Scott; Theim, Kelly] George Washington Univ, Natl Ctr Weight & Wellness, Washington, DC 20052 USA	George Washington University	Kahan, S (corresponding author), George Washington Univ, Natl Ctr Weight & Wellness, Washington, DC 20052 USA.			Kahan, Scott/0000-0002-3080-0661				Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Foster GD, 1997, J CONSULT CLIN PSYCH, V65, P79, DOI 10.1037/0022-006X.65.1.79; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Kolasa KM, 2010, NUTR CLIN PRACT, V25, P502, DOI 10.1177/0884533610380057; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					JC8	JC8		10.7326/ACPJC-2015-163-4-008	http://dx.doi.org/10.7326/ACPJC-2015-163-4-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26280443				2022-12-28	WOS:000364673500012
J	Williams, WB; Liao, HX; Moody, MA; Kepler, TB; Alam, SM; Gao, F; Wiehe, K; Trama, AM; Jones, K; Zhang, RJ; Song, HS; Marshall, DJ; Whitesides, JF; Sawatzki, K; Hua, AX; Liu, PH; Tay, MZ; Seaton, KE; Shen, XY; Foulger, A; Lloyd, KE; Parks, R; Pollara, J; Ferrari, G; Yu, JS; Vandergrift, N; Montefiori, DC; Sobieszczyk, ME; Hammer, S; Karuna, S; Gilbert, P; Grove, D; Grunenberg, N; McElrath, MJ; Mascola, JR; Koup, RA; Corey, L; Nabel, GJ; Morgan, C; Churchyard, G; Maenza, J; Keefer, M; Graham, BS; Baden, LR; Tomaras, GD; Haynes, BF				Williams, Wilton B.; Liao, Hua-Xin; Moody, M. Anthony; Kepler, Thomas B.; Alam, S. Munir; Gao, Feng; Wiehe, Kevin; Trama, Ashley M.; Jones, Kathryn; Zhang, Ruijun; Song, Hongshuo; Marshall, Dawn J.; Whitesides, John F.; Sawatzki, Kaitlin; Hua, Axin; Liu, Pinghuang; Tay, Matthew Z.; Seaton, Kelly E.; Shen, Xiaoying; Foulger, Andrew; Lloyd, Krissey E.; Parks, Robert; Pollara, Justin; Ferrari, Guido; Yu, Jae-Sung; Vandergrift, Nathan; Montefiori, David C.; Sobieszczyk, Magdalena E.; Hammer, Scott; Karuna, Shelly; Gilbert, Peter; Grove, Doug; Grunenberg, Nicole; McElrath, M. Juliana; Mascola, John R.; Koup, Richard A.; Corey, Lawrence; Nabel, Gary J.; Morgan, Cecilia; Churchyard, Gavin; Maenza, Janine; Keefer, Michael; Graham, Barney S.; Baden, Lindsey R.; Tomaras, Georgia D.; Haynes, Barton F.			Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies	SCIENCE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; DNA CANDIDATE VACCINE; AFFINITY B-CELLS; NONNEUTRALIZING ANTIBODIES; IMMUNOGENICITY EVALUATION; ENVELOPE GLYCOPROTEIN; GP41-GP120 INTERFACE; DEPENDENT EPITOPE; GERMINAL-CENTERS; PHASE-1 SAFETY	An HIV-1 DNA prime vaccine, with a recombinant adenovirus type 5 (rAd5) boost, failed to protect from HIV-1 acquisition. We studied the nature of the vaccine-induced antibody (Ab) response to HIV-1 envelope (Env). HIV-1-reactive plasma Ab titers were higher to Env gp41 than to gp120, and repertoire analysis demonstrated that 93% of HIV-1-reactive Abs from memory B cells responded to Env gp41. Vaccine-induced gp41-reactive monoclonal antibodies were non-neutralizing and frequently polyreactive with host and environmental antigens, including intestinal microbiota (IM). Next-generation sequencing of an immunoglobulin heavy chain variable region repertoire before vaccination revealed an Env-IM cross-reactive Ab that was clonally related to a subsequent vaccine-induced gp41-reactive Ab. Thus, HIV-1 Env DNA-rAd5 vaccine induced a dominant IM-polyreactive, non-neutralizing gp41-reactive Ab repertoire response that was associated with no vaccine efficacy.	[Williams, Wilton B.; Liao, Hua-Xin; Moody, M. Anthony; Alam, S. Munir; Gao, Feng; Wiehe, Kevin; Trama, Ashley M.; Jones, Kathryn; Zhang, Ruijun; Song, Hongshuo; Marshall, Dawn J.; Whitesides, John F.; Liu, Pinghuang; Tay, Matthew Z.; Seaton, Kelly E.; Shen, Xiaoying; Foulger, Andrew; Lloyd, Krissey E.; Parks, Robert; Pollara, Justin; Ferrari, Guido; Yu, Jae-Sung; Vandergrift, Nathan; Montefiori, David C.; Tomaras, Georgia D.; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Kepler, Thomas B.; Sawatzki, Kaitlin; Hua, Axin] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Sobieszczyk, Magdalena E.; Hammer, Scott] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Karuna, Shelly; Grunenberg, Nicole; McElrath, M. Juliana; Corey, Lawrence; Maenza, Janine] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Gilbert, Peter; Grove, Doug; Morgan, Cecilia] Fred Hutchinson Canc Res Ctr, SCHARP, Seattle, WA 98104 USA; [Mascola, John R.; Koup, Richard A.; Nabel, Gary J.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Churchyard, Gavin] Aurum Inst, Johannesburg, South Africa; [Keefer, Michael] Univ Rochester, Sch Med, Rochester, NY USA; [Baden, Lindsey R.] Brigham & Womens Hosp, Boston, MA 02115 USA	Duke University; Boston University; Columbia University; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Rochester; Harvard University; Brigham & Women's Hospital	Williams, WB (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27708 USA.	wilton.williams@duke.edu; barton.haynes@duke.edu	Sawatzki, Kaitlin/AAI-4849-2021; Corey, Lawrence/AAE-1796-2020; Zhang, RUIJUN/AAD-6887-2021; Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021; Ferrari, Guido/A-6088-2015; Tay, Matthew/GYQ-6959-2022; Moody, M/AAB-6947-2020; Ferrari, Guido/Z-2137-2019; Tomaras, Georgia/J-5041-2016; Alam, S. Munir/AAC-6711-2019	Sawatzki, Kaitlin/0000-0002-7933-3064; Corey, Lawrence/0000-0002-2179-2436; Zhang, RUIJUN/0000-0001-6785-9619; Graham, Barney S./0000-0001-8112-0853; Ferrari, Guido/0000-0001-7747-3349; Moody, M/0000-0002-3890-5855; Tay, Matthew Zirui/0000-0002-1763-913X; Jones, Kathryn/0000-0003-3815-5713; Seaton, Kelly/0000-0002-2009-3270; Vandergrift, Nathan/0000-0001-9994-5466; Churchyard, Gavin/0000-0002-4269-3699	NIH, NIAID UM-1 grant Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) [UM1 AI100645]; NIH NIAID Duke University Center for AIDS Research (CFAR) [P30-AI-64518]; NIH NIAID HVTN Laboratory Center [UM1AI068618]; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069511, UM1AI068614, UM1AI068618, UM1AI100645, UM1AI068635, UM1AI069470, UM1AI069412, U01AI069412, P30AI064518, UM1AI069481, ZIAAI005073] Funding Source: NIH RePORTER	NIH, NIAID UM-1 grant Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID); NIH NIAID Duke University Center for AIDS Research (CFAR); NIH NIAID HVTN Laboratory Center; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank G. Kelsoe for manuscript review, L. Armand for production of fluorophore-labeled reagents, and C. Stolarchuk, S. Stewart, A. Wang, R. Duffy, A. Deal, J. Eudailey, T. Von Holle, J. Alin, L. Oliver, F. Jaeger, and S. Arora for technical assistance. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Research materials used in this study are available from Duke University upon request and subsequent execution of an appropriate materials transfer agreement. Supported by NIH, NIAID UM-1 grant Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID; UM1 AI100645), NIH NIAID Duke University Center for AIDS Research (CFAR; P30-AI-64518), the NIH NIAID HVTN Laboratory Center UM1AI068618, and the intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH. W.B.W. designed and performed experiments, analyzed data, and co-wrote the paper; H.-X. L., K.J., M.A.M., D.J.M., and J.F.W. performed isolation of Abs, reviewed data, and edited the paper; T.B.K., A.H., K.W., K.S., and A.M.T. performed computational analysis of Ab sequences; F. G., R.Z., and H.S. sequenced Abs and performed NGS; S.M.A., P.L., M.Z.T., K.E.S., X.S., A. F., K.E.L., R.P., and J.-S.Y. performed Ab binding and functional assays; J.P. and G. F. performed ADCC assays; N.V., D.G., and P.G. performed statistical analysis; D.C.M. performed neutralization assays; M.E.S., S.H., S.K., N.G., M.J.M., J.R.M., R.A.K., L.C, G.J.N., C.M., G.C., J.M., M.K., B.S.G., and L.R.B. were members of the VRC or HVTN teams that carried out the clinical trials; G.D.T. analyzed data, designed experiments, reviewed data, and edited the paper; and B.F.H. conceived and designed the study, performed ANA analysis, reviewed all data, and cowrote the paper. GenBank accession numbers for sequences of the 221 Abs isolated via flow cytometry memory B cell single-cell sorting: immunoglobulin heavy chains, KT304331-KT304551; immunoglobulin light chains, KT304552-KT304772.	Alam SM, 2013, J VIROL, V87, P1554, DOI 10.1128/JVI.00718-12; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Darzentas N, 2010, LEUKEMIA, V24, P125, DOI 10.1038/leu.2009.186; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Friedman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037648; Goepfert PA, 2014, J INFECT DIS, V210, P99, DOI 10.1093/infdis/jiu003; Goo L, 2014, NAT MED, V20, P655, DOI 10.1038/nm.3565; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gray ES, 2011, J VIROL, V85, P7719, DOI 10.1128/JVI.00563-11; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hwang KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090725; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kepler TB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00170; Kepler TB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-444; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; KLEIN U, 1993, EUR J IMMUNOL, V23, P3272, DOI 10.1002/eji.1830231232; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Kwa S, 2015, J VIROL, V89, P4690, DOI 10.1128/JVI.03527-14; Lerner RA, 2011, MOL BIOSYST, V7, P1004, DOI 10.1039/c0mb00310g; Li QS, 2014, J IMMUNOL, V193, P3113, DOI 10.4049/jimmunol.1400820; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Liu PH, 2013, J VIROL, V87, P7828, DOI 10.1128/JVI.02737-12; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Robinson HL, 2013, EXPERT OPIN BIOL TH, V13, P197, DOI 10.1517/14712598.2012.743527; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tomaras GD, 2014, NAT MED, V20, P583, DOI 10.1038/nm.3598; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trama AM, 2014, CELL HOST MICROBE, V16, P215, DOI 10.1016/j.chom.2014.07.003; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wiehe K, 2014, IMMUNITY, V41, P909, DOI 10.1016/j.immuni.2014.11.014; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	72	149	154	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249							aab1253	10.1126/science.aab1253	http://dx.doi.org/10.1126/science.aab1253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26229114	Green Accepted			2022-12-28	WOS:000359415100028
J	Yan, N; Chen, X				Yan, Ning; Chen, Xi			Don't waste seafood waste	NATURE			English	Editorial Material							CHITIN; FERMENTATION		[Yan, Ning] Natl Univ Singapore, Green Chem, Singapore 117548, Singapore; [Chen, Xi] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Yan, N (corresponding author), Natl Univ Singapore, Green Chem, Singapore 117548, Singapore.	ning.yan@nus.edu.sg	Yan, Ning/B-8780-2013; Yan, Ning/ABI-5922-2020	Yan, Ning/0000-0002-1877-9206; Yan, Ning/0000-0002-1877-9206; chen, xi/0000-0003-3373-8768				Beaney P, 2005, J CHEM TECHNOL BIOT, V80, P145, DOI 10.1002/jctb.1164; Bobbink FD, 2015, GREEN CHEM, V17, P1024, DOI 10.1039/c4gc01631a; Chen X, 2014, CATAL SURV ASIA, V18, P164, DOI 10.1007/s10563-014-9171-1; Cira LA, 2002, PROCESS BIOCHEM, V37, P1359, DOI 10.1016/S0032-9592(02)00008-0; Food and Agriculture Organization of the United Nations FAO, 2014, STAT WORLD FISH AQ; Grand View Research, 2014, AM MARK AN PROD ETH; Kim S.-K., 2011, CHITIN CHITOSAN OLIG; Liu P, 2014, BIOCHEM ENG J, V91, P10, DOI 10.1016/j.bej.2014.07.004; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Zhang HC, 2012, CARBOHYD RES, V362, P13, DOI 10.1016/j.carres.2012.09.011	10	535	548	32	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					155	157		10.1038/524155a	http://dx.doi.org/10.1038/524155a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268177	Bronze			2022-12-28	WOS:000359386900008
J	Tavare, AN; Marmery, H				Tavare, Aniket N.; Marmery, Helen			Band Acro-osteolysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tavare, Aniket N.; Marmery, Helen] Royal Free London NHS Fdn Trust, London, England	University of London; University College London; Royal Free London NHS Foundation Trust	Tavare, AN (corresponding author), Royal Free London NHS Fdn Trust, London, England.	aniket.tavare@gmail.com							0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6							e6	10.1056/NEJMicm1311597	http://dx.doi.org/10.1056/NEJMicm1311597			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26244328				2022-12-28	WOS:000358987700011
J	Myung, P; Greco, V				Myung, Peggy; Greco, Valentina			Stem Cells Show Parental Control	CELL			English	Editorial Material							MAINTENANCE; AIRWAY	Stem cells interact with their niche to maintain an undifferentiated state. The study by Pardo-Saganta et al. shows that airway basal stem cells maintain secretory daughter cells in airway epithelia through forward regulation, suggesting that stem cells may serve as a niche for their progeny.	[Myung, Peggy; Greco, Valentina] Yale Univ, Sch Med, Dept Dermatol, Yale Canc Ctr,Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Greco, Valentina] Yale Univ, Sch Med, Dept Genet, Yale Stem Cell Ctr,Yale Canc Ctr, New Haven, CT 06510 USA	Yale University; Yale University	Myung, P (corresponding author), Yale Univ, Sch Med, Dept Dermatol, Yale Canc Ctr,Yale Stem Cell Ctr, New Haven, CT 06510 USA.	peggy.myung@yale.edu; valentina.greco@yale.edu			NIAMS NIH HHS [K08 AR066790] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR066790] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pardo-Saganta A., 2015, NATURE; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Zhao R, 2014, DEV CELL, V30, P151, DOI 10.1016/j.devcel.2014.06.004	10	0	0	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					476	477		10.1016/j.cell.2015.06.030	http://dx.doi.org/10.1016/j.cell.2015.06.030			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232219	Bronze			2022-12-28	WOS:000358801800007
J	Hole, J; Hirsch, M; Ball, E; Meads, C				Hole, Jenny; Hirsch, Martin; Ball, Elizabeth; Meads, Catherine			Music as an aid for postoperative recovery in adults: a systematic review and meta-analysis	LANCET			English	Review							OPERATING-ROOM; PAIN; COLONOSCOPY	Background Music is a non-invasive, safe, and inexpensive intervention that can be delivered easily and successfully. We did a systematic review and meta-analysis to assess whether music improves recovery after surgical procedures. Methods We included randomised controlled trials (RCTs) of adult patients undergoing surgical procedures, excluding those involving the central nervous system or head and neck, published in any language. We included RCTs in which any form of music initiated before, during, or after surgery was compared with standard care or other non-drug interventions. We searched MEDLINE, Embase, CINAHL, and Cochrane Central. We did meta-analysis with RevMan (version 5.2), with standardised mean differences (SMD) and random-effects models, and used Stata (version 12) for meta-regression. This study is registered with PROSPERO, number CRD42013005220. Findings We identified 4261 titles and abstracts, and included 73 RCTs in the systematic review, with size varying between 20 and 458 participants. Choice of music, timing, and duration varied. Comparators included routine care, headphones with no music, white noise, and undisturbed bed rest. Music reduced postoperative pain (SMD -0.77 [95% CI -0.99 to -0.56]), anxiety (-0.68 [-0.95 to -0.41]), and analgesia use (-0.37 [-0.54 to -0.20]), and increased patient satisfaction (1.09 [0.51 to 1.68]), but length of stay did not differ (SMD -0.11 [-0.35 to 0.12]). Subgroup analyses showed that choice of music and timing of delivery made little difference to outcomes. Meta-regression identified no causes of heterogeneity in eight variables assessed. Music was effective even when patients were under general anaesthetic. Interpretation Music could be offered as a way to help patients reduce pain and anxiety during the postoperative period. Timing and delivery can be adapted to individual clinical settings and medical teams.	[Hole, Jenny; Ball, Elizabeth] Univ London, Barts & London Sch Med & Dent, London E1 2AD, England; [Hirsch, Martin; Ball, Elizabeth] BartsHlth NHS Trust, London, England; [Meads, Catherine] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England	University of London; Queen Mary University London; Barts Health NHS Trust; Brunel University	Ball, E (corresponding author), Univ London, Barts & London Sch Med & Dent, London E1 2AD, England.	elizabeth.ball@bartshealth.nhs.uk		Hirsch, Martin/0000-0002-0192-2803; Meads, Catherine/0000-0002-2368-0665				AAGBI, 2010, AAGBI SAF GUID; ALLEN K, 1994, JAMA-J AM MED ASSOC, V272, P882, DOI 10.1001/jama.272.11.882; [Anonymous], 2009, SYSTEMATIC REV CRDS; Avidan MS, 2013, BRIT J ANAESTH, V110, P494, DOI 10.1093/bja/aet012; Bechtold ML, 2009, DIGEST DIS SCI, V54, P19, DOI 10.1007/s10620-008-0312-0; BRADT J, 2013, COCHRANE DB SYST REV, V6; Brandt J, 2013, COCHRANE DB SYST REV, V6; Centers for Disease Control and Prevention, FASTSTATS INP SURG; Cepeda MS, 2010, COCHRANE DB SYST REV, V8; Croom AM, 2012, FRONT PSYCHOL, V2, P1; Dobek CE, 2014, J PAIN, V15, P1057, DOI 10.1016/j.jpain.2014.07.006; Economidou E., 2012, HLTH SCI J, V6, P365; EGBERT LD, 1964, NEW ENGL J MED, V270, P825, DOI 10.1056/NEJM196404162701606; Engwall M, 2009, J PERIANESTH NURS, V24, P370, DOI 10.1016/j.jopan.2009.10.013; EVANS C, 1988, LANCET, V2, P491, DOI 10.1016/S0140-6736(88)90131-6; Hupkens S, 2012, PATIENT EDUC COUNS, V89, P411, DOI 10.1016/j.pec.2011.11.001; Jameson E, 2011, PAIN RES MANAG, V16, P27, DOI 10.1155/2011/856014; KANE E, 1914, JAMA-J AM MED ASSOC, V62, P1829, DOI DOI 10.1001/JAMA.1914.02560480063031; Khan K., 2011, SYSTEMATIC REV SUPPO; McCaffrey R, 2002, HOLIST NURS PRACT, V16, P231; McCaffrey R G, 2000, J Holist Nurs, V18, P378, DOI 10.1177/089801010001800408; Melzack R.C.K., 1968, SKIN SENSES; Moris DN, 2013, SURG ENDOSC, V27, P719, DOI 10.1007/s00464-012-2525-8; NHS improvement, 2011, NHS IMPR; Nightingale F., 1859, NOTES NURSING WHAT I; Nilsson Ulrica, 2008, AORN J, V87, P780, DOI 10.1016/j.aorn.2007.09.013; Royal College of Surgeons, SURG NHS NUMB; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Tam WWS, 2008, WORLD J GASTROENTERO, V14, P5336, DOI 10.3748/wjg.14.5336; Ullmann Y, 2008, INJURY, V39, P592, DOI 10.1016/j.injury.2006.06.021; Way TJ, 2013, J AM COLL SURGEONS, V216, P933, DOI 10.1016/j.jamcollsurg.2012.12.048; White J M, 1999, Am J Crit Care, V8, P220; Zarghi A., 2014, AM J APPL PSYCHOL, V2, P66	33	213	224	6	84	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1659	1671		10.1016/S0140-6736(15)60169-6	http://dx.doi.org/10.1016/S0140-6736(15)60169-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26277246	Green Submitted, Green Accepted			2022-12-28	WOS:000363197500033
J	van Weel, C				van Weel, Chris			Handwashing and community management of infections	LANCET			English	Editorial Material							INFLUENZA VACCINATION		[van Weel, Chris] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6500 HB Nijmegen, Netherlands; [van Weel, Chris] Australian Natl Univ, Canberra, ACT, Australia	Radboud University Nijmegen; Australian National University	van Weel, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, POB 9101, NL-6500 HB Nijmegen, Netherlands.	chris.vanweel@radboudumc.nl	van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701				[Anonymous], 2014, LANCET, V384, P281; De Maeseneer J., 2012, PATIENT PERSON PEOPL, V2, P601, DOI DOI 10.5750/IJPCM.V2I3.148; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Jagosh J, MILBANK Q, V201, P311; Jumaa PA, 2005, INT J INFECT DIS, V9, P3, DOI 10.1016/j.ijid.2004.05.005; Knottnerus JA, 2009, J CLIN EPIDEMIOL, V62, P675, DOI 10.1016/j.jclinepi.2008.10.006; Little P, 2015, LANCET; The European definition of General Practice / Family Medicine, 2011, EUR DEF GEN PRACT FA; WHO, GLOB INFL PROGR	10	0	0	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1603	1604		10.1016/S0140-6736(15)60460-3	http://dx.doi.org/10.1016/S0140-6736(15)60460-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU0HS	26256073				2022-12-28	WOS:000363197500006
J	Pless, M; Stupp, R; Ris, HB; Stahel, RA; Weder, W; Thierstein, S; Gerard, MA; Xyrafas, A; Fruh, M; Cathomas, R; Zippelius, A; Roth, A; Bijelovic, M; Ochsenbein, A; Meier, UR; Mamot, C; Rauch, D; Gautschi, O; Betticher, DC; Mirimanoff, RO; Peters, S				Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A.; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Frueh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R.; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C.; Mirimanoff, Rene-Olivier; Peters, Solange		SAKK Lung Cancer Project Grp	Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial	LANCET			English	Article							NEOADJUVANT CHEMOTHERAPY; RADIOTHERAPY; SURGERY; CHEMORADIOTHERAPY; RESECTION; SURVIVAL	Background One of the standard options in the treatment of stage IIIA/N2 non-small-cell lung cancer is neoadjuvant chemotherapy and surgery. We did a randomised trial to investigate whether the addition of neoadjuvant radiotherapy improves outcomes. Methods We enrolled patients in 23 centres in Switzerland, Germany and Serbia. Eligible patients had pathologically proven, stage IIIA/N2 non-small-cell lung cancer and were randomly assigned to treatment groups in a 1: 1 ratio. Those in the chemoradiotherapy group received three cycles of neoadjuvant chemotherapy (100 mg/m(2) cisplatin and 85 mg/m(2) docetaxel) followed by radiotherapy with 44 Gy in 22 fractions over 3 weeks, and those in the control group received neoadjuvant chemotherapy alone. All patients were scheduled to undergo surgery. Randomisation was stratified by centre, mediastinal bulk (less than 5 cm vs 5 cm or more), and weight loss (5% or more vs less than 5% in the previous 6 months). The primary endpoint was event-free survival. Analyses were done by intention to treat. This trial is registered with ClinicalTrials.gov,number NCT00030771. Findings From 2001 to 2012, 232 patients were enrolled, of whom 117 were allocated to the chemoradiotherapy group and 115 to the chemotherapy group. Median event-free survival was similar in the two groups at 12.8 months (95% CI 9.7-22.9) in the chemoradiotherapy group and 11.6 months (8.4-15.2) in the chemotherapy group (p=0.67). Median overall survival was 37.1 months (95% CI 22.6-50.0) with radiotherapy, compared with 26.2 months (19.9-52.1) in the control group. Chemotherapy-related toxic effects were reported in most patients, but 91% of patients completed three cycles of chemotherapy. Radiotherapy-induced grade 3 dysphagia was seen in seven (7%) patients. Three patients died in the control group within 30 days after surgery. Interpretation Radiotherapy did not add any benefit to induction chemotherapy followed by surgery. We suggest that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer.	[Pless, Miklos] Kantonsspital Winterthur, Dept Med Oncol, CH-8401 Winterthur, Switzerland; [Meier, Urs R.] Kantonsspital Winterthur, Dept Radiat Oncol, CH-8401 Winterthur, Switzerland; [Stupp, Roger] CHU Vaudois, Dept Med Oncol, Lausanne, Vaud, Switzerland; [Ris, Hans-Beat] CHU Vaudois, Dept Thorac Surg, Lausanne, Vaud, Switzerland; [Mirimanoff, Rene-Olivier] CHU Vaudois, Dept Radiat Oncol, Lausanne, Vaud, Switzerland; [Stupp, Roger] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland; [Stupp, Roger] Univ Zurich Hosp, Ctr Canc, CH-8091 Zurich, Switzerland; [Stahel, Rolf A.] Univ Zurich Hosp, Dept Med Oncol, CH-8091 Zurich, Switzerland; [Weder, Walter] Univ Zurich Hosp, Dept Thorac Surg, CH-8091 Zurich, Switzerland; [Thierstein, Sandra; Gerard, Marie-Aline] SAKK Coordinating Ctr, Bern, Switzerland; [Xyrafas, Alexandros] SAKK Dept Stat, Bern, Switzerland; [Frueh, Martin] Kantonsspital St Gallen, Dept Med Oncol, St Gallen, Switzerland; [Cathomas, Richard] Kantonsspital Graubunden, Dept Med Oncol, Chur, Switzerland; [Zippelius, Alfred] Univ Basel Hosp, Dept Med Oncol, CH-4031 Basel, Switzerland; [Roth, Arnaud] Hop Univ Geneve, Dept Med Oncol, Geneva, Switzerland; [Bijelovic, Milorad] Inst Pulm Dis Vojvodina, Dept Thorac Surg, Sremska Kamenica, Serbia; [Ochsenbein, Adrian] Univ Hosp Bern, Dept Med Oncol, CH-3010 Bern, Switzerland; [Mamot, Christoph] Kantonsspital Aarau, Dept Med Oncol, Aarau, Switzerland; [Rauch, Daniel] Reg Hosp, Dept Med Oncol, Thun, Switzerland; [Gautschi, Oliver] Kantonsspital Luzern, Dept Med Oncol, Luzern, Switzerland; [Betticher, Daniel C.] HFR Fribourg Hop cantonal, Dept Med Oncol, Fribourg, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; Kantonsspital Graubunden; University of Basel; University of Geneva; University of Bern; University Hospital of Bern; Kantonsspital Aarau AG (KSA); Lucerne Cantonal Hospital	Pless, M (corresponding author), Kantonsspital Winterthur, Dept Med Oncol, Brauerstr 15, CH-8401 Winterthur, Switzerland.	miklos.pless@ksw.ch; miklos.pless@ksw.ch	Stupp, Roger/L-3303-2019; peters, solange/ABF-2187-2020; Mamot, Christoph/GLU-1757-2022; Pless, Miklos/ABC-4054-2021	Ochsenbein, Adrian/0000-0003-1773-5436	Swiss State Secretariat for Education, Research and Innovation (SERI); Swiss Cancer League [KLS-02745-02-2011]; Sanofi	Swiss State Secretariat for Education, Research and Innovation (SERI); Swiss Cancer League; Sanofi(Sanofi-Aventis)	This study was supported by the Swiss State Secretariat for Education, Research and Innovation (SERI), the Swiss Cancer League (grant KLS-02745-02-2011 to MP), and Sanofi. We thank the patients and the investigators at all study sites for participation in the study.	Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; ALBAIN KS, 1995, J CLIN ONCOL, V13, P1880, DOI 10.1200/JCO.1995.13.8.1880; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Bentzen S, 2009, BASIC CLIN RADIOLOGY; Betticher DC, 2006, BRIT J CANCER, V94, P1099, DOI 10.1038/sj.bjc.6603075; Betticher DC, 2003, J CLIN ONCOL, V21, P1752, DOI 10.1200/JCO.2003.11.040; Burdett S, 2014, LANCET, V383, P1561, DOI 10.1016/S0140-6736(13)62159-5; Douillard JY, 2008, INT J RADIAT ONCOL, V72, P695, DOI 10.1016/j.ijrobp.2008.01.044; Eberhardt W, 2014, J CLIN ONCOL S, V32; Fleck J, 1993, P AN M AM SOC CLIN, V12, p1108a; Girard N, 2010, LUNG CANCER, V69, P86, DOI 10.1016/j.lungcan.2009.10.003; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Higgins K, 2009, INT J RADIAT ONCOL, V75, P1462, DOI 10.1016/j.ijrobp.2009.01.069; International Commission on Radiation Units and Measurement, 1993, 50 ICRU; Katakami N, 2012, CANCER-AM CANCER SOC, V118, P6126, DOI 10.1002/cncr.26689; Martini N, 1995, Chest Surg Clin N Am, V5, P189; O'Rourke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002140.pub3; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Stamatis G, 1999, ANN THORAC SURG, V68, P1144, DOI 10.1016/S0003-4975(99)00976-5; Stupp R, 2009, LANCET ONCOL, V10, P785, DOI 10.1016/S1470-2045(09)70172-X; Thomas M, 2008, LANCET ONCOL, V9, P636, DOI 10.1016/S1470-2045(08)70156-6; van Meerbeeck JP, 2007, JNCI-J NATL CANCER I, V99, P442, DOI 10.1093/jnci/djk093	23	202	215	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1049	1056		10.1016/S0140-6736(15)60294-X	http://dx.doi.org/10.1016/S0140-6736(15)60294-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26275735				2022-12-28	WOS:000361189200024
J	Lin, S; Diercks, CS; Zhang, YB; Kornienko, N; Nichols, EM; Zhao, YB; Paris, AR; Kim, D; Yang, P; Yaghi, OM; Chang, CJ				Lin, Song; Diercks, Christian S.; Zhang, Yue-Biao; Kornienko, Nikolay; Nichols, Eva M.; Zhao, Yingbo; Paris, Aubrey R.; Kim, Dohyung; Yang, Peidong; Yaghi, Omar M.; Chang, Christopher J.			Covalent organic frameworks comprising cobalt porphyrins for catalytic CO2 reduction in water	SCIENCE			English	Article							SELECTIVE ELECTROCATALYTIC REDUCTION; CARBON-DIOXIDE; ELECTROCHEMICAL REDUCTION; THIN-FILMS; MACROCYCLES; OXIDATION; NICKEL; PLANET	Conversion of carbon dioxide (CO2) to carbon monoxide (CO) and other value-added carbon products is an important challenge for clean energy research. Here we report modular optimization of covalent organic frameworks (COFs), in which the building units are cobalt porphyrin catalysts linked by organic struts through imine bonds, to prepare a catalytic material for aqueous electrochemical reduction of CO2 to CO. The catalysts exhibit high Faradaic efficiency (90%) and turnover numbers (up to 290,000, with initial turnover frequency of 9400 hour(-1)) at pH 7 with an overpotential of -0.55 volts, equivalent to a 26-fold improvement in activity compared with the molecular cobalt complex, with no degradation over 24 hours. X-ray absorption data reveal the influence of the COF environment on the electronic structure of the catalytic cobalt centers.	[Lin, Song; Diercks, Christian S.; Zhang, Yue-Biao; Kornienko, Nikolay; Nichols, Eva M.; Zhao, Yingbo; Paris, Aubrey R.; Yang, Peidong; Yaghi, Omar M.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Lin, Song; Nichols, Eva M.; Chang, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Diercks, Christian S.; Zhang, Yue-Biao; Yang, Peidong; Yaghi, Omar M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Zhang, Yue-Biao] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 201210, Peoples R China; [Yang, Peidong] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Yang, Peidong; Yaghi, Omar M.] Kavli Energy Nanosci Inst, Berkeley, CA 94720 USA; [Yaghi, Omar M.] King Fahd Univ Petr & Minerals, Dhahran 34464, Saudi Arabia; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; ShanghaiTech University; University of California System; University of California Berkeley; King Fahd University of Petroleum & Minerals; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	yaghi@berkeley.edu; chrischang@berkeley.edu	Nichols, Eva/ADF-7490-2022; Yaghi, Omar M/C-6749-2013; ZHANG, Yue-Biao/E-7870-2011; Zhao, Yingbo/AGG-0822-2022; Lin, Song/F-5472-2014; Lin, Song/ABD-5785-2021	ZHANG, Yue-Biao/0000-0002-8270-1067; Lin, Song/0000-0002-8880-6476; Lin, Song/0000-0002-8880-6476; Nichols, Eva/0000-0002-3718-7273; Kornienko, Nikolay/0000-0001-7193-2428; Kim, Dohyung/0000-0003-0201-9082; Yaghi, Omar/0000-0002-5611-3325	U.S. Department of Energy (DOE)/Lawrence Berkeley National Laboratory (LBNL) [101528-002]; BASF SE (Ludwigshafen, Germany); DOE, Office of Science, Office of Basic Energy Sciences, Energy Frontier Research Center [DESC0001015]; Office of Science, Office of Basic Energy Sciences, Materials Science and Engineering Division, DOE [DE-AC02-05CH11231]; NSF Graduate Research Fellowships Program; Amgen Scholar Program; DOE [DE-AC02-05CH11231]	U.S. Department of Energy (DOE)/Lawrence Berkeley National Laboratory (LBNL)(United States Department of Energy (DOE)); BASF SE (Ludwigshafen, Germany)(BASF); DOE, Office of Science, Office of Basic Energy Sciences, Energy Frontier Research Center(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, Materials Science and Engineering Division, DOE(United States Department of Energy (DOE)); NSF Graduate Research Fellowships Program(National Science Foundation (NSF)); Amgen Scholar Program; DOE(United States Department of Energy (DOE))	Financial support for energy catalysis in the C.J.C. laboratory was provided by U.S. Department of Energy (DOE)/Lawrence Berkeley National Laboratory (LBNL) grant 101528-002. Financial support for COF research in the O.M.Y. laboratory was provided by BASF SE (Ludwigshafen, Germany) for synthesis and by DOE, Office of Science, Office of Basic Energy Sciences, Energy Frontier Research Center grant DESC0001015 for adsorption and multivariate metallation. Financial support for energy catalysis in the P.Y. laboratory was supported by the Director of the Office of Science, Office of Basic Energy Sciences, Materials Science and Engineering Division, DOE, under contract no. DE-AC02-05CH11231(Surface). E.M.N. acknowledges the NSF Graduate Research Fellowships Program for a predoctoral fellowship. A.R.P. acknowledges the Amgen Scholar Program for support of undergraduate summer research. We thank C. Canlas (University of California, Berkeley) for the acquisition of solid-state nuclear magnetic resonance spectra and C. Zhu at the Advanced Light Source (ALS) at LBNL for the acquisition of GIWAXS data. XAS measurements were performed at the ALS. The ALS is an Office of Science user facility operated by LBNL for the DOE, Office of Science, and supported by the DOE under contract no. DE-AC02-05CH11231. We are indebted to Prince Dr. Turki bin Saud bin Mohammed Al-Saud, King Abdulaziz City for Science and Technology (Saudi Arabia), for valuable discussions concerning carbon capture and utilization applications. The data reported in the paper are presented in the supplementary materials.	Ahrenholtz SR, 2014, J AM CHEM SOC, V136, P2464, DOI 10.1021/ja410684q; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Behar D, 1998, J PHYS CHEM A, V102, P2870, DOI 10.1021/jp9807017; BELEY M, 1986, J AM CHEM SOC, V108, P7461, DOI 10.1021/ja00284a003; Bertrand GHV, 2013, P NATL ACAD SCI USA, V110, P4923, DOI 10.1073/pnas.1221824110; Bourrez M, 2011, ANGEW CHEM INT EDIT, V50, P9903, DOI 10.1002/anie.201103616; Bunck DN, 2012, ANGEW CHEM INT EDIT, V51, P1885, DOI 10.1002/anie.201108462; Calik M, 2014, J AM CHEM SOC, V136, P17802, DOI 10.1021/ja509551m; Cole EB, 2010, J AM CHEM SOC, V132, P11539, DOI 10.1021/ja1023496; Colson JW, 2011, SCIENCE, V332, P228, DOI 10.1126/science.1202747; Costentin C, 2013, CHEM SOC REV, V42, P2423, DOI 10.1039/c2cs35360a; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; de Groot F, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/10/104207; DeBlase CR, 2015, ACS NANO, V9, P3178, DOI 10.1021/acsnano.5b00184; Deng HX, 2010, SCIENCE, V327, P846, DOI 10.1126/science.1181761; Eisenberg R, 2011, INORG CHEM, V50, P9741, DOI 10.1021/ic2011748; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; FISHER B, 1980, J AM CHEM SOC, V102, P7361, DOI 10.1021/ja00544a035; Gray HB, 2009, NAT CHEM, V1, P7, DOI 10.1038/nchem.141; Guo J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3736; HAWECKER J, 1984, J CHEM SOC CHEM COMM, P328, DOI 10.1039/c39840000328; Kang P, 2013, CHEM SCI, V4, P3497, DOI 10.1039/c3sc51339d; Kim D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5948; Kornienko N, 2015, J AM CHEM SOC, V137, P7448, DOI 10.1021/jacs.5b03545; Kuhl KP, 2012, ENERG ENVIRON SCI, V5, P7050, DOI 10.1039/c2ee21234j; Kumar B, 2012, ANNU REV PHYS CHEM, V63, P541, DOI 10.1146/annurev-physchem-032511-143759; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Li CW, 2012, J AM CHEM SOC, V134, P7231, DOI 10.1021/ja3010978; Liu XH, 2013, J AM CHEM SOC, V135, P10470, DOI 10.1021/ja403464h; Lu WG, 2014, CHEM SOC REV, V43, P5561, DOI 10.1039/c4cs00003j; Ma LQ, 2010, NAT CHEM, V2, P838, DOI [10.1038/NCHEM.738, 10.1038/nchem.738]; Medina DD, 2014, ACS NANO, V8, P4042, DOI 10.1021/nn5000223; Park J, 2015, J AM CHEM SOC, V137, P1663, DOI 10.1021/ja5123528; Peterson AA, 2012, J PHYS CHEM LETT, V3, P251, DOI 10.1021/jz201461p; Pullen S, 2013, J AM CHEM SOC, V135, P16997, DOI 10.1021/ja407176p; Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786; Schneider J, 2012, ENERG ENVIRON SCI, V5, P9502, DOI 10.1039/c2ee22528j; Spitler EL, 2012, ANGEW CHEM INT EDIT, V51, P2623, DOI 10.1002/anie.201107070; Spitler EL, 2010, NAT CHEM, V2, P672, DOI [10.1038/NCHEM.695, 10.1038/nchem.695]; Thoi VS, 2013, J AM CHEM SOC, V135, P14413, DOI 10.1021/ja4074003; Wan S, 2011, CHEM MATER, V23, P4094, DOI 10.1021/cm201140r; Wang C, 2011, J AM CHEM SOC, V133, P13445, DOI 10.1021/ja203564w; Xiao DJ, 2014, NAT CHEM, V6, P590, DOI [10.1038/NCHEM.1956, 10.1038/nchem.1956]; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zhang S, 2014, J AM CHEM SOC, V136, P1734, DOI 10.1021/ja4113885; Zhu WL, 2013, J AM CHEM SOC, V135, P16833, DOI 10.1021/ja409445p	47	1565	1590	213	3105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1208	1213		10.1126/science.aac8343	http://dx.doi.org/10.1126/science.aac8343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26292706	Green Submitted			2022-12-28	WOS:000360968400039
J	Verchere, A; Menon, AK				Verchere, Alice; Menon, Anant K.			STRUCTURAL BIOLOGY Lipid gymnastics	NATURE			English	Editorial Material							LINKED OLIGOSACCHARIDES; BINDING; MSBA		[Verchere, Alice; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Verchere, A (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.	akm2003@med.cornell.edu	Menon, Anant/AAN-8663-2021	Menon, Anant/0000-0001-6924-2698				Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Kern NR, 2014, BIOPHYS J, V107, P1885, DOI 10.1016/j.bpj.2014.09.007; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; SCHENK B, 2001, GLYCOBIOLOGY, V11, P61; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zhou GP, 2003, GLYCOBIOLOGY, V13, P51, DOI 10.1093/glycob/cwg008	11	2	2	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					420	422		10.1038/nature15202	http://dx.doi.org/10.1038/nature15202			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26266983				2022-12-28	WOS:000360069300025
J	Flourakis, M; Kula-Eversole, E; Hutchison, AL; Han, TH; Aranda, K; Moose, DL; White, KP; Dinner, AR; Lear, BC; Ren, DJ; Diekman, CO; Raman, IM; Allada, R				Flourakis, Matthieu; Kula-Eversole, Elzbieta; Hutchison, Alan L.; Han, Tae Hee; Aranda, Kimberly; Moose, Devon L.; White, Kevin P.; Dinner, Aaron R.; Lear, Bridget C.; Ren, Dejian; Diekman, Casey O.; Raman, Indira M.; Allada, Ravi			A Conserved Bicycle Model for Circadian Clock Control of Membrane Excitability	CELL			English	Article							SUPRACHIASMATIC NUCLEUS NEURONS; RECTIFIER POTASSIUM CURRENT; BEHAVIORAL RHYTHMS; ION-CHANNEL; DROSOPHILA-MELANOGASTER; MOLECULAR OSCILLATIONS; PACEMAKER NEURONS; GENE-EXPRESSION; NEURAL ACTIVITY; CATION CHANNEL	Circadian clocks regulate membrane excitability in master pacemaker neurons to control daily rhythms of sleep and wake. Here, we find that two distinctly timed electrical drives collaborate to impose rhythmicity on Drosophila clock neurons. In the morning, a voltage-independent sodium conductance via the NA/NALCN ion channel depolarizes these neurons. This current is driven by the rhythmic expression of NCA localization factor-1, linking the molecular clock to ion channel function. In the evening, basal potassium currents peak to silence clock neurons. Remarkably, daily antiphase cycles of sodium and potassium currents also drive mouse clock neuron rhythms. Thus, we reveal an evolutionarily ancient strategy for the neural mechanisms that govern daily sleep and wake.	[Flourakis, Matthieu; Kula-Eversole, Elzbieta; Han, Tae Hee; Raman, Indira M.; Allada, Ravi] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Hutchison, Alan L.; Dinner, Aaron R.] Univ Chicago, Inst Biophys Dynam, Dept Chem, Med Scientist Training Program,James Franck Inst, Chicago, IL 60637 USA; [Aranda, Kimberly; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Moose, Devon L.; Lear, Bridget C.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Diekman, Casey O.] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA	Northwestern University; University of Chicago; University of Pennsylvania; University of Iowa; University of Chicago; New Jersey Institute of Technology	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	r-allada@northwestern.edu	Hutchison, Alan L/B-5769-2015	Hutchison, Alan L/0000-0003-4161-0772; Moose, Devon/0000-0002-1694-3981; Flourakis, Matthieu/0000-0002-5366-9125	National Institutes of Health (NIH) [R01NS052903, R01MH092273, NS055293, NS074257, R00GM080107]; National Science Foundation (NSF) Division of Mathematical Science grant [DMS1412877]; Defense Advanced Research Projects Agency (DARPA) [D12AP00023]; Northwestern University Flow Cytometry Facility; NINDS [NS054850]; Open Cloud Consortium (OCC); Gordon and Betty Moore Foundation; NSF; Cancer Center Support Grant [NCI CA060553]; Division Of Mathematical Sciences [1412877] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080107, T32GM007281, R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074257, R01NS052903, P30NS054850, R01NS055293] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Division of Mathematical Science grant; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Northwestern University Flow Cytometry Facility; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Open Cloud Consortium (OCC); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); Cancer Center Support Grant; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. White and H-S. Li for communicating results prior to publication; M. Vitaterna, K. Shimomura, A. Para, E. Zaharieva, D. Wokosin, C. Olker, and Jordan I. Robson for technical assistance; J. Gu, R. Scott, and B. White for the cloning and generation of UAS-NA HA flies; Dr. Jean Richa (Transgenic and Chimera Mouse Facility at the University of Pennsylvania) for ES cell injection; and M. Gallio for reagents and comments on a draft of the manuscript. We also thank Bloomington Drosophila stock center, the National Institute of Genetics (NIG), Vienna Drosophila RNAi center (VDRC) for reagents, and the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks. This work was supported by National Institutes of Health (NIH) grants R01NS052903 and R01MH092273 (to R.A.), NS055293 and NS074257 (to D.R.), R00GM080107 (to B.C.L.), and National Science Foundation (NSF) Division of Mathematical Science grant (DMS1412877 to C.O.D.). This effort was in part sponsored by the Defense Advanced Research Projects Agency (DARPA) (D12AP00023, to R.A.); the content of the information does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred. This work was also supported by the Northwestern University Flow Cytometry Facility, by a Cancer Center Support Grant (NCI CA060553). The two-photon microscope was supported by NINDS (NS054850). A.L.H. is a trainee of the NIH Medical Scientist Training program at the University of Chicago (NIGMS T32GM07281). This work made use of the Open Science Data Cloud (OSDC), which is an Open Cloud Consortium (OCC)-sponsored project. This work was supported, in part, by grants from Gordon and Betty Moore Foundation, the NSF, and major contributions from OCC members like the University of Chicago. Our work is in memory of Howard Nash, who re-discovered narrow abdomen and inspired our pursuit of studies of this channel.	Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Cavanaugh DJ, 2014, CELL, V157, P689, DOI 10.1016/j.cell.2014.02.024; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; de Jeu M, 1998, NEUROREPORT, V9, P3725, DOI 10.1097/00001756-199811160-00028; Diekman CO, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003196; Diekman CO, 2009, J BIOL RHYTHM, V24, P322, DOI 10.1177/0748730409337601; Flourakis M, 2015, METHOD ENZYMOL, V552, P23, DOI 10.1016/bs.mie.2014.10.005; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Ghezzi A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00015; Guo F, 2014, ELIFE, V3, DOI 10.7554/eLife.02780; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Hutchison AL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004094; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Izumo M, 2014, ELIFE, V3, DOI 10.7554/eLife.04617; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kudo T, 2011, J NEUROSCI, V31, P2746, DOI 10.1523/JNEUROSCI.5792-10.2011; Kuhlman SJ, 2006, J BIOL RHYTHM, V21, P470, DOI 10.1177/0748730406294316; Kuhlman SJ, 2004, EUR J NEUROSCI, V20, P1113, DOI 10.1111/j.1460-9568.2004.03555.x; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Kunst M, 2014, CURR BIOL, V24, P2652, DOI 10.1016/j.cub.2014.09.077; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lear BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078147; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Michel S, 1999, J BIOL RHYTHM, V14, P141, DOI 10.1177/074873099129000533; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Nahm SS, 2005, J NEUROSCI, V25, P9304, DOI 10.1523/jneurosci.2733-05.2005; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Park D, 2006, J NEUROPHYSIOL, V95, P3955, DOI 10.1152/jn.00117.2006; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; Raman IM, 2000, J NEUROSCI, V20, P9004; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schaap J, 2003, CHRONOBIOL INT, V20, P171, DOI 10.1081/CBI-120019311; Seluzicki A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001810; Shafer OT, 2002, J NEUROSCI, V22, P5946; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sim CK, 2007, J BIOL RHYTHM, V22, P445, DOI 10.1177/0748730407306041; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Tomaiuolo M, 2012, BIOPHYS J, V103, P2021, DOI 10.1016/j.bpj.2012.09.034; Xie L, 2013, NEURON, V77, P1069, DOI 10.1016/j.neuron.2013.01.018; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	60	127	127	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					836	848		10.1016/j.cell.2015.07.036	http://dx.doi.org/10.1016/j.cell.2015.07.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276633	Green Accepted, Bronze			2022-12-28	WOS:000359741400016
J	Sather, AC; Lee, HG; Colombe, JR; Zhang, AN; Buchwald, SL				Sather, Aaron C.; Lee, Hong Geun; Colombe, James R.; Zhang, Anni; Buchwald, Stephen L.			Dosage delivery of sensitive reagents enables glove-box-free synthesis	NATURE			English	Article							FLUORINE; CHEMISTRY; CATALYST; PARAFFIN; PHARMACEUTICALS	Contemporary organic chemists employ a broad range of catalytic and stoichiometric methods to construct molecules for applications in the material sciences(1), and as pharmaceuticals(2-5), agro-chemicals, and sensors(6). The utility of a synthetic method may be greatly reduced if it relies on a glove box to enable the use of air- and moisture-sensitive reagents or catalysts. Furthermore, many synthetic chemistry laboratories have numerous containers of partially used reagents that have been spoiled by exposure to the ambient atmosphere. This is exceptionally wasteful from both an environmental and a cost perspective. Here we report an encapsulation method for stabilizing and storing air-and moisture-sensitive compounds. We demonstrate this approach in three contexts, by describing single-use capsules that contain all of the reagents (catalysts, ligands, and bases) necessary for the glove-box-free palladium-catalysed carbon-fluorine(7-9), carbon-nitrogen(10,11,) and carbon-carbon(12) bond-forming reactions. This strategy should reduce the number of error-prone, tedious and time-consuming weighing procedures required for such syntheses and should be applicable to a wide range of reagents, catalysts, and substrate combinations.	[Sather, Aaron C.; Lee, Hong Geun; Colombe, James R.; Zhang, Anni; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu			National Institutes of Health [R01GM46059, 1F32GM108092-01A1]; National Science Foundation [1122374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108092, R01GM046059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institutes of Health under award number R01GM46059. A.C.S. thanks the National Institutes of Health for a postdoctoral fellowship (1F32GM108092-01A1). J.R.C. thanks the National Science Foundation for a pre-doctoral fellowship (1122374). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank Y. Ye for providingsamples of L2. We also thank M. Pirnot, Y. Wang, and C. Nguyen for assistance with the preparation of the manuscript.	Affouard C, 2015, ORG PROCESS RES DEV, V19, P476, DOI 10.1021/op500367p; Balz G, 1927, BER DTSCH CHEM GES, V60, P1186, DOI 10.1002/cber.19270600539; Bruno NC, 2013, CHEM SCI, V4, P916, DOI 10.1039/c2sc20903a; Campbell MG, 2015, CHEM REV, V115, P612, DOI 10.1021/cr500366b; Colombe JR, 2013, ORG LETT, V15, P5754, DOI 10.1021/ol402798z; Crawley M.L., 2012, APPL TRANSITION META; de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; DeGoey DA, 2009, J MED CHEM, V52, P2571, DOI 10.1021/jm900044w; Fang YQ, 2002, APPL CATAL A-GEN, V235, P33, DOI 10.1016/S0926-860X(02)00239-9; FINGER GC, 1956, J AM CHEM SOC, V78, P6034, DOI 10.1021/ja01604a022; Fors BP, 2010, J AM CHEM SOC, V132, P15914, DOI 10.1021/ja108074t; Grushin VV, 2010, ACCOUNTS CHEM RES, V43, P160, DOI 10.1021/ar9001763; Kosak M.K., 1995, Patent No. [005413924A, 005413924, US005413924 A]; Lee HG, 2014, J AM CHEM SOC, V136, P3792, DOI 10.1021/ja5009739; Lee HG, 2013, ORG LETT, V15, P5602, DOI 10.1021/ol402859k; Lennox AJJ, 2010, ISR J CHEM, V50, P664, DOI 10.1002/ijch.201000074; Magano J, 2011, CHEM REV, V111, P2177, DOI 10.1021/cr100346g; Michaudel Q, 2015, ACCOUNTS CHEM RES, V48, P712, DOI 10.1021/ar500424a; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Ozin G., 2009, NANOCHEMISTRY CHEM A; Paulini R, 2005, ANGEW CHEM INT EDIT, V44, P1788, DOI 10.1002/anie.200462213; Santanilla AB, 2015, SCIENCE, V347, P49, DOI 10.1126/science.1259203; Smart BE, 2001, J FLUORINE CHEM, V109, P3, DOI 10.1016/S0022-1139(01)00375-X; Taber D. F., 2005, Patent No. [US20050288257 A1, 20050288257]; Taber DF, 2003, J ORG CHEM, V68, P6047, DOI 10.1021/jo030005p; Taber DF, 2006, J ORG CHEM, V71, P8973, DOI 10.1021/jo061420v; Wang B., 2011, CHEMOSENSORS PRINCIP; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; WILD A, 2011, CHEM SOC REV, V40, P1459, DOI DOI 10.1039/c0cs00074d; Yandulov DV, 2007, J AM CHEM SOC, V129, P1342, DOI 10.1021/ja066930l	30	56	58	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					208	211		10.1038/nature14654	http://dx.doi.org/10.1038/nature14654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268191	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000359386900029
J	Rathi, VK; Krumholz, HM; Masoudi, FA; Ross, JS				Rathi, Vinay K.; Krumholz, Harlan M.; Masoudi, Frederick A.; Ross, Joseph S.			Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR DEVICES; FOOD; PATHWAY; TRIALS; SAFETY; TIME	IMPORTANCE The US Food and Drug Administration (FDA) approves high-risk medical devices, those that support or sustain human life or present potential unreasonable risk to patients, via the Premarket Approval (PMA) pathway. The generation of clinical evidence to understand device safety and effectiveness is shifting from predominantly premarket to continual study throughout the total product life cycle. OBJECTIVE To characterize the clinical evidence generated for high-risk therapeutic devices over the total product life cycle. DESIGN AND SETTING All clinical studies of high-risk therapeutic devices receiving initial market approval via the PMA pathway in 2010 and 2011 identified through ClinicalTrials.gov and publicly available FDA documents as of October 2014. MAIN OUTCOMES AND MEASURES Studies were characterized by type (pivotal, studies that served as the basis of FDA approval; FDA-required postapproval studies [PAS]; or manufacturer/investigator-initiated); premarket or postmarket; status (completed, ongoing, or terminated/unknown); and design features, including enrollment, comparator, and longest duration of primary effectiveness end point follow-up. RESULTS In 2010 and 2011, 28 high-risk therapeutic devices received initial marketing approval via the PMA pathway. We identified 286 clinical studies of these devices: 82 (28.7%) premarket and 204 (71.3%) postmarket, among which there were 52 (18.2%) nonpivotal premarket studies, 30 (10.5%) pivotal premarket studies, 33 (11.5%) FDA-required PAS, and 171 (59.8%) manufacturer/investigator-initiated postmarket studies. Six of 33 (18.2%) PAS and 20 of 171 (11.7%) manufacturer/investigator-initiated postmarket studies were reported as completed. No postmarket studies were identified for 5 (17.9%) devices; 3 or fewer were identified for 13 (46.4%) devices overall. Median enrollment was 65 patients (interquartile range [IQR], 25-111), 241 patients (IQR, 147-415), 222 patients (IQR, 119-640), and 250 patients (IQR, 60-800) for nonpivotal premarket, pivotal, FDA-required PAS, and manufacturer/investigator-initiated postmarket studies, respectively. Approximately half of all studies used no comparator (pivotal: 13/30 [43.3%]; completed postmarket: 16/26 [61.5%]; ongoing postmarket: 70/153 [45.8%]). Median duration of primary effectiveness end point follow-up was 3.0 months (IQR, 3.0-12.0), 9.0 months (IQR, 0.3-12.0), and 12.0 months (IQR, 7.0-24.0) for pivotal, completed postmarket, and ongoing postmarket studies, respectively. C ONCLUSIONS AND RELEVANCE Among high-risk therapeutic devices approved via the FDA PMA pathway, total product life cycle evidence generation varied in both the number and quality of premarket and postmarket studies, with approximately 13% of initiated postmarket studies completed between 3 and 5 years after FDA approval.	[Rathi, Vinay K.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Rathi, Vinay K.; Krumholz, Harlan M.; Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, Dept Internal Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Masoudi, Frederick A.] Univ Colorado, Aurora, CO USA; [Masoudi, Frederick A.] Colorado Cardiovasc Outcomes Res Consortium, Denver, CO USA; [Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, POB 208093, New Haven, CT 06520 USA.	joseph.ross@yale.edu	Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	Yale University School of Medicine Office of Student Research; National Heart, Lung, and Blood Institute Cardiovascular Outcomes Center [1U01HL105270-02]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Yale University School of Medicine Office of Student Research; National Heart, Lung, and Blood Institute Cardiovascular Outcomes Center; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was not supported by any external grants or funds. The authors assume full responsibility for the accuracy and completeness of the ideas presented. Mr Rathi is supported by the Yale University School of Medicine Office of Student Research. Drs Krumholz and Ross receive support through Yale University from Medtronic and Johnson & Johnson to develop methods of clinical trial data sharing, from the Centers of Medicare & Medicaid Services to develop and maintain performance measures that are used for public reporting, and from the Food and Drug Administration to develop methods for postmarket surveillance of medical devices. Dr Krumholz is supported by a National Heart, Lung, and Blood Institute Cardiovascular Outcomes Center Award (1U01HL105270-02). Dr Ross is supported by the National Institute on Aging (K08 AG032886) and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program.	[Anonymous], PREM APPR PMA DAT; [Anonymous], REC APPR DEV 2010 DE; [Anonymous], EXP ACC PREM APPR NO; [Anonymous], TOT PROD LIF CYCL; [Anonymous], REC APPR DEV 2011 DE; [Anonymous], FDAAA 801 REQUIREMEN; [Anonymous], PROD COD CLASS FIL M; [Anonymous], POST STUD PAS FREQ A; Avorn J, 2015, NEW ENGL J MED, V372, P2473, DOI 10.1056/NEJMp1506964; Chang L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2613; Chen CE, 2012, JAMA-J AM MED ASSOC, V308, P1740, DOI 10.1001/jama.2012.14491; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Gartenberg AJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g93; Hwang TJ, 2014, PEDIATRICS, V133, pE1197, DOI 10.1542/peds.2013-3348; Hwang TJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g217; Institute of Medicine, 2010, EV BIOM SURR ENDP CH; Kesselheim AS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7413; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Nieuwenhuijse MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5133; Pinnow E, 2014, J WOMENS HEALTH, V23, P218, DOI 10.1089/jwh.2013.4343; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Psaty BM, 2014, NEW ENGL J MED, V370, P2165, DOI 10.1056/NEJMp1401664; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; Rathi VK, 2015, OTOLARYNG HEAD NECK, V153, P400, DOI 10.1177/0194599815587508; Reynolds IS, 2014, JAMA INTERN MED, V174, P1773, DOI 10.1001/jamainternmed.2014.4194; Rising J, 2014, JAMA INTERN MED, V174, P1719, DOI 10.1001/jamainternmed.2014.4195; Rising JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117235; Rome BN, 2014, JAMA-J AM MED ASSOC, V311, P385, DOI 10.1001/jama.2013.284986; Ross JS, 2015, MED DEVICES-EVID RES, V8, P241, DOI 10.2147/MDER.S82964; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; U.S. Food and Drug Administration, PMA APPL CONT; U.S. Food and Drug Administration, POST STUD; US Food and Drug Administration, BAL PREM POSTM DAT C; US Food and Drug Administration, 2013, INV DEV EX IDES EARL; US Food and Drug Administration, PREM APPR PMA; US Food and Drug Administration, DES CONS PIV CLIN IN; US Food & Drug Administration, MED DEV REC; Zheng SY, 2014, ANN INTERN MED, V160, P798, DOI 10.7326/M13-2931	39	62	62	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					604	612		10.1001/jama.2015.8761	http://dx.doi.org/10.1001/jama.2015.8761			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262798	Bronze			2022-12-28	WOS:000359388600019
J	Liu, J				Liu, Joanne			Finish the fight against Ebola	NATURE			English	Editorial Material									Medecins Sans Frontieres, Geneva, Switzerland	Doctors Without Borders	Liu, J (corresponding author), Medecins Sans Frontieres, Geneva, Switzerland.	joanne.liu@geneva.msf.org						Evans DK, 2015, LANCET GLOB HEALTH, V3, pE439, DOI 10.1016/S2214-109X(15)00065-0; Henao-Restrepo AM, 2015, LANCET; Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6	3	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					27	29		10.1038/524027a	http://dx.doi.org/10.1038/524027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO2QS	26245564	Bronze			2022-12-28	WOS:000359002300012
J	Henry, DA				Henry, Dan A.			Hyponatremia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIAGNOSTIC-APPROACH; HYPERTONIC SALINE; RISK-FACTORS; GUIDELINE; DISEASE; UREA											Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Amin A, 2012, J HOSP MED, V7, P634, DOI 10.1002/jhm.1973; BARTTER FC, 1967, AM J MED, V42, P790, DOI 10.1016/0002-9343(67)90096-4; Chow KM, 2003, QJM-INT J MED, V96, P911, DOI 10.1093/qjmed/hcg157; CHUNG HM, 1987, AM J MED, V83, P905, DOI 10.1016/0002-9343(87)90649-8; EATON DC, 2013, VANDERS RENAL PHYSIO; Fenske W, 2010, AM J MED, V123, P652, DOI 10.1016/j.amjmed.2010.01.013; Furst H, 2000, AM J MED SCI, V319, P240, DOI 10.1097/00000441-200004000-00007; GOLDMAN MB, 1988, NEW ENGL J MED, V318, P397, DOI 10.1056/NEJM198802183180702; Hillier TA, 1999, AM J MED, V106, P399, DOI 10.1016/S0002-9343(99)00055-8; Hoorn EJ, 2005, QJM-INT J MED, V98, P529, DOI 10.1093/qjmed/hci081; Kovesdy CP, 2012, CIRCULATION, V125, P677, DOI 10.1161/CIRCULATIONAHA.111.065391; Leung AA, 2011, AM J MED, V124, P1064, DOI 10.1016/j.amjmed.2011.06.031; Mohmand HK, 2007, CLIN J AM SOC NEPHRO, V2, P1110, DOI 10.2215/CJN.00910207; MUSCH W, 1995, AM J MED, V99, P348, DOI 10.1016/S0002-9343(99)80180-6; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; Neville KA, 2006, ARCH DIS CHILD, V91, P226, DOI 10.1136/adc.2005.084103; Renneboog B, 2006, AM J MED, V119, P71, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]; Rodenburg EM, 2013, AM J KIDNEY DIS, V62, P67, DOI 10.1053/j.ajkd.2013.02.365; ROSE BD, 2001, CLIN PHYSL ACID BASE, P699; Sood L, 2013, AM J KIDNEY DIS, V61, P571, DOI 10.1053/j.ajkd.2012.11.032; Soupart A, 2012, CLIN J AM SOC NEPHRO, V7, P742, DOI 10.2215/CJN.06990711; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; STERNS RH, 1994, J AM SOC NEPHROL, V4, P1522; TANNEN RL, 1969, NEW ENGL J MED, V280, P1135, DOI 10.1056/NEJM196905222802101; TZAMALOUKAS AH, 2014, AM J MED SCI, P1; van Blijderveen JC, 2014, AM J MED, V127, P763, DOI 10.1016/j.amjmed.2014.04.014; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Wilkinson TJ, 1999, BRIT J CLIN PHARMACO, V47, P211, DOI 10.1046/j.1365-2125.1999.00872.x; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	30	21	24	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3							ITC1	10.7326/AITC201508040	http://dx.doi.org/10.7326/AITC201508040			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO6EX	26237763				2022-12-28	WOS:000359251100003
J	Anderegg, WRL; Schwalm, C; Biondi, F; Camarero, JJ; Koch, G; Litvak, M; Ogle, K; Shaw, JD; Shevliakova, E; Williams, AP; Wolf, A; Ziaco, E; Pacala, S				Anderegg, W. R. L.; Schwalm, C.; Biondi, F.; Camarero, J. J.; Koch, G.; Litvak, M.; Ogle, K.; Shaw, J. D.; Shevliakova, E.; Williams, A. P.; Wolf, A.; Ziaco, E.; Pacala, S.			Pervasive drought legacies in forest ecosystems and their implications for carbon cycle models	SCIENCE			English	Article							CLIMATE EXTREMES; RESILIENCE; ALLOCATION; FEEDBACKS; SAVANNA; DIEBACK; MEMORY; LIGHT; PLANT; HEAT	The impacts of climate extremes on terrestrial ecosystems are poorly understood but important for predicting carbon cycle feedbacks to climate change. Coupled climate-carbon cycle models typically assume that vegetation recovery from extreme drought is immediate and complete, which conflicts with the understanding of basic plant physiology. We examined the recovery of stem growth in trees after severe drought at 1338 forest sites across the globe, comprising 49,339 site-years, and compared the results with simulated recovery in climate-vegetation models. We found pervasive and substantial "legacy effects" of reduced growth and incomplete recovery for 1 to 4 years after severe drought. Legacy effects were most prevalent in dry ecosystems, among Pinaceae, and among species with low hydraulic safety margins. In contrast, limited or no legacy effects after drought were simulated by current climate-vegetation models. Our results highlight hysteresis in ecosystem-level carbon cycling and delayed recovery from climate extremes.	[Anderegg, W. R. L.; Wolf, A.; Ziaco, E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Anderegg, W. R. L.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Anderegg, W. R. L.] Univ Arizona, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Schwalm, C.; Koch, G.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Schwalm, C.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Biondi, F.; Ziaco, E.] Univ Nevada, DendroLab, Reno, NV 89557 USA; [Biondi, F.; Ziaco, E.] Univ Nevada, Grad Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA; [Camarero, J. J.] CSIC, Inst Pirenaico Ecol, Zaragoza 50192, Spain; [Litvak, M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Ogle, K.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Shaw, J. D.] US Forest Serv, Rocky Mt Res Stn, Ogden, UT 84401 USA; [Shevliakova, E.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; [Williams, A. P.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Princeton University; Utah System of Higher Education; University of Utah; University of Arizona; Northern Arizona University; Northern Arizona University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of New Mexico; Arizona State University; Arizona State University-Tempe; United States Department of Agriculture (USDA); United States Forest Service; National Oceanic Atmospheric Admin (NOAA) - USA; Columbia University	Anderegg, WRL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	anderegg@princeton.edu	Camarero, J. Julio/A-8602-2013; Williams, Park/B-8214-2016; Ziaco, Emanuele/ABB-4805-2020; Biondi, Franco/G-2536-2010	Camarero, J. Julio/0000-0003-2436-2922; Williams, Park/0000-0001-8176-8166; Biondi, Franco/0000-0003-0651-104X	NSF [DEB EF-1340270]; NOAA Climate and Global Change Postdoctoral Fellowship	NSF(National Science Foundation (NSF)); NOAA Climate and Global Change Postdoctoral Fellowship(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for this research was provided by NSF (grant no. DEB EF-1340270). W.R.L.A. was supported in part by a NOAA Climate and Global Change Postdoctoral Fellowship, administered by the University Corporation for Atmospheric Research. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the opinions or policies of the funding agencies. All tree-ring data are available at www.ncdc.noaa.gov/data-access/paleoclimatology-data/datasets/tree-ring. We thank all data contributers at the International Tree-Ring Data Bank. All CMIP5 data are available at http://cmip-pcmdi.llnl.gov/cmip5/data_portal.html. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups (listed in the supplementary materials) for producing and making available their model output. For CMIP, the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Ahlstrom A, 2015, SCIENCE, V348, P895, DOI 10.1126/science.aaa1668; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2013, GLOBAL CHANGE BIOL, V19, P1188, DOI 10.1111/gcb.12100; Anderegg WRL, 2012, TRENDS PLANT SCI, V17, P693, DOI 10.1016/j.tplants.2012.09.006; Arnone JA, 2008, NATURE, V455, P383, DOI 10.1038/nature07296; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Brodribb TJ, 2014, P NATL ACAD SCI USA, V111, P14489, DOI 10.1073/pnas.1407930111; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Corcuera L, 2004, TREES-STRUCT FUNCT, V18, P83, DOI 10.1007/s00468-003-0284-9; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Dybzinski R, 2011, AM NAT, V177, P153, DOI 10.1086/657992; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Farrior CE, 2013, AM NAT, V181, P314, DOI 10.1086/669153; GrissinoMayer HD, 1997, HOLOCENE, V7, P235, DOI 10.1177/095968369700700212; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Hacke UG, 2001, PLANT PHYSIOL, V125, P779, DOI 10.1104/pp.125.2.779; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Huntingford C, 2013, NAT GEOSCI, V6, P268, DOI [10.1038/ngeo1741, 10.1038/NGEO1741]; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Medvigy D, 2010, P NATL ACAD SCI USA, V107, P8275, DOI 10.1073/pnas.0912032107; Ogle K, 2015, ECOL LETT, V18, P221, DOI 10.1111/ele.12399; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Powell TL, 2013, NEW PHYTOL, V200, P350, DOI 10.1111/nph.12390; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Shevliakova E, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2007GB003176; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Virlouvet L, 2015, NEW PHYTOL, V205, P596, DOI 10.1111/nph.13080; Zhang Y., J GEOPHYS RES BIOGEO, V118, P148	38	619	636	76	552	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					528	532		10.1126/science.aab1833	http://dx.doi.org/10.1126/science.aab1833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228147				2022-12-28	WOS:000358713300054
J	Conn, CE; Bythell-Douglas, R; Neumann, D; Yoshida, S; Whittington, B; Westwood, JH; Shirasu, K; Bond, CS; Dyer, KA; Nelson, DC				Conn, Caitlin E.; Bythell-Douglas, Rohan; Neumann, Drexel; Yoshida, Satoko; Whittington, Bryan; Westwood, James H.; Shirasu, Ken; Bond, Charles S.; Dyer, Kelly A.; Nelson, David C.			Convergent evolution of strigolactone perception enabled host detection in parasitic plants	SCIENCE			English	Article							SEED-GERMINATION; ARABIDOPSIS; KARRIKIN; OROBANCHE; HORMONES; DWARF14; STRIGA; INHIBITION; RESPONSES; SIGNAL	Obligate parasitic plants in the Orobanchaceae germinate after sensing plant hormones, strigolactones, exuded from host roots. In Arabidopsis thaliana, the alpha/beta-hydrolase D14 acts as a strigolactone receptor that controls shoot branching, whereas its ancestral paralog, KAI2, mediates karrikin-specific germination responses. We observed that KAI2, but not D14, is present at higher copy numbers in parasitic species than in nonparasitic relatives. KAI2 paralogs in parasites are distributed into three phylogenetic clades. The fastest-evolving clade, KAI2d, contains the majority of KAI2 paralogs. Homology models predict that the ligand-binding pockets of KAI2d resemble D14. KAI2d transgenes confer strigolactone-specific germination responses to Arabidopsis thaliana. Thus, the KAI2 paralogs D14 and KAI2d underwent convergent evolution of strigolactone recognition, respectively enabling developmental responses to strigolactones in angiosperms and host detection in parasites.	[Conn, Caitlin E.; Neumann, Drexel; Dyer, Kelly A.; Nelson, David C.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Bythell-Douglas, Rohan; Bond, Charles S.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Yoshida, Satoko; Shirasu, Ken] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Whittington, Bryan; Westwood, James H.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA	University System of Georgia; University of Georgia; University of Western Australia; RIKEN; Virginia Polytechnic Institute & State University	Nelson, DC (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	dcnelson@uga.edu	yoshida, satoko/AAO-4892-2020; Shirasu, Ken/A-4455-2010; Bond, Charles S/B-4094-2011; Bond, Charles/AAF-9608-2020; Yoshida, Satoko/G-5003-2010; Yoshida, Satoko/AAZ-4757-2021; Shirasu, Ken/ABF-5306-2020	yoshida, satoko/0000-0002-9999-7861; Shirasu, Ken/0000-0002-0349-3870; Bond, Charles S/0000-0002-9584-6783; Bond, Charles/0000-0002-9584-6783; Yoshida, Satoko/0000-0002-9999-7861; Shirasu, Ken/0000-0002-0349-3870; Westwood, James/0000-0001-5127-7294; Nelson, David/0000-0001-9792-5015; Conn, Caitlin/0000-0003-0844-9550	University of Georgia (UGA) Research Foundation; NSF [IOS-1350561, DEB-1149350, DBI-0701748, IOS-1238057]; NSF Graduate Research Fellowship; National Institute of Food and Agriculture grant [135997]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [221S0002, 25711019, 25128716, 24228008]; Alberta Ministry of Innovation and Advanced Education; Alberta Innovates Technology Futures Innovates Centres of Research Excellence; Musea Ventures; BGI-Shenzhen; Grants-in-Aid for Scientific Research [15K21750, 25711019, 15H05955] Funding Source: KAKEN; Division Of Integrative Organismal Systems [1350561, 1238057] Funding Source: National Science Foundation	University of Georgia (UGA) Research Foundation; NSF(National Science Foundation (NSF)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Food and Agriculture grant; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Alberta Ministry of Innovation and Advanced Education; Alberta Innovates Technology Futures Innovates Centres of Research Excellence; Musea Ventures; BGI-Shenzhen; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Genome sequencing data are deposited in Sequence Read Archives at the National Center for Biotechnology Information (accession no. SRP056321) and the DNA Data Bank of Japan (accession no. DRA003500). D14 and KAI2 sequences and alignments are in supplementary material data files S1 to S4. Supported by the University of Georgia (UGA) Research Foundation, NSF grant IOS-1350561 (D.C.N.); an NSF Graduate Research Fellowship (C.E.C.); NSF grant DEB-1149350 (K.A.D.); National Institute of Food and Agriculture grant no. 135997, NSF grant DBI-0701748, and NSF grant IOS-1238057 (J.H.W.); and Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI grant nos. 221S0002, 25711019, 25128716, and 24228008 (S.Y., K.S.). We thank G. Ka-Shu Wong (U. of Alberta), C. dePamphilis (Penn State), J. Leebens-Mack (UGA), and the OneKP consortium (http://onekp.com) for Lamiales sequences. OneKP is funded by the Alberta Ministry of Innovation and Advanced Education, Alberta Innovates Technology Futures Innovates Centres of Research Excellence, Musea Ventures, and BGI-Shenzhen. B. Schmitz (UGA), M. French (Callaway Gardens), and A. Scaffidi and M. Waters (U. of Western Australia) provided materials.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Awad AA, 2006, PLANT GROWTH REGUL, V48, P221, DOI 10.1007/s10725-006-0009-3; BERNER DK, 1995, PLANT DIS, V79, P652, DOI 10.1094/PD-79-0652; Bythell-Douglas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054758; Fernandez-Aparicio M, 2009, ANN BOT-LONDON, V103, P423, DOI 10.1093/aob/mcn236; Fernandez-Aparicio M, 2011, SEED SCI RES, V21, P55, DOI 10.1017/S0960258510000371; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Guo YX, 2013, P NATL ACAD SCI USA, V110, P8284, DOI 10.1073/pnas.1306265110; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Jamil M, 2012, PLANTA, V235, P473, DOI 10.1007/s00425-011-1520-y; Kagiyama M, 2013, GENES CELLS, V18, P147, DOI 10.1111/gtc.12025; Liu Q, 2014, NEW PHYTOL, V202, P531, DOI 10.1111/nph.12692; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Scaffidi A, 2014, PLANT PHYSIOL, V165, P1221, DOI 10.1104/pp.114.240036; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Waldie T, 2014, PLANT J, V79, P607, DOI 10.1111/tpj.12488; Waters MT, 2014, PLANT J, V79, P623, DOI 10.1111/tpj.12430; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Xie XN, 2013, MOL PLANT, V6, P153, DOI 10.1093/mp/sss139; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zwanenburg B, 2013, MOL PLANT, V6, P38, DOI 10.1093/mp/sss141	24	184	189	14	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					540	543		10.1126/science.aab1140	http://dx.doi.org/10.1126/science.aab1140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228149				2022-12-28	WOS:000358713300057
J	Gonzales, KAU; Liang, H; Lim, YS; Chan, YS; Yeo, JC; Tan, CP; Gao, B; Le, BL; Tan, ZY; Low, KY; Liou, YC; Bard, F; Ng, HH				Gonzales, Kevin Andrew Uy; Liang, Hongqing; Lim, Yee-Siang; Chan, Yun-Shen; Yeo, Jia-Chi; Tan, Cheng-Peow; Gao, Bin; Le, Beilin; Tan, Zi-Ying; Low, Kok-Yao; Liou, Yih-Cherng; Bard, Frederic; Ng, Huck-Hui			Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways	CELL			English	Article							HUMAN EMBRYONIC STEM; DNA-DAMAGE; SELF-RENEWAL; MAINTAINS PLURIPOTENCY; DIFFERENTIATION; P53; EXPRESSION; APOPTOSIS; CATENIN; NURD	During differentiation, human embryonic stem cells (hESCs) shut down the regulatory network conferring pluripotency in a process we designated pluripotent state dissolution (PSD). In a high-throughput RNAi screen using an inclusive set of differentiation conditions, we identify centrally important and context-dependent processes regulating PSD in hESCs, including histone acetylation, chromatin remodeling, RNA splicing, and signaling pathways. Strikingly, we detected a strong and specific enrichment of cell-cycle genes involved in DNA replication and G2 phase progression. Genetic and chemical perturbation studies demonstrate that the S and G2 phases attenuate PSD because they possess an intrinsic propensity toward the pluripotent state that is independent of G1 phase. Our data therefore functionally establish that pluripotency control is hardwired to the cell-cycle machinery, where S and G2 phase-specific pathways deterministically restrict PSD, whereas the absence of such pathways in G1 phase potentially permits the initiation of differentiation.	[Gonzales, Kevin Andrew Uy; Liang, Hongqing; Lim, Yee-Siang; Chan, Yun-Shen; Yeo, Jia-Chi; Tan, Cheng-Peow; Gao, Bin; Le, Beilin; Tan, Zi-Ying; Ng, Huck-Hui] Genome Inst Singapore, Stem Cell & Regenerat Biol, Singapore 138672, Singapore; [Gonzales, Kevin Andrew Uy; Liou, Yih-Cherng] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Le, Beilin; Bard, Frederic; Ng, Huck-Hui] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Bard, Frederic] Inst Mol & Cellular Biol, Singapore 138673, Singapore; [Tan, Zi-Ying; Liou, Yih-Cherng; Ng, Huck-Hui] Natl Univ Singapore, Dept Biosci, Singapore 117543, Singapore; [Yeo, Jia-Chi; Low, Kok-Yao; Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ng, HH (corresponding author), Genome Inst Singapore, Stem Cell & Regenerat Biol, 60 Biopolis St, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Ng, Huck Hui/A-1135-2009; Chan, Yun-Shen/GWC-4616-2022; Bard, Frederic Andre Jean/G-9914-2011	Lim, Yee Siang/0000-0001-6522-7386; Gonzales, Kevin Andrew/0000-0001-7418-965X; Bard, Frederic Andre Jean/0000-0002-3783-4805; CHEN, Gao Bin/0000-0001-9988-1773; NG, HUCK HUI/0000-0001-6352-8417	Agency for Science, Technology, and Research, Singapore; National University of Singapore	Agency for Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	This work was funded by the Agency for Science, Technology, and Research, Singapore and the National University of Singapore. We thank G. Goh, J. Chia, P. Kumar, G. Periyasamy, H.M. Seah, P. Cheng, P. Kraus, F. Sachs, and I. Liu for assistance with experimental work. We also thank J.H. Ng, X. Lu, C. Chu, and Y. Hu for comments on the manuscript and U. Surana for intellectual discussion. The Tol2 cassette was a gift from K. Kawakami of the National Institute of Genetics, Japan.	Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018189; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Legartova S, 2014, BIOCHEM CELL BIOL, V92, P85, DOI 10.1139/bcb-2013-0082; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Lu XY, 2013, NAT CELL BIOL, V15, P1141, DOI 10.1038/ncb2839; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; SCOTT RE, 1982, P NATL ACAD SCI-BIOL, V79, P845, DOI 10.1073/pnas.79.3.845; Shilo A, 2014, RNA, V20, P505, DOI 10.1261/rna.042259.113; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang F, 2015, J CELL PHYSIOL, V230, P791, DOI 10.1002/jcp.24804; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	126	128	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					564	579		10.1016/j.cell.2015.07.001	http://dx.doi.org/10.1016/j.cell.2015.07.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232226	Green Accepted, Bronze			2022-12-28	WOS:000358801800016
J	Hateley, C; Alcada, J; Park, M; Vaid, N; Buckley, J				Hateley, Charlotte; Alcada, Joana; Park, Mirae; Vaid, Nidhi; Buckley, Jim			Pneumoperitoneum, a urological source	LANCET			English	Editorial Material									[Hateley, Charlotte; Buckley, Jim] Northwick Pk Hosp & Clin Res Ctr, Dept Infect Dis, Harrow HA1 3UJ, Middx, England; [Alcada, Joana; Park, Mirae; Vaid, Nidhi] Northwick Pk Hosp & Clin Res Ctr, Dept Med, Harrow HA1 3UJ, Middx, England	Imperial College London; Imperial College London	Buckley, J (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Dept Infect Dis, Harrow HA1 3UJ, Middx, England.	jimbuckley@nhs.net		Park, Mirae/0000-0002-7015-5943					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					284	284		10.1016/S0140-6736(15)60661-4	http://dx.doi.org/10.1016/S0140-6736(15)60661-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26277909	Bronze			2022-12-28	WOS:000368130700034
J	Grainger, JD; Locatelli, F; Chotsampancharoen, T; Donyush, E; Pongtanakul, B; Komvilaisak, P; Sosothikul, D; Drelichman, G; Sirachainan, N; Holzhauer, S; Lebedev, V; Lemons, R; Pospisilova, D; Ramenghi, U; Bussel, JB; Bakshi, KK; Iyengar, M; Chan, GW; Chagin, KD; Theodore, D; Marcello, LM; Bailey, CK				Grainger, John D.; Locatelli, Franco; Chotsampancharoen, Thirachit; Donyush, Elena; Pongtanakul, Bunchoo; Komvilaisak, Patcharee; Sosothikul, Darintr; Drelichman, Guillermo; Sirachainan, Nongnuch; Holzhauer, Susanne; Lebedev, Vladimir; Lemons, Richard; Pospisilova, Dagmar; Ramenghi, Ugo; Bussel, James B.; Bakshi, Kalpana K.; Iyengar, Malini; Chan, Geoffrey W.; Chagin, Karen D.; Theodore, Dickens; Marcello, Lisa M.; Bailey, Christine K.			Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; LONG-TERM; FOLLOW-UP; PURPURA; CHILDHOOD; MANAGEMENT; SPLENECTOMY; RITUXIMAB; HEMATOLOGY; EFFICACY	Background The thrombopoietin receptor agonist eltrombopag has been shown to be safe, tolerable, and effective for adults with chronic immune thrombocytopenia. We aimed to investigate the safety and efficacy of eltrombopag for children with chronic immune thrombocytopenia. Methods PETIT2 was a two part, randomised, multicentre, placebo-controlled study done at 38 centres in 12 countries (Argentina, Czech Republic, Germany, Hong Kong, Israel, Italy, Russia, Spain, Taiwan, Thailand, UK, and USA). Paediatric patients aged 1-17 years who had chronic immune thrombocytopenia and platelet counts less than 30 x 10(9) per L were randomly assigned (2:1) to receive eltrombopag or placebo. We stratified patients by age into three cohorts (patients aged 12-17 years, 6-11 years, and 1-5 years) before randomly entering them into a 13 week, double-blind period. Randomisation was done by the GlaxoSmithKline Registration and Medication Ordering System and both patients and study personnel were masked to treatment assignments. Patients who were allocated eltrombopag received tablets (except for those aged 1-5 years who received an oral suspension formulation) once per day for 13 weeks. Starting doses for patients aged 6-17 were based on bodyweight, and ethnic origin and ranged between 50 mg/day and 25 mg/day (starting dose for patients aged 1-5 years was 1.2 mg/kg/day or 0.8 mg/kg/day for east Asian patients). Patients who completed the double-blind period entered a 24 week open-label treatment period in which all patients received eltrombopag at either the starting dose (if they were formerly on placebo) or their established dose. The primary outcome was the proportion of patients achieving platelet counts of at least 50 x 10(9) per L in the absence of rescue therapy for 6 or more weeks from weeks 5 to 12 of the double-blind period. The intention-to-treat population included in the efficacy assessment consisted of all patients who were randomly assigned to one of the treatment groups, and the safety population included all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT01520909. Findings Beginning in March 15, 2012, 92 patients were enrolled, and the trial was completed on Jan 2, 2014. 63 patients were assigned to receive eltrombopag and 29 were assigned to receive placebo. In the double-blind period, three patients discontinued treatment because of adverse events: two patients in the eltrombopag group withdrew because of increased liver aminotransferases and one in the placebo group withdrew because of abdominal haemorrhage. 25 (40%) patients who received eltrombopag compared with one (3%) patient who received placebo achieved the primary outcome of platelet counts of at least 50 x 10(9) per L for 6 of the last 8 weeks of the double-blind period (odds ratio 18.0, 95% CI, 2.3-140.9; p=0.0004). Responses were similar in all cohorts (eltrombopag vs placebo: 39% vs 10% for patients aged 12-17 years, 42% vs 0% for patients aged 6-11 years, and 36% vs 0% for patients aged 1-5 years). Proportionately fewer patients who received eltrombopag (23 [37%] of 63 patients) had WHO grades 1-4 bleeding at the end of the double-blind period than did those who received placebo (16 [55%] of 29 patients); grades 2-4 bleeding were similar (three [5%] patients who received eltrombopag vs two [7%] patients who received placebo). During the 24-week open-label treatment period, 70 [80%] of 87 patients achieved platelet counts of 50 x 10(9) per L or more at least once. Adverse events that occurred more frequently with eltrombopag than with placebo included nasopharyngitis (11 [17%] patients), rhinitis (10 [16%] patients), upper respiratory tract infection (7 [11%] patients), and cough (7 [11%] patients). Serious adverse events occurred in five (8%) patients who received eltrombopag and four (14%) who received placebo. Safety was consistent between the open-label and double-blind periods. No deaths, malignancies, or thromboses occurred during the trial. Interpretation Eltrombopag, which produced a sustained platelet response in 40% of patients with chronic immune thrombocytopenia, is a suitable therapeutic option for children with chronic symptomatic immune thrombocytopenia. We identified no new safety concerns and few patients discontinued treatment because of adverse events.	[Grainger, John D.] Univ Manchester, Royal Manchester Childrens Hosp, Dept Haematol, Manchester, Lancs, England; [Grainger, John D.] Univ Manchester, Royal Manchester Childrens Hosp, NIHR Wellcome Trust Manchester CRF, Cent Manchester Hosp,NHS Fdn Trust, Manchester M13 9WL, Lancs, England; [Locatelli, Franco] Univ Pavia, IRCCS Osped Pediat Bambino Gesu, Rome, Italy; [Chotsampancharoen, Thirachit] Prince Songkla Univ, Songklanagarind Hosp, Bangkok, Thailand; [Donyush, Elena] Moscow Board Hlth, Izmaylovskaya Childrens City Clin Hosp, Moscow, Russia; [Pongtanakul, Bunchoo] Siriraj Hosp, Bangkok, Thailand; [Komvilaisak, Patcharee] Khon Kaen Univ, Srinagarind Hosp, Khon Kaen, Thailand; [Sosothikul, Darintr] Chulalongkorn Univ, Bangkok, Thailand; [Drelichman, Guillermo] Hosp Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, Argentina; [Sirachainan, Nongnuch] Ramathibodi Hosp, Bangkok, Thailand; [Holzhauer, Susanne] Charite, D-13353 Berlin, Germany; [Lebedev, Vladimir] GUZ Reg Childrens Clin Hosp, Krasnodar, Russia; [Lemons, Richard] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Pospisilova, Dagmar] Palacky Univ, Fac Hosp, CR-77147 Olomouc, Czech Republic; [Ramenghi, Ugo] Regina Margherita Childrens Hosp, Turin, Italy; [Bussel, James B.] Weill Cornell Med Coll, New York, NY USA; [Theodore, Dickens] GlaxoSmithKline, Res Triangle Pk, NC USA; [Bakshi, Kalpana K.; Iyengar, Malini; Chan, Geoffrey W.; Chagin, Karen D.; Marcello, Lisa M.; Bailey, Christine K.] GlaxoSmithKline, Collegeville, PA USA	Royal Manchester Children's Hospital; University of Manchester; Oxford University Hospitals NHS Foundation Trust; Royal Manchester Children's Hospital; University of Manchester; IRCCS Bambino Gesu; University of Pavia; Prince of Songkla University; Mahidol University; Khon Kaen University; Chulalongkorn University; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Mahidol University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Palacky University Olomouc; University Hospital Olomouc; A.O.U. Citta della Salute e della Scienza di Torino; Cornell University; GlaxoSmithKline; GlaxoSmithKline	Grainger, JD (corresponding author), Univ Manchester, Royal Manchester Childrens Hosp, NIHR Wellcome Trust Manchester CRF, NHS Fdn Trust,Cent Manchester Univ Hosp, Manchester M13 9WL, Lancs, England.	john.grainger@cmft.nhs.uk		Grainger, John/0000-0003-2626-0647; Chotsampancharoen, Thirachit/0000-0002-0111-6318	GlaxoSmithKline; Novartis Pharmaceuticals Corporation	GlaxoSmithKline(GlaxoSmithKline); Novartis Pharmaceuticals Corporation(Novartis)	The study was funded by GlaxoSmithKline; eltrombopag is an asset of Novartis AG as of March 2, 2015. We thank Andres Brainsky for his contributions to the study design, and Rosanna Tedesco for editorial assistance with the preparation of the manuscript. We also thank the patients and the principal investigators and their institutions for their contributions to the study (appendix). Editorial assistance was provided by Vanessa A Marrero and Nancy E Price of AOI Communications and was funded by GlaxoSmithKline and Novartis Pharmaceuticals Corporation.	Arnold DM, 2012, BLOOD, V119, P1356, DOI 10.1182/blood-2011-08-374777; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; Bennett CM, 2006, BLOOD, V107, P2639, DOI 10.1182/blood-2005-08-3518; Bisharat N, 2001, J INFECTION, V43, P182, DOI 10.1053/jinf.2001.0904; BLANCHETTE V, 1994, LANCET, V344, P703, DOI 10.1016/S0140-6736(94)92205-5; Boyle S, 2013, BLOOD, V121, P4782, DOI 10.1182/blood-2012-12-467068; Bussel JB, 2014, HAEMATOLOGICA, V99, P263; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Bussel JB, 2015, PEDIATR BLOOD CANCER, V62, P208, DOI 10.1002/pbc.25136; Bussel JB, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2315.2315; Bussel JB, 2011, BLOOD, V118, P28, DOI 10.1182/blood-2010-10-313908; Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; Cooper Nichola, 2010, Curr Rheumatol Rep, V12, P94, DOI 10.1007/s11926-010-0090-5; Erickson-Miller CL, 2009, STEM CELLS, V27, P424, DOI 10.1634/stemcells.2008-0366; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Grainger JD, 2013, ARCH DIS CHILD, V98, P895, DOI 10.1136/archdischild-2013-303784; Hedman A, 1997, ACTA PAEDIATR, V86, P226, DOI 10.1111/j.1651-2227.1997.tb08876.x; Kristinsson SY, 2014, HAEMATOLOGICA, V99, P392, DOI 10.3324/haematol.2013.092460; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036698; McMillan R, 2004, BLOOD, V103, P1364, DOI 10.1182/blood-2003-08-2672; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Neunert CE, 2008, PEDIATR BLOOD CANCER, V51, P513, DOI 10.1002/pbc.21621; Neunert CE, 2013, BLOOD, V121, P4457, DOI 10.1182/blood-2012-12-466375; Patel VL, 2012, BLOOD, V119, P5989, DOI 10.1182/blood-2011-11-393975; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; REID MM, 1995, ARCH DIS CHILD, V72, P125, DOI 10.1136/adc.72.2.125; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Saleh MN, 2013, BLOOD, V121, P537, DOI 10.1182/blood-2012-04-425512; Strullu M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-193; Vianelli N, 2013, HAEMATOLOGICA, V98, P875, DOI 10.3324/haematol.2012.075648; Wang KKW, 2014, HEALTH EXPECT, V17, P809, DOI 10.1111/j.1369-7625.2012.00806.x; Zeller B, 2000, PEDIATR HEMAT ONCOL, V17, P551, DOI 10.1080/08880010050122816	32	112	122	2	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1649	1658		10.1016/S0140-6736(15)61107-2	http://dx.doi.org/10.1016/S0140-6736(15)61107-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26231455				2022-12-28	WOS:000363197500032
J	Luo, J; Kesselheim, AS				Luo, Jing; Kesselheim, Aaron S.			The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Luo, Jing; Kesselheim, Aaron S.] Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law,Dept Med, Boston, MA 02115 USA; [Luo, Jing; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Luo, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	jluo1@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Gleeson DH, 2015, MED J AUSTRALIA, V202, P306, DOI 10.5694/mja14.01682; Kapczynski A, 2015, NEW ENGL J MED, V373, P201, DOI 10.1056/NEJMp1506158; Kapczynski A, 2013, NEW ENGL J MED, V369, P497, DOI 10.1056/NEJMp1304400; Knowledge Ecology International, 2015, CONS TEXT INT PROP C; Neuwelt PM, PATENTLY OBVIOUS PUB; Stastna K, ELI LILLY FILES 500M; Stiglitz JE, DONT TRADE AWAY OUR; Wang B, 2015, JAMA INTERN MED, V175, P635, DOI 10.1001/jamainternmed.2014.7968; Weisman J, PATENT PROTECTION DR	9	5	5	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1563	1564		10.1001/jama.2015.10872	http://dx.doi.org/10.1001/jama.2015.10872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26291894				2022-12-28	WOS:000363028500013
J	Yan, CY; Hang, J; Wan, RX; Huang, M; Wong, CCL; Shi, YG				Yan, Chuangye; Hang, Jing; Wan, Ruixue; Huang, Min; Wong, Catherine C. L.; Shi, Yigong			Structure of a yeast spliceosome at 3.6-angstrom resolution	SCIENCE			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; METAL-ION CATALYSIS; MESSENGER-RNA; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; U5 SNRNP; PRP19P-ASSOCIATED COMPLEX; RIBOSOMAL-SUBUNIT; ALLELES MODULATE; EM STRUCTURE	Splicing of precursor messenger RNA (pre-mRNA) in yeast is executed by the spliceosome, which consists of five small nuclear ribonucleoproteins (snRNPs), NTC (nineteen complex), NTC-related proteins (NTR), and a number of associated enzymes and cofactors. Here, we report the three-dimensional structure of a Schizosaccharomyces pombe spliceosome at 3.6-angstrom resolution, revealed by means of single-particle cryogenic electron microscopy. This spliceosome contains U2 and U5 snRNPs, NTC, NTR, U6 small nuclear RNA, and an RNA intron lariat. The atomic model includes 10,574 amino acids from 37 proteins and four RNA molecules, with a combined molecular mass of approximately 1.3 megadaltons. Spp42 (Prp8 in Saccharomyces cerevisiae), the key protein component of the U5 snRNP, forms a central scaffold and anchors the catalytic center. Both the morphology and the placement of protein components appear to have evolved to facilitate the dynamic process of pre-mRNA splicing. Our near-atomic-resolution structure of a central spliceosome provides a molecular framework for mechanistic understanding of pre-mRNA splicing.	[Yan, Chuangye; Hang, Jing; Wan, Ruixue; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci,Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci,Ctr Struct Bio, Beijing 100084, Peoples R China; [Huang, Min; Wong, Catherine C. L.] Chinese Acad Sci, Natl Ctr Prot Sci Shanghai, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Prot Sci,Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci,Ctr Struct Bio, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Wong, Catherine CL/0000-0001-7270-980X; Shi, Yigong/0000-0003-2030-168X	China's Ministry of Science and Technology [2014ZX09507003006]; National Natural Science Foundation of China [31130002, 31321062]	China's Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Tsinghua University Branch of the China National Center for Protein Sciences (Beijing) for providing the facility support. The computation was completed on the "Explorer 100" cluster system of the Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from China's Ministry of Science and Technology (grant 2014ZX09507003006) and the National Natural Science Foundation of China (grants 31130002 and 31321062). The atomic coordinates have been deposited in the Protein Data Bank with the accession code 3JB9. The EM maps have been deposited in the Electron Microscopy Data Bank with the accession codes EMD-6413 for the overall map and EMD-6414/6415/6416/6417/6418/6419/6420/6421 for the eight local maps. The authors declare no competing financial interests.	Azubel M, 2004, MOL CELL, V15, P833, DOI 10.1016/j.molcel.2004.07.022; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Boehringer D, 2004, NAT STRUCT MOL BIOL, V11, P463, DOI 10.1038/nsmb761; Burge CB, 1999, RNA WORLD, P525; Burns CG, 1999, P NATL ACAD SCI USA, V96, P13789, DOI 10.1073/pnas.96.24.13789; Burns R, 2014, NEUROLOGY, V83, P2175, DOI 10.1212/WNL.0000000000001053; Chen HR, 1999, P NATL ACAD SCI USA, V96, P5406, DOI 10.1073/pnas.96.10.5406; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; Chen WJ, 2014, CURR OPIN STRUC BIOL, V24, P141, DOI 10.1016/j.sbi.2014.01.009; Chen WJ, 2014, RNA, V20, P308, DOI 10.1261/rna.040980.113; Collins CA, 1999, GENE DEV, V13, P1970, DOI 10.1101/gad.13.15.1970; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cordin O, 2012, CURR OPIN CELL BIOL, V24, P431, DOI 10.1016/j.ceb.2012.03.004; De I, 2015, NAT STRUCT MOL BIOL, V22, P138, DOI 10.1038/nsmb.2951; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Dix I, 1998, RNA, V4, P1239, DOI 10.1017/S1355838298981109; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2014, CURR OPIN STRUC BIOL, V25, P57, DOI 10.1016/j.sbi.2013.12.002; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Golas MM, 2010, MOL CELL, V40, P927, DOI 10.1016/j.molcel.2010.11.023; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Hang J., 2015, SCIENCE; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Ilagan JO, 2013, RNA, V19, P400, DOI 10.1261/rna.034223.112; Jenkins JL, 2013, NUCLEIC ACIDS RES, V41, P3859, DOI 10.1093/nar/gkt046; Jurica MS, 2004, NAT STRUCT MOL BIOL, V11, P265, DOI 10.1038/nsmb728; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Lin PC, 2012, EMBO J, V31, P1579, DOI 10.1038/emboj.2012.7; Liu L, 2007, NAT STRUCT MOL BIOL, V14, P519, DOI 10.1038/nsmb1240; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Luhrmann R, 2009, CURR OPIN STRUC BIOL, V19, P96, DOI 10.1016/j.sbi.2009.01.001; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; Montemayor EJ, 2014, NAT STRUCT MOL BIOL, V21, P544, DOI 10.1038/nsmb.2832; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi MD, 2007, P NATL ACAD SCI USA, V104, P3195, DOI 10.1073/pnas.0611591104; Pomeranz Krummel Daniel A, 2009, Nature, V458, P475, DOI 10.1038/nature07851; Preker PJ, 1998, TRENDS BIOCHEM SCI, V23, P15, DOI 10.1016/S0968-0004(97)01156-0; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Query CC, 2012, RNA, V18, P1001, DOI 10.1261/rna.029421.111; Saha D, 2012, J BIOL CHEM, V287, P5390, DOI 10.1074/jbc.M111.298547; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Umen JG, 1996, GENETICS, V143, P723; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wolf E, 2009, EMBO J, V28, P2283, DOI 10.1038/emboj.2009.171; Xu DM, 2001, MOL CELL BIOL, V21, P1011, DOI 10.1128/MCB.21.4.1011-1023.2001; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhou LJ, 2014, NATURE, V506, P116, DOI 10.1038/nature12803; Zhou ZL, 2002, P NATL ACAD SCI USA, V99, P12203, DOI 10.1073/pnas.182427099	73	255	270	6	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1182	1191		10.1126/science.aac7629	http://dx.doi.org/10.1126/science.aac7629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26292707				2022-12-28	WOS:000360968400034
J	Strauss, SH; Costanza, A; Seguin, A				Strauss, Steven H.; Costanza, Adam; Seguin, Armand			Genetically engineered trees: Paralysis from good intentions Forest crises demand regulation and certification reform	SCIENCE			English	Editorial Material							BIOTECHNOLOGY; CROPS; DOMESTICATION; GENOMICS		[Strauss, Steven H.] Oregon State Univ, Corvallis, OR 97331 USA; [Costanza, Adam] Inst Forest Biosci, Cary, NC 27513 USA; [Seguin, Armand] Nat Resources Canada, Quebec City, PQ G1V 4C7, Canada	Oregon State University; Natural Resources Canada	Strauss, SH (corresponding author), Oregon State Univ, Corvallis, OR 97331 USA.	Steve.Strauss@OregonState.edu						Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Brunner AM, 2007, TREE GENET GENOMES, V3, P75, DOI 10.1007/s11295-006-0067-8; Burdon Rowland D., 2006, GENETICALLY MODIFIED; Costanza A, 2013, REGULATION CERTIFICA; Harfouche A, 2012, TRENDS PLANT SCI, V17, P64, DOI 10.1016/j.tplants.2011.11.005; Ledford H, 2014, NATURE, V512, P357, DOI 10.1038/512357a; Priest SH, 2000, NAT BIOTECHNOL, V18, P939, DOI 10.1038/79412; Strauss SH, 2003, SCIENCE, V300, P61, DOI 10.1126/science.1079514; Strauss SH, 2001, J FOREST, V99, P4; Strauss SH, 2010, BIOSCIENCE, V60, P729, DOI 10.1525/bio.2010.60.9.10; Walter C, 2010, NAT BIOTECHNOL, V28, P656, DOI 10.1038/nbt0710-656; Waltz E, 2014, NAT BIOTECHNOL, V32, P610, DOI 10.1038/nbt.2948; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	13	28	28	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					794	795		10.1126/science.aab0493	http://dx.doi.org/10.1126/science.aab0493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP4DR	26293942				2022-12-28	WOS:000359832700021
J	Tsuchiya, Y; Yoshimura, M; Sato, Y; Kuwata, K; Toh, S; Holbrook-Smith, D; Zhang, H; McCourt, P; Itami, K; Kinoshita, T; Hagihara, S				Tsuchiya, Yuichiro; Yoshimura, Masahiko; Sato, Yoshikatsu; Kuwata, Keiko; Toh, Shigeo; Holbrook-Smith, Duncan; Zhang, Hua; McCourt, Peter; Itami, Kenichiro; Kinoshita, Toshinori; Hagihara, Shinya			Probing strigolactone receptors in Striga hermonthica with fluorescence	SCIENCE			English	Article							ROOT PARASITIC PLANTS; GERMINATION STIMULANT; ARABIDOPSIS; RICE; DEGRADATION; INHIBITION; PERCEPTION; RESPONSES; HORMONES; DWARF14	Elucidating the signaling mechanism of strigolactones has been the key to controlling the devastating problem caused by the parasitic plant Striga hermonthica. To overcome the genetic intractability that has previously interfered with identification of the strigolactone receptor, we developed a fluorescence turn-on probe, Yoshimulactone Green (YLG), which activates strigolactone signaling and illuminates signal perception by the strigolactone receptors. Here we describe how strigolactones bind to and act via ShHTLs, the diverged family of alpha/beta hydrolase-fold proteins in Striga. Live imaging using YLGs revealed that a dynamic wavelike propagation of strigolactone perception wakes up Striga seeds. We conclude that ShHTLs function as the strigolactone receptors mediating seed germination in Striga. Our findings enable access to strigolactone receptors and observation of the regulatory dynamics for strigolactone signal transduction in Striga.	[Tsuchiya, Yuichiro; Yoshimura, Masahiko; Sato, Yoshikatsu; Kuwata, Keiko; Zhang, Hua; Itami, Kenichiro; Kinoshita, Toshinori; Hagihara, Shinya] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yoshimura, Masahiko; Itami, Kenichiro; Kinoshita, Toshinori; Hagihara, Shinya] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tsuchiya, Yuichiro; Toh, Shigeo; Holbrook-Smith, Duncan; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; [Itami, Kenichiro] Nagoya Univ, Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Itami Mol Nanocarbon Project,Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; University of Toronto; Japan Science & Technology Agency (JST); Nagoya University	Tsuchiya, Y (corresponding author), Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	yuichiro@itbm.nagoya-u.ac.jp; hagi@itbm.nagoya-u.ac.jp	Toh, Shigeo/E-4438-2014; Sato, Yoshikatsu/I-6129-2014; Toh, Shigeo/ABB-9441-2021; Hagihara, Shinya/I-6135-2014; Tsuchiya, Yuichiro/D-9777-2015; Kuwata, Keiko/I-6128-2014; Zhang, Hua/N-1151-2017; Itami, Kenichiro/B-5110-2011; Kinoshita, Toshinori/C-2891-2012; Hagihara, Shinya/P-9715-2019	Toh, Shigeo/0000-0002-6077-4556; Tsuchiya, Yuichiro/0000-0002-4599-1069; Zhang, Hua/0000-0002-4960-0838; Itami, Kenichiro/0000-0001-5227-7894; Kinoshita, Toshinori/0000-0001-7621-1259; Hagihara, Shinya/0000-0003-0348-7873; Holbrook-Smith, Duncan/0000-0003-0787-3165	Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency [643]; Ministry of Education, Culture, Sports, Science, and Technology [22119005]; Natural Sciences and Engineering Research Council of Canada; Japan Advanced Plant Science Network; World Premier International Research Center Initiative, Japan; Grants-in-Aid for Scientific Research [15K21750, 15H05955, 15H05491] Funding Source: KAKEN	Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Japan Advanced Plant Science Network; World Premier International Research Center Initiative, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Babikier for providing the Striga seeds; S. Yoshida and K. Shirasu for providing Phtheirospermum seeds; T. Nakagawa for the pGWB611 binary vector (31); M. Okumura for instructions on MEGA; E. Nambara for critical reading; H. Hirukawa and H. Tsuchiya for the artwork; and A. Miyazaki for proofreading the manuscript. This work was supported by the Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency (643 to T. K.) and by a Grant in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (22119005 to T. K.). Y.T., S.T., D.H.-S., and P.M. were funded by the Natural Sciences and Engineering Research Council of Canada. A part of this work was supported by the Japan Advanced Plant Science Network. ITbM is supported by the World Premier International Research Center Initiative, Japan. Nagoya U. has filed for a patent (patent application no. 2015-132707) regarding the following topic: "Fluorescent probes and screening methods for the small-molecule regulators of germination in Striga hermonthica." Inventors: S. Hagihara, M. Yoshimura, Y. Tsuchiya, K. Itami, and T. Kinoshita. Nucleotide and amino acid sequences corresponding to ShD14 and ShHTLs have been deposited in GenBank under accession numbers KR013120 to KR013131. YLG and YLGW are available from M. Yoshimura at Nagoya U. We declare no financial conflicts of interest in relation to this work. The supplemental materials contain additional data.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Awad AA, 2006, PLANT GROWTH REGUL, V48, P221, DOI 10.1007/s10725-006-0009-3; Chevalier F, 2014, PLANT CELL, V26, P1134, DOI 10.1105/tpc.114.122903; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Ejeta G., 2007, INTEGRATING NEW TECH, P3, DOI [10.1142/9789812771506_0001, DOI 10.1142/9789812771506_0001]; Fukui K, 2011, BIOORG MED CHEM LETT, V21, P4905, DOI 10.1016/j.bmcl.2011.06.019; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Kim HI, 2014, PHYTOCHEMISTRY, V103, P85, DOI 10.1016/j.phytochem.2014.03.030; Liu Q, 2014, NEW PHYTOL, V202, P531, DOI 10.1111/nph.12692; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Scaffidi A, 2014, PLANT PHYSIOL, V165, P1221, DOI 10.1104/pp.114.240036; Seto Y, 2014, P NATL ACAD SCI USA, V111, P1640, DOI 10.1073/pnas.1314805111; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Sugimoto Y, 2003, PHYSIOL PLANTARUM, V119, P137, DOI 10.1034/j.1399-3054.2003.00162.x; Thuring JWJF, 1997, J AGR FOOD CHEM, V45, P1409, DOI 10.1021/jf960443f; Toh S, 2014, CHEM BIOL, V21, P988, DOI 10.1016/j.chembiol.2014.07.005; Toh S, 2012, PLANT CELL PHYSIOL, V53, P107, DOI 10.1093/pcp/pcr176; Tsuchiya Y, 2012, MOL BIOSYST, V8, P464, DOI 10.1039/c1mb05195d; Tsuchiya Y, 2010, NAT CHEM BIOL, V6, P741, DOI [10.1038/NCHEMBIO.435, 10.1038/nchembio.435]; Ueno K, 2014, PHYTOCHEMISTRY, V108, P122, DOI 10.1016/j.phytochem.2014.09.018; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Yoneyama K, 2015, NEW PHYTOL, V206, P983, DOI 10.1111/nph.13375; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zwanenburg B, 2011, BIOORGAN MED CHEM, V19, P7394, DOI 10.1016/j.bmc.2011.10.057	31	167	174	14	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					864	868		10.1126/science.aab3831	http://dx.doi.org/10.1126/science.aab3831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293962				2022-12-28	WOS:000359832700049
J	Lazarou, M; Sliter, DA; Kane, LA; Sarraf, SA; Wang, CX; Burman, JL; Sideris, DP; Fogel, AI; Youle, RJ				Lazarou, Michael; Sliter, Danielle A.; Kane, Lesley A.; Sarraf, Shireen A.; Wang, Chunxin; Burman, Jonathon L.; Sideris, Dionisia P.; Fogel, Adam I.; Youle, Richard J.			The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy	NATURE			English	Article							PARKIN-MEDIATED MITOPHAGY; OPEN-ANGLE GLAUCOMA; DEPOLARIZED MITOCHONDRIA; SELECTIVE AUTOPHAGY; ACTIVATE PARKIN; PHOSPHORYLATION; OPTINEURIN; P62/SQSTM1; COMPLEX; BINDING	Protein aggregates and damaged organelles are tagged with ubiquitin chains to trigger selective autophagy. To initiate mitophagy, the ubiquitin kinase PINK1 phosphorylates ubiquitin to activate the ubiquitin ligase parkin, which builds ubiquitin chains on mitochondrial outer membrane proteins, where they act to recruit autophagy receptors. Using genome editing to knockout five autophagy receptors in HeLa cells, here we show that two receptors previously linked to xenophagy, NDP52 and optineurin, are the primary receptors for PINK1- and parkin-mediated mitophagy. PINK1 recruits NDP52 and optineurin, but not p62, to mitochondria to activate mitophagy directly, independently of parkin. Once recruited to mitochondria, NDP52 and optineurin recruit the autophagy factors ULK1, DFCP1 and WIPI1 to focal spots proximal to mitochondria, revealing a function for these autophagy receptors upstream of LC3. This supports a new model in which PINK1-generated phospho-ubiquitin serves as the autophagy signal on mitochondria, and parkin then acts to amplify this signal. This work also suggests direct and broader roles for ubiquitin phosphorylation in other autophagy pathways.	[Lazarou, Michael; Sliter, Danielle A.; Kane, Lesley A.; Sarraf, Shireen A.; Wang, Chunxin; Burman, Jonathon L.; Sideris, Dionisia P.; Fogel, Adam I.; Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	youler@ninds.nih.gov	Wang, Chunxin/B-9312-2016	Wang, Chunxin/0000-0001-6015-6806; Sarraf, Shireen/0000-0001-8489-6198; Lazarou, Michael/0000-0003-2150-5545	NIH, NINDS; National Health and Medical Research Council [GNT1063781]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003127, ZIANS002859, ZIANS003123] Funding Source: NIH RePORTER	NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Nezich and S. Banerjee in the Youle laboratory, C. Smith and the NINDS and NHLBI Flow Cytometry Core Facilities. This work was supported by the Intramural Research Program of the NIH, NINDS and the National Health and Medical Research Council (GNT1063781).	Ellinghaus D, 2013, GASTROENTEROLOGY, V145, P339, DOI 10.1053/j.gastro.2013.04.040; Fogel AI, 2013, MOL CELL BIOL, V33, P3675, DOI 10.1128/MCB.00079-13; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyama-Honda I, 2013, AUTOPHAGY, V9, P1491, DOI 10.4161/auto.25529; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Ordureau A, 2015, P NATL ACAD SCI USA, V112, P6637, DOI 10.1073/pnas.1506593112; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004861; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Svenning S, 2013, ESSAYS BIOCHEM, V55, P79, DOI [10.1042/bse0550079, 10.1042/BSE0550079]; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wild P, 2014, J CELL SCI, V127, P3, DOI 10.1242/jcs.140426; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111	42	1465	1512	36	445	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					309	+		10.1038/nature14893	http://dx.doi.org/10.1038/nature14893			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26266977	Green Accepted			2022-12-28	WOS:000359714000027
J	Sounier, R; Mas, C; Steyaert, J; Laeremans, T; Manglik, A; Huang, WJ; Kobilka, BK; Demene, H; Granier, S				Sounier, Remy; Mas, Camille; Steyaert, Jan; Laeremans, Toon; Manglik, Aashish; Huang, Weijiao; Kobilka, Brian K.; Demene, Helene; Granier, Sebastien			Propagation of conformational changes during mu-opioid receptor activation	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; DYNAMIC PROCESS; ANALGESIA; EFFICACY; RHODOPSIN; AGONIST; COMPLEX	mu-Opioid receptors (mu ORs) are G-protein-coupled receptors that are activated by a structurally diverse spectrum of natural and synthetic agonists including endogenous endorphin peptides, morphine and methadone. The recent structures of the mu OR in inactive(1) and agonist-induced active states (Huang et al., ref. 2) provide snapshots of the receptor at the beginning and end of a signalling event, but little is known about the dynamic sequence of events that span these two states. Here we use solution-state NMR to examine the process of mu OR activation using a purified receptor (mouse sequence) preparation in an amphiphile membrane-like environment. We obtain spectra of the mu OR in the absence of ligand, and in the presence of the high-affinity agonist BU72 alone, or with BU72 and a G protein mimetic nanobody. Our results show that conformational changes in transmembrane segments 5 and 6 (TM5 and TM6), which are required for the full engagement of a G protein, are almost completely dependent on the presence of both the agonist and the G protein mimetic nanobody, revealing a weak allosteric coupling between the agonist-binding pocket and the G-protein-coupling interface (TM5 and TM6), similar to that observed for the beta 2-adrenergic receptor(3). Unexpectedly, in the presence of agonist alone, we find larger spectral changes involving intracellular loop 1 and helix 8 compared to changes in TM5 and TM6. These results suggest that one or both of these domains may play a role in the initial interaction with the G protein, and that TM5 and TM6 are only engaged later in the process of complex formation. The initial interactions between the G protein and intracellular loop 1 and/or helix 8 may be involved in G-protein coupling specificity, as has been suggested for other family A G-protein-coupled receptors.	[Sounier, Remy; Mas, Camille; Granier, Sebastien] Univ Montpellier, Inst Genom Fonct, CNRS, INSERM,U1191,UMR 5203, F-34000 Montpellier, France; [Steyaert, Jan; Laeremans, Toon] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Steyaert, Jan; Laeremans, Toon] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Manglik, Aashish; Huang, Weijiao; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Demene, Helene] Univ Montpellier, Ctr Biochim Struct, CNRS, INSERM 1054,UMR 5048, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Granier, S (corresponding author), Univ Montpellier, Inst Genom Fonct, CNRS, INSERM,U1191,UMR 5203, F-34000 Montpellier, France.	helene@cbs.cnrs.fr; sebastien.granier@igf.cnrs.fr	Déméné, Hélène/AAZ-1691-2021; steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011; sounier, remy/D-6522-2019; Granier, Sebastien/J-1089-2016	Déméné, Hélène/0000-0002-7531-4309; Steyaert, Jan/0000-0002-3825-874X; sounier, remy/0000-0002-7802-2838; Kobilka, Brian/0000-0001-5958-3990; Huang, Weijiao/0000-0002-6253-7765	INSERM; CNRS; National Institutes of Health [NIDA-DA036246]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA036246] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We acknowledge support from INSERM (S.G.) and CNRS (H.D.) and from the National Institutes of Health Grant (NIDA-DA036246 to B.K.K. and S.G.). We also acknowledge the National Institute of Drug Abuse Drug Supply Program for providing [Dmt1] DALDA.	Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Huang W., 2015, NATURE; Kaye RG, 2011, MOL PHARMACOL, V79, P701, DOI 10.1124/mol.110.070177; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kofuku Y, 2014, ANGEW CHEM INT EDIT, V53, P13376, DOI 10.1002/anie.201406603; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Macht DI, 1915, P NATL ACAD SCI USA, V1, P582, DOI 10.1073/pnas.1.12.582; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McPherson J, 2010, MOL PHARMACOL, V78, P756, DOI 10.1124/mol.110.066613; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Neilan CL, 2004, EUR J PHARMACOL, V499, P107, DOI 10.1016/j.ejphar.2004.07.097; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	28	174	176	4	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					375	+		10.1038/nature14680	http://dx.doi.org/10.1038/nature14680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26245377	Green Published, Green Accepted			2022-12-28	WOS:000359714000041
J	Thornalley, DJR; Bauch, HA; Gebbie, G; Guo, W; Ziegler, M; Bernasconi, SM; Barker, S; Skinner, LC; Yu, J				Thornalley, D. J. R.; Bauch, H. A.; Gebbie, G.; Guo, W.; Ziegler, M.; Bernasconi, S. M.; Barker, S.; Skinner, L. C.; Yu, J.			A warm and poorly ventilated deep Arctic Mediterranean during the last glacial period	SCIENCE			English	Article							NORTH-ATLANTIC; OCEAN; WATERS; CIRCULATION; EVOLUTION; EXCHANGE; HISTORY; CLIMATE; SEA	Changes in the formation of dense water in the Arctic Ocean and Nordic Seas [the "Arctic Mediterranean" (AM)] probably contributed to the altered climate of the last glacial period. We examined past changes in AM circulation by reconstructing radiocarbon ventilation ages of the deep Nordic Seas over the past 30,000 years. Our results show that the glacial deep AM was extremely poorly ventilated (ventilation ages of up to 10,000 years). Subsequent episodic overflow of aged water into the mid-depth North Atlantic occurred during deglaciation. Proxy data also suggest that the deep glacial AM was similar to 2 degrees to 3 degrees C warmer than modern temperatures; deglacial mixing of the deep AM with the upper ocean thus potentially contributed to the melting of sea ice, icebergs, and terminal ice-sheet margins.	[Thornalley, D. J. R.; Gebbie, G.; Guo, W.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Thornalley, D. J. R.] UCL, Dept Geog, London WC1E 6BT, England; [Bauch, H. A.] Acad Sci Humanities & Literature, Mainz, Germany; [Bauch, H. A.] GEOMAR Helmholtz Ctr Ocean Res, D-24148 Kiel, Germany; [Ziegler, M.; Bernasconi, S. M.] Eidgenoss Tech Hsch Zurich, CH-8093 Zurich, Switzerland; [Barker, S.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3XQ, S Glam, Wales; [Skinner, L. C.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Yu, J.] Australian Natl Univ, Res Sch Earth Sci, Acton, ACT 0200, Australia	Woods Hole Oceanographic Institution; University of London; University College London; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Cardiff University; University of Cambridge; Australian National University	Thornalley, DJR (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	d.thornalley@cantab.net	Stephen, Barker/C-2770-2009; Bernasconi, Stefano M/E-5394-2010; Ziegler, Martin/N-9699-2013; Yu, Jimin/I-7770-2012	Stephen, Barker/0000-0001-7870-6431; Bernasconi, Stefano M/0000-0001-7672-8856; Ziegler, Martin/0000-0002-9126-7311; Ziegler, Martin/0000-0003-3198-6434; Yu, Jimin/0000-0002-3896-1777	WHOI Ocean and Climate Change Institute (OCCI) scholarship; OCCI grant [27071264]; WHOI OCCI; NSF [OIA-1124880, OCE-1357121, ANT-1246387]; WHOI J. Lamar Worzel Assistant Scientist Fund; Penzance Endowed Fund in Support of Assistant Scientists; European Union's Seventh Framework Programme for Research [298513]; Australian Research Council [DP140101393]; Natural Environment Research Council [NE/J008133/1]	WHOI Ocean and Climate Change Institute (OCCI) scholarship; OCCI grant; WHOI OCCI; NSF(National Science Foundation (NSF)); WHOI J. Lamar Worzel Assistant Scientist Fund; Penzance Endowed Fund in Support of Assistant Scientists; European Union's Seventh Framework Programme for Research; Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank L. Keigwin, T. Marchitto, J. McManus, and D. Oppo for discussions and comments on the manuscript. D.J.R.T. is grateful to T. Dokken for the suggestion to look to the AM for the source of the poorly ventilated water reconstructed from data collected south of Iceland. Funding was provided by a WHOI Ocean and Climate Change Institute (OCCI) scholarship and OCCI grant 27071264 (D.J.R.T.); WHOI OCCI and NSF grants OIA-1124880 and OCE-1357121 (G.G.); the WHOI J. Lamar Worzel Assistant Scientist Fund, the Penzance Endowed Fund in Support of Assistant Scientists, and NSF grant ANT-1246387 (W.G.); Marie Curie grant no. 298513 under the European Union's Seventh Framework Programme for Research (M.Z.); Australian Research Council Discovery Project grant DP140101393 (J.Y.); and Natural Environment Research Council grant NE/J008133/1 (S.B.). Research was planned and performed by D.J.R.T., except as follows: sample material, faunal counts, and N. pachyderma (s) delta<SUP>18</SUP>O data from core MD992276 were provided by H.A.B.; W.G., M.Z., and S.M.B. conducted clumped isotope measurements; and G.G. conducted the idealized one-dimensional modeling. The manuscript was written by D.J.R.T., with comments and contributions from all authors. Data used in this study can be found in the supplementary materials.	AAGAARD K, 1985, J GEOPHYS RES-OCEANS, V90, P4833, DOI 10.1029/JC090iC03p04833; Adkins JF, 2005, QUATERNARY SCI REV, V24, P581, DOI 10.1016/j.quascirev.2004.11.005; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; Bauch D, 2001, J GEOPHYS RES-OCEANS, V106, P9135, DOI 10.1029/1999JC000164; Bauch HA, 2001, QUATERNARY SCI REV, V20, P659, DOI 10.1016/S0277-3791(00)00098-6; Broecker W.S., 1982, TRACERS SEA; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cleroux C, 2011, QUATERNARY SCI REV, V30, P1875, DOI 10.1016/j.quascirev.2011.04.015; Cronin TM, 2012, NAT GEOSCI, V5, P631, DOI [10.1038/NGEO1557, 10.1038/ngeo1557]; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; Dokken TM, 1999, NATURE, V401, P458, DOI 10.1038/46753; Hoffmann SS, 2013, NATURE, V497, P603, DOI 10.1038/nature12145; Jakobsson M, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000302; JONES EP, 1995, DEEP-SEA RES PT I, V42, P737, DOI 10.1016/0967-0637(95)00013-V; Lear CH, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001880; Marcott SA, 2011, P NATL ACAD SCI USA, V108, P13415, DOI 10.1073/pnas.1104772108; Mauritzen C, 1996, DEEP-SEA RES PT I, V43, P769, DOI 10.1016/0967-0637(96)00037-4; Meland MY, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001416; Norgaard-Pedersen N, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000781; Pflaumann U, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000774; Polyak L, 2009, GLOBAL PLANET CHANGE, V68, P5, DOI 10.1016/j.gloplacha.2009.03.014; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rasmussen TL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036563; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Rippeth TP, 2015, NAT GEOSCI, V8, P191, DOI 10.1038/NGEO2350; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Sarnthein M, 2001, NORTHERN NORTH ATLANTIC: A CHANGING ENVIRONMENT, P365; Sarnthein M., 2007, OCEAN CIRCULATION ME, P175, DOI [10.1029/173gm13, DOI 10.1029/173GM13]; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Sortor RN, 2011, EARTH PLANET SC LETT, V310, P65, DOI 10.1016/j.epsl.2011.07.017; Spielhagen R., 2012, POLARFORSCHUNG, V82, P19; STEIN R, 1994, SCIENCE, V264, P692, DOI 10.1126/science.264.5159.692; Thiagarajan N, 2014, NATURE, V511, P75, DOI 10.1038/nature13472; Thornalley DJR, 2011, SCIENCE, V331, P202, DOI 10.1126/science.1196812; Timmermans ML, 2003, DEEP-SEA RES PT I, V50, P1305, DOI 10.1016/S0967-0637(03)00125-0; Tripati AK, 2010, GEOCHIM COSMOCHIM AC, V74, P5697, DOI 10.1016/j.gca.2010.07.006; VEUM T, 1992, NATURE, V356, P783, DOI 10.1038/356783a0; Wilson DJ, 2014, PALEOCEANOGRAPHY, V29, P1072, DOI 10.1002/2014PA002674; Yu JM, 2008, EARTH PLANET SC LETT, V271, P209, DOI 10.1016/j.epsl.2008.04.010	43	60	60	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					706	710		10.1126/science.aaa9554	http://dx.doi.org/10.1126/science.aaa9554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273049	Green Accepted, Green Submitted			2022-12-28	WOS:000359415100029
J	Sellers, MH; Dinner, SN				Sellers, Meredith H.; Dinner, Shira N.			Fatigue and an Elevated White Blood Cell Count	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITORS; BIOLOGY		[Sellers, Meredith H.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Dinner, Shira N.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Sellers, MH (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, 251 E Huron,Galter 3-150, Chicago, IL 60611 USA.	meredith.sellers@northwestern.edu						Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Huang XL, 2012, CANCER-AM CANCER SOC, V118, P3123, DOI 10.1002/cncr.26679; Jabbour E, 2011, BLOOD, V118, P4541, DOI 10.1182/blood-2011-04-348110; Jain P, 2013, BLOOD, V121, P4867, DOI 10.1182/blood-2013-03-490128; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Melo JV, 2004, HEMATOL ONCOL CLIN N, V18, P545, DOI 10.1016/j.hoc.2004.03.008; NCCN, CHRON MYEL LEUK VERS; Rohrbacher M, 2009, BEST PRACT RES CL HA, V22, P295, DOI 10.1016/j.beha.2009.07.007; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405	9	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					617	618		10.1001/jama.2015.4882	http://dx.doi.org/10.1001/jama.2015.4882			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262801				2022-12-28	WOS:000359388600022
J	Smith, JM				Smith, Jeanette M.			Afternoon in the Cluny Garden, Paris Charles Courtney Curran	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					542	543		10.1001/jama.2014.11909	http://dx.doi.org/10.1001/jama.2014.11909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262784				2022-12-28	WOS:000359388600032
J	Williams, DR; Wyatt, R				Williams, David R.; Wyatt, Ronald			Racial Bias in Health Care and Health Challenges and Opportunities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISCRIMINATION		[Williams, David R.] Harvard Univ, Dept Social & Behav Sci, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Williams, David R.] Harvard Univ, Dept African & African Amer Studies, Cambridge, MA 02138 USA; [Wyatt, Ronald] Joint Commiss, Oak Brook Terrace, IL 60181 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Wyatt, R (corresponding author), Joint Commiss, One Renaissance Blvd, Oak Brook Terrace, IL 60181 USA.	rwyatt@jointcommission.org						DeNavas-Walt C, INCOME POVERTY US; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Levine RS, 2001, PUBLIC HEALTH REP, V116, P474, DOI 10.1093/phr/116.5.474; Lewis TT, 2015, ANNU REV CLIN PSYCHO, V11, P407, DOI 10.1146/annurev-clinpsy-032814-112728; Pager D, 2008, ANNU REV SOCIOL, V34, P181, DOI 10.1146/annurev.soc.33.040406.131740; Paradies Y, 2014, J GEN INTERN MED, V29, P364, DOI 10.1007/s11606-013-2583-1; VANRYN M, 2011, BOIS REV, V8, P199; Verhaeghen P, 2011, BRIT J SOC PSYCHOL, V50, P501, DOI 10.1348/014466610X524254; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P771, DOI 10.1001/jama.2013.91	10	138	138	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					555	556		10.1001/jama.2015.9260	http://dx.doi.org/10.1001/jama.2015.9260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262792				2022-12-28	WOS:000359388600009
J	Belkin, A				Belkin, Aaron			Caring for Our Transgender Troops - The Negligible Cost of Transition-Related Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA	University of California System; University of California San Francisco	Belkin, A (corresponding author), Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA.							BROWN GR, 1988, ARCH SEX BEHAV, V17, P527, DOI 10.1007/BF01542340; CAL. DEP'T OF INS, 2012, EC IMP ASS GEND NOND; Gates GJ., 2014, TRANSGENDER MILITARY; Herman J. L., 2013, COSTS BENEFITS PROVI	4	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1089	1092		10.1056/NEJMp1509230	http://dx.doi.org/10.1056/NEJMp1509230			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR7UG	26267449				2022-12-28	WOS:000361556400003
J	Rejmanek, M				Rejmanek, Marcel			ECOLOGY Global trends in plant naturalization	NATURE			English	Editorial Material							INVASION	Many naturalized non-native plants pose ecological and economic threats. A quantitative analysis of the global distribution of naturalized plants confirms some anticipated trends and exposes new patterns. See Letter P.100	Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Rejmanek, M (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	mrejmanek@ucdavis.edu						Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; Darwin C., 1959, WHATS NEW, V67, P2; Essl F, 2015, ECOGRAPHY, V38, P488, DOI 10.1111/ecog.00905; Fridley JD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1157, DOI 10.1111/geb.12221; Gallien L, 2010, DIVERS DISTRIB, V16, P331, DOI 10.1111/j.1472-4642.2010.00652.x; Hulme PE, 2012, J APPL ECOL, V49, P10, DOI 10.1111/j.1365-2664.2011.02069.x; Rejmanek M, 2004, DIVERS DISTRIB, V10, P367, DOI 10.1111/j.1366-9516.2004.00107.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Seabloom EW, 2013, GLOBAL CHANGE BIOL, V19, P3677, DOI 10.1111/gcb.12370; Spear D, 2009, J ZOOL, V279, P1, DOI 10.1111/j.1469-7998.2009.00604.x; Stohlgren TJ, 2011, BIOL INVASIONS, V13, P1931, DOI 10.1007/s10530-011-0024-9; van Kleunen M, 2015, NATURE, V525, P100, DOI 10.1038/nature14910	12	12	13	7	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					39	40		10.1038/nature15206	http://dx.doi.org/10.1038/nature15206			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26287462				2022-12-28	WOS:000360594100018
J	Patel, N; Ram, D; Swiderska, N; Mewasingh, LD; Newton, RW; Offringa, M				Patel, Nikhil; Ram, Dipak; Swiderska, Nina; Mewasingh, Leena D.; Newton, Richard W.; Offringa, Martin			Febrile seizures	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TEMPORAL-LOBE EPILEPSY; STATUS EPILEPTICUS; HIPPOCAMPAL SCLEROSIS; UNPROVOKED SEIZURES; RISK-FACTORS; CHILDREN; CONVULSIONS; FEVER; INTERLEUKIN-1-BETA; PREDICTORS		[Patel, Nikhil; Newton, Richard W.] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England; [Ram, Dipak; Swiderska, Nina] Royal Manchester Childrens Hosp, Dept Neurol, Manchester M13 9WL, Lancs, England; [Mewasingh, Leena D.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Paediat Neurol, London W2 1NY, England; [Offringa, Martin] Hosp Sick Children, Res Inst, Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada	Imperial College London; Royal Manchester Children's Hospital; Imperial College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Newton, RW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England.	richard.newton@cmft.nhs.uk		Offringa, Martin/0000-0002-4402-5299				ALEISSA YA, 1995, J CHILD NEUROL, V10, P315, DOI 10.1177/088307389501000415; Alheim K, 1998, ANN NY ACAD SCI, V840, P51, DOI 10.1111/j.1749-6632.1998.tb09548.x; ALLDREDGE BK, 1995, PEDIATR NEUROL, V12, P213, DOI 10.1016/0887-8994(95)00044-G; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; [Anonymous], 1993, EPILEPSIA, V34, P592; Asano T, 2010, SCAND J IMMUNOL, V71, P447, DOI 10.1111/j.1365-3083.2010.02391.x; Audenaert D, 2006, HUM MUTAT, V27, P391, DOI 10.1002/humu.20279; Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berg AT, 1999, NEUROLOGY, V53, P1742, DOI 10.1212/WNL.53.8.1742; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; BERG AT, 1990, J PEDIATR-US, V116, P329, DOI 10.1016/S0022-3476(05)82816-1; BERG AT, 1993, AM J DIS CHILD, V147, P1101, DOI 10.1001/archpedi.1993.02160340087020; Berg AT, 1997, ARCH PEDIAT ADOL MED, V151, P371, DOI 10.1001/archpedi.1997.02170410045006; Cendes F, 2004, CURR OPIN NEUROL, V17, P161, DOI 10.1097/00019052-200404000-00013; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Doose H, 1997, EUR J PEDIATR, V156, P476, DOI 10.1007/s004310050643; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Gerard F, 2002, EPILEPSIA, V43, P581, DOI 10.1046/j.1528-1157.2002.43001.x; Haspolat S, 2002, J CHILD NEUROL, V17, P749, DOI 10.1177/08830738020170101501; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Hirose S, 2003, BRAIN DEV-JPN, V25, P304, DOI 10.1016/S0387-7604(03)00026-3; Hwang G, 2015, BRAIN DEV-JPN, V37, P315, DOI 10.1016/j.braindev.2014.06.003; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; Jones Tonia, 2007, Int J Med Sci, V4, P110; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kasperaviciute D, 2013, BRAIN, V136, P3140, DOI 10.1093/brain/awt233; Kimia A, 2010, PEDIATRICS, V126, P62, DOI 10.1542/peds.2009-2741; King EJ, 2012, DEV MED CHILD NEUROL, V54, P324, DOI 10.1111/j.1469-8749.2012.04227.x; Kneen R, 2005, ARCH DIS CHILD, V90, P3, DOI 10.1136/adc.2004.055442; Knudsen FU, 1996, BRAIN DEV-JPN, V18, P438, DOI 10.1016/S0387-7604(96)00059-9; Koepp MJ, 2000, J NEUROL NEUROSUR PS, V69, P716, DOI 10.1136/jnnp.69.6.716; Martinos MM, 2012, BRAIN, V135, P3153, DOI 10.1093/brain/aws213; Nabbout R, 2002, BRAIN, V125, P2668, DOI 10.1093/brain/awf281; Najaf-Zadeh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055270; Nakayama J, 2006, EPILEPSY RES, V70, pS190, DOI 10.1016/j.eplepyres.2005.11.023; National Institute for Health and Care Excellence, 2013, FEV ILLN CHILDR ASS; National Institute for Health and Care Excellence, 2013, CLIN KNOWL SUMM FEBR; National Institute for Health and Care Excellence. NICE Pathways, TREAT PROL REP SEIZ; Natsume J, 2007, ACTA NEUROL SCAND, V115, P25, DOI 10.1111/j.1600-0404.2007.00806.x; Offringa M, 1991, Paediatr Perinat Epidemiol, V5, P181, DOI 10.1111/j.1365-3016.1991.tb00699.x; Offringa M, 2001, BRIT MED J, V323, P1111, DOI 10.1136/bmj.323.7321.1111; OFFRINGA M, 1994, J PEDIATR-US, V124, P574, DOI 10.1016/S0022-3476(05)83136-1; Offringa M, 2012, COCHRANE DB SYST REV, V4; Oluwabusi T, 2012, CURR OPIN PEDIATR, V24, P259, DOI 10.1097/MOP.0b013e3283506765; Provenzale JM, 2008, AM J ROENTGENOL, V190, P976, DOI 10.2214/AJR.07.2407; Rosenbloom E, 2013, EUR J PAEDIATR NEURO, V17, P585, DOI 10.1016/j.ejpn.2013.04.008; Sapir D, 2000, BRAIN DEV-JPN, V22, P484, DOI 10.1016/S0387-7604(00)00187-X; Seinfeld S, 2014, EPILEPSIA, V55, P388, DOI 10.1111/epi.12526; Shinnar S, 2008, NEUROLOGY, V71, P170, DOI 10.1212/01.wnl.0000310774.01185.97; Shinnar S, 1997, EPILEPSIA, V38, P907, DOI 10.1111/j.1528-1157.1997.tb01256.x; Shinnar Shlomo, 2003, Epilepsy Curr, V3, P115, DOI 10.1046/j.1535-7597.2003.03401.x; Tang LJ, 2014, GENE, V533, P26, DOI 10.1016/j.gene.2013.09.071; Tarkka R, 2003, NEUROLOGY, V60, P215, DOI 10.1212/01.WNL.0000037482.55894.B1; Teran CG, 2012, PEDIATR EMERG CARE, V28, P493, DOI 10.1097/PEC.0b013e3182586f90; Thom M, 2009, J NEUROPATH EXP NEUR, V68, P928, DOI 10.1097/NEN.0b013e3181b05d67; Tomoum HY, 2007, J CHILD NEUROL, V22, P689, DOI 10.1177/0883073807304007; Trinka E, 2002, EPILEPSY RES, V50, P283, DOI 10.1016/S0920-1211(02)00083-9; Verity CM, 1998, NEW ENGL J MED, V338, P1723, DOI 10.1056/NEJM199806113382403; Verity CM, 1998, ARCH DIS CHILD, V78, P78, DOI 10.1136/adc.78.1.78; VERITY CM, 1991, BMJ-BRIT MED J, V303, P1373, DOI 10.1136/bmj.303.6814.1373; Visser AM, 2012, DEV MED CHILD NEUROL, V54, P1006, DOI 10.1111/j.1469-8749.2012.04405.x; Waruiru C, 2004, ARCH DIS CHILD, V89, P751, DOI 10.1136/adc.2003.028449; Yoong M, 2013, EPILEPSIA, V54, P2108, DOI 10.1111/epi.12426; Zuberi SM, 2011, NEUROLOGY, V76, P594, DOI 10.1212/WNL.0b013e31820c309b	66	55	57	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2015	351								h4240	10.1136/bmj.h4240	http://dx.doi.org/10.1136/bmj.h4240			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7OS	26286537				2022-12-28	WOS:000360078200003
J	Ulmer, S; Smorra, C; Mooser, A; Franke, K; Nagahama, H; Schneider, G; Higuchi, T; Van Gorp, S; Blaum, K; Matsuda, Y; Quint, W; Walz, J; Yamazaki, Y				Ulmer, S.; Smorra, C.; Mooser, A.; Franke, K.; Nagahama, H.; Schneider, G.; Higuchi, T.; Van Gorp, S.; Blaum, K.; Matsuda, Y.; Quint, W.; Walz, J.; Yamazaki, Y.			High-precision comparison of the antiproton-to-proton charge-to-mass ratio	NATURE			English	Article							SPECTROSCOPY; ELECTRON; CPT; ANTIHYDROGEN; HELIUM; TESTS; ION	Invariance under the charge, parity, time-reversal (CPT) transformation(1) is one of the fundamental symmetries of the standard model of particle physics. This CPT invariance implies that the fundamental properties of antiparticles and their matter-conjugates are identical, apart from signs. There is a deep link between CPT invariance and Lorentz symmetry-that is, the laws of nature seem to be invariant under the symmetry transformation of spacetime-although it is model dependent(2). A number of high-precision CPT and Lorentz invariance tests-using a co-magnetometer, a torsion pendulum and a maser, among others-have been performed(3), but only a few direct high-precision CPT tests that compare the fundamental properties of matter and antimatter are available(4-8). Here we report high-precision cyclotron frequency comparisons of a single antiproton and a negatively charged hydrogen ion (H-) carried out in a Penning trap system. From 13,000 frequency measurements we compare the charge-to-mass ratio for the antiproton (q/m)(p)- to that for the proton (q/m)(p) and obtain (q/m)(p)/(q/m)(p) - 1 - 1(69) x 10(-12). The measurements were performed at cyclotron frequencies of 29.6 megahertz, so our result shows that the CPT theorem holds at the atto-electronvolt scale. Our precision of 69 parts per trillion exceeds the energy resolution of previous antiproton-toproton mass comparisons(7,9) as well as the respective figure of merit of the standardmodel extension(10) by a factor of four. In addition, we give a limit on sidereal variations in the measured ratio of <720 parts per trillion. By following the arguments of ref. 11, our result can be interpreted as a stringent test of the weak equivalence principle of general relativity using baryonic antimatter, and it sets a new limit on the gravitational anomaly parameter of vertical bar alpha(g) - 1 vertical bar < 8.7 x 10(-7).	[Ulmer, S.; Smorra, C.; Mooser, A.; Franke, K.; Nagahama, H.; Schneider, G.; Higuchi, T.] RIKEN, Ulmer Initiat Res Unit, Wako, Saitama 3510198, Japan; [Smorra, C.] CERN, CH-1211 Geneva, Switzerland; [Franke, K.; Blaum, K.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Nagahama, H.; Higuchi, T.; Matsuda, Y.] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Schneider, G.; Walz, J.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Van Gorp, S.; Yamazaki, Y.] RIKEN, Atom Phys Lab, Wako, Saitama 3510198, Japan; [Quint, W.] GSI Helmholtzzentrum Schwerionenforsch, D-64291 Darmstadt, Germany; [Walz, J.] Helmholtz Inst Mainz, D-55099 Mainz, Germany	RIKEN; European Organization for Nuclear Research (CERN); Max Planck Society; University of Tokyo; Johannes Gutenberg University of Mainz; RIKEN; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Ulmer, S (corresponding author), RIKEN, Ulmer Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	stefan.ulmer@cern.ch	Ulmer, Stefan/AAC-8087-2022; Matsuda, Yasuyuki/C-3007-2008; Higuchi, Takashi/C-4571-2017; Smorra, Christian/C-5606-2017; Yamazaki, Yasunori/N-8018-2015; Lu, YuCheng/L-2929-2015	Ulmer, Stefan/0000-0002-4185-4147; Matsuda, Yasuyuki/0000-0002-9847-3791; Higuchi, Takashi/0000-0003-3281-4669; Yamazaki, Yasunori/0000-0001-5712-0853; Smorra, Christian/0000-0001-5584-7960	Antiproton Decelerator group; CERN groups; RIKEN Initiative Research Unit Program; RIKEN; RIKEN FPR; RIKEN JRA Program; MEXT [24000008]; Max-Planck Society; IMPRS-PTFS; EU (ERC) [290870-MEFUCO]; BMBF; Helmholtz-Gemeinschaft; CERN	Antiproton Decelerator group; CERN groups; RIKEN Initiative Research Unit Program; RIKEN; RIKEN FPR; RIKEN JRA Program; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Max-Planck Society(Max Planck SocietyFoundation CELLEX); IMPRS-PTFS; EU (ERC)(European Research Council (ERC)European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); Helmholtz-Gemeinschaft(Helmholtz Association); CERN	We acknowledge support by the Antiproton Decelerator group and all other CERN groups which provide support to Antiproton Decelerator experiments. We thank L. Bojtar and F. Butin for their invaluable support. We acknowledge financial support by the RIKEN Initiative Research Unit Program, RIKEN President Funding, RIKEN Pioneering Project Funding, RIKEN FPR Funding, the RIKEN JRA Program, the Grant-in-Aid for Specially Promoted Research (grant number 24000008) of MEXT, the Max-Planck Society, the IMPRS-PTFS, the EU (ERC advanced grant number 290870-MEFUCO), the BMBF, the Helmholtz-Gemeinschaft, and the CERN Fellowship programme.	Amole C, 2012, NATURE, V483, P439, DOI 10.1038/nature10942; Andresen GB, 2011, NAT PHYS, V7, P558, DOI [10.1038/NPHYS2025, 10.1038/nphys2025]; BHATIA AK, 1994, J PHYS B-AT MOL OPT, V27, P1299, DOI 10.1088/0953-4075/27/7/005; Bluhm R, 1998, PHYS REV D, V57, P3932, DOI 10.1103/PhysRevD.57.3932; BROWN LS, 1982, PHYS REV A, V25, P2423, DOI 10.1103/PhysRevA.25.2423; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; Colladay D, 1997, PHYS REV D, V55, P6760, DOI 10.1103/PhysRevD.55.6760; DiSciacca J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130801; Gabrielse G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213401; Gabrielse G, 1999, PHYS REV LETT, V82, P3198, DOI 10.1103/PhysRevLett.82.3198; GABRIELSE G, 1989, INT J MASS SPECTROM, V88, P319, DOI 10.1016/0168-1176(89)85027-X; Greenberg OW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.231602; Hori M, 2011, NATURE, V475, P484, DOI 10.1038/nature10260; HUGHES RJ, 1991, PHYS REV LETT, V66, P854, DOI 10.1103/PhysRevLett.66.854; Kostelecky VA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.11; Kuroda N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4089; LUDERS G, 1957, ANN PHYS-NEW YORK, V2, P1, DOI 10.1016/0003-4916(57)90032-5; Miller JP, 2007, REP PROG PHYS, V70, P795, DOI 10.1088/0034-4885/70/5/R03; Mooser A, 2014, NATURE, V509, P596, DOI 10.1038/nature13388; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; SCHWINGENHEUER B, 1995, PHYS REV LETT, V74, P4376, DOI 10.1103/PhysRevLett.74.4376; Smorra C, 2014, HYPERFINE INTERACT, V228, P31, DOI 10.1007/s10751-014-1018-7; Sturm S, 2014, NATURE, V506, P467, DOI 10.1038/nature13026; Thompson JK, 2004, NATURE, V430, P58, DOI 10.1038/nature02682; Ulmer S, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3271537; Ulmer S., 2013, SPSCTDR002 CERN; Van Dyck RS, 1999, AIP CONF PROC, V457, P101, DOI 10.1063/1.57450; VANDYCK RS, 1987, PHYS REV LETT, V59, P26, DOI 10.1103/PhysRevLett.59.26; WINELAND DJ, 1975, J APPL PHYS, V46, P919, DOI 10.1063/1.321602	29	88	89	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					196	199		10.1038/nature14861	http://dx.doi.org/10.1038/nature14861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268189	hybrid, Green Published			2022-12-28	WOS:000359386900026
J	Morton, L				Morton, Liza			WHAT YOUR PATIENT IS THINKING The heart of medicine: growing up with pioneering treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													Morton, Liza/T-3827-2019	Morton, Liza/0000-0001-5560-7561				Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2015	351								h3881	10.1136/bmj.h3881	http://dx.doi.org/10.1136/bmj.h3881			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XN	26269315	Bronze, Green Published			2022-12-28	WOS:000359741200002
J	Brechot, C				Brechot, Christian			Train Africa's scientists in crisis response	NATURE			English	Editorial Material									Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brechot, C (corresponding author), Inst Pasteur, Paris, France.	christian.brechot@pasteur.fr	BRECHOT, Christian/S-2011-2018						0	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					7	7		10.1038/524007a	http://dx.doi.org/10.1038/524007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO2QS	26245544	Bronze			2022-12-28	WOS:000359002300003
J	Clancey, G; Chhem, R				Clancey, Gregory; Chhem, Rethy			Hiroshima, Nagasaki, and Fukushima	LANCET			English	Editorial Material									[Clancey, Gregory] Natl Univ Singapore, Asia Res Inst, Dept Hist, Singapore 119077, Singapore; [Clancey, Gregory] Natl Univ Singapore, Tembusu Coll, Singapore 119077, Singapore; [Chhem, Rethy] Cambodia Dev Resource Inst, Phnom Penh, Cambodia	National University of Singapore; National University of Singapore	Clancey, G (corresponding author), Natl Univ Singapore, Asia Res Inst, Dept Hist, Singapore 119077, Singapore.	hisgkc@nus.edu.sg						Funabashi H, 2011, NONPROFIT CIV SOC ST, P37, DOI 10.1007/978-0-387-09626-1_2; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Mishima A, 1992, BITTER SEA HUMAN COS; Nagai Takashi, 1994, BELLS NAGASAKI; Ohtsuru A, 2015, LANCET, V386, P489, DOI 10.1016/S0140-6736(15)60994-1; Reich MR, 2015, LANCET, V386, P498, DOI 10.1016/S0140-6736(15)61030-3; Tsushima Yoshito, 2010, BMC Med Imaging, V10, P24, DOI 10.1186/1471-2342-10-24; Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Yoneyama, 1991, HIROSHIMA TRACES TIM, DOI 10.1525/california/9780520085862.001.0001	11	6	6	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					405	406		10.1016/S0140-6736(15)61414-3	http://dx.doi.org/10.1016/S0140-6736(15)61414-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251377				2022-12-28	WOS:000358761700004
J	Reich, MR; Goto, A				Reich, Michael R.; Goto, Aya			Towards long-term responses in Fukushima	LANCET			English	Editorial Material									[Reich, Michael R.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Goto, Aya] Fukushima Med Univ, Dept Publ Hlth, Fukushima, Japan	Harvard University; Harvard T.H. Chan School of Public Health; Fukushima Medical University	Reich, MR (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	michael_reich@harvard.edu						Aldrich DP, 2012, ASIA PACIFIC ISSUES, V103, P1; Aoki M, 2014, JAPAN TIMES TOK 0922; Bricker MK, 2014, FUKUSHIMA DAIICHI NU; Bromet EJ, 2011, WORLD PSYCHIATRY, V10, P83; Fackler M, 2013, NY TIMES; FAIRDO, 2013, 20131 FAIRDO I GLOB; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Kemeny J, 1979, REPORT PRESIDENTS CO; Kurokawa K, 2015, ROLE NATION STATE AD, P18; Leflar R., 2012, J ENV LAW LITIG, V27, P107; Lifton Robert Jay, 1968, DEATH LIFE SURVIVORS; Lochard J, 2009, Ann ICRP, V39, P1, DOI 10.1016/j.icrp.2009.09.008; Nakayachi K, 2010, RISK ANAL, V30, P143, DOI 10.1111/j.1539-6924.2009.01306.x; National Diet of Japan Fukushima Nuclear Accident Independent Investigation Commission, 2012, OFF REP EX SUMM; Nollet Kenneth E, 2011, Fukushima J Med Sci, V57, P86; Ohtsuru A, 2015, LANCET, V386, P489, DOI 10.1016/S0140-6736(15)60994-1; Pilling D, 2014, BENDING ADVERSITY JA, P257; Reich M. R., 1991, TOXIC POLITICS RESPO; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, V1406112 UNSCEAR; Weitzdorfer J., 2014, ASIA PACIFIC DISASTE, P119; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Yasutaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075308	23	11	11	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					498	500		10.1016/S0140-6736(15)61030-3	http://dx.doi.org/10.1016/S0140-6736(15)61030-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251395				2022-12-28	WOS:000358761700030
J	De Yoreo, JJ; Gilbert, PUPA; Sommerdijk, NAJM; Penn, RL; Whitelam, S; Joester, D; Zhang, HZ; Rimer, JD; Navrotsky, A; Banfield, JF; Wallace, AF; Michel, FM; Meldrum, FC; Colfen, H; Dove, PM				De Yoreo, James J.; Gilbert, Pupa U. P. A.; Sommerdijk, Nico A. J. M.; Penn, R. Lee; Whitelam, Stephen; Joester, Derk; Zhang, Hengzhong; Rimer, Jeffrey D.; Navrotsky, Alexandra; Banfield, Jillian F.; Wallace, Adam F.; Michel, F. Marc; Meldrum, Fiona C.; Coelfen, Helmut; Dove, Patricia M.			Crystallization by particle attachment in synthetic, biogenic, and geologic environments	SCIENCE			English	Review							AMORPHOUS CALCIUM-CARBONATE; LIQUID-LIQUID SEPARATION; URCHIN LARVAL SPICULE; CRYSTAL-GROWTH; ORIENTED ATTACHMENT; PRECURSOR PHASE; STRUCTURE-DIRECTION; INITIAL-STAGES; CRYO-TEM; NUCLEATION	Field and laboratory observations show that crystals commonly form by the addition and attachment of particles that range from multi-ion complexes to fully formed nanoparticles. The particles involved in these nonclassical pathways to crystallization are diverse, in contrast to classical models that consider only the addition of monomeric chemical species. We review progress toward understanding crystal growth by particle-attachment processes and show that multiple pathways result from the interplay of free-energy landscapes and reaction dynamics. Much remains unknown about the fundamental aspects, particularly the relationships between solution structure, interfacial forces, and particle motion. Developing a predictive description that connects molecular details to ensemble behavior will require revisiting long-standing interpretations of crystal formation in synthetic systems, biominerals, and patterns of mineralization in natural environments.	[De Yoreo, James J.] Pacific NW Natl Lab, Div Phys Sci, Richland, WA 99352 USA; [De Yoreo, James J.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA; [Gilbert, Pupa U. P. A.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Gilbert, Pupa U. P. A.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Gilbert, Pupa U. P. A.] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA; [Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, Lab Mat & Interface Chem, Dept Chem Engn & Chem, NL-5600 MB Eindhoven, Netherlands; [Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, Soft Matter CryoTEM Unit, Dept Chem Engn & Chem, NL-5600 MB Eindhoven, Netherlands; [Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Penn, R. Lee] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Whitelam, Stephen] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Joester, Derk] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Zhang, Hengzhong; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Rimer, Jeffrey D.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Navrotsky, Alexandra] Univ Calif Davis, Dept Chem, Peter A Rock Thermochem Lab, Davis, CA 95616 USA; [Wallace, Adam F.] Univ Delaware, Dept Geol Sci, Newark, DE 19716 USA; [Dove, Patricia M.] Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; [Meldrum, Fiona C.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Coelfen, Helmut] Univ Konstanz, Dept Chem, Phys Chem, D-78457 Constance, Germany	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Northwestern University; University of California System; University of California Berkeley; University of Houston System; University of Houston; University of California System; University of California Davis; University of Delaware; Virginia Polytechnic Institute & State University; University of Leeds; University of Konstanz	Dove, PM (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	dove@vt.edu	Wallace, Adam/A-9976-2012; Sommerdijk, Nico A.J.M./B-7239-2013; Joester, Derk/B-7525-2009; Gilbert, Pupa/A-6299-2010	Sommerdijk, Nico A.J.M./0000-0002-8956-195X; Gilbert, Pupa/0000-0002-0139-2099; Banfield, Jill/0000-0001-8203-8771; Meldrum, Fiona/0000-0001-9243-8517	Council on Geosciences of the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences; Engineering and Physical Sciences Research Council [EP/H005374/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1106208, 1213835] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1151098] Funding Source: National Science Foundation; EPSRC [EP/H005374/1] Funding Source: UKRI	Council on Geosciences of the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This article evolved from presentations and discussions at the workshop "Crystallization by Particle Attachment" held in December 2013 in Berkeley, California, sponsored by the Council on Geosciences of the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences. The authors thank the members of the council for their encouragement and assistance in developing this workshop. We also thank L. Addadi and S. Weiner for valuable comments and advice. In addition, the authors acknowledge the agencies that provided funding for their individual research programs, without which this workshop and article would not have been possible.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Baumgartner J, 2013, NAT MATER, V12, P310, DOI [10.1038/NMAT3558, 10.1038/nmat3558]; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Bewernitz MA, 2012, FARADAY DISCUSS, V159, P291, DOI 10.1039/c2fd20080e; Bierman MJ, 2009, ENERG ENVIRON SCI, V2, P1050, DOI 10.1039/b912095e; Boneschanscher MP, 2014, SCIENCE, V344, P1377, DOI 10.1126/science.1252642; Bray AJ, 2002, ADV PHYS, V51, P481, DOI 10.1080/00018730110117433; BURKETT SL, 1994, J PHYS CHEM-US, V98, P4647, DOI 10.1021/j100068a027; Burrows ND, 2013, CRYST GROWTH DES, V13, P3396, DOI 10.1021/cg4001939; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Cantaert B, 2012, ADV FUNCT MATER, V22, P907, DOI 10.1002/adfm.201102385; CARDEW PT, 1985, P ROY SOC LOND A MAT, V398, P415, DOI 10.1098/rspa.1985.0043; Chen Q, 2015, ACS CENTRAL SCI, V1, P33, DOI 10.1021/acscentsci.5b00001; Chernov A. A., 1984, SPRINGER SERIES SOLI, V36; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Davis TM, 2006, NAT MATER, V5, P400, DOI 10.1038/nmat1636; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Demichelis R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1604; DERJAGUIN B, 1945, ZH EKSP TEOR FIZ+, V15, P663; Dey A, 2010, NAT MATER, V9, P1010, DOI [10.1038/nmat2900, 10.1038/NMAT2900]; Dillaman R, 2005, J MORPHOL, V263, P356, DOI 10.1002/jmor.10311; Dumetz AC, 2008, BIOPHYS J, V94, P570, DOI 10.1529/biophysj.107.116152; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; Furukawa S, 2014, CHEM SOC REV, V43, P5700, DOI 10.1039/c4cs00106k; Gago-Duport L, 2008, J STRUCT BIOL, V162, P422, DOI 10.1016/j.jsb.2008.02.007; Gal A, 2014, ADV FUNCT MATER, V24, P5420, DOI 10.1002/adfm.201400676; Gal A, 2013, ANGEW CHEM INT EDIT, V52, P4867, DOI 10.1002/anie.201210329; Galkin O, 2002, P NATL ACAD SCI USA, V99, P8479, DOI 10.1073/pnas.122055299; Gebauer D, 2009, ADV MATER, V21, P435, DOI 10.1002/adma.200801614; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Gibaud T, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/32/322201; Gibbs GV, 2011, J PHYS CHEM A, V115, P12933, DOI 10.1021/jp204044k; Giuffre AJ, 2013, P NATL ACAD SCI USA, V110, P9261, DOI 10.1073/pnas.1222162110; Gong YUT, 2012, P NATL ACAD SCI USA, V109, P6088, DOI 10.1073/pnas.1118085109; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Gribb AA, 1997, AM MINERAL, V82, P717, DOI 10.2138/am-1997-7-809; Grotzinger J.P., 2000, CARBONATE SEDIMENTAT, P3, DOI [DOI 10.2110/PEC.00.67.0003, 10.2110/pec.00.67.0003]; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; Habraken WJEM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2490; Han TYJ, 2008, CHEM MATER, V20, P1064, DOI 10.1021/cm702032v; Hedges LO, 2012, SOFT MATTER, V8, P8624, DOI 10.1039/c2sm26038g; Herman I, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/19/194005; Hu Q, 2012, FARADAY DISCUSS, V159, P509, DOI 10.1039/c2fd20124k; Huang F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.155501; Ihli J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4169; Ivanov VK, 2014, RUSS CHEM REV+, V83, P1204, DOI 10.1070/RCR4453; Kashchiev D, 2003, J CHEM PHYS, V118, P1837, DOI 10.1063/1.1531614; Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P; Killian CE, 2009, J AM CHEM SOC, V131, P18404, DOI 10.1021/ja907063z; Kim YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5341; Kumar S, 2008, J AM CHEM SOC, V130, P17284, DOI 10.1021/ja8063167; Kuno M, 2008, PHYS CHEM CHEM PHYS, V10, P620, DOI 10.1039/b708296g; Lenders JJM, 2014, CRYST GROWTH DES, V14, P5561, DOI 10.1021/cg500816z; Li DS, 2013, CRYST GROWTH DES, V13, P422, DOI 10.1021/cg301388e; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Li M, 1999, NATURE, V402, P393, DOI 10.1038/46509; LOBO RF, 1995, J INCLUS PHENOM MOL, V21, P47; Lowenstam HA, 1989, BIOMINERALIZATION; Lupulescu AI, 2014, SCIENCE, V344, P729, DOI 10.1126/science.1250984; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; MARSHALL WL, 1981, J INORG NUCL CHEM, V43, P449, DOI 10.1016/0022-1902(81)80482-4; Meldrum FC, 2007, MACROMOL BIOSCI, V7, P152, DOI 10.1002/mabi.200600191; Metzler RA, 2010, J AM CHEM SOC, V132, P6329, DOI 10.1021/ja909735y; Michel FM, 2010, P NATL ACAD SCI USA, V107, P2787, DOI 10.1073/pnas.0910170107; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; Navrotsky A, 2011, CHEMPHYSCHEM, V12, P2207, DOI 10.1002/cphc.201100129; Nielsen MH, 2014, SCIENCE, V345, P1158, DOI 10.1126/science.1254051; Nielsen MH, 2014, MICROSC MICROANAL, V20, P425, DOI 10.1017/S1431927614000294; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Page AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.065701; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X; Petsev DN, 2003, P NATL ACAD SCI USA, V100, P792, DOI 10.1073/pnas.0333065100; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Pouget EM, 2010, J AM CHEM SOC, V132, P11560, DOI 10.1021/ja102439r; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Raju M, 2014, NANO LETT, V14, P1836, DOI 10.1021/nl404533k; Rieger J, 2007, FARADAY DISCUSS, V136, P265, DOI 10.1039/b701450c; Sand KK, 2012, CRYST GROWTH DES, V12, P842, DOI 10.1021/cg2012342; Scheifele B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042407; Schwahn D, 2007, J PHYS CHEM C, V111, P3224, DOI 10.1021/jp068813i; Shevchenko EV, 2006, J AM CHEM SOC, V128, P3620, DOI 10.1021/ja0564261; Song RQ, 2010, ADV MATER, V22, P1301, DOI 10.1002/adma.200901365; Stephens CJ, 2010, ADV FUNCT MATER, V20, P2108, DOI 10.1002/adfm.201000248; Suyatin DB, 2008, NANO LETT, V8, P1100, DOI 10.1021/nl073193y; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Tester CC, 2014, CHEM COMMUN, V50, P5619, DOI 10.1039/c4cc01457j; Tester CC, 2013, ADV FUNCT MATER, V23, P4185, DOI 10.1002/adfm.201203400; Tester CC, 2011, CRYSTENGCOMM, V13, P3975, DOI 10.1039/c1ce05153a; TOWE KM, 1967, J ULTRA MOL STRUCT R, V17, P1, DOI 10.1016/S0022-5320(67)80015-7; Van Driessche AES, 2012, SCIENCE, V336, P69, DOI 10.1126/science.1215648; Verwey E.J., 1948, THEORY STABILITY LYO; Vidavsky N, 2014, P NATL ACAD SCI USA, V111, P39, DOI 10.1073/pnas.1312833110; VOORHEES PW, 1985, J STAT PHYS, V38, P231, DOI 10.1007/BF01017860; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915; Wang XL, 2013, GEOCHIM COSMOCHIM AC, V103, P1, DOI 10.1016/j.gca.2012.10.044; Wang YW, 2013, ADV FUNCT MATER, V23, P5615, DOI 10.1002/adfm.201300861; Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Wolf SE, 2008, J AM CHEM SOC, V130, P12342, DOI 10.1021/ja800984y; Yang L, 2011, NANOSCALE, V3, P603, DOI 10.1039/c0nr00697a; Yuwono VM, 2010, J AM CHEM SOC, V132, P2163, DOI 10.1021/ja909769a; Zhang HZ, 2014, ACS NANO, V8, P6526, DOI 10.1021/nn503145w; Zhang HZ, 2012, J PHYS CHEM LETT, V3, P2882, DOI 10.1021/jz301161j; Zhang HZ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125444; Zhang HZ, 2003, NATURE, V424, P1025, DOI 10.1038/nature01845; Zhou L, 2008, SMALL, V4, P1566, DOI 10.1002/smll.200800520; ZRYD JL, 1995, J APPL POLYM SCI, V57, P1525, DOI 10.1002/app.1995.070571212	120	1088	1090	119	1571	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aaa6760	10.1126/science.aaa6760	http://dx.doi.org/10.1126/science.aaa6760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228157	Green Submitted, Green Accepted			2022-12-28	WOS:000358713300045
J	Kivimaki, M; Jokela, M; Nyberg, ST; Singh-Manoux, A; Fransson, EI; Alfredsson, L; Bjorner, JB; Borritz, M; Burr, H; Casini, A; Clays, E; De Bacquer, D; Dragano, N; Erbel, R; Geuskens, GA; Hamer, M; Hooftman, WE; Houtman, IL; Jockel, KH; Kittel, F; Knutsson, A; Koskenvuo, M; Lunau, T; Madsen, IEH; Nielsen, ML; Nordin, M; Oksanen, T; Pejtersen, JH; Pentti, J; Rugulies, R; Salo, P; Shipley, MJ; Siegrist, J; Steptoe, A; Suominen, SB; Theorell, T; Vahtera, J; Westerholm, PJM; Westerlund, H; O'Reilly, D; Kumari, M; Batty, GD; Ferrie, JE; Virtanen, M				Kivimaki, Mika; Jokela, Markus; Nyberg, Solja T.; Singh-Manoux, Archana; Fransson, Eleonor I.; Alfredsson, Lars; Bjorner, Jakob B.; Borritz, Marianne; Burr, Hermann; Casini, Annalisa; Clays, Els; De Bacquer, Dirk; Dragano, Nico; Erbel, Raimund; Geuskens, Goedele A.; Hamer, Mark; Hooftman, Wendela E.; Houtman, Irene L.; Jockel, Karl-Heinz; Kittel, France; Knutsson, Anders; Koskenvuo, Markku; Lunau, Thorsten; Madsen, Ida E. H.; Nielsen, Martin L.; Nordin, Maria; Oksanen, Tuula; Pejtersen, Jan H.; Pentti, Jaana; Rugulies, Reiner; Salo, Paula; Shipley, Martin J.; Siegrist, Johannes; Steptoe, Andrew; Suominen, Sakari B.; Theorell, Tores; Vahtera, Jussi; Westerholm, Peter J. M.; Westerlund, Hugo; O'Reilly, Dermot; Kumari, Meena; Batty, G. David; Ferrie, Jane E.; Virtanen, Marianna		IPD-Work Consortium	Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals	LANCET			English	Article							FOLLOW-UP; JOB STRAIN; PHYSICAL-ACTIVITY; BASE-LINE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEALTH INEQUALITIES; MORTALITY; PROJECT; STRESS	Background Long working hours might increase the risk of cardiovascular disease, but prospective evidence is scarce, imprecise, and mostly limited to coronary heart disease. We aimed to assess long working hours as a risk factor for incident coronary heart disease and stroke. Methods We identified published studies through a systematic review of PubMed and Embase from inception to Aug 20, 2014. We obtained unpublished data for 20 cohort studies from the Individual-Participant-Data Meta-analysis in Working Populations (IPD-Work) Consortium and open-access data archives. We used cumulative random-effects meta-analysis to combine effect estimates from published and unpublished data. Findings We included 25 studies from 24 cohorts in Europe, the USA, and Australia. The meta-analysis of coronary heart disease comprised data for 603 838 men and women who were free from coronary heart disease at baseline; the meta-analysis of stroke comprised data for 528 908 men and women who were free from stroke at baseline. Follow-up for coronary heart disease was 5.1 million person-years (mean 8.5 years), in which 4768 events were recorded, and for stroke was 3.8 million person-years (mean 7.2 years), in which 1722 events were recorded. In cumulative meta-analysis adjusted for age, sex, and socioeconomic status, compared with standard hours (35-40 h per week), working long hours (>= 55 h per week) was associated with an increase in risk of incident coronary heart disease (relative risk [RR] 1.13, 95% CI 1.02-1.26; p=0.02) and incident stroke (1.33, 1.11-1.61; p=0.002). The excess risk of stroke remained unchanged in analyses that addressed reverse causation, multivariable adjustments for other risk factors, and different methods of stroke ascertainment (range of RR estimates 1.30-1.42). We recorded a dose-response association for stroke, with RR estimates of 1.10 (95% CI 0.94-1.28; p=0.24) for 41-48 working hours, 1.27 (1.03-1.56; p=0.03) for 49-54 working hours, and 1.33 (1.11-1.61; p=0.002) for 55 working hours or more per week compared with standard working hours (p(trend)<0.0001). Interpretation Employees who work long hours have a higher risk of stroke than those working standard hours; the association with coronary heart disease is weaker. These findings suggest that more attention should be paid to the management of vascular risk factors in individuals who work long hours. Copyright (C) Kivimaki et al. Open Access article distributed under the terms of CC BY.	[Kivimaki, Mika; Singh-Manoux, Archana; Hamer, Mark; Shipley, Martin J.; Steptoe, Andrew; Kumari, Meena; Batty, G. David; Ferrie, Jane E.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Koskenvuo, Markku] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kivimaki, Mika] Univ Helsinki, Fac Med, Helsinki, Finland; [Jokela, Markus] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Nyberg, Solja T.; Oksanen, Tuula; Pentti, Jaana; Salo, Paula; Vahtera, Jussi; Virtanen, Marianna] Finnish Inst Occupat Hlth, Helsinki, Finland; [Nyberg, Solja T.; Oksanen, Tuula; Pentti, Jaana; Salo, Paula; Vahtera, Jussi; Virtanen, Marianna] Finnish Inst Occupat Hlth, Tampere, Finland; [Nyberg, Solja T.; Oksanen, Tuula; Pentti, Jaana; Salo, Paula; Vahtera, Jussi; Virtanen, Marianna] Finnish Inst Occupat Hlth, Turku, Finland; [Singh-Manoux, Archana] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Fransson, Eleonor I.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Fransson, Eleonor I.; Nordin, Maria; Theorell, Tores; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Alfredsson, Lars] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Bjorner, Jakob B.; Madsen, Ida E. H.; Rugulies, Reiner] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Borritz, Marianne] Koege Hosp, Dept Occupat Med, Copenhagen, Denmark; [Burr, Hermann] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany; [Casini, Annalisa; Kittel, France] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Clays, Els; De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Dragano, Nico; Lunau, Thorsten; Siegrist, Johannes] Univ Dusseldorf, Fac Med, Inst Med Sociol, Dusseldorf, Germany; [Erbel, Raimund] Univ Duisburg Essen, West German Heart Ctr Essen, Dept Cardiol, Essen, Germany; [Geuskens, Goedele A.; Hooftman, Wendela E.; Houtman, Irene L.] TNO, Hoofddorp, Netherlands; [Jockel, Karl-Heinz] Univ Duisburg Essen, Fac Med, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Nielsen, Martin L.] Frederiksberg Univ Hosp, Unit Social Med, DK-2000 Copenhagen, Denmark; [Nordin, Maria] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Pejtersen, Jan H.] Danish Natl Ctr Social Res, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Salo, Paula] Univ Turku, Dept Psychol, Turku, Finland; [Suominen, Sakari B.; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Suominen, Sakari B.] Folkhalsan Res Ctr, Helsinki, Finland; [Suominen, Sakari B.] Univ Skovde, Skovde, Sweden; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; [Westerholm, Peter J. M.] Uppsala Univ, Occupat & Environm Med, Uppsala, Sweden; [O'Reilly, Dermot] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Kumari, Meena] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Batty, G. David] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England	University of London; University College London; University of Helsinki; University of Helsinki; University of Helsinki; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Jonkoping University; Stockholm University; Stockholm County Council; National Research Centre for the Working Environment; Universite Libre de Bruxelles; Ghent University; Heinrich Heine University Dusseldorf; University of Duisburg Essen; Netherlands Organization Applied Science Research; University of Duisburg Essen; Mid-Sweden University; Umea University; University of Copenhagen; University of Copenhagen; University of Turku; University of Turku; Folkhalsan Research Center; University of Skovde; University of Turku; Uppsala University; Queens University Belfast; University of Essex; University of Edinburgh; University of Edinburgh; University of Bristol	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Steptoe, Andrew/Y-2440-2019; Casini, Annalisa/ABG-2250-2020; Alfredsson, Lars/AAC-9007-2019; Westerlund, Hugo/A-3049-2012; Rugulies, Reiner/E-8140-2010; Nielsen, Martin Lindhardt/E-3071-2012; Jokela, Markus/A-4669-2009; Siegrist, Johannes/AAL-6814-2021; Singh-Manoux, Archana/F-6804-2013; Oksanen, Tuula/AAK-5599-2021; Batty, GD/Y-4401-2018; Salo, Paula/D-6649-2013; Hamer, Mark/C-1602-2008; Ferrie, Jane/AAZ-2009-2020; Kivimaki, Mika/B-3607-2012; De Bacquer, Dirk/HGU-3191-2022; Pejtersen, Jan/AAP-2383-2020; Fransson, Eleonor I/J-7792-2013; Hamer, Mark/AAJ-6814-2021	Casini, Annalisa/0000-0002-3539-4500; Alfredsson, Lars/0000-0003-1688-6697; Westerlund, Hugo/0000-0002-8806-5698; Rugulies, Reiner/0000-0002-7752-131X; Nielsen, Martin Lindhardt/0000-0002-1523-0453; Jokela, Markus/0000-0003-0117-0012; Siegrist, Johannes/0000-0002-7530-4178; Singh-Manoux, Archana/0000-0002-1244-5037; Batty, GD/0000-0003-1822-5753; Salo, Paula/0000-0002-0812-277X; Hamer, Mark/0000-0002-8726-7992; Kivimaki, Mika/0000-0002-4699-5627; Fransson, Eleonor I/0000-0001-9042-4832; Hamer, Mark/0000-0002-8726-7992; Burr, Hermann/0000-0002-3864-6347; Clays, Els/0000-0002-1092-945X; Vahtera, Jussi/0000-0002-6036-061X; Suominen, Sakari B./0000-0001-6648-603X; Kumari, Meena/0000-0001-9716-1035; De Bacquer, Dirk/0000-0002-3202-7238	European Union New and Emerging Risks in Occupational Safety and Health research programme; Finnish Work Environment Fund; Swedish Research Council for Working Life and Social Research; German Social Accident Insurance (the AeKo-Project); Danish National Research Centre for the Working Environment; Academy of Finland, the BUPA Foundation [22094477]; Ministry of Social Affairs and Employment, the Netherlands; Medical Research Council [K013351]; UK Economic and Social Research Council; US National Institutes of Health [R01HL036310, R01AG034454]; British Heart Foundation; ESRC [ES/J023299/1, ES/L007509/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/L007509/1, ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1, G0100222] Funding Source: researchfish; Public Health Agency [STL/4918/13] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	European Union New and Emerging Risks in Occupational Safety and Health research programme; Finnish Work Environment Fund; Swedish Research Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); German Social Accident Insurance (the AeKo-Project); Danish National Research Centre for the Working Environment; Academy of Finland, the BUPA Foundation(Academy of Finland); Ministry of Social Affairs and Employment, the Netherlands(Netherlands Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The IPD-Work Consortium was funded by the European Union New and Emerging Risks in Occupational Safety and Health research programme, the Finnish Work Environment Fund, the Swedish Research Council for Working Life and Social Research, the German Social Accident Insurance (the AeKo-Project), Danish National Research Centre for the Working Environment, the Academy of Finland, the BUPA Foundation (grant 22094477), and the Ministry of Social Affairs and Employment, the Netherlands. MKi is supported by the Medical Research Council (grant number K013351), the UK Economic and Social Research Council, and the US National Institutes of Health (R01HL036310; R01AG034454). AS is supported by the British Heart Foundation.	Alfredsson L, 2002, SCAND J WORK ENV HEA, V28, P238, DOI 10.5271/sjweh.671; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Berkman LF, 1983, HLTH WAYS LIVING ALA; Borritz M, 2006, SCAND J PUBLIC HEALT, V34, P49, DOI 10.1080/14034940510032275; Brim OG, 2004, MAC FDN MEN, P1; Butterworth P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-44; De Bacquer D, 2005, AM J EPIDEMIOL, V161, P434, DOI 10.1093/aje/kwi040; de Camargo KR, 2011, GLOB PUBLIC HEALTH, V6, P102, DOI 10.1080/17441692.2010.514617; Egger M, 2001, CLIN MED, V1, P478, DOI 10.7861/clinmedicine.1-6-478; Feveile H, 2007, STAT TRANSIT, V8, P441; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; Fransson EI, 2015, STROKE, V46, P557, DOI 10.1161/STROKEAHA.114.008019; Fukuoka Y, 2010, AM J EMERG MED, V28, P734, DOI 10.1016/j.ajem.2009.06.020; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; Hamer M, 2012, CIRCULATION, V126, P928, DOI 10.1161/CIRCULATIONAHA.112.103879; HAUSER RM, 1985, AM EDUC RES J, V22, P1, DOI 10.3102/00028312022001001; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035463; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holtermann A, 2010, HEART, V96, P1638, DOI 10.1136/hrt.2010.197145; House JS, 2005, J GERONTOL B-PSYCHOL, V60, P15; Kang MY, 2012, J OCCUP ENVIRON MED, V54, P532, DOI 10.1097/JOM.0b013e31824fe192; Kivimaki M, 2015, LANCET DIABETES ENDO, V3, P27, DOI 10.1016/S2213-8587(14)70178-0; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Kumar A, 2014, INT J NEUROSCI, V124, P748, DOI 10.3109/00207454.2013.879130; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MADANS JH, 1986, PUBLIC HEALTH REP, V101, P474; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mazzaglia G, 2001, ADDICTION, V96, P1743, DOI 10.1046/j.1360-0443.2001.961217434.x; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Netterstrom B, 2010, INT J OCCUP MED ENV, V23, P217, DOI 10.2478/v10001-010-0031-6; Nielsen ML, 2002, WORK STRESS, V16, P191, DOI 10.1080/02678370210164003; Nyberg ST, 2012, J INTERN MED, V272, P65, DOI 10.1111/j.1365-2796.2011.02482.x; O'Reilly D, 2013, INT J EPIDEMIOL, V42, P1820, DOI 10.1093/ije/dyt211; OECD, 2004, REC LAB MARK DEV PRO; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; Sewell W. H., 1975, ED OCCUPATION EARNIN; Sherman DL, 2000, CORONARY ARTERY DIS, V11, P117, DOI 10.1097/00019501-200003000-00005; Smulders PGW, 2008, NETHERLANDS WORKING; Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775; Sparks K, 1997, J OCCUP ORGAN PSYCH, V70, P391, DOI 10.1111/j.2044-8325.1997.tb00656.x; Stang A, 2005, EUR J EPIDEMIOL, V20, P489, DOI 10.1007/s10654-005-5529-z; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tarumi K, 2003, IND HEALTH, V41, P101, DOI 10.2486/indhealth.41.101; Toker S, 2012, PSYCHOSOM MED, V74, P840, DOI 10.1097/PSY.0b013e31826c3174; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Uchiyama S, 1992, Sangyo Igaku, V34, P318; Uchiyama S, 2005, J OCCUP HEALTH, V47, P102, DOI 10.1539/joh.47.102; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Virtanen M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7772; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168	63	378	397	9	120	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1739	1746		10.1016/S0140-6736(15)60295-1	http://dx.doi.org/10.1016/S0140-6736(15)60295-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV0WK	26298822	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000363974200033
J	Hernandez, AF; Fleurence, RL; Rothman, RL				Hernandez, Adrian F.; Fleurence, Rachael L.; Rothman, Russell L.			The ADAPTABLE Trial and PCORnet: Shining Light on a New Research Paradigm	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hernandez, Adrian F.] Duke Clin Res Inst, Durham, NC 27715 USA; Patient Ctr Outcomes Res Inst, Washington, DC USA; Vanderbilt Univ, Nashville, TN 37235 USA	Duke University; Vanderbilt University	Hernandez, AF (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Hernandez, Adrian F/A-7818-2016	Hernandez, Adrian F/0000-0003-3387-9616; Rothman, Russsell/0000-0002-1506-3990				Collins FS, 2014, J AM MED INFORM ASSN, V21, P576, DOI 10.1136/amiajnl-2014-002864; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Hall HM, 2014, CIRC-CARDIOVASC QUAL, V7, P701, DOI 10.1161/CIRCOUTCOMES.113.000822; Inst Med, 2010, EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS IN CHRONIC DISEASE, P1; Kramer JM, 2012, CLIN PHARMACOL THER, V91, P535, DOI 10.1038/clpt.2011.341; National Patient-Centered Clinical Research Network, ADAPTABLE ASP STUD; National Patient-Centered Clinical Research Network, 2015, PCORNET COMM DAT MOD; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	9	77	76	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8					635	636		10.7326/M15-1460	http://dx.doi.org/10.7326/M15-1460			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26301537				2022-12-28	WOS:000363737400021
J	Landers, S				Landers, Stewart			Civil Rights and Health - Beyond Same-Sex Marriage	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US Hlth Serv, John Snow, Boston, MA 02125 USA		Landers, S (corresponding author), US Hlth Serv, John Snow, Boston, MA 02125 USA.							Grant J.M., 2011, INJUSTICE EVERY TURN; Kail BL, 2015, AM J PUBLIC HEALTH, V105, P1101, DOI 10.2105/AJPH.2015.302589; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Lithwick D, 2015, SLATE; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286	5	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1092	1093		10.1056/NEJMp1508488	http://dx.doi.org/10.1056/NEJMp1508488			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR7UG	26267450				2022-12-28	WOS:000361556400004
J	Gentili, M; Kowal, J; Tkach, M; Satoh, T; Lahaye, X; Conrad, C; Boyron, M; Lombard, B; Durand, S; Kroemer, G; Loew, D; Dalod, M; Thery, C; Manel, N				Gentili, Matteo; Kowal, Joanna; Tkach, Mercedes; Satoh, Takeshi; Lahaye, Xavier; Conrad, Cecile; Boyron, Marilyn; Lombard, Berangere; Durand, Sylvere; Kroemer, Guido; Loew, Damarys; Dalod, Marc; Thery, Clotilde; Manel, Nicolas			Transmission of innate immune signaling by packaging of cGAMP in viral particles	SCIENCE			English	Article							CYCLIC GMP-AMP; DENDRITIC CELLS; HIV-1; SENSOR; INTERFERON; 2ND-MESSENGER; DNA; VESICLES; APOBEC3G; SYNTHASE	Infected cells detect viruses through a variety of receptors that initiate cell-intrinsic innate defense responses. Cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase (cGAS) is a cytosolic sensor for many DNA viruses and HIV-1. In response to cytosolic viral DNA, cGAS synthesizes the second messenger 2'3'-cyclic GMP-AMP (cGAMP), which activates antiviral signaling pathways. We show that in cells producing virus, cGAS-synthesized cGAMP can be packaged in viral particles and extracellular vesicles. Viral particles efficiently delivered cGAMP to target cells. cGAMP transfer by viral particles to dendritic cells activated innate immunity and antiviral defenses. Finally, we show that cell-free murine cytomegalovirus and Modified Vaccinia Ankara virus contained cGAMP. Thus, transfer of cGAMP by viruses may represent a defense mechanism to propagate immune responses to uninfected target cells.	[Gentili, Matteo; Kowal, Joanna; Tkach, Mercedes; Satoh, Takeshi; Lahaye, Xavier; Conrad, Cecile; Thery, Clotilde; Manel, Nicolas] Inst Curie, INSERM, Immun & Canc Unit, U932, Paris, France; [Boyron, Marilyn; Dalod, Marc] Aix Marseille Univ UM2, INSERM, Ctr Immunol Marseille Luminy, U1104,CNRS,UMR7280, F-13288 Marseille, France; [Lombard, Berangere; Loew, Damarys] Inst Curie, Lab Spectrometrie Masse Prote, Paris, France; [Lombard, Berangere; Kroemer, Guido] Gustave Roussy Comprehens Canc Inst, Metabol & Cell Biol Platforms, F-94805 Villejuif, France; [Thery, Clotilde; Manel, Nicolas] Labex Dendrit Cell Biol DCBIOL, Paris, France; [Manel, Nicolas] Labex Vaccine Res Inst VRI, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Manel, N (corresponding author), Inst Curie, INSERM, Immun & Canc Unit, U932, Paris, France.	nicolas.manel@curie.fr	LAHAYE, Xavier/AAH-7407-2020; KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020; thery, clotilde/F-6373-2013; Manel, Nicolas/E-2128-2011; Dalod, Marc/AAK-6163-2020	KROEMER, Guido/0000-0002-9334-4405; thery, clotilde/0000-0001-8294-6884; Manel, Nicolas/0000-0002-1481-4430; Dalod, Marc/0000-0002-6436-7966; Kowal, Joanna/0000-0001-7849-6040; Gentili, Matteo/0000-0002-6970-8133; LAHAYE, Xavier/0000-0001-7124-1707; Damarys, Loew/0000-0002-9111-8842	ATIP-Avenir program; ANRS (France Recherche Nord and Sud SIDA-HIV Hepatites); Ville de Paris Emergence program; European FP7 Marie Curie Actions; Labex VRI [ANR-10-LABX-77]; Labex DCBIOL [ANR-10-IDEX-0001-02 PSL*, ANR-11-LABX-0043]; ACTERIA Foundation; Fondation Schlumberger pour l'Education et la Recherche European Research Council [309848 HIVINNATE]; Association pour la Recherche sur le Cancer (ARC) [SL220120605293]; Region Ile-de-France; Institut Thematique Multi-Organisme Cancer	ATIP-Avenir program; ANRS (France Recherche Nord and Sud SIDA-HIV Hepatites)(French National Research Agency (ANR)); Ville de Paris Emergence program; European FP7 Marie Curie Actions; Labex VRI; Labex DCBIOL; ACTERIA Foundation; Fondation Schlumberger pour l'Education et la Recherche European Research Council; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Region Ile-de-France(Region Ile-de-France); Institut Thematique Multi-Organisme Cancer	We declare no conflicts of interest. We thank M. Sitbon and J.-L. Battini for providing supernatant from the R187 hybridoma; A. Garcia-Sastre for providing H1N1 and H5N1 envelope coding plasmids; O. Schwartz for providing the IFN-beta-pGL3 plasmid and the Tetherin plasmid; P. Zimmermann for providing the anti-syntenin-1 antibody; P. Desai and L. Lorenzo for providing HSV-1 K26GFP; H. Raux and D. Blondel for help with vaccinia virus; P. Benaroch, S. Amigorena, and D. Rookhuizen for critical reading of the manuscript; and J. Rehwinkel and M. Benkirane for discussions. Some reagents were provided by the NIH AIDS Reagent Program. MVA-HIV and MVA-GFP are available from Agence Nationale de la Recherche sur le Sida (ANRS) and Transgene, respectively, under a material transfer agreement with ANRS. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. N.M. and Institut Curie have filed a provisional patent application (62051016) that relates to methods of preparation of viral particles with cyclic dinucleotides and their use for inducing immune responses. This work was supported by the ATIP-Avenir program, ANRS (France Recherche Nord and Sud SIDA-HIV Hepatites), the Ville de Paris Emergence program, European FP7 Marie Curie Actions, Labex VRI (ANR-10-LABX-77), Labex DCBIOL (ANR-10-IDEX-0001-02 PSL* and ANR-11-LABX-0043), ACTERIA Foundation, the Fondation Schlumberger pour l'Education et la Recherche European Research Council grant 309848 HIVINNATE (for N. M.), Labex DCBIOL and Association pour la Recherche sur le Cancer (ARC) SL220120605293 (for C.T.), and Region Ile-de-France and Institut Thematique Multi-Organisme Cancer 2014 for D.L. M.T. is a fellow from ARC.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Dai PH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003989; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Gould SJ, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20389; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pichlmair A, 2007, J VIROL, V81, P539, DOI 10.1128/JVI.01818-06; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; UZE G, 1994, J MOL BIOL, V243, P245, DOI 10.1006/jmbi.1994.1651; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963	34	168	179	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1232	1236		10.1126/science.aab3628	http://dx.doi.org/10.1126/science.aab3628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26229115				2022-12-28	WOS:000360968400045
J	Peacock, G; Iezzoni, LI; Harkin, TR				Peacock, Georgina; Iezzoni, Lisa I.; Harkin, Thomas R.			Health Care for Americans with Disabilities-25 Years after the ADA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Peacock, Georgina] CDC, Natl Ctr Birth Defects & Dev Disabil, Div Human Dev & Disabil, Atlanta, GA 30333 USA; [Iezzoni, Lisa I.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Iezzoni, Lisa I.] Harvard Univ, Sch Med, Med, Boston, MA USA; [Harkin, Thomas R.] US Senator, Ames, IA USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Peacock, G (corresponding author), CDC, Natl Ctr Birth Defects & Dev Disabil, Div Human Dev & Disabil, Atlanta, GA 30333 USA.				Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2015, MMWR MORB MORTAL WKL, V64, P777; [Anonymous], 2013, AHRQ PUBLICATION, V14-0006; Brault M.W., 2012, CURRENT POPULATION R; Krahn GL, 2015, AM J PUBLIC HEALTH, V105, pS198, DOI 10.2105/AJPH.2014.302182; Office of Disease Prevention and Health Promotion, HLTH PEOPL 2020 DIS	5	29	29	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					892	893		10.1056/NEJMp1508854	http://dx.doi.org/10.1056/NEJMp1508854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ2OB	26225616	Green Accepted			2022-12-28	WOS:000360439500004
J	Trumbore, S; Brando, P; Hartmann, H				Trumbore, S.; Brando, P.; Hartmann, H.			Forest health and global change	SCIENCE			English	Review							TREE MORTALITY; CLIMATE-CHANGE; CARBON; DISTURBANCES; DROUGHT; DYNAMICS	Humans rely on healthy forests to supply energy, building materials, and food and to provide services such as storing carbon, hosting biodiversity, and regulating climate. Defining forest health integrates utilitarian and ecosystem measures of forest condition and function, implemented across a range of spatial scales. Although native forests are adapted to some level of disturbance, all forests now face novel stresses in the form of climate change, air pollution, and invasive pests. Detecting how intensification of these stresses will affect the trajectory of forests is a major scientific challenge that requires developing systems to assess the health of global forests. It is particularly critical to identify thresholds for rapid forest decline, because it can take many decades for forests to restore the services that they provide.	[Trumbore, S.; Hartmann, H.] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Trumbore, S.] Univ Calif Irvine, Irvine, CA 92697 USA; [Brando, P.] Inst Pesquisa Ambiental Amazonia, BR-66035170 Belem, Para, Brazil; [Brando, P.] Woods Hole Res Ctr, Falmouth, MA 02450 USA	Max Planck Society; University of California System; University of California Irvine; Woods Hole Research Center	Trumbore, S (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	trumbore@bgc-jena.mpg.de	Brando, Paulo/AAC-9396-2019; Brando, Paulo M/C-4302-2012; Hartmann, Henrik/C-5632-2015; Trumbore, Susan/B-1948-2013	Brando, Paulo/0000-0001-8952-7025; Brando, Paulo M/0000-0001-8952-7025; Hartmann, Henrik/0000-0002-9926-5484; 	NSF [DEB-1146206]; Brazilian National Council for Scientific and Technological Development (Bolsa de Produtividade) [307084/2013-2]	NSF(National Science Foundation (NSF)); Brazilian National Council for Scientific and Technological Development (Bolsa de Produtividade)	P.B. received funding from NSF (DEB-1146206) and the Brazilian National Council for Scientific and Technological Development (Bolsa de Produtividade number 307084/2013-2). S.T. and H.H. thank C. Allen for sharing an early draft of his paper and the participants of the International Interdisciplinary Workshop on Tree Mortality, held in October 2014 in Jena, Germany.	Alencar A. A. C., 2015, ECOL APPL; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Baker D. B., 2010, J GEOPHYS RES D, V115; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Costanza Robert, 1992, P239; Diffenbaugh NS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043888; Edmonds RL, 2000, FOREST HLTH PROTECTI; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; FAO, 2010, GLOBAL FOREST RESOUR; FAO, 2005, 147 FAO; Field CB, 2012, SPECIAL REPORT WORKI; Flannigan M, 2009, GLOBAL CHANGE BIOL, V15, P549, DOI 10.1111/j.1365-2486.2008.01660.x; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Goulden ML, 2006, GLOBAL CHANGE BIOL, V12, P2146, DOI 10.1111/j.1365-2486.2006.01251.x; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hartmann H, 2015, NEW PHYTOL, V205, P965, DOI 10.1111/nph.13246; Hicke JA, 2012, GLOBAL CHANGE BIOL, V18, P7, DOI 10.1111/j.1365-2486.2011.02543.x; Janisch JE, 2002, TREE PHYSIOL, V22, P77, DOI 10.1093/treephys/22.2-3.77; Kayler ZE, 2015, FRONT ECOL ENVIRON, V13, P219, DOI 10.1890/140174; KOLB TE, 1994, J FOREST, V92, P10; Kolb TE, 1995, FOREST HLTH DIFFEREN, P5; Levick SR, 2013, BIOL CONSERV, V157, P121, DOI 10.1016/j.biocon.2012.07.009; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Litchman E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00254; Marengo JA, 2012, THEOR APPL CLIMATOL, V107, P73, DOI 10.1007/s00704-011-0465-1; Marra DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103711; McDowell NG, 2015, TRENDS PLANT SCI, V20, P114, DOI 10.1016/j.tplants.2014.10.008; Meir P, 2009, GEOPHYS MONOGR SER, V186, P429, DOI 10.1029/2009GM000882; Mildrexler DJ, 2007, ECOL APPL, V17, P235, DOI 10.1890/1051-0761(2007)017[0235:ANSMFC]2.0.CO;2; Mildrexler DJ, 2009, REMOTE SENS ENVIRON, V113, P2103, DOI 10.1016/j.rse.2009.05.016; Millar CI, 2015, SCIENCE, V349, P823, DOI 10.1126/science.aaa9933; Miller SD, 2011, P NATL ACAD SCI USA, V108, P19431, DOI 10.1073/pnas.1105068108; Nobre CA, 2009, CURR OPIN ENV SUST, V1, P28, DOI 10.1016/j.cosust.2009.07.003; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa KF, 2009, J FOREST, V107, P276; Scipal K., 2010, GEOSC REM SENS S IGA, P52; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; UN Reducing Emissions from Deforestation and forest Degradation (UN-REDD+) Programme, 2014, EM APPR FOR REF EM L; Wingfield MJ, 2015, SCIENCE, V349, P832, DOI 10.1126/science.aac6674	50	500	527	60	595	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					814	818		10.1126/science.aac6759	http://dx.doi.org/10.1126/science.aac6759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293952				2022-12-28	WOS:000359832700035
J	Worm, B				Worm, Boris			A most unusual (super)predator Effects of human hunting and fishing differ fundamentally from those of other predators	SCIENCE			English	Editorial Material									Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada	Dalhousie University	Worm, B (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada.	bworm@dal.ca						Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Darimont CT, 2015, SCIENCE, V349, P858, DOI 10.1126/science.aac4249; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Hutchings JA, 2012, TRENDS ECOL EVOL, V27, P542, DOI 10.1016/j.tree.2012.06.005; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005	12	13	13	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					784	785		10.1126/science.aac8697	http://dx.doi.org/10.1126/science.aac8697			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293936				2022-12-28	WOS:000359832700015
J	Sweeney, CJ; Chen, YH; Carducci, M; Liu, G; Jarrard, DF; Eisenberger, M; Wong, YN; Hahn, N; Kohli, M; Cooney, MM; Dreicer, R; Vogelzang, NJ; Picus, J; Shevrin, D; Hussain, M; Garcia, JA; DiPaola, RS				Sweeney, Christopher J.; Chen, Yu-Hui; Carducci, Michael; Liu, Glenn; Jarrard, David F.; Eisenberger, Mario; Wong, Yu-Ning; Hahn, Noah; Kohli, Manish; Cooney, Matthew M.; Dreicer, Robert; Vogelzang, Nicholas J.; Picus, Joel; Shevrin, Daniel; Hussain, Maha; Garcia, Jorge A.; DiPaola, Robert S.			Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; ANDROGEN-DEPRIVATION; INCREASED SURVIVAL; OPEN-LABEL; DOCETAXEL; CHEMOTHERAPY; MITOXANTRONE; CASTRATION; PREDNISONE; CARCINOMA	BACKGROUND Androgen-deprivation therapy (ADT) has been the backbone of treatment for metastatic prostate cancer since the 1940s. We assessed whether concomitant treatment with ADT plus docetaxel would result in longer overall survival than that with ADT alone. METHODS We assigned men with metastatic, hormone-sensitive prostate cancer to receive either ADT plus docetaxel (at a dose of 75 mg per square meter of body-surface area every 3 weeks for six cycles) or ADT alone. The primary objective was to test the hypothesis that the median overall survival would be 33.3% longer among patients receiving docetaxel added to ADT early during therapy than among patients receiving ADT alone. RESULTS A total of 790 patients (median age, 63 years) underwent randomization. After a median follow-up of 28.9 months, the median overall survival was 13.6 months longer with ADT plus docetaxel (combination therapy) than with ADT alone (57.6 months vs. 44.0 months; hazard ratio for death in the combination group, 0.61; 95% confidence interval [CI], 0.47 to 0.80; P<0.001). The median time to biochemical, symptomatic, or radiographic progression was 20.2 months in the combination group, as compared with 11.7 months in the ADT-alone group (hazard ratio, 0.61; 95% CI, 0.51 to 0.72; P<0.001). The rate of a prostate-specific antigen level of less than 0.2 ng per milliliter at 12 months was 27.7% in the combination group versus 16.8% in the ADT-alone group (P<0.001). In the combination group, the rate of grade 3 or 4 febrile neutropenia was 6.2%, the rate of grade 3 or 4 infection with neutropenia was 2.3%, and the rate of grade 3 sensory neuropathy and of grade 3 motor neuropathy was 0.5%. CONCLUSIONS Six cycles of docetaxel at the beginning of ADT for metastatic prostate cancer resulted in significantly longer overall survival than that with ADT alone. (Funded by the National Cancer Institute and others;	[Sweeney, Christopher J.] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Chen, Yu-Hui] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Sweeney, Christopher J.] Harvard Univ, Sch Med, Boston, MA USA; [Carducci, Michael; Eisenberger, Mario] Johns Hopkins Univ, Baltimore, MD USA; [Liu, Glenn; Jarrard, David F.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Jarrard, David F.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Wong, Yu-Ning] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA USA; [Hahn, Noah] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Kohli, Manish] Mayo Clin, Rochester, MN USA; [Cooney, Matthew M.] Univ Hosp Case Med Ctr, Seidman Canc Ctr, Cleveland, OH USA; [Garcia, Jorge A.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Dreicer, Robert] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA; [Vogelzang, Nicholas J.] Comprehens Canc Ctr Nevada, Las Vegas, NV USA; [Picus, Joel] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Shevrin, Daniel] NorthShore Univ HealthSystem, Evanston, IL USA; [Hussain, Maha] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [DiPaola, Robert S.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Indiana University System; Indiana University-Purdue University Indianapolis; Mayo Clinic; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation; University of Virginia; Comprehensive Cancer Centers of Nevada; Siteman Cancer Center; Washington University (WUSTL); NorthShore University Health System; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Sweeney, CJ (corresponding author), Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA.	christopher_sweeney@dfci.harvard.edu	Carducci, Michael/R-8164-2019; Kohli, Manish/AAN-8862-2021	Chen, Yu-Hui/0000-0003-4292-698X	National Cancer Institute; NATIONAL CANCER INSTITUTE [U10CA180801, U10CA023318, U10CA180802, U10CA021115, U10CA031946, UG1CA189828, U10CA066636, U10CA180795, UG1CA189829, U01CA080098, U10CA180853, U10CA086802, U10CA180888, U10CA180794, U10CA180799, U10CA180820, U10CA037403, U10CA180821, U10CA180790] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT00309985.	Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1970, ANAL BINARY DATA; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Dalesio O, 2000, LANCET, V355, P1491; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Gravis G, 2013, LANCET ONCOL, V14, P149, DOI 10.1016/S1470-2045(12)70560-0; Huggins C, 1941, CANCER RES, V1, P293; Hussain M, 2013, NEW ENGL J MED, V368, P1314, DOI 10.1056/NEJMoa1212299; James ND, 2015, EUR UROL, V67, P1028, DOI 10.1016/j.eururo.2014.09.032; Jennison C, 1990, STAT SCI, V5, P299, DOI DOI 10.1214/SS/1177012099; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Millikan RE, 2008, J CLIN ONCOL, V26, P5936, DOI 10.1200/JCO.2007.15.9830; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Tangen CM, 2012, J UROLOGY, V188, P1164, DOI 10.1016/j.juro.2012.06.046; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wu JN, 2014, CANCER-AM CANCER SOC, V120, P818, DOI 10.1002/cncr.28485	26	1654	1690	8	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					737	746		10.1056/NEJMoa1503747	http://dx.doi.org/10.1056/NEJMoa1503747			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26244877	Bronze, Green Accepted			2022-12-28	WOS:000359709400010
J	Williams, ME; Hadler, NM				Williams, Mark E.; Hadler, Nortin M.			In hospital rehabilitation units, adding individualized fall-prevention education to usual care reduced falls	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Williams, Mark E.] Univ N Carolina, Sch Med, Wilmington, NC 28401 USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Wilmington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Williams, ME (corresponding author), Univ N Carolina, Sch Med, Wilmington, NC 28401 USA.							Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Coussement J, 2008, J AM GERIATR SOC, V56, P29, DOI 10.1111/j.1532-5415.2007.01508.x; Hadler Nortin, 2011, RETHINKING AGING GRO	3	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					JC13	JC13		10.7326/ACPJC-2015-163-4-013	http://dx.doi.org/10.7326/ACPJC-2015-163-4-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26280435				2022-12-28	WOS:000364673500022
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What is publication bias in a meta-analysis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									St Georges Univ London, Inst Med & Biomed Educ, London, England	St Georges University London	Sedgwick, P (corresponding author), St Georges Univ London, Inst Med & Biomed Educ, London, England.		Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Huedo-Medina TB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8343	1	44	44	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2015	351								h4419	10.1136/bmj.h4419	http://dx.doi.org/10.1136/bmj.h4419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2YN	26276792				2022-12-28	WOS:000359744000002
J	Andersen, KG; Shapiro, BJ; Matranga, CB; Sealfon, R; Lin, AE; Moses, LM; Folarin, OA; Goba, A; Odia, I; Ehiane, PE; Momoh, M; England, EM; Winnicki, S; Branco, LM; Gire, SK; Phelan, E; Tariyal, R; Tewhey, R; Omoniwa, O; Fullah, M; Fonnie, R; Fonnie, M; Kanneh, L; Jalloh, S; Gbakie, M; Saffa, S; Karbo, K; Gladden, AD; Qu, J; Stremlau, M; Nekoui, M; Finucane, HK; Tabrizi, S; Vitti, JJ; Birren, B; Fitzgerald, M; McCowan, C; Ireland, A; Berlin, AM; Bochicchio, J; Tazon-Vega, B; Lennon, NJ; Ryan, EM; Bjornson, Z; Milner, DA; Lukens, AK; Broodie, N; Rowland, M; Heinrich, M; Akdag, M; Schieffelin, JS; Levy, D; Akpan, H; Bausch, DG; Rubins, K; McCormick, JB; Lander, ES; Gunther, S; Hensley, L; Okogbenin, S; Schaffner, SF; Okokhere, PO; Khan, SH; Grant, DS; Akpede, GO; Asogun, DA; Gnirke, A; Levin, JZ; Happi, CT; Garry, RF; Sabeti, PC				Andersen, Kristian G.; Shapiro, B. Jesse; Matranga, Christian B.; Sealfon, Rachel; Lin, Aaron E.; Moses, Lina M.; Folarin, Onikepe A.; Goba, Augustine; Odia, Ikponmwonsa; Ehiane, Philomena E.; Momoh, Mambu; England, Eleina M.; Winnicki, Sarah; Branco, Luis M.; Gire, Stephen K.; Phelan, Eric; Tariyal, Ridhi; Tewhey, Ryan; Omoniwa, Omowunmi; Fullah, Mohammed; Fonnie, Richard; Fonnie, Mbalu; Kanneh, Lansana; Jalloh, Simbirie; Gbakie, Michael; Saffa, Sidiki; Karbo, Kandeh; Gladden, Adrianne D.; Qu, James; Stremlau, Matthew; Nekoui, Mahan; Finucane, Hilary K.; Tabrizi, Shervin; Vitti, Joseph J.; Birren, Bruce; Fitzgerald, Michael; McCowan, Caryn; Ireland, Andrea; Berlin, Aaron M.; Bochicchio, James; Tazon-Vega, Barbara; Lennon, Niall J.; Ryan, Elizabeth M.; Bjornson, Zach; Milner, Danny A., Jr.; Lukens, Amanda K.; Broodie, Nisha; Rowland, Megan; Heinrich, Megan; Akdag, Marjan; Schieffelin, John S.; Levy, Danielle; Akpan, Henry; Bausch, Daniel G.; Rubins, Kathleen; McCormick, Joseph B.; Lander, Eric S.; Guenther, Stephan; Hensley, Lisa; Okogbenin, Sylvanus; Schaffner, Stephen F.; Okokhere, Peter O.; Khan, S. Humarr; Grant, Donald S.; Akpede, George O.; Asogun, Danny A.; Gnirke, Andreas; Levin, Joshua Z.; Happi, Christian T.; Garry, Robert F.; Sabeti, Pardis C.		Viral Hemorrhagic Fever Consortium	Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus	CELL			English	Article							CODON USAGE; PURIFYING SELECTION; L-RNA; FEVER; ADAPTATION; ANCIENT; TRANSMISSION; PATTERNS; DISEASE; EBOLA	The 2013-2015 West African epidemic of Ebola virus disease (EVD) reminds us of how little is known about biosafety level 4 viruses. Like Ebola virus, Lassa virus (LASV) can cause hemorrhagic fever with high case fatality rates. We generated a genomic catalog of almost 200 LASV sequences from clinical and rodent reservoir samples. We show that whereas the 2013-2015 EVD epidemic is fueled by human-to-human transmissions, LASV infections mainly result from reservoir-to-human infections. We elucidated the spread of LASV across West Africa and show that this migration was accompanied by changes in LASV genome abundance, fatality rates, codon adaptation, and translational efficiency. By investigating intrahost evolution, we found that mutations accumulate in epitopes of viral surface proteins, suggesting selection for immune escape. This catalog will serve as a foundation for the development of vaccines and diagnostics.	[Andersen, Kristian G.; Shapiro, B. Jesse; Lin, Aaron E.; Winnicki, Sarah; Gire, Stephen K.; Tewhey, Ryan; Stremlau, Matthew; Nekoui, Mahan; Tabrizi, Shervin; Vitti, Joseph J.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Andersen, Kristian G.; Shapiro, B. Jesse; Matranga, Christian B.; Sealfon, Rachel; Lin, Aaron E.; England, Eleina M.; Winnicki, Sarah; Gire, Stephen K.; Phelan, Eric; Tariyal, Ridhi; Tewhey, Ryan; Gladden, Adrianne D.; Qu, James; Stremlau, Matthew; Nekoui, Mahan; Finucane, Hilary K.; Tabrizi, Shervin; Birren, Bruce; Fitzgerald, Michael; McCowan, Caryn; Ireland, Andrea; Berlin, Aaron M.; Bochicchio, James; Tazon-Vega, Barbara; Lennon, Niall J.; Ryan, Elizabeth M.; Lander, Eric S.; Schaffner, Stephen F.; Gnirke, Andreas; Levin, Joshua Z.; Sabeti, Pardis C.] Broad Inst, Cambridge, MA 02142 USA; [Andersen, Kristian G.] Scripps Translat Sci Inst, Scripps Res Inst, La Jolla, CA 92037 USA; [Shapiro, B. Jesse] Univ Montreal, Dept Biol Sci, Montreal, PQ H2V 2S9, Canada; [Sealfon, Rachel] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Moses, Lina M.; Schieffelin, John S.; Levy, Danielle; Bausch, Daniel G.; Garry, Robert F.] Tulane Univ, Tulane Hlth Sci Ctr, New Orleans, LA 70118 USA; [Folarin, Onikepe A.; Odia, Ikponmwonsa; Ehiane, Philomena E.; Omoniwa, Omowunmi; Okogbenin, Sylvanus; Okokhere, Peter O.; Akpede, George O.; Asogun, Danny A.; Happi, Christian T.] Irrua Specialist Teaching Hosp, Inst Lassa Fever Res & Control, Irrua, Edo State, Nigeria; [Folarin, Onikepe A.; Happi, Christian T.] Redeemers Univ, Coll Nat Sci, Dept Biol Sci, Redemption City, Osun State, Nigeria; [Goba, Augustine; Momoh, Mambu; Fullah, Mohammed; Fonnie, Richard; Fonnie, Mbalu; Kanneh, Lansana; Jalloh, Simbirie; Gbakie, Michael; Saffa, Sidiki; Karbo, Kandeh; Khan, S. Humarr; Grant, Donald S.] Kenema Govt Hosp, Lassa Fever Lab, Kenema, Eastern Provinc, Sierra Leone; [Momoh, Mambu; Fullah, Mohammed] Eastern Polytech Coll, Kenema, Eastern Provinc, Sierra Leone; [Branco, Luis M.; Rowland, Megan; Heinrich, Megan; Akdag, Marjan] Zalgen Labs, Germantown, MD 20876 USA; [Bjornson, Zach] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94304 USA; [Milner, Danny A., Jr.; Lukens, Amanda K.; Sabeti, Pardis C.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Broodie, Nisha] Columbia Univ, Coll Med, New York, NY 10032 USA; [Akpan, Henry] Nigerian Fed Minist Hlth, Abuja, Fed Capital Ter, Nigeria; [Rubins, Kathleen] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [McCormick, Joseph B.] Univ Texas Sch Publ Hlth, Brownsville, TX 77030 USA; [Guenther, Stephan] Bernhard Nocht Inst Trop Med, Dept Virol, D-20259 Hamburg, Germany; [Hensley, Lisa] NIAID Integrated Res Facil, Frederick, MD 21702 USA; [Viral Hemorrhagic Fever Consortium] Tulane Univ, New Orleans, LA 70118 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Scripps Research Institute; Universite de Montreal; Massachusetts Institute of Technology (MIT); Tulane University; Redeemers University; Kenema Government Hospital; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; National Aeronautics & Space Administration (NASA); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Bernhard Nocht Institut fur Tropenmedizin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tulane University	Sabeti, PC (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.		Shapiro, B. Jesse/U-9337-2019; Berlin, Aaron M/AFY-6549-2022; Schaffner, Stephen F/D-1189-2011; Sabeti, Pardis/GQH-8610-2022; Vega, Barbara Tazon/J-6739-2015; Milner, Danny/K-3568-2019; Lin, Aaron/AAL-1625-2021	Shapiro, B. Jesse/0000-0001-6819-8699; Berlin, Aaron M/0000-0002-0714-2808; Vega, Barbara Tazon/0000-0003-4513-5104; Branco, Luis/0000-0001-8161-0182; Lin, Aaron/0000-0001-7400-4125; Nekoui, Mahan/0000-0001-7466-4801; McCormick, Joseph/0000-0002-5844-8102; Happi, Christian/0000-0002-3056-6705; Moses, Lina/0000-0003-4292-647X; Broodie, Nisha/0000-0001-6911-328X; Gunther, Stephan/0000-0002-6562-0230; Garry, Robert/0000-0002-5683-3250; Milner, Jr, Danny Arnold/0000-0002-6685-8208; Tabrizi, Shervin/0000-0003-2780-8432; Matranga, Christian/0000-0002-9037-5468; Schaffner, Stephen/0000-0001-6699-3568; Hensley, Lisa/0000-0003-1188-4342; Levin, Joshua/0000-0002-0170-3598	NIH; Department of Health and Human Services [1DP2OD006514-01]; NIAID [HHSN272200900049C, HHSN272201000022C, HHSN272200900018C, U19AI110818]; USAMRAA [W81XWH-10-1-0098]; Packard Foundation Fellowship for Science and Engineering; Broad Institute SPARC award; German Research Foundation [GU 883/1-1]; Carlsberg Foundation; Harvard MIDAS CCDD postdoctoral fellowship; Canada Research Chair; NSF [DGE 1122374, 1144152]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG008179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818, R01AI114855, U19AI109762] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USAMRAA; Packard Foundation Fellowship for Science and Engineering; Broad Institute SPARC award; German Research Foundation(German Research Foundation (DFG)); Carlsberg Foundation(Carlsberg Foundation); Harvard MIDAS CCDD postdoctoral fellowship; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank C. Edwards, X. Yang, M. Zody, B. Han, A. Andersen, I. Shlyakhter, D. Park, M. Henn, M. Busby, M. Kellis, C. Bishop, A. Haislip, L. Burchfield, A. Matthews, and F. Viloria for their help and advice. We also thank the Ministry of Health and Sanitation Government of Sierra Leone, Oyo State Ministry of Health, and the Federal Ministry of Health, Nigeria. A full list of members of the Viral Hemorrhagic Fever Consortium can be found at www.vhfc.org. This project was funded with federal funds from the NIH, Department of Health and Human Services (1DP2OD006514-01) and NIAID Contracts (HHSN272200900049C, HHSN272201000022C, HHSN272200900018C, and U19AI110818). The authors received additional support from USAMRAA (W81XWH-10-1-0098), a Packard Foundation Fellowship for Science and Engineering, a Broad Institute SPARC award, and the German Research Foundation (GU 883/1-1). K.G.A. was supported by a fellowship from the Carlsberg Foundation; B.J.S. was supported by a Harvard MIDAS CCDD postdoctoral fellowship and Canada Research Chair; and R.S. and A.E.L. received NSF GRFP fellowships (DGE 1122374 and 1144152). Tulane University and industry partners have filed patent applications for several Lassa-related technologies and may receive royalties or profits if commercial products are developed.	Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Anisimova M, 2007, HEREDITY, V99, P567, DOI 10.1038/sj.hdy.6801052; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Baize S, 2009, J VIROL, V83, P5890, DOI 10.1128/JVI.01948-08; Baum J, 2003, GENETICS, V163, P1327; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Calvignac-Spencer S, 2014, PLOS CURR, V6, P6, DOI DOI 10.1371/CURRENTS.0UTBREAKS.C0E035C86D; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Djavani M, 1997, VIROLOGY, V235, P414, DOI 10.1006/viro.1997.8722; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Ewald PW, 1994, EVOLUTION INFECT DIS; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gire SK, 2012, SCIENCE, V338, P750, DOI 10.1126/science.1225893; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Lalis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037068; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lauring AS, 2012, CELL HOST MICROBE, V12, P623, DOI 10.1016/j.chom.2012.10.008; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; Lipkin WI, 2013, NAT REV MICROBIOL, V11, P133, DOI 10.1038/nrmicro2949; Lo Iacono G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003398; LUKASHEVICH IS, 1992, VIROLOGY, V188, P600, DOI 10.1016/0042-6822(92)90514-P; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Parameswaran P, 2012, J VIROL, V86, P8546, DOI 10.1128/JVI.00736-12; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748; Shapiro BJ, 2009, TRENDS MICROBIOL, V17, P196, DOI 10.1016/j.tim.2009.02.002; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Southern Peter J., 1996, P675; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stenglein MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004900; Taylor DJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-193; TROUP JM, 1970, AM J TROP MED HYG, V19, P695, DOI 10.4269/ajtmh.1970.19.695; Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531; Vieth S, 2004, VIROLOGY, V318, P153, DOI 10.1016/j.virol.2003.09.009; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wertheim JO, 2013, J VIROL, V87, P7039, DOI 10.1128/JVI.03273-12; Wertheim JO, 2011, MOL BIOL EVOL, V28, P3355, DOI 10.1093/molbev/msr170	51	153	155	0	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					738	750		10.1016/j.cell.2015.07.020	http://dx.doi.org/10.1016/j.cell.2015.07.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276630	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000359741400009
J	Jungmann, KP				Jungmann, Klaus P.			PARTICLE PHYSICS Matter and antimatter scrutinized	NATURE			English	Editorial Material							VIOLATION		Univ Groningen, Van Swinderen Inst Particle Phys & Grav, NL-9447 AA Groningen, Netherlands	University of Groningen	Jungmann, KP (corresponding author), Univ Groningen, Van Swinderen Inst Particle Phys & Grav, NL-9447 AA Groningen, Netherlands.	k.h.k.j.jungmann@rug.nl	jungmann, klaus/H-1581-2013; Lu, YuCheng/L-2929-2015	jungmann, klaus/0000-0003-0571-4072; 				Bertolami O, 1997, PHYS LETT B, V395, P178, DOI 10.1016/S0370-2693(97)00062-2; Blaum K., 2013, ANN PHYS-BERLIN, V525, P539; Blaum K, 2013, ANN PHYS-BERLIN, V525, pA127, DOI 10.1002/andp.201300731; Dolgov A. D., 2004, FRASCATI PHYS SER, VXXXVI, P507; Gabrielse G, 1999, PHYS REV LETT, V82, P3198, DOI 10.1103/PhysRevLett.82.3198; HUGHES RJ, 1991, PHYS REV LETT, V66, P854, DOI 10.1103/PhysRevLett.66.854; Johansson T., 2014, HYPERFINE INTERACT, V228, P1, DOI DOI 10.1007/s10751-014-1073-0; LUDERS G, 1957, ANN PHYS-NEW YORK, V2, P1, DOI 10.1016/0003-4916(57)90032-5; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; SAKHAROV AD, 1967, JETP LETT-USSR, V5, P24; SCHWINGER J, 1951, PHYS REV, V82, P914, DOI 10.1103/PhysRev.82.914; Ulmer S, 2015, NATURE, V524, P196, DOI 10.1038/nature14861; Willmann L, 2016, ANN PHYS-BERLIN, V528, P108, DOI 10.1002/andp.201500008; WU CS, 1957, PHYS REV, V105, P1413, DOI 10.1103/PhysRev.105.1413	14	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					168	169		10.1038/524168a	http://dx.doi.org/10.1038/524168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268187	Green Published			2022-12-28	WOS:000359386900019
J	Reiling, J				Reiling, Jennifer			Psychiatric Evaluation of Those Returning from Combat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Murray JM, 1944, J AMER MED ASSOC, V126, P148, DOI 10.1001/jama.1944.02850380010004	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					522	522		10.1001/jama.2014.11902	http://dx.doi.org/10.1001/jama.2014.11902			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO1OI	26241610				2022-12-28	WOS:000358924500022
J	Silverman, JG; Servin, A; Goldenberg, SM; Magis-Rodriguez, C; Ritter, J; Raj, A; Brouwer, KC				Silverman, Jay G.; Servin, Argentina; Goldenberg, Shira M.; Magis-Rodriguez, Carlos; Ritter, Julie; Raj, Anita; Brouwer, Kimberly C.			Sexual Violence and HIV Infection Associated With Adolescent vs Adult Entry Into the Sex Trade in Mexico	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							WORKERS		[Silverman, Jay G.; Servin, Argentina; Ritter, Julie; Raj, Anita; Brouwer, Kimberly C.] Univ Calif San Diego, San Diego Sch Med, La Jolla, CA 92093 USA; [Goldenberg, Shira M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Magis-Rodriguez, Carlos] Minist Hlth Mexico, Natl Ctr Prevent & Control HIV AIDS, Mexico City, DF, Mexico	University of California System; University of California San Diego; University of British Columbia	Silverman, JG (corresponding author), Univ Calif San Diego, Ctr Gender Equ & Hlth, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jgsilverman@ucsd.edu	Ritter, Julie/AAR-9358-2021; Goldenberg, Shira/C-9627-2009	Ritter, Julie/0000-0002-5979-1869; Goldenberg, Shira/0000-0003-1633-9749; Servin, Argentina/0000-0001-5523-7767; Magis-Rodriguez, Carlos/0000-0001-5481-1253	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033194, R01DA028692] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW009343] Funding Source: Medline; NIDA NIH HHS [R01 DA033194, R01DA033194, R01DA028692, R01 DA028692] Funding Source: Medline; PHS HHS [P30A136214] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Silverman JG, 2011, J INFECT DIS, V204, pS1229, DOI 10.1093/infdis/jir540; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; US Department of State, 2014 TRAFF PERS REP	5	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					516	518		10.1001/jama.2015.7376	http://dx.doi.org/10.1001/jama.2015.7376			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO1OI	26241604	Green Accepted, Bronze			2022-12-28	WOS:000358924500017
J	Aubert, J				Aubert, Julien			Ancient planetary dynamos, take two	SCIENCE			English	Editorial Material							MAGNETIC-FIELD; CONVECTION; EVOLUTION; MERCURY		Univ Paris Diderot, Sorbonne Paris Cite, Inst Phys Globe Paris, CNRS, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Aubert, J (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Phys Globe Paris, CNRS, 1 Rue Jussieu, F-75005 Paris, France.	aubert@ipgp.fr	Aubert, Julien/A-5616-2011	Aubert, Julien/0000-0002-2756-0724				Anderson BJ, 2011, SCIENCE, V333, P1859, DOI 10.1126/science.1211001; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Johnson CL, 2015, SCIENCE, V348, P892, DOI 10.1126/science.aaa8720; Labrosse S, 2015, PHYS EARTH PLANET IN, V247, P36, DOI 10.1016/j.pepi.2015.02.002; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; Olson P, 2013, PHYS EARTH PLANET IN, V214, P87, DOI 10.1016/j.pepi.2012.10.003; Tarduno JA, 2015, SCIENCE, V349, P521, DOI 10.1126/science.aaa9114; Tosi N, 2013, J GEOPHYS RES-PLANET, V118, P2474, DOI 10.1002/jgre.20168; Wicht J, 2015, PLANETARY GEODESY AND REMOTE SENSING, P223	9	1	1	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					475	476		10.1126/science.aac6224	http://dx.doi.org/10.1126/science.aac6224			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228127				2022-12-28	WOS:000358713300029
J	Xian, Y; Wu, JJ; Obrien, EC; Fonarow, GC; Olson, DM; Schwamm, LH; Bhatt, DL; Smith, EE; Suter, RE; Hannah, D; Lindholm, B; Maisch, L; Greiner, MA; Lytle, BL; Pencina, MJ; Peterson, ED; Hernandez, AF				Xian, Ying; Wu, Jingjing; Obrien, Emily C.; Fonarow, Gregg C.; Olson, DaiWai M.; Schwamm, Lee H.; Bhatt, Deepak L.; Smith, Eric E.; Suter, Robert E.; Hannah, Deidre; Lindholm, Brianna; Maisch, Lesley; Greiner, Melissa A.; Lytle, Barbara L.; Pencina, Michael J.; Peterson, Eric D.; Hernandez, Adrian F.			Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUIDELINES-STROKE; ORAL ANTICOAGULATION; UNCERTAINTY LIFE; MORTALITY; PREVENTION; REGISTRY; QUALITY; PERFORMANCE; VALIDATION; POSTSTROKE	OBJECTIVE To examine the association between warfarin treatment and longitudinal outcomes after ischemic stroke in patients with atrial fibrillation in community practice. DESIGN Observational study. SETTING Hospitals (n=1487) participating in the Get With The Guidelines (GWTG)-Stroke program in the United States, from 2009 to 2011. PARTICIPANTS 12552 warfarin naive atrial fibrillation patients admitted to hospital for ischemic stroke and treated with warfarin compared with no oral anticoagulant at discharge, linked to Medicare claims for longitudinal outcomes. MAIN OUTCOME MEASURES Major adverse cardiovascular events (MACE) and home time, a patient centered outcomes measure defined as the total number of days free from institutional care after discharge. A propensity score inverse probability weighting method was used to account for all differences in observed characteristics between treatment groups. RESULTS Among 12 552 survivors of stroke, 11 039 (88%) were treated with warfarin at discharge. Warfarin treated patients were slightly younger and less likely to have history of previous stroke or coronary artery disease but had similar severity of stroke as measured by the National Institutes of Health Stroke Scale. Relative to those not treated, patients treated with warfarin had more days at home (as opposed to institutional care) during the two years after discharge (adjusted home time difference 47.6 days, 99% confidence interval 26.9 to 68.2). Patients discharged on warfarin treatment also had a reduced risk of MACE (adjusted hazard ratio 0.87, 99% confidence interval 0.78 to 0.98), all cause mortality (0.72, 0.63 to 0.84), and recurrent ischemic stroke (0.63, 0.48 to 0.83). These differences were consistent among clinically relevant subgroups by age, sex, stroke severity, and history of previous coronary artery disease and stroke. CONCLUSIONS Among ischemic stroke patients with atrial fibrillation, warfarin treatment was associated with improved long term clinical outcomes and more days at home.	[Xian, Ying; Wu, Jingjing; Obrien, Emily C.; Greiner, Melissa A.; Lytle, Barbara L.; Pencina, Michael J.; Peterson, Eric D.; Hernandez, Adrian F.] Duke Clin Res Inst, Durham, NC 27705 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA; [Olson, DaiWai M.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Neurol Surg, Dallas, TX 75390 USA; [Schwamm, Lee H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Stroke Serv, Boston, MA USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Brigham & Womens Hosp Heart & Vasc Ctr, Boston, MA USA; [Smith, Eric E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Suter, Robert E.] Univ Texas SW Med Ctr Dallas, Amer Heart Assoc, Dallas, TX 75390 USA	Duke University; University of California System; University of California Los Angeles; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Calgary; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xian, Y (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	ying.xian@duke.edu	Olson, DaiWai/I-5932-2019; Xian, Ying/O-1956-2019; Fonarow, Gregg C/D-5988-2014; Peterson, Eric David/ABF-5033-2021; Smith, Eric E/C-5443-2012; Hernandez, Adrian F/A-7818-2016	Olson, DaiWai/0000-0002-9280-078X; Fonarow, Gregg C/0000-0002-3192-8093; Smith, Eric E/0000-0003-3956-1668; Hernandez, Adrian F/0000-0003-3387-9616; Xian, Ying/0000-0002-1237-1162	Alberta Innovates [201300690] Funding Source: researchfish	Alberta Innovates		Andersen KK, 2007, STROKE, V38, P259, DOI 10.1161/01.STR.0000254622.52483.03; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Blackshear JL, 1996, LANCET, V348, P633; Bungard TJ, 2001, CAN MED ASSOC J, V165, P301; Bushnell CD, 2010, ARCH NEUROL-CHICAGO, V67, P1456, DOI 10.1001/archneurol.2010.190; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Elixhauser A, 1996, AHCPR PUBLICATION; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Hannah D, 2014, CIRC-CARDIOVASC QUAL, V7, P968, DOI 10.1161/CIRCOUTCOMES.114.001315; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Lichtman JH, 2011, NEUROLOGY, V76, P1976, DOI 10.1212/WNL.0b013e31821e54f3; McAlister FA, 2011, J AM COLL CARDIOL, V58, P1766, DOI 10.1016/j.jacc.2011.07.028; Mishra NK, 2011, STROKE, V42, P1046, DOI 10.1161/STROKEAHA.110.601302; O'Brien EC, 2014, CIRC-CARDIOVASC QUAL, V7, P970, DOI 10.1161/CIRCOUTCOMES.114.001484; PETERSEN P, 1989, LANCET, V1, P175; Quinn TJ, 2008, STROKE, V39, P231, DOI 10.1161/STROKEAHA.107.493320; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Reeves MJ, 2012, STROKE, V43, P44, DOI 10.1161/STROKEAHA.111.626978; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Weimar C, 2008, EUR NEUROL, V60, P142, DOI 10.1159/000144085; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; World Health Organization, 2004, ATLAS HEART DIS STRO; Xian Y, 2015, AM HEART J, V170, P36, DOI 10.1016/j.ahj.2015.04.008; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012	39	50	51	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2015	351								h3786	10.1136/bmj.h3786	http://dx.doi.org/10.1136/bmj.h3786			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UE	26232340	hybrid, Green Published			2022-12-28	WOS:000359011300002
J	Oskrochi, Y; Majeed, A; Easton, G				Oskrochi, Y.; Majeed, A.; Easton, G.			Bariatric surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Oskrochi, Y.; Majeed, A.; Easton, G.] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Charing Cross Hosp, London W6 8RF, England	Imperial College London	Oskrochi, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Charing Cross Hosp, London W6 8RF, England.	youssof.oskrochi@nhs.net	; Oskrochi, Youssof/N-4158-2014	Majeed, Azeem/0000-0002-2357-9858; Oskrochi, Youssof/0000-0001-6748-0457				Arterburn David E, 2014, BMJ, V349, pg3961, DOI 10.1136/bmj.g3961; National Institute for Health and Care Excellence, 2014, ID ASS MAN OV OB CHI, V189; NHS Choices, 2013, WEIGHT LOSS SURG; Patient.co.uk, 2013, SURG FOR OB; Public Health England, 2013, AUDIT C	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2015	351								h3802	10.1136/bmj.h3802	http://dx.doi.org/10.1136/bmj.h3802			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UC	26229049				2022-12-28	WOS:000359011100001
J	Ridley, A				Ridley, Anne			Alan Hall (1952-2015) Obituary	CELL			English	Biographical-Item									Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London	Ridley, A (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London SE1 1UL, England.	anne.ridley@kcl.ac.uk		Ridley, Anne/0000-0001-8186-5708				HALL A, PUBLICATION LIST	1	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1239	1240		10.1016/j.cell.2015.05.034	http://dx.doi.org/10.1016/j.cell.2015.05.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26247068	Bronze			2022-12-28	WOS:000355935000001
J	Neunert, CE; Grace, RF				Neunert, Cindy E.; Grace, Rachael F.			Thrombopoietin-receptor agonists in children with immune thrombocytopenia	LANCET			English	Editorial Material							DOUBLE-BLIND; CONTROLLED-TRIAL; PURPURA; ELTROMBOPAG; ROMIPLOSTIM; MANAGEMENT; EFFICACY		[Neunert, Cindy E.] Columbia Univ, Dept Pediat Hematol Oncol Bone Marrow Transplant, New York, NY 10032 USA; [Grace, Rachael F.] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Hematol Oncol, Boston, MA USA	Columbia University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Neunert, CE (corresponding author), Columbia Univ, Dept Pediat Hematol Oncol Bone Marrow Transplant, New York, NY 10032 USA.	cn2401@cumc.columbia.edu		Grace, Rachael/0000-0001-7302-0449				Brynes RK, 2015, AM J HEMATOL, V90, P598, DOI 10.1002/ajh.24011; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Bussel JB, 2015, PEDIATR BLOOD CANCER, V62, P208, DOI 10.1002/pbc.25136; Bussel JB, 2011, BLOOD, V118, P28, DOI 10.1182/blood-2010-10-313908; Bussel JB, 2009, LANCET, V373, P641, DOI 10.1016/S0140-6736(09)60402-5; Bussel JB, 2015, LANCET HAEMATOL; Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; Grainger JD, 2015, LANCET; Houwerzijl EJ, 2004, BLOOD, V103, P500, DOI 10.1182/blood-2003-01-0275; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2010, NEW ENGL J MED, V363, P1889, DOI 10.1056/NEJMoa1002625; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036698; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; SCHULMAN I, 1964, PEDIATRICS, V33, P979; United States Food and Drug Administration (FDA), 2015, HIGHL PRESCR INF	16	3	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1606	1609		10.1016/S0140-6736(15)61223-5	http://dx.doi.org/10.1016/S0140-6736(15)61223-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26231462				2022-12-28	WOS:000363197500008
J	Carpentier, A; Latremouille, C; Cholley, B; Smadja, DM; Roussel, JC; Boissier, E; Trochu, JN; Gueffet, JP; Treillot, M; Bizouarn, P; Meleard, D; Boughenou, MF; Ponzio, O; Grimme, M; Capel, A; Jansen, P; Hagege, A; Desnos, M; Fabiani, JN; Duveau, D				Carpentier, Alain; Latremouille, Christian; Cholley, Bernard; Smadja, David M.; Roussel, Jean-Christian; Boissier, Elodie; Trochu, Jean-Noel; Gueffet, Jean-Pierre; Treillot, Michele; Bizouarn, Philippe; Meleard, Denis; Boughenou, Marie-Fazia; Ponzio, Olivier; Grimme, Marc; Capel, Antoine; Jansen, Piet; Hagege, Albert; Desnos, Michel; Fabiani, Jean-Noel; Duveau, Daniel			First clinical use of a bioprosthetic total artificial heart: report of two cases	LANCET			English	Article							TRANSPLANTATION; BRIDGE	Background The development of artificial hearts in patients with end-stage heart disease have been confronted with the major issues of thromboembolism or haemorrhage. Since valvular bioprostheses are associated with a low incidence of these complications, we decided to use bioprosthetic materials in the construction of a novel artificial heart (C-TAH). We report here the device characteristics and its first clinical applications in two patients with end-stage dilated cardiomyopathy. The aim of the study was to evaluate safety and feasibility of the CARMAT TAH for patients at imminent risk of death from biventricular heart failure and not eligible for transplant. Methods The C-TAH is an implantable electro-hydraulically actuated pulsatile biventricular pump. All components, batteries excepted, are embodied in a single device positioned in the pericardial sac after excision of the native ventricles. We selected patients admitted to hospital who were at imminent risk of death, having irreversible biventricular failure, and not eligible for heart transplantation, from three cardiac surgery centres in France. Findings The C-TAH was implanted in two male patients. Patient 1, aged 76 years, had the C-TAH implantation on Dec 18, 2013; patient 2, aged 68 years, had the implantation on Aug 5, 2014. The cardiopulmonary bypass times for C-TAH implantation were 170 min for patient 1 and 157 min for patient 2. Both patients were extubated within the first 12 postoperative hours and had a rapid recovery of their respiratory and circulatory functions as well as a normal mental status. Patient 1 presented with a tamponade on day 23 requiring re-intervention. Postoperative bleeding disorders prompted anticoagulant discontinuation. The C-TAH functioned well with a cardiac output of 4.8-5.8 L/min. On day 74, the patient died due to a device failure. Autopsy did not detect any relevant thrombus formation within the bioprosthesis nor the different organs, despite a 50-day anticoagulant-free period. Patient 2 experienced a transient period of renal failure and a pericardial effusion requiring drainage, but otherwise uneventful postoperative course. He was discharged from the hospital on day 150 after surgery with a wearable system without technical assistance. After 4 months at home, the patient suffered low cardiac output. A change of C-TAH was attempted but the patient died of multiorgan failure. Interpretation This preliminary experience could represent an important contribution to the development of total artificial hearts using bioprosthetic materials.	[Carpentier, Alain; Latremouille, Christian; Ponzio, Olivier; Fabiani, Jean-Noel] Univ Paris 05, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, AP HP,Dept Cardiovasc Surg, F-75015 Paris, France; [Cholley, Bernard; Meleard, Denis; Boughenou, Marie-Fazia] Univ Paris 05, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, AP HP,Dept Anaesthesiol & Intens Care, F-75015 Paris, France; [Hagege, Albert; Desnos, Michel] Univ Paris 05, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, AP HP,Dept Cardiol, F-75015 Paris, France; [Smadja, David M.] Univ Paris 05, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, AP HP,Dept Haematol, F-75015 Paris, France; [Roussel, Jean-Christian; Boissier, Elodie; Trochu, Jean-Noel; Gueffet, Jean-Pierre; Treillot, Michele; Bizouarn, Philippe; Duveau, Daniel] Univ Nantes, Hop Guillaume & Rene Laennec, Inst Thorax, F-44035 Nantes, France; [Grimme, Marc; Capel, Antoine; Jansen, Piet] CARMAT SA, Velizy Villacoublay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes	Carpentier, A (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, Dept Cardiovasc Surg, F-75015 Paris, France.	alain.carpentier@egp.aphp.fr	CHOLLEY, Bernard/AAK-5354-2020; Smadja, David/M-3872-2017	CHOLLEY, Bernard/0000-0001-6388-6011; HAGEGE, Albert/0000-0003-4685-6077; Smadja, David/0000-0001-7731-9202	CARMAT SA	CARMAT SA	CARMAT SA.	Carpenter A, 2009, B ACAD NAT MED PARIS, V193, P1747, DOI 10.1016/S0001-4079(19)32408-2; CARPENTIER A, 1986, LANCET, V2, P97; CARPENTIER A, 1974, J THORAC CARDIOV SUR, V68, P771; Carpentier A, 2007, NAT MED, V13, P1165, DOI 10.1038/nm1645; COOLEY DA, 1969, AM J CARDIOL, V24, P723, DOI 10.1016/0002-9149(69)90460-3; COPELAND JG, 1986, JAMA-J AM MED ASSOC, V256, P2991; Copeland JG, 2012, J THORAC CARDIOVASC, V143, P727; DEVRIES WC, 1984, NEW ENGL J MED, V310, P273, DOI 10.1056/NEJM198402023100501; Dowling RD, 2003, ANN THORAC SURG, V75, pS93, DOI 10.1016/S0003-4975(03)00484-3; Feldman D, 2013, J HEART LUNG TRANSPL, V32, P157, DOI 10.1016/j.healun.2012.09.013; Harvey L, 2014, ANN CARDIOTHORAC SUR, V3, P475, DOI 10.3978/j.issn.2225-319X.2014.08.19; Jansen P, 2012, EUR J CARDIO-THORAC, V41, pe166, DOI 10.1093/ejcts/ezs187; Latremouille C, 2015, EUR J CARDIO-THORAC, V47, pE172, DOI 10.1093/ejcts/ezv010; Leprince P, 2003, J HEART LUNG TRANSPL, V22, P1296, DOI 10.1016/S1053-2498(03)00036-6; Palanzo DA, 2013, ARTIF ORGANS, V37, pE162, DOI 10.1111/aor.12158; Roussel JC, 2009, ANN THORAC SURG, V87, P124, DOI 10.1016/j.athoracsur.2008.09.048; Saczkowski R, 2012, ARTIF ORGANS, V36, P668, DOI 10.1111/j.1525-1594.2012.01497.x; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Whitlock RP, 2012, CHEST, V141, pE576S, DOI 10.1378/chest.11-2305	19	54	55	2	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1556	1563		10.1016/S0140-6736(15)60511-6	http://dx.doi.org/10.1016/S0140-6736(15)60511-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26231456				2022-12-28	WOS:000362878200029
J	Schweitzer, A; Horn, J; Mikolajczyk, RT; Krause, G; Ott, JJ				Schweitzer, Aparna; Horn, Johannes; Mikolajczyk, Rafael T.; Krause, Gerard; Ott, Joerdis J.			Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013	LANCET			English	Article							SUB-SAHARAN AFRICA; GLOBAL EPIDEMIOLOGY; C VIRUS; TRANSMISSION; AGE; PREVENTION; RISK; HBV	Background The quantification of the burden of disease attributable to hepatitis B virus (HBV) infection and the adaptation of prevention and control measures requires knowledge on its prevalence in the general population. For most countries such data are not routinely available. We estimated the national, regional, and global prevalence of chronic HBV infection. Methods For this systematic review and pooled analysis, we searched for data on prevalence of chronic HBV infection published between Jan 1, 1965, and Oct 23, 2013, in the databases Medline, Embase, CAB Abstracts (Global health), Popline, and Web of Science. We included studies reporting the hepatitis B surface antigen (HBsAg) serological marker of chronic HBV infection in non-high-risk groups and extracted data into a customised database. For each country, we calculated HBsAg prevalence estimates and 95% CIs weighted by study size. We extrapolated prevalence estimates to population sizes in 2010 to obtain the number of individuals with chronic HBV infection. Findings Of the 17 029 records screened, 1800 report on the prevalence of HBsAg covering 161 countries were included. HBsAg seroprevalence was 3.61% (95% CI 3.61-3.61) worldwide with highest endemicity in countries of the African region (total 8.83%, 8.82-8.83) and Western Pacific region (total 5.26%, 5.26-5.26). Within WHO regions, prevalence ranged from 0.20% (0.19-0.21; Mexico) to 13.55% (9.00-19.89; Haiti) in the Americas, to 0.48% (0.12-1.90; the Seychelles) to 22.38% (20.10-24.83; South Sudan) in the African region. We estimated that in 2010, globally, about 248 million individuals were HBsAg positive. Interpretation This first global assessment of country-level population prevalence of chronic HBV infection found a wide variation between countries and highlights the need for continued prevention and control strategies and the collection of reliable epidemiologic data using standardised methodology.	[Schweitzer, Aparna; Horn, Johannes; Mikolajczyk, Rafael T.; Krause, Gerard; Ott, Joerdis J.] Helmholtz Ctr Infect Res, Dept Epidemiol, D-38124 Braunschweig, Germany; [Schweitzer, Aparna; Horn, Johannes] Helmholtz Ctr Infect Res, PhD Programme Epidemiol Braunschweig Hannover, D-38124 Braunschweig, Germany; [Horn, Johannes; Mikolajczyk, Rafael T.] Helmholtz Ctr Infect Res, Res Grp Epidemiol & Stat Methods, D-38124 Braunschweig, Germany; [Mikolajczyk, Rafael T.; Krause, Gerard; Ott, Joerdis J.] Hannover Med Sch, Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Ott, JJ (corresponding author), Helmholtz Ctr Infect Res, Dept Epidemiol, D-38124 Braunschweig, Germany.	Joerdis.Ott@helmholtz-hzi.de	Jin, Zhi/O-3281-2015; Ibrahim, Essam Hassan/G-1960-2018; Mikolajczyk, Rafael/ABB-5259-2021	Ibrahim, Essam Hassan/0000-0003-0130-2257; Krause, Gerard/0000-0003-3328-8808; Horn, Johannes/0000-0001-6714-8016; Horn, Johannes/0000-0002-7171-3601	World Health Organization	World Health Organization(World Health Organization)	World Health Organization.	Ali M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-102; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; BEASLEY RP, 1981, LANCET, V2, P1129; CDC, 1999, 3 NAT HLTH NUTR EX S; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P574; Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313, DOI 10.1017/S0950268800001497; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Hahne SJM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-181; Howell J, 2014, J VIRAL HEPATITIS, V21, P381, DOI 10.1111/jvh.12263; Kiire CF, 1996, GUT, V38, pS5, DOI 10.1136/gut.38.Suppl_2.S5; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lemoine M, 2014, J HEPATOL, V60, pS414, DOI 10.1016/S0168-8278(14)61179-X; Lemoine M, 2014, LIVER INT, V34, P12, DOI 10.1111/liv.12283; McQuillian Geraldine M, 2010, NCHS Data Brief, P1; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Ott JJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-131; Sagoe-Moses C, 2001, NEW ENGL J MED, V345, P538, DOI 10.1056/NEJM200108163450711; Team R. D. C, 2011, R LANG ENV STAT COMP; Thursz M, 2012, NAT REV GASTRO HEPAT, V9, P492, DOI 10.1038/nrgastro.2012.155; Toy M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-337; UN-United Nations, 2012, WORLD POP PROSP 2012; US Centers for Disease Control and Prevention, 2012, ABCS HEP; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; WHO, 2014, HEP 67 WORLD HLTH AS; WHO, 2010, REP SAF INJ GLOB NET; WHO, 2002, HEP B GLOB AL RESP; WHO, 2015, HEP B; Zhang J, 2001, Can J Infect Dis, V12, P345	33	1666	1749	8	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1546	1555		10.1016/S0140-6736(15)61412-X	http://dx.doi.org/10.1016/S0140-6736(15)61412-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26231459				2022-12-28	WOS:000362878200028
J	Xu, T; Wu, AW; Makary, MA				Xu, Tim; Wu, Albert W.; Makary, Martin A.			The Potential Hazards of Hospital Consolidation Implications for Quality, Access, and Price	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTENSITY		[Xu, Tim; Makary, Martin A.] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; [Wu, Albert W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Makary, Martin A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Makary, MA (corresponding author), Johns Hopkins Univ, Sch Med, Halsted 610,600 N Wolfe St, Baltimore, MD 21287 USA.	mmakary1@jhmi.edu	Wu, Albert/AAJ-4780-2021					Buchmueller TC, 2006, J HEALTH ECON, V25, P740, DOI 10.1016/j.jhealeco.2005.10.006; Creswell J, 2015, NY TIMES; Cutler DM, 2013, JAMA-J AM MED ASSOC, V310, P1964, DOI 10.1001/jama.2013.281675; Gaynor M., 2012, IMPACT HOSP CONSOLID; Hayford TB, 2012, HEALTH SERV RES, V47, P1008, DOI 10.1111/j.1475-6773.2011.01351.x; Hirst EJ., 2015, CHICAGO TRIBUNE; Mitchell JM, 2013, NEW ENGL J MED, V369, P1629, DOI 10.1056/NEJMsa1201141; Thompson TS., 2015, ANTITRUST HLTH C JAN	8	33	33	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1337	1338		10.1001/jama.2015.7492	http://dx.doi.org/10.1001/jama.2015.7492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT2PH	26270867				2022-12-28	WOS:000362644700008
J	Haroon, NN; Paterson, JM; Li, P; Inman, RD; Haroon, N				Haroon, Nisha Nigil; Paterson, J. Michael; Li, Ping; Inman, Robert D.; Haroon, Nigil			Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality A Population-Based Study	ANNALS OF INTERNAL MEDICINE			English	Article							ENDOTHELIAL DYSFUNCTION; ADMINISTRATIVE DATA; DISEASE; RISK; MEN; SPONDYLOARTHRITIS; ATHEROSCLEROSIS; PREVALENCE; SURVIVAL; HEALTH	Background: Ankylosing spondylitis (AS) is a chronic inflammatory arthritis affecting the spine in young adults. It is associated with excess cardiovascular and cerebrovascular morbidity. Objective: To determine whether patients with AS are at increased risk for cardiovascular and cerebrovascular mortality. Design: Population-based retrospective cohort study using administrative health data. Setting: Ontario, Canada. Patients: 21 473 patients with AS aged 15 years or older and 86 606 comparators without AS, matched for age, sex, and location of residence. Measurements: The primary outcome was a composite of cardiovascular and cerebrovascular death. Hazard ratios (HRs) for vascular death were calculated; adjusted for history of cancer, diabetes, dementia, inflammatory bowel disease, hypertension, chronic kidney disease, and peripheral vascular disease; and, among those aged 66 years or older, relevant drug therapies. Independent risk factors for vascular mortality were identified in patients with AS. Results: The mean age of patients with AS was 46 years, and 53% were male. Patients and comparators were followed for 166 920 and 686 461 patient-years, respectively. Adjusted HRs for vascular death in AS were 1.36 (95% CI, 1.13 to 1.65) overall, 1.46 (CI, 1.13 to 1.87) in men, and 1.24 (CI, 0.92 to 1.67) in women. Significant risk factors for vascular death were age; male sex; lower income; dementia; chronic kidney disease; peripheral vascular disease; and, among patients aged 65 years or older, lack of exposure to nonsteroidal anti-inflammatory drugs and statins. Limitation: Diagnosis codes for AS were not validated in Ontario. Conclusion: Ankylosing spondylitis is associated with increased risk for vascular mortality. A comprehensive strategy to screen and treat modifiable vascular risk factors in AS is needed.	[Haroon, Nisha Nigil] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada; [Paterson, J. Michael; Li, Ping] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada; Toronto Western Res Inst, Toronto, ON, Canada; McMaster Univ, Hamilton, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University	Haroon, N (corresponding author), Toronto Western Hosp, 1E-425,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	Nigil.Haroon@uhn.ca		Inman, Robert/0000-0002-4750-1422; Haroon, Nigil/0000-0003-3210-4771	Arthritis Program, University Health Network, Toronto; Arthritis Society, Canada	Arthritis Program, University Health Network, Toronto; Arthritis Society, Canada	The Arthritis Program, University Health Network, Toronto; and The Arthritis Society, Canada.	Azevedo VF, 2010, RHEUMATOL INT, V30, P1411, DOI 10.1007/s00296-010-1416-3; Bakland G, 2011, ANN RHEUM DIS, V70, P1921, DOI 10.1136/ard.2011.151191; Balzi D, 2008, EPIDEMIOL PREV, V32, P22; Baraliakos X, 2014, ANN RHEUM DIS, V73, P710, DOI 10.1136/annrheumdis-2012-202698; Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bodnar N, 2011, J RHEUMATOL, V38, P723, DOI 10.3899/jrheum.100668; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Brophy S, 2012, SEMIN ARTHRITIS RHEU, V42, P140, DOI 10.1016/j.semarthrit.2012.02.008; Chen HH, 2014, RHEUMATOL INT, V34, P265, DOI 10.1007/s00296-013-2927-5; Dik VK, 2010, SCAND J RHEUMATOL, V39, P38, DOI 10.3109/03009740903096101; Elit L, 2013, GYNECOL ONCOL, V128, P95, DOI 10.1016/j.ygyno.2012.10.006; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hamdi W, 2012, J RHEUMATOL, V39, P322, DOI 10.3899/jrheum.110792; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Hollan I, 2008, SCAND J RHEUMATOL, V37, P18, DOI 10.1080/03009740701716868; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064155; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Juurlink D, 2006, CANADIAN I HLTH INFO; Kanathur N, 2010, CLIN CHEST MED, V31, P547, DOI 10.1016/j.ccm.2010.05.002; KAPROVE RE, 1980, ARTHRITIS RHEUM-US, V23, P57, DOI 10.1002/art.1780230110; KHAN MA, 1981, J RHEUMATOL, V8, P86; Lautermann D, 2002, CLIN EXP RHEUMATOL, V20, pS11; LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174, DOI 10.1136/ard.52.3.174; Levy AR, 2014, ARTHRIT CARE RES, V66, P440, DOI 10.1002/acr.22176; Lindhardsen J, 2013, ANN RHEUM DIS, DOI rg/10.1136/annrheumdis-2012-203137; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Margel D, 2013, J CLIN ONCOL, V31, P3069, DOI 10.1200/JCO.2012.46.7043; Mathieu S, 2008, RHEUMATOLOGY, V47, P1203, DOI 10.1093/rheumatology/ken198; Mok CC, 2011, ARTHRITIS RHEUM-US, V63, P1182, DOI 10.1002/art.30277; Papadakis JA, 2009, CLIN EXP RHEUMATOL, V27, P292; Papagoras C, 2013, CLIN EXP RHEUMATOL, V31, P612; Peters MJL, 2010, ANN RHEUM DIS, V69, P579, DOI 10.1136/ard.2009.110593; Peters MJL, 2010, J RHEUMATOL, V37, P161, DOI 10.3899/jrheum.090667; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; RADFORD EP, 1977, NEW ENGL J MED, V297, P572, DOI 10.1056/NEJM197709152971103; Reveille JD, 2012, ARTHRITIS RHEUM-US, V64, P1407, DOI 10.1002/art.33503; Roger VL, 2002, J CLIN EPIDEMIOL, V55, P593, DOI 10.1016/S0895-4356(02)00390-6; Sari I, 2006, RHEUMATOLOGY, V45, P283, DOI 10.1093/rheumatology/kei145; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Shah BR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-42; Singh JA, 2007, ARTHRIT RHEUM-ARTHR, V57, P648, DOI 10.1002/art.22682; Stavem K, 2002, QJM-INT J MED, V95, P143, DOI 10.1093/qjmed/95.3.143; Szabo SM, 2011, ARTHRITIS RHEUM-US, V63, P3294, DOI 10.1002/art.30581; Thakkar B, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1223; Tournadre A, 2013, ARTHRIT CARE RES, V65, P1482, DOI 10.1002/acr.22001; Tu Karen, 2007, Open Med, V1, pe18; Vallance P, 1997, LANCET, V349, P1391, DOI 10.1016/S0140-6736(96)09424-X; van Eijk IC, 2009, ANN RHEUM DIS, V68, P362, DOI 10.1136/ard.2007.086777; Vinsonneau U, 2008, JOINT BONE SPINE, V75, P18, DOI 10.1016/j.jbspin.2007.04.011; Wallis D, 2013, J RHEUMATOL, V40, P2038, DOI 10.3899/jrheum.130588; Wannamethee SG, 2004, HEART, V90, P1398, DOI 10.1136/hrt.2003.026104; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; Wilkins R, 2001, PCCF VERSION 3G USER; Williams J., 1996, PATTERNS HEALTHCARE, P339; Zochling J, 2008, CLIN EXP RHEUMATOL, V26, pS80; Zochling J, 2009, CLIN EXP RHEUMATOL, V27, pS127	57	161	167	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					409	+		10.7326/M14-2470	http://dx.doi.org/10.7326/M14-2470			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26258401				2022-12-28	WOS:000361365900015
J	Levayer, R; Hauert, B; Moreno, E				Levayer, Romain; Hauert, Barbara; Moreno, Eduardo			Cell mixing induced by myc is required for competitive tissue invasion and destruction	NATURE			English	Article							ADHERENS JUNCTIONS; ORGAN GROWTH; MYOSIN-II; DROSOPHILA; MECHANISMS; DELAMINATION; COMPARTMENTS; MIGRATION; APOPTOSIS; POLARITY	Cell-cell intercalation is used in several developmental processes to shape the normal body plan(1). There is no clear evidence that intercalation is involved in pathologies. Here we use the proto-oncogene myc to study a process analogous to early phase of tumour expansion: myc-induced cell competition(2-7). Cell competition is a conserved mechanism(5,6,8,9) driving the elimination of slow-proliferating cells (so-called 'losers') by faster-proliferating neighbours (so-called 'winners') through apoptosis(10) and is important in preventing developmental malformations and maintain tissue fitness(11). Here we show, using long-term live imaging of myc-driven competition in the Drosophila pupal notum and in the wing imaginal disc, that the probability of elimination of loser cells correlates with the surface of contact shared with winners. As such, modifying loser-winner interface morphology can modulate the strength of competition. We further show that elimination of loser clones requires winner-loser cell mixing through cell-cell intercalation. Cell mixing is driven by differential growth and the high tension at winner-winner interfaces relative to winner-loser and loser-loser interfaces, which leads to a preferential stabilization of winner-loser contacts and reduction of clone compactness over time. Differences in tension are generated by a relative difference in F-actin levels between loser and winner junctions, induced by differential levels of the membrane lipid phosphatidylinositol (3,4,5)-trisphosphate. Our results establish the first link between cell-cell intercalation induced by a proto-oncogene and how it promotes invasiveness and destruction of healthy tissues.	[Levayer, Romain; Hauert, Barbara; Moreno, Eduardo] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland	University of Bern	Moreno, E (corresponding author), Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland.	eduardo.moreno@izb.unibe.ch	Levayer, Romain/V-3665-2019	moreno, eduardo/0000-0001-5040-452X; Levayer, Romain/0000-0001-6769-1465	EMBO [ALTF 366-2012]; Human Frontier post-doctoral fellowship [LT000178/2013]; European Research Council; Swiss National Science Foundation; Josef Steiner Cancer Research Foundation; Swiss Cancer League	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier post-doctoral fellowship; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Josef Steiner Cancer Research Foundation; Swiss Cancer League	We thank members of the Moreno laboratory for reading this manuscript. We also thank M. Bergen for help on E-cad fluorescence recovery after photobleaching (FRAP) data collection. We are also very grateful to Y. Bellaiche, O. Baumann, J. Grossahns, H. Jasper, T. Lecuit, L. Legoff, G. Morata, H. Stocker, R. Sousa-Nunes, the Bloomington stock center and the Developmental Studies Hybridoma Bank for sharing stocks and reagents, to B. Aigouy for the Packing analyser software and the Center for Microscopy and Image Analysis (University of Zurich) for sharing equipment. R. L. was supported by an EMBO long-term fellowship (ALTF 366-2012) and a Human Frontier post-doctoral fellowship (LT000178/2013). Work in our laboratory is funded by the European Research Council, the Swiss National Science Foundation, the Josef Steiner Cancer Research Foundation and the Swiss Cancer League.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Bardet PL, 2013, DEV CELL, V25, P534, DOI 10.1016/j.devcel.2013.04.020; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brodland GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044281; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Corrigall D, 2007, DEV CELL, V13, P730, DOI 10.1016/j.devcel.2007.09.015; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Grosshans J, 2005, DEVELOPMENT, V132, P1009, DOI 10.1242/dev.01669; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Li W, 2009, CURR BIOL, V19, P1821, DOI 10.1016/j.cub.2009.09.023; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; Merino MM, 2015, CELL, V160, P461, DOI 10.1016/j.cell.2014.12.017; Merino MM, 2013, CURR BIOL, V23, P1300, DOI 10.1016/j.cub.2013.05.053; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Oda H, 2001, J CELL SCI, V114, P493; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Parisi F, 2011, CELL ADHES MIGR, V5, P366, DOI 10.4161/cam.5.4.17524; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Rhiner C, 2010, DEV CELL, V18, P985, DOI 10.1016/j.devcel.2010.05.010; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Sacan A, 2008, BIOINFORMATICS, V24, P1647, DOI 10.1093/bioinformatics/btn247; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723; Zhang C, 2015, ONCOGENE, V34, P2385, DOI 10.1038/onc.2014.160; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	53	87	87	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					476	+		10.1038/nature14684	http://dx.doi.org/10.1038/nature14684			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26287461	Green Submitted			2022-12-28	WOS:000360069300040
J	Gueroussov, S; Gonatopoulos-Pournatzis, T; Irimia, M; Raj, B; Lin, ZY; Gingras, AC; Blencowe, BJ				Gueroussov, Serge; Gonatopoulos-Pournatzis, Thomas; Irimia, Manuel; Raj, Bushra; Lin, Zhen-Yuan; Gingras, Anne-Claude; Blencowe, Benjamin J.			An alternative splicing event amplifies evolutionary differences between vertebrates	SCIENCE			English	Article							PTB; TRANSCRIPTOMES; DYNAMICS; TISSUES; PROTEIN; NEURONS; GENOMES; GENE	Alternative splicing (AS) generates extensive transcriptomic and proteomic complexity. However, the functions of species-and lineage-specific splice variants are largely unknown. Here we show that mammalian-specific skipping of polypyrimidine tract-binding protein 1 (PTBP1) exon 9 alters the splicing regulatory activities of PTBP1 and affects the inclusion levels of numerous exons. During neurogenesis, skipping of exon 9 reduces PTBP1 repressive activity so as to facilitate activation of a brain-specific AS program. Engineered skipping of the orthologous exon in chicken cells induces a large number of mammalian-like AS changes in PTBP1 target exons. These results thus reveal that a single exon-skipping event in an RNA binding regulator directs numerous AS changes between species. Our results further suggest that these changes contributed to evolutionary differences in the formation of vertebrate nervous systems.	[Gueroussov, Serge; Gonatopoulos-Pournatzis, Thomas; Irimia, Manuel; Raj, Bushra; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Gueroussov, Serge; Raj, Bushra; Gingras, Anne-Claude; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Irimia, Manuel] EMBL CRG Syst Biol Res Unit, Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Lin, Zhen-Yuan; Gingras, Anne-Claude] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Blencowe, BJ (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca	Irimia, Manuel/E-3040-2010; Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Irimia, Manuel/0000-0002-2179-2567; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Raj, Bushra/0000-0002-5833-0251; Gonatopoulos-Pournatzis, Thomas/0000-0003-2669-2570	Natural Sciences and Engineering Research Council of Canada; European Molecular Biology Organization; Ontario Institute for Regenerative Medicine; Human Frontier Science Program; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Ontario Institute for Regenerative Medicine; Human Frontier Science Program(Human Frontier Science Program); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank A. Dziembowski for providing DT40-Cre1 cells, U. Braunschweig for assistance with CLIP-seq analyses, and N. Barbosa-Morais and T. Sterne-Weiler for advice on statistical testing. We also acknowledge D. Torti, D. Leung, and G. O'Hanlon in the Donnelly Sequencing Centre for generating RNA-seq data. S.G. is supported by a Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Studentship, T.G.-P. is supported by fellowships from European Molecular Biology Organization and Ontario Institute for Regenerative Medicine, and M.I. was supported by a Long-Term Fellowship from the Human Frontier Science Program. This research was supported by grants from the Canadian Institutes of Health Research to B.J.B. and A.-C.G. and by a Natural Sciences and Engineering Research Council of Canada John C. Polanyi Award to B.J.B. B.J.B. holds the Banbury Chair in Medical Research at the University of Toronto. Data presented in this manuscript are archived in the Gene Expression Omnibus under accession number GSE69656.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Han A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003442; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Kafasla P, 2012, BIOCHEM SOC T, V40, P815, DOI 10.1042/BST20120044; Li YI, 2015, GENOME RES, V25, P1, DOI 10.1101/gr.181990.114; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Necsulea A, 2014, NAT REV GENET, V15, P734, DOI 10.1038/nrg3802; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Raj B, 2014, MOL CELL, V56, P90, DOI 10.1016/j.molcel.2014.08.011; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; Robinson F, 2006, J BIOL CHEM, V281, P800, DOI 10.1074/jbc.M510578200; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045	20	80	83	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					868	873		10.1126/science.aaa8381	http://dx.doi.org/10.1126/science.aaa8381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293963	Green Accepted			2022-12-28	WOS:000359832700050
J	Millar, CI; Stephenson, NL				Millar, Constance I.; Stephenson, Nathan L.			Temperate forest health in an era of emerging megadisturbance	SCIENCE			English	Review							CLIMATE-CHANGE; TREE MORTALITY; MEGA-FIRES; LAND MANAGEMENT; TIPPING POINTS; UNITED-STATES; VEGETATION; DROUGHT; PATTERNS; DECLINE	Although disturbances such as fire and native insects can contribute to natural dynamics of forest health, exceptional droughts, directly and in combination with other disturbance factors, are pushing some temperate forests beyond thresholds of sustainability. Interactions from increasing temperatures, drought, native insects and pathogens, and uncharacteristically severe wildfire are resulting in forest mortality beyond the levels of 20th-century experience. Additional anthropogenic stressors, such as atmospheric pollution and invasive species, further weaken trees in some regions. Although continuing climate change will likely drive many areas of temperate forest toward large- scale transformations, management actions can help ease transitions and minimize losses of socially valued ecosystem services.	[Millar, Constance I.] US Forest Serv, USDA, Pacific Southwest Res Stn, Albany, CA 94710 USA; [Stephenson, Nathan L.] US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA 93271 USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey	Millar, CI (corresponding author), US Forest Serv, USDA, Pacific Southwest Res Stn, Albany, CA 94710 USA.	cmillar@fs.fed.us			U.S. Forest Service; U.S. Geological Survey	U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); U.S. Geological Survey(United States Geological Survey)	We thank M. Dettinger (U.S. Geological Survey), C. J. Fettig (U.S. Forest Service), J. Hicke (University of Idaho), S. Stephens (University of California, Berkeley), and A. P. Williams (Lamont-Doherty Earth Observatory) for reviewing the draft manuscript; A. P. Williams for providing an update of FDSI trends for Fig. 3; and D. Delany (U.S. Forest Service) for help with figures. C.I.M. and N.L.S. are supported by the U.S. Forest Service and U.S. Geological Survey, respectively.	Adams MA, 2013, FOREST ECOL MANAG, V294, P250, DOI 10.1016/j.foreco.2012.11.039; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Anderegg WRL, 2015, NEW PHYTOL, V208, P674, DOI 10.1111/nph.13477; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bendixsen DP, 2015, FOREST ECOL MANAG, V347, P40, DOI 10.1016/j.foreco.2015.03.015; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Billings W.D., 1990, EARTH TRANSITION PAT, P301; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Breshears DD, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00266; Breshears DD, 2011, AMBIO, V40, P256, DOI 10.1007/s13280-010-0106-4; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Carnicer J, 2014, GLOBAL ECOL BIOGEOGR, V23, P371, DOI 10.1111/geb.12111; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; de Vries W, 2014, PLANT SOIL, V380, P1, DOI 10.1007/s11104-014-2056-2; Dietze MC, 2011, GLOBAL CHANGE BIOL, V17, P3312, DOI 10.1111/j.1365-2486.2011.02477.x; Diffenbaugh NS, 2015, P NATL ACAD SCI USA, V112, P3931, DOI 10.1073/pnas.1422385112; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Flannigan M, 2013, FOREST ECOL MANAG, V294, P54, DOI 10.1016/j.foreco.2012.10.022; Flower CE, 2015, ANNU REV PLANT BIOL, V66, P547, DOI 10.1146/annurev-arplant-043014-115540; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; Hember RA, 2012, GLOBAL CHANGE BIOL, V18, P2026, DOI 10.1111/j.1365-2486.2012.02669.x; Hicke JA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035032; Hoshika Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09871; Jenkins MJ, 2014, FOREST SCI, V60, P489, DOI 10.5849/forsci.13-017; Jiang XY, 2013, J CLIMATE, V26, P3671, DOI 10.1175/JCLI-D-12-00430.1; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Kauppi PE, 2015, BIOGEOSCIENCES, V12, P855, DOI 10.5194/bg-12-855-2015; KOLB TE, 1994, J FOREST, V92, P10; Law BE, 2014, GLOBAL CHANGE BIOL, V20, P3595, DOI 10.1111/gcb.12651; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lindner M, 2014, J ENVIRON MANAGE, V146, P69, DOI 10.1016/j.jenvman.2014.07.030; Matusick G, 2013, EUR J FOREST RES, V132, P497, DOI 10.1007/s10342-013-0690-5; McCabe G. J., 2015, CLIMATIC CHANGE, V2015, P1; McCabe GJ, 2010, CLIMATIC CHANGE, V99, P141, DOI 10.1007/s10584-009-9675-2; McDowell NG, 2015, NAT CLIM CHANGE, V5, P669, DOI [10.1038/nclimate2641, 10.1038/NCLIMATE2641]; McIntyre PJ, 2015, P NATL ACAD SCI USA, V112, P1458, DOI 10.1073/pnas.1410186112; Millar CI, 2014, ADV GLOB CHANGE RES, V57, P183, DOI 10.1007/978-94-007-7515-2_8; Millennium, 2005, EC HUM WELL BEING SY; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Piao SL, 2015, GLOBAL CHANGE BIOL, V21, P1601, DOI 10.1111/gcb.12795; Raffa KF, 2009, J FOREST, V107, P276; Reyer CPO, 2015, J ECOL, V103, P5, DOI 10.1111/1365-2745.12337; Rigling A, 2013, GLOBAL CHANGE BIOL, V19, P229, DOI 10.1111/gcb.12038; Salle A, 2014, FOREST ECOL MANAG, V328, P79, DOI 10.1016/j.foreco.2014.05.027; Staelens J., 2010, IUFRO WORLD SERIES M, P55; Stephens SL, 2014, FRONT ECOL ENVIRON, V12, P115, DOI 10.1890/120332; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x; Suarez ML, 2008, CAN J FOREST RES, V38, P3002, DOI 10.1139/X08-149; Sulak A, 2012, J FOREST, V110, P312, DOI 10.5849/jof.12-004; Teskey R, 2015, PLANT CELL ENVIRON, V38, P1699, DOI 10.1111/pce.12417; Thom D, 2016, BIOL REV, V91, P760, DOI 10.1111/brv.12193; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Vicente-Serrano SM, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/4/044001; Warren WA, 2007, SOC NATUR RESOUR, V20, P99, DOI 10.1080/08941920600901890; Weed AS, 2013, ECOL MONOGR, V83, P441, DOI 10.1890/13-0160.1; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Williams J, 2013, FOREST ECOL MANAG, V294, P4, DOI 10.1016/j.foreco.2012.06.030; Woods A. J., 2014, Journal of Forest Science (Prague), V60, P484, DOI 10.17221/18/2014-JFS	62	534	553	25	471	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					823	826		10.1126/science.aaa9933	http://dx.doi.org/10.1126/science.aaa9933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293954				2022-12-28	WOS:000359832700037
J	Philips, SJ; Canalizo-Hernandez, M; Yildirim, I; Schatz, GC; Mondragon, A; O'Halloran, TV				Philips, Steven J.; Canalizo-Hernandez, Monica; Yildirim, Ilyas; Schatz, George C.; Mondragon, Alfonso; O'Halloran, Thomas V.			Allosteric transcriptional regulation via changes in the overall topology of the core promoter	SCIENCE			English	Article							ESCHERICHIA-COLI; STRUCTURAL BASIS; DNA DISTORTION; MERR FAMILY; CRYSTAL-STRUCTURE; PROTEIN MERR; ACTIVATION; COPPER; CUER; MECHANISM	Many transcriptional activators act at a distance from core promoter elements and work by recruiting RNA polymerase through protein-protein interactions. We show here how the prokaryotic regulatory protein CueR both represses and activates transcription by differentially modulating local DNA structure within the promoter. Structural studies reveal that the repressor state slightly bends the promoter DNA, precluding optimal RNA polymerase-promoter recognition. Upon binding a metal ion in the allosteric site, CueR switches into an activator conformation. It maintains all protein-DNA contacts but introduces torsional stresses that kink and undertwist the promoter, stabilizing an A-form DNA-like conformation. These factors switch on and off transcription by exerting dynamic control of DNA stereochemistry, reshaping the core promoter and making it a better or worse substrate for polymerase.	[Philips, Steven J.; Mondragon, Alfonso; O'Halloran, Thomas V.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Canalizo-Hernandez, Monica; Yildirim, Ilyas; Schatz, George C.; O'Halloran, Thomas V.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [O'Halloran, Thomas V.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mondragon, A (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu; t-ohalloran@northwestern.edu	O'Halloran, Thomas/ABE-6125-2021; YILDIRIM, ILYAS/AAU-7013-2020; Schatz, George C./ABF-1341-2020	O'Halloran, Thomas/0000-0001-8732-5059; YILDIRIM, ILYAS/0000-0001-8357-1922; 	NIH [R01GM038784, U54CA143869]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Structural Biology Facility, Northwestern Lurie Cancer Center; NATIONAL CANCER INSTITUTE [U54CA143869, P30CA060553, U54CA193419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Structural Biology Facility, Northwestern Lurie Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge NIH grants R01GM038784 and U54CA143869, Life Sciences Collaborative Access Team staff assistance at the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for DOE Office of Science by Argonne National Laboratory (contract DE-AC02-06CH11357), and the Structural Biology Facility, Northwestern Lurie Cancer Center. Coordinates and structure factors (accession numbers 4WLS and 4WLW) are deposited in the Protein Data Bank.	Andoy NM, 2009, BIOPHYS J, V97, P844, DOI 10.1016/j.bpj.2009.05.027; Ansari A. Z., 1995, NATURE, V374, P370; ANSARI AZ, 1992, NATURE, V355, P87, DOI 10.1038/355087a0; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; COMESS KM, 1994, BIOCHEMISTRY-US, V33, P4175, DOI 10.1021/bi00180a010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001; GuzikevichGuerstein G, 1996, NAT STRUCT BIOL, V3, P32, DOI 10.1038/nsb0196-32; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Liu CH, 2012, BIOCHEMISTRY-US, V51, P937, DOI 10.1021/bi201196s; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; PARKHILL J, 1993, EMBO J, V12, P413, DOI 10.1002/j.1460-2075.1993.tb05673.x; Petersen C, 2000, GENE, V261, P289, DOI 10.1016/S0378-1119(00)00509-6; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; Summers AO, 2009, CURR OPIN MICROBIOL, V12, P138, DOI 10.1016/j.mib.2009.02.003; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	27	91	95	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					877	881		10.1126/science.aaa9809	http://dx.doi.org/10.1126/science.aaa9809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293965	Green Submitted, Green Accepted			2022-12-28	WOS:000359832700052
J	Mellins, ED; Kay, MA				Mellins, Elizabeth D.; Kay, Mark A.			Viral Vectors Take On HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTECTION		[Mellins, Elizabeth D.; Kay, Mark A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Mellins, ED (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.			Mellins, Elizabeth/0000-0003-2577-139X; Kay, Mark/0000-0002-2799-2615	NIDDK NIH HHS [R01 DK078424] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Chen WZ, 2014, J VIROL, V88, P1125, DOI 10.1128/JVI.02566-13; Chiang JJ, 2012, J VIROL, V86, P12417, DOI 10.1128/JVI.00967-12; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967	5	1	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					770	772		10.1056/NEJMcibr1504232	http://dx.doi.org/10.1056/NEJMcibr1504232			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287853				2022-12-28	WOS:000359709400015
J	Choa, R; Rayatt, S; Mahtani, K				Choa, Robert; Rayatt, Sukbhir; Mahtani, Kamal			EASILY MISSED? Marjolin's ulcer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SQUAMOUS-CELL CARCINOMA; MALIGNANCY; SKIN		[Choa, Robert; Rayatt, Sukbhir] Royal Stoke Univ Hosp, Dept Plast Surg, Stoke On Trent ST4 6QG, Staffs, England; [Mahtani, Kamal] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	Royal Stoke University Hospital; University of Oxford	Choa, R (corresponding author), Royal Stoke Univ Hosp, Dept Plast Surg, Stoke On Trent ST4 6QG, Staffs, England.	rob_choa@hotmail.com			National Institute for Health Research [CL-2011-13-006] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; BALDURSSON B, 1995, BRIT J DERMATOL, V133, P571, DOI 10.1111/j.1365-2133.1995.tb02707.x; Carlson AR, 2014, AM SURGEON, V80, pE61; Das KK, 2015, BURNS; Enoch Stuart, 2004, Int Wound J, V1, P165, DOI 10.1111/j.1742-4801.2004.00056.x; Fairbairn NG, 2011, INT WOUND J, V8, P533, DOI 10.1111/j.1742-481X.2011.00831.x; Kerr-Valentic MA, 2009, PLAST RECONSTR SURG, V123, P184, DOI 10.1097/PRS.0b013e3181904d86; Opara KO, 2011, NIGER HLTH J, V11, P107; Pavlovic S, 2011, INT WOUND J, V8, P419, DOI 10.1111/j.1742-481X.2011.00811.x; Pekarek Brian, 2011, J Am Col Certif Wound Spec, V3, P60, DOI 10.1016/j.jcws.2012.04.001; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Scottish Intercollegiate Guidelines Network, 2014, MAN PRIM CUT SQUAM C; Smith J, 2001, SKELETAL RADIOL, V30, P331, DOI 10.1007/s002560100355; Trotter MJ, 2003, ARCH PATHOL LAB MED, V127, P1489; Yu N, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-313	15	6	7	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h3997	10.1136/bmj.h3997	http://dx.doi.org/10.1136/bmj.h3997			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7PU	26290491				2022-12-28	WOS:000360081100001
J	McNab, S				McNab, Sarah			Isotonic vs Hypotonic Intravenous Fluids for Hospitalized Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MAINTENANCE FLUIDS; HYPONATREMIA	CLINICAL QUESTION Is isotonic fluid associated with a lower incidence of hyponatremia when compared with hypotonic fluid for maintenance intravenous fluid therapy in children? BOTTOM LINE Compared with hypotonic fluid, isotonic fluid is associated with a lower incidence of hyponatremia, without evidence of an increase in adverse outcomes.	[McNab, Sarah] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic, Australia; [McNab, Sarah] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [McNab, Sarah] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne	McNab, S (corresponding author), Royal Childrens Hosp Melbourne, Dept Gen Med, 52 Flemington Rd, Parkville, Vic 3052, Australia.	sarah.mcnab@rch.org.au						Friedman JN, 2015, JAMA PEDIATR, V169, P445, DOI 10.1001/jamapediatrics.2014.3809; Hoorn EJ, 2004, PEDIATRICS, V113, P1279, DOI 10.1542/peds.113.5.1279; Baron FAJ, 2013, ARCH ARGENT PEDIATR, V111, P281, DOI 10.5546/aap.2013.281; McNab S, 2014, COCHRANE DB SYST REV, V12, P1; Mcnab S, 2015, LANCET, V385, P1190, DOI 10.1016/S0140-6736(14)61459-8; National Patient Safety Agency, RED RISK HYP ADM INT; Pemde HK, 2015, INDIAN J PEDIATR, V82, P13, DOI 10.1007/s12098-014-1436-1; Shamim A, 2014, INDIAN PEDIATR, V51, P969, DOI 10.1007/s13312-014-0542-5	8	11	11	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					720	721		10.1001/jama.2015.7918	http://dx.doi.org/10.1001/jama.2015.7918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284724				2022-12-28	WOS:000360019100021
J	Seymour, CW; Rosengart, MR				Seymour, Christopher W.; Rosengart, Matthew R.			Septic Shock Advances in Diagnosis and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GOAL-DIRECTED THERAPY; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; HYDROXYETHYL STARCH; FLUID RESUSCITATION; HYDROCORTISONE THERAPY; ADULTS; METAANALYSIS; MORTALITY; OUTCOMES	IMPORTANCE Septic shock is a clinical emergency that occurs in more than 230 000 US patients each year. OBSERVATIONS AND ADVANCES In the setting of suspected or documented infection, septic shock is typically defined in a clinical setting by low systolic (<= 90 mm Hg) or mean arterial blood pressure (<= 65 mm Hg) accompanied by signs of hypoperfusion (eg, oliguria, hyperlactemia, poor peripheral perfusion, or altered mental status). Focused ultrasonography is recommended for the prompt recognition of complicating physiology (eg, hypovolemia or cardiogenic shock), while invasive hemodynamic monitoring is recommended only for select patients. In septic shock, 3 randomized clinical trials demonstrate that protocolized care offers little advantage compared with management without a protocol. Hydroxyethyl starch is no longer recommended, and debate continues about the role of various crystalloid solutions and albumin. CONCLUSIONS AND RELEVANCE The prompt diagnosis of septic shock begins with obtainment of medical history and performance of a physical examination for signs and symptoms of infection and may require focused ultrasonography to recognize more complex physiologic manifestations of shock. Clinicians should understand the importance of prompt administration of intravenous fluids and vasoactive medications aimed at restoring adequate circulation, and the limitations of protocol-based therapy, as guided by recent evidence.	[Seymour, Christopher W.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3550 Terrace St,Scaife Hall,Off 639, Pittsburgh, PA 15261 USA; [Seymour, Christopher W.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15261 USA; [Seymour, Christopher W.; Rosengart, Matthew R.] Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Rosengart, Matthew R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Seymour, CW (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3550 Terrace St,Scaife Hall,Off 639, Pittsburgh, PA 15261 USA.	seymourcw@upmc.edu			National Institutes of Health (NIH) [K23GM104022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM104022] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health (NIH) (K23GM104022).	Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Angus DC, 2015, INTENS CARE MED, V41, P1549, DOI 10.1007/s00134-015-3822-1; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; [Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; Asfar P, 2014, NEW ENGL J MED, V370, P1583, DOI 10.1056/NEJMoa1312173; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; Clermont G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022512; D'Aragon F, 2015, SHOCK, V43, P530, DOI 10.1097/SHK.0000000000000348; De Backer D, 2012, CRIT CARE MED, V40, P725, DOI 10.1097/CCM.0b013e31823778ee; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Gomez H, 2015, JAMA-J AM MED ASSOC, V313, P194, DOI 10.1001/jama.2014.13811; Hernandez G, 2013, INTENS CARE MED, V39, P1435, DOI 10.1007/s00134-013-2982-0; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Hoste EA, 2014, BRIT J ANAESTH, V113, P740, DOI 10.1093/bja/aeu300; Huang DT, 2013, INTENS CARE MED, V39, P1760, DOI 10.1007/s00134-013-3024-7; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Labovitz AJ, 2010, J AM SOC ECHOCARDIOG, V23, P1225, DOI 10.1016/j.echo.2010.10.005; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lewis RJ, 2010, JAMA-J AM MED ASSOC, V303, P777, DOI 10.1001/jama.2010.203; Lipcsey M, 2015, CRIT CARE RESUSC, V17, P6; LIU V, 2013, ANN AM THORAC SOC, V10, P466, DOI DOI 10.1513/AnnalsATS.201304-099OC; Manji RA, 2009, CRIT CARE CLIN, V25, P1, DOI 10.1016/j.ccc.2008.12.013; Millham FH, 2010, SURGERY, V148, P1026, DOI 10.1016/j.surg.2010.02.014; Morgan TJ, 2013, CURR OPIN CRIT CARE, V19, P299, DOI 10.1097/MCC.0b013e3283632d46; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Myburgh JA, 2013, NEW ENGL J MED, V369, P2462, DOI 10.1056/NEJMc1313345; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Patel GP, 2012, AM J RESP CRIT CARE, V185, P133, DOI 10.1164/rccm.201011-1897CI; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pearse RM, 2014, JAMA-J AM MED ASSOC, V311, P2181, DOI 10.1001/jama.2014.5305; Perner A, 2014, INTENS CARE MED, V40, P927, DOI 10.1007/s00134-014-3311-y; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Polito A, 2012, INTENS CARE MED, V38, P9, DOI 10.1007/s00134-011-2407-x; Puskarich MA, 2011, RESUSCITATION, V82, P1289, DOI 10.1016/j.resuscitation.2011.06.015; Rajaram SS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003408.pub3; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Reddy SK, 2014, CRIT CARE RESUSC, V16, P274; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; Richard JC, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0734-3; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rochwerg B, 2015, INTENS CARE MED, V41, P1561, DOI 10.1007/s00134-015-3794-1; Rochwerg B, 2014, ANN INTERN MED, V161, P347, DOI 10.7326/M14-0178; Rusconi AM, 2015, INTERN EMERG MED, V10, P731, DOI 10.1007/s11739-015-1248-y; Neto AS, 2012, CRIT CARE, V16, DOI 10.1186/cc11469; Shankar-Hari M, 2015, INTENS CARE MED, V41, P909, DOI 10.1007/s00134-015-3680-x; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Takala J, 2011, CRIT CARE, V15, DOI 10.1186/cc10273; Tisherman SA, 2004, J TRAUMA, V57, P898, DOI 10.1097/01.TA.0000133577.25793.E5; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Wang CS, 2014, ANESTH ANALG, V118, P346, DOI 10.1213/ANE.0000000000000050; Weil M H, 1971, Adv Exp Med Biol, V23, P13; Wiener RS, 2007, JAMA-J AM MED ASSOC, V298, P423, DOI 10.1001/jama.298.4.423; Wong HR, 2011, CRIT CARE MED, V39, P2511, DOI 10.1097/CCM.0b013e3182257675; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zhang L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0312-9; Zhang ZH, 2015, INTENS CARE MED, V41, P444, DOI 10.1007/s00134-014-3638-4; [No title captured]; [No title captured]; [No title captured]; [No title captured]	76	99	109	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					708	717		10.1001/jama.2015.7885	http://dx.doi.org/10.1001/jama.2015.7885			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284722	Green Accepted			2022-12-28	WOS:000360019100019
J	Famiglietti, JS; Cazenave, A; Eicker, A; Reager, JT; Rodell, M; Velicogna, I				Famiglietti, J. S.; Cazenave, A.; Eicker, A.; Reager, J. T.; Rodell, M.; Velicogna, I.			Satellites provide the big picture	SCIENCE			English	Editorial Material							WATER; MISSION		[Famiglietti, J. S.; Reager, J. T.; Velicogna, I.] CALTECH, NASA, Jet Prop Lab, Pasadena, CA 91125 USA; [Famiglietti, J. S.; Velicogna, I.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Famiglietti, J. S.] Univ Calif Irvine, Dept Civil & Environm Engn, Irvine, CA USA; [Cazenave, A.] CNES LEGOS, Toulouse, France; [Cazenave, A.] Int Space Sci Inst, Bern, Switzerland; [Eicker, A.] Univ Bonn, Inst Geodesy & Geoinformat, Bonn, Germany; [Rodell, M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Irvine; University of California System; University of California Irvine; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; University of Bonn; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Famiglietti, JS (corresponding author), CALTECH, NASA, Jet Prop Lab, Pasadena, CA 91125 USA.	james.famiglietti@jpl.nasa.gov	Famiglietti, James S/G-7383-2017; Rodell, Matthew/E-4946-2012; Eicker, Annette/B-6076-2014; Velicogna, Isabella/R-5561-2018	Famiglietti, James S/0000-0002-6053-5379; Rodell, Matthew/0000-0003-0106-7437; Eicker, Annette/0000-0002-9087-1445; Velicogna, Isabella/0000-0002-9020-1898				Anderson MC, 2011, HYDROL EARTH SYST SC, V15, P223, DOI 10.5194/hess-15-223-2011; Borsa AA, 2014, SCIENCE, V345, P1587, DOI 10.1126/science.1260279; Cazenave A, 2010, ANNU REV MAR SCI, V2, P145, DOI 10.1146/annurev-marine-120308-081105; Deems JS, 2013, HYDROL EARTH SYST SC, V17, P4401, DOI 10.5194/hess-17-4401-2013; Dery SJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031474; Durand M, 2010, P IEEE, V98, P766, DOI 10.1109/JPROC.2010.2043031; Entekhabi D, 2010, P IEEE, V98, P704, DOI 10.1109/JPROC.2010.2043918; Famiglietti JS, 2014, NAT CLIM CHANGE, V4, P945, DOI 10.1038/nclimate2425; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Famiglietti JS, 2013, SCIENCE, V340, P1300, DOI 10.1126/science.1236460; Hou AY, 2014, B AM METEOROL SOC, V95, P701, DOI 10.1175/BAMS-D-13-00164.1; Reager JT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040826; Richey AS, 2015, WATER RESOUR RES, V51, P5198, DOI 10.1002/2015WR017351; Richey AS, 2015, WATER RESOUR RES, V51, P5217, DOI 10.1002/2015WR017349; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rodell M., 2015, J CLIMATOL, DOI [10.1175/JCLI-D-14-00555, DOI 10.1175/JCLI-D-14-00555.(2015)]; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Thomas AC, 2014, GEOPHYS RES LETT, V41, P1537, DOI 10.1002/2014GL059323; Wood EF, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010090	20	72	74	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					684	685		10.1126/science.aac9238	http://dx.doi.org/10.1126/science.aac9238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273037	Green Submitted			2022-12-28	WOS:000359415100013
J	Tsai, CL; Williams, GJ; Perry, JJP; Tainer, JA				Tsai, Chi-Lin; Williams, Gareth J.; Perry, J. Jefferson P.; Tainer, John A.			An AAA plus ATPase Clamshell Targets Transposition	CELL			English	Editorial Material							MU	DNA transposition plays key roles in genome diversity, pathogenesis, and evolution. Yet, structural and mechanistic information on transposition targeting and regulation is limited. Arias-Palomo and Berger now define the decameric organization of the AAA+ ATPase IstB, unveiling key insights into its targeting and regulation of IstA transposase activity.	[Tsai, Chi-Lin; Williams, Gareth J.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Perry, J. Jefferson P.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Riverside; University of Texas System; UTMD Anderson Cancer Center	Tainer, JA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA.	jatainer@lbl.gov	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Tsai, Chi-Lin/0000-0002-0365-2405	NCI NIH HHS [P01 CA092584] Funding Source: Medline; NIEHS NIH HHS [R21ES025895, R21 ES025895] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025895] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arias-Palomo E, 2015, CELL, V162, P860, DOI 10.1016/j.cell.2015.07.037; Berger B, 2001, CELL MOL LIFE SCI, V58, P403, DOI 10.1007/PL00000866; Coleno-Costes A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003006; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mizuno N, 2013, P NATL ACAD SCI USA, V110, pE2441, DOI 10.1073/pnas.1309499110; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852	10	0	0	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					700	702		10.1016/j.cell.2015.07.050	http://dx.doi.org/10.1016/j.cell.2015.07.050			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276624	Bronze, Green Accepted			2022-12-28	WOS:000359741400003
J	Wang, B; Zhao, LD; Fish, M; Logan, CY; Nusse, R				Wang, Bruce; Zhao, Ludan; Fish, Matt; Logan, Catriona Y.; Nusse, Roel			Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver	NATURE			English	Article							STEM-CELLS; MATURE HEPATOCYTES; GENE-EXPRESSION; WNT PROTEINS; MOUSE; PROLIFERATION; EXPANSION; ACTIVATION; ZONATION; FATE	The source of new hepatocytes in the uninjured liver has remained an open question. By lineage tracing using the Wnt-responsive gene Axin2 in mice, we identify a population of proliferating and self-renewing cells adjacent to the central vein in the liver lobule. These pericentral cells express the early liver progenitor marker Tbx3, are diploid, and thereby differ from mature hepatocytes, which are mostly polyploid. The descendants of pericentral cells differentiate into Tbx3-negative, polyploid hepatocytes, and can replace all hepatocytes along the liver lobule during homeostatic renewal. Adjacent central vein endothelial cells provide Wnt signals that maintain the pericentral cells, thereby constituting the niche. Thus, we identify a cell population in the liver that subserves homeostatic hepatocyte renewal, characterize its anatomical niche, and identify molecular signals that regulate its activity.	[Wang, Bruce; Zhao, Ludan; Fish, Matt; Logan, Catriona Y.; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Stanford Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol,Sch Med, Stanford, CA 94305 USA; [Wang, Bruce] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Wang, Bruce] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nusse, R (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol,Sch Med, Stanford, CA 94305 USA.	bruce.wang@ucsf.edu; rnusse@stanford.edu		Wang, Bruce/0000-0003-3486-5494	Howard Hughes Medical Institute; Reed-Stinehart foundation;  [F32DK091005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091005, P30DK026743, K08DK101603] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Reed-Stinehart foundation; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the Howard Hughes Medical Institute and a grant from the Reed-Stinehart foundation. R.N. is an investigator with the Howard Hughes Medical Institute. B.W. was supported by F32DK091005. We thank D. M. Bissell and T. Desai for comments on the manuscript, V. Waehle for assistance in preparing RNA samples for RNA-seq, M. Britton for RNA-seq analysis, and P. Lovelace for assistance with FACS.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Ludtke THW, 2009, HEPATOLOGY, V49, P969, DOI 10.1002/hep.22700; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Moreira PI, 2007, TOXICOL APPL PHARM, V221, P102, DOI 10.1016/j.taap.2007.02.006; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; SCHWARZE PE, 1984, CARCINOGENESIS, V5, P1267, DOI 10.1093/carcin/5.10.1267; Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Vijayakumar S, 2011, CANCER CELL, V19, P601, DOI 10.1016/j.ccr.2011.03.010; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yu HMI, 2007, MECH DEVELOP, V124, P146, DOI 10.1016/j.mod.2006.10.002; ZAJICEK G, 1990, LIVER, V10, P137; ZAJICEK G, 1985, LIVER, V5, P293; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	48	434	453	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					180	+		10.1038/nature14863	http://dx.doi.org/10.1038/nature14863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26245375	Green Submitted, Green Accepted			2022-12-28	WOS:000359386900023
J	Zhang, R; Alushin, GM; Brown, A; Nogales, E				Zhang, Rui; Alushin, Gregory M.; Brown, Alan; Nogales, Eva			Mechanistic Origin of Microtubule Dynamic Instability and Its Modulation by EB Proteins	CELL			English	Article							ALPHA-BETA-TUBULIN; GTP HYDROLYSIS; PLUS-END; CRYO-EM; RESOLUTION; LATTICE; TRANSITIONS; TRACKING; COMPLEX; GROWTH	Microtubule (MT) dynamic instability is driven by GTP hydrolysis and regulated by microtubule-associated proteins, including the plus-end tracking end-binding protein (EB) family. We report six cryo-electron microscopy (cryo-EM) structures of MTs, at 3.5 angstrom or better resolution, bound to GMPCPP, GTP gamma S, or GDP, either decorated with kinesin motor domain after polymerization or copolymerized with EB3. Subtle changes around the E-site nucleotide during hydrolysis trigger conformational changes in alpha-tubulin around an "anchor point,'' leading to global lattice rearrangements and strain generation. Unlike the extended lattice of the GMPCPP-MT, the EB3-bound GTP gamma S-MT has a compacted lattice that differs in lattice twist from that of the also compacted GDP-MT. These results and the observation that EB3 promotes rapid hydrolysis of GMPCPP suggest that EB proteins modulate structural transitions at growing MT ends by recognizing and promoting an intermediate state generated during GTP hydrolysis. Our findings explain both EBs end-tracking behavior and their effect on microtubule dynamics.	[Zhang, Rui; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Alushin, Gregory M.] Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Brown, Alan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; MRC Laboratory Molecular Biology	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA.	enogales@lbl.gov	Brown, Alan/I-1473-2019	Brown, Alan/0000-0002-0021-0476; Alushin, Gregory/0000-0001-7250-4484	NIGMS [GM051487]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487, T32GM008295] Funding Source: NIH RePORTER; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Robert Glaeser for the use of the Titan microscope and for stimulating discussions. We thank Anchi Cheng and Tom Houwelling for assistance with Leginon installation and APPION data processing. We thank Alexis Rohou and Nikolaus Grigorieff for guidance in the use of FREALIGN. We also thank Stuart Howes for the purification of kinesin. The kinesin expression construct was a gift from Erik Jonsson and Ron Vale, and the EB3 cDNA was a gift from Clare Waterman. This work was funded by a grant from the NIGMS (GM051487 to E.N.). E.N. is a Howard Hughes Medical Institute investigator.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Anders KR, 2001, MOL BIOL CELL, V12, P3973, DOI 10.1091/mbc.12.12.3973; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; HAMEL E, 1984, J BIOL CHEM, V259, P1060; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; MANDELKOW EM, 1986, J CELL BIOL, V102, P1067, DOI 10.1083/jcb.102.3.1067; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Zhu ZQC, 2009, J BIOL CHEM, V284, P32651, DOI 10.1074/jbc.M109.013466	39	243	245	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					849	859		10.1016/j.cell.2015.07.012	http://dx.doi.org/10.1016/j.cell.2015.07.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26234155	Green Accepted, Bronze			2022-12-28	WOS:000359741400017
J	Maier, GP; Rapp, MV; Waite, JH; Israelachvili, JN; Butler, A				Maier, Greg P.; Rapp, Michael V.; Waite, J. Herbert; Israelachvili, Jacob N.; Butler, Alison			Adaptive synergy between catechol and lysine promotes wet adhesion by surface salt displacement	SCIENCE			English	Article							MUSSEL; PROTEINS; ENTEROBACTIN; HYDRATION; POLYMERS; COATINGS; PH	In physiological fluids and seawater, adhesion of synthetic polymers to solid surfaces is severely limited by high salt, pH, and hydration, yet these conditions have not deterred the evolution of effective adhesion by mussels. Mussel foot proteins provide insights about adhesive adaptations: Notably, the abundance and proximity of catecholic Dopa (3,4-dihydroxyphenylalanine) and lysine residues hint at a synergistic interplay in adhesion. Certain siderophores-bacterial iron chelators-consist of paired catechol and lysine functionalities, thereby providing a convenient experimental platform to explore molecular synergies in bioadhesion. These siderophores and synthetic analogs exhibit robust adhesion energies (E-ad >= -15 millijoules per square meter) to mica in saline pH 3.5 to 7.5 and resist oxidation. The adjacent catechol-lysine placement provides a "one-two punch," whereby lysine evicts hydrated cations from the mineral surface, allowing catechol binding to underlying oxides.	[Maier, Greg P.; Butler, Alison] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Rapp, Michael V.; Israelachvili, Jacob N.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Waite, J. Herbert] Univ Calif Santa Barbara, Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Israelachvili, Jacob N.] Univ Calif Santa Barbara, Mat Dept, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Waite, JH (corresponding author), Univ Calif Santa Barbara, Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	herbert.waite@lifesci.ucsb.edu; jacob@engineering.ucsb.edu; butler@chem.ucsb.edu	Butler, Alison/D-5094-2015	Butler, Alison/0000-0002-3525-7864	Materials Research and Science Engineering Centers Program of the National Science Foundation [DMR 1121053]; NSF [CHE-1411942]; NSF GRFP	Materials Research and Science Engineering Centers Program of the National Science Foundation; NSF(National Science Foundation (NSF)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD))	We are grateful for support from the Materials Research and Science Engineering Centers Program of the National Science Foundation under award DMR 1121053, NSF CHE-1411942 (A.B.), and NSF GRFP (M.R.).	Akdogan Y, 2014, ANGEW CHEM INT EDIT, V53, P11253, DOI 10.1002/anie.201406858; Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0; Israelachvili J, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/3/036601; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kastrup CJ, 2012, P NATL ACAD SCI USA, V109, P21444, DOI 10.1073/pnas.1217972110; Kim S, 2015, J MATER CHEM B, V3, P738, DOI 10.1039/c4tb01646g; Krogsgaard M, 2013, BIOMACROMOLECULES, V14, P297, DOI 10.1021/bm301844u; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Li YR, 2014, LANGMUIR, V30, P4358, DOI 10.1021/la501189n; PASHLEY RM, 1982, ADV COLLOID INTERFAC, V16, P57, DOI 10.1016/0001-8686(82)85006-9; Podsiadlo P, 2007, ADV MATER, V19, P949, DOI 10.1002/adma.200602706; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RODGERS SJ, 1987, INORG CHEM, V26, P1622, DOI 10.1021/ic00257a030; Rodriguez NRM, 2015, BIOFOULING, V31, P221, DOI 10.1080/08927014.2015.1026337; Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347; Sandy M, 2011, J NAT PROD, V74, P1207, DOI 10.1021/np200126z; Shao H, 2010, ADV MATER, V22, P729, DOI 10.1002/adma.200902380; Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Wang JH, 2008, CHEM MATER, V20, P20, DOI 10.1021/cm702375e; Wei Q, 2014, ANGEW CHEM INT EDIT, V53, P11650, DOI 10.1002/anie.201407113; White JD, 2011, MACROMOLECULES, V44, P5085, DOI 10.1021/ma201044x; YAMAMOTO H, 1987, J CHEM SOC PERK T 1, P613, DOI 10.1039/p19870000613; Yu J, 2013, P NATL ACAD SCI USA, V110, P15680, DOI 10.1073/pnas.1315015110; Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Zhang F, 2012, RSC ADV, V2, P8919, DOI 10.1039/c2ra21312e	29	419	434	47	537	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					628	632		10.1126/science.aab0556	http://dx.doi.org/10.1126/science.aab0556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250681	Green Submitted			2022-12-28	WOS:000359092900038
J	Greer, IA				Greer, Ian A.			Pregnancy Complicated by Venous Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARINS; CT PULMONARY ANGIOGRAPHY; ED AMERICAN-COLLEGE; ANTITHROMBOTIC THERAPY; POSTTHROMBOTIC SYNDROME; RISK-FACTORS; POSTPARTUM; EMBOLISM; THROMBOEMBOLISM	A 37-year-old primigravid woman presents at 12 weeks of gestation with a painful, swollen left leg, breathlessness, and lower abdominal pain. She has had hyperemesis for several weeks. She has no personal history of venous thrombosis, but she reports a family history of thrombosis in both her mother and her maternal aunt. On examination, she has a body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 36, and the entire leg is dusky and swollen. No abnormalities are detected on pulmonary examination, and the oxygen saturation is normal. How should her case be evaluated and treated?	[Greer, Ian A.] Univ Manchester, Fac Med & Human Sci, Manchester M13 9NT, Lancs, England	University of Manchester	Greer, IA (corresponding author), Univ Manchester, Fac Med & Human Sci, 46 Grafton St, Manchester M13 9NT, Lancs, England.	ian.greer@manchester.ac.uk			Sanofi; LEO Pharma	Sanofi; LEO Pharma(LEO Pharma)	Dr. Greer reports receiving lecture fees from Sanofi and LEO Pharma. No other potential conflict of interest relevant to this article was reported.	Allen C, 2006, RADIOLOGY, V240, P613, DOI 10.1148/radiol.2402051490; Bates SM, 2012, CHEST, V141, pE691S, DOI 10.1378/chest.11-2300; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Bourjeily G, 2010, LANCET, V375, P500, DOI 10.1016/S0140-6736(09)60996-X; Centre for Maternal and Child Enquiries (CMACE), 2011, BJOG S1, V118, P57; Chan WS, 2014, J OBSTET GYNAECOL CA, V36, P527, DOI 10.1016/S1701-2163(15)30569-7; Chan WS, 2013, CAN MED ASSOC J, V185, pE194, DOI 10.1503/cmaj.120895; Chan WS, 2009, ANN INTERN MED, V151, P85, DOI 10.7326/0003-4819-151-2-200907210-00004; Chan WS, 2002, ARCH INTERN MED, V162, P1170, DOI 10.1001/archinte.162.10.1170; Cutts BA, 2013, AM J OBSTET GYNECOL, V208, P102, DOI 10.1016/j.ajog.2012.06.035; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Greer IA, 2012, HEMATOL-AM SOC HEMAT, P203, DOI 10.1182/asheducation-2012.1.203; Groves AM, 2006, RADIOLOGY, V240, P765, DOI 10.1148/radiol.2403050910; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; HULL RD, 1990, ANN INTERN MED, V112, P663, DOI 10.7326/0003-4819-112-9-663; Hurwitz LM, 2009, AM J ROENTGENOL, V192, P244, DOI 10.2214/AJR.08.1066; Jacobsen AF, 2008, J THROMB HAEMOST, V6, P905, DOI 10.1111/j.1538-7836.2008.02961.x; Jacobsen AF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.041; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2005, AM J OBSTET GYNECOL, V193, P216, DOI 10.1016/j.ajog.2004.11.037; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Kane EV, 2013, EUR J OBSTET GYN R B, V169, P223, DOI 10.1016/j.ejogrb.2013.03.024; Kanungo J, 2011, OBSTET GYNECOL, V118, P872, DOI [10.1097/AOG.0b013e31822add60, 10.1097/AOG.0b013e3182310c4c]; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Khalafallah AA, 2012, THROMB RES, V130, pE171, DOI 10.1016/j.thromres.2012.05.022; Knol HM, 2012, THROMB RES, V130, P334, DOI 10.1016/j.thromres.2012.03.007; Le Gal G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2635; Mclintock C, 2012, AUST NZ J OBSTET GYN, V52, P14, DOI 10.1111/j.1479-828X.2011.01361.x; Milford W, 2009, AUST NZ J OBSTET GYN, V49, P331, DOI 10.1111/j.1479-828X.2009.01004.x; Nelson-Piercy C, 2011, EUR J OBSTET GYN R B, V159, P293, DOI 10.1016/j.ejogrb.2011.08.005; Nguyen CP, 2012, SEMIN ULTRASOUND CT, V33, P4, DOI 10.1053/j.sult.2011.09.003; O'Connor C, 2011, J MATERN-FETAL NEO M, V24, P1461, DOI 10.3109/14767058.2011.614652; Patel JP, 2013, CIRCULATION, V128, P1462, DOI 10.1161/CIRCULATIONAHA.113.003198; Raa GDT, 2009, THROMB RES, V124, P1, DOI 10.1016/j.thromres.2009.03.001; Remy-Jardin M, 1999, RADIOLOGY, V212, P615, DOI 10.1148/radiology.212.3.r99se02615; Ridge CA, 2009, AM J ROENTGENOL, V193, P1223, DOI 10.2214/AJR.09.2360; Righini M, 2013, HAEMATOLOGICA, V98, P545, DOI 10.3324/haematol.2012.072009; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; Romualdi E, 2013, J THROMB HAEMOST, V11, P270, DOI 10.1111/jth.12085; Scarsbrook AF, 2006, CLIN RADIOL, V61, P1, DOI 10.1016/j.crad.2005.08.015; Schembri GP, 2010, SEMIN NUCL MED, V40, P442, DOI 10.1053/j.semnuclmed.2010.07.007; Shahir K, 2010, AM J ROENTGENOL, V195, pW214, DOI 10.2214/AJR.09.3506; Tang AW, 2013, OBSTET MED, V6, P64, DOI 10.1177/1753495X12472642; Wik HS, 2012, J THROMB HAEMOST, V10, P840, DOI 10.1111/j.1538-7836.2012.04690.x	46	45	49	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					540	547		10.1056/NEJMcp1407434	http://dx.doi.org/10.1056/NEJMcp1407434			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26244307				2022-12-28	WOS:000358987700008
J	Loxterkamp, D				Loxterkamp, David			LETTER FROM NEW ENGLAND "Complicating relationships"-the water that doctors breathe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS; HABITS; CARE		Seaport Community Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com						Abramson S, 2000, CLIN J SPORT MED, V10, P40, DOI 10.1097/00042752-200001000-00008; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Bleich SN, 2012, OBESITY, V20, P999, DOI 10.1038/oby.2011.402; Brody H, 2000, J FAM PRACTICE, V49, P649; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Hash RB, 2003, PREV MED, V36, P41, DOI 10.1006/pmed.2002.1124; Hobbs FDR, 2002, FAM PRACT, V19, P596, DOI 10.1093/fampra/19.6.596; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; TURNER JA, 1994, JAMA-J AM MED ASSOC, V271, P1609, DOI 10.1001/jama.271.20.1609; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; WELLS KB, 1984, JAMA-J AM MED ASSOC, V252, P2846, DOI 10.1001/jama.252.20.2846; Zuger A., 2015, NY TIMES	15	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2015	351								h4185	10.1136/bmj.h4185	http://dx.doi.org/10.1136/bmj.h4185			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8AO	26238123				2022-12-28	WOS:000359387100007
J	Ribera, JM				Ribera, Josep-Maria			Leukaemic vasculitis from myelodysplastic syndrome in context	LANCET			English	Editorial Material							CUTIS		Univ Autonoma Barcelona, Josep Carreras Res Inst, ICO Hosp Germans Trias & Pujol, Dept Clin Haematol, Badalona 08916, Spain	Autonomous University of Barcelona; Catalan Institute of Oncology; Institut de Recerca Contra la Leucemia Josep Carreras (IJC)	Ribera, JM (corresponding author), Univ Autonoma Barcelona, Josep Carreras Res Inst, ICO Hosp Germans Trias & Pujol, Dept Clin Haematol, Badalona 08916, Spain.	jribera@iconcologia.net	Ribera, JM/B-8181-2009	Ribera, JM/0000-0003-1042-6024				Belizna C, 2013, AUTOIMMUN REV, V12, P943, DOI 10.1016/j.autrev.2013.01.005; Braun T, 2013, BEST PRACT RES CL HA, V26, P327, DOI 10.1016/j.beha.2013.09.003; Canueto J, 2011, J CUTAN PATHOL, V38, P360, DOI 10.1111/j.1600-0560.2010.01623.x; Odell I, LANCET, V386, P501; Oostvogels R, 2012, NETH J MED, V70, P63; Paydas S, 2000, BRIT J DERMATOL, V143, P773, DOI 10.1046/j.1365-2133.2000.03774.x	6	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					502	502		10.1016/S0140-6736(15)61285-5	http://dx.doi.org/10.1016/S0140-6736(15)61285-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251397				2022-12-28	WOS:000358761700032
J	Biele, J; Ulamec, S; Maibaum, M; Roll, R; Witte, L; Jurado, E; Munoz, P; Arnold, W; Auster, HU; Casas, C; Faber, C; Fantinati, C; Finke, F; Fischer, HH; Geurts, K; Guttler, C; Heinisch, P; Herique, A; Hviid, S; Kargl, G; Knapmeyer, M; Knollenberg, J; Kofman, W; Komle, N; Kuhrt, E; Lommatsch, V; Mottola, S; de Santayana, RP; Remetean, E; Scholten, F; Seidensticker, KJ; Sierks, H; Spohn, T				Biele, Jens; Ulamec, Stephan; Maibaum, Michael; Roll, Reinhard; Witte, Lars; Jurado, Eric; Munoz, Pablo; Arnold, Walter; Auster, Hans-Ulrich; Casas, Carlos; Faber, Claudia; Fantinati, Cinzia; Finke, Felix; Fischer, Hans-Herbert; Geurts, Koen; Guettler, Carsten; Heinisch, Philip; Herique, Alain; Hviid, Stubbe; Kargl, Guenter; Knapmeyer, Martin; Knollenberg, Joerg; Kofman, Wlodek; Koemle, Norbert; Kuehrt, Ekkehard; Lommatsch, Valentina; Mottola, Stefano; de Santayana, Ramon Pardo; Remetean, Emile; Scholten, Frank; Seidensticker, Klaus J.; Sierks, Holger; Spohn, Tilman			The landing(s) of Philae and inferences about comet surface mechanical properties	SCIENCE			English	Article							67P/CHURYUMOV-GERASIMENKO; STRENGTH; NUCLEUS; LANDER; IMPACT	The Philae lander, part of the Rosetta mission to investigate comet 67P/Churyumov-Gerasimenko, was delivered to the cometary surface in November 2014. Here we report the precise circumstances of the multiple landings of Philae, including the bouncing trajectory and rebound parameters, based on engineering data in conjunction with operational instrument data. These data also provide information on the mechanical properties (strength and layering) of the comet surface. The first touchdown site, Agilkia, appears to have a granular soft surface (with a compressive strength of 1 kilopascal) at least similar to 20 cm thick, possibly on top of a more rigid layer. The final landing site, Abydos, has a hard surface.	[Biele, Jens; Ulamec, Stephan; Maibaum, Michael; Fantinati, Cinzia; Finke, Felix; Fischer, Hans-Herbert; Geurts, Koen; Lommatsch, Valentina] Deutsch Zentrum Luft & Raumfahrt DLR Raumflugbetr, MUSC, D-51147 Cologne, Germany; [Witte, Lars] DLR Instr Raumfahrtsyst, D-28359 Bremen, Germany; [Roll, Reinhard; Guettler, Carsten; Sierks, Holger] Max Planck Inst Sonnensyst Forsch MPS, D-37077 Gottingen, Germany; [Faber, Claudia; Hviid, Stubbe; Knapmeyer, Martin; Knollenberg, Joerg; Kuehrt, Ekkehard; Mottola, Stefano; Scholten, Frank; Seidensticker, Klaus J.; Spohn, Tilman] DLR Inst Planetenforsch, D-12489 Berlin, Germany; [Munoz, Pablo; Casas, Carlos; de Santayana, Ramon Pardo] European Space Agcy, European Space Operat Ctr, D-64293 Darmstadt, Germany; [Auster, Hans-Ulrich; Heinisch, Philip] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; Austria Austrian Acad Sci, Space Res Inst, Inst Weltraumforsch IWF Graz, Graz, Austria; [Herique, Alain; Kofman, Wlodek] Univ Grenoble Alpes, F-38000 Grenoble, France; [Herique, Alain; Kofman, Wlodek] CNRS, Inst Planetol & Astrophys Grenoble, F-38000 Grenoble, France; [Jurado, Eric; Remetean, Emile] Ctr Natl Etud Spatiales, F-31400 Toulouse, France; [Arnold, Walter] Univ Gottingen, Inst Phys 1, D-37077 Gottingen, Germany; [Arnold, Walter] Univ Saarland, Dept Mat Sci, D-66123 Saarbrucken, Germany; Magellium, F-31521 Ramonville St Agne, France; [Munoz, Pablo; Casas, Carlos; de Santayana, Ramon Pardo] ESA, ESOC GMV, Grp Mecan Vuelo, D-64293 Darmstadt, Germany	Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society; Helmholtz Association; German Aerospace Centre (DLR); European Space Agency; Braunschweig University of Technology; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); University of Gottingen; Saarland University	Biele, J (corresponding author), Deutsch Zentrum Luft & Raumfahrt DLR Raumflugbetr, MUSC, Linder Hohe 1, D-51147 Cologne, Germany.	jens.biele@dlr.de	Kofman, Wlodek/C-4556-2008; Knapmeyer, Martin/A-5783-2012; Arnold, Walter K./G-4717-2011; Witte, Lars/AAA-7150-2021; Casas, Carlos M./ABF-4828-2021; Biele, Jens/ABI-1218-2020; Heinisch, Philip/X-8325-2019; Herique, Alain/E-7210-2017	Kofman, Wlodek/0000-0002-6744-8796; Knapmeyer, Martin/0000-0003-0319-2514; Arnold, Walter K./0000-0003-3588-8719; Witte, Lars/0000-0002-3921-2524; Casas, Carlos M./0000-0002-5623-2113; Biele, Jens/0000-0002-7414-829X; Heinisch, Philip/0000-0003-1873-3598; Herique, Alain/0000-0003-3699-883X; Seidensticker, Klaus J./0000-0003-3671-3769; Kargl, Gunter/0000-0001-9125-0256	German Ministerium fur Wirtschaft und Energie; Deutsches Zentrum fur Luft- und Raumfahrt [50QP1401]; CNES; CNRS; Universite Joseph Fourier, Grenoble	German Ministerium fur Wirtschaft und Energie; Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)); CNES(Centre National D'etudes Spatiales); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier, Grenoble	Rosetta is an ESA mission with contributions from its member states and NASA. Rosetta's Philae lander is provided by a consortium led by DLR, MPS, CNES, and Agenzia Spaziale Italiana (ASI). Further important contributions came from the Magyar Tudomanyos Akademia Wigner Fizikai Kutatokozpont, Max-Planck-Institut fur Extraterrestrische Physik (MPE), the Finnish Meteorological Institute (FMI), the UK Space Agency, Space Technology Ireland Ltd. (STIL), and IWF. The contribution of the ROMAP and RPC-MAG [Rosetta Plasma Consortium (RPC) Fluxgate Magnetometer] team was financially supported by the German Ministerium fur Wirtschaft und Energie and the Deutsches Zentrum fur Luft- und Raumfahrt under contract 50QP1401. The contribution of the CONSERT team was supported by CNES, CNRS, and Universite Joseph Fourier, Grenoble. The images and data used in this study are archived in (16). The authors thank the teams of Rosetta and Philae, including those for the scientific instruments, for making this endeavor possible. Special thanks go to the ESA flight dynamics team for its strong support to prepare and realize the landing of Philae. This mission would not have been possible without the outstanding contributions of the orbiter instrument teams needed for landing site selection and lander operations, in particular the OSIRIS, MIRO (Microwave Instrument for the Rosetta Orbiter), VIRTIS (Visible, Infrared, and Thermal Imaging Spectrometer); ALICE (An ultraviolet imaging spectrometer for the Rosetta orbiter), and ROSINA (Rosetta Orbiter Spectrometer for Ion and Neutral Analysis) teams. Special thanks go to M. Hilchenbach for stimulating discussions and M. Hofmann, P. Gutierrez-Marques, and C. Tubiana for the processing of OSIRIS images for this paper. The authors also express their appreciation to H. Rosenbauer, whose effort and inspiration were essential ALICE (An ultraviolet imaging spectrometer for the Rosetta orbiter) for the realization of Philae.	A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Auster HU, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5102; Bibring JP, 2015, SCIENCE, V349, DOI 10.1126/science.aab0671; Biele J, 2009, ACTA ASTRONAUT, V65, P1168, DOI 10.1016/j.actaastro.2009.03.041; Blum J, 2014, ICARUS, V235, P156, DOI 10.1016/j.icarus.2014.03.016; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Faber C, 2015, PLANET SPACE SCI, V106, P46, DOI 10.1016/j.pss.2014.11.023; Fornasier S, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525901; Heggy E, 2012, ICARUS, V221, P925, DOI 10.1016/j.icarus.2012.09.023; Hegler S, 2013, PLANET SPACE SCI, V89, P151, DOI 10.1016/j.pss.2013.09.015; Holsapple K. A., 2006, P 37 LPSC 37 LEAG CI; Kamoun P, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201423544; Kofman W, 2015, SCIENCE, V349, DOI 10.1126/science.aab0639; Komle NI, 2001, PLANET SPACE SCI, V49, P575, DOI 10.1016/S0032-0633(00)00169-0; Mottola S, 2015, SCIENCE, V349, DOI 10.1126/science.aab0232; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Spohn T, 2015, SCIENCE, V349, DOI 10.1126/science.aab0464; THOMAS H, 1994, ADV SPACE RES, V14, P207, DOI 10.1016/0273-1177(94)90271-2; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Tomas J, 2004, GRANUL MATTER, V6, P75, DOI 10.1007/s10035-004-0167-9; Trigo-Rodriguez JM, 2007, MON NOT R ASTRON SOC, V375, P415, DOI 10.1111/j.1365-2966.2006.11310.x; Trigo-Rodriguez JM, 2006, MON NOT R ASTRON SOC, V372, P655, DOI 10.1111/j.1365-2966.2006.10843.x; Witte L, 2014, J SPACECRAFT ROCKETS, V51, P1885, DOI 10.2514/1.A32906	23	198	200	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aaa9816	10.1126/science.aaa9816	http://dx.doi.org/10.1126/science.aaa9816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228158				2022-12-28	WOS:000358713300002
J	Bose, SK; Marder, TB				Bose, Shubhankar Kumar; Marder, Todd B.			A leap ahead for activating C-H bonds	SCIENCE			English	Editorial Material							CATALYZED BORYLATION; INSIGHTS		[Bose, Shubhankar Kumar; Marder, Todd B.] Univ Wurzburg, Inst Inorgan Chem, D-97074 Wurzburg, Germany	University of Wurzburg	Marder, TB (corresponding author), Univ Wurzburg, Inst Inorgan Chem, D-97074 Wurzburg, Germany.	todd.marder@uni-wuerzburg.de	Marder, Todd B./R-6017-2019; Lei, Aiwen/G-8033-2015; bose, shubhankar Kumar/AAV-8365-2020	Lei, Aiwen/0000-0001-8417-3061; Bose, Shubhankar Kumar/0000-0002-1057-2403; Marder, Todd/0000-0002-9990-0169	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge the support of the Deutsche Forschungsgemeinschaft.	Bagutski V, 2013, J AM CHEM SOC, V135, P474, DOI 10.1021/ja3100963; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Chow WK, 2013, RSC ADV, V3, P12518, DOI 10.1039/c3ra22905j; Hall DG, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, P1, DOI 10.1002/9783527639328; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Legare MA, 2015, SCIENCE, V349, P513, DOI 10.1126/science.aab3591; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; NGUYEN P, 1993, J AM CHEM SOC, V115, P9329, DOI 10.1021/ja00073a075; Prokofjevs A, 2011, ANGEW CHEM INT EDIT, V50, P2098, DOI 10.1002/anie.201005663; Ribas X, 2013, RSC CATAL SER, pVII; Stephan DW, 2015, ANGEW CHEM INT EDIT, V54, P6400, DOI 10.1002/anie.201409800; Tajuddin H, 2012, CHEM SCI, V3, P3505, DOI 10.1039/c2sc20776a; Vanchura BA, 2010, CHEM COMMUN, V46, P7724, DOI 10.1039/c0cc02041a; Welch GC, 2006, SCIENCE, V314, P1124, DOI 10.1126/science.1134230	15	43	43	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					473	474		10.1126/science.aac9244	http://dx.doi.org/10.1126/science.aac9244			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228126				2022-12-28	WOS:000358713300028
J	Legare, MA; Courtemanche, MA; Rochette, E; Fontaine, FG				Legare, Marc-Andre; Courtemanche, Marc-Andre; Rochette, Etienne; Fontaine, Frederic-Georges			Metal-free catalytic C-H bond activation and borylation of heteroarenes	SCIENCE			English	Article							FRUSTRATED-LEWIS-PAIR; FREE HYDROGEN ACTIVATION; DEPROTONATION MECHANISM; ARENES; CONSTRUCTION; REDUCTION; ARYLATION; INSIGHTS; SCOPE	Transition metal complexes are efficient catalysts for the C-H bond functionalization of heteroarenes to generate useful products for the pharmaceutical and agricultural industries. However, the costly need to remove potentially toxic trace metals from the end products has prompted great interest in developing metal-free catalysts that can mimic metallic systems. We demonstrated that the borane (1-TMP-2-BH2-C6H4)(2) (TMP, 2,2,6,6-tetramethylpiperidine) can activate the C-H bonds of heteroarenes and catalyze the borylation of furans, pyrroles, and electron-rich thiophenes. The selectivities complement those observed with most transition metal catalysts reported for this transformation.	[Legare, Marc-Andre; Courtemanche, Marc-Andre; Rochette, Etienne; Fontaine, Frederic-Georges] Univ Laval, Dept Chim, Ctr Catalyse & Chim Verte C3V, 1045 Ave Med, Quebec City, PQ G1V 0A6, Canada	Laval University	Fontaine, FG (corresponding author), Univ Laval, Dept Chim, Ctr Catalyse & Chim Verte C3V, 1045 Ave Med, Quebec City, PQ G1V 0A6, Canada.	frederic.fontaine@chm.ulaval.ca	Courtemanche, Marc-André/F-3308-2016	Courtemanche, Marc-André/0000-0002-3016-2487; Fontaine, Frederic-Georges/0000-0003-3385-0258	National Sciences and Engineering Research Council of Canada (NSERC); Centre in Green Chemistry and Catalysis (Quebec); NSERC; Fonds de Recherche du Quebec - Nature et Technologies	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre in Green Chemistry and Catalysis (Quebec); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec - Nature et Technologies	We acknowledge the contribution of N. Bouchard and J. Legare-Lavergne in the preparation of some compounds and discussions with S. A. Westcott and P. McBreen. We acknowledge D. Lariviere and L. Whitty-Leveille for the inductively coupled plasma mass spectrometry analyses and P. Audet for his technical help. The work was supported by the National Sciences and Engineering Research Council of Canada (NSERC) and the Centre in Green Chemistry and Catalysis (Quebec). Computational studies were made possible by Compute Canada. M.-A. L., M.-A.C., and E.R. acknowledge NSERC and the Fonds de Recherche du Quebec - Nature et Technologies for scholarships.	Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Basle O, 2012, CHEM COMMUN, V48, P4495, DOI 10.1039/c2cc30399j; Chernichenko K, 2015, ANGEW CHEM INT EDIT, V54, P1749, DOI 10.1002/anie.201410141; Chernichenko K, 2013, NAT CHEM, V5, P718, DOI [10.1038/NCHEM.1693, 10.1038/nchem.1693]; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Courtemanche MA, 2013, J AM CHEM SOC, V135, P9326, DOI 10.1021/ja404585p; Del Grosso A, 2011, ANGEW CHEM INT EDIT, V50, P2102, DOI 10.1002/anie.201006196; Del Grosso A, 2010, ORGANOMETALLICS, V29, P241, DOI 10.1021/om900893g; Dombray T, 2015, J AM CHEM SOC, V137, P4062, DOI 10.1021/jacs.5b00895; Furukawa T, 2015, CHEM COMMUN, V51, P6508, DOI 10.1039/c5cc01378j; Gomez-Gallego M, 2011, CHEM REV, V111, P4857, DOI 10.1021/cr100436k; Gorelsky SI, 2008, J AM CHEM SOC, V130, P10848, DOI 10.1021/ja802533u; Gorelsky SI, 2013, COORDIN CHEM REV, V257, P153, DOI 10.1016/j.ccr.2012.06.016; Gorelsky SI, 2012, J ORG CHEM, V77, P658, DOI 10.1021/jo202342q; Hall DG, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, P1, DOI 10.1002/9783527639328; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2014, GUID EL IMP Q3D; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Ji L, 2014, CHEM-EUR J, V20, P13618, DOI 10.1002/chem.201402273; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Larsen MA, 2014, J AM CHEM SOC, V136, P4287, DOI 10.1021/ja412563e; Mazzacano TJ, 2013, J AM CHEM SOC, V135, P17258, DOI 10.1021/ja408861p; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Nielsen FH, 1997, PLANT SOIL, V193, P199, DOI 10.1023/A:1004276311956; Profofjevs A., 2011, ANGEW CHEM INT EDIT, V50, P2098; Rousseaux S., 2012, MODERN TOOLS SYNTHES; Stephan DW, 2012, ORG BIOMOL CHEM, V10, P5740, DOI 10.1039/c2ob25339a; Stephan DW, 2010, ANGEW CHEM INT EDIT, V49, P46, DOI 10.1002/anie.200903708; Tajuddin H, 2012, CHEM SCI, V3, P3505, DOI 10.1039/c2sc20776a; Takagi J, 2002, TETRAHEDRON LETT, V43, P5649, DOI 10.1016/S0040-4039(02)01135-8; Usluer O, 2014, ACS MACRO LETT, V3, P1134, DOI 10.1021/mz500590d; Vanchura BA, 2010, CHEM COMMUN, V46, P7724, DOI 10.1039/c0cc02041a; Welch GC, 2006, SCIENCE, V314, P1124, DOI 10.1126/science.1134230; Wencel-Delord J, 2013, NAT CHEM, V5, P369, DOI 10.1038/nchem.1607	34	272	275	21	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					513	516		10.1126/science.aab3591	http://dx.doi.org/10.1126/science.aab3591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228143				2022-12-28	WOS:000358713300050
J	Sudmant, PH; Mallick, S; Nelson, BJ; Hormozdiari, F; Krumm, N; Huddleston, J; Coe, BP; Baker, C; Nordenfelt, S; Bamshad, M; Jorde, LB; Posukh, OL; Sahakyan, H; Watkins, WS; Yepiskoposyan, L; Abdullah, MS; Bravi, CM; Capelli, C; Hervig, T; Wee, JTS; Tyler-Smith, C; van Driem, G; Romero, IG; Jha, AR; Karachanak-Yankova, S; Toncheva, D; Comas, D; Henn, B; Kivisild, T; Ruiz-Linares, A; Sajantila, A; Metspalu, E; Parik, J; Villems, R; Starikovskaya, EB; Ayodo, G; Beall, CM; Di Rienzo, A; Hammer, MF; Khusainova, R; Khusnutdinova, E; Klitz, W; Winkler, C; Labuda, D; Metspalu, M; Tishkoff, SA; Dryomov, S; Sukernik, R; Patterson, N; Reich, D; Eichler, EE				Sudmant, Peter H.; Mallick, Swapan; Nelson, Bradley J.; Hormozdiari, Fereydoun; Krumm, Niklas; Huddleston, John; Coe, Bradley P.; Baker, Carl; Nordenfelt, Susanne; Bamshad, Michael; Jorde, Lynn B.; Posukh, Olga L.; Sahakyan, Hovhannes; Watkins, W. Scott; Yepiskoposyan, Levon; Abdullah, M. Syafiq; Bravi, Claudio M.; Capelli, Cristian; Hervig, Tor; Wee, Joseph T. S.; Tyler-Smith, Chris; van Driem, George; Romero, Irene Gallego; Jha, Aashish R.; Karachanak-Yankova, Sena; Toncheva, Draga; Comas, David; Henn, Brenna; Kivisild, Toomas; Ruiz-Linares, Andres; Sajantila, Antti; Metspalu, Ene; Parik, Jueri; Villems, Richard; Starikovskaya, Elena B.; Ayodo, George; Beall, Cynthia M.; Di Rienzo, Anna; Hammer, Michael F.; Khusainova, Rita; Khusnutdinova, Elza; Klitz, William; Winkler, Cheryl; Labuda, Damian; Metspalu, Mait; Tishkoff, Sarah A.; Dryomov, Stanislav; Sukernik, Rem; Patterson, Nick; Reich, David; Eichler, Evan E.			Global diversity, population stratification, and selection of human copy-number variation	SCIENCE			English	Article							HUMAN GENOME SEQUENCE; SEGMENTAL DUPLICATIONS; CODING VARIATION; POLYMORPHISMS; ASSOCIATION; DELETION; HISTORY; REGIONS; AUTISM; MICRODELETION	In order to explore the diversity and selective signatures of duplication and deletion human copy-number variants (CNVs), we sequenced 236 individuals from 125 distinct human populations. We observed that duplications exhibit fundamentally different population genetic and selective signatures than deletions and are more likely to be stratified between human populations. Through reconstruction of the ancestral human genome, we identify megabases of DNA lost in different human lineages and pinpoint large duplications that introgressed from the extinct Denisova lineage now found at high frequency exclusively in Oceanic populations. We find that the proportion of CNV base pairs to single-nucleotide-variant base pairs is greater among non-Africans than it is among African populations, but we conclude that this difference is likely due to unique aspects of non-African population history as opposed to differences in CNV load.	[Sudmant, Peter H.; Nelson, Bradley J.; Hormozdiari, Fereydoun; Krumm, Niklas; Huddleston, John; Coe, Bradley P.; Baker, Carl; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Mallick, Swapan; Nordenfelt, Susanne; Patterson, Nick; Reich, David] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA USA; [Mallick, Swapan; Nordenfelt, Susanne; Patterson, Nick; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98119 USA; [Jorde, Lynn B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA; [Posukh, Olga L.] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Posukh, Olga L.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Sahakyan, Hovhannes; Metspalu, Ene; Parik, Jueri; Villems, Richard; Metspalu, Mait] Estonian Bioctr, Evolutionary Biol Grp, EE-51010 Tartu, Estonia; [Sahakyan, Hovhannes; Yepiskoposyan, Levon] Natl Acad Sci Armenia, Inst Mol Biol, Lab Ethnogen, Yerevan 0014, Armenia; [Watkins, W. Scott] Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84112 USA; [Abdullah, M. Syafiq] Raja Isteri Pengiran Anak Saleha RIPAS Hosp, Bandar Seri Begawan, Brunei Darussal, Brunei; [Bravi, Claudio M.] CCT CONICET, Inst Multidisciplinario Biol Celular IMBICE, Lab Genet Mol Poblac, Rio Cuarto, Argentina; [Bravi, Claudio M.] CICPBA, Rio Cuarto, Argentina; [Capelli, Cristian] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Hervig, Tor] Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway; [Wee, Joseph T. S.] Natl Canc Ctr Singapore, Singapore, Singapore; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [van Driem, George] Univ Bern, Inst Linguist, CH-3012 Bern, Switzerland; [Romero, Irene Gallego; Jha, Aashish R.; Di Rienzo, Anna] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Karachanak-Yankova, Sena; Toncheva, Draga] Med Univ Sofia, Natl Human Genome Ctr, Dept Med Genet, Sofia 1431, Bulgaria; [Comas, David] CSIC UPF, Dept Ciencies Expt, Inst Biol Evolut, Barcelona 08003, Spain; [Henn, Brenna] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Kivisild, Toomas] Univ Cambridge, Div Biol Anthropol, Cambridge CB2 1QH, England; [Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Sajantila, Antti] Univ Helsinki, Dept Forens Med, Helsinki 00014, Finland; [Metspalu, Ene] Univ Tartu, Dept Evolutionary Biol, EE-5101 Tartu, Estonia; [Starikovskaya, Elena B.; Dryomov, Stanislav; Sukernik, Rem] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Lab Human Mol Genet, Novosibirsk 630090, Russia; [Ayodo, George] Ctr Global Hlth & Child Dev, Kisumu 40100, Kenya; [Beall, Cynthia M.] Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; [Hammer, Michael F.] Univ Arizona, Div Biotechnol, Arizona Res Labs, Tucson, AZ 85721 USA; [Khusainova, Rita; Khusnutdinova, Elza] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Khusainova, Rita; Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Russia; [Klitz, William] Univ Calif Berkeley, Integrat Biol, Berkeley, CA 94720 USA; [Winkler, Cheryl] NCI, Bas Res Lab, Ctr Canc Res, Leidos Biomed Res Inc,Frederick Natl Lab, Ft Detrick, MD 21702 USA; [Labuda, Damian] Univ Montreal, Ctr Hosp Univ CHU St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Tishkoff, Sarah A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Dryomov, Stanislav] Russian Acad Sci, Inst Archaeol & Ethnog, Siberian Branch, Dept Paleolith Archaeol, Novosibirsk 630090, Russia; [Sukernik, Rem] Altai State Univ, Barnaul 656000, Russia; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Huddleston, John; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Estonian Biocentre; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Utah System of Higher Education; University of Utah; University of Oxford; University of Bergen; National Cancer Centre Singapore (NCCS); Wellcome Trust Sanger Institute; University of Bern; University of Chicago; Medical University Sofia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Cambridge; University of London; University College London; University of Helsinki; University of Tartu; Russian Academy of Sciences; Case Western Reserve University; University of Arizona; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Pennsylvania; University of Pennsylvania; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Altai State University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Sukernik, Rem I/N-6990-2015; Coe, Bradley/A-2878-2009; Posukh, Olga L/Q-6065-2016; Comas, David/D-5382-2014; Karachanak-Yankova, Sena/AAL-2721-2021; Dryomov, Stanislav/N-5476-2015; Kivisild, Toomas/P-5889-2017; Metspalu, Mait/G-8671-2015; Starikovskaya, Elena/N-5636-2015; Khusainova, Rita/E-6061-2014; Sajantila, Antti/AAY-9084-2021; Khusnutdinova, Elza Kamilevna/A-4810-2013; Ruiz-Linares, Andres/AAR-1104-2021	Posukh, Olga L/0000-0003-1352-3591; Comas, David/0000-0002-5075-0956; Karachanak-Yankova, Sena/0000-0001-6441-629X; Kivisild, Toomas/0000-0002-6297-7808; Metspalu, Mait/0000-0003-3099-9161; Khusainova, Rita/0000-0002-8643-850X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Ruiz-Linares, Andres/0000-0001-8372-1011; van Driem, George/0000-0002-7185-0657; Jha, Aashish/0000-0003-3227-1086; Sajantila, Antti/0000-0003-4117-5248; Toncheva, Draga/0000-0002-7451-6363; Sudmant, Peter/0000-0002-9573-8248; Coe, Bradley/0000-0001-8471-4016; Capelli, Cristian/0000-0001-9348-9084; Sahakyan, Hovhannes/0000-0003-1596-2838; Gallego Romero, Irene/0000-0003-1613-8998; Di Rienzo, Anna/0000-0002-8982-9098	National Cancer Institute, NIH [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; NIH [2R01HG002385, 5DP1ES022577 05, 1R01DK104339-01, 1R01GM113657-01]; Paul G. Allen Family Foundation [11631]; Simons Foundation [SFARI 280376]; HOMINID grant from the NSF [BCS-1032255]; European Research Council [FP7 - 26213]; Ministry of Education and Science, Russian Federation [14.Z50.31.0010]; Estonian Research Council [IUT24-1]; European Regional Development Fund (European Union) through the Centre of Excellence in Genomics; University of Tartu; Wellcome Trust [098051]; NSF [0924726, 1153911]; Direct For Social, Behav & Economic Scie [1153911] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119577] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113657, T32GM007266] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Family Foundation; Simons Foundation; HOMINID grant from the NSF; European Research Council(European Research Council (ERC)European Commission); Ministry of Education and Science, Russian Federation(Ministry of Education and Science, Russian FederationRussian Federation); Estonian Research Council(Estonian Research Council); European Regional Development Fund (European Union) through the Centre of Excellence in Genomics; University of Tartu; Wellcome Trust(Wellcome TrustEuropean Commission); NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the volunteers who donated the DNA samples used in this study. This project has been funded in part with federal funds from the National Cancer Institute, NIH, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This work was also partly supported by NIH grant 2R01HG002385 and a grant (11631) from the Paul G. Allen Family Foundation to E.E.E. The sequencing for this study was supported by a grant from the Simons Foundation to D.R. (SFARI 280376) and by a HOMINID grant from the NSF to D.R. (BCS-1032255). T.K. is supported by a European Research Council Starting Investigator grant (FP7 - 26213). R.S. and S.D. received support from the Ministry of Education and Science, Russian Federation (14.Z50.31.0010). H.S., E.M., R.V., and M.M. are supported by Institutional Research Funding from the Estonian Research Council IUT24-1 and by the European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre and University of Tartu. S.A.T. is supported by NIH grants 5DP1ES022577 05, 1R01DK104339-01, and 1R01GM113657-01. C.T.-S. is supported by Wellcome Trust grant 098051. C.M.B. is supported by the NSF (award numbers 0924726 and 1153911). E.E.E. and D.R. are investigators of the Howard Hughes Medical Institute. Data are deposited into ENA (PRJEB9586 or ERP010710), and variant calls are deposited in dbVar (PRJNA285786). E.E.E. is on the scientific advisory board of DNAnexus, Incorporated, and is a consultant for Kunming University of Science and Technology (KUST) as part of the 1000 China Talent Program.	Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Davis JM, 2015, HUM GENET, V134, P569, DOI 10.1007/s00439-015-1537-6; Deciphering Developmental Disorders Study, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Do R, 2015, NAT GENET, V47, P126, DOI 10.1038/ng.3186; Duggan AT, 2014, AM J HUM GENET, V94, P721, DOI 10.1016/j.ajhg.2014.03.014; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Fu WQ, 2014, AM J HUM GENET, V95, P421, DOI 10.1016/j.ajhg.2014.09.006; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gravel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004023; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Hardwick RJ, 2014, HUM GENET, V133, P69, DOI 10.1007/s00439-013-1352-x; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	50	211	215	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253							aab3761	10.1126/science.aab3761	http://dx.doi.org/10.1126/science.aab3761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26249230	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000360968400033
J	Eickhoff, S; Brewitz, A; Gerner, MY; Klauschen, F; Komander, K; Hemmi, H; Garbi, N; Kaisho, T; Germain, RN; Kastenmuller, W				Eickhoff, Sarah; Brewitz, Anna; Gerner, Michael Y.; Klauschen, Frederick; Komander, Karl; Hemmi, Hiroaki; Garbi, Natalio; Kaisho, Tsuneyasu; Germain, Ronald Nathan; Kastenmueller, Wolfgang			Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions	CELL			English	Article							CROSS-PRESENTATION; IN-VIVO; CD8(+); ANTIGEN; CD4(+); MEMORY; HELP; RESPONSES; POPULATION; EXPANSION	Host defense against viruses and intracellular parasites depends on effector CD8(+) T cells, whose optimal clonal expansion, differentiation, and memory properties require signals from CD4(+) T cells. Here, we addressed the role of dendritic cell (DC) subsets in initial activation of the two T cell types and their co-operation. Surprisingly, initial priming of CD4(+) and CD8(+) T cells was spatially segregated within the lymph node and occurred on different DCs with temporally distinct patterns of antigen presentation via MHCI versus MHCII molecules. DCs that co-present antigen via both MHC molecules were detected at a later stage; these XCR1(+) DCs are the critical platform involved in CD4(+) T cell augmentation of CD8(+) T cell responses. These findings delineate the complex choreography of cellular interactions underlying effective cell-mediated antiviral responses, with implications for basic DC subset biology, as well as for translational application to the development of vaccines that evoke optimal T cell immunity.	[Eickhoff, Sarah; Brewitz, Anna; Komander, Karl; Garbi, Natalio; Kastenmueller, Wolfgang] Univ Bonn, Inst Expt Immunol, D-53105 Bonn, Germany; [Gerner, Michael Y.; Germain, Ronald Nathan] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Klauschen, Frederick] Charite, Inst Pathol, D-10117 Berlin, Germany; [Hemmi, Hiroaki; Kaisho, Tsuneyasu] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Hemmi, Hiroaki; Kaisho, Tsuneyasu] RIKEN Ctr Integrat Med Sci IMS RCAI, Lab Inflammatory Regulat, Yokohama, Kanagawa 2300045, Japan	University of Bonn; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Osaka University; RIKEN	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov; wkastenm@uni-bonn.de	Germain, Ronald N./Z-1945-2019; Klauschen, Frederick/C-5637-2015; Germain, Ronald/ABE-7090-2020	Klauschen, Frederick/0000-0002-9131-2389; Gerner, Michael/0000-0001-5406-8308	NIAID; NIH; DFG Excellence Cluster ImmunoSensation in Bonn, Germany [SFB670/SFB704]; NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia; Kishimoto Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for the Promotion of Science; Human Frontier Science Program (HFSP) [RGY007/2011]; Einstein Foundation Berlin; Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000758, ZIAAI000545, K22AI108628] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG Excellence Cluster ImmunoSensation in Bonn, Germany; NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia; Kishimoto Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Einstein Foundation Berlin; Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank S. Ebbinghaus and S. Rathmann for technical assistance; C. Kurts for scientific discussions and critically reading the manuscript; G. Sutter for help with generation of recombinant (rec.) MVA's; J. Bennink, R.M. Kedl, P. Knolle, and D.H. Busch for kindly providing VV-OVA, LM-B8R, AdOVA, and MHCI multimers, respectively. This research was supported by the Intramural Research Program, NIAID, and NIH. W.K. and N.G. are members of the DFG Excellence Cluster ImmunoSensation in Bonn, Germany and are supported by grant SFB670/SFB704. W.K. is supported by NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia. T.K. was supported by the Kishimoto Foundation, grants from The Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and Japan Society for the Promotion of Science. F.K. was supported by the Human Frontier Science Program (HFSP RGY007/2011) and the Einstein Foundation Berlin.	Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Becker M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00326; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Beuneu H, 2006, J IMMUNOL, V177, P1406, DOI 10.4049/jimmunol.177.3.1406; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; CASSELL D, 1988, ANN NY ACAD SCI, V532, P51, DOI 10.1111/j.1749-6632.1988.tb36325.x; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lin LCW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003329; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205; Wiesel M, 2010, J IMMUNOL, V185, P5188, DOI 10.4049/jimmunol.1001990; Xu RH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000768; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798	46	200	204	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1322	1337		10.1016/j.cell.2015.08.004	http://dx.doi.org/10.1016/j.cell.2015.08.004			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26296422	Green Accepted, Bronze			2022-12-28	WOS:000361247900021
J	Krishnaswamy, A; Yamagata, M; Duan, X; Hong, YK; Sanes, JR				Krishnaswamy, Arjun; Yamagata, Masahito; Duan, Xin; Hong, Y. Kate; Sanes, Joshua R.			Sidekick 2 directs formation of a retinal circuit that detects differential motion	NATURE			English	Article							GANGLION-CELLS; MOUSE RETINA; SYNAPTIC CONNECTIONS; TRANSGENIC MICE; AMACRINE CELLS; EXPRESSION; LIGHT; ORGANIZATION; MODULATION; EXCITATION	In the mammalian retina, processes of approximately 70 types of interneurons form specific synapses on roughly 30 types of retinal ganglion cells (RGCs) in a neuropil called the inner plexiform layer. Each RGC type extracts salient features from visual input, which are sent deeper into the brain for further processing(1-4). The specificity and stereotypy of synapses formed in the inner plexiform layer account for the feature-detecting ability of RGCs. Here we analyse the development and function of synapses on one mouse RGC type, called the W3B-RGC(5,6). These cells have the remarkable property of responding when the timing of the movement of a small object differs from that of the background, but not when they coincide(6). Such cells, known as local edge detectors or object motion sensors, can distinguish moving objects from a visual scene that is also moving(6-12). We show that W3B-RGCs receive strong and selective input from an unusual excitatory amacrine cell type known as VG3-AC (vesicular glutamate transporter 3). Both W3B-RGCs and VG3-ACs express the immunoglobulin superfamily recognition molecule sidekick 2 (Sdk2)(13,14), and both loss-and gain-of-function studies indicate that Sdk2-dependent homophilic interactions are necessary for the selectivity of the connection. The Sdk2-specified synapse is essential for visual responses of W3B-RGCs: whereas bipolar cells relay visual input directly to most RGCs, the W3B-RGCs receive much of their input indirectly, via the VG3-ACs. This non-canonical circuit introduces a delay into the pathway from photoreceptors in the centre of the receptive field to W3B-RGCs, which could improve their ability to judge the synchrony of local and global motion.	[Krishnaswamy, Arjun; Yamagata, Masahito; Duan, Xin; Hong, Y. Kate; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Krishnaswamy, Arjun; Yamagata, Masahito; Duan, Xin; Hong, Y. Kate; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	Yamagata, Masahito/H-6695-2016; Hong, Kate/ABH-6993-2020	Yamagata, Masahito/0000-0001-8193-2931; Hong, Kate/0000-0001-5810-8266	NIH [NS029169, EY022073, F31 NS055488]; NSERC (Canada); Banting Postdoctoral Fellowships; HHMI-Life Sciences Research Foundation; NATIONAL EYE INSTITUTE [R01EY022073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029169, F31NS055488, R01NS029169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Banting Postdoctoral Fellowships; HHMI-Life Sciences Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Soucy and J. Greenwood for assistance with constructing the two-photon microscope, the Genome Modification Facility at Harvard for generating mouse lines, and E. Feinberg for insight into the ion selectivity of ChR2. This work was supported by grants from the NIH (NS029169 and EY022073) to J.R.S., NSERC (Canada) and Banting Postdoctoral Fellowships to A.K., a HHMI-Life Sciences Research Foundation Postdoctoral Fellowship to X.D., and an NIH fellowship (F31 NS055488) to Y.K.H.	Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Asari H, 2014, NEURON, V81, P641, DOI 10.1016/j.neuron.2013.11.029; Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borghuis BG, 2014, J NEUROSCI, V34, P6128, DOI 10.1523/JNEUROSCI.4941-13.2014; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Duan X, 2014, CELL, V158, P793, DOI 10.1016/j.cell.2014.06.047; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Goebbels S, 2005, GENESIS, V42, P247, DOI 10.1002/gene.20138; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Grimes WN, 2011, VISUAL NEUROSCI, V28, P381, DOI 10.1017/S0952523811000290; Haverkamp S, 2004, J COMP NEUROL, V468, P251, DOI 10.1002/cne.10962; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; KATZ B, 1967, PROC R SOC SER B-BIO, V167, P23, DOI 10.1098/rspb.1967.0011; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Kim T, 2015, ELIFE, V4, DOI 10.7554/eLife.08025; Lee S, 2014, NEURON, V84, P708, DOI 10.1016/j.neuron.2014.10.021; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; PETERS A, 1976, J NEUROCYTOL, V5, P63, DOI 10.1007/BF01176183; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Russell TL, 2010, J NEUROPHYSIOL, V103, P2757, DOI 10.1152/jn.00987.2009; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; van Wyk M, 2006, J NEUROSCI, V26, P13250, DOI 10.1523/JNEUROSCI.1991-06.2006; Venkataramani S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088560; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018; Yamagata M, 2010, J NEUROSCI, V30, P3579, DOI 10.1523/JNEUROSCI.6319-09.2010; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	53	102	104	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					466	+		10.1038/nature14682	http://dx.doi.org/10.1038/nature14682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26287463	Green Accepted, Green Submitted			2022-12-28	WOS:000360069300038
J	Zhou, Y; Wong, CO; Cho, KJ; van der Hoeven, D; Liang, H; Thakur, DP; Luo, JL; Babic, M; Zinsmaier, KE; Zhu, MX; Hu, HZ; Venkatachalam, K; Hancock, JF				Zhou, Yong; Wong, Ching-On; Cho, Kwang-jin; van der Hoeven, Dharini; Liang, Hong; Thakur, Dhananiay P.; Luo, Jialie; Babic, Milos; Zinsmaier, Konrad E.; Zhu, Michael X.; Hu, Hongzhen; Venkatachalam, Kartik; Hancock, John F.			Membrane potential modulates plasma membrane phospholipid dynamics and K-Ras signaling	SCIENCE			English	Article							NANOCLUSTERS; PROTEINS; EXPRESSION; PLASTICITY	Plasma membrane depolarization can trigger cell proliferation, but how membrane potential influences mitogenic signaling is uncertain. Here, we show that plasma membrane depolarization induces nanoscale reorganization of phosphatidylserine and phosphatidylinositol 4,5-bisphosphate but not other anionic phospholipids. K-Ras, which is targeted to the plasma membrane by electrostatic interactions with phosphatidylserine, in turn undergoes enhanced nanoclustering. Depolarization-induced changes in phosphatidylserine and K-Ras plasma membrane organization occur in fibroblasts, excitable neuroblastoma cells, and Drosophila neurons in vivo and robustly amplify K-Ras-dependent mitogen-activated protein kinase (MAPK) signaling. Conversely, plasma membrane repolarization disrupts K-Ras nanoclustering and inhibits MAPK signaling. By responding to voltage-induced changes in phosphatidylserine spatiotemporal dynamics, K-Ras nanoclusters set up the plasma membrane as a biological field-effect transistor, allowing membrane potential to control the gain in mitogenic signaling circuits.	[Zhou, Yong; Wong, Ching-On; Cho, Kwang-jin; Liang, Hong; Thakur, Dhananiay P.; Luo, Jialie; Zhu, Michael X.; Hu, Hongzhen; Venkatachalam, Kartik; Hancock, John F.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [van der Hoeven, Dharini] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77054 USA; [Babic, Milos; Zinsmaier, Konrad E.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Zhu, Michael X.; Hu, Hongzhen; Venkatachalam, Kartik; Hancock, John F.] Univ Texas Grad Sch Biomed Sci, Program Cell & Regulatory Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Arizona	Hancock, JF (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	john.f.hancock@uth.tmc.edu	Cho, Kwang-jin/AAI-4923-2020	Zhou, Yong/0000-0002-0214-8151; Wong, Ching On/0000-0002-8602-2125; Babic, Milos/0000-0002-4040-0370; Hu, Hongzhen/0000-0002-8967-7522; Hancock, John/0000-0003-0542-4710	Cancer Prevention and Research Institute of Texas [RP130059]; NIH [R01NS081301]; NATIONAL CANCER INSTITUTE [R00CA188593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081301] Funding Source: NIH RePORTER; Direct For Biological Sciences [1121054] Funding Source: National Science Foundation	Cancer Prevention and Research Institute of Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grant RP130059 from the Cancer Prevention and Research Institute of Texas and grant R01NS081301 from NIH.	Ariotti N, 2014, J CELL BIOL, V204, P777, DOI 10.1083/jcb.201307055; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Groves JT, 1998, P NATL ACAD SCI USA, V95, P935, DOI 10.1073/pnas.95.3.935; Ha TS, 2014, P NATL ACAD SCI USA, V111, P7831, DOI 10.1073/pnas.1401938111; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Lee S, 2012, GENES CELLS, V17, P728, DOI 10.1111/j.1365-2443.2012.01622.x; OSHEA PS, 1984, BIOCHEM J, V220, P795, DOI 10.1042/bj2200795; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Starke-Peterkovic T, 2009, EUR BIOPHYS J BIOPHY, V39, P103, DOI 10.1007/s00249-008-0392-y; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; VANDERVALK JBF, 1990, EUR J PHARMACOL, V185, P99, DOI 10.1016/0014-2999(90)90215-R; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zhou Y, 2014, MOL CELL BIOL, V34, P862, DOI 10.1128/MCB.01227-13	21	179	183	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					873	876		10.1126/science.aaa5619	http://dx.doi.org/10.1126/science.aaa5619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293964	Green Accepted			2022-12-28	WOS:000359832700051
J	Kelley, AS; Morrison, RS				Kelley, Amy S.; Morrison, R. Sean			Palliative Care for the Seriously Ill	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; ADVANCED CANCER-PATIENTS; QUALITY-OF-LIFE; SPIRITUAL CARE; NEAR-DEATH; ADVANCED ILLNESS; MEDICAL-CARE; LAST WEEK; END; COMMUNICATION		[Kelley, Amy S.; Morrison, R. Sean] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, New York, NY 10029 USA; [Kelley, Amy S.; Morrison, R. Sean] James J Peters Vet Affairs Med Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Kelley, AS (corresponding author), Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	amy.kelley@mssm.edu			NATIONAL INSTITUTE ON AGING [K23AG040774, K24AG022345, R24AG044300, P30AG028741] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG028741, K24 AG022345, R24 AG044300, K23 AG040774] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson H, 2001, PALLIATIVE MED, V15, P279, DOI 10.1191/026921601678320269; Au DH, 2012, CHEST, V141, P726, DOI 10.1378/chest.11-0362; Back AL, 2003, J CLIN ONCOL, V21, P2433, DOI 10.1200/JCO.2003.09.073; Back AL, 2009, MASTERING COMMUNICAT; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Balboni TA, 2007, J CLIN ONCOL, V25, P555, DOI 10.1200/JCO.2006.07.9046; Balboni TA, 2010, J CLIN ONCOL, V28, P445, DOI 10.1200/JCO.2009.24.8005; Bausewein C., 2011, OUTCOME MEASUREMENT; Bausewein C, 2010, J PALLIAT MED, V13, P1109, DOI 10.1089/jpm.2010.0068; Block Susan D, 2002, J Palliat Med, V5, P243, DOI 10.1089/109662102753641214; Butler M, 2014, ANN INTERN MED, V161, P408, DOI 10.7326/M14-0644; Center to Advance Palliative Care, 2008, STAT STAT CARD ACC P; Ciemins EL, 2006, J PALLIAT MED, V9, P1401, DOI 10.1089/jpm.2006.9.1401; Eagar K, 2010, AUST HEALTH REV, V34, P186, DOI 10.1071/AH08718; Edmonds P, 2010, MULT SCLER J, V16, P627, DOI 10.1177/1352458510364632; El Nawawi NM, 2012, CURR OPIN SUPPORT PA, V6, P269, DOI 10.1097/SPC.0b013e3283530d13; Fainsinger RL, 2007, J PAIN SYMPTOM MANAG, V33, P634, DOI 10.1016/j.jpainsymman.2007.02.012; Gelfman LP, 2013, J PALLIAT MED, V16, P125, DOI 10.1089/jpm.2012.0427; GOMES B, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD007760.PUB2; Gomez-Batiste X, 2012, J PAIN SYMPTOM MANAG, V43, P783, DOI 10.1016/j.jpainsymman.2011.05.006; Hanratty B, 2006, PALLIATIVE MED, V20, P493, DOI 10.1191/0269216306pm1162oa; Higginson IJ, 2002, J PAIN SYMPTOM MANAG, V23, P96, DOI 10.1016/S0885-3924(01)00406-7; Higginson IJ, 2014, LANCET RESP MED, V2, P979, DOI 10.1016/S2213-2600(14)70226-7; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Johnson JR, 2014, CRIT CARE MED, V42, P1991, DOI 10.1097/CCM.0000000000000412; Johnson KS, 2013, J PALLIAT MED, V16, P1329, DOI 10.1089/jpm.2013.9468; Karus D, 2005, J PAIN SYMPTOM MANAG, V30, P408, DOI 10.1016/j.jpainsymman.2005.04.011; Kelley AS, 2013, J PALLIAT MED, V16, P730, DOI 10.1089/jpm.2013.9498; Lupu D, 2010, J PAIN SYMPTOM MANAG, V40, P899, DOI 10.1016/j.jpainsymman.2010.07.004; May P, 2014, J PALLIAT MED, V17, P1054, DOI 10.1089/jpm.2013.0594; Miller SC, 2010, J AM GERIATR SOC, V58, P1481, DOI 10.1111/j.1532-5415.2010.02968.x; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Modonesi C, 2005, J PAIN SYMPTOM MANAG, V30, P367, DOI 10.1016/j.jpainsymman.2005.04.007; Moens K, 2014, J PAIN SYMPTOM MANAG, V48, P660, DOI 10.1016/j.jpainsymman.2013.11.009; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; [National Center for Health Statistics Centers for Disease Control and Prevention], 2012, NAT NURS HOM SURV 20; National Consensus Project for Quality Palliative Care, 2013, CLIN PRACTICE GUIDEL; National Palliative Care Registry, 2014, ANN SURV SUMM RES 20; Nordgren Lena, 2003, Eur J Cardiovasc Nurs, V2, P213; Oi-Ling K, 2005, PALLIATIVE MED, V19, P228, DOI 10.1191/0269216305pm1001oa; Pautex S, 2007, J AM GERIATR SOC, V55, P1316, DOI 10.1111/j.1532-5415.2007.01267.x; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Potter J, 2003, PALLIATIVE MED, V17, P310, DOI 10.1191/0269216303pm760oa; Rabow M, 2013, J PALLIAT MED, V16, P1540, DOI 10.1089/jpm.2013.0153; Rodin D, 2015, SUPPORT CARE CANC; Schenker Y, 2014, J ONCOL PRACT, V10, pE37, DOI 10.1200/JOP.2013.001130; Smith S, 2014, PALLIATIVE MED, V28, P130, DOI 10.1177/0269216313493466; Spettell CM, 2009, J PALLIAT MED, V12, P827, DOI 10.1089/jpm.2009.0089; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; The Joint Commission, 2011, ADV CERT PALL CAR PR; Tulsky JA, 2011, ANN INTERN MED, V155, P593, DOI 10.7326/0003-4819-155-9-201111010-00007; Walsh D, 2000, SUPPORT CARE CANCER, V8, P175, DOI 10.1007/s005200050281; Winkelman WD, 2011, J PALLIAT MED, V14, P1022, DOI 10.1089/jpm.2010.0536; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	56	398	412	6	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					747	755		10.1056/NEJMra1404684	http://dx.doi.org/10.1056/NEJMra1404684			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287850	Green Accepted			2022-12-28	WOS:000359709400011
J	Prochaska, JJ				Prochaska, Judith J.			Nicotine Replacement Therapy as a Maintenance Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING-CESSATION; VARENICLINE	IMPORTANCE The US Food and Drug Administration adopted labeling for nicotine patches to allow use beyond the standard 8 weeks. This decision was based in part on data showing increased efficacy for 24 weeks of treatment. Few studies have examined whether the use of nicotine patches beyond 24 weeks provides additional therapeutic benefit. OBJECTIVE To compare 8 (standard), 24 (extended), and 52 (maintenance) weeks of nicotine patch treatment for promoting tobacco abstinence. DESIGN, SETTING, AND PARTICIPANTS We recruited 525 treatment-seeking smokers for a randomized clinical trial conducted from June 22, 2009, through April 15, 2014, through 2 universities. INTERVENTIONS Smokers received 12 smoking cessation behavioral counseling sessions and were randomized to 8, 24, or 52 weeks of nicotine patch treatment. MAIN OUTCOMES AND MEASURES The primary outcome was 7-day point prevalence abstinence, confirmed with breath levels of carbonmonoxide at 6 and 12 months (intention to treat). RESULTS At 24 weeks, 21.7% of participants in the standard treatment arm were abstinent, compared with 27.2% of participants in the extended and maintenance treatment arms (chi(2)(1) = 1.98; P = .17). In a multivariate model controlled for covariates, participants in the extended and maintenance treatment arms reported significantly greater abstinence rates at 24 weeks compared with participants in the standard treatment arm (odds ratio [OR], 1.70 [95% CI, 1.03-2.81]; P = .04), had a longer duration of abstinence until relapse (beta = 21.30 [95% CI, 10.30-32.25]; P < .001), reported smoking fewer cigarettes per day if not abstinent (mean [SD], 5.8 [5.3] vs 6.4 [5.1] cigarettes per day; beta = 0.43 [95% CI, 0.06-0.82]; P = .02), and reported more abstinent days (mean [SD], 80.5 [38.1] vs 68.2 [43.7] days; OR, 1.55 [95% CI, 1.06-2.26]; P = .02). At 52 weeks, participants in the maintenance treatment arm did not report significantly greater abstinence rates compared with participants in the standard and extended treatment arms (20.3% vs 23.8%; OR, 1.17 [95% CI, 0.69-1.98]; P = .57). Similarly, we found no difference in week 52 abstinence rates between participants in the extended and standard treatment arms (26.0% vs 21.7%; OR, 1.33 [95% CI, 0.72-2.45]; P = .36). Treatment duration was not associated with any adverse effects or adherence to the counseling regimen, but participants in the maintenance treatment arm reported lower adherence to the nicotine patch regimen compared with those in the standard and extended treatment arms (mean [SD], 3.94 [2.5], 4.61 [2.0], and 4.7 [2.4] patches/wk, respectively; F-2,F-522 = 6.03; P = .003). CONCLUSIONS AND RELEVANCE The findings support the safety of long-term use of nicotine patch treatment, although they do not support efficacy beyond 24 weeks of treatment in a broad group of smokers.	[Prochaska, Judith J.] Stanford Univ, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA	Stanford University	Prochaska, JJ (corresponding author), Stanford Univ, MSOB X316,1265 Welch Rd, Stanford, CA 94305 USA.	jpro@stanford.edu	Prochaska, Judith J/I-4510-2013	Prochaska, Judith J/0000-0001-7925-326X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA009253] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL117736, R01 HL117736] Funding Source: Medline; NIDA NIH HHS [P50 DA009253] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 2015, TOBACCO ATLAS; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Evins AE, 2014, JAMA-J AM MED ASSOC, V311, P145, DOI 10.1001/jama.2013.285113; Hall SM, 2011, AM J PUBLIC HEALTH, V101, P2349, DOI 10.2105/AJPH.2010.300084; Hall SM, 2009, ADDICTION, V104, P1043, DOI 10.1111/j.1360-0443.2009.02548.x; Hays JT, 2001, ANN INTERN MED, V135, P423, DOI 10.7326/0003-4819-135-6-200109180-00011; Lerman C, 2015, LANCET RESP MED, V3, P131, DOI 10.1016/S2213-2600(14)70294-2; Schnoll RA, 2015, JAMA INTERN MED, V175, P504, DOI 10.1001/jamainternmed.2014.8313; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64	9	8	8	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					718	719		10.1001/jama.2015.7460	http://dx.doi.org/10.1001/jama.2015.7460			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284723	Green Accepted			2022-12-28	WOS:000360019100020
J	Franklin, AD				Franklin, Aaron D.			Nanomaterials in transistors: From high-performance to thin-film applications	SCIENCE			English	Review							FIELD-EFFECT TRANSISTORS; WALLED CARBON NANOTUBES; ATOMIC LAYER DEPOSITION; LARGE-AREA; 2-DIMENSIONAL MATERIALS; TRANSPORT-PROPERTIES; CONTACT RESISTANCE; MOS2 TRANSISTORS; CURRENT RATIO; HIGH-YIELD	For more than 50 years, silicon transistors have been continuously shrunk to meet the projections of Moore's law but are now reaching fundamental limits on speed and power use. With these limits at hand, nanomaterials offer great promise for improving transistor performance and adding new applications through the coming decades. With different transistors needed in everything from high-performance servers to thin-film display backplanes, it is important to understand the targeted application needs when considering new material options. Here the distinction between high-performance and thin-film transistors is reviewed, along with the benefits and challenges to using nanomaterials in such transistors. In particular, progress on carbon nanotubes, as well as graphene and related materials (including transition metal dichalcogenides and X-enes), outlines the advances and further research needed to enable their use in transistors for high-performance computing, thin films, or completely new technologies such as flexible and transparent devices.	[Franklin, Aaron D.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA; [Franklin, Aaron D.] Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Duke University	Franklin, AD (corresponding author), Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.	aaron.franklin@duke.edu		Franklin, Aaron/0000-0002-1128-9327				Appenzeller J, 2005, IEEE T ELECTRON DEV, V52, P2568, DOI 10.1109/TED.2005.859654; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Auth CP, 1997, IEEE ELECTR DEVICE L, V18, P74, DOI 10.1109/55.553049; Avsar A, 2015, ACS NANO, V9, P4138, DOI 10.1021/acsnano.5b00289; Azcatl A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869149; Balendhran S, 2015, SMALL, V11, P640, DOI 10.1002/smll.201402041; Bangsaruntip S, 2009, INT EL DEVICES MEET, P272; Brady GJ, 2014, ACS NANO, V8, P11614, DOI 10.1021/nn5048734; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Cao Q, 2013, NAT NANOTECHNOL, V8, P180, DOI [10.1038/nnano.2012.257, 10.1038/NNANO.2012.257]; Chai Y, 2012, IEEE T ELECTRON DEV, V59, P12, DOI 10.1109/TED.2011.2170216; Chanana A, 2014, J APPL PHYS, V116, DOI 10.1063/1.4901998; Chandra B, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3622767; Chang HY, 2013, ACS NANO, V7, P5446, DOI 10.1021/nn401429w; Chen PC, 2011, NANO LETT, V11, P5301, DOI 10.1021/nl202765b; Chen ZH, 2005, NANO LETT, V5, P1497, DOI 10.1021/nl0508624; Choi SJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4752006; Cress CD, 2012, ELECTRONICS-SWITZ, V1, P23, DOI 10.3390/electronics1010023; Das S, 2014, NANO LETT, V14, P2861, DOI 10.1021/nl5009037; Das S, 2013, NANO LETT, V13, P100, DOI 10.1021/nl303583v; Datta S., 2005, THE EFFECT; Derivaz M, 2015, NANO LETT, V15, P2510, DOI 10.1021/acs.nanolett.5b00085; Dumcenco D, 2015, ACS NANO, V9, P4611, DOI 10.1021/acsnano.5b01281; English CD, 2014, IEEE DEVICE RES CONF, P193, DOI 10.1109/DRC.2014.6872363; Esmaeilzadeh H, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P365, DOI 10.1145/2024723.2000108; Farmer DB, 2006, NANO LETT, V6, P699, DOI 10.1021/nl052453d; Ferry DK, 2008, SCIENCE, V319, P579, DOI 10.1126/science.1154446; Flavel BS, 2014, ACS NANO, V8, P1817, DOI 10.1021/nn4062116; Fogden S, 2012, ACS NANO, V6, P54, DOI 10.1021/nn2041494; Franklin AD, 2014, ACS NANO, V8, P7333, DOI 10.1021/nn5024363; Franklin AD, 2013, NATURE, V498, P443, DOI 10.1038/498443a; Franklin AD, 2013, NANO LETT, V13, P2490, DOI 10.1021/nl400544q; Franklin AD, 2012, NANO LETT, V12, P758, DOI 10.1021/nl203701g; Franklin AD, 2010, NAT NANOTECHNOL, V5, P858, DOI [10.1038/nnano.2010.220, 10.1038/NNANO.2010.220]; Ganatra R, 2014, ACS NANO, V8, P4074, DOI 10.1021/nn405938z; George AS, 2014, ADV FUNCT MATER, V24, P7461, DOI 10.1002/adfm.201402519; Ha MJ, 2013, NANO LETT, V13, P954, DOI 10.1021/nl3038773; Han SP, 2012, NANO LETT, V12, P1129, DOI 10.1021/nl201818u; Homenick CM, 2014, J PHYS CHEM C, V118, P16156, DOI 10.1021/jp5030476; Hong XP, 2014, NAT NANOTECHNOL, V9, P682, DOI [10.1038/NNANO.2014.167, 10.1038/nnano.2014.167]; Hruska J., 2014, EXTREMETECH; Huang CC, 2014, NANOSCALE, V6, P12792, DOI 10.1039/c4nr04228j; Huang CM, 2014, NAT MATER, V13, P1096, DOI [10.1038/nmat4064, 10.1038/NMAT4064]; Jandhyala S, 2012, ACS NANO, V6, P2722, DOI 10.1021/nn300167t; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Jena D, 2013, P IEEE, V101, P1585, DOI 10.1109/JPROC.2013.2253435; Jeon J, 2015, IEEE T NANOTECHNOL, V14, P238, DOI 10.1109/TNANO.2014.2381667; Jin Z, 2014, NANOSCALE, V6, P14453, DOI 10.1039/c4nr04816d; Kamal C, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.085423; Kaul AB, 2014, J MATER RES, V29, P348, DOI 10.1557/jmr.2014.6; Khripin CY, 2013, J AM CHEM SOC, V135, P6822, DOI 10.1021/ja402762e; Kim B, 2014, NANO LETT, V14, P3683, DOI 10.1021/nl5016014; Knoch J, 2008, PHYS STATUS SOLIDI A, V205, P679, DOI 10.1002/pssa.200723528; Kumar J, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4916403; Kuo Y, 2013, ELECTROCHEM SOC INTE, V22, P55, DOI 10.1149/2.F06131if; Lam KT, 2014, IEEE ELECTR DEVICE L, V35, P963, DOI 10.1109/LED.2014.2333368; Lee D, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871100; Lee GH, 2013, ACS NANO, V7, P7931, DOI 10.1021/nn402954e; Lemme MC, 2014, MRS BULL, V39, P711, DOI 10.1557/mrs.2014.138; Liang XG, 2012, ACS NANO, V6, P9700, DOI 10.1021/nn303127y; Liu H, 2014, IEEE ELECTR DEVICE L, V35, P795, DOI 10.1109/LED.2014.2323951; Liu H, 2014, ACS NANO, V8, P4033, DOI 10.1021/nn501226z; Liu J, 2010, MRS BULL, V35, P315, DOI 10.1557/mrs2010.554; Liu W, 2013, NANO LETT, V13, P1983, DOI 10.1021/nl304777e; Lobez JM, 2014, ACS NANO, V8, P4954, DOI 10.1021/nn5009935; Mistry KS, 2013, ACS NANO, V7, P2231, DOI 10.1021/nn305336x; Moore G., 1965, ELECTRONICS, V38, P114, DOI [DOI 10.1109/N-SSC.2006.4785860, DOI 10.1109/JPROC.1998.658762]; Naguib M, 2014, ADV MATER, V26, P992, DOI 10.1002/adma.201304138; Ochedowski O, 2013, J APPL PHYS, V113, DOI 10.1063/1.4808460; Okada M, 2014, ACS NANO, V8, P8273, DOI 10.1021/nn503093k; Park H, 2012, NAT NANOTECHNOL, V7, P787, DOI [10.1038/nnano.2012.189, 10.1038/NNANO.2012.189]; Park J, 2014, NANO LETT, V14, P504, DOI 10.1021/nl403511s; Park S, 2015, ADV MATER, V27, P2656, DOI 10.1002/adma.201405289; Pop E, 2010, NANO RES, V3, P147, DOI 10.1007/s12274-010-1019-z; Pradhan NR, 2014, ACS NANO, V8, P5911, DOI 10.1021/nn501013c; Reddy D, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/31/313001; Rouhi N, 2011, ACS NANO, V5, P8471, DOI 10.1021/nn201828y; Roy T, 2014, ACS NANO, V8, P6259, DOI 10.1021/nn501723y; Salvatore GA, 2013, ACS NANO, V7, P8809, DOI 10.1021/nn403248y; Sangwan VK, 2012, ACS NANO, V6, P7480, DOI 10.1021/nn302768h; Schmidt H, 2014, NANO LETT, V14, P1909, DOI 10.1021/nl4046922; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Shastry TA, 2013, SMALL, V9, P45, DOI 10.1002/smll.201201398; Shekhar S, 2011, ACS NANO, V5, P1739, DOI 10.1021/nn102305z; Shih CJ, 2014, ACS NANO, V8, P5790, DOI 10.1021/nn500676t; Shimizu M, 2013, J PHYS CHEM C, V117, P11744, DOI 10.1021/jp3113254; Son D, 2014, NAT NANOTECHNOL, V9, P397, DOI [10.1038/nnano.2014.38, 10.1038/NNANO.2014.38]; Street RA, 2009, ADV MATER, V21, P2007, DOI 10.1002/adma.200803211; Sze S. M., 1981, PHYSICS OF SEMICONDU; Tanaka T, 2011, J AM CHEM SOC, V133, P17610, DOI 10.1021/ja208221g; Tao L, 2015, NAT NANOTECHNOL, V10, P227, DOI [10.1038/nnano.2014.325, 10.1038/NNANO.2014.325]; Tarasov A, 2014, ADV FUNCT MATER, V24, P6389, DOI 10.1002/adfm.201401389; Torrisi F, 2014, NAT NANOTECHNOL, V9, P738, DOI 10.1038/nnano.2014.218; Torrisi F, 2012, ACS NANO, V6, P2992, DOI 10.1021/nn2044609; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Tulevski GS, 2014, ACS NANO, V8, P8730, DOI 10.1021/nn503627h; Tulevski GS, 2013, ACS NANO, V7, P2971, DOI 10.1021/nn400053k; Wang H, 2014, NANOSCALE, V6, P12250, DOI 10.1039/c4nr03435j; Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803; Wilson M., 2008, RESEARCHERS DEVELOP; Xia FN, 2010, NANO LETT, V10, P715, DOI 10.1021/nl9039636; Yang R, 2014, NANOSCALE, V6, P12383, DOI 10.1039/c4nr03472d; Yu JH, 2015, NANO LETT, V15, P1031, DOI 10.1021/nl503897h; Yu LL, 2014, NANO LETT, V14, P3055, DOI 10.1021/nl404795z; Yu YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01866; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105; Zhou KG, 2014, ACS NANO, V8, P9914, DOI 10.1021/nn5042703	108	399	407	54	908	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249							aab2750	10.1126/science.aab2750	http://dx.doi.org/10.1126/science.aab2750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273059				2022-12-28	WOS:000359415100027
J	Antonijevic, SK; Wagner, LS; Kumar, A; Beck, SL; Long, MD; Zandt, G; Tavera, H; Condori, C				Antonijevic, Sanja Knezevic; Wagner, Lara S.; Kumar, Abhash; Beck, Susan L.; Long, Maureen D.; Zandt, George; Tavera, Hernando; Condori, Cristobal			The role of ridges in the formation and longevity of flat slabs	NATURE			English	Article							OCEANIC PLATEAU SUBDUCTION; SENSITIVITY KERNELS; LARAMIDE OROGENY; NAZCA PLATE; PERU; TOMOGRAPHY; BENEATH; LITHOSPHERE; VELOCITY; PHASE	Flat-slab subduction occurs when the descending plate becomes horizontal at some depth before resuming its descent into the mantle. It is often proposed as a mechanism for the uplifting of deep crustal rocks ('thick-skinned' deformation) far from plate boundaries, and for causing unusual patterns of volcanism, as far back as the Proterozoic eon(1). For example, the formation of the expansive Rocky Mountains and the subsequent voluminous volcanism across much of the western USA has been attributed to a broad region of flat-slab subduction beneath North America that occurred during the Laramide orogeny (80-55 million years ago)(2). Here we study the largest modern flat slab, located in Peru, to better understand the processes controlling the formation and extent of flat slabs. We present new data that indicate that the subducting Nazca Ridge is necessary for the development and continued support of the horizontal plate at a depth of about 90 kilometres. By combining constraints from Rayleigh wave phase velocities with improved earthquake locations, we find that the flat slab is shallowest along the ridge, while to the northwest of the ridge, the slab is sagging, tearing, and re-initiating normal subduction. On the basis of our observations, we propose a conceptual model for the temporal evolution of the Peruvian flat slab in which the flat slab forms because of the combined effects of trench retreat along the Peruvian plate boundary, suction, and ridge subduction. We find that while the ridge is necessary but not sufficient for the formation of the flat slab, its removal is sufficient for the flat slab to fail. This provides new constraints on our understanding of the processes controlling the beginning and end of the Laramide orogeny and other putative episodes of flat-slab subduction.	[Antonijevic, Sanja Knezevic; Kumar, Abhash] Univ N Carolina, Dept Geol Sci, Chapel Hill, NC 27599 USA; [Wagner, Lara S.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Beck, Susan L.; Zandt, George] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Long, Maureen D.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Tavera, Hernando; Condori, Cristobal] Inst Geofis Peru, Lima 15012, Peru	University of North Carolina; University of North Carolina Chapel Hill; Carnegie Institution for Science; University of Arizona; Yale University	Antonijevic, SK (corresponding author), Univ N Carolina, Dept Geol Sci, CB 3315, Chapel Hill, NC 27599 USA.	sknezevi@live.unc.edu	Wagner, Lara/P-8638-2019; QUISPE, CRISTOBAL CONDORI/AAS-1256-2020; Long, Maureen D/A-1383-2009	Wagner, Lara/0000-0001-7130-7761; QUISPE, CRISTOBAL CONDORI/0000-0003-2657-147X; Long, Maureen D/0000-0003-1936-3840; Knezevic Antonijevic, Sanja/0000-0003-4224-5746	NSF [EAR-0944184, EAR-0943991, EAR-0943962, EAR-0908777, EAR-0907880]; Division Of Earth Sciences [0943991, 0944184] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank R. Clayton and P. Davies for providing the records from eight PERUSE stations. The PULSE experiment was supported by NSF grants EAR-0944184 (to L.S.W.), EAR-0943991 (to S.L.B.) and EAR-0943962 (to M.D.L.). The CAUGHT project was supported by NSF grants EAR-0908777 (to L.S.W.) and EAR-0907880 (to S.L.B.).	Arrial PA, 2013, EARTH PLANET SC LETT, V363, P34, DOI 10.1016/j.epsl.2012.12.011; Bedle H, 2006, TECTONOPHYSICS, V424, P53, DOI 10.1016/j.tecto.2006.06.003; CAHILL T, 1992, J GEOPHYS RES-SOL EA, V97, P17503, DOI 10.1029/92JB00493; Dorbath C, 1996, GEOPHYS RES LETT, V23, P205, DOI 10.1029/95GL03778; Eakin C. M., 2014, J GEOPHYS RES, V41, P3438; Forsyth DW, 2005, GEOPHYS MONOGR SER, V157, P81, DOI 10.1029/156GM06; Gerya TV, 2009, EUR J MINERAL, V21, P649, DOI 10.1127/0935-1221/2009/0021-1931; Gripp AE, 2002, GEOPHYS J INT, V150, P321, DOI 10.1046/j.1365-246X.2002.01627.x; HASEGAWA A, 1981, J GEOPHYS RES, V86, P4971, DOI 10.1029/JB086iB06p04971; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Humphreys E, 2003, INT GEOL REV, V45, P575, DOI 10.2747/0020-6814.45.7.575; International Seismological Centre, 2012, INT SEISM CTR ON LIN; JAMES DE, 1971, J GEOPHYS RES, V76, P3246, DOI 10.1029/JB076i014p03246; Jones CH, 2011, GEOSPHERE, V7, P183, DOI 10.1130/GES00575.1; Kennett B.L.N., 1991, IASPEI 1991 SEISMOLO; Lienert R. B., 1986, B SEISMOL SOC AM, V76, P771; Liu LJ, 2010, NAT GEOSCI, V3, P353, DOI 10.1038/NGEO829; Manea VC, 2012, GEOLOGY, V40, P35, DOI 10.1130/G32543.1; Phillips K, 2014, GEOPHYS J INT, V196, P1889, DOI 10.1093/gji/ggt504; Rosenbaum G, 2005, EARTH PLANET SC LETT, V239, P18, DOI 10.1016/j.epsl.2005.08.003; Saito M., 1988, SEISMOLOGICAL ALGORI, P293; Scire A., GEOPHYS J INT UNPUB; Sigloch K, 2008, NAT GEOSCI, V1, P458, DOI 10.1038/ngeo231; Skinner SM, 2013, EARTH PLANET SC LETT, V371, P1, DOI 10.1016/j.epsl.2013.04.013; SNOKE JA, 1977, B SEISMOL SOC AM, V67, P1051; Tassara A, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003976; UYEDA S, 1980, B EARTHQ RES I TOKYO, V55, P55; van Hunen J, 2002, TECTONOPHYSICS, V352, P317, DOI 10.1016/S0040-1951(02)00263-9; VOGT PR, 1973, NATURE, V241, P189, DOI 10.1038/241189a0; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Ward KM, 2013, GEOPHYS J INT, V194, P1559, DOI 10.1093/gji/ggt166; Weeraratne DS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002273; Yang YJ, 2006, GEOPHYS J INT, V166, P1148, DOI 10.1111/j.1365-246X.2006.02972.x; Zhou Y, 2004, GEOPHYS J INT, V158, P142, DOI 10.1111/j.1365-246X.2004.02324.x	34	73	76	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					212	+		10.1038/nature14648	http://dx.doi.org/10.1038/nature14648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268192				2022-12-28	WOS:000359386900030
J	Moskowitz, SM; Shailam, R; Mark, EJ				Moskowitz, Samuel M.; Shailam, Randheer; Mark, Eugene J.			Case 25-2015: An 8-Year-Old Girl with a Chest-Wall Mass and a Pleural Effusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY ACTINOMYCOSIS; EMPYEMA-NECESSITATIS; ACTINOMYCETEMCOMITANS; LYMPHOMA		[Moskowitz, Samuel M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Shailam, Randheer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Moskowitz, Samuel M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Shailam, Randheer] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moskowitz, SM (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.				Vertex Pharmaceuticals; EnBiotix; MCIC Vermont; Kala Pharmaceuticals; Pfizer; Cowen Group; Gilead Sciences; Novartis; Rempex Pharmaceuticals; Savara Pharmaceuticals	Vertex Pharmaceuticals(Vertex Pharmaceuticals); EnBiotix; MCIC Vermont; Kala Pharmaceuticals; Pfizer(Pfizer); Cowen Group; Gilead Sciences(Gilead Sciences); Novartis(Novartis); Rempex Pharmaceuticals; Savara Pharmaceuticals	Dr. Moskowitz reports receiving fees for serving on advisory boards from Vertex Pharmaceuticals; consulting fees from EnBiotix, MCIC Vermont, Kala Pharmaceuticals, Pfizer, and Cowen Group; and grant support from Gilead Sciences, Novartis, Rempex Pharmaceuticals, Kala Pharmaceuticals, Vertex Pharmaceuticals, and Savara Pharmaceuticals; as well as holding a pending patent for intermediate-metabolism products that potentiate aminoglycoside antibiotics in bacterial infections (U.S. application number, 61,871,554). Dr. Mark reports providing expert testimony in litigation regarding asbestos exposure. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1979, CHEST, V76, P420; Baez JC, 2003, INFLAMMATORY RADIOGR, P23; Das Narla L, 2003, RADIOGRAPHICS, V23, P719, DOI 10.1148/rg.233025073; Haubek D, 2001, J DENT RES, V80, P1580, DOI 10.1177/00220345010800062001; Hodgson DC, 2003, INT J RADIAT ONCOL, V57, P1374, DOI 10.1016/S0360-3016(03)00765-X; Khalil Mohammed W, 2008, Interact Cardiovasc Thorac Surg, V7, P506, DOI 10.1510/icvts.2007.168658; Kim Y, 2003, CLIN IMAG, V27, P162, DOI 10.1016/S0899-7071(02)00543-0; Laennec RTH., 1819, AUSCULTATION MEDIATE; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Mabeza GF, 2003, EUR RESPIR J, V21, P545, DOI 10.1183/09031936.03.00089103; Mizell KN, 2008, J CLIN MICROBIOL, V46, P3534, DOI 10.1128/JCM.00989-08; Moore W, 1869, Br Med J, V1, P4; O'Sullivan P, 2007, BRIT J RADIOL, V80, P574, DOI 10.1259/bjr/16591964; Slots J, 1999, J Int Acad Periodontol, V1, P121; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Strachan RE, 2011, EMERG INFECT DIS, V17, P1839, DOI 10.3201/eid1710.101825; Wani NA, 2010, BRIT J RADIOL, V83, pE235, DOI 10.1259/bjr/69723351	17	14	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					657	667		10.1056/NEJMcpc1400836	http://dx.doi.org/10.1056/NEJMcpc1400836			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LE	26267626				2022-12-28	WOS:000359707700011
J	Stead, W				Stead, Wendy			A Story I Hope Ends Up Being True	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stead, Wendy] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Stead, Wendy] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Stead, W (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	wstead@bidmc.harvard.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					563	564		10.1001/jama.2015.5285	http://dx.doi.org/10.1001/jama.2015.5285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262781				2022-12-28	WOS:000359388600013
J	Chung, SC; Sundstrom, J; Gale, CP; James, S; Deanfield, J; Wallentin, L; Timmis, A; Jernberg, T; Hemingway, H				Chung, Sheng-Chia; Sundstrom, Johan; Gale, Chris P.; James, Stefan; Deanfield, John; Wallentin, Lars; Timmis, Adam; Jernberg, Tomas; Hemingway, Harry			Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERCUTANEOUS CORONARY INTERVENTION; STANDARDIZED MORTALITY-RATES; SHORT-TERM SURVIVAL; PERFORMING HOSPITALS; FOCUSED UPDATE; ASSOCIATION; MANAGEMENT; QUALITY; GUIDELINES; STATES	OBJECTIVE To assess the between hospital variation in use of guideline recommended treatments and clinical outcomes for acute myocardial infarction in Sweden and the United Kingdom. DESIGN Population based longitudinal cohort study using nationwide clinical registries. SETTING AND PARTICIPANTS Nationwide registry data comprising all hospitals providing acute myocardial infarction care in Sweden (SWEDEHEART/RIKS-HIA, n=87; 119 786 patients) and the UK (NICOR/MINAP, n=242; 391 077 patients), 2004-10. MAIN OUTCOME MEASURES Between hospital variation in 30 day mortality of patients admitted with acute myocardial infarction. RESULTS Case mix standardised 30 day mortality from acute myocardial infarction was lower in Swedish hospitals (8.4%) than in UK hospitals (9.7%), with less variation between hospitals (interquartile range 2.6% v 3.5%). In both countries, hospital level variation and 30 day mortality were inversely associated with provision of guideline recommended care. Compared with the highest quarter, hospitals in the lowest quarter for use of primary percutaneous coronary intervention had higher volume weighted 30 day mortality for ST elevation myocardial infarction (10.7% v 6.6% in Sweden; 12.7% v 5.8% in the UK). The adjusted odds ratio comparing the highest with the lowest quarters for hospitals' use of primary percutaneous coronary intervention was 0.70 (95% confidence interval 0.62 to 0.79) in Sweden and 0.68 (0.60 to 0.76) in the UK. Differences in risk between hospital quarters of treatment for non-ST elevation myocardial infarction and secondary prevention drugs for all discharged acute myocardial infarction patients were smaller than for reperfusion treatment in both countries. CONCLUSION Between hospital variation in 30 day mortality for acute myocardial infarction was greater in the UK than in Sweden. This was associated with, and may be partly accounted for by, the higher practice variation in acute myocardial infarction guideline recommended treatment in the UK hospitals. High quality healthcare across all hospitals, especially in the UK, with better use of guideline recommended treatment, may not only reduce unacceptable practice variation but also deliver improved clinical outcomes for patients with acute myocardial infarction.	[Chung, Sheng-Chia; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England; [Chung, Sheng-Chia; Hemingway, Harry] UCL, Inst Hlth Informat, London NW1 2DA, England; [Sundstrom, Johan; James, Stefan; Wallentin, Lars] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Gale, Chris P.] Uppsala Clin Res Ctr, Uppsala, Sweden; [Deanfield, John] Univ Leeds, Cardiovasc Hlth Sci, Leeds, W Yorkshire, England; [Timmis, Adam] Natl Ctr Cardiovasc Prevent & Outcomes, London, England; [Jernberg, Tomas] Barts Hlth London, Natl Inst Hlth Res, Cardiovasc Biomed Res Unit, London, England; Karolinska Inst, Cardiol Sect, Huddinge, Dept Med, Stockholm, Sweden	University of London; University College London; University of London; University College London; Uppsala University; Uppsala University; University of Leeds; Barts Health NHS Trust; Karolinska Institutet	Chung, SC (corresponding author), UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England.	s.chung@ucl.ac.uk	James, Stefan K/J-4554-2014; Sundström, Johan/A-6286-2009; Sundstrom, Johan/R-2139-2019; Demchuk, Andrew M/E-1103-2012; Hemingway, Harry/C-1219-2009	Sundström, Johan/0000-0003-2247-8454; Sundstrom, Johan/0000-0003-2247-8454; Demchuk, Andrew M/0000-0002-4930-7789; Deanfield, John/0000-0001-8806-6052; Gale, Chris/0000-0003-4732-382X; Chung, Sheng-Chia/0000-0001-6025-9207; Hemingway, Harry/0000-0003-2279-0624	European Implementation Score project - EU [223153]; National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z]; Medical Research Council Population Health Scientist Fellowship [MR/M015084/1]; Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership [G0902393/99558]; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; Wellcome Trust; Barts and the London Cardiovascular Biomedical Research Unit - National Institute for Health Research; Swedish Heart Lung Foundation; Swedish Research Council [2007-5942, 2010-1078]; Medical Research Council [MR/M015084/1, MR/K006584/1, MR/L01629X/1] Funding Source: researchfish; MRC [MR/L01629X/1, MR/M015084/1] Funding Source: UKRI	European Implementation Score project - EU; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Wellcome Trust(Wellcome Trust); Barts and the London Cardiovascular Biomedical Research Unit - National Institute for Health Research; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study has been supported by the European Implementation Score project, funded by the EU 7th Framework Programme (grant agreement 223153), National Institute for Health Research (programme grant RP-PG-0407-10314), Wellcome Trust (086091/Z/08/Z), Medical Research Council Population Health Scientist Fellowship (S-CC: grant MR/M015084/1), and Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (G0902393/99558) (HH, AT) and by awards to establish the Farr Institute of Health Informatics Research, London, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (S-CC). AT acknowledges the support of Barts and the London Cardiovascular Biomedical Research Unit, funded by the National Institute for Health Research. The Swedish Heart Lung Foundation (JS, TJ, and SJ) and the Swedish Research Council (JS: grants 2007-5942 and 2010-1078) supported the study. The sponsors had no role in the study design, the data collection, analysis, and interpretation, or the writing of the report.	Anderson JL, 2013, J AM COLL CARDIOL, V61, pE179, DOI 10.1016/j.jacc.2013.01.014; [Anonymous], SWEDEHEART 2011 ANN; Appleby J., 2011, VARIATIONS HLTH CARE; Bannink Lot, 2006, N Z Med J, V119, pU2313; Birkmeyer JD, 2009, ANNU REV MED, V60, P405, DOI 10.1146/annurev.med.60.062107.101214; Boggon R, 2011, EUR HEART J, V32, P2376, DOI 10.1093/eurheartj/ehr340; Boyle R., 2007, CORONARY HEART DIS 1; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Bradley EH, 2012, ANN INTERN MED, V156, P618, DOI 10.7326/0003-4819-156-9-201205010-00003; Bradley EH, 2010, AM J CARDIOL, V106, P1108, DOI 10.1016/j.amjcard.2010.06.014; Brown, 2006, APPL MIXED MODELS ME; Carlsson P, 2004, INT J TECHNOL ASSESS, V20, P44, DOI 10.1017/S0266462304000777; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Denaxas Spiros C, 2012, Int J Epidemiol, V41, P1625, DOI 10.1093/ije/dys188; Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381; Gale Christopher P, 2006, BMC Cardiovasc Disord, V6, P34, DOI 10.1186/1471-2261-6-34; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2014, EUR HEART J, V35, P2363, DOI 10.1093/eurheartj/ehu286; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Laut KG, 2013, EUROINTERVENTION, V9, P469, DOI 10.4244/EIJV9I4A76; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Limb M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2380; McLenachan JM, 2010, NATL ROLL OUT PRIMAR; McNamara RL, 2014, INT J CARDIOL, V175, P240, DOI 10.1016/j.ijcard.2014.04.270; Murphy NF, 2005, HEART, V91, P726, DOI 10.1136/hrt.2004.042929; Myocardial Ischaemia National Audit Project (MINAP), 2011, 10 MINAP; Organisation for Economic Co-operation and Development, OECD STATEXTRACTS; Packer C, 2006, INT J TECHNOL ASSESS, V22, P419, DOI 10.1017/S0266462306051336; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Peterson ED, 2009, CIRC-CARDIOVASC QUAL, V2, P491, DOI 10.1161/CIRCOUTCOMES.108.847145; Popescu I, 2009, CIRC-CARDIOVASC QUAL, V2, P221, DOI 10.1161/CIRCOUTCOMES.108.813790; Rapsomaniki E, 2014, INT COMP OUTCOMES 14; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Van de Werf F, 2009, REV ESP CARDIOL, V62, P293, DOI 10.1016/S1885-5857(09)71559-2; West RM, 2011, EUR HEART J, V32, P706, DOI 10.1093/eurheartj/ehq476; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; World Health Organization Regional Office for Europe, HLTH ALL DAT HFA DB	47	80	81	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2015	351								h3913	10.1136/bmj.h3913	http://dx.doi.org/10.1136/bmj.h3913			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AV	26254445	hybrid, Green Published			2022-12-28	WOS:000359387800001
J	Cooper, A; Turney, C; Hughen, KA; Brook, BW; McDonald, HG; Bradshaw, CJA				Cooper, Alan; Turney, Chris; Hughen, Konrad A.; Brook, Barry W.; McDonald, H. Gregory; Bradshaw, Corey J. A.			Abrupt warming events drove Late Pleistocene Holarctic megafaunal turnover	SCIENCE			English	Article							NORTH-ATLANTIC; POPULATION EXTINCTIONS; TROPICAL ATLANTIC; MILLENNIAL-SCALE; CLIMATE; CALIBRATION; DYNAMICS; RECORDS; CHRONOLOGIES; REGION	The mechanisms of Late Pleistocene megafauna extinctions remain fiercely contested, with human impact or climate change cited as principal drivers. We compared ancient DNA and radiocarbon data from 31 detailed time series of regional megafaunal extinctions and replacements over the past 56,000 years with standard and new combined records of Northern Hemisphere climate in the Late Pleistocene. Unexpectedly, rapid climate changes associated with interstadial warming events are strongly associated with the regional replacement or extinction of major genetic clades or species of megafauna. The presence of many cryptic biotic transitions before the Pleistocene/Holocene boundary revealed by ancient DNA confirms the importance of climate change in megafaunal population extinctions and suggests that metapopulation structures necessary to survive such repeated and rapid climatic shifts were susceptible to human impacts.	[Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Cooper, Alan; Brook, Barry W.; Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Turney, Chris] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Turney, Chris] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Hughen, Konrad A.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Brook, Barry W.; Bradshaw, Corey J. A.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Brook, Barry W.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [McDonald, H. Gregory] Natl Pk Serv, Museum Management Program, Ft Collins, CO 80525 USA	University of Adelaide; University of Adelaide; University of New South Wales Sydney; University of New South Wales Sydney; Woods Hole Oceanographic Institution; University of Adelaide; University of Tasmania; United States Department of the Interior	Cooper, A (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia.	alan.cooper@adelaide.edu.au; c.turney@unsw.edu.au	Bradshaw, Corey J.A./A-1311-2008; Brook, Barry W./G-2686-2011; Turney, Chris S M/P-8701-2018	Bradshaw, Corey J.A./0000-0002-5328-7741; Brook, Barry W./0000-0002-2491-1517; Turney, Chris S M/0000-0001-6733-0993; Cooper, Alan/0000-0002-7738-7851	NSF NESCENT workshop "Integrating datasets to investigate megafaunal extinction in the late Quaternary"; Australian Research Council	NSF NESCENT workshop "Integrating datasets to investigate megafaunal extinction in the late Quaternary"; Australian Research Council(Australian Research Council)	We thank the following museums and curators for their generous assistance with samples, advice and encouragement: Canadian Museum of Nature (R. Harington); American Museum of Natural History (R. Tedford); Natural History Museum London (A. Currant); Yukon Heritage Centre (J. Storer and G. Zazula); University of Alaska, Fairbanks (D. Guthrie, C. Gerlach, and P. Matheus), Royal Alberta Museum (J. Burns); Institute of Plant and Animal Ecology, RAS Yekaterinburg (P. Kosintsev and A. Vorobiev); Laboratory of Prehistory, St. Petersburg (V. Doronichev and L. Golovanova); D. Froese; T. Higham; A. Sher; J. Glimmerveen; B. Shapiro; T. Gilbert; E. Willerslev; R. Barnett; Yukon miners (B. and R. Johnson, the Christie family, K. Tatlow, S. and N. Schmidt); L. Dalen and J. Soubrier for data and assistance. This work was supported by NSF NESCENT workshop "Integrating datasets to investigate megafaunal extinction in the late Quaternary." A.C., C.T., B.W.B., and C.J.A.B. were supported by Australian Research Council Federation, Laureate and Future Fellowships. The new GICCO5-Cariaco Basin delta<SUP>18</SUP>O record is provided in (20) and also lodged on the Paleoclimatology Database (National Oceanic and Atmospheric Administration dataset ID: noaa-icecore-19015). The previously published radiocarbon data, with original references, is presented in (20). A.C. and C.T. conceived and performed research; A.C., C.J.A.B., C.T., and B.W.B. designed methods and performed analysis; A.C. and C.T. wrote the paper with input from all authors.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Austin WEN, 2012, QUATERNARY SCI REV, V36, P154, DOI 10.1016/j.quascirev.2010.12.014; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Brace S, 2012, P NATL ACAD SCI USA, V109, P20532, DOI 10.1073/pnas.1213322109; Bradshaw CJA, 2012, QUATERNARY SCI REV, V33, P14, DOI 10.1016/j.quascirev.2011.11.021; Buizert C, 2015, CLIM PAST, V11, P153, DOI 10.5194/cp-11-153-2015; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Cuvier G., 1796, MAGASIN ENCY J SCI L, V1, P303; DIAMOND JM, 1989, J ARCHAEOL SCI, V16, P167, DOI 10.1016/0305-4403(89)90064-2; Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604; Haynes G, 2013, QUATERN INT, V285, P89, DOI 10.1016/j.quaint.2010.07.026; Heaton TJ, 2013, RADIOCARBON, V55, P1975, DOI 10.2458/azu_js_rc.55.17777; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; Hughen KA, 2004, RADIOCARBON, V46, P1161, DOI 10.1017/S0033822200033075; Huntley B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061963; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; MacDonald GM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1881; Martin P.S., 1984, P354; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Mourier T, 2012, MOL BIOL EVOL, V29, P2241, DOI 10.1093/molbev/mss094; Muscheler R, 2014, EARTH PLANET SC LETT, V394, P209, DOI 10.1016/j.epsl.2014.03.024; OVERPECK JT, 1989, NATURE, V338, P553, DOI 10.1038/338553a0; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; PORTER SC, 1995, NATURE, V375, P305, DOI 10.1038/375305a0; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Shackleton NJ, 2004, QUATERNARY SCI REV, V23, P1513, DOI 10.1016/j.quascirev.2004.03.006; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Stuart AJ, 2004, NATURE, V431, P684, DOI 10.1038/nature02890; Stuart AJ, 2012, QUATERNARY SCI REV, V51, P1, DOI 10.1016/j.quascirev.2012.06.007; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Turney CSM, 2006, NATURE, V443, pE3, DOI 10.1038/nature05214; Tzedakis PC, 2007, NATURE, V449, P206, DOI 10.1038/nature06117; Wang X, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL030766, 10.1029/2007GL031149]; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013	42	180	182	11	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					602	606		10.1126/science.aac4315	http://dx.doi.org/10.1126/science.aac4315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250679				2022-12-28	WOS:000359092900032
J	Reingold, RB; Gostin, LO				Reingold, Rebecca B.; Gostin, Lawrence O.			Sexual Assaults Among University Students Prevention, Support, and Justice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Reingold, Rebecca B.; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Krebs C.P, 2007, CAMPUS SEXUAL ASSAUL; Lisak David, 2002, Violence Vict, V17, P73, DOI 10.1891/vivi.17.1.73.33638; Lombardi Kristen, 2010, LACK CONSEQUENCES SE; Sinozich S., 2014, RAPE SEXUAL ASSAULT; The White House, 2014, NOT AL 1 REP WHIT HO; U.S. Department of Education, 2014, QUEST ANSW TITL 9 SE; US Senate Subcommittee on Financial and Contracting Oversight-Majority Staff, 2014, SEX ASS CAMP TOO MAN	7	4	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					447	448		10.1001/jama.2015.6330	http://dx.doi.org/10.1001/jama.2015.6330			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO1OI	26241593				2022-12-28	WOS:000358924500006
J	Koperdanova, M; Cullis, JO				Koperdanova, Marianna; Cullis, Jonathan O.			RATIONAL TESTING Interpreting raised serum ferritin levels	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEMOCHROMATOSIS; MANAGEMENT; DIAGNOSIS		[Koperdanova, Marianna; Cullis, Jonathan O.] Salisbury Dist Hosp, Salisbury SP2 8BJ, Wilts, England	Salisbury District Hospital	Cullis, JO (corresponding author), Salisbury Dist Hosp, Salisbury SP2 8BJ, Wilts, England.	jonathan.cullis@salisbury.nhs.uk			Biotechnology and Biological Sciences Research Council [BB/L025752/1] Funding Source: researchfish; BBSRC [BB/L025752/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams PC, 2011, J HEPATOL, V55, P453, DOI 10.1016/j.jhep.2011.02.010; Adams PC, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2007.02.027; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330; Bozzini C, 2005, DIABETES CARE, V28, P2061, DOI 10.2337/diacare.28.8.2061; Hearnshaw S, 2006, WORLD J GASTROENTERO, V12, P5866, DOI 10.3748/wjg.v12.i36.5866; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Ogilvie C, 2012, PRIMARY CARE GLANCE; Ogilvie C, 2015, J CLIN PATHOL, V68, P218, DOI 10.1136/jclinpath-2014-202720; Ogilvie C, 2010, J CLIN PATHOL, V63, P1124, DOI 10.1136/jcp.2010.083188; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Trombini P, 2007, J HEPATOL, V46, P549, DOI 10.1016/j.jhep.2007.01.004; van Bokhoven MA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7251; WORWOOD M, 1982, CLIN HAEMATOL, V11, P275	15	40	41	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2015	351								h3692	10.1136/bmj.h3692	http://dx.doi.org/10.1136/bmj.h3692			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AO	26239322				2022-12-28	WOS:000359387100001
J	Henao-Restrepo, AM; Longini, IM; Egger, M; Dean, NE; Edmunds, WJ; Camacho, A; Carroll, MW; Doumbia, M; Draguez, B; Duraffour, S; Enwere, G; Grais, R; Gunther, S; Hossmann, S; Konde, MK; Kone, S; Kuisma, E; Levine, MM; Mandal, S; Norheim, G; Riveros, X; Soumah, A; Trelle, S; Vicari, AS; Watson, CH; Keita, S; Kieny, MP; Rottingen, JA				Henao-Restrepo, Ana Maria; Longini, Ira M.; Egger, Matthias; Dean, Natalie E.; Edmunds, W. John; Camacho, Anton; Carroll, Miles W.; Doumbia, Moussa; Draguez, Bertrand; Duraffour, Sophie; Enwere, Godwin; Grais, Rebecca; Gunther, Stephan; Hossmann, Stefanie; Konde, Mandy Kader; Kone, Souleymane; Kuisma, Eeva; Levine, Myron M.; Mandal, Sema; Norheim, Gunnstein; Riveros, Ximena; Soumah, Aboubacar; Trelle, Sven; Vicari, Andrea S.; Watson, Conall H.; Keita, Sakoba; Kieny, Marie Paule; Rottingen, John-Arne			Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial	LANCET			English	Article							MARBURG VIRUS; INFECTION	Background A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate. We report the results of an interim analysis of a trial of rVSV-ZEBOV in Guinea, west Africa. Methods For this open-label, cluster-randomised ring vaccination trial, suspected cases of Ebola virus disease in Basse-Guinee (Guinea, west Africa) were independently ascertained by Ebola response teams as part of a national surveillance system. After laboratory confirmation of a new case, clusters of all contacts and contacts of contacts were defined and randomly allocated 1: 1 to immediate vaccination or delayed (21 days later) vaccination with rVSV-ZEBOV (one dose of 2 x 10(7) plaque-forming units, administered intramuscularly in the deltoid muscle). Adults (age >= 18 years) who were not pregnant or breastfeeding were eligible for vaccination. Block randomisation was used, with randomly varying blocks, stratified by location (urban vs rural) and size of rings (<= 20 vs >20 individuals). The study is open label and masking of participants and field teams to the time of vaccination is not possible, but Ebola response teams and laboratory workers were unaware of allocation to immediate or delayed vaccination. Taking into account the incubation period of the virus of about 10 days, the prespecified primary outcome was laboratory-confirmed Ebola virus disease with onset of symptoms at least 10 days after randomisation. The primary analysis was per protocol and compared the incidence of Ebola virus disease in eligible and vaccinated individuals in immediate vaccination clusters with the incidence in eligible individuals in delayed vaccination clusters. This trial is registered with the Pan African Clinical Trials Registry, number PACTR201503001057193. Findings Between April 1, 2015, and July 20, 2015, 90 clusters, with a total population of 7651 people were included in the planned interim analysis. 48 of these clusters (4123 people) were randomly assigned to immediate vaccination with rVSV-ZEBOV, and 42 clusters (3528 people) were randomly assigned to delayed vaccination with rVSV-ZEBOV. In the immediate vaccination group, there were no cases of Ebola virus disease with symptom onset at least 10 days after randomisation, whereas in the delayed vaccination group there were 16 cases of Ebola virus disease from seven clusters, showing a vaccine efficacy of 100% (95% CI 74.7-100.0; p=0.0036). No new cases of Ebola virus disease were diagnosed in vaccinees from the immediate or delayed groups from 6 days post-vaccination. At the cluster level, with the inclusion of all eligible adults, vaccine effectiveness was 75.1% (95% CI -7.1 to 94.2; p=0.1791), and 76.3% (95% CI -15.5 to 95.1; p=0.3351) with the inclusion of everyone (eligible or not eligible for vaccination). 43 serious adverse events were reported; one serious adverse event was judged to be causally related to vaccination (a febrile episode in a vaccinated participant, which resolved without sequelae). Assessment of serious adverse events is ongoing. Interpretation The results of this interim analysis indicate that rVSV-ZEBOV might be highly efficacious and safe in preventing Ebola virus disease, and is most likely effective at the population level when delivered during an Ebola virus disease outbreak via a ring vaccination strategy.Copyright (C) 2015. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved.	[Henao-Restrepo, Ana Maria; Enwere, Godwin; Kone, Souleymane; Riveros, Ximena; Vicari, Andrea S.] WHO, CH-1211 Geneva, Switzerland; [Longini, Ira M.; Dean, Natalie E.] Univ Florida, Dept Biostat, Gainesville, FL USA; [Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Hossmann, Stefanie; Trelle, Sven] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Egger, Matthias] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Edmunds, W. John; Camacho, Anton] London Sch Hyg & Trop Med, Fac Epidemiol & Populat, London WC1, England; [Carroll, Miles W.; Kuisma, Eeva; Mandal, Sema] Publ Hlth England, Porton Down, Wilts, England; [Carroll, Miles W.; Duraffour, Sophie] Bernhard Nocht Inst Trop Med, European Mobile Lab Consortium, D-20359 Hamburg, Germany; [Gunther, Stephan] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arboviruses & Hemorrhag Fev, Dept Virol, D-20359 Hamburg, Germany; [Doumbia, Moussa] Ctr Dev Vaccins, Bamako, Mali; [Draguez, Bertrand] Med Sans Frontieres, Brussels, Belgium; [Grais, Rebecca; Soumah, Aboubacar] Epictr, Paris, France; [Konde, Mandy Kader] CEFORPAG, Conakry, Guinea; [Levine, Myron M.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Norheim, Gunnstein; Rottingen, John-Arne] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Rottingen, John-Arne] Univ Oslo, Dept Hlth & Soc, Oslo, Norway; [Keita, Sakoba] Minist Hlth, Ebola Response, Conakry, Guinea; [Rottingen, John-Arne] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	World Health Organization; State University System of Florida; University of Florida; University of Bern; University of Bern; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Public Health England; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; Doctors Without Borders; University System of Maryland; University of Maryland Baltimore; Norwegian Institute of Public Health (NIPH); University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Kieny, MP (corresponding author), Hlth Syst & Innovat, 20 Av Appia, CH-1211 Geneva 27, Switzerland.	kienym@who.int	Trelle, Sven/D-3760-2009; amsalu, ribka/G-8780-2019; Kieny, Marie-Paule/Q-1238-2019; Kieny, Marie-Paule/N-3914-2017	Trelle, Sven/0000-0002-8162-8910; Kieny, Marie-Paule/0000-0002-5943-6488; Egger, Matthias/0000-0001-7462-5132; camacho, anton/0000-0002-0023-3985; Freeman Grais, Rebecca/0000-0002-5037-8218; Mandal, Sema/0000-0003-3379-3118; Hossmann, Stefanie/0000-0003-1600-5925; Gunther, Stephan/0000-0002-6562-0230; Watson, Conall/0000-0002-2469-791X	WHO; Wellcome Trust (UK); Medecins Sans Frontieres; Norwegian Ministry of Foreign Affairs through the Research Council of Norway; Canadian Government through the Public Health Agency of Canada; Canadian Institutes of Health Research, International Development Research Centre; Department of Foreign Affairs, Trade and Development; Wellcome Trust; UK Department of International Development; Guinean Ministry of Health; Norwegian Ministry of Foreign Affairs; US Department of Defense; Public Health Agency of Canada; Swiss Agency for Therapeutic Products; Bill AMP; Melinda Gates Foundation; Health Canada; European Commission	WHO(World Health Organization); Wellcome Trust (UK)(Wellcome Trust); Medecins Sans Frontieres; Norwegian Ministry of Foreign Affairs through the Research Council of Norway; Canadian Government through the Public Health Agency of Canada; Canadian Institutes of Health Research, International Development Research Centre(Canadian Institutes of Health Research (CIHR)); Department of Foreign Affairs, Trade and Development; Wellcome Trust(Wellcome Trust); UK Department of International Development; Guinean Ministry of Health; Norwegian Ministry of Foreign Affairs; US Department of Defense(United States Department of Defense); Public Health Agency of Canada; Swiss Agency for Therapeutic Products; Bill AMP; Melinda Gates Foundation(CGIAR); Health Canada; European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding WHO, with support from the Wellcome Trust (UK); Medecins Sans Frontieres; the Norwegian Ministry of Foreign Affairs through the Research Council of Norway; and the Canadian Government through the Public Health Agency of Canada, Canadian Institutes of Health Research, International Development Research Centre, and Department of Foreign Affairs, Trade and Development.r We thank the people in Basse-Guinee for their participation, and all the field, laboratory, and data management staff who worked extremely hard and under difficult conditions to successfully implement this study. Merck Sharp & Dohme provided the vaccine used in the trial. We would like to acknowledge the support of the following organisations: Wellcome Trust, UK Department of International Development, Guinean Ministry of Health, Norwegian Ministry of Foreign Affairs, US Department of Defense, Public Health Agency of Canada, Swiss Agency for Therapeutic Products, the Bill & Melinda Gates Foundation, Health Canada, and the European Commission. We also thank the following individuals who directly contributed to the study: Jeremy Farrar, D A Henderson, Richard Peto, David Hone, Tore Godal, Djilali Abdelghafour, Yap Boum, Mar Cabeza-Cabrerizo, Rokiatu Dembele, Ibrahima Diatta, Mamoudou Harouna Djingarey, Julia Djonova, Andres Garcia, Myriam Grubo, Pierre Gsell, Yper Hall, Raul Iraheta, Olivier Lapujade, Nicola Low, Murray Lumpkin, Thomas Mauget, Christine Maure, Corinne Merle, Nicholas Misso, Bjorg Dystvold Nilsson, Marie-Pierre Preziosi, Vasee Moorthy, Jean-Marie Okwo Bele, William Perea, Guenal Rodier, Martina Rothenbuhler, Peter Smith, Samba Sow, Graciela Spizzamiglio, Milagritos Tapia, Guido Torelli, Sara Sofie Viksmoen Watle, and our colleagues at WHO for their support with implementation of the trial. We also thank all members of our scientific advisory group, our data and safety monitoring board, and the Guinea vaccine trial working group.	Aalen O, SURVIVAL EVENT HIST; Agnandji ST, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1502924, 10.1056/NEJMoa1502924., DOI 10.1056/NEJMOA1502924]; Agua-Agum J, 2015, NEW ENGL J MED, V372, P1274, DOI 10.1056/NEJMc1415318; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Donner A, 2000, DESIGN ANAL CLUSTER; Fenner F, SMALLPOX ITS ERADICA; Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Hayes RJ, 2009, INTERD STAT, P3; Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; R Core Team, 2008, R A LANGUAGE AND ENV; Rampling T, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1411627, DOI 10.1056/NEJMOA1411627, 10.1056/NEJMoa1411627.]; Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; WHO, LAB GUID DIAGN EB VI; WHO, SIT REP EB RESP ROAD; WHO, CONT TRAC OUTBR EB V; World Health Organization, 2014, CAS DEF REC EB MARB; Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0	25	539	564	9	264	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					857	866		10.1016/S0140-6736(15)61117-5	http://dx.doi.org/10.1016/S0140-6736(15)61117-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	26248676				2022-12-28	WOS:000360290000029
J	Haynes, CM				Haynes, Cole M.			CELL BIOLOGY Surviving import failure	NATURE			English	Editorial Material									Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Haynes, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.	haynesc@mskcc.org						Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Matsuo Y, 2014, NATURE, V505, P112, DOI 10.1038/nature12731; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Sammons MA, 2011, BIOCHEM BIOPH RES CO, V406, P13, DOI 10.1016/j.bbrc.2011.01.086; Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859; Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951	9	2	2	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					419	420		10.1038/nature14644	http://dx.doi.org/10.1038/nature14644			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26245372				2022-12-28	WOS:000360069300024
J	Murphy, JJ; Melchiorre, P				Murphy, John J.; Melchiorre, Paolo			ORGANIC CHEMISTRY Light opens pathways for nickel catalysis	NATURE			English	Editorial Material							ARYL HALIDES; COMPLEXES; PHOTOREDOX		[Murphy, John J.; Melchiorre, Paolo] Inst Chem Res Catalonia ICIQ, Tarragona 43007, Spain; [Melchiorre, Paolo] Catalan Inst Res & Adv Studies, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Rovira i Virgili; Institute of Chemical Research of Catalonia; ICREA	Murphy, JJ (corresponding author), Inst Chem Res Catalonia ICIQ, Tarragona 43007, Spain.	pmelchiorre@iciq.es	Melchiorre, Paolo/K-9301-2014	Melchiorre, Paolo/0000-0001-8722-4602; Murphy, John/0000-0001-8411-9540	ICREA Funding Source: Custom	ICREA(ICREA)		Camasso NM, 2015, SCIENCE, V347, P1218, DOI 10.1126/science.aaa4526; Han RY, 1997, J AM CHEM SOC, V119, P8135, DOI 10.1021/ja9714999; Mann G, 1997, J ORG CHEM, V62, P5413, DOI 10.1021/jo970453v; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Tasker SZ, 2015, J AM CHEM SOC, V137, P9531, DOI 10.1021/jacs.5b05597; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Terrett JA, 2015, NATURE, V524, P330, DOI 10.1038/nature14875; Torraca KE, 2001, J AM CHEM SOC, V123, P10770, DOI 10.1021/ja016863p; Wolter M, 2002, ORG LETT, V4, P973, DOI 10.1021/ol025548k; Zhou W, 2015, J AM CHEM SOC, V137, P7604, DOI 10.1021/jacs.5b04082; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	12	25	25	1	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					297	298		10.1038/nature15200	http://dx.doi.org/10.1038/nature15200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26266981				2022-12-28	WOS:000359714000022
J	Dyer, O; White, C; Rada, AG				Dyer, Owen; White, Caroline; Garcia Rada, Aser			BRIEFING Assisted dying: law and practice around the world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Garcia Rada, Aser/0000-0003-1026-2453				[Anonymous], 2014, CBC NEWS; Commission Nationale de Controle et d'Evaluation de la loi du, 2015, LOI 16 MARS 2009 EUT; Dierickx S, 2015, JAMA INTERN MED, V175, P1703, DOI 10.1001/jamainternmed.2015.3982; Dugan A., 2015, US SUPPORT DOCTOR AS; El Pais, 2014, PAIS; Gauthier S, 2015, J MED ETHICS, V41, P611, DOI 10.1136/medethics-2014-102091; Government of Quebec, 2015, PROV QUEB LAW END LI; Guzman D., 2012, MEDICO QUE HA PRACTI; Institut Europeen de Bioethique, 2014, RAPP COMM EV EUTH 20; Ipsos, 2015, EC ASS DYING RES 201; Kane L., 2014, MEDSCAPE ETHICS RE 1; La eutanasia de su padre bajo el trazo de, EL TIEMPO; Matador, 2015, EL TIEMPO       0705; Ministry of Health, 2010, EUTH ASS SUIC 25 QUE; Ogilvie AD, 1997, BRIT MED J, V314, P1849; Regional Euthanasia Review Committees, 2013, REG EUTH REV COMM AN; Thienpont L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007454; Vincent D., 2015, TORONTO STAR; Washington State Department of Health, 2014, 2014 DEATH DIGN ACT	19	27	28	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4481	10.1136/bmj.h4481	http://dx.doi.org/10.1136/bmj.h4481			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7PU	26290517				2022-12-28	WOS:000360081100011
J	Price, A				Price, Annabel			PERSONAL VIEW Mental capacity as a safeguard in assisted dying: clarity is needed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUICIDE		Univ Cambridge, Dept Psychiat, Cambridge CB2 0SP, England	University of Cambridge	Price, A (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge CB2 0SP, England.							Ganzini L, 2000, AM J PSYCHIAT, V157, P595, DOI 10.1176/appi.ajp.157.4.595; Hotopf M, 2011, BRIT J PSYCHIAT, V198, P83, DOI 10.1192/bjp.bp.110.083634; Price A, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-32; Price Annabel, 2011, BMJ Support Palliat Care, V1, P140, DOI 10.1136/bmjspcare-2011-000011; Wessely S, 2014, PRESIDENTS BLOG ASSI	5	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4461	10.1136/bmj.h4461	http://dx.doi.org/10.1136/bmj.h4461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP7PU	26294758				2022-12-28	WOS:000360081100008
J	Brophy, J; Leon, MB; Smith, CR				Brophy, James; Leon, M. B.; Smith, C. R.			Transcatheter and surgical aortic valve replacement did not differ for mortality in severe aortic stenosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McGill Univ, Montreal, PQ 75093, Canada	McGill University	Brophy, J (corresponding author), McGill Univ, Montreal, PQ 75093, Canada.		brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					JC4	JC4		10.7326/ACPJC-2015-163-4-004	http://dx.doi.org/10.7326/ACPJC-2015-163-4-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26280439				2022-12-28	WOS:000364673500004
J	Leventhal, AM; Strong, DR; Kirkpatrick, MG; Unger, JB; Sussman, S; Riggs, NR; Stone, MD; Khoddam, R; Samet, JM; Audrain-McGovern, J				Leventhal, Adam M.; Strong, David R.; Kirkpatrick, Matthew G.; Unger, Jennifer B.; Sussman, Steve; Riggs, Nathaniel R.; Stone, Matthew D.; Khoddam, Rubin; Samet, Jonathan M.; Audrain-McGovern, Janet			Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Exposure to nicotine in electronic cigarettes (e-cigarettes) is becoming increasingly common among adolescents who report never having smoked combustible tobacco. OBJECTIVE To evaluate whether e-cigarette use among 14-year-old adolescents who have never tried combustible tobacco is associated with risk of initiating use of 3 combustible tobacco products (ie, cigarettes, cigars, and hookah). DESIGN, SETTING, AND PARTICIPANTS Longitudinal repeated assessment of a school-based cohort at baseline (fall 2013, 9th grade, mean age = 14.1 years) and at a 6-month follow-up (spring 2014, 9th grade) and a 12-month follow-up (fall 2014, 10th grade). Ten public high schools in Los Angeles, California, were recruited through convenience sampling. Participants were students who reported never using combustible tobacco at baseline and completed follow-up assessments at 6 or 12 months (N = 2530). At each time point, students completed self-report surveys during in-classroom data collections. EXPOSURE Student self-report of whether he or she ever used e-cigarettes (yes or no) at baseline. MAIN OUTCOMES AND MEASURES Six-and 12-month follow-up reports on use of any of the following tobacco products within the prior 6 months: (1) any combustible tobacco product (yes or no); (2) combustible cigarettes (yes or no), (3) cigars (yes or no); (4) hookah (yes or no); and (5) number of combustible tobacco products (range: 0-3). RESULTS Past 6-month use of any combustible tobacco product was more frequent in baseline e-cigarette ever users (n = 222) than never users (n = 2308) at the 6-month follow-up (30.7% vs 8.1%, respectively; difference between groups in prevalence rates, 22.7%[95% CI, 16.4%-28.9%]) and at the 12-month follow-up (25.2% vs 9.3%, respectively; difference between groups, 15.9%[95% CI, 10.0%-21.8%]). Baseline e-cigarette use was associated with greater likelihood of use of any combustible tobacco product averaged across the 2 follow-up periods in the unadjusted analyses (odds ratio [OR], 4.27 [95% CI, 3.19-5.71]) and in the analyses adjusted for sociodemographic, environmental, and intrapersonal risk factors for smoking (OR, 2.73 [95% CI, 2.00-3.73]). Product-specific analyses showed that baseline e-cigarette use was positively associated with combustible cigarette (OR, 2.65 [95% CI, 1.73-4.05]), cigar (OR, 4.85 [95% CI, 3.38-6.96]), and hookah (OR, 3.25 [95% CI, 2.29-4.62]) use and with the number of different combustible products used (OR, 4.26 [95% CI, 3.16-5.74]) averaged across the 2 follow-up periods. CONCLUSIONS AND RELEVANCE Among high school students in Los Angeles, those who had ever used e-cigarettes at baseline compared with nonusers were more likely to report initiation of combustible tobacco use over the next year. Further research is needed to understand whether this association may be causal.	[Leventhal, Adam M.; Kirkpatrick, Matthew G.; Unger, Jennifer B.; Sussman, Steve; Stone, Matthew D.; Khoddam, Rubin; Samet, Jonathan M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Leventhal, Adam M.; Sussman, Steve; Khoddam, Rubin] Univ So Calif, Dept Psychol, Los Angeles, CA 90033 USA; [Strong, David R.] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Sussman, Steve] Univ So Calif, Sch SocialWork, Los Angeles, CA 90033 USA; [Riggs, Nathaniel R.] Colorado State Univ, Dept Human Dev & Family Studies, Ft Collins, CO 80523 USA; [Audrain-McGovern, Janet] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Southern California; University of Southern California; University of California System; University of California San Diego; University of Southern California; Colorado State University; University of Pennsylvania; Pennsylvania Medicine	Leventhal, AM (corresponding author), Univ So Calif, Keck Sch Med, 2250 Alcazar St,CSC 271, Los Angeles, CA 90033 USA.	adam.leventhal@usc.edu		Riggs, Nathaniel/0000-0002-1105-6718; Unger, Jennifer/0000-0001-9064-6603	National Institutes of Health [R01-DA033296, P50-CA180905]; NATIONAL CANCER INSTITUTE [P50CA180905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033296, R01DA026831, F31DA039708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants R01-DA033296 and P50-CA180905 from the National Institutes of Health.	[Anonymous], 2011, SAS 9 3 SYST OPT REF; Arrazola RA, 2015, MMWR-MORBID MORTAL W, V64, P426; Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Audrain-McGovern J, 2004, CANCER EPIDEM BIOMAR, V13, P2023; Benner AD, 2011, EDUC PSYCHOL REV, V23, P299, DOI 10.1007/s10648-011-9152-0; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Camenga DR, 2014, J ADOLESCENT HEALTH, V55, P588, DOI 10.1016/j.jadohealth.2014.06.016; Cardenas VM, 2015, ANN EPIDEMIOL, V25, P60, DOI 10.1016/j.annepidem.2014.09.013; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Collaco JM, 2015, JAMA PEDIATR, V169, P177, DOI 10.1001/jamapediatrics.2014.2898; Cooper ZD, 2009, DRUG ALCOHOL DEPEN, V103, P107, DOI 10.1016/j.drugalcdep.2009.01.023; Counotte DS, 2011, DEV COGN NEUROS-NETH, V1, P430, DOI 10.1016/j.dcn.2011.05.010; COVEY LS, 1990, AM J PUBLIC HEALTH, V80, P1330, DOI 10.2105/AJPH.80.11.1330; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P595, DOI 10.1001/jama.2014.7883; HOLM S, 1979, SCAND J STAT, V6, P65; Johnston L., 2015, MONITORING FUTURE NA; Johnston LD, USE ALCOHOL CIGARETT; Katz EC, 2000, COGNITIVE THER RES, V24, P1, DOI 10.1023/A:1005460107337; Kong G, 2015, NICOTINE TOB RES, V17, P847, DOI 10.1093/ntr/ntu257; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Peters Ronald J Jr, 2013, J Ethn Subst Abuse, V12, P300, DOI 10.1080/15332640.2013.819310; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Shihadeh A, 2015, NICOTINE TOB RES, V17, P158, DOI 10.1093/ntr/ntu175; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Strong DR, 2015, NICOTINE TOB RES, V17, P862, DOI 10.1093/ntr/ntu254; Thompson MP, 2007, J ADOLESCENT HEALTH, V40, P232, DOI 10.1016/j.jadohealth.2006.10.016; Tyas SL, 1998, TOB CONTROL, V7, P409, DOI 10.1136/tc.7.4.409; US Centers for Disease Control and Prevention, 2011, NAT YOUGH TOB SURV M; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; Wills TA, 2015, PEDIATRICS, V135, pE43, DOI 10.1542/peds.2014-0760	32	636	643	5	90	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					700	707		10.1001/jama.2015.8950	http://dx.doi.org/10.1001/jama.2015.8950			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284721	Bronze, Green Accepted			2022-12-28	WOS:000360019100018
J	Saunders, MR; Cifu, A; Vela, M				Saunders, Milda R.; Cifu, Adam; Vela, Monica			Screening for Chronic Kidney Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLYCEMIC CONTROL; ALBUMINURIA; PEOPLE		[Saunders, Milda R.] Univ Chicago, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA; [Cifu, Adam; Vela, Monica] Univ Chicago, Dept Med, Gen Internal Med Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Saunders, MR (corresponding author), Univ Chicago, Dept Med, Sect Hosp Med, 5841 S Maryland Ave,Mail Code 5000, Chicago, IL 60637 USA.	msaunders@uchicago.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK103111] Funding Source: NIH RePORTER; NIDDK NIH HHS [K23 DK103111] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2014, USRDS ANN DAT REP OV; Bash LD, 2008, ARCH INTERN MED, V168, P2440, DOI 10.1001/archinte.168.22.2440; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Plantinga LC, 2010, ADV CHRONIC KIDNEY D, V17, P225, DOI 10.1053/j.ackd.2010.03.002; Qaseem A, 2013, ANN INTERN MED, V159, P835, DOI 10.7326/0003-4819-159-12-201312170-00726; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537	8	23	23	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					615	616		10.1001/jama.2015.9425	http://dx.doi.org/10.1001/jama.2015.9425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262800	Green Accepted			2022-12-28	WOS:000359388600021
J	Watts, G				Watts, Geoff			Edgar Rodas Obituary	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					526	526		10.1016/S0140-6736(15)60763-2	http://dx.doi.org/10.1016/S0140-6736(15)60763-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8PG	26293431				2022-12-28	WOS:000359431900014
J	Chug, H; Trakhanov, S; Hulsmann, BB; Pleiner, T; Gorlich, D				Chug, Hema; Trakhanov, Sergei; Huelsmann, Bastian B.; Pleiner, Tino; Goerlich, Dirk			Crystal structure of the metazoan Nup62.Nup58.Nup54 nucleoporin complex	SCIENCE			English	Article							NUCLEAR-PORE COMPLEX; PERMEABILITY BARRIER; COILED COILS; P62 COMPLEX; ARCHITECTURE; CHANNEL; DOMAIN; NSP1P; TRANSLOCATION; PURIFICATION	Nuclear pore complexes (NPCs) conduct nucleocytoplasmic transport and gain transport selectivity through nucleoporin FG domains. Here, we report a structural analysis of the FG Nup62.58.54 complex, which is a crucial component of the transport system. It comprises a approximate to 13 nanometer-long trimerization interface with an unusual 2W3Fcoil, a canonical heterotrimeric coiled coil, and a kink that enforces a compact six-helix bundle. Nup54 also contains a ferredoxin-like domain. We further identified a heterotrimeric Nup93-binding module for NPC anchorage. The quaternary structure alternations in the Nup62 complex, which were previously proposed to trigger a general gating of the NPC, are incompatible with the trimer structure. We suggest that the highly elongated Nup62 complex projects barrier-forming FG repeats far into the central NPC channel, supporting a barrier that guards the entire cross section.	[Chug, Hema; Trakhanov, Sergei; Huelsmann, Bastian B.; Pleiner, Tino; Goerlich, Dirk] Max Planck Inst Biophys Chem, Dept Cellular Logist, D-37077 Gottingen, Germany	Max Planck Society	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Logist, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210; Chug, Hema/0000-0002-9889-7076; Pleiner, Tino/0000-0002-5104-0315	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft [SFB 860]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the crystallization facility of our institute for providing the robotic screening infrastructure; the team at the synchrotron facility of the Paul Scherrer Institute, Switzerland, for assistance in diffraction data acquisition; the VIB Nanobody Service Facility (Vrije Universiteit Brussel) for providing coding sequences for anti-Nup62 complex nanobodies; U. Steuerwald for support in crystallization; K. Gencalp for helping with MALS; R. Rees, J. Krull, and J. Schunemann for excellent technical help; M. Aksu and K. Gencalp for critical reading of the manuscript; and the Max-Planck-Gesellschaft and the Deutsche Forschungsgemeinschaft (SFB 860) for funding this work. Coordinates and structure factor files have been submitted to the Protein Data Bank (PDB) and are available under the accession codes 5C3L (Nup62.58.54 complex bound to Nb15) and 5C2U (Nup54 alpha beta domain bound to Nb10).	Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Bilokapic S, 2012, CURR OPIN CELL BIOL, V24, P86, DOI 10.1016/j.ceb.2011.12.011; BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251; Eibauer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8532; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Hurt E, 2015, CURR OPIN CELL BIOL, V34, P31, DOI 10.1016/j.ceb.2015.04.009; KITA K, 1993, J BIOCHEM-TOKYO, V113, P377, DOI 10.1093/oxfordjournals.jbchem.a124054; Koh J, 2015, CELL, V161, P1361, DOI 10.1016/j.cell.2015.05.013; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Schlaich NL, 1997, MOL BIOL CELL, V8, P33, DOI 10.1091/mbc.8.1.33; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Solmaz SR, 2013, P NATL ACAD SCI USA, V110, P5858, DOI 10.1073/pnas.1302655110; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; Ulrich A, 2014, MOL BIOL CELL, V25, P1484, DOI 10.1091/mbc.E13-12-0745; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	30	72	73	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					106	110		10.1126/science.aac7420	http://dx.doi.org/10.1126/science.aac7420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26292704				2022-12-28	WOS:000362098300056
J	Wang, YH; Kirtley, JR; Katmis, F; Jarillo-Herrero, P; Moodera, JS; Moler, KA				Wang, Y. H.; Kirtley, J. R.; Katmis, F.; Jarillo-Herrero, P.; Moodera, J. S.; Moler, K. A.			RETRACTED: Observation of chiral currents at the magnetic domain boundary of a topological insulator (retracted article see vol 350, pg 1482, 2015)	SCIENCE			English	Article; Retracted Publication							SURFACE; LIMIT	A magnetic domain boundary on the surface of a three-dimensional topological insulator is predicted to host a chiral edge state, but direct demonstration is challenging. We used a scanning superconducting quantum interference device to show that current in a magnetized topological insulator heterostructure (EuS/Bi2Se3) flows at the edge when the Fermi level is gate-tuned to the surface band gap. We further induced micrometer-scale magnetic structures on the heterostructure and detected a chiral edge current at the magnetic domain boundary. The chirality of the current was determined by magnetization of the surrounding domain, and its magnitude by the local chemical potential rather than the applied current. Such magnetic structures provide a platform for detecting topological magnetoelectric effects and may enable progress in quantum information processing and spintronics.	[Wang, Y. H.; Kirtley, J. R.; Moler, K. A.] Stanford Univ, Dept Phys & Appl Phys, Stanford, CA 94305 USA; [Wang, Y. H.; Moler, K. A.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Katmis, F.; Moodera, J. S.] MIT, Francis Bitter Magnet Lab, Cambridge, MA 02139 USA; [Katmis, F.; Moodera, J. S.] MIT, Plasma Sci & Fus Ctr, Cambridge, MA 02139 USA; [Katmis, F.; Jarillo-Herrero, P.; Moodera, J. S.] MIT, Dept Phys, Cambridge, MA 02139 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Wang, YH (corresponding author), Stanford Univ, Dept Phys & Appl Phys, Stanford, CA 94305 USA.	wangyhv@stanford.edu; kmoler@stanford.edu	; Jarillo-Herrero, Pablo/E-3755-2013	Moler, Kathryn/0000-0002-0233-8123; Jarillo-Herrero, Pablo/0000-0001-8217-8213	Center for Function Accelerated nanoMaterial Engineering (FAME), one of six centers of STARnet, a Semiconductor Research Corporation program - Microelectronics Advanced Research Corp. (MARCO); Defense Advanced Research Projects Agency (DARPA); Department of Energy (DOE), Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]; NSF-NSEC [0830228]; NSF IMR-MIP [0957616]; Urbanek Fellowship of the Department of Applied Physics at Stanford University; Massachusetts Institute of Technology's Materials Research Science and Engineering Center (MRSEC) through MRSEC Program of the National Science Foundation [DMR-0819762]; NSF [DMR-1207469]; ONR [N00014-13-1-0301]; DOE, Basic Energy Sciences Office, Division of Materials Sciences and Engineering [DE-SC0006418]	Center for Function Accelerated nanoMaterial Engineering (FAME), one of six centers of STARnet, a Semiconductor Research Corporation program - Microelectronics Advanced Research Corp. (MARCO); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Department of Energy (DOE), Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division; NSF-NSEC(National Science Foundation (NSF)); NSF IMR-MIP; Urbanek Fellowship of the Department of Applied Physics at Stanford University; Massachusetts Institute of Technology's Materials Research Science and Engineering Center (MRSEC) through MRSEC Program of the National Science Foundation; NSF(National Science Foundation (NSF)); ONR(Office of Naval Research); DOE, Basic Energy Sciences Office, Division of Materials Sciences and Engineering	These measurements were supported by the Center for Function Accelerated nanoMaterial Engineering (FAME), one of six centers of STARnet, a Semiconductor Research Corporation program sponsored by the Microelectronics Advanced Research Corp. (MARCO) and the Defense Advanced Research Projects Agency (DARPA). Preliminary measurements and analysis were supported by the Department of Energy (DOE), Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division, under contract DE-AC02-76SF00515. The SQUID microscope and sensors were developed with support from NSF-NSEC 0830228 and NSF IMR-MIP 0957616. Y.H.W. is partially supported by the Urbanek Fellowship of the Department of Applied Physics at Stanford University. For sample preparation, F.K., P.J-H., and J.S.M. acknowledge support by the Massachusetts Institute of Technology's Materials Research Science and Engineering Center (MRSEC) through the MRSEC Program of the National Science Foundation under award DMR-0819762. Partial support for sample development was provided by NSF (DMR-1207469), ONR (N00014-13-1-0301) (F.K. and J.S.M.), and by the DOE, Basic Energy Sciences Office, Division of Materials Sciences and Engineering, under award no. DE-SC0006418 (F.K. and P.J-H.). We are grateful for the assistance from G. Gibson, M. Ketchen, and M. Huber on developing the SQUID sensors and from I. Sochnikov, E. Spanton, J. Palmstrom, and K. C. Nowack on the measurement, as well as for stimulating discussions with S.-C. Zhang, X.-L. Qi, J. Wang, D. Goldhaber-Gordon, and B. I. Halperin.	Akhmerov AR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216404; Analytis JG, 2010, NAT PHYS, V6, P960, DOI 10.1038/NPHYS1861; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Checkelsky JG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196801; Checkelsky JG, 2012, NAT PHYS, V8, P729, DOI [10.1038/nphys2388, 10.1038/NPHYS2388]; Datta S., 1997, ELECT TRANSPORT MESO; Ferreira GJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106802; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Gardner BW, 2001, REV SCI INSTRUM, V72, P2361, DOI 10.1063/1.1364668; Ghosh DB, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.115211; Hammer R, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.235119; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Huber ME, 2001, IEEE T APPL SUPERCON, V11, P4048, DOI 10.1109/77.947383; Kirtley J. R., 2013, P 14 INT SUP EL C IS; Kitaev A. Y., 2001, PHYS USPEKHI, V44, P131; Kou XF, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.137201; Lee AT, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155103; Liu CX, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041307; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; Men'shov VN, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.224401; Meng QL, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176803; MOODERA JS, 1988, PHYS REV LETT, V61, P637, DOI 10.1103/PhysRevLett.61.637; Nowack KC, 2013, NAT MATER, V12, P787, DOI [10.1038/NMAT3682, 10.1038/nmat3682]; O'Mahony D, 2005, THIN SOLID FILMS, V488, P200, DOI 10.1016/j.tsf.2005.04.081; PANKRATOV OA, 1987, PHYS LETT A, V121, P360, DOI 10.1016/0375-9601(87)90307-0; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Spanton EM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.026804; Tserkovnyak Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187201; Wang YH, 2013, SCIENCE, V342, P453, DOI 10.1126/science.1239834; Wang YH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.207602; Wei P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.186807; Wickles C, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035151; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Yang QI, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.081407; Yokoyama T., 2013, PHYSICA E; Yoshioka D., 2002, QUANTUM HALL EFFECT; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Zhang Y, 2010, NAT PHYS, V6, P584, DOI 10.1038/NPHYS1689; Zyuzin AA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195413	39	14	14	2	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					948	952		10.1126/science.aaa0508	http://dx.doi.org/10.1126/science.aaa0508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26272905	Green Submitted			2022-12-28	WOS:000360646800046
J	Gauthier, S; Bernier, P; Kuuluvainen, T; Shvidenko, AZ; Schepaschenko, DG				Gauthier, S.; Bernier, P.; Kuuluvainen, T.; Shvidenko, A. Z.; Schepaschenko, D. G.			Boreal forest health and global change	SCIENCE			English	Review							CLIMATE-CHANGE IMPACTS; CANADA; CARBON; GROWTH; FIRE; VULNERABILITY; PRODUCTIVITY; ADAPTATION; DIVERSITY; DYNAMICS	The boreal forest, one of the largest biomes on Earth, provides ecosystem services that benefit society at levels ranging from local to global. Currently, about two-thirds of the area covered by this biome is under some form of management, mostly for wood production. Services such as climate regulation are also provided by both the unmanaged and managed boreal forests. Although most of the boreal forests have retained the resilience to cope with current disturbances, projected environmental changes of unprecedented speed and amplitude pose a substantial threat to their health. Management options to reduce these threats are available and could be implemented, but economic incentives and a greater focus on the boreal biome in international fora are needed to support further adaptation and mitigation actions.	[Gauthier, S.; Bernier, P.] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ G1V 4C7, Canada; [Kuuluvainen, T.] Univ Helsinki, Dept Forest Sci, FIN-00014 Helsinki, Finland; [Shvidenko, A. Z.; Schepaschenko, D. G.] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria	Natural Resources Canada; Canadian Forest Service; University of Helsinki; International Institute for Applied Systems Analysis (IIASA)	Gauthier, S (corresponding author), Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ G1V 4C7, Canada.	sylvie.gauthier@rncan.gc.ca	Shvidenko, Anatoly/I-1505-2016; Schepaschenko, Dmitry G./E-9603-2012; Gauthier, Sylvie/J-3923-2019	Shvidenko, Anatoly/0000-0001-7640-2151; Schepaschenko, Dmitry G./0000-0002-7814-4990; Gauthier, Sylvie/0000-0001-6720-0195				Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andrew ME, 2014, ENVIRON REV, V22, P135, DOI 10.1139/er-2013-0056; [Anonymous], 2014, TURN HEAT CONFR NEW; Baklanov A.A., 2013, REGIONAL ENV CHANGES, P303, DOI [10.1007/978-94-007-4569-8_8, DOI 10.1007/978-94-007-4569-8_8]; Beck PSA, 2011, ECOL LETT, V14, P373, DOI 10.1111/j.1461-0248.2011.01598.x; Blarquez O, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00006; Boisvert-Marsh L, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00111.1; Bolton DK, 2015, REMOTE SENS ENVIRON, V163, P48, DOI 10.1016/j.rse.2015.03.004; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boulanger Y, 2014, CAN J FOREST RES, V44, P365, DOI 10.1139/cjfr-2013-0372; Bradshaw CJA, 2015, GLOBAL PLANET CHANGE, V128, P24, DOI 10.1016/j.gloplacha.2015.02.004; Brandt JP, 2013, ENVIRON REV, V21, P207, DOI 10.1139/er-2013-0040; Burton P. J., 2010, IUFRO World Series, V25, P249; Burton P. J., 2013, MANAGING FORESTS COM, P79; Burton PJ, 2003, TOWARDS SUSTAINABLE MANAGEMENT OF THE BOREAL FOREST, P1; de Groot WJ, 2013, FOREST ECOL MANAG, V294, P35, DOI 10.1016/j.foreco.2012.09.027; Dolman AJ, 2012, BIOGEOSCIENCES, V9, P5323, DOI 10.5194/bg-9-5323-2012; FAO, 2010, 144E FAO; Federal Agency of Forest Service, 2009, FOR FUND RUSS FED ST; Food and Agriculture Organization (FAO), 2012, RUSS FED FOR SECT OU; Gauthier S, 2015, CAN J FOREST RES, V45, P1439, DOI 10.1139/cjfr-2015-0079; Gauthier S, 2014, ENVIRON REV, V22, P256, DOI 10.1139/er-2013-0064; Girardin MP, 2008, ECOL MODEL, V213, P209, DOI 10.1016/j.ecolmodel.2007.12.010; Groisman P. Y., 2013, REGIONAL ENV CHANGES, P57, DOI [10.1007/978-94-007-4569-8, DOI 10.1007/978-94-007-4569-8_6]; Gustafson EJ, 2010, ECOL APPL, V20, P700, DOI 10.1890/08-1693.1; Harper KA, 2015, J ECOL, V103, P550, DOI 10.1111/1365-2745.12398; Helmisaari HS, 2014, SCAND J FOREST RES, V29, P312, DOI 10.1080/02827581.2014.926097; IPCC, 2013, CLIMATE CHANGE 2022; Jasinski JPP, 2005, ECOL MONOGR, V75, P561, DOI 10.1890/04-1621; Kauppi PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111340; Kharuk V., 2007, Eurasian Journal of Forest Research, V10-2, P163; Kneeshaw D., 2011, SAGE HDB BIOGEOGRAPH, P263; Kurganova I, 2014, GLOBAL CHANGE BIOL, V20, P938, DOI 10.1111/gcb.12379; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Kurz WA, 2013, ENVIRON REV, V21, P260, DOI 10.1139/er-2013-0041; Kuuluvainen T., 2013, MANAGING FORESTS COM, P244; Kuuluvainen T, 2012, AMBIO, V41, P720, DOI 10.1007/s13280-012-0289-y; Kuuluvainen T, 2011, SILVA FENN, V45, P823, DOI 10.14214/sf.73; Langor DW, 2014, ENVIRON REV, V22, P372, DOI 10.1139/er-2013-0083; Lapenis A, 2005, GLOBAL CHANGE BIOL, V11, P2090, DOI 10.1111/j.1365-2486.2005.001069.x; Lempriere TC, 2013, ENVIRON REV, V21, P293, DOI 10.1139/er-2013-0039; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Maynard DG, 2014, ENVIRON REV, V22, P161, DOI 10.1139/er-2013-0057; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Moen J, 2014, CONSERV LETT, V7, P408, DOI 10.1111/conl.12098; Neigh CSR, 2013, REMOTE SENS ENVIRON, V137, P274, DOI 10.1016/j.rse.2013.06.019; Newell JP, 2014, EURASIAN GEOGR ECON, V55, P37, DOI 10.1080/15387216.2014.926254; Osawa A, 2010, ECOL STUD-ANAL SYNTH, V209, P459, DOI 10.1007/978-1-4020-9693-8_24; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Price DT, 2013, ENVIRON REV, V21, P322, DOI 10.1139/er-2013-0042; Pukkala T, 2014, J FORESTRY RES, V25, P627, DOI 10.1007/s11676-014-0501-y; Ramo J, 2014, SCAND J FOREST RES, V29, P777, DOI 10.1080/02827581.2014.982166; Reyer CPO, 2015, J ECOL, V103, P5, DOI 10.1111/1365-2745.12337; Rogers BM, 2015, NAT GEOSCI, V8, P228, DOI [10.1038/ngeo2352, 10.1038/NGEO2352]; Scheffer M, 2012, P NATL ACAD SCI USA, V109, P21384, DOI 10.1073/pnas.1219844110; Shorohova E, 2011, SILVA FENN, V45, P785, DOI 10.14214/sf.72; Shvidenko AZ, 2013, CONTEMP PROBL ECOL+, V6, P683, DOI 10.1134/S199542551307010X; Shvidenko A.Z., 2014, SIBIRSKIY LESNOY ZH, P69; State Program of the Russian Federation, DEV FOR MAN 2013 202; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Tchebakova NM, 2011, REG ENVIRON CHANGE, V11, P817, DOI 10.1007/s10113-011-0210-4; Thiffault E, 2011, ENVIRON REV, V19, P278, DOI [10.1139/A11-009, 10.1139/a11-009]; Venier LA, 2014, ENVIRON REV, V22, P457, DOI 10.1139/er-2013-0075; Zhang K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000621; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	67	513	541	40	581	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					819	822		10.1126/science.aaa9092	http://dx.doi.org/10.1126/science.aaa9092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293953				2022-12-28	WOS:000359832700036
J	Hamilton, P; Jaffe, M; Haslinger, P; Simmons, Q; Muller, H; Khoury, J				Hamilton, P.; Jaffe, M.; Haslinger, P.; Simmons, Q.; Mueller, H.; Khoury, J.			Atom-interferometry constraints on dark energy	SCIENCE			English	Article							COSMOLOGY	If dark energy, which drives the accelerated expansion of the universe, consists of a light scalar field, it might be detectable as a "fifth force" between normal-matter objects, in potential conflict with precision tests of gravity. Chameleon fields and other theories with screening mechanisms, however, can evade these tests by suppressing the forces in regions of high density, such as the laboratory. Using a cesium matter-wave interferometer near a spherical mass in an ultrahigh-vacuum chamber, we reduced the screening mechanism by probing the field with individual atoms rather than with bulk matter. We thereby constrained a wide class of dark energy theories, including a range of chameleon and other theories that reproduce the observed cosmic acceleration.	[Hamilton, P.; Jaffe, M.; Haslinger, P.; Simmons, Q.; Mueller, H.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Mueller, H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Khoury, J.] Univ Penn, Dept Phys & Astron, Ctr Particle Cosmol, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Pennsylvania	Muller, H (corresponding author), Univ Calif Berkeley, Dept Phys, 366 Le Conte Hall MS 7300, Berkeley, CA 94720 USA.	hm@berkeley.edu	Haslinger, Philipp/C-3004-2018; Hamilton, Paul/E-7891-2015	Haslinger, Philipp/0000-0002-2911-4787; Hamilton, Paul/0000-0001-6080-632X	David and Lucile Packard Foundation; Defense Advanced Research Projects Agency [N66001-12-1-4232]; NSF [PHY-1404566, PHY-1145525]; NASA [NNH13ZTT002N, NNH11ZTT001N]; Austrian Science Fund [J3680]; NASA Astrophysics Theory Program [NNX11AI95G]; Direct For Mathematical & Physical Scien [1404566] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Austrian Science Fund(Austrian Science Fund (FWF)); NASA Astrophysics Theory Program(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge important discussions with D. Budker, C. Burrage, A. Charman, Y. Nomura, S. Perlmutter, S. Rajendran, and P. Steinhardt. This work was supported by the David and Lucile Packard Foundation; a Defense Advanced Research Projects Agency Young Faculty Award (no. N66001-12-1-4232); NSF grant PHY-1404566; and NASA grants NNH13ZTT002N, NNH13ZTT002N, and NNH11ZTT001N. P. Has. thanks the Austrian Science Fund (grant J3680). The work of J.K. is supported by the NSF Faculty Early Career Development Program (award PHY-1145525) and the NASA Astrophysics Theory Program (grant NNX11AI95G).	Anastassopoulos V, 2015, PHYS LETT B, V749, P172, DOI 10.1016/j.physletb.2015.07.049; Brax P, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.123518; Brax P, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.035020; Burrage C, 2015, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2015/03/042; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; FRIEMAN JA, 1995, PHYS REV LETT, V75, P2077, DOI 10.1103/PhysRevLett.75.2077; Hall LJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.141302; Hamilton P, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.100405; Harber DM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.033610; Hohensee MA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.230404; Jenke T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.151105; Joyce A, 2015, PHYS REP, V568, P1, DOI 10.1016/j.physrep.2014.12.002; Kapner DJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.021101; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; Khoury J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171104; Lemmel H, 2015, PHYS LETT B, V743, P310, DOI 10.1016/j.physletb.2015.02.063; McGuirk JM, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033608; Mota DF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.151102; PEEBLES PJE, 1988, ASTROPHYS J, V325, pL17, DOI 10.1086/185100; Rosi G, 2014, NATURE, V510, P518, DOI 10.1038/nature13433; Rybka G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.051801; Steffen JH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.261803; Sugarbaker A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.113002; Tino GM, 2014, P INT SCH PHYS, V188, P457, DOI 10.3254/978-1-61499-448-0-457; Upadhye A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.102003; WETTERICH C, 1988, NUCL PHYS B, V302, P668, DOI 10.1016/0550-3213(88)90193-9; Zlatev I, 1999, PHYS REV LETT, V82, P896, DOI 10.1103/PhysRevLett.82.896	27	176	177	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					849	851		10.1126/science.aaa8883	http://dx.doi.org/10.1126/science.aaa8883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293958	Green Submitted			2022-12-28	WOS:000359832700044
J	Yang, Y; Darbari, VC; Zhang, N; Lu, D; Glyde, R; Wang, YP; Winkelman, JT; Gourse, RL; Murakami, KS; Buck, M; Zhang, XD				Yang, Yun; Darbari, Vidya C.; Zhang, Nan; Lu, Duo; Glyde, Robert; Wang, Yi-Ping; Winkelman, Jared T.; Gourse, Richard L.; Murakami, Katsuhiko S.; Buck, Martin; Zhang, Xiaodong			Structures of the RNA polymerase-sigma(54) reveal new and conserved regulatory strategies	SCIENCE			English	Article							II-TFIIB COMPLEX; TRANSCRIPTION INITIATION; ESCHERICHIA-COLI; SINGLE-MOLECULE; BACTERIAL; SIGMA; DNA; POLYMERASES; DOMAIN; HOLOENZYME	Transcription by RNA polymerase (RNAP) in bacteria requires specific promoter recognition by sigma factors. The major variant s factor (sigma(54)) initially forms a transcriptionally silent complex requiring specialized adenosine triphosphate-dependent activators for initiation. Our crystal structure of the 450-kilodalton RNAP-sigma(54) holoenzyme at 3.8 angstroms reveals molecular details of sigma(54) and its interactions with RNAP. The structure explains how sigma(54) targets different regions in RNAP to exert its inhibitory function. Although sigma(54) and the major s factor, sigma(70), have similar functional domains and contact similar regions of RNAP, unanticipated differences are observed in their domain arrangement and interactions with RNAP, explaining their distinct properties. Furthermore, we observe evolutionarily conserved regulatory hotspots in RNAPs that can be targeted by a diverse range of mechanisms to fine tune transcription.	[Yang, Yun; Darbari, Vidya C.; Lu, Duo; Glyde, Robert; Zhang, Xiaodong] Univ London Imperial Coll Sci Technol & Med, Struct Biol Ctr, South Kensington SW7 2AZ, England; [Darbari, Vidya C.; Lu, Duo; Glyde, Robert; Zhang, Xiaodong] Univ London Imperial Coll Sci Technol & Med, Dept Med, South Kensington SW7 2AZ, England; [Zhang, Nan; Buck, Martin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, South Kensington SW7 2AZ, England; [Yang, Yun; Wang, Yi-Ping] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Winkelman, Jared T.; Gourse, Richard L.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Murakami, Katsuhiko S.] Penn State Univ, Ctr RNA Mol Biol, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Imperial College London; Imperial College London; Imperial College London; Peking University; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, XD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Struct Biol Ctr, South Kensington SW7 2AZ, England.	xiaodong.zhang@imperial.ac.uk	Zhang, Nan/D-7231-2017	Zhang, Nan/0000-0002-1958-9914; Wang, Yiping/0000-0002-1995-8521; Murakami, Katsuhiko/0000-0003-2244-0501; Darbari, Vidya/0000-0002-3387-5108	Chinese National Science Foundation; China Scholarship Council; UK Biotechnology and Biological Sciences Research Council; NIH [GM087350, R37 GM37048]; National Key Basic Research Programme in China [2015CB755700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350, R37GM037048, T32GM007215] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J00717X/1, 1377217, BB/C504700/1, BB/L027135/1] Funding Source: researchfish; Medical Research Council [MR/N006828/1] Funding Source: researchfish; Wellcome Trust [098412/Z/12/Z] Funding Source: researchfish; BBSRC [BB/L027135/1, BB/J00717X/1] Funding Source: UKRI; MRC [MR/N006828/1] Funding Source: UKRI	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Basic Research Programme in China(National Basic Research Program of China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Michael and D. Bose for their earlier contributions to this project; A. Forster, J. Liu, and beamline scientists at the Diamond Light Source for their help with data collection; and members of X.Z.'s and M.B.'s labs for helpful discussion. We thank D. Wigley, R. Dixon, R. Weinzierl, C. Fernandez-Tornero, and R. Wigneshweraraj for critically reading the manuscript. Y.Y. was funded by the Chinese National Science Foundation and the China Scholarship Council. The majority of this work was funded by the UK Biotechnology and Biological Sciences Research Council to X.Z. and M.B. K.S.M. is supported by NIH grant GM087350. Y.-P.W. is funded by 973 National Key Basic Research Programme (2015CB755700) in China. J.T.W. and R.L.G. were supported by NIH grant R37 GM37048 (to R.L.G.). The atomic coordinate has been deposited in the Protein Data Bank with accession code 5BYH.	Bae B, 2013, P NATL ACAD SCI USA, V110, P19772, DOI 10.1073/pnas.1314576110; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Burrows PC, 2008, J MOL BIOL, V375, P43, DOI 10.1016/j.jmb.2007.10.045; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chaney M, 1999, MOL MICROBIOL, V33, P1200, DOI 10.1046/j.1365-2958.1999.01566.x; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Decker KB, 2013, ANNU REV MICROBIOL, V67, P113, DOI 10.1146/annurev-micro-092412-155756; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Feklistov A, 2014, ANNU REV MICROBIOL, V68, P357, DOI 10.1146/annurev-micro-092412-155737; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Guo YL, 2000, GENE DEV, V14, P2242, DOI 10.1101/gad.794800; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Sharma A, 2014, NUCLEIC ACIDS RES, V42, P5177, DOI 10.1093/nar/gku146; Wang JT, 1997, P NATL ACAD SCI USA, V94, P9538, DOI 10.1073/pnas.94.18.9538; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Wigneshweraraj SR, 2004, EMBO J, V23, P4264, DOI 10.1038/sj.emboj.7600407; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	30	51	54	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					882	885		10.1126/science.aab1478	http://dx.doi.org/10.1126/science.aab1478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293966	Green Accepted, Green Submitted			2022-12-28	WOS:000359832700053
J	Marmorstein, R; Simon, MC				Marmorstein, Ronen; Simon, M. Celeste			STRUCTURAL BIOLOGY Hypoxia response becomes crystal clear	NATURE			English	Editorial Material							RENAL-CELL CARCINOMA; TRANSCRIPTION FACTOR; INDUCIBLE FACTORS; HIF1A		[Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	marmor@mail.med.upenn.edu; celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021		NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Morris MR, 2009, ANTICANCER RES, V29, P4337; Ollerenshaw M, 2004, CANCER GENET CYTOGEN, V153, P122, DOI 10.1016/j.cancergencyto.2004.01.014; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/NCHEMBIO.1185, 10.1038/nchembio.1185]; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883	12	2	2	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					298	300		10.1038/nature14641	http://dx.doi.org/10.1038/nature14641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26245369				2022-12-28	WOS:000359714000023
J	Davies, MJ; Bergenstal, R; Bode, B; Kushner, RF; Lewin, A; Skjoth, TV; Andreasen, AH; Jensen, CB; DeFronzo, RA				Davies, Melanie J.; Bergenstal, Richard; Bode, Bruce; Kushner, Robert F.; Lewin, Andrew; Skjoth, Trine Vang; Andreasen, Arne Haahr; Jensen, Christine Bjorn; DeFronzo, Ralph A.		NN8022-1922 Study Grp	Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; OBESITY; PREVENTION; OVERWEIGHT; SAFETY	IMPORTANCE Weight loss of 5% to 10% can improve type 2 diabetes and related comorbidities. Few safe, effective weight-management drugs are currently available. OBJECTIVE To investigate efficacy and safety of liraglutide vs placebo for weight management in adults with overweight or obesity and type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS Fifty-six-week randomized (2: 1: 1), double-blind, placebo-controlled, parallel-group trial with 12-week observational off-drug follow-up period. The study was conducted at 126 sites in 9 countries between June 2011 and January 2013. Of 1361 participants assessed for eligibility, 846 were randomized. Inclusion criteria were body mass index of 27.0 or greater, age 18 years or older, taking 0 to 3 oral hypoglycemic agents (metformin, thiazolidinedione, sulfonylurea) with stable body weight, and glycated hemoglobin level 7.0% to 10.0% . INTERVENTIONS Once-daily, subcutaneous liraglutide (3.0 mg) (n = 423), liraglutide (1.8 mg) (n = 211), or placebo (n = 212), all as adjunct to 500 kcal/d dietary deficit and increased physical activity (>= 150 min/wk). MAIN OUTCOMES AND MEASURES Three coprimary end points: relative change in weight, proportion of participants losing 5% or more, or more than 10% , of baseline weight at week 56. RESULTS Baseline weight was 105.7 kg with liraglutide (3.0-mg dose), 105.8 kg with liraglutide (1.8-mg dose), and 106.5 kg with placebo. Weight loss was 6.0% (6.4 kg) with liraglutide (3.0-mg dose), 4.7% (5.0 kg) with liraglutide (1.8-mg dose), and 2.0% (2.2 kg) with placebo (estimated difference for liraglutide [3.0mg] vs placebo, -4.00% [95% CI, -5.10% to -2.90%]; liraglutide [1.8 mg] vs placebo, -2.71% [95% CI, -4.00% to -1.42%]; P < .001 for both). Weight loss of 5% or greater occurred in 54.3% with liraglutide (3.0mg) and 40.4% with liraglutide (1.8 mg) vs 21.4% with placebo (estimated difference for liraglutide [3.0mg] vs placebo, 32.9% [95% CI, 24.6% to 41.2%]; for liraglutide [1.8mg] vs placebo, 19.0% [95% CI, 9.1% to 28.8%]; P < .001 for both). Weight loss greater than 10% occurred in 25.2% with liraglutide (3.0mg) and 15.9% with liraglutide (1.8mg) vs 6.7% with placebo (estimated difference for liraglutide [3.0mg] vs placebo, 18.5% [95% CI, 12.7% to 24.4%], P < .001; for liraglutide [1.8mg] vs placebo, 9.3% [95% CI, 2.7% to 15.8%], P = .006). More gastrointestinal disorders were reported with liraglutide (3.0mg) vs liraglutide (1.8mg) and placebo. No pancreatitis was reported. CONCLUSIONS AND RELEVANCE Among overweight and obese participants with type 2 diabetes, use of subcutaneous liraglutide (3.0mg) daily, compared with placebo, resulted in weight loss over 56 weeks. Further studies are needed to evaluate longer-term efficacy and safety.	[Davies, Melanie J.] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Bergenstal, Richard] Int Diabet Ctr, Pk Nicollet Hlth Serv, Minneapolis, MN USA; [Bode, Bruce] Atlanta Diabet Associates, Atlanta, GA USA; [Kushner, Robert F.] Northwestern Univ, Chicago, IL 60611 USA; [Lewin, Andrew] Natl Res Inst, Los Angeles, CA USA; [Skjoth, Trine Vang; Andreasen, Arne Haahr; Jensen, Christine Bjorn] Nordisk AS, Soborg, Denmark; [DeFronzo, Ralph A.] Texas Diabet Inst, San Antonio, TX USA	University of Leicester; International Diabetes Center; Northwestern University	Davies, MJ (corresponding author), Leicester Gen Hosp, Leicester Diabet Ctr, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	melanie.davies@uhl-tr.nhs.uk	Jensen, Christine Bjoern/AAG-7900-2020	Davies, Melanie/0000-0002-9987-9371; Udden Hemmingsson, Joanna/0000-0002-0126-4257; Cariou, Bertrand/0000-0002-1580-8040	Novo Nordisk	Novo Nordisk(Novo Nordisk)	This study was funded by Novo Nordisk. Liraglutide is a Novo Nordisk A/S proprietary compound.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2015, VICT LIR RDNA OR INJ; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Bradley C, 1999, DIABETES CARE, V22, P530, DOI 10.2337/diacare.22.3.530; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Crosby RD, 2004, J CLIN EPIDEMIOL, V57, P1153, DOI 10.1016/j.jclinepi.2004.04.004; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; FDA, 2007, DEV PROD WEIGHT MAN, P1; Fontaine Kevin R, 2004, Eat Behav, V5, P85, DOI 10.1016/S1471-0153(03)00059-X; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Lean MEJ, 2014, INT J OBESITY, V38, P689, DOI 10.1038/ijo.2013.149; Maggio CA, 1997, DIABETES CARE, V20, P1744, DOI 10.2337/diacare.20.11.1744; Obesity Drug Outcome Measures, OB DRUG OUTC MEAS CO; Pi-Sunyer FX, 2008, POSTGRAD MED, V120, P5, DOI 10.3810/pgm.2008.07.1785; Pi-Sunyer FX, 2005, DIABETES CARE, V28, P1526, DOI 10.2337/diacare.28.6.1526; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Robinson LE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001986; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162; Wadden TA, 2013, INT J OBESITY, V37, P1443, DOI 10.1038/ijo.2013.120	28	456	473	7	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					687	699		10.1001/jama.2015.9676	http://dx.doi.org/10.1001/jama.2015.9676			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284720	Bronze			2022-12-28	WOS:000360019100017
J	Fekete, BM; Robarts, RD; Kumagai, M; Nachtnebel, HP; Odada, E; Zhulidov, AV				Fekete, Balazs M.; Robarts, Richard D.; Kumagai, Michio; Nachtnebel, Hans-Peter; Odada, Eric; Zhulidov, Alexander V.			Time for in situ renaissance	SCIENCE			English	Editorial Material							ALGORITHM; MODIS		[Fekete, Balazs M.] CUNY City Coll, Dept Civil Engn, CUNY Environm CrossRd Initiat, New York, NY 10031 USA; [Robarts, Richard D.] World Water & Climate Fdn, Saskatoon, SK S7N 4A2, Canada; [Kumagai, Michio] Ritsumeikan Univ, Res Org Sci & Technol, Shiga 5258577, Japan; [Nachtnebel, Hans-Peter] Univ Nat Resources & Life Sci, Inst Water Management Hydrol & Hydraul Engn, A-1190 Vienna, Austria; [Odada, Eric] Univ Nairobi, Coll Phys & Biol Sci, Nairobi, Kenya; [Zhulidov, Alexander V.] South Russian Ctr Preparat & Implementat Int Proj, Rostov Na Donu 344090, Russia	City University of New York (CUNY) System; City College of New York (CUNY); Ritsumeikan University; University of Natural Resources & Life Sciences, Vienna; University of Nairobi	Fekete, BM (corresponding author), CUNY City Coll, Dept Civil Engn, CUNY Environm CrossRd Initiat, New York, NY 10031 USA.	bfekete@ccny.cuny.edu						Bastiaanssen WGM, 1998, J HYDROL, V212, P198, DOI 10.1016/S0022-1694(98)00254-6; Fekete BM, 2012, J HYDROMETEOROL, V13, P1977, DOI 10.1175/JHM-D-11-0126.1; Lammers R., 2002, EOS T AM GEOPHYS UNI, V83, P13, DOI [10.1029/2002EO000007, DOI 10.1029/2002EO000007]; Mu Q, 2007, REMOTE SENS ENVIRON, V111, P519, DOI 10.1016/j.rse.2007.04.015; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Robarts R. D., 2008, P TAAL2007 12 WORLD, P167; Rogers DP, 2013, DIR DEV, P1, DOI 10.1596/978-1-4648-0026-9; Stokstad E, 1999, SCIENCE, V285, P1199, DOI 10.1126/science.285.5431.1199; The Global Runoff Data Center (GRDC), GLOB PREC CLIM CTR G; Vorosmarty C., 2001, EOS T AM GEOPHYS UN, V82, P54, DOI [DOI 10.1029/01EO00031, 10.1029/01EO00031, 10.1029/01-o00031]; WMO, 1999, EXCH HYDR DAT PROD; Zhulidov AV, 2000, CAN J FISH AQUAT SCI, V57, P1932, DOI 10.1139/cjfas-57-9-1932	12	44	44	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					685	686		10.1126/science.aac7358	http://dx.doi.org/10.1126/science.aac7358			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273038				2022-12-28	WOS:000359415100014
J	Martin, R; Bajo-Graneras, R; Moratalla, R; Perea, G; Araque, A				Martin, R.; Bajo-Graneras, R.; Moratalla, R.; Perea, G.; Araque, A.			Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways	SCIENCE			English	Article							ACTIVATION; PLASTICITY; STIMULATION; MODULATION; RELEASE	Astrocytes are important regulatory elements in brain function. They respond to neurotransmitters and release gliotransmitters that modulate synaptic transmission. However, the cell-and synapse-specificity of the functional relationship between astrocytes and neurons in certain brain circuits remains unknown. In the dorsal striatum, which mainly comprises two intermingled subtypes (striatonigral and striatopallidal) of medium spiny neurons (MSNs) and synapses belonging to two neural circuits (the direct and indirect pathways of the basal ganglia), subpopulations of astrocytes selectively responded to specific MSN subtype activity. These subpopulations of astrocytes released glutamate that selectively activated N-methyl-D-aspartate receptors in homotypic, but not heterotypic, MSNs. Likewise, astrocyte subpopulations selectively regulated homotypic synapses through metabotropic glutamate receptor activation. Therefore, bidirectional astrocyte-neuron signaling selectively occurs between specific subpopulations of astrocytes, neurons, and synapses.	[Martin, R.; Bajo-Graneras, R.; Moratalla, R.; Perea, G.] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Moratalla, R.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28029, Spain; [Araque, A.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Instituto de Salud Carlos III; University of Minnesota System; University of Minnesota Twin Cities	Araque, A (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	araque@umn.edu	Martín, Ricardo/J-1408-2018; Perea, Gertrudis/V-3308-2017; Moratalla, Rosario V/H-9280-2015; Bajo-Grañeras, Raquel/J-1247-2018	Martín, Ricardo/0000-0002-7645-4901; Perea, Gertrudis/0000-0001-5924-9175; Moratalla, Rosario V/0000-0002-7623-8010; Bajo-Grañeras, Raquel/0000-0001-8634-0687; Araque, Alfonso/0000-0003-3840-1144	Cajal Blue Brain, the Human Frontier Science Program [RGP0036/2014]; Wallin family; V. and L. Han; Ministerio de Economia y Competitividad of Spain [BFU2013-47265-R, CSD2010-00045, RYC-2012-12014, SAF2013-48532-R, CB06/05/0055]; Juan de la Cierva Program [JCI-2010-07693]	Cajal Blue Brain, the Human Frontier Science Program; Wallin family; V. and L. Han; Ministerio de Economia y Competitividad of Spain(Spanish Government); Juan de la Cierva Program	We thank D. Redish, W. Buno, A. Diez, and R. Gomez for helpful comments; J. Lerma and A. Valero for valuable help; B. Pro for technical assistance; and J. Chen (University of California-San Diego) and A. Zimmer (University of Bonn) for providing IP<INF>3</INF>R2<SUP>-/</SUP> and CB1R<SUP>-/-</SUP> mice, respectively. A. A. was supported by Cajal Blue Brain, the Human Frontier Science Program (grant RGP0036/2014), the Wallin family, and V. and L. Han. Support for this work was also provided by the Ministerio de Economia y Competitividad of Spain (grants BFU2013-47265-R, CSD2010-00045, and RYC-2012-12014 to G.P. and grants SAF2013-48532-R and CB06/05/0055 to R. Mo.) and by the Juan de la Cierva Program (grant JCI-2010-07693 to R. Ma.). Data described in the paper are archived at the Instituto Cajal (Madrid, Spain). The authors declare no competing financial interests.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Ares-Santos S, 2014, NEUROPSYCHOPHARMACOL, V39, P1066, DOI 10.1038/npp.2013.307; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Gomez-Gonzalo M., 2014, CEREB CORTEX; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Ruiz-DeDiego I, 2015, BIOL PSYCHIAT, V77, P95, DOI 10.1016/j.biopsych.2014.03.023; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shonesy BC, 2013, NAT NEUROSCI, V16, P456, DOI 10.1038/nn.3353; Suarez LM, 2014, BIOL PSYCHIAT, V75, P711, DOI 10.1016/j.biopsych.2013.05.006; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722	30	182	185	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					730	734		10.1126/science.aaa7945	http://dx.doi.org/10.1126/science.aaa7945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273054				2022-12-28	WOS:000359415100035
J	Asch, DA; Rosin, R				Asch, David A.; Rosin, Roy			Innovation as Discipline, Not Fad	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asch, David A.; Rosin, Roy] Univ Penn, Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Asch, DA (corresponding author), Univ Penn, Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X				Brown T., 2009, TEDMED 2009 SAN DIEG; Reis E., 2011, THE LEAN STARTUP; Savoia A., 2011, PRETOTYPING; Volpp KG, 2013, HEALTHCARE, V1, P4, DOI 10.1016/j.hjdsi.2013.04.007	4	32	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					592	594		10.1056/NEJMp1506311	http://dx.doi.org/10.1056/NEJMp1506311			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP2LE	26267619				2022-12-28	WOS:000359707700003
J	Park, HW; Kim, YC; Yu, B; Moroishi, T; Mo, JS; Plouffe, SW; Meng, ZP; Lin, KC; Yu, FX; Alexander, CM; Wang, CY; Guan, KL				Park, Hyun Woo; Kim, Young Chul; Yu, Bo; Moroishi, Toshiro; Mo, Jung-Soon; Plouffe, Steven W.; Meng, Zhipeng; Lin, Kimberly C.; Yu, Fa-Xing; Alexander, Caroline M.; Wang, Cun-Yu; Guan, Kun-Liang			Alternative Wnt Signaling Activates YAP/TAZ	CELL			English	Article							PROTEIN-INTERACTION NETWORK; HIPPO-YAP PATHWAY; STEM-CELLS; GASTRULATION; INHIBITION; TAZ; ADIPOGENESIS; REGENERATION; MECHANISMS; FRIZZLED-1	The transcriptional co-activators YAP and TAZ are key regulators of organ size and tissue homeostasis, and their dysregulation contributes to human cancer. Here, we discover YAP/TAZ as bona fide downstream effectors of the alternative Wnt signaling pathway. Wnt5a/b and Wnt3a induce YAP/TAZ activation independent of canonical Wnt/beta-catenin signaling. Mechanistically, we delineate the "alternative Wnt-YAP/TAZ signaling axis'' that consists of Wnt-FZD/ROR-Ga alpha(12/13)-Rho GTPases-Lats1/2 to promote YAP/TAZ activation and TEAD-mediated transcription. YAP/TAZ mediate the biological functions of alternative Wnt signaling, including gene expression, osteogenic differentiation, cell migration, and antagonism of Wnt/beta-catenin signaling. Together, our work establishes YAP/TAZ as critical mediators of alternative Wnt signaling.	[Park, Hyun Woo; Kim, Young Chul; Moroishi, Toshiro; Mo, Jung-Soon; Plouffe, Steven W.; Meng, Zhipeng; Lin, Kimberly C.; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Park, Hyun Woo; Kim, Young Chul; Moroishi, Toshiro; Mo, Jung-Soon; Plouffe, Steven W.; Meng, Zhipeng; Lin, Kimberly C.; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Kim, Young Chul] Vet Med Res Fdn, Dept Cardiol, San Diego, CA 92161 USA; [Yu, Bo; Wang, Cun-Yu] Univ Calif Los Angeles, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90095 USA; [Yu, Fa-Xing] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Yu, Fa-Xing] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Alexander, Caroline M.] Univ Wisconsin Madison, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI 53706 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Veterans Medical Research Foundation; University of California System; University of California Los Angeles; Fudan University; Fudan University; University of Wisconsin System; University of Wisconsin Madison	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Park, Hyun Woo/0000-0001-7736-2286; Yu, Fa-Xing/0000-0003-4834-9335; Moroishi, Toshiro/0000-0001-6419-3882; Kim, Young Chul/0000-0002-6782-2186	NIH [EY022611, CA132809, DE015964]; Cellular and Molecular Pharmacology training grant [T32 GM007752]; NATIONAL CANCER INSTITUTE [R01CA132809, R35CA196878] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964, R01DE019412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Pharmacology training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following colleagues for generously sharing the following materials: Dr. Duojia Pan for YAP transgenic mice, Dr. Ben Ho Park for PIK3CA mutation knockin MCF10A cells, Dr. Yingzi Yang for Gna11<SUP>-/-</SUP>Gnaq<SUP>f/f</SUP> and Gna12<SUP>-/-</SUP>Gna13<SUP>f/f</SUP> MEFs, Dr. Dae-Sik Lim for Lats1<SUP>-/-</SUP>Lats2<SUP>f/f</SUP> MEFs, Dr. Xi He for FZD1, FZD2, and FZD5 plasmids, and Dr. Liguang Chen for ROR1 plasmids. We also thank Dr. Karl Willert for the helpful discussion. This work was supported by grants from the NIH (EY022611, CA132809, and DE015964) to K.-L.G. and Cellular and Molecular Pharmacology training grant (T32 GM007752) to S.W.P.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Byun MR, 2014, CELL DEATH DIFFER, V21, P854, DOI 10.1038/cdd.2014.8; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Cizkova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015647; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lai D, 2013, CELL SIGNAL, V25, P1720, DOI 10.1016/j.cellsig.2013.05.002; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Rodrigues P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6458; Roman-Roman S, 2004, J BIOL CHEM, V279, P5725, DOI 10.1074/jbc.M309233200; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van Tienen FHJ, 2009, BIOCHEM BIOPH RES CO, V387, P207, DOI 10.1016/j.bbrc.2009.07.004; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	65	407	421	8	118	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					780	794		10.1016/j.cell.2015.07.013	http://dx.doi.org/10.1016/j.cell.2015.07.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276632	Green Accepted, Bronze			2022-12-28	WOS:000359741400012
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Bias in randomised controlled trials: comparison of crossover group and parallel group designs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Frank B, 2008, BRIT MED J, V336, P199, DOI 10.1136/bmj.39429.619653.80; Marston L, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4656; Sedgwick P., 2013, BMJ, V347, pf6304, DOI [DOI 10.1136/BMJ.F6304, 10.1136/bmj.f6304]; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3869; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3191; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1742	6	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2015	351								h4283	10.1136/bmj.h4283	http://dx.doi.org/10.1136/bmj.h4283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AV	26253465				2022-12-28	WOS:000359387800010
J	Lang, T				Lang, Trudie			Embed research in outbreak response	NATURE			English	Editorial Material							VIRUSES; CMX001		Univ Oxford, Global Hlth Res, Ctr Trop Med & Global Hlth, Oxford OX1 2JD, England	University of Oxford	Lang, T (corresponding author), Univ Oxford, Global Hlth Res, Ctr Trop Med & Global Hlth, Oxford OX1 2JD, England.	trudie.lang@ndm.ox.ac.uk		Lang, Trudie/0000-0003-2273-5975				[Anonymous], 2014, NATURE, V513, P143; Cohen J, 2014, SCIENCE, V346, P911, DOI 10.1126/science.346.6212.911; Florescu DF, 2014, EXPERT REV ANTI-INFE, V12, P1171, DOI 10.1586/14787210.2014.948847; Lamberti MJ, 2013, THER INNOV REGUL SCI, V47, P101, DOI 10.1177/2168479012469947; Matthes-Martin S, 2013, EXPERT REV ANTI-INFE, V11, P1017, DOI 10.1586/14787210.2013.836964; Painter W, 2012, ANTIMICROB AGENTS CH, V56, P2726, DOI 10.1128/AAC.05983-11	6	17	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					29	31		10.1038/524029a	http://dx.doi.org/10.1038/524029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO2QS	26245565	Bronze			2022-12-28	WOS:000359002300013
J	Palmer, BF; Clegg, DJ				Palmer, Biff F.; Clegg, Deborah J.			Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							METABOLIC-ACIDOSIS; LACTIC-ACIDOSIS; HYPERGLYCEMIC EMERGENCIES; SERUM POTASSIUM; BLOOD-PRESSURE; KETOACIDOSIS; INSULIN; SODIUM; HYPONATREMIA; HOMEOSTASIS	The prevalence of diabetes is increasing rapidly, and type 2 diabetes now accounts for 20 to 50% of cases of new-onset diabetes in young people. 1 Electrolyte disturbances are common in patients with diabetes and may be the result of an altered distribution of electrolytes related to hyperglycemia-induced osmotic fluid shifts or of total-body deficits brought about by osmotic diuresis. Complications from end-organ injury and the therapies used in the management of diabetes may also contribute to electrolyte disturbances. In this review, we highlight the ways in which specific electrolytes may be influenced by dysregulation in glucose homeostasis.	[Palmer, Biff F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Clegg, Deborah J.] Cedars Sinai Med Ctr, Biomed Res Dept, Diabet & Obes Res Div, Beverly Hills, CA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Cedars Sinai Medical Center	Palmer, BF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	biff.palmer@utsouthwestern.edu						ADROGUE HJ, 1984, KIDNEY INT, V25, P591, DOI 10.1038/ki.1984.62; Aronson PS, 2011, J AM SOC NEPHROL, V22, P1981, DOI 10.1681/ASN.2011040414; Barbagallo M, 2007, ARCH BIOCHEM BIOPHYS, V458, P40, DOI 10.1016/j.abb.2006.05.007; Beukhof CM, 2007, CLIN ENDOCRINOL, V66, P367, DOI 10.1111/j.1365-2265.2007.02741.x; BOLLI G, 1979, MINERVA MED, V70, P3783; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; Centers for Disease Control, 2020, NATL DIABETES STAT R; CHRISTENSEN NJ, 1974, DIABETES, V23, P1; Chua HR, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-23; Cox K, 2012, J CRIT CARE, V27, P132, DOI 10.1016/j.jcrc.2011.07.071; Elisaf MS, 1996, DIABETES RES CLIN PR, V34, P23, DOI 10.1016/S0168-8227(96)01332-0; EPSTEIN FH, 1983, NEW ENGL J MED, V309, P1450, DOI 10.1056/NEJM198312083092308; FISHER JN, 1983, J CLIN ENDOCR METAB, V57, P177, DOI 10.1210/jcem-57-1-177; FOSTER DW, 1983, NEW ENGL J MED, V309, P159; FRANKS M, 1948, ARCH INTERN MED, V81, P42, DOI 10.1001/archinte.1948.00220190050005; Goguen J, 2013, CAN J DIABETES, V37, pS72, DOI 10.1016/j.jcjd.2013.01.023; GOLDSTEIN DA, 1981, J CLIN ENDOCR METAB, V52, P116, DOI 10.1210/jcem-52-1-116; Halperin ML, 2010, J AM SOC NEPHROL, V21, P894, DOI 10.1681/ASN.2009080794; HALPERIN ML, 1985, AM J PHYSIOL, V248, pF607, DOI 10.1152/ajprenal.1985.248.4.F607; HALPERIN ML, 1988, CLIN INVEST MED, V11, P198; HALPERIN ML, 1989, DIABETES METAB REV, V5, P321, DOI 10.1002/dmr.5610050402; Hillier TA, 1999, AM J MED, V106, P399, DOI 10.1016/S0002-9343(99)00055-8; Hoorn EJ, 2011, J AM SOC NEPHROL, V22, P605, DOI 10.1681/ASN.2010080827; HUSTED FC, 1975, J CLIN INVEST, V56, P414, DOI 10.1172/JCI108107; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Kamel KS, 2015, NEW ENGL J MED, V372, P546, DOI 10.1056/NEJMra1207788; Karet FE, 2009, J AM SOC NEPHROL, V20, P251, DOI 10.1681/ASN.2008020166; KEBLER R, 1985, AM J MED, V79, P571, DOI 10.1016/0002-9343(85)90053-1; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; LALAU JD, 1989, INT J CLIN PHARM TH, V27, P285; Liamis G, 2013, AM J NEPHROL, V38, P50, DOI 10.1159/000351804; Lu JX, 2011, CLIN CHIM ACTA, V412, P286, DOI 10.1016/j.cca.2010.10.020; Mahler SA, 2011, AM J EMERG MED, V29, P670, DOI 10.1016/j.ajem.2010.02.004; MCNAIR P, 1981, ACTA ENDOCRINOL-COP, V96, P81, DOI 10.1530/acta.0.0960081; Nguyen TQ, 2011, CLIN J AM SOC NEPHRO, V6, P1533, DOI 10.2215/CJN.00750111; Nyenwe EA, 2011, DIABETES RES CLIN PR, V94, P340, DOI 10.1016/j.diabres.2011.09.012; Nyenwe EA, 2010, DIABETES CARE, V33, P1837, DOI 10.2337/dc10-0102; OH MS, 1990, NEPHRON, V54, P1, DOI 10.1159/000185800; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Palmer BF, 2003, ANN PHARMACOTHER, V37, P1694, DOI 10.1345/aph.1D105; Palmer BF, 2002, NEW ENGL J MED, V347, P1256, DOI 10.1056/NEJMra020676; Palmer BF, 2015, CLIN J AM SOC NEPHRO, V10, P1050, DOI 10.2215/CJN.08580813; Palmer BF, 2011, SEMIN NEPHROL, V31, P542, DOI 10.1016/j.semnephrol.2011.09.009; Palmer BF, 2010, AM J KIDNEY DIS, V56, P1184, DOI 10.1053/j.ajkd.2010.07.010; Palmer BF, 2010, AM J KIDNEY DIS, V56, P387, DOI 10.1053/j.ajkd.2010.01.020; Perazella MA, 2013, KIDNEY INT, V83, P553, DOI 10.1038/ki.2012.462; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; ROSCOE JM, 1975, CAN MED ASSOC J, V112, P452; SCHWARZ P, 1992, ACTA ENDOCRINOL-COP, V126, P260, DOI 10.1530/acta.0.1260260; Seidowsky A, 2009, CRIT CARE MED, V37, P2191, DOI 10.1097/CCM.0b013e3181a02490; Song J, 2006, AM J PHYSIOL-RENAL, V290, pF1055, DOI 10.1152/ajprenal.00108.2005; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; Taylor WH, 2001, DIABETES-METAB RES, V17, P175, DOI 10.1002/dmrr.199; Tzamaloukas AH, 2010, INT UROL NEPHROL, V42, P1015, DOI 10.1007/s11255-010-9831-7	55	110	116	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					548	559		10.1056/NEJMra1503102	http://dx.doi.org/10.1056/NEJMra1503102			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26244308				2022-12-28	WOS:000358987700009
J	Raiten, JM				Raiten, Jesse M.			Lessons of the Gacaca	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	University of Pennsylvania	Raiten, JM (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	j.raiten@gmail.com						[Anonymous], UNDP IN RWAND; Clover J, IMPROVING ACCESS ED; Gundersen I, UMUGANDA TOOL RECONC; Ingelaere B, GACACA COURTS RWANDA; Umuganda, UM	5	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					451	452		10.1001/jama.2015.6829	http://dx.doi.org/10.1001/jama.2015.6829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO1OI	26241595				2022-12-28	WOS:000358924500008
J	Rhodes, KV; Rodgers, M; Sommers, M; Hanlon, A; Chittams, J; Doyle, A; Datner, E; Crits-Christoph, P				Rhodes, Karin V.; Rodgers, Melissa; Sommers, Marilyn; Hanlon, Alexandra; Chittams, Jesse; Doyle, Andrea; Datner, Elizabeth; Crits-Christoph, Paul			Brief Motivational Intervention for Intimate Partner Violence and Heavy Drinking in the Emergency Department A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOMESTIC VIOLENCE; ALCOHOL-USE; AGGRESSION; SYMPTOMS; INJURY; AUDIT; RISK	IMPORTANCE Intimate partner violence (IPV) and heavy drinking are co-occurring public health problems, but integrated brief interventions for these conditions have not been tested. OBJECTIVE To determine whether a brief motivational intervention provided at the time of an emergency department (ED) visit reduces IPV and heavy drinking. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial conducted at 2 US academic urban EDs between January 2011 and December 2014 to assess the effectiveness of a motivational intervention for IPV-involved female ED patients (ages: 18-64 years; N = 600) who exceeded sex-specific safe drinking limits. All received social service referrals; 2: 2: 1 to brief intervention (n = 242), assessed control (n = 237), or no-contact control (n = 121). INTERVENTIONS A 20- to 30-minute manual-guided motivational intervention (recorded and monitored for fidelity) delivered by master's-level therapists with a follow-up telephone booster. The assessed control group received the same number of assessments as the brief intervention group; the no-contact control group was assessed only once at 3 months. MAIN OUTCOMES AND MEASURES Incidents of heavy drinking and experiencing IPV measured over prespecified, 12 weekly assessments using an interactive voice response system. RESULTS Of 600 participants, 80% were black women with a mean age of 32 years. Retention was 89% for 2 or more interactive voice response system calls. Seventy-eight percent of women completed the 3-month interview, 79% at 6 months, and 71% at 12 months. During the 12-week period following the brief motivational intervention, there were no significant differences between the intervention group and the assessed control group on weekly assessments for experiencing IPV (odds ratio [OR], 1.02; 95% CI, 0.98-1.06) or heavy drinking (OR, 0.99; 95% CI, 0.96-1.03). From baseline to 12 weeks, the number of women with any IPV in the past week decreased from 57%(134 of 237) in the intervention group to 43%(83 of 194) and from 63%(145 of 231) in the assessed control group to 41%(77 of 187) (absolute difference of 8%). From baseline to 12 weeks, the number of women with past week heavy drinking decreased from 51%(120 of 236) in the intervention group to 43%(83 of 194) and from 46%(107 of 231) in the assessed control group to 41%(77 of 187) (absolute difference of 3%). At 12 months, 43%(71 of 165) of the intervention group and 47%(78 of 165) of the assessed control group reported no IPV during the previous 3 months and 19% (29 of 152) of the intervention group and 24%(37 of 153) of the control group had reduced their alcohol consumption to sex-specific National Institute on Alcohol Abuse and Alcoholism safe drinking levels. CONCLUSIONS AND RELEVANCE For women experiencing IPV and heavy drinking, the use of a brief motivational intervention in the ED compared with assessed and no-contact controls did not significantly reduce the days of heavy drinking or incidents of IPV. These findings do not support a brief motivational intervention in this setting.	[Rhodes, Karin V.; Rodgers, Melissa; Datner, Elizabeth; Crits-Christoph, Paul] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rhodes, Karin V.; Doyle, Andrea] Univ Penn, Sch Social Policy & Practice, Philadelphia, PA 19104 USA; [Sommers, Marilyn; Hanlon, Alexandra; Chittams, Jesse] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Datner, Elizabeth] Philadelphia VA Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Rhodes, KV (corresponding author), Univ Penn, Ctr Emergency Care Policy & Res, Dept Emergency Med, Perelman Sch Med,HUP, 34th & Spruce St,First Floor Ravidin, Philadelphia, PA 19104 USA.	karin.rhodes@uphs.upenn.edu	Hanlon, Alexandra L/J-9585-2013; Crits-Christoph, Paul/X-4682-2018	Crits-Christoph, Paul/0000-0001-6858-8451	National Institute on Alcohol Abuse and Alcoholism [R01-AA018705]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018705] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project was funded by award R01-AA018705 from the National Institute on Alcohol Abuse and Alcoholism.	[Anonymous], REVISED GLOBAL SCALE; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Bair-Merritt MH, 2014, AM J PREV MED, V46, P188, DOI 10.1016/j.amepre.2013.10.001; Black MM, NATL IMTIMATE PARTNE; Bonomi AE, 2014, VIOLENCE AGAINST WOM, V20, P42, DOI 10.1177/1077801213520580; Braveman Paula, 2009, Pediatrics, V124 Suppl 3, pS163, DOI 10.1542/peds.2009-1100D; Zuckoff A, 2010, PARTN ABUSE, V1, P92, DOI 10.1891/1946-6560.1.1.92; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Caetano R, 2001, ALCOHOL RES HEALTH, V25, P58; Campbell JC, 2009, J INTERPERS VIOLENCE, V24, P653, DOI 10.1177/0886260508317180; CASCARDI M, 1992, ARCH INTERN MED, V152, P1178, DOI 10.1001/archinte.152.6.1178; Cerulli C, 2011, VIOLENCE AGAINST WOM, V17, P1529, DOI 10.1177/1077801211436304; Choo EK, 2013, DRUG ALCOHOL DEPEN, V127, P115, DOI 10.1016/j.drugalcdep.2012.06.021; Coker AL, 2012, VIOLENCE AGAINST WOM, V18, P118, DOI 10.1177/1077801212437908; D'Onofrio G, 2004, ALCOHOL RES HEALTH, V28, P63; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/088667005780927548; Institute of Medicine, CLIN PREV SERV WOM C; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kaysen D, 2007, ADDICT BEHAV, V32, P1272, DOI 10.1016/j.addbeh.2006.09.007; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Longabaugh R, 2001, J STUD ALCOHOL, V62, P806, DOI 10.15288/jsa.2001.62.806; Miller E, 2011, CONTRACEPTION, V83, P274, DOI 10.1016/j.contraception.2010.07.013; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; Moyers TB, 2005, J CONSULT CLIN PSYCH, V73, P590, DOI 10.1037/0022-006X.73.4.590; Nelson HD, SCREENING WOMEN INTI; Overup CS, 2015, ADDICT BEHAV, V41, P152, DOI 10.1016/j.addbeh.2014.10.006; Perez S, 2012, VIOLENCE AGAINST WOM, V18, P102, DOI 10.1177/1077801212437348; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Rhodes KV, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-10; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Smith P H, 1995, Womens Health, V1, P273; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Sommers MS, 2013, ALCOHOL CLIN EXP RES, V37, P1753, DOI 10.1111/acer.12142; Straus Murray A, 2004, Violence Vict, V19, P507; Testa M, 2011, AGGRESSIVE BEHAV, V37, P362, DOI 10.1002/ab.20391; US Department of Health and Human Services, HLTH CAR PROV ROL SC; US Department of Health & Human Services, HELP PAT WHO DRINK T; WILSNACK SC, 1991, AM J PUBLIC HEALTH, V81, P305, DOI 10.2105/AJPH.81.3.305	40	34	34	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					466	477		10.1001/jama.2015.8369	http://dx.doi.org/10.1001/jama.2015.8369			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO1OI	26241598	Green Accepted, Bronze			2022-12-28	WOS:000358924500011
J	Watts, G				Watts, Geoff			Koichi Tanigawa: a passionate voice in radiation disaster medicine	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					423	423		10.1016/S0140-6736(15)61436-2	http://dx.doi.org/10.1016/S0140-6736(15)61436-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251381				2022-12-28	WOS:000358761700012
J	Aubert, O; Kamar, N; Vernerey, D; Viglietti, D; Martinez, F; Duong-Van-Huyen, JP; Eladari, D; Empana, JP; Rabant, M; Verine, J; Rostaing, L; Congy, N; Guilbeau-Frugier, C; Mourad, G; Garrigue, V; Morelon, E; Giral, M; Kessler, M; Ladriere, M; Delahousse, M; Glotz, D; Legendre, C; Jouven, X; Lefaucheur, C; Loupy, A				Aubert, Olivier; Kamar, Nassim; Vernerey, Dewi; Viglietti, Denis; Martinez, Frank; Duong-Van-Huyen, Jean-Paul; Eladari, Dominique; Empana, Jean-Philippe; Rabant, Marion; Verine, Jerome; Rostaing, Lionel; Congy, Nicolas; Guilbeau-Frugier, Celine; Mourad, Georges; Garrigue, Valerie; Morelon, Emmanuel; Giral, Magali; Kessler, Michele; Ladriere, Marc; Delahousse, Michel; Glotz, Denis; Legendre, Christophe; Jouven, Xavier; Lefaucheur, Carmen; Loupy, Alexandre			Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIBODY-MEDIATED REJECTION; SURVIVAL BENEFIT; UNITED-STATES; RECIPIENTS; FAILURE; SCORE; RISK	OBJECTIVES To assess the long term outcomes of transplantation using expanded criteria donors (ECD; donors aged >= 60 years or aged 50-59 years with vascular comorbidities) and assess the main determinants of its prognosis. DESIGN Prospective, population based cohort study. SETTING Four French referral centres. PATICIPANTS Consecutive patients who underwent kidney transplantation between January 2004 and January 2011, and were followed up to May 2014. A validation cohort included patients from another four referral centres in France who underwent kidney transplantation between January 2002 and December 2011. MAIN OUTCOME MEASURES Long term kidney allograft survival, based on systematic assessment of donor, recipient, and transplant clinical characteristics; preimplantation biopsy; and circulating levels of donor specific anti-HLA (human leucocyte antigen) antibody (DSA) at baseline. RESULTS The study included 6891 patients (2763 in the principal cohort, 4128 in the validation cohort). Of 2763 transplantations performed, 916 (33.2%) used ECD kidneys. Overall, patients receiving ECD transplants had lower allograft survival after seven years than patients receiving transplants from standard criteria donors (SCD; 80% v 88%, P<0.001). Patients receiving ECD transplants who presented with circulating DSA at the time of transplantation had worse allograft survival after seven years than patients receiving ECD kidneys without circulating DSA at transplantation (44% v 85%, P<0.001). After adjusting for donor, recipient, and transplant characteristics, as well as preimplantation biopsy findings and baseline immunological parameters, the main independent determinants of long term allograft loss were identified as allocation of ECDs (hazard ratio 1.84 (95% confidence interval 1.5 to 2.3); P<0.001), presence of circulating DSA on the day of transplantation (3.00 (2.3 to 3.9); P<0.001), and longer cold ischaemia time (>12 h; 1.53 (1.1 to 2.1); P=0.011). Recipients of ECD kidneys with circulating DSA showed a 5.6-fold increased risk of graft loss compared with all other transplant therapies (P<0.001). ECD allograft survival at seven years significantly improved with screening and transplantation in the absence of circulating DSA (P<0.001) and with shorter (<12 h) cold ischaemia time (P=0.030), respectively. This strategy achieved ECD graft survival comparable to that of patients receiving an SCD transplant overall, translating to a 544.6 allograft life years saved during the nine years of study inclusion time. CONCLUSIONS Circulating DSA and cold ischaemia time are the main independent determinants of outcome from ECD transplantation. Allocation policies to avoid DSA and reduction of cold ischaemia time to increase efficacy could promote wider implement of ECD transplantation in the context of organ shortage.	[Aubert, Olivier; Vernerey, Dewi; Viglietti, Denis; Duong-Van-Huyen, Jean-Paul; Eladari, Dominique; Empana, Jean-Philippe; Delahousse, Michel; Glotz, Denis; Legendre, Christophe; Jouven, Xavier; Lefaucheur, Carmen; Loupy, Alexandre] Paris Descartes Univ, INSERM, Paris Translat Res Ctr Organ Transplantat, UMR S970, F-75015 Paris, France; [Kamar, Nassim; Rostaing, Lionel] Dept Nephrol & Organ Transplantat, Toulouse, France; [Kamar, Nassim; Rostaing, Lionel] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Kamar, Nassim; Rostaing, Lionel; Congy, Nicolas; Guilbeau-Frugier, Celine] Univ Toulouse 3, F-31062 Toulouse, France; [Viglietti, Denis; Glotz, Denis; Lefaucheur, Carmen] Hop St Louis, Assistance Publ Hop Paris, Dept Nephrol & Kidney Transplantat, Paris, France; [Martinez, Frank; Legendre, Christophe; Loupy, Alexandre] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Dept Kidney Transplantat, Sorbonne Paris, Paris, France; [Duong-Van-Huyen, Jean-Paul; Rabant, Marion] Hop Necker Enfants Malad, Dept Pathol, Paris, France; [Eladari, Dominique] Georges Pompidou European Hosp, Dept Renal Physiol, Paris, France; [Verine, Jerome] Hop St Louis, Dept Pathol, Paris, France; [Congy, Nicolas] INSERM, Fac Med Purpan, Mol Immunogenet Lab, EA 3034,IFR150, Toulouse, France; [Congy, Nicolas] Hop Rangueil, Dept Immunol, Toulouse, France; [Guilbeau-Frugier, Celine] Dept Pathol, Toulouse, France; [Mourad, Georges; Garrigue, Valerie] Dept Nephrol & Kidney Transplantat, Montpellier, France; [Morelon, Emmanuel] Hop Edouard Herriot, Groupement Hosp, Dept Nephrol & Kidney Transplantat, Lyon, France; [Morelon, Emmanuel; Giral, Magali; Kessler, Michele; Ladriere, Marc; Legendre, Christophe] Centaure Network, Nantes, France; [Giral, Magali] Dept Nephrol & Kidney Transplantat, Nantes, France; [Kessler, Michele; Ladriere, Marc] Dept Nephrol & Kidney Transplantat, Nancy, France; [Delahousse, Michel] Foch Hosp, Dept Nephrol & Kidney Transplantat, Paris, France; [Jouven, Xavier] Georges Pompidou European Hosp, Dept Cardiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Montpellier; CHU Lyon; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Loupy, A (corresponding author), Paris Descartes Univ, INSERM, Paris Translat Res Ctr Organ Transplantat, UMR S970, F-75015 Paris, France.	alexandreloupy@gmail.com	Aubert, Olivier/K-8526-2019; Congy-jolivet, Nicolas/AAP-1413-2021; Loupy, Alexandre/K-8512-2019; Rabant, Marion/ACD-2481-2022; Viglietti, Denis/J-3595-2019; lefaucheur, carmen/AAS-7494-2020; Empana, Jean-Philippe/AAF-6923-2021; Kamar, Nassim/L-6462-2014	Empana, Jean-Philippe/0000-0002-1469-7772; FRUGIER, Celine/0000-0003-2889-9188; Glotz, Denis/0000-0001-5258-4237; Eladari, Dominique/0000-0003-1067-0844; Kamar, Nassim/0000-0003-1930-8964; Congy, Nicolas/0000-0003-4263-1700				[Anonymous], 2013, ANN REPORT; [Anonymous], 2013, ANN REPORT; [Anonymous], 2013, ANN REPORT; [Anonymous], 2012, NY TIMES; [Anonymous], 2012, ANN REPORT; Azancot MA, 2014, KIDNEY INT, V85, P1161, DOI 10.1038/ki.2013.461; Cecka JM, 2008, AM J TRANSPLANT, V8, P735, DOI 10.1111/j.1600-6143.2007.02071.x; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Debout A, 2015, KIDNEY INT, V87, P343, DOI 10.1038/ki.2014.304; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frei U, 2008, AM J TRANSPLANT, V8, P50, DOI 10.1111/j.1600-6143.2007.02014.x; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Kayler LK, 2011, AM J TRANSPLANT, V11, P2657, DOI 10.1111/j.1600-6143.2011.03817.x; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lee E, 2013, STAT METHODS SURVIVA; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Lledo-Garcia E, 2014, CLIN TRANSPLANT, V28, P1155, DOI 10.1111/ctr.12434; Merion RM, 2005, JAMA-J AM MED ASSOC, V294, P2726, DOI 10.1001/jama.294.21.2726; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Ojo AO, 2001, J AM SOC NEPHROL, V12, P589, DOI 10.1681/ASN.V123589; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Rana A, 2015, JAMA SURG, V150, P252, DOI 10.1001/jamasurg.2014.2038; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Smits JMA, 2002, AM J TRANSPLANT, V2, P664, DOI 10.1034/j.1600-6143.2002.20713.x; Sung RS, 2008, AM J TRANSPLANT, V8, P783, DOI 10.1111/j.1600-6143.2008.02157.x; Tanriover B, 2014, Am J Transplant, V14, P404, DOI 10.1111/ajt.12553; Tuttle-Newhall JE, 2009, AM J TRANSPLANT, V9, P879, DOI 10.1111/j.1600-6143.2009.02565.x	34	110	116	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2015	351								h3557	10.1136/bmj.h3557	http://dx.doi.org/10.1136/bmj.h3557			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UE	26232393	Green Published, hybrid			2022-12-28	WOS:000359011300001
J	Mottola, S; Arnold, G; Grothues, HG; Jaumann, R; Michaelis, H; Neukum, G; Bibring, JP; Schroder, SE; Hamm, M; Otto, KA; Pelivan, I; Proffe, G; Scholten, F; Tirsch, D; Kreslavsky, M; Remetean, E; Souvannavong, F; Dolives, B				Mottola, S.; Arnold, G.; Grothues, H. -G.; Jaumann, R.; Michaelis, H.; Neukum, G.; Bibring, J. -P.; Schroeder, S. E.; Hamm, M.; Otto, K. A.; Pelivan, I.; Proffe, G.; Scholten, F.; Tirsch, D.; Kreslavsky, M.; Remetean, E.; Souvannavong, F.; Dolives, B.			The structure of the regolith on 67P/Churyumov-Gerasimenko from ROLIS descent imaging	SCIENCE			English	Article								The structure of the upper layer of a comet is a product of its surface activity. The Rosetta Lander Imaging System (ROLIS) on board Philae acquired close-range images of the Agilkia site during its descent onto comet 67P/Churyumov-Gerasimenko. These images reveal a photometrically uniform surface covered by regolith composed of debris and blocks ranging in size from centimeters to 5 meters. At the highest resolution of 1 centimeter per pixel, the surface appears granular, with no apparent deposits of unresolved sand-sized particles. The thickness of the regolith varies across the imaged field from 0 to 1 to 2 meters. The presence of aeolian-like features resembling wind tails hints at regolith mobilization and erosion processes. Modeling suggests that abrasion driven by airfall-induced particle "splashing" is responsible for the observed formations.	[Mottola, S.; Arnold, G.; Jaumann, R.; Michaelis, H.; Schroeder, S. E.; Hamm, M.; Otto, K. A.; Pelivan, I.; Proffe, G.; Scholten, F.; Tirsch, D.] German Aerosp Ctr DLR, Inst Planetary Res, Berlin, Germany; [Grothues, H. -G.] DLR, Space Management, Space Sci, Bonn, Germany; [Jaumann, R.; Neukum, G.] Free Univ Berlin, Inst Geol Sci, Berlin, Germany; [Bibring, J. -P.] Inst Space Astrophys, Orsay, France; [Hamm, M.] Humboldt Univ, Berlin, Germany; Univ Calif Santa Cruz, Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Remetean, E.] Ctr Natl Etud Spatiales, F-31055 Toulouse, France; [Souvannavong, F.; Dolives, B.] Magellium, Ramonville St Agne, France	Helmholtz Association; German Aerospace Centre (DLR); Helmholtz Association; German Aerospace Centre (DLR); Free University of Berlin; UDICE-French Research Universities; Universite Paris Saclay; Humboldt University of Berlin; University of California System; University of California Santa Cruz	Mottola, S (corresponding author), German Aerosp Ctr DLR, Inst Planetary Res, Berlin, Germany.	stefano.mottola@dlr.de	Kreslavsky, Mikhail/J-3425-2013; Jaumann, Ralf/N-1001-2018; Tirsch, Daniela/I-7916-2012; Schröder, Stefan/D-9709-2013	Jaumann, Ralf/0000-0002-9759-6597; Tirsch, Daniela/0000-0001-5905-5426; Schröder, Stefan/0000-0003-0323-8324; Pelivan, Ivanka/0000-0003-0732-8466; Dolives, Benoit/0000-0003-3397-3119; Kreslavsky, Mikhail/0000-0002-1900-826X; Hamm, Maximilian/0000-0002-7476-0892	DLR, German Aerospace Center	DLR, German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR))	ROLIS was funded, built, and managed by the DLR, German Aerospace Center, which we gratefully acknowledge. The ROLIS Team is indebted to the Lander Control Center (LCC, Cologne), CNES's Science, Operation, and Navigation Center (SONC) and the European Space Agency (ESA) for their support during the operations. The authors thank W. Bresch for his continued support during the development and operations of the experiment. The ROLIS calibrated data will be available through the ESA's Planetary Science Archive website (www.rssd.esa.int/index. php?project=PSA&page=index). This paper is dedicated to the memory of Gerhard Neukum.	ADAMS JB, 1967, J GEOPHYS RES, V72, P5705, DOI 10.1029/JZ072i022p05705; Biele J, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9816; Cheng AF, 2013, ICARUS, V222, P808, DOI 10.1016/j.icarus.2012.10.004; Ghosh S., 2005, FUNDAMENTALS COMPUTA; Greeley R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002491; Greeley R, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001481; Greeley R, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002971; HARTMANN WK, 1969, ICARUS, V10, P201, DOI 10.1016/0019-1035(69)90022-0; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; Kok JF, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/106901; Kok JF, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.074502; Mottola S, 2007, SPACE SCI REV, V128, P241, DOI 10.1007/s11214-006-9004-2; Rotundi A, 2015, SCIENCE, V347, DOI 10.1126/science.aaa3905; Scheeres DJ, 2010, ICARUS, V210, P968, DOI 10.1016/j.icarus.2010.07.009; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440	15	84	84	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aab0232	10.1126/science.aab0232	http://dx.doi.org/10.1126/science.aab0232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228151				2022-12-28	WOS:000358713300003
J	Diamond, MS; Pierson, TC				Diamond, Michael S.; Pierson, Theodore C.			Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control	CELL			English	Review							INFECTION; ENHANCEMENT; STABILITY; DYNAMICS; BIOLOGY; PROTEIN; BURDEN; IMPACT	Dengue virus (DENV) is a mosquito-transmitted RNA virus that infects an estimated 390 million humans each year. Here, we review recent advances in our understanding of the biology of DENV and describe knowledge gaps that have impacted the development of effective vaccines and therapeutics.	[Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, Dept Med, St Louis, MO 63110 USA.	diamond@wusm.wustl.edu; piersontc@mail.nih.gov	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165	National Institute of Allergy and Infectious Diseases; Burroughs Wellcome Fund; NIH [R01 AI073755, R01 AI098723]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000957, ZIAAI001022, R01AI073755, R01AI098723] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural program of the National Institute of Allergy and Infectious Diseases, the Burroughs Wellcome Fund, and NIH grants R01 AI073755 and R01 AI098723. We sincerely apologize to our colleagues whose primary studies we were unable to cite due to the limited scope and citation restrictions of this Review. M.S.D. has served as an ad hoc member of the external Scientific Advisory Board of Sanofi-Pasteur.	Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370; Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341; Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833; George S.L., 2015, J INFECT DIS; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115; Kirkpatrick B.D., 2015, J INFECT DIS; Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683; Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lindenbach BD, 2013, FIELDS VIROLOGY, P712; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Rey FA, 2013, NATURE, V497, P443, DOI 10.1038/497443a; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Syenina A, 2015, ELIFE, V4, DOI 10.7554/eLife.05291; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004	31	158	166	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					488	492		10.1016/j.cell.2015.07.005	http://dx.doi.org/10.1016/j.cell.2015.07.005			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232221	Green Accepted, Bronze			2022-12-28	WOS:000358801800009
J	Kaplan, GS				Kaplan, Gary S.			Health Care Scheduling and Access A Report From the IOM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Virginia Mason Hlth Syst, Seattle, WA 98101 USA	Virginia Mason Medical Center	Kaplan, GS (corresponding author), Virginia Mason Hlth Syst, 1100 Ninth Ave, Seattle, WA 98101 USA.	gary.kaplan@vmmc.org						Affairs V, 2014, INT REP REV PAT WAIT; Cima RR, 2011, J AM COLL SURGEONS, V213, P83, DOI 10.1016/j.jamcollsurg.2011.02.009; Gallucci G, 2005, PSYCHIAT SERV, V56, P344, DOI 10.1176/appi.ps.56.3.344; Hoffman KA, 2011, HEALTH INFORM J, V17, P256, DOI 10.1177/1460458211420090; Institute of Medicine, 2015, TRANSF HLTH CAR SCHE; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026	7	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1449	1450		10.1001/jama.2015.9431	http://dx.doi.org/10.1001/jama.2015.9431			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26226620				2022-12-28	WOS:000362647800008
J	Prina, E; Ranzani, OT; Torres, A				Prina, Elena; Ranzani, Otavio T.; Torres, Antoni			Community-acquired pneumonia	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; RESPIRATORY-TRACT INFECTIONS; CARE-ASSOCIATED PNEUMONIA; BETA-LACTAM MONOTHERAPY; C-REACTIVE PROTEIN; ANTIBIOTIC-THERAPY; RISK-FACTORS; HOSPITALIZED-PATIENTS; RESISTANT PATHOGENS; DOUBLE-BLIND	Community-acquired pneumonia causes great mortality and morbidity and high costs worldwide. Empirical selection of antibiotic treatment is the cornerstone of management of patients with pneumonia. To reduce the misuse of antibiotics, antibiotic resistance, and side-effects, an empirical, effective, and individualised antibiotic treatment is needed. Follow-up after the start of antibiotic treatment is also important, and management should include early shifts to oral antibiotics, stewardship according to the microbiological results, and short-duration antibiotic treatment that accounts for the clinical stability criteria. New approaches for fast clinical (lung ultrasound) and microbiological (molecular biology) diagnoses are promising. Community-acquired pneumonia is associated with early and late mortality and increased rates of cardiovascular events. Studies are needed that focus on the long-term management of pneumonia.	[Prina, Elena; Torres, Antoni] Univ Barcelona, Dept Pulmonol, Inst Invest August Pi & Sunyer IDIBAPS, Hosp Clin Barcelona,Ciber Enfermedades Resp CIBER, E-08036 Barcelona, Spain; [Ranzani, Otavio T.] Univ Sao Paulo, Resp Intens Care Unit, Div Pulm, Heart Inst,Hosp Clin, Sao Paulo, Brazil	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidade de Sao Paulo	Torres, A (corresponding author), Univ Barcelona, Dept Pulmonol, Inst Invest August Pi & Sunyer IDIBAPS, Hosp Clin Barcelona,Ciber Enfermedades Resp CIBER, E-08036 Barcelona, Spain.	ATORRES@clinic.ub.es	Torres, Antoni/H-6128-2017; Ranzani, Otavio T./K-1196-2012	Torres, Antoni/0000-0002-8643-2167; Ranzani, Otavio T./0000-0002-4677-6862; Prina, Elena/0000-0002-6937-8613				Aabenhus R, 2014, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD010130.PUB2; Alcon A, 2005, CLIN CHEST MED, V26, P39, DOI 10.1016/j.ccm.2004.10.013; Aliberti S, 2012, SEMIN RESP CRIT CARE, V33, P284, DOI 10.1055/s-0032-1315640; Aliberti S, 2012, CLIN INFECT DIS, V54, P470, DOI 10.1093/cid/cir840; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arancibia F, 2014, CHEST, V145, P290, DOI 10.1378/chest.13-0162; Arnold FW, 2007, AM J RESP CRIT CARE, V175, P1086, DOI 10.1164/rccm.200603-350OC; Arnold FW, 2013, RESP MED, V107, P1101, DOI 10.1016/j.rmed.2013.04.003; Asadi L, 2012, CLIN INFECT DIS, V55, P371, DOI 10.1093/cid/cis414; Azevedo LCP, 2013, CRIT CARE, V17, DOI 10.1186/cc12594; Barlow G, 2007, THORAX, V62, P67, DOI 10.1136/thx.2005.056689; Blasi F, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-6; Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8; Bochud PY, 2001, MEDICINE, V80, P75, DOI 10.1097/00005792-200103000-00001; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Brambilla AM, 2014, INTENS CARE MED, V40, P942, DOI 10.1007/s00134-014-3325-5; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Cao B, 2010, CLIN INFECT DIS, V51, P189, DOI 10.1086/653535; Capelastegui A, 2009, CHEST, V136, P1079, DOI 10.1378/chest.08-2950; Carratala J, 2005, ANN INTERN MED, V142, P165, DOI 10.7326/0003-4819-142-3-200502010-00006; Carratala J, 2012, ARCH INTERN MED, V172, P922, DOI 10.1001/archinternmed.2012.1690; Carrillo A, 2012, INTENS CARE MED, V38, P458, DOI 10.1007/s00134-012-2475-6; Chalmers JD, 2008, AM J MED, V121, P219, DOI 10.1016/j.amjmed.2007.10.033; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Chavez MA, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-50; Chen Y, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007720.PUB2; Cheng M, 2014, RESP CARE, V59, P557, DOI 10.4187/respcare.02758; Choudhury G, 2011, CLIN MICROBIOL INFEC, V17, P1852, DOI 10.1111/j.1469-0691.2011.03542.x; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Confalonieri M, 2013, CURR INFECT DIS REP, V15, P158, DOI 10.1007/s11908-013-0322-8; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Cunha BA, 2006, CLIN MICROBIOL INFEC, V12, P12, DOI 10.1111/j.1469-0691.2006.01393.x; Dean NC, 2001, AM J MED, V110, P451, DOI 10.1016/S0002-9343(00)00744-0; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dimopoulos G, 2008, DRUGS, V68, P1841, DOI 10.2165/00003495-200868130-00004; Dobler CC, 2013, RESPIROLOGY, V18, P923, DOI 10.1111/resp.12132; Drijkoningen JJC, 2014, CLIN MICROBIOL INFEC, V20, P45, DOI 10.1111/1469-0691.12461; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; Eliakim-Raz Noa, 2012, Cochrane Database Syst Rev, pCD004418, DOI 10.1002/14651858.CD004418.pub4; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Falguera M, 2010, THORAX, V65, P101, DOI 10.1136/thx.2009.118588; File TM, 2013, INFECT DIS CLIN N AM, V27, P99, DOI 10.1016/j.idc.2012.11.005; File TM, 2010, POSTGRAD MED, V122, P130, DOI 10.3810/pgm.2010.03.2130; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; FINE MJ, 1990, AM J MED, V88, pN1; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gajic O, 2005, INTENS CARE MED, V31, P922, DOI 10.1007/s00134-005-2625-1; Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC; Garin N, 2014, JAMA INTERN MED, V174, P1894, DOI 10.1001/jamainternmed.2014.4887; Gonzalez-Moraleja J, 1999, Arch Bronconeumol, V35, P312; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Haubitz S, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.03.042; Howard LSGE, 2005, J INFECTION, V50, P107, DOI 10.1016/j.jinf.2004.05.003; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Johnstone J, 2007, ARCH INTERN MED, V167, P1938, DOI 10.1001/archinte.167.18.1938; Jones B, 2013, AM J PUBLIC HEALTH, V103, pS289, DOI 10.2105/AJPH.2013.301342; Kalil AC, 2011, INTENS CARE MED, V37, P420, DOI 10.1007/s00134-010-2121-0; Khan AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052929; Kuster SP, 2014, CLIN INFECT DIS, V59, P944, DOI 10.1093/cid/ciu497; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Labarere J, 2012, ACAD EMERG MED, V19, P994, DOI 10.1111/j.1553-2712.2012.01424.x; Li JZ, 2007, AM J MED, V120, P783, DOI 10.1016/j.amjmed.2007.04.023; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Majumdar SR, 2011, CLIN INFECT DIS, V52, P325, DOI 10.1093/cid/ciq076; Malcolm C, 2003, ARCH INTERN MED, V163, P797, DOI 10.1001/archinte.163.7.797; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Martinez R, 2009, SEMIN RESP CRIT CARE, V30, P172, DOI 10.1055/s-0029-1202936; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; Menendez R, 2009, THORAX, V64, P987, DOI 10.1136/thx.2009.118612; Metlay JP, 2003, ANN INTERN MED, V138, P109, DOI 10.7326/0003-4819-138-2-200301210-00012; Millett ERC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075131; Misch EA, 2013, GENES IMMUN, V14, P420, DOI 10.1038/gene.2013.34; Moberley S, 2013, COCHRANE DATABASE SY, V1; Mortensen EM, 2014, JAMA-J AM MED ASSOC, V311, P2199, DOI 10.1001/jama.2014.4304; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Mundy LM, 2003, CHEST, V124, P883, DOI 10.1378/chest.124.3.883; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nava S, 2013, LANCET ONCOL, V14, P219, DOI 10.1016/S1470-2045(13)70009-3; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nie W, 2014, J ANTIMICROB CHEMOTH, V69, P1441, DOI 10.1093/jac/dku033; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; Noritomi DT, 2014, INTENS CARE MED, V40, P182, DOI 10.1007/s00134-013-3131-5; Ochoa-Gondar O, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-222; Oldach D, 2013, ANTIMICROB AGENTS CH, V57, P2526, DOI 10.1128/AAC.00197-13; Oliveira CF, 2013, CRIT CARE MED, V41, P2336, DOI 10.1097/CCM.0b013e31828e969f; Oosterheert JJ, 2006, BMJ-BRIT MED J, V333, P1193, DOI 10.1136/bmj.38993.560984.BE; Ott SR, 2012, EUR RESPIR J, V39, P611, DOI 10.1183/09031936.00098411; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Polgreen PM, 2007, INFECT CONT HOSP EP, V28, P212, DOI 10.1086/512174; Postma DF, 2015, NEW ENGL J MED, V372, P1312, DOI 10.1056/NEJMoa1406330; Povoa P, 2012, CURR OPIN INFECT DIS, V25, P199, DOI 10.1097/QCO.0b013e32834f44c7; Prina E, 2015, ANN AM THORAC SOC, V12, P153, DOI 10.1513/AnnalsATS.201407-305OC; Principi N, 2013, J ANTIMICROB CHEMOTH, V68, P506, DOI 10.1093/jac/dks457; Ramirez P, 2014, LANCET RESP MED, V2, P599, DOI 10.1016/S2213-2600(14)70142-0; Ramirez P, 2011, CRIT CARE MED, V39, P2211, DOI 10.1097/CCM.0b013e3182257445; Rautanen A, 2015, LANCET RESP MED, V3, P53, DOI 10.1016/S2213-2600(14)70290-5; Reissig A, 2012, CHEST, V142, P965, DOI 10.1378/chest.12-0364; Renaud B, 2012, CHEST, V142, P1447, DOI 10.1378/chest.11-2574; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Salih W, 2014, EUR RESPIR J, V43, P842, DOI 10.1183/09031936.00089513; Sanz F, 2014, RESPIROLOGY, V19, P1073, DOI 10.1111/resp.12346; Schembri S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1235; Schuetz P, 2015, CLIN CHEM LAB MED, V53, P583, DOI 10.1515/cclm-2014-1015; Schuetz P, 2014, INT J CARDIOL, V175, P464, DOI 10.1016/j.ijcard.2014.06.022; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Schulte B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110566; Shafiq M, 2013, J HOSP MED, V8, P68, DOI 10.1002/jhm.1992; Shimada T, 2009, CHEST, V136, P1576, DOI 10.1378/chest.08-2602; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Shorr AF, 2012, CLIN INFECT DIS, V54, P193, DOI 10.1093/cid/cir813; Sinclair A, 2013, J CLIN MICROBIOL, V51, P2303, DOI 10.1128/JCM.00137-13; Sligl WI, 2014, CRIT CARE MED, V42, P420, DOI 10.1097/CCM.0b013e3182a66b9b; Stolbrink M, 2014, J HOSP INFECT, V88, P34, DOI 10.1016/j.jhin.2014.05.006; Syrjala H, 1998, CLIN INFECT DIS, V27, P358, DOI 10.1086/514675; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; UK NCGC, 2014, PNEUM DIAGN MAN COMM; van der Eerden MM, 2005, THORAX, V60, P672, DOI 10.1136/thx.2004.030411; Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4; Webb BJ, 2015, RESP MED, V109, P1, DOI 10.1016/j.rmed.2014.10.017; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; Woodhead M, 2006, CRIT CARE, V10, DOI 10.1186/cc4927; Wunderink RG, 2005, SEMIN RESP CRIT CARE, V26, P553, DOI 10.1055/s-2005-925522; Wunderink RG, 2013, AM J RESP CRIT CARE, V188, P896, DOI 10.1164/rccm.201308-1536ED; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yu KT, 2008, ANN EMERG MED, V51, P651, DOI 10.1016/j.annemergmed.2007.10.022; Zhang YL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006607.pub4; Zhong NS, 2015, LANCET INFECT DIS, V15, P161, DOI 10.1016/S1473-3099(14)71018-7	144	276	290	7	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1097	1108		10.1016/S0140-6736(15)60733-4	http://dx.doi.org/10.1016/S0140-6736(15)60733-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR2VQ	26277247	Green Published, Bronze			2022-12-28	WOS:000361189200030
J	Bridgeman, A; Maelfait, J; Davenne, T; Partridge, T; Peng, Y; Mayer, A; Dong, T; Kaever, V; Borrow, P; Rehwinkel, J				Bridgeman, A.; Maelfait, J.; Davenne, T.; Partridge, T.; Peng, Y.; Mayer, A.; Dong, T.; Kaever, V.; Borrow, P.; Rehwinkel, J.			Viruses transfer the antiviral second messenger cGAMP between cells	SCIENCE			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; DNA; HIV-1; RECOGNITION; SYNTHASE; REVEALS; ROLES	Cyclic GMP-AMP synthase (cGAS) detects cytosolic DNA during virus infection and induces an antiviral state. cGAS signals by synthesis of a second messenger, cyclic GMP-AMP (cGAMP), which activates stimulator of interferon genes (STING). We show that cGAMP is incorporated into viral particles, including lentivirus and herpesvirus virions, when these are produced in cGAS-expressing cells. Virions transferred cGAMP to newly infected cells and triggered a STING-dependent antiviral program. These effects were independent of exosomes and viral nucleic acids. Our results reveal a way by which a signal for innate immunity is transferred between cells, potentially accelerating and broadening antiviral responses. Moreover, infection of dendritic cells with cGAMP-loaded lentiviruses enhanced their activation. Loading viral vectors with cGAMP therefore holds promise for vaccine development.	[Bridgeman, A.; Maelfait, J.; Davenne, T.; Peng, Y.; Mayer, A.; Dong, T.; Rehwinkel, J.] Univ Oxford, Radcliffe Dept Med, Weatherall Inst Mol Med, MRC,Human Immunol Unit, Oxford OX3 9DS, England; [Partridge, T.; Borrow, P.] Univ Oxford, Nuffield Dept Med, Oxford OX3 7FZ, England; [Kaever, V.] Hannover Med Sch, Inst Pharmacol, Res Core Unit Metabol, D-30625 Hannover, Germany	University of Oxford; University of Oxford; Hannover Medical School	Rehwinkel, J (corresponding author), Univ Oxford, Radcliffe Dept Med, Weatherall Inst Mol Med, MRC,Human Immunol Unit, Oxford OX3 9DS, England.	jan.rehwinkel@imm.ox.ac.uk	Mayer, A/AAM-2083-2021; Kaever, Volkhard/G-3280-2013; Rehwinkel, Jan/CAG-1436-2022; Maelfait, Jonathan/AAE-7827-2021	Mayer, A/0000-0002-6859-0612; Rehwinkel, Jan/0000-0003-3841-835X; Maelfait, Jonathan/0000-0002-1476-0583; Bridgeman, Anne/0000-0002-9478-6125; Dong, Tao/0000-0003-3545-3758; Davenne, Tamara/0000-0002-6582-2668; Borrow, Persephone/0000-0002-3877-9780	UK Medical Research Council [MRC] of the MRC Human Immunology Unit [MR/K012037]; Wellcome Trust [100954]; NIH, National Institute of Allergy and Infectious Diseases [AI 114266]; European Molecular Biology Organization; Marie Curie Actions (EMBOCOFUND) [GA-2010-267146]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114266] Funding Source: NIH RePORTER; Medical Research Council [MR/L018942/1, G0600520, MR/K012037/1, MC_UU_12010/8, G1001046] Funding Source: researchfish; Wellcome Trust [100954/Z/13/Z] Funding Source: researchfish; MRC [MC_UU_12010/8, G1001046, G0600520, MR/K012037/1, MR/L018942/1] Funding Source: UKRI	UK Medical Research Council [MRC] of the MRC Human Immunology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Actions (EMBOCOFUND); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Klenerman, Q. Sattentau, S. Rowland-Jones, and K. James for reagents and advice; D. Gaughan, M.-Y. Sun, and A. Simmons for hMDDCs; A. Garbe for help with mass spectrometry; and C. Reis e Sousa, V. Cerundolo, A. Armitage, G. J. Towers, and J. Rasaiyaah for critical discussions. We thank J. Sharpe and J. Sloane-Stanley (Weatherall Institute of Molecular Medicine Mouse Transgenic and Knockout Facility) for help with rederivation of cGas<SUP>-/-</SUP> mice. Mpys<SUP>-/-</SUP> mice and sperm from cGas<SUP>-/-</SUP> mice were provided by J. Cambier and the European Mouse Mutant Archive, respectively, and are subject to materials transfer agreements. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was funded by the UK Medical Research Council [MRC core funding of the MRC Human Immunology Unit and grant no. MR/K012037 (P.B.)], by the Wellcome Trust [grant no. 100954 (J.R.)], and by the NIH, National Institute of Allergy and Infectious Diseases [grant no. AI 114266 (P.B.)]. J.M. was a recipient of a long-term postdoctoral fellowship from the European Molecular Biology Organization and was also supported by Marie Curie Actions (EMBOCOFUND2010, GA-2010-267146). A provisional patent (U.S. patent application 62/051,016) has been filed pertaining to biological applications relating to the use of cGAMP-loaded viral particles.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Dai PH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003989; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Laguette N, 2012, TRENDS IMMUNOL, V33, P26, DOI 10.1016/j.it.2011.11.002; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Neil SJD, 2013, CURR TOP MICROBIOL, V371, P67, DOI 10.1007/978-3-642-37765-5_3; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2007, J VIROL, V81, P539, DOI 10.1128/JVI.01818-06; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Sun CL, 2015, J IMMUNOL, V194, P1819, DOI 10.4049/jimmunol.1402495; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Wang LCS, 2012, MOL THER, V20, P736, DOI 10.1038/mt.2011.228; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963	27	151	160	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1228	1232		10.1126/science.aab3632	http://dx.doi.org/10.1126/science.aab3632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26229117	Green Submitted, Green Accepted			2022-12-28	WOS:000360968400044
J	Waszak, SM; Delaneau, O; Gschwind, AR; Kilpinen, H; Raghav, SK; Witwicki, RM; Orioli, A; Wiederkehr, M; Panousis, NI; Yurovsky, A; Romano-Palumbo, L; Planchon, A; Bielser, D; Padioleau, I; Udin, G; Thurnheer, S; Hacker, D; Hernandez, N; Reymond, A; Deplancke, B; Dermitzakis, ET				Waszak, Sebastian M.; Delaneau, Olivier; Gschwind, Andreas R.; Kilpinen, Helena; Raghav, Sunil K.; Witwicki, Robert M.; Orioli, Andrea; Wiederkehr, Michael; Panousis, Nikolaos I.; Yurovsky, Alisa; Romano-Palumbo, Luciana; Planchon, Alexandra; Bielser, Deborah; Padioleau, Ismael; Udin, Gilles; Thurnheer, Sarah; Hacker, David; Hernandez, Nouria; Reymond, Alexandre; Deplancke, Bart; Dermitzakis, Emmanouil T.			Population Variation and Genetic Control of Modular Chromatin Architecture in Humans	CELL			English	Article							TRANSCRIPTION FACTOR-BINDING; HUMAN GENOME; HISTONE MODIFICATIONS; REGULATORY VARIATION; SEQUENCE VARIATION; EVOLUTION; DISEASE; CELLS; DNA; IDENTIFICATION	Chromatin state variation at gene regulatory elements is abundant across individuals, yet we understand little about the genetic basis of this variability. Here, we profiled several histone modifications, the transcription factor (TF) PU.1, RNA polymerase II, and gene expression in lymphoblastoid cell lines from 47 whole-genome sequenced individuals. We observed that distinct cis-regulatory elements exhibit coordinated chromatin variation across individuals in the form of variable chromatin modules (VCMs) at sub-Mb scale. VCMs were associated with thousands of genes and preferentially cluster within chromosomal contact domains. We mapped strong proximal and weak, yet more ubiquitous, distal-acting chromatin quantitative trait loci (cQTL) that frequently explain this variation. cQTLs were associated with molecular activity at clusters of cis-regulatory elements and mapped preferentially within TF-bound regions. We propose that local, sequence-independent chromatin variation emerges as a result of genetic perturbations in cooperative interactions between cis-regulatory elements that are located within the same genomic domain.	[Waszak, Sebastian M.; Raghav, Sunil K.; Udin, Gilles; Deplancke, Bart] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Waszak, Sebastian M.; Delaneau, Olivier; Gschwind, Andreas R.; Kilpinen, Helena; Panousis, Nikolaos I.; Yurovsky, Alisa; Padioleau, Ismael; Deplancke, Bart; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Delaneau, Olivier; Kilpinen, Helena; Panousis, Nikolaos I.; Yurovsky, Alisa; Romano-Palumbo, Luciana; Planchon, Alexandra; Bielser, Deborah; Padioleau, Ismael; Dermitzakis, Emmanouil T.] Univ Geneva, Dept Genet Med & Dev, Sch Med, CH-1211 Geneva, Switzerland; [Delaneau, Olivier; Kilpinen, Helena; Panousis, Nikolaos I.; Yurovsky, Alisa; Padioleau, Ismael; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Gschwind, Andreas R.; Witwicki, Robert M.; Orioli, Andrea; Wiederkehr, Michael; Hernandez, Nouria; Reymond, Alexandre] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Thurnheer, Sarah; Hacker, David] Ecole Polytech Fed Lausanne, Sch Life Sci, Prot Express Core Facil, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Deplancke, B (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland.	bart.deplancke@epfl.ch; emmanouil.dermitzakis@unige.ch	Padioleau, Ismaël/AAE-8927-2019; Raghav, Sunil/AAL-1121-2021; Waszak, Sebastian M./D-7828-2015; Kutalik, Zoltan/HHZ-5697-2022; /AAR-2792-2021	Padioleau, Ismaël/0000-0003-4935-3248; Waszak, Sebastian M./0000-0003-3042-9521; Kutalik, Zoltan/0000-0001-8285-7523; Reymond, Alexandre/0000-0003-1030-8327; Gschwind, Andreas/0000-0002-0769-6907; Hernandez, Nouria/0000-0003-1465-4585; Delaneau, Olivier/0000-0002-3906-8446; Panousis, Nikolaos/0000-0003-2890-5592; Kilpinen, Helena/0000-0001-6692-6154; Deplancke, Bart/0000-0001-9935-843X	Swiss National Science Foundation [CRSI33_130326, 31003A_132958, 31003A_130342, 149984, 31003A_129835, 31003A_138323]; European Research Council; Louis-Jeantet Foundation; SystemsX grant [3826]; NIH [MH101814]; European Molecular Biology Organization fellowship [ALTF 2010-337]; doctoral school of the Faculty of Biology and Medicine, University of Lausanne; NCCR Frontiers in Genetics Program; Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich); Ecole Polytechnique Federale de Lausanne; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101814] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Louis-Jeantet Foundation; SystemsX grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization fellowship(European Molecular Biology Organization (EMBO)); doctoral school of the Faculty of Biology and Medicine, University of Lausanne; NCCR Frontiers in Genetics Program; Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich); Ecole Polytechnique Federale de Lausanne; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by Swiss National Science Foundation grants CRSI33_130326 (E.T.D., B.D., A.R., N.H.), 31003A_132958 (N.H.), 31003A_130342 and 149984 (E.T.D.), 31003A_129835 (A.R.), and 31003A_138323 (B.D.); the European Research Council (E.T.D.); the Louis-Jeantet Foundation (E.T.D.); SystemsX grant 3826 (E.T.D.); NIH MH101814 (E.T.D.); European Molecular Biology Organization fellowship ALTF 2010-337 (H.K.); a fellowship from the doctoral school of the Faculty of Biology and Medicine, University of Lausanne (R.M.W.); the NCCR Frontiers in Genetics Program (E.T.D., B.D.); the Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich) (B.D.); and Ecole Polytechnique Federale de Lausanne (B.D.). The computations were performed at the Vital-IT (http://www.vital-it.ch) Center for High-Performance Computing of the Swiss Institute of Bioinformatics.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cusanovich DA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004226; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Karczewski KJ, 2011, P NATL ACAD SCI USA, V108, P13353, DOI 10.1073/pnas.1103105108; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schlattl A, 2011, GENOME RES, V21, P2004, DOI 10.1101/gr.122614.111; Shlyueva D, 2014, MOL CELL, V54, P180, DOI 10.1016/j.molcel.2014.02.026; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Spivakov M, 2014, BIOESSAYS, V36, P798, DOI 10.1002/bies.201400036; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; Waszak SM, 2014, BIOINFORMATICS, V30, P165, DOI 10.1093/bioinformatics/btt667; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934; Zhou HF, 2015, CELL HOST MICROBE, V17, P205, DOI 10.1016/j.chom.2014.12.013	48	134	138	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1039	1050		10.1016/j.cell.2015.08.001	http://dx.doi.org/10.1016/j.cell.2015.08.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26300124	Bronze			2022-12-28	WOS:000360589900014
J	Krablin, R				Krablin, Richard			A risk worth taking	SCIENCE			English	Editorial Material											Krablin, R (corresponding author), Corp Environm Performance, Environm Hlth & Safety Matters Ind, Bethlehem, PA USA.								0	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					894	894		10.1126/science.349.6250.894	http://dx.doi.org/10.1126/science.349.6250.894			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293967				2022-12-28	WOS:000359832700054
J	Nguyen, CP; Hirsch, MS; Moeny, D; Kaul, S; Mohamoud, M; Joffe, HV				Christine P. Nguyen; Hirsch, Mark S.; Moeny, David; Kaul, Suresh; Mohamoud, Mohamed; Joffe, Hylton V.			Testosterone and "Age-Related Hypogonadism" - FDA Concerns	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Christine P. Nguyen; Hirsch, Mark S.; Moeny, David; Kaul, Suresh; Mohamoud, Mohamed; Joffe, Hylton V.] Food & Drug Adm, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Nguyen, CP (corresponding author), Food & Drug Adm, Silver Spring, MD 20993 USA.		Mohamoud, Mohamed/AAE-6438-2022	Mohamoud, Mohamed/0000-0002-5997-4876	Intramural FDA HHS [FD999999] Funding Source: Medline	Intramural FDA HHS		Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Institute of Medicine, 2004, TEST AG CLIN RES DIR; Layton JB, 2014, J CLIN ENDOCR METAB, V99, P835, DOI 10.1210/jc.2013-3570; Wang C, 2009, J ANDROL, V30, P1, DOI 10.2164/jandrol.108.006486	4	106	112	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					689	691		10.1056/NEJMp1506632	http://dx.doi.org/10.1056/NEJMp1506632			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287846	Green Accepted			2022-12-28	WOS:000359709400003
J	Hennessey, JV; Klein, I; Woeber, KA; Cobin, R; Garber, JR				Hennessey, James V.; Klein, Irwin; Woeber, Kenneth A.; Cobin, Rhoda; Garber, Jeffrey R.			Aggressive Case Finding: A Clinical Strategy for the Documentation of Thyroid Dysfunction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SUBCLINICAL HYPOTHYROIDISM; PRACTICE GUIDELINES; SYMPTOMS		Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Harvard Vanguard Med Associates, Boston, MA USA; NYU, Sch Med, New York, NY USA; Icahn Sch Med Mt Sinai, New York, NY 10029 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; Amer Assoc Clin Endocrinologists Thyroid Sci Task, Jacksonville, FL USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard Vanguard Medical Associates; New York University; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco	Hennessey, JV (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Gryzmish 619, Boston, MA 02215 USA.	jhenness@bidmc.harvard.edu						Bahn RS, 2011, ENDOCR PRACT, V17, P456, DOI 10.4158/EP.17.3.456; Brenta G, 2013, ARQ BRAS ENDOCRINOL, V57, P265, DOI 10.1590/S0004-27302013000400003; Canaris GJ, 1997, J GEN INTERN MED, V12, P544, DOI 10.1046/j.1525-1497.1997.07109.x; Carle A, 2014, EUR J ENDOCRINOL, V171, P593, DOI 10.1530/EJE-14-0481; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; LeFevre ML, 2015, ANN INTERN MED, V162, P641, DOI 10.7326/M15-0483; Razvi S, 2008, J CLIN ENDOCR METAB, V93, P2998, DOI 10.1210/jc.2008-0167; Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159; Rugge JB, 2015, ANN INTERN MED, V162, P35, DOI 10.7326/M14-1456	10	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					311	+		10.7326/M15-0762	http://dx.doi.org/10.7326/M15-0762			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LC	26280417				2022-12-28	WOS:000360286400011
J	Patel, JJ				Patel, Jayshil J.			Writing the Wrong	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BEDSIDE; PATIENT		Med Coll Wisconsin, Dept Med, Div Pulm & Crit Care Med, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Patel, JJ (corresponding author), Med Coll Wisconsin, Dept Med, Div Pulm & Crit Care Med, Milwaukee, WI 53226 USA.	jpatel2@mcw.edu						Chi J, 2014, JAMA-J AM MED ASSOC, V312, P2331, DOI 10.1001/jama.2014.12820; Elder A, 2013, JAMA-J AM MED ASSOC, V310, P799, DOI 10.1001/jama.2013.227195; Fletcher KE, 2012, J GEN INTERN MED, V27, P1432, DOI 10.1007/s11606-012-2120-7; Hirschtick RE, 2006, JAMA-J AM MED ASSOC, V295, P2335, DOI 10.1001/jama.295.20.2335; LaCombe MA, 1997, ANN INTERN MED, V126, P217, DOI 10.7326/0003-4819-126-3-199702010-00007; McGee S, 2014, JAMA-J AM MED ASSOC, V311, P1971, DOI 10.1001/jama.2013.286201; Toll E, 2012, JAMA-J AM MED ASSOC, V307, P2497, DOI 10.1001/jama.2012.4946; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	8	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					671	672		10.1001/jama.2015.5281	http://dx.doi.org/10.1001/jama.2015.5281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284716				2022-12-28	WOS:000360019100013
J	Arias-Palomo, E; Berger, JM				Arias-Palomo, Ernesto; Berger, James M.			An Atypical AAA plus ATPase Assembly Controls Efficient Transposition through DNA Remodeling and Transposase Recruitment	CELL			English	Article							STRAND-TRANSFER-REACTION; YERSINIA-PESTIS; STRUCTURAL ORGANIZATION; RETROVIRAL INTEGRATION; NUCLEOTIDE-SEQUENCE; MU-TRANSPOSITION; BACTERIOPHAGE MU; SYNAPTIC COMPLEX; PROTEIN; INSERTION	Transposons are ubiquitous genetic elements that drive genome rearrangements, evolution, and the spread of infectious disease and drug-resistance. Many transposons, such as Mu, Tn7, and IS21, require regulatory AAA+ ATPases for function. We use X-ray crystallography and cryo-electron microscopy to show that the ATPase subunit of IS21, IstB, assembles into a clamshell-shaped decamer that sandwiches DNA between two helical pentamers of ATP-associated AAA+ domains, sharply bending the duplex into a 180 degrees U-turn. Biochemical studies corroborate key features of the structure and further show that the IS21 transposase, IstA, recognizes the IstB.DNA complex and promotes its disassembly by stimulating ATP hydrolysis. Collectively, these studies reveal a distinct manner of higher-order assembly and client engagement by a AAA+ ATPase and suggest a mechanistic model where IstB binding and subsequent DNA bending primes a selected insertion site for efficient transposition.	[Arias-Palomo, Ernesto; Berger, James M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Berger, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	jmberger@jhmi.edu	Arias Palomo, Ernesto/L-1853-2017; Bustelo, Xose R./A-9526-2010; Garcia, Pedro/L-2808-2017	Bustelo, Xose R./0000-0001-9398-6072; Arias-Palomo, Ernesto/0000-0002-2706-7411; Garcia, Pedro/0000-0001-6717-8717	"Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i" from the Spanish Ministry of Education; Mathers Foundation [GM071747, 9005-6422]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM071747, R01GM071747] Funding Source: NIH RePORTER	"Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i" from the Spanish Ministry of Education; Mathers Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to: Eva Nogales and her research group, and the beamline 8.3.1 staff at the Advanced Light Source, for help with structural data collection and analysis; Fang Wu from the Macrolab (UC, Berkeley) for her assistance with the site-directed mutagenesis; Nancy Craig for critically reading the manuscript; and the Berger laboratory for helpful discussions. This work has been supported by a post-doctoral fellowship from the "Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i 2008-2011'' from the Spanish Ministry of Education (to E.A.P.), and the NIGMS and Mathers Foundation (GM071747 and 9005-6422 to J.M.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ade C, 2013, CURR OPIN VIROL, V3, P639, DOI 10.1016/j.coviro.2013.09.002; Allue-Guardia A, 2013, J VIROL, V87, P13665, DOI 10.1128/JVI.02860-13; ARAKAWA Y, 1995, ANTIMICROB AGENTS CH, V39, P1612, DOI 10.1128/AAC.39.7.1612; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; BAKER TA, 1991, CELL, V65, P1003, DOI 10.1016/0092-8674(91)90552-A; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Buchrieser C, 1998, MOL MICROBIOL, V30, P965, DOI 10.1046/j.1365-2958.1998.01124.x; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Craig NL., 2002, MOBILE DNA-UK; CRAIGIE R, 1986, CELL, V45, P793, DOI 10.1016/0092-8674(86)90554-4; CRAIGIE R, 1985, P NATL ACAD SCI USA, V82, P7570, DOI 10.1073/pnas.82.22.7570; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Dyda F, 2012, Q REV BIOPHYS, V45, P493, DOI 10.1017/S0033583512000145; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Filippov AA, 1995, CONTRIB TO MICROBIOL, V13, P306; GAMAS P, 1992, NUCLEIC ACIDS RES, V20, P2525, DOI 10.1093/nar/20.10.2525; Greene EC, 2002, MOL CELL, V9, P1079, DOI 10.1016/S1097-2765(02)00514-2; Greene EC, 2002, EMBO J, V21, P1477, DOI 10.1093/emboj/21.6.1477; HALLET B, 1994, MOL MICROBIOL, V14, P131, DOI 10.1111/j.1365-2958.1994.tb01273.x; Harshey RM, 2006, CRIT REV BIOCHEM MOL, V41, P387, DOI 10.1080/10409230600946015; Hickman AB, 2014, CELL, V158, P353, DOI 10.1016/j.cell.2014.05.037; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; KAUFMAN PD, 1992, CELL, V69, P27, DOI 10.1016/0092-8674(92)90116-T; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1997, DOI 10.1093/nar/20.8.1997; Kuduvalli PN, 2001, EMBO J, V20, P924, DOI 10.1093/emboj/20.4.924; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MAXWELL A, 1987, P NATL ACAD SCI USA, V84, P699, DOI 10.1073/pnas.84.3.699; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MILLER JL, 1984, NUCLEIC ACIDS RES, V12, P8627, DOI 10.1093/nar/12.22.8627; Mizuno N, 2013, P NATL ACAD SCI USA, V110, pE2441, DOI 10.1073/pnas.1309499110; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PODLADCHIKOVA ON, 1994, FEMS MICROBIOL LETT, V121, P269, DOI 10.1111/j.1574-6968.1994.tb07111.x; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; REIMMANN C, 1989, MOL GEN GENET, V215, P416, DOI 10.1007/BF00427038; REIMMANN C, 1990, EMBO J, V9, P4055, DOI 10.1002/j.1460-2075.1990.tb07627.x; SAKAI J, 1995, EMBO J, V14, P4374, DOI 10.1002/j.1460-2075.1995.tb00112.x; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schmid S, 1998, J MOL BIOL, V282, P571, DOI 10.1006/jmbi.1998.2041; Schmid S, 1999, J BACTERIOL, V181, P2286, DOI 10.1128/JB.181.7.2286-2289.1999; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Stellwagen AE, 1997, GENETICS, V145, P573; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; SURETTE MG, 1989, J BIOL CHEM, V264, P3028; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang M, 2005, GENE DEV, V19, P1422, DOI 10.1101/gad.1317605; Tubio J. M. C., 2014, SCIENCE, V345; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; XU K, 1993, PLASMID, V29, P1, DOI 10.1006/plas.1993.1001	79	22	22	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					860	871		10.1016/j.cell.2015.07.037	http://dx.doi.org/10.1016/j.cell.2015.07.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276634	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000359741400018
J	Bian, WJ; Miao, WY; He, SJ; Qiu, Z; Yu, X				Bian, Wen-Jie; Miao, Wan-Ying; He, Shun-Ji; Qiu, Zilong; Yu, Xiang			Coordinated Spine Pruning and Maturation Mediated by Inter-Spine Competition for Cadherin/Catenin Complexes	CELL			English	Article							DENDRITIC SPINES; N-CADHERIN; SYNAPTIC PLASTICITY; DIVERSE REGIONS; BETA-CATENIN; SYNAPSES; STABILITY; CA1; SYNAPTOGENESIS; MORPHOGENESIS	Dendritic spines are postsynaptic compartments of excitatory synapses that undergo dynamic changes during development, including rapid spinogenesis in early postnatal life and significant pruning during adolescence. Spine pruning defects have been implicated in developmental neurological disorders such as autism, yet much remains to be uncovered regarding its molecular mechanism. Here, we show that spine pruning and maturation in the mouse somatosensory cortex are coordinated via the cadherin/catenin cell adhesion complex and bidrectionally regulated by sensory experience. We further demonstrate that locally enhancing cadherin/catenin-dependent adhesion or photo-stimulating a contacting channelrhodopsin-expressing axon stabilized the manipulated spine and eliminated its neighbors, an effect requiring cadherin/catenin-dependent adhesion. Importantly, we show that differential cadherin/catenin-dependent adhesion between neighboring spines biased spine fate in vivo. These results suggest that activity-induced inter-spine competition for beta-catenin provides specificity for concurrent spine maturation and elimination and thus is critical for the molecular control of spine pruning during neural circuit refinement.	[Bian, Wen-Jie; Miao, Wan-Ying; He, Shun-Ji; Qiu, Zilong; Yu, Xiang] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Brain Sci, Inst Neurosci,State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Bian, Wen-Jie] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Brain Sci, Inst Neurosci,State Key Lab Neurosci, Shanghai 200031, Peoples R China.	yuxiang@ion.ac.cn	Bian, Wenjie/ABC-2696-2021	Bian, Wenjie/0000-0002-0426-1297; Miao, Wanying/0000-0003-3972-2572; Yu, Xiang/0000-0003-1225-7666; HE, SHUNJI/0000-0002-0630-3534	Ministry of Science and Technology [2011CBA00400]; National Natural Science Foundation of China [31125015, 31321091]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Drs. Klaus Nave, Makato M. Taketo, and the European Mutant Mouse Archive for transgenic mice, and Drs. Hailan Hu, Wei Lu, Thomas Sudhof, Chin-Yin Tai, Roger Tsien, and Yi-Zheng Wang for constructs. We thank He-Ling Song, Yuan Lu, Yue Sun, Zong-Fang Wan, Xue-Zhi Zeng, and Sha-Jin Huang for technical assistance and Dr. Yunqing Wen for help with the custom-made LED system. We thank the ION Optical Imaging Core Facility and Transgenic Core Facility for excellent technical support. We are grateful to colleagues at ION and members of the X.Y. laboratory for suggestions and comments. This work was supported by grants from the Ministry of Science and Technology (2011CBA00400) and the National Natural Science Foundation of China (31125015 and 31321091).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Benson DL, 2012, CURR OPIN NEUROBIOL, V22, P397, DOI 10.1016/j.conb.2011.09.011; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Elston GN, 2009, J NEUROSCI, V29, P3271, DOI 10.1523/JNEUROSCI.5216-08.2009; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; English CN, 2012, P NATL ACAD SCI USA, V109, P19456, DOI 10.1073/pnas.1206492109; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Harris KM, 2012, COLD SPRING HARB PER, V4, P5, DOI DOI 10.1101/CSHPERSPECT.A005587; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Higley MJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005686; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Huttenlocher P.R., 2002, NEURAL PLASTICITY EF; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Lee KJ, 2013, J NEUROSCI, V33, P9794, DOI 10.1523/JNEUROSCI.0848-12.2013; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI 10.1109/SPL.2011.5782616; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; RAKIC P, 1994, PROG BRAIN RES, V102, P227; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Suarez MA, 2012, PEDIATR CLIN N AM, V59, P203, DOI 10.1016/j.pcl.2011.10.012; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Yuste R, 2013, ANNU REV NEUROSCI, V36, P429, DOI 10.1146/annurev-neuro-062111-150455; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zheng JJ, 2014, NAT NEUROSCI, V17, P391, DOI 10.1038/nn.3634; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	72	102	111	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					808	822		10.1016/j.cell.2015.07.018	http://dx.doi.org/10.1016/j.cell.2015.07.018			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26255771	Bronze			2022-12-28	WOS:000359741400014
J	Raman, KV; Moodera, JS				Raman, Karthik V.; Moodera, Jagadeesh S.			MATERIALS CHEMISTRY A magnetic facelift for non-magnetic metals	NATURE			English	Editorial Material							SPINTRONICS	Copper and manganese have been engineered to show magnetism at room temperature in thin films interfaced with organic molecules. The findings show promise for developing new magnetic materials. SEE LETTER P. 69	[Raman, Karthik V.] Tata Inst Fundamental Res, TIFR Ctr Interdisciplinary Sci, Hyderabad 500075, Telangana, India; [Moodera, Jagadeesh S.] MIT, Francis Bitter Magnet Lab, Dept Phys, Cambridge, MA 02139 USA; [Moodera, Jagadeesh S.] MIT, Plasma Sci & Fus Ctr, Cambridge, MA 02139 USA	Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Raman, KV (corresponding author), Tata Inst Fundamental Res, TIFR Ctr Interdisciplinary Sci, Hyderabad 500075, Telangana, India.	kvraman@tifrh.res.in						Al Ma'Mari F, 2015, NATURE, V524, P69, DOI 10.1038/nature14621; Atodiresei N, 2014, MRS BULL, V39, P596, DOI 10.1557/mrs.2014.130; Bairagi K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.247203; Brede J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047204; Drew AJ, 2009, NAT MATER, V8, P109, DOI 10.1038/NMAT2333; Ibach H., 2009, SOLID STATE PHYS, V5th; Levitin R. Z., 1988, Soviet Physics - Uspekhi, V31, P730, DOI 10.1070/PU1988v031n08ABEH004922; Moodera JS, 2014, MRS BULL, V39, P578, DOI 10.1557/mrs.2014.128; Raman KV, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4890496; Raman KV, 2013, NATURE, V493, P509, DOI 10.1038/nature11719; Stoner EC, 1938, PROC R SOC LON SER-A, V165, P0372, DOI 10.1098/rspa.1938.0066	11	9	9	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					42	43		10.1038/524042a	http://dx.doi.org/10.1038/524042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26245578				2022-12-28	WOS:000359002300025
J	Gornall, J				Gornall, Jonathan			HUMANITARIAN AID Healthcare for Syrian refugees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						Mathers I., 2015, NEW WAYS TREAT DIS K; MSF, 2015, SILENT CRIS TREAT NO; UNHCR, 2015, 3RP REG REF RES PLAN; UNHCR, 2014, SYR REF LEB SURP 1 M; UNHCR, 2015, FUND SHORT LEAV SYR; UNHCR, 2015, MOR TRAG WID SYR TRI; UNHCR, 2014, SYR REF LEB SEC TERT	7	13	13	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2015	351								h4150	10.1136/bmj.h4150	http://dx.doi.org/10.1136/bmj.h4150			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AQ	26243793				2022-12-28	WOS:000359387300004
J	Hasegawa, A; Tanigawa, K; Ohtsuru, A; Yabe, H; Maeda, M; Shigemura, J; Ohira, T; Tominaga, T; Akashi, M; Hirohashi, N; Ishikawa, T; Kamiya, K; Shibuya, K; Yamashita, S; Chhem, RK				Hasegawa, Arifumi; Tanigawa, Koichi; Ohtsuru, Akira; Yabe, Hirooki; Maeda, Masaharu; Shigemura, Jun; Ohira, Tetsuya; Tominaga, Takako; Akashi, Makoto; Hirohashi, Nobuyuki; Ishikawa, Tetsuo; Kamiya, Kenji; Shibuya, Kenji; Yamashita, Shunichi; Chhem, Rethy K.			Health effects of radiation and other health problems in the aftermath of nuclear accidents, with an emphasis on Fukushima	LANCET			English	Article							POWER-PLANT ACCIDENT; ACADEMIC-MEDICAL-CENTER; WHOLE-BODY-COUNTER; MENTAL-HEALTH; NPP ACCIDENT; DISASTER; JAPAN; EXPOSURE; RESIDENTS; WORKERS	437 nuclear power plants are in operation at present around the world to meet increasing energy demands. Unfortunately, five major nuclear accidents have occurred in the past-ie, at Kyshtym (Russia [ then USSR], 1957), Windscale Piles (UK, 1957), Three Mile Island (USA, 1979), Chernobyl (Ukraine [ then USSR], 1986), and Fukushima (Japan, 2011). The effects of these accidents on individuals and societies are diverse and enduring. Accumulated evidence about radiation health effects on atomic bomb survivors and other radiation-exposed people has formed the basis for national and international regulations about radiation protection. However, past experiences suggest that common issues were not necessarily physical health problems directly attributable to radiation exposure, but rather psychological and social effects. Additionally, evacuation and long-term displacement created severe health-care problems for the most vulnerable people, such as hospital inpatients and elderly people.	[Hasegawa, Arifumi] Fukushima Med Univ, Dept Radiat Disaster Med, Fukushima 9601295, Japan; [Tanigawa, Koichi] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Fukushima 9601295, Japan; [Ohtsuru, Akira] Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima 9601295, Japan; [Yabe, Hirooki] Fukushima Med Univ, Dept Neuropsychiat, Fukushima 9601295, Japan; [Maeda, Masaharu] Fukushima Med Univ, Dept Disaster Psychiat, Fukushima 9601295, Japan; [Ohira, Tetsuya] Fukushima Med Univ, Dept Epidemiol, Fukushima 9601295, Japan; [Ishikawa, Tetsuo] Fukushima Med Univ, Dept Radiat Phys & Chem, Fukushima 9601295, Japan; [Shigemura, Jun] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan; [Tominaga, Takako] Natl Inst Radiol Sci, Dept Radiat Emergency Med Assistance Team Med Sec, Chiba 260, Japan; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Hirohashi, Nobuyuki] Hiroshima Univ, Dept Emergency & Crit Care Med, Hiroshima, Japan; [Kamiya, Kenji] Hiroshima Univ, Dept Expt Oncol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Yamashita, Shunichi] Nagasaki Univ, Dept Radiat Med Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Chhem, Rethy K.] Cambodia Dev Resource Inst, Phnom Penh, Cambodia	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; National Defense Medical College - Japan; National Institutes for Quantum Science & Technology; University of Tokyo; Hiroshima University; Hiroshima University; Nagasaki University	Tanigawa, K (corresponding author), Fukushima Med Univ, Fukushima Global Med Sci Ctr, 1 Hikariga Oka, Fukushima 9601295, Japan.	tanigawa@fmu.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Shibuya, Kenji/0000-0003-2528-7530; Yamashita, Shunichi/0000-0001-6399-6261	Fukushima Medical University; Hiroshima University; Nagasaki University	Fukushima Medical University; Hiroshima University; Nagasaki University	We thank Kenneth Nollet (Fukushima Medical University) for English proofreading. This work was supported by Fukushima Medical University, Hiroshima University, and Nagasaki University. The views expressed in this report are solely those of the authors.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Akashi M, 2010, HEALTH PHYS, V98, P804, DOI 10.1097/HP.0b013e3181ac924a; Bernard AM, 1996, ACAD MED, V71, P262, DOI 10.1097/00001888-199603000-00019; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Bromet EJ, 2012, J RADIOL PROT, V32, pN71, DOI 10.1088/0952-4746/32/1/N71; Bromet EJ, 2011, SOC PSYCH PSYCH EPID, V46, P393, DOI 10.1007/s00127-010-0203-5; Brumfiel G, 2013, NATURE, V493, P290, DOI 10.1038/493290a; Butler D, 2011, NATURE, V472, P13, DOI 10.1038/472400a; Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875; CUTTER S, 1982, DISASTERS, V6, P116, DOI 10.1111/j.1467-7717.1982.tb00765.x; Cuttler JM, 2012, DOSE-RESPONSE, V10, P473, DOI 10.2203/dose-response.12-013.Cuttler; Etherington G, 2014, INT J RADIAT BIOL, V90, P1088, DOI 10.3109/09553002.2014.942920; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Fukushima Health Survey Examination Committee, 2014, BAS SURV RAD DOS EST, V24; Fukushima Prefectural Government, RES GLASS BADG MEAS; Glionna John M., 2014, LOS ANGELES TIMES; Gonzalez AJ, 2007, HEALTH PHYS, V93, P571, DOI 10.1097/01.HP.0000282037.88438.3d; Gordon HS, 1996, MED CARE, V34, P295, DOI 10.1097/00005650-199604000-00002; Guey LT, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-27; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Harasawa K, 2012, LANCET, V379, P2240, DOI 10.1016/S0140-6736(12)60978-7; Havenaar JM, 1997, AM J PSYCHIAT, V154, P1605, DOI 10.1176/ajp.154.11.1605; Havenaar JM, 2002, TOXIC TURMOIL PSYCHO; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P196, DOI 10.2183/pjab.89.196; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Ichiseki H, 2013, LANCET, V381, P204, DOI 10.1016/S0140-6736(13)60091-4; *INT COMM RAD PROT, 1991, REC INT COMM RAD PRO; International Atomic Energy Agency, OP LONG TERM SHUTD R; International Atomic Energy Agency, INT NUCL RAD EV SCAL; International Atomic Energy Agency, 2013, 60 YEARS AT PEAC; International Atomic Energy Agency, 2010, EN EL NUCL POW EST P; International Commission on Radiological Protection, 2009, APPL COMM REC PROT P; Katata G, 2012, J ENVIRON RADIOACTIV, V111, P2, DOI 10.1016/j.jenvrad.2011.09.011; Kawakami N, NATL SURVEY MENTAL H; Koizumi Akio, 2012, Environmental Health and Preventive Medicine, V17, P292, DOI 10.1007/s12199-011-0251-9; Maeda M, 2013, RAD DISASTER MED, P79; Maekawa K, 2011, J CLIN EXP MED, V239, P1056; Matsuda N, 2013, RADIAT RES, V179, P663, DOI 10.1667/RR3232.1; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; MAXWELL C, 1982, AM J PUBLIC HEALTH, V72, P275, DOI 10.2105/AJPH.72.3.275; McCurry J, 2013, LANCET, V381, P791, DOI 10.1016/S0140-6736(13)60611-X; Ministry of Health, EXP DOS DISTR WORK F; Ministry of Health, 2012, EST INT EXP MEAS RAD; Morita N, 2013, RADIAT RES, V180, P299, DOI 10.1667/RR3372.1; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; Nagataki S, 2008, THYROID, V18, P667, DOI 10.1089/thy.2007.0379; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Naoi Yutaka, 2013, Am J Disaster Med, V8, P87, DOI 10.5055/ajdm.2013.0114; National Diet of Japan, 2012, OFF REP FUK NUCL ACC; National Police Agency, 2011, DAM SIT POL MEAS REL; Nikepelov BV, 1957, INFCIRC368 IAEA; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Ohira Tetsuya, 2014, Fukushima J Med Sci, V60, P211, DOI 10.5387/fms.2014-25; Radiation Emergency Assistance Center, 1944, MAJOR RAD ACC WORLDW; Radiation Medical Science Center for Fukushima Health Management Survey, 2013, P 12 PREF OV COMM M; Radiation Medical Science Center for Fukushima Health Management Survey, 2013, P 11 PREF OV COMM M; Rahu K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004516; Reconstruction Agency, 2014, EARTHQ REL DEATH GRE; Sato O, 2013, J RADIOL PROT, V33, P823, DOI 10.1088/0952-4746/33/4/823; Satoh H., 2015, J DIABETES RES, V2015, DOI DOI 10.1155/2015/627390; Save the Children, 2012, FUK FAM CHILDR FAM A; Sawada A, 2004, PSYCHIATRY, V67, P43, DOI 10.1521/psyc.67.1.43.31249; Shibuya K, 2014, LANCET, V383, P1883, DOI 10.1016/S0140-6736(14)60909-0; Shigemura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087516; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shigemura J, 2012, AM J PSYCHIAT, V169, P784, DOI 10.1176/appi.ajp.2012.12030387; SMITH JS, 1981, JAMA-J AM MED ASSOC, V245, P1656; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Sugimoto A, 2012, B WORLD HEALTH ORGAN, V90, P629, DOI 10.2471/BLT.11.094474; Sugimoto A, 2014, ENVIRON HEALTH PERSP, V122, P587, DOI 10.1289/ehp.1306848; Sugimoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106377; Tanaka S I, 2001, J Radiat Res, V42 Suppl, pS1; Tanigawa K, 2013, RAD DISASTER MED PER, P30; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Tominaga T, 2014, HEALTH PHYS, V106, P630, DOI 10.1097/HP.0000000000000093; Tsubokura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100302; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; UN Scientific Committee on the Effects of Atomic Radiation, 2013, UNSCEAR 1993 REP GEN; United Nations. Scientific Committee on the Effects of Atomic Radiation, 2010, SOURC EFF ION RAD UN SOURC EFF ION RAD UN; United Nations Scientific Committee on the Effects of Atomic Radiation, 2013, UNSCEAR 2013 REP; United States President's Commission on the Accident at Three Mile Island, 1979, REP PRES COMM ACC 3; Valentin J, 2007, 2007 RECOMMENDATIONS; Wakeford R, 2007, J RADIOL PROT, V27, P211, DOI 10.1088/0952-4746/27/3/E02; Walsh L, 2014, RADIAT RES, V182, P556, DOI 10.1667/RR13779.1; WHO, 2014, HLTH RISK ASS NUCL A; Wilson R, 2012, DOSE-RESPONSE, V10, P480, DOI 10.2203/dose-response.11-058.Wilson; Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1; Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019; Yasumura Seiji, 2014, Fukushima J Med Sci, V60, P192, DOI 10.5387/fms.2014-13; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105	92	145	152	0	115	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					479	488		10.1016/S0140-6736(15)61106-0	http://dx.doi.org/10.1016/S0140-6736(15)61106-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251393	Green Published			2022-12-28	WOS:000358761700028
J	Kamiya, K; Ozasa, K; Akiba, S; Niwa, O; Kodama, K; Takamura, N; Zaharieva, EK; Kimura, Y; Wakeford, R				Kamiya, Kenji; Ozasa, Kotaro; Akiba, Suminori; Niwa, Ohstura; Kodama, Kazunori; Takamura, Noboru; Zaharieva, Elena K.; Kimura, Yuko; Wakeford, Richard			Long-term effects of radiation exposure on health	LANCET			English	Article							ATOMIC-BOMB SURVIVORS; SOLID CANCER INCIDENCE; IONIZING-RADIATION; IN-UTERO; THYROID-CANCER; CHILDHOOD LEUKEMIA; CT SCANS; RISK; MORTALITY; CHERNOBYL	Late-onset effects of exposure to ionising radiation on the human body have been identified by long-term, large-scale epidemiological studies. The cohort study of Japanese survivors of the atomic bombings of Hiroshima and Nagasaki (the Life Span Study) is thought to be the most reliable source of information about these health effects because of the size of the cohort, the exposure of a general population of both sexes and all ages, and the wide range of individually assessed doses. For this reason, the Life Span Study has become fundamental to risk assessment in the radiation protection system of the International Commission on Radiological Protection and other authorities. Radiation exposure increases the risk of cancer throughout life, so continued follow-up of survivors is essential. Overall, survivors have a clear radiation-related excess risk of cancer, and people exposed as children have a higher risk of radiation-induced cancer than those exposed at older ages. At high doses, and possibly at low doses, radiation might increase the risk of cardiovascular disease and some other non-cancer diseases. Hereditary effects in the children of atomic bomb survivors have not been detected. The dose-response relation for cancer at low doses is assumed, for purposes of radiological protection, to be linear without a threshold, but has not been shown definitively. This outstanding issue is not only a problem when dealing appropriately with potential health effects of nuclear accidents, such as at Fukushima and Chernobyl, but is of growing concern in occupational and medical exposure. Therefore, the appropriate dose-response relation for effects of low doses of radiation needs to be established.	[Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Hiroshima 7348553, Japan; [Zaharieva, Elena K.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Genet & Cell Biol, Hiroshima 7348553, Japan; [Ozasa, Kotaro] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Japan; [Kodama, Kazunori] Radiat Effects Res Fdn, Hiroshima, Japan; [Akiba, Suminori] Kagoshima Univ, Grad Sch Med & Dent Sci, Epidemiol & Prevent Med, Kagoshima 890, Japan; [Niwa, Ohstura] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Fukushima, Japan; [Takamura, Noboru; Kimura, Yuko] Nagasaki Univ, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Wakeford, Richard] Univ Manchester, Inst Populat Hlth, Ctr Occupat & Environm Hlth, Manchester, Lancs, England	Hiroshima University; Hiroshima University; Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan; Kagoshima University; Fukushima Medical University; Nagasaki University; University of Manchester	Kamiya, K (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	kkamiya@hiroshima-u.ac.jp	Wakeford, Richard/I-1978-2019; OZASA, Kotaro/ABF-3001-2020	Wakeford, Richard/0000-0002-2934-0987; OZASA, Kotaro/0000-0002-5637-1383; Takamura, Noboru/0000-0002-5552-3234; Akiba, Suminori/0000-0001-9004-3167	Japanese Ministry of Health, Labour and Welfare; US Department of Energy; RERF [1-75, 2-75, 2-61, 4-75, 4-10]; Grants-in-Aid for Scientific Research [15K12207, 15K00540] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); US Department of Energy(United States Department of Energy (DOE)); RERF(Radiation Effects Research Foundation - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, are a public interest foundation funded by the Japanese Ministry of Health, Labour and Welfare and the US Department of Energy. This publication was supported by RERF Research Protocols 1-75, 2-75, 2-61, 4-75, and 4-10. The views of the authors do not necessarily reflect those of the two governments. We thank Fumie Okubo for her valuable assistance with technical and administrative matters.	Adams MJ, 2012, RADIAT RES, V177, P220, DOI 10.1667/RR2746.1; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Atomic Bomb Survivors Support Division Hiroshima Prefectural Government, 2014, AT BOMB SURV SUPP DI, P1; Atomic Bomb Survivors Support Division Nagasaki Prefectural Government, 2014, AT BOMB SURV SUPP DI, P8; BITHELL JF, 1975, BRIT J CANCER, V31, P271, DOI 10.1038/bjc.1975.62; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510; Codman E., 1902, PHILADELPHIA M J, V9, P438; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; Daniel J, 1896, Science, V3, P562, DOI 10.1126/science.3.67.562; Delongchamp RR, 1997, RADIAT RES, V147, P385, DOI 10.2307/3579348; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Drozdovitch V, 2013, RADIAT RES, V179, P597, DOI 10.1667/RR3153.1; Egawa H, 2012, RADIAT RES, V178, P191, DOI 10.1667/RR2819.1; FOLLEY JH, 1952, AM J MED, V13, P311, DOI 10.1016/0002-9343(52)90285-4; Francis T, 1955, 3359 AT BOMB CAS COM; Furukawa K, 2010, RADIAT RES, V174, P72, DOI 10.1667/RR2083.1; Hamatani K, 2008, CANCER RES, V68, P7176, DOI 10.1158/0008-5472.CAN-08-0293; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Hayashi T, 2013, RADIAT RES, V180, P60, DOI 10.1667/RR3183.1; Hayashi T, 2012, FASEB J, V26, P4765, DOI 10.1096/fj.12-215228; Honda S, 2002, PSYCHIAT CLIN NEUROS, V56, P575, DOI 10.1046/j.1440-1819.2002.01057.x; Hsu WL, 2013, RADIAT RES, V179, P361, DOI 10.1667/RR2892.1; ICRP, 2003, ANN ICRP, V33, P126; Ishida M, 1959, 459 AT BOMB CAS COMM; Iwanaga M, 2011, J CLIN ONCOL, V29, P428, DOI 10.1200/JCO.2010.31.3080; Izumi S, 2003, BRIT J CANCER, V89, P1709, DOI 10.1038/sj.bjc.6601322; Izumi S, 2003, INT J CANCER, V107, P292, DOI 10.1002/ijc.11400; Kendall GM, 2013, LEUKEMIA, V27, P3, DOI 10.1038/leu.2012.151; Kesminiene A, 2012, RADIAT RES, V178, P425, DOI 10.1667/RR2975.1; Kodaira M, 2010, RADIAT RES, V173, P205, DOI 10.1667/RR1991.1; Kusunoki Y, 2008, INT J RADIAT BIOL, V84, P1, DOI 10.1080/09553000701616106; Kusunoki Y, 2010, RADIAT RES, V174, P870, DOI 10.1667/RR1847.1; Leeman-Neill RJ, 2014, CANCER-AM CANCER SOC, V120, P799, DOI 10.1002/cncr.28484; Leeman-Neill RJ, 2013, CANCER-AM CANCER SOC, V119, P1792, DOI 10.1002/cncr.27893; Li CI, 2010, CANCER RES, V70, P7187, DOI 10.1158/0008-5472.CAN-10-0276; Little MP, 2002, INT J RADIAT BIOL, V78, P1001, DOI 10.1080/0955300021000013803; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Ministry of Health, AT BOMB SURV COMPR M; Muller HJ, 1928, GENETICS, V13, P279; Nakano M, 2007, RADIAT RES, V167, P693, DOI 10.1667/RR0718.1; NAKASHIMA E, 1994, RADIAT RES, V138, P121, DOI 10.2307/3578855; NEEL JV, 1988, AM J HUM GENET, V42, P663; NEEL JV, 1990, AM J HUM GENET, V46, P1053; Ohtaki K, 2004, RADIAT RES, V161, P373, DOI 10.1667/3147; Ohtsuru A, 2015, LANCET, V386, P489, DOI 10.1016/S0140-6736(15)60994-1; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; Otake M, 1998, INT J RADIAT BIOL, V74, P159, DOI 10.1080/095530098141555; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pernot E, 2012, MUTAT RES-REV MUTAT, V751, P258, DOI 10.1016/j.mrrev.2012.05.003; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Preston RJ, 2015, HEALTH PHYS, V108, P125, DOI 10.1097/HP.0000000000000224; Pukkala E, 2006, INT J CANCER, V119, P651, DOI 10.1002/ijc.21885; RERF, 2008, BRIEF DESCR; Richardson D, 2009, RADIAT RES, V172, P368, DOI 10.1667/RR1801.1; SCHULL WJ, 1966, AM J HUM GENET, V18, P328; Sera N, 2013, RADIAT RES, V179, P46, DOI 10.1667/RR2863.1; Shibata Y, 2001, LANCET, V358, P1965, DOI 10.1016/S0140-6736(01)06971-9; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Stewart AM, 2000, INT J EPIDEMIOL, V29, P708, DOI 10.1093/ije/29.4.708; Takahashi I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000654; Tatsukawa Y, 2013, J RADIOL PROT, V33, P281, DOI 10.1088/0952-4746/33/2/281; The Committee for the Compilation of Materials on the Damage by the Atomic Bombs in Hiroshima and Nagasak, 1979, DAM AT BOMB HIR NAG, P241; Pham TM, 2013, RADIAT RES, V180, P539, DOI 10.1667/RR13421.1; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2008, SCI ANN EP STUD RAD, V1; UNSCEAR, 2008, SCI ANN B EP EV CARD; UNSCEAR, 2008, SCI ANN D HLTH EFF D; UNSCEAR, 2013, SCI ANN A LEV EFF RA; UNSCEAR, 2013, SCI ANN B EFF ION RA; US National Academy of Sciences National Research Council Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, 2006, HLTH RISKS EXP LOW L, P13; Wakeford R, 2003, INT J RADIAT BIOL, V79, P293, DOI 10.1080/0955300031000114729; Wakeford R, 2008, RADIAT PROT DOSIM, V132, P166, DOI 10.1093/rpd/ncn272; Walsh L, 2014, J RADIOL PROT, V34, pE1, DOI 10.1088/0952-4746/34/1/E1; Weinberg R. A., 2013, BIOL CANC; Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; Yamada M, 2002, SOC PSYCH PSYCH EPID, V37, P409, DOI 10.1007/s00127-002-0572-5; Yamada M, 1991, MED BASIS RAD PREPAR, P155; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967; Zablotska LB, 2013, ENVIRON HEALTH PERSP, V121, P59, DOI 10.1289/ehp.1204996	85	181	198	2	128	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					469	478		10.1016/S0140-6736(15)61167-9	http://dx.doi.org/10.1016/S0140-6736(15)61167-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251392				2022-12-28	WOS:000358761700027
J	Fee, E				Fee, Elizabeth			Signing the US Medicare Act: a long political struggle	LANCET			English	Editorial Material									Natl Lib Med, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Fee, E (corresponding author), Natl Lib Med, Bethesda, MD 20894 USA.	feee@mail.nih.gov							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					332	333		10.1016/S0140-6736(15)61400-3	http://dx.doi.org/10.1016/S0140-6736(15)61400-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN5CX	26227457				2022-12-28	WOS:000358448400012
J	MacLachlan, JH; Locarnini, S; Cowie, BC				MacLachlan, Jennifer H.; Locarnini, Stephen; Cowie, Benjamin C.			Estimating the global prevalence of hepatitis B	LANCET			English	Editorial Material							VIRUS INFECTION; UNITED-STATES; EPIDEMIOLOGY		[MacLachlan, Jennifer H.; Locarnini, Stephen; Cowie, Benjamin C.] Doherty Inst Infect & Immun, WHO Collaborating Ctr Viral Hepatitis VIDRL, Melbourne, Vic 3000, Australia	Victorian Infectious Diseases Reference Laboratory	MacLachlan, JH (corresponding author), Doherty Inst Infect & Immun, WHO Collaborating Ctr Viral Hepatitis VIDRL, Melbourne, Vic 3000, Australia.	jennifer.maclachlan@mh.org.au	Jin, Zhi/O-3281-2015; Cowie, Benjamin/HFZ-9941-2022	Cowie, Benjamin/0000-0002-7087-5895; MacLachlan, Jennifer/0000-0002-7654-4536				[Anonymous], 2011, Wkly Epidemiol Rec, V86, P180; El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Hill A, 2015, J VIRUS ERAD, V1, P103; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Locarnini S, 2015, J HEPATOL, V62, pS76, DOI 10.1016/j.jhep.2015.01.018; MacLachlan JH, 2013, AUST NZ J PUBL HEAL, V37, P416, DOI 10.1111/1753-6405.12049; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Schweitzer A, 2015, LANCET; WHO, 2015, WHO GUID PREV CAR TR; World Health Organization, 2012, PREV CONTR VIR HEP I	12	42	45	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1515	1517		10.1016/S0140-6736(15)61116-3	http://dx.doi.org/10.1016/S0140-6736(15)61116-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5VC	26231458				2022-12-28	WOS:000362878200008
J	Galanie, S; Thodey, K; Trenchard, IJ; Interrante, MF; Smolke, CD				Galanie, Stephanie; Thodey, Kate; Trenchard, Isis J.; Interrante, Maria Filsinger; Smolke, Christina D.			SYNTHETIC BIOLOGY Complete biosynthesis of opioids in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; OPIUM POPPY; BENZYLISOQUINOLINE ALKALOIDS; FERMENTATIVE PRODUCTION; MORPHINE BIOSYNTHESIS; MEMBRANE-PROTEINS; PLANT ALKALOIDS; GENE; VECTORS; PATHWAY	Opioids are the primary drugs used in Western medicine for pain management and palliative care. Farming of opium poppies remains the sole source of these essential medicines, despite diverse market demands and uncertainty in crop yields due to weather, climate change, and pests. We engineered yeast to produce the selected opioid compounds thebaine and hydrocodone starting from sugar. All work was conducted in a laboratory that is permitted and secured for work with controlled substances. We combined enzyme discovery, enzyme engineering, and pathway and strain optimization to realize full opiate biosynthesis in yeast. The resulting opioid biosynthesis strains required the expression of 21 (thebaine) and 23 (hydrocodone) enzyme activities from plants, mammals, bacteria, and yeast itself. This is a proof of principle, and major hurdles remain before optimization and scale-up could be achieved. Open discussions of options for governing this technology are also needed in order to responsibly realize alternative supplies for these medically relevant compounds.	[Galanie, Stephanie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Thodey, Kate; Trenchard, Isis J.; Interrante, Maria Filsinger; Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Smolke, CD (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	csmolke@stanford.edu	Galanie, Stephanie/T-1373-2019	Galanie, Stephanie/0000-0001-5712-2568	NIH [SIG 1S10RR02557401, AT007886]; Agilent Technologies; NSF; ARCS Foundation; Stanford University; Stanford Research Experiences for Undergraduates fellowship; National Center for Complementary & Integrative Health [DP1AT007886] Funding Source: NIH RePORTER; Directorate For Engineering [1066100] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agilent Technologies; NSF(National Science Foundation (NSF)); ARCS Foundation; Stanford University(Stanford University); Stanford Research Experiences for Undergraduates fellowship; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Stanford Cell Sciences Imaging Facility for providing fluorescence microscopy access (Leica SP5, NIH grant SIG 1S10RR02557401) and training; Agilent Technologies for an award through their Global Academic Research Support Program; T. Kutchan and P. Facchini for contributing Papaver samples to the 1KP and PMS transcriptome projects, respectively; W. Lau of the Sattely laboratory for training, growing plants, and helpful discussions regarding plant experiments; and Y. Li, Y.-H. Wang, A. P. Klein, D. Endy for valuable feedback in the preparation of the manuscript. Supported by NIH grant AT007886 (C.D.S.), a NSF fellowship (S.G., I.J.T.), an ARCS Foundation fellowship (I.J.T.), a Stanford University fellowship (S.G.), and a Stanford Research Experiences for Undergraduates fellowship (M.F.I.). Strains making controlled substances (e.g., thebaine, hydrocodone) can only be provided to laboratories/institutions that have the appropriate approvals and licenses (e.g., DEA permits). Stanford University has a pending patent application on this work on which S.G., K.T., I.J.T., and C.D.S. are inventors. C.D.S., K.T., and I.J.T. are co-founders of Antheia Inc.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; BATTERSBY AR, 1965, J CHEM SOC, P3323, DOI 10.1039/jr9650003323; Beaudoin GAW, 2014, PLANTA, V240, P19, DOI 10.1007/s00425-014-2056-8; Bradsher K., 2014, NY TIMES; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Daubner SC, 2006, J MOL BIOL, V359, P299, DOI 10.1016/j.jmb.2006.03.016; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DEEKNAMKUL W, 1992, PHYTOCHEMISTRY, V31, P813, DOI 10.1016/0031-9422(92)80020-F; DeLoache WC, 2015, NAT CHEM BIOL, V11, P465, DOI 10.1038/nchembio.1816; Facchini PJ, 2012, TRENDS BIOTECHNOL, V30, P127, DOI 10.1016/j.tibtech.2011.10.001; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Flagfeldt DB, 2009, YEAST, V26, P545, DOI 10.1002/yea.1705; Fossati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124459; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; FUKUDA K, 1992, J FERMENT BIOENG, V74, P117, DOI 10.1016/0922-338X(92)80012-8; Garfinkel MS, 2007, BIOSECUR BIOTERROR, V5, P359, DOI 10.1089/bsp.2007.0923; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Gomes T, 2014, ADDICTION, V109, P1482, DOI 10.1111/add.12598; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hawkins K., 2008, THESIS CALTECH; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Hegemann Johannes H, 2006, Methods Mol Biol, V313, P129; Higashi Y, 2011, J BIOL CHEM, V286, P6532, DOI 10.1074/jbc.M110.168633; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; IMS Institute for Healthcare Informatics, 2015, MED US SPEND SHIFTS; International Narcotics Control Board, 2014, NARC DRUGS EST WORLD; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; Li WL, 2000, J PHARMACEUT BIOMED, V24, P325, DOI 10.1016/S0731-7085(00)00422-2; Matasci N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-17; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Nakagawa A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06695; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; NOGAE I, 1990, GENE, V96, P161, DOI 10.1016/0378-1119(90)90248-P; Oye K, 2015, NATURE, V521, P281, DOI 10.1038/521281a; Paddon CJ, 2014, NAT REV MICROBIOL, V12, P355, DOI 10.1038/nrmicro3240; PATH, 2014, STAB ANT DRUG SUPPL; Raith K, 2003, J AM SOC MASS SPECTR, V14, P1262, DOI 10.1016/S1044-0305(03)00539-7; Reed JW, 2015, ACCOUNTS CHEM RES, V48, P674, DOI 10.1021/ar500427k; Reuben DB, 2015, ANN INTERN MED, V162, P295, DOI 10.7326/M14-2775; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; SCHMIDHEINI T, 1989, J BACTERIOL, V171, P1245, DOI 10.1128/jb.171.3.1245-1253.1989; Schmidt J, 2005, EUR J MASS SPECTROM, V11, P325, DOI 10.1255/ejms.745; Seya Marie-Josephine, 2011, J Pain Palliat Care Pharmacother, V25, P6, DOI 10.3109/15360288.2010.536307; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Trenchard IJ, 2015, METAB ENG, V31, P74, DOI 10.1016/j.ymben.2015.06.010; Trenchard IJ, 2015, METAB ENG, V30, P96, DOI 10.1016/j.ymben.2015.05.001; Valent S, 2004, INT J BIOCHEM CELL B, V36, P1266, DOI 10.1016/j.biocel.2003.10.014; Wijekoon CP, 2012, PLANT J, V69, P1052, DOI 10.1111/j.1365-313X.2011.04855.x; Winzer T, 2015, SCIENCE, V349, P309, DOI 10.1126/science.aab1852; World Health Organization, 2013, 18 WHO ESS MED LIST; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	66	543	618	45	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1095	1100		10.1126/science.aac9373	http://dx.doi.org/10.1126/science.aac9373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26272907	Green Accepted			2022-12-28	WOS:000360628900041
J	Liddicoat, BJ; Piskol, R; Chalk, AM; Ramaswami, G; Higuchi, M; Hartner, JC; Li, JB; Seeburg, PH; Walkley, CR				Liddicoat, Brian J.; Piskol, Robert; Chalk, Alistair M.; Ramaswami, Gokul; Higuchi, Miyoko; Hartner, Jochen C.; Li, Jin Billy; Seeburg, Peter H.; Walkley, Carl R.			RNA EDITING RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself	SCIENCE			English	Article							ADENOSINE-DEAMINASE; ENZYME ADAR1; INTERFERON; MOUSE; IDENTIFICATION; MUTATIONS; APOPTOSIS; GENOME; SITES; GENE	Adenosine-to-inosine (A-to-I) editing is a highly prevalent posttranscriptional modification of RNA, mediated by ADAR (adenosine deaminase acting on RNA) enzymes. In addition to RNA editing, additional functions have been proposed for ADAR1. To determine the specific role of RNA editing by ADAR1, we generated mice with an editing-deficient knock-in mutation (Adar(1E861A), where E861A denotes Glu(861)-> Ala(861)). Adar1(E861A)/(E861A) embryos died at similar to E13.5 (embryonic day 13.5), with activated interferon and double-stranded RNA (dsRNA)-sensing pathways. Genome-wide analysis of the in vivo substrates of ADAR1 identified clustered hyperediting within long dsRNA stem loops within 3' untranslated regions of endogenous transcripts. Finally, embryonic death and phenotypes of Adar(1E861A/E861A) were rescued by concurrent deletion of the cytosolic sensor of dsRNA, MDA5. A-to-I editing of endogenous dsRNA is the essential function of ADAR1, preventing the activation of the cytosolic dsRNA response by endogenous transcripts.	[Liddicoat, Brian J.; Chalk, Alistair M.; Walkley, Carl R.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Liddicoat, Brian J.; Chalk, Alistair M.; Walkley, Carl R.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Piskol, Robert; Ramaswami, Gokul; Li, Jin Billy] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Higuchi, Miyoko; Seeburg, Peter H.] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Hartner, Jochen C.] Tacon Biosci, D-51063 Cologne, Germany	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Stanford University; Max Planck Society	Walkley, CR (corresponding author), St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia.	cwalkley@svi.edu.au	Walkley, Carl/AAO-6021-2020; Chalk, Alistair/B-3019-2008	Walkley, Carl/0000-0002-4784-9031; Chalk, Alistair/0000-0002-9630-6236	Leukaemia Foundation; National Health and Medical Research Council (NHMRC) [1021216]; NHMRC [559016]; German Academic Exchange Service Postdoctoral Fellowship; Stanford University; Stanford Genome Training Program (NIH) [T32 HG000044]; Stanford Graduate Fellowship; NIH [R01GM102484]; Ellison Medical Foundation; Stanford University Department of Genetics; Victorian State Government Operational Infrastructure Support Scheme; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102484] Funding Source: NIH RePORTER	Leukaemia Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); German Academic Exchange Service Postdoctoral Fellowship; Stanford University(Stanford University); Stanford Genome Training Program (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Stanford University Department of Genetics; Victorian State Government Operational Infrastructure Support Scheme; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Sankaran, S. Orkin, L. Purton, and J. Heierhorst for discussion and SVH BioResources Centre for animal care. Data sets described in the paper are deposited in Gene Expression Omnibus (accession number GSE58917). This work was supported by the Leukaemia Foundation (C.R.W.), a Leukaemia Foundation Ph.D. scholarship (B.J.L), National Health and Medical Research Council (NHMRC) Project Grant 1021216, NHMRC Career Development Award 559016 (C.R.W.), a German Academic Exchange Service Postdoctoral Fellowship (R.P.), a Stanford University Dean's Fellowship (R.P.), Stanford Genome Training Program (NIH grant T32 HG000044) and Stanford Graduate Fellowship (G.R.), NIH grant R01GM102484 (J.B.L.), the Ellison Medical Foundation (J.B.L.), and the Stanford University Department of Genetics (J.B.L.). This work was also supported in part by the Victorian State Government Operational Infrastructure Support Scheme (to St. Vincent's Institute of Medical Research). C. R.W. was the Leukaemia Foundation Phillip Desbrow Senior Research Fellow. J.C.H. is an employee of Taconic Biosciences. Taconic Biosciences had no role in the preparation and content of this Report. All other authors declare no conflicts of interest. Author contributions: M.H., P.H.S., and J.C.H. generated the knock-in mouse line; B.J.L., R.P., A.M.C., G.R., J.C.H., J.B.L., and C.R.W. performed experiments and analyzed and interpreted data; M.H., P.H.S., and J.C.H. provided intellectual input and conceptual advice; and B.J.L. and C.R.W. wrote the manuscript.	Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Washburn MC, 2014, CELL REP, V6, P599, DOI 10.1016/j.celrep.2014.01.011; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736	22	426	437	6	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1115	1120		10.1126/science.aac7049	http://dx.doi.org/10.1126/science.aac7049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26275108	Green Accepted			2022-12-28	WOS:000360628900045
J	Boddie, C; Watson, M; Ackerman, G; Gronvall, GK				Boddie, Crystal; Watson, Matthew; Ackerman, Gary; Gronvall, Gigi Kwik			Assessing the bioweapons threat Is there a foundation of agreement among experts about risk?	SCIENCE			English	Editorial Material									[Boddie, Crystal; Watson, Matthew; Gronvall, Gigi Kwik] Univ Pittsburgh, Med Ctr, UPMC Ctr Hlth Secur, Baltimore, MD 21202 USA; [Ackerman, Gary] Univ Maryland, Natl Consortium Study Terrorism & Response Terror, Unconvent Weap & Technol Div, College Pk, MD 20742 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Gronvall, GK (corresponding author), Univ Pittsburgh, Med Ctr, UPMC Ctr Hlth Secur, Baltimore, MD 21202 USA.	ggronvall@upmc.edu						Rowe G, 2001, INT SER OPER RES MAN, V30, P125, DOI 10.1007/978-0-306-47630-3_7; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; White House Office of Science and Technology Policy, 2014, DOING DIL ASS RISKS	3	13	15	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					792	793		10.1126/science.aab0713	http://dx.doi.org/10.1126/science.aab0713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP4DR	26293941				2022-12-28	WOS:000359832700020
J	Goo, L; Pierson, TC				Goo, Leslie; Pierson, Theodore C.			DENGUE VIRUS Bumps in the road to therapeutic antibodies	NATURE			English	Editorial Material							NEUTRALIZING ANTIBODIES		[Goo, Leslie; Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Goo, L (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	piersontc@mail.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000957] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110	15	1	1	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					295	296		10.1038/524295a	http://dx.doi.org/10.1038/524295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26289200				2022-12-28	WOS:000359714000021
J	Klig, JE; Madhavan, VL; Rebello, GN; Shailam, R				Klig, Jean E.; Madhavan, Vandana L.; Rebello, Gleeson N.; Shailam, Randheer			Case 26-2015: A 9-Month-Old Girl with Recurrent Fevers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEPTIC ARTHRITIS; PROLONGED FEVER; UNKNOWN ORIGIN; CHILDREN; HIP; ALGORITHM; INFANCY; MODEL		[Klig, Jean E.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Madhavan, Vandana L.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Rebello, Gleeson N.] Massachusetts Gen Hosp, Dept Orthopaed, Boston, MA 02114 USA; [Shailam, Randheer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Klig, Jean E.] Harvard Univ, Sch Med, Dept Emergency Med, Boston, MA USA; [Madhavan, Vandana L.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Rebello, Gleeson N.] Harvard Univ, Sch Med, Dept Orthopaed, Boston, MA USA; [Shailam, Randheer] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Klig, JE (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.		Klig, Jean/N-8505-2019		Harvard Medical School Department of Continuing Education	Harvard Medical School Department of Continuing Education	This case was presented at the postgraduate course "Primary Care Pediatrics," directed by Drs. John P. T. Co, Peter T. Greenspan, Ronni L. Goldsmith, Janice A. Lowe, and Ronald E. Kleinman and sponsored by the Harvard Medical School Department of Continuing Education.	ALDERSON M, 1987, J ORTHOP RES, V5, P261, DOI 10.1002/jor.1100050213; Alpern ER, 2010, TXB PEDIAT EMERGENCY, V6th, P295; Chow A, 2011, WORLD J PEDIATR, V7, P5, DOI 10.1007/s12519-011-0240-5; CRAIGEN MAC, 1992, J BONE JOINT SURG BR, V74, P541, DOI 10.1302/0301-620X.74B4.1624513; Dobbs MB, 2003, J PEDIATR ORTHOPED, V23, P162, DOI 10.1097/00004694-200303000-00006; Domachowske JB, 2006, PEDIATR INFECT DIS J, V25, P1067, DOI 10.1097/01.inf.0000243916.35881.14; Forlin E, 2008, J PEDIATR ORTHOPED, V28, P524, DOI 10.1097/BPO.0b013e31817bb079; HALLEL T, 1978, CLIN ORTHOP RELAT R, P115; HARRIS ED, 1972, ARTHRITIS RHEUM, V15, P497, DOI 10.1002/art.1780150505; Kocher MS, 1999, J BONE JOINT SURG AM, V81A, P1662, DOI 10.2106/00004623-199912000-00002; LOHR JA, 1977, CLIN PEDIATR, V16, P768, DOI 10.1177/000992287701600905; Ludwig S, 2010, TXB PEDIAT EMERGENCY, P1; Mathews CJ, 2008, CURR OPIN RHEUMATOL, V20, P457, DOI 10.1097/BOR.0b013e3283036975; MCCLUNG HJ, 1972, AM J DIS CHILD, V124, P544, DOI 10.1001/archpedi.1972.02110160082009; MITCHELL GP, 1980, ORTHOP CLIN N AM, V11, P51; Palazzi DL, 2009, FEIGIN CHERRYS TXB P, V8th, P857; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001; PIZZO PA, 1975, PEDIATRICS, V55, P468; RIEGELSNIELSEN P, 1987, ACTA ORTHOP SCAND, V58, P14, DOI 10.3109/17453678709146335; SMITH R L, 1983, Journal of Orthopaedic Research, V1, P136, DOI 10.1002/jor.1100010204	20	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					757	766		10.1056/NEJMcpc1400843	http://dx.doi.org/10.1056/NEJMcpc1400843			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287852				2022-12-28	WOS:000359709400013
J	Cotton, D				Cotton, Deborah			Celebrating the ACP Centennial: From the Annals Archive-Non-A, Non-B Hepatitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		HOOFNAGLE JH, 1977, ANN INTERN MED, V87, P14, DOI 10.7326/0003-4819-87-1-14; Onofrey S, 2015, ANN INTERN MED, V163, P254, DOI 10.7326/M14-2939	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					315	315		10.7326/M15-1300	http://dx.doi.org/10.7326/M15-1300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LC	26280418				2022-12-28	WOS:000360286400013
J	Haynes, RB				Haynes, R. Brian			David Lawrence Sackett, MD, MSc (Epidemiology), 1934-2015	ANNALS OF INTERNAL MEDICINE			English	Biographical-Item									McMaster Univ, Hamilton, ON L8S 4L8, Canada	McMaster University	Haynes, RB (corresponding author), McMaster Univ, Hamilton, ON L8S 4L8, Canada.							[Anonymous], 1995, LANCET, V346, P785; HAYNES RB, 1987, ANN INTERN MED, V106, P598; SACKETT D, PUBLICATION LIST; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4							JC2	10.7326/ACPJC-2015-163-4-002	http://dx.doi.org/10.7326/ACPJC-2015-163-4-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LC	26280437				2022-12-28	WOS:000360286400001
J	Farmer, ME; Baran, PS				Farmer, Marcus E.; Baran, Phil S.			ORGANIC CHEMISTRY A cure for catalyst poisoning	NATURE			English	Editorial Material							FLUORINATION		[Farmer, Marcus E.; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Farmer, ME (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	pbaran@scripps.edu						Colombe JR, 2013, ORG LETT, V15, P5754, DOI 10.1021/ol402798z; Fors BP, 2010, J AM CHEM SOC, V132, P15914, DOI 10.1021/ja108074t; Ishihara Y., 2013, PORTABLE CHEM CONSUL; Lee HG, 2014, J AM CHEM SOC, V136, P3792, DOI 10.1021/ja5009739; Lee HG, 2013, ORG LETT, V15, P5602, DOI 10.1021/ol402859k; Mothes F. A. B., 1834, French Patent, Patent No. 9690; Sather AC, 2015, NATURE, V524, P208, DOI 10.1038/nature14654; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Wilbert M. I., 1913, AM J PHARM, V85, P559	9	4	4	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					164	165		10.1038/524164a	http://dx.doi.org/10.1038/524164a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268186				2022-12-28	WOS:000359386900016
J	Teng, G; Maman, Y; Resch, W; Kim, M; Yamane, A; Qian, J; Kieffer-Kwon, KR; Mandal, M; Ji, YH; Meffre, E; Clark, MR; Cowell, LG; Casellas, R; Schatz, DG				Teng, Grace; Maman, Yaakov; Resch, Wolfgang; Kim, Min; Yamane, Arito; Qian, Jason; Kieffer-Kwon, Kyong-Rim; Mandal, Malay; Ji, Yanhong; Meffre, Eric; Clark, Marcus R.; Cowell, Lindsay G.; Casellas, Rafael; Schatz, David G.			RAG Represents a Widespread Threat to the Lymphocyte Genome	CELL			English	Article							ILLEGITIMATE V(D)J RECOMBINATION; HISTONE H3; INTRAGENIC DELETIONS; B-CELL; GENE; MECHANISMS; REARRANGEMENT; COMPLEXES; TRANSLOCATIONS; INVOLVEMENT	The RAG1 endonuclease, together with its cofactor RAG2, is essential for V(D)J recombination but is a potent threat to genome stability. The sources of RAG1 mis-targeting and the mechanisms that have evolved to suppress it are poorly understood. Here, we report that RAG1 associates with chromatin at thousands of active promoters and enhancers in the genome of developing lymphocytes. The mouse and human genomes appear to have responded by reducing the abundance of "cryptic'' recombination signals near RAG1 binding sites. This depletion operates specifically on the RSS heptamer, whereas nonamers are enriched at RAG1 binding sites. Reversing this RAG-driven depletion of cleavage sites by insertion of strong recombination signals creates an ectopic hub of RAG-mediated V(D)J recombination and chromosomal translocations. Our findings delineate rules governing RAG binding in the genome, identify areas at risk of RAG-mediated damage, and highlight the evolutionary struggle to accommodate programmed DNA damage in developing lymphocytes.	[Teng, Grace; Maman, Yaakov; Meffre, Eric; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Resch, Wolfgang; Yamane, Arito; Qian, Jason; Kieffer-Kwon, Kyong-Rim; Casellas, Rafael] NCI, Genom & Immun, NIAMS, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Kim, Min; Cowell, Lindsay G.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Div Biomed Informat, Dallas, TX 75390 USA; [Mandal, Malay; Clark, Marcus R.] Univ Chicago, Rheumatol Sect, Dept Med, Chicago, IL 60637 USA; [Mandal, Malay; Clark, Marcus R.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Ji, Yanhong] Xi An Jiao Tong Univ, Coll Med, Dept Immunol & Microbiol, Xian 710061, Shaanxi, Peoples R China; [Schatz, David G.] Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago; University of Chicago; Xi'an Jiaotong University; Howard Hughes Medical Institute	Casellas, R (corresponding author), NCI, Genom & Immun, NIAMS, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	casellar@mail.nih.gov; david.schatz@yale.edu		Resch, Wolfgang/0000-0001-7594-5963; Kim, Min Soo/0000-0001-7035-9092; Qian, Jason/0000-0002-1144-2547	NIH NRSA Institutional Postdoctoral Training Grant [T32 AI007019]; Cancer Research Institute Irvington Postdoctoral Fellowship; NIAMS, NIH; Burroughs Wellcome Fund Career Award;  [R37 AI32524];  [R01 GM0888847]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019, R37AI032524, R01AI120715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER	NIH NRSA Institutional Postdoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Irvington Postdoctoral Fellowship; NIAMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank S. Zhou for assistance with mice, E. Corbett for antibody production, Y. Zhang and F. Alt for the Atm<SUP>-/-</SUP> I-SceI v-abl cell line, J. Henao-Meija for the CRISPR/Cas9 guide RNA sequence for Hprt, and S. Smale and J. Langermann for valuable advice. This work was supported in part by an NIH NRSA Institutional Postdoctoral Training Grant (T32 AI007019) and a Cancer Research Institute Irvington Postdoctoral Fellowship (G.T.), R37 AI32524 (D.G.S.), R01 GM0888847 (M.C.), by the Intramural Research Program of NIAMS, NIH (R.C.), and by a Burroughs Wellcome Fund Career Award (L.G.C.). D.G.S. is an investigator of the Howard Hughes Medical Institute. This study used high-performance computational capabilities of the NIH Biowulf Linux cluster.	Agard EA, 2000, MOL CELL BIOL, V20, P5032, DOI 10.1128/MCB.20.14.5032-5040.2000; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Askary A, 2014, CELL REP, V7, P307, DOI 10.1016/j.celrep.2014.03.005; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Coster G, 2012, J BIOL CHEM, V287, P36488, DOI 10.1074/jbc.M112.402487; Cowell LG, 2002, GENOME BIOL, V3; Deng ZM, 2015, CELL RES, V25, P181, DOI 10.1038/cr.2015.1; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Gigi V, 2014, NUCLEIC ACIDS RES, V42, P6352, DOI 10.1093/nar/gku295; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Grazini U, 2010, MOL CELL, V37, P282, DOI 10.1016/j.molcel.2009.12.035; Hawwari A, 2007, P NATL ACAD SCI USA, V104, P903, DOI 10.1073/pnas.0608248104; Helmink BA, 2012, ANNU REV IMMUNOL, V30, P175, DOI 10.1146/annurev-immunol-030409-101320; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Jones JM, 2011, IMMUNOL LETT, V136, P156, DOI 10.1016/j.imlet.2011.01.005; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kumar S, 2013, GENE DEV, V27, P2439, DOI 10.1101/gad.227165.113; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Merelli I, 2010, NUCLEIC ACIDS RES, V38, pW262, DOI 10.1093/nar/gkq391; Onozawa M, 2012, GENE CHROMOSOME CANC, V51, P525, DOI 10.1002/gcc.21942; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Ranganath S, 2008, J IMMUNOL, V180, P2339, DOI 10.4049/jimmunol.180.4.2339; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Sakata J, 2004, CARCINOGENESIS, V25, P1069, DOI 10.1093/carcin/bgh094; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Steinel NC, 2013, J EXP MED, V210, P233, DOI 10.1084/jem.20121605; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Tepsuporn S, 2014, CANCER IMMUNOL RES, V2, P857, DOI 10.1158/2326-6066.CIR-14-0090; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Tsuji H, 2004, CANCER RES, V64, P8882, DOI 10.1158/0008-5472.CAN-03-1163; Wang XM, 2008, NAT IMMUNOL, V9, P794, DOI 10.1038/ni.1614; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhao SY, 2009, J MOL BIOL, V387, P744, DOI 10.1016/j.jmb.2009.02.020	47	71	71	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					751	765		10.1016/j.cell.2015.07.009	http://dx.doi.org/10.1016/j.cell.2015.07.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26234156	Bronze, Green Accepted			2022-12-28	WOS:000359741400010
J	Betton, V; Ingrams, G				Betton, Victoria; Ingrams, Grant			Should all NHS premises provide free access to wi-fi?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Betton, Victoria] Leeds & York Partnership NHS Fdn Trust, Leeds, W Yorkshire, England; [Ingrams, Grant] BMA Gen Practitioners Comm, IT Subcomm, London, England		Betton, V (corresponding author), Leeds & York Partnership NHS Fdn Trust, Leeds, W Yorkshire, England.							Bostock S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1602; Commonwealth Fund, 2012 INT HLTH POL SU; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Dutton H, CULTURES INTERNET IN; Health and Social Care Information Centre, GP2GP FAQS; HM Government, 2014, PERS HLTH CAR 2020 U; NHS England, 2014, NHS 5 YEAR FORW VIEW; Popham J., 2014, WIFI HOSP RESOURCES; Richardson J., 2015, MOBILE HELPING CLOSE; Spacey R, 2014, MANAGING ACCESS INTE; Steele R, 2015, BJPSYCH ADV, V21, P63, DOI DOI 10.1192/APT.BP.113.011908; Tinder Foundation, NHS WID DIG PART	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2015	351								h4098	10.1136/bmj.h4098	http://dx.doi.org/10.1136/bmj.h4098			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XN	26268808	Green Accepted			2022-12-28	WOS:000359741200005
J	Patzer, RE; Plantinga, LC; Paul, S; Gander, J; Krisher, J; Sauls, L; Gibney, EM; Mulloy, L; Pastan, SO				Patzer, Rachel E.; Plantinga, Laura C.; Paul, Sudeshna; Gander, Jennifer; Krisher, Jenna; Sauls, Leighann; Gibney, Eric M.; Mulloy, Laura; Pastan, Stephen O.			Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SOUTHEASTERN UNITED-STATES; RACIAL DISPARITIES; NEIGHBORHOOD POVERTY; SOCIOECONOMIC-STATUS; WAITING-LIST; ACCESS; RACE; CARE; COMPLETION; PROVISION	IMPORTANCE Dialysis facilities in the United States are required to educate patients with end-stage renal disease about all treatment options, including kidney transplantation. Patients receiving dialysis typically require a referral for kidney transplant evaluation at a transplant center from a dialysis facility to start the transplantation process, but the proportion of patients referred for transplantation is unknown. OBJECTIVE To describe variation in dialysis facility-level referral for kidney transplant evaluation and factors associated with referral among patients initiating dialysis in Georgia, the US state with the lowest kidney transplantation rates. DESIGN, SETTING, AND PARTICIPANTS Examination of United States Renal Data System data from a cohort of 15 279 incident, adult (18-69 years) patients with end-stage renal disease from 308 Georgia dialysis facilities from January 2005 to September 2011, followed up through September 2012, linked to kidney transplant referral data collected from adult transplant centers in Georgia in the same period. MAIN OUTCOMES AND MEASURES Referral for kidney transplant evaluation within 1 year of starting dialysis at any of the 3 Georgia transplant centers was the primary outcome; placement on the deceased donor waiting list was also examined. RESULTS The median within-facility percentage of patients referred within 1 year of starting dialysis was 24.4%(interquartile range, 16.7%-33.3%) and varied from 0% to 75.0%. Facilities in the lowest tertile of referral (<19.2%) were more likely to treat patients living in high-poverty neighborhoods (absolute difference, 21.8%[95% CI, 14.1%-29.4%]), had a higher patient to social worker ratio (difference, 22.5 [95% CI, 9.7-35.2]), and were more likely nonprofit (difference, 17.6%[95% CI, 7.7%-27.4%]) compared with facilities in the highest tertile of referral (>31.3%). In multivariable, multilevel analyses, factors associated with lower referral for transplantation, such as older age, white race, and nonprofit facility status, were not always consistent with the factors associated with lower waitlisting. CONCLUSIONS AND RELEVANCE In Georgia overall, a limited proportion of patients treated with dialysis were referred for kidney transplant evaluation between 2005 and 2011, but there was substantial variability in referral among facilities. Variables associated with referral were not always associated with waitlisting, suggesting that different factors may account for disparities in referral.	[Patzer, Rachel E.; Gander, Jennifer] Emory Univ, Sch Med, Dept Surg, Div Transplantat, Atlanta, GA 30322 USA; [Patzer, Rachel E.; Plantinga, Laura C.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Patzer, Rachel E.; Pastan, Stephen O.] Emory Transplant Ctr, Atlanta, GA USA; [Plantinga, Laura C.; Pastan, Stephen O.] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Paul, Sudeshna] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Krisher, Jenna; Sauls, Leighann] Southeastern Kidney Council Inc, End Stage Renal Dis Network 6, Raleigh, NC USA; [Gibney, Eric M.] Piedmont Healthcare, Piedmont Transplant Inst, Atlanta, GA USA; [Mulloy, Laura] Georgia Regents Univ, Dept Med, Div Nephrol, Augusta, GA USA	Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; Emory University; University System of Georgia; Augusta University	Patzer, RE (corresponding author), Emory Univ, Sch Med, Dept Surg, Div Transplantat, 101 Woodruff Circle,5101 Woodruff Mem Res Bldg, Atlanta, GA 30322 USA.	rpatzer@emory.edu	Pastan, Stephen/AAC-6622-2022		National Institute on Minority Health and Health Disparities [R24MD008077]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institute on Minority Health and Health Disparities grant R24MD008077.	Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Alexander GC, 2002, AM J KIDNEY DIS, V40, P824, DOI 10.1053/ajkd.2002.35695; Arce CM, 2013, CLIN J AM SOC NEPHRO, V8, P2149, DOI 10.2215/CJN.01560213; Ashby VB, 2007, AM J TRANSPLANT, V7, P1412, DOI 10.1111/j.1600-6143.2007.01785.x; Ayanian JZ, 2004, AM J KIDNEY DIS, V43, P350, DOI 10.1053/j.ajkd.2003.10.022; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Balhara KS, 2012, AM J TRANSPLANT, V12, P3104, DOI 10.1111/j.1600-6143.2012.04207.x; Bunnapradist S, 2010, HDB KIDNEY TRANSPLAN, P77; Centers for Medicare & Medicaid Services (CMS), 2008, COND COV END STAG RE; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; Kasiske BL, 1998, J AM SOC NEPHROL, V9, P2142; Kasiske BL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013295.11876.C9; Keith D, 2008, CLIN J AM SOC NEPHRO, V3, P463, DOI 10.2215/CJN.02220507; Kianda MN, 2011, CLIN TRANSPLANT, V25, P576, DOI 10.1111/j.1399-0012.2010.01317.x; Kucirka LM, 2012, AM J TRANSPLANT, V12, P351, DOI 10.1111/j.1600-6143.2011.03865.x; Ladin K, 2009, AM J TRANSPLANT, V9, P669, DOI 10.1111/j.1600-6143.2009.02561.x; Organ Procurement and Transplantation Network (OPTN) Minority Affairs Committee, 2014, ED GUID PAT REF KIDN; Patzer RE, 2014, AM J TRANSPLANT, V14, P1562, DOI 10.1111/ajt.12749; Patzer RE, 2014, AM J TRANSPLANT, V14, P1499, DOI 10.1111/ajt.12748; Patzer RE, 2012, AM J TRANSPLANT, V12, P358, DOI 10.1111/j.1600-6143.2011.03927.x; Patzer RE, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-171; Patzer RE, 2012, NAT REV NEPHROL, V8, P533, DOI 10.1038/nrneph.2012.117; Patzer RE, 2009, J AM SOC NEPHROL, V20, P1333, DOI 10.1681/ASN.2008030335; PERNEGER TV, 1995, ARCH INTERN MED, V155, P1201, DOI 10.1001/archinte.155.11.1201; Saunders MR, 2010, AM J TRANSPLANT, V10, P1912, DOI 10.1111/j.1600-6143.2010.03206.x; Sehgal AR, 2005, ESRD SPEC STUD DEV D; Srinivas TR, 2014, AM J TRANSPLANT, V14, P1506, DOI 10.1111/ajt.12747; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; U. S. Renal Data System, 2014, USRDS 2014 ANN DAT R; Waterman AD, 2013, CLIN J AM SOC NEPHRO, V8, P995, DOI 10.2215/CJN.08880812; Weng FL, 2005, AM J KIDNEY DIS, V46, P734, DOI 10.1053/j.ajkd.2005.06.011; Yoder LAG, 2013, AM J KIDNEY DIS, V62, P1130, DOI 10.1053/j.ajkd.2013.05.007	34	84	85	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					582	594		10.1001/jama.2015.8897	http://dx.doi.org/10.1001/jama.2015.8897			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262796	Green Accepted, Bronze			2022-12-28	WOS:000359388600017
J	Pavlou, M; Ambler, G; Seaman, SR; Guttmann, O; Elliott, P; King, M; Omar, RZ				Pavlou, Menelaos; Ambler, Gareth; Seaman, Shaun R.; Guttmann, Oliver; Elliott, Perry; King, Michael; Omar, Rumana Z.			How to develop a more accurate risk prediction model when there are few events	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REGRESSION-ANALYSIS; PROGNOSIS	When the number of events is low relative to the number of predictors, standard regression could produce overfitted risk models that make inaccurate predictions. Use of penalised regression may improve the accuracy of risk prediction	[Pavlou, Menelaos; Ambler, Gareth; Omar, Rumana Z.] UCL, Dept Stat Sci, London WC1E 6BT, England; [Seaman, Shaun R.] MRC, Cambridge, England; [Guttmann, Oliver] UCL, Inst Cardiovasc Sci, Sch Life & Med Sci, London WC1E 6BT, England; [Elliott, Perry] Heart Hosp, Inherited Cardiac Dis Unit, London, England; [King, Michael] UCL, Div Psychiat, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Pavlou, M (corresponding author), UCL, Dept Stat Sci, Mortimer St, London WC1E 6BT, England.	m.pavlou@ucl.ac.uk	Elliott, Perry/AAR-3430-2020	Elliott, Perry/0000-0003-3383-3984; Seaman, Shaun/0000-0003-3726-5937; Omar, Rumana/0000-0003-1483-1932	UK Medical Research Council [MR/J013692/1]; MRC [U105260558]; Medical Research Council [MR/J013692/1, MC_U105260558] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10210] Funding Source: researchfish; MRC [MR/J013692/1, MC_U105260558] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MP, GA, and RZO were supported by the UK Medical Research Council grant MR/J013692/1. SRS was supported by the MRC programme grant U105260558.	Ambler G, 2005, CIRCULATION, V112, P224, DOI 10.1161/CIRCULATIONAHA.104.515049; Ambler G, 2012, STAT MED, V31, P1150, DOI 10.1002/sim.4371; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Debray TPA, 2014, STAT MED, V33, P2341, DOI 10.1002/sim.6080; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; HOSMER DW, 1989, APPL LOGISTIC REGRES; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; O'Mahony C, 2014, EUR HEART J, V35, P2010, DOI 10.1093/eurheartj/eht439; Omar RZ, 2001, HEART, V86, P57, DOI 10.1136/heart.86.1.57; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; VERWEIJ PJM, 1994, STAT MED, V13, P2427, DOI 10.1002/sim.4780132307; Ye JM, 1998, J AM STAT ASSOC, V93, P120, DOI 10.2307/2669609; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	22	316	319	2	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2015	351								h3868	10.1136/bmj.h3868	http://dx.doi.org/10.1136/bmj.h3868			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XG	26264962	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000359740400001
J	Kale, MJ; Christopher, P				Kale, Matthew J.; Christopher, Phillip			Plasmons at the interface	SCIENCE			English	Editorial Material							METAL NANOPARTICLES; NANOSTRUCTURES; SURFACE		[Kale, Matthew J.; Christopher, Phillip] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA; [Christopher, Phillip] Univ Calif Riverside, Mat Sci Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Kale, MJ (corresponding author), Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.	christopher@engr.ucr.edu	Christopher, Phillip/E-8921-2013	Christopher, Phillip/0000-0002-4898-5510; Kale, Matthew/0000-0002-3039-3111				Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Christopher P, 2012, NAT MATER, V11, P1044, DOI [10.1038/nmat3454, 10.1038/NMAT3454]; Christopher P, 2011, NAT CHEM, V3, P467, DOI [10.1038/NCHEM.1032, 10.1038/nchem.1032]; Govorov AO, 2013, J PHYS CHEM C, V117, P16616, DOI 10.1021/jp405430m; HOVEL H, 1993, PHYS REV B, V48, P18178, DOI 10.1103/PhysRevB.48.18178; Kale MJ, 2014, NANO LETT, V14, P5405, DOI 10.1021/nl502571b; Knight MW, 2011, SCIENCE, V332, P702, DOI 10.1126/science.1203056; Mubeen S, 2013, NAT NANOTECHNOL, V8, P247, DOI 10.1038/nnano.2013.18; Petek H, 2000, SCIENCE, V288, P1402, DOI 10.1126/science.288.5470.1402; Voisin C, 2000, PHYS REV LETT, V85, P2200, DOI 10.1103/PhysRevLett.85.2200; Wu K, 2015, SCIENCE, V349, P632, DOI 10.1126/science.aac5443	11	64	66	3	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					587	588		10.1126/science.aac8522	http://dx.doi.org/10.1126/science.aac8522			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250672				2022-12-28	WOS:000359092900022
J	Temmerman, S; Kirwan, ML				Temmerman, Stijn; Kirwan, Matthew L.			Building land with a rising sea	SCIENCE			English	Editorial Material							LEVEL; MANAGEMENT; RISE; FACE		[Temmerman, Stijn] Univ Antwerp, Ecosyst Management Res Grp, B-2000 Antwerp, Belgium; [Kirwan, Matthew L.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA	University of Antwerp; William & Mary; Virginia Institute of Marine Science	Temmerman, S (corresponding author), Univ Antwerp, Ecosyst Management Res Grp, B-2000 Antwerp, Belgium.	stijn.temmerman@uantwerpen.be; kirwan@vims.edu	Temmerman, Stijn/C-5521-2009	Temmerman, Stijn/0000-0003-3346-9115	Direct For Biological Sciences [1237733] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		[Anonymous], [No title captured]; Auerbach LW, 2015, NAT CLIM CHANGE, V5, P153, DOI [10.1038/nclimate2472, 10.1038/NCLIMATE2472]; Barbier EB, 2014, SCIENCE, V345, P1250, DOI 10.1126/science.1254629; Coastal Protection and Restoration Authority of Louisiana (CPRA), 2012, LOUIS COMPR MAST PLA; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Giosan L, 2014, NATURE, V516, P31, DOI 10.1038/516031a; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Ma ZJ, 2014, SCIENCE, V346, P912, DOI 10.1126/science.1257258; Pethick J, 2013, GLOBAL PLANET CHANGE, V111, P237, DOI 10.1016/j.gloplacha.2013.09.019; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Tessler ZD, 2015, SCIENCE, V349, P638, DOI 10.1126/science.aab3574; Vandenbruwaene W, 2011, GEOMORPHOLOGY, V130, P115, DOI 10.1016/j.geomorph.2011.03.004	13	92	95	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					588	589		10.1126/science.aac8312	http://dx.doi.org/10.1126/science.aac8312			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3WW	26250673				2022-12-28	WOS:000359092900023
J	Sumner, SA; Mercy, JA; Dahlberg, LL; Hillis, SD; Klevens, J; Houry, D				Sumner, Steven A.; Mercy, James A.; Dahlberg, Linda L.; Hillis, Susan D.; Klevens, Joanne; Houry, Debra			Violence in the United States Status, Challenges, and Opportunities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTIMATE PARTNER VIOLENCE; ADVERSE CHILDHOOD EXPERIENCES; PEDIATRIC PRIMARY-CARE; PREVENTING VIOLENCE; SAFE ENVIRONMENT; YOUTH VIOLENCE; RISK-FACTORS; INTERVENTION; MALTREATMENT; HEALTH	IMPORTANCE Interpersonal violence, which includes child abuse and neglect, youth violence, intimate partner violence, sexual violence, and elder abuse, affects millions of US residents each year. However, surveillance systems, programs, and policies to address violence often lack broad, cross-sector collaboration, and there is limited awareness of effective strategies to prevent violence. OBJECTIVES To describe the burden of interpersonal violence in the United States, explore challenges to violence prevention efforts and to identify prevention opportunities. DATA SOURCES We reviewed data from health and law enforcement surveillance systems including the National Vital Statistics System, the Federal Bureau of Investigation's Uniform Crime Reports, the US Justice Department's National Crime Victimization Survey, the National Survey of Children's Exposure to Violence, the National Child Abuse and Neglect Data System, the National Intimate Partner and Sexual Violence Survey, the Youth Risk Behavior Surveillance System, and the National Electronic Injury Surveillance System-All Injury Program. RESULTS Homicide rates have decreased from a peak of 10.7 per 100 000 persons in 1980 to 5.1 per 100 000 in 2013. Aggravated assault rates have decreased from a peak of 442 per 100 000 in 1992 to 242 per 100 000 in 2012. Nevertheless, annually, there are more than 16 000 homicides and 1.6 million nonfatal assault injuries requiring treatment in emergency departments. More than 12 million adults experience intimate partner violence annually and more than 10 million children younger than 18 years experience some form of maltreatment from a caregiver, ranging from neglect to sexual abuse, but only a small percentage of these violent incidents are reported to law enforcement, health care clinicians, or child protective agencies. Moreover, exposure to violence increases vulnerability to a broad range of mental and physical health problems over the life course; for example, meta-analyses indicate that exposure to physical abuse in childhood is associated with a 54% increased odds of depressive disorder, a 78% increased odds of sexually transmitted illness or risky sexual behavior, and a 32% increased odds of obesity. Rates of violence vary by age, geographic location, sex, and race/ethnicity, and significant disparities exist. Homicide is the leading cause of death for non-Hispanic blacks from age 1 through 44 years, whereas it is the fifth most common cause of death among non-Hispanic whites in this age range. Additionally, efforts to understand, prevent, and respond to interpersonal violence have often neglected the degree to which many forms of violence are interconnected at the individual level, across relationships and communities, and even intergenerationally. The most effective violence prevention strategies include parent and family-focused programs, early childhood education, school-based programs, therapeutic or counseling interventions, and public policy. For example, a systematic review of early childhood home visitation programs found a 38.9% reduction in episodes of child maltreatment in intervention participants compared with control participants. CONCLUSIONS AND RELEVANCE Progress has been made in reducing US rates of interpersonal violence even though a significant burden remains. Multiple strategies exist to improve violence prevention efforts, and health care providers are an important part of this solution.	[Sumner, Steven A.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30341 USA; [Sumner, Steven A.; Mercy, James A.; Dahlberg, Linda L.; Klevens, Joanne] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Violence Prevent, Atlanta, GA 30341 USA; [Hillis, Susan D.; Houry, Debra] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Sumner, SA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Violence Prevent, 4770 Buford Hwy NE,Mailstop F-63, Atlanta, GA 30341 USA.	hvo5@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Anderson Laurie M, 2002, MMWR Recomm Rep, V51, P1; [Anonymous], 2015, GUID COMM PREV SERV; Asal V, 2010, POLITICS POLICY, V38, P175, DOI 10.1111/j.1747-1346.2010.00234.x; Beyer K, 2015, TRAUMA VIOLENCE ABUS, V16, P16, DOI 10.1177/1524838013515758; Bilukha O, 2005, AM J PREV MED, V28, P11, DOI 10.1016/j.amepre.2004.10.004; Blumstein A., 2000, CRIME DROP AM; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Breiding MJ, 2014, MMWR SURVEILL SUMM, V63, P1; Brener ND, 1999, JAMA-J AM MED ASSOC, V282, P440, DOI 10.1001/jama.282.5.440; Cancian M, 2013, SOC SERV REV, V87, P417, DOI 10.1086/671929; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Catalano S, 2013, INTITMATE PARTNER VI; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention National Center for Health Statistics, DEATH RAT SEL CAUS 1; Cooper C, 2006, J TRAUMA, V61, P534, DOI 10.1097/01.ta.0000236576.81860.8c; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Coulton CJ, 2007, CHILD ABUSE NEGLECT, V31, P1117, DOI 10.1016/j.chiabu.2007.03.023; Dahlberg LL, 2001, AM J PREV MED, V20, P3, DOI 10.1016/S0749-3797(00)00268-3; Drake B, 2011, PEDIATRICS, V127, P471, DOI 10.1542/peds.2010-1710; Dubowitz H, 2011, PEDIATRICS, V127, pE962, DOI 10.1542/peds.2010-1845; Dubowitz H, 2009, PEDIATRICS, V123, P858, DOI 10.1542/peds.2008-1376; Eckenrode J, 2014, PEDIATRICS, V133, P454, DOI 10.1542/peds.2013-1707; Family Violence Prevention and Services Program, AFF CAR ACT FAQ GUID; Farrington D.P., 1998, SERIOUS VIOLENT JUVE; Farrington DP., 2009, CAMPBELL SYSTEMATIC, V5, pI, DOI [10.4073/csr.2009.6, DOI 10.4073/CSR.2009.6]; Farst K, 2013, PEDIATRICS, V131, pE1796, DOI 10.1542/peds.2012-1464; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Federal Bureau of Investigation, UN CRIM REP; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2013, JAMA PEDIATR, V167, P614, DOI 10.1001/jamapediatrics.2013.42; Florence C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3313; Foshee VA, 2014, PREV SCI, V15, P907, DOI 10.1007/s11121-014-0472-4; Furlong M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008225.pub2; Garcia- Moreno C, 2013, VIOLENCE WOMEN MENTA; Haegerich TM, 2011, AM J LIFESTYLE MED, V5, P392, DOI 10.1177/1559827611409127; Hahn R, 2007, AM J PREV MED, V33, pS114, DOI 10.1016/j.amepre.2007.04.012; Hamby S, 2012, PSYCHOL VIOLENCE, V2, P111, DOI 10.1037/a0027191; Hamby S, 2010, CHILD ABUSE NEGLECT, V34, P734, DOI 10.1016/j.chiabu.2010.03.001; Harris A. R., 2002, HOMICIDE STUDIES, V6, P128, DOI DOI 10.1177/108876790200600203; Health Research and Educational Trust, 2015, HOSP APPR INT CYCL V; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Hillis SD, 2004, PEDIATRICS, V113, P320, DOI 10.1542/peds.113.2.320; Holt VL, 2002, JAMA-J AM MED ASSOC, V288, P589, DOI 10.1001/jama.288.5.589; Hong JS, 2012, AGGRESS VIOLENT BEH, V17, P311, DOI 10.1016/j.avb.2012.03.003; Hsieh CC, 1993, CRIM JUSTICE REV, V18, P183; Ingram DD, 2015, MMWR-MORBID MORTAL W, V64, P133; Jennings WG, 2012, AGGRESS VIOLENT BEH, V17, P16, DOI 10.1016/j.avb.2011.09.003; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Katz J, 2013, VIOLENCE VICTIMS, V28, P1054, DOI 10.1891/0886-6708.VV-D-12-00113; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; Klevens J, 2012, J INTERPERS VIOLENCE, V27, P1987, DOI 10.1177/0886260511431441; Knox V, 2000, REFORMING WELFARE RE; Kuo FE, 2001, ENVIRON BEHAV, V33, P543, DOI 10.1177/00139160121973124; Leventhal JM, 2012, PEDIATRICS, V130, P847, DOI 10.1542/peds.2012-0922; Lipsey M.W., 2007, CAMPBELL SYSTEMATIC, V31, P1, DOI DOI 10.4073/CSR.2007.6; MacDonald J, 2010, INJURY PREV, V16, P327, DOI 10.1136/ip.2009.024943; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Millett LS, 2013, CHILD MALTREATMENT, V18, P71, DOI 10.1177/1077559513484821; Moffitt TE, 2000, CRIMINOLOGY, V38, P199, DOI 10.1111/j.1745-9125.2000.tb00888.x; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Piquero A., 2008, CAMPBELL SYST REV, V4, P1, DOI [10.4073/csr.2008.11, DOI 10.4073/CSR.2008.11]; Planty M, 2013, FEMALE VICTIMS SEXUA; Polanin JR, 2012, SCHOOL PSYCHOL REV, V41, P47; Priest N, 2013, SOC SCI MED, V95, P115, DOI 10.1016/j.socscimed.2012.11.031; Reynolds AJ, 2001, JAMA-J AM MED ASSOC, V285, P2339, DOI 10.1001/jama.285.18.2339; Reynolds AJ, 2003, CHILD DEV, V74, P3, DOI 10.1111/1467-8624.00518; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schweinhart L.J., 2005, LIFETIME EFFECTS HIG; Shattuck, 2013, UPDATED TRENDS CHILD; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Spoth RL, 2000, ARCH PEDIAT ADOL MED, V154, P1248, DOI 10.1001/archpedi.154.12.1248; Stein BD, 2003, JAMA-J AM MED ASSOC, V290, P603, DOI 10.1001/jama.290.5.603; Stith SM, 2009, AGGRESS VIOLENT BEH, V14, P13, DOI 10.1016/j.avb.2006.03.006; Substance Abuse and Mental Health Services Administration, 2014, SUBST AB MENT HLTH S; US Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, CHILD MALTREATMENT; Walton MA, 2010, JAMA-J AM MED ASSOC, V304, P527, DOI 10.1001/jama.2010.1066; Washington State Institute for Public Policy, 2015, BEN COST RES; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wildeman C, 2014, JAMA PEDIATR, V168, P706, DOI 10.1001/jamapediatrics.2014.410; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2002, WORLD REPORT VIOLENC	86	156	158	3	129	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					478	488		10.1001/jama.2015.8371	http://dx.doi.org/10.1001/jama.2015.8371			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO1OI	26241599	Green Accepted			2022-12-28	WOS:000358924500012
J	Li, MY; Shi, YM; Cheng, CC; Lu, LS; Lin, YC; Tang, HL; Tsai, ML; Chu, CW; Wei, KH; He, JH; Chang, WH; Suenaga, K; Li, LJ				Li, Ming-Yang; Shi, Yumeng; Cheng, Chia-Chin; Lu, Li-Syuan; Lin, Yung-Chang; Tang, Hao-Lin; Tsai, Meng-Lin; Chu, Chih-Wei; Wei, Kung-Hwa; He, Jr-Hau; Chang, Wen-Hao; Suenaga, Kazu; Li, Lain-Jong			Epitaxial growth of a monolayer WSe2-MoS2 lateral p-n junction with an atomically sharp interface	SCIENCE			English	Article							MOS2; LAYERS; PHOTOLUMINESCENCE; HETEROSTRUCTURES; HETEROJUNCTIONS; CHALCOGENIDES; GENERATION; ENERGY	Two-dimensional transition metal dichalcogenides (TMDCs) such as molybdenum sulfide MoS2 and tungsten sulfide WSe2 have potential applications in electronics because they exhibit high on-off current ratios and distinctive electro-optical properties. Spatially connected TMDC lateral heterojunctions are key components for constructing monolayer p-n rectifying diodes, light-emitting diodes, photovoltaic devices, and bipolar junction transistors. However, such structures are not readily prepared via the layer-stacking techniques, and direct growth favors the thermodynamically preferred TMDC alloys. We report the two-step epitaxial growth of lateral WSe2-MoS2 heterojunction, where the edge of WSe2 induces the epitaxial MoS2 growth despite a large lattice mismatch. The epitaxial growth process offers a controllable method to obtain lateral heterojunction with an atomically sharp interface.	[Li, Ming-Yang; Shi, Yumeng; Tang, Hao-Lin; Li, Lain-Jong] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Li, Ming-Yang; Cheng, Chia-Chin; Chu, Chih-Wei] Acad Sinica, Res Ctr Appl Sci, Taipei 10617, Taiwan; [Cheng, Chia-Chin; Wei, Kung-Hwa] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan; [Lu, Li-Syuan; Chang, Wen-Hao] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 30050, Taiwan; [Lin, Yung-Chang; Suenaga, Kazu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Tsai, Meng-Lin; He, Jr-Hau] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Chang, Wen-Hao] Minist Sci & Technol, TCECM, Taipei, Taiwan	King Abdullah University of Science & Technology; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Institute of Advanced Industrial Science & Technology (AIST); King Abdullah University of Science & Technology	Li, LJ (corresponding author), King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia.	lance.li@kaust.edu.sa	Lin, Yung-Chang/G-1545-2015; Li, Lain-Jong/D-5244-2011; He, Jr-Hau/B-5141-2011; Chang, Wen-Hao/C-4906-2013; Chang, Wen-Hao/O-2704-2019; Shi, Yumeng/A-7349-2012; Suenaga, Kazu/E-2339-2014; Chu, Chih Wei/C-2349-2009; He, Jr-Hau/Y-2620-2019	Lin, Yung-Chang/0000-0002-3968-7239; Li, Lain-Jong/0000-0002-4059-7783; He, Jr-Hau/0000-0003-1886-9241; Chang, Wen-Hao/0000-0003-4880-6006; Chang, Wen-Hao/0000-0003-4880-6006; Shi, Yumeng/0000-0002-9623-3778; Suenaga, Kazu/0000-0002-6107-1123; Chu, Chih Wei/0000-0003-0979-1729; He, Jr-Hau/0000-0003-1886-9241; Tang, Haolin/0000-0003-1041-5376; Wei, Kung-Hwa/0000-0002-0248-4091	King Abdullah University of Science and Technology (Saudi Arabia), Ministry of Science and Technology (MOST); Taiwan Consortium of Emergent Crystalline Materials (TCECM); Academia Sinica (Taiwan); Japan Science and Technology Agency research acceleration program; TCECM; MOST of Taiwan [NSC102-2119-M-009-002-MY3]; Center for Interdisciplinary Science of Nation Chiao Tung University;  [AOARD-134137]	King Abdullah University of Science and Technology (Saudi Arabia), Ministry of Science and Technology (MOST); Taiwan Consortium of Emergent Crystalline Materials (TCECM); Academia Sinica (Taiwan)(Academia Sinica - Taiwan); Japan Science and Technology Agency research acceleration program(Japan Science & Technology Agency (JST)); TCECM; MOST of Taiwan; Center for Interdisciplinary Science of Nation Chiao Tung University; 	L.-J.L. acknowledges support from King Abdullah University of Science and Technology (Saudi Arabia), Ministry of Science and Technology (MOST) and Taiwan Consortium of Emergent Crystalline Materials (TCECM), Academia Sinica (Taiwan), and AOARD-134137 (USA). Y.-C.L. and K.S. acknowledge support from the Japan Science and Technology Agency research acceleration program. W.-H.C. acknowledges the support from TCECM, MOST of Taiwan under grant NSC102-2119-M-009-002-MY3 and the Center for Interdisciplinary Science of Nation Chiao Tung University.	Castellanos-Gomez A, 2013, NANO LETT, V13, P5361, DOI 10.1021/nl402875m; Chiu M.-H., 2015, NATURE COMMUN; Chiu MH, 2014, ACS NANO, V8, P9649, DOI 10.1021/nn504229z; Conley HJ, 2013, NANO LETT, V13, P3626, DOI 10.1021/nl4014748; Duan XD, 2014, NAT NANOTECHNOL, V9, P1024, DOI [10.1038/NNANO.2014.222, 10.1038/nnano.2014.222]; Fang H, 2014, P NATL ACAD SCI USA, V111, P6198, DOI 10.1073/pnas.1405435111; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/NMAT4091, 10.1038/nmat4091]; Gutierrez HR, 2013, NANO LETT, V13, P3447, DOI 10.1021/nl3026357; Heine T, 2015, ACCOUNTS CHEM RES, V48, P65, DOI 10.1021/ar500277z; Hsu WT, 2014, ACS NANO, V8, P2951, DOI 10.1021/nn500228r; Huang CM, 2014, NAT MATER, V13, P1096, DOI [10.1038/nmat4064, 10.1038/NMAT4064]; Huang JK, 2014, ACS NANO, V8, P923, DOI 10.1021/nn405719x; Hui YY, 2013, ACS NANO, V7, P7126, DOI 10.1021/nn4024834; Ji QQ, 2013, NANO LETT, V13, P3870, DOI 10.1021/nl401938t; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Kumar N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.161403; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Li HM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7564; Li YL, 2013, NANO LETT, V13, P3329, DOI 10.1021/nl401561r; McGilp J. F., 1995, EPIOPTICS LINEAR NON; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Reider G. A., 1995, PHOTONIC PROBES SURF, V2; SHEN YR, 1989, ANNU REV PHYS CHEM, V40, P327, DOI 10.1146/annurev.pc.40.100189.001551; Shi YM, 2012, NANO LETT, V12, P2784, DOI [10.1021/nl204562J, 10.1021/nl204562j]; Su SH, 2014, SMALL, V10, P2589, DOI 10.1002/smll.201302893; Yang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05649; Zeng HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01608; Zhu CR, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.121301	28	822	833	66	1103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					524	528		10.1126/science.aab4097	http://dx.doi.org/10.1126/science.aab4097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228146				2022-12-28	WOS:000358713300053
J	Watts, G				Watts, Geoff			Levi Watkins Obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					334	334		10.1016/S0140-6736(15)61401-5	http://dx.doi.org/10.1016/S0140-6736(15)61401-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN5CX	26227458				2022-12-28	WOS:000358448400013
J	Zhang, Q; Zhao, K; Shen, QC; Han, YM; Gu, Y; Li, X; Zhao, DZ; Liu, YQ; Wang, CM; Zhang, X; Su, XP; Liu, J; Ge, W; Levine, RL; Li, N; Cao, XT				Zhang, Qian; Zhao, Kai; Shen, Qicong; Han, Yanmei; Gu, Yan; Li, Xia; Zhao, Dezhi; Liu, Yiqi; Wang, Chunmei; Zhang, Xiang; Su, Xiaoping; Liu, Juan; Ge, Wei; Levine, Ross L.; Li, Nan; Cao, Xuetao			Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6	NATURE			English	Article							KAPPA-B-ZETA; CELL SELF-RENEWAL; DNA DEMETHYLATION; GENE-EXPRESSION; AUTOIMMUNE-DISEASES; INTERFERON-GAMMA; T-CELLS; CYTOKINE; INNATE; 5-METHYLCYTOSINE	Epigenetic modifiers have fundamental roles in defining unique cellular identity through the establishment and maintenance of lineage-specific chromatin and methylation status(1). Several DNA modifications such as 5-hydroxymethylcytosine (5hmC) are catalysed by the ten eleven translocation (Tet) methylcytosine dioxygenase family members2, and the roles of Tet proteins in regulating chromatin architecture and gene transcription independently of DNA methylation have been gradually uncovered(3). However, the regulation of immunity and inflammation by Tet proteins independent of their role in modulating DNA methylation remains largely unknown. Here we show that Tet2 selectively mediates active repression of interleukin-6 (IL-6) transcription during inflammation resolution in innate myeloid cells, including dendritic cells and macrophages. Loss of Tet2 resulted in the upregulation of several inflammatory mediators, including IL-6, at late phase during the response to lipopolysaccharide challenge. Tet2-deficient mice were more susceptible to endotoxin shock and dextran-sulfate-sodium-induced colitis, displaying a more severe inflammatory phenotype and increased IL-6 production compared to wild-type mice. I kappa B zeta, an IL-6-specific transcription factor, mediated specific targeting of Tet2 to the Il6 promoter, further indicating opposite regulatory roles of I kappa B zeta at initial and resolution phases of inflammation. For the repression mechanism, independent of DNA methylation and hydroxymethylation, Tet2 recruited Hdac2 and repressed transcription of Il6 via histone deacetylation. We provide mechanistic evidence for the gene-specific transcription repression activity of Tet2 via histone deacetylation and for the prevention of constant transcription activation at the chromatin level for resolving inflammation.	[Zhang, Qian; Zhao, Kai; Li, Xia; Zhao, Dezhi; Wang, Chunmei; Ge, Wei; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zhang, Qian; Zhao, Kai; Li, Xia; Zhao, Dezhi; Wang, Chunmei; Ge, Wei; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Dept Immunol, Beijing 100005, Peoples R China; [Zhang, Qian; Shen, Qicong; Han, Yanmei; Gu, Yan; Liu, Yiqi; Zhang, Xiang; Su, Xiaoping; Liu, Juan; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Zhang, Qian; Shen, Qicong; Han, Yanmei; Gu, Yan; Liu, Yiqi; Zhang, Xiang; Su, Xiaoping; Liu, Juan; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Levine, Ross L.] Mem Sloan Kettering Canc, Human Oncol & Pathogenesis Program, New York, NY 10016 USA; [Levine, Ross L.] Mem Sloan Kettering Canc, Leukemia Serv, Dept Med, New York, NY 10016 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University; Naval Medical University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Cao, XT (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China.	caoxt@immunol.org	Liu, Yiqi/AAK-1630-2020; levine, ross/AAE-7658-2019; Han, Yanmei/D-8995-2016; Li, Xia/AAB-9647-2019; shen, qicong/GYJ-2803-2022	Zhao, Kai/0000-0002-3889-2118	National Key Basic Research Program of China [2013CB530503]; National Natural Science Foundation of China [31200654, 31390431, 81230074, 81123006]; NATIONAL CANCER INSTITUTE [R01CA173636, P30CA008748] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Key Basic Research Program of China (2013CB530503) and the National Natural Science Foundation of China (31200654, 31390431, 81230074, 81123006).	Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Liu J, 2014, NAT IMMUNOL, V15, P612, DOI 10.1038/ni.2898; Liu YQ, 2015, J IMMUNOL, V194, P2838, DOI 10.4049/jimmunol.1402087; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Rampal R, 2014, CELL REP, V9, P1841, DOI 10.1016/j.celrep.2014.11.004; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tlaskalova-Hogenova H, 2005, ANN NY ACAD SCI, V1051, P787, DOI 10.1196/annals.1361.122; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738	29	437	461	6	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					389	+		10.1038/nature15252	http://dx.doi.org/10.1038/nature15252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26287468	Green Accepted			2022-12-28	WOS:000361297900046
J	Schreiber, M; Hodgman, SS; Bordia, P; Luschen, HP; Fischer, MH; Vosk, R; Altman, E; Schneider, U; Bloch, I				Schreiber, Michael; Hodgman, Sean S.; Bordia, Pranjal; Lueschen, Henrik P.; Fischer, Mark H.; Vosk, Ronen; Altman, Ehud; Schneider, Ulrich; Bloch, Immanuel			Observation of many-body localization of interacting fermions in a quasirandom optical lattice	SCIENCE			English	Article							ANDERSON LOCALIZATION; ULTRACOLD ATOMS; SYSTEM; GAS; THERMALIZATION; EQUILIBRIUM; RELAXATION; TRANSPORT; INSULATOR; MATTER	Many-body localization (MBL), the disorder-induced localization of interacting particles, signals a breakdown of conventional thermodynamics because MBL systems do not thermalize and show nonergodic time evolution. We experimentally observed this nonergodic evolution for interacting fermions in a one-dimensional quasirandom optical lattice and identified the MBL transition through the relaxation dynamics of an initially prepared charge density wave. For sufficiently weak disorder, the time evolution appears ergodic and thermalizing, erasing all initial ordering, whereas above a critical disorder strength, a substantial portion of the initial ordering persists. The critical disorder value shows a distinctive dependence on the interaction strength, which is in agreement with numerical simulations. Our experiment paves the way to further detailed studies of MBL, such as in noncorrelated disorder or higher dimensions.	[Schreiber, Michael; Hodgman, Sean S.; Bordia, Pranjal; Lueschen, Henrik P.; Schneider, Ulrich; Bloch, Immanuel] Univ Munich, Fak Phys, D-80799 Munich, Germany; [Schreiber, Michael; Hodgman, Sean S.; Bordia, Pranjal; Lueschen, Henrik P.; Schneider, Ulrich; Bloch, Immanuel] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Fischer, Mark H.; Vosk, Ronen; Altman, Ehud] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-7610001 Rehovot, Israel; [Schneider, Ulrich] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Munich; Max Planck Society; Weizmann Institute of Science; University of Cambridge	Bloch, I (corresponding author), Univ Munich, Fak Phys, Schellingstr 4, D-80799 Munich, Germany.	imb@mpq.mpg.de	Hodgman, Sean/AAV-2779-2021; Schneider, Ulrich/N-4820-2015; Bloch, Immanuel/N-9169-2019; Fischer, Mark Hannes/K-2548-2013; Fischer, Mark Hannes/ABF-1974-2020; Bloch, Immanuel/G-3174-2010	Schneider, Ulrich/0000-0003-4345-9498; Fischer, Mark Hannes/0000-0003-0810-6064; Fischer, Mark Hannes/0000-0003-0810-6064; Bloch, Immanuel/0000-0002-0679-4759; Hodgman, Sean/0000-0002-2417-350X; Altman, Ehud/0000-0003-4068-8287	Deutsche Forschungsgemeinschaft [FOR801]; European Commission (UQUAM); European Commission (AQuS); U.S. Defense Advanced Research Projects Agency; Minerva Foundation; ISF [1594/11]; Nanosystems Initiative Munich (NIM); Swiss Society of Friends of the Weizmann Institute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission (UQUAM); European Commission (AQuS); U.S. Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Minerva Foundation; ISF(Israel Science Foundation); Nanosystems Initiative Munich (NIM); Swiss Society of Friends of the Weizmann Institute	We acknowledge useful discussions with F. Essler and technical assistance by D. Garbe and F. Gorg during the setup of the experiment. We acknowledge financial support by the Deutsche Forschungsgemeinschaft (FOR801, Deutsch-Israelisches Kooperationsprojekt Quantum phases of ultracold atoms in optical lattices), the European Commission (UQUAM and AQuS), the U.S. Defense Advanced Research Projects Agency (Quantum Emulations of New Materials Using Ultracold Atoms), the Minerva Foundation, ISF grant no. 1594/11, Nanosystems Initiative Munich (NIM), and the Swiss Society of Friends of the Weizmann Institute.	ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Andraschko F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.217201; Aubry S., 1980, Annals of the Israel Physical Society, V3, P133; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Bar Lev Y, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.100601; Bardarson JH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.017202; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Bauer B., 2013, J STAT MECH-THEORY E, V09; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; D'Errico C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.095301; Deissler B, 2010, NAT PHYS, V6, P354, DOI 10.1038/NPHYS1635; DEUTSCH JM, 1991, PHYS REV A, V43, P2046, DOI 10.1103/PhysRevA.43.2046; Essler F. H., 2005, ONE DIMENSIONAL HUBB, DOI 10.1017%2Fcbo9780511534843; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; Gadway B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145306; Gornyi IV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.206603; Gramsch C, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.053615; Gring M, 2012, SCIENCE, V337, P1318, DOI 10.1126/science.1224953; Huse DA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174202; Imbrie J. Z., 2014, MANY BODY LOCALIZATI; Iyer S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134202; Jendrzejewski F, 2012, NAT PHYS, V8, P398, DOI [10.1038/NPHYS2256, 10.1038/nphys2256]; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kondov SS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.083002; Kondov SS, 2011, SCIENCE, V334, P66, DOI 10.1126/science.1209019; Lahini Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013906; Lux J, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.053608; Ovadia M., 2014, EVIDENCE FINITE TEMP; Pal A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174411; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Pichler H, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.063605; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Schneider U, 2012, NAT PHYS, V8, P213, DOI [10.1038/nphys2205, 10.1038/NPHYS2205]; Schwartz T, 2007, NATURE, V446, P52, DOI 10.1038/nature05623; Sebby-Strabley J, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.033605; Serbyn M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174302; Serbyn M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.127201; Serbyn M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.260601; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; SREDNICKI M, 1994, PHYS REV E, V50, P888, DOI 10.1103/PhysRevE.50.888; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Vasseur R, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.217201; Vosk R., 2014, THEORY MANY BODY LOC; Vosk R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067204; Wiersma DS, 1997, NATURE, V390, P671, DOI 10.1038/37757; Winkler K, 2006, NATURE, V441, P853, DOI 10.1038/nature04918; Znidaric M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064426	51	1029	1032	5	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					842	845		10.1126/science.aaa7432	http://dx.doi.org/10.1126/science.aaa7432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26229112	Green Submitted			2022-12-28	WOS:000359832700042
J	Weiss, Y; McNeill, J; Pearson, DG; Nowell, GM; Ottley, CJ				Weiss, Yaakov; McNeill, John; Pearson, D. Graham; Nowell, Geoff M.; Ottley, Chris J.			Highly saline fluids from a subducting slab as the source for fluid-rich diamonds	NATURE			English	Article							TRACE-ELEMENT; INFRARED-ABSORPTION; QUANTITATIVE-DETERMINATION; SILICATE INCLUSIONS; COEXISTING FLUID; FORMING FLUIDS; MANTLE; EVOLUTION; NITROGEN; METASOMATISM	The infiltration of fluids into continental lithospheric mantle is a key mechanism for controlling abrupt changes in the chemical and physical properties of the lithospheric root(1,2), as well as diamond formation(3), yet the origin and composition of the fluids involved are still poorly constrained. Such fluids are trapped within diamonds when they form(4-7) and so diamonds provide a unique means of directly characterizing the fluids that percolate through the deep continental lithospheric mantle. Here we show a clear chemical evolutionary trend, identifying saline fluids as parental to silicic and carbonatitic deep mantle melts, in diamonds from the Northwest Territories, Canada. Fluid-rock interaction along with in situ melting cause compositional transitions, as the saline fluids traverse mixed peridotite-eclogite lithosphere. Moreover, the chemistry of the parental saline fluids-especially their strontium isotopic compositions-and the timing of host diamond formation suggest that a subducting Mesozoic plate under western North America is the source of the fluids. Our results imply a strong association between subduction, mantle metasomatism and fluid-rich diamond formation, emphasizing the importance of subduction-derived fluids in affecting the composition of the deep lithospheric mantle.	[Weiss, Yaakov] Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10964 USA; [McNeill, John; Nowell, Geoff M.; Ottley, Chris J.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Pearson, D. Graham] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	Columbia University; Durham University; University of Alberta	Weiss, Y (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10964 USA.	yweiss@ldeo.columbia.edu	Pearson, Graham/AAN-5507-2020	Nowell, Geoff/0000-0003-3229-128X	National Science Foundation [1348045]; Diamond Trading Company at Durham University; Deep Carbon Observatory (Sloan Foundation); Israel Science Foundation [435/12]; Division Of Earth Sciences [1348045] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Diamond Trading Company at Durham University; Deep Carbon Observatory (Sloan Foundation); Israel Science Foundation(Israel Science Foundation); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Y.W. acknowledges his Lamont postdoctoral fellowship and National Science Foundation grant no. 1348045. We thank T. Stachel and D. Walker for discussions and J. J. Gurney, J. Carlson, T. Nowicki and BHP Minerals/Dominion Diamonds for access to diamonds from the Ekati mine. J.M. was funded by a scholarship from the Diamond Trading Company at Durham University. D.G.P. completed this work under tenure of a Canada Excellence Research Chair, with support from the Deep Carbon Observatory (Sloan Foundation). Y.W. thanks Israel Science Foundation grant number 435/12 for funding the EPMA and Fourier transform infrared (FTIR) analyses at the Hebrew University. D. E. Jacob, M. Santosh and M. Walter made excellent suggestions that greatly improved this paper. This is Lamont-Doherty Earth Observatory contribution number 7908.	Allen DE, 2005, GEOCHIM COSMOCHIM AC, V69, P675, DOI 10.1016/j.gca.2004.07.016; Aulbach S, 2007, J PETROL, V48, P1843, DOI 10.1093/petrology/egm041; Bach W, 2001, GEOCHIM COSMOCHIM AC, V65, P3267, DOI 10.1016/S0016-7037(01)00677-9; BASTIN GF, 1991, ELECTRON PROBE QUANTITATION, P145; Benoit M, 1996, CHEM GEOL, V134, P199, DOI 10.1016/S0009-2541(96)00087-3; BOYD SR, 1994, PHILOS MAG B, V69, P1149, DOI 10.1080/01418639408240185; BOYD SR, 1995, PHILOS MAG B, V72, P351, DOI 10.1080/13642819508239089; Carlson RW, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000156; Charlier BLA, 2006, CHEM GEOL, V232, P114, DOI 10.1016/j.chemgeo.2006.02.015; Creighton S, 2010, CONTRIB MINERAL PETR, V159, P645, DOI 10.1007/s00410-009-0446-x; Currie CA, 2011, EARTH PLANET SC LETT, V303, P59, DOI 10.1016/j.epsl.2010.12.036; CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007; Dixon JE, 2004, EARTH PLANET SC LETT, V222, P451, DOI 10.1016/j.epsl.2004.03.022; Facer J, 2009, J PETROL, V50, P1443, DOI 10.1093/petrology/egp037; Font L, 2007, J ANAL ATOM SPECTROM, V22, P513, DOI 10.1039/b616328a; Griffin WL, 2009, J PETROL, V50, P1185, DOI 10.1093/petrology/egn033; Harlou R, 2009, CHEM GEOL, V260, P254, DOI 10.1016/j.chemgeo.2008.12.020; Jacob DE, 2014, EARTH-SCI REV, V136, P21, DOI 10.1016/j.earscirev.2014.05.005; Jones CE, 2001, AM J SCI, V301, P112, DOI 10.2475/ajs.301.2.112; KIFLAWI I, 1994, PHILOS MAG B, V69, P1141, DOI 10.1080/01418639408240184; Klein-BenDavid O, 2004, LITHOS, V77, P243, DOI 10.1016/j.lithos.2004.04.003; Klein-BenDavid O, 2007, GEOCHIM COSMOCHIM AC, V71, P723, DOI 10.1016/j.gca.2006.10.008; Klein-BenDavid O, 2014, GEOCHIM COSMOCHIM AC, V125, P146, DOI 10.1016/j.gca.2013.09.022; Klein-BenDavid O, 2010, EARTH PLANET SC LETT, V289, P123, DOI 10.1016/j.epsl.2009.10.035; KLINKHAMMER GP, 1994, GEOCHIM COSMOCHIM AC, V58, P5105, DOI 10.1016/0016-7037(94)90297-6; NAVON O, 1988, NATURE, V335, P784, DOI 10.1038/335784a0; Nazzareni S, 2008, AM MINERAL, V93, P1429, DOI 10.2138/am.2008.2802; Rowe MC, 2009, GEOLOGY, V37, P439, DOI 10.1130/G25530A.1; Rudnick R.L., 1994, KIMBERLITES RELATED, P336; Sarkar C, 2015, LITHOS, V218, P155, DOI 10.1016/j.lithos.2015.01.017; Schmidt M. W., 2003, TREAT GEOCHEM, V3, P567, DOI DOI 10.1016/B0-08-043751-6/03034-6; Shephard GE, 2014, J GEOPHYS RES-SOL EA, V119, P7889, DOI 10.1002/2014JB011078; Shirey SB, 2013, REV MINERAL GEOCHEM, V75, P355, DOI 10.2138/rmg.2013.75.12; Smith D, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000675; Stachel T, 2008, ORE GEOL REV, V34, P5, DOI 10.1016/j.oregeorev.2007.05.002; Stachel T, 2004, LITHOS, V77, P1, DOI 10.1016/j.lithos.2004.03.027; Taylor WR, 1996, GEOCHIM COSMOCHIM AC, V60, P4725, DOI 10.1016/S0016-7037(96)00302-X; TAYLOR WR, 1990, AM MINERAL, V75, P1290; Tomlinson EL, 2006, EARTH PLANET SC LETT, V250, P581, DOI 10.1016/j.epsl.2006.08.005; Tomlinson EL, 2009, EARTH PLANET SC LETT, V279, P362, DOI 10.1016/j.epsl.2009.01.010; van Achterbergh E, 2002, GEOLOGY, V30, P743, DOI 10.1130/0091-7613(2002)030<0743:SSFQCF>2.0.CO;2; Weiss Y, 2013, EARTH PLANET SC LETT, V376, P110, DOI 10.1016/j.epsl.2013.06.021; Weiss Y, 2011, EARTH PLANET SC LETT, V309, P337, DOI 10.1016/j.epsl.2011.07.012; Weiss Y, 2010, CHEM GEOL, V275, P26, DOI 10.1016/j.chemgeo.2010.04.010; Weiss Y, 2009, LITHOS, V112, P660, DOI 10.1016/j.lithos.2009.05.038; Zaitsev A. M., 2001, OPTICAL PROPERTIES D, V502	46	111	113	4	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					339	+		10.1038/nature14857	http://dx.doi.org/10.1038/nature14857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26289205				2022-12-28	WOS:000359714000033
J	Everett, BM; Brooks, MM; Vlachos, HEA; Chaitman, BR; Frye, RL; Bhatt, DL				Everett, Brendan M.; Brooks, Maria Mori; Vlachos, Helen E. A.; Chaitman, Bernard R.; Frye, Robert L.; Bhatt, Deepak L.		BARI 2D Study Grp	Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGHLY SENSITIVE ASSAY; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; EARLY-DIAGNOSIS; T ASSAY; ASSOCIATION; RISK; ELEVATIONS; MANAGEMENT; MORTALITY	BACKGROUND Cardiac troponin concentrations are used to identify patients who would benefit from urgent revascularization for acute coronary syndromes. We hypothesized that they might be used in patients with stable ischemic heart disease to identify those at high risk for cardiovascular events who might also benefit from prompt coronary revascularization. METHODS We measured the cardiac troponin T concentration at baseline with a high-sensitivity assay in 2285 patients who had both type 2 diabetes and stable ischemic heart disease and were enrolled in the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes trial. We tested for an association between the troponin T concentration and a composite end point of death from cardiovascular causes, myocardial infarction, or stroke; we then evaluated whether random assignment to prompt revascularization reduced the rate of the composite end point in patients with an abnormal troponin T concentration (>= 14 ng per liter) as compared with those with a normal troponin T concentration (<14 ng per liter). RESULTS Of the 2285 patients, 2277 (99.6%) had detectable (>= 3 ng per liter) troponin T concentrations and 897 (39.3%) had abnormal troponin T concentrations at baseline. The 5-year rate of the composite end point was 27.1% among the patients who had had abnormal troponin T concentrations at baseline, as compared with 12.9% among those who had had normal baseline troponin T concentrations. In models that were adjusted for cardiovascular risk factors, severity of diabetes, electrocardiographic abnormalities, and coronary anatomy, the hazard ratio for the composite end point among patients with abnormal troponin T concentrations was 1.85 (95% confidence interval [CI], 1.48 to 2.32; P<0.001). Among patients with abnormal troponin T concentrations, random assignment to prompt revascularization, as compared with medical therapy alone, did not result in a significant reduction in the rate of the composite end point (hazard ratio, 0.96; 95% CI, 0.74 to 1.25). CONCLUSIONS The cardiac troponin T concentration was an independent predictor of death from cardiovascular causes, myocardial infarction, or stroke in patients who had both type 2 diabetes and stable ischemic heart disease. An abnormal troponin T value of 14 ng per liter or higher did not identify a subgroup of patients who benefited from random assignment to prompt coronary revascularization. (Funded by the National Institutes of Health and Roche Diagnostics; BARI 2D ClinicalTrials.gov number, NCT00006305.)	[Everett, Brendan M.; Bhatt, Deepak L.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Everett, Brendan M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Everett, Brendan M.] Harvard Univ, Sch Med, Boston, MA USA; [Brooks, Maria Mori; Vlachos, Helen E. A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Brooks, Maria Mori; Vlachos, Helen E. A.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Chaitman, Bernard R.] St Louis Univ, Ctr Cardiovasc Care, Sch Med, St Louis, MO 63103 USA; [Frye, Robert L.] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Louis University; Mayo Clinic	Everett, BM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	beverett@partners.org		Rutter, Martin/0000-0001-6380-539X; Brooks, Maria/0000-0002-2030-7873	National Institutes of Health; Roche Diagnostics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL061746, U01HL061744, R21HL121495, U01HL063804, U01HL061748] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Diagnostics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funded by the National Institutes of Health and Roche Diagnostics; BARI 2D ClinicalTrials.gov number, NCT00006305.	Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Apple FS, 2014, CLIN BIOCHEM, V47, P867, DOI 10.1016/j.clinbiochem.2014.06.008; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brooks MM, 2008, AM HEART J, V156, P528, DOI [10.1016/j.ahj.2008.05.015, 10.1016/j.ajh.2008.05.015]; Chaitman BR, 2009, CIRCULATION, V120, P2529, DOI 10.1161/CIRCULATIONAHA.109.913111; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Everett BM, 2011, CIRCULATION, V123, P2811, DOI 10.1161/CIRCULATIONAHA.110.009928; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Gore MO, 2014, J AM COLL CARDIOL, V63, P1441, DOI 10.1016/j.jacc.2013.12.032; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Wallentin L, 2014, CIRCULATION, V129, P293, DOI 10.1161/CIRCULATIONAHA.113.004420; White HD, 2014, J AM COLL CARDIOL, V63, P345, DOI 10.1016/j.jacc.2013.08.1643; White HD, 2011, J AM COLL CARDIOL, V57, P2406, DOI 10.1016/j.jacc.2011.01.029	22	170	174	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					610	620		10.1056/NEJMoa1415921	http://dx.doi.org/10.1056/NEJMoa1415921			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LE	26267622	Green Accepted, Bronze			2022-12-28	WOS:000359707700006
J	Robbiani, DF; Deroubaix, S; Feldhahn, N; Oliveira, TY; Callen, E; Wang, Q; Jankovic, M; Silva, IT; Rommel, PC; Bosque, D; Eisenreich, T; Nussenzweig, A; Nussenzweig, MC				Robbiani, Davide F.; Deroubaix, Stephanie; Feldhahn, Niklas; Oliveira, Thiago Y.; Callen, Elsa; Wang, Qiao; Jankovic, Mila; Silva, Israel T.; Rommel, Philipp C.; Bosque, David; Eisenreich, Tom; Nussenzweig, Andre; Nussenzweig, Michel C.			Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma	CELL			English	Article							CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; C-MYC GENE; BURKITT-LYMPHOMA; CHROMOSOMAL TRANSLOCATIONS; SEQUENCING REVEALS; GERMINAL CENTER; FRAGILE SITES; ACTIVATION; MICE	Chronic infection with Plasmodium falciparum was epidemiologically associated with endemic Burkitt's lymphoma, a mature B cell cancer characterized by chromosome translocation between the c-myc oncogene and Igh, over 50 years ago. Whether infection promotes B cell lymphoma, and if so by which mechanism, remains unknown. To investigate the relationship between parasitic disease and lymphomagenesis, we used Plasmodium chabaudi (Pc) to produce chronic malaria infection in mice. Pc induces prolonged expansion of germinal centers (GCs), unique compartments in which B cells undergo rapid clonal expansion and express activation-induced cytidine deaminase (AID), a DNA mutator. GC B cells elicited during Pc infection suffer widespread DNA damage, leading to chromosome translocations. Although infection does not change the overall rate, it modifies lymphomagenesis to favor mature B cell lymphomas that are AID dependent and show chromosome translocations. Thus, malaria infection favors mature B cell cancers by eliciting protracted AID expression in GC B cells.	[Robbiani, Davide F.; Deroubaix, Stephanie; Feldhahn, Niklas; Oliveira, Thiago Y.; Wang, Qiao; Jankovic, Mila; Silva, Israel T.; Rommel, Philipp C.; Bosque, David; Eisenreich, Tom; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Callen, Elsa; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Robbiani, DF (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	drobbiani@rockefeller.edu; nussen@rockefeller.edu	Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Rommel, Philipp C/AAP-1813-2020; Oliveira, Thiago Y/ABF-5186-2020; Silva, Israel T/N-3858-2014; Robbiani, Davide F./AAF-7662-2019	Oliveira, Thiago Y/0000-0002-2654-0879; Rommel, Philipp C/0000-0002-9790-4086; Oliveira, Thiago Y/0000-0002-2654-0879; Silva, Israel T/0000-0002-4687-1499; Robbiani, Davide F./0000-0001-7379-3484; Wang, Qiao/0000-0001-6416-1733	Worldwide Cancer Research [11-0022]; Fondazione Ettore e Valeria Rossi; NIH [AI112602, AI037526, AI072529]; NIH, the National Cancer Institute, the Center for Cancer Research; Department of Defense grant (BCRP DOD Idea Expansion Award) [11557134]; NATIONAL CANCER INSTITUTE [ZIABC010283, ZIABC010959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112602, R01AI072529, R01AI037526, R37AI037526] Funding Source: NIH RePORTER	Worldwide Cancer Research; Fondazione Ettore e Valeria Rossi; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, the National Cancer Institute, the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grant (BCRP DOD Idea Expansion Award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank members of the lab for discussions and suggestions, the MR4 for providing the malaria parasites contributed by Drs. W. Peters, B. Robinson, and I. Landau, Dr. Frank Costantini for providing the ROSA26-targeting plasmids, and Dr. Rafael Casellas for AID<SUP>GFP</SUP> mice. A particular thank you goes to Klara Velinzon and Yelena Shatalina for FACS sorting and one goes to Ariel Halper-Stromberg for help with Figure 2. Moreover, the authors are thankful to Dr. Julie White (Laboratory of Comparative Pathology, Memorial Sloan-Kettering Cancer Center) for histopathological evaluation. This work was supported by a grant (11-0022) from Worldwide Cancer Research (formerly known as Association for International Cancer Research), by the Fondazione Ettore e Valeria Rossi, and by an NIH grant (AI112602) (to D.F.R.). This work was also supported in part by NIH grants (AI037526 and AI072529) (to M.C.N.). A.N. and E.C. are supported by the Intramural Research Program of the NIH, the National Cancer Institute, the Center for Cancer Research, and a Department of Defense grant (BCRP DOD Idea Expansion Award, grant 11557134). N.F. is a Bennett Fellow of Leukaemia and Lymphoma Research. M.C.N. is an HHMI Investigator. This manuscript is dedicated to Georg Klein on the occasion of his 90th birthday.	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; BURKITT D P, 1961, East Afr Med J, V38, P511; CARTER R, 1975, ANN TROP MED PARASIT, V69, P187, DOI 10.1080/00034983.1975.11687000; Cesarman E, 2014, ANNU REV PATHOL-MECH, V9, P349, DOI 10.1146/annurev-pathol-012513-104656; Chesi M, 1998, BLOOD, V91, P4457, DOI 10.1182/blood.V91.12.4457.412k48_4457_4463; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Epeldegui M, 2010, IMMUNOL RES, V48, P72, DOI 10.1007/s12026-010-8168-8; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Horne-Debets JM, 2013, CELL REP, V5, P1204, DOI 10.1016/j.celrep.2013.11.002; Jankovic M, 2013, MOL CELL, V49, P623, DOI 10.1016/j.molcel.2012.11.029; Janz S, 2003, GENE CHROMOSOME CANC, V36, P211, DOI 10.1002/gcc.10178; Kameoka Y, 2004, ONCOGENE, V23, P9148, DOI 10.1038/sj.onc.1208136; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Koduru PRK, 1997, BLOOD, V90, P4078, DOI 10.1182/blood.V90.10.4078; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Magrath I, 1990, Adv Cancer Res, V55, P133, DOI 10.1016/S0065-230X(08)60470-4; Magrath I, 2012, BRIT J HAEMATOL, V156, P744, DOI 10.1111/j.1365-2141.2011.09013.x; Marcucci F, 2011, BLOOD, V117, P1792, DOI 10.1182/blood-2010-06-275818; Marino S, 2000, GENE DEV, V14, P994; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; O'Shea D, 2008, BLOOD, V112, P3126, DOI 10.1182/blood-2008-05-154013; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Peters W, 2000, ANN TROP MED PARASIT, V94, P23, DOI 10.1080/00034980057581; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang Q, 2014, P NATL ACAD SCI USA, V111, P18667, DOI 10.1073/pnas.1420575111; Young KH, 2008, BLOOD, V112, P3088, DOI 10.1182/blood-2008-01-129783; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zucca E, 2000, BLOOD, V96, P410; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	73	96	97	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					727	737		10.1016/j.cell.2015.07.019	http://dx.doi.org/10.1016/j.cell.2015.07.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276629	Bronze, Green Accepted			2022-12-28	WOS:000359741400008
J	Sahni, A; Patel, A				Sahni, Ashima; Patel, Aiyub			Hemoptysis Associated with Paragonimus westermani	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sahni, Ashima] Cook Cty Hosp, Chicago, IL 60612 USA; [Patel, Aiyub] UnityPoint Clin, Peoria, IL USA	John H Stroger Junior Hospital Cook County	Sahni, A (corresponding author), Cook Cty Hosp, Chicago, IL 60612 USA.	1984ashima@gmail.com							0	1	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					E7	E7		10.1056/NEJMicm1409087	http://dx.doi.org/10.1056/NEJMicm1409087			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LE	26267642				2022-12-28	WOS:000359707700001
J	Gawande, A				Gawande, Atul			Global surgery	LANCET			English	Editorial Material									[Gawande, Atul] Brigham & Womens Hosp, Ariadne Labs, Boston, MA 02215 USA; [Gawande, Atul] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, A (corresponding author), Brigham & Womens Hosp, Ariadne Labs, Boston, MA 02215 USA.	safesurgery@ariadnelabs.org							0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					523	525		10.1016/S0140-6736(15)60764-4	http://dx.doi.org/10.1016/S0140-6736(15)60764-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8PG	26293430				2022-12-28	WOS:000359431900013
J	Cho, S; Kim, S; Kim, JH; Zhao, J; Seok, J; Keum, DH; Baik, J; Choe, DH; Chang, KJ; Suenaga, K; Kim, SW; Lee, YH; Yang, H				Cho, Suyeon; Kim, Sera; Kim, Jung Ho; Zhao, Jiong; Seok, Jinbong; Keum, Dong Hoon; Baik, Jaeyoon; Choe, Duk-Hyun; Chang, K. J.; Suenaga, Kazu; Kim, Sung Wng; Lee, Young Hee; Yang, Heejun			Phase patterning for ohmic homojunction contact in MoTe2	SCIENCE			English	Article							MOS2 TRANSISTORS; RESISTANCE; TRANSITION; SUPERCONDUCTIVITY; GRAPHENE	In physiological fluids and seawater, adhesion of synthetic polymers to solid surfaces is severely limited by high salt, pH, and hydration, yet these conditions have not deterred the evolution of effective adhesion bymussels. Mussel foot proteins provide insights about adhesive adaptations: Notably, the abundance and proximity of catecholic Dopa (3,4-dihydroxyphenylalanine) and lysine residues hint at a synergistic interplay in adhesion. Certain siderophores-bacterial iron chelators-consist of paired catechol and lysine functionalities, thereby providing a convenient experimental platform to explore molecular synergies in bioadhesion. These siderophores and synthetic analogs exhibit robust adhesion energies (E-ad >= -15 millijoules per square meter) to mica in saline pH 3.5 to 7.5 and resist oxidation. The adjacent catechol-lysine placement provides a "one-two punch," whereby lysine evicts hydrated cations from the mineral surface, allowing catechol binding to underlying oxides.	[Cho, Suyeon; Kim, Sera; Kim, Jung Ho; Zhao, Jiong; Seok, Jinbong; Keum, Dong Hoon; Lee, Young Hee] Sungkyunkwan Univ, Inst Basic Sci, IBS Ctr Integrated Nanostruct Phys CINAP, Suwon 440746, South Korea; [Kim, Sera; Kim, Jung Ho; Seok, Jinbong; Keum, Dong Hoon; Kim, Sung Wng; Lee, Young Hee; Yang, Heejun] Sungkyunkwan Univ, Dept Energy Sci, Suwon 440746, South Korea; [Baik, Jaeyoon] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, South Korea; [Choe, Duk-Hyun; Chang, K. J.] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Suenaga, Kazu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Pohang University of Science & Technology (POSTECH); Korea Advanced Institute of Science & Technology (KAIST); National Institute of Advanced Industrial Science & Technology (AIST)	Kim, SW (corresponding author), Sungkyunkwan Univ, Dept Energy Sci, Suwon 440746, South Korea.	kimsungwng@skku.edu; leeyoung@skku.edu; h.yang@skku.edu	YANG, Heejun/A-8468-2010; Chang, Kee Joo/C-1989-2011; Choe, Duk-Hyun/G-5980-2010; Kim, Sung Wng/A-4747-2013; Lee, Young Hee/A-5424-2013; Suenaga, Kazu/E-2339-2014; Zhao, Jiong/P-5735-2017	Choe, Duk-Hyun/0000-0002-2775-8976; Kim, Sung Wng/0000-0002-4802-5421; Suenaga, Kazu/0000-0002-6107-1123; Zhao, Jiong/0000-0002-7411-0734; Kim, Jung Ho/0000-0003-4931-3553; Cho, Suyeon/0000-0003-1931-9663	Institute for Basic Science [IBS-R011-D1]; National Research Foundation of Korea (NRF) [NRF-2014R1A1A2056386]; NRF [2013R1A1A1008025, NRF-2005-0093845]	Institute for Basic Science; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NRF	We acknowledge support from the Institute for Basic Science (IBS-R011-D1), the National Research Foundation of Korea (NRF) under grant NRF-2014R1A1A2056386 (H.Y.), the NRF under grant 2013R1A1A1008025 (S.W.K.), and the NRF under grant NRF-2005-0093845 (D.H.C. and K.J.C.). All data described are presented in the supplementary materials.	Byun KE, 2013, NANO LETT, V13, P4001, DOI [10.1021/nl402367y, 10.1021/nl3047305]; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/NCHEM.1589, 10.1038/nchem.1589]; CONAN A, 1984, J PHYS-PARIS, V45, P459, DOI 10.1051/jphys:01984004503045900; Das S, 2013, NANO LETT, V13, P100, DOI 10.1021/nl303583v; Duerloo KAN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5214; Eda G, 2012, ACS NANO, V6, P7311, DOI 10.1021/nn302422x; Han GH, 2011, ACS NANO, V5, P263, DOI 10.1021/nn1026438; Heising J, 1999, J AM CHEM SOC, V121, P638, DOI 10.1021/ja983043c; Kappera R, 2014, NAT MATER, V13, P1128, DOI [10.1038/nmat4080, 10.1038/NMAT4080]; Keum DH, 2015, NAT PHYS, V11, P482, DOI [10.1038/nphys3314, 10.1038/NPHYS3314]; Leong WS, 2015, ACS NANO, V9, P869, DOI 10.1021/nn506567r; Lin YF, 2014, ADV MATER, V26, P3263, DOI 10.1002/adma.201305845; Lin YC, 2014, NAT NANOTECHNOL, V9, P391, DOI [10.1038/nnano.2014.64, 10.1038/NNANO.2014.64]; Morosan E, 2006, NAT PHYS, V2, P544, DOI 10.1038/nphys360; Pradhan NR, 2014, ACS NANO, V8, P5911, DOI 10.1021/nn501013c; Shen DW, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216404; Sipos B, 2008, NAT MATER, V7, P960, DOI 10.1038/nmat2318; Vellinga M. B., 1970, J SOLID STATE CHEM, V2, P299, DOI DOI 10.1016/0022-4596(70)90085-X; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Yamamoto M, 2014, ACS NANO, V8, P3895, DOI 10.1021/nn5007607; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; YU AYC, 1970, SOLID STATE ELECTRON, V13, P239, DOI 10.1016/0038-1101(70)90056-0; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329	23	734	737	51	978	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					625	628		10.1126/science.aab3175	http://dx.doi.org/10.1126/science.aab3175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250680				2022-12-28	WOS:000359092900037
J	Goedert, M				Goedert, Michel			Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled A beta, tau, and alpha-synuclein	SCIENCE			English	Review							MULTIPLE-SYSTEM ATROPHY; GLIAL CYTOPLASMIC INCLUSIONS; GENOME-WIDE ASSOCIATION; CREUTZFELDT-JAKOB-DISEASE; TRANSGENIC MICE; NEURODEGENERATIVE-DISEASES; LEWY BODIES; EXPERIMENTAL TRANSMISSION; IDENTIFIES VARIANTS; COMMON VARIANTS	The pathological assembly of Ab, tau, and alpha-synuclein is at the heart of Alzheimer's and Parkinson's diseases. Extracellular deposits of Ab and intraneuronal tau inclusions define Alzheimer's disease, whereas intracellular inclusions of alpha-synuclein make up the Lewy pathology of Parkinson's disease. Most cases of disease are sporadic, but some are inherited in a dominant manner. Mutations frequently occur in the genes encoding Ab, tau, and alpha-synuclein. Overexpression of these mutant proteins can give rise to disease-associated phenotypes. Protein assembly begins in specific regions of the brain during the process of Alzheimer's and Parkinson's diseases, from where it spreads to other areas.	MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Goedert, M (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk			UK Medical Research Council [U105184291]; Association pour la Recherche sur Alzheimer; MRC [MC_U105184291] Funding Source: UKRI; Medical Research Council [MC_U105184291] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association pour la Recherche sur Alzheimer; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	I am grateful to S. B. Prusiner for his input and to F. Clavaguera, R. A. Crowther, D. S. Eisenberg, B. Ghetti, S. H. W. Scheres, M. G. Spillantini, and M. Tolnay for helpful comments on the manuscript. H. Braak, R. A. Crowther, K. Del Tredici, D. Eisenberg, B. Ghetti, G. Lingley, M. R. Sawaya and M. G. Spillantini helped with the figures. Our work is supported by the UK Medical Research Council (U105184291) and the "Association pour la Recherche sur Alzheimer." I am an Honorary Professor in the Department of Clinical Neurosciences, University of Cambridge.	Acx H, 2014, J BIOL CHEM, V289, P4346, DOI 10.1074/jbc.M113.530907; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; ALPER T, 1966, BIOCHEM BIOPH RES CO, V22, P278, DOI 10.1016/0006-291X(66)90478-5; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; BAKER HF, 1993, INT J EXP PATHOL, V74, P441; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Boluda S, 2015, ACTA NEUROPATHOL, V129, P221, DOI 10.1007/s00401-014-1373-0; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2009, ADV ANAT EMBRYOL CEL, V201, P1; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2015, ADV ANAT EMBRYOL CEL, V215, P1, DOI 10.1007/978-3-319-12679-1_1; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Burre J, 2015, J NEUROSCI, V35, P5221, DOI 10.1523/JNEUROSCI.4650-14.2015; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Clavaguera F, 2014, ACTA NEUROPATHOL, V127, P299, DOI 10.1007/s00401-013-1231-5; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; CROWTHER T, 1989, ANN MED, V21, P127, DOI 10.3109/07853898909149199; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Duyckaerts C, 2015, ACTA NEUROPATHOL, V129, P749, DOI 10.1007/s00401-015-1390-7; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; FRASER H, 1982, NATURE, V295, P149, DOI 10.1038/295149a0; Fritschi SK, 2014, ACTA NEUROPATHOL, V128, P477, DOI 10.1007/s00401-014-1339-2; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; GOUDSMIT J, 1980, NEUROLOGY, V30, P945, DOI 10.1212/WNL.30.9.945; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jenner P, 2013, J PARKINSON DIS, V3, P1, DOI 10.3233/JPD-130175; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mead S, 2009, NEW ENGL J MED, V361, P2056, DOI 10.1056/NEJMoa0809716; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nakamura K, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0208-0; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; OWEN F, 1989, LANCET, V1, P51; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Potter R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005615; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1985, J INFECT DIS, V152, P971, DOI 10.1093/infdis/152.5.971; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Sandberg MK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5347; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schweighauser M, 2015, ACTA NEUROPATHOL, V129, P157, DOI 10.1007/s00401-014-1360-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Svensson E., 2015, ANN NEUROL, DOI [10.1002/ana24448, DOI 10.1002/ANA24448]; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Wells GAH, 2007, J GEN VIROL, V88, P1363, DOI 10.1099/vir.0.82421-0; Xie T, 2014, P NATL ACAD SCI USA, V111, P13349, DOI 10.1073/pnas.1414837111; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094	139	567	583	18	458	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248							1255555	10.1126/science.1255555	http://dx.doi.org/10.1126/science.1255555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250687				2022-12-28	WOS:000359092900031
J	Vorosmarty, CJ; Hoekstra, AY; Bunn, SE; Conway, D; Gupta, J				Voeroesmarty, C. J.; Hoekstra, A. Y.; Bunn, S. E.; Conway, D.; Gupta, J.			What scale for water governance?	SCIENCE			English	Editorial Material							THREATS		[Voeroesmarty, C. J.] CUNY, Adv Sci Res Ctr, New York, NY 10021 USA; [Hoekstra, A. Y.] Univ Twente, Twente Water Ctr, NL-7500 AE Enschede, Netherlands; [Bunn, S. E.] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Conway, D.] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Gupta, J.] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Gupta, J.] UNESCO IHE Inst Water Educ, Delft, Netherlands	City University of New York (CUNY) System; University of Twente; Griffith University; University of London; London School Economics & Political Science; University of Amsterdam; IHE Delft Institute for Water Education	Vorosmarty, CJ (corresponding author), CUNY, Adv Sci Res Ctr, New York, NY 10021 USA.	Charles.Vorosmarty@asrc.cuny.edu	Hoekstra, Arjen Y./B-4980-2008; Gupta, Joyeeta/L-8672-2013; Bunn, Stuart E/B-9065-2008	Hoekstra, Arjen Y./0000-0002-4769-5239; Bunn, Stuart E/0000-0002-6540-3586; Conway, Declan/0000-0002-4590-6733; Gupta, Joyeeta/0000-0003-1424-2660	NSF [CNH-1115025]; Global Environment Facility [TWAP/DHI-11813758]; NASA [LCLUC-NNX12AD28G]; Global Water System Project; Grantham Foundation for the Protection of the Environment; Direct For Biological Sciences [1115025] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Global Environment Facility; NASA(National Aeronautics & Space Administration (NASA)); Global Water System Project; Grantham Foundation for the Protection of the Environment; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge support from the NSF (CNH-1115025), Global Environment Facility (TWAP/DHI-11813758), NASA (LCLUC-NNX12AD28G), Global Water System Project, and Grantham Foundation for the Protection of the Environment.	[Anonymous], 2014, POST 2015 GLOB GOAL; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Gupta J, 2013, CURR OPIN ENV SUST, V5, P573, DOI 10.1016/j.cosust.2013.09.003; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; National Research Council, 2012, HIM GLAC CLIM CHANG, DOI 10.17226/13449; Subramanian A, 2014, WATER POLICY, V16, P824, DOI 10.2166/wp.2014.010; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; WHO UNICEF, 2012, PROGR DRINK WAT SAN; World Economic Forum, 2015, GLOB RISKS 2015, V10th; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0	12	145	149	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					478	479		10.1126/science.aac6009	http://dx.doi.org/10.1126/science.aac6009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN8SP	26228130	Green Accepted			2022-12-28	WOS:000358713300031
J	Yang, L; Calay, ES; Fan, J; Arduini, A; Kunz, RC; Gygi, SP; Yalcin, A; Fu, SN; Hotamisligil, GS				Yang, Ling; Calay, Ediz S.; Fan, Jason; Arduini, Alessandro; Kunz, Ryan C.; Gygi, Steven P.; Yalcin, Abdullah; Fu, Suneng; Hotamisligil, Goekhan S.			S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; HEPATIC ER STRESS; CELL FATE; INSULIN-RESISTANCE; PROTEIN; IRE1; ACTIVATION; REVEALS; DECAY; XBP-1	The association between inflammation and endoplasmic reticulum (ER) stress has been observed in many diseases. However, if and how chronic inflammation regulates the unfolded protein response (UPR) and alters ER homeostasis in general, or in the context of chronic disease, remains unknown. Here, we show that, in the setting of obesity, inflammatory input through increased inducible nitric oxide synthase (iNOS) activity causes S-nitrosylation of a key UPR regulator, IRE1 alpha, which leads to a progressive decline in hepatic IRE1 alpha-mediated XBP1 splicing activity in both genetic (ob/ob) and dietary (high-fat diet-induced) models of obesity. Finally, in obese mice with liver-specific IRE1 alpha deficiency, reconstitution of IRE1 alpha expression with a nitrosylation-resistant variant restored IRE1 alpha-mediated XBP1 splicing and improved glucose homeostasis in vivo. Taken together, these data describe a mechanism by which inflammatory pathways compromise UPR function through iNOS-mediated S-nitrosylation of IRE1 alpha, which contributes to defective IRE1 alpha activity, impaired ER function, and prolonged ER stress in obesity.	[Yang, Ling; Calay, Ediz S.; Fan, Jason; Arduini, Alessandro; Yalcin, Abdullah; Fu, Suneng; Hotamisligil, Goekhan S.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Yang, Ling; Calay, Ediz S.; Fan, Jason; Arduini, Alessandro; Yalcin, Abdullah; Fu, Suneng; Hotamisligil, Goekhan S.] Harvard Univ, TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Boston, MA 02115 USA; [Kunz, Ryan C.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Yalcin, Abdullah/AAG-4175-2019	Yalcin, Abdullah/0000-0001-8604-4749; Fan, Jason/0000-0003-3481-1728; Arduini, Alessandro/0000-0002-0038-8741; Yang, Ling/0000-0002-3105-3063	American Heart Association Postdoctoral Fellowship; NIH [DK052539]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Hotamisligil laboratory for their contributions and discussions. We are especially grateful to K. C. Claiborn, A. Tirosh, G. Tuncman, and S. Widenmaier for their critical reading of the manuscript; T. Nakamura (University of Cincinnati) for providing the IRE1-RD construct; and P. Li (NIH) and Y. Lee for scientific discussions and insights. We thank A. Marette (Laval University, Canada) for providing materials for the preliminary experiments and discussions; T. Iwawaki (Gunma University, Japan) for the generous gift of the conditional IRE1 alpha-deletion mouse model; F. Urano (Washington University in St. Louis) for providing the IRE1 alpha<SUP>-/-</SUP> MEFs and constructs; R. Prywes (Columbia University) for providing the FLAG-IRE1 alpha construct; and M. Talipov, M. Ivanov, and Q. Timerghazin (Marquette University) for assistance in computational modeling of nitrosylated IRE1 alpha. L.Y. is supported by American Heart Association Postdoctoral Fellowship. This work is supported in part by a grant from NIH to G.S.H. (DK052539).	Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Derakhshan B, 2007, NAT PROTOC, V2, P1685, DOI 10.1038/nprot.2007.210; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Han YC, 2014, SCIENCE, V343, P1244, DOI 10.1126/science.1249845; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-47; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Murray CI, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013441; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Noronha BT, 2005, DIABETES, V54, P1082, DOI 10.2337/diabetes.54.4.1082; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Prischi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4554; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sreejayan N, 2008, OBESITY, V16, P1331, DOI 10.1038/oby.2008.217; Talipov MR, 2013, J PHYS CHEM B, V117, P1827, DOI 10.1021/jp310664z; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang LK, 2012, NAT CHEM BIOL, V8, P982, DOI [10.1038/NCHEMBIO.1094, 10.1038/nchembio.1094]; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	44	156	159	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					500	506		10.1126/science.aaa0079	http://dx.doi.org/10.1126/science.aaa0079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228140	Green Accepted			2022-12-28	WOS:000358713300047
J	Yoon, KW; Byun, S; Kwon, E; Hwang, SY; Chu, KK; Hiraki, M; Jo, SH; Weins, A; Hakroush, S; Cebulla, A; Sykes, DB; Greka, A; Mundel, P; Fisher, DE; Mandinova, A; Lee, SW				Yoon, Kyoung Wan; Byun, Sanguine; Kwon, Eunjeong; Hwang, So-Young; Chu, Kiki; Hiraki, Masatsugu; Jo, Seung-Hee; Weins, Astrid; Hakroush, Samy; Cebulla, Angelika; Sykes, David B.; Greka, Anna; Mundel, Peter; Fisher, David E.; Mandinova, Anna; Lee, Sam W.			Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53	SCIENCE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PHOSPHATIDYLSERINE RECEPTOR; AUTOIMMUNE-DISEASES; STEM-CELLS; EMBRYONIC-DEVELOPMENT; GENE; EXPRESSION; EXPOSURE; PHAGOCYTOSIS; INFLAMMATION	The inefficient clearance of dying cells can lead to abnormal immune responses, such as unresolved inflammation and autoimmune conditions. We show that tumor suppressor p53 controls signaling-mediated phagocytosis of apoptotic cells through its target, Death Domain1 alpha (DD1 alpha), which suggests that p53 promotes both the proapoptotic pathway and postapoptotic events. DD1 alpha appears to function as an engulfment ligand or receptor that engages in homophilic intermolecular interaction at intercellular junctions of apoptotic cells and macrophages, unlike other typical scavenger receptors that recognize phosphatidylserine on the surface of dead cells. DD1 alpha-deficient mice showed in vivo defects in clearing dying cells, which led to multiple organ damage indicative of immune dysfunction. p53-induced expression of DD1 alpha thus prevents persistence of cell corpses and ensures efficient generation of precise immune responses.				swlee@mgh.harvard.edu	HIRAKI, Masatsugu/L-7593-2019; Fisher, David/AAH-2878-2019; Byun, Sanguine/AAR-5451-2021	Mattigk, Angelika/0000-0001-8710-458X; Hakroush, Samy/0000-0002-2843-3567; Byun, Sanguine/0000-0003-3903-5887	Deutsche Forschungsgemeinschaft [HA 6334/1-1]; MD student fellowship stipends from Boehringer Ingelheim Fonds; NIH [CA149477, CA142805, CA80058, S10RR027673, DK57683, DK062472, DK091218, DK093378]; NATIONAL CANCER INSTITUTE [R01CA149477, P01CA080058, R01CA142805] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091218, R01DK057683, R01DK099465, R01DK095045, R01DK062472] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MD student fellowship stipends from Boehringer Ingelheim Fonds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Cutaneous Biology Research Center of MGH, J. H. Lee, J. Park, M. Kashiwagi, J. Seavitt, S. Ezell, A. Gurkar, T. Namba, and M. Choo for helpful suggestions on experiments and C. Ford and T. Woo for technical assistance. We also thank A. Sharpe and G. Freeman for precious advice, guidance during the study, and generous reading of the manuscript. This paper is dedicated to the memory of Victor Fung. We also thank T. Strom for TIM family protein constructs and Z. Wang for the Protein Core from MGH. S. H. was supported by a research stipend from the Deutsche Forschungsgemeinschaft (HA 6334/1-1) and currently is in the Department of Pathology, University Medical Center Gottingen, Gottingen, Germany. A. C. was supported by MD student fellowship stipends from Boehringer Ingelheim Fonds. The work was partially funded by NIH grants CA149477, CA142805, CA80058, S10RR027673, DK57683, DK062472, DK091218, and DK093378.	Aloia L, 2010, J BIOL CHEM, V285, P7776, DOI 10.1074/jbc.M109.077156; Arizti P, 2000, MOL CELL BIOL, V20, P7450, DOI 10.1128/MCB.20.20.7450-7459.2000; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Brown L, 2007, EMBO J, V26, P3410, DOI 10.1038/sj.emboj.7601779; Campbell HG, 2012, CELL CYCLE, V11, P446, DOI 10.4161/cc.11.3.19054; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Cooks T, 2014, CARCINOGENESIS, V35, P1680, DOI 10.1093/carcin/bgu134; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Devitt A, 2004, J CELL BIOL, V167, P1161, DOI 10.1083/jcb.200410057; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P504, DOI 10.1006/bbrc.1999.1820; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fairhurst AM, 2006, ADV IMMUNOL, V92, P1, DOI 10.1016/S0065-2776(06)92001-X; Fang L, 2001, EMBO J, V20, P1931, DOI 10.1093/emboj/20.8.1931; Feldman CH, 2013, ARTHRITIS RHEUM-US, V65, P753, DOI 10.1002/art.37795; Flies DB, 2014, J CLIN INVEST, V124, P1966, DOI 10.1172/JCI74589; Flies DB, 2011, J IMMUNOL, V187, P1537, DOI 10.4049/jimmunol.1100660; Fray MA, 2014, IMMUNITY, V40, P633, DOI 10.1016/j.immuni.2014.05.001; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Green DR, 2000, NATURE, V405, P28, DOI 10.1038/35011175; Hakroush S, 2009, AM J PATHOL, V175, P1883, DOI 10.2353/ajpath.2009.080792; HALAZONETIS TD, 1993, EMBO J, V12, P1021, DOI 10.1002/j.1460-2075.1993.tb05743.x; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hirose Y, 2012, P NATL ACAD SCI USA, V109, P4263, DOI 10.1073/pnas.1117560109; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Hummer BT, 2001, J VIROL, V75, P7774, DOI 10.1128/JVI.75.16.7774-7777.2001; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jung DJ, 2010, J BIOL CHEM, V285, P7995, DOI 10.1074/jbc.M109.047985; Kawashima H, 2013, J IMMUNOL, V191, P3614, DOI 10.4049/jimmunol.1300509; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Le Mercier I, 2014, CANCER RES, V74, P1933, DOI 10.1158/0008-5472.CAN-13-1506; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lines JL, 2014, CANCER IMMUNOL RES, V2, P510, DOI 10.1158/2326-6066.CIR-14-0072; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Nagata S, 2010, ANN NY ACAD SCI, V1209, P10, DOI 10.1111/j.1749-6632.2010.05749.x; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; O'Callaghan CA, 2004, BEST PRACT RES CL RH, V18, P411, DOI 10.1016/j.berh.2004.03.002; Okuda Y, 2003, J NEUROIMMUNOL, V135, P29, DOI 10.1016/S0165-5728(02)00428-9; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park JS, 2013, ARTHRITIS RHEUM-US, V65, P949, DOI 10.1002/art.37841; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Sakr MA, 2010, CANCER SCI, V101, P2368, DOI 10.1111/j.1349-7006.2010.01675.x; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Takatori H, 2014, CRIT REV IMMUNOL, V34, P509, DOI 10.1615/CritRevImmunol.2014012193; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang L, 2014, P NATL ACAD SCI USA, V111, P14846, DOI 10.1073/pnas.1407447111; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; Watanabe M, 2014, IMMUNITY, V40, P681, DOI 10.1016/j.immuni.2014.04.006; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhang SZ, 2011, FASEB J, V25, P2387, DOI 10.1096/fj.10-175299; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443	83	135	151	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							1261669	10.1126/science.1261669	http://dx.doi.org/10.1126/science.1261669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228159	Green Submitted, Green Accepted			2022-12-28	WOS:000358713300046
J	Brown, A; Shao, SC; Murray, J; Hegde, RS; Ramakrishnan, V				Brown, Alan; Shao, Sichen; Murray, Jason; Hegde, Ramanujan S.; Ramakrishnan, V.			Structural basis for stop codon recognition in eukaryotes	NATURE			English	Article							TERMINATION FACTOR ERF1; RELEASE FACTOR ERF1; PARTICLE ELECTRON CRYOMICROSCOPY; TRANSFER-RNA HYDROLYSIS; CRYO-EM STRUCTURE; TRANSLATION TERMINATION; CRYSTAL-STRUCTURE; 70S RIBOSOME; COMPLEX; RESOLUTION	Termination of protein synthesis occurs when a translating ribosome encounters one of three universally conserved stop codons: UAA, UAG or UGA. Release factors recognize stop codons in the ribosomal A-site to mediate release of the nascent chain and recycling of the ribosome. Bacteria decode stop codons using two separate release factors with differing specificities for the second and third bases(1). By contrast, eukaryotes rely on an evolutionarily unrelated omnipotent release factor (eRF1) to recognize all three stop codons(2). The molecular basis of eRF1 discrimination for stop codons over sense codons is not known. Here we present cryoelectron microscopy (cryo-EM) structures at 3.5-3.8 angstrom resolution of mammalian ribosomal complexes containing eRF1 interacting with each of the three stop codons in the A-site. Binding of eRF1 flips nucleotide A1825 of 18S ribosomal RNA so that it stacks on the second and third stop codon bases. This configuration pulls the fourth position base into the A-site, where it is stabilized by stacking against G626 of 18S rRNA. Thus, eRF1 exploits two rRNA nucleotides also used during transfer RNA selection to drive messenger RNA compaction. In this compacted mRNA conformation, stop codons are favoured by a hydrogen-bonding network formed between rRNA and essential eRF1 residues that constrains the identity of the bases. These results provide a molecular framework for eukaryotic stop codon recognition and have implications for future studies on the mechanisms of canonical and premature translation termination(3,4).	[Brown, Alan; Shao, Sichen; Murray, Jason; Hegde, Ramanujan S.; Ramakrishnan, V.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Hegde, RS (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk; ramak@mrc-lmb.cam.ac.uk	Brown, Alan/I-1473-2019	Brown, Alan/0000-0002-0021-0476; Hegde, Ramanujan/0000-0001-8338-852X; Shao, Sichen/0000-0003-2679-5537; Ramakrishnan, V/0000-0002-4699-2194	UK Medical Research Council [MC_UP_A022_1007, MC_U105184332]; Career Development Fellowship; St John's College Title A fellowship; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; NIH Oxford-Cambridge Scholars' Program; MRC [MC_UP_A022_1007, MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332, MC_UP_A022_1007] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Career Development Fellowship; St John's College Title A fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; NIH Oxford-Cambridge Scholars' Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C. Savva, F. de Haas, and S. Welsch for assisting with cryo-EM data collection, J. Grimmett and T. Darling for computing support, D. Barford for critically reading the manuscript, and I. Fernandez, J. Llacer, G. Murshudov, S. Scheres, and R. Voorhees for useful discussions. Gctf is available on request from K. Zhang (kzhang@mrc-lmb.cam.ac.uk). This work was supported by the UK Medical Research Council (MC_UP_A022_1007 to R.S.H. and MC_U105184332 to V.R.). A.B. was supported by a Career Development Fellowship. S. S. was supported by a St John's College Title A fellowship. J.M. thanks T. Dever, NICHD, and the NIH Oxford-Cambridge Scholars' Program for support. V.R. was supported by a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation.	Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; BROWN CM, 1990, NUCLEIC ACIDS RES, V18, P6339, DOI 10.1093/nar/18.21.6339; Bulygin KN, 2010, RNA, V16, P1902, DOI 10.1261/rna.2066910; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chavatte L, 2002, EMBO J, V21, P5302, DOI 10.1093/emboj/cdf484; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng Z, 2009, GENE DEV, V23, P1106, DOI 10.1101/gad.1770109; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Feng T, 2014, MOL CELL, V53, P645, DOI 10.1016/j.molcel.2013.12.028; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12-386497-0.00002-5, 10.1016/B978-0-12.386497.000002-5]; Karcher A, 2008, J BIOL CHEM, V283, P7962, DOI 10.1074/jbc.M707347200; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Kolosov P, 2005, NUCLEIC ACIDS RES, V33, P6418, DOI 10.1093/nar/gki927; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Kryuchkova P, 2013, NUCLEIC ACIDS RES, V41, P4573, DOI 10.1093/nar/gkt113; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Muhs M, 2015, MOL CELL, V57, P422, DOI 10.1016/j.molcel.2014.12.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Preis A, 2014, CELL REP, V8, P59, DOI 10.1016/j.celrep.2014.04.058; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Seit-Nebi A, 2002, EMBO REP, V3, P881, DOI 10.1093/embo-reports/kvf178; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shao SC, 2014, MOL CELL, V55, P880, DOI 10.1016/j.molcel.2014.07.006; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Shirokikh NE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1025; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Taylor D, 2012, P NATL ACAD SCI USA, V109, P18413, DOI 10.1073/pnas.1216730109; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wong LE, 2012, NUCLEIC ACIDS RES, V40, P5751, DOI 10.1093/nar/gks192	49	164	167	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					493	+		10.1038/nature14896	http://dx.doi.org/10.1038/nature14896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26245381	Green Accepted			2022-12-28	WOS:000360069300044
J	Margoliash, D; Tchernichovski, O				Margoliash, Daniel; Tchernichovski, Ofer			Marmoset kids actually listen	SCIENCE			English	Editorial Material							DYNAMICS; SONG		[Margoliash, Daniel] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Tchernichovski, Ofer] CUNY Hunter Coll, Dept Psychol, New York, NY 10065 USA	University of Chicago; City University of New York (CUNY) System; Hunter College (CUNY)	Margoliash, D (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dan@bigbird.uchicago.edu	Tchernichovski, Ofer/AAC-5678-2019	Tchernichovski, Ofer/0000-0001-6788-614X				Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; DAWKINS R, 1996, CLIMBING MOUNT IMPOS; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Goldstein MH, 2008, PSYCHOL SCI, V19, P515, DOI 10.1111/j.1467-9280.2008.02117.x; Margoliash D, 2009, TRENDS COGN SCI, V13, P505, DOI 10.1016/j.tics.2009.10.003; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Takahashi DY, 2015, SCIENCE, V349, P734, DOI 10.1126/science.aab1058; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Watson SK, 2015, CURR BIOL, V25, P495, DOI 10.1016/j.cub.2014.12.032	10	12	13	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					688	689		10.1126/science.aac7860	http://dx.doi.org/10.1126/science.aac7860			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273040				2022-12-28	WOS:000359415100016
J	Rivera, LB; Bergers, G				Rivera, Lee B.; Bergers, Gabriele			Tumor angiogenesis, from foe to friend	SCIENCE			English	Editorial Material							COMBINATION THERAPY; ANGIOCRINE FACTORS; VASCULAR NICHE; GROWTH		[Rivera, Lee B.; Bergers, Gabriele] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rivera, LB (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA 94158 USA.	lee.rivera@ucsf.edu; gabriele.bergers@ucsf.edu	Bergers, Gabriele/AAJ-5535-2020	Bergers, Gabriele/0000-0003-3545-5171				Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cao ZW, 2014, CANCER CELL, V25, P350, DOI 10.1016/j.ccr.2014.02.005; Hollebecque A, 2012, CURR OPIN ONCOL, V24, P305, DOI 10.1097/CCO.0b013e32835249de; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Tavora B, 2014, NATURE, V514, P112, DOI 10.1038/nature13541; Wong PP, 2015, CANCER CELL, V27, P123, DOI 10.1016/j.ccell.2014.10.015	10	78	82	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					694	695		10.1126/science.aad0862	http://dx.doi.org/10.1126/science.aad0862			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273044				2022-12-28	WOS:000359415100020
J	Dwork, C; Feldman, V; Hardt, M; Pitassi, T; Reingold, O; Roth, A				Dwork, Cynthia; Feldman, Vitaly; Hardt, Moritz; Pitassi, Toniann; Reingold, Omer; Roth, Aaron			The reusable holdout: Preserving validity in adaptive data analysis	SCIENCE			English	Article							FALSE DISCOVERY; STABILITY	Misapplication of statistical data analysis is a common cause of spurious discoveries in scientific research. Existing approaches to ensuring the validity of inferences drawn from data assume a fixed procedure to be performed, selected before the data are examined. In common practice, however, data analysis is an intrinsically adaptive process, with new analyses generated on the basis of data exploration, as well as the results of previous analyses on the same data. We demonstrate a new approach for addressing the challenges of adaptivity based on insights from privacy-preserving data analysis. As an application, we show how to safely reuse a holdout data set many times to validate the results of adaptively chosen analyses.	[Dwork, Cynthia] Microsoft Res, Mountain View, CA 94043 USA; [Feldman, Vitaly] IBM Almaden Res Ctr, San Jose, CA 95120 USA; [Hardt, Moritz] Google Res, Mountain View, CA 94043 USA; [Pitassi, Toniann] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Reingold, Omer] Samsung Res Amer, Mountain View, CA 94043 USA; [Roth, Aaron] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA	Microsoft; International Business Machines (IBM); Google Incorporated; University of Toronto; Samsung; University of Pennsylvania	Dwork, C (corresponding author), Microsoft Res, Mountain View, CA 94043 USA.	dwork@microsoft.com; vitaly@post.harvard.edu; m@mrtz.org; toni@cs.toronto.edu; omer.reingold@gmail.com; aaroth@cis.upenn.edu			NSF CAREER grant [CNS 1253345]; NSF [CCF 1101389]; Alfred P. Sloan Foundation; Natural Sciences and Engineering Research Council of Canada; Direct For Computer & Info Scie & Enginr [1065060] Funding Source: National Science Foundation	NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Authors are listed in alphabetical order. A.R. was supported in part by an NSF CAREER grant (CNS 1253345), NSF grant CCF 1101389, and the Alfred P. Sloan Foundation. T.P. was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada. We thank S. Arora, M. F. Balcan, A. Blum, D. Foster, M. Kearns, J. Kleinberg, A. Rakhlin, P. Rigollet, W. Su, and J. Ullman for enlightening discussions about this work. We also thank the Simons Institute for the Theory of Computing at the University of California Berkeley, where part of this research was done.	Aharoni E, 2011, IEEE ACM T COMPUT BI, V8, P1431, DOI 10.1109/TCBB.2010.105; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bousquet O, 2002, J MACH LEARN RES, V2, P499, DOI 10.1162/153244302760200704; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chambers C., 2013, GUARDIAN US     0605; Dwork C, 2006, LECT NOTES COMPUT SC, V3876, P265, DOI 10.1007/11681878_14; Foster DP, 2008, J R STAT SOC B, V70, P429, DOI 10.1111/j.1467-9868.2007.00643.x; FREEDMAN DA, 1983, AM STAT, V37, P152, DOI 10.2307/2685877; Gelman A, 2014, AM SCI, V102, P460, DOI 10.1511/2014.111.460; HASTIE T, 2009, SPRINGER SERIES STAT; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Javanmard A., 2015, ONLINE CONTROL FALSE; Poggio T, 2004, NATURE, V428, P419, DOI 10.1038/nature02341; Rao R. B., 2008, P 2008 SIAM INT C DA, P588, DOI DOI 10.1137/1.9781611972788.54; Reunanen J., 2003, Journal of Machine Learning Research, V3, P1371, DOI 10.1162/153244303322753715; Shalev-Shwartz S, 2010, J MACH LEARN RES, V11, P2635; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632	17	136	138	7	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					636	638		10.1126/science.aaa9375	http://dx.doi.org/10.1126/science.aaa9375			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250683				2022-12-28	WOS:000359092900040
J	Hall, J				Hall, Jane			INTERNATIONAL HEALTH CARE SYSTEMS Australian Health Care - The Challenge of Reform in a Fragmented System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2007, Australia	University of Technology Sydney	Hall, J (corresponding author), Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2007, Australia.			Hall, Jane/0000-0002-2191-0543				Australian Government Department of the Prime Minister and Cabinet, 2014, 3 AUSTR GOV DEP PRIM; Hall J, 2010, HEALTH ECON, V19, P1259, DOI 10.1002/hec.1652; Sax S, 1985, STRIFE INTERESTS POL	3	43	43	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					493	497		10.1056/NEJMp1410737	http://dx.doi.org/10.1056/NEJMp1410737			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO2LM	26244304				2022-12-28	WOS:000358987700001
J	Heisler, DB; Kudryashova, E; Grinevich, DO; Suarez, C; Winkelman, JD; Birukov, KG; Kotha, SR; Parinandi, NL; Vavylonis, D; Kovar, DR; Kudryashov, DS				Heisler, David B.; Kudryashova, Elena; Grinevich, Dmitry O.; Suarez, Cristian; Winkelman, Jonathan D.; Birukov, Konstantin G.; Kotha, Sainath R.; Parinandi, Narasimham L.; Vavylonis, Dimitrios; Kovar, David R.; Kudryashov, Dmitri S.			ACD toxin-produced actin oligomers poison formin-controlled actin polymerization	SCIENCE			English	Article							CROSS-LINKING DOMAIN; CHOLERAE RTX TOXIN; FILAMENT ELONGATION; PROTECTIVE ANTIGEN; PROFILIN ISOFORMS; ATP HYDROLYSIS; LETHAL FACTOR; TARGET-CELLS; FH1 DOMAIN; TRANSLOCATION	The actin cross-linking domain (ACD) is an actin-specific toxin produced by several pathogens, including life-threatening spp. of Vibrio cholerae, Vibrio vulnificus, and Aeromonas hydrophila. Actin cross-linking by ACD is thought to lead to slow cytoskeleton failure owing to a gradual sequestration of actin in the form of nonfunctional oligomers. Here, we found that ACD converted cytoplasmic actin into highly toxic oligomers that potently "poisoned" the ability of major actin assembly proteins, formins, to sustain actin polymerization. Thus, ACD can target the most abundant cellular protein by using actin oligomers as secondary toxins to efficiently subvert cellular functions of actin while functioning at very low doses.	[Heisler, David B.; Kudryashova, Elena; Grinevich, Dmitry O.; Kudryashov, Dmitri S.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Heisler, David B.; Kudryashov, Dmitri S.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Suarez, Cristian; Winkelman, Jonathan D.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Birukov, Konstantin G.] Univ Chicago, Sect Pulm & Crit Care, Dept Med, Chicago, IL 60637 USA; [Birukov, Konstantin G.] Univ Chicago, Lung Injury Ctr, Dept Med, Chicago, IL 60637 USA; [Kotha, Sainath R.; Parinandi, Narasimham L.] Ohio State Univ, Coll Med, Dept Med,Dorothy M Davis Heart & Lung Res Inst, Lipid Signaling & Lipid Lab,Div Pulm Allergy Cri, Columbus, OH 43210 USA; [Vavylonis, Dimitrios] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA; [Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Chicago; University of Chicago; University of Chicago; University System of Ohio; Ohio State University; Lehigh University; University of Chicago	Kudryashova, E (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	kudryashova.1@osu.edu; kudryashov.1@osu.edu	Kudryashov, Dmitri/P-9004-2014; Kudryashova, Elena/K-8223-2019; Birukov, Konstantin/FJB-5755-2022; Heisler, David/AAU-2189-2020; Kudryashova, Elena/ADL-6316-2022	Kudryashova, Elena/0000-0002-1646-1229; Heisler, David/0000-0002-6482-4215; Kudryashova, Elena/0000-0002-1646-1229; Kudryashov, Dmitri/0000-0003-1782-3305	Ohio State University; American Heart Association [13IRG14780028]; NIH [R01 GM079265, R01 GM098430]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079265, R01GM114666, R01GM098430] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Vartiainen and T. Viita (University of Helsinki) for donating double-tagged SHA-actin plasmid. This work was supported by The Ohio State University startup funds (to D.S.K.), American Heart Association Innovative Research Grant (13IRG14780028 to D.S.K.), NIH (R01 GM079265 to D.R.K. and R01 GM098430 to D.V.). D.B.H. purified proteins, conducted pyrene actin and TIRFM experiments, analyzed data, and cowrote the manuscript; E.K. conducted cell culture, pull-down and immunoblotting experiments, analyzed data, and cowrote the manuscript; D.O.G. purified proteins and conducted pyrene actin assays; C.S., J.D.W., and D.R.K. conducted TIRFM and analyzed data; K.G.B., S.R.K., and N.L.P. conducted TEER; D.V. performed modeling; D.S.K. coordinated the study, analyzed data, and cowrote the manuscript. The authors declare no conflict of interest. Supplementary materials contain additional data.	ARORA N, 1994, INFECT IMMUN, V62, P4955, DOI 10.1128/IAI.62.11.4955-4961.1994; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Courtemanche N, 2013, BIOCHEMISTRY-US, V52, P6456, DOI 10.1021/bi400682n; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Geissler B, 2009, MOL MICROBIOL, V73, P858, DOI 10.1111/j.1365-2958.2009.06810.x; GIESELMANN R, 1995, EUR J BIOCHEM, V229, P621, DOI 10.1111/j.1432-1033.1995.tb20506.x; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kudryashov DS, 2008, J BIOL CHEM, V283, P445, DOI 10.1074/jbc.M703910200; Kudryashov DS, 2010, J BIOL CHEM, V285, P25591, DOI 10.1074/jbc.M110.123869; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Kudryashov DS, 2004, BIOPHYS J, V87, P1136, DOI 10.1529/biophysj.104.042242; Kudryashova E, 2014, IMMUNITY, V41, P709, DOI 10.1016/j.immuni.2014.10.018; Kudryashova E, 2014, MOL MICROBIOL, V92, P1056, DOI 10.1111/mmi.12615; Kudryashova E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045721; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lemichez E, 2013, EXP CELL RES, V319, P2329, DOI 10.1016/j.yexcr.2013.04.021; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Schmoller KM, 2011, BIOPHYS J, V101, P803, DOI 10.1016/j.bpj.2011.07.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Sept D, 1999, BIOPHYS J, V77, P2911, DOI 10.1016/S0006-3495(99)77124-9; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Sliman SM, 2010, MOL CELL BIOCHEM, V333, P9, DOI 10.1007/s11010-009-0199-x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suarez C, 2015, DEV CELL, V32, P43, DOI 10.1016/j.devcel.2014.10.027; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Yarmola EG, 2008, BIOPHYS J, V95, P5544, DOI 10.1529/biophysj.108.134569	44	34	41	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					535	539		10.1126/science.aab4090	http://dx.doi.org/10.1126/science.aab4090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228148	Green Accepted			2022-12-28	WOS:000358713300056
J	Kofman, W; Herique, A; Barbin, Y; Barriot, JP; Ciarletti, V; Clifford, S; Edenhofer, P; Elachi, C; Eyraud, C; Goutail, JP; Heggy, E; Jorda, L; Lasue, J; Levasseur-Regourd, AC; Nielsen, E; Pasquero, P; Preusker, F; Puget, P; Plettemeier, D; Rogez, Y; Sierks, H; Statz, C; Svedhem, H; Williams, I; Zine, S; Van Zyl, J				Kofman, Wlodek; Herique, Alain; Barbin, Yves; Barriot, Jean-Pierre; Ciarletti, Valerie; Clifford, Stephen; Edenhofer, Peter; Elachi, Charles; Eyraud, Christelle; Goutail, Jean-Pierre; Heggy, Essam; Jorda, Laurent; Lasue, Jeremie; Levasseur-Regourd, Anny-Chantal; Nielsen, Erling; Pasquero, Pierre; Preusker, Frank; Puget, Pascal; Plettemeier, Dirk; Rogez, Yves; Sierks, Holger; Statz, Christoph; Svedhem, Hakan; Williams, Iwan; Zine, Sonia; Van Zyl, Jakob			Properties of the 67P/Churyumov-Gerasimenko interior revealed by CONSERT radar	SCIENCE			English	Article							POLAR LAYERED DEPOSITS; COMET 67P/CHURYUMOV-GERASIMENKO; SUBSURFACE; NUCLEUS; PERMITTIVITY; 81P/WILD-2; FREQUENCY; ICE; CO2	The Philae lander provides a unique opportunity to investigate the internal structure of a comet nucleus, providing information about its formation and evolution in the early solar system. We present Comet Nucleus Sounding Experiment by Radiowave Transmission (CONSERT) measurements of the interior of Comet 67P/Churyumov-Gerasimenko. From the propagation time and form of the signals, the upper part of the "head" of 67P is fairly homogeneous on a spatial scale of tens of meters. CONSERT also reduced the size of the uncertainty of Philae's final landing site down to approximately 21 by 34 square meters. The average permittivity is about 1.27, suggesting that this region has a volumetric dust/ice ratio of 0.4 to 2.6 and a porosity of 75 to 85%. The dust component may be comparable to that of carbonaceous chondrites.	[Kofman, Wlodek; Herique, Alain; Pasquero, Pierre; Puget, Pascal; Rogez, Yves; Zine, Sonia] Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France; [Barbin, Yves] CNRS, IPAG, F-38000 Grenoble, France; [Barbin, Yves] Aix Marseille Univ, Univ Toulon, INSU, CNRS,MIO,IRD,UM 110, F-83957 La Garde, France; [Barriot, Jean-Pierre] Geodesy Observ Tahiti, F-98702 Faaa, Tahiti, France; [Ciarletti, Valerie; Goutail, Jean-Pierre] Univ Versailles St Quentin En Yvelines, UVSQ, UPSay, F-78280 Guyancourt, France; Univ Paris 06, Sorbonne Univ, F-78280 Guyancourt, France; [Ciarletti, Valerie; Goutail, Jean-Pierre] CNRS INSU, F-78280 Guyancourt, France; [Ciarletti, Valerie; Goutail, Jean-Pierre] Inst Pierre Simon Laplace, Lab Atmospheres Milieux Observat Spatiales LATMOS, F-78280 Guyancourt, France; [Clifford, Stephen] Lunar & Planetary Inst, Houston, TX 77058 USA; [Edenhofer, Peter] Ruhr Univ Bochum, Fac Elect Engn & Informat Technol, D-44780 Bochum, Germany; [Elachi, Charles; Heggy, Essam; Van Zyl, Jakob] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Nielsen, Erling; Sierks, Holger] Max Planck Inst Sonnensyst Forsch MPS, D-37077 Gottingen, Germany; [Plettemeier, Dirk; Statz, Christoph] Tech Univ Dresden, D-01069 Dresden, Germany; [Svedhem, Hakan] ESA, European Space Res & Technol Ctr ESTEC Noordwijk, Noordwijk, Netherlands; [Williams, Iwan] Queen Mary Univ London, London E1 4NS, England; [Jorda, Laurent] Lab Astrophys Marseille Pole Etoile, F-13388 Marseille, France; [Levasseur-Regourd, Anny-Chantal] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Levasseur-Regourd, Anny-Chantal] UVSQ, UPSay, F-75005 Paris, France; [Levasseur-Regourd, Anny-Chantal] CNRS, INSU, F-75005 Paris, France; [Levasseur-Regourd, Anny-Chantal] LATMOS IPSL, BC 102, F-75005 Paris, France; [Lasue, Jeremie] Univ Toulouse, F-31028 Toulouse, France; [Lasue, Jeremie] UPS OMP, F-31028 Toulouse, France; [Lasue, Jeremie] IRAP, F-31028 Toulouse, France; [Lasue, Jeremie] 2 CNRS, F-31028 Toulouse, France; [Eyraud, Christelle] Aix Marseille Univ, CNRS, Cent Marseille, Inst Fresnel UMR 7249, F-13013 Marseille, France; [Preusker, Frank] German Aerosp Ctr DLR, D-12489 Berlin, Germany; [Heggy, Essam] Univ So Calif, Ming Hsieh Dept Elect Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Ruhr University Bochum; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Technische Universitat Dresden; University of London; Queen Mary University London; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Universite de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; German Aerospace Centre (DLR); University of Southern California	Kofman, W (corresponding author), Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France.	wlodek.kofman@obs.ujf-grenoble.fr	Herique, Alain/E-7210-2017; Kofman, Wlodek/C-4556-2008; Jorda, Laurent/AAA-1718-2021; Barriot, Jean-Pierre/AAD-6709-2021; Ciarletti, Valérie/F-4752-2010; Heggy, Essam/AAL-8124-2020	Herique, Alain/0000-0003-3699-883X; Kofman, Wlodek/0000-0002-6744-8796; Barriot, Jean-Pierre/0000-0002-2112-9685; Ciarletti, Valérie/0000-0001-9483-0539; Heggy, Essam/0000-0001-7476-2735; Zine, Sonia/0000-0002-2872-0291; Williams, Iwan Prys/0000-0002-8069-1344; Eyraud, Christelle/0000-0002-8386-1089; JORDA, Laurent/0000-0001-8735-3308	CNES; CNRS; Universite Joseph Fourier (UJF); DLR; MPS; Rhone-Alpes region [CPER07_13 CIRA]; OSUG@2020 labex [ANR10 LABX56]; Equip@Meso project of the program Investissements d'Avenir [ANR-10-EQPX-29-01]; Science and Technology Facilities Council [ST/J001546/1] Funding Source: researchfish; STFC [ST/J001546/1] Funding Source: UKRI	CNES(Centre National D'etudes Spatiales); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier (UJF); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); MPS; Rhone-Alpes region(Region Auvergne-Rhone-Alpes); OSUG@2020 labex; Equip@Meso project of the program Investissements d'Avenir(French National Research Agency (ANR)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Rosetta is an European Space Agency (ESA) mission with contributions from its member states and National Aeronautics and Space Administration (NASA). Rosetta's Philae lander is provided by a consortium led by Deutsches Zentrum fur Luft- und Raumfahrt (DLR), Max Planck Institut fur Sonnesystemforschung (MPS), Centre National d'Etudes Spatiales (CNES), and Agenzia Spaziale Italiana (ASI). The CONSERT instrument was designed, built, and operated by IPAG, LATMOS, and MPS and was financially supported by CNES, CNRS, Universite Joseph Fourier (UJF), DLR, and MPS. The authors thank the teams of Rosetta [Rosetta Mission Operation Center (RMOC) and Rosetta Science Ground Segment (RSGS)] and Philae (Rosetta Lander Control Center (LCC) and Rosetta Lander Science Operation & Navigation Center (SONC)) for making possible the CONSERT operations. Most of the computations presented in this paper were performed using the Calcul Intensif, Modelisation, Experimentation Numerique (CIMENT) infrastructure (https://ciment.ujf-grenoble.fr), including the Froggy platform, which is supported by the Rhone-Alpes region (GRANT CPER07_13 CIRA), the OSUG@2020 labex (reference ANR10 LABX56), the Equip@Meso project (reference ANR-10-EQPX-29-01) of the program Investissements d'Avenir supervised by the Agence Nationale pour la Recherche and France-Grille (www.france-grilles.fr). Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. All CONSERT data are released through the PSA archive of ESA (www.rssd.esa.int/index.php?project=PSA&page=rosetta).	Andersson O, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/24/244115; Benna M, 2004, IEEE T ANTENN PROPAG, V52, P709, DOI 10.1109/TAP.2004.825564; Biele J, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9816; Boisson J, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003768; Brownlee D, 2012, METEORIT PLANET SCI, V47, P453, DOI 10.1111/j.1945-5100.2012.01339.x; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Ehrenfreund P, 2000, ANNU REV ASTRON ASTR, V38, P427, DOI 10.1146/annurev.astro.38.1.427; Festou MC, 2004, SPACE SCI S, P3; Flynn GJ, 2006, SCIENCE, V314, P1731, DOI 10.1126/science.1136141; GOUGH SR, 1972, CAN J CHEMISTRY, V50, P3046, DOI 10.1139/v72-483; GROTHE H, 1993, J CRYST GROWTH, V127, P1010, DOI 10.1016/0022-0248(93)90778-U; Hadamcik E, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014167; Hanner MS, 2004, SPACE SCI S, P555; Heggy E, 2012, ICARUS, V221, P925, DOI 10.1016/j.icarus.2012.09.023; Herique A, 1999, PLANET SPACE SCI, V47, P885, DOI 10.1016/S0032-0633(98)00144-5; Joswiak DJ, 2012, METEORIT PLANET SCI, V47, P471, DOI 10.1111/j.1945-5100.2012.01337.x; Kamoun P, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201423544; Klinger J, 1996, PLANET SPACE SCI, V44, P637, DOI 10.1016/0032-0633(96)00067-0; Kofman W, 1998, ADV SPACE RES, V21, P1589, DOI 10.1016/S0273-1177(97)00952-6; Ono T, 2008, EARTH PLANETS SPACE, V60, P321, DOI 10.1186/BF03352797; Pettinelli E, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001869; Phillips RJ, 2011, SCIENCE, V332, P838, DOI 10.1126/science.1203091; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Schulz R, 2015, NATURE, V518, P216, DOI 10.1038/nature14159; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Sihvola A., 2004, ELECTROMAGNETIC MIXI; Stephan T, 2008, SPACE SCI REV, V138, P247, DOI 10.1007/s11214-007-9291-2	28	179	179	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aab0639	10.1126/science.aab0639	http://dx.doi.org/10.1126/science.aab0639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228153	Green Published			2022-12-28	WOS:000358713300005
J	Macintosh, B; Graham, JR; Barman, T; De Rosa, RJ; Konopacky, Q; Marley, MS; Marois, C; Nielsen, EL; Pueyo, L; Rajan, A; Rameau, J; Saumon, D; Wang, JJ; Patience, J; Ammons, M; Arriaga, P; Artigau, E; Beckwith, S; Brewster, J; Bruzzone, S; Bulger, J; Burningham, B; Burrows, AS; Chen, C; Chiang, E; Chilcote, JK; Dawson, RI; Dong, R; Doyon, R; Draper, ZH; Duchene, G; Esposito, TM; Fabrycky, D; Fitzgerald, MP; Follette, KB; Fortney, JJ; Gerard, B; Goodsell, S; Greenbaum, AZ; Hibon, P; Hinkley, S; Cotten, TH; Hung, LW; Ingraham, P; Johnson-Groh, M; Kalas, P; Lafreniere, D; Larkin, JE; Lee, J; Line, M; Long, D; Maire, J; Marchis, F; Matthews, BC; Max, CE; Metchev, S; Millar-Blanchaer, MA; Mittal, T; Morley, CV; Morzinski, KM; Murray-Clay, R; Oppenheimer, R; Palmer, DW; Patel, R; Perrin, MD; Poyneer, LA; Rafikov, RR; Rantakyro, FT; Rice, EL; Rojo, P; Rudy, AR; Ruffio, JB; Ruiz, MT; Sadakuni, N; Saddlemyer, L; Salama, M; Savransky, D; Schneider, AC; Sivaramakrishnan, A; Song, I; Soummer, R; Thomas, S; Vasisht, G; Wallace, JK; Ward-Duong, K; Wiktorowicz, SJ; Wolff, SG; Zuckerman, B				Macintosh, B.; Graham, J. R.; Barman, T.; De Rosa, R. J.; Konopacky, Q.; Marley, M. S.; Marois, C.; Nielsen, E. L.; Pueyo, L.; Rajan, A.; Rameau, J.; Saumon, D.; Wang, J. J.; Patience, J.; Ammons, M.; Arriaga, P.; Artigau, E.; Beckwith, S.; Brewster, J.; Bruzzone, S.; Bulger, J.; Burningham, B.; Burrows, A. S.; Chen, C.; Chiang, E.; Chilcote, J. K.; Dawson, R. I.; Dong, R.; Doyon, R.; Draper, Z. H.; Duchene, G.; Esposito, T. M.; Fabrycky, D.; Fitzgerald, M. P.; Follette, K. B.; Fortney, J. J.; Gerard, B.; Goodsell, S.; Greenbaum, A. Z.; Hibon, P.; Hinkley, S.; Cotten, T. H.; Hung, L-W.; Ingraham, P.; Johnson-Groh, M.; Kalas, P.; Lafreniere, D.; Larkin, J. E.; Lee, J.; Line, M.; Long, D.; Maire, J.; Marchis, F.; Matthews, B. C.; Max, C. E.; Metchev, S.; Millar-Blanchaer, M. A.; Mittal, T.; Morley, C. V.; Morzinski, K. M.; Murray-Clay, R.; Oppenheimer, R.; Palmer, D. W.; Patel, R.; Perrin, M. D.; Poyneer, L. A.; Rafikov, R. R.; Rantakyroe, F. T.; Rice, E. L.; Rojo, P.; Rudy, A. R.; Ruffio, J-B.; Ruiz, M. T.; Sadakuni, N.; Saddlemyer, L.; Salama, M.; Savransky, D.; Schneider, A. C.; Sivaramakrishnan, A.; Song, I.; Soummer, R.; Thomas, S.; Vasisht, G.; Wallace, J. K.; Ward-Duong, K.; Wiktorowicz, S. J.; Wolff, S. G.; Zuckerman, B.			Discovery and spectroscopy of the young jovian planet 51 Eri b with the Gemini Planet Imager	SCIENCE			English	Article							RADIAL-VELOCITIES; T DWARFS; SOLAR NEIGHBORHOOD; MASS COMPANION; GIANT PLANETS; STARS; BINARY; CLOUDS; GAS; ORBIT	Directly detecting thermal emission from young extrasolar planets allows measurement of their atmospheric compositions and luminosities, which are influenced by their formation mechanisms. Using the Gemini Planet Imager, we discovered a planet orbiting the similar to 20-million-year-old star 51 Eridani at a projected separation of 13 astronomical units. Near-infrared observations show a spectrum with strong methane and water-vapor absorption. Modeling of the spectra and photometry yields a luminosity (normalized by the luminosity of the Sun) of 1.6 to 4.0 x 10(-6) and an effective temperature of 600 to 750 kelvin. For this age and luminosity, "hot-start" formation models indicate a mass twice that of Jupiter. This planet also has a sufficiently low luminosity to be consistent with the "cold-start" core-accretion process that may have formed Jupiter.	[Macintosh, B.; Nielsen, E. L.; Follette, K. B.; Ruffio, J-B.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Macintosh, B.; Ammons, M.; Palmer, D. W.; Poyneer, L. A.] Lawrence Livermore Natl Lab, Livermore, CA 94040 USA; [Graham, J. R.; De Rosa, R. J.; Wang, J. J.; Beckwith, S.; Chiang, E.; Dawson, R. I.; Dong, R.; Duchene, G.; Kalas, P.; Mittal, T.; Salama, M.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Barman, T.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Konopacky, Q.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Marley, M. S.; Burningham, B.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Marois, C.; Draper, Z. H.; Gerard, B.; Johnson-Groh, M.; Matthews, B. C.; Saddlemyer, L.] Natl Res Council Canada, Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada; [Marois, C.; Draper, Z. H.; Gerard, B.; Johnson-Groh, M.; Matthews, B. C.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Nielsen, E. L.; Brewster, J.; Kalas, P.; Marchis, F.; Ruffio, J-B.] Search Extraterr Intelligence Inst, Carl Sagan Ctr, Mountain View, CA 94043 USA; [Pueyo, L.; Chen, C.; Greenbaum, A. Z.; Long, D.; Perrin, M. D.; Sivaramakrishnan, A.; Soummer, R.; Wolff, S. G.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Rajan, A.; Patience, J.; Bulger, J.; Ward-Duong, K.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Rameau, J.; Artigau, E.; Doyon, R.; Lafreniere, D.] Univ Montreal, Inst Rech Exoplanetes, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Saumon, D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Arriaga, P.; Esposito, T. M.; Fitzgerald, M. P.; Hung, L-W.; Larkin, J. E.; Zuckerman, B.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Bruzzone, S.; Metchev, S.] Univ Western Ontario, Ctr Planetary Sci & Explorat, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Bulger, J.] Subaru Telescope, Hilo, HI 96720 USA; [Burningham, B.] Univ Hertfordshire, Sci & Technol Res Inst, Hatfield AL10 9AB, Herts, England; [Burrows, A. S.; Rafikov, R. R.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Chilcote, J. K.; Maire, J.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Duchene, G.] Univ Grenoble Alpes, CNRS, Inst Planetol & Astrophys Grenoble, F-38000 Grenoble, France; [Fabrycky, D.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Fortney, J. J.; Line, M.; Max, C. E.; Morley, C. V.; Rudy, A. R.; Wiktorowicz, S. J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Goodsell, S.] Univ Durham, Dept Phys, Durham DH1, England; [Goodsell, S.; Hibon, P.; Rantakyroe, F. T.; Sadakuni, N.] Gemini Observ, La Serena, Chile; [Greenbaum, A. Z.; Wolff, S. G.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Hinkley, S.] Univ Exeter, Astrophys Grp, Exeter EX4 4QL, Devon, England; [Cotten, T. H.; Lee, J.; Song, I.] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Ingraham, P.; Thomas, S.] Large Synopt Survey Telescope, Tucson, AZ 85719 USA; [Metchev, S.; Patel, R.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Millar-Blanchaer, M. A.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Morzinski, K. M.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Murray-Clay, R.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Oppenheimer, R.; Rice, E. L.] Amer Museum Nat Hist, Dept Astrophys, New York, NY 10024 USA; [Rice, E. L.] CUNY Coll Staten Isl, Dept Engn Sci & Phys, Staten Isl, NY 10314 USA; [Rojo, P.; Ruiz, M. T.] Univ Chile, Dept Astron, Santiago, Chile; [Sadakuni, N.] Univ Space Res Assoc, NASA Armstrong Flight Res Ctr, Stratospher Observ Infrared Astron, Palmdale, CA 93550 USA; [Savransky, D.] Cornell Univ, Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Schneider, A. C.] Univ Toledo, Phys & Astron, Toledo, OH 43606 USA; [Vasisht, G.; Wallace, J. K.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Stanford University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of Arizona; University of California System; University of California San Diego; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Research Council Canada; University of Victoria; Space Telescope Science Institute; Arizona State University; Arizona State University-Tempe; Universite de Montreal; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Los Angeles; Western University (University of Western Ontario); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Hertfordshire; Princeton University; University of Toronto; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); University of Chicago; University of California System; University of California Santa Cruz; Durham University; Johns Hopkins University; University of Exeter; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto; University of Arizona; University of California System; University of California Santa Barbara; American Museum of Natural History (AMNH); City University of New York (CUNY) System; College of Staten Island (CUNY); Universidad de Chile; National Aeronautics & Space Administration (NASA); Universities Space Research Association (USRA); Cornell University; University System of Ohio; University of Toledo; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Macintosh, B (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA.	bmacintosh@stanford.edu	Song, Inseok/GSI-5721-2022; Savransky, Dmitry/M-1298-2014; Rojo, Patricio/I-5765-2016; Rojo, Patricio/AAD-5227-2020; Vasisht, Gautam/AAP-3022-2020; Wallace, James/AAA-5741-2020; Patel, Rahul/L-3203-2019; Ruiz, María Teresa/I-5770-2016; Fitzgerald, Michael/C-2642-2009; Rice, Emily/G-4446-2013	Song, Inseok/0000-0002-5815-7372; Savransky, Dmitry/0000-0002-8711-7206; Vasisht, Gautam/0000-0002-1871-6264; Patel, Rahul/0000-0002-5025-6827; Ruiz, María Teresa/0000-0002-6799-1537; Esposito, Thomas/0000-0002-0792-3719; Salama, Maissa/0000-0002-5082-6332; Fitzgerald, Michael/0000-0002-0176-8973; Schneider, Adam/0000-0002-6294-5937; Macintosh, Bruce/0000-0003-1212-7538; Follette, Katherine/0000-0002-7821-0695; Morzinski, Katie/0000-0002-1384-0063; Greenbaum, Alexandra/0000-0002-7162-8036; Burningham, Ben/0000-0003-4600-5627; Long, Douglas/0000-0002-2508-9211; Fabrycky, Daniel/0000-0003-3750-0183; Kalas, Paul/0000-0002-6221-5360; Wang, Jason/0000-0003-0774-6502; Konopacky, Quinn/0000-0002-9936-6285; De Rosa, Robert/0000-0002-4918-0247; Dong, Ruobing/0000-0001-9290-7846; Nielsen, Eric/0000-0001-6975-9056; Arriaga, Pauline/0000-0001-6364-2834; Oppenheimer, Rebecca/0000-0001-7130-7681; Marley, Mark/0000-0002-5251-2943; Metchev, Stanimir/0000-0003-3050-8203; Rice, Emily/0000-0002-3252-5886; Perrin, Marshall/0000-0002-3191-8151	NSF [AST-1411868, AST-0909188, AST-1313718, AST-1413718, AST-1405505, DGE-123825, DGE-1311230, DGE-1232825, DGE-1144087]; NASA [NNX14AJ80G, NNH15AZ591, NNX15AD95G, NNX11AD21G, NNH11ZDA001N]; Fonds de Recherche du Quebec; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Direct For Mathematical & Physical Scien [1413718, 1153335] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1413744, 1211568, 1518332] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Fonds de Recherche du Quebec; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is based on observations obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy under a cooperative agreement with NSF on behalf of the Gemini partnership, whose membership includes: NSF (United States); the National Research Council (Canada); the Comision Nacional de Investigacion Cientifica y Tecnologica (Chile); the Australian Research Council (Australia); the Ministerio da Ciencia, Tecnologia e Inovacao (Brazil); and Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina). The research was supported by grants from NSF, including AST-1411868 (B.M., K.F., J.P., and A.R.), AST-0909188 and AST-1313718 (J.R.G., P.K., R.D.R., and J.W.), AST-1413718 (M.P.F. and G.D.), and AST-1405505 (T.B.). Support was also provided by grants from NASA, including NNX14AJ80G (B.M., F.M., E.N., and M.P.), NNH15AZ591 (D.S. and M.M.), NNX15AD95G (J.R.G. and P.K.), NNX11AD21G (J.R.G. and P.K.), and NNH11ZDA001N (S.M. and R.P.). J.R., R.D., and D.L. acknowledge support from the Fonds de Recherche du Quebec. Support is acknowledged from NSF fellowships DGE-123825 (A.Z.G.), DGE-1311230 (K.W.-D.), DGE-1232825 (S.G.W.), and DGE-1144087 (L.W.H.). Portions of this work were performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. GPI data are archived at the Gemini Science Archive: www.cadc-ccda.hia-iha.nrc-cnrc.gc.ca/en/gsa/.	ABT HA, 1995, ASTROPHYS J SUPPL S, V99, P135, DOI 10.1086/192182; Amara A, 2012, MON NOT R ASTRON SOC, V427, P948, DOI 10.1111/j.1365-2966.2012.21918.x; Bailey JI, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/16; Bailey V, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/1/L4; Barman T. S., SIMULTANEOUS DETECTI; Barman TS, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/65; Barman TS, 2005, ESA SPEC PUBL, V560, P437; Bergfors C, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014114; Beuzit J.-L., 2010, SPIR LYOT 2010 DIR D; Binks AS, 2014, MON NOT R ASTRON SOC, V438, pL11, DOI 10.1093/mnrasl/slt141; Brandt TD, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/1; Burgasser A., THIS RES HAS BENEFIT; Burningham B, 2013, MON NOT R ASTRON SOC, V433, P457, DOI 10.1093/mnras/stt740; Burrows A, 2006, ASTROPHYS J, V640, P1063, DOI 10.1086/500293; Carson J, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/2/L32; Chauvin G, 2005, ASTRON ASTROPHYS, V438, pL25, DOI 10.1051/0004-6361:200500116; Chauvin G, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118346; Chilcote J, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/1/L3; Chilcote JK, 2012, PROC SPIE, V8446, DOI 10.1117/12.925790; Colina L, 1996, ASTRON J, V112, P307, DOI 10.1086/118016; Currie T, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/133; CUTRI RM, 2003, 2MASS ALL SKY; Delorme P, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118223; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Feigelson ED, 2006, ASTRON J, V131, P1730, DOI 10.1086/499923; Gagne J, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/121; Golimowski DA, 2004, ASTRON J, V127, P3516, DOI 10.1086/420709; Gontcharov GA, 2006, ASTRON LETT+, V32, P759, DOI 10.1134/S1063773706110065; Houdebine ER, 2012, MON NOT R ASTRON SOC, V426, P1591, DOI 10.1111/j.1365-2966.2012.21787.x; Janson M, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/17; Janson M, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L4; Janson M, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/44; Jovanovic N., SUBARU CORONAGRAPHIC; Kalas P, 2008, SCIENCE, V322, P1345, DOI 10.1126/science.1166609; Kirkpatrick JD, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/156; Konopacky QM, 2014, PROC SPIE, V9147, DOI 10.1117/12.2056646; Kratter KM, 2010, ASTROPHYS J, V710, P1375, DOI 10.1088/0004-637X/710/2/1375; Kuzuhara M, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/11; Lafreniere D, 2007, ASTROPHYS J, V660, P770, DOI 10.1086/513180; Lafreniere D, 2008, ASTROPHYS J LETT, V689, pL153, DOI 10.1086/595870; Macintosh B, 2014, P NATL ACAD SCI USA, V111, P12661, DOI 10.1073/pnas.1304215111; Macintosh BA, 2008, PROC SPIE, V7015, DOI 10.1117/12.788083; Madhusudhan N, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/34; Maire J, 2014, PROC SPIE, V9147, DOI 10.1117/12.2056732; Mamajek EE, 2014, MON NOT R ASTRON SOC, V445, P2169, DOI 10.1093/mnras/stu1894; Marley MS, 2007, ASTROPHYS J, V655, P541, DOI 10.1086/509759; Marley MS, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/135; Marley MS, 2002, ASTROPHYS J, V568, P335, DOI 10.1086/338800; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; Marois C, 2000, P SOC PHOTO-OPT INS, V4008, P788, DOI 10.1117/12.395537; Marois C, 2014, PROC SPIE, V9148, DOI 10.1117/12.2055245; Marois C, 2010, PROC SPIE, V7736, DOI 10.1117/12.857225; Mawet D, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/97; Morley CV, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/172; Naud ME, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/5; Nidever DL, 2002, ASTROPHYS J SUPPL S, V141, P503, DOI 10.1086/340570; Oppenheimer BR, 2012, PROC SPIE, V8447, DOI 10.1117/12.926419; Patel RI, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/1/10; Perrin MD, 2014, PROC SPIE, V9147, DOI 10.1117/12.2055246; Pickles AJ, 1998, PUBL ASTRON SOC PAC, V110, P863, DOI 10.1086/316197; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Pueyo L, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/31; Racine R, 1999, PUBL ASTRON SOC PAC, V111, P587, DOI 10.1086/316367; Rafikov RR, 2006, ASTROPHYS J, V648, P666, DOI 10.1086/505695; Rameau J, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/2/L15; Rameau J, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220984; Reyle C, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913234; Riviere-Marichalar P, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201322901; Saumon D, 2006, ASTROPHYS J, V647, P552, DOI 10.1086/505419; Saumon D, 2008, ASTROPHYS J, V689, P1327, DOI 10.1086/592734; Sheinis AI, 2002, PUBL ASTRON SOC PAC, V114, P851, DOI 10.1086/341706; Simon M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/158; Skemer AJ, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/17; Soummer R, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L28; Spiegel DS, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/174; TORRES CAO, 2008, HDB STAR FORMING REG, V0002, P00757; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; WILSON RE, 1953, GENER CATAL STELL; Yelda S, 2010, ASTROPHYS J, V725, P331, DOI 10.1088/0004-637X/725/1/331; Zahnle KJ, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/41; Zuckerman B, 2004, ANNU REV ASTRON ASTR, V42, P685, DOI 10.1146/annurev.astro.42.053102.134111; Zuckerman B, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L27; Zuckerman B, 2001, ASTROPHYS J, V562, pL87, DOI 10.1086/337968	89	375	377	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					64	67		10.1126/science.aac5891	http://dx.doi.org/10.1126/science.aac5891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26272904	Green Accepted, Green Submitted			2022-12-28	WOS:000362098300045
J	Darimont, CT; Fox, CH; Bryan, HM; Reimchen, TE				Darimont, Chris T.; Fox, Caroline H.; Bryan, Heather M.; Reimchen, Thomas E.			The unique ecology of human predators	SCIENCE			English	Article							GLOBAL FISHERIES; TOP; EXPLOITATION; EXTINCTIONS; ECOSYSTEM; EVOLUTION; COLLAPSE; DECLINE; WILD	Paradigms of sustainable exploitation focus on population dynamics of prey and yields to humanity but ignore the behavior of humans as predators. We compared patterns of predation by contemporary hunters and fishers with those of other predators that compete over shared prey (terrestrial mammals and marine fishes). Our global survey (2125 estimates of annual finite exploitation rate) revealed that humans kill adult prey, the reproductive capital of populations, at much higher median rates than other predators (up to 14 times higher), with particularly intense exploitation of terrestrial carnivores and fishes. Given this competitive dominance, impacts on predators, and other unique predatory behavior, we suggest that humans function as an unsustainable "super predator," which-unless additionally constrained by managers-will continue to alter ecological and evolutionary processes globally.	[Darimont, Chris T.; Fox, Caroline H.; Bryan, Heather M.] Univ Victoria, Dept Geog, Stn CSC, Victoria, BC V8W 2Y2, Canada; [Darimont, Chris T.; Fox, Caroline H.; Bryan, Heather M.] Raincoast Conservat Fdn, Sidney, BC V8L 3Y3, Canada; [Darimont, Chris T.; Bryan, Heather M.] Hakai Inst, Heriot Bay, BC V0P 1H0, Canada; [Reimchen, Thomas E.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada	University of Victoria; Hakai Institute; University of Victoria	Darimont, CT (corresponding author), Univ Victoria, Dept Geog, Stn CSC, POB 1700, Victoria, BC V8W 2Y2, Canada.	darimont@uvic.ca			Natural Sciences and Engineering Research Council of Canada [435683]; National Research Council Canada [2354]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada	We thank M. Arseneau, L. Grant, H. Kobluk, J. Nelson, and S. Leaver for data collection; L. Reshitnyk for creating fig. S1; and P. Ehlers and J. Ehlers for statistical assistance. S. Anderson, J. Baum, T. Branch, J. Brashares, A. Calestagne, S. Carlson, T. Davies, D. Kramer, T. Levi, J. Reynolds, and the "Ecology@UVic" discussion group offered insight on drafts. We thank the Raincoast Conservation, Tula, Wilburforce, and Willowgrove Foundations. C.T.D. and T.E.R. acknowledge Natural Sciences and Engineering Research Council of Canada Discovery Grant 435683 and National Research Council Canada Operating Grant 2354, respectively. Data and R code available in Dryad (doi:10.5061/dryad.238b2). T.E.R. conceived of the idea and created the preliminary data set. C.T.D., H.M.B., C.H.F., and T.E.R. designed the research. C.T.D. led data collection and project management. H.M.B., C.T.D., and C.H.F. conducted analyses. C.T.D., C.H.F., H.M.B., and T.E.R. wrote the manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Branch TA, 2008, MAR POLICY, V32, P38, DOI 10.1016/j.marpol.2007.04.001; Brashares JS, 2014, SCIENCE, V345, P376, DOI 10.1126/science.1256734; Collins C, 2011, ANIM CONSERV, V14, P474, DOI 10.1111/j.1469-1795.2011.00458.x; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fowler CW, 2003, P ROY SOC B-BIOL SCI, V270, P2579, DOI 10.1098/rspb.2003.2553; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; HILBORN R, 1995, ANNU REV ECOL SYST, V26, P45, DOI 10.1146/annurev.es.26.110195.000401; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2010, BIOSCIENCE, V60, P516, DOI 10.1525/bio.2010.60.7.7; Shackell NL, 2010, P ROY SOC B-BIOL SCI, V277, P1353, DOI 10.1098/rspb.2009.1020; Stenseth NC, 2009, NATURE, V457, P803, DOI 10.1038/457803a; Vermeij GJ, 2012, EVOLUTION, V66, P2007, DOI 10.1111/j.1558-5646.2012.01592.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	27	212	213	5	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					858	860		10.1126/science.aac4249	http://dx.doi.org/10.1126/science.aac4249			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293961				2022-12-28	WOS:000359832700047
J	Takahashi, DY; Fenley, AR; Teramoto, Y; Narayanan, DZ; Borjon, JI; Holmes, P; Ghazanfar, AA				Takahashi, D. Y.; Fenley, A. R.; Teramoto, Y.; Narayanan, D. Z.; Borjon, J. I.; Holmes, P.; Ghazanfar, A. A.			The developmental dynamics of marmoset monkey vocal production	SCIENCE			English	Article							EXPRESSION; EVOLUTION; PRIMATE; BIRDSONG	Human vocal development occurs through two parallel interactive processes that transform infant cries into more mature vocalizations, such as cooing sounds and babbling. First, natural categories of sounds change as the vocal apparatus matures. Second, parental vocal feedback sensitizes infants to certain features of those sounds, and the sounds are modified accordingly. Paradoxically, our closest living ancestors, nonhuman primates, are thought to undergo few or no production-related acoustic changes during development, and any such changes are thought to be impervious to social feedback. Using early and dense sampling, quantitative tracking of acoustic changes, and biomechanical modeling, we showed that vocalizations in infant marmoset monkeys undergo dramatic changes that cannot be solely attributed to simple consequences of growth. Using parental interaction experiments, we found that contingent parental feedback influences the rate of vocal development. These findings overturn decades-old ideas about primate vocalizations and show that marmoset monkeys are a compelling model system for early vocal development in humans.	[Takahashi, D. Y.; Fenley, A. R.; Teramoto, Y.; Narayanan, D. Z.; Borjon, J. I.; Holmes, P.; Ghazanfar, A. A.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Takahashi, D. Y.; Fenley, A. R.; Narayanan, D. Z.; Borjon, J. I.; Ghazanfar, A. A.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Holmes, P.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Holmes, P.] Princeton Univ, Program Appl & Computat Math, Princeton, NJ 08544 USA; [Ghazanfar, A. A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Princeton University; Princeton University	Takahashi, DY (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	takahashiyd@gmail.com; asifg@princeton.edu	Borjon, Jeremy I./AAN-6817-2020	Borjon, Jeremy I./0000-0001-9114-3362; Teramoto Kimura, Yayoi/0000-0003-3419-0351	Pew Latin American Fellowship; Brazilian Science Without Borders Fellowship; NSF; James S. McDonnell Scholar Award	Pew Latin American Fellowship; Brazilian Science Without Borders Fellowship; NSF(National Science Foundation (NSF)); James S. McDonnell Scholar Award	We thank L. Kelly for providing comments on an earlier draft. This work was supported by a Pew Latin American Fellowship (D.Y.T.), a Brazilian Science Without Borders Fellowship (D.Y.T.), an NSF Graduate Fellowship (J.I.B.), and the James S. McDonnell Scholar Award (A.A.G). Data for each figure are available in the supplementary materials.	Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; Bezerra BM, 2008, INT J PRIMATOL, V29, P671, DOI 10.1007/s10764-008-9250-0; Borjon JI, 2014, BRAIN BEHAV EVOLUT, V84, P93, DOI 10.1159/000365346; Byrge L, 2014, TRENDS COGN SCI, V18, P395, DOI 10.1016/j.tics.2014.04.010; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Elowson AM, 1998, BEHAVIOUR, V135, P643, DOI 10.1163/156853998792897905; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Kato M, 2014, BRAIN LANG, V133, P26, DOI 10.1016/j.bandl.2014.03.007; Kogan JA, 1998, J ACOUST SOC AM, V103, P2185, DOI 10.1121/1.421364; Leao AD, 2009, COMPUT BIOL MED, V39, P853, DOI 10.1016/j.compbiomed.2009.05.009; Lipkind D, 2011, P NATL ACAD SCI USA, V108, P15572, DOI 10.1073/pnas.1012941108; Oller D.K, 2000, EMERGENCE SPEECH CAP, DOI [10.4324/9781410602565, DOI 10.4324/9781410602565]; Pistorio AL, 2006, J ACOUST SOC AM, V120, P1655, DOI 10.1121/1.2225899; Perl YS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051909; Scheiner E, 2002, J VOICE, V16, P509, DOI 10.1016/S0892-1997(02)00127-3; Syal S, 2011, DEVELOPMENTAL SCI, V14, P417, DOI 10.1111/j.1467-7687.2010.00997.x; Takahashi DY, 2013, CURR BIOL, V23, P2162, DOI 10.1016/j.cub.2013.09.005; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Thelen E., 1991, BIOBEHAVIORAL FDN LA, P339	22	156	158	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					734	738		10.1126/science.aab1058	http://dx.doi.org/10.1126/science.aab1058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273055				2022-12-28	WOS:000359415100036
J	Mann, K; Clandinin, TR				Mann, Kevin; Clandinin, Thomas R.			Neurons Rho to Get in Shape for the Day	CELL			English	Editorial Material							PLASTICITY	Linking structural changes in neurons to animal behavior has proven challenging. New findings by Pesakou et al. tie daily cycles of axon arbor extension and retraction, mediated by Rho activity, to circadian and seasonal patterns of behavior in the fruit fly.	[Mann, Kevin; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu			NEI NIH HHS [R01 EY022638] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY022638] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Attardo A, 2015, NATURE; Becquet D, 2008, GLIA, V56, P294, DOI 10.1002/glia.20613; FENTRESS JC, 1977, ANN NY ACAD SCI, V290, P370, DOI 10.1111/j.1749-6632.1977.tb39739.x; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; House DRC, 2011, NEURON, V72, P819, DOI 10.1016/j.neuron.2011.09.008; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Petsakou A, 2015, CELL, V162, P823, DOI 10.1016/j.cell.2015.07.010; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038	8	0	0	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					698	699		10.1016/j.cell.2015.07.044	http://dx.doi.org/10.1016/j.cell.2015.07.044			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276623	Bronze			2022-12-28	WOS:000359741400002
J	Farne, H				Farne, Hugo			Publishers' charges for scoring systems may change clinical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATRIAL-FIBRILLATION; RISK		[Farne, Hugo] Univ London Imperial Coll Sci Technol & Med, Resp Med, London W2 1NY, England	Imperial College London	Farne, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Resp Med, St Marys Hosp Campus, London W2 1NY, England.	hugo.farne@gmail.com	Farne, Hugo/N-6519-2017; Farne, Hugo/H-3349-2015	Farne, Hugo/0000-0003-2556-3953; Farne, Hugo/0000-0003-2556-3953				Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Cheung CK, 2007, OXFORD HDB CLIN MED; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Eysenbach G, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e8; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gingras Y, 2009, SCIENCE, V323, P36, DOI 10.1126/science.323.5910.36a; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Sperr EV, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-58; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002	12	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2015	351								h4325	10.1136/bmj.h4325	http://dx.doi.org/10.1136/bmj.h4325			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XN	26269463				2022-12-28	WOS:000359741200013
J	Palmer, MA; Liu, JG; Matthews, JH; Mumba, M; D'Odorico, P				Palmer, Margaret A.; Liu, Junguo; Matthews, John H.; Mumba, Musonda; D'Odorico, Paolo			Water security: Gray or green?	SCIENCE			English	Editorial Material							HYDROPOWER; MANAGEMENT; CLIMATE	Building engineered structures, such as dams and dikes, has been the conventional approach to water management. Some suggest that such "gray" infrastructure make way for "green" ecosystem-based approaches. In this second of three debates, Science invited arguments for how these approaches can address the challenge of building the water security of rapidly growing societies worldwide.	[Palmer, Margaret A.; D'Odorico, Paolo] Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA; [Liu, Junguo] Beijing Forestry Univ, Sch Nat Conservat, Beijing 10083, Peoples R China; [Liu, Junguo] South Univ Sci & Technol China, Sch Environm Sci & Engn, Shenzhen 518055, Peoples R China; [Matthews, John H.] Alliance Global Water Adaptat, Corvallis, OR 97330 USA; [Mumba, Musonda] United Nations Environm Programme, Nairobi, Kenya; [D'Odorico, Paolo] Univ Virginia, Charlottesville, VA 22904 USA	Beijing Forestry University; Southern University of Science & Technology; University of Virginia	Palmer, MA (corresponding author), Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA.	mpalmer@umd.edu; junguo.liu@gmail.com	Liu, Junguo/B-3021-2012; Palmer, Margaret A/F-9648-2013; D'Odorico, Paolo/A-5836-2008	Liu, Junguo/0000-0002-5745-6311; Palmer, Margaret A/0000-0003-1468-7993; D'Odorico, Paolo/0000-0002-0007-5833; matthews, john/0000-0002-7005-2661				Ansar A, 2014, ENERG POLICY, V69, P43, DOI 10.1016/j.enpol.2013.10.069; Bonan G.B., 2008, ECOLOGICAL CLIMATOLO, DOI [10.1017/CBO9781107339200, DOI 10.1017/CBO9781107339200]; Critchley W., 2008, Conserving land, protecting water, P107, DOI 10.1079/9781845933876.0107; Galizia M. C., 2015, 10 YEARS WORLD BANK; Heine RA, 2012, HYDROL PROCESS, V26, P3225, DOI 10.1002/hyp.8261; Koch BJ, 2014, J AM WATER RESOUR AS, V50, P1594, DOI 10.1111/jawr.12223; Lawrence D, 2015, NAT CLIM CHANGE, V5, P27, DOI [10.1038/nclimate2430, 10.1038/NCLIMATE2430]; Liu JG, 2013, GLOBAL ENVIRON CHANG, V23, P633, DOI 10.1016/j.gloenvcha.2013.02.002; Luo SL, 2015, OCEAN COAST MANAGE, V103, P134, DOI 10.1016/j.ocecoaman.2014.08.008; Moberg F, 2003, OCEAN COAST MANAGE, V46, P27, DOI 10.1016/S0964-5691(02)00119-9; Ortloff C.R., 2009, WATER ENG ANCIENT WO; Roa-Garcia MC, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009582; Rockstrom J., 2014, WATER RESILIENCE HUM; Russi D., 2013, EC ECOSYSTEMS BIODIV; Stakhiv EZ, 2011, J AM WATER RESOUR AS, V47, P1183, DOI 10.1111/j.1752-1688.2011.00589.x; Stive MJF, 2013, J COASTAL RES, V29, P1001, DOI 10.2112/JCOASTRES-D-13-00070.1; Talberth J., 2013, SOLN J, V40; Troy TJ, 2015, WATER RESOUR RES, V51, P4806, DOI 10.1002/2015WR017046; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	19	98	104	5	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					584	585		10.1126/science.aac7778	http://dx.doi.org/10.1126/science.aac7778			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250670				2022-12-28	WOS:000359092900020
J	Creutzfeldt, CJ; Longstreth, WT; Holloway, RG				Creutzfeldt, Claire J.; Longstreth, W. T.; Holloway, Robert G.			Predicting decline and survival in severe acute brain injury: the fourth trajectory	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-LIFE CARE; STROKE; END; DISABILITY; DECISIONS; STATEMENT	Three illness trajectories have been proposed to conceptualise how function declines as diseases advance to death: a short decline as with cancer; an episodic decline as with heart failure; and a prolonged decline as with dementia (fig 1 double down arrow).(1 2) These frameworks allow patients, family members, providers, and healthcare planners to prepare for next steps as they confront the limits of modern medicine and to develop compassionate healthcare systems that allow patients to live, age, and die with self respect and grace. None of the existing trajectories is suitable for patients with severe acute brain injury,(3) a distinct group of neurological catastrophes for which the patient and their families are typically unprepared. Examples include vascular brain injury (both focal as with stroke and global as after cardiac arrest); inflammatory brain injury (infectious and non-infectious); and traumatic brain injury. Patients present acutely neurologically devastated and face a trajectory that often results in either early death or a more uncertain prognosis that may resemble the chronic disease trajectory with prolonged dwindling. Although the exact number of patients affected by this heterogeneous group of diseases is unknown, the numbers of deaths worldwide every year from stroke (6.7 million), sudden cardiac arrest (3.7 million), and traumatic brain injury (>1 million) suggest that their contribution to both death and adult disability are large enough to warrant attention. (4-6) Improved emergency response services and advances in acute and critical care management across all of these conditions, are likely to increase the numbers of patients surviving the initial period. Adopting a fourth trajectory for these patients (fig 2 double down arrow) could help prepare providers, patients, and their families to make more informed and critical decisions about care.	[Creutzfeldt, Claire J.; Longstreth, W. T.] Univ Washington, Dept Neurol, Seattle, WA 98104 USA; [Holloway, Robert G.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Holloway, Robert G.] Univ Rochester, Med Ctr, Dept Med, Div Palliat Care, Rochester, NY 14642 USA	University of Washington; University of Washington Seattle; University of Rochester; University of Rochester	Creutzfeldt, CJ (corresponding author), Univ Washington, Dept Neurol, 325 Ninth Ave, Seattle, WA 98104 USA.	clairejc@uw.edu	Creutzfeldt, Claire/AAA-1282-2020					Back Anthony L, 2003, Ann Intern Med, V138, P439; Creutzfeldt CJ, 2012, STROKE, V43, P3405, DOI 10.1161/STROKEAHA.112.673376; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Epstein RM, 2011, ANN FAM MED, V9, P454, DOI 10.1370/afm.1301; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Luengo-Fernandez R, 2013, STROKE, V44, P2854, DOI 10.1161/STROKEAHA.113.001584; Lynn J, 1997, JAMA-J AM MED ASSOC, V277, P1633, DOI 10.1001/jama.277.20.1633; Lynn J, 2003, LIVING WELL END LIFE; Mehra R, 2007, J ELECTROCARDIOL, V40, pS118, DOI 10.1016/j.jelectrocard.2007.06.023; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Ullberg T, 2015, STROKE, V46, P389, DOI 10.1161/STROKEAHA.114.006538; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	17	45	45	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2015	351								h3904	10.1136/bmj.h3904	http://dx.doi.org/10.1136/bmj.h3904			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AT	26251409				2022-12-28	WOS:000359387600001
J	Nattie, E				Nattie, Eugene			Ondine Undone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nattie, Eugene] Dartmouth Coll, Geisel Sch Med, Lebanon, NH 03756 USA	Dartmouth College	Nattie, E (corresponding author), Dartmouth Coll, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA.							Deng BS, 2007, J APPL PHYSIOL, V103, P1772, DOI 10.1152/japplphysiol.00075.2007; Kumar NN, 2015, SCIENCE, V348, P1255, DOI 10.1126/science.aaa0922; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Ray RS, 2011, SCIENCE, V333, P637, DOI 10.1126/science.1205295	4	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					573	575		10.1056/NEJMcibr1507734	http://dx.doi.org/10.1056/NEJMcibr1507734			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26244313				2022-12-28	WOS:000358987700015
J	Vasconcelos, I; Mendes, MD; Linke, J; Schoenegg, W				Vasconcelos, Ines; Mendes, Miguel de Sousa; Linke, Joerg; Schoenegg, Winfried			CASE REVIEW Sudden onset diffuse erythema and oedema of the breast	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; CHEMOTHERAPY; CARBOPLATIN; MASTECTOMY; CARCINOMA; DIAGNOSIS		[Vasconcelos, Ines; Schoenegg, Winfried] Berlin Breast Ctr Kurfurstendamm, D-10719 Berlin, Germany; [Mendes, Miguel de Sousa] Vivantes Hosp, Berlin, Germany; [Linke, Joerg] German Fed Armed Forces Pathol Practice, Berlin, Germany		Vasconcelos, I (corresponding author), Berlin Breast Ctr Kurfurstendamm, D-10719 Berlin, Germany.	ines.mv@gmail.com						Buchholz TA, 2002, ONCOLOGIST, V7, P539, DOI 10.1634/theoncologist.7-6-539; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345; Fleming RYD, 1997, ANN SURG ONCOL, V4, P452, DOI 10.1007/BF02303668; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Kell Malcolm R, 2005, Breast Dis, V22, P67; Resetkova E, 2008, SEMIN ONCOL, V35, P25, DOI 10.1053/j.seminoncol.2007.11.013; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Stearns V, 2002, ANN SURG ONCOL, V9, P235, DOI 10.1245/aso.2002.9.3.235; von Minckwitz G, 2014, LANCET ONCOL, V15, P747, DOI 10.1016/S1470-2045(14)70160-3; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2015	351								h4166	10.1136/bmj.h4166	http://dx.doi.org/10.1136/bmj.h4166			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AT	26251406				2022-12-28	WOS:000359387600002
J	Cole, TB				Cole, Thomas B.			March Through a Swamp in Pursuit of Slaves John Gabriel Stedman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					434	435		10.1001/jama.2014.11895	http://dx.doi.org/10.1001/jama.2014.11895			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO1OI	26241582				2022-12-28	WOS:000358924500029
J	[Anonymous]				[Anonymous]			A nuclear shadow from Hiroshima and Nagasaki to Fukushima	LANCET			English	Editorial Material																			0	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					403	403						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251374	Bronze			2022-12-28	WOS:000358761700001
J	Little, P; Stuart, B; Hobbs, FDR; Moore, M; Barnett, J; Popoola, D; Middleton, K; Kelly, J; Mullee, M; Raftery, J; Yao, GQ; Carman, W; Fleming, D; Stokes-Lampard, H; Williamson, I; Joseph, J; Miller, S; Yardley, L				Little, Paul; Stuart, Beth; Hobbs, F. D. R.; Moore, Mike; Barnett, Jane; Popoola, Deborah; Middleton, Karen; Kelly, Joanne; Mullee, Mark; Raftery, James; Yao, Guiqing; Carman, William; Fleming, Douglas; Stokes-Lampard, Helen; Williamson, Ian; Joseph, Judith; Miller, Sascha; Yardley, Lucy			An internet-delivered handwashing intervention to modify infl uenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trial	LANCET			English	Article							PRESCRIBING STRATEGIES; REDUCE TRANSMISSION; INFLUENZA-A; HEALTH; RISK; COMPLICATIONS	Background Handwashing to prevent transmission of respiratory tract infections (RTIs) has been widely advocated, especially during the H1N1 pandemic. However, the role of handwashing is debated, and no good randomised evidence exists among adults in non-deprived settings. We aimed to assess whether an internet-delivered intervention to modify handwashing would reduce the number of RTIs among adults and their household members. Methods We recruited individuals sharing a household by mailed invitation through general practices in England. After consent, participants were randomised online by an automated computer-generated random number programme to receive either no access or access to a bespoke automated web-based intervention that maximised handwashing intention, monitored handwashing behaviour, provided tailored feedback, reinforced helpful attitudes and norms, and addressed negative beliefs. We enrolled participants into an additional cohort (randomised to receive intervention or no intervention) to assess whether the baseline questionnaire on handwashing would affect handwashing behaviour. Participants were not masked to intervention allocation, but statistical analysis commands were constructed masked to group. The primary outcome was number of episodes of RTIs in index participants in a modified intention-to-treat population of randomly assigned participants who completed follow-up at 16 weeks. This trial is registered with the ISRCTN registry, number ISRCTN75058295. Findings Across three winters between Jan 17, 2011, and March 31, 2013, we enrolled 20066 participants and randomly assigned them to receive intervention (n=10040) or no intervention (n=10026). 16 908 (84%) participants were followed up with the 16 week questionnaire (8241 index participants in intervention group and 8667 in control group). After 16 weeks, 4242 individuals (51%) in the intervention group reported one or more episodes of RTI compared with 5135 (59%) in the control group (multivariate risk ratio 0.86, 95% CI 0.83-0.89; p<0.0001). The intervention reduced transmission of RTIs (reported within 1 week of another household member) both to and from the index person. We noted a slight increase in minor self-reported skin irritation (231 [4%] of 5429 in intervention group vs 79 [1%] of 6087 in control group) and no reported serious adverse events. Interpretation In non-pandemic years, an effective internet intervention designed to increase handwashing could have an important effect in reduction of infection transmission. In view of the heightened concern during a pandemic and the likely role of the internet in access to advice, the intervention also has potential for effective implementation during a pandemic.	[Little, Paul; Stuart, Beth; Moore, Mike; Barnett, Jane; Middleton, Karen; Kelly, Joanne; Mullee, Mark; Raftery, James; Yao, Guiqing; Williamson, Ian] Univ Southampton, Primary Care & Populat Sci Unit, Southampton, Hants, England; [Mullee, Mark] Univ Southampton, NIHR Res Design Serv South Cent, Southampton, Hants, England; [Joseph, Judith; Miller, Sascha; Yardley, Lucy] Univ Southampton, Ctr Applicat Hlth Psychol, Southampton, Hants, England; [Hobbs, F. D. R.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Popoola, Deborah; Stokes-Lampard, Helen] Univ Birmingham, Birmingham, W Midlands, England; [Fleming, Douglas] Res & Surveillance Ctr RCGP, Birmingham, W Midlands, England; [Carman, William] Univ Glasgow, West Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland	University of Southampton; University of Southampton; University of Southampton; University of Oxford; University of Birmingham; University of Glasgow	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton S016 5ST, Hants, England.	p.little@soton.ac.uk	Moore, Michael/C-3447-2011	Moore, Michael/0000-0002-5127-4509; Yardley, Lucy/0000-0002-3853-883X; Joseph, Judith/0000-0002-0835-882X; hobbs, richard/0000-0001-7976-7172; Stuart, Beth/0000-0001-5432-7437; Little, Paul/0000-0003-3664-1873	Medical Research Council; Efficacy and Mechanism Evaluation (EME) Programme [09/800/22]; MRC; NIHR; ESRC [ES/F029624/1] Funding Source: UKRI; MRC [G0700459] Funding Source: UKRI; Economic and Social Research Council [ES/F029624/1] Funding Source: researchfish; Medical Research Council [G0700459] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10273, IS-SPC-0514-10043] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Efficacy and Mechanism Evaluation (EME) Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Medical Research Council.; We thank all the patients and health-care professionals who have contributed their time and effort and helpful insights to make PRIMIT possible. We thank the trial steering committee for their support and advice throughout the study. We thank PZ Cussons (Manchester, UK) for supplying hand gel. This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (study number 09/800/22), an MRC and NIHR partnership. The EME Programme is funded by the MRC and NIHR, with contributions from the CSO in Scotland and NISCHR in Wales and the HSC R&D Division, Public Health Agency in Northern Ireland.. The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NHS, NIHR, or the Department of Health.	Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Bourgeois FT, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.984; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x; Hay AD, 2004, BRIT J GEN PRACT, V54, P9; Janssen AP, 2006, J PUBLIC HEALTH MAN, V12, P388; Jefferson T, 2011, COCHRANE DB SYST REV, V7; Lee GM, 2005, PEDIATRICS, V115, P852, DOI 10.1542/peds.2004-0856; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Madjid M, 2003, CIRCULATION, V108, P2730, DOI 10.1161/01.CIR.0000102380.47012.92; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Miller S, 2012, PSYCHOL HEALTH MED, V17, P59, DOI 10.1080/13548506.2011.564188; Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x; Morrison LG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-258; Roberts L, 2000, PEDIATRICS, V105, P738, DOI 10.1542/peds.105.4.738; Rogers R. W., 1983, SOCIAL PSYCHOPHYSIOL, P153, DOI DOI 10.1093/DEAFED/ENT031; Sandora TJ, 2005, PEDIATRICS, V116, P587, DOI 10.1542/peds.2005-0199; Simpson JCG, 2000, THORAX, V55, P1040, DOI 10.1136/thorax.55.12.1040; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WOODHEAD MA, 1987, LANCET, V1, P671; Yardley L, 2011, J HEALTH PSYCHOL, V16, P353, DOI 10.1177/1359105310377538; Yardley L, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1963; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	29	61	62	4	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1631	1639		10.1016/S0140-6736(15)60127-1	http://dx.doi.org/10.1016/S0140-6736(15)60127-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26256072	Green Submitted, Green Accepted			2022-12-28	WOS:000363197500030
J	Twomey, PS; Smith, BL; McDermott, C; Novitt-Moreno, A; McCarthy, W; Kachur, SP; Arguin, PM				Twomey, Patrick S.; Smith, Bryan L.; McDermott, Cathy; Novitt-Moreno, Anne; McCarthy, William; Kachur, S. Patrick; Arguin, Paul M.			Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under an Investigational New Drug Protocol	ANNALS OF INTERNAL MEDICINE			English	Article							FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; QUINIDINE; RISK; ARTEMISININ; MANAGEMENT; RESISTANCE; THERAPY; DISEASE; ADULTS	Background: Quinidine gluconate, the only U.S. Food and Drug Administration-approved treatment for life-threatening malaria in the United States, has a problematic safety profile and is often unavailable in hospitals. Objective: To assess the safety and clinical benefit of intravenous artesunate as an alternative to quinidine. Design: Retrospective case series. Setting: U.S. hospitals. Patients: 102 patients aged 1 to 72 years (90% adults; 61% men) with severe and complicated malaria. Patients received 4 weight-based doses of intravenous artesunate (2.4 mg/kg) under a treatment protocol implemented by the Centers for Disease Control and Prevention between January 2007 and December 2010. At baseline, 35% had evidence of cerebral malaria, and 17% had severe hepatic impairment. Eligibility required the presence of microscopically confirmed malaria, need for intravenous treatment, and an impediment to quinidine. Measurements: Clinical and laboratory data from each patient's hospital records were abstracted retrospectively, including information from baseline through a maximum 7-day follow-up, and presented before a physician committee to evaluate safety and clinical benefit outcomes. Results: 7 patients died (mortality rate, 6.9%). The most frequent adverse events were anemia (65%) and elevated hepatic enzyme levels (49%). All deaths and most adverse events were attributed to the severity of malaria. Patients' symptoms generally improved or resolved within 3 days, and the median time to discharge from the intensive care unit was 4 days, even for patients with severe liver disease or cerebral malaria. More than 100 concomitant medications were used, with no documented drug-drug interactions. Limitation: Potential late-presenting safety issues might occur outside the 7-day follow-up. Conclusion: Artesunate was a safe and clinically beneficial alternative to quinidine.	[Twomey, Patrick S.] US Army Med Mat Dev Act, Ft Detrick, MD 21702 USA; Fast Track Drugs & Biol, North Potomac, MD USA; Ctr Dis Control & Prevent, Bethesda, MD USA	United States Department of Defense; United States Army; Centers for Disease Control & Prevention - USA	Twomey, PS (corresponding author), US Army Med Mat Dev Act, 1430 Vet Dr, Ft Detrick, MD 21702 USA.	patrick.s.twomey.mil@mail.mil	Kachur, Patrick/ABE-7220-2021		Office of the Surgeon General, Department of the U.S. Army	Office of the Surgeon General, Department of the U.S. Army	Office of the Surgeon General, Department of the U.S. Army.	Abanyie FA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-340; Abdallah TM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-148; Abro AH, 2009, JCPSP-J COLL PHYSICI, V19, P363, DOI 06.2009/JCPSP.363366; Alves C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-306; [Anonymous], TREATM GUID TREATM M; Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328; Bartoloni A, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.026; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Briggs M, 2013, MMWR-MORBID MORTAL W, V62, P5; Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Centers for Disease Control and Prevention, 2012, ART IS AV TREAT SEV; Centers for Disease Control and Prevention, 2013, GUID TREATM MAL US B; Centers for Disease Control and Prevention, 2015, MAL FACTS; Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116; Devlin JW, 2010, CRIT CARE MED, V38, pS231, DOI 10.1097/CCM.0b013e3181de125a; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Faiz MA, 2005, LANCET, V366, P717; Higgins SJ, 2011, EXPERT REV ANTI-INFE, V9, P803, DOI [10.1586/eri.11.96, 10.1586/ERI.11.96]; Ilett KF, 2002, BRIT J CLIN PHARMACO, V53, P23, DOI 10.1046/j.0306-5251.2001.01519.x; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kreeftmeijer-Vegter AR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-102; Kremsner PG, 2012, J INFECT DIS, V205, P312, DOI 10.1093/infdis/jir724; Li QG, 2009, AM J TROP MED HYG, V81, P615, DOI 10.4269/ajtmh.2009.09-0150; Lon C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-217; MESHNICK SR, 1994, T ROY SOC TROP MED H, V88, P31, DOI 10.1016/0035-9203(94)90468-5; Miller RS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-255; Mishra SK, 2006, J POSTGRAD MED, V52, P281; Muhlberger N, 2003, CLIN INFECT DIS, V36, P990, DOI 10.1086/374224; Nadjm B, 2012, INFECT DIS CLIN N AM, V26, P243, DOI 10.1016/j.idc.2012.03.010; National Kidney Disease Education Program, 2013, HOM LAB EV GFR EST G; Phillips A, 2009, CLIN INFECT DIS, V48, P871, DOI 10.1086/597258; PHILLIPS RE, 1986, BRIT MED J, V292, P1319, DOI 10.1136/bmj.292.6531.1319; Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96; Shah S, 2009, JCPSP-J COLL PHYSICI, V19, P367, DOI 06.2009/JCPSP.367370; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Viskin S, 2013, J AM COLL CARDIOL, V62, P355, DOI 10.1016/j.jacc.2013.04.009; Viskin S, 2013, J AM COLL CARDIOL, V61, P2383, DOI 10.1016/j.jacc.2013.02.077; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2013, WHO INF NOT DEL HAEM; Wroblewski HA, 2012, ANTIMICROB AGENTS CH, V56, P4495, DOI 10.1128/AAC.06396-11; Zamidei L, 2010, MINERVA ANESTESIOL, V76, P66	44	25	26	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7					498	+		10.7326/M15-0910	http://dx.doi.org/10.7326/M15-0910			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26301474	Green Accepted			2022-12-28	WOS:000362496400003
J	van Kleunen, M; Dawson, W; Essl, F; Pergl, J; Winter, M; Weber, E; Kreft, H; Weigelt, P; Kartesz, J; Nishino, M; Antonova, LA; Barcelona, JF; Cabezas, FJ; Cardenas, D; Cardenas-Toro, J; Castano, N; Chacon, E; Chatelain, C; Ebel, AL; Figueiredo, E; Fuentes, N; Groom, QJ; Henderson, L; Inderjit; Kupriyanov, A; Masciadri, S; Meerman, J; Morozova, O; Moser, D; Nickrent, DL; Patzelt, A; Pelser, PB; Baptiste, MP; Poopath, M; Schulze, M; Seebens, H; Shu, WS; Thomas, J; Velayos, M; Wieringa, JJ; Pysek, P				van Kleunen, Mark; Dawson, Wayne; Essl, Franz; Pergl, Jan; Winter, Marten; Weber, Ewald; Kreft, Holger; Weigelt, Patrick; Kartesz, John; Nishino, Misako; Antonova, Liubov A.; Barcelona, Julie F.; Cabezas, Francisco J.; Cardenas, Dairon; Cardenas-Toro, Juliana; Castano, Nicolas; Chacon, Eduardo; Chatelain, Cyrille; Ebel, Aleksandr L.; Figueiredo, Estrela; Fuentes, Nicol; Groom, Quentin J.; Henderson, Lesley; Inderjit; Kupriyanov, Andrey; Masciadri, Silvana; Meerman, Jan; Morozova, Olga; Moser, Dietmar; Nickrent, Daniel L.; Patzelt, Annette; Pelser, Pieter B.; Baptiste, Maria P.; Poopath, Manop; Schulze, Maria; Seebens, Hanno; Shu, Wen-sheng; Thomas, Jacob; Velayos, Mauricio; Wieringa, Jan J.; Pysek, Petr			Global exchange and accumulation of non-native plants	NATURE			English	Article							INVASIONS; DIVERSITY; PATTERNS; ISLAND; FLORA; US	All around the globe, humans have greatly altered the abiotic and biotic environment with ever-increasing speed. One defining feature of the Anthropocene epoch(1,2) is the erosion of biogeographical barriers by human-mediated dispersal of species into new regions, where they can naturalize and cause ecological, economic and social damage(3). So far, no comprehensive analysis of the global accumulation and exchange of alien plant species between continents has been performed, primarily because of a lack of data. Here we bridge this knowledge gap by using a unique global database on the occurrences of naturalized alien plant species in 481 mainland and 362 island regions. In total, 13,168 plant species, corresponding to 3.9% of the extant global vascular flora, or approximately the size of the native European flora, have become naturalized somewhere on the globe as a result of human activity. North America has accumulated the largest number of naturalized species, whereas the Pacific Islands show the fastest increase in species numbers with respect to their land area. Continents in the Northern Hemisphere have been the major donors of naturalized alien species to all other continents. Our results quantify for the first time the extent of plant naturalizations worldwide, and illustrate the urgent need for globally integrated efforts to control, manage and understand the spread of alien species.	[van Kleunen, Mark; Dawson, Wayne] Univ Konstanz, Dept Biol, Ecol, D-78464 Constance, Germany; [Essl, Franz; Chacon, Eduardo; Moser, Dietmar] Univ Vienna, Div Conservat Vegetat & Landscape Ecol, A-1030 Vienna, Austria; [Pergl, Jan; Pysek, Petr] Czech Acad Sci, Dept Invas Ecol, Inst Bot, CZ-25243 Pruhonice, Czech Republic; [Winter, Marten] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Weber, Ewald] Univ Potsdam, Inst Biochem & Biol, D-14469 Potsdam, Germany; [Kreft, Holger; Weigelt, Patrick] Univ Gottingen, Biodivers Macroecol & Conservat Biogeog, D-37077 Gottingen, Germany; [Kartesz, John; Nishino, Misako] Biota North Amer Program BONAP, Chapel Hill, NC 27516 USA; [Antonova, Liubov A.] Russian Acad Sci, Far East Branch, Inst Aquat & Ecol Problems, Khabarovsk 680000, Russia; [Barcelona, Julie F.; Pelser, Pieter B.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Cabezas, Francisco J.; Velayos, Mauricio] CSIC, Dept Biodiversidad & Conservacio, Real Jardin Bot, E-28014 Madrid, Spain; [Cardenas, Dairon; Castano, Nicolas] Herbario Amazonico Colombiano, Inst Amazon Invest Cienti Sinchi, Bogota 110311, Colombia; [Cardenas-Toro, Juliana; Baptiste, Maria P.] Inst Invest Recursos Biol Alexander von Humboldt, Bogota 111311, Colombia; [Cardenas-Toro, Juliana] Monash Univ, Arts Fac, Melbourne, Vic 3145, Australia; [Chacon, Eduardo] Univ Costa Rica, Escuela Biol, San Jose 11501, Costa Rica; [Chatelain, Cyrille] Conservatoire & Jardin Botan Ville Geneve, CH-1292 Geneva, Switzerland; [Ebel, Aleksandr L.] Tomsk State Univ, Lab Plant Taxon & Phylogeny, Tomsk 634050, Russia; [Figueiredo, Estrela] Nelson Mandela Metropolitan Univ, Dept Bot, ZA-6031 Port Elizabeth, South Africa; [Figueiredo, Estrela] Univ Coimbra, Ctr Funct Ecol, Dept Ciencias Vida, P-3001455 Coimbra, Portugal; [Fuentes, Nicol] Univ Concepcion, Inst Ecol & Biodiversidad, Fac Ciencias Forest, Concepcion 403000, Chile; [Groom, Quentin J.] Botan Garden Meise, B-1860 Meise, Belgium; [Henderson, Lesley] ARC Plant Protect Res Inst, ZA-0001 Pretoria, South Africa; [Inderjit] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Inderjit] Univ Delhi, Ctr Environm Management Degraded Ecosyst, Delhi 110007, India; [Kupriyanov, Andrey] Inst Human Ecol SB RAS, Kemerovo 650065, Russia; [Masciadri, Silvana] Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, BR-59078900 Natal, RN, Brazil; [Masciadri, Silvana] Univ Republica, Oceanol & Ecol Marina, Fac Ciencias, Montevideo 11400, Uruguay; [Meerman, Jan] Belize Trop Forest Studies, Belmopan, Belize; [Morozova, Olga] Inst Geog RAS, Moscow 119017, Russia; [Nickrent, Daniel L.] So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA; [Patzelt, Annette] Diwan Royal Court, Oman Bot Garden, Muscat 122, Oman; [Poopath, Manop] Wildlife & Plant Conservat, Dept Natl Pk, Forest Herbarium BKF, Bangkok 10900, Thailand; [Schulze, Maria] Univ Halle Wittenberg, Dept Biol, D-06108 Halle, Germany; [Seebens, Hanno] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26111 Oldenburg, Germany; [Shu, Wen-sheng] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Shu, Wen-sheng] Sun Yat Sen Univ, Coll Ecol & Evolut, Guangdong Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Thomas, Jacob] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Wieringa, Jan J.] Nat Biodivers Ctr, Bot Sect, NL-2333 CR Leiden, Netherlands; [Wieringa, Jan J.] Wageningen Univ, Biosystemat Grp, NL-6708 PB Wageningen, Netherlands; [Pysek, Petr] Charles Univ Prague, Fac Sci, Dept Ecol, CZ-12844 Prague, Czech Republic; Univ Stellenbosch, Dept Bot & Zool, Ctr Invest Biol, ZA-7602 Matieland, South Africa	University of Konstanz; University of Vienna; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Potsdam; University of Gottingen; Russian Academy of Sciences; University of Canterbury; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Alliance; International Center for Tropical Agriculture - CIAT; Monash University; Universidad Costa Rica; Tomsk State University; Nelson Mandela University; Universidade de Coimbra; Universidad de Concepcion; University of Delhi; University of Delhi; Universidade Federal do Rio Grande do Norte; Universidad de la Republica, Uruguay; Institute of Geography, Russian Academy of Sciences; Russian Academy of Sciences; Southern Illinois University System; Southern Illinois University; Martin Luther University Halle Wittenberg; Carl von Ossietzky Universitat Oldenburg; Sun Yat Sen University; Sun Yat Sen University; King Saud University; Naturalis Biodiversity Center; Wageningen University & Research; Charles University Prague; Stellenbosch University	van Kleunen, M (corresponding author), Univ Konstanz, Dept Biol, Ecol, Univ Str 10, D-78464 Constance, Germany.	mark.vankleunen@uni-konstanz.de	Ebel, Alexandr L./N-7649-2014; Cabezas, Francisco J./ABG-2629-2020; Weigelt, Patrick/E-2122-2014; Chacón-Madrigal, Eduardo/AAK-1048-2021; Seebens, Hanno/I-2310-2019; Nickrent, Daniel/AAA-8411-2020; Pysek, Petr/B-1957-2012; Wieringa, Jan J./D-9517-2015; Thomas, Jacob/C-1195-2011; Essl, Franz/ABE-7064-2020; Groom, Quentin/H-3062-2019; Winter, Marten/E-7979-2011; Velayos, Mauricio/I-1714-2015; Kreft, Holger/A-4736-2008; Kreft, Holger/AAY-7573-2020; Morozova, Olga/C-8633-2018; Cabezas, Francisco J./ABG-3403-2020; van Kleunen, Mark/B-3769-2009; Pergl, Jan/H-1071-2011; Cabezas, Francisco José/A-8859-2016	Cabezas, Francisco J./0000-0003-0614-0445; Weigelt, Patrick/0000-0002-2485-3708; Chacón-Madrigal, Eduardo/0000-0002-8328-5456; Seebens, Hanno/0000-0001-8993-6419; Wieringa, Jan J./0000-0003-0566-372X; Essl, Franz/0000-0001-8253-2112; Groom, Quentin/0000-0002-0596-5376; Winter, Marten/0000-0002-9593-7300; Velayos, Mauricio/0000-0002-0919-3545; Kreft, Holger/0000-0003-4471-8236; Kreft, Holger/0000-0003-4471-8236; Cabezas, Francisco J./0000-0003-0614-0445; van Kleunen, Mark/0000-0002-2861-3701; Pergl, Jan/0000-0002-0045-1974; Fuentes, Nicol/0000-0002-3773-9832; Ebel, Aleksandr/0000-0002-7889-4580; Dawson, Wayne/0000-0003-3402-0774; Chatelain, Cyrille/0000-0001-6929-0008; Antonova, Lyubov/0000-0003-3059-3305; Figueiredo, Estrela/0000-0002-8511-8213; Morozova, Olga/0000-0003-2950-351X; Moser, Dietmar/0000-0002-2745-7508	Deutsche Forschungsgemeinschaft [KL 1866/9-1]; Austrian Climate and Energy Fund (SpecAdapt) [KR11AC0K00355]; Centre of Excellence PLADIAS (Czech Science Foundation) [14-36079G]; Czech Academy of Sciences [RVO 67985939]; Praemium Academiae award from The Czech Academy of Sciences; Helmholtz Centre for Environmental Research (UFZ); German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig [DFG FZT 118]; Deutsche Forschungsgemeinschaft (DFG) Free Floater Program in the Excellence Initiative at the University of Gottingen; BEFmate project from the Ministry of Science and Culture of Lower Saxony; German VW-Foundation; project Flora de Guinea Ecuatorial [CGL2012-32934]; Project ICM [05-002]; Project Fondecyt Postdoc [3120125]; Research Center of the College of Science, King Saud University, Riyadh, Saudi Arabia;  [PFB-23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Climate and Energy Fund (SpecAdapt); Centre of Excellence PLADIAS (Czech Science Foundation); Czech Academy of Sciences(Czech Academy of Sciences); Praemium Academiae award from The Czech Academy of Sciences; Helmholtz Centre for Environmental Research (UFZ)(Helmholtz Association); German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig; Deutsche Forschungsgemeinschaft (DFG) Free Floater Program in the Excellence Initiative at the University of Gottingen(German Research Foundation (DFG)); BEFmate project from the Ministry of Science and Culture of Lower Saxony; German VW-Foundation; project Flora de Guinea Ecuatorial; Project ICM; Project Fondecyt Postdoc(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Research Center of the College of Science, King Saud University, Riyadh, Saudi Arabia(King Saud University); 	We thank the DAISIE team, the CONABIO team, E. Zykova, J. K. Vinogradova, S. R. Majorov, M. Schmidt, M. Newman, P. Thomas, R. Pooma, S. McCune, S. S. Tjitrosoedirdjo, H. Roy, S. Rorke, J. Danihelka, Z. Barina, A. Zeddam, S. Masciadri, Z. Barina and P. Nowak for data contributions, Z. Sixtova, B. Ruter, E. Mamonova, M. Krick, O. Michels and T. Scheu for digitizing data and internet searches, G. Muller and J. Moat for help with shapefiles, L. Cayuela for help with the R package Taxonstand, and T. Blackburn, A. Meyer and M. Rejmanek for comments on previous versions of the manuscript. M.v.K. and W.D. acknowledge funding by the Deutsche Forschungsgemeinschaft (KL 1866/9-1). F.E. acknowledges funding by the Austrian Climate and Energy Fund (project number KR11AC0K00355, SpecAdapt). J. P. and P. P. were supported by the Centre of Excellence PLADIAS (Czech Science Foundation project number 14-36079G) and long-term research development project RVO 67985939 (The Czech Academy of Sciences). P. P. acknowledges support by Praemium Academiae award from The Czech Academy of Sciences. M.W. and M. S. acknowledge funding from the Helmholtz Centre for Environmental Research (UFZ) and the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (DFG FZT 118). P.W. and H. K. acknowledge funding from the Deutsche Forschungsgemeinschaft (DFG) Free Floater Program in the Excellence Initiative at the University of Gottingen and in the scope of the BEFmate project from the Ministry of Science and Culture of Lower Saxony. H. S. acknowledges support by the German VW-Foundation. F.J.C. and M.V. acknowledge support of the project Flora de Guinea Ecuatorial, 4 (CGL2012-32934). N.F. thanks the Projects ICM 05-002, PFB-23 and Fondecyt Postdoc 3120125. J. T. acknowledges the support of the Research Center of the College of Science, King Saud University, Riyadh, Saudi Arabia.	Abel GJ, 2014, SCIENCE, V343, P1520, DOI 10.1126/science.1248676; Blackburn TM, 2008, GLOBAL ECOL BIOGEOGR, V17, P246, DOI 10.1111/j.1466-8238.2007.00361.x; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Brickell C., 2004, AM HORTICULTURAL SOC; Brummit RK., 2001, WORLD GEOGRAPHICAL S; Cayuela L., 2014, TAXONSTAND TAXONOMIC; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Cullen J., 2011, EUROPEAN GARDEN FLOR; Darwin C., 1959, ORIGIN SPECIES MEANS; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; di Castri F., 1989, SCOPE, V37, P1; Elton C. S., 1958, ECOLOGY INVASIONS AN, P77; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Fridley JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003630; Heywood V. H., 2013, EUROPEAN CODE CONDUC; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Kalwij JM, 2012, J VEG SCI, V23, P998, DOI 10.1111/j.1654-1103.2012.01407.x; Keller W, 2011, WORLD ECON, V34, P853, DOI 10.1111/j.1467-9701.2011.01358.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Lambdon PW, 2008, PRESLIA, V80, P101; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; R Development Core Team, 2009, R LANG ENV STAT COMP; Ralph C., 2004, AFRICA ENV OUTLOOK; Rejmanek M, 1996, ECOL STU AN, V122, P153; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; van Wilgen NJ, 2011, DIVERS DISTRIB, V17, P172, DOI 10.1111/j.1472-4642.2010.00717.x	35	529	566	43	644	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					100	+		10.1038/nature14910	http://dx.doi.org/10.1038/nature14910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26287466	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000360594100033
J	Wrobel, L; Topf, U; Bragoszewski, P; Wiese, S; Sztolsztener, ME; Oeljeklaus, S; Varabyova, A; Lirski, M; Chroscicki, P; Mroczek, S; Januszewicz, E; Dziembowski, A; Koblowska, M; Warscheid, B; Chacinska, A				Wrobel, Lidia; Topf, Ulrike; Bragoszewski, Piotr; Wiese, Sebastian; Sztolsztener, Malgorzata E.; Oeljeklaus, Silke; Varabyova, Aksana; Lirski, Maciej; Chroscicki, Piotr; Mroczek, Seweryn; Januszewicz, Elzbieta; Dziembowski, Andrzej; Koblowska, Marta; Warscheid, Bettina; Chacinska, Agnieszka			Mistargeted mitochondrial proteins activate a proteostatic response in the cytosol	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; INTERMEMBRANE SPACE; PRESEQUENCE TRANSLOCASE; 20S PROTEASOME; IMPORT; DEGRADATION; COOPERATION; CHAPERONES; LONGEVITY; CYTOSCAPE	Most of the mitochondrial proteome originates from nuclear genes and is transported into the mitochondria after synthesis in the cytosol. Complex machineries which maintain the specificity of protein import and sorting include the TIM23 translocase responsible for the transfer of precursor proteins into the matrix, and the mitochondrial intermembrane space import and assembly (MIA) machinery required for the biogenesis of intermembrane space proteins. Dysfunction of mitochondrial protein sorting pathways results in diminishing specific substrate proteins, followed by systemic pathology of the organelle and organismal death(1-4). The cellular responses caused by accumulation of mitochondrial precursor proteins in the cytosol are mainly unknown. Here we present a comprehensive picture of the changes in the cellular transcriptome and proteome in response to a mitochondrial import defect and precursor over-accumulation stress. Pathways were identified that protect the cell against mitochondrial biogenesis defects by inhibiting protein synthesis and by activation of the proteasome, a major machine for cellular protein clearance. Proteasomal activity is modulated in proportion to the quantity of mislocalized mitochondrial precursor proteins in the cytosol. We propose that this type of unfolded protein response activated by mistargeting of proteins (UPRam) is beneficial for the cells. UPRam provides a means for buffering the consequences of physiological slowdown in mitochondrial protein import and for counteracting pathologies that are caused or contributed by mitochondrial dysfunction.	[Wrobel, Lidia; Topf, Ulrike; Bragoszewski, Piotr; Sztolsztener, Malgorzata E.; Varabyova, Aksana; Chroscicki, Piotr; Januszewicz, Elzbieta; Chacinska, Agnieszka] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Wiese, Sebastian; Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Dept Biochem & Funct Prote, Fac Biol, D-79104 Freiburg, Germany; [Wiese, Sebastian; Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Wiese, Sebastian; Warscheid, Bettina] Univ Freiburg, ZBSA Ctr Biol Syst Anal, D-79104 Freiburg, Germany; [Lirski, Maciej; Mroczek, Seweryn; Dziembowski, Andrzej; Koblowska, Marta] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Mroczek, Seweryn; Dziembowski, Andrzej] Univ Warsaw, Fac Biol, Dept Genet & Biotechnol, PL-02106 Warsaw, Poland; [Koblowska, Marta] Univ Warsaw, Fac Biol, Lab Syst Biol, PL-02106 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Freiburg; University of Freiburg; University of Freiburg; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; University of Warsaw	Chacinska, A (corresponding author), Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.	bettina.warscheid@biologie.uni-freiburg.de; achacinska@iimcb.gov.pl	Topf, Ulrike/AAG-2503-2020; Brągoszewski, Piotr/ABD-7014-2020	Topf, Ulrike/0000-0003-2172-2427; Brągoszewski, Piotr/0000-0002-9684-6750; Dziembowski, Andrzej/0000-0001-8492-7572; Koblowska, Marta/0000-0003-4497-6200; Mroczek, Seweryn/0000-0001-5026-1741; Chacinska, Agnieszka/0000-0002-2832-2568; Chroscicki, Piotr/0000-0002-4291-3284; Wrobel, Lidia/0000-0002-5127-5616; Warscheid, Bettina/0000-0001-5096-1975	PRIDE Team, EBI; Deutsche Forschungsgemeinschaft; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; Excellence Initiative of the German State Government [EXC 294 BIOSS]; Foundation for Polish Science - Welcome Programme - EU within the European Regional Development Fund; National Science Centre [2011/02/B/NZ2/01402, 2013/11/B/NZ3/00974, 2013/08/T/NZ1/00770, 2013/11/D/NZ1/02294]; Ministerial Ideas Plus schema [000263]; Swiss National Science Foundation [PP300P3-147899]	PRIDE Team, EBI; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; Foundation for Polish Science - Welcome Programme - EU within the European Regional Development Fund; National Science Centre(National Science Centre, Poland); Ministerial Ideas Plus schema; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank A. Fergin, B. Knapp, B. Guiard, W. Voos, M. Glickman, A. Gornicka, A. Loniewska-Lwowska, and T. Wegierski for materials, experimental assistance and discussions. Deposition of the data to the ProteomeXchange Consortium is supported by PRIDE Team, EBI. Research in the B. W. laboratory is supported by the Deutsche Forschungsgemeinschaft and the Excellence Initiative of the German Federal & State Governments (EXC 294 BIOSS). Research in the A.C. laboratory was supported by Foundation for Polish Science - Welcome Programme co-financed by the EU within the European Regional Development Fund (L.W., M.E.S. and E.J.), National Science Centre grants 2011/02/B/NZ2/01402 (L.W., U.T. and A.V.) and 2013/11/B/NZ3/00974 (P.C.) and Ministerial Ideas Plus schema 000263 (E.J.). L.W. and U.T. were also supported by National Science Centre grant 2013/08/T/NZ1/00770 and Swiss National Science Foundation postdoctoral fellowship (PP300P3-147899), respectively. P.B. was supported by the National Science Centre grant 2013/11/D/NZ1/02294.	Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bottinger L, 2012, MOL BIOL CELL, V23, P3957, DOI 10.1091/mbc.E12-05-0358; Bragoszewski P, 2015, P NATL ACAD SCI USA, V112, P7713, DOI 10.1073/pnas.1504615112; Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Cankorur-Cetinkaya A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038351; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fischer M, 2013, MOL BIOL CELL, V24, P2160, DOI 10.1091/mbc.E12-12-0862; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hanssum A, 2014, MOL CELL, V55, P566, DOI 10.1016/j.molcel.2014.06.017; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lytovchenko O, 2014, EMBO J, V33, P1624, DOI 10.15252/embj.201488076; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Schreiner B, 2012, MOL BIOL CELL, V23, P4335, DOI 10.1091/mbc.E12-05-0420; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VESTWEBER D, 1988, EMBO J, V7, P1147, DOI 10.1002/j.1460-2075.1988.tb02924.x; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	53	243	246	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					485	+		10.1038/nature14951	http://dx.doi.org/10.1038/nature14951			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26245374	Green Submitted			2022-12-28	WOS:000360069300042
J	Liu, Z; Guan, DB; Wei, W; Davis, SJ; Ciais, P; Bai, J; Peng, SS; Zhang, Q; Hubacek, K; Marland, G; Andres, RJ; Crawford-Brown, D; Lin, JT; Zhao, HY; Hong, CP; Boden, TA; Feng, KS; Peters, GP; Xi, FM; Liu, JG; Li, Y; Zhao, Y; Zeng, N; He, KB				Liu, Zhu; Guan, Dabo; Wei, Wei; Davis, Steven J.; Ciais, Philippe; Bai, Jin; Peng, Shushi; Zhang, Qiang; Hubacek, Klaus; Marland, Gregg; Andres, Robert J.; Crawford-Brown, Douglas; Lin, Jintai; Zhao, Hongyan; Hong, Chaopeng; Boden, Thomas A.; Feng, Kuishuang; Peters, Glen P.; Xi, Fengming; Liu, Junguo; Li, Yuan; Zhao, Yu; Zeng, Ning; He, Kebin			Reduced carbon emission estimates from fossil fuel combustion and cement production in China	NATURE			English	Article							CO2 EMISSIONS; POLLUTANTS	Nearly three-quarters of the growth in global carbon emissions from the burning of fossil fuels and cement production between 2010 and 2012 occurred in China(1,2). Yet estimates of Chinese emissions remain subject to large uncertainty; inventories of China's total fossil fuel carbon emissions in 2008 differ by 0.3 gigatonnes of carbon, or 15 per cent(1,3-5). The primary sources of this uncertainty are conflicting estimates of energy consumption and emission factors, the latter being uncertain because of very few actual measurements representative of the mix of Chinese fuels. Here we re-evaluate China's carbon emissions using updated and harmonized energy consumption and clinker production data and two new and comprehensive sets of measured emission factors for Chinese coal. We find that total energy consumption in China was 10 per cent higher in 2000-2012 than the value reported by China's national statistics(6), that emission factors for Chinese coal are on average 40 per cent lower than the default values recommended by the Intergovernmental Panel on Climate Change(7), and that emissions from China's cement production are 45 per cent less than recent estimates(1,4). Altogether, our revised estimate of China's CO2 emissions from fossil fuel combustion and cement production is 2.49 gigatonnes of carbon (2 standard deviations = +/-7.3 per cent) in 2013, which is 14 per cent lower than the emissions reported by other prominent inventories(1,4,8). Over the full period 2000 to 2013, our revised estimates are 2.9 gigatonnes of carbon less than previous estimates of China's cumulative carbon emissions(1,4). Our findings suggest that overestimation of China's emissions in 2000-2013 may be larger than China's estimated total forest sink in 1990-2007 (2.66 gigatonnes of carbon)(9) or China's land carbon sink in 2000-2009 (2.6 gigatonnes of carbon)(10).	[Liu, Zhu] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Guan, Dabo; Davis, Steven J.; Xi, Fengming] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Liu, Zhu] CALTECH, Resnick Sustainabil Inst, Pasadena, CA 91125 USA; [Guan, Dabo; Zhang, Qiang; Zhao, Hongyan; Hong, Chaopeng] Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China; [Guan, Dabo; Li, Yuan] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England; [Wei, Wei] Chinese Acad Sci, Shanghai Adv Res Inst, CAS Key Lab Lowcarbon Convers Sci & Engn, Shanghai 201203, Peoples R China; [Davis, Steven J.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Ciais, Philippe; Peng, Shushi] UVSQ, CEA CNRS, CE Orme Merisiers, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Bai, Jin] Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, Taiyuan 030001, Peoples R China; [Peng, Shushi] CNRS, F-38041 Grenoble, France; [Peng, Shushi] UJF Grenoble 1, LGGE, UMR5183, F-38041 Grenoble, France; [Hubacek, Klaus; Feng, Kuishuang] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Marland, Gregg] Appalachian State Univ, Res Inst Environm Energy & Econ, Boone, NC 28608 USA; [Andres, Robert J.; Boden, Thomas A.] Oak Ridge Natl Lab, Carbon Dioxide Informat Anal Ctr, Oak Ridge, TN 37831 USA; [Crawford-Brown, Douglas] Univ Cambridge, Dept Land Econ, Cambridge Ctr Climate Change Mitigat Res, Cambridge CB3 9EP, England; [Lin, Jintai] Peking Univ, Sch Phys, Dept Atmospher & Ocean Sci, Lab Climate & Ocean Atmosphere Studies, Beijing 100871, Peoples R China; [Hong, Chaopeng; He, Kebin] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut C, Beijing 100084, Peoples R China; [Peters, Glen P.] CICERO, N-0318 Oslo, Norway; [Xi, Fengming] Chinese Acad Sci, CAS Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China; [Liu, Junguo] Beijing Forestry Univ, Sch Nat Conservat, Beijing 10083, Peoples R China; [Liu, Junguo] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria; [Liu, Junguo] South Univ Sci & Technol China, Sch Environm Sci & Engn, Shenzhen 518055, Peoples R China; [Zhao, Yu] Nanjing Univ, State Key Lab Pollut Control& Resource Reuse, Nanjing 210023, Jiangsu, Peoples R China; [Zhao, Yu] Nanjing Univ, Sch Environm, Nanjing 210023, Jiangsu, Peoples R China; [Zeng, Ning] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Zeng, Ning] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Zeng, Ning] Chinese Acad Sci, Inst Atmospher Phys, Beijing 100029, Peoples R China	Harvard University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; California Institute of Technology; Tsinghua University; University of East Anglia; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; University of California System; University of California Irvine; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Institute of Coal Chemistry, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University System of Maryland; University of Maryland College Park; University of North Carolina; Appalachian State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Cambridge; Peking University; Tsinghua University; Chinese Academy of Sciences; Beijing Forestry University; International Institute for Applied Systems Analysis (IIASA); Southern University of Science & Technology; Nanjing University; Nanjing University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Liu, Z (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	liuzhu@iae.ac.cn; dabo.guan@uea.ac.uk; weiwei@sari.ac.cn; hekb@tsinghua.edu.cn	Zeng, Ning/A-3130-2008; Ciais, Philippe/A-6840-2011; Liu, Zhu/A-4634-2013; Peng, Shushi/J-4779-2014; Hubacek, Klaus/K-3500-2019; Liu, Junguo/B-3021-2012; Peters, Glen P/B-1012-2008; Guan, Dabo/Y-2406-2019; Feng, Kuishuang/Y-2541-2019; Zhang, Qiang/D-9034-2012; Guan, Dabo/K-5534-2017; He, Kebin/ABF-5224-2020; Lin, Jintai/A-8872-2012; Hong, Chaopeng/AAN-2336-2021; PENG, Shushi/AAS-2603-2020; Davis, Steven/Y-2838-2019; Davis, Steven J/F-9968-2010	Zeng, Ning/0000-0002-7489-7629; Ciais, Philippe/0000-0001-8560-4943; Liu, Zhu/0000-0002-8968-7050; Peng, Shushi/0000-0001-5098-726X; Liu, Junguo/0000-0002-5745-6311; Peters, Glen P/0000-0001-7889-8568; Guan, Dabo/0000-0003-3773-3403; Guan, Dabo/0000-0003-3773-3403; Lin, Jintai/0000-0002-2362-2940; Hong, Chaopeng/0000-0002-8825-9062; PENG, Shushi/0000-0001-5098-726X; Davis, Steven/0000-0002-9338-0844; Davis, Steven J/0000-0002-9338-0844; Bai, Jin/0000-0002-8623-1656; Li, Yuan/0000-0001-9158-6390; ANDRES, ROBERT/0000-0001-8781-4979	Chinese Academy of Sciences; China's National Basic Research Program; National Natural Science Foundation of China (NSFC) [XDA05010109, 2014CB441301, XDA05010110, XDA05010103, XDA05010101, 41328008, 41222036]; Italy's Ministry for Environment, Land and Sea; Economic and Social Research Council [ES/L016028]; Institute of Applied Ecology, Chinese Academy of Sciences; European Research Council [ERC-2013-SyG 610028-IMBALANCE-P]; US Department of Energy, Office of Science, Biological and Environmental Research under US Department of Energy [DE-AC05-00OR22725]; NSFC [41422502, 41175127, 41161140353, 91425303, 41473076]; International Science AMP; Technology Cooperation Program of China [2012DFA91530]; Natural Science Foundation of Beijing, China [8151002]; National Program for Support of Top-notch Young Professionals; Fundamental Research Funds for the Central Universities [TD-JC-2013-2]; China CDM Fund [2013051, 2013124]; Shenyang Science and Technology Planning [F14-232-6-01, F14-134-9-00]; Norwegian Research Council [235523]; Economic and Social Research Council [ES/L016028/1] Funding Source: researchfish; ESRC [ES/L016028/1] Funding Source: UKRI	Chinese Academy of Sciences(Chinese Academy of Sciences); China's National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Italy's Ministry for Environment, Land and Sea; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Institute of Applied Ecology, Chinese Academy of Sciences(Chinese Academy of Sciences); European Research Council(European Research Council (ERC)European Commission); US Department of Energy, Office of Science, Biological and Environmental Research under US Department of Energy(United States Department of Energy (DOE)); NSFC(National Natural Science Foundation of China (NSFC)); International Science AMP; Technology Cooperation Program of China; Natural Science Foundation of Beijing, China(Beijing Natural Science Foundation); National Program for Support of Top-notch Young Professionals; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China CDM Fund; Shenyang Science and Technology Planning; Norwegian Research Council(Research Council of NorwayEuropean Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Strategic Priority Research Program "Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences, and by China's National Basic Research Program and National Natural Science Foundation of China (NSFC) funded projects (grants XDA05010109, 2014CB441301, XDA05010110, XDA05010103, XDA05010101, 41328008 and 41222036). Z.L. acknowledges Harvard University Giorgio Ruffolo fellowship and support from Italy's Ministry for Environment, Land and Sea. D.G. acknowledges the Economic and Social Research Council funded project "Dynamics of Green Growth in European and Chinese Cities" (ES/L016028) and the Philip Leverhulme Prize. S.J.D. acknowledges support from the Institute of Applied Ecology, Chinese Academy of Sciences Fellowships for Young International Distinguished Scientists. P.C. and S.P. acknowledge support of the European Research Council Synergy grant ERC-2013-SyG 610028-IMBALANCE-P. R.J.A. and T.A.B. were sponsored by the US Department of Energy, Office of Science, Biological and Environmental Research under US Department of Energy contract DE-AC05-00OR22725. J. Lin acknowledges the NSFC (41422502 and 41175127). J. Liu acknowledges the International Science & Technology Cooperation Program of China (2012DFA91530), the NSFC (41161140353, 91425303), The Natural Science Foundation of Beijing, China (8151002), the National Program for Support of Top-notch Young Professionals, and Fundamental Research Funds for the Central Universities (TD-JC-2013-2). F.X. acknowledges the NSFC (41473076), China CDM Fund (2013051, 2013124) and Shenyang Science and Technology Planning (F14-232-6-01, F14-134-9-00). G.P.P. acknowledges funding from the Norwegian Research Council (235523). The authors are grateful to S. Piao, L. Cao and J. Yan for insightful comments.	Andres RJ, 2012, BIOGEOSCIENCES, V9, P1845, DOI 10.5194/bg-9-1845-2012; Andres RJ, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.23616; [Anonymous], CHIN EN STAT YB; [Anonymous], 2013, GLOBAL REGIONAL NATL; BP, 2014, STAT REV WORLD ENERG; China Cement Association, 2014, CHIN CEM ALM 2012 20; Fridley D, 2011, INVENTORY CHINAS ENE; Fridley E. D., 2008, CHINA ENERGY DATABOO; Gregg JS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032887; Guan DB, 2012, NAT CLIM CHANGE, V2, P672, DOI [10.1038/NCLIMATE1560, 10.1038/nclimate1560]; Hatch J. R., 2006, CHEM ANAL COAL COAL; Holz CA, 2014, CHINA ECON REV, V30, P309, DOI 10.1016/j.chieco.2014.06.009; IEA, 2013, CO2 EM FUEL COMB; *INT PAN CLIM CHAN, 1997, REV 1996 IPCC GUID N; Intergovernmental Panel of Climate Change, 2006, 2006 IPCC GUIDELINES; Ke J, 2013, ENERG POLICY, V57, P172, DOI 10.1016/j.enpol.2013.01.028; Kurokawa J, 2013, ATMOS CHEM PHYS, V13, P11019, DOI 10.5194/acp-13-11019-2013; Lin JT, 2011, ATMOS CHEM PHYS, V11, P8171, DOI 10.5194/acp-11-8171-2011; Liu JG, 2009, SCIENCE, V325, P675, DOI 10.1126/science.325_675; Liu M, 2013, ATMOS CHEM PHYS, V13, P10873, DOI 10.5194/acp-13-10873-2013; Liu Z, 2015, NATURE, V522, P279, DOI 10.1038/522279a; Liu Z, 2013, NATURE, V500, P143, DOI 10.1038/500143a; Marland G, 2012, NAT CLIM CHANGE, V2, P645, DOI 10.1038/nclimate1670; Moriarty R, 2014, EARTH SYST SCI DATA, V7, P521, DOI DOI 10.5194/ESSDD-7-521-2014; National Bureau of Statistics, 2014, CHIN STAT YB 1996 20; National Development and Reform Commission, 2012, GUID CHIN PROV GHG E; National Development and Reform Commission, 2012, 2 NAT COMM CLIM CHAN; National Development and Reform Commission of China, 2007, PEOPL REP CHIN NAT G; Olivier JGJ, 2013, TRENDS GLOBAL CO2 EM; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peters G., 2006, 42006 INDECOL NORW U; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Raupach MR, 2014, NAT CLIM CHANGE, V4, P873, DOI 10.1038/NCLIMATE2384; Rawski TG, 2001, CHINA ECON REV, V12, P347, DOI 10.1016/S1043-951X(01)00062-1; Reuter M, 2014, NAT GEOSCI, V7, P792, DOI 10.1038/NGEO2257; Shen L, 2014, RENEW SUST ENERG REV, V34, P337, DOI 10.1016/j.rser.2014.03.025; Sinton J. E., 2002, J ENERGY LIT, V8, P22; Sinton JE, 2001, CHINA ECON REV, V12, P373, DOI 10.1016/S1043-951X(01)00067-0; State Administration of Coal Mine Safety, 2013, CHIN COAL IND YB; The United Nations, 2010, EN STAT DAT; Tu J., 2011, IND ORG CHINESE COAL; Zhao Y, 2012, ATMOS ENVIRON, V59, P214, DOI 10.1016/j.atmosenv.2012.05.027; Zhao Y, 2010, ATMOS ENVIRON, V44, P1515, DOI 10.1016/j.atmosenv.2010.01.017	43	844	931	262	1818	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					335	+		10.1038/nature14677	http://dx.doi.org/10.1038/nature14677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26289204	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000359714000032
J	Brewer, C				Brewer, Colin			PERSONAL VIEW Assisted dying: legal ambiguity lets down families as well as patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Brewer C, 2015, ILL SEE MYSELF OUT T	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4453	10.1136/bmj.h4453	http://dx.doi.org/10.1136/bmj.h4453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7PU	26289319				2022-12-28	WOS:000360081100007
J	Chang, AY; Barry, M				Chang, Andrew Y.; Barry, Michele			The Global Health Implications of e-Cigarettes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ELECTRONIC CIGARETTES		[Chang, Andrew Y.; Barry, Michele] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Barry, Michele] Stanford Univ, Ctr Innovat Global Hlth, Stanford, CA 94305 USA	Stanford University; Stanford University	Barry, M (corresponding author), Stanford Univ, Ctr Innovat Global Hlth, 291 Campus Dr,Room LK3C02, Stanford, CA 94305 USA.	michele.barry@stanford.edu		Chang, Andrew/0000-0002-3009-6678				[Anonymous], 2014, C PRAT WHO FRAM CONV; Chatham-Stephens K, 2014, MMWR-MORBID MORTAL W, V63, P292; Gilmore AB, 2015, LANCET, V385, P1029, DOI 10.1016/S0140-6736(15)60312-9; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Gravely S, 2014, INT J ENV RES PUB HE, V11, P11691, DOI 10.3390/ijerph111111691; Hakim D., 2015, NY TIMES; Headley D., 2014, HYPERACTIVITY E CIGA; Rahman MA, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-21; who, 2004, WHO TECH REP SER, V923, P1	9	11	11	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					663	664		10.1001/jama.2015.8676	http://dx.doi.org/10.1001/jama.2015.8676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284714				2022-12-28	WOS:000360019100009
J	Quinn, K				Quinn, Kevin			The 8 Basic Payment Methods in Health Care	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY; VOLUME; HOME	Eight basic payment methods are applicable across all types of health care. Each method is defined by the unit of payment (per time period, beneficiary, recipient, episode, day, service, dollar of cost, or dollar of charges). These methods are more specific than common terms, such as capitation, fee for service, global payment, and cost reimbursement. They also correspond to the division of financial risk between payer and provider, with each method reflecting a risk factor within the health care spending identity. Financial risk gradually shifts from being primarily on providers when payment is per time period to being primarily on payers when payment is per dollar of charges. Method 4 (per episode) marks the line between epidemiologic and treatment risk. The 8 methods are typically combined to balance risk and thus balance incentives between payers and providers. This taxonomy makes it easier to understand trends in payment reform-especially the shifting division of financial risk and the movement toward value-based purchasing-and types of payment reform, such as bundling, accountable care organizations, medical homes, and cost sharing. The taxonomy also enables prediction of conflicts between payers and providers. For each unit of payment, providers are rewarded for increasing units while decreasing their own cost per unit. No payment method is neutral on quality because each encourages and discourages the provision of care overall and in particular situations. Many professional norms and business practices have been established to mitigate undesirable incentives. Health care differs from many other industries in that the unit of payment remains variable and unsettled.	Xerox Corp, Helena, MT 59601 USA	Xerox	Quinn, K (corresponding author), Xerox Corp, 34 North Last Chance Gulch, Helena, MT 59601 USA.	kevin.quinn@xerox.com		Quinn, Kevin/0000-0003-4149-2286				American Medical Association, REG NIGHTM THREAT CA; Andrews S, CMS FINALIZES COMPRE; [Anonymous], IMPL GLOB PAYM; ARROW KJ, 1963, AM ECON REV, V53, P941; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Brownlee S., 2007, OVERTREATED WHY TOO; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Centers for Medicare and Medicaid Services, MED PROV UT PAYM DAT; Centers for Medicare and Medicaid Services,, NAT CORR COD IN ED; Centers for Medicare & Medicaid Services, 2020, MED AC CAR EP ACE DE; Charlesworth A., 2012, REFORMING PAYMENT HL; Coleman KA, 2008, REFINEMENT MEDICARES; Coulam R F, 1991, Health Care Financ Rev Annu Suppl, P45; Davies K, 2014, MIRROR MIRROR WALL P; Doherty RB, 2015, ANN INTERN MED, V163, P138, DOI 10.7326/M15-0992; Duchovny N, 2007, FACTORS UNDERLYING G; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Ginsburg PB, 2014, HEALTH AFFAIR, V33, P1067, DOI 10.1377/hlthaff.2013.0810; Ginsburg PB, 2005, HLTH AFF MILLWOOD S; Huber M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4163; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Institute of Medicine, 2010, HEALTHC IMP LOW COST; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Kaiser Family Foundation, 2015, JAMA-J AM MED ASSOC, V313, P19, DOI [10.1001/jama.2014.17249, DOI 10.1001/JAMA.2014.17249]; Mayes R, 2006, MEDICARE PROSPECTIVE; McClellan M, 2015, JAMA-J AM MED ASSOC, V313, P2128, DOI 10.1001/jama.2015.5087; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Newhouse J.P., 2002, PRICING PRICELESS HL; Quinn K, 2014, ANN INTERN MED, V160, P426, DOI 10.7326/M13-2115; Quinn K, 2010, J AMBUL CARE MANAG, V33, P38, DOI 10.1097/JAC.0b013e3181cfc12a; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Schlenker RE, 2005, HEALTH SERV RES, V40, P177, DOI 10.1111/j.1475-6773.2005.00348.x; Schone E., 2013, RISK ADJUSTMENT WHAT; Schroeder SA, 2013, NEW ENGL J MED, V368, P2029, DOI 10.1056/NEJMsb1302322; Smith SL, 2014, MEDICARE RBRVS 2014; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Thomson S, 2013, HEALTH AFFAIR, V32, P704, DOI 10.1377/hlthaff.2012.0964; Toussaint J, 2013, JAMA-J AM MED ASSOC, V310, P1341, DOI 10.1001/jama.2013.279149; Tsai TC, 2015, HEALTH AFFAIR, V34, P371, DOI 10.1377/hlthaff.2014.0900; U.S. Agency for Healthcare Research and Quality, OV NAT NAT INP SAMPL; U.S. Government Accountability Office, 2012, GAO12966 US GOV ACC; United States Census Bureau, POPULATION; VanLare JM, 2012, NEW ENGL J MED, V367, P292, DOI 10.1056/NEJMp1204939; Vertrees J, 2013, ABILITY EVENT BASED; Wynn BO, 2007, EVALUATION SEVERITY	45	26	26	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					300	+		10.7326/M14-2784	http://dx.doi.org/10.7326/M14-2784			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LC	26259075				2022-12-28	WOS:000360286400009
J	Dhara, S; Mele, EJ; Agarwal, R				Dhara, Sajal; Mele, Eugene J.; Agarwal, Ritesh			Voltage-tunable circular photogalvanic effect in silicon nanowires	SCIENCE			English	Article							SPIN PHOTOCURRENTS; PHOTODETECTION	Electronic bands in crystals can support nontrivial topological textures arising from spin-orbit interactions, but purely orbital mechanisms can realize closely related dynamics without breaking spin degeneracies, opening up applications in materials containing only light elements. One such application is the circular photogalvanic effect (CPGE), which is the generation of photocurrents whose magnitude and polarity depend on the chirality of optical excitation. We show that the CPGE can arise from interband transitions at the metal contacts to silicon nanowires, where inversion symmetry is locally broken by an electric field. Bias voltage that modulates this field further controls the sign and magnitude of the CPGE. The generation of chirality-dependent photocurrents in silicon with a purely orbital-based mechanism will enable new functionalities in silicon that can be integrated with conventional electronics.	[Dhara, Sajal; Agarwal, Ritesh] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Mele, Eugene J.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Agarwal, R (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.	riteshag@seas.upenn.edu		Dhara, Sajal/0000-0002-1549-4475; Agarwal, Ritesh/0000-0002-1289-4334	U.S. Army Research Office [W911NF-09-1-0477, W911NF-11-1-0024]; Laboratory for Research on the Structure of Matter, NSF Materials Research Science and Engineering Center [DMR-1120901]; U.S. Department of Energy-Basic Energy Sciences [DE FG02 84ER45118]; CINT, a U.S. Department of Energy, Office of Basic Energy Sciences User Facility at Los Alamos National Laboratory [DE-AC52-06NA25396]; Sandia National Laboratories [DE-AC04-94AL85000]	U.S. Army Research Office; Laboratory for Research on the Structure of Matter, NSF Materials Research Science and Engineering Center; U.S. Department of Energy-Basic Energy Sciences(United States Department of Energy (DOE)); CINT, a U.S. Department of Energy, Office of Basic Energy Sciences User Facility at Los Alamos National Laboratory(United States Department of Energy (DOE)); Sandia National Laboratories(United States Department of Energy (DOE))	This work was supported by the U.S. Army Research Office (grants W911NF-09-1-0477 and W911NF-11-1-0024) and the seed project support from the Laboratory for Research on the Structure of Matter, NSF Materials Research Science and Engineering Center grant DMR-1120901. E.J.M. is supported by the U.S. Department of Energy-Basic Energy Sciences under grant DE FG02 84ER45118. Si NWs were provided by B. Tian (Chicago) and CINT, a U.S. Department of Energy, Office of Basic Energy Sciences User Facility at Los Alamos National Laboratory (contract DE-AC52-06NA25396) and Sandia National Laboratories (contract DE-AC04-94AL85000). The data described in the paper are archived by the Agarwal Group at the University of Pennsylvania.	Ahn Y, 2005, NANO LETT, V5, P1367, DOI 10.1021/nl050631x; Aufray B, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3419932; Ciucivara A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.113309; Cricenti A, 1996, J VAC SCI TECHNOL A, V14, P2448, DOI 10.1116/1.580035; De Padova P, 2008, NANO LETT, V8, P271, DOI 10.1021/nl072591y; Fan PY, 2013, NANO LETT, V13, P392, DOI 10.1021/nl303535s; Ganichev SD, 2003, J PHYS-CONDENS MAT, V15, pR935, DOI 10.1088/0953-8984/15/20/204; Ganichev SD, 2002, NATURE, V417, P153, DOI 10.1038/417153a; Ivchenko EL, 2008, SEMICOND SCI TECH, V23, DOI 10.1088/0268-1242/23/11/114007; Ivchenko EL, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155404; Justo JF, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045303; Kara A, 2012, SURF SCI REP, V67, P1, DOI 10.1016/j.surfrep.2011.10.001; Karch J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.121312; Karch J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/35/355307; Knight MW, 2011, SCIENCE, V332, P702, DOI 10.1126/science.1203056; Rurali R, 2010, REV MOD PHYS, V82, P427, DOI 10.1103/RevModPhys.82.427; Sakamoto K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045304; SATO T, 1971, PHYS REV B, V4, P1950, DOI 10.1103/PhysRevB.4.1950; Setvin M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115317; Sturman B. I., 1992, PHOTOVOLTAIC PHOTORE; Tarasenko SA, 2007, JETP LETT+, V85, P182, DOI 10.1134/S0021364007030113; Tarasenko SA, 2005, JETP LETT+, V81, P231, DOI 10.1134/1.1921322; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340; Yang M, 2006, IEEE T ELECTRON DEV, V53, P965, DOI 10.1109/TED.2006.872693; Zhang RQ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2047555	25	55	55	7	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					726	729		10.1126/science.aac6275	http://dx.doi.org/10.1126/science.aac6275			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273053				2022-12-28	WOS:000359415100034
J	Huang, TY; Gung, Y; Kuo, BY; Chiao, LY; Chen, YN				Huang, T. -Y.; Gung, Y.; Kuo, B. -Y.; Chiao, L. -Y.; Chen, Y. -N.			Layered deformation in the Taiwan orogen	SCIENCE			English	Article							SEISMIC ANISOTROPY; BENEATH; COLLISION; MODELS	The underthrusting of continental crust during mountain building is an issue of debate for orogens at convergent continental margins. We report three-dimensional seismic anisotropic tomography of Taiwan that shows a nearly 90 degrees rotation of anisotropic fabrics across a 10- to 20-kilometer depth, consistent with the presence of two layers of deformation. The upper crust is dominated by collision-related compressional deformation, whereas the lower crust of Taiwan, mostly the crust of the subducted Eurasian plate, is dominated by convergence-parallel shear deformation. We interpret this lower crustal shearing as driven by the continuous sinking of the Eurasian mantle lithosphere when the surface of the subducted plate is coupled with the orogen. The two-layer deformation clearly defines the role of subduction in the formation of the Taiwan mountain belt.	[Huang, T. -Y.; Gung, Y.] Natl Taiwan Univ, Dept Geosci, Taipei 10764, Taiwan; [Kuo, B. -Y.] Acad Sinica, Inst Earth Sci, Taipei 115, Taiwan; [Chiao, L. -Y.; Chen, Y. -N.] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University	Gung, Y (corresponding author), Natl Taiwan Univ, Dept Geosci, Taipei 10764, Taiwan.	ycgung@ntu.edu.tw; byk@earth.sinica.edu.tw	Kuo, Ban-Yuan/S-5573-2016	Gung, Yuancheng/0000-0001-7550-4025; Chiao, Ling-Yun/0000-0002-4619-7561	Ministry of Science and Technology of Taiwan [MOST 103-2116-M-002 -026]; Academia Sinica, Taiwan [AS-104-TP-A04]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	We thank W.-T. Liang, F. T. Wu, K.-L. Wang, T.-F. Yui, W.-S. Chen, and J. Suppe for helpful discussions and comments. T. Byrne helped clarify the geological implications in an early draft and provided inspiring discussion. We thank three reviewers for their critical comments. We acknowledge the Taiwan Integrated Geodynamics Research (TAIGER) project, The Taiwan Earthquake Research Data Center (TECDC), Broad-Band Array in Taiwan for Seismology (BATS), and Central Weather Bureau Broad-Band array (CWBBB) for providing continuous broadband seismic waveforms. This work was supported by the Ministry of Science and Technology of Taiwan (MOST 103-2116-M-002 -026) and Academia Sinica, Taiwan (AS-104-TP-A04). All the data used in this study are available in the following websites: CWBBB: http://gdms.cwb.gov.tw/index.php; BATS: http://bats.earth.sinica.edu.tw; TAIGER: http://ds.iris.edu/mda/YM?timewindow=2006-2009.	Beaumont C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002809; Bertrand EA, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008688; Byrne T, 2011, FRONT EARTH SCI SER, P213, DOI 10.1007/978-3-540-88558-0_8; Carena S, 2002, GEOLOGY, V30, P935, DOI 10.1130/0091-7613(2002)030<0935:ADOTIB>2.0.CO;2; Chen CH, 2003, EARTH PLANETS SPACE, V55, P223, DOI 10.1186/BF03351753; Chiao LY, 2001, GEOPHYS J INT, V145, P517, DOI 10.1046/j.0956-540x.2001.01403.x; DAVIS D, 1983, J GEOPHYS RES, V88, P1153, DOI 10.1029/JB088iB02p01153; ERNST WG, 1983, J METAMORPH GEOL, V1, P305, DOI 10.1111/j.1525-1314.1983.tb00277.x; Hao KC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038148; Ho CS., 1999, INTRO GEOLOGY TAIWAN; Hsu YJ, 2009, TECTONOPHYSICS, V479, P4, DOI 10.1016/j.tecto.2008.11.016; Huang TY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050727; Huang WC, 2000, J GEOPHYS RES-SOL EA, V105, P27979, DOI 10.1029/2000JB900339; Kuo-Chen H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053649; Lee YH, 2015, GEOLOGY, V43, P451, DOI 10.1130/G36373.1; MAINPRICE D, 1989, J STRUCT GEOL, V11, P175, DOI 10.1016/0191-8141(89)90042-4; Nabelek J, 2009, SCIENCE, V325, P1371, DOI 10.1126/science.1167719; Rousset B, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009571; Rudnick R. L., 2014, TREATISE GEOCHEMISTR, Vsecond; Schulte-Pelkum V, 2005, NATURE, V435, P1222, DOI 10.1038/nature03678; Silver PG, 1996, ANNU REV EARTH PL SC, V24, P385, DOI 10.1146/annurev.earth.24.1.385; Simoes M, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004824; Tatham DJ, 2008, EARTH PLANET SC LETT, V267, P118, DOI 10.1016/j.epsl.2007.11.042; Wu FT, 2014, J ASIAN EARTH SCI, V90, P173, DOI 10.1016/j.jseaes.2014.03.024; Wu FT, 1997, TECTONOPHYSICS, V274, P191, DOI 10.1016/S0040-1951(96)00304-6; Yamato P, 2009, GEOPHYS J INT, V176, P307, DOI 10.1111/j.1365-246X.2008.03977.x	26	52	53	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					720	723		10.1126/science.aab1879	http://dx.doi.org/10.1126/science.aab1879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273051				2022-12-28	WOS:000359415100032
J	McDonnell, JJ				McDonnell, Jeffrey J.			Creating a research brand	SCIENCE			English	Editorial Material									[McDonnell, Jeffrey J.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [McDonnell, Jeffrey J.] Univ Aberdeen, Aberdeen AB9 1FX, Scotland	University of Saskatchewan; University of Aberdeen	McDonnell, JJ (corresponding author), Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada.		McDonnell, Jeffrey J/I-6400-2013	McDonnell, Jeffrey J/0000-0002-3880-3162					0	2	2	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					758	758		10.1126/science.349.6249.758	http://dx.doi.org/10.1126/science.349.6249.758			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO8JO	26273058				2022-12-28	WOS:000359415100040
J	Petersdorf, EW; Malkki, M; O'hUigin, C; Carrington, M; Gooley, T; Haagenson, MD; Horowitz, MM; Spellman, SR; Wang, T; Stevenson, P				Petersdorf, Effie W.; Malkki, Mari; O'hUigin, Colm; Carrington, Mary; Gooley, Ted; Haagenson, Michael D.; Horowitz, Mary M.; Spellman, Stephen R.; Wang, Tao; Stevenson, Philip			High HLA-DP Expression and Graft-versus-Host Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; UNRELATED-DONOR; MARROW TRANSPLANTATION; LYMPHOCYTE INFUSION; HLA-DPB1 MISMATCHES; HEPATITIS-B; ALLELES; ANTIGENS; INFECTION; RISK	BACKGROUND Transplantation of hematopoietic cells from unrelated donors can cure blood disorders but carries a significant risk of acute graft-versus-host disease (GVHD). The risk is higher when the recipient and donor are HLA-DPB1-mismatched, but the mechanisms leading to GVHD are unknown. The HLA-DPB1 regulatory region variant rs9277534 is associated with HLA-DPB1 expression. We tested the hypothesis that the GVHD risk correlates with the rs9277534 allele linked to the mismatched HLA-DPB1 in the recipient. METHODS We genotyped rs9277534 in 3505 persons to define rs9277534-DPB1 haplotypes. Among 1441 recipients of transplants from HLA-A,B,C,DRB1,DQB1-matched unrelated donors with only one HLA-DPB1 mismatch, linkage of the rs9277534 A and G alleles to the mismatched HLA-DPB1 was determined. HLA-DPB1 expression was assessed by means of a quantitative polymerase-chain-reaction assay. The risk of acute GVHD among recipients whose mismatched HLA-DPB1 allele was linked to rs9277534G (high expression) was compared with the risk among recipients whose mismatched HLA-DPB1 allele was linked to rs9277534A (low expression). RESULTS The mean HLA-DPB1 expression was lower with rs9277534A than with rs9277534G. Among recipients of transplants from donors with rs9277534A-linked HLA-DPB1, the risk of acute GVHD was higher for recipients with rs9277534G-linked HLA-DPB1 mismatches than for recipients with rs9277534A-linked HLA-DPB1 mismatches (hazard ratio, 1.54; 95% confidence interval [CI], 1.25 to 1.89; P<0.001), as was the risk of death due to causes other than disease recurrence (hazard ratio, 1.25; 95% CI, 1.00 to 1.57; P = 0.05). CONCLUSIONS The risk of GVHD associated with HLA-DPB1 mismatching was influenced by the HLA-DPB1 rs9277534 expression marker. Among recipients of HLA-DPB1-mismatched transplants from donors with the low-expression allele, recipients with the high-expression allele had a high risk of GVHD. (Funded by the National Institutes of Health and others.)	[Petersdorf, Effie W.; Malkki, Mari; Gooley, Ted; Stevenson, Philip] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Petersdorf, Effie W.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [O'hUigin, Colm; Carrington, Mary] Frederick Natl Labs Canc Res, Leidos Biomed Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD USA; [Carrington, Mary] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Carrington, Mary] Harvard Univ, Boston, MA 02115 USA; [Haagenson, Michael D.; Spellman, Stephen R.] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Horowitz, Mary M.; Wang, Tao] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Center for International Blood & Marrow Transplant Research; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin	Petersdorf, EW (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, D4-115,1100 Fairview Ave N, Seattle, WA 98109 USA.	epetersd@fredhutch.org	horowitz, Mary/ABH-2173-2021		National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA018029, U24CA076518, P30CA015704, R01CA100019] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and others.	Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Cutler C, 2009, THOMAS HEMATOPOIETIC, P1287, DOI DOI 10.1002/9781444303537.CH86; EDWARDS JA, 1986, J IMMUNOL, V137, P490; Fernandez-Vina MA, 2013, BLOOD, V121, P4603, DOI 10.1182/blood-2013-02-481945; Fleischhauer K, 2012, LANCET ONCOL, V13, P366, DOI 10.1016/S1470-2045(12)70004-9; Good RA, 1976, IMMUNOBIOLOGY BONE M, P103; GUARDIOLA J, 1993, CRIT REV IMMUNOL, V13, P247; HOROWITZ MM, 1990, BLOOD, V75, P555; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Malkki Mari, 2012, Methods Mol Biol, V882, P173, DOI 10.1007/978-1-61779-842-9_10; MARTIN PJ, 1991, BONE MARROW TRANSPL, V8, P217; Mickelson E, 2009, THOMAS HEMATOPOIETIC, P145; Moran D, 2013, HUM IMMUNOL, V74, P557, DOI 10.1016/j.humimm.2012.11.009; Petersdorf EW, 2014, BLOOD, V124, P3996, DOI 10.1182/blood-2014-09-599969; Petersdorf EW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003974; Petersdorf EW, 2001, NEW ENGL J MED, V345, P1794, DOI 10.1056/NEJMoa011826; Petersdorf EW, 2001, BRIT J HAEMATOL, V112, P988, DOI 10.1046/j.1365-2141.2001.02655.x; Pidala J, 2014, BLOOD, V124, P2596, DOI 10.1182/blood-2014-05-576041; Rutten CE, 2013, BIOL BLOOD MARROW TR, V19, P40, DOI 10.1016/j.bbmt.2012.07.020; Rutten CE, 2010, BLOOD, V115, P151, DOI 10.1182/blood-2009-10-249821; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw BE, 2010, LEUKEMIA, V24, P58, DOI 10.1038/leu.2009.239; Stevanovic S, 2013, BLOOD, V122, P1963, DOI 10.1182/blood-2012-12-470872; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Thus KA, 2014, BIOL BLOOD MARROW TR, V20, P1705, DOI 10.1016/j.bbmt.2014.06.026; Zino E, 2004, BLOOD, V103, P1417, DOI 10.1182/blood-2003-04-1279	29	177	178	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					599	609		10.1056/NEJMoa1500140	http://dx.doi.org/10.1056/NEJMoa1500140			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LE	26267621	Green Accepted			2022-12-28	WOS:000359707700005
J	Kim, JB; Weichman, ML; Sjolander, TF; Neumark, DM; Klos, J; Alexander, MH; Manolopoulos, DE				Kim, Jongjin B.; Weichman, Marissa L.; Sjolander, Tobias F.; Neumark, Daniel M.; Klos, Jacek; Alexander, Millard H.; Manolopoulos, David E.			Spectroscopic observation of resonances in the F + H-2 reaction	SCIENCE			English	Article							TRANSITION-STATE; PHOTODETACHMENT SPECTROSCOPY; DYNAMICAL RESONANCES; PHOTOELECTRON; DISTRIBUTIONS; IONS	Photodetachment spectroscopy of the FH2- and FD2- anions allows for the direct observation of reactive resonances in the benchmark reaction F + H-2 -> H-F + H. Using cooled anion precursors and a high-resolution electron spectrometer, we observe several narrow peaks not seen in previous experiments. Theoretical calculations, based on a highly accurate F + H-2 potential energy surface, convincingly assign these peaks to resonances associated with quasibound states in the HF + H and DF + D product arrangements and with a quasibound state in the transition state region of the F + H-2 reaction. The calculations also reveal quasibound states in the reactant arrangement, which have yet to be resolved experimentally.	[Kim, Jongjin B.; Weichman, Marissa L.; Sjolander, Tobias F.; Neumark, Daniel M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Neumark, Daniel M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Klos, Jacek; Alexander, Millard H.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Alexander, Millard H.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Manolopoulos, David E.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Oxford	Neumark, DM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dneumark@berkeley.edu; mha@umd.edu; david.manolopoulos@chem.ox.ac.uk	Weichman, Marissa/AAU-3310-2020; Manolopoulos, David/AAV-1276-2021; Neumark, Daniel M/B-9551-2009; /A-6457-2008	Neumark, Daniel M/0000-0002-3762-9473; /0000-0002-7407-303X; Weichman, Marissa/0000-0002-2551-9146; Manolopoulos, David/0000-0002-7111-0763	Air Force Office of Scientific Research (AFOSR) [FA9550-12-1-0160]; Defense University Research Instrumentation Program (DURIP) [FA9550-11-1-0330]; National Science Foundation; U.S. National Science Foundation [CHE-1213332]; Wolfson Foundation; Royal Society	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense University Research Instrumentation Program (DURIP); National Science Foundation(National Science Foundation (NSF)); U.S. National Science Foundation(National Science Foundation (NSF)); Wolfson Foundation; Royal Society(Royal Society of London)	The experimental part of this work was funded by the Air Force Office of Scientific Research (AFOSR) under grant no. FA9550-12-1-0160 and the Defense University Research Instrumentation Program (DURIP) under grant no. FA9550-11-1-0330. M.L.W. thanks the National Science Foundation for a graduate research fellowship. The experimental data are available upon request from dneumark@berkeley.edu. M.H.A. is grateful for partial support by the U.S. National Science Foundation under grant CHE-1213332. D.E.M. is funded by the Wolfson Foundation and the Royal Society.	ALEXANDER MH, 1994, J CHEM PHYS, V101, P2887, DOI 10.1063/1.468431; Blondel C, 2001, J PHYS B-AT MOL OPT, V34, P2757, DOI 10.1088/0953-4075/34/13/701; BRADFORTH SE, 1993, J CHEM PHYS, V99, P6345, DOI 10.1063/1.465873; Castillo JF, 1996, J CHEM PHYS, V104, P6531, DOI 10.1063/1.471373; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Fernandez-Alonso F, 2002, ANNU REV PHYS CHEM, V53, P67, DOI 10.1146/annurev.physchem.53.091001.094554; Fu B, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2955729; Hock C, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4772406; HOLMGREN SL, 1977, J CHEM PHYS, V67, P4414, DOI 10.1063/1.434572; Lique F, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3603453; Liu KP, 2012, ADV CHEM PHYS, V149, P1; Manolopoulos DE, 2002, NATURE, V419, P266, DOI 10.1038/419266a; Manolopoulos DE, 1997, J CHEM SOC FARADAY T, V93, P673, DOI 10.1039/a606090k; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Neumark DM, 2005, PHYS CHEM CHEM PHYS, V7, P433, DOI 10.1039/b417886f; NEUMARK DM, 1985, J CHEM PHYS, V82, P3045, DOI 10.1063/1.448254; Osterwalder A, 2004, J CHEM PHYS, V121, P6317, DOI 10.1063/1.1787491; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Russell CL, 1996, CHEM PHYS LETT, V256, P465, DOI 10.1016/0009-2614(96)00445-9; Schatz GC, 2000, SCIENCE, V288, P1599, DOI 10.1126/science.288.5471.1599; Skodje RT, 2012, ADV QUANTUM CHEM, V63, P119, DOI 10.1016/B978-0-12-397009-1.00003-5; Skodje RT, 2000, J CHEM PHYS, V112, P4536, DOI 10.1063/1.481041; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; WALLER IM, 1990, J PHYS CHEM-US, V94, P2240, DOI 10.1021/j100369a009; Wang T, 2014, J PHYS CHEM LETT, V5, P3049, DOI 10.1021/jz501460k; Yacovitch TI, 2012, FARADAY DISCUSS, V157, P399, DOI 10.1039/c2fd20011b; Yang XM, 2008, ACCOUNTS CHEM RES, V41, P981, DOI 10.1021/ar700258g; ZHANG JZH, 1990, J CHEM PHYS, V92, P1811, DOI 10.1063/1.458063	30	84	86	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					510	513		10.1126/science.aac6939	http://dx.doi.org/10.1126/science.aac6939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228142	Green Submitted			2022-12-28	WOS:000358713300049
J	Yap, TA; Koo, MS; Ambrose, RF; Wake, DB; Vredenburg, VT				Yap, Tiffany A.; Koo, Michelle S.; Ambrose, Richard F.; Wake, David B.; Vredenburg, Vance T.			Averting a North American biodiversity crisis	SCIENCE			English	Editorial Material							BATRACHOCHYTRIUM-SALAMANDRIVORANS; DISEASE; CHYTRIDIOMYCOSIS; EXTINCTION		[Yap, Tiffany A.; Ambrose, Richard F.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA USA; [Yap, Tiffany A.; Koo, Michelle S.; Wake, David B.; Vredenburg, Vance T.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Yap, Tiffany A.; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Ambrose, Richard F.] Univ Calif Los Angeles, Dept Environm Hlth Sci, Los Angeles, CA USA; [Wake, David B.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; California State University System; San Francisco State University; University of California System; University of California Los Angeles; University of California System; University of California Berkeley	Vredenburg, VT (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	vancev@sfsu.edu	Ambrose, Richard F./AAQ-1192-2020; KOO, Michelle S./AAD-8688-2020; Wake, David/AAA-6766-2021	Ambrose, Richard F./0000-0001-8653-6487; KOO, Michelle S./0000-0003-0410-722X; Wake, David/0000-0003-4835-2497; Vredenburg, Vance/0000-0002-9682-1190	UCLA-Charles F. Scott Fellowship; NSF [IOS-1258133]	UCLA-Charles F. Scott Fellowship; NSF(National Science Foundation (NSF))	This work was supported by UCLA-Charles F. Scott Fellowship (T.A.Y.) and NSF IOS-1258133 (V.T.V.). We thank S.M. Rovito for Mexican species occurrence data and the Museum of Vertebrate Zoology at University of California, Berkeley, for technical support. Original data are archived at AmphibiaWeb, VertNet, the International Union for Conservation of Nature, WorldClim, and the U.S. Fish and Wildlife Service, and we thank these organizations and collections for sharing their data. We also thank the anonymous reviewers.	AmphibiaWeb, 2015, INF AMPH BIOL CONS; Bales EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116405; Best ML, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00302.1; Blooi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11788; Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Blooi M., 2015, SCI REP, V5, P1; Chan HK, 2015, SCIENCE, V348, P291, DOI 10.1126/science.aaa3141; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Cunningham AA, 2015, VET REC, V176, P468, DOI 10.1136/vr.h2264; Langwig KE, 2015, FRONT ECOL ENVIRON, V13, P195, DOI 10.1890/140241; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Muletz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103728; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tompkins DM, 2015, TRENDS PARASITOL, V31, P149, DOI 10.1016/j.pt.2015.01.007; Voyles J., 2014, ECOHEALTH, V11, P2008; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105	21	95	97	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					481	482		10.1126/science.aab1052	http://dx.doi.org/10.1126/science.aab1052			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228132				2022-12-28	WOS:000358713300033
J	Ku, C; Nelson-Sathi, S; Roettger, M; Sousa, FL; Lockhart, PJ; Bryant, D; Hazkani-Covo, E; McInerney, JO; Landan, G; Martin, WF				Ku, Chuan; Nelson-Sathi, Shijulal; Roettger, Mayo; Sousa, Filipa L.; Lockhart, Peter J.; Bryant, David; Hazkani-Covo, Einat; McInerney, James O.; Landan, Giddy; Martin, William F.			Endosymbiotic origin and differential loss of eukaryotic genes	NATURE			English	Article							FALSE DISCOVERY RATE; PROTEIN FAMILIES; MITOCHONDRIAL GENOMES; SEQUENCE-ANALYSIS; EVOLUTION; MODEL; CLASSIFICATION; COMPLEXITY; PHYLOGENY; DATABASE	Chloroplasts arose from cyanobacteria, mitochondria arose from proteobacteria. Both organelles have conserved their prokaryotic biochemistry, but their genomes are reduced, and most organelle proteins are encoded in the nucleus. Endosymbiotic theory posits that bacterial genes in eukaryotic genomes entered the eukaryotic lineage via organelle ancestors. It predicts episodic influx of prokaryotic genes into the eukaryotic lineage, with acquisition corresponding to endosymbiotic events. Eukaryotic genome sequences, however, increasingly implicate lateral gene transfer, both from prokaryotes to eukaryotes and among eukaryotes, as a source of gene content variation in eukaryotic genomes, which predicts continuous, lineage-specific acquisition of prokaryotic genes in divergent eukaryotic groups. Here we discriminate between these two alternatives by clustering and phylogenetic analysis of eukaryotic gene families having prokaryotic homologues. Our results indicate (1) that gene transfer from bacteria to eukaryotes is episodic, as revealed by gene distributions, and coincides with major evolutionary transitions at the origin of chloroplasts and mitochondria; (2) that gene inheritance in eukaryotes is vertical, as revealed by extensive topological comparison, sparse gene distributions stemming from differential loss; and (3) that continuous, lineage-specific lateral gene transfer, although it sometimes occurs, does not contribute to long-term gene content evolution in eukaryotic genomes.	[Ku, Chuan; Nelson-Sathi, Shijulal; Roettger, Mayo; Sousa, Filipa L.; Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Lockhart, Peter J.] Massey Univ, Inst Fundamental Sci, Palmerston North 4474, New Zealand; [Bryant, David] Univ Otago, Dept Math & Stat, Dunedin 9054, New Zealand; [Hazkani-Covo, Einat] Open Univ Israel, Dept Nat & Life Sci, IL-43107 Raanana, Israel; [McInerney, James O.] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [McInerney, James O.] Univ Manchester, Manchester M13 9PL, Lancs, England; [Landan, Giddy] Univ Kiel, Inst Microbiol, Genom Microbiol Grp, D-24118 Kiel, Germany; [Martin, William F.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Heinrich Heine University Dusseldorf; Massey University; University of Otago; Open University Israel; Maynooth University; University of Manchester; University of Kiel; Universidade Nova de Lisboa	Martin, WF (corresponding author), Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany.	bill@hhu.de	Martin, William F./O-5446-2015; Ku, Chuan/N-3093-2013; Sousa, Filipa L./H-6192-2012; Mcinerney, James/AAF-7234-2020; Landan, Giddy/C-1086-2019; Sousa, Filipa/ACC-2848-2022	Martin, William F./0000-0003-1478-6449; Ku, Chuan/0000-0001-6414-4423; Sousa, Filipa L./0000-0002-4075-1701; Landan, Giddy/0000-0002-2502-8750; Sousa, Filipa/0000-0002-4084-1942; Hazkani-Covo, Einat/0000-0002-4878-6001; Nelson-Sathi, Shijulal/0000-0002-3346-0383	European Research Council [232975, 666053, 281357]; Templeton Foundation [48177]; Open University of Israel Research Fund; German-Israeli Foundation [I-1321-203.13/2015]; New Zealand BioProtection CoRE; German Academic Exchange Service [57076385]; Alexander von Humboldt Foundation	European Research Council(European Research Council (ERC)European Commission); Templeton Foundation; Open University of Israel Research Fund; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); New Zealand BioProtection CoRE; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank the following funding agencies: the European Research Council grants 232975, 666053(W.F.M.) and 281357(G.L.; to T. Dagan); the Templeton Foundation grant 48177 (J.O.M.); the Open University of Israel Research Fund (E.H.-C.); the German-Israeli Foundation grant I-1321-203.13/2015 (E.H.-C., W.F.M.), the New Zealand BioProtection CoRE (P.J.L.); the German Academic Exchange Service PhD stipend 57076385 (C.K.); an Alexander von Humboldt Foundation fellowship (D.B.). Computational support of the Zentrum fur Informations- und Medientechnologie at the Heinrich-Heine University is acknowledged.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Alsmark C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r19; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Ponce D, 2013, P NATL ACAD SCI USA, V110, pE1594, DOI 10.1073/pnas.1211371110; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Archibald J, 2014, ONE PLUS ONE EQUALS; Artamonova II, 2013, APPL ENVIRON MICROB, V79, P6868, DOI 10.1128/AEM.01635-13; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cotton JA, 2010, P NATL ACAD SCI USA, V107, P17252, DOI 10.1073/pnas.1000265107; Crisp A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0607-3; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104; de Vries J, 2002, P NATL ACAD SCI USA, V99, P2094, DOI 10.1073/pnas.042263399; Derelle R, 2015, P NATL ACAD SCI USA, V112, pE693, DOI 10.1073/pnas.1420657112; Domman D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7421; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo ZH, 2005, MOL BIOL EVOL, V22, P2166, DOI 10.1093/molbev/msi215; Guy L, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016022; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; Hazkani-Covo E, 2007, MOL BIOL EVOL, V24, P13, DOI 10.1093/molbev/msl149; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Huang JL, 2013, BIOESSAYS, V35, P868, DOI 10.1002/bies.201300007; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Jackson CJ, 2014, GENOME BIOL EVOL, V6, P2774, DOI 10.1093/gbe/evu218; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Koonin EV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016188; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Ku C., 2015, P NATL ACAD SCI US; Lahr DJG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022780; Landan Giddy, 2008, Pac Symp Biocomput, P15; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802; Lang D, 2008, TRENDS PLANT SCI, V13, P542, DOI 10.1016/j.tplants.2008.07.002; Langdon WB, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-3; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Lobkovsky AE, 2013, GENOME BIOL EVOL, V5, P233, DOI 10.1093/gbe/evt002; Lockhart PJ, 1998, MOL BIOL EVOL, V15, P1183, DOI 10.1093/oxfordjournals.molbev.a026025; Lockhart PJ, 2000, MOL BIOL EVOL, V17, P835, DOI 10.1093/oxfordjournals.molbev.a026363; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Maier UG, 2013, GENOME BIOL EVOL, V5, P2318, DOI 10.1093/gbe/evt181; Margulis L, 2000, P NATL ACAD SCI USA, V97, P6954, DOI 10.1073/pnas.97.13.6954; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nei M., 2013, MUTATION DRIVEN EVOL; Nelson-Sathi S, 2015, NATURE, V517, P77, DOI 10.1038/nature13805; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Okamoto N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007080; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Petitjean C, 2015, GENOME BIOL EVOL, V7, P191, DOI 10.1093/gbe/evu274; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Semple C., 2003, PHYLOGENETICS; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEEL MA, 1993, NATURE, V364, P440, DOI 10.1038/364440a0; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Yoon HS, 2006, J PHYCOL, V42, P482, DOI 10.1111/j.1529-8817.2006.00210.x; Yue JP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2148; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173; Zar J. H., 2014, BIOSTAT ANAL; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	103	177	182	7	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					427	+		10.1038/nature14963	http://dx.doi.org/10.1038/nature14963			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26287458				2022-12-28	WOS:000360069300029
J	Nillegoda, NB; Kirstein, J; Szlachcic, A; Berynskyy, M; Stank, A; Stengel, F; Arnsburg, K; Gao, XC; Scior, A; Aebersold, R; Guilbride, DL; Wade, RC; Morimoto, RI; Mayer, MP; Bukau, B				Nillegoda, Nadinath B.; Kirstein, Janine; Szlachcic, Anna; Berynskyy, Mykhaylo; Stank, Antonia; Stengel, Florian; Arnsburg, Kristin; Gao, Xuechao; Scior, Annika; Aebersold, Ruedi; Guilbride, D. Lys; Wade, Rebecca C.; Morimoto, Richard I.; Mayer, Matthias P.; Bukau, Bernd			Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation	NATURE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; SWISS-MODEL REPOSITORY; CROSS-LINKED PEPTIDES; J-DOMAIN; MOLECULAR CHAPERONES; YEAST CYTOSOL; IN-VITRO; DIFFUSIONAL ASSOCIATION; FUNCTIONAL SPECIFICITY; COCHAPERONE DNAJ	Protein aggregates are the hallmark of stressed and ageing cells, and characterize several pathophysiological states(1,2). Healthy metazoan cells effectively eliminate intracellular protein aggregates(3,4,) indicating that efficient disaggregation and/or degradation mechanisms exist. However, metazoans lack the key heat-shock protein disaggregase HSP100 of non-metazoan HSP70-dependent protein disaggregation systems(5,6), and the human HSP70 system alone, even with the crucial HSP110 nucleotide exchange factor, has poor disaggregation activity in vitro4,7. This unresolved conundrum is central to protein quality control biology. Here we show that synergic cooperation between complexed J-protein co-chaperones of classes A and B unleashes highly efficient protein disaggregation activity in human and nematode HSP70 systems. Metazoan mixed-class J-protein complexes are transient, involve complementary charged regions conserved in the J-domains and carboxy-terminal domains of each J-protein class, and are flexible with respect to subunit composition. Complex formation allows J-proteins to initiate transient higher order chaperone structures involving HSP70 and interacting nucleotide exchange factors. A network of cooperative class A and B J-protein interactions therefore provides the metazoan HSP70 machinery with powerful, flexible, and finely regulatable disaggregase activity and a further level of regulation crucial for cellular protein quality control.	[Nillegoda, Nadinath B.; Szlachcic, Anna; Gao, Xuechao; Guilbride, D. Lys; Wade, Rebecca C.; Mayer, Matthias P.; Bukau, Bernd] Univ Heidelberg ZMBH, German Canc Res Ctr DKFZ, Ctr Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Kirstein, Janine; Arnsburg, Kristin; Scior, Annika] Leibniz Inst Mol Pharmacol FMP, D-13125 Berlin, Germany; [Berynskyy, Mykhaylo; Stank, Antonia; Wade, Rebecca C.] HITS, D-69118 Heidelberg, Germany; [Stank, Antonia] Heidelberg Univ, Heidelberg Grad Sch Math & Computat Methods Sci, D-69120 Heidelberg, Germany; [Stengel, Florian; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Wade, Rebecca C.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, D-69120 Heidelberg, Germany; [Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Ruprecht Karls University Heidelberg; Northwestern University	Bukau, B (corresponding author), Univ Heidelberg ZMBH, German Canc Res Ctr DKFZ, Ctr Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany.	n.nillegoda@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013; Wade, Rebecca/L-1489-2019	Mayer, Matthias P./0000-0002-7859-3112; Wade, Rebecca/0000-0001-5951-8670; Stengel, Florian/0000-0003-1447-4509; Bukau, Bernd/0000-0003-0521-7199; Nillegoda, Nadinath/0000-0002-9980-3991; Szlachcic, Anna/0000-0003-0574-1476; Kirstein, Janine/0000-0003-4990-2497	Deutsche Forschungsgemeinschaft [SFB1036, BU617/19-1, EXC257, SFB740]; Alexander von Humboldt Foundation; National Institutes of Health (NIGMS); National Institutes of Health (NIA); National Institutes of Health (NIMS); Ellison Medical Foundation; Daniel F. and Ada L. Rice Foundation; German Federal Ministry of Education and Research (BMBF) Virtual Liver Network; EU FEP Flagship Programme Human Brain Project [0315749, 604102]; Klaus Tschira Foundation; Sir Henry Wellcome Postdoctoral Fellowship; ETH Zurich; ERC [233226]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026647, R37AG026647] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIMS); Ellison Medical Foundation(Lawrence Ellison Foundation); Daniel F. and Ada L. Rice Foundation; German Federal Ministry of Education and Research (BMBF) Virtual Liver Network(Federal Ministry of Education & Research (BMBF)); EU FEP Flagship Programme Human Brain Project; Klaus Tschira Foundation; Sir Henry Wellcome Postdoctoral Fellowship; ETH Zurich(ETH Zurich); ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Mogk for critical reading of the manuscript and S. Ungelenk for Hsp26. This work was funded by the Deutsche Forschungsgemeinschaft (SFB1036, BU617/19-1 to B.B.; EXC257, SFB740 to J.K.), Alexander von Humboldt Foundation Postdoctoral Fellowships (to N.B.N. and A.Sz.), National Institutes of Health (the NIGMS, NIA, NIMS), Ellison Medical Foundation and Daniel F. and Ada L. Rice Foundation (to R.I.M.), German Federal Ministry of Education and Research (BMBF) Virtual Liver Network and EU FEP Flagship Programme Human Brain Project (0315749, 604102 to R.C.W.), Klaus Tschira Foundation (to M.B., A.St. and R.C.W.), Sir Henry Wellcome Postdoctoral Fellowship (to F. S.), ETH Zurich and ERC advanced grant Proteomics v3.0 (233226 to R.A.).	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P1540, DOI 10.1107/S0907444913010640; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Carra S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0409; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Cyr Douglas M, 2015, Subcell Biochem, V78, P91, DOI 10.1007/978-3-319-11731-7_4; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Dixit A, 2011, J BIOL CHEM, V286, P18878, DOI 10.1074/jbc.M111.222828; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Elcock AH, 1999, J MOL BIOL, V291, P149, DOI 10.1006/jmbi.1999.2919; Gabdoulline RR, 2009, J AM CHEM SOC, V131, P9230, DOI 10.1021/ja809567k; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; Gabdoulline RR, 1996, J PHYS CHEM-US, V100, P3868, DOI 10.1021/jp953109f; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; Genevaux P, 2002, GENETICS, V162, P1045; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Martinez M, 2015, J COMPUT CHEM, V36, P1631, DOI 10.1002/jcc.23971; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Skouri-Panet F, 2012, BIOCHIMIE, V94, P975, DOI 10.1016/j.biochi.2011.12.018; Spagnuolo CC, 2006, J AM CHEM SOC, V128, P12040, DOI 10.1021/ja063212q; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Suzuki H, 2010, BIOCHEMISTRY-US, V49, P8577, DOI 10.1021/bi100876n; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027	59	205	208	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					247	+		10.1038/nature14884	http://dx.doi.org/10.1038/nature14884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26245380	Green Submitted, Green Accepted			2022-12-28	WOS:000359386900038
J	Karim, SSA; Karim, QA; Kharsany, ABM; Baxter, C; Grobler, AC; Werner, L; Kashuba, A; Mansoor, LE; Samsunder, N; Mindel, A; Gengiah, TN				Karim, Salim S. Abdool; Karim, Quarraisha Abdool; Kharsany, Ayesha B. M.; Baxter, Cheryl; Grobler, Anneke C.; Werner, Lise; Kashuba, Angela; Mansoor, Leila E.; Samsunder, Natasha; Mindel, Adrian; Gengiah, Tanuja N.		Caprisa 004 Trial Grp	Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREEXPOSURE PROPHYLAXIS; ORAL TENOFOVIR; HIV PREVENTION; PREVALENCE; HSV-2; ANTIBODIES; WOMEN	BACKGROUND Globally, herpes simplex virus type 2 (HSV-2) infection is the most common cause of genital ulcer disease. Effective prevention strategies for HSV-2 infection are needed to achieve the goals of the World Health Organization global strategy for the prevention and control of sexually transmitted infections. METHODS We assessed the effectiveness of pericoital tenofovir gel, an antiviral microbicide, in preventing HSV-2 acquisition in a subgroup of 422 HSV-2-negative women enrolled in the Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 study, a double-blind, randomized, placebo-controlled trial. Incident HSV-2 cases were identified by evidence of seroconversion on an HSV-2 IgG enzyme-linked immunosorbent assay between study enrollment and exit. A confirmatory analysis was performed by Western blot testing. RESULTS The HSV-2 incidence rate was 10.2 cases per 100 person-years (95% confidence interval [CI], 6.8 to 14.7) among 202 women assigned to tenofovir gel, as compared with 21.0 cases per 100 person-years (95% CI, 16.0 to 27.2) among 222 women assigned to placebo gel (incidence rate ratio, 0.49; 95% CI, 0.30 to 0.77; P = 0.003). The HSV-2 incidence rate among the 25 women with vaginal tenofovir concentrations of 10,000 ng per milliliter or more was 5.7 cases per 100 person-years, as compared with 15.5 cases per 100 person-years among the 103 women with no detectable vaginal tenofovir (incidence rate ratio, 0.37; 95% CI, 0.04 to 1.51; P = 0.14). As confirmed by Western blot testing, there were 16 HSV-2 seroconversions among women assigned to tenofovir gel as compared with 36 among those assigned to the placebo gel (incidence rate ratio, 0.45; 95% CI, 0.23 to 0.82; P = 0.005). CONCLUSIONS In this study in South Africa, pericoital application of tenofovir gel reduced HSV-2 acquisition in women. (Funded by the U. S. Agency for International Development and others; ClinicalTrials.gov number, NCT00441298.)	[Karim, Salim S. Abdool; Karim, Quarraisha Abdool; Kharsany, Ayesha B. M.; Baxter, Cheryl; Grobler, Anneke C.; Werner, Lise; Mansoor, Leila E.; Samsunder, Natasha; Mindel, Adrian; Gengiah, Tanuja N.] CAPRISA, Durban, South Africa; [Karim, Salim S. Abdool] Univ KwaZulu Natal, Durban, South Africa; [Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Kashuba, Angela] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA	University of Kwazulu Natal; Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Karim, SSA (corresponding author), CAPRISA, Doris Duke Med Res Inst, 2nd Fl,Private Bag X7, ZA-4013 Congella, South Africa.	caprisa@caprisa.org	Karim, Salim Abdool/P-3117-2019; Baxter, Cheryl/Q-5349-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Abdool/AAE-7118-2019; Mlisana, Koleka/N-6204-2013	Karim, Salim Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Mindel, Adrian/0000-0002-8780-9982; Naranbhai, Vivek/0000-0003-4281-8882; Grobler, Anneke/0000-0002-7809-7688; Gengiah, Tanuja/0000-0002-3405-5128; Mlisana, Koleka/0000-0002-8436-3268	U.S. Agency for International Development; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	U.S. Agency for International Development(United States Agency for International Development (USAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the U.S. Agency for International Development and others; ClinicalTrials.gov number, NCT00441298.	Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Ashley RL, 1998, J CLIN MICROBIOL, V36, P294, DOI 10.1128/JCM.36.1.294-295.1998; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Celum C, 2014, ANN INTERN MED, V161, P11, DOI 10.7326/M13-2471; Delany-Moretlwe S, 2010, SEX TRANSM INFECT, V86, P46, DOI 10.1136/sti.2009.036541; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Karim QA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-67; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Mansoor LE, 2014, AIDS BEHAV, V18, P811, DOI 10.1007/s10461-014-0751-x; Marcus JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091513; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Martin ET, 2009, ARCH INTERN MED, V169, P1233, DOI 10.1001/archinternmed.2009.177; Rees H, 2015, C RETR OPP INF CROI; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Tan DHS, 2011, AIDS, V25, P207, DOI 10.1097/QAD.0b013e328341ddf7; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; World Health Organization, 2007, GLOB STRAT PREV CONT	25	67	71	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					530	539		10.1056/NEJMoa1410649	http://dx.doi.org/10.1056/NEJMoa1410649			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26244306	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-28	WOS:000358987700007
J	Kovacs, IA; Barabasi, AL				Kovacs, Istvan A.; Barabasi, Albert-Laszlo			NETWORK SCIENCE Destruction perfected	NATURE			English	Editorial Material								Pinpointing the nodes whose removal most effectively disrupts a network has become a lot easier with the development of an efficient algorithm. Potential applications might include cybersecurity and disease control. SEE LETTER P. 65	[Kovacs, Istvan A.; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Kovacs, Istvan A.; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	Northeastern University; Northeastern University	Kovacs, IA (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	alb@neu.edu	Kovacs, Istvan/A-8447-2013; Barabasi, Albert-Laszlo/S-6474-2017	Kovacs, Istvan/0000-0002-6890-6277; Barabasi, Albert/0000-0002-4028-3522				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Garey M.R., 1979, COMPUTERS INTRACTABI; Hashimoto K., 1989, ADV STUD PURE MATH, V15, P211, DOI DOI 10.1016/B978-0-12-330580-0.50015-X; Morone F, 2015, NATURE, V524, P65, DOI 10.1038/nature14604; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013	8	31	33	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					38	39		10.1038/524038a	http://dx.doi.org/10.1038/524038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26245576				2022-12-28	WOS:000359002300022
J	Spiegel, PB				Spiegel, Paul B.			The State of the World's Refugees The Importance of Work, Cash Assistance, and Health Insurance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Off United Nations High Commissioner Refugees, CH-1211 Geneva, Switzerland		Spiegel, PB (corresponding author), Off United Nations High Commissioner Refugees, 94 Rue Montbrillant, CH-1211 Geneva, Switzerland.	spiegel@unhcr.org	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				[Anonymous], POL ALT CAMPS; [Anonymous], 2014, COMP YOUR COUNTR OFF; [Anonymous], IMP REF NEIGHB COUNT; [Anonymous], EM EC IMP CASH ASS L; [Anonymous], MIGR DEV BRIEF; Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825; Guterres A, 2012, JAMA-J AM MED ASSOC, V308, P673, DOI 10.1001/2012.jama.10161	7	7	7	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					445	446		10.1001/jama.2015.8767	http://dx.doi.org/10.1001/jama.2015.8767			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO1OI	26241592				2022-12-28	WOS:000358924500005
J	Odell, ID; Zeidan, AM; Parker, TL; Colegio, OR; Subtil, A				Odell, Ian D.; Zeidan, Amer M.; Parker, Terri L.; Colegio, Oscar R.; Subtil, Antonio			Leukaemic vasculitis with myelodysplastic syndrome	LANCET			English	Editorial Material							CUTIS		[Odell, Ian D.; Colegio, Oscar R.; Subtil, Antonio] Yale Univ, Dept Dermatol, New Haven, CT 06520 USA; [Zeidan, Amer M.; Parker, Terri L.] Yale Univ, Sect Hematol, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Yale University	Odell, ID (corresponding author), Yale Univ, Sch Med, Dept Dermatol, 333 Cedar St, New Haven, CT 06520 USA.	ian.odell@yale.edu		Colegio, Oscar/0000-0002-9524-6235; Odell, Ian/0000-0003-3990-6929; Colegio, Oscar/0000-0002-6519-3718				Jones D, 1997, AM J CLIN PATHOL, V107, P637; Paydas S, 2000, BRIT J DERMATOL, V143, P773, DOI 10.1046/j.1365-2133.2000.03774.x; Seckin D, 2009, J AM ACAD DERMATOL, V61, P519, DOI 10.1016/j.jaad.2008.11.888; Swerdlow SH, 2008, WHO CLASSIFICATION T; YIANNIAS JA, 1992, J AM ACAD DERMATOL, V26, P38, DOI 10.1016/0190-9622(92)70003-X	5	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					501	502		10.1016/S0140-6736(15)61165-5	http://dx.doi.org/10.1016/S0140-6736(15)61165-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251396				2022-12-28	WOS:000358761700031
J	Bibring, JP; Langevin, Y; Carter, J; Eng, P; Gondet, B; Jorda, L; Le Mouelic, S; Mottola, S; Pilorget, C; Poulet, F; Vincendon, M				Bibring, J. -P.; Langevin, Y.; Carter, J.; Eng, P.; Gondet, B.; Jorda, L.; Le Mouelic, S.; Mottola, S.; Pilorget, C.; Poulet, F.; Vincendon, M.			67P/Churyumov-Gerasimenko surface properties as derived from CIVA panoramic images	SCIENCE			English	Article								The structure and composition of cometary constituents, down to their microscopic scale, are critical witnesses of the processes and ingredients that drove the formation and evolution of planetary bodies toward their present diversity. On board Rosetta's lander Philae, the Comet Infrared and Visible Analyser (CIVA) experiment took a series of images to characterize the surface materials surrounding the lander on comet 67P/Churyumov-Gerasimenko. Images were collected twice: just after touchdown, and after Philae finally came to rest, where it acquired a full panorama. These images reveal a fractured surface with complex structure and a variety of grain scales and albedos, possibly constituting pristine cometary material.	[Bibring, J. -P.; Langevin, Y.; Carter, J.; Eng, P.; Gondet, B.; Pilorget, C.; Poulet, F.; Vincendon, M.] Univ Paris Sud, CNRS, Inst Astrophys Spatiale IAS, F-91405 Orsay, France; [Jorda, L.] Univ Aix Marseille, INSU, CNRS, Lab Astrophys Marseille LAM,UMR7326, Marseille, France; [Le Mouelic, S.] CNRS, UMR6112, Lab Planetol & Geodynam, Nantes, France; [Le Mouelic, S.] Univ Nantes, Nantes, France; [Mottola, S.] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetary Res, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; Helmholtz Association; German Aerospace Centre (DLR)	Bibring, JP (corresponding author), Univ Paris Sud, CNRS, Inst Astrophys Spatiale IAS, F-91405 Orsay, France.	bibring@ias.u-psud.fr	Jorda, Laurent/AAA-1718-2021	Eng, Peter/0000-0002-8072-3203; Le Mouelic, Stephane/0000-0001-5260-1367; JORDA, Laurent/0000-0001-8735-3308				Bibring JP, 2007, SPACE SCI REV, V128, P397, DOI 10.1007/s11214-006-9135-5; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Goesmann F, 2015, SCIENCE, V349, DOI 10.1126/science.aab0689; Mottola S, 2015, SCIENCE, V349, DOI 10.1126/science.aab0232; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Wright IP, 2015, SCIENCE, V349, DOI 10.1126/science.aab0673	7	50	50	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aab0671	10.1126/science.aab0671	http://dx.doi.org/10.1126/science.aab0671			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228154				2022-12-28	WOS:000358713300006
J	Zitvogel, L; Kroemer, G				Zitvogel, Laurence; Kroemer, Guido			A p53-regulated immune checkpoint relevant to cancer	SCIENCE			English	Editorial Material							TUMOR-SUPPRESSOR P53; INFLAMMATION		[Zitvogel, Laurence] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France; [Zitvogel, Laurence] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 507, F-94805 Villejuif, France; [Kroemer, Guido] Univ Paris 05, Ctr Rech Cordeliers, INSERM U1138, Equipe Labellisee Ligue Natl Canc 11, F-75006 Paris, France; Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Kroemer, Guido] Univ Paris 06, F-75006 Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France; Inst Gustave Roussy, Metabol & Cell Biol Platforms, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy	Kroemer, G (corresponding author), Univ Paris 05, Ctr Rech Cordeliers, INSERM U1138, Equipe Labellisee Ligue Natl Canc 11, F-75006 Paris, France.	kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998				Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Kawashima H, 2013, J IMMUNOL, V191, P3614, DOI 10.4049/jimmunol.1300509; Le Mercier I, 2014, CANCER RES, V74, P1933, DOI 10.1158/0008-5472.CAN-13-1506; Okuda Y, 2003, J NEUROIMMUNOL, V135, P29, DOI 10.1016/S0165-5728(02)00428-9; Park JS, 2013, ARTHRITIS RHEUM-US, V65, P949, DOI 10.1002/art.37841; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang L, 2014, P NATL ACAD SCI USA, V111, P14846, DOI 10.1073/pnas.1407447111; Watanabe M, 2014, IMMUNITY, V40, P681, DOI 10.1016/j.immuni.2014.04.006; Yoon KW, 2015, SCIENCE, V349, DOI 10.1126/science.1261669; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	15	20	20	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					476	477		10.1126/science.aac8475	http://dx.doi.org/10.1126/science.aac8475			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228128				2022-12-28	WOS:000358713300030
J	Beier, KT; Steinberg, EE; DeLoach, KE; Xie, S; Miyamichi, K; Schwarz, L; Gao, XJJ; Kremer, EJ; Malenka, RC; Luo, LQ				Beier, Kevin T.; Steinberg, Elizabeth E.; DeLoach, Katherine E.; Xie, Stanley; Miyamichi, Kazunari; Schwarz, Lindsay; Gao, Xiaojing J.; Kremer, Eric J.; Malenka, Robert C.; Luo, Liqun			Circuit Architecture of VTA Dopamine Neurons Revealed by Systematic Input-Output Mapping	CELL			English	Article							VENTRAL TEGMENTAL AREA; PREFRONTAL CORTEX; MOTIVATIONAL SIGNALS; GABAERGIC NEURONS; AVERSIVE STIMULI; PROJECTIONS; REWARD; RAT; GLUTAMATE; INHIBITION	Dopamine (DA) neurons in the midbrain ventral tegmental area (VTA) integrate complex inputs to encode multiple signals that influence motivated behaviors via diverse projections. Here, we combine axon-initiated viral transduction with rabies-mediated trans-synaptic tracing and Cre-based cell-type-specific targeting to systematically map input-output relationships of VTA-DA neurons. We found that VTA-DA (and VTA-GABA) neurons receive excitatory, inhibitory, and modulatory input from diverse sources. VTA-DA neurons projecting to different forebrain regions exhibit specific biases in their input selection. VTA-DA neurons projecting to lateral and medial nucleus accumbens innervate largely non-overlapping striatal targets, with the latter also sending extensive extra-striatal axon collaterals. Using electrophysiology and behavior, we validated new circuits identified in our tracing studies, including a previously unappreciated top-down reinforcing circuit from anterior cortex to lateral nucleus accumbens via VTA-DA neurons. This study highlights the utility of our viral-genetic tracing strategies to elucidate the complex neural substrates that underlie motivated behaviors.	[Beier, Kevin T.; DeLoach, Katherine E.; Xie, Stanley; Miyamichi, Kazunari; Schwarz, Lindsay; Gao, Xiaojing J.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Beier, Kevin T.; DeLoach, Katherine E.; Xie, Stanley; Miyamichi, Kazunari; Schwarz, Lindsay; Gao, Xiaojing J.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Beier, Kevin T.; Steinberg, Elizabeth E.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Kremer, Eric J.] CNRS, Inst Genet Mol Montpellier, F-34293 Montpellier, France; [Kremer, Eric J.] Univ Montpellier, F-34000 Montpellier, France	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA.	malenka@stanford.edu; lluo@stanford.edu	Miyamichi, Kazunari/AAO-3705-2021; Schwarz, Lindsay/N-8125-2018; Kremer, Eric J/D-3734-2013; Gao, Xiaojing/K-2376-2016; Kremer, EJ/P-9838-2019	Schwarz, Lindsay/0000-0002-0613-5518; Kremer, EJ/0000-0001-6114-7530; Beier, Kevin/0000-0002-4934-1338; Luo, Liqun/0000-0001-5467-9264; Gao, Xiaojing/0000-0002-3094-1456	NIH grant [TR01MH099647]; Hughes Collaborative Innovation Award; NRSA Postdoctoral Fellowship [1F32DA038913-01]; Simons Foundation Autism Research Initiative; NIMH Silvio Conte Center at Stanford [P50 MH086403]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403, R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, F32DA038913] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hughes Collaborative Innovation Award; NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; NIMH Silvio Conte Center at Stanford; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Temkin for reagents; S. Lammel and M. Taylor for technical assistance and helpful discussions; T. Lerner, B. Weissbourd, and T. Mosca for advice and critiques on the manuscript; and K. Deissorth for coordinating publications. This work was supported by an NIH grant (TR01MH099647) and a Hughes Collaborative Innovation Award to L.L., an NRSA Postdoctoral Fellowship (1F32DA038913-01) to K.T.B., and a grant from the Simons Foundation Autism Research Initiative and the NIMH Silvio Conte Center at Stanford (P50 MH086403) to R.C.M.	Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; FALLON JH, 1981, J NEUROSCI, V1, P1361; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Karreman M, 1996, J NEUROCHEM, V66, P589; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Korotkova TM, 2003, J NEUROSCI, V23, P7; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Marinelli M, 2014, NEUROSCIENCE, V282, P176, DOI 10.1016/j.neuroscience.2014.07.034; Matsumoto M, 2013, NEURON, V79, P1011, DOI 10.1016/j.neuron.2013.07.002; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; McDevitt RA, 2014, CELL REP, V8, P1857, DOI 10.1016/j.celrep.2014.08.037; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Morales M, 2014, NEUROSCIENCE, V282, P60, DOI 10.1016/j.neuroscience.2014.05.032; PHILLIPSON OT, 1979, J COMP NEUROL, V187, P117, DOI 10.1002/cne.901870108; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Schwarz LA, 2015, NATURE; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Takatoh J, 2013, NEURON, V77, P346, DOI 10.1016/j.neuron.2012.11.010; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Weissbourd B, 2014, NEURON, V83, P645, DOI 10.1016/j.neuron.2014.06.024; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Zahm DS, 2011, J COMP NEUROL, V519, P3159, DOI 10.1002/cne.22670; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808	47	480	486	9	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					622	634		10.1016/j.cell.2015.07.015	http://dx.doi.org/10.1016/j.cell.2015.07.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232228	Green Accepted, Bronze			2022-12-28	WOS:000358801800020
J	Cunha, BA; Burillo, A; Bouza, E				Cunha, Burke A.; Burillo, Almudena; Bouza, Emilio			Legionnaires' disease	LANCET			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; LEGIONELLA-PNEUMOPHILA SEROGROUPS; URINARY ANTIGEN TESTS; SEQUENCE-BASED SCHEME; MONOCLONAL-ANTIBODIES; ANTIMICROBIAL AGENTS; PONTIAC FEVER; UNITED-STATES; IN-VITRO; INTRACELLULAR ACTIVITIES	Since first identified in early 1977, bacteria of the genus Legionella are recognised as a common cause of community-acquired pneumonia and a rare cause of hospital-acquired pneumonia. Legionella bacteria multisystem manifestations mainly affect susceptible patients as a result of age, underlying debilitating conditions, or immunosuppression. Water is the major natural reservoir for Legionella, and the pathogen is found in many different natural and artificial aquatic environments such as cooling towers or water systems in buildings, including hospitals. The term given to the severe pneumonia and systemic infection caused by Legionella bacteria is Legionnaires' disease. Over time, the prevalence of legionellosis or Legionnaires' disease has risen, which might indicate a greater awareness and reporting of the disease. Advances in microbiology have led to a better understanding of the ecological niches and pathogenesis of the condition. Legionnaires' disease is not always suspected because of its non-specific symptoms, and the diagnostic tests routinely available do not off er the desired sensitivity. However, effective antibiotics are available. Disease notification systems provide the basis for initiating investigations and limiting the scale and recurrence of outbreaks. This report reviews our current understanding of this disease.	[Cunha, Burke A.] Winthrop Univ Hosp, Div Infect Dis, Mineola, NY 11501 USA; [Cunha, Burke A.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; [Burillo, Almudena; Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Div Clin Microbiol & Infect Dis, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Burillo, Almudena; Bouza, Emilio] Univ Complutense Madrid, Madrid, Spain; [Bouza, Emilio] CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain	Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; General University Gregorio Maranon Hospital; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Cunha, BA (corresponding author), Winthrop Univ Hosp, Div Infect Dis, 222 Stn Plaza North, Mineola, NY 11501 USA.	bacunha@winthrop.org	Bouza, Emilio/D-8661-2014	Bouza, Emilio/0000-0001-6967-9267; Burillo, Almudena/0000-0003-2545-4204	Fondo de Investigacion Sanitaria (FIS), Fund for Health Research of the Ministry of Health and Consumer Services of Spain [PSI 09/01257]	Fondo de Investigacion Sanitaria (FIS), Fund for Health Research of the Ministry of Health and Consumer Services of Spain	This Seminar was partially supported by the Fondo de Investigacion Sanitaria (FIS), Fund for Health Research of the Ministry of Health and Consumer Services of Spain (PSI 09/01257). The funder of this Seminar had no role in design, data collection, data analysis, data interpretation, or writing of the report.	Allen JG, 2012, AM J INFECT CONTROL, V40, P917, DOI 10.1016/j.ajic.2012.01.013; American Society of Heating, 2000, GUID 12 2000 MIN RIS; Ampel N M, 1990, Semin Respir Infect, V5, P30; ANDERSEN BB, 1987, NEUROLOGY, V37, P333, DOI 10.1212/WNL.37.2.333; ANDERSON R, 1988, J ANTIMICROB CHEMOTH, V22, P923, DOI 10.1093/jac/22.6.923; [Anonymous], 2013, FDA DRUG SAF COMM FD; ARMENGOL S, 1992, INT J CARDIOL, V37, P418, DOI 10.1016/0167-5273(92)90276-9; Bartram Jamie, 2007, P1; Berkelman RL, 2014, CLIN INFECT DIS, V58, P144, DOI 10.1093/cid/cit657; Bernander S, 2004, APMIS, V112, P210, DOI 10.1111/j.1600-0463.2004.apm1120307.x; BRABENDER W, 1983, JAMA-J AM MED ASSOC, V250, P3091, DOI 10.1001/jama.250.22.3091; Breiman R F, 1998, Semin Respir Infect, V13, P84; Bruin JP, 2014, J ANTIMICROB CHEMOTH, V69, P2869, DOI 10.1093/jac/dku196; Bruin JP, 2012, DIAGN MICR INFEC DIS, V72, P103, DOI 10.1016/j.diagmicrobio.2011.09.016; Burnsed LJ, 2007, CLIN INFECT DIS, V44, P222, DOI 10.1086/510387; Carratala J, 2010, CURR OPIN INFECT DIS, V23, P152, DOI 10.1097/QCO.0b013e328336835b; Chatfield Christa H, 2013, Methods Mol Biol, V954, P151, DOI 10.1007/978-1-62703-161-5_7; Cho MC, 2012, ANN LAB MED, V32, P133, DOI [10.3343/alm.2012.32.2.126, 10.3343/alm.2012.32.2.133]; Cloud JL, 2000, J CLIN MICROBIOL, V38, P1709, DOI 10.1128/JCM.38.5.1709-1712.2000; CORDES LG, 1980, MED CLIN N AM, V64, P395, DOI 10.1016/S0025-7125(16)31600-5; Cunha B A, 1998, Semin Respir Infect, V13, P116; Cunha B A, 2015, Clin Microbiol Infect, V21, pe45, DOI 10.1016/j.cmi.2015.02.015; Cunha BA, 2008, HEART LUNG, V37, P311, DOI 10.1016/j.hrtlng.2007.12.003; Cunha BA, 2008, HEART LUNG, V37, P238, DOI 10.1016/j.hrtlng.2007.10.003; Cunha BA, 2010, INFECT DIS CLIN N AM, V24, P73, DOI 10.1016/j.idc.2009.10.014; Doebbeling B N, 1987, Semin Respir Infect, V2, P206; DOURNON E, 1988, J INFECT DIS, V157, P496, DOI 10.1093/infdis/157.3.496; DOWLING JN, 1992, MICROBIOL REV, V56, P32, DOI 10.1128/MMBR.56.1.32-60.1992; Dunbar LM, 2004, CURR MED RES OPIN, V20, P555, DOI 10.1185/030079904125003304; Edelstein P., 2011, MANUAL CLIN MICROBIO, V1, P770; Edelstein PH, 2007, CLIN INFECT DIS, V44, P229, DOI 10.1086/510394; Edelstein Paul H., 2008, P1; Edelstein PH, 1995, CLIN INFECT DIS, V21, pS265, DOI 10.1093/clind/21.Supplement_3.S265; EDELSTEIN PH, 1994, ANTIMICROB AGENTS CH, V38, P200, DOI 10.1128/AAC.38.2.200; Edelstein PH, 2005, ANTIMICROB AGENTS CH, V49, P2533, DOI 10.1128/AAC.49.6.2533-2535.2005; EDELSTEIN PH, 1991, ANTIMICROB AGENTS CH, V35, P180, DOI 10.1128/AAC.35.1.180; Edelstein PH, 1998, ANN INTERN MED, V129, P328, DOI 10.7326/0003-4819-129-4-199808150-00012; EDELSTEIN PH, 1980, AM REV RESPIR DIS, V121, P317; Edelstein PH., 2010, PRINCIPLES PRACTICE, V7th, P2969; ENGLAND AC, 1981, ANN INTERN MED, V94, P164, DOI 10.7326/0003-4819-94-2-164; Erdogan H, 2010, ENVIRON MONIT ASSESS, V171, P487, DOI 10.1007/s10661-009-1293-y; FANG GD, 1990, MEDICINE, V69, P307, DOI 10.1097/00005792-199009000-00004; Fernandez-Cruz A, 2011, J CLIN MICROBIOL, V49, P3409, DOI 10.1128/JCM.00770-11; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLIERMANS CB, 1981, CURR MICROBIOL, V6, P89, DOI 10.1007/BF01569010; Fraser D W, 1980, Ann N Y Acad Sci, V353, P61, DOI 10.1111/j.1749-6632.1980.tb18906.x; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; FRY NK, 1991, FEMS MICROBIOL LETT, V83, P165; FRY NK, 1991, J GEN MICROBIOL, V137, P1215, DOI 10.1099/00221287-137-5-1215; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Garau J, 2010, J CHEMOTHERAPY, V22, P264, DOI 10.1179/joc.2010.22.4.264; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Garcia-Vidal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061036; Garrison LE, 2014, INFECT CONT HOSP EP, V35, P898, DOI 10.1086/676871; Garrison LE, 2013, 8 INT C LEG MELB AUS; Goldman L, 2010, GOLDMANS CECIL MED; GOLDONI P, 1995, J MED MICROBIOL, V42, P269, DOI 10.1099/00222615-42-4-269; GRANADOS A, 1989, EUR RESPIR J, V2, P130; Gudiol C, 2007, CLIN MICROBIOL INFEC, V13, P1125, DOI 10.1111/j.1469-0691.2007.01805.x; Gupta SK, 2001, CHEST, V120, P1064, DOI 10.1378/chest.120.4.1064; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; Heath CH, 1996, EUR J CLIN MICROBIOL, V15, P286, DOI 10.1007/BF01695659; HEATH PD, 1986, J NEUROL NEUROSUR PS, V49, P216, DOI 10.1136/jnnp.49.2.216-a; Helbig JH, 2012, EUR J CLIN MICROBIOL, V31, P1673, DOI 10.1007/s10096-011-1492-7; Helbig JH, 2002, EUR J CLIN MICROBIOL, V21, P710, DOI 10.1007/s10096-002-0820-3; Helbig JH, 1997, J CLIN MICROBIOL, V35, P2841, DOI 10.1128/JCM.35.11.2841-2845.1997; Helbig JH, 2003, J CLIN MICROBIOL, V41, P838, DOI 10.1128/JCM.41.2.838-840.2003; Heuner K, 2008, LEGIONELLA MOL MICRO; Hicks Lauri A., 2011, Morbidity and Mortality Weekly Report, V60, P1083; Hilbi H, 2010, MOL MICROBIOL, V76, P1, DOI 10.1111/j.1365-2958.2010.07086.x; HOFFLIN JM, 1987, ANN INTERN MED, V106, P209, DOI 10.7326/0003-4819-106-2-209; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Jarraud Sophie, 2013, Methods Mol Biol, V954, P27, DOI 10.1007/978-1-62703-161-5_2; JOHNSON JT, 1985, LANCET, V2, P298; JOLY JR, 1986, J CLIN MICROBIOL, V23, P768, DOI 10.1128/JCM.23.4.768-771.1986; Joseph Carol, 2013, Methods Mol Biol, V954, P73, DOI 10.1007/978-1-62703-161-5_4; KIRBY BD, 1980, MEDICINE, V59, P188; Klein N C, 1998, Semin Respir Infect, V13, P140; Kozak Natalia A, 2013, Methods Mol Biol, V954, P3, DOI 10.1007/978-1-62703-161-5_1; Kozak-Muiznieks NA, 2014, J CLIN MICROBIOL, V52, P201, DOI 10.1128/JCM.01973-13; KUGLER JW, 1983, AM J MED, V74, P281, DOI 10.1016/0002-9343(83)90629-0; KUZMAN I, 1995, SCAND J INFECT DIS, V27, P503, DOI 10.3109/00365549509047054; Lanternier F, 2013, CHEST, V144, P990, DOI 10.1378/chest.12-2820; Lee Susanne, 2013, Methods Mol Biol, V954, P87, DOI 10.1007/978-1-62703-161-5_5; Lettinga KD, 2002, CLIN INFECT DIS, V35, P11, DOI 10.1086/340738; Levy ML, 2010, PRIM CARE RESP J, V19, P21, DOI 10.4104/pcrj.2010.00014; Lin Y S, 1998, Semin Respir Infect, V13, P147; Lin YE, 2011, CURR OPIN INFECT DIS, V24, P350, DOI 10.1097/QCO.0b013e3283486c6e; Luck Christian, 2013, Methods Mol Biol, V954, P119, DOI 10.1007/978-1-62703-161-5_6; Pedro-Botet ML, 2009, EXPERT OPIN PHARMACO, V10, P1109, DOI [10.1517/14656560902900820, 10.1517/14656560902900820 ]; Mandell GL, 2010, MANDELL DOUGLAS BENN; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARRE R, 2002, LEGIONELLA; MARRIE TJ, 1991, EPIDEMIOL INFECT, V107, P591, DOI 10.1017/S0950268800049293; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; Martin Deanna, 2012, Health Facil Manage, V25, P41; Martinez MN, 2012, ANTIMICROB AGENTS CH, V56, P2795, DOI 10.1128/AAC.05360-11; MAYOCK R, 1983, AM J MED, V75, P534, DOI 10.1016/0002-9343(83)90362-5; Menasalvas A, 1998, REV ESP CARDIOL, V51, P79; Mentasti M, 2012, EUR J CLIN MICROBIOL, V31, P2017, DOI 10.1007/s10096-011-1535-0; Merault N, 2011, APPL ENVIRON MICROB, V77, P1708, DOI 10.1128/AEM.02261-10; Mulazimoglu L, 2001, CHEST, V120, P1049, DOI 10.1378/chest.120.4.1049; Murdoch DR, 2013, CLIN INFECT DIS, V57, P1275, DOI 10.1093/cid/cit504; MYEROWITZ RL, 1979, NEW ENGL J MED, V301, P953, DOI 10.1056/NEJM197911013011801; Nazanian EJ, 2008, DIAGN MICR INFEC DIS, V62, P125, DOI 10.1016/j.diagmicrobio.2008.05.004; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; O'Connor BA, 2007, EPIDEMIOL INFECT, V135, P34, DOI 10.1017/S095026880600656X; Pasculle A W, 1987, Semin Respir Infect, V2, P222; Pasculle AW, 2010, CLIN MICROBIOLOGY PR; Paterson DL, 1997, CLIN INFECT DIS, V25, P1430, DOI 10.1086/516138; POHLOD DJ, 1981, J ANTIMICROB CHEMOTH, V7, P335, DOI 10.1093/jac/7.4.335; RADAELLI F, 1991, HEMATOL ONCOL, V9, P125; Ratcliff RM, 1998, J CLIN MICROBIOL, V36, P1560, DOI 10.1128/JCM.36.6.1560-1567.1998; Ratcliff Rodney M, 2013, Methods Mol Biol, V954, P57, DOI 10.1007/978-1-62703-161-5_3; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; RHOMBERG PR, 1994, DIAGN MICR INFEC DIS, V19, P175, DOI 10.1016/0732-8893(94)90063-9; ROIG J, 1991, CHEST, V99, P344, DOI 10.1378/chest.99.2.344; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Sabria M, 2013, MANUAL INFECT DIS; Sanchez F, 1998, Rev Esp Quimioter, V11, P147; Sandkovsky U, 2008, AIDS PATIENT CARE ST, V22, P473, DOI 10.1089/apc.2007.0111; SANTIAGO EB, 1981, MED CLIN-BARCELONA, V77, P298; Sato T, 2011, ANTIMICROB AGENTS CH, V55, P1594, DOI 10.1128/AAC.01474-10; SAURA P, 1993, CLIN INFECT DIS, V17, P298, DOI 10.1093/clinids/17.2.298; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Shimada T, 2009, CHEST, V136, P1576, DOI 10.1378/chest.08-2602; Singh N, 2004, Transpl Infect Dis, V6, P58, DOI 10.1111/j.1399-3062.2004.062_2.x; STEELE TW, 1990, APPL ENVIRON MICROB, V56, P49, DOI 10.1128/AEM.56.1.49-53.1990; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Stockholm, 2013, LEG DIS EUR 2011; STOUT J, 1982, NEW ENGL J MED, V306, P466, DOI 10.1056/NEJM198202253060807; Stout JE, 2007, INFECT CONT HOSP EP, V28, P818, DOI 10.1086/518754; Stout JE, 1998, DIAGN MICR INFEC DIS, V30, P37, DOI 10.1016/S0732-8893(97)00174-0; Stout JE, 2003, INFECT CONT HOSP EP, V24, P563, DOI 10.1086/502251; Stout JE, 1997, NEW ENGL J MED, V337, P682, DOI 10.1056/NEJM199709043371006; Tan MJ, 2000, CHEST, V117, P398, DOI 10.1378/chest.117.2.398; US Food and Drug Administration, 2013, FDA DRUG SAF COMM AZ; vantHullenaar NGM, 1996, NETH J MED, V49, P202, DOI 10.1016/0300-2977(96)00044-7; Versalovic J, 2011, MANUAL CLIN MICROBIO; Viasus D, 2013, MEDICINE, V92, P51, DOI 10.1097/MD.0b013e31827f6104; VILDE JL, 1986, ANTIMICROB AGENTS CH, V30, P743, DOI 10.1128/AAC.30.5.743; von Baum H, 2008, CLIN INFECT DIS, V46, P1356, DOI 10.1086/586741; WEISENBURGER DD, 1981, ARCH PATHOL LAB MED, V105, P130; WINN WC, 1993, INFECT DIS CLIN N AM, V7, P377; WOODHEAD MA, 1987, BRIT J DIS CHEST, V81, P133, DOI 10.1016/0007-0971(87)90130-6; Yu H, 2009, INTERNAL MED, V48, P1997, DOI 10.2169/internalmedicine.48.2647; Yu VL, 2008, CLIN INFECT DIS, V46, P1365, DOI 10.1086/586742; YU VL, 1982, AM J MED, V73, P357, DOI 10.1016/0002-9343(82)90727-6; Yu VL, 2004, CHEST, V125, P2135, DOI 10.1378/chest.125.6.2135; YU VL, 2000, PRINCIPLES PRACTICE, P2424; Yzerman EPF, 2002, J CLIN MICROBIOL, V40, P3232, DOI 10.1128/JCM.40.9.3232-3236.2002	151	257	264	12	139	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					376	385		10.1016/S0140-6736(15)60078-2	http://dx.doi.org/10.1016/S0140-6736(15)60078-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26231463				2022-12-28	WOS:000368516500036
J	Kamal, AH; Maguire, JM; Meier, DE				Kamal, Arif H.; Maguire, Jennifer M.; Meier, Diane E.			Evolving the Palliative Care Workforce to Provide Responsive, Serious Illness Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HOSPICE		[Kamal, Arif H.] Duke Clin Res Inst, Durham, NC 27710 USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Icahn School of Medicine at Mount Sinai	Kamal, AH (corresponding author), Duke Clin Res Inst, 2400 Pratt St,Room 8043, Durham, NC 27710 USA.	arif.kamal@duke.edu	Maguire, Jane M.M./D-8427-2017	Maguire, Jane M.M./0000-0001-5722-8311				Accreditation Council for Graduate Medical Education, 2015, ACGME PUBL PROGR SEA; American Academy of Hospice and Palliative Medicine, NUMB CERT HOSP PALL; Center to Advance Palliative Care, 2014, NAT PALL CAR REG ANN; Feely MA, 2011, J PALLIAT MED, V14, P272, DOI 10.1089/jpm.2010.0455; Kamal A, 2014, J CLIN ONCOL S31, V32; Lupu D, 2010, J PAIN SYMPTOM MANAG, V40, P899, DOI 10.1016/j.jpainsymman.2010.07.004; National Hospice and Palliative Care Organization, 2014, NHPCOS FACTS FIG HOS; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Wu SY, 2000, PROJECTION CHRONIC I	9	44	44	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8					637	+		10.7326/M15-0071	http://dx.doi.org/10.7326/M15-0071			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26258800				2022-12-28	WOS:000363737400022
J	Kellermann, AL; Desai, NR				Kellermann, Arthur L.; Desai, Nihar R.			Obstacles to Developing Cost-Lowering Health Technology The Inventor's Dilemma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kellermann, Arthur L.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Desai, Nihar R.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Desai, Nihar R.] Yale Univ, Sch Med, Dept Cardiol, New Haven, CT USA; [Desai, Nihar R.] Yale Ctr Outcomes Res & Evaluat, New Haven, CT USA	Uniformed Services University of the Health Sciences - USA; Yale University; Yale University; Yale University	Kellermann, AL (corresponding author), Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	akellermann@usuhs.edu			AHRQ HHS [K12 HS023000] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS023000] Funding Source: NIH RePORTER; AHRQ [5K12HS023000-05] Funding Source: Federal RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Congressional Budget Office, TECHN CHANG GROWTH H; Desai NR, CARDIOVASCULAR POLYP; Garber S, 2014, REDIRECTING INNOVATI; Husten L., FDA ADVISORY PANEL O; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Neumann PJ, 2012, NEW ENGL J MED, V367, P1775, DOI 10.1056/NEJMp1208386; US Centers for Disease and Prevention, HEART DIS STROK PREV; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	9	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1447	1448		10.1001/jama.2015.10114	http://dx.doi.org/10.1001/jama.2015.10114			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26280344				2022-12-28	WOS:000362647800007
J	Seweryn, P; Van, LB; Kjeldgaard, M; Russo, CJ; Passmore, LA; Hove-Jensen, B; Jochimsen, B; Brodersen, DE				Seweryn, Paulina; Van, Lan Bich; Kjeldgaard, Morten; Russo, Christopher J.; Passmore, Lori A.; Hove-Jensen, Bjarne; Jochimsen, Bjarne; Brodersen, Ditlev E.			Structural insights into the bacterial carbon-phosphorus lyase machinery	NATURE			English	Article							RADICAL SAM; MECHANISM; PHOSPHATE; VALIDATION; METABOLISM; PRODUCTS; REVEALS; COMPLEX; SYSTEM; TILT	Phosphorus is required for all life and microorganisms can extract it from their environment through several metabolic pathways. When phosphate is in limited supply, some bacteria are able to use phosphonate compounds, which require specialized enzymatic machinery to break the stable carbon-phosphorus (C-P) bond. Despite its importance, the details of how this machinery catabolizes phosphonates remain unknown. Here we determine the crystal structure of the 240-kilodalton Escherichia coli C-P lyase core complex (PhnG-PhnH-PhnI-PhnJ; PhnGHIJ), and show that it is a two-fold symmetric hetero-octamer comprising an intertwined network of subunits with unexpected self-homologies. It contains two potential active sites that probably couple phosphonate compounds to ATP and subsequently hydrolyse the C-P bond. We map the binding site of PhnK on the complex using electron microscopy, and show that it binds to a conserved insertion domain of PhnJ. Our results provide a structural basis for understanding microbial phosphonate breakdown.	[Seweryn, Paulina; Van, Lan Bich; Kjeldgaard, Morten; Hove-Jensen, Bjarne; Jochimsen, Bjarne; Brodersen, Ditlev E.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Russo, Christopher J.; Passmore, Lori A.] Med Res Council Lab Mol Biol, Cambridge CB2 0QH, England	Aarhus University; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Brodersen, DE (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10c, DK-8000 Aarhus C, Denmark.	deb@mbg.au.dk	Brodersen, Ditlev E./AAQ-5241-2020	Russo, Christopher/0000-0002-4442-744X; Passmore, Lori/0000-0003-1815-3710	European Research Council [261151]; MRC [MC_U105192715]; Danish National Research Foundation 'Centre for mRNP biogenesis and metabolism'; Medical Research Council [MC_U105192715] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002082] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation 'Centre for mRNP biogenesis and metabolism'(Danmarks Grundforskningsfond); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	We are thankful to T. L. Sorensen at Diamond, T. Weinert at SLS as well as beamline staff at ESRF and MAX-Lab for help during X-ray data acquisition and S. Chen, C. G. Savva, J. Grimmett and T. Darling at the MRC-LMB for technical assistance with electron microscopy. This work was supported by the European Research Council grant no. 261151 (L.A.P.), MRC grant MC_U105192715 (L.A.P.), and the Danish National Research Foundation 'Centre for mRNP biogenesis and metabolism' (D.E.B.).	Adams MA, 2008, J BACTERIOL, V190, P1072, DOI 10.1128/JB.01274-07; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Booker Squire J, 2010, F1000 Biol Rep, V2, P52, DOI 10.3410/B2-52; CHEN CM, 1990, J BIOL CHEM, V265, P4461; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ermantraut E, 1998, ULTRAMICROSCOPY, V74, P75, DOI 10.1016/S0304-3991(98)00025-4; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; FROST JW, 1987, J AM CHEM SOC, V109, P2166, DOI 10.1021/ja00241a039; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hove-Jensen B, 2003, J BACTERIOL, V185, P2793, DOI 10.1128/JB.185.9.2793-2801.2003; Hove-Jensen B, 2014, MICROBIOL MOL BIOL R, V78, P176, DOI 10.1128/MMBR.00040-13; Hove-Jensen B, 2011, J AM CHEM SOC, V133, P3617, DOI 10.1021/ja1102713; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Imazu K, 1998, APPL ENVIRON MICROB, V64, P3754; Jochimsen B, 2011, P NATL ACAD SCI USA, V108, P11393, DOI 10.1073/pnas.1104922108; Kamat SS, 2013, NATURE, V497, P132, DOI 10.1038/nature12061; Kamat SS, 2011, NATURE, V480, P570, DOI 10.1038/nature10622; Karl DM, 2000, NATURE, V406, P31, DOI 10.1038/35017683; Knablein J, 1997, J MOL BIOL, V270, P1, DOI 10.1006/jmbi.1997.1074; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li XL, 2013, ACTA CRYSTALLOGR D, V69, P256, DOI 10.1107/S0907444912045180; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; METCALF WW, 1993, GENE, V129, P27, DOI 10.1016/0378-1119(93)90692-V; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; QUINN JP, 1989, LETT APPL MICROBIOL, V8, P113, DOI 10.1111/j.1472-765X.1989.tb00236.x; Ren Z, 2015, BIOCHEMISTRY-US, V54, P3400, DOI 10.1021/acs.biochem.5b00194; Rizk SS, 2006, PROTEIN SCI, V15, P1745, DOI 10.1110/ps.062135206; Russo CJ, 2014, J STRUCT BIOL, V187, P112, DOI 10.1016/j.jsb.2014.06.006; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; SCHOWANEK D, 1990, APPL ENVIRON MICROB, V56, P895, DOI 10.1128/AEM.56.4.895-903.1990; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thorn A, 2013, ACTA CRYSTALLOGR D, V69, P2251, DOI 10.1107/S0907444913027534; WACKETT LP, 1987, J BACTERIOL, V169, P710, DOI 10.1128/jb.169.2.710-717.1987; White AK, 2007, ANNU REV MICROBIOL, V61, P379, DOI 10.1146/annurev.micro.61.080706.093357; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yakovleva GM, 1998, APPL MICROBIOL BIOT, V49, P573, DOI 10.1007/s002530051215	48	38	40	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					68	+		10.1038/nature14683	http://dx.doi.org/10.1038/nature14683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26280334	Green Accepted			2022-12-28	WOS:000360594100026
J	Abitua, PB; Gainous, TB; Kaczmarczyk, AN; Winchell, CJ; Hudson, C; Kamata, K; Nakagawa, M; Tsuda, M; Kusakabe, TG; Levine, M				Abitua, Philip Barron; Gainous, T. Blair; Kaczmarczyk, Angela N.; Winchell, Christopher J.; Hudson, Clare; Kamata, Kaori; Nakagawa, Masashi; Tsuda, Motoyuki; Kusakabe, Takehiro G.; Levine, Michael			The pre-vertebrate origins of neurogenic placodes	NATURE			English	Article							GONADOTROPIN-RELEASING-HORMONE; NEURAL CREST; CIONA-INTESTINALIS; MESSENGER-RNA; EXPRESSION; EVOLUTION; GENERATION; INDUCTION; RELAXIN-3; SYSTEM	The sudden appearance of the neural crest and neurogenic placodes in early branching vertebrates has puzzled biologists for over a century(1). These embryonic tissues contribute to the development of the cranium and associated sensory organs, which were crucial for the evolution of the vertebrate "new head"(2,3). Aprevious study suggests that rudimentary neural crest cells existed in ancestral chordates(4). However, the evolutionary origins of neurogenic placodes have remained obscure owing to a paucity of embryonic data from tunicates, the closest living relatives to those early vertebrates(5). Here we show that the tunicate Ciona intestinalis exhibits a proto-placodal ectoderm (PPE) that requires inhibition of bone morphogenetic protein (BMP) and expresses the key regulatory determinant Six1/ 2 and its co-factor Eya, a developmental process conserved across vertebrates. The Ciona PPE is shown to produce ciliated neurons that express genes for gonadotropin releasing hormone (GnRH), a G-protein-coupled receptor for relaxin-3 (RXFP3) and a functional cyclic nucleotide-gated channel (CNGA), which suggests dual chemosensory and neurosecretory activities. These observations provide evidence that Ciona has a neurogenic proto-placode, which forms neurons that appear to be related to those derived from the olfactory placode and hypothalamic neurons of vertebrates. We discuss the possibility that the PPE-derived GnRH neurons of Ciona resemble an ancestral cell type, a progenitor to the complex neuronal circuit that integrates sensory information and neuroendocrine functions in vertebrates.	[Abitua, Philip Barron; Gainous, T. Blair; Kaczmarczyk, Angela N.; Winchell, Christopher J.; Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Hudson, Clare] Univ Paris 06, Sorbonne Univ, CNRS, Lab Biol Dev Villefranche Sur Mer,Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Kamata, Kaori; Nakagawa, Masashi; Tsuda, Motoyuki] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Kusakabe, Takehiro G.] Konan Univ, Fac Sci & Engn, Inst Integrat Neurobiol, Kobe, Hyogo 6588501, Japan; [Kusakabe, Takehiro G.] Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo 6588501, Japan	University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Hyogo; Konan University; Konan University	Levine, M (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	msl2@princeton.edu	Hudson, Clare/X-7618-2019; Kusakabe, Takehiro/H-7178-2012	Hudson, Clare/0000-0003-1585-8328; Kusakabe, Takehiro/0000-0002-8325-3665; Abitua, Philip/0000-0002-8264-0807; Levine, Michael/0000-0001-7629-0081; Abitua, Angela/0000-0002-8059-4050; Gainous, T. Blair/0000-0002-8987-3195	National Institutes of Health [NS076542]; Japan Society for the Promotion of Science [25650118, 25290067]; Japan Space Forum [h160179]; Agence Nationale de la Recherche [ANR-09-BLAN-0013-01]; National Science Foundation; California Institute for Regenerative Medicine; Grants-in-Aid for Scientific Research [25650118] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Space Forum; Agence Nationale de la Recherche(French National Research Agency (ANR)); National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Miyamoto and M. Kotera for technical assistance and A. Stolfi for cloning Chordin. GFP. This work was supported by a grant from the National Institutes of Health (NS076542) and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25650118, 25290067) and from the Japan Space Forum (h160179). Portions of this study were facilitated by the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology in Japan. The work of C.H. in the laboratory of H. Yasuo was funded by the Agence Nationale de la Recherche (ANR-09-BLAN-0013-01). P.B.A. and A.N.K. were supported by predoctoral fellowships from the National Science Foundation and California Institute for Regenerative Medicine, respectively.	Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Christiaen L, 2005, DEV BIOL, V277, P557, DOI 10.1016/j.ydbio.2004.10.008; Christiaen L, 2010, DEV BIOL, V340, P179, DOI 10.1016/j.ydbio.2009.11.006; Constantin S, 2008, ENDOCRINOLOGY, V149, P279, DOI 10.1210/en.2007-0955; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; El Majdoubi M, 2002, ENDOCRINOLOGY, V143, P2441, DOI 10.1210/en.143.6.2441; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gaskell W. H., 1908, ORIGIN VERTEBRATES; GORBMAN A, 1995, GEN COMP ENDOCR, V97, P171, DOI 10.1006/gcen.1995.1016; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Hudson C, 2005, DEVELOPMENT, V132, P1199, DOI 10.1242/dev.01688; Isberg V, 2014, NUCLEIC ACIDS RES, V42, pD422, DOI 10.1093/nar/gkt1255; Kamesh N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-129; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Konno A, 2010, DEV BIOL, V337, P42, DOI 10.1016/j.ydbio.2009.10.012; Kusakabe TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041955; Kwon HJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001133; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; McGowan BM, 2008, AM J PHYSIOL-ENDOC M, V295, pE278, DOI 10.1152/ajpendo.00028.2008; Patthey C, 2014, DEV BIOL, V389, P82, DOI 10.1016/j.ydbio.2014.01.017; REESE TS, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.2.209; Rehm E Jay, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5127; Reichert S, 2013, DEVELOPMENT, V140, P4435, DOI 10.1242/dev.098707; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steventon B, 2014, DEV BIOL, V389, P28, DOI 10.1016/j.ydbio.2014.01.021; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terakado K, 2001, GEN COMP ENDOCR, V124, P277, DOI 10.1006/gcen.2001.7728; Wagner E, 2012, DEVELOPMENT, V139, P2351, DOI 10.1242/dev.078485; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winchell CJ, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-4; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Wray S, 2010, J NEUROENDOCRINOL, V22, P743, DOI 10.1111/j.1365-2826.2010.02034.x; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	44	67	68	0	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					462	+		10.1038/nature14657	http://dx.doi.org/10.1038/nature14657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26258298	Green Accepted			2022-12-28	WOS:000360069300037
J	Lafferty, KD; Deleo, G; Briggs, CJ; Dobson, AP; Gross, T; Kuris, AM				Lafferty, Kevin D.; DeLeo, Giulio; Briggs, Cheryl J.; Dobson, Andrew P.; Gross, Thilo; Kuris, Armand M.			A general consumer-resource population model	SCIENCE			English	Article								Food-web dynamics arise from predator-prey, parasite-host, and herbivore-plant interactions. Models for such interactions include up to three consumer activity states (questing, attacking, consuming) and up to four resource response states (susceptible, exposed, ingested, resistant). Articulating these states into a general model allows for dissecting, comparing, and deriving consumer-resource models. We specify this general model for 11 generic consumer strategies that group mathematically into predators, parasites, and micropredators and then derive conditions for consumer success, including a universal saturating functional response. We further show how to use this framework to create simple models with a common mathematical lineage and transparent assumptions. Underlying assumptions, missing elements, and composite parameters are revealed when classic consumer-resource models are derived from the general model.	[Lafferty, Kevin D.] Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA; [Briggs, Cheryl J.; Kuris, Armand M.] Univ Calif Santa Barbara, Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [DeLeo, Giulio] Stanford Univ, Woods Inst Environm, Hopkins Marine Stn, Stanford, CA 94305 USA; [Dobson, Andrew P.] Princeton Univ, Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dobson, Andrew P.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Gross, Thilo] Univ Bristol, Dept Engn Math, Bristol, Avon, England	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Stanford University; Princeton University; The Santa Fe Institute; University of Bristol	Lafferty, KD (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA.	klafferty@usgs.gov	Lafferty, Kevin D./B-3888-2009; Gross, Thilo/B-4444-2010; De Leo, Giulio/AAC-5098-2019	Gross, Thilo/0000-0002-1356-6690; De Leo, Giulio/0000-0002-4186-3369	National Center for Ecological Analysis and Synthesis, a Center - NSF [DEB-0553768]; University of California-Santa Barbara; State of California; NSF Ecology of Infectious Diseases [OCE-1115965]; MacDonnel Foundation; Division Of Ocean Sciences [1115838] Funding Source: National Science Foundation	National Center for Ecological Analysis and Synthesis, a Center - NSF; University of California-Santa Barbara(University of California System); State of California; NSF Ecology of Infectious Diseases; MacDonnel Foundation; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was conducted as a part of the Parasites and Food Webs Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (grant DEB-0553768), the University of California-Santa Barbara, and the State of California, and by NSF Ecology of Infectious Diseases (grant OCE-1115965). A.P.D. was also sponsored by a Complexity Grant from the MacDonnel Foundation. Any use of trade, product, or firm names in this publication is for descriptive purposes only and does not imply endorsement by the U.S. government. We thank H. McCallum, M. Pascual, M. Wilber, R. Hechinger, J. McLaughlin, R. Warner, and S. Weinstein.	ANDERSON R M, 1991; Dawes JHP, 2013, J THEOR BIOL, V327, P11, DOI 10.1016/j.jtbi.2013.02.017; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Gross T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016205; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Malthus T R, 1973, ESSAY PRINCIPLE POPU; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Murdoch W.W., 2013, CONSUMER RESOURCE DY	8	56	56	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					854	857		10.1126/science.aaa6224	http://dx.doi.org/10.1126/science.aaa6224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293960				2022-12-28	WOS:000359832700046
J	Schmiedmayer, J; Abele, H				Schmiedmayer, Joerg; Abele, Hartmut			Probing the dark side Fundamental questions about dark matter and dark energy are probed in laboratory experiments	SCIENCE			English	Editorial Material									[Schmiedmayer, Joerg; Abele, Hartmut] Univ Vienna, Atominst, Vienna Ctr Quantum Sci & Technol, A-1020 Vienna, Austria	University of Vienna	Schmiedmayer, J (corresponding author), Univ Vienna, Atominst, Vienna Ctr Quantum Sci & Technol, TU Wien Stad Allee 2, A-1020 Vienna, Austria.	schmiedmayer@atomchip.org; abele@ati.ac.at	Schmiedmayer, Jörg/B-4717-2008; Schmiedmayer, Jörg/M-9669-2019; Abele, Hartmut A/D-5087-2009	Schmiedmayer, Jörg/0000-0001-7799-5614; Schmiedmayer, Jörg/0000-0001-7799-5614; Abele, Hartmut A/0000-0002-6832-9051	Austrian Science Fund (FWF) [I 862] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Aprile E, 2015, SCIENCE, V349, P851, DOI 10.1126/science.aab2069; Aprile E, 2012, ASTROPART PHYS, V35, P573, DOI 10.1016/j.astropartphys.2012.01.003; Baudis L, 2012, PHYS DARK UNIVERSE, V1, P94, DOI 10.1016/j.dark.2012.10.006; Bernabei R, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2648-7; Brax P, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.083004; Brax P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.111301; Burrage C, 2015, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2015/03/042; Einstein A., 1917, PREUSS AKAD WISS SIT, V142; Hamilton P, 2015, SCIENCE, V349, P849, DOI 10.1126/science.aaa8883; Jenke T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.151105; Khoury J, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.044026; Lemmel H, 2015, PHYS LETT B, V743, P310, DOI 10.1016/j.physletb.2015.02.063; RATRA B, 1988, PHYS REV D, V37, P3406, DOI 10.1103/PhysRevD.37.3406; WETTERICH C, 1988, NUCL PHYS B, V302, P668, DOI 10.1016/0550-3213(88)90193-9	14	7	7	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					786	787		10.1126/science.aac9828	http://dx.doi.org/10.1126/science.aac9828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293937				2022-12-28	WOS:000359832700016
J	Barbier, EB				Barbier, Edward B.			Hurricane Katrina's lessons for the world	NATURE			English	Editorial Material							CLIMATE-CHANGE		Univ Wyoming, Econ, Laramie, WY 82071 USA	University of Wyoming	Barbier, EB (corresponding author), Univ Wyoming, Econ, Laramie, WY 82071 USA.	ebarbier@uwyo.edu						[Anonymous], 2012, LOUIS COMPR MAST PLA; [Anonymous], 2005, TROPICAL CYCLONE REP; Center for International Earth Science + Information Network-CIESIN-Columbia University, 2013, LOW EL COAST ZON LEC; Cinner JE, 2012, GLOBAL ENVIRON CHANG, V22, P12, DOI 10.1016/j.gloenvcha.2011.09.018; DasGupta R, 2013, OCEAN COAST MANAGE, V80, P107, DOI 10.1016/j.ocecoaman.2013.04.010; Dasgupta S, 2010, VULNERABILITY BANGLA; Gulf Coast Ecosystem Recovery Task Force 2011Gulf Coast Ecosystem Recovery Task Force, 2011, GULF MEX REG EC REST; Rawlani AK, 2011, MITIG ADAPT STRAT GL, V16, P845, DOI 10.1007/s11027-011-9298-6; Woodruff JD, 2013, NATURE, V504, P44, DOI 10.1038/nature12855	9	15	14	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					285	287		10.1038/524285a	http://dx.doi.org/10.1038/524285a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP2NN	26289191	Bronze			2022-12-28	WOS:000359714000011
J	Merckx, VSFT; Hendriks, KP; Beentjes, KK; Mennes, CB; Becking, LE; Peijnenburg, KTCA; Afendy, A; Arumugam, N; de Boer, H; Biun, A; Buang, MM; Chen, PP; Chung, AYC; Dow, R; Feijen, FAA; Feijen, H; Soest, CFV; Geml, J; Geurts, R; Gravendeel, B; Hovenkamp, P; Imbun, P; Ipor, I; Janssens, SB; Jocque, M; Kappes, H; Khoo, E; Koomen, P; Lens, F; Majapun, RJ; Morgado, LN; Neupane, S; Nieser, N; Pereira, JT; Rahman, H; Sabran, S; Sawang, A; Schwallier, RM; Shim, PS; Smit, H; Sol, N; Spait, M; Stech, M; Stokvis, F; Sugau, JB; Suleiman, M; Sumail, S; Thomas, DC; van Tol, J; Tuh, FYY; Yahya, BE; Nais, J; Repin, R; Lakim, M; Schilthuizen, M				Merckx, Vincent S. F. T.; Hendriks, Kasper P.; Beentjes, Kevin K.; Mennes, Constantijn B.; Becking, Leontine E.; Peijnenburg, Katja T. C. A.; Afendy, Aqilah; Arumugam, Nivaarani; de Boer, Hugo; Biun, Alim; Buang, Matsain M.; Chen, Ping-Ping; Chung, Arthur Y. C.; Dow, Rory; Feijen, Frida A. A.; Feijen, Hans; Soest, Cobi Feijen-van; Geml, Jozsef; Geurts, Rene; Gravendeel, Barbara; Hovenkamp, Peter; Imbun, Paul; Ipor, Isa; Janssens, Steven B.; Jocque, Merlijn; Kappes, Heike; Khoo, Eyen; Koomen, Peter; Lens, Frederic; Majapun, Richard J.; Morgado, Luis N.; Neupane, Suman; Nieser, Nico; Pereira, Joan T.; Rahman, Homathevi; Sabran, Suzana; Sawang, Anati; Schwallier, Rachel M.; Shim, Phyau-Soon; Smit, Harry; Sol, Nicolien; Spait, Maipul; Stech, Michael; Stokvis, Frank; Sugau, John B.; Suleiman, Monica; Sumail, Sukaibin; Thomas, Daniel C.; van Tol, Jan; Tuh, Fred Y. Y.; Yahya, Bakhtiar E.; Nais, Jamili; Repin, Rimi; Lakim, Maklarin; Schilthuizen, Menno			Evolution of endemismon a young tropical mountain	NATURE			English	Article							DIVERSIFICATION; BIODIVERSITY; KINABALU; ISLANDS; FORESTS; ORIGIN; MODEL	Tropical mountains are hot spots of biodiversity and endemism(1-3), but the evolutionary origins of their unique biotas are poorly understood(4). In varying degrees, local and regional extinction, long-distance colonization, and local recruitment may all contribute to the exceptional character of these communities(5). Also, it is debated whether mountain endemics mostly originate from local lowland taxa, or from lineages that reach the mountain by long-range dispersal from cool localities elsewhere(6). Here we investigate the evolutionary routes to endemism by sampling an entire tropical mountain biota on the 4,095-metre-high Mount Kinabalu in Sabah, East Malaysia. We discover that most of its unique biodiversity is younger than the mountain itself (6 million years), and comprises a mix of immigrant pre-adapted lineages and descendants from local lowland ancestors, although substantial shifts from lower to higher vegetation zones in this latter group were rare. These insights could improve forecasts of the likelihood of extinction and 'evolutionary rescue'(7) in montane biodiversity hot spots under climate change scenarios.	[Merckx, Vincent S. F. T.; Hendriks, Kasper P.; Beentjes, Kevin K.; Mennes, Constantijn B.; Becking, Leontine E.; Peijnenburg, Katja T. C. A.; de Boer, Hugo; Chen, Ping-Ping; Dow, Rory; Feijen, Frida A. A.; Feijen, Hans; Soest, Cobi Feijen-van; Geml, Jozsef; Gravendeel, Barbara; Hovenkamp, Peter; Kappes, Heike; Lens, Frederic; Morgado, Luis N.; Nieser, Nico; Schwallier, Rachel M.; Smit, Harry; Sol, Nicolien; Stech, Michael; Stokvis, Frank; Thomas, Daniel C.; van Tol, Jan; Schilthuizen, Menno] Nat Biodivers Ctr, NL-2333 CR Leiden, Netherlands; [Merckx, Vincent S. F. T.; Geml, Jozsef; Gravendeel, Barbara; Lens, Frederic; Schilthuizen, Menno] Leiden Univ, Inst Biol Leiden, NL-2333 BE Leiden, Netherlands; [Hendriks, Kasper P.] Univ Groningen, Groningen Inst Evolutionary Life Sci, NL-9747 AG Groningen, Netherlands; [Becking, Leontine E.] Univ Wageningen & Res Ctr, Marine Anim Ecol Grp, NL-6700 AH Wageningen, Netherlands; [Becking, Leontine E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Peijnenburg, Katja T. C. A.] Univ Amsterdam, Inst Biodivers & Ecosystem Dynam, NL-1098 XH Amsterdam, Netherlands; [Afendy, Aqilah; Arumugam, Nivaarani; Rahman, Homathevi; Sawang, Anati; Suleiman, Monica; Yahya, Bakhtiar E.; Schilthuizen, Menno] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu 88400, Sabah, Malaysia; [Arumugam, Nivaarani] Univ Malaysia Kelantan, Fac Earth Sci, Jeli 17600, Kelantan Darul, Malaysia; [de Boer, Hugo] Uppsala Univ, Dept Organismal Biol, S-75236 Uppsala, Sweden; [de Boer, Hugo] Univ Oslo, Nat Hist Museum, NO-0318 Oslo, Norway; [Biun, Alim; Buang, Matsain M.; Imbun, Paul; Shim, Phyau-Soon; Spait, Maipul; Sumail, Sukaibin; Tuh, Fred Y. Y.; Nais, Jamili; Repin, Rimi; Lakim, Maklarin] Sabah Pk, Kota Kinabalu 88806, Sabah, Malaysia; [Chung, Arthur Y. C.; Khoo, Eyen; Majapun, Richard J.; Pereira, Joan T.; Sabran, Suzana; Sugau, John B.] Forest Res Ctr, Sabah Forestry Dept, Sandakan 90175, Sabah, Malaysia; [Geurts, Rene] Wageningen Univ, Dept Plant Sci, Mol Biol Lab, NL-6700 AP Wageningen, Netherlands; [Gravendeel, Barbara] Univ Appl Sci Leiden, NL-2333 CK Leiden, Netherlands; [Ipor, Isa] Univ Malaysia Sarawak, Fac Resource Sci & Technol, Kota Samarahan 94300, Sarawak, Malaysia; [Janssens, Steven B.] Bot Garden Meise, B-1860 Meise, Belgium; [Jocque, Merlijn] Royal Belgian Inst Nat Sci Aquat & Terr Ecol, B-1000 Brussels, Belgium; [Jocque, Merlijn] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Kappes, Heike] Univ Cologne, Inst Zool, D-50674 Cologne, Germany; [Koomen, Peter] Nat Museum Fryslan, NL-8911 EM Leeuwarden, Netherlands; [Neupane, Suman] Univ Connecticut, EEB Dept, Storrs, CT 06269 USA; [Thomas, Daniel C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Thomas, Daniel C.] Singapore Bot Gardens, Singapore 259569, Singapore	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; University of Groningen; Wageningen University & Research; University of California System; University of California Berkeley; University of Amsterdam; Universiti Malaysia Sabah; Universiti Malaysia Kelantan; Uppsala University; University of Oslo; Pusat Penyelidikan Hutan; Wageningen University & Research; University of Malaysia Sarawak; Royal Belgian Institute of Natural Sciences; Rutgers State University Newark; Rutgers State University New Brunswick; University of Cologne; University of Connecticut; University of Hong Kong	Schilthuizen, M (corresponding author), Nat Biodivers Ctr, Darwinweg 2, NL-2333 CR Leiden, Netherlands.	Menno.Schilthuizen@naturalis.nl	Beentjes, Kevin/O-1238-2015; Geml, Jozsef/C-2223-2018; Merckx, Vincent/C-6025-2011; Geml, Jozsef/AAW-9993-2020; Beentjes, Kevin/AAA-6143-2021; de Boer, Hugo Joris/AAS-7585-2020; Lens, Frederic/B-8482-2011; Peijnenburg, Katja TCA/F-7176-2016; Hovenkamp, P/G-7471-2011; Hendriks, Kasper/HGD-0087-2022	Geml, Jozsef/0000-0001-8745-0423; Merckx, Vincent/0000-0002-3959-8623; Beentjes, Kevin/0000-0001-7669-3809; de Boer, Hugo Joris/0000-0003-1985-7859; Lens, Frederic/0000-0002-5001-0149; Peijnenburg, Katja TCA/0000-0001-7544-1079; Hovenkamp, P/0000-0002-4124-2175; Gravendeel, Barbara/0000-0002-6508-0895; Hendriks, Kasper/0000-0003-0245-8368; Neupane, Suman/0000-0002-8094-3775; Dow, Rory/0000-0002-0760-4822; Thomas, Daniel Caspar/0000-0002-1307-6042; Arumugam, Nivaarani/0000-0001-9106-4955	Netherlands FES; Netherlands Organization for Scientific Research [821.01.002, 825.12.007]; Alberta Mennega Foundation; Ecology Fund of the Royal Netherlands Academy of Sciences; Uyttenboogaart-Eliasen Foundation; Pro Acarologia Basiliensis; ESEB Outreach Fund; Treub Foundation	Netherlands FES; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Alberta Mennega Foundation; Ecology Fund of the Royal Netherlands Academy of Sciences; Uyttenboogaart-Eliasen Foundation; Pro Acarologia Basiliensis; ESEB Outreach Fund; Treub Foundation	We acknowledge the mountain guides of Sabah Parks for their help with material collection, ongoing assistance to continuing research in the area, and recent efforts following the 5 June 2015 earthquake. R. Butot, M. de Jong, and B. Driessen carried out DNA extractions and PCRs. P. Wilkie provided a tissue sample for Payena. For the fungi, T. Semenova extracted DNA from the soil samples and E. Duijm generated the reads on the Ion Torrent sequencer. B. Blankevoort and E. J. Bosch prepared Fig. 1. J. Holloway (Natural History Museum, London, UK), I. Das (Universiti Malaysia Sarawak), and T. S. Liew (Naturalis, UMS) provided background on Kinabalu endemism, and R. Hall (University of London) on its geological history. R. Etienne (University of Groningen), R. Hall (University of London) and F. Bossuyt (Free University Brussels) read a draft of the paper. Collection and export permits were supplied by the Sabah Biodiversity Centre. Besides institutional support via Netherlands FES-funding, this project received funding via grants 821.01.002 and 825.12.007 of the Netherlands Organization for Scientific Research, the Alberta Mennega Foundation, the Ecology Fund of the Royal Netherlands Academy of Sciences, the Uyttenboogaart-Eliasen Foundation, and Pro Acarologia Basiliensis. G. van Uffelen, R. van Vugt, and P. Kessler (Botanic Gardens, Leiden) and T. de Winter, G. Thijsse, B. Hoeksema, H. Dautzenberg, J. Mols, and E. van Nieukerken (Naturalis) gave advice on transportation of specimens. Artist I. Kopelman and Naturalis general director E. van Huis (Naturalis) accompanied the expedition participants in the field. J. Gunsalam and P. Jilan (Sabah Parks Board of Trustees) officiated the opening and closing ceremony, respectively. P. Basintal, E. van Huis and E. Smets supervised the expedition as directors for the organizing institutions. Media coverage and communications were facilitated by J. van Alphen, A. Mohd. R. P. Dahlan, K. de Greef, A. Kromhout, J. Schilthuizen, E. E. Soudi, L. Stek, A. Taminiau, and M. Z. Abdul Wahab. Sabah Parks staff members L. Apin, B. Busin, B. Butit, J. Gampoyo, G. Gangko, B. Gangku, S. Gangku, P. Gimpiton, M. Gunggutou, T. Gunggutou, G. Gunsalam, J. Guntabid, I. Isnain, K. Ag. Jalil, Y. Johalin, R. M. Karim, Y. Kumin, D. Laban, A. Lahi, J. Lapidin, M. Latim, N. Maidin, N. Majuakim, R. Miadin, Y. Miki, M. Moguring, H. Mujih, F. Simin, K. C. Sion, D. Sumbin, D. Tingoh, E. Yakin, were invaluable for all manner of logistics and other support before, during, and after the expedition, in the field and at the stations and administrative offices. For the Forest Research Centre researchers, J. B. Dawat, M. Gumbilil, A. J. Jaimin, Jei. Jumian, Jem. Jumian, J. L. Yukang, P. J. Miun, M. A. T. Mustapha, and B. Saludin assisted in the field. T. Siew of Borneo Indah Sdn. Bhd. was the local supplier for consumables and field equipment. We thank the ESEB Outreach Fund and the Treub Foundation for funding outreach activities in Kinabalu Park and the Crocker Range Park. N. Raes helped with the niche modelling.	Barkman TJ, 2001, SYST BOT, V26, P658; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Cottam MA, 2013, J GEOL SOC LONDON, V170, P805, DOI 10.1144/jgs2011-130; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Culmsee H, 2013, J BIOGEOGR, V40, P1997, DOI 10.1111/jbi.12138; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Ornelas JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056283; Gawin DF, 2014, AUK, V131, P86, DOI 10.1642/AUK-13-190.1; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; Graham CH, 2014, ECOGRAPHY, V37, P711, DOI 10.1111/ecog.00578; GRUBB PJ, 1971, NATURE, V229, P44, DOI 10.1038/229044a0; Hall R., 2008, GEOLOGY MOUNT KINABA; Hoorn C, 2013, NAT GEOSCI, V6, P154, DOI 10.1038/ngeo1742; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Korner C, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P3; La Sorte Frank A, 2010, Proc Biol Sci, V277, P3401, DOI 10.1098/rspb.2010.0612; Madrinan Santiago, 2013, Frontiers in Genetics, V4, P192, DOI 10.3389/fgene.2013.00192; Matzke NJ, 2013, FRONT BIOGEOGR, V5, P242, DOI DOI 10.21425/F5FBG19694; Meade A., 2015, BAYESTRAITS VERSION; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; Rambaut A., 2007, TRACER V1 4; Rodriguez-Castaneda G, 2010, ECOL LETT, V13, P1348, DOI 10.1111/j.1461-0248.2010.01525.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schiffers K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0083; Schwery O, 2015, NEW PHYTOL, V207, P355, DOI 10.1111/nph.13234; VANSTEENIS CGG, 1964, PROC R SOC SER B-BIO, V161, P7, DOI 10.1098/rspb.1964.0072; Warren BH, 2015, ECOL LETT, V18, P200, DOI 10.1111/ele.12398; Watson DM, 2002, J BIOGEOGR, V29, P823, DOI 10.1046/j.1365-2699.2002.00726.x; Whitehead J., 1893, EXPLORATION MOUNT KI; Wong K. M., 1996, KINABALU SUMMIT BORN; Zwickl D, 2006, THESIS U TEXAS AUSTI	34	193	205	8	226	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					347	+		10.1038/nature14949	http://dx.doi.org/10.1038/nature14949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26266979	Green Accepted			2022-12-28	WOS:000359714000035
J	Marzi, A; Robertson, SJ; Haddock, E; Feldmann, F; Hanley, PW; Scott, DP; Strong, JE; Kobinger, G; Best, SM; Feldmann, H				Marzi, Andrea; Robertson, Shelly J.; Haddock, Elaine; Feldmann, Friederike; Hanley, Patrick W.; Scott, Dana P.; Strong, James E.; Kobinger, Gary; Best, Sonja M.; Feldmann, Heinz			VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain	SCIENCE			English	Article							NONHUMAN-PRIMATES; VACCINE	The latest Ebola virus (EBOV) epidemic spread rapidly through Guinea, Sierra Leone, and Liberia, creating a global public health crisis and accelerating the assessment of experimental therapeutics and vaccines in clinical trials. One of those vaccines is based on recombinant vesicular stomatitis virus expressing the EBOV glycoprotein (VSV-EBOV), a live-attenuated vector with marked preclinical efficacy. Here, we provide the preclinical proof that VSV-EBOV completely protects macaques against lethal challenge with the West African EBOV-Makona strain. Complete and partial protection was achieved with a single dose given as late as 7 and 3 days before challenge, respectively. This indicates that VSV-EBOV may protect humans against EBOV infections in West Africa with relatively short time to immunity, promoting its use for immediate public health responses.	[Marzi, Andrea; Robertson, Shelly J.; Haddock, Elaine; Best, Sonja M.; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Feldmann, Friederike; Hanley, Patrick W.; Scott, Dana P.] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Strong, James E.; Kobinger, Gary] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Public Health Agency of Canada	Feldmann, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA.	feldmannh@niaid.nih.gov	Marzi, Andrea/AAF-4617-2020; Best, Sonja M/G-7301-2017	Marzi, Andrea/0000-0003-0186-9587; Best, Sonja M/0000-0003-0206-297X; Hanley, Patrick/0000-0003-2300-1818	Rocky Mountain Veterinary Branch [NIH, National Institute of Allergy and Infectious Diseases (NIAID)]; Division of Intramural Research, NIAID, NIH; Public Health Agency of Canada; Center for Security Science Program, Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001163, ZIAAI001089, ZIGAI001048, ZIAAI001125] Funding Source: NIH RePORTER	Rocky Mountain Veterinary Branch [NIH, National Institute of Allergy and Infectious Diseases (NIAID)]; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Agency of Canada; Center for Security Science Program, Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Rocky Mountain Veterinary Branch [NIH, National Institute of Allergy and Infectious Diseases (NIAID)] for its support of this study. This work was jointly funded by the Division of Intramural Research, NIAID, NIH; the Public Health Agency of Canada; and the Center for Security Science Program, Canada. Use of the GMP-produced vaccine material is regulated through the Public Health Agency of Canada. The authors declare no competing financial interests. H.F. is a co-applicant on two patents regarding VSV-EBOV (U.S. patent application nos. PCT/CA03/01125US and 61/014,626). The data are available via figshare: http://dx.doi.org/10.6084/m9.figshare.1456239.	Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Lai LL, 2015, JAMA-J AM MED ASSOC, V313, P1249, DOI 10.1001/jama.2015.1995; Marzi A, 2015, EMERG INFECT DIS, V21, P1777, DOI 10.3201/eid2110.150259; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Mateo M, 2010, J VIROL, V84, P1169, DOI 10.1128/JVI.01372-09; Mire CE, 2015, NATURE, V520, P688, DOI 10.1038/nature14428; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; WHO, 2015, EB VACC EFF TRIAL LA; World Health Organization (WHO), 2015, EB SIT REP 3 JUN 201	24	151	153	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					739	742		10.1126/science.aab3920	http://dx.doi.org/10.1126/science.aab3920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26249231				2022-12-28	WOS:000359415100037
J	Rosenbaum, L				Rosenbaum, Lisa			The Paternalism Preference - Choosing Unshared Decision Making	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Fraenkel L, 2009, ARTHRIT RHEUM-ARTHR, V61, P1674, DOI 10.1002/art.24947; Kalanithi P, 2014, NY TIMES; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; Peters E, 2007, MED CARE RES REV, V64, P169, DOI 10.1177/10775587070640020301; Ullmann-Margalit E, 1998, NOT WANTING KNOW DIS	5	54	55	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					589	592		10.1056/NEJMp1508418	http://dx.doi.org/10.1056/NEJMp1508418			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP2LE	26267618				2022-12-28	WOS:000359707700002
J	Arneth, A				Arneth, Almut			CLIMATE SCIENCE Uncertain future for vegetation cover	NATURE			English	Editorial Material							LAND-USE; CARBON-CYCLE; MODELS	How will Earth's vegetation cover respond to climate change, and how does this compare with changes associated with human land use? Modelling studies reveal how little we still know, and act as a clarion call for further work.	Karlsruhe Inst Technol, Dept Environm Atmospher Res, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Arneth, A (corresponding author), Karlsruhe Inst Technol, Dept Environm Atmospher Res, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany.	almut.arneth@kit.edu	Arneth, Almut/B-2702-2013	Arneth, Almut/0000-0001-6616-0822				Arneth A, 2014, NAT CLIM CHANGE, V4, P550, DOI [10.1038/nclimate2250, 10.1038/NCLIMATE2250]; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Davies-Barnard T, 2015, GLOBAL BIOGEOCHEM CY, V29, P842, DOI 10.1002/2014GB004949; Murray-Rust D, 2014, ENVIRON MODELL SOFTW, V59, P187, DOI 10.1016/j.envsoft.2014.05.019; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Stocker BD, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.23188; van Asselen S, 2012, GLOBAL CHANGE BIOL, V18, P3125, DOI 10.1111/j.1365-2486.2012.02759.x; Warlind D, 2014, BIOGEOSCIENCES, V11, P6131, DOI 10.5194/bg-11-6131-2014; Wilkenskjeld S., 2014, Biogeosciences, V11, P4817, DOI 10.5194/bg-11-4817-2014	10	30	35	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					44	45		10.1038/524044a	http://dx.doi.org/10.1038/524044a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26245579				2022-12-28	WOS:000359002300027
J	Klevens, J; Sadowski, LS; Kee, R; Garcia, D; Lokey, C				Klevens, Joanne; Sadowski, Laura S.; Kee, Romina; Garcia, Diana; Lokey, Colby			Effect of Screening for Partner Violence on Use of Health Services at 3-Year Follow-up of a Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CARE SETTINGS		[Klevens, Joanne; Lokey, Colby] US Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA 30341 USA; [Sadowski, Laura S.; Kee, Romina; Garcia, Diana] John H Stroger Jr Hosp Cook Cty, Collaborat Res Unit, Chicago, IL USA	Centers for Disease Control & Prevention - USA; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Klevens, J (corresponding author), US Ctr Dis Control & Prevent, Div Violence Prevent, 4770 Buford Hwy,Mailstop F-63, Atlanta, GA 30341 USA.	jklevens@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; O'Doherty LJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2913; World Health Organisation, 2013, RESPONDING INTIMATE	6	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					515	516		10.1001/jama.2015.6755	http://dx.doi.org/10.1001/jama.2015.6755			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO1OI	26241603	Bronze, Green Accepted			2022-12-28	WOS:000358924500016
J	Kuffova, L; Forrester, JV; Dick, A				Kuffova, Lucia; Forrester, John V.; Dick, Andrew			PRACTICE POINTER Assessing the painful, uninflamed eye in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIFFERENTIAL-DIAGNOSIS		[Kuffova, Lucia] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Sect Immun Infect & Inflammat, Aberdeen AB25 2ZD, Scotland; [Forrester, John V.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Ocular Immunol Program, Crawley, WA 6009, Australia; [Forrester, John V.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA 6009, Australia; [Dick, Andrew] Univ Bristol, Sch Clin Sci, Acad Unit Ophthalmol, Bristol BS8 1TD, Avon, England; [Dick, Andrew] Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London EC1V 2PD, England; [Dick, Andrew] UCL, Inst Ophthalmol, London EC1V 2PD, England	University of Aberdeen; University of Western Australia; Lions Eye Institute; University of Western Australia; University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Forrester, JV (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Ocular Immunol Program, Crawley, WA 6009, Australia.	j.forrester@abdn.ac.uk		Dick, Andrew/0000-0002-0742-3159	Chief Scientist Office [ETM/351] Funding Source: researchfish	Chief Scientist Office		Anderson DF, 1998, J ROY SOC MED, V91, P127, DOI 10.1177/014107689809100303; Brazis PW, 2002, NEUROLOGIST, V8, P82, DOI 10.1097/00127893-200203000-00003; Davey C, 1992, OCCAS PAP R COLL GEN, V58, P56; Granet D, 2008, ALLERGY ASTHMA PROC, V29, P565, DOI 10.2500/aap.2008.29.3170; Guly CM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4976; Pareja JA, 2010, HEADACHE, V50, P1286, DOI 10.1111/j.1526-4610.2010.01659.x; Perumal D, 2011, NEW ZEAL MED J, V124, P35; Piagkou M, 2012, PAIN PRACT, V12, P399, DOI 10.1111/j.1533-2500.2011.00507.x; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Rietveld RP, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-54; Saarela M, 2014, STROKE, V45, pE3, DOI 10.1161/STROKEAHA.113.003710; Schelfaut D, 2012, EUR J EMERG MED, V19, P181, DOI 10.1097/MEJ.0b013e328349ee6d; Terelak-Borys B, 2012, MED SCI MONITOR, V18, pRA138, DOI 10.12659/MSM.883260; VINCENT AJP, 1989, HEADACHE, V29, P523, DOI 10.1111/j.1526-4610.1989.hed2908523.x; Zakrzewska Joanna M, 2009, BMJ Clin Evid, V2009	15	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2015	351								h3216	10.1136/bmj.h3216	http://dx.doi.org/10.1136/bmj.h3216			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AQ	26242844	Green Published			2022-12-28	WOS:000359387300001
J	Tomita, T; Kuga, K; Uwatoko, Y; Coleman, P; Nakatsuji, S				Tomita, Takahiro; Kuga, Kentaro; Uwatoko, Yoshiya; Coleman, Piers; Nakatsuji, Satoru			Strange metal without magnetic criticality	SCIENCE			English	Article							QUANTUM PHASE-TRANSITIONS; CRITICAL-POINTS; HEAVY; TEMPERATURE	A fundamental challenge to our current understanding of metals is the observation of qualitative departures from Fermi liquid behavior. The standard view attributes such non-Fermi liquid phenomena to the scattering of electrons off quantum critical fluctuations of an underlying order parameter. Although the possibility of non-Fermi liquid behavior isolated from the border of magnetism has long been speculated, no experimental confirmation has been made. Here, we report on the observation of a strange metal region away from a magnetic instability in an ultrapure single crystal. In particular, we show that the heavy-fermion superconductor beta-YbAlB4 forms a possible phase with strange metallic behavior across an extensive pressure regime, distinctly separated from a high-pressure magnetic quantum phase transition by a Fermi liquid phase.	[Tomita, Takahiro; Kuga, Kentaro; Uwatoko, Yoshiya; Nakatsuji, Satoru] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Tomita, Takahiro] Nihon Univ, Coll Humanities & Sci, Tokyo 1568550, Japan; [Coleman, Piers] Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, Piscataway, NJ 08854 USA; [Coleman, Piers] Univ London, Dept Phys, Egham TW20 0EX, Surrey, England; [Nakatsuji, Satoru] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Nihon University; Rutgers State University New Brunswick; University of London; Royal Holloway University London; Japan Science & Technology Agency (JST)	Nakatsuji, S (corresponding author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	satoru@issp.u-tokyo.ac.jp	Tomita, Takahiro/AFP-9002-2022	Tomita, Takahiro/0000-0002-3706-0184; Nakatsuji, Satoru/0000-0001-9134-659X	Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers from the Japanese Society for the Promotion of Science [R2604]; PRESTO, Japan Science and Technology Agency (JST); Grant for Basic Science Research Projects from the Sumitomo Foundation; U.S. National Science Foundation [DMR-1309929]; U.S. National Science Foundation I2CAM International Materials Institute Award [DMR-0844115]; NSF [PHYS-1066293];  [25707030];  [24740243]; Division Of Materials Research [1309929] Funding Source: National Science Foundation	Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers from the Japanese Society for the Promotion of Science; PRESTO, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grant for Basic Science Research Projects from the Sumitomo Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Science Foundation I2CAM International Materials Institute Award(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); ; ; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Y. Shimura, H. Takahashi, G. G. Lonzarich, Y. Matsumoto, E. C. T. O'Farrell, K. Matsubayashi, N. Horie, and K. Ueda for support and useful discussions. This work is partially supported by grants-in-aid (nos. 25707030 and 24740243) and the Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (no. R2604) from the Japanese Society for the Promotion of Science; by PRESTO, Japan Science and Technology Agency (JST); by Grant for Basic Science Research Projects from the Sumitomo Foundation; by U.S. National Science Foundation grant DMR-1309929 (P.C.) and U.S. National Science Foundation I2CAM International Materials Institute Award, grant DMR-0844115 (P.C. and S.N.); and by NSF grant no. PHYS-1066293 and the hospitality of the Aspen Center for Physics (P.C. and S.N.). The use of the facilities of the Materials Design and Characterization Laboratory at the Institute for Solid State Physics, The University of Tokyo, is gratefully acknowledged.	Bud'ko SL, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014415; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Cubrovic M, 2009, SCIENCE, V325, P439, DOI 10.1126/science.1174962; Custers J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.186402; Doiron-Leyraud N, 2003, NATURE, V425, P595, DOI 10.1038/nature01968; Faulkner T, 2010, SCIENCE, V329, P1043, DOI 10.1126/science.1189134; Friedemann S, 2009, NAT PHYS, V5, P465, DOI 10.1038/NPHYS1299; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Goltsev AV, 2005, J PHYS-CONDENS MAT, V17, pS813, DOI 10.1088/0953-8984/17/11/011; Grigera SA, 2001, SCIENCE, V294, P329, DOI 10.1126/science.1063539; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Jain JK, 2009, P NATL ACAD SCI USA, V106, P9131, DOI 10.1073/pnas.0902901106; Kuga K, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.224413; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; Machida Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.156405; Matsumoto Y, 2011, SCIENCE, V331, P316, DOI 10.1126/science.1197531; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Moriya T., 1985, SPIN FLUCTUATIONS IT; Nakatsuji S, 2008, NAT PHYS, V4, P603, DOI 10.1038/nphys1002; Nevidomskyy AH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.077202; Okawa M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.247201; Paul I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026402; Pixley JH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.086403; Ramires A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176404; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Senthil T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.216403; Si QM, 2006, PHYSICA B, V378-80, P23, DOI 10.1016/j.physb.2006.01.156; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Takashima S, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.043704; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Watanabe S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.186403; Zhu LJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.066404	32	58	58	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					506	509		10.1126/science.1262054	http://dx.doi.org/10.1126/science.1262054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228141	Green Submitted			2022-12-28	WOS:000358713300048
J	Brown, RJ; Meehan, CA; Gorden, P				Brown, Rebecca J.; Meehan, Cristina Adelia; Gorden, Phillip			Leptin Does Not Mediate Hypertension Associated With Human Obesity	CELL			English	Editorial Material								Hypertension and obesity are known to be linked, with recent studies in mice proposing that leptin may be mediating this effect. This regulation, however, may not extend to humans, where a yet-to-be-identified factor is likely the underlying cause of hypertension.	[Brown, Rebecca J.; Meehan, Cristina Adelia; Gorden, Phillip] NIDDK, Diabetes Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gorden, P (corresponding author), NIDDK, Diabetes Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	phillipg@intra.niddk.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047052, ZIADK047050] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK047050] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Simonds SE, 2014, CELL, V159, P1404, DOI 10.1016/j.cell.2014.10.058	4	33	35	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					465	466		10.1016/j.cell.2015.07.007	http://dx.doi.org/10.1016/j.cell.2015.07.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232214	Green Accepted, Bronze			2022-12-28	WOS:000358801800002
J	Qian, MB; Utzinger, J; Keiser, J; Zhou, XN				Qian, Men-Bao; Utzinger, Juerg; Keiser, Jennifer; Zhou, Xiao-Nong			Clonorchiasis	LANCET			English	Review							EXCRETORY-SECRETORY PRODUCTS; FLUKE OPISTHORCHIS-VIVERRINI; PROTECTIVE IMMUNE-RESPONSE; CARCINOGENIC LIVER FLUKE; FRESH-WATER FISHES; KATO-KATZ METHOD; SINENSIS INFECTION; CHOLANGIOCARCINOMA CELLS; MITOCHONDRIAL GENOMES; SONOGRAPHIC FINDINGS	On Aug 21, 1875, James McConnell published in The Lancet his findings from a post-mortem examination of a 20-year-old Chinese man-undertaken at the Medical College Hospital in Calcutta, India-in whom he found Clonorchis sinensis in the bile ducts. Now, exactly 140 years later, we have a sound understanding of the lifecycle of this liver fluke, including key clinical, diagnostic, and epidemiological features. Developments in the so-called -omics sciences have not only advanced our knowledge of the biology and pathology of the parasite, but also led to the discovery of new diagnostic, drug, and vaccine targets. C sinensis infection is primarily related to liver and biliary disorders, especially cholangiocarcinoma. Clonorchiasis mainly occurs in east Asia, as a result of the region's social-ecological systems and deeply rooted cultural habit of consuming raw freshwater fish. The Kato-Katz technique, applied on fresh stool samples, is the most widely used diagnostic approach. Praziquantel is the treatment of choice and has been considered for preventive chemotherapy. Tribendimidine showed good safety and therapeutic profiles in phase 2 trials and warrants further investigation. Still today, the precise distribution, the exact number of infected people, subtle morbidities and pathogenesis, and the global burden of clonorchiasis are unknown. Integrated control strategies, consisting of preventive chemotherapy; information, education, and communication; environmental management; and capacity building through intersectoral collaboration should be advocated.	[Qian, Men-Bao; Zhou, Xiao-Nong] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China; [Qian, Men-Bao; Zhou, Xiao-Nong] Minist Hlth, Key Lab Parasite & Vector Biol, Shanghai, Peoples R China; [Qian, Men-Bao; Zhou, Xiao-Nong] World Hlth Org Collaborating Ctr Trop Dis, Shanghai, Peoples R China; [Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Keiser, Jennifer] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; Univ Basel, Basel, Switzerland	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Zhou, XN (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China.	ipdzhouxn@sh163.net			International Development Research Center (IDRC); Canadian International Development Agency (CIDA); Australian Agency for International Development (AusAID) in partnership with the Global Health Research Initiative [105509-00001002-023]; European Research Council [ERC-2013-CoG 614739-A_HERO]	International Development Research Center (IDRC); Canadian International Development Agency (CIDA); Australian Agency for International Development (AusAID) in partnership with the Global Health Research Initiative; European Research Council(European Research Council (ERC)European Commission)	We thank Ying-Dan Chen, Cheng-Wen Gu, Ting-Jun Zhu, Robert Bergquist, and Shang Xia for their assistance in the accompanying video project. This investigation was supported by the International Development Research Center (IDRC), the Canadian International Development Agency (CIDA), and the Australian Agency for International Development (AusAID) in partnership with the Global Health Research Initiative (grant number 105509-00001002-023). JK is grateful to the European Research Council for financial support (ERC-2013-CoG 614739-A_HERO). The funders of this work had no role in design, data collection, data analysis, the decision to publish the report, or preparation of the manuscript. M-BQ and X-NZ had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Anh NTL, 2009, ACTA TROP, V112, P198, DOI 10.1016/j.actatropica.2009.07.027; [Anonymous], 1995, World Health Organ Tech Rep Ser, V849, P1; [Anonymous], 2008, ZHONGGUO SHI YONG YI; [Anonymous], 1983, XIN YI XUE; [Anonymous], 2010, ZHONGGUO XUE XI CHON, V22, P533; ATTWOOD HD, 1978, PATHOLOGY, V10, P153, DOI 10.3109/00313027809063494; Bae YA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002211; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Cai XQ, 2012, PARASITOL RES, V110, P235, DOI 10.1007/s00436-011-2477-2; Cai XQ, 2010, PARASITOL RES, V106, P1379, DOI 10.1007/s00436-010-1812-3; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chen DX, 2010, PARASITOL RES, V107, P835, DOI 10.1007/s00436-010-1936-5; Chen MingGang, 1994, Tropical Diseases Bulletin, V91, pR7; Chen WJ, 2014, PARASITOL RES, V113, P3409, DOI 10.1007/s00436-014-4006-6; Chen XB, 1988, BENGBU YI XUE YUAN X, V13, P215; Chen Y, 2013, PARASITOLOGY, V140, P1377, DOI 10.1017/S0031182013000498; Chen YG, 1982, XUZHOU YI XUE YUAN X, V2, P48; Cho SH, 2008, KOREAN J PARASITOL, V46, P133, DOI 10.3347/kjp.2008.46.3.133; Choi BI, 2004, CLIN MICROBIOL REV, V17, P540, DOI 10.1128/CMR.17.3.540-552.2004; Choi D, 2008, J GASTROEN HEPATOL, V23, pE399, DOI 10.1111/j.1440-1746.2007.05242.x; Choi D, 2009, KOREAN J PARASITOL, V47, P19, DOI 10.3347/kjp.2009.47.1.19; Choi Min-Ho, 2003, Korean Journal of Parasitology, V41, P35, DOI 10.3347/kjp.2003.41.1.35; Choi MH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000601; Choi MS, 2005, AM J TROP MED HYG, V73, P1139, DOI 10.4269/ajtmh.2005.73.1139; Chung Byung-Suk, 2004, Korean Journal of Parasitology, V42, P19, DOI 10.3347/kjp.2004.42.1.19; COBBOLD TS, 1875, LANCET, V106, P423; De Nguyen Van, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 1, P12; Dung DT, 2007, EMERG INFECT DIS, V13, P1828, DOI 10.3201/eid1312.070554; Fang Yue-Yi, 2008, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V26, P99; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; Gao X, 2006, GUO JI MIAN YI XUE Z, V29, P55; He FQ, 2000, SHI YONG GAN ZANG BI, V5, P114; Hong ST, 2003, DIAGN MICR INFEC DIS, V47, P345, DOI 10.1016/S0732-8893(03)00113-5; Hsu H. F., 1938, Chinese Medical Journal Shanghai Suppl ii, P385; HSU H. F., 1940, Chinese Medical Journal, P244; Huang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054732; Hung NM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-142; IARC, 1994, IARC MONOGRAPHS EVAL, V61; Johansen MV, 2010, ADV PARASIT, V73, P171, DOI 10.1016/S0065-308X(10)73007-4; Joo KR, 2005, YONSEI MED J, V46, P794, DOI 10.3349/ymj.2005.46.6.794; Nam JH, 2012, INT J PARASITOL, V42, P103, DOI 10.1016/j.ijpara.2011.11.001; Ju JW, 2009, PROTEOMICS, V9, P3066, DOI 10.1002/pmic.200700613; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Keiser J, 2009, CLIN MICROBIOL REV, V22, P466, DOI 10.1128/CMR.00012-09; Kim DW, 2010, MOL BIOCHEM PARASIT, V173, P10, DOI 10.1016/j.molbiopara.2010.03.005; Kim JH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001339; KIM M S, 1982, Korea University Medical Journal, V19, P107; Kim TI, 2008, PARASITOL RES, V103, P1377, DOI 10.1007/s00436-008-1144-8; Kim TI, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001414; Kim TI, 2009, KOREAN J PARASITOL, V47, pS59, DOI 10.3347/kjp.2009.47.S.S59; Kim TS, 2009, KOREAN J PARASITOL, V47, P37, DOI 10.3347/kjp.2009.47.1.37; Kim YH, 1999, AM J ROENTGENOL, V172, P1293, DOI 10.2214/ajr.172.5.10227505; Kim YJ, 2008, PARASITOL RES, V102, P411, DOI 10.1007/s00436-007-0778-2; Kim YJ, 2009, PARASITOL RES, V104, P1011, DOI 10.1007/s00436-008-1283-y; Le TH, 2006, EXP PARASITOL, V112, P109, DOI 10.1016/j.exppara.2005.09.012; Lee JS, 2006, VACCINE, V24, P2358, DOI 10.1016/j.vaccine.2005.11.062; Lee JS, 2006, SCAND J IMMUNOL, V63, P169, DOI 10.1111/j.1365-3083.2006.01721.x; Lee JM, 2011, KOREAN J PARASITOL, V49, P273, DOI 10.3347/kjp.2011.49.3.273; LEE SH, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1227; Li BZ, 1983, DONG WU XUE ZA ZHI, V18, P3; Li L, 2004, JI SHENG CHONG BING, V2, P187; Li Shunyu, 2004, Parasitol Res, V93, P36, DOI 10.1007/s00436-004-1097-5; Liang Chi, 2009, Chinese Journal of Parasitology and Parasitic Diseases, V27, P148; Lin RQ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-180; Liu Y, 1999, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V17, P271; LIU YH, 1991, CHINESE MED J-PEKING, V104, P27; Loss A., 1907, ANN TROP MED PARASIT, V1, P123; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Mcconnell J. E. P., 1875, Lancet, P271; Nakamura-Uchiyama F, 2003, INTERNAL MED, V42, P222, DOI 10.2169/internalmedicine.42.222; Nie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113208; Oh JK, 2014, TROP MED INT HEALTH, V19, P1096, DOI 10.1111/tmi.12338; Pak JH, 2014, PARASITOL RES, V113, P4447, DOI 10.1007/s00436-014-4127-y; Pak JH, 2009, J CELL BIOCHEM, V108, P1376, DOI 10.1002/jcb.22368; Pak J, 2009, PARASITOL RES, V104, P1035, DOI 10.1007/s00436-008-1286-8; PAOCHANG H, 1955, J PATHOL BACTERIOL, V70, P53, DOI 10.1002/path.1700700106; Petney TN, 2013, INT J PARASITOL, V43, P1031, DOI 10.1016/j.ijpara.2013.07.007; Qian MB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-314; Qian MB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-194; Qian MB, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-4; Qian MB, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-4; Qian MB, 2013, CLIN INFECT DIS, V56, pE76, DOI 10.1093/cid/cis1011; Qian MB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001377; Qiao T, 2014, ACTA TROP, V138, P28, DOI 10.1016/j.actatropica.2014.06.004; Qiao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042471; QIU ZD, 1985, CHIN J CLIN HEPATOL, V1, P47; Qu ZQ, 1980, SICHUAN YI XUE, V1, P243; Qu ZQ, 1980, SICHUAN YI XUE, V1, P238; Rim H.-J., 1986, Korean Journal of Parasitology, V24, P1; Rim H. J., 1979, KOREA U MED J, V16, P459; Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; Sanpool O, 2012, PARASITOL RES, V111, P89, DOI 10.1007/s00436-011-2804-7; Shekhovtsov SV, 2010, PARASITOL INT, V59, P100, DOI 10.1016/j.parint.2009.10.012; Shen CH, 2007, AM J TROP MED HYG, V76, P603, DOI 10.4269/ajtmh.2007.76.603; Shin HR, 2010, J KOREAN MED SCI, V25, P1011, DOI 10.3346/jkms.2010.25.7.1011; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Smout MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000611; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Sripa B, 2010, ADV PARASIT, V72, P305, DOI 10.1016/S0065-308X(10)72011-X; Sripa B, 2009, HEPATOLOGY, V50, P1273, DOI 10.1002/hep.23134; Sun LM, 2006, ZHONGGUO BING YUAN S, V1, P145; T'ang Chung-Chang, 1963, Chinese Medical Journal, V82, P545; Traub RJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000367; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Uddin MH, 2012, PARASITOL INT, V61, P118, DOI 10.1016/j.parint.2011.07.002; Van TP, 2011, FOODBORNE PATHOG DIS, V8, P255, DOI 10.1089/fpd.2010.0670; Wang Q N, 1980, Zhonghua Nei Ke Za Zhi, V19, P288; Wang XY, 2014, VACCINE, V32, P1338, DOI 10.1016/j.vaccine.2014.01.039; Wang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033703; Wang XY, 2012, PARASITOL RES, V110, P1411, DOI 10.1007/s00436-011-2642-7; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; WEI DX, 1980, WUHAN YI XUE YUAN XU, V9, P1; WEI DX, 1980, WUHAN YI XUE YUAN XU, V9, P107; Wei P, 2013, THESIS GUANGXI U; Weng YQ, 1990, ZHONGGUO JI SHENG CH, V3, P317; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, 2010, WORK OV GLOB IMP NEG; Xiao SH, 2013, ACTA TROP, V126, P115, DOI 10.1016/j.actatropica.2013.01.009; Xie Hong-Yan, 2010, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V28, P176; Xu LL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003046; Xu Yan, 2014, Zhongguo Xuexichongbing Fangzhi Zazhi, V26, P203; Yang LC, 2004, CHIN J HEPATOBILIARY, V10, P165; Yao FB, 1984, XUZHOU YI XUE YUAN X, V4, P19; YEN CM, 1992, ANN TROP MED PARASIT, V86, P263, DOI 10.1080/00034983.1992.11812663; Yoo WG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001208; Yoshida Y, 2012, PARASITOL INT, V61, P5, DOI 10.1016/j.parint.2011.06.003; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Zhang H, 2008, KOREAN J PARASITOL, V46, P17, DOI 10.3347/kjp.2008.46.1.17; Zhang HM, 2008, PARASITOL RES, V102, P1111, DOI 10.1007/s00436-008-0878-7; Zhang QiWen, 2009, China Tropical Medicine, V9, P1012; ZHANG QW, 2009, ZHONGGUO RE DAI YI X, V9, P1125; Zhang RL, 2007, PARASITOL RES, V101, P179, DOI 10.1007/s00436-006-0441-3; Zhang Y, 2014, VET PARASITOL, V204, P209, DOI 10.1016/j.vetpar.2014.05.007; ZHENG CL, 2009, THESIS GUANGXI U NAT; Zheng MH, 2013, PARASITOL RES, V112, P1287, DOI 10.1007/s00436-012-3264-4; Zheng MH, 2011, PARASITOL RES, V109, P737, DOI 10.1007/s00436-011-2316-5; Zhou ZW, 2008, VACCINE, V26, P1817, DOI 10.1016/j.vaccine.2008.02.015; Ziegler AD, 2011, SCIENCE, V331, P282, DOI 10.1126/science.331.6015.282-b	139	149	191	1	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					800	810		10.1016/S0140-6736(15)60313-0	http://dx.doi.org/10.1016/S0140-6736(15)60313-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26299184				2022-12-28	WOS:000370418000040
J	Knowles, CH; Horrocks, EJ; Bremner, SA; Stevens, N; Norton, C; O'Connell, PR; Eldridge, S				Knowles, Charles H.; Horrocks, Emma J.; Bremner, Stephen A.; Stevens, Natasha; Norton, Christine; O'Connell, P. Ronan; Eldridge, Sandra		CONFIDeNT Study Grp	Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; PLACEBO-RESPONSES	Background Percutaneous tibial nerve stimulation (PTNS) is a new ambulatory therapy for faecal incontinence. Data from case series suggest it has beneficial outcomes in 50-80% patients; however its effectiveness against sham electrical stimulation has not been investigated. We therefore aimed to assess the short-term efficacy of PTNS against sham electrical stimulation in adults with faecal incontinence. Methods We did a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial (CONtrol of Faecal Incontinence using Distal NeuromodulaTion [CONFIDeNT]) in 17 specialist hospital units in the UK that had the skills to manage patients with faecal incontinence. Eligible participants aged 18 years or older with substantial faecal incontinence for whom conservative treatments (such as dietary changes and pelvic floor exercises) had not worked, were randomly assigned (1: 1) to receive either PTNS (via the Urgent PC neuromodulation system) or sham stimulation (via a transcutaneous electrical nerve stimulation machine to the lateral forefoot) once per week for 12 weeks. Randomisation was done with permuted block sizes of two, four, and six, and was stratified by sex and then by centre for women. Patients and outcome assessors were both masked to treatment allocation for the 14-week duration of the trial (but investigators giving the treatment were not masked). The primary outcome was a clinical response to treatment, which we defined as a 50% or greater reduction in episodes of faecal incontinence per week. We assessed this outcome after 12 treatment sessions, using data from patients' bowel diaries. Analysis was by intention to treat, and missing data were multiply imputed. This trial is registered with the ISRCTN registry, number 88559475, and is closed to new participants. Findings Between Jan 23, 2012, and Oct 31, 2013, we randomly assigned 227 eligible patients (of 373 screened) to receive either PTNS (n=115) or sham stimulation (n=112). 12 patients withdrew from the trial: seven from the PTNS group and five from the sham group (mainly because they could not commit to receiving treatment every week). Two patients (one in each group) withdrew because of an adverse event that was unrelated to treatment (exacerbation of fibromyalgia and rectal bleeding). 39 (38%) of 103 patients with full data from bowel diaries in the PTNS group had a 50% or greater reduction in the number of episodes of faecal incontinence per week compared with 32 (31%) of 102 patients in the sham group (adjusted odds ratio 1.28, 95% CI 0.72-2.28; p=0.396). No serious adverse events related to treatment were reported in the trial. Seven mild, related adverse events were reported in each treatment group, mainly pain at the needle site (four in PTNS, three in sham). Interpretation PTNS given for 12 weeks did not confer significant clinical benefit over sham electrical stimulation in the treatment of adults with faecal incontinence. Further studies are warranted to determine its efficacy in the long term, and in patient subgroups (ie, those with urgency).	[Knowles, Charles H.; Horrocks, Emma J.] Univ London, Blizard Inst, Natl Ctr Bowel Res & Surg Innovat, London, England; [Bremner, Stephen A.; Stevens, Natasha; Eldridge, Sandra] Univ London, Blizard Inst, Pragmat Clin Trials Unit, London, England; [Norton, Christine] Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, London WC2R 2LS, England; [O'Connell, P. Ronan] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland	University of London; University of London; University of London; King's College London; University College Dublin	Knowles, CH (corresponding author), Natl Ctr Bowel Res & Surg Innovat, London E1 2AT, England.	c.h.knowles@qmul.ac.uk	O'Connell, Patrick Ronan/H-6583-2019; Bremner, Stephen/R-4038-2016	O'Connell, Patrick Ronan/0000-0002-1846-5629; Bremner, Stephen/0000-0003-0790-7070; Eldridge, Sandra/0000-0001-5638-2317	Pragmatic Clinical Trials Unit (PCTU); Barts; London School of Medicine and Dentistry; UK NIHR Health Technology Assessment (HTA) programme [HTA 09/104/16]; National Institute for Health Research [09/104/16, NF-SI-0514-10066] Funding Source: researchfish	Pragmatic Clinical Trials Unit (PCTU); Barts; London School of Medicine and Dentistry; UK NIHR Health Technology Assessment (HTA) programme; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research.; The trial was under the auspices of the Chief Investigator and the Pragmatic Clinical Trials Unit (PCTU), Barts and The London School of Medicine and Dentistry (sponsor: Queen Mary University of London). It was funded by the UK NIHR Health Technology Assessment (HTA) programme (HTA 09/104/16). The views and opinions expressed in this report are those of the authors and are not necessarily those of the HTA programme, NIHR, the UK National Health Service, or the UK Department of Health. We would like to acknowledge the following people in relation to the CONFIDeNT study: Deborah Gilbert (Patient and Public Involvement representative), Norman Williams (clinical adviser), Sandy Smith, Mike Waring, Lara Edwards, Anitha Manivannan, Glenn Poon, Syed Arafath, and Polly Jordan (the Data Management and Quality Assurance team), and Elaine Denny and Daniel Altmann (the Data and Safety Monitoring committee).	Asari SA, 2014, COLORECTAL DIS, V16, pO393, DOI DOI 10.1111/CODI.12680; Brown SR, 2013, COCHRANE DB SYST REV, V7; Carpenter JR, 2011, J STAT SOFTW, V45, P1; Cotterill N, 2011, DIS COLON RECTUM, V54, P1235, DOI 10.1097/DCR.0b013e3182272128; Enck P, 2012, EUR J GASTROEN HEPAT, V24, P1, DOI 10.1097/MEG.0b013e32834bb951; EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229; George AT, 2013, BRIT J SURG, V100, P330, DOI 10.1002/bjs.9000; Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0; Horrocks EJ, 2014, BRIT J SURG, V101, P457, DOI 10.1002/bjs.9391; Hotouras A, 2012, COLORECTAL DIS, V14, P1101, DOI 10.1111/j.1463-1318.2011.02906.x; Hotouras A, 2014, SURG TODAY, V44, P2124, DOI 10.1007/s00595-014-0898-0; Kahan BC, 2013, STAT MED, V32, P1136, DOI 10.1002/sim.5667; Leroi AM, 2012, AM J GASTROENTEROL, V107, P1888, DOI 10.1038/ajg.2012.330; MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3; Musial F, 2007, WORLD J GASTROENTERO, V13, P3425, DOI 10.3748/wjg.v13.i25.3425; National Institute for Health and Care Excellence, 2007, FAEC INC MAN FAEC IN; National Institute for Health and Care Excellence, 2011, NICE INT PROC GUID I; NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559; Pacheco-Lopez G, 2006, BRAIN BEHAV IMMUN, V20, P430, DOI 10.1016/j.bbi.2006.05.003; Peters KM, 2010, J UROLOGY, V183, P1438, DOI 10.1016/j.juro.2009.12.036; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Thin NN, 2015, BRIT J SURG, V102, P349, DOI 10.1002/bjs.9695; Vaizey CJ, 2014, COLORECTAL DIS, V16, P156, DOI 10.1111/codi.12566; Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77; Wexner SD, 2010, ANN SURG, V251, P441, DOI 10.1097/SLA.0b013e3181cf8ed0; Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	28	82	89	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1640	1648		10.1016/S0140-6736(15)60314-2	http://dx.doi.org/10.1016/S0140-6736(15)60314-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26293315				2022-12-28	WOS:000363197500031
J	Hang, J; Wan, RX; Yan, CY; Shi, YG				Hang, Jing; Wan, Ruixue; Yan, Chuangye; Shi, Yigong			Structural basis of pre-mRNA splicing	SCIENCE			English	Article							METAL-ION CATALYSIS; SMALL NUCLEAR-RNA; GROUP-II INTRONS; CONFORMATIONAL REARRANGEMENT; DESIGN PRINCIPLES; DEPENDENT ATPASE; EXON-LIGATION; PROTEIN PRP22; U6 SNRNAS; 2ND STEP	Splicing of precursor messenger RNA is performed by the spliceosome. In the cryogenic electron microscopy structure of the yeast spliceosome, U5 small nuclear ribonucleoprotein acts as a central scaffold onto which U6 and U2 small nuclear RNAs (snRNAs) are intertwined to form a catalytic center next to Loop I of U5 snRNA. Magnesium ions are coordinated by conserved nucleotides in U6 snRNA. The intron lariat is held in place through base-pairing interactions with both U2 and U6 snRNAs, leaving the variable-length middle portion on the solvent-accessible surface of the catalytic center. The protein components of the spliceosome anchor both 5' and 3' ends of the U2 and U6 snRNAs away from the active site, direct the RNA sequences, and allow sufficient flexibility between the ends and the catalytic center. Thus, the spliceosome is in essence a protein-directed ribozyme, with the protein components essential for the delivery of critical RNA molecules into close proximity of one another at the right time for the splicing reaction.	[Hang, Jing; Wan, Ruixue; Yan, Chuangye; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci,Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci,Ctr Struct Bio, Beijing 100084, Peoples R China	Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Prot Sci,Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci,Ctr Struct Bio, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2014ZX09507003006]; National Natural Science Foundation of China [31130002, 31321062]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Tsinghua University Branch of the China National Center for Protein Sciences (Beijing) for providing the facility support. The computation was completed on the "Explorer 100" cluster system of the Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology (grant 2014ZX09507003006) and the National Natural Science Foundation of China (grants 31130002 and 31321062). The authors declare no competing financial interests.	Anokhina M, 2013, EMBO J, V32, P2804, DOI 10.1038/emboj.2013.198; Aronova A, 2007, RNA, V13, P1437, DOI 10.1261/rna.572807; Bacikova D, 2002, RNA, V8, P1280, DOI 10.1017/S1355838202023099; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; Collins CA, 1999, GENE DEV, V13, P1970, DOI 10.1101/gad.13.15.1970; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; Cordin O, 2012, CURR OPIN CELL BIOL, V24, P431, DOI 10.1016/j.ceb.2012.03.004; Crotti LB, 2007, GENE DEV, V21, P1204, DOI 10.1101/gad.1538207; DeLano W.L, PYMOL MOL GRAPHICS S; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2014, CURR OPIN STRUC BIOL, V25, P57, DOI 10.1016/j.sbi.2013.12.002; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hahn D, 2010, BIOCHEM SOC T, V38, P1105, DOI 10.1042/BST0381105; KIM SH, 1992, EMBO J, V11, P2319, DOI 10.1002/j.1460-2075.1992.tb05291.x; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Liu L, 2007, NAT STRUCT MOL BIOL, V14, P519, DOI 10.1038/nsmb1240; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Montemayor EJ, 2014, NAT STRUCT MOL BIOL, V21, P544, DOI 10.1038/nsmb.2832; Moore M. J., 1993, COLD SPRING HARBOR M; Pena V, 2009, MOL CELL, V35, P454, DOI 10.1016/j.molcel.2009.08.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Robart AR, 2014, NATURE, V514, P193, DOI 10.1038/nature13790; Sashital DG, 2004, NAT STRUCT MOL BIOL, V11, P1237, DOI 10.1038/nsmb863; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; Toor N, 2006, NUCLEIC ACIDS RES, V34, P6461, DOI 10.1093/nar/gkl820; Umen JG, 1996, GENETICS, V143, P723; Valadkhan S, 2003, RNA, V9, P892, DOI 10.1261/rna.5440303; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Wagner JDO, 1998, EMBO J, V17, P2926, DOI 10.1093/emboj/17.10.2926; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zimmerly S, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0037-5	52	131	142	4	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1191	1198		10.1126/science.aac8159	http://dx.doi.org/10.1126/science.aac8159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26292705				2022-12-28	WOS:000360968400035
J	Sefik, E; Geva-Zatorsky, N; Oh, S; Konnikova, L; Zemmour, D; McGuire, AM; Burzyn, D; Ortiz-Lopez, A; Lobera, M; Yang, J; Ghosh, S; Earl, A; Snapper, SB; Jupp, R; Kasper, D; Mathis, D; Benoist, C				Sefik, Esen; Geva-Zatorsky, Naama; Oh, Sungwhan; Konnikova, Liza; Zemmour, David; McGuire, Abigail Manson; Burzyn, Dalia; Ortiz-Lopez, Adriana; Lobera, Mercedes; Yang, Jianfei; Ghosh, Shomir; Earl, Ashlee; Snapper, Scott B.; Jupp, Ray; Kasper, Dennis; Mathis, Diane; Benoist, Christophe			Individual intestinal symbionts induce a distinct population of ROR gamma(+) regulatory T cells	SCIENCE			English	Article							TH17 CELLS; DIFFERENTIATION; GAMMA; T(H)17; INFLAMMATION; HOMEOSTASIS; METABOLITES; MECHANISMS; GENERATION; MICROBIOTA	T regulatory cells that express the transcription factor Foxp3 (Foxp3(+) T-regs) promote tissue homeostasis in several settings. We now report that symbiotic members of the human gut microbiota induce a distinct T-reg population in the mouse colon, which constrains immunoinflammatory responses. This induction-which we find to map to a broad, but specific, array of individual bacterial species-requires the transcription factor Ror gamma, paradoxically, in that Ror gamma is thought to antagonize FoxP3 and to promote T helper 17 (T(H)17) cell differentiation. Ror gamma's transcriptional footprint differs in colonic T-regs and T(H)17 cells and controls important effector molecules. Ror gamma, and the T-regs that express it, contribute substantially to regulating colonic T(H)1/T(H)17 inflammation. Thus, the marked context-specificity of Ror gamma results in very different outcomes even in closely related cell types.	[Sefik, Esen; Geva-Zatorsky, Naama; Oh, Sungwhan; Zemmour, David; Burzyn, Dalia; Ortiz-Lopez, Adriana; Kasper, Dennis; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Mathis, Diane; Benoist, Christophe] Brigham & Womens Hosp, Boston, MA 02115 USA; [Konnikova, Liza; Snapper, Scott B.] Brigham & Womens Hosp, Div Gastroenterol & Hepatol, Boston, MA 02115 USA; [Konnikova, Liza; Snapper, Scott B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [McGuire, Abigail Manson; Earl, Ashlee] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lobera, Mercedes; Yang, Jianfei; Ghosh, Shomir] Tempero Pharmaceut, Cambridge, MA 02139 USA; [Jupp, Ray] UCB Pharma, Slough, Berks, England	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UCB Pharma SA	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Manson, Abigail/B-7132-2016; Geva-Zatorsky, Naama/AAP-9176-2021	Manson, Abigail/0000-0002-3800-0714; Geva-Zatorsky, Naama/0000-0002-7303-854X; Zemmour, David/0000-0002-0990-217X; Konnikova, Yelizaveta/0000-0003-4804-5497; Earl, Ashlee/0000-0001-7857-9145; Sefik, Esen/0000-0002-6807-3498	NIH [R01-AI51530, R56-AI110630]; J.P.B. Foundation; UCB Pharma; Helmsley Charitable Trust; Wolpow Family Chair in the Center for Inflammatory Bowel Disease Treatment and Research; Boehringer Ingelheim Fonds; Human Frontier Science Program; European Molecular Biology Organization [ALTF 251-2011]; Weizmann-National Postdoctoral Award for Advancing Women in Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051530, R56AI110630, T32AI007061, R01AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK102771, P30DK034854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.P.B. Foundation; UCB Pharma(UCB Pharma SA); Helmsley Charitable Trust; Wolpow Family Chair in the Center for Inflammatory Bowel Disease Treatment and Research; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Human Frontier Science Program(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Weizmann-National Postdoctoral Award for Advancing Women in Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Onderdonk, C. Dong, A. Rudensky, R. Lee, V. Kuchroo, and L. Bry for microbial and mouse strains and S. Edwards, A. T. Sherpa, K. Hattori, K. Rothamel, and R. Cruse for help with mice or profiling. TMP778 is available to academic investigators from G.S.K. under a material transfer agreement that does not unduly affect or prohibit publication. The data are tabulated in supplementary materials and deposited at the National Center for Biotechnology Information, NIH, Gene Expression Omnibus (GSE68009). E.S., N.G.-Z., D.K., D.M., C.B., and Harvard Medical School have filed a provisional patent application related to work presented in this paper. This work was supported by NIH R01-AI51530 and R56-AI110630 and the J.P.B. Foundation (D.M. and C.B.); a Sponsored Research Agreement from UCB Pharma (D.M., C. B., D.K., and A.E.); the Helmsley Charitable Trust and the Wolpow Family Chair in the Center for Inflammatory Bowel Disease Treatment and Research (S. B. S.). E.S. and D.Z. were supported by fellowships from the Boehringer Ingelheim Fonds, N.G.-Z. by the Human Frontier Science Program and European Molecular Biology Organization (ALTF 251-2011) fellowships and the Weizmann-National Postdoctoral Award for Advancing Women in Science.	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Ai TL, 2014, IMMUNOL REV, V259, P60, DOI 10.1111/imr.12171; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Du RJ, 2014, J LEUKOCYTE BIOL, V96, P39, DOI 10.1189/jlb.1RU0114-010RR; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	31	478	497	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					993	997		10.1126/science.aaa9420	http://dx.doi.org/10.1126/science.aaa9420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26272906	Green Accepted			2022-12-28	WOS:000360646800058
J	Chen, FX; Woodfin, AR; Gardini, A; Rickels, RA; Marshall, SA; Smith, ER; Shiekhattar, R; Shilatifard, A				Chen, Fei Xavier; Woodfin, Ashley R.; Gardini, Alessandro; Rickels, Ryan A.; Marshall, Stacy A.; Smith, Edwin R.; Shiekhattar, Ramin; Shilatifard, Ali			PAF1, a Molecular Regulator of Promoter-Proximal Pausing by RNA Polymerase II	CELL			English	Article							ELONGATION COMPLEX SEC; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; P-TEFB; H2B MONOUBIQUITINATION; TERMINAL REPEAT; HSP70 GENE; HISTONE H3; HIV-1 TAT; IN-VIVO	The control of promoter-proximal pausing and the release of RNA polymerase II (Pol II) is a widely used mechanism for regulating gene expression in metazoans, especially for genes that respond to environmental and developmental cues. Here, we identify that Pol-II-associated factor 1 (PAF1) possesses an evolutionarily conserved function in metazoans in the regulation of promoter-proximal pausing. Reduction in PAF1 levels leads to an increased release of paused Pol II into gene bodies at thousands of genes. PAF1 depletion results in increased nascent and mature transcripts and increased levels of phosphorylation of Pol II's C-terminal domain on serine 2 (Ser2P). These changes can be explained by the recruitment of the Ser2P kinase super elongation complex (SEC) effecting increased release of paused Pol II into productive elongation, thus establishing PAF1 as a regulator of promoter-proximal pausing by Pol II.	[Chen, Fei Xavier; Woodfin, Ashley R.; Rickels, Ryan A.; Marshall, Stacy A.; Smith, Edwin R.; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA; [Gardini, Alessandro; Shiekhattar, Ramin] Univ Miami, Dept Human Genet, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA; [Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Shilatifard, Ali] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Miami; Stowers Institute for Medical Research; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, 320 E Super St, Chicago, IL 60611 USA.	ash@northwestern.edu		CHEN, FEI/0000-0002-7827-7988; Woodfin, Ashley/0000-0003-4154-6002	National Institutes of Health [R01 GM078455, R01 GM105754, R01GM069905]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA214035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105754, R01GM069905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Molecular Biology core facility at the Stowers Institute for library preparation and next-generation sequencing and the Stowers Institute Tissue Culture core facility for help with cell culture. We thank Laura Shilatifard for editorial assistance. These studies were supported, in part, by grants from the National Institutes of Health R01 GM078455 and R01 GM105754 to R.S. and R01GM069905 to A.S.	BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Chen F, 2015, GENE DEV, V29, P39, DOI 10.1101/gad.246173.114; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Crisucci EM, 2011, GENET RES INT, V2011, DOI 10.4061/2011/707641; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Gardini A, 2014, MOL CELL, V56, P128, DOI 10.1016/j.molcel.2014.08.004; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JS, 2012, GENE DEV, V26, P914, DOI 10.1101/gad.186841.112; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li J, 2013, MOL CELL, V50, P711, DOI 10.1016/j.molcel.2013.05.016; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith E, 2013, GENE DEV, V27, P1079, DOI 10.1101/gad.215137.113; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Stadelmayer B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6531; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; Thornton JL, 2014, GENE DEV, V28, P115, DOI 10.1101/gad.232215.113; TOOHEY MG, 1989, GENE DEV, V3, P265, DOI 10.1101/gad.3.3.265; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Wade PA, 1996, MOL CELL BIOL, V16, P1641; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	55	128	130	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1003	1015		10.1016/j.cell.2015.07.042	http://dx.doi.org/10.1016/j.cell.2015.07.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26279188	Bronze, Green Accepted			2022-12-28	WOS:000360589900011
J	Terrett, JA; Cuthbertson, JD; Shurtleff, VW; MacMillan, DWC				Terrett, Jack A.; Cuthbertson, James D.; Shurtleff, Valerie W.; MacMillan, David W. C.			Switching on elusive organometallic mechanisms with photoredox catalysis	NATURE			English	Article							OXYGEN-ATOM TRANSFER; REDUCTIVE-ELIMINATION; MERGING PHOTOREDOX; NITROUS-OXIDE; NICKEL; ACTIVATION; ARYLATION; HALIDES	Transition-metal-catalysed cross-coupling reactions have become one of the most used carbon-carbon and carbon-heteroatom bond-forming reactions in chemical synthesis. Recently, nickel catalysis has been shown to participate in a wide variety of C-C bond-forming reactions, most notably Negishi, Suzuki-Miyaura, Stille, Kumada and Hiyama couplings(1,2). Despite the tremendous advances in C-C fragment couplings, the ability to forge C-O bonds in a general fashion via nickel catalysis has been largely unsuccessful. The challenge for nickel-mediated alcohol couplings has been the mechanistic requirement for the critical C-O bond-forming step (formally known as the reductive elimination step) to occur via a Ni(III) alkoxide intermediate. Here we demonstrate that visible-light-excited photoredox catalysts can modulate the preferred oxidation states of nickel alkoxides in an operative catalytic cycle, thereby providing transient access to Ni(III) species that readily participate in reductive elimination. Using this synergistic merger of photoredox and nickel catalysis, we have developed a highly efficient and general carbon-oxygen coupling reaction using abundant alcohols and aryl bromides. More notably, we have developed a general strategy to 'switch on' important yet elusive organometallic mechanisms via oxidation state modulations using only weak light and single-electron-transfer catalysts.	[Terrett, Jack A.; Cuthbertson, James D.; Shurtleff, Valerie W.; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Cuthbertson, James/0000-0003-3820-6816	National Institute of General Medical Sciences [R01 GM093213-01]; Bristol-Myers Squibb; Marie Curie Actions for an International Outgoing Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); Marie Curie Actions for an International Outgoing Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by the National Institute of General Medical Sciences (R01 GM093213-01) and gifts from Merck, AbbVie and Bristol-Myers Squibb. J.A.T. thanks Bristol-Myers Squibb for a Graduate Fellowship. J.D.C. thanks Marie Curie Actions for an International Outgoing Fellowship. The authors thank Eric R. Welin for assistance in preparing Ni(II) complexes.	AMATORE C, 1988, ORGANOMETALLICS, V7, P2203, DOI 10.1021/om00100a019; Camasso NM, 2015, SCIENCE, V347, P1218, DOI 10.1126/science.aaa4526; Durandetti M, 1996, NEW J CHEM, V20, P659; Han RY, 1997, J AM CHEM SOC, V119, P8135, DOI 10.1021/ja9714999; Hopkinson MN, 2014, CHEM-EUR J, V20, P3874, DOI 10.1002/chem.201304823; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; Kataoka N, 2002, J ORG CHEM, V67, P5553, DOI 10.1021/jo025732j; Klein A, 2008, INORG CHEM, V47, P11324, DOI 10.1021/ic8007365; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; Macgregor SA, 2003, FARADAY DISCUSS, V124, P111, DOI 10.1039/b212309f; Mann G, 1997, J ORG CHEM, V62, P5413, DOI 10.1021/jo970453v; MATSUNAGA PT, 1993, J AM CHEM SOC, V115, P2075, DOI 10.1021/ja00058a085; MATSUNAGA PT, 1995, POLYHEDRON, V14, P175, DOI 10.1016/0277-5387(94)00330-H; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Narayanam JMR, 2009, J AM CHEM SOC, V131, P8756, DOI 10.1021/ja9033582; Netherton MR, 2004, ADV SYNTH CATAL, V346, P1525, DOI 10.1002/adsc.200404223; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Osawa M, 2007, DALTON T, P827, DOI 10.1039/b618007h; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Sahoo B, 2013, J AM CHEM SOC, V135, P5505, DOI 10.1021/ja400311h; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Torraca KE, 2001, J AM CHEM SOC, V123, P10770, DOI 10.1021/ja016863p; Wolter M, 2002, ORG LETT, V4, P973, DOI 10.1021/ol025548k; Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c; Zhou W, 2015, J AM CHEM SOC, V137, P7604, DOI 10.1021/jacs.5b04082; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	30	366	368	18	613	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					330	334		10.1038/nature14875	http://dx.doi.org/10.1038/nature14875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26266976	Green Accepted			2022-12-28	WOS:000359714000031
J	Hawkes, N				Hawkes, Nigel			BRIEFING Admitting when mistakes are made	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Australian Commission on Safety and Quality in Healthcare, 2014, AUSTR OP DISCL FRAM; Dalton D, 2014, BUILDING CULTURE CAN; Dyer C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1829; Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7334; General Medical Council, 2015, CONS CHANG IND SANCT; Openness and honesty when things go wrong: the professional duty of candour. June 2015. https:// www. gmc- uk. org, 2015, OP HON THINGS GO WRO	6	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4474	10.1136/bmj.h4474	http://dx.doi.org/10.1136/bmj.h4474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7PU	26290433				2022-12-28	WOS:000360081100010
J	Albertin, CB; Simakov, O; Mitros, T; Wang, ZY; Pungor, JR; Edsinger-Gonzales, E; Brenner, S; Ragsdale, CW; Rokhsar, DS				Albertin, Caroline B.; Simakov, Oleg; Mitros, Therese; Wang, Z. Yan; Pungor, Judit R.; Edsinger-Gonzales, Eric; Brenner, Sydney; Ragsdale, Clifton W.; Rokhsar, Daniel S.			The octopus genome and the evolution of cephalopod neural and morphological novelties	NATURE			English	Article							BINDING DOMAIN; GENE-CLUSTER; GENERATION; ALIGNMENT; ELEMENTS; DUPLICATION; COMPLEXITY; DATABASE; TOPHAT; ORIGIN	Coleoid cephalopods (octopus, squid and cuttlefish) are active, resourceful predators with a rich behavioural repertoire(1). They have the largest nervous systems among the invertebrates(2) and present other striking morphological innovations including camera-like eyes, prehensile arms, a highly derived early embryogenesis and a remarkably sophisticated adaptive colouration system(1,3). To investigate the molecular bases of cephalopod brain and body innovations, we sequenced the genome and multiple transcriptomes of the California two-spot octopus, Octopus bimaculoides. We found no evidence for hypothesized whole-genome duplications in the octopus lineage(4-6). The core developmental and neuronal gene repertoire of the octopus is broadly similar to that found across invertebrate bilaterians, except for massive expansions in two gene families previously thought to be uniquely enlarged in vertebrates: the protocadherins, which regulate neuronal development, and the C2H2 superfamily of zinc-finger transcription factors. Extensive messenger RNA editing generates transcript and protein diversity in genes involved in neural excitability, as previously described(7), as well as in genes participating in a broad range of other cellular functions. We identified hundreds of cephalopod-specific genes, many of which showed elevated expression levels in such specialized structures as the skin, the suckers and the nervous system. Finally, we found evidence for large-scale genomic rearrangements that are closely associated with transposable element expansions. Our analysis suggests that substantial expansion of a handful of gene families, along with extensive remodelling of genome linkage and repetitive content, played a critical role in the evolution of cephalopod morphological innovations, including their large and complex nervous systems.	[Albertin, Caroline B.; Ragsdale, Clifton W.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Simakov, Oleg; Edsinger-Gonzales, Eric; Brenner, Sydney; Rokhsar, Daniel S.] Grad Univ, Okinawa Inst Sci & Technol, Onna, Okinawa 9040495, Japan; [Simakov, Oleg] Heidelberg Univ, Ctr Organismal Studies, D-69117 Heidelberg, Germany; [Mitros, Therese; Edsinger-Gonzales, Eric; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wang, Z. Yan; Pungor, Judit R.; Ragsdale, Clifton W.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA	University of Chicago; Okinawa Institute of Science & Technology Graduate University; Ruprecht Karls University Heidelberg; University of California System; University of California Berkeley; University of Chicago; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Ragsdale, CW (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	cragsdale@uchicago.edu; dsrokhsar@gmail.com	Simakov, Oleg/AAV-2494-2020; Simakov, Oleg/G-4572-2015	Simakov, Oleg/0000-0002-3585-4511; Simakov, Oleg/0000-0002-3585-4511; Albertin, Caroline/0000-0003-0933-7665; Pungor, Judit/0000-0002-3858-9442; Wang, Z Yan/0000-0002-7094-1696; Rokhsar, Daniel/0000-0002-8704-2224	Molecular Genetics Unit of the Okinawa Institute of Science and Technology Graduate University; NSF [IOS-1354898, DGE-0903637]; NIH [R03 HD064887, S10RR029668, S10RR027303]; University of Chicago Functional Genomics Facility by NIH [UL1 TR000430]; Division Of Integrative Organismal Systems [1354898] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD064887, T32HD055164] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD056094] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027303, S10RR029668] Funding Source: NIH RePORTER	Molecular Genetics Unit of the Okinawa Institute of Science and Technology Graduate University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Functional Genomics Facility by NIH; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank C. T. Brown and J. Rosenthal for making Doryteuthis RNA-seq data available before publication; C. Ha, J. Orenstein, J. Brandenburger, M. Glotzer and H. Gui for bioinformatic assistance; S. Shigeno for help with tissue dissection; C. Huffard and R. Caldwell for providing the O. bimaculoides specimen used for genomic DNA isolation; and E. Begovic for genomic DNA preparation. This work was supported by the Molecular Genetics Unit of the Okinawa Institute of Science and Technology Graduate University (S.B. and D.S.R.) and by funding from the NSF (IOS-1354898) and NIH (R03 HD064887) to C.W.R. and from the NSF (DGE-0903637) to Z.Y.W. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 instrumentation grants S10RR029668 and S10RR027303, and the University of Chicago Functional Genomics Facility, supported by NIH grant UL1 TR000430.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bonnaud L, 2004, CR BIOL, V327, P133, DOI 10.1016/j.crvi.2003.12.004; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brown C. T., 2014, LOLIGO PEALEII SQUID; Callaerts P, 2002, P NATL ACAD SCI USA, V99, P2088, DOI 10.1073/pnas.042683899; Chapman JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023501; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Cummins SF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-28; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichler EE, 1998, GENOME RES, V8, P791, DOI 10.1101/gr.8.8.791; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grasso FW, 2009, BRAIN BEHAV EVOLUT, V74, P231, DOI 10.1159/000258669; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hallinan NM, 2011, GENOME BIOL EVOL, V3, P1150, DOI 10.1093/gbe/evr087; Hanlon RT, 1996, CEPHALOPOD BEHAV; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; HOLLAND PWH, 1994, DEVELOPMENT, P125; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu H, 2014, GENOME BIOL EVOL, V6, P510, DOI 10.1093/gbe/evu030; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Naef A., 2000, CEPHALOPODA EMBRYOLO; Nithianantharajah J, 2013, NAT NEUROSCI, V16, P16, DOI 10.1038/nn.3276; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; OHSHIMA K, 1994, J MOL BIOL, V243, P25, DOI 10.1006/jmbi.1994.1627; Palavicini JP, 2009, RNA, V15, P1208, DOI 10.1261/rna.1471209; Pickford G. E., 1949, Bulletin of the Bingham Oceanographic Collection, V12, P1; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shomrat T, 2011, CURR BIOL, V21, P1773, DOI 10.1016/j.cub.2011.09.011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Smit A, 1996, REPEATMASKER OPEN 30; Smit AFA, 2008, REPEATMODELER OPEN 1; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Strugnell J, 2005, MOL PHYLOGENET EVOL, V37, P426, DOI 10.1016/j.ympev.2005.03.020; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Nierop P, 2005, J NEUROSCI, V25, P10617, DOI 10.1523/JNEUROSCI.2015-05.2005; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wells MJ, 1978, OCTOPUS PHYSL BEHAV, DOI 10.1007/978-94-017-2468-5; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yoshida M, 2011, GENE, V483, P63, DOI 10.1016/j.gene.2011.05.027; Young J. Z., 1971, ANATOMY NERVOUS SYST; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	58	322	331	16	357	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					220	+		10.1038/nature14668	http://dx.doi.org/10.1038/nature14668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268193	Green Accepted, hybrid			2022-12-28	WOS:000359386900032
J	Shachar, S; Voss, TC; Pegoraro, G; Sciascia, N; Misteli, T				Shachar, Sigal; Voss, Ty C.; Pegoraro, Gianluca; Sciascia, Nicholas; Misteli, Tom			Identification of Gene Positioning Factors Using High-Throughput Imaging Mapping	CELL			English	Article							RECURRENT CHROMOSOMAL TRANSLOCATIONS; SPATIAL GENOME ORGANIZATION; NUCLEAR LAMINA INTERACTIONS; HUMAN-CELLS; EARLY G1; CHROMATIN; REORGANIZATION; ARCHITECTURE; MITOSIS; LOCUS	Genomes are arranged non-randomly in the 3D space of the cell nucleus. Here, we have developed HIPMap, a high-precision, high-throughput, automated fluorescent in situ hybridization imaging pipeline, for mapping of the spatial location of genome regions at large scale. High-throughput imaging position mapping (HIPMap) enabled an unbiased siRNA screen for factors involved in genome organization in human cells. We identify 50 cellular factors required for proper positioning of a set of functionally diverse genomic loci. Positioning factors include chromatin remodelers, histone modifiers, and nuclear envelope and pore proteins. Components of the replication and post-replication chromatin reassembly machinery are prominently represented among positioning factors, and timely progression of cells through replication, but not mitosis, is required for correct gene positioning. Our results establish a method for the large-scale mapping of genome locations and have led to the identification of a compendium of cellular factors involved in spatial genome organization.	[Shachar, Sigal; Sciascia, Nicholas; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Voss, Ty C.; Pegoraro, Gianluca] NCI, High Throughput Imaging Facil HiTIF, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Pegoraro, Gianluca/K-4233-2016	Pegoraro, Gianluca/0000-0003-2843-9464	Intramural Research Program of the National Institutes of Health (NIH), NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC011567, ZIABC010309] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), NCI; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Karen Meaburn for insightful suggestions for developing hiFISH, members of the Misteli laboratory for helpful discussions and comments, Laurent Ozbun from the NCI HiTIF for technical assistance with the screen, and Murali Palangat for help with polymerase II activity assays. This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, and Center for Cancer Research. T.C.V. is an employee of Perkin Elmer Cooperation.	Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Botta M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.79; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cvackova Z, 2009, J STRUCT BIOL, V165, P107, DOI 10.1016/j.jsb.2008.10.007; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fernandez P, 2014, CELL REP, V9, P248, DOI 10.1016/j.celrep.2014.08.069; Ferrai C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000588; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Gilbert DM, 2010, COLD SH Q B, V75, P143, DOI 10.1101/sqb.2010.75.011; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Joyce EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002667; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Meaburn KJ, 2008, J CELL BIOL, V180, P39, DOI 10.1083/jcb.200708204; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Meaburn KJ, 2007, AGING CELL, V6, P139, DOI 10.1111/j.1474-9726.2007.00270.x; Meaburn KJ, 2009, J CELL BIOL, V187, P801, DOI 10.1083/jcb.200909127; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Nandy K, 2012, CYTOM PART A, V81A, P743, DOI 10.1002/cyto.a.22097; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Smellie A, 2006, J CHEM INF MODEL, V46, P201, DOI 10.1021/ci050404g; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Speicher MR, 2005, NAT REV GENET, V6, P782, DOI 10.1038/nrg1692; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wang AHJ, 2013, EMBO J, V32, P1075, DOI 10.1038/emboj.2013.54; Wei Z, 2013, J BIOL CHEM, V288, P22369, DOI 10.1074/jbc.R113.485292; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	53	110	115	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					911	923		10.1016/j.cell.2015.07.035	http://dx.doi.org/10.1016/j.cell.2015.07.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276637	Bronze, Green Accepted			2022-12-28	WOS:000359741400022
J	Bayer, R; Galea, S				Bayer, Ronald; Galea, Sandro			Public Health in the Precision-Medicine Era	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bayer, Ronald] Columbia Univ, Ctr Hist & Eth Publ Hlth, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Galea, Sandro] Boston Univ, Off Dean, Sch Publ Hlth, Boston, MA 02215 USA	Columbia University; Boston University	Bayer, R (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Mailman Sch Publ Hlth, New York, NY 10027 USA.		Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945				[Anonymous], 2013, MMWR SURVEILL SUM S3, V62, P184; Bassett MT, 2015, NEW ENGL J MED, V372, P1085, DOI 10.1056/NEJMp1500529; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins FS, 2015, JAMA-J AM MED ASSOC, V313, P131, DOI 10.1001/jama.2014.16736; Porter Eduardo, 2015, NY TIMES	5	139	146	0	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					499	501		10.1056/NEJMp1506241	http://dx.doi.org/10.1056/NEJMp1506241			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO2LM	26244305				2022-12-28	WOS:000358987700003
J	Ventevogel, P; Spiegel, P				Ventevogel, Peter; Spiegel, Paul			Psychological Treatments for Orphans and Vulnerable Children Affected by Traumatic Events and Chronic Adversity in Sub-Saharan Africa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MENTAL-HEALTH; RESILIENCE; COUNTRIES	IMPORTANCE Orphans and vulnerable children (OVC) are at high risk for experiencing trauma and related psychosocial problems. Despite this, no randomized clinical trials have studied evidence-based treatments for OVC in low-resource settings. OBJECTIVE To evaluate the effectiveness of lay counselor-provided trauma-focused cognitive behavioral therapy (TF-CBT) to address trauma and stress-related symptoms among OVC in Lusaka, Zambia. DESIGN, SETTING, AND PARTICIPANTS This randomized clinical trial compared TF-CBT and treatment as usual (TAU) (varying by site) for children recruited from August 1, 2012, through July 31, 2013, and treated until December 31, 2013, for trauma-related symptoms from 5 community sites within Lusaka, Zambia. Children were aged 5 through 18 years and had experienced at least one traumatic event and reported significant trauma-related symptoms. Analysis was with intent to treat. INTERVENTIONS The intervention group received 10 to 16 sessions of TF-CBT (n = 131). The TAU group (n = 126) received usual community services offered to OVC. MAIN OUTCOMES AND MEASURES The primary outcomewas mean item change in trauma and stress-related symptoms using a locally validated version of the UCLA Posttraumatic Stress Disorder Reaction Index (range, 0-4) and functional impairment using a locally developed measure (range, 0-4). Outcomes were measured at baseline and within 1 month after treatment completion or after a waiting period of approximately 4.5 months after baseline for TAU. RESULTS At follow-up, the mean item change in trauma symptom score was -1.54 (95% CI, -1.81 to -1.27), a reduction of 81.9%, for the TF-CBT group and -0.37 (95% CI, -0.57 to -0.17), a reduction of 21.1%, for the TAU group. The mean item change for functioning was -0.76 (95% CI, -0.98 to -0.54), a reduction of 89.4%, and -0.54 (95% CI, -0.80 to -0.29), a reduction of 68.3%, for the TF-CBT and TAU groups, respectively. The difference in change between groups was statistically significant for both outcomes (P < .001). The effect size (Cohen d) was 2.39 for trauma symptoms and 0.34 for functioning. Lay counselors participated in supervision and assessed whether the intervention was provided with fidelity in all 5 community settings. CONCLUSIONS AND RELEVANCE The TF-CBT adapted for Zambia substantially decreased trauma and stress-related symptoms and produced a smaller improvement in functional impairment among OVC having experienced high levels of trauma.	[Ventevogel, Peter; Spiegel, Paul] United Nations High Commissioner Refugees, Geneva, Switzerland		Spiegel, P (corresponding author), Off United Nations High Commissioner Refugees, 94 Rue Montbrillant, CH-1211 Geneva, Switzerland.	spiegel@unhcr.org	Spiegel, Paul/AAL-3238-2021; Ventevogel, Peter/D-5831-2015	Spiegel, Paul/0000-0002-6158-6661; Ventevogel, Peter/0000-0002-3567-8861				Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Murray LK, 2015, JAMA PEDIATR, V169, P761, DOI 10.1001/jamapediatrics.2015.0580; Panter-Brick C, 2015, J CHILD PSYCHOL PSYC, V56, P814, DOI 10.1111/jcpp.12350; Patel V, 2011, BEHAV RES THER, V49, P523, DOI 10.1016/j.brat.2011.06.012; Tol WA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-56; Tol WA, 2013, JAMA-J AM MED ASSOC, V310, P477, DOI 10.1001/jama.2013.166723; Ventevogel P, 2014, INT REV PSYCHIATR, V26, P669, DOI 10.3109/09540261.2014.966067; Wessells MG, 2015, J CHILD PSYCHOL PSYC, V56, P18, DOI 10.1111/jcpp.12367	9	8	8	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					511	+		10.1001/jama.2015.8383	http://dx.doi.org/10.1001/jama.2015.8383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO1OI	26241602				2022-12-28	WOS:000358924500015
J	Low, D; Roland, D; Baird, G; Chantler, C				Low, David; Roland, Damian; Baird, Gillian; Chantler, Cyril			Safeguarding children and improving their care in the UK	LANCET			English	Editorial Material									[Low, David] Royal Coll Paediat & Child Hlth Informat Qual Com, London, England; [Roland, Damian] Univ Leicester, Paediat Emergency Med Sapphire Grp, Hlth Sci, Leicester, Leics, England; [Baird, Gillian] Guys & St Thomas NHS Fdn Trust, Kings Coll Paediat Neurosci, Kings Hlth Partners, London, England; [Chantler, Cyril] UCL Partners Acad Hlth Sci Partnership, London W1T 7HA, England	University of Leicester; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London	Low, D (corresponding author), Royal Coll Paediat & Child Hlth Informat Qual Com, London, England.	chantler@doctors.org.uk	Roland, Damian/D-9553-2018	Roland, Damian/0000-0001-9334-5144				Blades R, 2014, IMPL STUD INT REV 2; Brandon M, 2012, NEW LEARRNING SERIOU; Children and Young People's Health Outcomes Forum, 2014, REP CHILDR YOUNG PEO; Department for Education, 2014, SUPP PUP SCH MED CON; Department for Education & Department for Health, 2014, SPEC ED NEEDS DIS CO; Ewing C., 2015, REPORT CHILDREN YOUN; Health and Social Care Information Centre, 2015, CHILD PROT INF SHAR; Laming H., 2003, VICTORIA CLIMBIE INQ; National Society for the Prevention of Cruelty to Children, 2014, CAS REV PUBL 2014; NHS England, 2014, NHS NUMB SURV REP	10	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					313	314		10.1016/S0140-6736(15)61246-6	http://dx.doi.org/10.1016/S0140-6736(15)61246-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN5CX	26227451	Green Submitted			2022-12-28	WOS:000358448400004
J	Han, JH; Sullivan, N; Leas, BF; Pegues, DA; Kaczmarek, JL; Umscheid, CA				Han, Jennifer H.; Sullivan, Nancy; Leas, Brian F.; Pegues, David A.; Kaczmarek, Janice L.; Umscheid, Craig A.			Cleaning Hospital Room Surfaces to Prevent Health Care-Associated Infections A Technical Brief	ANNALS OF INTERNAL MEDICINE			English	Review							VANCOMYCIN-RESISTANT ENTEROCOCCUS; CLOSTRIDIUM-DIFFICILE INFECTION; HYDROGEN-PEROXIDE VAPOR; QUATERNARY AMMONIUM-COMPOUNDS; ENVIRONMENTAL CONTAMINATION; STAPHYLOCOCCUS-AUREUS; PATIENT ROOMS; REDUCE CONTAMINATION; INANIMATE SURFACES; ULTRAVIOLET-LIGHT	The cleaning of hard surfaces in hospital rooms is critical for reducing health care-associated infections. This review describes the evidence examining current methods of cleaning, disinfecting, and monitoring cleanliness of patient rooms, as well as contextual factors that may affect implementation and effectiveness. Key informants were interviewed, and a systematic search for publications since 1990 was done with the use of several bibliographic and gray literature resources. Studies examining surface contamination, colonization, or infection with Clostridium difficile, methicillin-resistant Staphylococcus aureus, or vancomycin-resistant enterococci were included. Eighty studies were identified-76 primary studies and 4 systematic reviews. Forty-nine studies examined cleaning methods, 14 evaluated monitoring strategies, and 17 addressed challenges or facilitators to implementation. Only 5 studies were randomized, controlled trials, and surface contamination was the most commonly assessed outcome. Comparative effectiveness studies of disinfecting methods and monitoring strategies were uncommon. Future research should evaluate and compare newly emerging strategies, such as self-disinfecting coatings for disinfecting and adenosine triphosphate and ultraviolet/fluorescent surface markers for monitoring. Studies should also assess patient-centered outcomes, such as infection, when possible. Other challenges include identifying high-touch surfaces that confer the greatest risk for pathogen transmission; developing standard thresholds for defining cleanliness; and using methods to adjust for confounders, such as hand hygiene, when examining the effect of disinfecting methods.	Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn Hlth Syst, Ctr Evidence Based Practice, Philadelphia, PA USA; Penn Med Evidence Based Practice Ctr, ECRI Inst, Plymouth Meeting, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Han, JH (corresponding author), Hosp Univ Penn, Div Infect Dis, Dept Med, 811 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	jennifer.han@uphs.upenn.edu		Umscheid, Craig/0000-0003-1853-1013; Han, Jennifer/0000-0003-4744-8067; Leas, Brian/0000-0003-2450-8434	AHRQ [HHSA 290-2012-00011-I]; National Institutes of Health [K01-AI103028]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI103028] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded under AHRQ (contract HHSA 290-2012-00011-I). This topic was nominated by a member of the 3M Hospital Hygiene Global Advisory Board on behalf of the Board. This work was also supported in part by the National Institutes of Health (K01-AI103028; Dr. Han).	Al-Hamad A, 2008, J HOSP INFECT, V70, P328, DOI 10.1016/j.jhin.2008.08.006; Alfa MJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-268; Alfa MJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-64; Amodio E, 2014, J INFECT PUBLIC HEAL, V7, P92, DOI 10.1016/j.jiph.2013.09.005; Andersen BM, 2009, J HOSP INFECT, V71, P57, DOI 10.1016/j.jhin.2008.09.014; Anderson DJ, 2013, INFECT CONT HOSP EP, V34, P466, DOI 10.1086/670215; BERNSTEIN JA, 1994, J ALLERGY CLIN IMMUN, V94, P257, DOI 10.1016/0091-6749(94)90048-5; Best EL, 2014, J HOSP INFECT, V87, P25, DOI 10.1016/j.jhin.2014.02.005; BEST M, 1990, J CLIN MICROBIOL, V28, P2234, DOI 10.1128/JCM.28.10.2234-2239.1990; Blue Jennifer, 2008, Can J Infect Control, V23, P216; Boyce JM, 2014, AM J INFECT CONTROL, V42, P326, DOI 10.1016/j.ajic.2013.09.009; Boyce JM, 2013, INFECT CONT HOSP EP, V34, P521, DOI 10.1086/670212; Boyce JM, 2011, INFECT CONT HOSP EP, V32, P1187, DOI 10.1086/662626; Boyce JM, 2011, INFECT CONT HOSP EP, V32, P737, DOI 10.1086/661222; Brakovich B, 2013, J HEALTHC QUAL, V35, P15, DOI 10.1111/j.1945-1474.2011.00182.x; Branch-Elliman W, 2014, AM J INFECT CONTROL, V42, P195, DOI 10.1016/j.ajic.2013.08.012; Byers KE, 1998, INFECT CONT HOSP EP, V19, P261; Carling PC, 2008, INFECT CONT HOSP EP, V29, P1, DOI 10.1086/524329; Carling PC, 2008, INFECT CONT HOSP EP, V29, P1035, DOI 10.1086/591940; Carling PC, 2006, AM J INFECT CONTROL, V34, P513, DOI 10.1016/j.ajic.2005.09.001; Carling PC, 2010, CRIT CARE MED, V38, P1054, DOI 10.1097/CCM.0b013e3181cdf705; Carter Yvonne, 2011, Nurs Times, V107, P22; Casey AL, 2010, J HOSP INFECT, V74, P72, DOI 10.1016/j.jhin.2009.08.018; Chan HT, 2011, J HOSP INFECT, V79, P125, DOI 10.1016/j.jhin.2011.06.009; Dancer SJ, 2008, LANCET INFECT DIS, V8, P101, DOI 10.1016/S1473-3099(07)70241-4; Datta R, 2011, ARCH INTERN MED, V171, P491, DOI 10.1001/archinternmed.2011.64; De Lorenzi S, 2006, J HOSP INFECT, V62, P346, DOI 10.1016/j.jhin.2005.09.021; Dettenkofer M, 2004, AM J INFECT CONTROL, V32, P84, DOI 10.1016/j.ajic.2003.07.006; Drees M, 2008, CLIN INFECT DIS, V46, P678, DOI 10.1086/527394; Eckstein BC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-61; Engelbrecht K, 2013, AM J INFECT CONTROL, V41, P908, DOI 10.1016/j.ajic.2013.01.017; Falagas ME, 2011, J HOSP INFECT, V78, P171, DOI 10.1016/j.jhin.2010.12.006; Feczko R, 2012, CROTHALL HEALTHCARES; Friedman ND, 2013, AM J INFECT CONTROL, V41, P227, DOI 10.1016/j.ajic.2012.03.021; Gillespie E, 2013, AM J INFECT CONTROL, V41, P461, DOI 10.1016/j.ajic.2012.07.003; Goldenberg SD, 2012, J HOSP INFECT, V82, P64, DOI 10.1016/j.jhin.2012.06.004; Goodman ER, 2008, INFECT CONT HOSP EP, V29, P593, DOI 10.1086/588566; Grabsch EA, 2012, J HOSP INFECT, V82, P234, DOI 10.1016/j.jhin.2012.08.010; Guise JM, 2014, J CLIN EPIDEMIOL, V67, P1181, DOI 10.1016/j.jclinepi.2014.06.010; Haas JP, 2014, AM J INFECT CONTROL, V42, P586, DOI 10.1016/j.ajic.2013.12.013; Hacek DM, 2010, AM J INFECT CONTROL, V38, P350, DOI 10.1016/j.ajic.2009.11.003; Hamilton D, 2010, J HOSP INFECT, V74, P62, DOI 10.1016/j.jhin.2009.08.006; Havill NL, 2012, INFECT CONT HOSP EP, V33, P507, DOI 10.1086/665326; Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845; Hedin G, 2010, J HOSP INFECT, V75, P112, DOI 10.1016/j.jhin.2010.02.007; Hess AS, 2013, INFECT CONT HOSP EP, V34, P487, DOI 10.1086/670205; Hota B, 2009, J HOSP INFECT, V71, P123, DOI 10.1016/j.jhin.2008.10.030; Jinadatha C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-187; Karpanen TJ, 2012, INFECT CONT HOSP EP, V33, P3, DOI 10.1086/663644; Koll BS, 2014, J HEALTHC QUAL, V36, P35, DOI 10.1111/jhq.12002; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kundrapu S, 2012, INFECT CONT HOSP EP, V33, P1039, DOI 10.1086/667730; LANDAU GD, 1964, ARCHIV OTOLARYNGOL, V80, P174, DOI 10.1001/archotol.80.2.174; Leas B.F., 2015, ENV CLEANING PREVENT; Levin J, 2013, AM J INFECT CONTROL, V41, P746, DOI 10.1016/j.ajic.2013.02.010; Luick L, 2013, AM J INFECT CONTROL, V41, P751, DOI 10.1016/j.ajic.2012.09.019; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mahida N, 2013, J HOSP INFECT, V84, P332, DOI 10.1016/j.jhin.2013.05.005; Malik RE, 2003, AM J INFECT CONTROL, V31, P181, DOI 10.1067/mic.2003.34; Manian FA, 2013, AM J INFECT CONTROL, V41, P537, DOI 10.1016/j.ajic.2012.06.014; McDonald LC, 2013, CLIN INFECT DIS, V56, P36, DOI 10.1093/cid/cis845; McMullen KM, 2007, INFECT CONT HOSP EP, V28, P205, DOI 10.1086/511791; Mitchell B. G., 2013, Healthcare Infection, V18, P23, DOI 10.1071/HI12047; Mitchell BG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004522; MRVOS R, 1993, SOUTHERN MED J, V86, P654, DOI 10.1097/00007611-199306000-00013; Mulvey D, 2011, J HOSP INFECT, V77, P25, DOI 10.1016/j.jhin.2010.08.006; Munoz-Price LS, 2011, INFECT CONT HOSP EP, V32, P283, DOI 10.1086/658666; Murphy C. L., 2011, Healthcare Infection, V16, P156, DOI 10.1071/HI11024; Nerandzic MM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-120; Omidbakhsh N, 2006, AM J INFECT CONTROL, V34, P251, DOI 10.1016/j.ajic.2005.06.002; Orenstein R, 2011, INFECT CONT HOSP EP, V32, P1137, DOI 10.1086/662586; Passaretti CL, 2013, CLIN INFECT DIS, V56, P27, DOI 10.1093/cid/cis839; Po JL, 2009, AM J INFECT CONTROL, V37, P778, DOI 10.1016/j.ajic.2009.02.005; Purohit A, 2000, INT ARCH OCC ENV HEA, V73, P423, DOI 10.1007/s004200000162; Ragan K, 2012, AM J INFECT CONTROL, V40, P284, DOI 10.1016/j.ajic.2011.04.003; Ramphal Lilly, 2014, Proc (Bayl Univ Med Cent), V27, P88; REISZ GR, 1986, CHEST, V89, P49, DOI 10.1378/chest.89.1.49; Rupp ME, 2014, INFECT CONT HOSP EP, V35, P866, DOI 10.1086/676873; Rupp ME, 2014, INFECT CONT HOSP EP, V35, P721, DOI 10.1086/676431; Rutala WA, 1998, INFECT CONT HOSP EP, V19, P323; Rutala WA, 1997, CLIN MICROBIOL REV, V10, P597, DOI 10.1128/CMR.10.4.597; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P1025, DOI 10.1086/656244; Salgado CD, 2013, INFECT CONT HOSP EP, V34, P479, DOI 10.1086/670207; SATTAR SA, 1989, EPIDEMIOL INFECT, V102, P493, DOI 10.1017/S0950268800030211; Schmidt MG, 2013, INFECT CONT HOSP EP, V34, P530, DOI 10.1086/670224; Schmidt MG, 2012, AM J INFECT CONTROL, V40, P559, DOI 10.1016/j.ajic.2011.07.013; Schmidt MG, 2012, J CLIN MICROBIOL, V50, P2217, DOI 10.1128/JCM.01032-12; Sexton JD, 2010, AM J INFECT CONTROL, V38, P368, DOI 10.1016/j.ajic.2010.01.004; Sigler V, 2013, J HOSP INFECT, V83, P253, DOI 10.1016/j.jhin.2012.12.009; Sitzlar B, 2013, INFECT CONT HOSP EP, V34, P459, DOI 10.1086/670217; Sjoberg M, 2014, APMIS, V122, P800, DOI 10.1111/apm.12218; Smith P. W., 2013, Healthcare Infection, V18, P10, DOI 10.1071/HI12049; Smith PW, 2014, INFECT CONT HOSP EP, V35, P564, DOI 10.1086/675839; Snyder GM, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-26; Sodexo Quality of Life Services, HLTH CARE; Stewart M, 2014, INFECT CONT HOSP EP, V35, P1505, DOI 10.1086/678595; Trajtman AN, 2013, J HOSP INFECT, V84, P166, DOI 10.1016/j.jhin.2013.03.004; Wagenvoort JHT, 2000, J HOSP INFECT, V45, P231, DOI 10.1053/jhin.2000.0757; Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Wendt C, 1998, J CLIN MICROBIOL, V36, P3734, DOI 10.1128/JCM.36.12.3734-3736.1998; Whitaker J, 2007, AM J INFECT CONTROL, V35, P310, DOI 10.1016/j.ajic.2006.08.010; Wiemken TL, 2014, AM J INFECT CONTROL, V42, P329, DOI 10.1016/j.ajic.2013.09.031; Wilcox MH, 2003, J HOSP INFECT, V54, P109, DOI 10.1016/S0195-6701(02)00400-0; Wilson APR, 2011, CRIT CARE MED, V39, P651, DOI 10.1097/CCM.0b013e318206bc66	105	107	119	2	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8					598	+		10.7326/M15-1192	http://dx.doi.org/10.7326/M15-1192			37	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26258903	Green Accepted			2022-12-28	WOS:000363737400018
J	De Franco, E; Flanagan, SE; Houghton, JAL; Allen, HL; Mackay, DJG; Temple, IK; Ellard, S; Hattersley, AT				De Franco, Elisa; Flanagan, Sarah E.; Houghton, Jayne A. L.; Allen, Hana Lango; Mackay, Deborah J. G.; Temple, I. Karen; Ellard, Sian; Hattersley, Andrew T.			The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study	LANCET			English	Article							WOLCOTT-RALLISON-SYNDROME; ACTIVATING MUTATIONS; ORAL SULFONYLUREAS; KIR6.2 MUTATIONS; GENE; MELLITUS; INSULIN; DIAGNOSIS; KCNJ11; CHILDREN	Background Traditional genetic testing focusses on analysis of one or a few genes according to clinical features; this approach is changing as improved sequencing methods enable simultaneous analysis of several genes. Neonatal diabetes is the presenting feature of many discrete clinical phenotypes defined by different genetic causes. Genetic subtype defines treatment, with improved glycaemic control on sulfonylurea treatment for most patients with potassium channel mutations. We investigated the effect of early, comprehensive testing of all known genetic causes of neonatal diabetes. Methods In this large, international, cohort study, we studied patients with neonatal diabetes diagnosed with diabetes before 6 months of age who were referred from 79 countries. We identified mutations by comprehensive genetic testing including Sanger sequencing, 6q24 methylation analysis, and targeted next-generation sequencing of all known neonatal diabetes genes. Findings Between January, 2000, and August, 2013, genetic testing was done in 1020 patients (571 boys, 449 girls). Mutations in the potassium channel genes were the most common cause (n=390) of neonatal diabetes, but were identified less frequently in consanguineous families (12% in consanguineous families vs 46% in non-consanguineous families; p<0.0001). Median duration of diabetes at the time of genetic testing decreased from more than 4 years before 2005 to less than 3 months after 2012. Earlier referral for genetic testing affected the clinical phenotype. In patients with genetically diagnosed Wolcott-Rallison syndrome, 23 (88%) of 26 patients tested within 3 months from diagnosis had isolated diabetes, compared with three (17%) of 18 patients referred later (>4 years; p<0.0001), in whom skeletal and liver involvement was common. Similarly, for patients with genetically diagnosed transient neonatal diabetes, the diabetes had remitted in only ten (10%) of 101 patients tested early (<3 months) compared with 60 (100%) of the 60 later referrals (p<0.0001). Interpretation Patients are now referred for genetic testing closer to their presentation with neonatal diabetes. Comprehensive testing of all causes identified causal mutations in more than 80% of cases. The genetic result predicts the best diabetes treatment and development of related features. This model represents a new framework for clinical care with genetic diagnosis preceding development of clinical features and guiding clinical management.	[De Franco, Elisa; Flanagan, Sarah E.; Houghton, Jayne A. L.; Allen, Hana Lango; Ellard, Sian; Hattersley, Andrew T.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Mackay, Deborah J. G.; Temple, I. Karen] Salisbury Fdn Trust, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Mackay, Deborah J. G.; Temple, I. Karen] Univ Hosp Southampton NHS Trust, Southampton, Hants, England; [Mackay, Deborah J. G.] Univ Southampton, Fac Med, Human Genet & Genom Med, Southampton SO9 5NH, Hants, England	University of Exeter; University of Southampton	Hattersley, AT (corresponding author), Univ Exeter, Sch Med, Exeter EX2 5DW, Devon, England.	A.T.Hattersley@exeter.ac.uk	temple, isabel K/K-2391-2015; Mackay, Deborah JG/B-2879-2015	Temple, Isabel Karen/0000-0002-6045-1781; Lango Allen, Hana/0000-0002-7803-8688; Flanagan, Sarah/0000-0002-8670-6340; Ellard, Sian/0000-0002-7620-5526; Hattersley, Andrew/0000-0001-5620-473X; Mackay, Deborah JG/0000-0003-3088-4401	Wellcome Trust [WT098395/Z/12/Z]; Diabetes UK [12/0004501];  [WT097835MF];  [WT101650MA]; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); ; ; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Wellcome Trust (grant number WT098395/Z/12/Z). Also grants number WT097835MF and WT101650MA (via support to the University of Exeter Sequencing Service) and Diabetes UK (grant number 12/0004501). We thank all the families and their referring clinicians and Richard Caswell, Karen Moore, Audrey Farbos, and Konrad Paszkiewicz for their expert technical assistance with the next-generation sequencing.	Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Bittles AH, 2008, COMMUNITY GENET, V11, P324, DOI 10.1159/000133304; Bonnefond A, 2014, DIABETES CARE, V37, P460, DOI 10.2337/dc13-0698; Busiah K, 2013, LANCET DIABETES ENDO, V1, P199, DOI 10.1016/S2213-8587(13)70059-7; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Codner E, 2005, DIABETES CARE, V28, P758, DOI 10.2337/diacare.28.3.758; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Edghill EL, 2006, DIABETES, V55, P1895, DOI 10.2337/db06-0094; Ellard S, 2013, DIABETOLOGIA, V56, P1958, DOI 10.1007/s00125-013-2962-5; Flanagan SE, 2007, DIABETES, V56, P1930, DOI 10.2337/db07-0043; Flanagan SE, 2011, J CLIN ENDOCR METAB, V96, pE498, DOI 10.1210/jc.2010-1906; Gao R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-13; Gardner RJ, 2000, HUM MOL GENET, V9, P589, DOI 10.1093/hmg/9.4.589; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Gloyn AL, 2005, HUM MOL GENET, V14, P925, DOI 10.1093/hmg/ddi086; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Hattersley A, 2006, PEDIATR DIABETES, V7, P352, DOI 10.1111/j.1399-5448.2006.00217.x; Iafusco D, 2012, ACTA DIABETOL, V49, P405, DOI 10.1007/s00592-011-0331-8; Iafusco D, 2002, DIABETOLOGIA, V45, P798, DOI 10.1007/s00125-002-0837-2; Julier C, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-29; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Mackay DJG, 2005, HUM GENET, V116, P255, DOI 10.1007/s00439-004-1236-1; O'Sullivan J, 2012, J MED GENET, V49, P322, DOI 10.1136/jmedgenet-2012-100847; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Rafiq M, 2008, DIABETES CARE, V31, P204, DOI 10.2337/dc07-1785; Rubio-Cabezas O, 2012, PEDIATR DIABETES, V13, P315, DOI 10.1111/j.1399-5448.2011.00824.x; Sagen JV, 2004, DIABETES, V53, P2713, DOI 10.2337/diabetes.53.10.2713; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Shimomura K, 2007, NEUROLOGY, V69, P1342, DOI 10.1212/01.wnl.0000268488.51776.53; Slingerland AS, 2006, DIABETOLOGIA, V49, P2559, DOI 10.1007/s00125-006-0407-0; Slingerland AS, 2009, DIABETOLOGIA, V52, P1683, DOI 10.1007/s00125-009-1416-6; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Temple IK, 2002, J MED GENET, V39, P872, DOI 10.1136/jmg.39.12.872; Temple IK, 1996, HUM MOL GENET, V5, P1117, DOI 10.1093/hmg/5.8.1117; Valencia CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053083	38	171	172	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					957	963		10.1016/S0140-6736(15)60098-8	http://dx.doi.org/10.1016/S0140-6736(15)60098-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26231457	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000361182700027
J	Charo, RA				Charo, R. Alta			Fetal Tissue Fallout	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [Charo, R. Alta] Univ Wisconsin, Dept Med Hist Bioeth, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				[Anonymous], 1988, REP ADV COMM DIR NAT; [Anonymous], INN APPR TREATM PARK; Childress J., 1991, BIOMEDICAL POLITICS, P215; Miller, 2015, WASH POST; Sonfield A, 2014, MOVING FORWARD FAMIL	5	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					890	891		10.1056/NEJMp1510279	http://dx.doi.org/10.1056/NEJMp1510279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ2OB	26267448				2022-12-28	WOS:000360439500003
J	Claussnitzer, M; Dankel, SN; Kim, KH; Quon, G; Meuleman, W; Haugen, C; Glunk, V; Sousa, IS; Beaudry, JL; Puviindran, V; Abdennur, NA; Liu, J; Svensson, PA; Hsu, YH; Drucker, DJ; Mellgren, G; Hui, CC; Hauner, H; Kellis, M				Claussnitzer, Melina; Dankel, Simon N.; Kim, Kyoung-Han; Quon, Gerald; Meuleman, Wouter; Haugen, Christine; Glunk, Viktoria; Sousa, Isabel S.; Beaudry, Jacqueline L.; Puviindran, Vijitha; Abdennur, Nezar A.; Liu, Jannel; Svensson, Per-Arne; Hsu, Yi-Hsiang; Drucker, Daniel J.; Mellgren, Gunnar; Hui, Chi-Chung; Hauner, Hans; Kellis, Manolis			FTO Obesity Variant Circuitry and Adipocyte Browning in Humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; ADIPOSE-TISSUE; GENE-EXPRESSION; ADULT OBESITY; RISK; CHILDHOOD; LOCUS; IRX3	BACKGROUND Genomewide association studies can be used to identify disease-relevant genomic regions, but interpretation of the data is challenging. The FTO region harbors the strongest genetic association with obesity, yet the mechanistic basis of this association remains elusive. METHODS We examined epigenomic data, allelic activity, motif conservation, regulator expression, and gene coexpression patterns, with the aim of dissecting the regulatory circuitry and mechanistic basis of the association between the FTO region and obesity. We validated our predictions with the use of directed perturbations in samples from patients and from mice and with endogenous CRISPR-Cas9 genome editing in samples from patients. RESULTS Our data indicate that the FTO allele associated with obesity represses mitochondrial thermogenesis in adipocyte precursor cells in a tissue-autonomous manner. The rs1421085 T-to-C single-nucleotide variant disrupts a conserved motif for the ARID5B repressor, which leads to derepression of a potent preadipocyte enhancer and a doubling of IRX3 and IRX5 expression during early adipocyte differentiation. This results in a cell-autonomous developmental shift from energy-dissipating beige (brite) adipocytes to energy-storing white adipocytes, with a reduction in mitochondrial thermogenesis by a factor of 5, as well as an increase in lipid storage. Inhibition of Irx3 in adipose tissue in mice reduced body weight and increased energy dissipation without a change in physical activity or appetite. Knockdown of IRX3 or IRX5 in primary adipocytes from participants with the risk allele restored thermogenesis, increasing it by a factor of 7, and overexpression of these genes had the opposite effect in adipocytes from nonrisk-allele carriers. Repair of the ARID5B motif by CRISPR-Cas9 editing of rs1421085 in primary adipocytes from a patient with the risk allele restored IRX3 and IRX5 repression, activated browning expression programs, and restored thermogenesis, increasing it by a factor of 7. CONCLUSIONS Our results point to a pathway for adipocyte thermogenesis regulation involving ARID5B, rs1421085, IRX3, and IRX5, which, when manipulated, had pronounced pro-obesity and anti-obesity effects. (Funded by the German Research Center for Environmental Health and others.)	[Claussnitzer, Melina; Hsu, Yi-Hsiang] Harvard Univ, Harvard Med Sch, Gerontol Div, Beth Israel Deaconess Med Ctr Hebrew SeniorLife, Boston, MA 02215 USA; [Claussnitzer, Melina; Quon, Gerald; Meuleman, Wouter; Abdennur, Nezar A.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Claussnitzer, Melina; Quon, Gerald; Meuleman, Wouter; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA USA; [Claussnitzer, Melina; Hauner, Hans] Helmholtz Ctr Munich, Clin Cooperat Grp Nutrigen & Type Diabet 2, Munich, Germany; [Claussnitzer, Melina; Glunk, Viktoria; Sousa, Isabel S.; Hauner, Hans] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Ctr Nutr Med, ZIEL Inst Food & Hlth, D-80290 Munich, Germany; [Dankel, Simon N.; Haugen, Christine; Mellgren, Gunnar] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, N-5020 Bergen, Norway; [Dankel, Simon N.; Haugen, Christine; Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Kim, Kyoung-Han; Puviindran, Vijitha; Liu, Jannel; Hui, Chi-Chung] Univ Toronto, Program Dev & Stem Cell Biol, Hosp Sick Children, Toronto, ON M5S 1A1, Canada; [Kim, Kyoung-Han; Puviindran, Vijitha; Liu, Jannel; Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Beaudry, Jacqueline L.; Drucker, Daniel J.] Mt Sinai Hosp, Dept Med, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Svensson, Per-Arne] Univ Gothenburg, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden	Harvard University; Harvard Medical School; Hebrew SeniorLife; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Bergen; University of Bergen; Haukeland University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Gothenburg	Claussnitzer, M (corresponding author), Harvard Univ, Harvard Med Sch, Gerontol Div, Beth Israel Deaconess Med Ctr Hebrew SeniorLife, 1200 Ctr St, Boston, MA 02215 USA.	melina@broadinstitute.org; manoli@mit.edu	Svensson, Per-Arne/R-4626-2019; Mellgren, Gunnar/AAG-6573-2020; Kim, Kyoung-Han/AAZ-4908-2021; Drucker, Daniel J/A-4092-2010; Kellis, Manolis/ABE-7385-2020	Mellgren, Gunnar/0000-0001-6282-4986; Kellis, Manolis/0000-0001-7113-9630; Abdennur, Nezar/0000-0001-5814-0864; Quon, Gerald/0000-0002-1716-0153; Dankel, Simon/0000-0001-6972-1824; Meuleman, Wouter/0000-0002-1196-5401; Kim, Kyoung-Han/0000-0002-0433-656X	German Research Center for Environmental Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008155, R01HG004037, RC1HG005334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113708] Funding Source: NIH RePORTER	German Research Center for Environmental Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the German Research Center for Environmental Health and others	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Jowett JBM, 2010, DIABETES, V59, P726, DOI 10.2337/db09-1277; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2014, J INTERN MED, V276, P364, DOI 10.1111/joim.12255; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Whitson RH, 1999, BIOCHEM BIOPH RES CO, V258, P326, DOI 10.1006/bbrc.1999.0643; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yamakawa T, 2010, BIOCHEM BIOPH RES CO, V391, P277, DOI 10.1016/j.bbrc.2009.11.049	31	746	767	21	214	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					895	907		10.1056/NEJMoa1502214	http://dx.doi.org/10.1056/NEJMoa1502214			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26287746	Green Accepted, Green Published			2022-12-28	WOS:000360439500005
J	Zhou, QJ; Lai, Y; Bacaj, T; Zhao, ML; Lyubimov, AY; Uervirojnangkoorn, M; Zeldin, OB; Brewster, AS; Sauter, NK; Cohen, AE; Soltis, SM; Alonso-Mori, R; Chollet, M; Lemke, HT; Pfuetzner, RA; Choi, UB; Weis, WI; Diao, JJ; Sudhof, TC; Brunger, AT				Zhou, Qiangjun; Lai, Ying; Bacaj, Taulant; Zhao, Minglei; Lyubimov, Artem Y.; Uervirojnangkoorn, Monarin; Zeldin, Oliver B.; Brewster, Aaron S.; Sauter, Nicholas K.; Cohen, Aina E.; Soltis, S. Michael; Alonso-Mori, Roberto; Chollet, Matthieu; Lemke, Henrik T.; Pfuetzner, Richard A.; Choi, Ucheor B.; Weis, William I.; Diao, Jiajie; Suedhof, Thomas C.; Brunger, Axel T.			Architecture of the synaptotagmin-SNARE machinery for neuronal exocytosis	NATURE			English	Article							MEMBRANE-FUSION; C2B DOMAIN; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; SYNAPTIC-TRANSMISSION; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; SYNCHRONOUS RELEASE; VESICLE DOCKING; CALCIUM SENSOR	Synaptotagmin-1 and neuronal SNARE proteins have central roles in evoked synchronous neurotransmitter release; however, it is unknown how they cooperate to trigger synaptic vesicle fusion. Here we report atomic-resolution crystal structures of Ca2+- and Mg2+-bound complexes between synaptotagmin-1 and the neuronal SNARE complex, one of which was determined with diffraction data froman X-ray free-electron laser, leading to an atomic-resolution structure with accurate rotamer assignments for many side chains. The structures reveal several interfaces, including a large, specific, Ca2+-independent and conserved interface. Tests of this interface by mutagenesis suggest that it is essential for Ca2+-triggered neurotransmitter release in mouse hippocampal neuronal synapses and for Ca2+-triggered vesicle fusion in a reconstituted system. We propose that this interface forms before Ca2+ triggering, moves en bloc as Ca2+ influx promotes the interactions between synaptotagmin-1 and the plasma membrane, and consequently remodels the membrane to promote fusion, possibly in conjunction with other interfaces.	[Zhou, Qiangjun; Lai, Ying; Bacaj, Taulant; Zhao, Minglei; Lyubimov, Artem Y.; Uervirojnangkoorn, Monarin; Zeldin, Oliver B.; Pfuetzner, Richard A.; Choi, Ucheor B.; Diao, Jiajie; Suedhof, Thomas C.; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Zhou, Qiangjun; Lai, Ying; Zhao, Minglei; Lyubimov, Artem Y.; Uervirojnangkoorn, Monarin; Zeldin, Oliver B.; Pfuetzner, Richard A.; Choi, Ucheor B.; Diao, Jiajie; Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Zhou, Qiangjun; Lai, Ying; Zhao, Minglei; Lyubimov, Artem Y.; Uervirojnangkoorn, Monarin; Zeldin, Oliver B.; Pfuetzner, Richard A.; Choi, Ucheor B.; Weis, William I.; Diao, Jiajie; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Zhou, Qiangjun; Lai, Ying; Zhao, Minglei; Lyubimov, Artem Y.; Uervirojnangkoorn, Monarin; Zeldin, Oliver B.; Pfuetzner, Richard A.; Choi, Ucheor B.; Weis, William I.; Diao, Jiajie; Brunger, Axel T.] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Brewster, Aaron S.; Sauter, Nicholas K.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Cohen, Aina E.; Soltis, S. Michael; Alonso-Mori, Roberto; Chollet, Matthieu; Lemke, Henrik T.] SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	tcs1@stanford.edu; brunger@stanford.edu	Lai, Ying/E-5220-2015; Lemke, Henrik Till T/N-7419-2016; Weis, William I/G-1437-2011; Diao, Jiajie/A-3425-2008; Sauter, Nicholas K/K-3430-2012; alonso mori, roberto/G-2638-2013	Lai, Ying/0000-0001-5347-5155; Lemke, Henrik Till T/0000-0003-1577-8643; Weis, William I/0000-0002-5583-6150; Diao, Jiajie/0000-0003-4288-3203; Cohen, Aina/0000-0003-2414-9427; Zhou, Qiangjun/0000-0002-7768-0249; alonso mori, roberto/0000-0002-5357-0934; Zhou, Qiangjun/0000-0003-1789-9588; Brunger, Axel/0000-0001-5121-2036	NIH [P41 GM103403]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Institutes of Health [R37MH63105, MH086403, GM095887, GM102520]; HHMI Collaborative Innovation Award (HCIA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095887, R01GM077071, R01GM102520, P41GM103393, P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403, R37MH063105] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Collaborative Innovation Award (HCIA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. S. Padolina for help with protein purification, the Northeastern Collaborative Access Team (supported by NIH P41 GM103403) at Advanced Photon Source for X-ray data collection, and the SSRL/LCLS scientists E. L. Baxter, P. Ehrensberger, T. I. Eriksson, Y. Feng, M. Hollenbeck, E. G. Kovaleva, S. E. McPhillips, S. Nelson, J. Song, Y. Tsai, V. Vinetsky and D. Zhu for their invaluable assistance with data collection at the LCLS XPP facility. Use of the Stanford Synchrotron Radiation Lightsource (SSRL) and Linac Coherent Light Source (LCLS), SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). Portions of this research were carried out at the Linac Coherent Light Source (LCLS) at the SLAC National Accelerator Laboratory. LCLS is an Office of Science User Facility operated for the US Department of Energy Office of Science by Stanford University. This research was supported in part by the National Institutes of Health (R37MH63105 to A.T.B.; MH086403 to T.C.S.; GM095887 and GM102520 to N.K.S and A.S.B); and by a HHMI Collaborative Innovation Award (HCIA) to A.T.B. and W.I.W.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aeffner S, 2012, P NATL ACAD SCI USA, V109, pE1609, DOI 10.1073/pnas.1119442109; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BONIFACIO R, 1984, OPT COMMUN, V50, P373, DOI 10.1016/0030-4018(84)90105-6; Brewer KD, 2015, NAT STRUCT MOL BIOL, V22, P555, DOI 10.1038/nsmb.3035; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Cipriano D. J., 2013, J BIOL CHEM; Cohen AE, 2014, P NATL ACAD SCI USA, V111, P17122, DOI 10.1073/pnas.1418733111; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Hattne J, 2014, NAT METHODS, V11, P545, DOI [10.1038/NMETH.2887, 10.1038/nmeth.2887]; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kochubey O, 2011, NEURON, V69, P736, DOI 10.1016/j.neuron.2011.01.013; Kondratenko A. M., 1980, PART ACCEL, V10, P207; Krishnakumar SS, 2013, BIOPHYS J, V105, P2507, DOI 10.1016/j.bpj.2013.10.029; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kyoung MJ, 2013, NAT PROTOC, V8, P1, DOI 10.1038/nprot.2012.134; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Lai Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03756; Lai Y, 2013, BIOCHEM J, V456, P25, DOI 10.1042/BJ20130949; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Masumoto T, 2012, MOL CELL NEUROSCI, V49, P1, DOI 10.1016/j.mcn.2011.09.007; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohrmann R, 2013, J NEUROSCI, V33, P14417, DOI 10.1523/JNEUROSCI.1236-13.2013; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rothman JE, 2014, ANGEW CHEM INT EDIT, V53, P12676, DOI 10.1002/anie.201402380; Rufener E, 2005, BIOCHEMISTRY-US, V44, P18, DOI 10.1021/bi048370d; Sauter NK, 2014, ACTA CRYSTALLOGR D, V70, P3299, DOI 10.1107/S1399004714024134; Sauter NK, 2013, ACTA CRYSTALLOGR D, V69, P1274, DOI 10.1107/S0907444913000863; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; SOLEM JC, 1986, J OPT SOC AM B, V3, P1551, DOI 10.1364/JOSAB.3.001551; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Uervirojnangkoorn M, 2015, ELIFE, V4, DOI 10.7554/eLife.05421; Urzhumtseva L, 2009, ACTA CRYSTALLOGR D, V65, P297, DOI 10.1107/S0907444908044296; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Vrljic M, 2011, BIOCHEMISTRY-US, V50, P9998, DOI 10.1021/bi200998y; Wang J, 2014, P NATL ACAD SCI USA, V111, P13966, DOI 10.1073/pnas.1415849111; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zeldin OB, 2015, ACTA CRYSTALLOGR D, V71, P352, DOI 10.1107/S1399004714025875; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.03251	87	188	190	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					62	+		10.1038/nature14975	http://dx.doi.org/10.1038/nature14975			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26280336	Green Submitted, Green Accepted			2022-12-28	WOS:000360594100025
J	Alvarez, GA; Suter, D; Kaiser, R				Alvarez, Gonzalo A.; Suter, Dieter; Kaiser, Robin			Localization-delocalization transition in the dynamics of dipolar-coupled nuclear spins	SCIENCE			English	Article							MANY-BODY SYSTEM; QUANTUM-SYSTEMS; MOBILITY EDGE; ATOMS; ENTANGLEMENT; PROPAGATION; COHERENCE; LATTICE; STATES; GASES	Nonequilibrium dynamics of many-body systems are important in many scientific fields. Here, we report the experimental observation of a phase transition of the quantum coherent dynamics of a three-dimensional many-spin system with dipolar interactions. Using nuclear magnetic resonance (NMR) on a solid-state system of spins at room-temperature, we quench the interaction Hamiltonian to drive the evolution of the system. Depending on the quench strength, we then observe either localized or extended dynamics of the system coherence. We extract the critical exponents for the localized cluster size of correlated spins and diffusion coefficient around the phase transition separating the localized from the delocalized dynamical regime. These results show that NMR techniques are well suited to studying the nonequilibrium dynamics of complex many-body systems.	[Alvarez, Gonzalo A.] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Suter, Dieter] Tech Univ Dortmund, Fak Phys, D-44221 Dortmund, Germany; [Kaiser, Robin] Univ Nice Sophia Antipolis, CNRS, Inst Nonlineaire Nice, F-06560 Valbonne, France	Weizmann Institute of Science; Dortmund University of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Alvarez, GA (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	gonzalo.a.alvarez@weizmann.ac.il; dieter.suter@tu-dortmund.de; robin.kaiser@inln.cnrs.fr	Alvarez, Gonzalo A/B-2329-2010; kaiser, robin/J-3641-2014	Alvarez, Gonzalo A/0000-0002-7328-357X; kaiser, robin/0000-0001-5194-3680	Deutsche Forschungsgemeinschaft [Su 192/24-1]; Alexander von Humboldt Foundation; European Commission [PIEF-GA-2012-328605]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank J. Chabe, F. Hebert, and E. Altman for fruitful discussions. This work was supported by the Deutsche Forschungsgemeinschaft through Su 192/24-1. G.A.A. acknowledges the support of the Alexander von Humboldt Foundation and of the European Commission under the Marie Curie Intra-European Fellowship for Career Development grant PIEF-GA-2012-328605.	Alvarez GA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.230403; Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; ANDERSON PW, 1978, REV MOD PHYS, V50, P191, DOI 10.1103/RevModPhys.50.191; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; BAUM J, 1985, J CHEM PHYS, V83, P2015, DOI 10.1063/1.449344; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Burzuri E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.097203; Cheneau M, 2012, NATURE, V481, P484, DOI 10.1038/nature10748; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Jendrzejewski F, 2012, NAT PHYS, V8, P398, DOI [10.1038/NPHYS2256, 10.1038/nphys2256]; Jurcevic P, 2014, NATURE, V511, P202, DOI 10.1038/nature13461; Kraemer C, 2012, SCIENCE, V336, P1416, DOI 10.1126/science.1221878; Lacelle S., 1991, ADV MAGN OPT RESON, V16, P173; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lemarie G, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.043626; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Oganesyan V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155111; Richerme P, 2014, NATURE, V511, P198, DOI 10.1038/nature13450; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Ronnow HM, 2005, SCIENCE, V308, P389, DOI 10.1126/science.1108317; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schachenmayer J, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031015; Semeghini G, 2015, NAT PHYS, V11, P554, DOI 10.1038/NPHYS3339; Slichter C. P., 1996, PRINCIPLES MAGNETIC; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Vosk R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067204; Waldherr G, 2014, NATURE, V506, P204, DOI 10.1038/nature12919; WARREN WS, 1979, PHYS REV LETT, V43, P1791, DOI 10.1103/PhysRevLett.43.1791; WEGNER FJ, 1976, Z PHYS B CON MAT, V25, P327, DOI 10.1007/BF01315248; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483	34	83	83	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					846	848		10.1126/science.1261160	http://dx.doi.org/10.1126/science.1261160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293957	Green Submitted			2022-12-28	WOS:000359832700043
J	Cox, AL				Cox, Andrea L.			Global control of hepatitis C virus A comprehensive strategy to control HCV infection must include a vaccine	SCIENCE			English	Editorial Material							UNITED-STATES; REINFECTION		Johns Hopkins Univ, Baltimore, MD 21205 USA	Johns Hopkins University	Cox, AL (corresponding author), Johns Hopkins Univ, Baltimore, MD 21205 USA.	acox@jhmi.edu		Cox, Andrea/0000-0002-9331-2462				Franco S, 2014, GASTROENTEROLOGY, V147, P599, DOI 10.1053/j.gastro.2014.05.010; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Honegger JR, 2014, SEMIN LIVER DIS, V34, P79, DOI 10.1055/s-0034-1371081; Krishnan P, 2015, 50 ANN M EUR ASS STU; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Wyles D, 2015, 50 ANN M EUR ASS STU	14	79	81	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					790	791		10.1126/science.aad1302	http://dx.doi.org/10.1126/science.aad1302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP4DR	26293940				2022-12-28	WOS:000359832700019
J	Mitchell, EG; Kenchington, CG; Liu, AG; Matthews, JJ; Butterfield, NJ				Mitchell, Emily G.; Kenchington, Charlotte G.; Liu, Alexander G.; Matthews, Jack J.; Butterfield, Nicholas J.			Reconstructing the reproductive mode of an Ediacaran macro-organism	NATURE			English	Article							POINT PATTERN-ANALYSIS; MISTAKEN POINT; SPATIAL STRUCTURE; SPORE DISPERSAL; SEED DISPERSAL; NEWFOUNDLAND; COMMUNITIES; DYNAMICS; INSIGHTS; FOSSILS	Enigmatic macrofossils of late Ediacaran age (580-541 million years ago) provide the oldest known record of diverse complex organisms on Earth, lying between the microbially dominated ecosystems of the Proterozoic and the Cambrian emergence of the modern biosphere(1). Among the oldest and most enigmatic of these macrofossils are the Rangeomorpha, a group characterized by modular, self-similar branching and a sessile benthic habit(2-4). Localized occurrences of large in situ fossilized rangeomorph populations allow fundamental aspects of their biology to be resolved using spatial point process techniques(5). Here we use such techniques to identify recurrent clustering patterns in the rangeomorph Fractofusus, revealing a complex life history of multigenerational, stolon-like asexual reproduction, interspersed with dispersal by waterborne propagules. Ecologically, such a habit would have allowed both for the rapid colonization of a localized area and for transport to new, previously uncolonized areas. The capacity of Fractofusus to derive adult morphology by two distinct reproductive modes documents the sophistication of its underlying developmental biology.	[Mitchell, Emily G.; Kenchington, Charlotte G.; Butterfield, Nicholas J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Kenchington, Charlotte G.] British Geol Survey, Nottingham NG12 5GG, England; [Liu, Alexander G.] Univ Bristol, Sch Earth Sci, Bristol BS8 1TQ, Avon, England; [Matthews, Jack J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England	University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Bristol; University of Oxford	Mitchell, EG (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	ek338@cam.ac.uk	Butterfield, Nicholas/AAV-8215-2021; Mitchell, Emily/AAK-1991-2020	Butterfield, Nicholas/0000-0002-3046-7520; Mitchell, Emily/0000-0001-6517-2231; Matthews, Jack/0000-0001-5350-8439; Liu, Alexander/0000-0002-3985-982X	Natural Environment Research Council [NE/I005927/1, NE/J5000045/1, NE/L011409/1, NE/G523539/1]; Cambridge Philosophical Society; Natural Environment Research Council [1095099, bgs05002] Funding Source: researchfish; NERC [NE/L011409/1, NE/I005927/1, bgs05002] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Cambridge Philosophical Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Parks and Natural Areas Division, Department of Environment and Conservation, Government of Newfoundland and Labrador, provided permits to conduct research within the Mistaken Point Ecological Reserve in 2010, while the Department of Tourism, Culture and Recreation provided permits for palaeontological research on the Bonavista Peninsula in 2012. Access to both of the aforementioned fossil localities is by scientific research permit only. Contact the relevant Department listed above for further information. This work has been supported by the Natural Environment Research Council (grant numbers NE/I005927/1 to C.G.K., NE/J5000045/1 to J.J.M., NE/L011409/1 to A.G.L. and NE/G523539/1 to E.G.M.), and a Henslow Junior Research Fellowship from the Cambridge Philosophical Society to A.G.L. We thank M. Laflamme for discussions on this manuscript.	Araki K, 2009, ANN BOT-LONDON, V104, P71, DOI 10.1093/aob/mcp092; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2000, AUST NZ J STAT, V42, P283, DOI 10.1111/1467-842X.00128; Baddeley A, 2011, STAT SCI, V26, P613, DOI 10.1214/11-STS367; Benus AP., 1988, GEOLOGICAL SURVEY B, P8; BERMAN M, 1986, J R STAT SOC C-APPL, V35, P54; Brasier MD, 2012, PALAEONTOLOGY, V55, P1105, DOI 10.1111/j.1475-4983.2012.01164.x; Brasier MD, 2009, J GEOL SOC LONDON, V166, P363, DOI 10.1144/0016-76492008-011; Chen L, 2014, NATURE, V516, P238, DOI 10.1038/nature13766; Chiu S. N., 2013, STOCHASTIC GEOMETRY, V3rd; Clapham ME, 2011, TOP GEOBIOL, V36, P3, DOI 10.1007/978-94-007-0680-4_1; Clapham ME, 2003, PALEOBIOLOGY, V29, P527, DOI 10.1666/0094-8373(2003)029<0527:POTOKA>2.0.CO;2; Cuthill JFH, 2014, P NATL ACAD SCI USA, V111, P13122, DOI 10.1073/pnas.1408542111; Darroch SAF, 2013, PALEOBIOLOGY, V39, P591, DOI 10.1666/12051; Diggle P.J., 2003, STAT ANAL SPATIAL PO; Droser ML, 2008, SCIENCE, V319, P1660, DOI 10.1126/science.1152595; Fedonkin M.A., 1985, VENDIAN SYSTEM, V1, P70; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Fraley C., 2006, MCLUST VERSION 3 R P; Fraley C, 2007, J CLASSIF, V24, P155, DOI [10.1007/s00357-007-0004-5, 10.1007/s00357-007-0004-z]; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Gaylord B, 2006, ECOL MONOGR, V76, P481, DOI 10.1890/0012-9615(2006)076[0481:MSDICE]2.0.CO;2; Gehling JG, 2007, CAN J EARTH SCI, V44, P367, DOI 10.1139/E07-003; Grabarnik P, 2011, ECOL MODEL, V222, P3888, DOI 10.1016/j.ecolmodel.2011.10.005; Hofmann HJ, 2008, J PALEONTOL, V82, P1, DOI 10.1666/06-087.1; Hua H, 2005, GEOLOGY, V33, P277, DOI 10.1130/G21198.1; Illian J.., 2008, STAT ANAL MODELLING, V70; LEVIN SA, 1995, ECOLOGICAL TIME SERI, V2, P277; Lin YC, 2011, OECOLOGIA, V165, P175, DOI 10.1007/s00442-010-1718-x; Liu AG, 2015, GONDWANA RES, V27, P1355, DOI 10.1016/j.gr.2014.11.002; Liu AG, 2011, PALAEONTOLOGY, V54, P607, DOI 10.1111/j.1475-4983.2010.01024.x; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Myrow P., 1988, B NY STATE MUS, V463, P1; Narbonne GM, 2004, SCIENCE, V305, P1141, DOI 10.1126/science.1099727; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; Narbonne GM, 2014, J PALEONTOL, V88, P207, DOI 10.1666/13-053; Narbonne GM, 2009, J PALEONTOL, V83, P503, DOI 10.1666/08-072R1.1; Pelissier R, 2001, J VEG SCI, V12, P99, DOI 10.2307/3236678; Penny AM, 2014, SCIENCE, V344, P1504, DOI 10.1126/science.1253393; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; R Development Core Team, 2009, R LANG ENV STAT COMP; Russo SE, 2004, ECOL LETT, V7, P1058, DOI 10.1111/j.1461-0248.2004.00668.x; Shanks AL, 2009, BIOL BULL-US, V216, P373; Shen B, 2008, SCIENCE, V319, P81, DOI 10.1126/science.1150279; Stoyan D., 1995, STOCHASTIC GEOMETRY; THOMAS M, 1949, BIOMETRIKA, V36, P18; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; Wiegand T., 2013, HDB SPATIAL POINT PA; Wiegand T, 2007, ECOLOGY, V88, P3088, DOI 10.1890/06-1350.1; Wiegand T, 2006, J ECOL, V94, P825, DOI 10.1111/j.1365-2745.2006.01113.x; Wood DA, 2003, CAN J EARTH SCI, V40, P1375, DOI 10.1139/E03-048; Yuan XL, 2013, CHINESE SCI BULL, V58, P701, DOI 10.1007/s11434-012-5483-6	55	64	65	1	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					343	+		10.1038/nature14646	http://dx.doi.org/10.1038/nature14646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26237408	Green Accepted, Green Submitted			2022-12-28	WOS:000359714000034
J	Liu, Z				Liu, Zhe			Lighting Up Genes in Single Cells at Scale	CELL			English	Editorial Material							ORGANIZATION; GENOME	In this issue, Shachar et al. report a high-throughput imaging position mapping platform (HIPmap) enabling large-scale, high-resolution localization of 3D gene positions in single cells. Coupling loss-of-function screens with HIPmap, the authors identify DNA replication rather than mitosis as a major determinant of genome positioning.	Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Liu, Z (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	liuz11@janelia.hhmi.org						Belmont AS, 2014, CURR OPIN CELL BIOL, V26, P69, DOI 10.1016/j.ceb.2013.10.002; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Liu Z, 2015, MOL CELL, V58, P644, DOI 10.1016/j.molcel.2015.02.033; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Shachar S, 2015, CELL, V162, P911, DOI 10.1016/j.cell.2015.07.035; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114	10	1	1	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					705	707		10.1016/j.cell.2015.07.052	http://dx.doi.org/10.1016/j.cell.2015.07.052			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276626	Bronze			2022-12-28	WOS:000359741400005
J	Schlesinger, M; Grob, R; Shaller, D; Martino, SC; Parker, AM; Finucane, ML; Cerully, JL; Rybowski, L				Schlesinger, Mark; Grob, Rachel; Shaller, Dale; Martino, Steven C.; Parker, Andrew M.; Finucane, Melissa L.; Cerully, Jennifer L.; Rybowski, Lise			Taking Patients' Narratives about Clinicians from Anecdote to Science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH; CHOICE; EXPERIENCES; INFORMATION; STRATEGIES; BARRIERS; DOCTORS; ONLINE		[Schlesinger, Mark] Yale Univ, New Haven, CT 06520 USA; [Grob, Rachel] Univ Wisconsin, Madison, WI 53706 USA; [Shaller, Dale] Shaller Consulting Grp, Stillwater, MN USA; [Martino, Steven C.; Parker, Andrew M.; Finucane, Melissa L.; Cerully, Jennifer L.] RAND Corp, Pittsburgh, PA USA; [Rybowski, Lise] Severyn Grp, Ashburn, VA USA	Yale University; University of Wisconsin System; University of Wisconsin Madison; RAND Corporation	Schlesinger, M (corresponding author), Yale Univ, New Haven, CT 06520 USA.		Parker, Andrew M/B-2466-2009	Parker, Andrew M/0000-0001-7511-0894				[Anonymous], 2004, NAT SURV CONS EXP PA; Bekker HL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S9; Collier R, 2012, CAN MED ASSOC J, V184, pE629, DOI 10.1503/cmaj.109-4205; Detz A, 2013, J MED INTERNET RES, V15, P157, DOI 10.2196/jmir.2552; Emmert M, 2013, J MED INTERNET RES, V15, pe157, DOI 10.2196/jmir.2655; Fiese BH, 2003, J PEDIATR-US, V143, P457, DOI 10.1067/S0022-3476(03)00448-7; Friedberg MW, 2011, J GEN INTERN MED, V26, P498, DOI 10.1007/s11606-010-1597-1; Gao GG, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2003; Garbutt J, 2003, ANN FAM MED, V29, P103; Geissler KH, 2013, MED CARE RES REV, V70, P621, DOI 10.1177/1077558713496319; GREAVES F, 2014, QUAL SAF HEALTH CARE, V71, P65; Greaves F, 2013, BMJ QUAL SAF, V22, P251, DOI 10.1136/bmjqs-2012-001527; Greenhalgh T, 1999, BRIT MED J, V318, P48; Hanauer DA, 2014, JAMA-J AM MED ASSOC, V311, P734, DOI 10.1001/jama.2013.283194; Health Research Institute, 2012, SCOR HEALTHC NAV CUS; Hibbard JH, 2002, HEALTH SERV RES, V37, P291, DOI 10.1111/1475-6773.024; JENKINSON C, 2002, ANN FAM MED, V11, P335; Kadry B, 2011, J MED INTERNET RES, V13, pe95; Lagu T, 2010, JAMA-J AM MED ASSOC, V304, P1711, DOI 10.1001/jama.2010.1499; Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0; Lansky D, 2012, HLTH AFFAIRS BL 0409; Lopez A, 2012, J GEN INTERN MED, V27, P685, DOI 10.1007/s11606-011-1958-4; Marshall M, 2010, BMJ-BRIT MED J, V341, pc5272; McAdams DP, 2006, J CONSTR PSYCHOL, V19, P109, DOI 10.1080/10720530500508720; McCartney M, 2009, BMJ B, V338, pb1033; Peters E, 2006, J COMMUN, V56, pS140, DOI 10.1111/j.1460-2466.2006.00287.x; Reese E, 2011, J COGN DEV, V12, P424, DOI 10.1080/15248372.2011.587854; Sabin James E, 2013, Virtual Mentor, V15, P932, DOI 10.1001/virtualmentor.2013.15.11.ecas2-1311; Schlesinger M, 2002, MILBANK Q, V80, P709, DOI 10.1111/1468-0009.00029; Schlesinger M, 2014, MED CARE RES REV, V71, p38S, DOI 10.1177/1077558713496321; Schlesinger M, 2010, HEALTH ECON POLICY L, V5, P365, DOI 10.1017/S174413311000006X; Shaller D, 2014, MED CARE RES REV, V71, p17S, DOI 10.1177/1077558713493118; Sick B, 2011, AM J MED QUAL, V26, P433, DOI 10.1177/1062860611400898; Sinaiko AD, 2012, HEALTH AFFAIR, V31, P602, DOI 10.1377/hlthaff.2011.1197; Tompson J, 2014, FINDING QUALITY DOCT; Trigg L, 2011, J HEALTH SERV RES PO, V16, P102, DOI 10.1258/jhsrp.2010.010010; Tsianakas V, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-271; Winterbottom A, 2008, SOC SCI MED, V67, P2079, DOI 10.1016/j.socscimed.2008.09.037; Ziebland S, 2012, MILBANK Q, V90, P219, DOI 10.1111/j.1468-0009.2012.00662.x	39	63	63	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					675	679		10.1056/NEJMsb1502361	http://dx.doi.org/10.1056/NEJMsb1502361			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP2LE	26267629				2022-12-28	WOS:000359707700014
J	Tangye, SG; Brink, R; Goodnow, CC; Phan, TG				Tangye, Stuart G.; Brink, Robert; Goodnow, Christopher C.; Phan, Tri Giang			SnapShot: Interactions between B Cells and T Cells	CELL			English	Editorial Material							RESPONSES; DISEASE; FH	Dynamic interactions between B and T cells underpin the development of adaptive humoral immune responses to infections and vaccines. Recent advances in the molecular and spatiotemporal control of these interactions during primary responses have contributed greatly to elucidating the molecular pathogenesis of numerous immunodeficiency and autoimmune diseases. The next challenge is to determine how and where memory B and T cells interact during secondary responses to facilitate the rapid and robust response that characterizes anamnestic immunity.	[Tangye, Stuart G.; Brink, Robert; Goodnow, Christopher C.; Phan, Tri Giang] Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia; [Tangye, Stuart G.; Brink, Robert; Goodnow, Christopher C.; Phan, Tri Giang] UNSW, St Vincents Clin Sch, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Tangye, SG (corresponding author), Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia.		Goodnow, Christopher C/V-8108-2018; Tangye, Stuart G/H-4023-2014; Brink, Robert/B-7910-2010; Phan, Tri/G-3937-2012	Goodnow, Christopher C/0000-0001-5296-6155; Tangye, Stuart G/0000-0002-5360-5180; Brink, Robert/0000-0002-9586-3655; Phan, Tri/0000-0002-4909-2984	National Health & Medical Research Council of Australia	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work performed in the authors' labs is supported by research grants and fellowships awarded by the National Health & Medical Research Council of Australia.	Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Hale JS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00016; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Sage PT, 2015, TRENDS IMMUNOL, V36, P410, DOI 10.1016/j.it.2015.05.005; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Tangye SG, 2015, CURR OPIN IMMUNOL, V34, P107, DOI 10.1016/j.coi.2015.02.010; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432	10	22	25	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4							926.e1	10.1016/j.cell.2015.07.055	http://dx.doi.org/10.1016/j.cell.2015.07.055			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276638	Bronze			2022-12-28	WOS:000359741400025
J	Yi, JJ; Berrios, J; Newbern, JM; Snider, WD; Philpot, BD; Hahn, KM; Zylka, MJ				Yi, Jason J.; Berrios, Janet; Newbern, Jason M.; Snider, William D.; Philpot, Benjamin D.; Hahn, Klaus M.; Zylka, Mark J.			An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A	CELL			English	Article							ANGELMAN SYNDROME GENE; UBIQUITIN LIGASE; UBE3A/E6-AP; EXPRESSION; DEFICITS; BINDING; MOUSE; P53	Deletion of UBE3A causes the neurodevelopmental disorder Angelman syndrome (AS), while duplication or triplication of UBE3A is linked to autism. These genetic findings suggest that the ubiquitin ligase activity of UBE3A must be tightly maintained to promote normal brain development. Here, we found that protein kinase A(PKA) phosphorylates UBE3A in a region outside of the catalytic domain at residue T485 and inhibits UBE3A activity toward itself and other substrates. A de novo autism-linked missense mutation disrupts this phosphorylation site, causing enhanced UBE3A activity in vitro, enhanced substrate turnover in patient-derived cells, and excessive dendritic spine development in the brain. Our study identifies PKA as an upstream regulator of UBE3A activity and shows that an autism-linked mutation disrupts this phosphorylation control. Moreover, our findings implicate excessive UBE3A activity and the resulting synaptic dysfunction to autism pathogenesis.	[Yi, Jason J.; Berrios, Janet; Snider, William D.; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Yi, Jason J.; Berrios, Janet; Snider, William D.; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; [Yi, Jason J.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Yi, Jason J.; Snider, William D.; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Newbern, Jason M.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Arizona State University; Arizona State University-Tempe	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu	, Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Hahn, Klaus/0000-0002-1970-7562; Yi, Jason/0000-0001-9648-9899; Newbern, Jason/0000-0003-2865-0112	Angelman Syndrome Foundation; Foundation for Angelman Syndrome Therapeutics; Simons Foundation [274426]; NIMH [R01MH093372]; NINDS [R01NS085093, P30NS045892]; NIH Pioneer Award from The National Institutes of Health [DP1ES024088]; NIGMS [P01-GM103723]; Basic and Clinical Grant from Autism Speaks [7760]; Christina Castellana postdoctoral fellowship of the Foundation for Angelman Syndrome Therapeutics; NICHD [T32HD040127, U54HD079124]; CISMM imaging core in the Hahn lab [5P41EB002025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110, U54HD079124, T32HD040127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES024088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM103723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031768, K99NS076661, R00NS076661, R01NS085093, P30NS045892] Funding Source: NIH RePORTER	Angelman Syndrome Foundation; Foundation for Angelman Syndrome Therapeutics; Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Pioneer Award from The National Institutes of Health; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Basic and Clinical Grant from Autism Speaks; Christina Castellana postdoctoral fellowship of the Foundation for Angelman Syndrome Therapeutics; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CISMM imaging core in the Hahn lab; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Gabriela Salazar and Jayalakshmi Miriyala for technical assistance, Bonnie Taylor-Blake for help with confocal imaging, Yaohong Wu for help with in utero electroporations, David Smalley and Lee Graves for performing mass spectrometry analysis, Lei Xing for cortical lysates, and Rong Mao and Tatiana Tvrdik from The University of Utah and ARUP Laboratories for disclosing the UBE3A c.349T>C; p.C117R mutation. Immortalized lymphocytes from the Simons Simplex Collection were acquired from the NIMH Center for Genetic Studies via the Rutgers University Cell and DNA Repository. This work was supported by grants from the Angelman Syndrome Foundation (M.J.Z., B.D.P.), a Grant-In-Aid from the Foundation for Angelman Syndrome Therapeutics (M.J.Z.), The Simons Foundation (SFARI Award 274426, B.D.P.), the NIMH (R01MH093372; M.J.Z., B.D.P.), NINDS (R01NS085093, B.D.P.), a NIH Pioneer Award from The National Institutes of Health (DP1ES024088; M.J.Z.), the NIGMS (P01-GM103723; K.M.H.), and a Basic and Clinical Grant (#7760) from Autism Speaks (K.M.H.). J.J.Y. is a recipient of the Christina Castellana postdoctoral fellowship of the Foundation for Angelman Syndrome Therapeutics and was supported by NICHD (T32HD040127). The confocal imaging core was funded by grants from NINDS (P30NS045892) and NICHD (U54HD079124) and the CISMM imaging core in the Hahn lab by 5P41EB002025.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Camprubi C, 2009, AM J MED GENET A, V149A, P343, DOI 10.1002/ajmg.a.32659; Chen JA, 2015, ANNU REV PATHOL-MECH, V10, P111, DOI 10.1146/annurev-pathol-012414-040405; Cohen P, 2014, NAT IMMUNOL, V15, P521, DOI 10.1038/ni.2892; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Germain ND, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-44; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Lemak A, 2011, J BIOMOL NMR, V51, P185, DOI 10.1007/s10858-011-9552-y; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lu Y, 2011, J BIOL CHEM, V286, P26496, DOI 10.1074/jbc.M111.254912; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Noor A, 2015, HUM MUTAT, V36, P689, DOI 10.1002/humu.22800; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Piochon C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6586; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	40	98	98	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					795	807		10.1016/j.cell.2015.06.045	http://dx.doi.org/10.1016/j.cell.2015.06.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26255772	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000359741400013
J	Joye, SB				Joye, Samantha B.			Deepwater Horizon, 5 years on	SCIENCE			English	Editorial Material							FLOW-RATE; OIL; DISPERSANTS; PLUME		Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Joye, SB (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	mjoye@uga.edu						Almeda R, 2014, ECOTOX ENVIRON SAFE, V106, P76, DOI 10.1016/j.ecoenv.2014.04.028; Camilli R, 2012, P NATL ACAD SCI USA, V109, P20235, DOI 10.1073/pnas.1100385108; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Du MR, 2012, ENVIRON SCI TECHNOL, V46, P10499, DOI 10.1021/es301363k; Joye SB, 2011, NAT GEOSCI, V4, P160, DOI [10.1038/ngeo1067, 10.1038/NGEO1067]; Kleindienst S, 2015, NAT REV MICROBIOL, V13, P388, DOI 10.1038/nrmicro3452; Lubchenco J, 2012, P NATL ACAD SCI USA, V109, P20212, DOI 10.1073/pnas.1204729109; MACDONALD IR, 2010, SIGNIFICANCE, V7, P149, DOI DOI 10.1111/J.1740-9713.2010.00449.X; MAGNUSON JJ, 1990, BIOSCIENCE, V40, P495, DOI 10.2307/1311317; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Passow U, 2016, DEEP-SEA RES PT II, V129, P232, DOI 10.1016/j.dsr2.2014.10.001; Prince RC, 2015, ENVIRON SCI TECHNOL, V49, P6376, DOI 10.1021/acs.est.5b00961; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P15906, DOI 10.1073/pnas.1414873111; Venn-Watson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126538	15	138	144	4	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					592	593		10.1126/science.aab4133	http://dx.doi.org/10.1126/science.aab4133			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26250675				2022-12-28	WOS:000359092900025
J	Rekart, ML				Rekart, Michael L.			Caring for sex workers	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEXUALLY-TRANSMITTED INFECTIONS; SUB-SAHARAN AFRICA; HUMAN-PAPILLOMAVIRUS INFECTION; FEMALE TRANSGENDER PERSONS; HEPATITIS-B VACCINATION; INJECTING DRUG-USERS; HIV-INFECTION; HEALTH-CARE; ANTIRETROVIRAL THERAPY; REPRODUCTIVE HEALTH		Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Rekart, ML (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada.	Michael.rekart@ubc.ca						Abad N, 2015, AIDS BEHAV, V19, P1701, DOI 10.1007/s10461-015-1013-2; Abdel-Aleem H, MISOPROSTOL CERVICAL; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; ALEGRIA M, 1994, AM J PUBLIC HEALTH, V84, P2000, DOI 10.2105/AJPH.84.12.2000; Alfirevic Z, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD001338.PUB3; [Anonymous], 1998, Morbidity and Mortality Weekly Report, V47, P1; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2014, PREEXP PROPH PREV HI; [Anonymous], EP PREV VACC PREV DI; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Aral SO, 2008, SEXUALLY TRANSMITTED; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral S, 2010, AIDS CARE, V22, P112, DOI 10.1080/09540120903012551; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baral SD, 2015, LANCET, V385, P260, DOI 10.1016/S0140-6736(14)60801-1; Bart PA, 2000, AIDS, V14, P1887, DOI 10.1097/00002030-200009080-00002; Basu A, 2011, WOMEN HEALTH, V51, P106, DOI 10.1080/03630242.2010.550992; Becker M, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/842576; Behets F, 2005, SEX TRANSM INFECT, V81, P472, DOI 10.1136/sti.2005.015107; Behets FMTF, 2003, TROP MED INT HEALTH, V8, P251, DOI 10.1046/j.1365-3156.2003.01017.x; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Blanchard JF, 2008, SEXUALLY TRANSMITTED; Blank S, 2012, PEDIATRICS, V130, pE756, DOI 10.1542/peds.2012-1990; Bletzer KV, 2003, MED ANTHROPOL Q, V17, P251, DOI 10.1525/maq.2003.17.2.251; Brown, 2021, PEOPLE MANAGEMENT; Butler LM, 2009, JAIDS-J ACQ IMM DEF, V50, P162, DOI 10.1097/QAI.0b013e31819388a9; Carr S, 1996, AIDS CARE, V8, P489, DOI 10.1080/09540129650125678; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; CDC, 2001, MMWR RECOMM REP, V59, P1; CDC, 2002, MMWR RECOMM REP, V54, P1; Chacham AS, 2007, REPROD HEALTH MATTER, V15, P108, DOI 10.1016/S0968-8080(07)29292-4; Chen YY, 2013, HEALTH CARE WOMEN IN, V34, P122, DOI 10.1080/07399332.2011.610535; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Chudakov B, 2002, J SEX MARITAL THER, V28, P305, DOI 10.1080/00926230290001439; Clarke A, 2006, INT J STD AIDS, V17, P74, DOI 10.1258/095646206775455685; Clatts MC, 2007, SEX HEALTH, V4, P261, DOI 10.1071/SH07018; Clements TM., 1996, BERKELEY WOMENS LJ, V11, P49; Clements-Nolle K, 2001, AM J PUBLIC HEALTH, V91, P915, DOI 10.2105/AJPH.91.6.915; Cohan D, 2006, SEX TRANSM INFECT, V82, P418, DOI 10.1136/sti.2006.020628; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; COOK LS, 1994, AM J PUBLIC HEALTH, V84, P197, DOI 10.2105/AJPH.84.2.197; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Dalabetta GA, 2008, SEXUALLY TRANSMITTED; Dane C, C RETR OPP INF CROI; Darragh TM, 2012, SEX HEALTH, V9, P556, DOI 10.1071/SH12003; Das P, 2015, LANCET, V385, P3, DOI 10.1016/S0140-6736(14)61064-3; De Cock KM, 2009, LANCET, V373, P7, DOI 10.1016/S0140-6736(08)61732-8; Decker MR, 2015, LANCET, V385, P186, DOI 10.1016/S0140-6736(14)60800-X; Decker MR, 2011, J EPIDEMIOL COMMUN H, V65, P334, DOI 10.1136/jech.2009.096834; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Delvaux T, 2003, REPROD HEALTH MATTER, V11, P88, DOI 10.1016/S0968-8080(03)02163-3; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Donovan B, 2004, LANCET, V363, P545, DOI 10.1016/S0140-6736(04)15543-8; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; Downe S, 2009, BJOG-INT J OBSTET GY, V116, P518, DOI 10.1111/j.1471-0528.2008.02067.x; Duff P, 2015, HEALTH CARE WOMEN IN, V36, P1039, DOI 10.1080/07399332.2014.989437; Duff P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099664; ElBassel N, 1997, AM J PUBLIC HEALTH, V87, P66, DOI 10.2105/AJPH.87.1.66; Elmore-Meegan M, 2004, REPROD HEALTH MATTER, V12, P50, DOI 10.1016/S0968-8080(04)23125-1; Esler D, 2008, AUST FAM PHYSICIAN, V37, P590; EUROPAP/TAMPEP, 1998, HUSTL HLTH; European Network Male Prostitution (ENMP), 2002, TIPS TRICKS MOD GOOD; Farley M, 2024, J TRAUMA PRACTICE, V2, P33; Feldblum PJ, 2007, CONTRACEPTION, V76, P105, DOI 10.1016/j.contraception.2007.04.009; Fontanet AL, 1998, AIDS, V12, P1851, DOI 10.1097/00002030-199814000-00017; Ford N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079981; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Global Network of Sex Work Projects (NSWP), 2011, FEM MAL TRANSG SEX W; Go VF, 2011, AIDS BEHAV, V15, P163, DOI 10.1007/s10461-010-9758-0; Gorbach PM, 2012, SEX TRANSM DIS, V39, P59, DOI 10.1097/OLQ.0b013e318235502b; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Harcourt C, 2000, AUST NZ J PUBL HEAL, V24, P84; Hawkes S, 2009, SEX TRANSM INFECT, V85, P8, DOI 10.1136/sti.2008.033910; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Human Rights Watch, 2013, TREAT US HUM BEINGS; Izulla P, 2013, JAIDS-J ACQ IMM DEF, V62, P220, DOI 10.1097/QAI.0b013e318278ba1b; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Jeal N, 2004, BRIT J GEN PRACT, V54, P515; Jeal N, 2004, J PUBLIC HEALTH-UK, V26, P147, DOI 10.1093/pubmed/fdh124; Jiang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087674; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kempf M.C., 2020, WEEXPAND PREP DEMONS; Khan MR, 2009, CONTRACEPTION, V79, P221, DOI 10.1016/j.contraception.2008.09.011; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krajden M, 2011, CLIN VACCINE IMMUNOL, V18, P418, DOI 10.1128/CVI.00489-10; Kriitmaa K, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000386735.87177.2a; Kundodyiwa TW, 2009, OBSTET GYNECOL, V113, P374, DOI 10.1097/AOG.0b013e3181945859; Kurtz SP, 2005, J HEALTH CARE POOR U, V16, P345, DOI 10.1353/hpu.2005.0038; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Li Q, 2010, ALCOHOL ALCOHOLISM, V45, P188, DOI 10.1093/alcalc/agp095; Liu SS, 2012, SEX TRANSM DIS, V39, P251, DOI 10.1097/OLQ.0b013e31824a0903; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; Lurie P, 1998, JAMA-J AM MED ASSOC, V25, P1769; Machtinger EL, 2012, AIDS BEHAV, V16, P2091, DOI 10.1007/s10461-011-0127-4; Madeiro AP, 2015, CIENC SAUDE COLETIVA, V20, P587, DOI 10.1590/1413-81232015202.11202014; Madeiro AP, 2012, CIENC SAUDE COLETIVA, V17, P1735, DOI 10.1590/S1413-81232012000700012; Mak R, 2004, SEX TRANSM INFECT, V80, P118, DOI 10.1136/sti.2002.003749; Mak R, 2003, SEX TRANSM INFECT, V79, P157, DOI 10.1136/sti.79.2.157; Mardh PA, 1999, EUR J CONTRACEP REPR, V4, P165, DOI 10.3109/13625189909040811; Marschall T, 2008, EUR J GASTROEN HEPAT, V20, P1214, DOI 10.1097/MEG.0b013e32830e289e; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mayer KH, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P1; Mayer KH, 2008, SEXUALLY TRANSMITTED; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Minichiello V, 2003, AIDS CARE, V15, P549, DOI 10.1080/0954012031000134782; Moore RD, 2008, CLIN INFECT DIS, V47, P1102, DOI 10.1086/592115; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Morineau G, 2011, CONTRACEPTION, V84, P194, DOI 10.1016/j.contraception.2010.11.003; Muldoon KA, 2015, AIDS CARE, V27, P512, DOI 10.1080/09540121.2014.978732; Muraguri N, 2015, JAIDS-J ACQ IMM DEF, V68, P91, DOI 10.1097/QAI.0000000000000368; Mutua G, 2013, PLOS ONE, V7; National Institute of Allergy and Infectious Disease, 2015, QUEST ANSW START HIV; Nemoto T, 2004, AM J PUBLIC HEALTH, V94, P1193, DOI 10.2105/AJPH.94.7.1193; Nemoto T, 2011, AM J PUBLIC HEALTH, V101, P1980, DOI 10.2105/AJPH.2010.197285; Niccolai LM, 2013, CULT HEALTH SEX, V15, P480, DOI 10.1080/13691058.2013.766931; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Oldenburg CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103549; Opeiario D, 2008, JAIDS-J ACQ IMM DEF, V48, P97, DOI 10.1097/QAI.0b013e31816e3971; Overs C, MAKING SEX WORK SAFE; Paavonen J., 2007, SEX TRANSM DIS, V4th; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Patterson TL, 2008, J INFECT DIS, V197, P728, DOI 10.1086/527379; Persist Health Project, 2014, NO LECT STINK EYE HE; Phrasisombath K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-37; Pisani E, 2004, SEX TRANSM INFECT, V80, P536, DOI 10.1136/sti.2003.007500; Plana M, 2000, AIDS, V14, P1921, DOI 10.1097/00002030-200009080-00007; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Potterat JJ, 2004, AM J EPIDEMIOL, V159, P778, DOI 10.1093/aje/kwh110; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; Prata N, 2010, HEALTH POLICY, V94, P1, DOI 10.1016/j.healthpol.2009.08.012; Quinn R, 2012, AIDS RES HUM RETROV, V28, P1734, DOI [10.1089/aid.2011.0307, 10.1089/AID.2011.0307]; Ray S, 2001, J URBAN HEALTH, V78, P581, DOI 10.1093/jurban/78.4.581; Reisen Carol A, 2007, J LGBT Health Res, V3, P29, DOI 10.1080/15574090802263421; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Rekart ML, 2008, SEXUALLY TRANSMITTED; Renzi C, 2003, AIDS, V17, P727, DOI 10.1097/00002030-200303280-00011; Rhodes T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a811; Risser JMH, 2005, INT J TRANSGENDERISM, V8, P67, DOI 10.1300/J485v08n02_07; Ross MW, 2012, SCAND J WORK ENV HEA, V38, P105, DOI 10.5271/sjweh.3184; Rusakova M, 2015, LANCET, V385, P211, DOI 10.1016/S0140-6736(14)61042-4; Russi JC, 2003, AM J TROP MED HYG, V68, P716, DOI 10.4269/ajtmh.2003.68.716; Sanders T, 2004, SOCIOL HEALTH ILL, V26, P557, DOI 10.1111/j.0141-9889.2004.00405.x; Schwitters A, 2015, AIDS BEHAV, V19, pS68, DOI 10.1007/s10461-014-0957-y; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Sevelius JM, 2014, ANN BEHAV MED, V47, P5, DOI 10.1007/s12160-013-9565-8; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2005, J URBAN HEALTH, V82, P488, DOI 10.1093/jurban/jti076; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Sharpe TT, 2001, QUAL HEALTH RES, V11, P612, DOI 10.1177/104973201129119334; Shindel AW, 2010, ACAD MED, V85, P1321, DOI 10.1097/ACM.0b013e3181e6c4a0; Silverman BG, 1997, SEX TRANSM DIS, V24, P11, DOI 10.1097/00007435-199701000-00004; Smith Michael D, 2008, Int J Sex Health, V19, P27; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; Steen R, 2012, AIDS, V26, P437, DOI 10.1097/QAD.0b013e32834ed991; Stimson GV, 2005, INT J DRUG POLICY, V16, pS7, DOI 10.1016/j.drugpo.2005.02.007; Stone E, J ACQUIR IMMUNE DEFI, V199, P495; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Strathdee SA, 2015, LANCET, V385, P4, DOI 10.1016/S0140-6736(14)60980-6; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Street Health, 2014, STREET BAS SEX WORK; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Swain SN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-357; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; The Teresa Group, 2014, DIFF DEC TOOL CAR WO; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; UNAIDS, 2009, UNAIDS GUID NOT HIV; UNAIDS, 2002, SEX WORK HIV AIDS; Vallely A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010661; van Steenbergen JE, 2002, J HEPATOL, V37, P507, DOI 10.1016/S0168-8278(02)00213-1; Vanwesenbeeck I, 2002, ANN REV SEX RES, V12, P242; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Vuylsteke B, 2001, SEX TRANSM INFECT, V77, P351, DOI 10.1136/sti.77.5.351; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Ward H, 2000, SEX TRANSM INFECT, V76, P292, DOI 10.1136/sti.76.4.292; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Whitaker T, 2011, QUAL HEALTH RES, V21, P1086, DOI 10.1177/1049732311404031; WHO, 2014, COMM MAN OP OV; WHO, 2011, PREV TREATM HIV SEX; WHO, 2014, GUID SCREEN CAR TREA; WHO, 2013, WHO GUID SCREEN TREA; WHO, 2007, MAL CIRC INF PACK; WHO, 2013, GUID US DEV AD MAL C; WHO, 2010, MENT HLTH GAP ACT PR; WHO, 2015, WHO GUID PREV CAR TR; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; WHO UNODC UNAIDS, 2012, WHO UNODC UNAIDS TEC; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Willis BM, 2002, LANCET, V359, P1417, DOI 10.1016/S0140-6736(02)08355-1; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wong WCW, 2006, HEALTH POLICY, V77, P140, DOI 10.1016/j.healthpol.2005.04.007; World Bank, 2013, GLOB HIV EP SEX WORK; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2014, VIOLENCE AGAINST WOM; World Health Organization, 2005, TOOLK TARG HIV AIDS; World Health Organization, 2013, IMPL COMPR HIV STI P; World Health Organization, 2009, GUID PSYCH ASS PHARM; World Health Organization, 2014, POL BRIEF CONS GUID; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; Young TN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002835.pub3; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575; [No title captured]	221	10	10	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2015	351								h4011	10.1136/bmj.h4011	http://dx.doi.org/10.1136/bmj.h4011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8AR	26246422				2022-12-28	WOS:000359387400001
J	Betz, ME; Wintemute, GJ				Betz, Marian E.; Wintemute, Garen J.			Physician Counseling on Firearm Safety A New Kind of Cultural Competence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INJURY PREVENTION		[Betz, Marian E.] Univ Colorado, Sch Med, Dept Emergency Med, Denver, CO USA; [Wintemute, Garen J.] Univ Calif Davis, Violence Prevent Res Program, Dept Emergency Med, Sacramento, CA 95817 USA	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Davis	Betz, ME (corresponding author), Univ Colorado, Sch Med, Dept Emergency Med, 12401 E 17th Ave,B-215, Aurora, CO 80045 USA.	marian.betz@ucdenver.edu	Betz, Marian E./H-3303-2017	Betz, Marian E./0000-0003-1643-6565	NATIONAL INSTITUTE ON AGING [K23AG043123] Funding Source: NIH RePORTER; NIA NIH HHS [K23AG043123, K23 AG043123] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], CULT LANG HLTH LIT; Becher EC, 2000, AM J PUBLIC HEALTH, V90, P1626, DOI 10.2105/AJPH.90.10.1626; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Olson LM, 2007, INJURY PREV, V13, P99, DOI 10.1136/ip.2006.012401; Price JH, 2013, J EMERG MED, V44, P1007, DOI 10.1016/j.jemermed.2012.11.010; Smith GA, 2009, PEDIATRICS, V124, P393, DOI 10.1542/peds.2009-0943; Vriniotis M, 2015, SUICIDE LIFE-THREAT, V45, P157, DOI 10.1111/sltb.12123; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337	8	69	69	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					449	450		10.1001/jama.2015.7055	http://dx.doi.org/10.1001/jama.2015.7055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO1OI	26241594	Green Accepted			2022-12-28	WOS:000358924500007
J	Imperiale, TF; Monahan, PO; Stump, TE; Glowinski, EA; Ransohoff, DF				Imperiale, Thomas F.; Monahan, Patrick O.; Stump, Timothy E.; Glowinski, Elizabeth A.; Ransohoff, David F.			Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							COST-EFFECTIVENESS; TOMOGRAPHIC COLONOGRAPHY; SCREENING COLONOSCOPY; AMERICAN-COLLEGE; PREDICTION MODEL; AVERAGE RISK; CANCER; POPULATION; PREVALENCE; ADENOMAS	Background: Several methods are recommended equally strongly for colorectal cancer screening in average-risk persons. Risk stratification would enable tailoring of screening within this group, with less invasive tests (sigmoidoscopy or occult blood tests) for lower-risk persons and colonoscopy for higher-risk persons. Objective: To create a risk index for advanced neoplasia (colorectal cancer and adenomas or serrated polyps >= 1.0 cm, villous histology, or high-grade dysplasia) anywhere in the colorectum, using the most common risk factors for colorectal neoplasia. Design: Cross-sectional study. Setting: Multiple endoscopy units, primarily in the Midwest. Patients: Persons aged 50 to 80 years undergoing initial screening colonoscopy (December 2004 to September 2011). Measurements: Derivation and validation of a risk index based on points from regression coefficients for age, sex, waist circumference, cigarette smoking, and family history of colorectal cancer. Results: Among 2993 persons in the derivation set, prevalence of advanced neoplasia was 9.4%. Risks for advanced neoplasia in persons at very low, low, intermediate, and high risk were 1.92% (95% CI, 0.63% to 4.43%), 4.88% (CI, 3.79% to 6.18%), 9.93% (CI, 8.09% to 12.0%), and 24.9% (CI, 21.1% to 29.1%), respectively (P < 0.001). Sigmoidoscopy to the descending colon in the low-risk groups would have detected 51 of 70 (73% [CI, 61% to 83%]) advanced neoplasms. Among 1467 persons in the validation set, corresponding risks for advanced neoplasia were 1.65% (CI, 0.20% to 5.84%), 3.31% (CI, 2.08% to 4.97%), 10.9% (CI, 8.26% to 14.1%), and 22.3% (CI, 16.9% to 28.5%), respectively (P < 0.001). Sigmoidoscopy would have detected 21 of 24 (87.5% [CI, 68% to 97%]) advanced neoplasms. Limitations: Split-sample validation; results apply to first-time screening. Conclusion: This index stratifies risk for advanced neoplasia among average-risk persons by identifying lower-risk groups for which noncolonoscopy strategies may be effective and efficient and a higher-risk group for which colonoscopy may be preferred.	[Imperiale, Thomas F.] Indiana Univ, Med Ctr, Regenstrief Inst, Indianapolis, IN 46202 USA; [Monahan, Patrick O.] Indiana Univ, Sch Med, Indianapolis, IN 46202 USA; [Stump, Timothy E.] Indiana Univ, Dept Biostat, Sch Med, Indianapolis, IN 46202 USA; [Glowinski, Elizabeth A.] Indianapolis Gastroenterol Res Fdn, Indianapolis, IN 46237 USA; [Ransohoff, David F.] Univ N Carolina, Chapel Hill, NC 27599 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of North Carolina; University of North Carolina Chapel Hill	Imperiale, TF (corresponding author), Indiana Univ, Med Ctr, Regenstrief Inst, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.	timperia@iu.edu		Imperiale, Thomas/0000-0001-7586-1073	National Cancer Institute; Walther Cancer Institute; Indiana University Simon Cancer Center; Indiana Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE [R01CA104459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Walther Cancer Institute; Indiana University Simon Cancer Center; Indiana Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Cancer Institute, Walther Cancer Institute, Indiana University Simon Cancer Center, and Indiana Clinical and Translational Sciences Institute.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Ballew C, 2009, AM J PREV MED, V36, P329, DOI 10.1016/j.amepre.2008.11.021; Betes M, 2003, AM J GASTROENTEROL, V98, P2648, DOI 10.1016/j.amjgastroenterol.2203.09.041; Brenner H, 2013, CANCER EPIDEM BIOMAR, V22, P1043, DOI 10.1158/1055-9965.EPI-13-0162; Cai QC, 2012, AM J EPIDEMIOL, V175, P584, DOI 10.1093/aje/kwr337; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Centers for Disease Control and Prevention (CDC), 2013, MMWR-MORBID MORTAL W, V62, P881; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Driver JA, 2007, AM J MED, V120, P257, DOI 10.1016/j.amjmed.2006.05.055; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797; Friedenberg FK, 2012, DIGEST DIS SCI, V57, P489, DOI 10.1007/s10620-011-1952-z; Giacosa A, 1999, EUR J CANCER PREV, V8, pS53; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Hassan C, 2013, CANCER-AM CANCER SOC, V119, P2549, DOI 10.1002/cncr.28007; Heitman SJ, 2005, CAN MED ASSOC J, V173, P877, DOI 10.1503/cmaj.050553; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Imperiale TF, 2012, AM J MED, V125, P1181, DOI 10.1016/j.amjmed.2012.05.026; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kaminski MF, 2014, GUT, V63, P1112, DOI 10.1136/gutjnl-2013-304965; Kwah J, 2014, DIGEST DIS SCI, V59, P2264, DOI 10.1007/s10620-014-3132-4; Lansdorp-Vogelaar I, 2009, GASTROINTEST ENDOSC, V70, P96, DOI 10.1016/j.gie.2008.08.040; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levitzky BE, 2011, AM J GASTROENTEROL, V106, P1099, DOI 10.1038/ajg.2011.20; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lin OS, 2006, GASTROENTEROLOGY, V131, P1011, DOI 10.1053/j.gastro.2006.08.015; Parekh M, 2008, ALIMENT PHARM THER, V27, P697, DOI 10.1111/j.1365-2036.2008.03632.x; Park HW, 2012, GASTROINTEST ENDOSC, V76, P818, DOI 10.1016/j.gie.2012.06.013; Park Y, 2009, J CLIN ONCOL, V27, P694, DOI 10.1200/JCO.2008.17.4813; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Pignone M, 2005, EC MOD COL CANC SCR; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rodriguez-Moranta Francisco, 2008, Gastroenterol Hepatol, V31, P405, DOI 10.1157/13125585; Schroy PC, 2013, ANN INTERN MED, V159, P13, DOI 10.7326/0003-4819-159-1-201307020-00004; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1661, DOI 10.1053/j.gastro.2004.09.052; Sharaf RN, 2013, AM J GASTROENTEROL, V108, P120, DOI 10.1038/ajg.2012.380; Steele CB, 2013, MMWR-MORBID MORTAL W, V62, P53; Steele RJC, 2013, UNITED EUR GASTROENT, V1, P198, DOI 10.1177/2050640613489281; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tangka FKL, 2013, CANCER-AM CANCER SOC, V119, P2863, DOI 10.1002/cncr.28154; Tao S, 2014, CLIN GASTROENTEROL H, V12, P478, DOI 10.1016/j.cgh.2013.08.042; Taylor DP, 2010, GASTROENTEROLOGY, V138, P877, DOI 10.1053/j.gastro.2009.11.044; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wang Y, 2008, CANCER CAUSE CONTROL, V19, P783, DOI 10.1007/s10552-008-9141-x; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	52	67	71	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5					339	U56		10.7326/M14-1720	http://dx.doi.org/10.7326/M14-1720			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0OM	26259154	Green Accepted, Green Submitted			2022-12-28	WOS:000360296000005
J	Archibald, JM				Archibald, John M.			EVOLUTION Gene transfer in complex cells	NATURE			English	Editorial Material							NUCLEAR GENOMES; EUKARYOTES		[Archibald, John M.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Archibald, John M.] Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Toronto, ON, Canada	Dalhousie University; Canadian Institute for Advanced Research (CIFAR)	Archibald, JM (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.	john.archibald@dal.ca						Alsmark C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r19; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Doolittle WE, 1998, TRENDS GENET, V14, P307; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Huang JL, 2013, BIOESSAYS, V35, P868, DOI 10.1002/bies.201300007; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962	11	6	6	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					423	424		10.1038/nature15205	http://dx.doi.org/10.1038/nature15205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26287464				2022-12-28	WOS:000360069300027
J	Saeed, M; Andreo, U; Chung, HY; Espiritu, C; Branch, AD; Silva, JM; Rice, CM				Saeed, Mohsan; Andreo, Ursula; Chung, Hyo-Young; Espiritu, Christine; Branch, Andrea D.; Silva, Jose M.; Rice, Charles M.			SEC14L2 enables pan-genotype HCV replication in cell culture	NATURE			English	Article							HEPATITIS-C VIRUS; INFECTIOUS CDNA-CLONES; EFFICIENT REPLICATION; PROTEIN; RNA; MUTATIONS; REPLICONS; 2A; 1A; 3A	Since its discovery in 1989, efforts to grow clinical isolates of the hepatitis C virus (HCV) in cell culture have met with limited success. Only the JFH-1 isolate has the capacity to replicate efficiently in cultured hepatoma cells without cell culture-adaptive mutations(1-3). We hypothesized that cultured cells lack one or more factors required for the replication of clinical isolates. To identify the missing factors, we transduced Huh-7.5 human hepatoma cells with a pooled lentivirus-based human complementary DNA (cDNA) library, transfected the cells with HCV subgenomic replicons lacking adaptive mutations, and selected for stable replicon colonies. This led to the identification of a single cDNA, SEC14L2, that enabled RNA replication of diverse HCV genotypes in several hepatoma cell lines. This effect was dose-dependent, and required the continuous presence of SEC14L2. Full-length HCV genomes also replicated and produced low levels of infectious virus. Remarkably, SEC14L2-expressing Huh-7.5 cells also supported HCV replication following inoculation with patient sera. Mechanistic studies suggest that SEC14L2 promotes HCV infection by enhancing vitamin E-mediated protection against lipid peroxidation. This provides a foundation for development of in vitro replication systems for all HCV isolates, creating a useful platform to dissect the mechanisms by which cell culture-adaptive mutations act.	[Saeed, Mohsan; Andreo, Ursula; Chung, Hyo-Young; Espiritu, Christine; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA; [Branch, Andrea D.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA; [Silva, Jose M.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA.	ricec@mail.rockefeller.edu	Saeed, Mohsan/AAM-8375-2021		National Institutes of Health, NCI [R01CA057973]; NIAID [R01AI072613, R01AI099284]; NIDDK [R01DK090317]; NIDA [DA031095]; Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; American Association for the Study of Liver Diseases; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M.D. Memorial Fund; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099284, R01AI072613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031095] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; American Association for the Study of Liver Diseases; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M.D. Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Y. Matsuura for HEP3B/miR-122 cells, J. Bukh for pJ6CF and pTNcc/GLuc, S. M. Lemon and D. Yamane for pH77S.3/GLuc, pH77S.3, and pH77D/GLuc, and D. Manor for [<SUP>14</SUP>C]RRR-alpha-tocopherol. We also thank E. Castillo and A. Webson for laboratory assistance, H. H. Hoffman and L. Andrus for technical input, and W. M. Schneider, M. M. Li and M. R. MacDonald for critical reading of the manuscript. This work was supported in part by the National Institutes of Health, NCI grant R01CA057973, NIAID grants R01AI072613 and R01AI099284 (to C.M.R.), NIDDK grant R01DK090317 and NIDA grant DA031095 (to A.D.B.), by a Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University (to M. S.), and by a Liver Scholar Award from American Association for the Study of Liver Diseases (U.A.). The Greenberg Medical Research Institute, the Starr Foundation, the Ronald A. Shellow, M.D. Memorial Fund and anonymous donors provided the additional funding (to C.M.R.).	Allen-Baume V, 2002, FEBS LETT, V531, P74, DOI 10.1016/S0014-5793(02)03412-9; Aravind L, 1999, CURR BIOL, V9, pR195, DOI 10.1016/S0960-9822(99)80127-4; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Chung HY, 2014, J VIROL, V88, P11022, DOI 10.1128/JVI.01582-14; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12; Gottwein JM, 2010, J VIROL, V84, P5277, DOI 10.1128/JVI.02667-09; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kempna P, 2003, FREE RADICAL BIO MED, V34, P1458, DOI 10.1016/S0891-5849(03)00173-4; Kinge CNW, 2014, ANTIMICROB AGENTS CH, V58, P5386, DOI 10.1128/AAC.03534-14; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Mokashi V, 2005, ARCH BIOCHEM BIOPHYS, V435, P175, DOI 10.1016/j.abb.2004.11.030; Mokashi V, 2005, ARCH BIOCHEM BIOPHYS, V433, P474, DOI 10.1016/j.abb.2004.10.002; Murayama A, 2007, J VIROL, V81, P8030, DOI 10.1128/JVI.02088-06; Murayama A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000885; Neuzil J, 2006, BIOCHEM BIOPH RES CO, V343, P1113, DOI 10.1016/j.bbrc.2006.03.052; Ni J, 2005, CANCER RES, V65, P9807, DOI 10.1158/0008-5472.CAN-05-1334; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Rodriguez-Barrueco Ruth, 2013, Methods Mol Biol, V980, P353, DOI 10.1007/978-1-62703-287-2_21; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Scheel TKH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002696; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Shabman RS, 2007, J VIROL, V81, P237, DOI 10.1128/JVI.01590-06; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Suthar MS, 2005, J VIROL, V79, P4219, DOI 10.1128/JVI.79.7.4219-4228.2005; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889; Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255; Yoshimoto T, 2003, J IMMUNOL, V171, P1352, DOI 10.4049/jimmunol.171.3.1352	45	84	84	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					471	+		10.1038/nature14899	http://dx.doi.org/10.1038/nature14899			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26266980	Green Accepted			2022-12-28	WOS:000360069300039
J	Aprile, E; Agostini, F; Alfonsi, M; Arazi, L; Arisaka, K; Arneodo, F; Auger, M; Balan, C; Barrow, P; Baudis, L; Bauermeister, B; Behrens, A; Brown, A; Brown, E; Bruenner, S; Bruno, G; Budnik, R; Butikofer, L; Cardoso, JMR; Cervantes, M; Coderre, D; Colijn, AP; Contreras, H; Cussonneau, JP; Decowski, MP; Di Giovanni, A; Duchovni, E; Fattori, S; Ferella, AD; Fieguth, A; Fulgione, W; Gao, F; Garbini, M; Geis, C; Goetzke, LW; Grignon, C; Gross, E; Hampel, W; Italy, R; Kaether, F; Kaminsky, B; Kessler, G; Kish, A; Landsman, H; Lang, RF; Le Calloch, M; Lellouch, D; Levinson, L; Levy, C; Lindemann, S; Lindner, M; Lopes, JAM; Lyashenko, A; Macmullin, S; Marrodan Undagoita, T; Masbou, J; Massoli, FV; Mayani Paras, D; Melgarejo Fernandez, AJ; Meng, Y; Messina, M; Miguez, B; Molinario, A; Morana, G; Murra, M; Naganoma, J; Ni, K; Oberlack, U; Orrigo, SEA; Pakarha, P; Pantic, E; Persiani, R; Piastra, F; Pienaar, J; Plante, G; Priel, N; Rauch, L; Reichard, S; Reuter, C; Rizzo, A; Rosendahl, S; dos Santos, JMF; Sartorelli, G; Schindler, S; Schreiner, S; Schumann, M; Scotto Lavina, L; Selvi, M; Shagin, P; Simgen, H; Teymourian, A; Thers, D; Tiseni, A; Trinchero, G; Tunnell, C; Vitells, O; Wall, R; Wang, H; Weber, M; Weinheimer, C				Aprile, E.; Agostini, F.; Alfonsi, M.; Arazi, L.; Arisaka, K.; Arneodo, F.; Auger, M.; Balan, C.; Barrow, P.; Baudis, L.; Bauermeister, B.; Behrens, A.; Brown, A.; Brown, E.; Bruenner, S.; Bruno, G.; Budnik, R.; Butikofer, L.; Cardoso, J. M. R.; Cervantes, M.; Coderre, D.; Colijn, A. P.; Contreras, H.; Cussonneau, J. P.; Decowski, M. P.; Di Giovanni, A.; Duchovni, E.; Fattori, S.; Ferella, A. D.; Fieguth, A.; Fulgione, W.; Gao, F.; Garbini, M.; Geis, C.; Goetzke, L. W.; Grignon, C.; Gross, E.; Hampel, W.; Italy, R.; Kaether, F.; Kaminsky, B.; Kessler, G.; Kish, A.; Landsman, H.; Lang, R. F.; Le Calloch, M.; Lellouch, D.; Levinson, L.; Levy, C.; Lindemann, S.; Lindner, M.; Lopes, J. A. M.; Lyashenko, A.; Macmullin, S.; Marrodan Undagoitia, T.; Masbou, J.; Massoli, F. V.; Mayani Paras, D.; Melgarejo Fernandez, A. J.; Meng, Y.; Messina, M.; Miguez, B.; Molinario, A.; Morana, G.; Murra, M.; Naganoma, J.; Ni, K.; Oberlack, U.; Orrigo, S. E. A.; Pakarha, P.; Pantic, E.; Persiani, R.; Piastra, F.; Pienaar, J.; Plante, G.; Priel, N.; Rauch, L.; Reichard, S.; Reuter, C.; Rizzo, A.; Rosendahl, S.; dos Santos, J. M. F.; Sartorelli, G.; Schindler, S.; Schreiner, S.; Schumann, M.; Scotto Lavina, L.; Selvi, M.; Shagin, P.; Simgen, H.; Teymourian, A.; Thers, D.; Tiseni, A.; Trinchero, G.; Tunnell, C.; Vitells, O.; Wall, R.; Wang, H.; Weber, M.; Weinheimer, C.		XENON Collaboration	Exclusion of leptophilic dark matter models using XENON100 electronic recoil data	SCIENCE			English	Article								Laboratory experiments searching for galactic dark matter particles scattering off nuclei have so far not been able to establish a discovery. We use data from the XENON100 experiment to search for dark matter interacting with electrons. With no evidence for a signal above the low background of our experiment, we exclude a variety of representative dark matter models that would induce electronic recoils. For axial-vector couplings to electrons, we exclude cross sections above 6 x 10(-35) cm(2) for particle masses of m(chi) = 2 GeV/c(2). Independent of the dark matter halo, we exclude leptophilic models as an explanation for the long-standing DAMA/LIBRA signal, such as couplings to electrons through axial-vector interactions at a 4.4 sigma confidence level, mirror dark matter at 3.6 sigma, and luminous dark matter at 4.6 sigma.	[Aprile, E.; Goetzke, L. W.; Melgarejo Fernandez, A. J.; Messina, M.; Rizzo, A.; Weber, M.] Columbia Univ, Dept Phys, New York, NY USA; [Agostini, F.; Ferella, A. D.] INFN, Lab Nazl Gran Sasso, Laquila, Italy; [Agostini, F.; Ferella, A. D.; Fulgione, W.] Gran Sasso Sci Inst, Laquila, Italy; [Agostini, F.; Garbini, M.; Morana, G.; Persiani, R.; Sartorelli, G.; Selvi, M.] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Agostini, F.; Massoli, F. V.; Morana, G.; Persiani, R.; Selvi, M.] INFN Bologna, Bologna, Italy; [Alfonsi, M.; Decowski, M. P.; Tunnell, C.] Nikhef, Amsterdam, Netherlands; [Alfonsi, M.; Colijn, A. P.; Decowski, M. P.; Tiseni, A.] Univ Amsterdam, Amsterdam, Netherlands; [Arazi, L.; Budnik, R.; Gross, E.; Italy, R.; Landsman, H.; Le Calloch, M.; Levinson, L.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, Rehovot, Israel; [Arisaka, K.; Lyashenko, A.; Pantic, E.; Wang, H.] Univ Calif Los Angeles, Phys & Aston Dept, Los Angeles, CA USA; [Arneodo, F.; Di Giovanni, A.] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates; [Auger, M.; Barrow, P.; Baudis, L.; Behrens, A.; Kessler, G.; Kish, A.; Mayani Paras, D.; Pakarha, P.] Univ Zurich, Phys Inst, Zurich, Switzerland; [Balan, C.; Cardoso, J. M. R.; Lopes, J. A. M.; Orrigo, S. E. A.; dos Santos, J. M. F.] Univ Coimbra, Dept Phys, Coimbra, Portugal; [Bauermeister, B.; Fattori, S.; Geis, C.; Grignon, C.; Oberlack, U.; Schindler, S.] Johannes Gutenberg Univ Mainz, Inst Phys & Exzellenzcluster PRISMA, Mainz, Germany; [Brown, A.; Cervantes, M.; Lang, R. F.; Macmullin, S.; Reichard, S.; Reuter, C.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN USA; [Brown, E.; Cervantes, M.; Lang, R. F.; Reuter, C.] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY USA; [Bruenner, S.; Hampel, W.; Kaether, F.; Lindner, M.; Marrodan Undagoitia, T.; Rauch, L.; Simgen, H.] Max Planck Inst Kernphys, Heidelberg, Germany; [Bruno, G.; Rosendahl, S.; Weinheimer, C.] Wilhelms Univ Munster, Inst Kerphys, Munster, Germany; [Butikofer, L.; Coderre, D.; Kaminsky, B.; Schumann, M.] Univ Bern, Albert Einstein Ctr Fundamental Phys, Bern, Switzerland; [Cussonneau, J. P.; Le Calloch, M.; Masbou, J.; Thers, D.] Univ Nantes, CNRS, In2p3, Ecole Mines Nantes,SUBATECH, Nantes, France; [Gao, F.] Shanghai Jiao Tong Univ, Dept Phys & Astron, Shanghai, Peoples R China; [Molinario, A.; Trinchero, G.] INFN Torino, Turin, Italy; [Miguez, B.; Molinario, A.] Osservatorio Astrofis Torino, Turin, Italy; [Naganoma, J.] Rice Univ, Dept Phys & Astron, Houston, TX USA; [Lopes, J. A. M.] Coimbra Engn Inst, Coimbra, Portugal; [Orrigo, S. E. A.] Univ Valencia, CSIC, IFIC, Valencia, Spain	Columbia University; Gran Sasso Science Institute (GSSI); Istituto Nazionale di Fisica Nucleare (INFN); Gran Sasso Science Institute (GSSI); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); FOM National Institute for Subatomic Physics; University of Amsterdam; Weizmann Institute of Science; University of California System; University of California Los Angeles; University of Zurich; Universidade de Coimbra; Johannes Gutenberg University of Mainz; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Rensselaer Polytechnic Institute; Max Planck Society; University of Munster; University of Bern; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); IMT - Institut Mines-Telecom; IMT Atlantique; Nantes Universite; Shanghai Jiao Tong University; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Astrofisica (INAF); Rice University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia	Cervantes, M; Lang, RF (corresponding author), Purdue Univ, Dept Phys & Astron, W Lafayette, IN USA.	mcervant@purdue.edu; rafael@purdue.edu	Persiani, Rino/AFS-1824-2022; Piastra, Francesco/AAB-2778-2019; Fulgione, Walter/C-8255-2016; Arazi, Lior/AAH-9851-2019; Baudis, Laura/ABE-1796-2021; Lindner, Manfred/HCI-4657-2022; Oberlack, Uwe/AAP-4464-2020; Kish, Alexander/I-6213-2019; Orrigo, Sonja/AAR-2509-2021; Ni, Kaixuan/GRS-0431-2022; Di+Giovanni, Adriano/AAY-9242-2020; Thers, Dominique/AAD-8085-2022; Selvi, Marco/D-9021-2013; Massoli, Fabio Valerio/AAV-3705-2020; matias-lopes, jose a/H-6074-2012; MESSINA, Marcello/U-5632-2018; Decowski, Michal Patrick/A-4341-2011; Arneodo, Francesco/E-5061-2015; Cardoso, Joao Manuel/J-4486-2013	Persiani, Rino/0000-0002-3100-1466; Piastra, Francesco/0000-0001-8848-5089; Fulgione, Walter/0000-0002-2388-3809; Baudis, Laura/0000-0003-4710-1768; Lindner, Manfred/0000-0002-3704-6016; Kish, Alexander/0000-0002-1648-3727; Orrigo, Sonja/0000-0003-2173-4233; Di+Giovanni, Adriano/0000-0002-8462-4894; Thers, Dominique/0000-0002-9052-9703; Selvi, Marco/0000-0003-0243-0840; Massoli, Fabio Valerio/0000-0001-6447-1301; matias-lopes, jose a/0000-0002-6366-2963; Agostini, Federica/0000-0001-6753-948X; MESSINA, Marcello/0000-0002-6475-7649; Lang, Rafael/0000-0001-7594-2746; Ni, Kaixuan/0000-0003-2566-0091; Decowski, Michal Patrick/0000-0002-1577-6229; Tunnell, Christopher/0000-0001-8158-7795; Cussonneau, Jean Pierre/0000-0001-5061-4973; dos Santos, Joaquim Marques Ferreira/0000-0002-8841-6523; Garbini, Marco/0000-0002-3016-6373; Ferella, Alfredo Davide/0000-0002-6006-9160; Budnik, Ran/0000-0002-1963-9408; Arazi, Lior/0000-0002-7624-5827; Arneodo, Francesco/0000-0002-1061-0510; Fattori, Serena/0000-0002-9381-7620; Schumann, Marc/0000-0002-5036-1256; Cardoso, Joao Manuel/0000-0002-8832-8208; Gao, Fei/0000-0003-1376-677X; Marrodan Undagoitia, Teresa/0000-0001-9332-6074; Trinchero, Gian Carlo/0000-0003-0866-6379	National Science Fundation; Department of Energy; Swiss National Science Foundation; Volkswagen Foundation; Bundesministerium fur Bildung und Forschung; Max Planck Gesellschaft; Research Center Elementary Forces and Mathematical Foundations; Foundation for Fundamental Research on Matter; Weizmann Institute of Science; Initial Training Network Invisibles; Fundacao para a Ciencia e a Tecnologia; Region des Pays de la Loire; Science and Technology Commission of Shanghai Municipality; National Natural Science Foundation of China; Istituto Nazionale di Fisica Nucleare; Laboratori Nazionali del Gran Sasso; Direct For Mathematical & Physical Scien [1104733, 1206061, 1104720] Funding Source: National Science Foundation; Division Of Physics [1413358, 1412965, 1104740] Funding Source: National Science Foundation	National Science Fundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Volkswagen Foundation(Volkswagen); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Gesellschaft(Max Planck Society); Research Center Elementary Forces and Mathematical Foundations; Foundation for Fundamental Research on Matter(FOM (The Netherlands)); Weizmann Institute of Science; Initial Training Network Invisibles; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Region des Pays de la Loire(Region Pays de la Loire); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Istituto Nazionale di Fisica Nucleare(Istituto Nazionale di Fisica Nucleare (INFN)); Laboratori Nazionali del Gran Sasso; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Kopp for providing the calculated wave functions and for useful discussions. We gratefully acknowledge support from the National Science Fundation, Department of Energy, Swiss National Science Foundation, Volkswagen Foundation, Bundesministerium fur Bildung und Forschung, Max Planck Gesellschaft, Research Center Elementary Forces and Mathematical Foundations, Foundation for Fundamental Research on Matter, Weizmann Institute of Science, Initial Training Network Invisibles, Fundacao para a Ciencia e a Tecnologia, Region des Pays de la Loire, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China, and Istituto Nazionale di Fisica Nucleare. We are grateful to Laboratori Nazionali del Gran Sasso for hosting and supporting the XENON project. XENON data are archived at the Laboratori Nazionali del Gran Sasso.	Aprile E, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.062009; Aprile E, 2014, ASTROPART PHYS, V54, P11, DOI 10.1016/j.astropartphys.2013.10.002; Aprile E, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.021301; Aprile E, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.112004; Aprile E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.181301; Aprile E, 2012, ASTROPART PHYS, V35, P573, DOI 10.1016/j.astropartphys.2012.01.003; Aprile E, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.052003; Aprile E, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.082001; Bai Y, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/11/052; Baudis L, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.115015; Bell NF, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.035027; Bergstrom L, 2012, ANN PHYS-BERLIN, V524, P479, DOI 10.1002/andp.201200116; Bernabei R, 2008, EUR PHYS J C, V56, P333, DOI 10.1140/epjc/s10052-008-0662-y; Bernabei R, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.023506; Bernabei R, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2648-7; Chang S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.011301; Chang S, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.125011; DRUKIER AK, 1986, PHYS REV D, V33, P3495, DOI 10.1103/PhysRevD.33.3495; Feldstein B, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.075019; Freese K, 2013, REV MOD PHYS, V85, P1561, DOI 10.1103/RevModPhys.85.1561; Herrero-Garcia J, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/03/005; Kudryavtsev VA, 2010, ASTROPART PHYS, V33, P91, DOI 10.1016/j.astropartphys.2009.12.003; Manalaysay A, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3436636; Savage C, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/04/010; Szydagis M, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/10/P10002; Szydagis M., 2013, INSTRUM, V8	29	55	55	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					851	854		10.1126/science.aab2069	http://dx.doi.org/10.1126/science.aab2069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293959	Green Submitted, Green Accepted			2022-12-28	WOS:000359832700045
J	Haney, CH; Ausubel, FM				Haney, Cara H.; Ausubel, Frederick M.			Plant microbiome blueprints A plant defense hormone shapes the root microbiome	SCIENCE			English	Editorial Material									[Haney, Cara H.; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Haney, Cara H.; Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Haney, CH (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	haney@molbio.mgh.harvard.edu	Haney, Cara/ABG-7161-2020	Haney, Cara/0000-0002-6099-6677	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK040561] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Carvalhais LC, 2014, APPL SOIL ECOL, V84, P1, DOI 10.1016/j.apsoil.2014.06.011; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Haney CH, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.51, 10.1038/nplants.2015.51]; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825	11	26	27	3	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					788	789		10.1126/science.aad0092	http://dx.doi.org/10.1126/science.aad0092			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293938				2022-12-28	WOS:000359832700017
J	Basnyat, B				Basnyat, Buddha			Tackle Nepal's typhoid problem now	NATURE			English	Editorial Material									Patan Hosp, Oxford Univ Clin Res Unit, Oxford, England	University of Oxford	Basnyat, B (corresponding author), Patan Hosp, Oxford Univ Clin Res Unit, Oxford, England.	buddha.basnyat@ndm.ox.ac.uk						Dunstan SJ, 2014, NAT GENET, V46, P1333, DOI 10.1038/ng.3143	1	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					267	267		10.1038/524267a	http://dx.doi.org/10.1038/524267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP2NN	26289172	Bronze			2022-12-28	WOS:000359714000003
J	Matsuda, N; Tanaka, K				Matsuda, Noriyuki; Tanaka, Keiji			CELL BIOLOGY Tagged tags engage disposal	NATURE			English	Editorial Material							ACTIVATE PARKIN; UBIQUITIN CHAIN; MITOPHAGY; MITOCHONDRIA; PINK1; PHOSPHORYLATION; DEGRADATION; P62/SQSTM1; RECEPTOR					matsuda-nr@igakuken.or.jp; tanaka-kj@igakuken.or.jp	Matsuda, Noriyuki/AAI-3156-2020	Matsuda, Noriyuki/0000-0001-8199-952X	Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Fiesel FC, 2015, EMBO REP; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Padman BS, 2013, AUTOPHAGY, V9, P1862, DOI 10.4161/auto.26557; Pallanck L, 2006, NATURE, V441, P1058, DOI 10.1038/4411058a; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004861; Wauer T., 2015, NATURE; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	19	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					294	295		10.1038/nature15199	http://dx.doi.org/10.1038/nature15199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26266982				2022-12-28	WOS:000359714000020
J	Tonkin, AL				Tonkin, Anne L.			"Lifting the carpet" on cheating in medical school exams	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTEXTUAL INFLUENCES; ACADEMIC DISHONESTY; STUDENTS; BEHAVIOR		Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia	University of Adelaide	Tonkin, AL (corresponding author), Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia.	anne.tonkin@adelaide.edu.au						[Anonymous], 2013, ABC NEWS; Bell SK, 2011, CHEST, V140, P519, DOI 10.1378/chest.10-2533; Berlin L, 2012, J AM COLL RADIOL, V9, P380, DOI 10.1016/j.jacr.2012.02.002; Hughes JMC, 2006, CAN J HIGH EDUC, V36, P1; Dehn R. W., 2003, J PHYS ASSISTANT ED, V14, P190; Gallant TB, 2006, J HIGH EDUC-UK, V77, P839, DOI 10.1080/00221546.2006.11778946; Glick SM, 2001, BRIT MED J, V322, P250, DOI 10.1136/bmj.322.7281.250; Hejri SM, 2013, MED EDUC, V47, P144, DOI 10.1111/medu.12085; Henning MA, 2013, MED TEACH, V35, pE1211, DOI 10.3109/0142159X.2012.737962; Kusnoor AV, 2013, SOUTH MED J, V106, P479, DOI 10.1097/SMJ.0b013e3182a14388; McCabe D., 2005, INT J ED INTEGRITY, V1.1, P1, DOI DOI 10.21913/IJEI.V1I1.14; McCabe DL, 2002, RES HIGH EDUC, V43, P357, DOI 10.1023/A:1014893102151; McCabe DL, 1997, RES HIGH EDUC, V38, P379, DOI 10.1023/A:1024954224675; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Rennie SC, 2001, BRIT MED J, V322, P274, DOI 10.1136/bmj.322.7281.274; Ruhnke GW, 2013, MAYO CLIN PROC, V88, P438, DOI 10.1016/j.mayocp.2013.02.003; SIERLES F, 1980, J MED EDUC, V55, P124; Taradi SK, 2012, J MED ETHICS, V38, P376, DOI 10.1136/medethics-2011-100015; Whitley BE, 1998, RES HIGH EDUC, V39, P235, DOI 10.1023/A:1018724900565; Yekta AS, 2010, J PARAMED SCI, V1, P1	20	8	8	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2015	351								h4014	10.1136/bmj.h4014	http://dx.doi.org/10.1136/bmj.h4014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP7OS	26286467				2022-12-28	WOS:000360078200001
J	Gittis, AH; Brasier, DJ				Gittis, Aryn H.; Brasier, Daniel J.			Astrocytes tell neurons when to listen up	SCIENCE			English	Editorial Material							BASAL GANGLIA; CELL-TYPES; COMMUNICATION; MODULATION		[Gittis, Aryn H.; Brasier, Daniel J.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Gittis, Aryn H.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gittis, AH (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	agittis@cmu.edu; dbrasier@cmu.edu	Gittis, Aryn/I-6128-2016	Gittis, Aryn/0000-0002-3591-5775	NINDS NIH HHS [R00 NS076524] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Martin R, 2015, SCIENCE, V349, P730, DOI 10.1126/science.aaa7945; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Matthias K, 2003, J NEUROSCI, V23, P1750; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Tremblay L, 2015, MOVEMENT DISORD, V30, P1155, DOI 10.1002/mds.26199; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	15	4	4	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					690	691		10.1126/science.aad0678	http://dx.doi.org/10.1126/science.aad0678			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273041				2022-12-28	WOS:000359415100017
J	Aiden, EL; Casellas, R				Aiden, Erez Lieberman; Casellas, Rafael			Somatic Rearrangement in B Cells: It's (Mostly) Nuclear Physics	CELL			English	Review							V(D)J RECOMBINATION; HUMAN GENOME; DNA BREAKS; REVEALS; TRANSLOCATIONS; MECHANISMS; LYMPHOCYTES; PRINCIPLES; LOCUS	We discuss how principles of nuclear architecture drive typical gene rearrangements in B lymphocytes, whereas translocation hot spots and recurrent lesions reflect the extent of AID-mediated DNA damage and selection.	[Aiden, Erez Lieberman] Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA; [Casellas, Rafael] NIAMS, Genom & Immun, Bethesda, MD 20892 USA; [Casellas, Rafael] NCI, NIH, Bethesda, MD 20892 USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Casellas, R (corresponding author), NIAMS, Genom & Immun, 10 Ctr Dr, Bethesda, MD 20892 USA.	rafael.casellas@nih.gov	Aiden, Erez Lieberman/A-2908-2010		Intramural NIH HHS [Z01 AR041148-04] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148, ZICAR041186] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alinikula J, 2014, CELL, V159, P1490, DOI 10.1016/j.cell.2014.12.007; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Gramlich HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039601; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kovalchuk AL, 2012, P NATL ACAD SCI USA, V109, P10972, DOI 10.1073/pnas.1200106109; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin SG, 2015, P NATL ACAD SCI USA, V112, P1815, DOI 10.1073/pnas.1424936112; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Subrahmanyam R, 2012, CURR TOP MICROBIOL, V356, P39, DOI 10.1007/82_2011_153; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386	17	13	13	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					708	711		10.1016/j.cell.2015.07.034	http://dx.doi.org/10.1016/j.cell.2015.07.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276627	Green Accepted, Bronze			2022-12-28	WOS:000359741400006
J	Martin, DC; Matuszewski, M; Morrissey, P; Neill, JD; Moore, A; Cantalupo, S; Prochaska, JX; Chang, D				Martin, D. Christopher; Matuszewski, Mateusz; Morrissey, Patrick; Neill, James D.; Moore, Anna; Cantalupo, Sebastiano; Prochaska, J. Xavier; Chang, Daphne			A giant protogalactic disk linked to the cosmic web	NATURE			English	Article							MEDIUM EMISSION OBSERVATIONS; LY-ALPHA EMISSION; INTERGALACTIC MEDIUM; HOST GALAXIES; QUASAR ACTIVITY; GAS; REDSHIFT; SPECTROSCOPY; ABSORPTION; RADIATION	The specifics of how galaxies form from, and are fuelled by, gas from the intergalactic medium remain uncertain. Hydrodynamic simulations suggest that 'cold accretion flows'-relatively cool (temperatures of the order of 104 kelvin), unshocked gas streaming along filaments of the cosmic web into dark-matter halos(1-3)-are important. These flows are thought to deposit gas and angular momentum into the circumgalactic medium, creating disk-or ring-like structures that eventually coalesce into galaxies that form at filamentary intersections(4,5). Recently, a large and luminous filament, consistent with such a cold accretion flow, was discovered near the quasi-stellar object QSO UM287 at redshift 2.279 using narrow-band imaging(6). Unfortunately, imaging is not sufficient to constrain the physical characteristics of the filament, to determine its kinematics, to explain how it is linked to nearby sources, or to account for its unusual brightness, more than a factor of ten above what is expected for a filament. Here we report a two-dimensional spectroscopic investigation of the emitting structure. We find that the brightest emission region is an extended rotating hydrogen disk with a velocity profile that is characteristic of gas in a darkmatter halo with a mass of 10(13) solar masses. This giant protogalactic disk appears to be connected to a quiescent filament that may extend beyond the virial radius of the halo. The geometry is strongly suggestive of a cold accretion flow.	[Martin, D. Christopher; Matuszewski, Mateusz; Morrissey, Patrick; Neill, James D.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Moore, Anna] CALTECH, Cahill Ctr Astrophys, Caltech Opt Observ, Pasadena, CA 91125 USA; [Cantalupo, Sebastiano] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Prochaska, J. Xavier] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Prochaska, J. Xavier] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA	California Institute of Technology; California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Martin, DC (corresponding author), CALTECH, Cahill Ctr Astrophys, 1216 East Calif Blvd,Mail Code 278-17, Pasadena, CA 91125 USA.	cmartin@srl.caltech.edu		Prochaska, J. Xavier/0000-0002-7738-6875; Morrissey, Patrick/0000-0001-8177-1023; Moore, Anna/0000-0002-2894-6936; Cantalupo, Sebastiano/0000-0001-5804-1428	National Science Foundation; California Institute of Technology	National Science Foundation(National Science Foundation (NSF)); California Institute of Technology	We thank T. Tombrello and S. Kulkarni for their support of PCWI. This work was supported by the National Science Foundation and the California Institute of Technology.	BARNES JE, 1988, ASTROPHYS J, V331, P699, DOI 10.1086/166593; BERTOLDI F, 1989, ASTROPHYS J, V346, P735, DOI 10.1086/168055; Birnboim Y, 2003, MON NOT R ASTRON SOC, V345, P349, DOI 10.1046/j.1365-8711.2003.06955.x; Bullock JS, 2001, ASTROPHYS J, V555, P240, DOI 10.1086/321477; Cantalupo S, 2005, ASTROPHYS J, V628, P61, DOI 10.1086/430758; Cantalupo S, 2008, ASTROPHYS J, V672, P48, DOI 10.1086/523298; Cantalupo S, 2014, NATURE, V506, P63, DOI 10.1038/nature12898; CUILLANDRE JC, 1994, ASTRON ASTROPHYS, V281, P603; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Ferland GJ, 2013, REV MEX ASTRON ASTR, V49, P137; Glazebrook K, 2001, PUBL ASTRON SOC PAC, V113, P197, DOI 10.1086/318625; Guyon O, 2006, ASTROPHYS J SUPPL S, V166, P89, DOI 10.1086/505030; Hennawi JF, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/58; Hibbard JE, 2001, ASTRON J, V122, P2969, DOI 10.1086/324102; Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P356, DOI 10.1086/524362; Hutchings JB, 2006, ASTRON J, V131, P680, DOI 10.1086/498725; Hutchings JB, 2003, ASTRON J, V125, P1053, DOI 10.1086/367810; Kawakatu N, 2006, ASTROPHYS J, V637, P104, DOI 10.1086/498255; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Krumholz MR, 2009, ASTROPHYS J, V699, P850, DOI 10.1088/0004-637X/699/1/850; Martin DC, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/107; Martin DC, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/106; Matuszewski M., 2010, P SPIE GROUND BASED; McGaugh SS, 2010, ASTROPHYS J LETT, V708, pL14, DOI 10.1088/2041-8205/708/1/L14; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; NEUFELD DA, 1990, ASTROPHYS J, V350, P216, DOI 10.1086/168375; Prescott MKM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/62; Prescott MKM, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/86; Prochaska JX, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/136; Sembach KR, 1996, ASTRON J, V112, P797, DOI 10.1086/118055; Springel V, 1999, MON NOT R ASTRON SOC, V307, P162, DOI 10.1046/j.1365-8711.1999.02613.x; Stewart KR, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/74; Stewart KR, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/39; TOOMRE A, 1972, ASTROPHYS J, V178, P623, DOI 10.1086/151823; Urrutia T, 2008, ASTROPHYS J, V674, P80, DOI 10.1086/523959	35	60	60	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					192	+		10.1038/nature14616	http://dx.doi.org/10.1038/nature14616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26245373				2022-12-28	WOS:000359386900025
J	White, MF				White, Morris F.			LONGEVITY Mapping the path to a longer life	NATURE			English	Editorial Material							SPAN; RECEPTOR		Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	White, MF (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK098655] Funding Source: Medline; NIGMS NIH HHS [P50 GM021700] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alic N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004619; Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005; Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105	16	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					170	171		10.1038/524170a	http://dx.doi.org/10.1038/524170a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268188	Green Accepted			2022-12-28	WOS:000359386900021
J	Hellowell, M				Hellowell, Mark			Borrowing to save: can NHS bodies ease financial pressures by terminating PFI contracts?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hellowell, Mark] Univ Edinburgh, Global Publ Hlth Unit, Edinburgh EH8 9LD, Midlothian, Scotland	University of Edinburgh	Hellowell, M (corresponding author), Univ Edinburgh, Global Publ Hlth Unit, Edinburgh EH8 9LD, Midlothian, Scotland.	mark.hellowell@ed.ac.uk		Hellowell, Mark/0000-0003-3474-2080				Addleshaw Goddard, 2014, ADDL GODD ACT INN PF; Appleby J, 2014, NHS PRODUCTIVITY CHA; HM Treasury, 2013, INFR UK PRIV FIN IN; House of Commons Treasury Select Committee, 2014, 10 SESS 2013 14 12 M; National Audit Office, CHOIC FIN CAP INV; National Audit Office, 2014, FIN SUST NHS BOD; Pollock AM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d324	7	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2015	351								h4030	10.1136/bmj.h4030	http://dx.doi.org/10.1136/bmj.h4030			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XN	26268574	Green Published			2022-12-28	WOS:000359741200004
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Who is to blame for older people's readmission?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2013, NURSING TIMES; Battye F, 2012, RES REPORT OLD PEOPL; Conroy S, 2012, AGE AGEING, V41, P702, DOI 10.1093/ageing/afs154; Cowling TE, 2014, J ROY SOC MED, V107, P432, DOI 10.1177/0141076814542669; Feinmann J., 2014, DAILY MAIL; Healthwatch England, 2015, SAF HOM WHAT HAPP PE; Macready N., 2012, LINK LENGTH HOSP STA; National Institute for Health Research: Service Delivery and Organisation Programme, 2012, UND IMPR TRANS OLD P; NHS Benchmarking Network, 2014, NAT AUD INT CAR SUMM; NHS Confederation Foundation Trust Network, 2011, BRIEF IMP NONP AC RE; Royal Voluntary Service, 2013, AV UNH RET RAD RED R	11	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2015	351								h4244	10.1136/bmj.h4244	http://dx.doi.org/10.1136/bmj.h4244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AV	26253123	Bronze			2022-12-28	WOS:000359387800004
J	Damaraju, D; Steiner, T; Wade, J; Gin, K; FitzGerald, JM				Damaraju, Deepti; Steiner, Ted; Wade, John; Gin, Kenneth; FitzGerald, J. Mark			A Surprising Cause of Chronic Cough	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WHIPPLES-DISEASE; TROPHERYMA-WHIPPLEI; PATHOGENESIS	A 63-year-old nonsmoking white man presented to the clinic with a 2-year history of cough. The cough was dry, and it was worse at night. The cough had begun after an upper respiratory tract infection and a trip to South America. The patient was prescribed antibiotics by a family physician but had no improvement; he was then given a combination inhaler (salmeterol and fluticasone) and had minimal improvement.	[Damaraju, Deepti; Steiner, Ted; Wade, John; Gin, Kenneth; FitzGerald, J. Mark] Univ British Columbia, Dept Med, Vancouver, BC, Canada	University of British Columbia	Damaraju, D (corresponding author), 5288 Melbourne St,Apt 1702, Vancouver, BC V5R 6E6, Canada.	deepti.damaraju@gmail.com		Steiner, Ted/0000-0002-3136-6668	Bayer; Forest; Boehringer Ingelheim; Pfizer	Bayer(Bayer AG); Forest; Boehringer Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer)	Dr. Gin reports receiving fees for serving on advisory boards from Bayer, Forest, Boehringer Ingelheim, and Pfizer. No other potential conflict of interest relevant to this article was reported.	Algin Ahmet, 2012, BMC Res Notes, V5, P600, DOI 10.1186/1756-0500-5-600; Berent R, 2009, BMJ CASE REP; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Dobbins WI, 1985, WHIPPLES DIS; Durand DV, 1997, MEDICINE, V76, P170, DOI 10.1097/00005792-199705000-00003; FEURLE GE, 1994, DIGEST DIS SCI, V39, P1642, DOI 10.1007/BF02087770; Pavord ID, 2008, LANCET, V371, P1375, DOI 10.1016/S0140-6736(08)60596-6; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Schoniger-Hekele M, 2007, APPL ENVIRON MICROB, V73, P2033, DOI 10.1128/AEM.02335-06; Urbanski G, 2012, CHEST, V141, P1595, DOI 10.1378/chest.11-1812	11	2	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					561	566		10.1056/NEJMcps1303787	http://dx.doi.org/10.1056/NEJMcps1303787			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26244310				2022-12-28	WOS:000358987700012
J	Hilton, RG; Galy, V; Gaillardet, J; Dellinger, M; Bryant, C; O'Regan, M; Grocke, DR; Coxall, H; Bouchez, J; Calmels, D				Hilton, Robert G.; Galy, Valier; Gaillardet, Jerome; Dellinger, Mathieu; Bryant, Charlotte; O'Regan, Matt; Groecke, Darren R.; Coxall, Helen; Bouchez, Julien; Calmels, Damien			Erosion of organic carbon in the Arctic as a geological carbon dioxide sink	NATURE			English	Article							PERMAFROST-CARBON; ISOTOPIC COMPOSITION; CLIMATE-CHANGE; SEDIMENT; VULNERABILITY; PEATLANDS; COASTAL; BURIAL; MATTER; RIVERS	Soils of the northern high latitudes store carbon over millennial timescales (thousands of years) and contain approximately double the carbon stock of the atmosphere(1-3). Warming and associated permafrost thaw can expose soil organic carbon and result in mineralization and carbon dioxide (CO2) release(4-6). However, some of this soil organic carbon may be eroded and transferred to rivers(7-9). If it escapes degradation during river transport and is buried in marine sediments, then it can contribute to a longer-term (more than ten thousand years), geological CO2 sink(8-10). Despite this recognition, the erosional flux and fate of particulate organic carbon (POC) in large rivers at high latitudes remains poorly constrained. Here, we quantify the source of POC in the Mackenzie River, the main sediment supplier to the Arctic Ocean(11,12), and assess its flux and fate. We combine measurements of radiocarbon, stable carbon isotopes and element ratios to correct for rock-derived POC10,13,14. Our samples reveal that the eroded biospheric POC has resided in the basin for millennia, with a mean radiocarbon age of 5,800 +/- 800 years, much older than the POC in large tropical rivers(13,14). From the measured biospheric POC content and variability in annual sediment yield(15), we calculate a biospheric POC flux of 2.2(-0.9)(+1.3) teragrams of carbon per year from the Mackenzie River, which is three times the CO2 drawdown by silicate weathering in this basin(16). Offshore, we find evidence for efficient terrestrial organic carbon burial over the Holocene period, suggesting that erosion of organic carbon-rich, high-latitude soils may result in an important geological CO2 sink.	[Hilton, Robert G.] Univ Durham, Dept Geog, South Rd, Durham DH1 3LE, England; [Galy, Valier] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Gaillardet, Jerome; Dellinger, Mathieu; Bouchez, Julien] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, UMR CNRS 7154, F-75005 Paris, France; [Bryant, Charlotte] NERC Radiocarbon Facil, E Kilbride G75 OQF, Lanark, Scotland; [O'Regan, Matt; Coxall, Helen] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Groecke, Darren R.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Calmels, Damien] Univ Paris Sud, Lab GEOPS, UMR CNRS 8148, F-91405 Orsay, France	Durham University; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Stockholm University; Durham University; UDICE-French Research Universities; Universite Paris Saclay	Hilton, RG (corresponding author), Univ Durham, Dept Geog, South Rd, Durham DH1 3LE, England.	r.g.hilton@durham.ac.uk	GAILLARDET, Jerome/F-9096-2010; Hilton, Robert/C-4890-2013; Bouchez, Julien/E-7034-2017; Galy, valier/AAD-2248-2021; Dellinger, Mathieu/AAK-9397-2021; galy, valier/I-6185-2012; O'Regan, Matt/P-6277-2019; Grocke, Darren R./F-4799-2015	GAILLARDET, Jerome/0000-0001-7982-1159; Bouchez, Julien/0000-0003-4832-1615; Galy, valier/0000-0003-0385-8443; Dellinger, Mathieu/0000-0002-1770-4333; galy, valier/0000-0003-0385-8443; O'Regan, Matt/0000-0002-6046-1488; Grocke, Darren R./0000-0003-2296-7530; Coxall, Helen/0000-0002-2843-2898	Natural Environment Research Council (NERC), UK [1611.0312]; CNRS (OXYMORE); CNRS (CANNIBALT); Woods Hole Oceanographic Institution Arctic Research Initiative; Early Career Research Grant by the British Society for Geomorphology; US National Science Foundation [OCE-0928582]; Royal Society University Fellowship; NERC [NRCF010001] Funding Source: UKRI; Natural Environment Research Council [NRCF010001] Funding Source: researchfish	Natural Environment Research Council (NERC), UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CNRS (OXYMORE); CNRS (CANNIBALT); Woods Hole Oceanographic Institution Arctic Research Initiative; Early Career Research Grant by the British Society for Geomorphology; US National Science Foundation(National Science Foundation (NSF)); Royal Society University Fellowship(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Radiocarbon measurements were funded by the Natural Environment Research Council (NERC), UK (Allocation 1611.0312) to R.G.H and C.B. Fieldwork was funded by CNRS (OXYMORE and CANNIBALT) to J.G. and R.G.H., the Woods Hole Oceanographic Institution Arctic Research Initiative to V.G. and an Early Career Research Grant by the British Society for Geomorphology to R.G.H. V.G. was supported by the US National Science Foundation (OCE-0928582) and H.C. by a Royal Society University Fellowship. The research was carried out under Scientific Research Licence No. 14802 issued by the Aurora Research Centre, who we thank for logistical support (in particular D. Ross and J. Gareis). We also thank I. Peters for preparation of offshore borehole samples, C. Johnson, X. Philippon and M. Bollard for analytical assistance, E. Tipper and K. Hilton for field assistance and discussions and D. Ofukany, G. Lennie, R. Wedel and R. Pilling of Environment Canada for loan of equipment.	BERNER RA, 1990, SCIENCE, V249, P1382, DOI 10.1126/science.249.4975.1382; Bird M, 2002, EUR J SOIL SCI, V53, P393, DOI 10.1046/j.1365-2389.2002.00444.x; Blair NE, 2012, ANNU REV MAR SCI, V4, P401, DOI 10.1146/annurev-marine-120709-142717; Bouchez J, 2014, GEOCHIM COSMOCHIM AC, V133, P280, DOI 10.1016/j.gca.2014.02.032; Brown J., 1998, CIRCUM ARCTIC MAP PE; Burdige DJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002368; Carson MA, 1998, ARCTIC, V51, P116; Coulthard RD, 2010, QUAT GEOCHRONOL, V5, P419, DOI 10.1016/j.quageo.2010.03.002; Dellinger M, 2014, EARTH PLANET SC LETT, V401, P359, DOI 10.1016/j.epsl.2014.05.061; Drenzek NJ, 2007, MAR CHEM, V103, P146, DOI 10.1016/j.marchem.2006.06.017; Feng XJ, 2013, P NATL ACAD SCI USA, V110, P14168, DOI 10.1073/pnas.1307031110; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; Galy V, 2015, NATURE, V521, P204, DOI 10.1038/nature14400; Galy V, 2011, NAT GEOSCI, V4, P843, DOI [10.1038/ngeo1293, 10.1038/NGEO1293]; Goni MA, 2005, MAR CHEM, V93, P53, DOI 10.1016/j.marchem.2004.08.001; Goni MA, 2013, J GEOPHYS RES-OCEANS, V118, P4017, DOI 10.1002/jgrc.20286; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Guo LD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030689; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hilton RG, 2014, EARTH PLANET SC LETT, V403, P27, DOI 10.1016/j.epsl.2014.06.021; Hilton RG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004314; Hilton RG, 2010, GEOCHIM COSMOCHIM AC, V74, P3164, DOI 10.1016/j.gca.2010.03.004; Hugelius G, 2014, BIOGEOSCIENCES, V11, P6573, DOI 10.5194/bg-11-6573-2014; Johnston DT, 2012, NATURE, V483, P320, DOI 10.1038/nature10854; Komada T, 2008, LIMNOL OCEANOGR-METH, V6, P254, DOI 10.4319/lom.2008.6.254; Kuhry P, 1996, ECOLOGY, V77, P271, DOI 10.2307/2265676; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Macdonald RW, 1998, MAR GEOL, V144, P255, DOI 10.1016/S0025-3227(97)00106-0; MacDougall AH, 2012, NAT GEOSCI, V5, P719, DOI [10.1038/NGEO1573, 10.1038/ngeo1573]; MORAN K, 1989, J SEDIMENT PETROL, V59, P88; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schadel C, 2014, GLOBAL CHANGE BIOL, V20, P641, DOI 10.1111/gcb.12417; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Stein R., 2004, ORGANIC CARBON CYCLE; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Sundquist E.T., 2004, TREATISE GEOCHEMISTR, V8, P425; Vonk JE, 2012, NATURE, V489, P137, DOI 10.1038/nature11392; Vonk JE, 2013, NAT GEOSCI, V6, P675, DOI 10.1038/ngeo1937; Whiteside JH, 2011, PALAEOGEOGR PALAEOCL, V301, P1, DOI 10.1016/j.palaeo.2010.11.025	42	116	120	18	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					84	+		10.1038/nature14653	http://dx.doi.org/10.1038/nature14653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26245581	Green Submitted, Green Accepted			2022-12-28	WOS:000359002300036
J	Hering, JG; Sedlak, DL; Tortajada, C; Biswas, AK; Niwagaba, C; Breu, T				Hering, J. G.; Sedlak, D. L.; Tortajada, C.; Biswas, A. K.; Niwagaba, C.; Breu, T.			Local perspectives on water	SCIENCE			English	Editorial Material									[Hering, J. G.] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Hering, J. G.] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam IBP, Zurich, Switzerland; [Hering, J. G.] Swiss Fed Inst Technol EPFL, Sch Architecture Civil & Environm Engn ENAC, Lausanne, Switzerland; [Sedlak, D. L.] Univ Calif Berkeley, ReNUWIt Engn Res Ctr, Berkeley, CA 94720 USA; [Tortajada, C.; Biswas, A. K.] Third World Ctr Water Management, Atizapan, Mexico; [Tortajada, C.; Biswas, A. K.] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 117548, Singapore; [Niwagaba, C.] Makerere Univ, CEDAT, Dept Civil & Environm Engn, Kampala, Uganda; [Breu, T.] Univ Bern, CDE, Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California Berkeley; National University of Singapore; Makerere University; University of Bern	Hering, JG (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.	janet.hering@eawag.ch	Biswas, Asit K./F-4658-2016; Tortajada, Cecilia/E-7516-2016	Biswas, Asit K./0000-0001-9332-4298; Tortajada, Cecilia/0000-0001-6308-4924				Biswas AK, 2010, INT J WATER RESOUR D, V26, P129, DOI 10.1080/07900627.2010.488853; Briscoe J., 2011, OECD GLOB FOR ENV MA; Mehtonen K, 2008, WATER RESOUR DEV MAN, P207, DOI 10.1007/978-3-540-74928-8_8; Mekdaschi-Studer R., 2013, WATER HARVESTING GUI; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Sedlak D., 2014, WATER 4 0 PRESENT FU; Strande L, 2014, FAECAL SLUDGE MANAGEMENT: SYSTEMS APPROACH FOR IMPLEMENTATION AND OPERATION, P1; United Nations, 2014, MILL DEV GOALS REP 2; United Nations Environment Programme, 2012, ENV FUT WE WANT	10	22	22	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					479	480		10.1126/science.aac5902	http://dx.doi.org/10.1126/science.aac5902			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN8SP	26228131	Green Accepted			2022-12-28	WOS:000358713300032
J	McDowell, G				McDowell, Gary			Why not have a life?	SCIENCE			English	Editorial Material									[McDowell, Gary] Tufts Univ, Medford, MA 02155 USA	Tufts University	McDowell, G (corresponding author), Boston Coll, Chestnut Hill, MA 02167 USA.		McDowell, Gary/H-3382-2019	McDowell, Gary/0000-0002-9470-3799					0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					554	554		10.1126/science.349.6247.554	http://dx.doi.org/10.1126/science.349.6247.554			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN8SP	26228150	Bronze			2022-12-28	WOS:000358713300058
J	Spohn, T; Knollenberg, J; Ball, AJ; Banaszkiewicz, M; Benkhoff, J; Grott, M; Grygorczuk, J; Huttig, C; Hagermann, A; Kargl, G; Kaufmann, E; Komle, N; Kuhrt, E; Kossacki, KJ; Marczewski, W; Pelivan, I; Schrodter, R; Seiferlin, K				Spohn, T.; Knollenberg, J.; Ball, A. J.; Banaszkiewicz, M.; Benkhoff, J.; Grott, M.; Grygorczuk, J.; Huettig, C.; Hagermann, A.; Kargl, G.; Kaufmann, E.; Koemle, N.; Kuehrt, E.; Kossacki, K. J.; Marczewski, W.; Pelivan, I.; Schroedter, R.; Seiferlin, K.			Thermal and mechanical properties of the near-surface layers of comet 67P/Churyumov-Gerasimenko	SCIENCE			English	Article							ROSETTA LANDER PHILAE; 9P/TEMPEL 1; SIMULATION; INERTIA; MODEL; CONDUCTIVITY; ROUGHNESS; STRENGTH; NUCLEUS; BODIES	Thermal and mechanical material properties determine comet evolution and even solar system formation because comets are considered remnant volatile-rich planetesimals. Using data from the Multipurpose Sensors for Surface and Sub-Surface Science (MUPUS) instrument package gathered at the Philae landing site Abydos on comet 67P/Churyumov-Gerasimenko, we found the diurnal temperature to vary between 90 and 130 K. The surface emissivity was 0.97, and the local thermal inertia was 85 +/- 35 J m(-2) K(-1)s(-1/2). The MUPUS thermal probe did not fully penetrate the near-surface layers, suggesting a local resistance of the ground to penetration of >4 megapascals, equivalent to >2 megapascal uniaxial compressive strength. A sintered near-surface microporous dust-ice layer with a porosity of 30 to 65% is consistent with the data.	[Spohn, T.; Knollenberg, J.; Grott, M.; Huettig, C.; Kuehrt, E.; Pelivan, I.; Schroedter, R.] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetary Res, Berlin, Germany; [Ball, A. J.; Benkhoff, J.] European Space Agcy, European Space Res & Technol Ctr ESTEC, NL-2200 AG Noordwijk, Netherlands; [Banaszkiewicz, M.; Grygorczuk, J.; Marczewski, W.] Polish Acad Sci, Space Res Ctr, PL-01237 Warsaw, Poland; [Hagermann, A.; Kaufmann, E.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Kargl, G.; Koemle, N.] Austrian Acad Sci Graz, Space Res Inst, Graz, Austria; Univ Warsaw, Fac Phys, Warsaw, Poland; [Seiferlin, K.] Univ Bern, Inst Phys, Bern, Switzerland	Helmholtz Association; German Aerospace Centre (DLR); European Space Agency; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Open University - UK; University of Warsaw; University of Bern	Spohn, T (corresponding author), Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetary Res, Berlin, Germany.	tilman.spohn@dlr.de	Banaszkiewicz, Marek/HII-4723-2022; Ball, Andrew/B-6747-2009; Marczewski, Wojciech/AAH-6018-2019	Ball, Andrew/0000-0003-1593-3279; Kargl, Gunter/0000-0001-9125-0256; Benkhoff, Johannes/0000-0002-4307-9703; Kossacki, Konrad/0000-0003-4033-0023; Pelivan, Ivanka/0000-0003-0732-8466; Hagermann, Axel/0000-0002-1818-9396	DLR; Helmholtz Association [PD-106]; Polish Academy of Sciences; Austrian Academy of Sciences; UK Science and Technology Facilities Council [ST/L000776-1]; Science and Technology Facilities Council [ST/L000776/1, ST/I001964/1] Funding Source: researchfish; STFC [ST/L000776/1, ST/I001964/1] Funding Source: UKRI	DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Helmholtz Association(Helmholtz Association); Polish Academy of Sciences; Austrian Academy of Sciences; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The authors are indebted to DLR, the Helmholtz Association (grant PD-106 to I.P.), the Polish Academy of Sciences, the Austrian Academy of Sciences, and the UK Science and Technology Facilities Council grant ST/L000776-1 to A.H.) for funding and to ESA for providing the opportunity to be on this exciting mission. The data used in this letter are available through the ESA Planetary Science Archive www.rssd.esa.int/psa.	Biele J, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9816; Biele J, 2009, ACTA ASTRONAUT, V65, P1168, DOI 10.1016/j.actaastro.2009.03.041; Blum J, 2014, ICARUS, V235, P156, DOI 10.1016/j.icarus.2014.03.016; Blum J, 2006, ASTROPHYS J, V652, P1768, DOI 10.1086/508017; Davidsson BJR, 2013, ICARUS, V224, P154, DOI 10.1016/j.icarus.2013.02.008; Davidsson BJR, 2009, ICARUS, V201, P335, DOI 10.1016/j.icarus.2008.12.039; Delbo M, 2007, ICARUS, V190, P236, DOI 10.1016/j.icarus.2007.03.007; Groussin O, 2013, ICARUS, V222, P580, DOI 10.1016/j.icarus.2012.10.003; GRUN E, 1991, GEOPHYS RES LETT, V18, P245, DOI 10.1029/90GL02522; Gulkis S, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0709; HERMAN G, 1987, ICARUS, V69, P314, DOI 10.1016/0019-1035(87)90108-4; Holsapple KA, 2007, ICARUS, V187, P345, DOI 10.1016/j.icarus.2006.08.029; Kochan HW, 1999, ASTROPHYS SPACE SC L, V236, P623; Komle NI, 2001, PLANET SPACE SCI, V49, P575, DOI 10.1016/S0032-0633(00)00169-0; Kossacki KJ, 2015, ICARUS, V245, P348, DOI 10.1016/j.icarus.2014.09.044; Krause M, 2011, ICARUS, V214, P286, DOI 10.1016/j.icarus.2011.04.024; Lowry S, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220116; Rotundi A, 2015, SCIENCE, V347, DOI 10.1126/science.aaa3905; Schulson R.M., 2009, CREEP FRACTURE ICE; Seidensticker KJ, 2007, SPACE SCI REV, V128, P301, DOI 10.1007/s11214-006-9118-6; Seiferlin K, 1996, PLANET SPACE SCI, V44, P691, DOI 10.1016/0032-0633(96)00068-2; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Spohn T, 2007, SPACE SCI REV, V128, P339, DOI 10.1007/s11214-006-9081-2; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Trigo-Rodriguez JM, 2009, PLANET SPACE SCI, V57, P243, DOI 10.1016/j.pss.2008.02.011; WINTER DF, 1969, ASTROPHYS J, V156, P1135, DOI 10.1086/150041	26	141	142	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aab0464	10.1126/science.aab0464	http://dx.doi.org/10.1126/science.aab0464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228152	Green Accepted			2022-12-28	WOS:000358713300004
J	Battisti, WP; Wager, E; Baltzer, L; Bridges, D; Cairns, A; Carswell, CI; Citrome, L; Gurr, JA; Mooney, LA; Moore, BJ; Pena, T; Sanes-Miller, CH; Veitch, K; Woolley, KL; Yarker, YE				Battisti, Wendy P.; Wager, Elizabeth; Baltzer, Lise; Bridges, Dan; Cairns, Angela; Carswell, Christopher I.; Citrome, Leslie; Gurr, James A.; Mooney, LaVerne A.; Moore, B. Jane; Pena, Teresa; Sanes-Miller, Carol H.; Veitch, Keith; Woolley, Karen L.; Yarker, Yvonne E.			Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3	ANNALS OF INTERNAL MEDICINE			English	Article								This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmaceutical, medical device, diagnostics, and biotechnology companies. The recommendations are designed to help individuals and organizations maintain ethical and transparent publication practices and comply with legal and regulatory requirements. These recommendations cover publications in peer-reviewed journals and presentations (oral or poster) at scientific congresses. The International Society for Medical Publication Professionals invited more than 3000 professionals worldwide to apply for a position on the steering committee, or as a reviewer, for this guideline. The GPP2 authors reviewed all applications (n = 241) and assembled an 18-member steering committee that represented 7 countries and a diversity of publication professions and institutions. From the 174 selected reviewers, 94 sent comments on the second draft, which steering committee members incorporated after discussion and consensus. The resulting guideline includes new sections (Principles of Good Publication Practice for Company-Sponsored Medical Research, Data Sharing, Studies That Should Be Published, and Plagiarism), expands guidance on the International Committee of Medical Journal Editors' authorship criteria and common authorship issues, improves clarity on appropriate author payment and reimbursement, and expands information on the role of medical writers. By following good publication practices (including GPP3), individuals and organizations will show integrity; accountability; and responsibility for accurate, complete, and transparent reporting in their publications and presentations.	Janssen Res & Dev, Raritan, NJ USA; [Wager, Elizabeth] Sideview, Princes Risborough HP27 9DE, Bucks, England; [Baltzer, Lise] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; [Bridges, Dan] Nucleus Global, London EC1V 9AZ, England; [Cairns, Angela] Ashfield Healthcare Commun, Macclesfield SK11 7HQ, Cheshire, England; Springer Int Publishing, PharmacoEcon, Cham, Switzerland; New York Med Coll, Valhalla, NY 10595 USA; [Gurr, James A.] Medimmune Inc, Gaithersburg, MD 20878 USA; [Mooney, LaVerne A.] Pfizer, New York, NY 10023 USA; [Moore, B. Jane] Medtronic, Mounds View, MN 55112 USA; Bristol Myers Squibb Co, Philadelphia, PA USA; [Sanes-Miller, Carol H.] Baxalta, Deerfield, IL 60015 USA; [Veitch, Keith] Keithveitch Commun, NL-1073 SP Amsterdam, Netherlands; [Woolley, Karen L.] ProScribe Envis Pharma Grp, Sydney, NSW 2113, Australia; [Yarker, Yvonne E.] Medicite, Yardley, PA 19067 USA	Johnson & Johnson; Janssen Pharmaceuticals; Novo Nordisk; Springer Nature; New York Medical College; AstraZeneca; Medimmune; Pfizer; Medtronic; Bristol-Myers Squibb	Wager, E (corresponding author), Sideview, 19 Stn Rd, Princes Risborough HP27 9DE, Bucks, England.	liz@sideview.demon.co.uk	CITROME, LESLIE/G-6428-2012; Carswell, Chris/AAU-3160-2021	CITROME, LESLIE/0000-0002-6098-9266; Bridges, Daniel/0000-0003-3850-9809; Carswell, Christopher/0000-0003-0828-0548; Mooney, LaVerne A./0000-0003-1120-356X; Wager, Elizabeth/0000-0002-4202-7813	Actavis (Forest); Alexza Pharmaceuticals; Alkermes; Bristol-Myers Squibb; Eli Lilly; Forum Pharmaceuticals (En-Vivo); Genentech; Janssen; Jazz Pharmaceuticals; Lundbeck; Merck; Medivation; Mylan; Novartis; Noven Pharmaceuticals; Otsuka; Pfizer; Reckitt Benckiser; Reviva Pharmaceuticals; Shire; Sunovion Pharmaceuticals; Takeda Pharmaceutical Company; Teva Pharmaceutical Industries; Valeant Pharmaceuticals International; AstraZeneca; Takeda Vaccines; Bill & Melinda Gates Foundation; ProScribe (Envision Pharma Group); Board of Trustees of ISMPP	Actavis (Forest); Alexza Pharmaceuticals; Alkermes; Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Forum Pharmaceuticals (En-Vivo); Genentech(Roche HoldingGenentech); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Lundbeck(Lundbeck Corporation); Merck(Merck & Company); Medivation; Mylan; Novartis(Novartis); Noven Pharmaceuticals; Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Reckitt Benckiser; Reviva Pharmaceuticals; Shire; Sunovion Pharmaceuticals; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Teva Pharmaceutical Industries(Teva Pharmaceutical Industries); Valeant Pharmaceuticals International; AstraZeneca(AstraZeneca); Takeda Vaccines; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); ProScribe (Envision Pharma Group); Board of Trustees of ISMPP	Dr. Battisti is an employee of Janssen Research & Development and reports nonfinancial support from the ISMPP outside the submitted work. Dr. Wager reports personal fees from various universities, scholarly societies, drug companies, and publishers for training and consultancy outside the submitted work. Ms. Baltzer is an employee of Novo Nordisk and owns stock in the company. Dr. Bridges is an employee of Nucleus Global, which provides medical education services, including medical writing and publication planning, to the pharmaceutical industry; he is a member of the Board of Trustees of ISMPP, which is a not-for-profit organization that is focused on the ethical and effective publication of medical research to inform treatment decisions. Ms. Cairns is an employee of Ashfield Healthcare Communications, which provides services, including publication planning and professional medical writing, to pharmaceutical, medical device, and diagnostics industries and authors; she has served on several ISMPP committees, including the Certification Board of Trustees. Mr. Carswell is a salaried employee of Springer Science+Business Media. Dr. Citrome reports personal fees from Actavis (Forest), Alexza Pharmaceuticals, Alkermes, Bristol-Myers Squibb, Eli Lilly, Forum Pharmaceuticals (En-Vivo), Genentech, Janssen, Jazz Pharmaceuticals, Lundbeck, Merck, Medivation, Mylan, Novartis, Noven Pharmaceuticals, Otsuka, Pfizer, Reckitt Benckiser, Reviva Pharmaceuticals, Shire, Sunovion Pharmaceuticals, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, and Valeant Pharmaceuticals International for consultancy; personal fees from Actavis (Forest), AstraZeneca, Janssen, Jazz Pharmaceuticals, Lundbeck, Merck, Novartis, Otsuka, Pfizer, Shire, Sunovion Pharmaceuticals, Takeda Pharmaceutical Company, and Teva Pharmaceutical Industries for work as a speaker; other items (stocks [small number of shares of common stock] and long-term ownership) from Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck, and Pfizer outside the submitted work; and is the Editor-in-Chief of the International Journal of Clinical Practice. Dr. Gurr reports work with MedImmune and Bristol-Myers Squibb under a contract with Aerotek Scientific outside the submitted work and holds Pfizer stock. Dr. Mooney is a Pfizer employee, holds Pfizer stock, and is on the Board of Trustees and a steering committee member of the Medical Publishing Insights and Practice initiative. Ms. Moore is a member of ISMPP; she is an employee and shareholder of Medtronic. Dr. Pena reports stock awards from Bristol-Myers Squibb and AstraZeneca outside the submitted work; she is an employee of Bristol-Myers Squibb and the Board of Trustees chair for ISMPP. Ms. Sanes-Miller reports employment at AstraZeneca from 2008 to 2012 and stock in the company. She is currently employed at Baxalta and has stock in the company. She was a member of the ISMPP Certification Board of Trustees from 2010 to 2014 and chair from 2013 to 2014; she is currently a member of ISMPP. Dr. Veitch is a freelance consultant in medical publications, having previously managed publication groups at GlaxoSmithKline Biologicals, Sanofi Pasteur, and Novartis Vaccines and Diagnostics; he has recently been a paid consultant for Takeda Vaccines and the Bill & Melinda Gates Foundation and is a member of the ISMPP European Union committee. Dr.; Woolley reports personal fees from ProScribe (Envision Pharma Group) outside the submitted work; she is actively involved in not-for-profit organizations that encourage ethical medical publication practices. Dr. Woolley voluntarily serves on the Board of Trustees of ISMPP, which has sponsored the development of GPP3. She conducts research on the value and integrity of medical publication professionals and provides ethical medical writing support and training courses, particularly to authors from low- and middle-income countries. Dr. Yarker reports nonfinancial support from ISMPP and Ashfield Healthcare during the conduct of the study; she is the chair elect of the ISMPP Board of Trustees, past chair of the ISMPP Ethics Committee, and past treasurer of the ISMPP Board of Trustees. In addition, Drs. Battisti, Bridges, Gurr, Woolley, and Yarker; Ms. Cairns; Ms. Moore; and Ms. Sanes-Miller are ISMPP Certified Medical Publication Professionals. Further details about contributorship and the steering committee for GPP3 can be found in Appendix 2 and Appendix 3 (available at annals.org), respectively. Disclosures can also be viewed at www.acponline.org/authors/icmje /ConflictOfInterestForms.do?msNum=M15-0288.	Council of Science Editors, 2015, CSES WHIT PAP PROM I; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Graf C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4330; Wager E, 2003, CURR MED RES OPIN, V19, P149, DOI 10.1185/030079903125001767; Wager E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004780	5	229	230	3	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					461	+		10.7326/M15-0288	http://dx.doi.org/10.7326/M15-0288			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26259067				2022-12-28	WOS:000361365900020
J	Groop, L				Groop, Leif			Genetics and neonatal diabetes: towards precision medicine	LANCET			English	Editorial Material							GLUTAMIC-ACID DECARBOXYLASE; ALPHA-GENE; MUTATIONS; ONSET; MELLITUS; INSULIN; KIR6.2		[Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci, Malmo, Sweden; [Groop, Leif] Univ Helsinki, Finnish Inst Mol Med, Helsinki 20502, Finland	Lund University; University of Helsinki	Groop, L (corresponding author), Lund Univ, Ctr Diabet, Dept Clin Sci, Malmo, Sweden.	leif.groop@med.lu.se						CHRISTGAU S, 1991, J BIOL CHEM, V266, P21257; CHRISTY M, 1976, LANCET, V2, P142; De Franco E, 2015, LANCET; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Lim ET, 2014, AM J HUM GENET, V95, P509, DOI 10.1016/j.ajhg.2014.09.015; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Slingerland AS, 2006, DIABETOLOGIA, V49, P2559, DOI 10.1007/s00125-006-0407-0; Spegel P, 2013, DIABETES, V62, P653, DOI 10.2337/db12-0827; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	12	9	12	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					934	935		10.1016/S0140-6736(15)61428-3	http://dx.doi.org/10.1016/S0140-6736(15)61428-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26231461	Green Submitted, hybrid			2022-12-28	WOS:000361182700005
J	Galetzka, J; Melgar, D; Genrich, JF; Geng, J; Owen, S; Lindsey, EO; Xu, X; Bock, Y; Avouac, JP; Adhikari, LB; Upreti, BN; Pratt-Sitaula, B; Bhattarai, TN; Sitaula, BP; Moore, A; Hudnut, KW; Szeliga, W; Normandeau, J; Fend, M; Flouzat, M; Bollinger, L; Shrestha, P; Koirala, B; Gautam, U; Bhatterai, M; Gupta, R; Kandel, T; Timsina, C; Sapkota, SN; Rajaure, S; Maharjan, N				Galetzka, J.; Melgar, D.; Genrich, J. F.; Geng, J.; Owen, S.; Lindsey, E. O.; Xu, X.; Bock, Y.; Avouac, J-P; Adhikari, L. B.; Upreti, B. N.; Pratt-Sitaula, B.; Bhattarai, T. N.; Sitaula, B. P.; Moore, A.; Hudnut, K. W.; Szeliga, W.; Normandeau, J.; Fend, M.; Flouzat, M.; Bollinger, L.; Shrestha, P.; Koirala, B.; Gautam, U.; Bhatterai, M.; Gupta, R.; Kandel, T.; Timsina, C.; Sapkota, S. N.; Rajaure, S.; Maharjan, N.			Slip pulse and resonance of the Kathmandu basin during the 2015 Gorkha earthquake, Nepal	SCIENCE			English	Article							STRONG-MOTION; GROUND-MOTION; RUPTURE; GPS; INVERSION; TIME	Detailed geodetic imaging of earthquake ruptures enhances our understanding of earthquake physics and associated ground shaking. The 25 April 2015 moment magnitude 7.8 earthquake in Gorkha, Nepal was the first large continental megathrust rupture to have occurred beneath a high-rate (5-hertz) Global Positioning System (GPS) network. We used GPS and interferometric synthetic aperture radar data to model the earthquake rupture as a slip pulse similar to 20 kilometers in width, similar to 6 seconds in duration, and with a peak sliding velocity of 1.1 meters per second, which propagated toward the Kathmandu basin at similar to 3.3 kilometers per second over similar to 140 kilometers. The smooth slip onset, indicating a large (similar to 5-meter) slip-weakening distance, caused moderate ground shaking at high frequencies (>1 hertz; peak ground acceleration, similar to 16% of Earth's gravity) and minimized damage to vernacular dwellings. Whole-basin resonance at a period of 4 to 5 seconds caused the collapse of tall structures, including cultural artifacts.	[Galetzka, J.; Genrich, J. F.; Owen, S.; Avouac, J-P] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; [Melgar, D.] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Geng, J.; Lindsey, E. O.; Xu, X.; Bock, Y.] Univ Calif San Diego, Scripps Inst Oceanog, Cecil H & Ida M Green Inst Geophys & Planetary Ph, La Jolla, CA 92037 USA; [Moore, A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Avouac, J-P] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Adhikari, L. B.; Shrestha, P.; Koirala, B.; Gautam, U.; Bhatterai, M.; Gupta, R.; Kandel, T.; Timsina, C.; Sapkota, S. N.; Rajaure, S.; Maharjan, N.] Dept Mines & Geol, Kathmandu, Nepal; [Upreti, B. N.] Nepal Acad Sci & Technol, Khumaltar, Lalitpur, Nepal; [Pratt-Sitaula, B.] Cent Washington Univ, Dept Geol Sci, Ellensberg, WA 98926 USA; [Bhattarai, T. N.; Sitaula, B. P.] Tribhuvan Univ, Kathmandu, Nepal; [Hudnut, K. W.] US Geol Survey, Pasadena, CA 91106 USA; [Szeliga, W.] CWU, Pacific Northwest Geodet Array, Ellensburg, WA 98926 USA; [Szeliga, W.] CWU, Dept Geol Sci, Ellensburg, WA 98926 USA; [Normandeau, J.; Fend, M.] UNAVCO, Boulder, CO 80301 USA; [Flouzat, M.; Bollinger, L.] CEA, DASE, F-91297 Bruyeres Le Chatel, Arpajon, France	California Institute of Technology; University of California System; University of California Berkeley; University of California System; University of California San Diego; Scripps Institution of Oceanography; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Cambridge; Nepal Academy of Science & Technology (NAST); Central Washington University; Tribhuvan University; United States Department of the Interior; United States Geological Survey; Central Washington University; Central Washington University; CEA	Avouac, JP (corresponding author), CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA.	avouac@gps.caltech.edu	Lindsey, Eric/AAF-1015-2020; Bollinger, Laurent/B-7636-2008; Hudnut, Kenneth W/B-1945-2009; Adhikari, Lok Bijaya/E-4037-2018; Avouac, Jean-Philippe/B-5699-2015; Hudnut, Kenneth W/AAB-4549-2020; Xu, Xiaohua/AAD-4509-2020	Bollinger, Laurent/0000-0002-5116-860X; Hudnut, Kenneth W/0000-0002-3168-4797; Avouac, Jean-Philippe/0000-0002-3060-8442; Hudnut, Kenneth W/0000-0002-3168-4797; Geng, Jianghui/0000-0002-8776-5801; Xu, Xiaohua/0000-0002-1213-3017; Timsina, Chintan/0000-0003-2222-3806; Lindsey, Eric/0000-0003-2274-8215; Gupta, Ratnamani/0000-0002-0534-1520	Caltech; DASE; Gordon and Betty Moore Foundation [GBMF 423.01, GBMF 3024]; NSF [EAR-1345136]; United Nations Development Programme; Nepal Academy for Science and Technology; NASA (USA); Department of Foreign International Development (UK); NSF; NASA under NSF [EAR-1261833]; NASA [NNX14AQ53G, NNX14AT33G]; Royal Society; Division Of Earth Sciences [1345136, 1261833] Funding Source: National Science Foundation	Caltech; DASE; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); United Nations Development Programme; Nepal Academy for Science and Technology; NASA (USA)(National Aeronautics & Space Administration (NASA)); Department of Foreign International Development (UK); NSF(National Science Foundation (NSF)); NASA under NSF; NASA(National Aeronautics & Space Administration (NASA)); Royal Society(Royal Society of London); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The GPS data are available from the UNAVCO website. The InSAR data are available at http://topex.ucsd.edu/nepal/. The Nepal Geodetic Array was funded by Caltech and DASE (to J.-P.A.) and by the Gordon and Betty Moore Foundation, through grant GBMF 423.01 to the Caltech Tectonics Observatory; support was maintained by NSF grant EAR-1345136. A. Miner and the Pacific Northwest Geodetic Array (PANGA) at CWU are thanked for technical assistance with the construction and operation of the Tribhuvan University (TU)-CWU network. Additional funding for the TU-CWU network came from the United Nations Development Programme and the Nepal Academy for Science and Technology. The high-rate data were recovered thanks to (i) a rapid intervention funded by NASA (USA) and the Department of Foreign International Development (UK) and (ii) engineering services provided by UNAVCO via the GAGE (Geodesy Advancing Geosciences and EarthScope) Facility, with support from NSF and NASA under NSF Cooperative Agreement no. EAR-1261833. We also thank Trimble Navigation and the Vaidya family for supporting the rapid response. The accelerometer record at KATNP was provided by USGS. We thank A. Nathan (U.S. Embassy in Kathmandu), S. Hough, D. Given, I. Flores, and J. Luetgert for contributions to the installation of this station. Research at UC-Berkeley was funded by the Gordon and Betty Moore Foundation through grant GBMF 3024. A portion of this work was carried out at JPL under a contract with the NASA. The GPS data were processed by the Advanced Rapid Imaging and Analysis Center for Natural Hazards (JPL) and the Scripps Orbit and Permanent Array Center. The effort at the Scripps Institution of Oceanography was funded by NASA grants NNX14AQ53G and NNX14AT33G. Advanced Land Observing Satellite-2 data were provided by the Japan Aerospace Exploration Agency under investigations 1148 and 1413. J.-P.A. thanks the Royal Society for support. We thank D. Dreger for discussion and W. Mooney for comments. J.-P.A led the study and wrote the article. D.M. performed the kinematic modeling and wrote the article. Y.B. supervised the high-rate data processing and wrote the article. J.Ga. led the field operations. J.Ge. conducted the high-rate data processing. S.O., A.M., W.S., and J.F.G. conducted the low-rate data analysis to estimate coseismic offsets. E.O.L. and X.X. conducted the InSAR data processing. L.B. helped to organize the field operations. All other authors contributed to building and servicing the GPS stations and to the post-earthquake data recovery. All authors edited the article.	Ader T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009071; Avouac JP, 2015, NAT GEOSCI, V8, P708, DOI 10.1038/NGEO2518; Bilham R, 1997, NATURE, V386, P61, DOI 10.1038/386061a0; BILHAM R, 1995, CURR SCI INDIA, V69, P101; Bizzarri A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002198; Cattin R, 2000, J GEOPHYS RES-SOL EA, V105, P13389, DOI 10.1029/2000JB900032; Emore GL, 2007, B SEISMOL SOC AM, V97, P357, DOI 10.1785/0120060153; European Space Agency, 2015, NEP EARTHQ SENT 1 IN; Guatteri M, 2000, B SEISMOL SOC AM, V90, P98, DOI 10.1785/0119990053; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Ide S, 1997, J GEOPHYS RES-SOL EA, V102, P27379, DOI 10.1029/97JB02675; Ji C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020448; Kathamandu Valley Earthquake Risk Management Project, 1998, KATHM VALL EARTHQ RI; Kozdon JE, 2013, B SEISMOL SOC AM, V103, P1275, DOI 10.1785/0120120136; Lindsey E., 2015, NEPAL EARTHQUAKE LIN; Lu X, 2007, P NATL ACAD SCI USA, V104, P18931, DOI 10.1073/pnas.0704268104; Melgar D, 2015, J GEOPHYS RES-SOL EA, V120, P3324, DOI 10.1002/2014JB011832; Mikumo T, 2003, B SEISMOL SOC AM, V93, P264, DOI 10.1785/0120020082; Moribayashi S., 1980, J JAPAN SOC ENG GEOL, V21, P80, DOI [10.5110/jjseg.21.80, DOI 10.5110/JJSEG.21.80]; Mugnier JL, 2011, TECTONOPHYSICS, V509, P33, DOI 10.1016/j.tecto.2011.05.012; Nikolaidis RM, 2001, J GEOPHYS RES-SOL EA, V106, P21897, DOI 10.1029/2001JB000329; NSET, 2015, GORKH EARTHQ INT MAP; Oglesby DD, 1998, SCIENCE, V280, P1055, DOI 10.1126/science.280.5366.1055; Pant M. R., 2002, ADARSA, V2, P29; Paudyal YR, 2012, EARTHQ ENG ENG VIB, V11, P257, DOI 10.1007/s11803-012-0115-3; Rana B. S. J. B., 1935, NEPAL KO MAHA BHUKAM; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Tinti E, 2005, B SEISMOL SOC AM, V95, P1211, DOI 10.1785/0120040177; USGS, 2015, NETQUAKES STAT KATNP; Worden CB, 2012, B SEISMOL SOC AM, V102, P204, DOI 10.1785/0120110156; Yue H, 2013, J GEOPHYS RES-SOL EA, V118, P5453, DOI 10.1002/jgrb.50379	31	278	292	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1091	1095		10.1126/science.aac6383	http://dx.doi.org/10.1126/science.aac6383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26249228	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000360628900040
J	Perez, C; Gerber, S; Boilevin, J; Bucher, M; Darbre, T; Aebi, M; Reymond, JL; Locher, KP				Perez, Camilo; Gerber, Sabina; Boilevin, Jeremy; Bucher, Monika; Darbre, Tamis; Aebi, Markus; Reymond, Jean-Louis; Locher, Kaspar P.			Structure and mechanism of an active lipid-linked oligosaccharide flippase	NATURE			English	Article							BINDING CASSETTE TRANSPORTER; X-RAY-STRUCTURE; ATP-BINDING; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; TRANSBILAYER TRANSLOCATION; CRYSTAL-STRUCTURE; GLYCOSYLATION; DOLICHOL; EXPORT	The flipping of membrane-embedded lipids containing large, polar head groups is slow and energetically unfavourable, and is therefore catalysed by flippases, the mechanisms of which are unknown. A prominent example of a flipping reaction is the translocation of lipid-linked oligosaccharides that serve as donors in N-linked protein glycosylation. In Campylobacter jejuni, this process is catalysed by the ABC transporter PglK. Here we present a mechanism of PglK-catalysed lipid-linked oligosaccharide flipping based on crystal structures in distinct states, a newly devised in vitro flipping assay, and in vivo studies. PglK can adopt inward-and outward-facing conformations in vitro, but only outward-facing states are required for flipping. While the pyrophosphate-oligosaccharide head group of lipid-linked oligosaccharides enters the translocation cavity and interacts with positively charged side chains, the lipidic polyprenyl tail binds and activates the transporter but remains exposed to the lipid bilayer during the reaction. The proposed mechanism is distinct from the classical alternating-access model applied to other transporters.	[Perez, Camilo; Gerber, Sabina; Bucher, Monika; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Boilevin, Jeremy; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Aebi, Markus] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch	Perez, Camilo/N-9542-2016; Perez, Camilo/AAA-8733-2021	Perez, Camilo/0000-0002-5800-0084; Reymond, Jean-Louis/0000-0003-2724-2942	Swiss National Science Foundation (SNF) [31003A-146191]; ETH	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); ETH(ETH Zurich)	We thank the staff scientists at the PX beamline of the Swiss Light Source for help with data collection, and M. Napiorkowska and A. Ramirez for assistance with PglB assays. This work was supported by the Swiss National Science Foundation (SNF 31003A-146191 to K.P.L. and Transglyco Sinergia program to M. A., J.-L.R. and K.P.L.). C.P. acknowledges support from the ETH postdoctoral fellowship program.	ABEIJON C, 1990, J BIOL CHEM, V265, P14691; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Eckford PDW, 2010, BIOCHEM J, V429, P195, DOI 10.1042/BJ20100144; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; HANOVER JA, 1979, J BIOL CHEM, V254, P9237; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones C, 2005, AN ACAD BRAS CIENC, V77, P293, DOI 10.1590/S0001-37652005000200009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kodigepalli KM, 2015, FEBS LETT, V589, P3, DOI 10.1016/j.febslet.2014.11.036; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Liu F, 2014, J AM CHEM SOC, V136, P566, DOI 10.1021/ja409409h; Lizak C, 2014, J BIOL CHEM, V289, P735, DOI 10.1074/jbc.M113.524751; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Sanyal S, 2010, P NATL ACAD SCI USA, V107, P11289, DOI 10.1073/pnas.1002408107; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Sharom FJ, 2011, IUBMB LIFE, V63, P736, DOI 10.1002/iub.515; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stone Alex, 2012, J Chem Biol, V5, P131, DOI 10.1007/s12154-012-0078-x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tatar LD, 2007, MICROBIOL-SGM, V153, P2518, DOI 10.1099/mic.0.2007/006312-0; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	61	150	152	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					433	+		10.1038/nature14953	http://dx.doi.org/10.1038/nature14953			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26266984	Green Accepted			2022-12-28	WOS:000360069300030
J	Vafabakhsh, R; Levitz, J; Isacoff, EY				Vafabakhsh, Reza; Levitz, Joshua; Isacoff, Ehud Y.			Conformational dynamics of a class C G-protein-coupled receptor	NATURE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LIGAND-INDUCED REARRANGEMENT; SINGLE-MOLECULE FRET; STRUCTURAL BASIS; ACTIVATION; TRAJECTORIES; PHARMACOLOGY; DOMAIN; STATE	G-protein-coupled receptors (GPCRs) constitute the largest family of membrane receptors in eukaryotes. Crystal structures have provided insight into GPCR interactions with ligands and G proteins(1,2), but our understanding of the conformational dynamics of activation is incomplete. Metabotropic glutamate receptors (mGluRs) are dimeric class C GPCRs that modulate neuronal excitability, synaptic plasticity, and serve as drug targets for neurological disorders(3,4). A 'clamshell' ligand-binding domain (LBD), which contains the ligand-binding site, is coupled to the transmembrane domain via a cysteine-rich domain, and LBD closure seems to be the first step in activation(5,6). Crystal structures of isolated mGluR LBD dimers led to the suggestion that activation also involves a reorientation of the dimer interface from a 'relaxed' to an 'active' state(7,8), but the relationship between ligand binding, LBD closure and dimer interface rearrangement in activation remains unclear. Here we use single-molecule fluorescence resonance energy transfer to probe the activation mechanism of full-length mammalian group II mGluRs. We show that the LBDs interconvert between three conformations: resting, activated and a short-lived intermediate state. Orthosteric agonists induce transitions between these conformational states, with efficacy determined by occupancy of the active conformation. Unlike mGluR2, mGluR3 displays basal dynamics, which are Ca2+-dependent and lead to basal protein activation. Our results support a general mechanism for the activation of mGluRs in which agonist binding induces closure of the LBDs, followed by dimer interface reorientation. Our experimental strategy should be widely applicable to study conformational dynamics in GPCRs and other membrane proteins.	[Vafabakhsh, Reza; Levitz, Joshua; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function [2PN2EY018241]; National Science Foundation (EAGER) [IOS-1451027]; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090527] Funding Source: NIH RePORTER	National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (EAGER)(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Z. Fu and H. Okada for technical assistance, J. P. Pin for generously providing the SNAP-and CLIP-tagged mGluRs and advice on their properties, and J. P. Pin, E. Margeat, P. Rondard, A. Jain, A. Reiner and members of the Isacoff laboratory for discussions. Funding was provided by the National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (2PN2EY018241) and the National Science Foundation (EAGER: IOS-1451027). R.V. is a Merck fellow of the Life Science Research Foundation.	Bockenhauer S, 2011, J PHYS CHEM B, V115, P13328, DOI 10.1021/jp204843r; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Haran G, 2004, CHEM PHYS, V307, P137, DOI 10.1016/j.chemphys.2004.05.017; Hlavackova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002720; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lohse MJ, 2014, CURR OPIN CELL BIOL, V27, P87, DOI 10.1016/j.ceb.2013.11.009; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nash MS, 2001, J BIOL CHEM, V276, P19286, DOI 10.1074/jbc.M007600200; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Olofsson L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6206; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Xue L, 2015, NAT CHEM BIOL, V11, P134, DOI [10.1038/nchembio.1711, 10.1038/NCHEMBIO.1711]; Yamashita T, 2004, J NEUROCHEM, V91, P484, DOI 10.1111/j.1471-4159.2004.02739.x; Yanagawa M, 2009, MOL PHARMACOL, V76, P201, DOI 10.1124/mol.109.056549; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	32	107	109	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					497	+		10.1038/nature14679	http://dx.doi.org/10.1038/nature14679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8BT	26258295	Green Accepted, Green Submitted			2022-12-28	WOS:000371582600001
J	Wu, DL; Potluri, N; Lu, JP; Kim, YC; Rastinejad, F				Wu, Dalei; Potluri, Nalini; Lu, Jingping; Kim, Youngchang; Rastinejad, Fraydoon			Structural integration in hypoxia-inducible factors	NATURE			English	Article							PAS-B DOMAIN; LIGAND-BINDING; TRANSCRIPTION FACTOR; CANCER BIOLOGY; DIMERIZATION; PROTEINS; HETERODIMERIZATION; IDENTIFICATION; HIF-2-ALPHA; RECOGNITION	The hypoxia-inducible factors (HIFs) coordinate cellular adaptations to low oxygen stress by regulating transcriptional programs in erythropoiesis, angiogenesis and metabolism. These programs promote the growth and progression of many tumours, making HIFs attractive anticancer targets. Transcriptionally active HIFs consist of HIF-alpha and ARNT (also called HIF-1 beta) subunits. Here we describe crystal structures for each of mouse HIF-2 alpha-ARNT and HIF-1 alpha-ARNT heterodimers in states that include bound small molecules and their hypoxia response element. A highly integrated quaternary architecture is shared by HIF-2 alpha-ARNT and HIF-1 alpha-ARNT, wherein ARNT spirals around the outside of each HIF-alpha subunit. Five distinct pockets are observed that permit small-molecule binding, including PAS domain encapsulated sites and an interfacial cavity formed through subunit heterodimerization. The DNA-reading head rotates, extends and cooperates with a distal PAS domain to bind hypoxia response elements. HIF-alpha mutations linked to human cancers map to sensitive sites that establish DNA binding and the stability of PAS domains and pockets.	[Wu, Dalei; Potluri, Nalini; Lu, Jingping; Rastinejad, Fraydoon] Sanford Burnham Prebys Med Discovery Inst, Metab Dis Program, Orlando, FL 32827 USA; [Kim, Youngchang] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA	Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Argonne National Laboratory	Rastinejad, F (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Metab Dis Program, Orlando, FL 32827 USA.	frastinejad@sbpdiscovery.org		Kim, Youngchang/0000-0002-1610-4889				Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cardoso R, 2012, PROTEIN SCI, V21, P1885, DOI 10.1002/pro.2172; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Girgis CM, 2012, TRENDS ENDOCRIN MET, V23, P372, DOI 10.1016/j.tem.2012.05.003; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Guo YR, 2015, J BIOL CHEM, V290, P7707, DOI 10.1074/jbc.M114.632786; Guo YR, 2013, ACS CHEM BIOL, V8, P626, DOI 10.1021/cb300604u; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hewitson KS, 2004, DRUG DISCOV TODAY, V9, P704, DOI 10.1016/S1359-6446(04)03202-7; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kalousi A, 2010, J CELL SCI, V123, P2976, DOI 10.1242/jcs.068122; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Key J, 2009, J AM CHEM SOC, V131, P17647, DOI 10.1021/ja9073062; Kroeger N, 2013, CANCER-AM CANCER SOC, V119, P1547, DOI 10.1002/cncr.27947; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miranda E, 2013, J AM CHEM SOC, V135, P10418, DOI 10.1021/ja402993u; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Morris MR, 2009, ANTICANCER RES, V29, P4337; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Ollerenshaw M, 2004, CANCER GENET CYTOGEN, V153, P122, DOI 10.1016/j.cancergencyto.2004.01.014; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/NCHEMBIO.1185, 10.1038/nchembio.1185]; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; To KKW, 2006, EMBO J, V25, P4784, DOI 10.1038/sj.emboj.7601369; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang ZX, 2013, CELL RES, V23, P213, DOI 10.1038/cr.2012.170; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13	64	170	185	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					303	+		10.1038/nature14883	http://dx.doi.org/10.1038/nature14883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26245371				2022-12-28	WOS:000359714000026
J	Cole, TB				Cole, Thomas B.			Les buveurs d'absinthe (The Absinthe Drinkers) Jean-Francois Raffaelli	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					652	653		10.1001/jama.2014.11923	http://dx.doi.org/10.1001/jama.2014.11923			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284706				2022-12-28	WOS:000360019100031
J	Kim, J; Baik, SS; Ryu, SH; Sohn, Y; Park, S; Park, BG; Denlinger, J; Yi, Y; Choi, HJ; Kim, KS				Kim, Jimin; Baik, Seung Su; Ryu, Sae Hee; Sohn, Yeongsup; Park, Soohyung; Park, Byeong-Gyu; Denlinger, Jonathan; Yi, Yeonjin; Choi, Hyoung Joon; Kim, Keun Su			Observation of tunable band gap and anisotropic Dirac semimetal state in black phosphorus	SCIENCE			English	Article							ELECTRONIC-STRUCTURE; BILAYER GRAPHENE; FIELD; HETEROSTRUCTURES; MOBILITY; FERMIONS	Black phosphorus consists of stacked layers of phosphorene, a two-dimensional semiconductor with promising device characteristics. We report the realization of a widely tunable band gap in few-layer black phosphorus doped with potassium using an in situ surface doping technique. Through band structure measurements and calculations, we demonstrate that a vertical electric field from dopants modulates the band gap, owing to the giant Stark effect, and tunes the material from a moderate-gap semiconductor to a band-inverted semimetal. At the critical field of this band inversion, the material becomes a Dirac semimetal with anisotropic dispersion, linear in armchair and quadratic in zigzag directions. The tunable band structure of black phosphorus may allow great flexibility in design and optimization of electronic and optoelectronic devices.	[Kim, Jimin; Ryu, Sae Hee; Sohn, Yeongsup; Kim, Keun Su] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Baik, Seung Su; Park, Byeong-Gyu; Yi, Yeonjin; Choi, Hyoung Joon] Yonsei Univ, Dept Phys, Seoul 120749, South Korea; [Baik, Seung Su; Choi, Hyoung Joon] Yonsei Univ, Ctr Computat Studies Adv Elect Mat Properties, Seoul 120749, South Korea; [Ryu, Sae Hee; Sohn, Yeongsup; Kim, Keun Su] Inst for Basic Sci Korea, Ctr Artificial Low Dimens Elect Syst, Pohang 790784, South Korea; [Park, Byeong-Gyu] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, South Korea; [Denlinger, Jonathan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	Pohang University of Science & Technology (POSTECH); Yonsei University; Yonsei University; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kim, KS (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea.	keunsukim@postech.edu	Choi, Hyoung Joon/N-8933-2015; Kim, Keun Su/GLU-3086-2022; Ryu, Sae Hee/AAV-1956-2021	Choi, Hyoung Joon/0000-0001-8565-8597; Ryu, Sae Hee/0000-0003-3207-7582; Kim, Jimin/0000-0002-1690-9396; Yi, Yeonjin/0000-0003-4944-8319	National Research Foundation of Korea [2011-0018306, 2013R1A1A1004778]; Korea Institute of Science and Technology Information Supercomputing Center [KSC-2013-C3-062]; Yonsei University Future-Leading Research Initiative [2014-22-0123]; Ministry of Science, ICT and Future Planning; Pohang University of Science and Technology; U.S. Department of Energy, Office of Sciences [DE-AC02-05CH11231];  [IBS-R014-D1]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Institute of Science and Technology Information Supercomputing Center; Yonsei University Future-Leading Research Initiative; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Pohang University of Science and Technology; U.S. Department of Energy, Office of Sciences(United States Department of Energy (DOE)); 	This work was supported by IBS-R014-D1. S.S.B. and H.J.C. acknowledge support from the National Research Foundation of Korea (grant 2011-0018306). Computational resources have been provided by Korea Institute of Science and Technology Information Supercomputing Center (project KSC-2013-C3-062). S.P. and Y.Y. acknowledge support from the National Research Foundation of Korea (grant 2013R1A1A1004778) and Yonsei University Future-Leading Research Initiative of 2014 (2014-22-0123). PLS-II was supported in part by the Ministry of Science, ICT and Future Planning and Pohang University of Science and Technology. The Advanced Light Source was supported by the U.S. Department of Energy, Office of Sciences, under contract DE-AC02-05CH11231. We thank S. W. Jung, W. J. Shin, Y. K. Kim, and B. Kim for help with ARPES experiments.	Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Churchill HH, 2014, NAT NANOTECHNOL, V9, P330, DOI 10.1038/nnano.2014.85; Dai J, 2014, J PHYS CHEM LETT, V5, P1289, DOI 10.1021/jz500409m; Fei RX, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.195319; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Han CQ, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085101; Khoo KH, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.201401; Kim KS, 2013, NAT MATER, V12, P887, DOI [10.1038/NMAT3717, 10.1038/nmat3717]; Koenig SP, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868132; Li LK, 2014, NAT NANOTECHNOL, V9, P372, DOI [10.1038/NNANO.2014.35, 10.1038/nnano.2014.35]; Li Y, 2014, J PHYS CHEM C, V118, P23970, DOI 10.1021/jp506881v; Liu H, 2014, ACS NANO, V8, P4033, DOI 10.1021/nn501226z; Liu QH, 2015, NANO LETT, V15, P1222, DOI 10.1021/nl5043769; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; MORITA A, 1986, APPL PHYS A-MATER, V39, P227, DOI 10.1007/BF00617267; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Peng XH, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085402; Qian XF, 2014, SCIENCE, V346, P1344, DOI 10.1126/science.1256815; Qiao JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5475; Ramasubramaniam A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205325; Reich ES, 2014, NATURE, V506, P19, DOI 10.1038/506019a; Rodin AS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.176801; Rudenko AN, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.201408; TAKAHASHI T, 1984, PHYS REV B, V29, P1105, DOI 10.1103/PhysRevB.29.1105; TAKAO Y, 1981, J PHYS SOC JPN, V50, P3362, DOI 10.1143/JPSJ.50.3362; Yang BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5898; Yue Q, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/33/335501; Zheng FW, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085423	31	628	642	26	760	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					723	726		10.1126/science.aaa6486	http://dx.doi.org/10.1126/science.aaa6486			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273052	Green Submitted			2022-12-28	WOS:000359415100033
J	Wang, XR; Li, CJ; Lu, WM; Paudel, TR; Leusink, DP; Hoek, M; Poccia, N; Vailionis, A; Venkatesan, T; Coey, JMD; Tsymbal, EY; Ariando; Hilgenkamp, H				Wang, X. Renshaw; Li, C. J.; Lu, W. M.; Paudel, T. R.; Leusink, D. P.; Hoek, M.; Poccia, N.; Vailionis, A.; Venkatesan, T.; Coey, J. M. D.; Tsymbal, E. Y.; Ariando; Hilgenkamp, H.			Imaging and control of ferromagnetism in LaMnO3/SrTiO3 heterostructures	SCIENCE			English	Article							CRITICAL THICKNESS; OXIDE; CATALYSTS	Oxide heterostructures often exhibit unusual physical properties that are absent in the constituent bulk materials. Here, we report an atomically sharp transition to a ferromagnetic phase when polar antiferromagnetic LaMnO3 (001) films are grown on SrTiO3 substrates. For a thickness of six unit cells or more, the LaMnO3 film abruptly becomes ferromagnetic over its entire area, which is visualized by scanning superconducting quantum interference device microscopy. The transition is explained in terms of electronic reconstruction originating from the polar nature of the LaMnO3 (001) films. Our results demonstrate that functionalities can be engineered in oxide films that are only a few atomic layers thick.	[Wang, X. Renshaw; Leusink, D. P.; Hoek, M.; Poccia, N.; Hilgenkamp, H.] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Li, C. J.; Lu, W. M.; Venkatesan, T.; Coey, J. M. D.; Ariando] Natl Univ Singapore, NUSNNI Nanocore, Singapore 117548, Singapore; [Li, C. J.; Venkatesan, T.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Paudel, T. R.; Tsymbal, E. Y.] Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA; [Paudel, T. R.; Tsymbal, E. Y.] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE USA; [Vailionis, A.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Venkatesan, T.; Ariando] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Venkatesan, T.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore; [Venkatesan, T.] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117548, Singapore; [Coey, J. M. D.] Univ Dublin Trinity Coll, Sch Phys, Dublin 2, Ireland; [Coey, J. M. D.] Univ Dublin Trinity Coll, Ctr Res Adapt Nanostruct & Nanodevices, Dublin 2, Ireland	University of Twente; National University of Singapore; National University of Singapore; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Stanford University; National University of Singapore; National University of Singapore; National University of Singapore; Trinity College Dublin; Trinity College Dublin	Wang, XR (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wang.xiao@utwente.nl; venky@nus.edu.sg	, Ariando/F-8953-2012; Li, CJ/R-6461-2019; Renshaw Wang, Xiao/I-5352-2012; Li, Changjian/V-3501-2019; Poccia, Nicola/L-1130-2016; Tsymbal, Evgeny/G-3493-2013; Li, Chao-Jun/G-3522-2019; Vailionis, Arturas/C-5202-2008	, Ariando/0000-0002-0598-426X; Renshaw Wang, Xiao/0000-0002-5503-9899; Li, Changjian/0000-0002-5779-7466; Poccia, Nicola/0000-0001-7982-0113; Tsymbal, Evgeny/0000-0002-6728-5480; Li, Chao-Jun/0000-0002-3859-8824; Vailionis, Arturas/0000-0001-5878-1864; Coey, John Michael David/0000-0003-0053-8452; Venkatesan, Thirumalai/0000-0001-9683-4584; Hilgenkamp, Hans/0000-0001-6109-8804	Dutch Foundation for Fundamental Research on Matter (FOM) foundation; Netherlands Organisation for Scientific Research (NWO) [680-50-1114]; Singapore National Research Foundation (NRF) [NRF-CRP 8-2011-06, NRF-CRP10-2012-02]; NUS FRC (AcRF Tier 1 grant) [R-144-000-346-112]; NSF through Materials Research Science and Engineering Center (MRSEC) [DMR-1420645]; Science Foundation Ireland [10/IN1.13006]; European Union FP7 IFOX Project	Dutch Foundation for Fundamental Research on Matter (FOM) foundation; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Singapore National Research Foundation (NRF)(National Research Foundation, Singapore); NUS FRC (AcRF Tier 1 grant); NSF through Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union FP7 IFOX Project	We thank M. S. Golden, A. Brinkman, D. Schlom, M. Huijben, Y. L. Zhao, and W. G. van der Wiel for valuable discussions; D. Veldhuis for assistance in SQUID design and fabrication; and J. R. Kirtley and the IBM T. J. Watson Research Center for providing the microscopy setup. This research was financially supported by the Dutch Foundation for Fundamental Research on Matter (FOM) foundation and through Netherlands Organisation for Scientific Research (NWO)-VICI and Rubicon grants (2011, 680-50-1114). The work at NUS is supported by the Singapore National Research Foundation (NRF) under the Competitive Research Programs (CRP Award no. NRF-CRP 8-2011-06 and CRP Award no. NRF-CRP10-2012-02) and the NUS FRC (AcRF Tier 1 grant no. R-144-000-346-112). Parts of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The work at University of Nebraska was supported by the NSF through Materials Research Science and Engineering Center (MRSEC, grant no. DMR-1420645). J.M.D.C. acknowledges support from Science Foundation Ireland grant 10/IN1.13006 and the European Union FP7 IFOX Project. All data are available in the supplementary materials.	Boris AV, 2011, SCIENCE, V332, P937, DOI 10.1126/science.1202647; Burton JD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.157203; CHAINANI A, 1993, PHYS REV B, V47, P15397, DOI 10.1103/PhysRevB.47.15397; Coey JMD, 1999, ADV PHYS, V48, P167, DOI 10.1080/000187399243455; Dagotto E, 2001, PHYS REP, V344, P1, DOI 10.1016/S0370-1573(00)00121-6; Fujishiro H, 1998, J PHYS SOC JPN, V67, P2582, DOI 10.1143/JPSJ.67.2582; Garcia-Barriocanal J, 2010, ADV MATER, V22, P627, DOI 10.1002/adma.200902263; Gibert M, 2012, NAT MATER, V11, P195, DOI [10.1038/nmat3224, 10.1038/NMAT3224]; GOODENOUGH JB, 1955, PHYS REV, V100, P564, DOI 10.1103/PhysRev.100.564; GUPTA A, 1995, APPL PHYS LETT, V67, P3494, DOI 10.1063/1.115258; Huijben M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094413; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Kalisky B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1931; Kim CH, 2010, SCIENCE, V327, P1624, DOI 10.1126/science.1184087; Kirtley JR, 1999, ANNU REV MATER SCI, V29, P117, DOI 10.1146/annurev.matsci.29.1.117; MATSUMOT.G, 1970, J PHYS SOC JPN, V29, P606, DOI 10.1143/JPSJ.29.606; Mondal P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.172403; Monkman EJ, 2012, NAT MATER, V11, P855, DOI [10.1038/NMAT3405, 10.1038/nmat3405]; Mundy JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4464; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Roldan M. A., 2013, MICROSC MICROANAL, V19, P1916; Saitoh E, 2001, NATURE, V410, P180, DOI 10.1038/35065547; Sawada H, 1997, PHYS REV B, V56, P12154, DOI 10.1103/PhysRevB.56.12154; Shah AB, 2010, ADV MATER, V22, P1156, DOI 10.1002/adma.200904198; Skumryev V, 1999, EUR PHYS J B, V11, P401, DOI 10.1007/s100510050950; Son WJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245411; Suntivich J, 2011, NAT CHEM, V3, P546, DOI 10.1038/nchem.1069; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Xia J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.140407	29	126	128	7	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					716	719		10.1126/science.aaa5198	http://dx.doi.org/10.1126/science.aaa5198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273050				2022-12-28	WOS:000359415100031
J	Guo, Y; Xu, Q; Canzio, D; Shou, J; Li, JH; Gorkin, DU; Jung, I; Wu, HY; Zhai, YN; Tang, YX; Lu, YC; Wu, YH; Jia, ZL; Li, W; Zhang, MQ; Ren, B; Krainer, AR; Maniatis, T; Wu, Q				Guo, Ya; Xu, Quan; Canzio, Daniele; Shou, Jia; Li, Jinhuan; Gorkin, David U.; Jung, Inkyung; Wu, Haiyang; Zhai, Yanan; Tang, Yuanxiao; Lu, Yichao; Wu, Yonghu; Jia, Zhilian; Li, Wei; Zhang, Michael Q.; Ren, Bing; Krainer, Adrian R.; Maniatis, Tom; Wu, Qiang			CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function	CELL			English	Article							PROTEIN-DNA INTERACTIONS; ALPHA GENE-CLUSTER; PROTOCADHERIN-ALPHA; GAMMA-PROTOCADHERINS; REGULATORY ELEMENTS; PROMOTER CHOICE; CELL-ADHESION; BINDING; BETA; ORGANIZATION	CTCF and the associated cohesin complex play a central role in insulator function and higher-order chromatin organization of mammalian genomes. Recent studies identified a correlation between the orientation of CTCF-binding sites (CBSs) and chromatin loops. To test the functional significance of this observation, we combined CRISPR/Cas9-based genomic-DNA-fragment editing with chromosome-conformation-capture experiments to show that the location and relative orientations of CBSs determine the specificity of long-range chromatin looping in mammalian genomes, using protocadherin (Pcdh) and beta-globin as model genes. Inversion of CBS elements within the Pcdh enhancer reconfigures the topology of chromatin loops between the distal enhancer and target promoters and alters gene-expression patterns. Thus, although enhancers can function in an orientation-independent manner in reporter assays, in the native chromosome context, the orientation of at least some enhancers carrying CBSs can determine both the architecture of topological chromatin domains and enhancer/promoter specificity. These findings reveal how 3D chromosome architecture can be encoded by linear genome sequences.	[Guo, Ya; Xu, Quan; Shou, Jia; Li, Jinhuan; Wu, Haiyang; Zhai, Yanan; Tang, Yuanxiao; Lu, Yichao; Wu, Yonghu; Jia, Zhilian; Li, Wei; Wu, Qiang] Shanghai Jiao Tong Univ, Collaborat Innovat Ctr Syst Biomed, Inst Syst Biomed, Ctr Comparat Biomed,MOE Key Lab Syst Biomed, Shanghai 200240, Peoples R China; [Guo, Ya; Xu, Quan; Shou, Jia; Li, Jinhuan; Wu, Haiyang; Zhai, Yanan; Tang, Yuanxiao; Lu, Yichao; Wu, Yonghu; Jia, Zhilian; Li, Wei; Wu, Qiang] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200240, Peoples R China; [Guo, Ya; Xu, Quan; Shou, Jia; Li, Jinhuan; Wu, Haiyang; Zhai, Yanan; Tang, Yuanxiao; Lu, Yichao; Wu, Yonghu; Jia, Zhilian; Li, Wei; Wu, Qiang] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, BioX Ctr, Key Lab Genet Dev & Neuropsychiat Disorders MOE, Shanghai 200240, Peoples R China; [Canzio, Daniele; Maniatis, Tom] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gorkin, David U.; Jung, Inkyung; Ren, Bing] Univ Calif San Diego, San Diego Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Gorkin, David U.; Jung, Inkyung; Ren, Bing] Univ Calif San Diego, San Diego Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhang, Michael Q.] Univ Texas Dallas, Dept Mol & Cell Biol, Ctr Syst Biol, Richardson, TX 75080 USA; [Zhang, Michael Q.] Tsinghua Univ, TNLIST Dept Automat, Ctr Synthet & Syst Biol, MOE Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China; [Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Columbia University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Dallas; Tsinghua University; Cold Spring Harbor Laboratory	Maniatis, T (corresponding author), Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, 701 West 168th St, New York, NY 10032 USA.	tm2472@cumc.columbia.edu; qwu123@gmail.com	Jia, Zhilian/AAQ-4373-2021; Wu, Qiang/A-6751-2009; Jung, Inkyung/CAJ-5773-2022	Jia, Zhilian/0000-0002-9761-1857; Wu, Qiang/0000-0003-3841-3591; Guo, Ya/0000-0001-5350-266X; Gorkin, David/0000-0003-4944-4107; Krainer, Adrian/0000-0001-9024-9501; Xu, Quan/0000-0002-7659-1658; Jung, Inkyung/0000-0002-5885-2754	MOST [2009CB918700, 2012CB316503]; NSFC [31171015, 31470820, 81261120390, 91019016]; Shanghai Municipality [13XD1402000, 14JC1403600]; State Key Laboratory of Medical Genomics; NIH [NS043915, HG001696]; NCI [3P01-CA013106-41S1]; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS043915, R01NS043915] Funding Source: NIH RePORTER	MOST; NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Municipality; State Key Laboratory of Medical Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Capecchi, Z. Chen, S. Lomvardas, K. Monahan, S. O'Keeffe, L. Peng, and Y. Shi for critical reading of the manuscript, and we thank X. Huang and J. Xi for providing CRISPR/Cas9 plasmids. This study was supported by grants from MOST (2009CB918700), NSFC (31171015 and 31470820), Shanghai Municipality (13XD1402000 and 14JC1403600), and State Key Laboratory of Medical Genomics to Q.W.; from NIH (NS043915) to T.M.; from a collaborative grant between NSFC (81261120390) and NCI (3P01-CA013106-41S1) to Q.W. and A.R.K.; and from NIH (HG001696), MOST (2012CB316503), and NSFC (91019016) to M.Q.Z. D.C. is a Helen Hay Whitney postdoctoral fellow. Q.W. is a Shanghai Subject Chief Scientist.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Chen WV, 2012, NEURON, V75, P402, DOI 10.1016/j.neuron.2012.06.039; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Doyle B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003867; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Garrett AM, 2012, NEURON, V74, P269, DOI 10.1016/j.neuron.2012.01.028; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Jia ZL, 2014, MOL CELL BIOL, V34, P3895, DOI 10.1128/MCB.00760-14; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kehayova P, 2011, P NATL ACAD SCI USA, V108, P17195, DOI 10.1073/pnas.1114357108; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Monahan K, 2012, P NATL ACAD SCI USA, V109, P9125, DOI 10.1073/pnas.1205074109; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yokota S, 2011, J BIOL CHEM, V286, P31885, DOI 10.1074/jbc.M111.245605; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204	52	544	568	10	175	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					900	910		10.1016/j.cell.2015.07.038	http://dx.doi.org/10.1016/j.cell.2015.07.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276636	Green Accepted, Bronze			2022-12-28	WOS:000359741400021
J	Rothschild, G; von Krusenstiern, AN; Basu, U				Rothschild, Gerson; von Krusenstiern, A. Nikolai; Basu, Uttiya			Malaria-Induced B Cell Genomic Instability	CELL			English	Editorial Material							SUPER-ENHANCERS; TARGETS AID; TRANSCRIPTION; TRANSLOCATION; LYMPHOMA		[Rothschild, Gerson; von Krusenstiern, A. Nikolai; Basu, Uttiya] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University	Basu, U (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA.	ub2121@cumc.columbia.edu		von Krusenstiern, A. Nikolai/0000-0002-4131-7851	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099195] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008651] Funding Source: NIH RePORTER; NIAID NIH HHS [1R01AI099195-01A1] Funding Source: Medline; NIH HHS [DP2 OD008651, 1DP2OD008651-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Magrath I, 2012, BRIT J HAEMATOL, V156, P744, DOI 10.1111/j.1365-2141.2011.09013.x; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004	9	3	3	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					696	697		10.1016/j.cell.2015.07.051	http://dx.doi.org/10.1016/j.cell.2015.07.051			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276622	Bronze			2022-12-28	WOS:000359741400001
J	Howle, WD; Oran, MD				Howle, W. D.; Oran, M. D.			Some Remarks on Alleged Degeneracy (Reprinted from vol 25, pg 251, 1895)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1895, JAMA, V25, P251	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					630	630		10.1001/jama.2014.11916	http://dx.doi.org/10.1001/jama.2014.11916			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262812	Green Submitted			2022-12-28	WOS:000359388600031
J	O'Dowd, A				O'Dowd, Adrian			Lack of information on "fit notes" renders them useless, says study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Institution of Occupational Safety and Health, 2015, GETT BEST FIT NOT	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2015	351								h4214	10.1136/bmj.h4214	http://dx.doi.org/10.1136/bmj.h4214			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AQ	26243786				2022-12-28	WOS:000359387300006
J	Watts, G				Watts, Geoff			Alan Jurgen Brotherton Obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					426	426		10.1016/S0140-6736(15)61438-6	http://dx.doi.org/10.1016/S0140-6736(15)61438-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251383				2022-12-28	WOS:000358761700014
J	Wright, IP; Sheridan, S; Barber, SJ; Morgan, GH; Andrews, DJ; Morse, AD				Wright, I. P.; Sheridan, S.; Barber, S. J.; Morgan, G. H.; Andrews, D. J.; Morse, A. D.			CHO-bearing organic compounds at the surface of 67P/Churyumov-Gerasimenko revealed by Ptolemy	SCIENCE			English	Article							MASS-SPECTRA; COMETARY; FORMALDEHYDE; POLYOXYMETHYLENE; GRAINS; ORIGIN; IONS	The surface and subsurface of comets preserve material from the formation of the solar system. The properties of cometary material thus provide insight into the physical and chemical conditions during their formation. We present mass spectra taken by the Ptolemy instrument 20 minutes after the initial touchdown of the Philae lander on the surface of comet 67P/Churyumov-Gerasimenko. Regular mass distributions indicate the presence of a sequence of compounds with additional -CH2- and -O- groups (mass/charge ratios 14 and 16, respectively). Similarities with the detected coma species of comet Halley suggest the presence of a radiation-induced polymer at the surface. Ptolemy measurements also indicate an apparent absence of aromatic compounds such as benzene, a lack of sulfur-bearing species, and very low concentrations of nitrogenous material.	[Wright, I. P.; Sheridan, S.; Barber, S. J.; Morgan, G. H.; Andrews, D. J.; Morse, A. D.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Wright, IP (corresponding author), Open Univ, Dept Phys Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	ian.wright@open.ac.uk		Sheridan, Simon/0000-0002-6059-6841; Barber, Simeon/0000-0003-1408-667X	Science and Technology Facilities Council; UK Space Agency; STFC [ST/L000776/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000776/1] Funding Source: researchfish; UK Space Agency [ST/K001973/1] Funding Source: researchfish	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	The paper is dedicated to the memory of C. Pillinger, who was the original proposer of the Ptolemy instrument. We acknowledge the interest and inputs from our colleagues involved with the Ptolemy science team. Ptolemy was developed in a collaborative venture between The Open University and RAL Space, with funding provided by the Science and Technology Facilities Council and the UK Space Agency. We acknowledge the efforts and patience of our colleagues at the Lander Control Centre and the Science Operation and Navigation Centre, as well as the lander principal scientists J.-P. Bibring and H. Bohnhardt. All Ptolemy data are available from the Planetary Science Archive of the European Space Agency and the Planetary Data System archive of NASA.	Andrews DJ, 2012, PLANET SPACE SCI, V66, P179, DOI 10.1016/j.pss.2011.09.005; Biele J, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9816; Cottin H, 2001, ASTROPHYS J, V556, P417, DOI 10.1086/321579; Cottin H, 2008, SPACE SCI REV, V138, P179, DOI 10.1007/s11214-008-9399-z; Finzi AE, 2007, SPACE SCI REV, V128, P281, DOI 10.1007/s11214-006-9134-6; Goesmann F, 2007, SPACE SCI REV, V128, P257, DOI 10.1007/s11214-006-9000-6; Goesmann F, 2015, SCIENCE, V349, DOI 10.1126/science.aab0689; Hassig M, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0276; He J, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/49; HUEBNER WF, 1987, SCIENCE, V237, P628, DOI 10.1126/science.237.4815.628; KORTH A, 1986, NATURE, V321, P335, DOI 10.1038/321335a0; McDonald GD, 1996, ICARUS, V122, P107, DOI 10.1006/icar.1996.0112; Milam SN, 2006, ASTROPHYS J, V649, P1169, DOI 10.1086/506501; MITCHELL DL, 1992, ICARUS, V98, P125, DOI 10.1016/0019-1035(92)90213-Q; MITCHELL DL, 1987, SCIENCE, V237, P626, DOI 10.1126/science.237.4815.626; MOORE MH, 1990, ASTROPHYS J, V365, pL39, DOI 10.1086/185883; Morse AD, 2009, ROSETTA ESAS MISSION, P669; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Linstrom P. J., 2015, 69 NIST; REINHARD R, 1986, NATURE, V321, P313, DOI 10.1038/321313a0; Rubin M, 2015, SCIENCE, V348, P232, DOI 10.1126/science.aaa6100; SAGAN C, 1979, NATURE, V277, P102, DOI 10.1038/277102a0; SCHUTTE WA, 1993, ICARUS, V104, P118, DOI 10.1006/icar.1993.1087; Spohn T, 2015, SCIENCE, V349, DOI 10.1126/science.aab0464; Wickramasinghe N. C., 1975, MON NOT R ASTRON SOC, V170, p11P	25	93	93	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aab0673	10.1126/science.aab0673	http://dx.doi.org/10.1126/science.aab0673			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228155				2022-12-28	WOS:000358713300007
J	Ostroff, L; Zeng, HK				Ostroff, Linnaea; Zeng, Hongkui			Electron Microscopy at Scale	CELL			English	Editorial Material							CIRCUIT	The essential details of cellular interactions at synaptic level in the brain are still largely unknown. In this issue, Kasthuri et al. report new experimental and computational technologies for large-scale electron microscopy data collection and analysis, and through saturated reconstruction uncover synaptic connectional specificity that cannot be predicted by simple axonal-dendritic proximity.	[Ostroff, Linnaea; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98103 USA	Allen Institute for Brain Science	Ostroff, L (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	linnaeao@alleninstitute.org; hongkuiz@alleninstitute.org		Ostroff, Linnaea/0000-0002-3348-342X				Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; DEROBERTIS EDP, 1954, EXP CELL RES, V6, P543, DOI 10.1016/0014-4827(54)90209-8; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; SHEPARD GM, 1991, FDN NEURON DOCTRINE; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	9	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					474	475		10.1016/j.cell.2015.07.031	http://dx.doi.org/10.1016/j.cell.2015.07.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232218	Bronze			2022-12-28	WOS:000358801800006
J	Chisti, MJ; Salam, MA; Smith, JH; Ahmed, T; Pietroni, MAC; Shahunja, KM; Shahid, ASMSB; Faruque, ASG; Ashraf, H; Bardhan, PK; Sharifuzzaman; Graham, SM; Duke, T				Chisti, Mohammod J.; Salam, Mohammed A.; Smith, Jonathan H.; Ahmed, Tahmeed; Pietroni, Mark A. C.; Shahunja, K. M.; Shahid, Abu S. M. S. B.; Faruque, Abu S. G.; Ashraf, Hasan; Bardhan, Pradip K.; Sharifuzzaman; Graham, Stephen M.; Duke, Trevor			Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial	LANCET			English	Article							CHILDHOOD PNEUMONIA; OXYGEN-THERAPY; CHLORAMPHENICOL; MANAGEMENT; INFANTS; CPAP	Background In developing countries, mortality in children with very severe pneumonia is high, even with the provision of appropriate antibiotics, standard oxygen therapy, and other supportive care. We assessed whether oxygen therapy delivered by bubble continuous positive airway pressure (CPAP) improved outcomes compared with standard low-flow and high-flow oxygen therapies. Methods This open, randomised, controlled trial took place in Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh. We randomly assigned children younger than 5 years with severe pneumonia and hypoxaemia to receive oxygen therapy by either bubble CPAP (5 L/min starting at a CPAP level of 5 cm H2O), standard low-flow nasal cannula (2 L/min), or high-flow nasal cannula (2 L/kg per min up to the maximum of 12 L/min). Randomisation was done with use of the permuted block methods (block size of 15 patients) and Fisher and Yates tables of random permutations. The primary outcome was treatment failure (ie, clinical failure, intubation and mechanical ventilation, death, or termination of hospital stay against medical advice) after more than 1 h of treatment. Primary and safety analyses were by intention to treat. We did two interim analyses and stopped the trial after the second interim analysis on Aug 3, 2013, as directed by the data safety and monitoring board. This trial is registered at ClinicalTrials.gov, number NCT01396759. Findings Between Aug 4, 2011, and July 17, 2013, 225 eligible children were recruited. We randomly allocated 79 (35%) children to receive oxygen therapy by bubble CPAP, 67 (30%) to low-flow oxygen therapy, and 79 (35%) to high-flow oxygen therapy. Treatment failed for 31 (14%) children, of whom five (6%) had received bubble CPAP, 16 (24%) had received low-flow oxygen therapy, and ten (13%) had received high-flow oxygen therapy. Significantly fewer children in the bubble CPAP group had treatment failure than in the low-flow oxygen therapy group (relative risk [RR] 0.27, 99.7% CI 0.07-0.99; p=0.0026). No difference in treatment failure was noted between patients in the bubble CPAP and those in the high-flow oxygen therapy group (RR 0.50, 99.7% 0.11-2.29; p=0.175). 23 (10%) children died. Three (4%) children died in the bubble CPAP group, ten (15%) children died in the low-flow oxygen therapy group, and ten (13%) children died in the high-flow oxygen therapy group. Children who received oxygen by bubble CPAP had significantly lower rates of death than the children who received oxygen by low-flow oxygen therapy (RR 0.25, 95% CI 0.07-0.89; p=0.022). Interpretation Oxygen therapy delivered by bubble CPAP improved outcomes in Bangladeshi children with very severe pneumonia and hypoxaemia compared with standard low-flow oxygen therapy. Use of bubble CPAP oxygen therapy could have a large effect in hospitals in developing countries where the only respiratory support for severe childhood pneumonia and hypoxaemia is low-flow oxygen therapy. The trial was stopped early because of higher mortality in the low-flow oxygen group than in the bubble CPAP group, and we acknowledge that the early cessation of the trial reduces the certainty of the findings. Further research is needed to test the feasibility of scaling up bubble CPAP in district hospitals and to improve bubble CPAP delivery technology.	[Chisti, Mohammod J.; Salam, Mohammed A.; Ahmed, Tahmeed; Shahunja, K. M.; Shahid, Abu S. M. S. B.; Faruque, Abu S. G.; Ashraf, Hasan; Bardhan, Pradip K.; Sharifuzzaman] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Dhaka, Bangladesh; [Chisti, Mohammod J.; Graham, Stephen M.; Duke, Trevor] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Chisti, Mohammod J.; Graham, Stephen M.; Duke, Trevor] Royal Childrens Hosp, Intens Care Unit, Melbourne, Vic 3052, Australia; [Smith, Jonathan H.] UCL Inst Child Hlth, Portex Unit Paediat Anaesthesia, London, England; [Pietroni, Mark A. C.] Publ Hlth South Gloucestershire, South Gloucestershire, England; [Graham, Stephen M.] Int Union TB & Lung Dis, Paris, France	International Centre for Diarrhoeal Disease Research (ICDDR); Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; University of London; University College London	Duke, T (corresponding author), Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	trevor.duke@rch.org.au	Shahunja, K M/AAR-6229-2020; Smith, Jonathan/S-9476-2019; Chisti, Mohammod J/A-7216-2018	Shahunja, K M/0000-0002-9345-206X; Graham, Stephen/0000-0003-3525-2294; Smith, Jonathan/0000-0002-0295-6773	International Centre for Diarrhoeal Disease Research, Bangladesh; Centre for International Child Health, University of Melbourne; Centre for International Child Health, through a Knowledge Hubs for Health grant from Australian Agency for International Development (AusAID) [Gr 00837]; University of Melbourne; government of Australia; government of Bangladesh; government of Canada; government of Sweden; government of UK	International Centre for Diarrhoeal Disease Research, Bangladesh; Centre for International Child Health, University of Melbourne; Centre for International Child Health, through a Knowledge Hubs for Health grant from Australian Agency for International Development (AusAID); University of Melbourne(University of Melbourne); government of Australia; government of Bangladesh; government of Canada(CGIAR); government of Sweden; government of UK	International Centre for Diarrhoeal Disease Research, Bangladesh, and Centre for International Child Health, University of Melbourne.; This research was partly funded by the Centre for International Child Health, through a Knowledge Hubs for Health grant from Australian Agency for International Development (AusAID; grant number Gr 00837). MJC received a PhD scholarship from University of Melbourne to complete this study. We thank Colin Robertson for support as a member of MJC's PhD Advisory Panel and staff at the Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute for statistical advice. We thank the physicians, clinical fellows, nurses, and members of nutrition team for their contribution during patient enrolment and data collection. We thank the parents of children involved in this study for their generous participation. We thank the governments of Australia, Bangladesh, Canada, Sweden, and the UK for providing core or unrestricted support to the International Centre for Diarrhoeal Disease Research, Bangladesh.	Ahmed T, 2001, LANCET, V353, P1912; BAHL R, 1995, ANN TROP PAEDIATR, V15, P173, DOI 10.1080/02724936.1995.11747768; Banajeh SM, 1997, ANN TROP PAEDIATR, V17, P321, DOI 10.1080/02724936.1997.11747905; Cambonie G, 2008, INTENS CARE MED, V34, P1865, DOI 10.1007/s00134-008-1201-x; Chisti MJ, 2012, TROP MED INT HEALTH, V17, P106, DOI 10.1111/j.1365-3156.2011.02890.x; De Paoli AG, 2003, ARCH DIS CHILD-FETAL, V88, P168; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Duke T, 2014, PAEDIATR INT CHILD H, V34, P3, DOI 10.1179/2046905513Y.0000000102; Fisher RA., 1974, STAT TABLES BIOL AGR; Frey B, 2001, EUR J PEDIATR, V160, P556, DOI 10.1007/s004310100798; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Keenan W, 2013, J PEDIATR-US, V162, P892, DOI 10.1016/j.jpeds.2012.11.075; Lampland AL, 2009, J PEDIATR-US, V154, P177, DOI 10.1016/j.jpeds.2008.07.021; Martin S, 2014, ARCH DIS CHILD-FETAL, V99, pF495, DOI 10.1136/archdischild-2013-305519; McKiernan C, 2010, J PEDIATR-US, V156, P634, DOI 10.1016/j.jpeds.2009.10.039; MISHRA S, 1993, J TROP PEDIATRICS, V39, P288, DOI 10.1093/tropej/39.5.288; Pocock SJ, 1983, CLIN TRIALS PRACTICA, P66; Schibler A, 2011, INTENS CARE MED, V37, P847, DOI 10.1007/s00134-011-2177-5; Sehgal V, 1997, Indian Pediatr, V34, P213; SHANN F, 1985, LANCET, V2, P684; Smyth A, 1997, ARCH DIS CHILD, V77, P227, DOI 10.1136/adc.77.3.227; Spentzas Thomas, 2009, J Intensive Care Med, V24, P323, DOI 10.1177/0885066609340622; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; ten Brink F, 2013, PEDIATR CRIT CARE ME, V14, pE326, DOI 10.1097/PCC.0b013e31828a894d; Tiewsoh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-15; Van den Heuvel M, 2011, ANN TROP PAEDIATR, V31, P59, DOI 10.1179/1465328110Y.0000000001; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wild M, 2001, BRIT J ANAESTH, V3, P92; Wilson PT, 2013, J PEDIATR-US, V162, P988, DOI 10.1016/j.jpeds.2012.10.022; World Health Organization, 2013, HOSP CAR CHILDR GUID	33	149	158	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1057	1065		10.1016/S0140-6736(15)60249-5	http://dx.doi.org/10.1016/S0140-6736(15)60249-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26296950				2022-12-28	WOS:000361189200025
J	Bai, XC; Yan, CY; Yang, GH; Lu, PL; Ma, D; Sun, LF; Zhou, R; Scheres, SHW; Shi, YG				Bai, Xiao-chen; Yan, Chuangye; Yang, Guanghui; Lu, Peilong; Ma, Dan; Sun, Linfeng; Zhou, Rui; Scheres, Sjors H. W.; Shi, Yigong			An atomic structure of human gamma-secretase	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; AMYLOID PRECURSOR PROTEIN; TERMINAL PAL MOTIF; ALZHEIMERS-DISEASE; CATALYTIC PORE; BETA-APP; PRESENILIN; NICASTRIN; COMPLEXES; APH-1	Dysfunction of the intramembrane protease gamma-secretase is thought to cause Alzheimer's disease, with most mutations derived from Alzheimer's disease mapping to the catalytic subunit presenilin 1 (PS1). Here we report an atomic structure of human gamma-secretase at 3.4 angstrom resolution, determined by single-particle cryo-electron microscopy. Mutations derived from Alzheimer's disease affect residues at two hotspots in PS1, each located at the centre of a distinct four transmembrane segment (TM) bundle. TM2 and, to a lesser extent, TM6 exhibit considerable flexibility, yielding a plastic active site and adaptable surrounding elements. The active site of PS1 is accessible from the convex side of the TM horseshoe, suggesting considerable conformational changes in nicastrin extracellular domain after substrate recruitment. Component protein APH-1 serves as a scaffold, anchoring the lone transmembrane helix from nicastrin and supporting the flexible conformation of PS1. Ordered phospholipids stabilize the complex inside the membrane. Our structure serves as a molecular basis for mechanistic understanding of c-secretase function.	[Bai, Xiao-chen; Scheres, Sjors H. W.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Yan, Chuangye; Yang, Guanghui; Lu, Peilong; Ma, Dan; Sun, Linfeng; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ Key Lab Prot Sci,Tsinghua Peking Join, Beijing 100084, Peoples R China	MRC Laboratory Molecular Biology; Tsinghua University	Bai, XC (corresponding author), MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge CB2 0QH, England.	xcbai@mrc-lmb.cam.ac.uk; scheres@mrc-lmb.cam.ac.uk; shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Scheres, Sjors H.W./AAY-2265-2021; Bai, Xiao-chen/HGV-1244-2022	Scheres, Sjors H.W./0000-0002-0462-6540; Bai, Xiao-chen/0000-0002-4234-5686; Lu, Peilong/0000-0001-5894-9268; Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2014ZX09507003006]; National Natural Science Foundation of China [31130002, 31321062]; European Union Marie Curie Fellowship; UK Medical Research Council [MC_UP_A025_1013]; Medical Research Council [MC_UP_A025_1013] Funding Source: researchfish; MRC [MC_UP_A025_1013] Funding Source: UKRI	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Union Marie Curie Fellowship(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Chen and C. Savva for support with electron microscopy, and J. Grimmett and T. Darling for support with high-performance computing. This work was supported by funds from the Ministry of Science and Technology (2014ZX09507003006 to Y.S.), the National Natural Science Foundation of China (31130002 and 31321062 to Y.S.), a European Union Marie Curie Fellowship (to X.C.B.), and the UK Medical Research Council (MC_UP_A025_1013, to S.H.W.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alzheimer A., 1907, ZENTRALBL NERVENHEIL, V30, P177; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; Crystal AS, 2003, J BIOL CHEM, V278, P20117, DOI 10.1074/jbc.M213107200; Dang SY, 2015, P NATL ACAD SCI USA, V112, P3344, DOI 10.1073/pnas.1502150112; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; DeLano W.L, PYMOL MOL GRAPHICS S; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Elad N, 2015, J CELL SCI, V128, P589, DOI 10.1242/jcs.164384; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esselens C, 2012, FASEB J, V26, P3765, DOI 10.1096/fj.11-201368; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Goo JS, 2013, MOL NEUROBIOL, V48, P232, DOI 10.1007/s12035-013-8453-3; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li X., 2013, NATURE METHODS, V10, P584; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li Y, 2014, STRUCTURE, V22, P125, DOI 10.1016/j.str.2013.09.018; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P16298, DOI 10.1074/jbc.M109.000067; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sun LF, 2015, P NATL ACAD SCI USA, V112, P6003, DOI 10.1073/pnas.1506242112; Takagi-Niidome S, 2015, J NEUROSCI, V35, P2646, DOI 10.1523/JNEUROSCI.3164-14.2015; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takeo K, 2012, J BIOL CHEM, V287, P25834, DOI 10.1074/jbc.M111.336347; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xie T, 2014, P NATL ACAD SCI USA, V111, P13349, DOI 10.1073/pnas.1414837111; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	52	371	393	13	403	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					212	+		10.1038/nature14892	http://dx.doi.org/10.1038/nature14892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26280335	Green Accepted			2022-12-28	WOS:000360927400030
J	Borio, L; Cox, E; Lurie, N				Borio, Luciana; Cox, Edward; Lurie, Nicole			Combating Emerging Threats - Accelerating the Availability of Medical Therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Borio, Luciana] US FDA, Off Commissioner, Silver Spring, MD 20993 USA; [Cox, Edward] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Lurie, Nicole] US Dept HHS, Off Assistant Secretary Preparedness & Response, Washington, DC 20201 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Borio, L (corresponding author), US FDA, Off Commissioner, Silver Spring, MD 20993 USA.							Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; [Anonymous], RAPIVAB PER INJ INTR; Sorbello A, 2012, CLIN INFECT DIS, V55, P1, DOI 10.1093/cid/cis351; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; WHO, 2014, ETH CONS US UNR INT	5	25	25	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					993	995		10.1056/NEJMp1508708	http://dx.doi.org/10.1056/NEJMp1508708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ9TV	26244879				2022-12-28	WOS:000360959000004
J	Zhang, F; Yao, J; Ke, JY; Zhang, L; Lam, VQ; Xin, XF; Zhou, XE; Chen, J; Brunzelle, J; Griffin, PR; Zhou, MG; Xu, HE; Melcher, K; He, SY				Zhang, Feng; Yao, Jian; Ke, Jiyuan; Zhang, Li; Lam, Vinh Q.; Xin, Xiu-Fang; Zhou, X. Edward; Chen, Jian; Brunzelle, Joseph; Griffin, Patrick R.; Zhou, Mingguo; Xu, H. Eric; Melcher, Karsten; He, Sheng Yang			Structural basis of JAZ repression of MYC transcription factors in jasmonate signalling	NATURE			English	Article							ACTIVATION DOMAINS; GENE-EXPRESSION; ARABIDOPSIS; PROTEINS; CORONATINE; MEDIATOR; RECEPTOR; DEFENSE; COMPLEX; RESPONSES	The plant hormone jasmonate plays crucial roles in regulating plant responses to herbivorous insects and microbial pathogens and is an important regulator of plant growth and development(1-7). Keymediators of jasmonate signalling include MYC transcription factors, which are repressed by jasmonate ZIM-domain (JAZ) transcriptional repressors in the resting state. In the presence of active jasmonate, JAZ proteins function as jasmonate co-receptors by forming a hormone-dependent complex with COI1, the F-box subunit of an SCF-type ubiquitin E3 ligase(8-11). The hormone-dependent formation of the COI1-JAZ co-receptor complex leads to ubiquitination and proteasome-dependent degradation of JAZ repressors and release of MYC proteins from transcriptional repression(3,10,12). The mechanism by which JAZ proteins repress MYC transcription factors and how JAZ proteins switch between the repressor function in the absence of hormone and the co-receptor function in the presence of hormone remain enigmatic. Here we show that Arabidopsis MYC3 undergoes pronounced conformational changes when bound to the conserved Jas motif of the JAZ9 repressor. The Jas motif, previously shown to bind to hormone as a partly unwound helix, forms a complete alpha-helix that displaces the amino (N)-terminal helix ofMYC3 and becomes an integral part of theMYC N-terminal fold. In this position, the Jas helix competitively inhibits MYC3 interaction with the MED25 subunit of the transcriptional Mediator complex. Our structural and functional studies elucidate a dynamic molecular switchmechanism that governs the repression and activation of a major plant hormone pathway.	[Zhang, Feng; Ke, Jiyuan; Zhou, X. Edward; Chen, Jian; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Zhang, Feng; Ke, Jiyuan; Zhou, X. Edward; Chen, Jian; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Lab Struct Biol & Biochem, Grand Rapids, MI 49503 USA; [Zhang, Feng; Yao, Jian; Zhang, Li; Xin, Xiu-Fang; He, Sheng Yang] Michigan State Univ, DOE Plant Res Lab, E Lansing, MI 48824 USA; [Zhang, Feng; Zhou, Mingguo] Nanjing Agr Univ, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China; [Yao, Jian] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Zhang, Li; He, Sheng Yang] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Lam, Vinh Q.; Griffin, Patrick R.] Scripps Florida, Scripps Res Inst, Translat Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Chen, Jian] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China; [Brunzelle, Joseph] Northwestern Univ, Synchrotron Res Ctr, Dept Mol Pharmacol & Biol Chem, Life Sci Collaborat Access Team, Argonne, IL 60439 USA; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Key Lab Receptor Res,VARI SIMM Ctr,Ctr Struct & F, Shanghai 200031, Peoples R China; [He, Sheng Yang] Michigan State Univ, Howard Hughes Med Inst, E Lansing, MI 48824 USA	Van Andel Institute; Van Andel Institute; Michigan State University; United States Department of Energy (DOE); Nanjing Agricultural University; Western Michigan University; Michigan State University; Scripps Research Institute; State University System of Florida; University of Florida; Zhejiang Sci-Tech University; Northwestern University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Howard Hughes Medical Institute; Michigan State University	Xu, HE (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA.	Eric.Xu@vai.org; Karsten.Melcher@vai.org; hes@msu.edu	Melcher, Karsten/AAZ-3861-2020; Zhang, Li/AAA-6476-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Zhang, Li/0000-0003-3112-7373; He, Sheng Yang/0000-0003-1308-498X; Chen, Jian/0000-0003-2735-3925; Brunzelle, Joseph/0000-0001-9197-0018; Xu, H. Eric/0000-0002-6829-8144	Gordon and Betty Moore Foundation [GBMF3037]; China Scholarship Council; Van Andel Research Institute; National Institutes of Health [R01 GM102545, R01AI060761]; Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science) [DE-FG02-91ER20021]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Office of Science of the US Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060761, R01AI068718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102545] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); China Scholarship Council(China Scholarship Council); Van Andel Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported by the Gordon and Betty Moore Foundation (GBMF3037, to S.Y.H.), the China Scholarship Council (to F.Z.), Van Andel Research Institute (to H.E.X. and K.M.), the National Institutes of Health (R01 GM102545 to K.M. and R01AI060761 to S.Y.H.), and the Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science Grant DE-FG02-91ER20021 (to S.Y.H.). We thank S. Grant for administrative support and staff members of the Life Science Collaborative Access Team of the Advanced Photon Source for assistance in data collection at the beam lines of sector 21, which is in part funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). Use of the Advanced Photon Source was supported by the Office of Science of the US Department of Energy, under contract number DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also thank G. Howe and K. Aung for reading the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Browse J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259pe9; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Figueroa P, 2012, PLANT CELL PHYSIOL, V53, P330, DOI 10.1093/pcp/pcr178; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Liechti R, 2002, SCIENCE, V296, P1649, DOI 10.1126/science.1071547; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2000, J MOL BIOL, V301, P1097, DOI 10.1006/jmbi.2000.4034; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Smolen GA, 2002, GENETICS, V161, P1235; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Sun XL, 2013, PLANT CELL, V25, P38, DOI 10.1105/tpc.112.106062; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Wager A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00041; Withers J, 2012, P NATL ACAD SCI USA, V109, P20148, DOI 10.1073/pnas.1210054109; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Yao Jian, 2013, Methods Mol Biol, V1011, P63, DOI 10.1007/978-1-62703-414-2_6; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	43	181	198	35	292	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					269	+		10.1038/nature14661	http://dx.doi.org/10.1038/nature14661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26258305	Green Accepted, Green Submitted			2022-12-28	WOS:000360927400043
J	Dunn, KE; Dannenberg, F; Ouldridge, TE; Kwiatkowska, M; Turberfield, AJ; Bath, J				Dunn, Katherine E.; Dannenberg, Frits; Ouldridge, Thomas E.; Kwiatkowska, Marta; Turberfield, Andrew J.; Bath, Jonathan			Guiding the folding pathway of DNA origami	NATURE			English	Article							SINGLE-STRANDED-DNA; NANOSCALE SHAPES; PERSISTENCE LENGTHS; FLEXIBILITY; THERMODYNAMICS; NANOSTRUCTURES; HYBRIDIZATION; STABILITY; MOLECULES; MAGNESIUM	DNA origami is a robust assembly technique that folds a single-stranded DNA template into a target structure by annealing it with hundreds of short 'staple' strands(1-4.) Its guiding design principle is that the target structure is the single most stable configuration(5). The folding transition is cooperative(4,6,7) and, as in the case of proteins, is governed by information encoded in the polymer sequence(8-11). A typical origami folds primarily into the desired shape, but misfolded structures can kinetically trap the system and reduce the yield(2). Although adjusting assembly conditions(2,12) or following empirical design rules(12,13) can improve yield, well-folded origami often need to be separated from misfolded structures(2,3,14-16). The problem could in principle be avoided if assembly pathway and kinetics were fully understood and then rationally optimized. To this end, here we present a DNA origami system with the unusual property of being able to form a small set of distinguishable and well-folded shapes that represent discrete and approximately degenerate energy minima in a vast folding landscape, thus allowing us to probe the assembly process. The obtained high yield of well-folded origami structures confirms the existence of efficient folding pathways, while the shape distribution provides information about individual trajectories through the folding landscape. We find that, similarly to protein folding, the assembly of DNA origami is highly cooperative; that reversible bond formation is important in recovering from transient misfoldings; and that the early formation of long-range connections can very effectively enforce particular folds. We use these insights to inform the design of the system so as to steer assembly towards desired structures. Expanding the rational design process to include the assembly pathway should thus enable more reproducible synthesis, particularly when targeting more complex structures. We anticipate that this expansion will be essential if DNA origami is to continue its rapid development(1-3,17-19) and become a reliable manufacturing technology(20).	[Dunn, Katherine E.; Dannenberg, Frits; Turberfield, Andrew J.; Bath, Jonathan] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Dannenberg, Frits; Kwiatkowska, Marta] Univ Oxford, Dept Comp Sci, Oxford OX1 3QD, England; [Ouldridge, Thomas E.] Univ Oxford, Dept Phys, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England	University of Oxford; University of Oxford; University of Oxford	Bath, J (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	a.turberfield@physics.ox.ac.uk; j.bath@physics.ox.ac.uk	Turberfield, Andrew J/O-2135-2017	Turberfield, Andrew J/0000-0002-3876-0190; Dunn, Katherine Elizabeth/0000-0002-5068-4354; Kwiatkowska, Marta/0000-0001-9022-7599; Ouldridge, Thomas/0000-0001-8114-8602	Engineering and Physical Sciences Research Council [EP/G037930/1, EP/P504287/1]; Human Frontier Science Program [RGP0030/2013]; Microsoft Research PhD Scholarship; ERC Advanced Grant VERIWARE; Royal Society-Wolfson Research Merit Award; BBSRC [BB/M005739/1] Funding Source: UKRI; EPSRC [EP/G037930/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M005739/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/A10274/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Human Frontier Science Program(Human Frontier Science Program); Microsoft Research PhD Scholarship(Microsoft); ERC Advanced Grant VERIWARE; Royal Society-Wolfson Research Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank K.V. Gothelf, M. Dong, A.L.B. Kodal, S. Helmig and S. Zhang (Department of Chemistry and Interdisciplinary Nanoscience Centre iNano, Aarhus, Denmark) for assistance with AFM imaging. This research was supported by Engineering and Physical Sciences Research Council grants EP/G037930/1 and EP/P504287/1, a Human Frontier Science Program grant RGP0030/2013, a Microsoft Research PhD Scholarship (F.D.), the ERC Advanced Grant VERIWARE (F.D. and M.K.) and a Royal Society-Wolfson Research Merit Award (A.J.T.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arbona JM, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4773405; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Chen H, 2012, P NATL ACAD SCI USA, V109, P799, DOI 10.1073/pnas.1119057109; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Fink TMA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198103; Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ke YG, 2012, CHEM SCI, V3, P2587, DOI 10.1039/c2sc20446k; Kershner RJ, 2009, NAT NANOTECHNOL, V4, P557, DOI [10.1038/nnano.2009.220, 10.1038/NNANO.2009.220]; Levinthal C., 1969, U ILLINOIS B, V67, P22; Martin TG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2095; Mills JB, 1999, J MOL BIOL, V285, P245, DOI 10.1006/jmbi.1998.2287; MORRISON LE, 1993, BIOCHEMISTRY-US, V32, P3095, DOI 10.1021/bi00063a022; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626; Ouldridge TE, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/10/104102; Owczarzy R, 2008, BIOCHEMISTRY-US, V47, P5336, DOI 10.1021/bi702363u; Perrault SD, 2014, ACS NANO, V8, P5132, DOI 10.1021/nn5011914; Peryet N., 2000, THESIS WAYNE STATE U; Rayleigh, 1919, PHILOS MAG, V37, P321, DOI 10.1080/14786440408635894; Rivetti C, 1998, J MOL BIOL, V280, P41, DOI 10.1006/jmbi.1998.1830; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Saenger W., 1984, PRINCIPLES NUCL ACID; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Song J, 2012, J AM CHEM SOC, V134, P9844, DOI 10.1021/ja3017939; Wickham SFJ, 2011, NAT NANOTECHNOL, V6, P166, DOI [10.1038/nnano.2010.284, 10.1038/NNANO.2010.284]; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s; Zhang PH, 2010, PROTEIN EXPRES PURIF, V69, P226, DOI 10.1016/j.pep.2009.09.003	47	109	115	6	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					82	+		10.1038/nature14860	http://dx.doi.org/10.1038/nature14860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26287459	Green Submitted			2022-12-28	WOS:000360594100029
J	Hunter, DJ; D'Agostino, RB				Hunter, David J.; D'Agostino, Ralph B., Sr.			Let's Not Put All Our Eggs in One Basket	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hunter, David J.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Hunter, DJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.							Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Menis J, 2014, EUR RESPIR REV, V23, P367, DOI 10.1183/09059180.00004214; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457	5	13	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					691	693		10.1056/NEJMp1508144	http://dx.doi.org/10.1056/NEJMp1508144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287847				2022-12-28	WOS:000359709400004
J	Lee, AYY; Kamphuisen, PW; Meyer, G; Bauersachs, R; Janas, MS; Jarner, MF; Khorana, AA				Lee, Agnes Y. Y.; Kamphuisen, Pieter W.; Meyer, Guy; Bauersachs, Rupert; Janas, Mette S.; Jarner, Mikala F.; Khorana, Alok A.		CATCH Investigators	Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOLECULAR-WEIGHT HEPARIN; PREVENTION; DISEASE	IMPORTANCE Low-molecular-weight heparin is recommended over warfarin for the treatment of acute venous thromboembolism (VTE) in patients with active cancer largely based on results of a single, large trial. OBJECTIVE To study the efficacy and safety of tinzaparin vs warfarin for treatment of acute, symptomatic VTE in patients with active cancer. DESIGN, SETTINGS, AND PARTICIPANTS A randomized, open-label study with blinded central adjudication of study outcomes enrolled patients in 164 centers in Asia, Africa, Europe, and North, Central, and South America between August 2010 and November 2013. Adult patients with active cancer (defined as histologic diagnosis of cancer and receiving anticancer therapy or diagnosed with, or received such therapy, within the previous 6 months) and objectively documented proximal deep vein thrombosis (DVT) or pulmonary embolism, with a life expectancy greater than 6 months and without contraindications for anticoagulation, were followed up for 180 days and for 30 days after the last study medication dose for collection of safety data. INTERVENTIONS Tinzaparin (175 IU/kg) once daily for 6 months vs conventional therapy with tinzaparin (175 IU/kg) once daily for 5 to 10 days followed by warfarin at a dose adjusted to maintain the international normalized ratio within the therapeutic range (2.0-3.0) for 6 months. MAIN OUTCOMES AND MEASURES Primary efficacy outcome was a composite of centrally adjudicated recurrent DVT, fatal or nonfatal pulmonary embolism, and incidental VTE. Safety outcomes included major bleeding, clinically relevant nonmajor bleeding, and overall mortality. RESULTS Nine hundred patients were randomized and included in intention-to-treat efficacy and safety analyses. Recurrent VTE occurred in 31 of 449 patients treated with tinzaparin and 45 of 451 patients treated with warfarin (6-month cumulative incidence, 7.2% for tinzaparin vs 10.5% for warfarin; hazard ratio [HR], 0.65 [95% CI, 0.41-1.03]; P = .07). There were no differences in major bleeding (12 patients for tinzaparin vs 11 patients for warfarin; HR, 0.89 [95% CI, 0.40-1.99]; P = .77) or overall mortality (150 patients for tinzaparin vs 138 patients for warfarin; HR, 1.08 [95% CI, 0.85-1.36]; P = .54). A significant reduction in clinically relevant nonmajor bleeding was observed with tinzaparin (49 of 449 patients for tinzaparin vs 69 of 451 patients for warfarin; HR, 0.58 [95% CI, 0.40-0.84]; P = .004). CONCLUSIONS AND RELEVANCE Among patients with active cancer and acute symptomatic VTE, the use of full-dose tinzaparin (175 IU/kg) daily compared with warfarin for 6 months did not significantly reduce the composite measure of recurrent VTE and was not associated with reductions in overall mortality or major bleeding, but was associated with a lower rate of clinically relevant nonmajor bleeding. Further studies are needed to assess whether the efficacy outcomes would be different in patients at higher risk of recurrent VTE.	[Lee, Agnes Y. Y.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Lee, Agnes Y. Y.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Kamphuisen, Pieter W.] Univ Groningen, Univ Med Ctr Groningen, Dept Vasc Med, Groningen, Netherlands; [Meyer, Guy] Univ Paris 05, Hop Europeen Georges Pompidou, INSERM, U970, Paris, France; [Bauersachs, Rupert] Darmstadt Hosp, Dept Vasc Med, Darmstadt, Germany; [Bauersachs, Rupert] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Haemostasis, D-55122 Mainz, Germany; [Janas, Mette S.; Jarner, Mikala F.] LEO Pharma, Ballerup, Denmark; [Khorana, Alok A.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA	University of British Columbia; British Columbia Cancer Agency; University of Groningen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Klinikum Darmstadt; Johannes Gutenberg University of Mainz; LEO Pharma; Cleveland Clinic Foundation	Lee, AYY (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.		Ditl, Pavel/J-6473-2017; Otero-Candelera, Remedios/G-7312-2016; ABOELHASSAN, Rasha/AAF-6491-2021; de Azevedo, Sergio Jobim/P-5115-2015	Ditl, Pavel/0000-0002-7807-4494; Otero-Candelera, Remedios/0000-0002-2265-1221; ABOELHASSAN, Rasha/0000-0003-4755-6105; Khorana, Alok/0000-0002-9509-0998; Kamphuisen, Pieter/0000-0002-6263-0177	LEO Pharma; Sondra and Stephen Hardis Endowed Chair in Oncology Research; Scott Hamilton CARES Initiative	LEO Pharma(LEO Pharma); Sondra and Stephen Hardis Endowed Chair in Oncology Research; Scott Hamilton CARES Initiative	The study was sponsored and funded by LEO Pharma and had research support from the Sondra and Stephen Hardis Endowed Chair in Oncology Research and the Scott Hamilton CARES Initiative (Dr Khorana).	Akl E.A., 2011, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD006650.PUB3; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hull RD, 2006, AM J MED, V119, P1062, DOI 10.1016/j.amjmed.2006.02.022; Hutten BA, 2000, J CLIN ONCOL, V18, P3078, DOI 10.1200/JCO.2000.18.17.3078; Imberti D, 2008, HAEMATOLOGICA, V93, P273, DOI 10.3324/haematol.11458; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Khorana A A, 2012, J Thromb Haemost, V10, P2602; Khorona AA, 2015, CIRC-CARDIOVASC QUAL, V8, pA210; Kleinjan A, 2013, THROMB HAEMOSTASIS, V110, P959, DOI 10.1160/TH13-05-0414; Lee AYY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-284; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lee AYY, 2014, BLOOD, V124; Lyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351; Mandala M, 2011, ANN ONCOL S, pvi85, DOI [10.1093/annonc/mdr392, DOI 10.1093/ANN0NC/MDR392]; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Palareti G, 2000, THROMB HAEMOSTASIS, V84, P805; Parpia S, 2011, CONTEMP CLIN TRIALS, V32, P829, DOI 10.1016/j.cct.2011.07.005; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Spirk D, 2011, THROMB HAEMOSTASIS, V105, P962, DOI 10.1160/TH11-01-0002	24	425	434	0	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					677	686		10.1001/jama.2015.9243	http://dx.doi.org/10.1001/jama.2015.9243			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284719	Bronze			2022-12-28	WOS:000360019100016
J	Padwal, R				Padwal, Raj			Review: Ambulatory blood pressure monitoring predicts cardiovascular events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HYPERTENSION; DIAGNOSIS		Univ Alberta, Edmonton, AB, Canada	University of Alberta	Padwal, R (corresponding author), Univ Alberta, Edmonton, AB, Canada.		Padwal, Raj/G-6903-2016	Padwal, Raj/0000-0003-3541-2817				Cloutier L, 2015, CAN J CARDIOL, V31, P620, DOI 10.1016/j.cjca.2015.02.014; Daskalopoulou SS, 2015, CAN J CARDIOL, V31, P549, DOI 10.1016/j.cjca.2015.02.016; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; National Institute for Health and Care Excellence, 2011, HYP CLIN MAN PRIM HY	4	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					JC14	JC14		10.7326/ACPJC-2015-163-4-014	http://dx.doi.org/10.7326/ACPJC-2015-163-4-014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26280436				2022-12-28	WOS:000364673500024
J	Rohde, PP; Dowling, JP				Rohde, Peter P.; Dowling, Jonathan P.			The on-ramp to the all-optical quantum information processing highway	SCIENCE			English	Editorial Material							COMPUTATION		[Rohde, Peter P.] Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst QCIS, Sydney, NSW 2007, Australia; [Dowling, Jonathan P.] Louisiana State Univ, Hearne Inst Theoret Phys, Baton Rouge, LA 70803 USA; [Dowling, Jonathan P.] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA	University of Technology Sydney; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Rohde, PP (corresponding author), Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst QCIS, Sydney, NSW 2007, Australia.	dr.rohde@gmail.com; jdowling@lsu.edu	Rohde, Peter/M-8244-2019	Rohde, Peter/0000-0002-5814-7289				Aaronson S., 2011, P 43 ANN ACM S THEOR, P333; DEUTSCH D, 1992, P ROY SOC LOND A MAT, V439, P553, DOI 10.1098/rspa.1992.0167; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Motes KR, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.170802; O'Brien JL, 2003, NATURE, V426, P264, DOI 10.1038/nature02054	6	4	4	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					696	696		10.1126/science.aac7250	http://dx.doi.org/10.1126/science.aac7250			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273045				2022-12-28	WOS:000359415100021
J	Petsakou, A; Sapsis, TP; Blau, J				Petsakou, Afroditi; Sapsis, Themistoklis P.; Blau, Justin			Circadian Rhythms in Rho1 Activity Regulate Neuronal Plasticity and Network Hierarchy	CELL			English	Article							RAT SUPRACHIASMATIC NUCLEUS; DOMINANT CEREBELLAR-ATAXIA; DROSOPHILA-MELANOGASTER; MYOSIN PHOSPHATASE; PACEMAKER NEURONS; FAMILY GTPASES; CLOCK NEURONS; LIGHT; MORPHOGENESIS; OSCILLATORS	Neuronal plasticity helps animals learn from their environment. However, it is challenging to link specific changes in defined neurons to altered behavior. Here, we focus on circadian rhythms in the structure of the principal s-LNv clock neurons in Drosophila. By quantifying neuronal architecture, we observed that s-LNv structural plasticity changes the amount of axonal material in addition to cycles of fasciculation and defasciculation. We found that this is controlled by rhythmic Rho1 activity that retracts s-LNv axonal termini by increasing myosin phosphorylation and simultaneously changes the balance of pre-synaptic and dendritic markers. This plasticity is required to change clock network hierarchy and allow seasonal adaptation. Rhythms in Rho1 activity are controlled by clock-regulated transcription of Puratrophin-1-like (Pura), a Rho1 GEF. Since spinocerebellar ataxia is associated with mutations in human Puratrophin-1, our data support the idea that defective actin-related plasticity underlies this ataxia.	[Petsakou, Afroditi; Blau, Justin] NYU, Dept Biol, New York, NY 10003 USA; [Sapsis, Themistoklis P.] NYU, Courant Inst Appl Math, New York, NY 10003 USA; [Sapsis, Themistoklis P.] MIT, Dept Mech Engn, Cambridge, MA 02142 USA; [Blau, Justin] New York Univ Abu Dhabi, Ctr Genom Syst Biol, Abu Dhabi, U Arab Emirates; [Blau, Justin] New York Univ Abu Dhabi, Program Biol, Abu Dhabi, U Arab Emirates	New York University; New York University; Massachusetts Institute of Technology (MIT)	Blau, J (corresponding author), NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.	justin.blau@nyu.edu			NCRR, NIH; NYU's GSAS MacCracken Program; Dean's Dissertation Fellowship; NYU Courant Institute postdoctoral fellowship; NIH [GM063911, NS077156]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS077156] Funding Source: NIH RePORTER	NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NYU's GSAS MacCracken Program; Dean's Dissertation Fellowship; NYU Courant Institute postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Vivian Budnik, Paul Hardin, Brian McCabe, Tim Mosca, Jae Park, Michael Rosbash, Amita Sehgal, Stephan Sigrist, Sergio Simoes, Jessica Treisman, the DSHB and the VDRC, Kyoto and Bloomington Stock Centers for flies and antibodies. We thank Anita Burgos and Samantha Raymond for their contributions and Hsaio-Yun Liu for advice on shRNA. We thank Rich Bonneau, Lionel Christiaen, Claude Desplan, Erik Herzog, Adrian Rothenfluh, Chris Rushlow, and Mark Siegal for invaluable discussions, Claire Bertet, Matthieu Cavey, Ben Collins, Chris Hackley, and Zhonghua Zhu for comments on the manuscript, and Erin Meekhof for making the graphical abstract. We also thank Herman Wijnen for communicating unpublished data. This investigation was conducted in facilities constructed with support from Research Facilities Improvement Grant Number C06 RR-15518-01 from the NCRR, NIH. Imaging was performed at NYU's Center for Genomics & Systems Biology. A.P. was partly supported by NYU's GSAS MacCracken Program and a Dean's Dissertation Fellowship. T.P.S. was partly supported by an NYU Courant Institute postdoctoral fellowship. This work was supported by NIH grants GM063911 and NS077156 to J.B.	Amino T, 2007, J HUM GENET, V52, P643, DOI 10.1007/s10038-007-0154-1; Gorostiza EA, 2014, CURR BIOL, V24, P2161, DOI 10.1016/j.cub.2014.07.063; Becquet D, 2008, GLIA, V56, P294, DOI 10.1002/glia.20613; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Collins B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001959; Collins B, 2012, NEURON, V74, P706, DOI 10.1016/j.neuron.2012.02.034; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Gerber A, 2013, CELL, V152, P492, DOI 10.1016/j.cell.2012.12.027; Girardet C, 2010, EUR J NEUROSCI, V31, P359, DOI 10.1111/j.1460-9568.2009.07071.x; Gonzalez-Billault C, 2012, CYTOSKELETON, V69, P464, DOI 10.1002/cm.21034; Guo F, 2014, ELIFE, V3, DOI 10.7554/eLife.02780; Gupta M, 2013, J BIOL CHEM, V288, P14522, DOI 10.1074/jbc.M112.430371; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Mizrak D, 2012, CURR BIOL, V22, P1871, DOI 10.1016/j.cub.2012.07.070; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Simoes S, 2006, DEVELOPMENT, V133, P4257, DOI 10.1242/dev.02588; Sivachenko A, 2013, NEURON, V79, P281, DOI 10.1016/j.neuron.2013.05.015; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Veeman MT, 2013, DEV BIOL, V373, P281, DOI 10.1016/j.ydbio.2012.11.009; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yasuyama K, 2010, J COMP NEUROL, V518, P292, DOI 10.1002/cne.22210; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Yuan Q, 2011, SCIENCE, V333, P1458, DOI 10.1126/science.1207121; Zelinski EL, 2014, NEUROSCI BIOBEHAV R, V40, P80, DOI 10.1016/j.neubiorev.2014.01.007; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056	44	51	53	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					823	835		10.1016/j.cell.2015.07.010	http://dx.doi.org/10.1016/j.cell.2015.07.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26234154	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000359741400015
J	Berian, JR; Benson, AB; Nelson, H				Berian, Julia R.; Benson, Al B., III; Nelson, Heidi			Young Age and Aggressive Treatment in Colon Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER; ADJUVANT THERAPY	IMPORTANCE Colon cancer is increasing among adults younger than 50 years. However, the prognosis of young-onset colon cancer remains poorly defined given significant age-related demographic, disease, and treatment differences. OBJECTIVE To define stage-specific treatments and prognosis of colon cancer diagnosed in young adults (ages 18-49 years) vs older adults (ages 65-75 years) outside of the clinical trial setting while accounting for real-world age-related variations in patient, tumor, and treatment factors. DESIGN, SETTING, AND PARTICIPANTS A nationwide cohort study was conducted among US hospitals accredited by the American College of Surgeons Commission on Cancer. Participants were 13 102 patients diagnosed as having young-onset colon adenocarcinoma aged 18 to 49 years and 37 007 patients diagnosed as having later-onset colon adenocarcinoma aged 65 to 75 years treated between January 1, 2003, and December 31, 2005, and reported to the National Cancer Data Base. EXPOSURES Patients who underwent surgical resection and postoperative systemic chemotherapy of curative intent. MAIN OUTCOMES AND MEASURES The primary end point was stage-specific relative survival, an objective measure of survival among patients with cancer, adjusting for baseline mortality rates and independent of the data on cause of death. The secondary end point was stage-specific likelihood of receiving postoperative systemic chemotherapy. RESULTS Most young-onset colon cancer was initially seen at advanced stages (61.8% had stage III or IV). After adjusting for patient-related and tumor-related factors, young patients were more likely to receive systemic chemotherapy, particularly multiagent regimens, at all stages relative to those with lateronset disease. These odds ratios were 2.88 (95% CI, 2.21-3.77) for stage I, 3.93 (95% CI, 3.58-4.31) for stage II, 2.42 (95% CI, 2.18-2.68) for stage III, and 2.74 (95% CI, 2.44-3.07) for stage IV. The significantly more intense treatments received by younger patients were unmatched by any survival gain, which was nil for stage II (relative risk, 0.90; 95% CI, 0.69-1.17) and marginal for stage III (relative risk, 0.89; 95% CI, 0.81-0.97) and stage IV (relative risk, 0.84; 95% CI, 0.79-0.90). CONCLUSIONS AND RELEVANCE Young adults with colon cancer received significantly more postoperative systemic chemotherapy at all stages, but they experienced only minimal gain in adjusted survival compared with their older counterparts who received less treatment. This mismatch suggests that attention should be given to long-term cancer survivorship in young adults with colon cancer because they likely face survivorship needs that are distinct from those of their older counterparts.	[Berian, Julia R.] Amer Coll Surg, Div Res & Optimal Patient Care, Chicago, IL USA; [Berian, Julia R.] Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA; [Benson, Al B., III] Northwestern Univ, Dept Med Hematol Oncol, Chicago, IL 60611 USA; [Nelson, Heidi] Mayo Clin, Dept Surg, Rochester, MN USA	American College of Surgeons; University of Chicago; University of Chicago Medical Center; Northwestern University; Mayo Clinic	Berian, JR (corresponding author), Univ Chicago Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	julia.berian@uchospitals.edu		Berian, Julia/0000-0001-9754-3631				[Anonymous], 2015, COL CANC VERS 3 2015; Bailey CE, 2015, JAMA SURG, V150, P17, DOI 10.1001/jamasurg.2014.1756; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Kneuertz PJ, 2015, JAMA SURG, V150, P402, DOI 10.1001/jamasurg.2014.3572; Renfro LA, 2015, ANN ONCOL, V26, P950, DOI 10.1093/annonc/mdv073; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Wang MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10645	8	15	15	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					613	614		10.1001/jama.2015.9379	http://dx.doi.org/10.1001/jama.2015.9379			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26262799				2022-12-28	WOS:000359388600020
J	Ohtsuru, A; Tanigawa, K; Kumagai, A; Niwa, O; Takamura, N; Midorikawa, S; Nollet, K; Yamashita, S; Ohto, H; Chhem, RK; Clarke, M				Ohtsuru, Akira; Tanigawa, Koichi; Kumagai, Atsushi; Niwa, Ohtsura; Takamura, Noboru; Midorikawa, Sanae; Nollet, Kenneth; Yamashita, Shunichi; Ohto, Hitoshi; Chhem, Rethy K.; Clarke, Mike			Nuclear disasters and health: lessons learned, challenges, and proposals	LANCET			English	Article							EAST JAPAN EARTHQUAKE; POWER-PLANT; RISK COMMUNICATION; HURRICANE SANDY; FUKUSHIMA CITY; NEW-YORK; ACCIDENT; EVACUATION; RADIATION; MANAGEMENT	Past nuclear disasters, such as the atomic bombings in 1945 and major accidents at nuclear power plants, have highlighted similarities in potential public health effects of radiation in both circumstances, including health issues unrelated to radiation exposure. Although the rarity of nuclear disasters limits opportunities to undertake rigorous research of evidence-based interventions and strategies, identification of lessons learned and development of an effective plan to protect the public, minimise negative effects, and protect emergency workers from exposure to high-dose radiation is important. Additionally, research is needed to help decision makers to avoid premature deaths among patients already in hospitals and other vulnerable groups during evacuation. Since nuclear disasters can affect hundreds of thousands of people, a substantial number of people are at risk of physical and mental harm in each disaster. During the recovery period after a nuclear disaster, physicians might need to screen for psychological burdens and provide general physical and mental health care for many affected residents who might experience long-term displacement. Reliable communication of personalised risks has emerged as a challenge for health-care professionals beyond the need to explain radiation protection. To overcome difficulties of risk communication and provide decision aids to protect workers, vulnerable people, and residents after a nuclear disaster, physicians should receive training in nuclear disaster response. This training should include evidence-based interventions, support decisions to balance potential harms and benefits, and take account of scientific uncertainty in provision of community health care. An open and joint learning process is essential to prepare for, and minimise the effects of, future nuclear disasters.	[Ohtsuru, Akira; Midorikawa, Sanae] Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima 9601295, Japan; [Tanigawa, Koichi; Niwa, Ohtsura; Nollet, Kenneth] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Fukushima 9601295, Japan; [Kumagai, Atsushi] Fukushima Med Univ, Educ Ctr Disaster Med, Fukushima 9601295, Japan; [Ohto, Hitoshi] Fukushima Med Univ, Radiat Med Sci Ctr, Fukushima 9601295, Japan; [Yamashita, Shunichi] Nagasaki Univ, Dept Radiat Med Sci, Nagasaki 852, Japan; [Takamura, Noboru] Nagasaki Univ, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Chhem, Rethy K.] Cambodia Dev Resource Inst, Phnom Penh, Cambodia; [Clarke, Mike] Queens Univ Belfast, Royal Hosp, Ctr Publ Hlth, Belfast, Antrim, North Ireland	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Nagasaki University; Nagasaki University; Queens University Belfast	Ohtsuru, A (corresponding author), Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima 9601295, Japan.	ohtsuru@fmc.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Yamashita, Shunichi/0000-0001-6399-6261; Takamura, Noboru/0000-0002-5552-3234	Fukushima Medical University; Hiroshima University; Nagasaki University; MRC [G0901530] Funding Source: UKRI; Medical Research Council [G0901530] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K00540] Funding Source: KAKEN	Fukushima Medical University; Hiroshima University; Nagasaki University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Fukushima Medical University, Hiroshima University, and Nagasaki University for generous support. The views expressed in this report are solely those of the authors. We thank Masafumi Abe, Shin-ichi Suzuki, Satoru Suzuki, and Seiji Yasumura (Fukushima Medical University, Fukushima, Japan) for their academic support. We thank Mitsuko Fujino, Akira Sakai, Makoto Miyazaki, Hisashi Sato, Naohiro Tsuyama, Takashi Ohba, Koji Yoshida, and Kiyotaka Yasui (Fukushima Medical University, Fukushima city, Japan), and Tomoyoshi Oikawa (Minamisoma Municipal General Hospital, Minamisoma city, Japan) for nuclear disaster medical education and training.	Allen Claire, 2014, J Evid Based Med, V7, P234, DOI 10.1111/jebm.12127; [Anonymous], ACT DEV CRIS MAN SYS; [Anonymous], 2011, JJAAM; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Bromet EJ, 2012, J RADIOL PROT, V32, pN71, DOI 10.1088/0952-4746/32/1/N71; Butler D, 2011, NATURE, V472, P13, DOI 10.1038/472400a; Chan TC, 2004, ACAD EMERG MED, V11, P1229, DOI 10.1197/j.aem.2004.08.018; Covello VT, 2011, HEALTH PHYS, V101, P511, DOI 10.1097/HP.0b013e3182299549; CUTTER S, 1982, DISASTERS, V6, P116, DOI 10.1111/j.1467-7717.1982.tb00765.x; Davies E, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7357; Evidence Aid Priority Setting Group, 2013, PLOS CURR, V5; Fukushima Prefectural Government, 2014, RES SURV INT EV; Fukushima Radiation and Health, P 17 PREF OV COMM M; Gerdin M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001632; Gonzalez AJ, 2013, J RADIOL PROT, V33, P497, DOI 10.1088/0952-4746/33/3/497; Goto A, 2014, DISASTERS, V38, ps179, DOI 10.1111/disa.12070; Goto A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-129; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P196, DOI 10.2183/pjab.89.196; Health Physics Society, IS POT IOD MAG BULL; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Ichiseki H, 2013, LANCET, V381, P204, DOI 10.1016/S0140-6736(13)60091-4; International Committee on Radiological Protection, 1991, ICRP PUBL; Ito Y, 2013, NAT REV ENDOCRINOL, V9, P178, DOI 10.1038/nrendo.2012.257; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; KASPERSON RE, 1992, SOCIAL THEORIES OF RISK, P153; Kim Y, 2011, BRIT J PSYCHIAT, V199, P411, DOI 10.1192/bjp.bp.110.085472; Klein Kelly R, 2007, Disaster Manag Response, V5, P56, DOI 10.1016/j.dmr.2007.03.001; Koido Y., 2011, Journal of the National Institute of Public Health, V60, P495; Kondo H, 2009, PREHOSP DISASTER MED, V24, P556, DOI 10.1017/S1049023X00007512; Kudo D, 2013, DISASTER MED PUBLIC, V7, P461, DOI 10.1017/dmp.2013.77; Maekawa K, 2011, J CLIN EXP MED, V239, P1056; Malilay J, 2014, AM J PUBLIC HEALTH, V104, P2092, DOI 10.2105/AJPH.2014.302010; MAXWELL C, 1982, AM J PUBLIC HEALTH, V72, P275, DOI 10.2105/AJPH.72.3.275; Ministry of Health Labour and Welfare, EM MED INF SYST HOSP; Neria Y, 2011, AM PSYCHOL, V66, P429, DOI 10.1037/a0024791; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; O'Malley P, 2009, B WORLD HEALTH ORGAN, V87, P614, DOI 10.2471/BLT.08.056689; Ochi S., 2014, PLOS CURR, V18, P6; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Pfenninger EG, 2010, INT J EMERG MED, V3, P9, DOI 10.1007/s12245-009-0140-9; Prylyko V, 2011, HLTH EFFECTS CHERNOB, P533; Radiation Emergency Medicine Network, LOC RAD EM MED FAC; Save the Children, 2012, FUK FAM CHILDR FAM A; Schmemann Serge, 1986, NY TIMES; Sekiya Naoya, 2011, Fukushima J Med Sci, V57, P93; Shibuya K, 2014, LANCET, V383, P1883, DOI 10.1016/S0140-6736(14)60909-0; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shlyakhter A, 1992, PUBLIC UNDERST SCI, V1, P251, DOI DOI 10.1088/0963-6625/1/3/002; SMITH JS, 1981, JAMA-J AM MED ASSOC, V245, P1656; Staudenherz A, 2011, INT J OCCUP ENV MED, V2, P133; Tanigawa K, 2013, RAD DISASTER MED PER; The Fukushima Nuclear Accident Independent Investigation Commission, 2012, NAT DIET JAPAN; The Joint US-Japan Aerial Measuring Systems Data, RAD ASS EFF FUK DAII; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Tokyo Electric Power Company, DISTR WORK EXP DOS; Tominaga T, 2014, HEALTH PHYS, V106, P630, DOI 10.1097/HP.0000000000000093; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, SOURC EFF ION RAD; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, SOURC EFF RISKS ION; United States President's Commission on the Accident at Three Mile Island, 1979, REP PRES COMM ACC 3; VanDevanter N, 2014, J URBAN HEALTH, V91, P603, DOI 10.1007/s11524-014-9889-0; Wells KB, 2013, PSYCHIAT CLIN N AM, V36, P451, DOI 10.1016/j.psc.2013.05.002; Wilson R, 2012, DOSE-RESPONSE, V10, P480, DOI 10.2203/dose-response.11-058.Wilson; Wisner B, 2014, BIOSECUR BIOTERROR; World Health Organization, 1999, GUID IOD PROPH FOLL; Yamashita S, 2014, HEALTH PHYS, V106, P166, DOI 10.1097/HP.0000000000000007; Yamashita S, 2013, RESPIR INVESTIG, V51, P128, DOI 10.1016/j.resinv.2013.05.007; Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Zipkin DA, 2014, ANN INTERN MED, V161, P270, DOI 10.7326/M14-0295	72	83	86	3	71	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					489	497		10.1016/S0140-6736(15)60994-1	http://dx.doi.org/10.1016/S0140-6736(15)60994-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN9IY	26251394				2022-12-28	WOS:000358761700029
J	Vella, D				Vella, Dominic			Two leaps forward for robot locomotion	SCIENCE			English	Editorial Material							WATER; WALKING		Math Inst, Oxford OX2 6GG, England	University of Oxford	Vella, D (corresponding author), Math Inst, Andrew Wiles Bldg,Woodstock Rd, Oxford OX2 6GG, England.	dominic.vella@maths.ox.ac.uk	Vella, Dominic/A-9070-2008	Vella, Dominic/0000-0003-1341-8863				Bartlett NW, 2015, SCIENCE, V349, P161, DOI 10.1126/science.aab0129; Burrows M, 2012, CURR BIOL, V22, pR990, DOI 10.1016/j.cub.2012.10.045; Bush JWM, 2006, ANNU REV FLUID MECH, V38, P339, DOI 10.1146/annurev.fluid.38.050304.092157; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Hu DL, 2007, EXP FLUIDS, V43, P769, DOI 10.1007/s00348-007-0339-6; Hu DL, 2003, NATURE, V424, P663, DOI 10.1038/nature01793; Koh JS, 2015, SCIENCE, V349, P517, DOI 10.1126/science.aab1637; Noblin X, 2012, SCIENCE, V335, P1322, DOI 10.1126/science.1215985; Ozcan O, 2014, INT J ADV ROBOT SYST, V11, DOI 10.5772/58701; Pandey A, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/24001; Vella D, 2015, ANNU REV FLUID MECH, V47, P115, DOI 10.1146/annurev-fluid-010814-014627	11	5	5	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					472	473		10.1126/science.aac7882	http://dx.doi.org/10.1126/science.aac7882			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228125				2022-12-28	WOS:000358713300027
J	Reich, MR; Harris, J; Ikegami, N; Maeda, A; Cashin, C; Araujo, EC; Takemi, K; Evans, TG				Reich, Michael R.; Harris, Joseph; Ikegami, Naoki; Maeda, Akiko; Cashin, Cheryl; Araujo, Edson C.; Takemi, Keizo; Evans, Timothy G.			Moving towards universal health coverage: lessons from 11 country studies	LANCET			English	Article							THAILAND	In recent years, many countries have adopted universal health coverage (UHC) as a national aspiration. In response to increasing demand for a systematic assessment of global experiences with UHC, the Government of Japan and the World Bank collaborated on a 2-year multicountry research programme to analyse the processes of moving towards UHC. The programme included 11 countries (Bangladesh, Brazil, Ethiopia, France, Ghana, Indonesia, Japan, Peru, Thailand, Turkey, and Vietnam), representing diverse geographical, economic, and historical contexts. The study identifi ed common challenges and opportunities and useful insights for how to move towards UHC. The study showed that UHC is a complex process, fraught with challenges, many possible pathways, and various pitfalls-but is also feasible and achievable. Movement towards UHC is a long-term policy engagement that needs both technical knowledge and political know-how. Technical solutions need to be accompanied by pragmatic and innovative strategies that address the national political economy context.	[Reich, Michael R.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Harris, Joseph] Boston Univ, Dept Sociol, Boston, MA 02215 USA; [Ikegami, Naoki] Keio Univ, Tokyo, Japan; [Cashin, Cheryl] Results Dev Inst, Washington, DC USA; [Maeda, Akiko; Araujo, Edson C.; Evans, Timothy G.] World Bank, Hlth Nutr & Populat Global Practice, 1818 H St NW, Washington, DC 20433 USA; [Takemi, Keizo] Natl Diet Japan, House Councillors, Tokyo, Japan	Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Keio University; The World Bank	Maeda, A (corresponding author), World Bank, Hlth Nutr & Populat Global Practice, 1818 H St NW, Washington, DC 20433 USA.	amaeda@worldbank.org						Araujo E, 2014, CONTRACTING PRIMARY; Araujo EC, 2013, 78506 HNP WORLD BANK; Bangladesh Health Watch, 2007, STAT HLTH BANGL 2007; Barroy H, 2014, COUNTRY SUMMARY REPO; Bump J., 2014, TURKEY WAY UNIVERSAL; Uga MAD, 2007, HEALTH AFFAIR, V26, P1017, DOI 10.1377/hlthaff.26.4.1017; El-Saharty S, 2014, COUNTRY SUMMARY REPO; Harris J., 2012, THESIS U WISCONSIN M; Harris J, 2015, J HEALTH POLIT POLIC, V40, P165, DOI 10.1215/03616878-2854689; Ikegami N., 2014, UNIVERSAL HLTH COVER; Ikegami N., 2014, UNIVERSAL HLTH COVER, P69; Jimenez Michelle, 2015, ANAL HLTH CARE LABOR; Maeda A, 2014, DIR DEV, P1, DOI 10.1596/978-1-4648-0297-3; Marzoeki P, 2014, COUNTRY SUMMARY REPO; Otoo N, 2014, COUNTRY SUMMARY REPO; Patcharanarumol W, 2014, COUNTRY SUMMARY REPO; Poole A., 2011, HOW TO NOTES POLITIC; Reich MR, 2012, POLITICAL EC ANAL FO; Roberts MJ, 2015, HEALTH SYST REFORM, V1, P22, DOI 10.1080/23288604.2014.995981; Senior M, 2014, NAT BIOTECHNOL, V32, P501, DOI 10.1038/nbt0614-501; Takaku R, 2014, UNIVERSAL HLTH COVER; Teerawattananon Y, 2009, INT J TECHNOL ASSESS, V25, P241, DOI 10.1017/S0266462309090709; The World Bank, 2015, UN HLTH COV INCL SUS; Vermeersch C, 2014, COUNTRY SUMMARY REPO; Wang H, ETHIOPIA HLTH EXTENS; Wang H, 2014, COUNTRY SUMMARY REPO; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Bank, 2008, POL EC POL REF ISS I	28	155	157	1	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					811	816		10.1016/S0140-6736(15)60002-2	http://dx.doi.org/10.1016/S0140-6736(15)60002-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26299185				2022-12-28	WOS:000370418000041
J	Dzau, VJ; Rodin, J				Dzau, Victor J.; Rodin, Judith			Creating a Global Health Risk Framework	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dzau, Victor J.] Natl Acad Med, Washington, DC 20001 USA; [Rodin, Judith] Rockefeller Fdn, New York, NY USA	National Academies of Sciences, Engineering & Medicine	Dzau, VJ (corresponding author), Natl Acad Med, Washington, DC 20001 USA.							Kamal-Yanni M., 2015, NEVER AGAIN BUILDING; Medecins Sans Frontieres, 2015, PUSH LIM YEAR LARG E; National Academy of Medicine, 2015, GLOB HLTH RISK FRAM; World Health Organisation, 2015, FACT CONTR UND SPREA	4	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					991	993		10.1056/NEJMp1509136	http://dx.doi.org/10.1056/NEJMp1509136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ9TV	26244878				2022-12-28	WOS:000360959000003
J	Accardi, A				Accardi, Alessio			Lipids link ion channels and cancer Membrane voltage connects lipid organization to cell proliferation	SCIENCE			English	Editorial Material									[Accardi, Alessio] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA; [Accardi, Alessio] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Accardi, Alessio] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	Accardi, A (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA.	ala2022@med.cornell.edu		Accardi, Alessio/0000-0002-6584-0102	NIGMS NIH HHS [R01 GM085232, R01 GM106717] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; CONE CD, 1974, ANN NY ACAD SCI, V238, P420, DOI 10.1111/j.1749-6632.1974.tb26808.x; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Litan A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00086; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Rao VR, 2015, CANCERS, V7, P849, DOI 10.3390/cancers7020813; STILLWELL EF, 1973, NATURE-NEW BIOL, V246, P110, DOI 10.1038/newbio246110a0; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619	12	19	19	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					789	790		10.1126/science.aad0874	http://dx.doi.org/10.1126/science.aad0874			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293939	Green Accepted			2022-12-28	WOS:000359832700018
J	Wingfield, MJ; Brockerhoff, EG; Wingfield, BD; Slippers, B				Wingfield, M. J.; Brockerhoff, E. G.; Wingfield, B. D.; Slippers, B.			Planted forest health: The need for a global strategy	SCIENCE			English	Review							SOUTHERN-HEMISPHERE; ECOSYSTEM SERVICES; BIOLOGICAL-CONTROL; PESTS; PATHOGENS; DISEASES; INSECTS; DETERMINANTS; REGULATIONS; POPULATIONS	Several key tree genera are used in planted forests worldwide, and these represent valuable global resources. Planted forests are increasingly threatened by insects and microbial pathogens, which are introduced accidentally and/or have adapted to new host trees. Globalization has hastened tree pest emergence, despite a growing awareness of the problem, improved understanding of the costs, and an increased focus on the importance of quarantine. To protect the value and potential of planted forests, innovative solutions and a better-coordinated global approach are needed. Mitigation strategies that are effective only in wealthy countries fail to contain invasions elsewhere in the world, ultimately leading to global impacts. Solutions to forest pest problems in the future should mainly focus on integrating management approaches globally, rather than single-country strategies. A global strategy to manage pest issues is vitally important and urgently needed.	[Wingfield, M. J.; Wingfield, B. D.; Slippers, B.] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, South Africa; [Brockerhoff, E. G.] Scion New Zealand Forest Res Inst, Christchurch 8540, New Zealand	University of Pretoria	Wingfield, MJ (corresponding author), Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, South Africa.	mike.wingfield@fabi.up.ac.za	Brockerhoff, Eckehard Gustav/C-1528-2009; Wingfield, Brenda D./B-1376-2008; Wingfield, Michael J/A-9473-2008; Slippers, Bernard/A-9351-2008	Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; Wingfield, Brenda D./0000-0002-6189-1519; Slippers, Bernard/0000-0003-1491-3858	Tree Protection Co-operative Programme (TPCP); National Research Foundation (NRF); Department of Trade and Industry (DTI); Department of Water Affairs and Forestry (DAFF); Science and Technology (DST) of South Africa; Ministry of Business, Innovation, and Employment	Tree Protection Co-operative Programme (TPCP); National Research Foundation (NRF); Department of Trade and Industry (DTI); Department of Water Affairs and Forestry (DAFF); Science and Technology (DST) of South Africa; Ministry of Business, Innovation, and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	We thank members of the Tree Protection Co-operative Programme (TPCP); the National Research Foundation (NRF); and the Departments of Trade and Industry (DTI), Water Affairs and Forestry (DAFF), and Science and Technology (DST) of South Africa for support. Contributions by E.G.B. were supported by Ministry of Business, Innovation, and Employment core funding to Scion. We also thank many colleagues for sharing their perspectives with us regarding the health of forests internationally. The views expressed in this paper are our own.	[Anonymous], 2015, SCIENCE, V348, P264; Bebber DP, 2014, NEW PHYTOL, V202, P901, DOI 10.1111/nph.12722; Berbegal M, 2013, PHYTOPATHOLOGY, V103, P851, DOI 10.1094/PHYTO-11-12-0281-R; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Branco M, 2015, J APPL ECOL, V52, P69, DOI 10.1111/1365-2664.12362; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Brockerhoff EG, 2013, FOREST ECOL MANAG, V301, P43, DOI 10.1016/j.foreco.2012.09.018; Copping LG, 2000, PEST MANAG SCI, V56, P651, DOI 10.1002/1526-4998(200008)56:8<651::AID-PS201>3.0.CO;2-U; Duran A, 2008, PLANT PATHOL, V57, P715, DOI 10.1111/j.1365-3059.2008.01893.x; Ennos RA, 2015, FORESTRY, V88, P41, DOI 10.1093/forestry/cpu048; Eschen R, 2015, ENVIRON SCI POLICY, V51, P228, DOI 10.1016/j.envsci.2015.04.021; FAO, 2010, 163 FAO; Fauvergue X, 2012, EVOL APPL, V5, P424, DOI 10.1111/j.1752-4571.2012.00272.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Garnas JR, 2012, INT J PEST MANAGE, V58, P211, DOI 10.1080/09670874.2012.698764; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Gryzenhout M, 2004, STUD MYCOL, P119; Haack RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096611; Hamelin RC, 2012, CAN J PLANT PATHOL, V34, P20, DOI 10.1080/07060661.2012.665389; Hantula J, 2014, ENVIRON SCI POLICY, V37, P158, DOI 10.1016/j.envsci.2013.09.011; Hunter GC, 2009, MOL PLANT PATHOL, V10, P1, DOI 10.1111/j.1364-3703.2008.00516.x; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Maddison DR, 2012, TRENDS ECOL EVOL, V27, P72, DOI 10.1016/j.tree.2011.10.010; Morin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035434; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Nadel RL, 2010, BIOL INVASIONS, V12, P1067, DOI 10.1007/s10530-009-9524-2; Nadel RL, 2012, ANN FOREST SCI, V69, P757, DOI 10.1007/s13595-012-0200-9; Ninan KN, 2013, ECOL ECON, V93, P137, DOI 10.1016/j.ecolecon.2013.05.005; Ploetz RC, 2013, PLANT DIS, V97, P856, DOI 10.1094/PDIS-01-13-0056-FE; Roy BA, 2014, FRONT ECOL ENVIRON, V12, P457, DOI 10.1890/130240; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Slippers B, 2015, ANNU REV ENTOMOL, V60, P601, DOI 10.1146/annurev-ento-010814-021118; Vira B., 2015, IUFRO WORLD SERIES, V33, P1; Wingfield MJ, 2008, SOUTH FORESTS, V70, P139, DOI 10.2989/SOUTH.FOR.2008.70.2.9.537; Wingfield Michael J., 2010, New Zealand Journal of Forestry Science, V40, pS95; Wingfield MJ, 2003, AUSTRALAS PLANT PATH, V32, P133, DOI 10.1071/AP03024; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	41	262	272	16	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					832	836		10.1126/science.aac6674	http://dx.doi.org/10.1126/science.aac6674			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26293956				2022-12-28	WOS:000359832700039
J	Bally, J				Bally, John			ASTROPHYSICS Mystery survivor of a supermassive black hole	NATURE			English	Editorial Material							CENTER CLOUD G2; GALACTIC-CENTER; SIMULATIONS; PLANETS; STAR		Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80389 USA	University of Colorado System; University of Colorado Boulder	Bally, J (corresponding author), Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80389 USA.	john.bally@colorado.edu						Ballone A, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/13; Bally J, 2000, ASTRON J, V119, P2919, DOI 10.1086/301385; Eckart A, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201219994; Gillessen S, 2012, NATURE, V481, P51, DOI 10.1038/nature10652; Liu HB, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/195; Lu JR, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/155; Mapelli M, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/197; Morris M, 2012, NATURE, V481, P32, DOI 10.1038/nature10767; Murray-Clay RA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2044; Schartmann M, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/155; Scoville N, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/108; Valencia-S M, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/125; Wang L, 2015, MON NOT R ASTRON SOC, V449, P3543, DOI 10.1093/mnras/stv542; Yusef-Zadeh F, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/2/L26; Zajacek M., 2015, PREPRINT	15	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					301	302		10.1038/524301a	http://dx.doi.org/10.1038/524301a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26289202				2022-12-28	WOS:000359714000025
J	Landrigan, PJ; Benbrook, C				Landrigan, Philip J.; Benbrook, Charles			GMOs, Herbicides, and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Landrigan, Philip J.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Benbrook, Charles] Washington State Univ, Dept Crops & Soil Sci, Pullman, WA 99164 USA	Icahn School of Medicine at Mount Sinai; Washington State University	Landrigan, PJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.		Benbrook, Charles/L-6589-2019					[Anonymous], AD GEN ENG CROPS US; [Committee on Identifying and Assessing Unintended Effects of Genetically Engineered Foods on Human Health National Research Council], 2004, SAF GEN ENG FOODS AP; Duke SO, 2015, PEST MANAG SCI, V71, P652, DOI 10.1002/ps.3863; Guyton KZ, 2015, LANCET ONCOL, V16, P490, DOI 10.1016/S1470-2045(15)70134-8; Loomis D, 2015, LANCET ONCOL	5	30	31	0	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					693	695		10.1056/NEJMp1505660	http://dx.doi.org/10.1056/NEJMp1505660			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP2LU	26287848				2022-12-28	WOS:000359709400005
J	Wilson, DJ; Sudhir, V; Piro, N; Schilling, R; Ghadimi, A; Kippenberg, TJ				Wilson, D. J.; Sudhir, V.; Piro, N.; Schilling, R.; Ghadimi, A.; Kippenberg, T. J.			Measurement-based control of a mechanical oscillator at its thermal decoherence rate	NATURE			English	Article							BACK-ACTION; QUANTUM; FEEDBACK; MOTION; NOISE	In real-time quantum feedback protocols(1,2), the record of a continuous measurement is used to stabilize a desired quantum state. Recent years have seen successful applications of these protocols in a variety of well-isolated micro-systems, including microwave photons(3) and superconducting qubits(4). However, stabilizing the quantum state of a tangibly massive object, such as a mechanical oscillator, remains very challenging: the main obstacle is environmental decoherence, which places stringent requirements on the timescale in which the state must be measured. Here we describe a position sensor that is capable of resolving the zero-point motion of a solid-state, 4.3-megahertz nanomechanical oscillator in the timescale of its thermal decoherence, a basic requirement for real-time (Markovian) quantum feedback control tasks, such as ground-state preparation. The sensor is based on evanescent optomechanical coupling to a high-Q microcavity(5), and achieves an imprecision four orders of magnitude below that at the standard quantum limit for a weak continuous position measurement(6)-a 100-fold improvement over previous reports(7-9)-while maintaining an imprecision-back-action product that is within a factor of five of the Heisenberg uncertainty limit. As a demonstration of its utility, we use the measurement as an error signal with which to feedback cool the oscillator. Using radiation pressure as an actuator, the oscillator is cold damped(10) with high efficiency: from a cryogenic-bath temperature of 4.4 kelvin to an effective value of 1.1 +/- 0.1 millikelvin, corresponding to a mean phonon number of 5.3 +/- 0.6 (that is, a ground-state probability of 16 per cent). Our results set a new benchmark for the performance of a linear position sensor, and signal the emergence of mechanical oscillators as practical subjects for measurement-based quantum control.	[Wilson, D. J.; Sudhir, V.; Piro, N.; Schilling, R.; Ghadimi, A.; Kippenberg, T. J.] Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kippenberg, TJ (corresponding author), Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, CH-1015 Lausanne, Switzerland.	tobias.kippenberg@epfl.ch	Sudhir, Vivishek/E-5943-2011; Kippenberg, T. J./B-3133-2013; P, N/AAQ-5967-2021	Sudhir, Vivishek/0000-0002-5397-6950; Kippenberg, T. J./0000-0002-3408-886X; ghadimi, aftab/0000-0001-6815-0062	ERC Advanced Grant (QuREM); DARPA/MTO ORCHID programme; Marie Curie Initial Training Network 'Cavity Quantum Optomechanics' (cQOM); Swiss National Science Foundation - NCCR of Quantum Engineering (QSIT); European Commission [303029, 331985]	ERC Advanced Grant (QuREM); DARPA/MTO ORCHID programme; Marie Curie Initial Training Network 'Cavity Quantum Optomechanics' (cQOM); Swiss National Science Foundation - NCCR of Quantum Engineering (QSIT)(Swiss National Science Foundation (SNSF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We acknowledge nanofabrication advice from E. Gavartin in the early stages of the project. All samples were fabricated at the CMi (Center for Micro-Nanotechnology) at EPFL. Research was funded by an ERC Advanced Grant (QuREM), by the DARPA/MTO ORCHID programme, the Marie Curie Initial Training Network 'Cavity Quantum Optomechanics' (cQOM), the Swiss National Science Foundation and through support from the NCCR of Quantum Engineering (QSIT). N.P. and D.J.W. acknowledge support from the European Commission through Marie Skodowska-Curie Fellowships: IEF project 303029 and IIF project 331985, respectively.	Abbott B, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/073032; Anetsberger G, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.061804; Anetsberger G, 2009, NAT PHYS, V5, P909, DOI 10.1038/NPHYS1425; Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Bushev P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043003; CAVES CM, 1980, PHYS REV LETT, V45, P75, DOI 10.1103/PhysRevLett.45.75; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Cohadon PF, 1999, PHYS REV LETT, V83, P3174, DOI 10.1103/PhysRevLett.83.3174; Courty JM, 2001, EUR PHYS J D, V17, P399, DOI 10.1007/s100530170014; D'Urso B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.043001; Gavartin E, 2012, NAT NANOTECHNOL, V7, P509, DOI [10.1038/nnano.2012.97, 10.1038/NNANO.2012.97]; Genes C, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.033804; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Jacobs K, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.043812; Li TC, 2011, NAT PHYS, V7, P527, DOI [10.1038/nphys1952, 10.1038/NPHYS1952]; Mancini S, 1998, PHYS REV LETT, V80, P688, DOI 10.1103/PhysRevLett.80.688; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; Poggio M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.017201; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Szorkovszky A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.213603; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2009, NAT NANOTECHNOL, V4, P820, DOI [10.1038/NNANO.2009.343, 10.1038/nnano.2009.343]; Verhagen E, 2012, NATURE, V482, P63, DOI 10.1038/nature10787; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Westphal T, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.063806; WISEMAN HM, 1995, PHYS REV A, V51, P2459, DOI 10.1103/PhysRevA.51.2459; WISEMAN HM, 1994, PHYS REV A, V49, P5159, DOI 10.1103/PhysRevA.49.5159.2; Wiseman HM, 2009, QUANTUM MEASUREMENT	30	196	198	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					325	329		10.1038/nature14672	http://dx.doi.org/10.1038/nature14672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26258303	Green Submitted			2022-12-28	WOS:000359714000030
J	Kapur, N				Kapur, Narinder			PERSONAL VIEW Professional bodies should provide accreditation of healthcare services to improve patient safety	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; ERRORS		UCL, London WC1E 7HJ, England	University of London; University College London	Kapur, N (corresponding author), UCL, London WC1E 7HJ, England.							[Anonymous], 2015, HLTH SERVICE J, P4; Buetow SA, 2003, QUAL SAF HEALTH CARE, V12, P129, DOI 10.1136/qhc.12.2.129; Evans R, 2004, BMJ-BRIT MED J, V328, P1240, DOI 10.1136/bmj.328.7450.1240; Francis R., 2013, REPORT MID STAFFORDS; Greenfield D, 2014, INT J QUAL HEALTH C, V26, P372, DOI 10.1093/intqhc/mzu039; Greenfield D, 2009, QUAL SAF HEALTH CARE, V18, P162, DOI 10.1136/qshc.2009.032359; Kapur N, 2009, CLIN GOV INT J, V14, P24; Kapur N, 2014, PSYCHOLOGIST, V27, P16; O'Leary DS, 2000, BRIT MED J, V320, P727, DOI 10.1136/bmj.320.7237.727; Peter TF, 2010, AM J CLIN PATHOL, V134, P550, DOI 10.1309/AJCPH1SKQ1HNWGHF; Shaw CD, 2014, INT J QUAL HEALTH C, V26, P100, DOI 10.1093/intqhc/mzu023; Valori R, 2013, CLIN MED, V13, P538, DOI 10.7861/clinmedicine.13-6-538; Wang HF, 2015, THER CLIN RISK MANAG, V11, P393, DOI 10.2147/TCRM.S79238	13	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4420	10.1136/bmj.h4420	http://dx.doi.org/10.1136/bmj.h4420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP7PU	26290164				2022-12-28	WOS:000360081100005
J	Li, BZ; Threapleton, DE; Wang, JY; Xu, JM; Yuan, JQ; Zhang, C; Li, P; Ye, QL; Guo, B; Mao, C; Ye, DQ				Li, Bao-Zhu; Threapleton, Diane Erin; Wang, Ji-Yao; Xu, Jian-Ming; Yuan, Jin-Qiu; Zhang, Chao; Li, Peng; Ye, Qian-Ling; Guo, Biao; Mao, Chen; Ye, Dong-Qing			Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUADRUPLE CONCOMITANT THERAPY; TRIPLE 1ST-LINE THERAPY; SEQUENTIAL THERAPY; DUODENAL-ULCER; DRUG THERAPY; OPEN-LABEL; ERADICATION; INFECTION; MANAGEMENT; PROBIOTICS	OBJECTIVE To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens. Design Systematic review and network meta-analysis. Data sources Cochrane Library, PubMed, and Embase without language or date restrictions. Study selection Full text reports of randomised controlled trials that compared different eradication treatments for H pylori among adults. Results Of the 15 565 studies identified, 143 were eligible and included. Data on 14 kinds of treatments were available. Of 91 possible comparisons for the efficacy outcome, 34 were compared directly and the following treatments performed better: seven days of concomitant treatment (proton pump inhibitor and three kinds of antibiotics administered together), 10 or 14 days of concomitant treatment, 10 or 14 days of probiotic supplemented triple treatment (standard triple treatment which is probiotic supplemented), 10 or 14 days of levofloxacin based triple treatment (proton pump inhibitor, levofloxacin, and antibiotic administered together), 14 days of hybrid treatment (proton pump inhibitor and amoxicillin used for seven days, followed by a proton pump inhibitor, amoxicillin, clarithromycin, and 5-nitroimidazole for another seven days), and 10 or 14 days of sequential treatment (five or seven days of a proton pump inhibitor plus amoxicillin, followed by five or seven additional days of a proton pump inhibitor plus clarithromycin and 5-nitroimidazole or amoxicillin). In terms of tolerance, all treatments were considered tolerable, but seven days of probiotic supplemented triple treatment and seven days of levofloxacin based triple treatment ranked best in terms of the proportion of adverse events reported. Conclusion Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori.	[Li, Bao-Zhu; Zhang, Chao; Li, Peng; Ye, Dong-Qing] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Li, Bao-Zhu; Zhang, Chao; Li, Peng; Ye, Dong-Qing] Anhui Med Univ, Anhui Prov Lab Populat Hlth & Major Dis Screening, Hefei, Anhui, Peoples R China; [Threapleton, Diane Erin; Yuan, Jin-Qiu; Mao, Chen] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Wang, Ji-Yao] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Xu, Jian-Ming] Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei, Peoples R China; [Ye, Qian-Ling; Guo, Biao] Anhui Med Univ, Affiliated Hosp 2, Hefei, Anhui, Peoples R China; [Mao, Chen] Chinese Univ Hong Kong, Hong Kong Branch, Chinese Cochrane Ctr, Hong Kong, Hong Kong, Peoples R China	Anhui Medical University; Anhui Medical University; Chinese University of Hong Kong; Fudan University; Anhui Medical University; Anhui Medical University; Chinese University of Hong Kong	Ye, DQ (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.	ydq@ahmu.edu.cn	Threapleton, Diane/AAP-8205-2021; Mao, Chen/AAW-2742-2020; Mao, Chen/G-9805-2013; Li, Bao-Zhu/GLU-3542-2022; Yuan, Jinqiu/A-4867-2018	Threapleton, Diane/0000-0002-5884-3372; Mao, Chen/0000-0002-6537-6215; Mao, Chen/0000-0001-7471-1516; Li, Peng/0000-0002-2533-1864; Ye, Dongqing/0000-0001-6604-9614	Chinese national high level personnel special support plan	Chinese national high level personnel special support plan	This systematic review was funded by the Chinese national high level personnel special support plan.	Aydin A, 2007, EUR J INTERN MED, V18, P496, DOI 10.1016/j.ejim.2007.02.018; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Ching SS, 2008, WORLD J GASTROENTERO, V14, P3855, DOI 10.3748/wjg.14.3855; Dang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111030; den Hollander WJ, 2013, J GASTROEN HEPATOL, V28, P1705, DOI 10.1111/jgh.12315; Dias S, 2 NICE DSU; Du YQ, 2012, WORLD J GASTROENTERO, V18, P6302, DOI 10.3748/wjg.v18.i43.6302; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; Eusebi LH, 2014, HELICOBACTER, V19, P1, DOI 10.1111/hel.12165; Fakheri H, 2014, WORLD J GASTROENTERO, V20, P10355, DOI 10.3748/wjg.v20.i30.10355; Gatta L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4587; Georgopoulos SD, 2013, EXPERT OPIN PHARMACO, V14, P211, DOI 10.1517/14656566.2013.763926; Gisbert JP, 2011, ALIMENT PHARM THER, V34, P604, DOI 10.1111/j.1365-2036.2011.04770.x; Gisbert JP, 2012, CLIN EXP GASTROENTER, V5, P23, DOI 10.2147/CEG.S25419; Gong EJ, 2014, J KOREAN MED SCI, V29, P704, DOI 10.3346/jkms.2014.29.5.704; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Greenberg ER, 2011, LANCET, V378, P507, DOI 10.1016/S0140-6736(11)60825-8; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hung IFN, 2009, HELICOBACTER, V14, P505, DOI 10.1111/j.1523-5378.2009.00722.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kim JS, 2014, CLIN RES HEPATOL GAS, V38, P118, DOI 10.1016/j.clinre.2013.10.001; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liou JM, 2013, LANCET, V381, P205, DOI 10.1016/S0140-6736(12)61579-7; Loymans RJB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3009; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; MARSHALL BJ, 1984, LANCET, V1, P1311; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Moayyedi P, 2007, LANCET, V370, P1010, DOI 10.1016/S0140-6736(07)61455-X; Song MJ, 2010, HELICOBACTER, V15, P206, DOI 10.1111/j.1523-5378.2010.00751.x; Stagg HR, 2014, ANN INTERN MED, V161, P419, DOI 10.7326/M14-1019; Testerman TL, 2014, WORLD J GASTROENTERO, V20, P12781, DOI 10.3748/wjg.v20.i36.12781; Ungan M, 2001, CURR THER RES CLIN E, V62, P462, DOI 10.1016/S0011-393X(01)80057-6; Urdaci MC, 2004, J CLIN GASTROENTEROL, V38, pS86, DOI 10.1097/01.mcg.0000128925.06662.69; Uygun A, 2012, TURK J GASTROENTEROL, V23, P8, DOI 10.4318/tjg.2012.0392; Vaira D, 2007, ANN INTERN MED, V146, P556, DOI 10.7326/0003-4819-146-8-200704170-00006; Valooran GJ, 2011, SCAND J GASTROENTERO, V46, P1045, DOI 10.3109/00365521.2011.584894; Venerito M, 2013, DIGESTION, V88, P33, DOI 10.1159/000350719; Wang B, 2015, HELICOBACTER, V20, P79, DOI 10.1111/hel.12180; Wang B, 2014, WORLD J GASTROENTERO, V20, P14973, DOI 10.3748/wjg.v20.i40.14973; Wang ZH, 2013, J CLIN GASTROENTEROL, V47, P25, DOI 10.1097/MCG.0b013e318266f6cf; Wu DC, 2010, CLIN GASTROENTEROL H, V8, P36, DOI 10.1016/j.cgh.2009.09.030; Ye CL, 2014, PHARMACOEPIDEM DR S, V23, P443, DOI 10.1002/pds.3581; Yuan JQ, 2013, EUR UROL, V63, P902, DOI 10.1016/j.eururo.2013.01.012; Yuan YH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008337.pub2; Zhu R, 2014, WORLD J GASTROENTERO, V20, P18013, DOI 10.3748/wjg.v20.i47.18013; Zou J, 2009, HELICOBACTER, V14, P97, DOI 10.1111/j.1523-5378.2009.00716.x	49	110	119	3	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4052	10.1136/bmj.h4052	http://dx.doi.org/10.1136/bmj.h4052			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7PU	26290044	Green Published, hybrid			2022-12-28	WOS:000360081100002
J	McLeod, BD				McLeod, B. D.			Combination intensive DMARD therapy is noninferior to TNF inhibitors for reducing disability in active RA Comment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									UBC Southern Med Program, Kelowna, BC, Canada		McLeod, BD (corresponding author), UBC Southern Med Program, Kelowna, BC, Canada.							Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					JC9	JC9		10.7326/ACPJC-2015-163-4-009	http://dx.doi.org/10.7326/ACPJC-2015-163-4-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26280444				2022-12-28	WOS:000364673500014
J	Singh, ND; Criscoe, DR; Skolfield, S; Kohl, KP; Keebaugh, ES; Schlenke, TA				Singh, Nadia D.; Criscoe, Dallas R.; Skolfield, Shelly; Kohl, Kathryn P.; Keebaugh, Erin S.; Schlenke, Todd A.			Fruit flies diversify their offspring in response to parasite infection	SCIENCE			English	Article							CROSSING-OVER; DROSOPHILA-MELANOGASTER; DNA REARRANGEMENTS; SEX; RECOMBINATION; MAINTENANCE; CHROMOSOME; EVOLUTION; TRIGGERS; FEMALES	The evolution of sexual reproduction is often explained by Red Queen dynamics: Organisms must continually evolve to maintain fitness relative to interacting organisms, such as parasites. Recombination accompanies sexual reproduction and helps diversify an organism's offspring, so that parasites cannot exploit static host genotypes. Here we show that Drosophila melanogaster plastically increases the production of recombinant offspring after infection. The response is consistent across genetic backgrounds, developmental stages, and parasite types but is not induced after sterile wounding. Furthermore, the response appears to be driven by transmission distortion rather than increased recombination. Our study extends the Red Queen model to include the increased production of recombinant offspring and uncovers a remarkable ability of hosts to actively distort their recombination fraction in rapid response to environmental cues.	[Singh, Nadia D.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Singh, Nadia D.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Criscoe, Dallas R.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Skolfield, Shelly; Schlenke, Todd A.] Reed Coll, Dept Biol, Portland, OR 97202 USA; [Kohl, Kathryn P.] Winthrop Univ, Dept Biol, Rock Hill, SC 29733 USA; [Keebaugh, Erin S.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Baylor College of Medicine; Reed College - Oregon; Emory University	Singh, ND (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	ndsingh@ncsu.edu; schlenkt@reed.edu		Schlenke, Todd/0000-0003-3091-3057	North Carolina State University; NSF [1257469]	North Carolina State University; NSF(National Science Foundation (NSF))	We thank B. Lazzaro for providing bacterial strains and for guidance on experimental design; S. Ruzsa and T. Post for technical assistance; J. Olson and M. Sikes for their assistance with obtaining institutional biosafety approval; J. Mahaffey, J. Alonso, A. Stepanova, and M. Scott for generously providing access to equipment required for this work; and T. F. C. Mackay, E. A. Stone, and D. M. Nielsen for guidance on statistical analysis. Comments from two editors and three anonymous reviewers markedly improved this manuscript. This work was supported by startup funds provided by North Carolina State University to N.D.S. and by NSF grant 1257469 to T.A.S. Data are deposited in the Dryad Repository (doi: 10.5061/dryad.8jj28).	Agrawal AF, 2005, GENETICS, V171, P803, DOI 10.1534/genetics.105.041301; Andronic L, 2012, CAN J PLANT SCI, V92, P1083, DOI [10.4141/CJPS2011-197, 10.4141/cjps2011-197]; BELYAEV DK, 1982, BIOL ZBL, V101, P705; Bhagat R, 2004, CYTOGENET GENOME RES, V107, P160, DOI 10.1159/000080594; Bridges CB, 1915, J EXP ZOOL, V19, P1, DOI 10.1002/jez.1400190102; Busch JW, 2004, EVOLUTION, V58, P2584, DOI 10.1111/j.0014-3820.2004.tb00886.x; Carton Y., 1986, Genetics and Biology of Drosophila, V3e, P347; Greeff M, 2010, GENETICA, V138, P737, DOI 10.1007/s10709-010-9454-z; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Hadany L, 2003, GENETICS, V165, P2167; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; JAENIKE J, 1978, Evolutionary Theory, V3, P191; KING RC, 1968, J MORPHOL, V124, P143, DOI 10.1002/jmor.1051240203; Kovalchuk I, 2003, NATURE, V423, P760, DOI 10.1038/nature01683; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; McKean KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-76; Mehrotra Sonam, 2008, V2, P125, DOI 10.1007/7050_2007_028; Morgan TH, 1914, BIOL BULL-US, V26, P195, DOI 10.2307/1536193; Mostowy R, 2012, J EVOLUTION BIOL, V25, P2033, DOI 10.1111/j.1420-9101.2012.02584.x; Neel JV, 1941, GENETICS, V26, P506; Priest NK, 2007, EVOLUTION, V61, P160, DOI 10.1111/j.1558-5646.2007.00013.x; Soper DM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1091; Stern C, 1926, P NATL ACAD SCI USA, V12, P530, DOI 10.1073/pnas.12.8.530; Zhong WH, 2011, BEHAV ECOL SOCIOBIOL, V65, P493, DOI 10.1007/s00265-010-1117-7	25	46	46	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					747	750		10.1126/science.aab1768	http://dx.doi.org/10.1126/science.aab1768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26273057				2022-12-28	WOS:000359415100039
J	Zaret, KS				Zaret, Kenneth S.			REGENERATIVE BIOLOGY Maintaining liver mass	NATURE			English	Editorial Material							MATURE HEPATOCYTES; MOUSE-LIVER; STEM-CELLS; FATE; HOMEOSTASIS; ZONATION; NICHE		[Zaret, Kenneth S.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Zaret, Kenneth S.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Zaret, KS (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.	zaret@mail.med.upenn.edu						Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Yang J, 2014, HEPATOLOGY, V60, P964, DOI 10.1002/hep.27082; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003	14	5	5	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					165	166		10.1038/nature15201	http://dx.doi.org/10.1038/nature15201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26245376				2022-12-28	WOS:000359386900017
J	Patel, NJ; Filippidis, A				Patel, Nirav J.; Filippidis, Aristotelis			A Giant Aneurysm of the Anterior Communicating Artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Patel, Nirav J.; Filippidis, Aristotelis] Boston Med Ctr, Boston, MA 02118 USA	Boston Medical Center	Patel, NJ (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.	nirav.patel@bmc.org							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					560	560		10.1056/NEJMicm1413193	http://dx.doi.org/10.1056/NEJMicm1413193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26244309				2022-12-28	WOS:000358987700010
J	Jones, M; de Keyser, P				Jones, Melvyn; de Keyser, Paul			SPOT DIAGNOSIS Rash on the arms and legs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jones, Melvyn] UCL, Sch Med, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England; [de Keyser, Paul] Royal Free London NHS Fdn Trust, Barnet Hosp, Dept Paediat, London, England	University of London; University College London; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust	Jones, M (corresponding author), UCL, Sch Med, Res Dept Primary Care & Populat Hlth, Royal Free Campus, London NW3 2PF, England.	melvyn.jones@ucl.ac.uk	Jones, Melvyn/C-2300-2008	Jones, Melvyn/0000-0002-8766-7443				JAMES DG, 1961, BRIT MED J, V1, P853, DOI 10.1136/bmj.1.5229.853; Requena L, 2007, SEMIN CUTAN MED SURG, V26, P114, DOI 10.1016/j.sder.2007.02.009	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2015	351								h4131	10.1136/bmj.h4131	http://dx.doi.org/10.1136/bmj.h4131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8AO	26240059				2022-12-28	WOS:000359387100006
J	Smith, M				Smith, Matthew			The art of medicine An ounce of prevention	LANCET			English	Editorial Material									[Smith, Matthew] Univ Strathclyde, Sch Humanities, Glasgow G4 0LT, Lanark, Scotland; [Smith, Matthew] Univ Strathclyde, Ctr Social Hist Hlth & Healthcare, Glasgow G4 0LT, Lanark, Scotland	University of Strathclyde; Glasgow Caledonian University; University of Strathclyde	Smith, M (corresponding author), Univ Strathclyde, Sch Humanities, Glasgow G4 0LT, Lanark, Scotland.	m.smith@strath.ac.uk		Smith, Matthew/0000-0002-9267-2124	Arts and Humanities Research Council [AH/L009641/1] Funding Source: researchfish; AHRC [AH/L009641/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					424	425		10.1016/S0140-6736(15)61437-4	http://dx.doi.org/10.1016/S0140-6736(15)61437-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	CN9IY	26251382	Green Submitted			2022-12-28	WOS:000358761700013
J	Oliver, D				Oliver, David			David Oliver: Is the NHS at war?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Geriatr & Acute Med, Reading, Berks, England		Oliver, D (corresponding author), Geriatr & Acute Med, Reading, Berks, England.	David.Oliver.1@city.ac.uk						Ham C, 2015, GUARDIAN; Health Foundation, 2015, HLTH FDN RESP SUMM B; Hunt J., 2015, MAKING HEALTHCARE MO; King's Fund, 2015, Q MON REP; McKeon A., 2014, BETTER CARE FUND DO; NHS England, 2014, 5 YEAR FORW VIEW; Nuffield Trust, 2015, NUFF TRUST RESP CART; Oliver D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2684; Oliver D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5538; Rose S, 2015, BETTER LEADERSHIP TO; Royal College of Nursing, 2015, NICE SUSP WORK SAF S	11	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2015	351								h4127	10.1136/bmj.h4127	http://dx.doi.org/10.1136/bmj.h4127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UE	26231347	Bronze			2022-12-28	WOS:000359011300009
J	Singer, JR; Weaver, CT				Singer, Jeffrey R.; Weaver, Casey T.			Daughter's Tolerance of Mom Matters in Mate Choice	CELL			English	Editorial Material							REGULATORY T-CELLS	Mendelian genetics presumes inheritance of fitness through DNA. Kinder et al. find that maternal microchimerism induces stable immune tolerance to non-inherited maternal antigens in offspring. Female offspring that share these antigens with their mate experience reduced fetal wasting, establishing a role for vertical transmission of non-genetic information in reproductive fitness.	[Singer, Jeffrey R.; Weaver, Casey T.] Univ Birmingham, Dept Pathol, Birmingham, AL 35294 USA		Singer, JR (corresponding author), Univ Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	jrsinger@uab.edu; cweaver@uab.edu	Singer, Jeffrey/AAO-7314-2020	Singer, Jeffrey/0000-0001-7033-3001; Weaver, Casey/0000-0002-2180-1793	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103744, P01DK071176, F30DK105680, R01DK093015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI107759] Funding Source: Medline; NIDDK NIH HHS [P01 DK071176, R01 DK093015, R01 DK103744, F30 DK105680] Funding Source: Medline; NIGMS NIH HHS [T32GM008361, T32 GM008361] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kinder JM, 2015, CELL, V162, P505, DOI 10.1016/j.cell.2015.07.006; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; OWEN RD, 1954, P NATL ACAD SCI USA, V40, P420, DOI 10.1073/pnas.40.6.420; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	9	0	0	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					467	469		10.1016/j.cell.2015.07.030	http://dx.doi.org/10.1016/j.cell.2015.07.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232215	Green Accepted, Bronze			2022-12-28	WOS:000358801800003
J	Mazin, II				Mazin, Igor I.			SUPERCONDUCTIVITY Extraordinarily conventional	NATURE			English	Editorial Material							LIQUID-HELIUM	Attitudes to high-temperature superconductivity have swung from disbelief to a conviction that it occurs only 'unconventionally'. But conventional superconductivity is now reported at record high temperatures. See Letter P.73	Naval Res Lab, Ctr Computat Mat Sci, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Mazin, II (corresponding author), Naval Res Lab, Ctr Computat Mat Sci, Washington, DC 20375 USA.	mazin@dave.nrl.navy.mil	Mazin, Igor I/B-6576-2008; Mazin, Igor/L-4294-2019	Mazin, Igor/0000-0001-9456-7099				Akashi R, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.224513; ANDERSON PW, 1964, SCIENCE, V144, P373, DOI 10.1126/science.144.3617.373; ASHCROFT NW, 1968, PHYS REV LETT, V21, P1748, DOI 10.1103/PhysRevLett.21.1748; Ashcroft NW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187002; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Cohen ML., 1972, AIP CONF P, V4, P17, DOI [10.1063/1.2946185, DOI 10.1063/1.2946185]; DOLGOV OV, 1981, REV MOD PHYS, V53, P81, DOI 10.1103/RevModPhys.53.81; Drozdov AP, 2015, NATURE, V525, P73, DOI 10.1038/nature14964; Duan DF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06968; Errea I, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.157004; Flores-Livas J. A., 2015, PREPRINT; Ginzburg V. L., 1969, Journal of Statistical Physics, V1, P3, DOI 10.1007/BF01007238; Ginzburg V. L., 1982, HIGH TEMPERATURE SUP; Kamerlingh Onnes H, 1911, COMMUN PHYS LAB U LE, V120; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kapitza P, 1938, NATURE, V141, P74, DOI 10.1038/141074a0; London F, 1938, NATURE, V141, P643, DOI 10.1038/141643a0; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; SCHILLING A, 1993, NATURE, V363, P56, DOI 10.1038/363056a0	20	23	23	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					40	41		10.1038/nature15203	http://dx.doi.org/10.1038/nature15203			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26280332				2022-12-28	WOS:000360594100019
J	Van Keymeulen, A; Lee, MY; Ousset, M; Brohee, S; Rorive, S; Giraddi, RR; Wuidart, A; Bouvencourt, G; Dubois, C; Salmon, I; Sotiriou, C; Phillips, WA; Blanpain, C				Van Keymeulen, Alexandra; Lee, May Yin; Ousset, Marielle; Brohee, Sylvain; Rorive, Sandrine; Giraddi, Rajshekhar R.; Wuidart, Aline; Bouvencourt, Gaelle; Dubois, Christine; Salmon, Isabelle; Sotiriou, Christos; Phillips, Wayne A.; Blanpain, Cedric			Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity	NATURE			English	Article							MAMMARY-GLAND DEVELOPMENT; MOUSE MODEL; STEM-CELLS; CANCER; ACTIVATION; IDENTIFICATION; ETV6-NTRK3; MUTATIONS; PACKAGE; FATE	Breast cancer is the most frequent cancer in women and consists of heterogeneous types of tumours that are classified into different histological and molecular subtypes(1,2). PIK3CA and P53 (also known as TP53) are the two most frequently mutated genes and are associated with different types of human breast cancers(3). The cellular origin and the mechanisms leading to PIK3CA-induced tumour heterogeneity remain unknown. Here we used a genetic approach in mice to define the cellular origin of Pik3ca-derived tumours and the impact of mutations in this gene on tumour heterogeneity. Surprisingly, oncogenic Pik3ca(H1047R) mutant expression at physiological levels(4) in basal cells using keratin (K)5-CreER(T2) mice induced the formation of luminal oestrogen receptor (ER)-positive/progesterone receptor (PR)-positive tumours, while its expression in luminal cells using K8-CReERT2 mice gave rise to luminal ER+PR+ tumours or basal-like ER-PR- tumours. Concomitant deletion of p53 and expression of Pik3ca(H1047R) accelerated tumour development and induced more aggressive mammary tumours. Interestingly, expression of Pik3ca(H1047R) in unipotent basal cells gave rise to luminal-like cells, while its expression in unipotent luminal cells gave rise to basal-like cells before progressing into invasive tumours. Transcriptional profiling of cells that underwent cell fate transition upon Pik3ca(H1047R) expression in unipotent progenitors demonstrated a profound oncogene-induced reprogramming of these newly formed cells and identified gene signatures characteristic of the different cell fate switches that occur upon Pik3ca(H1047R) expression in basal and luminal cells, which correlated with the cell of origin, tumour type and different clinical outcomes. Altogether our study identifies the cellular origin of Pik3ca-induced tumours and reveals that oncogenic Pik3ca(H1047R) activates a multipotent genetic program in normally lineage-restricted populations at the early stage of tumour initiation, setting the stage for future intratumoural heterogeneity. These results have important implications for our understanding of the mechanisms controlling tumour heterogeneity and the development of new strategies to block PIK3CA breast cancer initiation.	[Van Keymeulen, Alexandra; Lee, May Yin; Ousset, Marielle; Giraddi, Rajshekhar R.; Wuidart, Aline; Bouvencourt, Gaelle; Dubois, Christine; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Brohee, Sylvain; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, B-1000 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] Univ Libre Bruxelles, Erasme Hosp, Dept Pathol, B-1070 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] CMMI, DIAPATH, B-6041 Gosselies, Belgium; [Phillips, Wayne A.] Peter MacCallum Canc Ctr, Surg Oncol Res Lab, Melbourne, Vic 3002, Australia; [Phillips, Wayne A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3002, Australia; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	avkeymeu@ulb.ac.be; Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Phillips, Wayne A/H-8070-2013; Lee, May Yin/AAB-3450-2021	Phillips, Wayne A/0000-0002-7961-638X; Lee, May Yin/0000-0003-2366-9463; OUSSET, Marielle/0000-0002-2092-2729; Giraddi, Rajshekhar/0000-0001-9728-7674	Agency for Science, Technology and Research (A*STAR, Singapore); FNRS; TELEVIE; foundation "Amis de l'institut Jules Bordet"; European Regional Development Fund; Wallonia; National Health and Medical Research Council of Australia; Fondation Contre le Cancer; ULB fondation; Fond Yvonne Boel; Fond Gaston Ithier; foundation Bettencourt Schueller; foundation Baillet Latour; European Research Council	Agency for Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; foundation "Amis de l'institut Jules Bordet"; European Regional Development Fund(European Commission); Wallonia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fondation Contre le Cancer; ULB fondation; Fond Yvonne Boel; Fond Gaston Ithier; foundation Bettencourt Schueller; foundation Baillet Latour; European Research Council(European Research Council (ERC)European Commission)	C.B. is an investigator of WELBIO, A.V.K. is Chercheur Qualifie of the FNRS, C.S. is Maitre de Recherche of the FNRS, M.Y.L. is supported by the Agency for Science, Technology and Research (A*STAR, Singapore) fellowship, M.O. and A.W. are supported by FNRS fellowships, R.R.G. is supported by a TELEVIE fellowship and S.B. is supported by the foundation "Amis de l'institut Jules Bordet". The Center for Microscopy and Molecular Imaging is supported by the European Regional Development Fund and Wallonia. W.A.P. is supported by project grants from the National Health and Medical Research Council of Australia. This work was supported by the FNRS, TELEVIE, a research grant from the Fondation Contre le Cancer, the ULB fondation, the Fond Yvonne Boel, the Fond Gaston Ithier, the foundation Bettencourt Schueller, the foundation Baillet Latour, and the European Research Council.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Euhus DM, 2002, CANCER CELL, V2, P347, DOI 10.1016/S1535-6108(02)00184-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Hayes MM, 2011, J CLIN PATHOL, V64, P477, DOI 10.1136/jcp.2010.087718; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kasprzyk A., 2011, DATABASE-OXFORD, V2011, DOI DOI 10.1093/DATABASE/BAR049; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Owens TW, 2014, CANCER RES, V74, P5277, DOI 10.1158/0008-5472.CAN-14-0053; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rorive S, 2010, MODERN PATHOL, V23, P1418, DOI 10.1038/modpathol.2010.136; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shehata M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0411-0; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tikoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036924; Tilch E, 2014, BREAST CANCER RES TR, V143, P385, DOI 10.1007/s10549-013-2798-1; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Weigelt B, 2010, MOL ONCOL, V4, P192, DOI 10.1016/j.molonc.2010.04.004; Wu J, 2012, ONCOGENE, V31, P333, DOI 10.1038/onc.2011.227; Yin B, 2015, ONCOGENE, V34, P761, DOI 10.1038/onc.2014.8; Yuan W, 2013, ONCOGENE, V32, P318, DOI 10.1038/onc.2012.53	43	216	217	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					119	123		10.1038/nature14665	http://dx.doi.org/10.1038/nature14665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26266985				2022-12-28	WOS:000360594100037
J	Kanekiyo, M; Bu, W; Joyce, MG; Meng, G; Whittle, JRR; Baxa, U; Yamamoto, T; Narpala, S; Todd, JP; Rao, SS; McDermott, AB; Koup, RA; Rossmann, MG; Mascola, JR; Graham, BS; Cohen, JI; Nabel, GJ				Kanekiyo, Masaru; Bu, Wei; Joyce, M. Gordon; Meng, Geng; Whittle, James R. R.; Baxa, Ulrich; Yamamoto, Takuya; Narpala, Sandeep; Todd, John-Paul; Rao, Srinivas S.; McDermott, Adrian B.; Koup, Richard A.; Rossmann, Michael G.; Mascola, John R.; Graham, Barney S.; Cohen, Jeffrey I.; Nabel, Gary J.			Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; INFECTIOUS-MONONUCLEOSIS; CRYSTAL-STRUCTURE; IN-VITRO; GLYCOPROTEIN; FERRITIN; HIV-1; NEUTRALIZATION; PROTECTION	Epstein-Barr virus (EBV) represents a major global health problem. Though it is associated with infectious mononucleosis and similar to 200,000 cancers annually worldwide, a vaccine is not available. The major target of immunity is EBV glycoprotein 350/220 (gp350) that mediates attachment to B cells through complement receptor 2 (CR2/CD21). Here, we created self-assembling nanoparticles that displayed different domains of gp350 in a symmetric array. By focusing presentation of the CR2-binding domain on nanoparticles, potent neutralizing antibodies were elicited in mice and non-human primates. The structurally designed nanoparticle vaccine increased neutralization 10- to 100-fold compared to soluble gp350 by targeting a functionally conserved site of vulnerability, improving vaccine-induced protection in a mouse model. This rational approach to EBV vaccine design elicited potent neutralizing antibody responses by arrayed presentation of a conserved viral entry domain, a strategy that can be applied to other viruses.	[Kanekiyo, Masaru; Joyce, M. Gordon; Whittle, James R. R.; Yamamoto, Takuya; Narpala, Sandeep; Todd, John-Paul; Rao, Srinivas S.; McDermott, Adrian B.; Koup, Richard A.; Mascola, John R.; Graham, Barney S.; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Bu, Wei; Cohen, Jeffrey I.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Meng, Geng; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Baxa, Ulrich] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Canc Res Technol Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cohen, JI (corresponding author), NIAID, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov; gary.nabel@sanofi.com	Kanekiyo, Masaru/Y-9820-2018; Mascola, John/AAI-7193-2021; Yamamoto, Takuya/L-2642-2013; Meng, Geng/ACY-1510-2022; Graham, Barney S./AAC-5898-2019	Kanekiyo, Masaru/0000-0001-5767-1532; Yamamoto, Takuya/0000-0003-3753-1211; Graham, Barney S./0000-0001-8112-0853; Baxa, Ulrich/0000-0002-7263-5078; McDermott, Adrian/0000-0003-0616-9117	Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005124, ZIAAI000913, ZIAAI000978, ZICAI005123, ZIAAI005073] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; Frederick National Laboratory for Cancer Research, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Hartman (VRC) for help with manuscript preparation; S.-Y. Ko, H. Bao, C. Chiedi, M. Dillon, and K. Wuddie (VRC) for help with animal studies; K. Foulds and V. Letukas (VRC) for monkey sample processing; P. Radecki (LID) for help with serum analyses; A. Wheatley, S. Andrews, T. Zhou, and H. Yassine (VRC) for technical advice; Y. Okuno (Osaka University) for providing C179 antibody; and X. Chen (VRC) for help with transfections. This work was supported by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and in part with federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. M.K., W.B., J.I.C., and G.J.N. are named as inventors on a patent application describing the data presented in this paper, which has been filed by the National Institutes of Health.	Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Bachmann MF, 1997, SCIENCE, V276, P2024, DOI 10.1126/science.276.5321.2024; Chen ZC, 2007, J VIROL, V81, P8989, DOI 10.1128/JVI.00906-07; Chen ZC, 2013, P NATL ACAD SCI USA, V110, P20242, DOI 10.1073/pnas.1320041110; Chen ZC, 2011, J VIROL, V85, P4354, DOI 10.1128/JVI.02553-10; Cho KJ, 2009, J MOL BIOL, V390, P83, DOI 10.1016/j.jmb.2009.04.078; Cohen JI, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002878; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Elliott SL, 2008, J VIROL, V82, P1448, DOI 10.1128/JVI.01409-07; EPSTEIN MA, 1985, NATURE, V318, P287, DOI 10.1038/318287a0; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Georgiev IS, 2013, CURR OPIN HIV AIDS, V8, P382, DOI 10.1097/COH.0b013e328363a90e; GU SY, 1995, DEV BIOL STAND, V84, P171; Huard DJE, 2013, NAT CHEM BIOL, V9, P169, DOI [10.1038/NCHEMBIO.1163, 10.1038/nchembio.1163]; Hutt-Fletcher LM, 2007, J VIROL, V81, P7825, DOI 10.1128/JVI.00445-07; Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]; Jaaskelainen A, 2007, SMALL, V3, P1362, DOI 10.1002/smll.200700011; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Khurana S, 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3002336; Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364; Lee CC, 2013, ACTA CRYSTALLOGR D, V69, P1935, DOI 10.1107/S0907444913016776; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Li C.Q., 2006, IND BIOTECHNOL, V2, P143, DOI [DOI 10.1089/IND.2006.2.143, 10.1089/ind.2006.2.143]; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; LUKA J, 1984, J IMMUNOL METHODS, V67, P145, DOI 10.1016/0022-1759(84)90093-0; Machiels B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002387; McLellan A., 2013, HLTH SERV J, V123, P3; MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086; Meng G, 2013, J VIROL, V87, P12523, DOI 10.1128/JVI.01822-13; Moutschen M, 2007, VACCINE, V25, P4697, DOI 10.1016/j.vaccine.2007.04.008; Ogembo JG, 2013, CELL REP, V3, P371, DOI 10.1016/j.celrep.2013.01.023; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Sashihara J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002308; Sashihara J, 2009, VIROLOGY, V391, P249, DOI 10.1016/j.virol.2009.06.013; SERAFINICESSI F, 1989, VIROLOGY, V170, P1, DOI 10.1016/0042-6822(89)90345-0; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; TANNER J, 1988, J VIROL, V62, P4452, DOI 10.1128/JVI.62.12.4452-4464.1988; THORLEYLAWSON DA, 1982, J VIROL, V43, P730, DOI 10.1128/JVI.43.2.730-736.1982; THORLEYLAWSON DA, 1980, P NATL ACAD SCI-BIOL, V77, P5307, DOI 10.1073/pnas.77.9.5307; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; van den Brink EN, 2005, J VIROL, V79, P1635, DOI 10.1128/JVI.79.3.1635-1644.2005; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Young KA, 2008, J VIROL, V82, P11217, DOI 10.1128/JVI.01673-08; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	53	182	195	2	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1090	1100		10.1016/j.cell.2015.07.043	http://dx.doi.org/10.1016/j.cell.2015.07.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26279189	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000360589900018
J	Huang, WJ; Manglik, A; Venkatakrishnan, AJ; Laeremans, T; Feinberg, EN; Sanborn, AL; Kato, HE; Livingston, KE; Thorsen, TS; Kling, RC; Granier, S; Gmeiner, P; Husbands, SM; Traynor, JR; Weis, WI; Steyaert, J; Dror, RO; Kobilka, BK				Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sebastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K.			Structural insights into mu-opioid receptor activation	NATURE			English	Article							CRYSTALLIZING MEMBRANE-PROTEINS; DYNAMIC PROCESS; MICE LACKING; FORCE-FIELD; COMPLEX; BINDING; CHARMM; MODEL; VALIDATION; RHODOPSIN	Activation of the mu-opioid receptor (mu OR) is responsible for the efficacy of the most effective analgesics. To shed light on the structural basis for mu OR activation, here we report a 2.1 angstrom X-ray crystal structure of the murine mu OR bound to the morphinan agonist BU72 and a G protein mimetic camelid antibody fragment. The BU72-stabilized changes in the mu OR binding pocket are subtle and differ from those observed for agonist-bound structures of the beta(2)-adrenergic receptor (beta(2)AR) and the M2 muscarinic receptor. Comparison with active beta(2)AR reveals a common rearrangement in the packing of three conserved amino acids in the core of the mu OR, and molecular dynamics simulations illustrate how the ligand-binding pocket is conformationally linked to this conserved triad. Additionally, an extensive polar network between the ligand-binding pocket and the cytoplasmic domains appears to play a similar role in signal propagation for all three G-protein-coupled receptors.	[Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Thorsen, Thor S.; Weis, William I.; Dror, Ron O.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.; Feinberg, Evan N.; Sanborn, Adrian L.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.; Feinberg, Evan N.; Sanborn, Adrian L.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Laeremans, Toon; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Laeremans, Toon; Steyaert, Jan] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Livingston, Kathryn E.; Traynor, John R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Kling, Ralf C.; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91052 Erlangen, Germany; [Granier, Sebastien] Univ Montpellier, Inst Genom Fonct, CNRS, UMR 5203,INSERM,U1191, F-34000 Montpellier, France; [Husbands, Stephen M.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Michigan System; University of Michigan; University of Erlangen Nuremberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Bath; Stanford University	Manglik, A (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 CampusDrive, Stanford, CA 94305 USA.	amanglik@stanford.edu; kobilka@stanford.edu	Kato, Hideaki/AAQ-4323-2020; Weis, William I/G-1437-2011; Granier, Sebastien/J-1089-2016; Gmeiner, Peter/N-5275-2015; Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022	Kato, Hideaki/0000-0002-1941-5535; Weis, William I/0000-0002-5583-6150; Steyaert, Jan/0000-0002-3825-874X; Kobilka, Brian/0000-0001-5958-3990; Huang, Weijiao/0000-0002-6253-7765; Gmeiner, Peter/0000-0002-4127-197X; Husbands, Stephen/0000-0002-9928-6322; Feinberg, Evan/0000-0002-7989-8751; Dror, Ron/0000-0002-6418-2793	Stanford Medical Scientist Training Program; American Heart Association; National Institutes of Health [R37DA036246, R01GM083118]; Terman Faculty Fellowship; Eli Lilly and Company through the Lilly Research Program; Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA036246] Funding Source: NIH RePORTER	Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terman Faculty Fellowship; Eli Lilly and Company through the Lilly Research Program; Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We acknowledge support from the Stanford Medical Scientist Training Program and the American Heart Association (A.M.), National Institutes of Health grants R37DA036246 (B.K.K. and S.G.) and R01GM083118 (B.K.K.), a Terman Faculty Fellowship (R.O.D.), Eli Lilly and Company through the Lilly Research Program (R.O.D.), and the Mathers Foundation (B.K.K. and W.I.W). We also acknowledge the National Institute of Drug Abuse Drug Supply Program for providing [Dmt<SUP>1</SUP>] DALDA. We thank D. Maurel and S. Agnel from the ARPEGE facility (Institut de Genomique Fonctionnelle) for assistance with cell-based G<INF>i</INF> coupling assays, H. El Hassan for expert technical assistance, and S. Hertig, N. Latorraca and K. Cavalotti for assistance with molecular dynamics simulations and analysis.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROWNSTEIN MJ, 1993, P NATL ACAD SCI USA, V90, P5391, DOI 10.1073/pnas.90.12.5391; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Case DA, 2014, AMBER 14; Chaturvedi K, 2000, MOL BRAIN RES, V76, P64, DOI 10.1016/S0169-328X(99)00332-0; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Husbands SM, 2005, EUR J PHARMACOL, V509, P117, DOI 10.1016/j.ejphar.2004.12.035; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Knierim B, 2008, J BIOL CHEM, V283, P4967, DOI 10.1074/jbc.M703059200; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller-Gallacher JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092727; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Neilan CL, 2004, EUR J PHARMACOL, V499, P107, DOI 10.1016/j.ejphar.2004.07.097; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schiller PW, 2000, EUR J MED CHEM, V35, P895, DOI 10.1016/S0223-5234(00)01171-5; Sounier R., 2015, NATURE; TAKEMORI AE, 1981, EUR J PHARMACOL, V70, P445, DOI 10.1016/0014-2999(81)90355-1; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	64	542	548	7	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					315	+		10.1038/nature14886	http://dx.doi.org/10.1038/nature14886			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26245379	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000359714000028
J	Hyman, DM; Puzanov, I; Subbiah, V; Faris, JE; Chau, I; Blay, JY; Wolf, J; Raje, NS; Diamond, EL; Hollebecque, A; Gervais, R; Elez-Fernandez, ME; Italiano, A; Hofheinz, RD; Hidalgo, M; Chan, E; Schuler, M; Lasserre, SF; Makrutzki, M; Sirzen, F; Veronese, ML; Tabernero, J; Baselga, J				Hyman, David M.; Puzanov, Igor; Subbiah, Vivek; Faris, Jason E.; Chau, Ian; Blay, Jean-Yves; Wolf, Juergen; Raje, Noopur S.; Diamond, Eli L.; Hollebecque, Antoine; Gervais, Radj; Elena Elez-Fernandez, Maria; Italiano, Antoine; Hofheinz, Ralf-Dieter; Hidalgo, Manuel; Chan, Emily; Schuler, Martin; Lasserre, Susan Frances; Makrutzki, Martina; Sirzen, Florin; Veronese, Maria Luisa; Tabernero, Josep; Baselga, Jose			Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERDHEIM-CHESTER DISEASE; LANGERHANS CELL HISTIOCYTOSIS; METASTATIC COLORECTAL-CANCER; LUNG-CANCER; 1ST-LINE TREATMENT; HIGH PREVALENCE; CHEMOTHERAPY; TRIAL; EGFR; INHIBITION	BACKGROUND BRAF V600 mutations occur in various nonmelanoma cancers. We undertook a histology-independent phase 2 "basket" study of vemurafenib in BRAF V600 mutation-positive nonmelanoma cancers. METHODS We enrolled patients in six prespecified cancer cohorts; patients with all other tumor types were enrolled in a seventh cohort. A total of 122 patients with BRAF V600 mutation-positive cancer were treated, including 27 patients with colorectal cancer who received vemurafenib and cetuximab. The primary end point was the response rate; secondary end points included progression-free and overall survival. RESULTS In the cohort with non-small-cell lung cancer, the response rate was 42% (95% confidence interval [CI], 20 to 67) and median progression-free survival was 7.3 months (95% CI, 3.5 to 10.8). In the cohort with Erdheim-Chester disease or Langerhans'-cell histiocytosis, the response rate was 43% (95% CI, 18 to 71); the median treatment duration was 5.9 months (range, 0.6 to 18.6), and no patients had disease progression during therapy. There were anecdotal responses among patients with pleomorphic xanthoastrocytoma, anaplastic thyroid cancer, cholangiocarcinoma, salivary-duct cancer, ovarian cancer, and clear-cell sarcoma and among patients with colorectal cancer who received vemurafenib and cetuximab. Safety was similar to that in prior studies of vemurafenib for melanoma. CONCLUSIONS BRAF V600 appears to be a targetable oncogene in some, but not all, nonmelanoma cancers. Preliminary vemurafenib activity was observed in non-small-cell lung cancer and in Erdheim-Chester disease and Langerhans'-cell histiocytosis. The histologic context is an important determinant of response in BRAF V600-mutated cancers.	[Hyman, David M.; Diamond, Eli L.; Baselga, Jose] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Puzanov, Igor; Chan, Emily] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Subbiah, Vivek] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Faris, Jason E.; Raje, Noopur S.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Chau, Ian] Royal Marsden Hosp, Sutton, Surrey, England; [Blay, Jean-Yves] Ctr Leon Berard, F-69373 Lyon, France; [Hollebecque, Antoine] Inst Gustave Roussy, Villejuif, France; [Gervais, Radj] Ctr Hosp Univ Cote Nacre, Ctr Francois Baclesse, Caen, France; [Italiano, Antoine] Inst Bergonie Canc Ctr, Bordeaux, France; [Wolf, Juergen] Univ Hosp Cologne, Cologne, Germany; [Hofheinz, Ralf-Dieter] Univ Med Mannheim, Mannheim, Germany; [Schuler, Martin] Univ Hosp Essen, West Gerrman Canc Ctr, Essen, Germany; [Schuler, Martin] German Canc Consortium, Heidelberg, Germany; [Elena Elez-Fernandez, Maria; Tabernero, Josep] Vall Hebron Univ Hosp, Barcelona, Spain; [Elena Elez-Fernandez, Maria; Tabernero, Josep] Univ Autonoma Barcelona, Inst Oncol, E-08193 Barcelona, Spain; [Hidalgo, Manuel] Hosp Univ Madrid Sanchinarro, Madrid, Spain; [Lasserre, Susan Frances; Makrutzki, Martina; Sirzen, Florin; Veronese, Maria Luisa] F Hoffmann La Roche, Basel, Switzerland	Memorial Sloan Kettering Cancer Center; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Royal Marsden NHS Foundation Trust; UNICANCER; Centre Leon Berard; UNICANCER; Gustave Roussy; CHU de Caen NORMANDIE; UNICANCER; Centre Francois Baclesse; Universite de Caen Normandie; UNICANCER; Institut Bergonie; University of Cologne; Ruprecht Karls University Heidelberg; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Roche Holding	Baselga, J (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	baselgaj@mskcc.org	Élez, Elena/AAH-2945-2019; Blay, Jean-Yves/N-3966-2016; Hollebecque, Antoine/M-2695-2013; Chau, Ian/ABC-2023-2020; Tabernero, Josep/AAG-5026-2019; Subbiah, Vivek/O-3347-2019; PUZANOV, IGOR/AAP-2966-2020	Blay, Jean-Yves/0000-0001-7190-120X; Hollebecque, Antoine/0000-0003-2869-7551; Chau, Ian/0000-0003-0286-8703; Tabernero, Josep/0000-0002-2495-8139; Subbiah, Vivek/0000-0002-6064-6837; PUZANOV, IGOR/0000-0002-9803-3497; Diamond, Eli/0000-0001-5456-5961	F. Hoffmann-La Roche/Genentech; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	F. Hoffmann-La Roche/Genentech(Hoffmann-La RocheRoche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by F. Hoffmann-La Roche/Genentech; ClinicalTrials.gov number, NCT01524978.	Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Bang YJ, 2010, LANCET, V376, P1302; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Diamond EL, 2014, BLOOD, V124, P483, DOI 10.1182/blood-2014-03-561381; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Goeppert B, 2014, MODERN PATHOL, V27, P1028, DOI 10.1038/modpathol.2013.206; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Kimura ET, 2003, CANCER RES, V63, P1454; Kopetz S, 2010, J CLIN ONCOL S, V28; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lin Y, 2004, BIOMETRICS, V60, P482, DOI 10.1111/j.0006-341X.2004.00193.x; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; National Cancer Institute National Institutes of Health U.S. Department of Health and Human Services, 2009, NIH PUBL, V09-7473; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zelboraf (vemurafenib, 2014, ZELB VEM PRESCR INF	33	1150	1201	1	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					726	736		10.1056/NEJMoa1502309	http://dx.doi.org/10.1056/NEJMoa1502309			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287849	Green Accepted, Bronze			2022-12-28	WOS:000359709400009
J	Jehangir, W; Osman, M				Jehangir, Waqas; Osman, Mohamed			Electrical Alternans with Pericardial Tamponade	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jehangir, Waqas; Osman, Mohamed] Raritan Bay Med Ctr, Perth Amboy, NJ 08861 USA		Jehangir, W (corresponding author), Raritan Bay Med Ctr, Perth Amboy, NJ 08861 USA.	wjehangir@hotmail.com	Jehangir, Waqas/H-9626-2014; Jehangir, Waqas/AAL-6399-2021	Jehangir, Waqas/0000-0002-0730-5013; Jehangir, Waqas/0000-0002-0730-5013					0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8							e10	10.1056/NEJMicm1408805	http://dx.doi.org/10.1056/NEJMicm1408805			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26287870				2022-12-28	WOS:000359709400002
J	Davis, J; Finlay, I				Davis, Jacky; Finlay, Ilora			HEAD TO HEAD Would judicial consent for assisted dying protect vulnerable people?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE		[Davis, Jacky] Whittington Hosp, London, England; [Finlay, Ilora] Cardiff Univ, Palliat Med, Cardiff CF10 3AX, S Glam, Wales; [Finlay, Ilora] Natl Council Palliat Care, London, England; [Finlay, Ilora] BMA, London, England	University of London; University College London; Cardiff University	Davis, J (corresponding author), Whittington Hosp, London, England.							[Anonymous], 2014, MEDECONNECT HEALTHCA; [Anonymous], 2015, GUARDIAN; Association for Palliative Medicine, 2015, ASS PALL MED GREAT B; Battin MP, 2007, J MED ETHICS, V33, P591, DOI 10.1136/jme.2007.022335; Canadian Medical Association, 2014, CMA POL EUTH ASS DEA; Dierickx S, 2015, JAMA INTERN MED, V175, P1703, DOI 10.1001/jamainternmed.2015.3982; Dignitas, 2015, ACC SUIC MEMB DIGN Y; Dignity in Dying, 2014, FREED INF REQ; Finlay IG, 2011, J MED ETHICS, V37, P171, DOI 10.1136/jme.2010.037044; Ganzini L, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1682; George RJD, 2005, BMJ-BRIT MED J, V331, P684, DOI 10.1136/bmj.331.7518.684; Jackson A Oregon Hospice Association, 2006, REALITY ASSISTED DYI; Lerner BH, 2015, JAMA INTERN MED, V175, P1640, DOI 10.1001/jamainternmed.2015.4086; Medix, 2014, EUTH PHYS ASS SUIC; Populus, 2015, DIGN DYING POLL; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Seale C, 2009, PALLIATIVE MED, V23, P198, DOI 10.1177/0269216308102042; Whitcomb D., 2015, REUTERS	18	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2015	351								h4437	10.1136/bmj.h4437	http://dx.doi.org/10.1136/bmj.h4437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7PU	26294757				2022-12-28	WOS:000360081100006
J	[Anonymous]				[Anonymous]			Of Science, Humanism, and Medicine (Reprinted from JAMA, vol 193, pg 610, 1965)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		RENNER WF, 1965, J AMER MED ASSOC, V193, P563, DOI 10.1001/jama.1965.03090070013003; 1965, JAMA, V193, P610	2	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					734	734		10.1001/jama.2014.11930	http://dx.doi.org/10.1001/jama.2014.11930			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26284733				2022-12-28	WOS:000360019100029
J	Belfort, MA; Saade, GR; Thom, E; Blackwell, SC; Reddy, UM; Thorp, JM; Tita, ATN; Miller, RS; Peaceman, AM; McKenna, DS; Chien, EKS; Rouse, DJ; Gibbs, RS; El-Sayed, YY; Sorokin, Y; Caritis, SN; VanDorsten, JP				Belfort, Michael A.; Saade, George R.; Thom, Elizabeth; Blackwell, Sean C.; Reddy, Uma M.; Thorp, John M. J.; Tita, Alan T. N.; Miller, Russell S.; Peaceman, Alan M.; McKenna, David S.; Chien, Edward K. S.; Rouse, Dwight J.; Gibbs, Ronald S.; El-Sayed, Yasser Y.; Sorokin, Yoram; Caritis, Steve N.; VanDorsten, J. Peter		Eunice Kennedy Shriver Natl Inst C	A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELECTROCARDIOGRAM; CARDIOTOCOGRAPHY; WOMEN	BACKGROUND It is unclear whether using fetal electrocardiographic (ECG) ST-segment analysis as an adjunct to conventional intrapartum electronic fetal heart-rate monitoring modifies intrapartum and neonatal outcomes. METHODS We performed a multicenter trial in which women with a singleton fetus who were attempting vaginal delivery at more than 36 weeks of gestation and who had cervical dilation of 2 to 7 cm were randomly assigned to "open" or "masked" monitoring with fetal ST-segment analysis. The masked system functioned as a normal fetal heart-rate monitor. The open system displayed additional information for use when uncertain fetal heart-rate patterns were detected. The primary outcome was a composite of intrapartum fetal death, neonatal death, an Apgar score of 3 or less at 5 minutes, neonatal seizure, an umbilical-artery blood pH of 7.05 or less with a base deficit of 12 mmol per liter or more, intubation for ventilation at delivery, or neonatal encephalopathy. RESULTS A total of 11,108 patients underwent randomization; 5532 were assigned to the open group, and 5576 to the masked group. The primary outcome occurred in 52 fetuses or neonates of women in the open group (0.9%) and 40 fetuses or neonates of women in the masked group (0.7%) (relative risk, 1.31; 95% confidence interval, 0.87 to 1.98; P = 0.20). Among the individual components of the primary outcome, only the frequency of a 5-minute Apgar score of 3 or less differed significantly between neonates of women in the open group and those in the masked group (0.3% vs. 0.1%, P = 0.02). There were no significant between-group differences in the rate of cesarean delivery (16.9% and 16.2%, respectively; P = 0.30) or any operative delivery (22.8% and 22.0%, respectively; P = 0.31). Adverse events were rare and occurred with similar frequency in the two groups. CONCLUSIONS Fetal ECG ST-segment analysis used as an adjunct to conventional intrapartum electronic fetal heart-rate monitoring did not improve perinatal outcomes or decrease operative-delivery rates. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and Neoventa Medical; ClinicalTrials.gov number, NCT01131260.)	[Belfort, Michael A.] Med Univ S Carolina, Charleston, SC 29425 USA; [Saade, George R.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Thom, Elizabeth] George Washington Univ, Ctr Biostat, Washington, DC USA; [Blackwell, Sean C.] Univ Texas Hlth Sci Ctr Houston, Childrens Mem Hermann Hosp, Houston, TX 77030 USA; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA; [Thorp, John M. J.] Univ N Carolina, Chapel Hill, NC USA; [Tita, Alan T. N.] Univ Alabama Birmingham, Birmingham, AL USA; [Miller, Russell S.] Columbia Univ, New York, NY USA; [Peaceman, Alan M.] Northwestern Univ, Chicago, IL 60611 USA; [McKenna, David S.] Ohio State Univ, Columbus, OH 43210 USA; [Chien, Edward K. S.] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH 44106 USA; [Rouse, Dwight J.] Brown Univ, Providence, RI 02912 USA; [Gibbs, Ronald S.] Univ Colorado, Sch Med, Aurora, CO USA; [El-Sayed, Yasser Y.] Stanford Univ, Stanford, CA 94305 USA; [Sorokin, Yoram] Wayne State Univ, Detroit, MI USA; [Caritis, Steve N.] Univ Pittsburgh, Pittsburgh, PA USA; [VanDorsten, J. Peter] Med Univ S Carolina, Charleston, SC USA	Medical University of South Carolina; University of Texas System; University of Texas Medical Branch Galveston; George Washington University; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; Columbia University; Northwestern University; University System of Ohio; Ohio State University; Case Western Reserve University; MetroHealth System; Brown University; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; Wayne State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of South Carolina	Belfort, MA (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.	belfort@bcm.edu		Chien, Edward/0000-0003-3268-0111; Tita, Alan/0000-0002-7244-9056	Eunice Kennedy Shriver National Institute of Child Health and Human Development; Neoventa Medical; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027915, UG1HD053097, U10HD036801, U10HD068282, UG1HD040545, UG1HD040485, U10HD068268, U10HD027917, U10HD021410, UG1HD068282, UG1HD040560, UG1HD034208, UG1HD040544, U10HD040560, U10HD040544, U10HD040500, U10HD027869, U10HD034208, U10HD040485, UG1HD040500, UG1HD027869, U10HD053097, UG1HD068268, UG1HD040512, UG1HD027915, U10HD040512, U10HD040545] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD021410, U01HD036801] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Neoventa Medical; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and Neoventa Medical; ClinicalTrials.gov number, NCT01131260.	Amer-Wahlin I, 2001, LANCET, V358, P534, DOI 10.1016/S0140-6736(01)05703-8; [Anonymous], 2014, Obstet Gynecol, V123, P896, DOI 10.1097/01.AOG.0000445580.65983.d2; Begley C, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-85; Bloom SL, 2006, NEW ENGL J MED, V355, P2195, DOI 10.1056/NEJMoa061170; Cahill AG, 2009, OBSTET GYNECOL, V114, P124, DOI [10.1097/AOG.0b013e3181a99def, 10.1097/AOG.0b013e3181aef106]; Food and Drug Administration, 2005, APPR LETT STAN S31 F; GELLI MG, 1969, ACTA OBSTET GYN SCAN, V48, P34, DOI 10.3109/00016346909156625; HOKEGARD KH, 1981, ACTA PHYSIOL SCAND, V113, P1, DOI 10.1111/j.1748-1716.1981.tb06853.x; Kaandorp J, 2013, AM J OBSTET GYNECOL, V208, pS14, DOI 10.1016/j.ajog.2012.10.194; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Neilson JP, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000116.pub2; Oian P, 2014, ACTA OBSTET GYN SCAN, V93, P570, DOI 10.1111/aogs.12414; Ojala K, 2006, BJOG-INT J OBSTET GY, V113, P419, DOI 10.1111/j.1471-0528.2006.00886.x; Rosen KG, 2013, AM J OBSTET GYNECOL, V209, P394, DOI 10.1016/j.ajog.2013.05.013; ROSEN KG, 1976, BIOL NEONATE, V30, P17; Schuit E, 2013, AM J OBSTET GYNECOL, V209, P394, DOI 10.1016/j.ajog.2013.05.014; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SIGGAARD.O, 1971, SCAND J CLIN LAB INV, V27, P239, DOI 10.3109/00365517109080214; Steer PJ, 2014, ACTA OBSTET GYN SCAN, V93, P533, DOI 10.1111/aogs.12369; Vayssiere C, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.007; WATANABE T, 1992, AM J OBSTET GYNECOL, V166, P246, DOI 10.1016/0002-9378(92)91867-A; Westerhuis MEMH, 2009, BJOG-INT J OBSTET GY, V116, P545, DOI 10.1111/j.1471-0528.2008.02092.x; WESTGATE J, 1993, AM J OBSTET GYNECOL, V169, P1151, DOI 10.1016/0002-9378(93)90273-L; Westgate JA, 2001, AM J OBSTET GYNECOL, V184, P743, DOI 10.1067/mob.2001.111932	24	102	108	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					632	641		10.1056/NEJMoa1500600	http://dx.doi.org/10.1056/NEJMoa1500600			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LE	26267623	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000359707700008
J	Chaloupka, FJ; Sweanor, D; Warner, KE				Chaloupka, Frank J.; Sweanor, David; Warner, Kenneth E.			Differential Taxes for Differential Risks - Toward Reduced Harm from Nicotine-Yielding Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chaloupka, Frank J.] Univ Illinois, Chicago, IL 60607 USA; [Sweanor, David] Univ Ottawa, Ottawa, ON, Canada; [Sweanor, David] Univ Nottingham, Nottingham NG7 2RD, England; [Warner, Kenneth E.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Ottawa; University of Nottingham; University of Michigan System; University of Michigan	Chaloupka, FJ (corresponding author), Univ Illinois, Chicago, IL 60607 USA.			Warner, Kenneth/0000-0002-8214-1776	NATIONAL CANCER INSTITUTE [U01CA154248] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA154248] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Department of Health, 2014, HLTH CONS SMOK 50 YE; International Agency for Research on Cancer, 2011, IARC HDB CANC PREV, V14; Nutt DJ, 2014, EUR ADDICT RES, V20, P218, DOI 10.1159/000360220; Ramstrom L, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-14; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1	5	62	62	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					594	597		10.1056/NEJMp1505710	http://dx.doi.org/10.1056/NEJMp1505710			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP2LE	26267620	Green Submitted, Green Published			2022-12-28	WOS:000359707700004
J	Ketov, SV; Sun, YH; Nachum, S; Lu, Z; Checchi, A; Beraldin, AR; Bai, HY; Wang, WH; Louzguine-Luzgin, DV; Carpenter, MA; Greer, AL				Ketov, S. V.; Sun, Y. H.; Nachum, S.; Lu, Z.; Checchi, A.; Beraldin, A. R.; Bai, H. Y.; Wang, W. H.; Louzguine-Luzgin, D. V.; Carpenter, M. A.; Greer, A. L.			Rejuvenation of metallic glasses by non-affine thermal strain	NATURE			English	Article							DEEP CRYOGENIC TREATMENT; MECHANICAL-PROPERTIES; STRUCTURAL RELAXATION; LIQUID; DYNAMICS; STRENGTH	When a spatially uniform temperature change is imposed on a solid with more than one phase, or on a polycrystal of a single, non-cubic phase (showing anisotropic expansion-contraction), the resulting thermal strain is inhomogeneous (non-affine). Thermal cycling induces internal stresses, leading to structural and property changes that are usually deleterious. Glasses are the solids that form on cooling a liquid if crystallization is avoided-they might be considered the ultimate, uniform solids, without the microstructural features and defects associated with polycrystals. Here we explore the effects of cryogenic thermal cycling on glasses, specifically metallic glasses. We show that, contrary to the null effect expected from uniformity, thermal cycling induces rejuvenation, reaching less relaxed states of higher energy. We interpret these findings in the context that the dynamics in liquids become heterogeneous on cooling towards the glass transition(1), and that there may be consequent heterogeneities in the resulting glasses. For example, the vibrational dynamics of glassy silica at long wavelengths are those of an elastic continuum, but at wavelengths less than approximately three nanometres the vibrational dynamics are similar to those of a polycrystal with anisotropic grains(2). Thermal cycling of metallic glasses is easily applied, and gives improvements in compressive plasticity. The fact that such effects can be achieved is attributed to intrinsic non-uniformity of the glass structure, giving a non-uniform coefficient of thermal expansion. While metallic glasses may be particularly suitable for thermal cycling, the non-affine nature of strains in glasses in general deserves further study, whether they are induced by applied stresses or by temperature change.	[Ketov, S. V.; Louzguine-Luzgin, D. V.; Greer, A. L.] Tohoku Univ, WPI Adv Inst Mat Res WPI AIMR, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan; [Sun, Y. H.; Nachum, S.; Checchi, A.; Beraldin, A. R.; Greer, A. L.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0FS, England; [Lu, Z.; Bai, H. Y.; Wang, W. H.] Chinese Acad Sci, Inst Phys, Beijing 100080, Peoples R China; [Checchi, A.; Beraldin, A. R.] Univ Padua, Dept Management & Engn, I-36100 Vicenza, Italy; [Carpenter, M. A.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	Tohoku University; University of Cambridge; Chinese Academy of Sciences; Institute of Physics, CAS; University of Padua; University of Cambridge	Greer, AL (corresponding author), Tohoku Univ, WPI Adv Inst Mat Res WPI AIMR, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	alg13@cam.ac.uk	Greer, Lindsay A.L./E-9433-2017; Lu, Zhen/AAQ-9357-2020; Sergey, Ketov/G-5558-2011; Carpenter, Michael A/D-4860-2015; LOUZGUINE, Dmitri/D-2492-2010	Sergey, Ketov/0000-0002-6002-603X; LOUZGUINE, Dmitri/0000-0001-5716-4987; Beraldin, Andrea Roberto/0000-0003-2828-1740; Bai, Hai Yang/0000-0001-7687-7624; Lu, Zhen/0000-0002-6202-8709	World Premier International Research Center Initiative (WPI), MEXT, Japan; NSF China; MOST 973 China; Engineering and the Engineering and Physical Sciences Research Council, UK (Materials World Network); China Scholarship Council (CSC); EPSRC [EP/I035404/1, EP/I036079/1] Funding Source: UKRI; NERC [NE/F017081/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I035404/1, EP/I036079/1] Funding Source: researchfish; Natural Environment Research Council [NE/B505738/1, NE/F017081/1] Funding Source: researchfish	World Premier International Research Center Initiative (WPI), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NSF China(National Natural Science Foundation of China (NSFC)); MOST 973 China; Engineering and the Engineering and Physical Sciences Research Council, UK (Materials World Network)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); China Scholarship Council (CSC)(China Scholarship Council); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan, by NSF China and MOST 973 China, and by the Engineering and the Engineering and Physical Sciences Research Council, UK (Materials World Network project). Y.H.S. acknowledges support from a China Scholarship Council (CSC) scholarship. M. L. Falk, T. C. Hufnagel, E. Ma, D. B. Miracle and J. Orava are thanked for discussions. All data accompanying this publication are directly available within the publication and the accompanying Extended Data figures and tables.	Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051; Baldi G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.185503; Cheng YQ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134115; Churyumov AY, 2012, MAT SCI ENG A-STRUCT, V550, P358, DOI 10.1016/j.msea.2012.04.087; Concustell A, 2011, SCRIPTA MATER, V64, P1091, DOI 10.1016/j.scriptamat.2011.02.028; Concustell A, 2009, PHIL MAG LETT, V89, P831, DOI 10.1080/09500830903337919; Conner RD, 1999, J MATER RES, V14, P3292, DOI 10.1557/JMR.1999.0445; Demetriou MD, 2011, NAT MATER, V10, P123, DOI [10.1038/nmat2930, 10.1038/NMAT2930]; Ding J, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754121; Ding J, 2014, P NATL ACAD SCI USA, V111, P14052, DOI 10.1073/pnas.1412095111; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; EGAMI T, 1982, J PHYS F MET PHYS, V12, P2141, DOI 10.1088/0305-4608/12/10/010; Egami T, 2013, METALS-BASEL, V3, P77, DOI 10.3390/met3010077; FIELD JS, 1993, J MATER RES, V8, P297, DOI 10.1557/JMR.1993.0297; Greer AL, 2013, MAT SCI ENG R, V74, P71, DOI 10.1016/j.mser.2013.04.001; Gruneisen E, 1912, ANN PHYS-BERLIN, V39, P257; Hufnagel TC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064204; Ichitsubo T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.245501; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; Kalsi NS, 2010, MATER MANUF PROCESS, V25, P1077, DOI 10.1080/10426911003720862; Ke HB, 2011, SCRIPTA MATER, V64, P966, DOI 10.1016/j.scriptamat.2011.01.047; Lee SC, 2008, SCRIPTA MATER, V58, P591, DOI 10.1016/j.scriptamat.2007.11.036; Liu YH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.125504; Ma B.M., 1983, NUCL REACTOR MAT APP, P149; Magagnosc DJ, 2014, ACTA MATER, V74, P165, DOI 10.1016/j.actamat.2014.04.002; McKnight REA, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/7/075229; Mear FO, 2008, SCRIPTA MATER, V59, P1243, DOI 10.1016/j.scriptamat.2008.08.023; Mendelev MI, 2009, J APPL PHYS, V105, DOI 10.1063/1.3068306; Meng FQ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4753998; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Packard CE, 2010, J MATER RES, V25, P2251, DOI 10.1557/JMR.2010.0299; Packard CE, 2010, PHILOS MAG, V90, P1373, DOI 10.1080/14786430903352664; Poulsen HF, 2005, NAT MATER, V4, P33, DOI 10.1038/nmat1266; Preciado M, 2014, J MATER SCI, V49, P8183, DOI 10.1007/s10853-014-8527-2; Santos MV, 2014, CRYOBIOLOGY, V69, P488, DOI 10.1016/j.cryobiol.2014.10.010; Wagner H, 2011, NAT MATER, V10, P439, DOI [10.1038/NMAT3024, 10.1038/nmat3024]; Wang WH, 2007, PROG MATER SCI, V52, P540, DOI 10.1016/j.pmatsci.2006.07.003; Wang X, 2013, J ALLOY COMPD, V575, P449, DOI 10.1016/j.jallcom.2013.05.194; WEAIRE D, 1971, ACTA METALL MATER, V19, P779, DOI 10.1016/0001-6160(71)90134-9; Yamasaki M, 2004, APPL PHYS LETT, V84, P4653, DOI 10.1063/1.1759768; Yu HB, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.015504; Yu HB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3204; Yu HB, 2013, MATER TODAY, V16, P183, DOI 10.1016/j.mattod.2013.05.002; Yuan C, 2015, J ALLOY COMPD, V619, P513, DOI 10.1016/j.jallcom.2014.08.201	44	444	456	34	580	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					200	+		10.1038/nature14674	http://dx.doi.org/10.1038/nature14674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26268190	Green Accepted			2022-12-28	WOS:000359386900027
J	Nichols, MH; Corces, VG				Nichols, Michael H.; Corces, Victor G.			A CTCF Code for 3D Genome Architecture	CELL			English	Editorial Material							ORGANIZATION; REVEALS	The architectural protein CTCF plays a complex role in decoding the functional output of the genome. Guo et al. now show that the orientation of a CTCF site restricts its choice of interacting partner, thus creating a code that predicts the three-dimensional organization of the genome. We propose a DNA extrusion model to account for orientation-specific loop formation.	[Nichols, Michael H.; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	vcorces@emory.edu		Corces, Victor/0000-0001-5140-4337	NIGMS NIH HHS [R01 GM035463] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035463] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; MacPherson MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-101; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038	9	103	106	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 13	2015	162	4					702	705		10.1016/j.cell.2015.07.053	http://dx.doi.org/10.1016/j.cell.2015.07.053			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP2XP	26276625	Green Accepted, Bronze			2022-12-28	WOS:000359741400004
J	Ellul, MA; Gholkar, SA; Cross, TJ				Ellul, Mark A.; Gholkar, Santosh A.; Cross, Timothy J.			Hepatic encephalopathy due to liver cirrhosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							AMMONIA; MANAGEMENT; DIAGNOSIS; LACTULOSE; OVERT; TRANSPLANTATION; QUANTIFICATION; HYPERAMMONEMIA; EMBOLIZATION; PATHOGENESIS		[Ellul, Mark A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England; [Gholkar, Santosh A.] City Hlth Ctr, Manchester M1 1PL, Lancs, England; [Cross, Timothy J.] Royal Liverpool Univ Hosp, Dept Gastroenterol, Liverpool L7 8XP, Merseyside, England	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Cross, TJ (corresponding author), Royal Liverpool Univ Hosp, Dept Gastroenterol, Liverpool L7 8XP, Merseyside, England.	tim.cross@rlbuht.nhs.uk	Ellul, Mark/HGU-9086-2022	Ellul, Mark/0000-0002-6115-8245	National Institute for Health Research [ACF-2013-07-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Adams RD, 1953, RES PUBL ASSOC RES N, V32, P198; Als-Nielsen B, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003044.pub2, DOI 10.1002/14651858.CD003044.PUB2]; Amer Assoc Study Liver Dis, 2014, J HEPATOL, V61, P642, DOI 10.1016/j.jhep.2014.05.042; Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; Amodio P, 1999, HEPATOLOGY, V29, P1662, DOI 10.1002/hep.510290619; Amodio P, 2008, J HEPATOL, V49, P346, DOI 10.1016/j.jhep.2008.04.022; Amodio P, 2013, HEPATOLOGY, V58, P325, DOI 10.1002/hep.26370; An J, 2014, ALIMENT PHARM THER, V39, P1418, DOI 10.1111/apt.12771; Ardizzone G, 2006, TRANSPLANT P, V38, P789, DOI 10.1016/j.transproceed.2006.01.039; Bai M, 2011, J GASTROEN HEPATOL, V26, P943, DOI 10.1111/j.1440-1746.2011.06663.x; Bajaj JS, 2010, ALIMENT PHARM THER, V31, P537, DOI 10.1111/j.1365-2036.2009.04211.x; Bajaj JS, 2008, GASTROENTEROLOGY, V135, P1591, DOI 10.1053/j.gastro.2008.07.021; Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309; Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128; Basile AS, 2002, NEUROCHEM INT, V41, P115, DOI 10.1016/S0197-0186(02)00032-3; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Bathgate AJ, 2006, LANCET, V367, P2045, DOI 10.1016/S0140-6736(06)68904-6; Bianchi G, 2012, CLIN LIVER DIS, V16, P159, DOI 10.1016/j.cld.2011.12.003; Bustamante J, 1999, J HEPATOL, V30, P890, DOI 10.1016/S0168-8278(99)80144-5; Cabral CM, 2011, NUTR CLIN PRACT, V26, P155, DOI 10.1177/0884533611400086; CAMMA C, 1993, DIGEST DIS SCI, V38, P916, DOI 10.1007/BF01295920; Carey I, 2015, BMJ SUPPORT PALLIAT, V5, P12, DOI 10.1136/bmjspcare-2013-000634; Cordoba J, 2004, J HEPATOL, V41, P38, DOI 10.1016/j.jhep.2004.03.023; Desjardins P, 2012, NEUROCHEM INT, V60, P690, DOI 10.1016/j.neuint.2012.02.001; Drivers Medical Group DVLA, 2014, MED PRACT GLANC GUID; Duseja A, 2010, DIGEST DIS SCI, V55, P3188, DOI 10.1007/s10620-010-1377-0; Fanelli F, 2009, AM J ROENTGENOL, V193, P1696, DOI 10.2214/AJR.09.2968; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Gluud LL, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001939.pub2; HAWKINS RA, 1994, ADV EXP MED BIOL, V368, P125; Iwasa M, 2015, HEPATOL RES, V45, P1155, DOI 10.1111/hepr.12495; Jalan R, 2007, MED HYPOTHESES, V69, P1064, DOI 10.1016/j.mehy.2006.12.061; Jalan R, 2004, CLIN SCI, V106, P467, DOI 10.1042/CS20030357; Jiang MS, 2015, CLIN RES HEPATOL GAS, V39, pE5, DOI 10.1016/j.clinre.2014.08.001; Kendrick E, 2013, GETTING IT RIGHT IMP; Kircheis G, 2002, HEPATOLOGY, V35, P357, DOI 10.1053/jhep.2002.30957; Kramer L, 2000, HEPATOLOGY, V31, P30, DOI 10.1002/hep.510310107; Lacerda G, 2006, NEUROLOGY, V67, pS28, DOI 10.1212/WNL.67.12_suppl_4.S28; Laleman W, 2013, HEPATOLOGY, V57, P2448, DOI 10.1002/hep.26314; Lauridsen MM, 2013, METAB BRAIN DIS, V28, P231, DOI 10.1007/s11011-012-9373-z; Martin P, 2014, HEPATOLOGY, V59, P1144, DOI 10.1002/hep.26972; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; McGee RG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008716.pub2; Merli M, 2013, METAB BRAIN DIS, V28, P281, DOI 10.1007/s11011-012-9365-z; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Nabi E, 2014, CLIN GASTROENTEROL H, V12, P1384, DOI 10.1016/j.cgh.2013.12.020; National Institute for Health and Care Excellence, 2015, RIF PREV EP OV HEP E; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; NHS Right Care, 2013, NHS ATL VAR HEALTHC; Paik YH, 2005, YONSEI MED J, V46, P399, DOI 10.3349/ymj.2005.46.3.399; Patidar KR, 2014, AM J GASTROENTEROL, V109, P1757, DOI 10.1038/ajg.2014.264; Rahimi RS, 2014, JAMA INTERN MED, V174, P1727, DOI 10.1001/jamainternmed.2014.4746; Rai R, 2015, J CLIN EXP HEPATOL, V5, pS29, DOI 10.1016/j.jceh.2014.12.003; Riggio O, 2012, CLIN LIVER DIS, V16, P133, DOI 10.1016/j.cld.2011.12.008; Rossle M, 2013, J HEPATOL, V59, P1081, DOI 10.1016/j.jhep.2013.06.014; Scott TR, 2013, WORLD J GASTROENTERO, V19, P9240, DOI 10.3748/wjg.v19.i48.9240; Sharma BC, 2009, GASTROENTEROLOGY, V137, P885, DOI 10.1053/j.gastro.2009.05.056; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; Simon-Talero M, 2013, J HEPATOL, V59, P1184, DOI 10.1016/j.jhep.2013.07.020; Stewart CA, 2005, CLIN GASTROENTEROL H, V3, P197, DOI 10.1016/S1542-3565(04)00531-2; Stewart J, 2014, LIVER TRANSPLANT, V20, P1256, DOI 10.1002/lt.23944; VINCE AJ, 1980, J MED MICROBIOL, V13, P177, DOI 10.1099/00222615-13-2-177; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Xu J, 2014, HEPATOB PANCREAT DIS, V13, P354, DOI 10.1016/S1499-3872(14)60280-0; Zhu GQ, 2015, ALIMENT PHARM THER, V41, P624, DOI 10.1111/apt.13122	66	22	23	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2015	351								h4187	10.1136/bmj.h4187	http://dx.doi.org/10.1136/bmj.h4187			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2XG	26265724				2022-12-28	WOS:000359740400005
J	Al Ma'Mari, F; Moorsom, T; Teobaldi, G; Deacon, W; Prokscha, T; Luetkens, H; Lee, S; Sterbinsky, GE; Arena, DA; MacLaren, DA; Flokstra, M; Ali, M; Wheeler, MC; Burnell, G; Hickey, BJ; Cespedes, O				Al Ma'Mari, Fatma; Moorsom, Timothy; Teobaldi, Gilberto; Deacon, William; Prokscha, Thomas; Luetkens, Hubertus; Lee, Steve; Sterbinsky, George E.; Arena, Dario A.; MacLaren, Donald A.; Flokstra, Machiel; Ali, Mannan; Wheeler, May C.; Burnell, Gavin; Hickey, Bryan J.; Cespedes, Oscar			Beating the Stoner criterion using molecular interfaces	NATURE			English	Article							GENERATION; ENERGY; LENGTH	Only three elements are ferromagnetic at room temperature: the transition metals iron, cobalt and nickel. The Stoner criterion explains why iron is ferromagnetic but manganese, for example, is not, even though both elements have an unfilled 3d shell and are adjacent in the periodic table: according to this criterion, the product of the density of states and the exchange integral must be greater than unity for spontaneous spin ordering to emerge(1,2). Here we demonstrate that it is possible to alter the electronic states of non-ferromagnetic materials, such as diamagnetic copper and paramagnetic manganese, to overcome the Stoner criterion and make them ferromagnetic at room temperature. This effect is achieved via interfaces between metallic thin films and C-60 molecular layers. The emergent ferromagnetic state exists over several layers of the metal before being quenched at large sample thicknesses by the material's bulk properties. Although the induced magnetization is easily measurable by magnetometry, low-energy muon spin spectroscopy(3) provides insight into its distribution by studying the depolarization process of low-energy muons implanted in the sample. This technique indicates localized spin-ordered states at, and close to, the metal-molecule interface. Density functional theory simulations suggest a mechanism based on magnetic hardening of the metal atoms, owing to electron transfer(4,5). This mechanism might allow for the exploitation of molecular coupling to design magnetic metamaterials using abundant, non-toxic components such as organic semiconductors. Charge transfer at molecular interfaces may thus be used to control spin polarization or magnetization, with consequences for the design of devices for electronic, power or computing applications (see, for example, refs 6 and 7).	[Al Ma'Mari, Fatma; Moorsom, Timothy; Deacon, William; Ali, Mannan; Wheeler, May C.; Burnell, Gavin; Hickey, Bryan J.; Cespedes, Oscar] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Teobaldi, Gilberto] Univ Liverpool, Stephenson Inst Renewable Energy, Dept Chem, Liverpool L69 3BX, Merseyside, England; [Prokscha, Thomas; Luetkens, Hubertus] Paul Scherrer Inst, Lab Muon Spin Spect, CH-5232 Villigen, Switzerland; [Lee, Steve; Flokstra, Machiel] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Sterbinsky, George E.; Arena, Dario A.] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA; [MacLaren, Donald A.] Univ Glasgow, Sch Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland	University of Leeds; University of Liverpool; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of St Andrews; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Glasgow	Cespedes, O (corresponding author), Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England.	o.cespedes@leeds.ac.uk	Ali, Mannan/P-6098-2017; Burnell, Gavin/C-8950-2009; MacLaren, D A/A-5568-2010; Luetkens, Hubertus/G-1831-2011; Hickey, B J/B-3333-2016; Lee, Stephen/G-9791-2016	Burnell, Gavin/0000-0002-9486-0639; MacLaren, D A/0000-0003-0641-686X; Luetkens, Hubertus/0000-0002-5842-9788; Hickey, B J/0000-0001-8289-5618; Lee, Stephen/0000-0002-2020-3310; TEOBALDI, Gilberto/0000-0001-6068-6786; Ali, Mannan/0000-0002-7426-7731; Moorsom, Timothy/0000-0002-1771-7185; Flokstra, Machiel Geert/0000-0002-4333-1358	Engineering and Physical Sciences Research Council [EP/K00512X/1, EP/K036408/1, EP/J01060X/1, EP/I004483/1]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; EPSRC [EP/J021156/1, EP/I004483/1, EP/M000923/1, EP/I00419X/1, EP/K036408/1, EP/K00512X/1, EP/J01060X/1, EP/K013610/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1231114, EP/I00419X/1, EP/J021156/1, EP/M000923/1, EP/K013610/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council through grants EP/K00512X/1, EP/K036408/1, EP/J01060X/1 and EP/I004483/1. Use of the N8 POLARIS (EPSRC EP/K000225/1), ARCHER (via the UKCP Consortium, EP/K013610/1), and the High Performance Computing (HPC) Wales facilities is acknowledged. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DE-AC02-98CH10886.	ANSALDO EJ, 1991, NATURE, V353, P121, DOI 10.1038/353121a0; Bakule P, 2004, CONTEMP PHYS, V45, P203, DOI 10.1080/00107510410001676803; Barraud C, 2010, NAT PHYS, V6, P615, DOI 10.1038/NPHYS1688; Beeler MC, 2013, NATURE, V498, P201, DOI 10.1038/nature12185; Brede J, 2014, NAT NANOTECHNOL, V9, P1018, DOI [10.1038/NNANO.2014.235, 10.1038/nnano.2014.235]; Callsen M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106805; Cho SW, 2007, SYNTHETIC MET, V157, P160, DOI 10.1016/j.synthmet.2007.01.006; Coey JMD, 2005, SOLID STATE SCI, V7, P660, DOI 10.1016/j.solidstatesciences.2004.11.012; Drew AJ, 2009, NAT MATER, V8, P109, DOI 10.1038/NMAT2333; DUTY TL, 1994, HYPERFINE INTERACT, V86, P789, DOI 10.1007/BF02068978; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Geng YN, 2014, NAT MATER, V13, P163, DOI [10.1038/nmat3813, 10.1038/NMAT3813]; JANAK JF, 1977, PHYS REV B, V16, P255, DOI 10.1103/PhysRevB.16.255; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Maccherozzi F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267201; METHFESSEL M, 1989, PHYS REV B, V40, P3616, DOI 10.1103/PhysRevB.40.3616; Moodera JS, 2014, MRS BULL, V39, P578, DOI 10.1557/mrs.2014.128; Moorsom T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.125311; Morenzoni E, 2002, NUCL INSTRUM METH B, V192, P254, DOI 10.1016/S0168-583X(01)01166-1; MORENZONI E, 1994, PHYS REV LETT, V72, P2793, DOI 10.1103/PhysRevLett.72.2793; Pai WW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.036103; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Powell AK, 2010, NAT CHEM, V2, P351, DOI 10.1038/nchem.637; Prokscha T, 2008, NUCL INSTRUM METH A, V595, P317, DOI 10.1016/j.nima.2008.07.081; Raman KV, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4890496; Raman KV, 2013, NATURE, V493, P509, DOI 10.1038/nature11719; Sanvito S, 2010, NAT PHYS, V6, P562, DOI 10.1038/nphys1714; SCHWARZ K, 1984, J PHYS F MET PHYS, V14, pL129, DOI 10.1088/0305-4608/14/7/008; Stoner EC, 1939, PROC R SOC LON SER-A, V169, P339, DOI 10.1098/rspa.1939.0003; Stoner EC, 1938, PROC R SOC LON SER-A, V165, P0372, DOI 10.1098/rspa.1938.0066; Tamai A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075134; Tseng TC, 2010, NAT CHEM, V2, P374, DOI [10.1038/NCHEM.591, 10.1038/nchem.591]; Vandewal K, 2014, NAT MATER, V13, P63, DOI [10.1038/NMAT3807, 10.1038/nmat3807]; Vobornik I, 2011, NANO LETT, V11, P4079, DOI 10.1021/nl201275q; Warner M, 2013, NATURE, V503, P504, DOI 10.1038/nature12597; Xu G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075419; Zhang XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2423	37	119	119	298	1810	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					69	U128		10.1038/nature14621	http://dx.doi.org/10.1038/nature14621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26245580	Green Accepted			2022-12-28	WOS:000359002300033
J	Simon, SL; Bouville, A				Simon, Steven L.; Bouville, Andre			Health effects of nuclear weapons testing	LANCET			English	Editorial Material							RADIOACTIVE FALLOUT; CANCER-RISKS; TEST-SITE; EXPOSURE; WORLDWIDE; LEUKEMIA		[Simon, Steven L.; Bouville, Andre] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Simon, SL (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	ssimon@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIACP010185] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bennett BG, 2002, HEALTH PHYS, V82, P644, DOI 10.1097/00004032-200205000-00011; Bouville A, 2002, HEALTH PHYS, V82, P690, DOI 10.1097/00004032-200205000-00015; CONARD RA, 1970, J AMER MED ASSOC, V214, P316, DOI 10.1001/jama.214.2.316; DARBY SC, 1992, BRIT MED J, V304, P1005, DOI 10.1136/bmj.304.6833.1005; de Vathaire F, 2010, BRIT J CANCER, V103, P1115, DOI 10.1038/sj.bjc.6605862; Gilbert ES, 2002, HEALTH PHYS, V82, P726, DOI 10.1097/00004032-200205000-00017; Gilbert ES, 2010, RADIAT RES, V173, P659, DOI 10.1667/RR2057.1; Gordeev K, 2006, J RADIAT RES, V47, pA137, DOI 10.1269/jrr.47.A137; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; KERBER RA, 1993, JAMA-J AM MED ASSOC, V270, P2076; Land CE, 2015, RADIAT RES, V183, P159, DOI 10.1667/RR13794.1; National Cancer Institute, 1997, EST EXP THYR DOS REC; National Research Council, 1999, EXP AM PEOPL IOD 131; Ohtsuru A, 2015, LANCET, V386, P489, DOI 10.1016/S0140-6736(15)60994-1; Simon SL, 2006, AM SCI, V94, P48, DOI 10.1511/2006.1.48; Simon SL, 2002, HEALTH PHYS, V82, P706, DOI 10.1097/00004032-200205000-00016; Simon SL, 2010, HEALTH PHYS, V99, P105, DOI 10.1097/HP.0b013e3181dc523c; STEVENS W, 1990, JAMA-J AM MED ASSOC, V264, P585, DOI 10.1001/jama.264.5.585; *UN SCI COMM EFF A, 2000, SOURC EFF ION RAD RE	20	7	8	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					407	409		10.1016/S0140-6736(15)61037-6	http://dx.doi.org/10.1016/S0140-6736(15)61037-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26251378				2022-12-28	WOS:000358761700005
J	Lerner, TN; Shilyansky, C; Davidson, TJ; Evans, KE; Beier, KT; Zalocusky, KA; Crow, AK; Malenka, RC; Luo, L; Tomer, R; Deisseroth, K				Lerner, Talia N.; Shilyansky, Carrie; Davidson, Thomas J.; Evans, Kathryn E.; Beier, Kevin T.; Zalocusky, Kelly A.; Crow, Ailey K.; Malenka, Robert C.; Luo, Liqun; Tomer, Raju; Deisseroth, Karl			Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits	CELL			English	Article							VENTRAL TEGMENTAL AREA; DORSOLATERAL STRIATUM; DORSOMEDIAL STRIATUM; NIGROSTRIATAL DOPAMINE; SUBSTANTIA-NIGRA; AVERSIVE STIMULI; SOCIAL-BEHAVIOR; HABIT FORMATION; NEURONS; MIDBRAIN	Recent progress in understanding the diversity of midbrain dopamine neurons has highlighted the importance-and the challenges-of defining mammalian neuronal cell types. Although neurons may be best categorized using inclusive criteria spanning biophysical properties, wiring of inputs, wiring of outputs, and activity during behavior, linking all of these measurements to cell types within the intact brains of living mammals has been difficult. Here, using an array of intact-brain circuit interrogation tools, including CLARITY, COLM, optogenetics, viral tracing, and fiber photometry, we explore the diversity of dopamine neurons within the substantia nigra pars compacta (SNc). We identify two parallel nigrostriatal dopamine neuron subpopulations differing in biophysical properties, input wiring, output wiring to dorsomedial striatum (DMS) versus dorsolateral striatum (DLS), and natural activity patterns during free behavior. Our results reveal independently operating nigrostriatal information streams, with implications for understanding the logic of dopaminergic feedback circuits and the diversity of mammalian neuronal cell types.	[Lerner, Talia N.; Davidson, Thomas J.; Zalocusky, Kelly A.; Tomer, Raju; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lerner, Talia N.; Davidson, Thomas J.; Zalocusky, Kelly A.; Crow, Ailey K.; Tomer, Raju; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Shilyansky, Carrie; Beier, Kevin T.; Malenka, Robert C.; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Evans, Kathryn E.; Beier, Kevin T.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Beier, Kevin T.; Malenka, Robert C.] Stanford Univ, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Beier, Kevin T.; Luo, Liqun; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Zalocusky, Kelly A.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Lerner, Talia/AAB-5439-2020; Lerner, Talia/AGW-7812-2022; Core, Vector/CAF-4832-2022	Lerner, Talia/0000-0002-3875-0654; Beier, Kevin/0000-0002-4934-1338; Evans, Kathryn/0000-0003-4352-005X; Luo, Liqun/0000-0001-5467-9264	NRSA [1F32MH105053-01, 1F31MH105151-01]; Hughes Collaborative Innovation Award (HCIA); NIMH Silvio Conte Center at Stanford [P50 MH086403]; Simons Foundation; Gatsby Foundation; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H. L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; Vincent VC Woo Fund; Albert Yu Foundation; Mary Bechman Foundation; DARPA Neuro-FAST program; NIMH; NIDA; NSF; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH105053, P50MH086403, F31MH105151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA038913] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hughes Collaborative Innovation Award (HCIA); NIMH Silvio Conte Center at Stanford; Simons Foundation; Gatsby Foundation; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H. L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; Vincent VC Woo Fund; Albert Yu Foundation; Mary Bechman Foundation; DARPA Neuro-FAST program; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Ye and K. Engberg for advice on CLARITY; C. Ramakrishnan, S. Pak, A. Shi On Hong, A. Wang, A. Lei, and H. Swanson for assistance with animal husbandry and reagent production and acquisition; P. Rothwell and L. Steinberg for advice and sharing of transgenic mouse lines; E. Callaway for advice on rabies tracing; and the entire K. D. and L. L. labs for invaluable discussion. We also thank E. Kremer (IGMM) for supplying CAV-cre, M. Kay (Stanford) for providing the pRC-DJ plasmid used to produce AAVDJ, the Stanford Viral and Vector Core for packaging AAVDJ, and D. Kim for supplying pGP-CMV-GCaMP6f (Addgene plasmid #40755), which was recloned in our lab by C. Ramakrishnan. We thank the UNC vector core for supplying the AAV5 and AAV8 vectors used in these studies and the Salk Vector Core for supplying rabies (amplified in-house by the L. L. lab). T.N.L. was supported by a Stanford Dean's Postdoctoral Fellowship and by an NRSA Postdoctoral Fellowship (1F32MH105053-01). K. A. Z. was supported by an NRSA Predoctoral Fellowship (1F31MH105151-01). This work was also supported by the Hughes Collaborative Innovation Award (HCIA) and the NIMH Silvio Conte Center at Stanford (P50 MH086403 to R.C.M.). K. D. is supported by the DARPA Neuro-FAST program, NIMH, NIDA, NSF, the Simons Foundation, the Gatsby Foundation, the Wiegers Family Fund, the Nancy and James Grosfeld Foundation, the H. L. Snyder Medical Foundation, the Samuel and Betsy Reeves Fund, the Vincent VC Woo Fund, and the Albert Yu and Mary Bechman Foundations. All optogenetics (http://www.optogenetics.org), CLARITY (http://clarityresourcecenter.org), and COLM (http://clarityresourcecenter.com/COLM.html) reagents and protocols are distributed and supported freely.	Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Bocklisch C, 2013, SCIENCE, V341, P1521, DOI 10.1126/science.1237059; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Darvas M, 2010, J NEUROSCI, V30, P1158, DOI 10.1523/JNEUROSCI.4576-09.2010; Darvas M, 2009, P NATL ACAD SCI USA, V106, P14664, DOI 10.1073/pnas.0907299106; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Featherstone RE, 2004, NEUROSCIENCE, V124, P23, DOI 10.1016/j.neuroscience.2003.10.038; Fiorillo CD, 2013, SCIENCE, V341, P546, DOI 10.1126/science.1238699; Fiorillo CD, 2013, J NEUROSCI, V33, P4693, DOI 10.1523/JNEUROSCI.3886-12.2013; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Haber SN, 2000, J NEUROSCI, V20, P2369; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Ilango A, 2014, J NEUROSCI, V34, P817, DOI 10.1523/JNEUROSCI.1703-13.2014; Kim SY, 2013, TRENDS COGN SCI, V17, P596, DOI 10.1016/j.tics.2013.10.005; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Rossi MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065799; Schiemann J, 2012, NAT NEUROSCI, V15, P1272, DOI 10.1038/nn.3185; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwarz LA, 2015, NATURE; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	55	368	372	4	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					635	647		10.1016/j.cell.2015.07.014	http://dx.doi.org/10.1016/j.cell.2015.07.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232229	Green Accepted, Bronze			2022-12-28	WOS:000358801800021
J	Sullivan, LB; Gui, DY; Hosios, AM; Bush, LN; Freinkman, E; Vander Heiden, MG				Sullivan, Lucas B.; Gui, Dan Y.; Hosios, Aaron M.; Bush, Lauren N.; Freinkman, Elizaveta; Vander Heiden, Matthew G.			Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells	CELL			English	Article							TUMOR-CELLS; MITOCHONDRIAL DYSFUNCTION; REDUCTIVE CARBOXYLATION; GLUTAMINE-METABOLISM; ALPHA-KETOGLUTARATE; AEROBIC GLYCOLYSIS; MAMMALIAN-CELLS; CANCER-CELLS; REDOX STATE; EXPRESSION	Mitochondrial respiration is important for cell proliferation; however, the specific metabolic requirements fulfilled by respiration to support proliferation have not been defined. Here, we show that a major role of respiration in proliferating cells is to provide electron acceptors for aspartate synthesis. This finding is consistent with the observation that cells lacking a functional respiratory chain are auxotrophic for pyruvate, which serves as an exogenous electron acceptor. Further, the pyruvate requirement can be fulfilled with an alternative electron acceptor, alpha-ketobutyrate, which provides cells neither carbon nor ATP. Alpha-ketobutyrate restores proliferation when respiration is inhibited, suggesting that an alternative electron acceptor can substitute for respiration to support proliferation. We find that electron acceptors are limiting for producing aspartate, and supplying aspartate enables proliferation of respiration deficient cells in the absence of exogenous electron acceptors. Together, these data argue a major function of respiration in proliferating cells is to support aspartate synthesis.	[Sullivan, Lucas B.; Gui, Dan Y.; Hosios, Aaron M.; Bush, Lauren N.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sullivan, Lucas B.; Gui, Dan Y.; Hosios, Aaron M.; Bush, Lauren N.; Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Freinkman, Elizaveta] Whitehead Inst Biomed Res, Nine Cambridge Ctr, Cambridge, MA 02142 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	mvh@mit.edu		Sullivan, Lucas/0000-0002-6745-8222; Sullivan, Lauren/0000-0003-0285-4846	Burroughs Wellcome Fund; NIH [P30CA1405141, GG006413, R01 CA168653, T32 GM007753]; American Cancer Society [PF-15-096-01-TBE]; HHMI International Student Research fellowship; Vertex Scholars Program; Alex's Lemonade Stand Undergraduate Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA168653, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007753] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); HHMI International Student Research fellowship; Vertex Scholars Program(Vertex Pharmaceuticals); Alex's Lemonade Stand Undergraduate Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Burroughs Wellcome Fund and the NIH (P30CA1405141, GG006413, and R01 CA168653) to M.G.V.H., a postdoctoral fellowship, PF-15-096-01-TBE from the American Cancer Society to L.B.S., NIH (T32 GM007753) to D.Y.G., HHMI International Student Research fellowship and the Vertex Scholars Program to A.M.H., and Alex's Lemonade Stand Undergraduate Research Fellowship to L.N.B., We thank Alena Heath for graphic design and members of the Vander Heiden lab for thoughtful discussion. We also thank C. Moraes, I.F.M. de Coo, and Navdeep Chandel for the 143B CytB and 143B WT cybrid cell lines. M.G.V.H. is a consultant and SAB member for Agios Pharmaceuticals which seeks to target metabolism for cancer therapy.	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Chen WW, 2014, CELL REP, V7, P27, DOI 10.1016/j.celrep.2014.02.046; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Geissler A, 2000, MOL BIOL CELL, V11, P3977, DOI 10.1091/mbc.11.11.3977; GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HARRIS M, 1980, SOMAT CELL GENET, V6, P699, DOI 10.1007/BF01538969; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; HOWELL N, 1979, SOMAT CELL GENET, V5, P833, DOI 10.1007/BF01542645; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; KOVACEVIC Z, 1971, BIOCHEM J, V125, P757, DOI 10.1042/bj1250757; KROLL W, 1983, Z NATURFORSCH C, V38, P604; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; LOFFLER M, 1982, MOL CELL BIOCHEM, V48, P77; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MORAIS R, 1994, CANCER RES, V54, P3889; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; VANDENBOGERT C, 1992, J CELL PHYSIOL, V152, P632, DOI 10.1002/jcp.1041520323; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Warburg O, 1924, BIOCHEM Z, V152, P309; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295; Zhao YZ, 2015, CELL METAB, V21, P777, DOI 10.1016/j.cmet.2015.04.009; ZIELKE HR, 1984, FED PROC, V43, P121; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	49	635	647	12	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					552	563		10.1016/j.cell.2015.07.017	http://dx.doi.org/10.1016/j.cell.2015.07.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232225	Green Accepted, Bronze			2022-12-28	WOS:000358801800015
J	Eberhardt, WEE; Stuschke, M				Eberhardt, Wilfried E. E.; Stuschke, Martin			Multimodal treatment of non-small-cell lung cancer	LANCET			English	Editorial Material							PHASE-III; CONCURRENT CHEMORADIATION; INDUCTION CHEMOTHERAPY; TRIAL; SURGERY; CHEMORADIOTHERAPY; RESECTION; SURVIVAL; THERAPY; CRT		[Eberhardt, Wilfried E. E.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Med Oncol,Ruhrlandklin, D-45122 Essen, Germany; [Stuschke, Martin] Univ Hosp Essen, West German Tumour Ctr, Dept Radiat Oncol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Eberhardt, WEE (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Med Oncol,Ruhrlandklin, D-45122 Essen, Germany.	wilfried.eberhardt@uni-duisburg-essen.de		Eberhardt, Wilfried Ernst Erich/0000-0003-4284-3586				Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Bradley J, 2013, J THORAC ONCOL, V8, pS3; Brunelli A, 2009, EUR RESPIR J, V34, P17, DOI 10.1183/09031936.00184308; Cerfolio RJ, 2009, EUR J CARDIO-THORAC, V35, P718, DOI 10.1016/j.ejcts.2008.12.029; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Douillard JY, 2008, INT J RADIAT ONCOL, V72, P695, DOI 10.1016/j.ijrobp.2008.01.044; Eberhardt WEE, 2015, ANN ONCOL, V26, P1573, DOI 10.1093/annonc/mdv187; Eberhardt WEE, 2014, J CLIN ONCOL S, V32, p5s; Eberhardt WEE, 2013, LUNG CANCER, V82, P83, DOI 10.1016/j.lungcan.2013.06.007; Pless M, 2015, LANCET; Stuschke M, 2014, INT J RADIAT ONCOL, V90, pS146, DOI 10.1016/j.ijrobp.2014.05.617	12	14	15	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1018	1020		10.1016/S0140-6736(15)61083-2	http://dx.doi.org/10.1016/S0140-6736(15)61083-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26275734				2022-12-28	WOS:000361189200006
J	Durst, R; Sauls, K; Peal, DS; deVlaming, A; Toomer, K; Leyne, M; Salani, M; Talkowski, ME; Brand, H; Perrocheau, M; Simpson, C; Jett, C; Stone, MR; Charles, F; Chiang, C; Lynch, SN; Bouatia-Naji, N; Delling, FN; Freed, LA; Tribouilloy, C; Le Tourneau, T; LeMarec, H; Fernandez-Friera, L; Solis, J; Trujillano, D; Ossowski, S; Estivill, X; Dina, C; Bruneval, P; Chester, A; Schott, JJ; Irvine, KD; Mao, YP; Wessels, A; Motiwala, T; Puceat, M; Tsukasaki, Y; Menick, DR; Kasiganesan, H; Nie, XJ; Broome, AM; Williams, K; Johnson, A; Markwald, RR; Jeunemaitre, X; Hagege, A; Levine, RA; Milan, DJ; Norris, RA; Slaugenhaupt, SA				Durst, Ronen; Sauls, Kimberly; Peal, David S.; deVlaming, Annemarieke; Toomer, Katelynn; Leyne, Maire; Salani, Monica; Talkowski, Michael E.; Brand, Harrison; Perrocheau, Maelle; Simpson, Charles; Jett, Christopher; Stone, Matthew R.; Charles, Florie; Chiang, Colby; Lynch, Stacey N.; Bouatia-Naji, Nabila; Delling, Francesca N.; Freed, Lisa A.; Tribouilloy, Christophe; Le Tourneau, Thierry; LeMarec, Herve; Fernandez-Friera, Leticia; Solis, Jorge; Trujillano, Daniel; Ossowski, Stephan; Estivill, Xavier; Dina, Christian; Bruneval, Patrick; Chester, Adrian; Schott, Jean-Jacques; Irvine, Kenneth D.; Mao, Yaopan; Wessels, Andy; Motiwala, Tahirali; Puceat, Michel; Tsukasaki, Yoshikazu; Menick, Donald R.; Kasiganesan, Harinath; Nie, Xingju; Broome, Ann-Marie; Williams, Katherine; Johnson, Amanda; Markwald, Roger R.; Jeunemaitre, Xavier; Hagege, Albert; Levine, Robert A.; Milan, David J.; Norris, Russell A.; Slaugenhaupt, Susan A.			Mutations in DCHS1 cause mitral valve prolapse	NATURE			English	Article							ECHOCARDIOGRAPHIC EVIDENCE; FILAMIN-A; EXPRESSION; GENE; QUANTIFICATION; IDENTIFICATION; REGURGITATION; LOCUS; FAT	Mitral valve prolapse (MVP) is a common cardiac valve disease that affects nearly 1 in 40 individuals(1-3). It can manifest as mitral regurgitation and is the leading indication for mitral valve surgery(4,5). Despite a clear heritable component, the genetic aetiology leading to non-syndromic MVP has remained elusive. Four affected individuals from a large multigenerational family segregating non-syndromic MVP underwent capture sequencing of the linked interval on chromosome 11. We report a missense mutation in the DCHS1 gene, the human homologue of the Drosophila cell polarity gene dachsous (ds), that segregates with MVP in the family. Morpholino knockdown of the zebrafish homologue dachsous1b resulted in a cardiac atrioventricular canal defect that could be rescued by wild-type human DCHS1, but not by DCHS1 messenger RNA with the familial mutation. Further genetic studies identified two additional families in which a second deleterious DCHS1 mutation segregates with MVP. Both DCHS1 mutations reduce protein stability as demonstrated in zebrafish, cultured cells and, notably, in mitral valve interstitial cells (MVICs) obtained during mitral valve repair surgery of a proband. Dchs1(+/-) mice had prolapse of thickened mitral leaflets, which could be traced back to developmental errors in valve morphogenesis. DCHS1 deficiency in MVP patient MVICs, as well as in Dchs1(+/-) mouse MVICs, result in altered migration and cellular patterning, supporting these processes as aetiological underpinnings for the disease. Understanding the role of DCHS1 in mitral valve development and MVP pathogenesis holds potential for therapeutic insights for this very common disease.	[Durst, Ronen; Leyne, Maire; Salani, Monica; Talkowski, Michael E.; Brand, Harrison; Simpson, Charles; Jett, Christopher; Stone, Matthew R.; Charles, Florie; Chiang, Colby; Milan, David J.; Slaugenhaupt, Susan A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Res Inst, Boston, MA 02114 USA; [Durst, Ronen; Leyne, Maire; Salani, Monica; Talkowski, Michael E.; Brand, Harrison; Simpson, Charles; Jett, Christopher; Stone, Matthew R.; Charles, Florie; Chiang, Colby; Milan, David J.; Slaugenhaupt, Susan A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA; [Durst, Ronen] Hadassah Hebrew Univ, Med Ctr, Div Cardiol, Jerusalem, Israel; [Sauls, Kimberly; deVlaming, Annemarieke; Toomer, Katelynn; Wessels, Andy; Motiwala, Tahirali; Williams, Katherine; Johnson, Amanda; Markwald, Roger R.; Norris, Russell A.] Med Univ S Carolina, Childrens Res Inst, Cardiovasc Dev Biol Ctr, Dept Regenerat Med & Cell Biol,Dept Med, Charleston, SC 29425 USA; [Peal, David S.; Lynch, Stacey N.; Milan, David J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr,Cardiol Div, Boston, MA 02114 USA; [Talkowski, Michael E.; Brand, Harrison] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Perrocheau, Maelle; Bouatia-Naji, Nabila; Jeunemaitre, Xavier; Hagege, Albert] Paris Cardiovasc Res Ctr, INSERM, UMR 970, F-75015 Paris, France; [Bouatia-Naji, Nabila; Jeunemaitre, Xavier; Hagege, Albert; Levine, Robert A.] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75006 Paris, France; [Delling, Francesca N.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02215 USA; [Freed, Lisa A.] Yale Univ, Sch Med, Heart & Vasc Ctr, Yale New Haven Hosp, New Haven, CT 06510 USA; [Tribouilloy, Christophe] Univ Hosp Amiens, Dept Cardiol, F-80000 Amiens, France; [Tribouilloy, Christophe] Jules Verne Univ Picardie, U 1088, INSERM, F-80000 Amiens, France; [Le Tourneau, Thierry; LeMarec, Herve; Dina, Christian; Schott, Jean-Jacques] INSERM, U1087, F-44007 Nantes, France; [Le Tourneau, Thierry; LeMarec, Herve; Dina, Christian; Schott, Jean-Jacques] Univ Hosp, Inst Thorax, F-44007 Nantes, France; [Fernandez-Friera, Leticia; Solis, Jorge] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid 28029, Spain; [Fernandez-Friera, Leticia; Solis, Jorge] Hosp Univ Monteprincipe, Madrid 28660, Spain; [Trujillano, Daniel; Estivill, Xavier] Ctr Genom Regulat, Genet Causes Dis Grp, Barcelona 08003, Catalonia, Spain; [Trujillano, Daniel; Ossowski, Stephan; Estivill, Xavier] UPF, Barcelona 08002, Catalonia, Spain; [Trujillano, Daniel; Estivill, Xavier] Hosp del Mar Med Res Inst IMIM, Barcelona 08003, Catalonia, Spain; [Trujillano, Daniel; Estivill, Xavier] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona 08036, Catalonia, Spain; [Ossowski, Stephan] CRG, Genom & Epigen Variat Dis Grp, Barcelona 08003, Catalonia, Spain; [Dina, Christian; Schott, Jean-Jacques] CNRS, UMR 6291, F-44007 Nantes, France; [Dina, Christian; Schott, Jean-Jacques] Univ Nantes, F-44322 Nantes, France; [Dina, Christian; Schott, Jean-Jacques] CHU Nantes, Serv Cardiol, Inst Thorax, F-44093 Nantes, France; [Bruneval, Patrick] Hop Europe Georges Pompidou, Serv Anat Pathol, F-75015 Paris, France; [Chester, Adrian] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Heart Sci Ctr, London SW7 2AZ, England; [Irvine, Kenneth D.; Mao, Yaopan] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Irvine, Kenneth D.; Mao, Yaopan] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Puceat, Michel] Aix Marseille Univ, Med Sch La Timone, Team Physiopathol Cardiac Dev, INSERM,UMR S910, F-13885 Marseille, France; [Tsukasaki, Yoshikazu] Univ Texas Hlth Ctr Tyler Northeast Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Menick, Donald R.; Kasiganesan, Harinath] Med Univ S Carolina, Div Cardiol, Dept Med, Gazes Cardiac Res Inst, Charleston, SC 29425 USA; [Nie, Xingju; Broome, Ann-Marie] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [Jeunemaitre, Xavier] Hop Europeen Georges Pompidou, AP HP, AP HP, F-75015 Paris, France; [Hagege, Albert] Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, F-75015 Paris, France; [Levine, Robert A.] Harvard Univ, Massachusetts Gen Hosp, Cardiac Ultrasound Lab, Div Cardiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Hebrew University of Jerusalem; Hadassah University Medical Center; Medical University of South Carolina; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yale University; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Nantes Universite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Medical University of South Carolina; Medical University of South Carolina; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital	Slaugenhaupt, SA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Res Inst, Boston, MA 02114 USA.	norrisra@musc.edu; slaugenhaupt@chgr.mgh.harvard.edu	Bouatia-Naji, Nabila/AGF-1400-2022; Le Tourneau, Thierry/D-5428-2015; Le Marec, Hervé/D-2718-2015; Dina, Christian R/D-3535-2015; Estivill, Xavier/A-3125-2013; nie, xingju/AFR-3358-2022; Schott, jean-Jacques/F-8842-2013; PUCEAT, michel/R-6140-2017; BOUATIA-NAJI, NABILA/D-5863-2013; JEUNEMAITRE, Xavier/AAQ-4853-2021; solis, jorge/E-2709-2018; Fernandez Friera, Leticia/E-9931-2015	Bouatia-Naji, Nabila/0000-0001-5424-2134; Le Marec, Hervé/0000-0002-8288-8693; Dina, Christian R/0000-0002-7722-7348; Estivill, Xavier/0000-0002-0723-2256; nie, xingju/0000-0003-4247-8945; Schott, jean-Jacques/0000-0002-9578-9475; JEUNEMAITRE, Xavier/0000-0001-5925-381X; Talkowski, Michael/0000-0003-2889-0992; solis, jorge/0000-0002-4227-7062; PUCEAT, michel/0000-0001-9055-7563; HAGEGE, Albert/0000-0003-4685-6077; Chiang, Colby/0000-0002-4113-6065; Broome, Ann-Marie/0000-0002-2384-5212; Durst, Ronen/0000-0003-3559-1050; Fernandez Friera, Leticia/0000-0002-4237-2166	Fondation Leducq (Paris, France) Mitral Transatlantic Network of Excellence grant [07CVD04]; Innovation in Clinical Research award of the Doris Duke Charitable Foundation; Aetna Quality Care Research Fund; National Heart Lung and Blood Institute Resequencing and Genotyping (RSG) Service; National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR018823]; French Society of Cardiology; National Heart Lung and Blood Institute [R01HL122906-01, R01-HL33756, COBRE 1P30 GM103342, 8P20 GM103444-07, R01-HL109004, R01-HL127692, RO1-HL095696]; VA Merit Review [BX002327]; National Institute of Mental Health [R00-MH095867]; Hassenfeld Scholar Program; March of Dimes; M.G.H. Scholars Program; American Heart Association [09GRNT2060075, 11SDG5270006, 2261354, 15GRNT25080052]; National Science Foundation [EPS-0903795]; NHLBI [K24 HL67434, R01HL72265, R01HL109506]; Ellison Foundation, Boston, MA; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756, R01HL109506, R01HL072265, K24HL067434, R01HL109004, R01HL122906, K23HL116652, R01HL095696, R01HL127692, R01HL128099, T32HL007260, T32HL007208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103444, P30GM103342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095867, K99MH095867] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002327] Funding Source: NIH RePORTER	Fondation Leducq (Paris, France) Mitral Transatlantic Network of Excellence grant(Leducq Foundation); Innovation in Clinical Research award of the Doris Duke Charitable Foundation; Aetna Quality Care Research Fund; National Heart Lung and Blood Institute Resequencing and Genotyping (RSG) Service; National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources; French Society of Cardiology; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Merit Review(US Department of Veterans Affairs); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hassenfeld Scholar Program; March of Dimes(March of Dimes); M.G.H. Scholars Program; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ellison Foundation, Boston, MA; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Fondation Leducq (Paris, France) Mitral Transatlantic Network of Excellence grant 07CVD04. MVP patient studies were supported by an Innovation in Clinical Research award of the Doris Duke Charitable Foundation, by an award of the Aetna Quality Care Research Fund, and by a gift from Rena M. Shulsky, New York, New York (S.A.S. and R.A.L.). Sequencing of the candidate region was performed at the Venter Institute through a grant from the National Heart Lung and Blood Institute Resequencing and Genotyping (RS&G) Service (S.A.S.). The work at MUSC was performed in a facility constructed with support from the National Institutes of Health, Grant Number C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources. Collection of the MVP France cohort was supported by the French Society of Cardiology. Other funding sources: National Heart Lung and Blood Institute: R01HL122906-01 (A.W.), R01-HL33756 (R.R.M.), COBRE 1P30 GM103342 (R.R.M., R.A.N., A.W.), 8P20 GM103444-07 (R.R.M. and R.A.N.), R01-HL109004 (D.J.M.), R01-HL127692 (D.J.M., S.A.S., R.A.N., R.A.L.); RO1-HL095696 (D.R.M.), VA Merit Review BX002327 (D.R.M.); National Institute of Mental Health R00-MH095867 (M.E.T.) The Hassenfeld Scholar Program (D.J.M.); The March of Dimes (M.E.T.); M.G.H. Scholars Program (S.A.S., M.E.T.); American Heart Association: 09GRNT2060075 (A.W.), 11SDG5270006 (R.A.N.), 2261354 (D.J.M.), 15GRNT25080052 (R.A.N.); National Science Foundation: EPS-0903795 (R.R.M.); NHLBI K24 HL67434, R01HL72265 and R01HL109506 and the Ellison Foundation, Boston, MA (R.A.L.), Howard Hughes Medical Institute (K.D.I.), and a gift from Michael Zak (D.J.M.). Thanks to T. Brown (MUSC) for his guidance on MRI studies, C. Hanscom (M.G.H.) for assistance with genomic libraries, and E. Lim (H.M.S.) for contributions in interpreting the exome mutation data. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Freed LA, 2003, AM J HUM GENET, V72, P1551, DOI 10.1086/375452; Freed LA, 2002, J AM COLL CARDIOL, V40, P1298, DOI 10.1016/S0735-1097(02)02161-7; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; KOLIBASH AJ, 1986, AM J CARDIOL, V58, P762, DOI 10.1016/0002-9149(86)90352-8; Kolpa HJ, 2013, DEVELOPMENT, V140, P2172, DOI 10.1242/dev.084475; LEVINE RA, 1989, CIRCULATION, V80, P589, DOI 10.1161/01.CIR.80.3.589; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; Li Kelvin, 2010, BMC Res Notes, V3, P191, DOI 10.1186/1756-0500-3-191; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nesta F, 2005, CIRCULATION, V112, P2022, DOI 10.1161/CIRCULATIONAHA.104.516930; Nesta F, 2003, J AM SOC ECHOCARDIOG, V16, P1301, DOI 10.1067/j.echo.2003.09.003; Norris RA, 2010, DEV DYNAM, V239, P2118, DOI 10.1002/dvdy.22346; Norris RA, 2004, ANAT REC PART A, V281A, P1227, DOI 10.1002/ar.a.20135; Norris RA, 2008, DEV BIOL, V316, P200, DOI 10.1016/j.ydbio.2008.01.003; PERLOFF JK, 1987, AM HEART J, V113, P1324, DOI 10.1016/0002-8703(87)90961-6; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Sauls K, 2012, CARDIOVASC RES, V96, P109, DOI 10.1093/cvr/cvs238; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Tsukasaki Y, 2014, P NATL ACAD SCI USA, V111, P16011, DOI 10.1073/pnas.1418990111; Vaishnava P, 2011, NAT REV CARDIOL, V8, P173, DOI 10.1038/nrcardio.2010.203; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; WALLER BF, 1984, AM J CARDIOL, V53, P139, DOI 10.1016/0002-9149(84)90698-2; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Xu F, 2011, TISSUE ENG PART C-ME, V17, P641, DOI 10.1089/ten.tec.2011.0038; Zuppiroli A, 1998, AM J CARDIOL, V82, P823, DOI 10.1016/S0002-9149(98)00454-8	40	112	116	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					109	+		10.1038/nature14670	http://dx.doi.org/10.1038/nature14670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26258302	Green Submitted, Green Accepted			2022-12-28	WOS:000360594100035
J	Classen, DC; Mermel, LA				Classen, David C.; Mermel, Leonard A.			Specialty Society Clinical Practice Guidelines Time for Evolution or Revolution?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTIONS		[Classen, David C.] Univ Utah, Div Epidemiol, Dept Internal Med, Salt Lake City, UT 84103 USA; [Mermel, Leonard A.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Mermel, Leonard A.] Rhode Isl Hosp, Div Infect Dis, Providence, RI USA	Utah System of Higher Education; University of Utah; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Classen, DC (corresponding author), Univ Utah, 561 E Northmont Way, Salt Lake City, UT 84103 USA.	dcclassen@hotmail.com	Mermel, Leonard/Z-1475-2019					Bindslev JBB, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-19; Brawley O, 2011, JAMA-J AM MED ASSOC, V306, P2495, DOI 10.1001/jama.2011.1800; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Henig O, 2013, CLIN MICROBIOL INFEC, V19, P1106, DOI 10.1111/1469-0691.12348; Jacobs AK, 2014, CIRCULATION, V130, P1208, DOI 10.1161/CIR.0000000000000090; Lopez-Jimenez F, 2014, MAYO CLIN PROC, V89, P1257, DOI 10.1016/j.mayocp.2014.06.016; Pronovost PJ, 2013, JAMA-J AM MED ASSOC, V310, P2501, DOI 10.1001/jama.2013.281334; Reames BN, 2013, J CLIN ONCOL, V31, P2563, DOI 10.1200/JCO.2012.46.8371; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060	9	32	32	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					871	872		10.1001/jama.2015.7462	http://dx.doi.org/10.1001/jama.2015.7462			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26237739				2022-12-28	WOS:000360392100009
J	Antonelli, A				Antonelli, Alexandre			BIODIVERSITY Multiple origins of mountain life	NATURE			English	Editorial Material							CLIMATE-CHANGE		[Antonelli, Alexandre] Univ Gothenburg, Dept Biol & Environm Sci, SE-40530 Gothenburg, Sweden; [Antonelli, Alexandre] Gothenburg Bot Garden, SE-41319 Gothenburg, Sweden	University of Gothenburg	Antonelli, A (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, SE-40530 Gothenburg, Sweden.	alexandre.antonelli@bioenv.gu.se	Antonelli, Alexandre/ABE-6321-2020; Antonelli, Alexandre/A-5353-2011	Antonelli, Alexandre/0000-0003-1842-9297; Antonelli, Alexandre/0000-0003-1842-9297				Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Fritz SA, 2013, TRENDS ECOL EVOL, V28, P509, DOI 10.1016/j.tree.2013.05.004; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hoorn C, 2013, NAT GEOSCI, V6, P154, DOI 10.1038/ngeo1742; Hughes CE, 2015, NEW PHYTOL, V207, P275, DOI 10.1111/nph.13230; Humboldt A, 1805, ESSAI GEOGRAPHIE PLA, DOI DOI 10.5962/BHL.TITLE.9309; Merckx VSFT, 2015, NATURE, V524, P347, DOI 10.1038/nature14949; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Spehn EM, 2011, PLANT ECOL DIVERS, V4, P301, DOI 10.1080/17550874.2012.698660; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	10	39	38	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					300	301		10.1038/nature14645	http://dx.doi.org/10.1038/nature14645			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26266978				2022-12-28	WOS:000359714000024
J	Levison, HF; Kretke, KA; Duncan, MJ				Levison, Harold F.; Kretke, Katherine A.; Duncan, Martin J.			Growing the gas-giant planets by the gradual accumulation of pebbles	NATURE			English	Article							PROTOPLANETARY DISKS; SOLAR-SYSTEM; CIRCUMSTELLAR DISKS; ACCRETION; NEBULA; GROWTH; CORES; PLANETESIMALS; EVOLUTION; MASS	It is widely held that the first step in forming gas-giant planets, such as Jupiter and Saturn, was the production of solid 'cores' each with a mass roughly ten times that of the Earth1,2. Getting the cores to form before the solar nebula dissipates (in about one to ten million years; ref. 3) has been a major challenge for planet formation models(4,5). Recently models have emerged in which 'pebbles' (centimetre-to-metre-sized objects) are first concentrated by aerodynamic drag and then gravitationally collapse to form objects 100 to 1,000 kilometres in size(6-9). These 'planetesimals' can then efficiently accrete left-over pebbles(10) and directly form the cores of giant planets(11,12). This model is known as 'pebble accretion'; theoretically, it can produce cores of ten Earth masses in only a few thousand years(11,13). Unfortunately, full simulations of this process(13) show that, rather than creating a few such cores, it produces a population of hundreds of Earth-mass objects that are inconsistent with the structure of the Solar System. Here we report that this difficulty can be overcome if pebbles form slowly enough to allow the planetesimals to gravitationally interact with one another. In this situation, the largest planetesimals have time to scatter their smaller siblings out of the disk of pebbles, thereby stifling their growth. Our models show that, for a large and physically reasonable region of parameter space, this typically leads to the formation of one to four gas giants between 5 and 15 astronomical units from the Sun, in agreement with the observed structure of the Solar System.	[Levison, Harold F.; Kretke, Katherine A.] SW Res Inst, Boulder, CO 80302 USA; [Levison, Harold F.; Kretke, Katherine A.] NASA Solar Syst Explorat Res Virtual Inst, Boulder, CO 80302 USA; [Duncan, Martin J.] Queens Univ, Dept Phys Engn Phys & Astron, Kingston, ON K7L 3N6, Canada	National Aeronautics & Space Administration (NASA); Queens University - Canada	Levison, HF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	hal@boulder.swri.edu			NSF	NSF(National Science Foundation (NSF))	This work was supported by an NSF Astronomy and Astrophysics Research Grant (principal investigator H.F.L.). We thank A. Johansen, M. Lambrechts, A. Morbidelli, D. Nesvorny and C. Ormel for discussions.	ADACHI I, 1976, PROG THEOR PHYS, V56, P1756, DOI 10.1143/PTP.56.1756; Andrews SM, 2010, ASTROPHYS J, V723, P1241, DOI 10.1088/0004-637X/723/2/1241; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; Chambers JE, 2014, ICARUS, V233, P83, DOI 10.1016/j.icarus.2014.01.036; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Cuzzi JN, 2001, ASTROPHYS J, V546, P496, DOI 10.1086/318233; Dobbs-Dixon I, 2007, ASTROPHYS J, V660, P791, DOI 10.1086/512537; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; FERNANDEZ JA, 1984, ICARUS, V58, P109, DOI 10.1016/0019-1035(84)90101-5; Goldreich P, 2004, ASTROPHYS J, V614, P497, DOI 10.1086/423612; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Hayashi C., 1981, Progress of Theoretical Physics Supplement, P35, DOI 10.1143/PTPS.70.35; Hernandez J, 2009, ASTROPHYS J, V707, P705, DOI 10.1088/0004-637X/707/1/705; Ida S, 2008, ASTROPHYS J, V673, P487, DOI 10.1086/523754; IDA S, 1990, ICARUS, V88, P129, DOI 10.1016/0019-1035(90)90182-9; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; Kretke KA, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/6/109; Lambrechts M, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201423814; Lambrechts M, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424343; Levison HF, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/4/119; Levison HF, 2010, ASTRON J, V139, P1297, DOI 10.1088/0004-6256/139/4/1297; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; MIZUNO H, 1978, PROG THEOR PHYS, V60, P699, DOI 10.1143/PTP.60.699; NAKAGAWA Y, 1986, ICARUS, V67, P375, DOI 10.1016/0019-1035(86)90121-1; Ormel CW, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014903; Papaloizou JCB, 2000, MON NOT R ASTRON SOC, V315, P823, DOI 10.1046/j.1365-8711.2000.03466.x; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Rafikov RR, 2006, ASTROPHYS J, V648, P666, DOI 10.1086/505695; Ricci L, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913403; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; STEWART GR, 1988, ICARUS, V74, P542, DOI 10.1016/0019-1035(88)90120-0; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Youdin AN, 2005, ASTROPHYS J, V620, P459, DOI 10.1086/426895	39	158	158	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					322	+		10.1038/nature14675	http://dx.doi.org/10.1038/nature14675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26289203	Green Submitted			2022-12-28	WOS:000359714000029
J	Beyrer, C; Birx, DL; Bekker, LG; Barre-Sinoussi, F; Cahn, P; Dybul, MR; Eholie, SP; Kavanagh, MM; Katabira, ET; Lundgren, JD; Mworeko, L; Pala, M; Puttanakit, T; Ryan, O; Sidibe, M; Montaner, JSG				Beyrer, Chris; Birx, Deborah L.; Bekker, Linda-Gail; Barre-Sinoussi, Francoise; Cahn, Pedro; Dybul, Mark R.; Eholie, Serge P.; Kavanagh, Matthew M.; Katabira, Elly T.; Lundgren, Jens D.; Mworeko, Lilian; Pala, Marama; Puttanakit, Thanyawee; Ryan, Owen; Sidibe, Michel; Montaner, Julio S. G.		Vancouver Consensus Signatories	The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will	LANCET			English	Editorial Material							THERAPY		[Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Beyrer, Chris; Ryan, Owen] Int AIDS Soc, Geneva, Switzerland; [Birx, Deborah L.] US Presidents Emergency Plan AIDS Relief, Washington, DC USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Barre-Sinoussi, Francoise] Inst Pasteur, Paris, France; [Cahn, Pedro] Univ Buenos Aires, Sch Med, Buenos Aires, DF, Argentina; [Dybul, Mark R.] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Eholie, Serge P.] Univ Felix Houphouet Boigny, Sch Med, Abidjan, Cote Ivoire; [Eholie, Serge P.] Int Assoc Providers AIDS Care, Washington, DC USA; [Kavanagh, Matthew M.] Hlth Global Access Project, New York, NY USA; [Kavanagh, Matthew M.] Univ Penn, Dept Polit Sci, Philadelphia, PA 19104 USA; [Kavanagh, Matthew M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Katabira, Elly T.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Lundgren, Jens D.] Univ Copenhagen, Rigshosp, DK-1168 Copenhagen, Denmark; [Mworeko, Lilian] Int Community Women Living HIV East Africa, Kampala, Uganda; [Pala, Marama] Int Indigenous Working Grp HIV & AIDS, Waikato, New Zealand; [Puttanakit, Thanyawee] Chulalongkorn Univ, Bangkok, Thailand; [Sidibe, Michel] UNAIDS, Geneva, Switzerland; [Montaner, Julio S. G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Buenos Aires; University of Pennsylvania; University of Pennsylvania; Makerere University; Rigshospitalet; University of Copenhagen; Chulalongkorn University; UNAIDS; University of British Columbia	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	mkav@sas.upenn.edu	Bekker, Linda-Gail/AAZ-8929-2020; Nyangulu, Wongani/L-5291-2019; Lundgren, Jens/AAE-6876-2019; Shacklett, Barbara/A-7288-2009; Eholie, Serge/T-6008-2019	Nyangulu, Wongani/0000-0001-6192-6534; Shacklett, Barbara/0000-0002-7067-732X; Arvieux, Cedric/0000-0003-2332-2507; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Sabin, Miriam/0000-0002-7758-8338; Rakhmanina, Natella/0000-0002-2246-4581; Venter, Willem/0000-0002-4157-732X; Boyd, Mark/0000-0002-6848-3307; Hassounah, Said/0000-0002-9712-1313; Katz, Ingrid/0000-0002-3014-238X; Lundgren, Jens/0000-0001-8901-7850	Alberta Innovates [201201140] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097667] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI094189] Funding Source: Medline; NIMH NIH HHS [K23 MH097667] Funding Source: Medline	Alberta Innovates; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 2019, IDF DIABETES ATLAS, V9th; Beyrer C, 2015, VANCOUVER CONSENSUS; Cohen M, 2015, 8 INT AIDS SOC C HIV; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Grinsztejn B, 2015, 8 INT AIDS SOC C HIV; Gupta S., 2015, GLOBAL DATABASE NATL; Hayes R, 2015, 8 INT AIDS SOC C HIV; Jain V, 2014, AIDS, V28, P2241, DOI 10.1097/QAD.0000000000000401; Liu A, 2015, 8 INT AIDS SOC C HIV; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mosquita F., 2015, 8 INT AIDS SOC C HIV; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, THE GAP REP	13	21	21	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					505	507		10.1016/S0140-6736(15)61458-1	http://dx.doi.org/10.1016/S0140-6736(15)61458-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8PG	26293427				2022-12-28	WOS:000359431900004
J	Muller, M; Biswas, A; Martin-Hurtado, R; Tortajada, C				Muller, Mike; Biswas, Asit; Martin-Hurtado, Roberto; Tortajada, Cecilia			Built infrastructure is essential	SCIENCE			English	Editorial Material									[Muller, Mike] Univ Witwatersrand, Sch Governance, Johannesburg, South Africa; [Biswas, Asit; Tortajada, Cecilia] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 117548, Singapore; [Biswas, Asit; Tortajada, Cecilia] Third World Ctr Water Management, Atizapan, Mexico; [Martin-Hurtado, Roberto] Alboran Consulting, London, England	University of Witwatersrand; National University of Singapore	Muller, M (corresponding author), Univ Witwatersrand, Sch Governance, Johannesburg, South Africa.	mike.muller@wits.ac.za	muller, mike/AAI-5023-2020; Tortajada, Cecilia/E-7516-2016; Biswas, Asit K./F-4658-2016	muller, mike/0000-0002-4252-3200; Tortajada, Cecilia/0000-0001-6308-4924; Biswas, Asit K./0000-0001-9332-4298				Binnie C, 2014, THAMES TIDEWAY TUNNE; Biswas AK, 2003, INT J WATER RESOUR D, V19, P377, DOI 10.1080/0790062032000122998; Brown C., 2010, POLICY RES WORKING P; Department of Economic and Social Affairs Population Division United Nations, 2012, STESASERA336 POP DIV; Department of Economic and Social Affairs UN Population Division, 2014, STESASERA352 UN POP; Grey D, 2007, WATER POLICY, V9, P545, DOI 10.2166/wp.2007.021; Mol A.P.J., 2014, OKOLOGISCHE MODERNIS, P35; Muller M., 2011, AFRICA FOCUS GOVERNA; National Audit Office, 2014, THAM TID TUNN EARL R; Normile D, 2010, SCIENCE, V327, P1568, DOI 10.1126/science.327.5973.1568; Office of Water U.S. Environmental Protection Agency, 2013, 4606MEPA816R13006 OF; Organization for Economic Cooperation and Development, 2012, ENV OUTL 2050; Scarborough H, 2015, DESALINATION, V358, P61, DOI 10.1016/j.desal.2014.12.013; Seckler D., 1999, International Journal of Water Resources Development, V15, P29, DOI 10.1080/07900629948916; Tortajada C., 2012, IMPACTS LARGE DAMS; UN Environment Programme, 2014, GREEN INFR GUID WAT; Zhao Y, 2013, BIOGEOSCIENCES, V10, P1219, DOI 10.5194/bg-10-1219-2013	17	36	36	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					585	586		10.1126/science.aac7606	http://dx.doi.org/10.1126/science.aac7606			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3WW	26250671				2022-12-28	WOS:000359092900021
J	Polusny, MA; Erbes, CR; Thuras, P; Moran, A; Lamberty, GJ; Collins, RC; Rodman, JL; Lim, KO				Polusny, Melissa A.; Erbes, Christopher R.; Thuras, Paul; Moran, Amy; Lamberty, Greg J.; Collins, Rose C.; Rodman, John L.; Lim, Kelvin O.			Mindfulness-Based Stress Reduction for Posttraumatic Stress Disorder Among Veterans A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE PROCESSING THERAPY; PROLONGED EXPOSURE THERAPY; QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; PTSD; DEPRESSION; PARTICIPATION; INTERVENTION; MEDITATION; PROGRAM	IMPORTANCE Mindfulness-based interventions may be acceptable to veterans who have poor adherence to existing evidence-based treatments for posttraumatic stress disorder (PTSD). OBJECTIVE To compare mindfulness-based stress reduction with present-centered group therapy for treatment of PTSD. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of 116 veterans with PTSD recruited at the Minneapolis Veterans Affairs Medical Center from March 2012 to December 2013. Outcomes were assessed before, during, and after treatment and at 2-month follow-up. Data collection was completed on April 22, 2014. INTERVENTIONS Participants were randomly assigned to receive mindfulness-based stress reduction therapy (n = 58), consisting of 9 sessions (8 weekly 2.5-hour group sessions and a daylong retreat) focused on teaching patients to attend to the present moment in a nonjudgmental, accepting manner; or present-centered group therapy (n = 58), an active-control condition consisting of 9 weekly 1.5-hour group sessions focused on current life problems. MAIN OUTCOMES AND MEASURES The primary outcome, change in PTSD symptom severity over time, was assessed using the PTSD Checklist (range, 17-85; higher scores indicate greater severity; reduction of 10 or more considered a minimal clinically important difference) at baseline and weeks 3, 6, 9, and 17. Secondary outcomes included PTSD diagnosis and symptom severity assessed by independent evaluators using the Clinician-Administered PTSD Scale along with improvements in depressive symptoms, quality of life, and mindfulness. RESULTS Participants in the mindfulness-based stress reduction group demonstrated greater improvement in self-reported PTSD symptom severity during treatment (change in mean PTSD Checklist scores from 63.6 to 55.7 vs 58.8 to 55.8 with present-centered group therapy; between-group difference, 4.95; 95% CI, 1.92-7.99; P = .002) and at 2-month follow-up (change in mean scores from 63.6 to 54.4 vs 58.8 to 56.0, respectively; difference, 6.44; 95% CI, 3.34-9.53, P < .001). Although participants in the mindfulness-based stress reduction group were more likely to showclinically significant improvement in self-reported PTSD symptom severity (48.9% vs 28.1% with present-centered group therapy; difference, 20.9%; 95% CI, 2.2%-39.5%; P = .03) at 2-month follow-up, theywere no more likely to have loss of PTSD diagnosis (53.3% vs 47.3%, respectively; difference, 6.0%; 95% CI, -14.1% to 26.2%; P = .55). CONCLUSIONS AND RELEVANCE Among veterans with PTSD, mindfulness-based stress reduction therapy, compared with present-centered group therapy, resulted in a greater decrease in PTSD symptom severity. However, the magnitude of the average improvement suggests a modest effect.	[Polusny, Melissa A.; Erbes, Christopher R.; Thuras, Paul; Moran, Amy; Lamberty, Greg J.; Collins, Rose C.; Rodman, John L.; Lim, Kelvin O.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Polusny, Melissa A.; Erbes, Christopher R.] Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Polusny, Melissa A.; Erbes, Christopher R.; Thuras, Paul; Lamberty, Greg J.; Lim, Kelvin O.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Polusny, MA (corresponding author), Minneapolis VA Med Ctr B68 2, One Vet Dr, Minneapolis, MN 55417 USA.	melissa.polusny@va.gov	Polusny, Melissa Anderson/N-8112-2014; Lim, Kelvin/AAF-6833-2020; Polusny, Melissa/X-8158-2019	Polusny, Melissa Anderson/0000-0002-4932-305X; Polusny, Melissa/0000-0002-4932-305X; Lim, Kelvin/0000-0002-2390-7268	VA [5I01CX000683-01]	VA(US Department of Veterans Affairs)	This material is the result of work supported with resources and the use of facilities at the Minneapolis VA Health Care System, Minneapolis, Minnesota. This research was supported by VA grant 5I01CX000683-01 to Dr Lim.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; First M. B., 1997, STRUCTURED CLIN INTE; Forbes D, 2012, J ANXIETY DISORD, V26, P442, DOI 10.1016/j.janxdis.2012.01.006; Foy DW, 2004, GROUP INTERVENTIONS, P116; Frost ND, 2014, J TRAUMA STRESS, V27, P1, DOI 10.1002/jts.21881; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Institute of Medicine, 2007, TREATM POSTTR STRESS; Jeffreys MD, 2014, J ANXIETY DISORD, V28, P108, DOI 10.1016/j.janxdis.2013.04.010; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kearney DJ, 2013, J CLIN PSYCHOL, V69, P14, DOI 10.1002/jclp.21911; Kearney DJ, 2012, J CLIN PSYCHOL, V68, P101, DOI 10.1002/jclp.20853; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kimbrough E, 2010, J CLIN PSYCHOL, V66, P17, DOI 10.1002/jclp.20624; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lang AJ, 2012, BEHAV MODIF, V36, P759, DOI 10.1177/0145445512441200; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Niles BL, 2012, PSYCHOL TRAUMA-US, V4, P538, DOI 10.1037/a0026161; Resick PA, 2015, J CONSULT CLIN PSYCH, V83, P1058, DOI 10.1037/ccp0000016; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; Suris A, 2013, J TRAUMA STRESS, V26, P28, DOI 10.1002/jts.21765; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124	37	185	188	3	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					456	465		10.1001/jama.2015.8361	http://dx.doi.org/10.1001/jama.2015.8361			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO1OI	26241597	Bronze			2022-12-28	WOS:000358924500010
J	Spoont, MR; Williams, JW; Kehle-Forbes, S; Nieuwsma, JA; Mann-Wrobel, MC; Gross, R				Spoont, Michele R.; Williams, John W., Jr.; Kehle-Forbes, Shannon; Nieuwsma, Jason A.; Mann-Wrobel, Monica C.; Gross, Raz			Does This Patient Have Posttraumatic Stress Disorder? Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DSM-IV DISORDERS; PRIMARY-CARE; PTSD CHECKLIST; MENTAL-HEALTH; PROLONGED EXPOSURE; PERFORMANCE-CHARACTERISTICS; SCREENING INSTRUMENT; DIAGNOSTIC-ACCURACY; TRAUMATIC EVENTS; FEMALE VETERANS	IMPORTANCE Posttraumatic stress disorder (PTSD) is a relatively common mental health condition frequently seen, though often unrecognized, in primary care settings. Identifying and treating PTSD can greatly improve patient health and well-being. OBJECTIVE To systematically review the utility of self-report screening instruments for PTSD among primary care and high-risk populations. EVIDENCE REVIEW We searched MEDLINE and the National Center for PTSD's Published International Literature on Traumatic Stress (PILOTS) databases for articles published on screening instruments for PTSD published from January 1981 through March 2015. Study quality was rated using Quality Assessment of Diagnostic Accuracy Studies (QUADAS) criteria. STUDY SELECTION Studies of screening instruments for PTSD evaluated using gold standard structured clinical diagnostic interviews that had interview samples of at least 50 individuals. FINDINGS We identified 2522 citations, retrieved 318 for further review, and retained 23 cohort studies that evaluated 15 screening instruments for PTSD. Of the 23 studies, 15 were conducted in primary care settings in the United States (n = 14 707 were screened, n = 5374 given diagnostic interview, n = 814 had PTSD) and 8 were conducted in community settings following probable trauma exposure (ie, natural disaster, terrorism, and military deployment; n = 5302 were screened, n = 4263 given diagnostic interview, n = 393 were known to have PTSD with an additional 50 inferred by rates reported by authors). Two screens, the Primary Care PTSD Screen (PC-PTSD) and the PTSD Checklist were the best performing instruments. The 4-item PC-PTSD has a positive likelihood ratio of 6.9 (95% CI, 5.5-8.8) and a negative likelihood ratio of 0.30 (95% CI, 0.21-0.44) using the same score indicating a positive screen as used by the Department of Veterans Affairs in all of its primary care clinics. The 17-item PTSD Checklist has a positive likelihood ratio of 5.2 (95% CI, 3.6-7.5) and a negative likelihood ratio of 0.33 (95% CI, 0.29-0.37) using scores of around 40 as indicating a positive screen. Using the same score employed by primary care clinics in the Department of Veterans Affairs to indicate a positive screen, the 4-item PC-PTSD has a sensitivity of 0.69 (95% CI, 0.55-0.81), a specificity of 0.92 (95% CI, 0.86-0.95), a positive likelihood ratio of 8.49 (95% CI, 5.56-12.96) and a negative likelihood ratio of 0.34 (95% CI, 0.22-0.48). For the 17-item PTSD Checklist, scores around 40 as indicating a positive screen, have a sensitivity of 0.70 (95% CI, 0.64-0.77), a specificity of 0.90 (95% CI, 0.84-0.93), a positive likelihood ratio of 6.8 (95% CI, 4.7-9.9) and a negative likelihood ratio of 0.33 (95% CI, 0.27-0.40). CONCLUSIONS AND RELEVANCE Two screening instruments, the PC-PTSD and the PTSD Checklist, show reasonable performance characteristics for use in primary care clinics or in community settings with high-risk populations. Both are easy to administer and interpret and can readily be incorporated into a busy practice setting.	[Spoont, Michele R.] US Dept Vet Affairs, Natl Ctr Posttraumat Stress Disorder, Minneapolis Vet Affairs Healthcare Syst, Minneapolis, MN USA; [Spoont, Michele R.; Kehle-Forbes, Shannon] Minneapolis Vet Affairs Healthcare Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; [Spoont, Michele R.; Kehle-Forbes, Shannon] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Williams, John W., Jr.] Durham Vet Affairs Med Ctr, US Dept Vet Affairs Evidence Based Synth Ctr, Durham, NC USA; [Williams, John W., Jr.] Duke Univ, Sch Med, Div Gen Internal Med, Durham, NC USA; [Nieuwsma, Jason A.] Durham Vet Affairs Med Ctr, Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Nieuwsma, Jason A.; Mann-Wrobel, Monica C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Mann-Wrobel, Monica C.] Durham Vet Affairs Med Ctr, Dept Mental Hlth, Durham, NC USA; [Gross, Raz] Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Gross, Raz] Chaim Sheba Med Ctr, Gertner Inst Hlth Policy & Epidemiol, IL-52621 Tel Hashomer, Israel	US Department of Veterans Affairs; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Spoont, MR (corresponding author), Minneapolis Vet Affairs Healthcare Syst, Ctr Chron Dis Outcomes Res, 152,Bldg 9,1 Vet Dr, Minneapolis, MN 55417 USA.	michele.spoont@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative (VA-ESP) [09-009, 09-010]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative (VA-ESP)(US Department of Veterans Affairs)	This report is based on research conducted by the Evidence-based Synthesis Program (ESP) Center located at the Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, and expanded on by the ESP Center located at the Durham Veterans Affairs Medical Center, Durham, North Carolina. Both centers are funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative (VA-ESP Project #09-009 and VA-ESP Project #09-010, respectively). The initial evidence report is available at http://www.hsrd.research.va.gov/publications/esp/ptsd-screening.cfm.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; Arbisi PA, 2012, PSYCHOL ASSESSMENT, V24, P1034, DOI 10.1037/a0028014; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Boscarino JA, 1997, PSYCHOSOM MED, V59, P605, DOI 10.1097/00006842-199711000-00008; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Boscarino JA, 2006, COMPR PSYCHIAT, V47, P503, DOI 10.1016/j.comppsych.2006.02.006; Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 2008, ARCH GEN PSYCHIAT, V65, P431, DOI 10.1001/archpsyc.65.4.431; Brewin CR, 2010, J TRAUMA STRESS, V23, P393, DOI 10.1002/jts.20529; Byers AL, 2014, JAMA PSYCHIAT, V71, P540, DOI 10.1001/jamapsychiatry.2014.5; Calhoun PS, 2012, DEPRESS ANXIETY, V29, P1032, DOI 10.1002/da.22012; Calhoun PS, 2010, PSYCHIAT RES, V178, P330, DOI 10.1016/j.psychres.2009.11.009; Chiu S, 2011, ANN CLIN PSYCHIATRY, V23, P95; Davydow DS, 2013, GEN HOSP PSYCHIAT, V35, P226, DOI 10.1016/j.genhosppsych.2012.12.005; Deykin EY, 2001, PSYCHOSOM MED, V63, P835, DOI 10.1097/00006842-200109000-00018; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Durai UNB, 2011, J AM GERIATR SOC, V59, P1087, DOI 10.1111/j.1532-5415.2011.03407.x; Edmondson D, 2013, BRIT J HEALTH PSYCH, V18, P799, DOI 10.1111/bjhp.12022; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Freedy JR, 2010, FAM PRACT, V27, P615, DOI 10.1093/fampra/cmq049; Gaynes BN, 2010, ANN FAM MED, V8, P160, DOI 10.1370/afm.1092; Gerritsen AAM, 2006, SOC PSYCH PSYCH EPID, V41, P18, DOI 10.1007/s00127-005-0003-5; Gill JM, 2013, J PSYCHOSOM RES, V74, P301, DOI 10.1016/j.jpsychores.2012.10.013; Gore KL, 2013, PSYCHOL ASSESSMENT, V25, P1032, DOI 10.1037/a0033325; Harris LW., 2014, DIAGNOSTIC STAT MANU, DOI [DOI 10.1176/APPI.BOOKS.9780890425596.DSM05, 10.1176/appi, DOI 10.1176/APPI]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houston JP, 2011, POSTGRAD MED, V123, P89, DOI 10.3810/pgm.2011.09.2463; Insana SP, 2013, J TRAUMA STRESS, V26, P192, DOI 10.1002/jts.21793; Institute of Medicine (IOM), 2012, TREATM POSTTR STRESS; Jonas DE, PSYCHOL PHARM TREATM; Kartha A, 2008, MED CARE, V46, P388, DOI 10.1097/MLR.0b013e31815dc5d2; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P768; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2014, WORLD PSYCHIATRY, V13, P265, DOI 10.1002/wps.20150; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Kimerling R, 2006, J GEN INTERN MED, V21, P65, DOI 10.1111/j.1525-1497.2005.00292.x; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Liebschutz J, 2007, J GEN INTERN MED, V22, P719, DOI 10.1007/s11606-007-0161-0; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Means-Christensen AJ, 2006, GEN HOSP PSYCHIAT, V28, P108, DOI 10.1016/j.genhosppsych.2005.08.010; Miller MW, 2013, PSYCHOL TRAUMA-US, V5, P501, DOI 10.1037/a0029730; Perkonigg A, 2005, AM J PSYCHIAT, V162, P1320, DOI 10.1176/appi.ajp.162.7.1320; Perrin M, 2014, SOC PSYCH PSYCH EPID, V49, P447, DOI 10.1007/s00127-013-0762-3; Pietrzak RH, 2012, J AM GERIATR SOC, V60, P296, DOI 10.1111/j.1532-5415.2011.03788.x; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Roberts AL, 2011, PSYCHOL MED, V41, P71, DOI 10.1017/S0033291710000401; Royal College of Psychiatrists and British Psychological Society, POSTTR STRESS DIS PT; Santiago PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059236; Savoca Elizabeth, 2000, J Ment Health Policy Econ, V3, P199, DOI 10.1002/mhp.102; Schnurr PP., PTSD CHECKLIST DSM 5; Simel DL, 2008, RATIONAL CLIN EXAMIN, P9; Skogstad M, 2013, OCCUP MED-OXFORD, V63, P175, DOI 10.1093/occmed/kqt003; Skopp NA, 2012, J CLIN PSYCHOL, V68, P1253, DOI 10.1002/jclp.21887; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Stein MB, 2000, GEN HOSP PSYCHIAT, V22, P261, DOI 10.1016/S0163-8343(00)00080-3; Tarrier N, 2004, SOC PSYCH PSYCH EPID, V39, P927, DOI 10.1007/s00127-004-0828-3; The Management of Post-Traumatic Stress Working Group, VA DOD CLIN PRACT GU; US, USPSTF A B REC; US Dept of Veterans Affairs, SCREEN POSTTR STRESS; US Dept of Veterans Affairs, FIND ASS MEAS; US Dept of Veterans Affairs, PTSD SCREEN INSTR; VA National Center for PTSD, PRIM CAR PTSD SCREEN; VA National Center for PTSD, US PTSD CHECKL DSM 4; Wake S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3232; Walker EA, 2002, GEN HOSP PSYCHIAT, V24, P375, DOI 10.1016/S0163-8343(02)00203-7; Wang PS, 2006, AM J PSYCHIAT, V163, P1187, DOI 10.1176/appi.ajp.163.7.1187; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wright KM, 2007, J TRAUMA STRESS, V20, P965, DOI 10.1002/jts.20279; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004; Zen AL, 2012, HEALTH PSYCHOL, V31, P194, DOI 10.1037/a0025989	84	64	65	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2015	314	5					501	510		10.1001/jama.2015.7877	http://dx.doi.org/10.1001/jama.2015.7877			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO1OI	26241601				2022-12-28	WOS:000358924500014
J	Goesmann, F; Rosenbauer, H; Bredehoft, JH; Cabane, M; Ehrenfreund, P; Gautier, T; Giri, C; Kruger, H; Le Roy, L; MacDermott, AJ; McKenna-Lawlor, S; Meierhenrich, UJ; Caro, GMM; Raulin, F; Roll, R; Steele, A; Steininger, H; Sternberg, R; Szopa, C; Thiemann, W; Ulamec, S				Goesmann, Fred; Rosenbauer, Helmut; Bredehoeft, Jan Hendrik; Cabane, Michel; Ehrenfreund, Pascale; Gautier, Thomas; Giri, Chaitanya; Krueger, Harald; Le Roy, Lena; MacDermott, Alexandra J.; McKenna-Lawlor, Susan; Meierhenrich, Uwe J.; Munoz Caro, Guillermo M.; Raulin, Francois; Roll, Reinhard; Steele, Andrew; Steininger, Harald; Sternberg, Robert; Szopa, Cyril; Thiemann, Wolfram; Ulamec, Stephan			Organic compounds on comet 67P/Churyumov-Gerasimenko revealed by COSAC mass spectrometry	SCIENCE			English	Article							PREBIOTIC CHEMISTRY; ORIGIN; ION	Comets harbor the most pristine material in our solar system in the form of ice, dust, silicates, and refractory organic material with some interstellar heritage. The evolved gas analyzer Cometary Sampling and Composition (COSAC) experiment aboard Rosetta's Philae lander was designed for in situ analysis of organic molecules on comet 67P/Churyumov-Gerasimenko. Twenty-five minutes after Philae's initial comet touchdown, the COSAC mass spectrometer took a spectrum in sniffing mode, which displayed a suite of 16 organic compounds, including many nitrogen-bearing species but no sulfur-bearing species, and four compounds-methyl isocyanate, acetone, propionaldehyde, and acetamide-that had not previously been reported in comets.	[Goesmann, Fred; Rosenbauer, Helmut; Giri, Chaitanya; Krueger, Harald; Munoz Caro, Guillermo M.; Roll, Reinhard; Steininger, Harald] Max Planck Inst Solar Syst Res, Justus von Liebig Weg 3, D-37077 Gottingen, Germany; [Bredehoeft, Jan Hendrik; Thiemann, Wolfram] Univ Bremen, Inst Appl & Phys Chem, D-28359 Bremen, Germany; [Cabane, Michel; Szopa, Cyril] Sorbonne Univ, Univ Paris Saclay,Univ Paris 06, Univ Versailles St Quentin,IPSL, CNRS,Inst Natl Sci Univers,Lab Atmospheres Milieu, F-75005 Paris, France; [Ehrenfreund, Pascale] Leiden Observ, NL-2300 RA Leiden, Netherlands; [Ehrenfreund, Pascale] George Washington Univ, Inst Space Policy, Washington, DC 20052 USA; [Gautier, Thomas] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Giri, Chaitanya; Meierhenrich, Uwe J.] Univ Nice Sophia Antipolis, Inst Chim Nice, CNRS, UMR 7272, F-06108 Nice, France; [Le Roy, Lena] Univ Bern, Ctr Space & Habitabil, CH-3012 Bern, Switzerland; [MacDermott, Alexandra J.] Univ Houston Clear Lake City, Houston, TX 77058 USA; [McKenna-Lawlor, Susan] Space Technol Ireland Ltd, Maynooth, Kildare, Ireland; [Munoz Caro, Guillermo M.] CSIC, Inst Nacl Tecn Aeroespacial, Ctr Astrobiol, Madrid 28850, Spain; [Raulin, Francois; Sternberg, Robert] Univ Paris Est Creteil, UMR CNRS 7583, LISA, F-94000 Creteil, France; [Raulin, Francois; Sternberg, Robert] Univ Paris Diderot, F-94000 Creteil, France; [Steele, Andrew] Carnegie Inst Sci, Geophys Lab, Washington, DC USA; [Ulamec, Stephan] Deutsch Zentrum Luft & Raumfahrt DLR, German Aerosp Ctr, D-51147 Cologne, Germany	University of Bremen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Leiden University; Leiden University - Excl LUMC; George Washington University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Cote d'Azur; University of Bern; University of Houston System; University of Houston; University of Houston Clear Lake; Maynooth University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; Carnegie Institution for Science; Helmholtz Association; German Aerospace Centre (DLR)	Goesmann, F (corresponding author), Max Planck Inst Solar Syst Res, Justus von Liebig Weg 3, D-37077 Gottingen, Germany.	goesmann@mps.mpg.de	MacDermott, Alexandra/AAC-6416-2020; szopa, cyril/C-6865-2015; Meierhenrich, Uwe J/A-1643-2008; Muñoz, Guillermo M/L-6370-2014; Steele, Andrew/A-3573-2013; Gautier, Thomas/D-4856-2012; Bredehöft, Jan Hendrik/E-4221-2012	szopa, cyril/0000-0002-0090-4056; Meierhenrich, Uwe J/0000-0001-6422-3930; Muñoz, Guillermo M/0000-0001-7003-7368; Steele, Andrew/0000-0001-9643-2841; Gautier, Thomas/0000-0002-9794-5056; Bredehöft, Jan Hendrik/0000-0002-7977-6762; Le Roy, Lena/0000-0002-5984-6153	Deutsches Zentrum fur Luft- und Raumfahrt (DLR) [50 QP 1302]; Centre National d'Etudes Spatiales (CNES) grant at LATMOS; Centre National d'Etudes Spatiales (CNES) grant LISA; L'Agence Nationale de la Recherche [ANR-12-IS07-0006]; NASA Astrobiology Institute; NASA Postdoctoral Program at Goddard Space Flight Center; Programme de Developpement d'Experiences scientifiques through Enterprise Ireland; Welch Foundation	Deutsches Zentrum fur Luft- und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Centre National d'Etudes Spatiales (CNES) grant at LATMOS; Centre National d'Etudes Spatiales (CNES) grant LISA; L'Agence Nationale de la Recherche(French National Research Agency (ANR)); NASA Astrobiology Institute; NASA Postdoctoral Program at Goddard Space Flight Center; Programme de Developpement d'Experiences scientifiques through Enterprise Ireland; Welch Foundation(The Welch Foundation)	This work was supported by Deutsches Zentrum fur Luft- und Raumfahrt (DLR) under contract no. 50 QP 1302, and by Centre National d'Etudes Spatiales (CNES) grants at LATMOS and LISA. U.J.M. was funded by L'Agence Nationale de la Recherche (ANR-12-IS07-0006). Support from the NASA Astrobiology Institute (P.E.), the NASA Postdoctoral Program at Goddard Space Flight Center (T.G.), Programme de Developpement d'Experiences scientifiques through Enterprise Ireland (S. McK.L.), and the Welch Foundation (A.J.MacD.) is acknowledged. Rosetta is a European Space Agency (ESA) mission with contributions from member states and NASA. The Philae lander was provided by a consortium led by DLR, Max-Planck-Institut fur Sonnensystemforschung, CNES, and Agenzia Spatiale Italiana. The data used in this study are available through ESA's Planetary Science Archive (www.rssd.esa.int/index.php? project=PSA&page=rosetta).	Biele J, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9816; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Crovisier J, 2009, EARTH MOON PLANETS, V105, P267, DOI 10.1007/s11038-009-9293-z; DiSanti MA, 2008, SPACE SCI REV, V138, P127, DOI 10.1007/s11214-008-9361-0; Goesmann F, 2007, SPACE SCI REV, V128, P257, DOI 10.1007/s11214-006-9000-6; Goesmann F, 2012, PLANET SPACE SCI, V66, P187, DOI 10.1016/j.pss.2012.01.012; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Hassig M, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0276; Irvine WM, 1998, ORIGINS LIFE EVOL B, V28, P365, DOI 10.1023/A:1006574110907; Kim YS, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/68; Mandt KE, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004139; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Caro GMM, 2013, CHEM SOC REV, V42, P2173, DOI 10.1039/c2cs35425j; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; ORO J, 1992, ORIGINS LIFE EVOL B, V21, P267; Pascal R, 2005, TOP CURR CHEM, V259, P69, DOI 10.1007/b136707; Ritson D, 2012, NAT CHEM, V4, P895, DOI [10.1038/NCHEM.1467, 10.1038/nchem.1467]; Saladino R, 2007, CHEM BIODIVERS, V4, P694, DOI 10.1002/cbdv.200790059; Stein S.E.., 2005, 69 NIST, P20899; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Wright IP, 2015, SCIENCE, V349, DOI 10.1126/science.aab0673; WYCKOFF S, 1991, ASTROPHYS J, V367, P641, DOI 10.1086/169659	23	312	315	5	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aab0689	10.1126/science.aab0689	http://dx.doi.org/10.1126/science.aab0689			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26228156				2022-12-28	WOS:000358713300008
J	Lee, JM; Wheeler, VC; Chao, MJ; Vonsattel, JPG; Pinto, RM; Lucente, D; Abu-Elneel, K; Ramos, EM; Mysore, JS; Gillis, T; MacDonald, ME; Gusella, JF; Harold, D; Stone, TC; Escott-Price, V; Han, J; Vedernikov, A; Holmans, P; Jones, L; Kwak, S; Mahmoudi, M; Orth, M; Landwehrmeyer, GB; Paulsen, JS; Dorsey, ER; Shoulson, I; Myers, RH				Lee, Jong-Min; Wheeler, Vanessa C.; Chao, Michael J.; Vonsattel, Jean Paul G.; Pinto, Ricardo Mouro; Lucente, Diane; Abu-Elneel, Kawther; Ramos, Eliana Marisa; Mysore, Jayalakshmi Srinidhi; Gillis, Tammy; MacDonald, Marcy E.; Gusella, James F.; Harold, Denise; Stone, Timothy C.; Escott-Price, Valentina; Han, Jun; Vedernikov, Alexey; Holmans, Peter; Jones, Lesley; Kwak, Seung; Mahmoudi, Mithra; Orth, Michael; Landwehrmeyer, G. Bernhard; Paulsen, Jane S.; Dorsey, E. Ray; Shoulson, Ira; Myers, Richard H.		Genetic Modifiers Huntingtons Dis	Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease	CELL			English	Article							AGE-OF-ONSET; DNA-REPAIR; GENOMEWIDE ASSOCIATION; HD MAPS; FAN1; SCAN; KIAA1018/FAN1; REPLICATION; INSTABILITY; KINDREDS	As a Mendelian neurodegenerative disorder, the genetic risk of Huntington's disease (HD) is conferred entirely by an HTT CAG repeat expansion whose length is the primary determinant of the rate of pathogenesis leading to disease onset. To investigate the pathogenic process that precedes disease, we used genome-wide association (GWA) analysis to identify loci harboring genetic variations that alter the age at neurological onset of HD. A chromosome 15 locus displays two independent effects that accelerate or delay onset by 6.1 years and 1.4 years, respectively, whereas a chromosome 8 locus hastens onset by 1.6 years. Association at MLH1 and pathway analysis of the full GWA results support a role for DNA handling and repair mechanisms in altering the course of HD. Our findings demonstrate that HD disease modification in humans occurs in nature and offer a genetic route to identifying in-human validated therapeutic targets in this and other Mendelian disorders.					Pinto, Ricardo Mouro/AAD-1048-2021; Paulsen, Jane/AAQ-2932-2020; Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Chao, Michael J./I-3697-2017; Mahmoudi, Morteza/F-3432-2011; Holmans, Peter/F-4518-2015	Pinto, Ricardo Mouro/0000-0001-6744-2805; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Chao, Michael J./0000-0001-6834-4342; Mahmoudi, Morteza/0000-0002-2575-9684; Paulsen, Jane/0000-0002-0983-228X; Holmans, Peter/0000-0003-0870-9412; Escott-Price, Valentina/0000-0003-1784-5483; Harold, Denise/0000-0001-5195-0143	CHDI Foundation; National Institutes of Health (USA) [X01HG006074, U01NS082079, R01NS091161, R01HG002449, P50NS016367]; Medical Research Council (UK) [G0801418, MR/L010305/1]; Auspex Pharmaceuticals; Prana Biotechnology Ltd; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040068, U01NS082079, R01NS073947, R01NS091161, P50NS016367] Funding Source: NIH RePORTER; Medical Research Council [MR/L010305/1, G0801418, MR/L023784/2] Funding Source: researchfish; MRC [MR/L023784/2, G0801418] Funding Source: UKRI	CHDI Foundation; National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Auspex Pharmaceuticals; Prana Biotechnology Ltd; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the CHDI Foundation, by grants X01HG006074, U01NS082079, R01NS091161, R01HG002449, and P50NS016367 from the National Institutes of Health (USA), and by grants G0801418 and MR/L010305/1 from the Medical Research Council (UK). Although not directly related to this work, E.R.D. has received grant support from Auspex Pharmaceuticals and Prana Biotechnology Ltd, and as of May 12, 2014, after completion of his term leading the Huntington Study Group, I.S. became a compensated non-executive director for Prana Biotechnology Ltd.	Antonacci F, 2014, NAT GENET, V46, P1293, DOI 10.1038/ng.3120; Aronin N, 2014, MOVEMENT DISORD, V29, P1455, DOI 10.1002/mds.26020; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brown M.B., 1975, BIOMETRICS, V31, P978; Chaudhury I, 2014, MOL CELL BIOL, V34, P3939, DOI 10.1128/MCB.00457-14; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Dorsey ER, 2008, ARCH NEUROL-CHICAGO, V65, P1582, DOI 10.1001/archneur.65.12.1582; Dorsey ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029522; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Gayan J, 2008, GENET EPIDEMIOL, V32, P445, DOI 10.1002/gepi.20317; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Gusella JF, 2014, MOVEMENT DISORD, V29, P1359, DOI 10.1002/mds.26001; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Ionita-Laza I, 2014, P NATL ACAD SCI USA, V111, P343, DOI 10.1073/pnas.1309475110; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kuo ML, 2012, SCI REP-UK, V2, DOI 10.1038/srep00822; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2012, AM J HUM GENET, V90, P434, DOI 10.1016/j.ajhg.2012.01.005; Li JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-71; Li JL, 2003, AM J HUM GENET, V73, P682, DOI 10.1086/378133; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Moskvina V, 2011, GENET EPIDEMIOL, V35, P861, DOI 10.1002/gepi.20636; Ortega Z, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00077, 10.3389/fnmo1.2014.00077]; Orth Michael, 2010, PLoS Curr, V2, DOI 10.1371/currents.RRN1184; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Pinto RM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003930; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Pontarin G, 2011, J BIOL CHEM, V286, P11132, DOI 10.1074/jbc.M110.202283; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Sehgal R, 2014, GENES-BASEL, V5, P497, DOI 10.3390/genes5030497; Shoulson I, 2006, ARCH NEUROL-CHICAGO, V63, P991; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101	37	359	361	3	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					516	526		10.1016/j.cell.2015.07.003	http://dx.doi.org/10.1016/j.cell.2015.07.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232222	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000358801800012
J	Pourkheirandish, M; Hensel, G; Kilian, B; Senthil, N; Chen, G; Sameri, M; Azhaguvel, P; Sakuma, S; Dhanagond, S; Sharma, R; Mascher, M; Himmelbach, A; Gottwald, S; Nair, SK; Tagiri, A; Yukuhiro, F; Nagamura, Y; Kanamori, H; Matsumoto, T; Willcox, G; Middleton, CP; Wicker, T; Walther, A; Waugh, R; Fincher, GB; Stein, N; Kumlehn, J; Sato, K; Komatsuda, T				Pourkheirandish, Mohammad; Hensel, Goetz; Kilian, Benjamin; Senthil, Natesan; Chen, Guoxiong; Sameri, Mohammad; Azhaguvel, Perumal; Sakuma, Shun; Dhanagond, Sidram; Sharma, Rajiv; Mascher, Martin; Himmelbach, Axel; Gottwald, Sven; Nair, Sudha K.; Tagiri, Akemi; Yukuhiro, Fumiko; Nagamura, Yoshiaki; Kanamori, Hiroyuki; Matsumoto, Takashi; Willcox, George; Middleton, Christopher P.; Wicker, Thomas; Walther, Alexander; Waugh, Robbie; Fincher, Geoffrey B.; Stein, Nils; Kumlehn, Jochen; Sato, Kazuhiro; Komatsuda, Takao			Evolution of the Grain Dispersal System in Barley	CELL			English	Article							HORDEUM-VULGARE L.; LEAF ABSCISSION; RACHIS-1 BTR1; OHALO-II; BRITTLE; GENE; DOMESTICATION; CULTIVATION; GENOME; PREDICTION	About 12,000 years ago in the Near East, humans began the transition from hunter-gathering to agriculture-based societies. Barley was a founder crop in this process, and the most important steps in its domestication were mutations in two adjacent, dominant, and complementary genes, through which grains were retained on the inflorescence at maturity, enabling effective harvesting. Independent recessive mutations in each of these genes caused cell wall thickening in a highly specific grain "disarticulation zone," converting the brittle floral axis (the rachis) of the wild-type into a tough, non-brittle form that promoted grain retention. By tracing the evolutionary history of allelic variation in both genes, we conclude that spatially and temporally independent selections of germplasm with a non-brittle rachis were made during the domestication of barley by farmers in the southern and northern regions of the Levant, actions that made a major contribution to the emergence of early agrarian societies.	[Pourkheirandish, Mohammad; Senthil, Natesan; Chen, Guoxiong; Sameri, Mohammad; Azhaguvel, Perumal; Sakuma, Shun; Nair, Sudha K.; Tagiri, Akemi; Yukuhiro, Fumiko; Nagamura, Yoshiaki; Kanamori, Hiroyuki; Matsumoto, Takashi; Komatsuda, Takao] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Hensel, Goetz; Kilian, Benjamin; Dhanagond, Sidram; Sharma, Rajiv; Mascher, Martin; Himmelbach, Axel; Gottwald, Sven; Stein, Nils; Kumlehn, Jochen] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Stadt Seeland, Germany; [Willcox, George] Univ Lyon 2, Archeorient CNRS, UMR 5133, F-07460 Berrias, France; [Middleton, Christopher P.; Wicker, Thomas] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Walther, Alexander] Univ Gothenburg, Dept Earth Sci, S-40530 Gothenburg, Sweden; [Waugh, Robbie] Univ Dundee, James Hutton Inst, Dundee DD2 5DA, Scotland; [Fincher, Geoffrey B.] Univ Adelaide, Sch Agr Food & Wine, ARC Ctr Excellence Plant Cell Walls, Osmond, SA 5066, Australia; [Sato, Kazuhiro] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	National Institute of Agrobiological Sciences - Japan; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); University of Zurich; University of Gothenburg; James Hutton Institute; University of Dundee; University of Adelaide; Okayama University	Komatsuda, T (corresponding author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan.	takao@affrc.go.jp	Kumlehn, Jochen/AAF-8241-2020; Sharma, Rajiv/W-9683-2019; Sakuma, Shun/AAH-6260-2020; Stein, Nils/F-7507-2017; Sakuma, Shun/C-5719-2019; Wicker, Thomas/Z-1978-2019; NATESAN, SENTHIL/AAH-2917-2019; Hensel, Goetz/ABA-8238-2020; Hensel, G./F-9957-2010; SATO, Kazuhiro/B-2504-2011; Pourkheirandish, Mohammad/AAS-7002-2021	Kumlehn, Jochen/0000-0001-7080-7983; Sharma, Rajiv/0000-0003-3488-8688; Sakuma, Shun/0000-0003-1622-5346; Stein, Nils/0000-0003-3011-8731; Sakuma, Shun/0000-0003-1622-5346; NATESAN, SENTHIL/0000-0002-2930-0715; Hensel, Goetz/0000-0002-5539-3097; Hensel, G./0000-0002-5539-3097; SATO, Kazuhiro/0000-0001-8818-5203; Pourkheirandish, Mohammad/0000-0003-4337-3600; Mascher, Martin/0000-0001-6373-6013; Kilian, Benjamin/0000-0002-9145-6980; Nair, Sudha/0000-0002-0220-0175; Tagiri, Akemi/0000-0002-6445-2335; , Thomas/0000-0002-6777-7135; Himmelbach, Axel/0000-0001-7338-0946	Japan Science and Technology Agency (CREST); Japanese Society for Promotion of Science; German Science Foundation Priority Programme [SPP1530]; Australian Research Council; NIAS Tsukuba; IPK Gatersleben; University of Dundee; James Hutton Institute; Biotechnology and Biological Sciences Research Council [BB/L026317/1] Funding Source: researchfish; BBSRC [BB/L026317/1] Funding Source: UKRI	Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); German Science Foundation Priority Programme; Australian Research Council(Australian Research Council); NIAS Tsukuba; IPK Gatersleben; University of Dundee; James Hutton Institute; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Ashikari, T. Izawa, M. Yano, J.F. Ma, and Y. Mano for reading the manuscript, T.R. Endo, A. Graner, R.v. Bothmer, F.R. Blattner, N. Sentoku, N. Wang, and A. Fukuda for helpful discussions, K. Mayer and M. Pfeifer for investigating synteny in model grass genomes. We wish to thank R. Burton, M. Henderson, Hweit-Ting Tan, and N. Hara for their skilled technical assistance with the microscopy, H. Koyama and J. Keilwagen for their assistance in sequence alignment, W. Weissgerber and all technicians, field staff, and students for their excellent technical assistance. We thank J. Russell and I.K. Dawson for manually curating geographic coordinates of barley accessions and D. Stengel for sequence data submission. We are grateful to K. Takeda, J. Valkoun, H. Ozkan, E. Fridman, S. Hubner, S. Jakob, S. Shaaf, B. Steffenson, H. Hirabayashi, the German Federal ex situ Genebank at Gatersleben, the National BioResource Project of Japan, the USDA National Plant Germplasm System and Agricultural Research Service, the International Center for Agricultural Research in Dry Areas (ICARDA), and the Max Planck Institute for Plant Breeding Research Cologne, for providing grain/DNA/information related to the barley accessions. The authors acknowledge financial support given by the Japan Science and Technology Agency (CREST) to K.S. and T.K., by the Japanese Society for Promotion of Science to M.P., C.G., S.K.N., P.A., N. Senthil, and T.K., by the German Science Foundation Priority Programme SPP1530 to B.K., by the Australian Research Council for its long term support of our cell wall research programs to G.B.F., and by NIAS Tsukuba and IPK Gatersleben. R.W. acknowledges support from The University of Dundee and the James Hutton Institute.	Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Azhaguvel P, 2007, ANN BOT-LONDON, V100, P1009, DOI 10.1093/aob/mcm129; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Beck B.B, 2010, INTRO PLANT STRUCTUR; Bowling AJ, 2011, AM J BOT, V98, P619, DOI 10.3732/ajb.1000268; Burton RA, 2010, PLANT PHYSIOL, V153, P1716, DOI 10.1104/pp.110.158329; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Dai F, 2014, P NATL ACAD SCI USA, V111, P13403, DOI 10.1073/pnas.1414335111; Forster BP, 2007, ANN BOT-LONDON, V100, P725, DOI 10.1093/aob/mcm183; Hillman G., 1989, PLANT FOOD EC EPIPAL; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hurst LD, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-62; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Johnson I. J., 1943, JOUR AMER SOC AGRON, V35, P101; Judd WS, 1999, PLANT SYSTEMATICS PH; Kachroo A, 2002, PLANT CELL, V14, pS227, DOI 10.1105/tpc.010440; Kimura S, 1999, PLANT CELL PHYSIOL, V40, P335, DOI 10.1093/oxfordjournals.pcp.a029546; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; Komatsuda T, 2004, THEOR APPL GENET, V109, P986, DOI 10.1007/s00122-004-1710-0; Komatsuda T, 2002, THEOR APPL GENET, V105, P85, DOI 10.1007/s00122-001-0858-0; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Makino T, 2008, MOL BIOL EVOL, V25, P1855, DOI 10.1093/molbev/msn137; Middleton CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085761; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Schiemann E., 1921, F R INDUKT ABSTAMM V, V26, P109; Schmutzer T, 2014, CYTOGENET GENOME RES, V142, P66, DOI 10.1159/000356460; Senthil N, 2005, EUPHYTICA, V145, P215, DOI 10.1007/s10681-005-1166-6; TAKAHASHI R., 1964, Berichte des Ohara Instituts fur Landwirtschaftliche Biologie, Okayama Universitat, V12, P99; Takahashi R., 1955, ORIGIN EVOLUTION CUL, V7; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Tanno K, 2012, VEG HIST ARCHAEOBOT, V21, P107, DOI 10.1007/s00334-011-0316-0; Ubisch GV., 1915, F R INDUKT ABSTAMM V, V14, P226, DOI DOI 10.1007/BF01813441; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang HF, 2010, PROTOPLASMA, V247, P111, DOI 10.1007/s00709-010-0159-z; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; Weiss E, 2008, J ARCHAEOL SCI, V35, P2400, DOI 10.1016/j.jas.2008.03.012; Wendler N, 2014, PLANT BIOTECHNOL J, V12, P1122, DOI 10.1111/pbi.12219; Willcox G, 2008, VEG HIST ARCHAEOBOT, V17, P313, DOI 10.1007/s00334-007-0121-y; Willcox G, 2013, SCIENCE, V341, P39, DOI 10.1126/science.1240496; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	42	169	178	10	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					527	539		10.1016/j.cell.2015.07.002	http://dx.doi.org/10.1016/j.cell.2015.07.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26232223	Bronze			2022-12-28	WOS:000358801800013
J	Hoag, H				Hoag, Hannah			RESEARCH CONTINUITY Be prepared	NATURE			English	Editorial Material							POLLEN											Chretien ML, 2010, J CELL PHYSIOL, V224, P352, DOI 10.1002/jcp.22125; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Pisaric MFJ, 2001, QUATERNARY SCI REV, V20, P235, DOI 10.1016/S0277-3791(00)00120-7; Pisaric MFJ, 2001, ARCT ANTARCT ALP RES, V33, P19, DOI 10.2307/1552273	4	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					117	119		10.1038/nj7554-117a	http://dx.doi.org/10.1038/nj7554-117a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ5QP	26046134	Bronze			2022-12-28	WOS:000355543400042
J	Jaffe, S				Jaffe, Susan			50 years of Medicare	LANCET			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					419	420		10.1016/S0140-6736(15)61418-0	http://dx.doi.org/10.1016/S0140-6736(15)61418-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN9IY	26233600				2022-12-28	WOS:000358761700011
